PT	AU	BA	BE	GP	AF	BF	CA	TI	SO	SE	BS	LA	DT	CT	CY	CL	SP	HO	DE	ID	AB	C1	C3	RP	EM	RI	OI	FU	FP	FX	CR	NR	TC	Z9	U1	U2	PU	PI	PA	SN	EI	BN	J9	JI	PD	PY	VL	IS	PN	SU	SI	MA	BP	EP	AR	DI	DL	D2	EA	PG	WC	WE	SC	GA	PM	OA	HC	HP	DA	UT
J	Solomon, B; Kingsford, C				Solomon, Brad; Kingsford, Carl			Fast search of thousands of short-read sequencing experiments	NATURE BIOTECHNOLOGY			English	Article							CASCADING BLOOM FILTERS; RNA-SEQ READS; TEXT; COMPRESSION; EFFICIENT; INDEXES; GRAPHS	The amount of sequence information in public repositories is growing at a rapid rate. Although these data are likely to contain clinically important information that has not yet been uncovered, our ability to effectively mine these repositories is limited. Here we introduce Sequence Bloom Trees (SBTs), a method for querying thousands of short-read sequencing experiments by sequence, 162 times faster than existing approaches. The approach searches large data archives for all experiments that involve a given sequence. We use SBTs to search 2,652 human blood, breast and brain RNA-seq experiments for all 214,293 known transcripts in under 4 days using less than 239 MB of RAM and a single CPU. Searching sequence archives at this scale and in this time frame is currently not possible using existing tools.	[Solomon, Brad] Carnegie Mellon Univ, Sch Comp Sci, Joint Carnegie Mellon Univ Univ Pittsburgh, PhD Program Computat Biol,Computat Biol Dept, Pittsburgh, PA 15213 USA; [Kingsford, Carl] Carnegie Mellon Univ, Sch Comp Sci, Computat Biol Dept, Pittsburgh, PA 15213 USA	Carnegie Mellon University; Carnegie Mellon University	Kingsford, C (corresponding author), Carnegie Mellon Univ, Sch Comp Sci, Computat Biol Dept, Pittsburgh, PA 15213 USA.	carlk@cs.cmu.edu			Gordon and Betty Moore Foundation's Data-Driven Discovery Initiative [GBMF4554]; US National Science Foundation [CCF-1256087, CCF-1319998]; US National Institutes of Health [R21HG006913, R01HG007104]; US National Institutes of Health as part of the Howard Hughes Medical Institute (HHMI)-National Institute of Biomedical Imaging and Bioengineering (NIBIB) Interfaces Initiative [T32 EB009403]; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R21HG006913, R01HG007104] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [T32EB009403] Funding Source: NIH RePORTER; Direct For Computer & Info Scie & Enginr [1445606] Funding Source: National Science Foundation; Division of Computing and Communication Foundations [1256087] Funding Source: National Science Foundation	Gordon and Betty Moore Foundation's Data-Driven Discovery Initiative; US National Science Foundation(National Science Foundation (NSF)); US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); US National Institutes of Health as part of the Howard Hughes Medical Institute (HHMI)-National Institute of Biomedical Imaging and Bioengineering (NIBIB) Interfaces Initiative; NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); Direct For Computer & Info Scie & Enginr(National Science Foundation (NSF)NSF - Directorate for Computer & Information Science & Engineering (CISE)); Division of Computing and Communication Foundations(National Science Foundation (NSF)NSF - Directorate for Computer & Information Science & Engineering (CISE))	This research is funded in part by the Gordon and Betty Moore Foundation's Data-Driven Discovery Initiative through grant GBMF4554 to C.K., by the US National Science Foundation (CCF-1256087, CCF-1319998) and by the US National Institutes of Health (R21HG006913, R01HG007104). C.K. received support as an Alfred P. Sloan Research Fellow. B.S. is a predoctoral trainee supported by US National Institutes of Health training grant T32 EB009403 as part of the Howard Hughes Medical Institute (HHMI)-National Institute of Biomedical Imaging and Bioengineering (NIBIB) Interfaces Initiative." We would like to thank D. Filippova, J. Fong, H. Wang, E. Sefer, G. Johnson, and especially G. Marcais, G. Duggal and R. Patro for sharing their source code, and for valuable discussions and comments on the manuscript.	Baeza-Yates RA, 1999, MODERN INFORM RETRIE; BLOOM BH, 1970, COMMUN ACM, V13, P422, DOI 10.1145/362686.362692; Broder A., 2004, INTERNET MATH, V1, P485, DOI [DOI 10.1080/15427951.2004.10129096, 10.1080/15427951.2004.10129096]; Brown C.T., ARXIV12034802QBIOGN; Burrows M, 1994, BLOCK SORTING LOSSLE; Camacho C, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-421; Chikhi R, 2013, ALGORITHM MOL BIOL, V8, DOI 10.1186/1748-7188-8-22; Crainiceanu A., 2013, P 2 INT WORKSH CLOUD, DOI [10.1145/2501928.2501931, DOI 10.1145/2501928.2501931]; Crainiceanu A, 2015, INFORM SYST, V54, P311, DOI 10.1016/j.is.2015.01.002; Daniels NM, 2013, BIOINFORMATICS, V29, P283, DOI 10.1093/bioinformatics/btt214; Dobin A, 2013, BIOINFORMATICS, V29, P15, DOI 10.1093/bioinformatics/bts635; Ferragina P, 2005, J ACM, V52, P552, DOI 10.1145/1082036.1082039; Gog S, 2014, LECT NOTES COMPUT SC, V8504, P326, DOI 10.1007/978-3-319-07959-2_28; Grossi R, 2005, SIAM J COMPUT, V35, P378, DOI 10.1137/S0097539702402354; Grossi R., 2011, 2011 First International Conference on Data Compression, Communications and Processing, P210, DOI 10.1109/CCP.2011.16; Leinonen R, 2011, NUCLEIC ACIDS RES, V39, pD19, DOI 10.1093/nar/gkq1019; Loh PR, 2012, NAT BIOTECHNOL, V30, P627, DOI 10.1038/nbt.2241; Marcais G, 2011, BIOINFORMATICS, V27, P764, DOI 10.1093/bioinformatics/btr011; Melsted P, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-333; Navarro G, 2000, INFORM RETRIEVAL, V3, P49, DOI 10.1023/A:1009934302807; Navarro G, 2007, ACM COMPUT SURV, V39, DOI 10.1145/1216370.1216372; Patro R, 2014, NAT BIOTECHNOL, V32, P462, DOI 10.1038/nbt.2862; Pell J, 2012, P NATL ACAD SCI USA, V109, P13272, DOI 10.1073/pnas.1121464109; Philippe N, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-3-r30; Raman R, 2002, SIAM PROC S, P233; Rasmussen KR, 2006, J COMPUT BIOL, V13, P296, DOI 10.1089/cmb.2006.13.296; Rozov R, 2014, BMC BIOINFORMATICS, V15, DOI 10.1186/1471-2105-15-S9-S7; Salikhov K, 2014, ALGORITHM MOL BIOL, V9, DOI 10.1186/1748-7188-9-2; Stranneheim H, 2010, BIOINFORMATICS, V26, P1595, DOI 10.1093/bioinformatics/btq230; Witten Ian H., 1999, MANAGING GIGABYTES; Yu YW, 2015, CELL SYST, V1, P130, DOI 10.1016/j.cels.2015.08.004; Zhang QP, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0101271; Ziviani N, 2000, COMPUTER, V33, P37, DOI 10.1109/2.881693	33	72	72	0	6	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156	1546-1696		NAT BIOTECHNOL	Nat. Biotechnol.	MAR	2016	34	3					300	+		10.1038/nbt.3442	http://dx.doi.org/10.1038/nbt.3442			6	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	DG1CJ	26854477	Green Accepted, Bronze			2022-12-27	WOS:000371802600026
J	Hendel, A; Bak, RO; Clark, JT; Kennedy, AB; Ryan, DE; Roy, S; Steinfeld, I; Lunstad, BD; Kaiser, RJ; Wilkens, AB; Bacchetta, R; Tsalenko, A; Dellinger, D; Bruhn, L; Porteus, MH				Hendel, Ayal; Bak, Rasmus O.; Clark, Joseph T.; Kennedy, Andrew B.; Ryan, Daniel E.; Roy, Subhadeep; Steinfeld, Israel; Lunstad, Benjamin D.; Kaiser, Robert J.; Wilkens, Alec B.; Bacchetta, Rosa; Tsalenko, Anya; Dellinger, Douglas; Bruhn, Laurakay; Porteus, Matthew H.			Chemically modified guide RNAs enhance CRISPR-Cas genome editing in human primary cells	NATURE BIOTECHNOLOGY			English	Article							SOLID-PHASE; T-CELLS; CCR5; OLIGONUCLEOTIDES; PHOSPHONOACETATE; SYSTEMS; GLOBIN; GENES; LOCI; HIV	CRISPR-Cas-mediated genome editing relies on guide RNAs that direct site-specific DNA cleavage facilitated by the Cas endonuclease. Here we report that chemical alterations to synthesized single guide RNAs (sgRNAs) enhance genome editing efficiency in human primary T cells and CD34(+) hematopoietic stem and progenitor cells. Co-delivering chemically modified sgRNAs with Cas9 mRNA or protein is an efficient RNA- or ribonucleoprotein (RNP)-based delivery method for the CRISPR-Cas system, without the toxicity associated with DNA delivery. This approach is a simple and effective way to streamline the development of genome editing with the potential to accelerate a wide array of biotechnological and therapeutic applications of the CRISPR-Cas technology.	[Hendel, Ayal; Bak, Rasmus O.; Clark, Joseph T.; Wilkens, Alec B.; Bacchetta, Rosa; Porteus, Matthew H.] Stanford Univ, Dept Pediat, Stanford, CA 94305 USA; [Kennedy, Andrew B.; Ryan, Daniel E.; Kaiser, Robert J.; Tsalenko, Anya; Bruhn, Laurakay] Agilent Res Labs, Santa Clara, CA USA; [Roy, Subhadeep; Lunstad, Benjamin D.; Dellinger, Douglas] Agilent Res Labs, Boulder, CO USA; [Steinfeld, Israel] Agilent Res Labs, Tel Aviv, Israel	Stanford University; Agilent Technologies; Agilent Technologies	Porteus, MH (corresponding author), Stanford Univ, Dept Pediat, Stanford, CA 94305 USA.	laurakay_bruhn@agilent.com; mporteus@stanford.edu	Hendel, Ayal/GMW-7991-2022; Huang, ZhiXin/H-5123-2017; Bak, Rasmus O./AAH-9748-2021	Huang, ZhiXin/0000-0003-0705-1970; Bak, Rasmus O./0000-0002-7383-0297; Hendel, Ayal/0000-0002-3388-6202; Bacchetta, Rosa/0000-0002-0606-6268; Clark, Joseph/0000-0001-7764-6000	Myotonic Dystrophy Foundation; Danish Council for Independent Research, Medical Sciences [DFF-1331-00735B, DFF-1333-00106B]; Amon Carter Foundation; Laurie Krauss Lacob Faculty Scholar Award in Pediatric Translational Research; US National Institutes of Health [PN2EY018244, R01-AI097320]; NATIONAL EYE INSTITUTE [PN2EY018244] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI120766, R01AI097320] Funding Source: NIH RePORTER	Myotonic Dystrophy Foundation; Danish Council for Independent Research, Medical Sciences(Det Frie Forskningsrad (DFF)); Amon Carter Foundation; Laurie Krauss Lacob Faculty Scholar Award in Pediatric Translational Research; US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	A.H. was supported by the Myotonic Dystrophy Foundation. R.O.B. was supported through an Individual Postdoctoral grant (DFF-1333-00106B) and a Sapere Aude, Research Talent grant (DFF-1331-00735B), both from the Danish Council for Independent Research, Medical Sciences. M.H.P. gratefully acknowledges the support of the Amon Carter Foundation, the Laurie Krauss Lacob Faculty Scholar Award in Pediatric Translational Research and US National Institutes of Health grant support PN2EY018244 and R01-AI097320. We thank R. Perriman, and Porteus laboratory members and C. Carstens, S. Laderman and Agilent laboratories members for helpful input, comments and discussion.	Brinkman EK, 2014, NUCLEIC ACIDS RES, V42, DOI 10.1093/nar/gku936; Chen BH, 2013, CELL, V155, P1479, DOI 10.1016/j.cell.2013.12.001; Cong L, 2013, SCIENCE, V339, P819, DOI 10.1126/science.1231143; Cradick TJ, 2014, MOL THER-NUCL ACIDS, V3, DOI 10.1038/mtna.2014.64; Cradick TJ, 2013, NUCLEIC ACIDS RES, V41, P9584, DOI 10.1093/nar/gkt714; Deleavey GF, 2012, CHEM BIOL, V19, P937, DOI 10.1016/j.chembiol.2012.07.011; Dellinger DJ, 2003, J AM CHEM SOC, V125, P940, DOI 10.1021/ja027983f; Dellinger DJ, 2011, J AM CHEM SOC, V133, P11540, DOI 10.1021/ja201561z; Eckstein F, 2014, NUCLEIC ACID THER, V24, P374, DOI 10.1089/nat.2014.0506; Gilbert LA, 2014, CELL, V159, P647, DOI 10.1016/j.cell.2014.09.029; Hendel A, 2015, TRENDS BIOTECHNOL, V33, P132, DOI 10.1016/j.tibtech.2014.12.001; Hendel A, 2014, CELL REP, V7, P293, DOI 10.1016/j.celrep.2014.02.040; Hsu PD, 2014, CELL, V157, P1262, DOI 10.1016/j.cell.2014.05.010; Hsu PD, 2013, NAT BIOTECHNOL, V31, P827, DOI 10.1038/nbt.2647; Jinek M, 2012, SCIENCE, V337, P816, DOI 10.1126/science.1225829; Li H, 2010, BIOINFORMATICS, V26, P589, DOI 10.1093/bioinformatics/btp698; Lombardo A, 2011, NAT METHODS, V8, P861, DOI [10.1038/NMETH.1674, 10.1038/nmeth.1674]; Mali P, 2013, SCIENCE, V339, P823, DOI 10.1126/science.1232033; Mandal PK, 2014, CELL STEM CELL, V15, P643, DOI 10.1016/j.stem.2014.10.004; O'Connell MR, 2014, NATURE, V516, P263, DOI 10.1038/nature13769; Tebas P, 2014, NEW ENGL J MED, V370, P901, DOI 10.1056/NEJMoa1300662; Threlfall RN, 2012, ORG BIOMOL CHEM, V10, P746, DOI 10.1039/c1ob06614e; Voit RA, 2014, NUCLEIC ACIDS RES, V42, P1365, DOI 10.1093/nar/gkt947; Yi GH, 2014, MOL THER-NUCL ACIDS, V3, DOI 10.1038/mtna.2014.52	24	605	722	9	251	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156	1546-1696		NAT BIOTECHNOL	Nat. Biotechnol.	SEP	2015	33	9					985	U232		10.1038/nbt.3290	http://dx.doi.org/10.1038/nbt.3290			7	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	CR0EK	26121415	Green Accepted			2022-12-27	WOS:000360990900027
J	[Anonymous]				[Anonymous]			Court invalidates Sequenom's prenatal test patent	NATURE BIOTECHNOLOGY			English	News Item																			0	0	0	0	1	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156	1546-1696		NAT BIOTECHNOL	Nat. Biotechnol.	AUG	2015	33	8					791	791		10.1038/nbt0815-791b	http://dx.doi.org/10.1038/nbt0815-791b			1	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	CO6OB	26252123				2022-12-27	WOS:000359274900036
J	[Anonymous]				[Anonymous]			PureTech floats away	NATURE BIOTECHNOLOGY			English	News Item																			0	0	0	0	0	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156	1546-1696		NAT BIOTECHNOL	Nat. Biotechnol.	AUG	2015	33	8					792	792		10.1038/nbt0815-792a	http://dx.doi.org/10.1038/nbt0815-792a			1	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	CO6OB	26252126	Bronze			2022-12-27	WOS:000359274900037
J	Chen, HJ; Sun, J; Huang, ZL; Hou, H; Arcilla, M; Rakhilin, N; Joe, DJ; Choi, J; Gadamsetty, P; Milsom, J; Nandakumar, G; Longman, R; Zhou, XK; Edwards, R; Chen, JL; Chen, KY; Bu, PC; Wang, LH; Xu, YT; Munroe, R; Abratte, C; Miller, AD; Gumus, ZH; Shuler, M; Nishimura, N; Edelmann, W; Shen, XL; Lipkin, SM				Chen, Huanhuan Joyce; Sun, Jian; Huang, Zhiliang; Hou, Harry, Jr.; Arcilla, Myra; Rakhilin, Nikolai; Joe, Daniel J.; Choi, Jiahn; Gadamsetty, Poornima; Milsom, Jeff; Nandakumar, Govind; Longman, Randy; Zhou, Xi Kathy; Edwards, Robert; Chen, Jonlin; Chen, Kai Yuan; Bu, Pengcheng; Wang, Lihua; Xu, Yitian; Munroe, Robert; Abratte, Christian; Miller, Andrew D.; Guemues, Zeynep H.; Shuler, Michael; Nishimura, Nozomi; Edelmann, Winfried; Shen, Xiling; Lipkin, Steven M.			Comprehensive models of human primary and metastatic colorectal tumors in immunodeficient and immunocompetent mice by chemokine targeting	NATURE BIOTECHNOLOGY			English	Article							COLON-CANCER; PREIMPLANTATION DEVELOPMENT; GENOME ANALYSIS; MOUSE MODELS; EXPRESSION; RECEPTORS; CELLS; CHEMOSENSITIVITY; CHEMORESISTANCE; MECHANISMS	Current orthotopic xenograft models of human colorectal cancer (CRC) require surgery and do not robustly form metastases in the liver, the most common site clinically. CCR9 traffics lymphocytes to intestine and colorectum. We engineered use of the chemokine receptor CCR9 in CRC cell lines and patient-derived cells to create primary gastrointestinal (GI) tumors in immunodeficient mice by tail-vein injection rather than surgery. The tumors metastasize inducibly and robustly to the liver. Metastases have higher DKK4 and NOTCH signaling levels and are more chemoresistant than paired subcutaneous xenografts. Using this approach, we generated 17 chemokine-targeted mouse models (CTMMs) that recapitulate the majority of common human somatic CRC mutations. We also show that primary tumors can be modeled in immunocompetent mice by microinjecting CCR9-expressing cancer cell lines into early-stage mouse blastocysts, which induces central immune tolerance. We expect that CTMMs will facilitate investigation of the biology of CRC metastasis and drug screening.	[Chen, Huanhuan Joyce; Rakhilin, Nikolai; Joe, Daniel J.; Choi, Jiahn; Gadamsetty, Poornima; Bu, Pengcheng; Wang, Lihua; Xu, Yitian; Shuler, Michael; Nishimura, Nozomi; Shen, Xiling] Cornell Univ, Dept Biomed Engn, Ithaca, NY USA; [Chen, Huanhuan Joyce; Sun, Jian; Huang, Zhiliang; Arcilla, Myra; Longman, Randy; Guemues, Zeynep H.; Lipkin, Steven M.] Weill Cornell Med Coll, Dept Med, New York, NY 10065 USA; [Hou, Harry, Jr.; Edelmann, Winfried] Albert Einstein Coll Med, Dept Cell Biol, New York, NY USA; [Milsom, Jeff; Nandakumar, Govind] Weill Cornell Med Coll, Dept Surg, New York, NY USA; [Zhou, Xi Kathy] Weill Cornell Med Coll, Dept Healthcare Policy & Res, New York, NY USA; [Edwards, Robert] Univ Calif Irvine, Dept Pathol, Irvine, CA 92717 USA; [Chen, Jonlin; Chen, Kai Yuan; Bu, Pengcheng; Shen, Xiling] Cornell Univ, Sch Elect & Comp Engn, Ithaca, NY USA; [Munroe, Robert; Abratte, Christian; Miller, Andrew D.] Cornell Univ, Coll Vet Med & Biol Sci, Ithaca, NY USA; [Guemues, Zeynep H.] Icahn Sch Med Mt Sinai, Dept Genet & Genom Sci, New York, NY 10029 USA	Cornell University; Cornell University; Yeshiva University; Cornell University; Cornell University; University of California System; University of California Irvine; Cornell University; Cornell University; Icahn School of Medicine at Mount Sinai	Lipkin, SM (corresponding author), Weill Cornell Med Coll, Dept Med, New York, NY 10065 USA.	xs66@cornell.edu; stl2012@med.cornell.edu	Nishimura, Nozomi/AAV-2425-2020; Choi, Jiahn/E-8284-2018; Joe, Daniel J./F-1128-2015; Nishimura, Nozomi/P-8908-2015	Nishimura, Nozomi/0000-0003-4342-9416; Choi, Jiahn/0000-0001-7344-767X; Joe, Daniel J./0000-0002-1945-8236; Nishimura, Nozomi/0000-0003-4342-9416; Bu, Pengcheng/0000-0002-3208-0354; Gumus, Zeynep/0000-0002-7364-2202	National Science Foundation (NSF) [1137269, NSF 1106153, NSF GRFP-2011131053]; National Institutes of Health (NIH) [R01 GM095990, CA098626, NIH 2UL1-RR024996, NIH UH2TR000516]; Defense Advanced Research Projects Agency [19-1091726]; NATIONAL CANCER INSTITUTE [R01CA098626, R01CA076329, P30CA013330, R56CA098626] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UH2TR000516, UL1TR001414, UL1TR000457] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR024996] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [K08DK099381] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM114254, R01GM095990] Funding Source: NIH RePORTER	National Science Foundation (NSF)(National Science Foundation (NSF)); National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Defense Advanced Research Projects Agency(United States Department of DefenseDefense Advanced Research Projects Agency (DARPA)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank other members of the Lipkin laboratory and Shen Laboratory for helpful discussions. We also thank the Cornell BRC imaging and Stem Cell and Transgenic Core Facilities. This work was supported by the National Science Foundation (NSF) 1137269, NSF 1106153, NSF GRFP-2011131053, National Institutes of Health (NIH) R01 GM095990, CA098626, NIH 2UL1-RR024996, NIH UH2TR000516, Defense Advanced Research Projects Agency 19-1091726, and generous donations by Matthew Bell and Fred Greenberg.	Bleul CC, 2000, EUR J IMMUNOL, V30, P3371, DOI 10.1002/1521-4141(2000012)30:12<3371::AID-IMMU3371>3.0.CO;2-L; Cao ZW, 2014, CANCER CELL, V25, P350, DOI 10.1016/j.ccr.2014.02.005; Chen C, 2014, SOURCE CODE BIOL MED, V9, DOI 10.1186/1751-0473-9-8; Chen HJ, 2012, J CLIN INVEST, V122, P3184, DOI 10.1172/JCI62110; DANCIS J, 1972, ACTA ENDOCRINOL-COP, P347; Ebert MPA, 2012, NEW ENGL J MED, V366, P44, DOI 10.1056/NEJMoa1009473; Eds Johan Auwerx S.L.A., 2013, CURRENT PROTOCOLS MO; Ellis Lee M, 2004, Clin Colorectal Cancer, V4 Suppl 2, pS55, DOI 10.3816/CCC.2004.s.009; He K, 2010, REPROD BIOL ENDOCRIN, V8, DOI 10.1186/1477-7827-8-41; Jahid S, 2012, CANCER DISCOV, V2, P540, DOI 10.1158/2159-8290.CD-11-0267; Kabelitz D, 2003, CRIT REV IMMUNOL, V23, P339, DOI 10.1615/CritRevImmunol.v23.i56.10; LAUTT WW, 1985, AM J PHYSIOL, V249, pG549, DOI 10.1152/ajpgi.1985.249.5.G549; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Li X, 2007, PHYSIOL GENOMICS, V29, P290, DOI 10.1152/physiolgenomics.00269.2006; Maekawa M, 2005, DEVELOPMENT, V132, P1773, DOI 10.1242/dev.01729; McKenna A, 2010, GENOME RES, V20, P1297, DOI 10.1101/gr.107524.110; Meng RD, 2009, CANCER RES, V69, P573, DOI 10.1158/0008-5472.CAN-08-2088; Meurens F, 2007, IMMUNOLOGY, V120, P544, DOI 10.1111/j.1365-2567.2006.02532.x; Meurens F, 2006, VET IMMUNOL IMMUNOP, V113, P313, DOI 10.1016/j.vetimm.2006.05.014; Nagy A., 2003, MANIPULATING MOUSE E; Okumura K, 2006, ONCOL REP, V15, P875; Schneider JS, 2009, STEM CELL REV REP, V5, P369, DOI 10.1007/s12015-009-9089-6; Sikandar SS, 2010, CANCER RES, V70, P1469, DOI 10.1158/0008-5472.CAN-09-2557; Siolas D, 2013, CANCER RES, V73, P5315, DOI 10.1158/0008-5472.CAN-13-1069; THIEL H, 1980, SURG GYNECOL OBSTET, V150, P587; Wagner M, 2009, J GASTROINTEST SURG, V13, P1781, DOI 10.1007/s11605-009-0948-x; Walters S, 2013, INT J CANCER, V132, P676, DOI 10.1002/ijc.27651; Youn BS, 2001, BLOOD, V98, P925, DOI 10.1182/blood.V98.4.925; Yu CR, 2000, J IMMUNOL, V164, P1293, DOI 10.4049/jimmunol.164.3.1293	29	23	23	2	21	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156	1546-1696		NAT BIOTECHNOL	Nat. Biotechnol.	JUN	2015	33	6					656	+		10.1038/nbt.3239	http://dx.doi.org/10.1038/nbt.3239			8	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	CK2DE	26006007	Green Accepted, Green Submitted			2022-12-27	WOS:000356019700026
J	Kim, HU; Ryu, JY; Lee, JO; Lee, SY				Kim, Hyun Uk; Ryu, Jae Yong; Lee, Jong Ok; Lee, Sang Yup			A systems approach to traditional oriental medicine	NATURE BIOTECHNOLOGY			English	Article							DRUG-COMBINATIONS; NATURAL-PRODUCT; MECHANISMS; INTEGRATION; TARGETS; IMPACT; CELLS; TCM		[Kim, Hyun Uk; Ryu, Jae Yong; Lee, Jong Ok; Lee, Sang Yup] Korea Adv Inst Sci & Technol, Metab & Biomol Engn Natl Res Lab, Dept Chem & Biomol Engn,Plus Program BK21, Ctr Syst & Synthet Biotechnol,Inst BioCentury, Taejon 305701, South Korea; [Kim, Hyun Uk; Lee, Jong Ok; Lee, Sang Yup] Korea Adv Inst Sci & Technol, BioInformat Res Ctr, Taejon 305701, South Korea; [Lee, Sang Yup] Korea Adv Inst Sci & Technol, BioProc Engn Res Ctr, Taejon 305701, South Korea; [Kim, Hyun Uk; Lee, Sang Yup] Tech Univ Denmark, Novo Nordisk Fdn Ctr Biosustainabil, Horsholm, Denmark	Korea Advanced Institute of Science & Technology (KAIST); Korea Advanced Institute of Science & Technology (KAIST); Korea Advanced Institute of Science & Technology (KAIST); Technical University of Denmark	Kim, HU (corresponding author), Korea Adv Inst Sci & Technol, Metab & Biomol Engn Natl Res Lab, Dept Chem & Biomol Engn,Plus Program BK21, Ctr Syst & Synthet Biotechnol,Inst BioCentury, Taejon 305701, South Korea.	leesy@kaist.ac.kr	Kim, Hyun Uk/F-4509-2018; Lee, Sang Yup/C-1526-2011	Kim, Hyun Uk/0000-0001-7224-642X; Lee, Sang Yup/0000-0003-0599-3091	Novo Nordisk Fonden [NNF10CC1016517] Funding Source: researchfish; NNF Center for Biosustainability [New Bioactive Compounds] Funding Source: researchfish	Novo Nordisk Fonden(Novo Nordisk Foundation); NNF Center for Biosustainability		Agren R, 2014, MOL SYST BIOL, V10, DOI 10.1002/msb.145122; Blazier AS, 2012, FRONT PHYSIOL, V3, DOI 10.3389/fphys.2012.00299; Chen CYC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0015939; Cheung F, 2011, NATURE, V480, pS82, DOI 10.1038/480S82a; Dar AC, 2012, NATURE, V486, P80, DOI 10.1038/nature11127; Ding M, 2007, J PHARM PHARMACOL, V59, P1027, DOI 10.1211/jpp.59.7.0016; Dobson PD, 2009, DRUG DISCOV TODAY, V14, P31, DOI 10.1016/j.drudis.2008.10.011; Feng Y, 2010, BRIT J PHARMACOL, V161, P113, DOI 10.1111/j.1476-5381.2010.00826.x; Ganesan A, 2008, CURR OPIN CHEM BIOL, V12, P306, DOI 10.1016/j.cbpa.2008.03.016; Gujral TS, 2014, P NATL ACAD SCI USA, V111, P5048, DOI 10.1073/pnas.1403080111; Hawkes D, 2014, TRENDS PHARMACOL SCI, V35, P111, DOI 10.1016/j.tips.2014.01.002; Hebar A, 2013, EXPERT REV CLIN PHAR, V6, P23, DOI [10.1586/ECP.12.71, 10.1586/ecp.12.71]; Irwin JJ, 2012, J CHEM INF MODEL, V52, P1757, DOI 10.1021/ci3001277; Jayaseelan KV, 2012, BMC BIOINFORMATICS, V13, DOI 10.1186/1471-2105-13-106; Jia J, 2009, NAT REV DRUG DISCOV, V8, P111, DOI 10.1038/nrd2683; Jung JY, 2011, KOR J MED HIST, V20, P1; Kanehisa M, 2012, NUCLEIC ACIDS RES, V40, pD109, DOI 10.1093/nar/gkr988; Keiser MJ, 2009, NATURE, V462, P175, DOI 10.1038/nature08506; Khanna V, 2011, J CHEMINFORMATICS, V3, DOI 10.1186/1758-2946-3-30; Kim HU, 2012, BIOTECHNOL J, V7, P330, DOI 10.1002/biot.201100159; Kim HU, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2010.115; Kim TY, 2010, METAB ENG, V12, P105, DOI 10.1016/j.ymben.2009.05.004; Knox C, 2011, NUCLEIC ACIDS RES, V39, pD1035, DOI 10.1093/nar/gkq1126; Li S, 2011, BMC SYST BIOL, V5, DOI 10.1186/1752-0509-5-S1-S10; Liu X, 2013, TRENDS PHARMACOL SCI, V34, P620, DOI 10.1016/j.tips.2013.09.004; Ma XH, 2009, DRUG DISCOV TODAY, V14, P579, DOI 10.1016/j.drudis.2009.03.012; Mardinoglu A, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4083; McCarty MF, 2006, MED HYPOTHESES, V66, P1093, DOI 10.1016/j.mehy.2004.11.046; McKnight SL, 2010, SCIENCE, V330, P1338, DOI 10.1126/science.1199908; Oh C, 2013, KOR J MED HIST, V22, P1; Rahman SA, 2009, J CHEMINFORMATICS, V1, DOI 10.1186/1758-2946-1-12; Schmidt BM, 2007, NAT CHEM BIOL, V3, P360, DOI 10.1038/nchembio0707-360; Spink BC, 2003, BIOCHEM PHARMACOL, V66, P2313, DOI 10.1016/j.bcp.2003.08.019; Thiele I, 2013, NAT BIOTECHNOL, V31, P419, DOI 10.1038/nbt.2488; van der Greef J, 2011, NATURE, V480, pS87, DOI 10.1038/480S87a; Wang L, 2008, P NATL ACAD SCI USA, V105, P4826, DOI 10.1073/pnas.0712365105; Xu ZG, 2011, NATURE, V480, pS90, DOI 10.1038/480S90a	37	60	61	0	30	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156	1546-1696		NAT BIOTECHNOL	Nat. Biotechnol.	MAR	2015	33	3					264	268		10.1038/nbt.3167	http://dx.doi.org/10.1038/nbt.3167			5	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	CD0ME	25748918	Bronze			2022-12-27	WOS:000350766900022
J	Klijn, C; Durinck, S; Stawiski, EW; Haverty, PM; Jiang, ZS; Liu, HB; Degenhardt, J; Mayba, O; Gnad, F; Liu, JF; Pau, G; Reeder, J; Cao, Y; Mukhyala, K; Selvaraj, SK; Yu, MM; Zynda, GJ; Brauer, MJ; Wu, TD; Gentleman, RC; Manning, G; Yauch, RL; Bourgon, R; Stokoe, D; Modrusan, Z; Neve, RM; de Sauvage, FJ; Settleman, J; Seshagiri, S; Zhang, ZM				Klijn, Christiaan; Durinck, Steffen; Stawiski, Eric W.; Haverty, Peter M.; Jiang, Zhaoshi; Liu, Hanbin; Degenhardt, Jeremiah; Mayba, Oleg; Gnad, Florian; Liu, Jinfeng; Pau, Gregoire; Reeder, Jens; Cao, Yi; Mukhyala, Kiran; Selvaraj, Suresh K.; Yu, Mamie; Zynda, Gregory J.; Brauer, Matthew J.; Wu, Thomas D.; Gentleman, Robert C.; Manning, Gerard; Yauch, Robert L.; Bourgon, Richard; Stokoe, David; Modrusan, Zora; Neve, Richard M.; de Sauvage, Frederic J.; Settleman, Jeffrey; Seshagiri, Somasekar; Zhang, Zemin			A comprehensive transcriptional portrait of human cancer cell lines	NATURE BIOTECHNOLOGY			English	Article							TO-MESENCHYMAL TRANSITION; GENE-EXPRESSION PATTERNS; COPY-NUMBER ALTERATION; BREAST-CANCER; MOLECULAR PHARMACOLOGY; DRUG-SENSITIVITY; TYROSINE KINASE; IDENTIFICATION; INHIBITOR; GENOME	Tumor-derived cell lines have served as vital models to advance our understanding of oncogene function and therapeutic responses. Although substantial effort has been made to define the genomic constitution of cancer cell line panels, the transcriptome remains understudied. Here we describe RNA sequencing and single-nucleotide polymorphism ( SNP) array analysis of 675 human cancer cell lines. We report comprehensive analyses of transcriptome features including gene expression, mutations, gene fusions and expression of non-human sequences. Of the 2,200 gene fusions catalogued, 1,435 consist of genes not previously found in fusions, providing many leads for further investigation. We combine multiple genome and transcriptome features in a pathway-based approach to enhance prediction of response to targeted therapeutics. Our results provide a valuable resource for studies that use cancer cell lines.	[Klijn, Christiaan; Durinck, Steffen; Stawiski, Eric W.; Haverty, Peter M.; Jiang, Zhaoshi; Liu, Hanbin; Degenhardt, Jeremiah; Mayba, Oleg; Gnad, Florian; Liu, Jinfeng; Pau, Gregoire; Reeder, Jens; Cao, Yi; Mukhyala, Kiran; Zynda, Gregory J.; Brauer, Matthew J.; Wu, Thomas D.; Gentleman, Robert C.; Manning, Gerard; Bourgon, Richard; Zhang, Zemin] Genentech Inc, Dept Bioinformat & Computat Biol, San Francisco, CA 94080 USA; [Durinck, Steffen; Stawiski, Eric W.; Modrusan, Zora; de Sauvage, Frederic J.; Seshagiri, Somasekar] Genentech Inc, Dept Mol Biol, San Francisco, CA 94080 USA; [Cao, Yi; Selvaraj, Suresh K.; Yu, Mamie; Yauch, Robert L.; Stokoe, David; Neve, Richard M.; Settleman, Jeffrey] Genentech Inc, Dept Oncol, San Francisco, CA 94080 USA	Roche Holding; Genentech; Roche Holding; Genentech; Roche Holding; Genentech	Settleman, J (corresponding author), Genentech Inc, Dept Oncol, San Francisco, CA 94080 USA.	jeffrees@gene.com; sekar@gene.com; zemin@pku.edu.cn	de Sauvage, Frederic/ABE-8400-2020; Manning, Gerard/C-8308-2009	de Sauvage, Frederic/0000-0002-5275-2584; Bourgon, Richard/0000-0002-5890-4374; Manning, Gerard/0000-0002-5087-9151; Gnad, Florian/0000-0002-2287-2251; Klijn, Christiaan/0000-0003-0878-4121; Seshagiri, Somasekar/0000-0003-4272-6443; Liu, Jinfeng/0000-0002-0343-8222				Abaan OD, 2013, CANCER RES, V73, P4372, DOI 10.1158/0008-5472.CAN-12-3342; Acunzo M, 2013, P NATL ACAD SCI USA, V110, P8573, DOI 10.1073/pnas.1302107110; Alves CP, 2013, STEM CELLS, V31, P2827, DOI 10.1002/stem.1547; Anders S, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-10-r106; [Anonymous], 2010, NAT REV CANC, V10, P441; Barretina J, 2012, NATURE, V483, P603, DOI 10.1038/nature11003; Barrett SD, 2008, BIOORG MED CHEM LETT, V18, P6501, DOI 10.1016/j.bmcl.2008.10.054; Berger MF, 2010, GENOME RES, V20, P413, DOI 10.1101/gr.103697.109; Beroukhim R, 2010, NATURE, V463, P899, DOI 10.1038/nature08822; Bignell GR, 2010, NATURE, V463, P893, DOI 10.1038/nature08768; Campbell PJ, 2008, NAT GENET, V40, P722, DOI 10.1038/ng.128; DeRisi J, 1996, NAT GENET, V14, P457; Drmanac R, 2010, SCIENCE, V327, P78, DOI 10.1126/science.1181498; Druker BJ, 2001, NEW ENGL J MED, V344, P1031, DOI 10.1056/NEJM200104053441401; Edgren H, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-1-r6; Folkes AJ, 2008, J MED CHEM, V51, P5522, DOI 10.1021/jm800295d; Fu WQ, 2013, NATURE, V493, P216, DOI 10.1038/nature11690; Garnett MJ, 2012, NATURE, V483, P570, DOI 10.1038/nature11005; Garraway LA, 2013, CELL, V153, P17, DOI 10.1016/j.cell.2013.03.002; Gentleman RC, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-10-r80; Gonzalez-Perez A, 2011, AM J HUM GENET, V88, P440, DOI 10.1016/j.ajhg.2011.03.004; Greenman CD, 2010, BIOSTATISTICS, V11, P164, DOI 10.1093/biostatistics/kxp045; Haibe-Kains B, 2013, NATURE, V504, P389, DOI 10.1038/nature12831; Hoeflich KP, 2012, CANCER RES, V72, P210, DOI 10.1158/0008-5472.CAN-11-1515; Jiang ZS, 2012, GENOME RES, V22, P593, DOI 10.1101/gr.133926.111; Lai AZ, 2009, TRENDS CELL BIOL, V19, P542, DOI 10.1016/j.tcb.2009.07.002; Lawrence MS, 2013, NATURE, V499, P214, DOI 10.1038/nature12213; Lin Z, 2012, J VIROL, V86, P2970, DOI 10.1128/JVI.06717-11; Liu JF, 2012, GENOME RES, V22, P2315, DOI 10.1101/gr.140988.112; Lukk M, 2010, NAT BIOTECHNOL, V28, P322, DOI 10.1038/nbt0410-322; McDermott U, 2008, CANCER RES, V68, P3389, DOI 10.1158/0008-5472.CAN-07-6186; McPherson A, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1001138; Mermel CH, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-4-r41; Mitelman F., MITELMAN DATABASE CH; Mohammadi M, 1998, EMBO J, V17, P5896, DOI 10.1093/emboj/17.20.5896; Neve RM, 2006, CANCER CELL, V10, P515, DOI 10.1016/j.ccr.2006.10.008; Robinson DR, 2011, NAT MED, V17, P1646, DOI 10.1038/nm.2580; Ross DT, 2000, NAT GENET, V24, P227, DOI 10.1038/73432; Scherf U, 2000, NAT GENET, V24, P236, DOI 10.1038/73439; Seshagiri S, 2012, NATURE, V488, P660, DOI 10.1038/nature11282; Shah N, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-818; Sharma SV, 2010, NAT REV CANCER, V10, P241, DOI 10.1038/nrc2820; Singh D, 2012, SCIENCE, V337, P1231, DOI 10.1126/science.1220834; Sutherlin DP, 2011, J MED CHEM, V54, P7579, DOI 10.1021/jm2009327; Taube JH, 2010, P NATL ACAD SCI USA, V107, P15449, DOI 10.1073/pnas.1004900107; Turner N, 2010, NAT REV CANCER, V10, P116, DOI 10.1038/nrc2780; Weinstein JN, 1997, SCIENCE, V275, P343, DOI 10.1126/science.275.5298.343; Wu TD, 2005, BIOINFORMATICS, V21, P1859, DOI 10.1093/bioinformatics/bti310; Wu TD, 2010, BIOINFORMATICS, V26, P873, DOI 10.1093/bioinformatics/btq057; Wu YM, 2013, CANCER DISCOV, V3, P636, DOI 10.1158/2159-8290.CD-13-0050	50	385	408	3	81	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156	1546-1696		NAT BIOTECHNOL	Nat. Biotechnol.	MAR	2015	33	3					306	+		10.1038/nbt.3080	http://dx.doi.org/10.1038/nbt.3080			10	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	CD0ME	25485619				2022-12-27	WOS:000350766900029
J	Moignard, V; Woodhouse, S; Haghverdi, L; Lilly, AJ; Tanaka, Y; Wilkinson, AC; Buettner, F; Macaulay, IC; Jawaid, W; Diamanti, E; Nishikawa, SI; Piterman, N; Kouskoff, V; Theis, FJ; Fisher, J; Gottgens, B				Moignard, Victoria; Woodhouse, Steven; Haghverdi, Laleh; Lilly, Andrew J.; Tanaka, Yosuke; Wilkinson, Adam C.; Buettner, Florian; Macaulay, Iain C.; Jawaid, Wajid; Diamanti, Evangelia; Nishikawa, Shin-Ichi; Piterman, Nir; Kouskoff, Valerie; Theis, Fabian J.; Fisher, Jasmin; Goettgens, Berthold			Decoding the regulatory network of early blood development from single-cell gene expression measurements	NATURE BIOTECHNOLOGY			English	Article							EMBRYONIC STEM-CELL; YOLK-SAC; HEMATOPOIETIC DEVELOPMENT; DEFINITIVE HEMATOPOIESIS; RNA-SEQ; ADULT HEMATOPOIESIS; FATE DECISIONS; MOUSE EMBRYOS; LEUKEMIA; MICE	Reconstruction of the molecular pathways controlling organ development has been hampered by a lack of methods to resolve embryonic progenitor cells. Here we describe a strategy to address this problem that combines gene expression profiling of large numbers of single cells with data analysis based on diffusion maps for dimensionality reduction and network synthesis from state transition graphs. Applying the approach to hematopoietic development in the mouse embryo, we map the progression of mesoderm toward blood using single-cell gene expression analysis of 3,934 cells with blood-forming potential captured at four time points between E7.0 and E8.5. Transitions between individual cellular states are then used as input to develop a single-cell network synthesis toolkit to generate a computationally executable transcriptional regulatory network model of blood development. Several model predictions concerning the roles of Sox and Hox factors are validated experimentally. Our results demonstrate that single-cell analysis of a developing organ coupled with computational approaches can reveal the transcriptional programs that underpin organogenesis.	[Moignard, Victoria; Woodhouse, Steven; Tanaka, Yosuke; Wilkinson, Adam C.; Jawaid, Wajid; Diamanti, Evangelia; Goettgens, Berthold] Univ Cambridge, Cambridge Inst Med Res, Dept Haematol, Cambridge, England; [Moignard, Victoria; Woodhouse, Steven; Tanaka, Yosuke; Wilkinson, Adam C.; Diamanti, Evangelia; Goettgens, Berthold] Univ Cambridge, Cambridge Stem Cell Inst, Wellcome Trust Med Res Council, Cambridge, England; [Haghverdi, Laleh; Buettner, Florian; Theis, Fabian J.] Helmholtz Zentrum Munchen, Inst Computat Biol, Neuherberg, Germany; [Haghverdi, Laleh; Theis, Fabian J.] Tech Univ Munich, Dept Math, Garching, Germany; [Lilly, Andrew J.; Kouskoff, Valerie] Univ Manchester, Paterson Inst Canc Res, Canc Res UK Stem Cell Haematopoiesis Grp, Manchester, Lancs, England; [Tanaka, Yosuke; Nishikawa, Shin-Ichi] RIKEN Ctr Dev Biol, Lab Stem Cell Biol, Chuo Ku, Kobe, Hyogo, Japan; [Macaulay, Iain C.] Wellcome Trust Sanger Inst, EBI Single Cell Genom Ctr, Sanger Inst, Cambridge, England; [Piterman, Nir] Univ Leicester, Dept Comp Sci, Leicester, Leics, England; [Fisher, Jasmin] Microsoft Res Cambridge, Cambridge, England; [Fisher, Jasmin] Univ Cambridge, Dept Biochem, Cambridge CB2 1QW, England	University of Cambridge; University of Cambridge; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; Technical University of Munich; Cancer Research UK; Paterson Institute for Cancer Research; University of Manchester; RIKEN; Wellcome Trust Sanger Institute; University of Leicester; Microsoft; University of Cambridge	Gottgens, B (corresponding author), Univ Cambridge, Cambridge Inst Med Res, Dept Haematol, Cambridge, England.	jasmin.fisher@microsoft.com; bg200@cam.ac.uk	Theis, Fabian J/ABD-5212-2021; Buettner, Florian/ABF-1230-2020; Jawaid, Wajid/L-3625-2016	Theis, Fabian J/0000-0002-2419-1943; Buettner, Florian/0000-0001-5587-6761; Jawaid, Wajid/0000-0002-4861-6694; Fisher, Jasmin/0000-0003-4477-9047; Piterman, Nir/0000-0002-8242-5357; Gottgens, Berthold/0000-0001-6302-5705; Macaulay, Iain/0000-0002-6761-757X; Haghverdi, Laleh/0000-0001-9280-9170	Medical Research Council; Biotechnology and Biological Sciences Research Council; Leukaemia and Lymphoma Research; Leukemia and Lymphoma Society; Wellcome Trust; Medical Research Council Studentship and Centenary Award; Microsoft Research PhD Scholarship; Biotechnology and Biological Sciences Research Council [BB/I00050X/1] Funding Source: researchfish; Cancer Research UK [12486, 12765] Funding Source: researchfish; Medical Research Council [MR/M008975/1, MC_PC_12009, G0900951] Funding Source: researchfish; BBSRC [BB/I00050X/1] Funding Source: UKRI; MRC [G0900951, MR/M008975/1] Funding Source: UKRI	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Leukaemia and Lymphoma Research; Leukemia and Lymphoma Society(Leukemia and Lymphoma Society); Wellcome Trust(Wellcome Trust); Medical Research Council Studentship and Centenary Award(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Microsoft Research PhD Scholarship(Microsoft); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Cancer Research UK(Cancer Research UK); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	We thank J. Downing (St. Jude Children's Research Hospital, Memphis, TN, USA) for the Runx1-ires-GFP mouse. Research in the authors' laboratory is supported by the Medical Research Council, Biotechnology and Biological Sciences Research Council, Leukaemia and Lymphoma Research, the Leukemia and Lymphoma Society, Microsoft Research and core support grants by the Wellcome Trust to the Cambridge Institute for Medical Research and Wellcome Trust - MRC Cambridge Stem Cell Institute. V.M. is supported by a Medical Research Council Studentship and Centenary Award and S.W. by a Microsoft Research PhD Scholarship.	Amir ED, 2013, NAT BIOTECHNOL, V31, P545, DOI 10.1038/nbt.2594; Bailey N.T.J., 1995, STAT METHODS BIOL, V1995, P255; Bonzanni N, 2013, BIOINFORMATICS, V29, P80, DOI 10.1093/bioinformatics/btt243; Chen MJ, 2009, NATURE, V457, P887, DOI 10.1038/nature07619; Coifman RR, 2005, P NATL ACAD SCI USA, V102, P7426, DOI 10.1073/pnas.0500334102; Costa G, 2012, TRENDS IMMUNOL, V33, P215, DOI 10.1016/j.it.2012.01.012; Ding G, 2013, DEV DYNAM, V242, P254, DOI 10.1002/dvdy.23923; Dobin A, 2013, BIOINFORMATICS, V29, P15, DOI 10.1093/bioinformatics/bts635; DOWNS KM, 1993, DEVELOPMENT, V118, P1255; Fan R, 2012, BLOOD, V119, pE139, DOI 10.1182/blood-2011-12-396754; Fujiwara Y, 1996, P NATL ACAD SCI USA, V93, P12355, DOI 10.1073/pnas.93.22.12355; Gandillet A, 2009, BLOOD, V114, P4813, DOI 10.1182/blood-2009-06-226290; Garg A, 2008, BIOINFORMATICS, V24, P1917, DOI 10.1093/bioinformatics/btn336; Guo GJ, 2013, CELL STEM CELL, V13, P492, DOI 10.1016/j.stem.2013.07.017; Guo GJ, 2010, DEV CELL, V18, P675, DOI 10.1016/j.devcel.2010.02.012; Kabrun N, 1997, DEVELOPMENT, V124, P2039; Kataoka H, 2011, BLOOD, V118, P6975, DOI 10.1182/blood-2011-05-352658; Koksal AS, 2013, ACM SIGPLAN NOTICES, V48, P469, DOI 10.1145/2480359.2429125; Krumsiek J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022649; Kyba M, 2002, CELL, V109, P29, DOI 10.1016/S0092-8674(02)00680-3; Lorsbach RB, 2004, BLOOD, V103, P2522, DOI 10.1182/blood-2003-07-2439; Loughran SJ, 2008, NAT IMMUNOL, V9, P810, DOI 10.1038/ni.1617; Lux CT, 2008, BLOOD, V111, P3435, DOI 10.1182/blood-2007-08-107086; MAGIN TM, 1992, NUCLEIC ACIDS RES, V20, P3795, DOI 10.1093/nar/20.14.3795; Mikkola HKA, 2003, BLOOD, V101, P508, DOI 10.1182/blood-2002-06-1699; Mitjavila-Garcia MT, 2002, DEVELOPMENT, V129, P2003; Moignard V, 2013, BLOOD CELL MOL DIS, V51, P239, DOI 10.1016/j.bcmd.2013.07.007; Moignard V, 2013, NAT CELL BIOL, V15, P363, DOI 10.1038/ncb2709; North T, 1999, DEVELOPMENT, V126, P2563; Picelli S, 2014, NAT PROTOC, V9, P171, DOI 10.1038/nprot.2014.006; Pimanda JE, 2007, P NATL ACAD SCI USA, V104, P17692, DOI 10.1073/pnas.0707045104; Pina C, 2012, NAT CELL BIOL, V14, P287, DOI 10.1038/ncb2442; ROBB L, 1995, P NATL ACAD SCI USA, V92, P7075, DOI 10.1073/pnas.92.15.7075; Sachs K, 2005, SCIENCE, V308, P523, DOI 10.1126/science.1105809; Sacilotto N, 2013, P NATL ACAD SCI USA, V110, P11893, DOI 10.1073/pnas.1300805110; Samokhvalov IM, 2007, NATURE, V446, P1056, DOI 10.1038/nature05725; Sanchez-Castillo M, 2015, NUCLEIC ACIDS RES, V43, pD1117, DOI 10.1093/nar/gku895; Schlaeger TM, 2005, BLOOD, V105, P3871, DOI 10.1182/blood-2004-11-4467; Shalaby F, 1997, CELL, V89, P981, DOI 10.1016/S0092-8674(00)80283-4; SHALABY F, 1995, NATURE, V376, P62, DOI 10.1038/376062a0; SHIVDASANI RA, 1995, NATURE, V373, P432, DOI 10.1038/373432a0; Stahlberg A, 2011, NUCLEIC ACIDS RES, V39, DOI 10.1093/nar/gkq1182; Sumanas S, 2008, BLOOD, V111, P4500, DOI 10.1182/blood-2007-09-110569; Swiers G, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3924; Tanaka Y, 2012, P NATL ACAD SCI USA, V109, P4515, DOI 10.1073/pnas.1115828109; Tang FC, 2011, NAT METHODS, V8, pS6, DOI [10.1038/NMETH.1557, 10.1038/nmeth.1557]; Taoudi S, 2011, GENE DEV, V25, P251, DOI 10.1101/gad.2009211; Thiery JP, 2009, CELL, V139, P871, DOI 10.1016/j.cell.2009.11.007; Thoms JAI, 2011, BLOOD, V117, P7079, DOI 10.1182/blood-2010-12-317990; Tischler J, 2013, CURR OPIN BIOTECH, V24, P69, DOI 10.1016/j.copbio.2012.09.013; Trapnell C, 2014, NAT BIOTECHNOL, V32, P381, DOI 10.1038/nbt.2859; van der Maaten L, 2008, J MACH LEARN RES, V9, P2579; Wareing S, 2012, STEM CELLS, V30, P1521, DOI 10.1002/stem.1115; Wilkinson AC, 2013, BIOL OPEN, V2, P1229, DOI 10.1242/bio.20136296; Wilson NK, 2009, BLOOD, V113, P5456, DOI 10.1182/blood-2009-01-200048; Xu HL, 2014, PLOS COMPUT BIOL, V10, DOI 10.1371/journal.pcbi.1003777; Xue ZG, 2013, NATURE, V500, P593, DOI 10.1038/nature12364; Yan LY, 2013, NAT STRUCT MOL BIOL, V20, P1131, DOI 10.1038/nsmb.2660	58	227	227	2	77	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156	1546-1696		NAT BIOTECHNOL	Nat. Biotechnol.	MAR	2015	33	3					269	+		10.1038/nbt.3154	http://dx.doi.org/10.1038/nbt.3154			11	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	CD0ME	25664528	Green Accepted			2022-12-27	WOS:000350766900023
J	Carriere, Y; Crickmore, N; Tabashnik, BE				Carriere, Yves; Crickmore, Neil; Tabashnik, Bruce E.			Optimizing pyramided transgenic Bt crops for sustainable pest management	NATURE BIOTECHNOLOGY			English	Article							BACILLUS-THURINGIENSIS TOXINS; EUROPEAN CORN-BORER; HELICOVERPA-ZEA LEPIDOPTERA; FIELD-DERIVED STRAIN; INSECT RESISTANCE; TOLERANCE RESPONSE; CROSS-RESISTANCE; MULTIPLE TOXINS; FITNESS COSTS; CRY1AB TOXIN	Transgenic crop pyramids producing two Or more Bacillus thuringiensis (Bt) toxins that kill the same insect pest have been widely used to delay evolution of pest resistance. To assess the potential of pyramids to achieve this goal, we analyze data from 38 studies that report effects of ten Bt toxins used in transgenic crops against 15 insect pests. We find that compared with optimal low levels of insect survival, survival on currently used pyramids is often higher for both susceptible insects and insects resistant to one of the toxins in the pyramid. Furthermore, we find that cross-resistance and antagonism between toxins used in pyramids are common, and that these problems are associated with the similarity of the amino acid sequences of domains II and III of the toxins, respectively. This analysis should assist in future pyramid design and the development of sustainable resistance management strategies.	[Carriere, Yves; Tabashnik, Bruce E.] Univ Arizona, Dept Entomol, Tucson, AZ 85721 USA; [Crickmore, Neil] Univ Sussex, Sch Life Sci, Brighton, E Sussex, England	University of Arizona; University of Sussex	Carriere, Y (corresponding author), Univ Arizona, Dept Entomol, Tucson, AZ 85721 USA.	ycarrier@ag.arizona.edu		Crickmore, Neil/0000-0002-8448-0763	US Department of Agriculture (USDA) Biotechnology Risk Assessment [2011-33522-30729]	US Department of Agriculture (USDA) Biotechnology Risk Assessment(United States Department of Agriculture (USDA))	We thank J. Rick for help with searching the literature for cross-resistance data and F. Huang for providing data from one of his publications. This study was supported by US Department of Agriculture (USDA) Biotechnology Risk Assessment Grant Award 2011-33522-30729.	Adamczyk JJ, 2004, FLA ENTOMOL, V87, P427, DOI 10.1653/0015-4040(2004)087[0427:LAFPOC]2.0.CO;2; Ali MI, 2007, J ECON ENTOMOL, V100, P921, DOI 10.1603/0022-0493(2007)100[921:SOBATB]2.0.CO;2; Alphey N, 2008, THEOR ECOL-NETH, V1, P103, DOI 10.1007/s12080-008-0010-8; Alyokhin A, 2011, NAT BIOTECHNOL, V29, P577, DOI 10.1038/nbt.1911; An JJ, 2010, J ECON ENTOMOL, V103, P2169, DOI 10.1603/EC10105; Bravo A, 2013, MICROB BIOTECHNOL, V6, P17, DOI 10.1111/j.1751-7915.2012.00342.x; Brevault T, 2013, P NATL ACAD SCI USA, V110, P5806, DOI 10.1073/pnas.1216719110; Brevault T, 2012, EVOL APPL, V5, P53, DOI 10.1111/j.1752-4571.2011.00207.x; Burd AD, 2003, J ECON ENTOMOL, V96, P137, DOI 10.1603/0022-0493-96.1.137; Burkness Eric C, 2010, GM Crops, V1, P337, DOI 10.4161/gmcr.1.5.14765; Caccia S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009975; Caprio MA, 1998, J ECON ENTOMOL, V91, P1021, DOI 10.1093/jee/91.5.1021; Carmona D, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019952; Carpenter JE, 2010, NAT BIOTECHNOL, V28, P319, DOI 10.1038/nbt0410-319; Carriere Y, 2003, P NATL ACAD SCI USA, V100, P1519, DOI 10.1073/pnas.0436708100; Carriere Y, 2001, P ROY SOC B-BIOL SCI, V268, P1475, DOI 10.1098/rspb.2001.1689; Carriere Y, 2012, P NATL ACAD SCI USA, V109, P775, DOI 10.1073/pnas.1117851109; Carriere Y, 2010, EVOL APPL, V3, P561, DOI 10.1111/j.1752-4571.2010.00129.x; Cattaneo MG, 2006, P NATL ACAD SCI USA, V103, P7571, DOI 10.1073/pnas.0508312103; Crespo ALB, 2011, J INVERTEBR PATHOL, V107, P185, DOI 10.1016/j.jip.2011.04.007; Crespo ALB, 2009, PEST MANAG SCI, V65, P1071, DOI 10.1002/ps.1793; Crowder DW, 2009, J THEOR BIOL, V261, P423, DOI 10.1016/j.jtbi.2009.08.017; de Maagd RA, 2003, ANNU REV GENET, V37, P409, DOI 10.1146/annurev.genet.37.110801.143042; Downes S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012567; Dutton A., 2004, Bulletin OILB/SROP, V27, P49; Edgerton MD, 2012, NAT BIOTECHNOL, V30, P493, DOI 10.1038/nbt.2259; Ferre J, 2002, ANNU REV ENTOMOL, V47, P501, DOI 10.1146/annurev.ento.47.091201.145234; Gao YL, 2009, J ECON ENTOMOL, V102, P1217, DOI 10.1603/029.102.0347; Gassmann AJ, 2014, P NATL ACAD SCI USA, V111, P5141, DOI 10.1073/pnas.1317179111; Gassmann AJ, 2009, ANNU REV ENTOMOL, V54, P147, DOI 10.1146/annurev.ento.54.110807.090518; Gouffon C, 2011, APPL ENVIRON MICROB, V77, P3182, DOI 10.1128/AEM.02791-10; Gould F, 1998, ANNU REV ENTOMOL, V43, P701, DOI 10.1146/annurev.ento.43.1.701; GOULD F, 1986, ENVIRON ENTOMOL, V15, P1, DOI 10.1093/ee/15.1.1; Gould F, 2006, J ECON ENTOMOL, V99, P2091, DOI 10.1603/0022-0493-99.6.2091; Groeters FR, 2000, J ECON ENTOMOL, V93, P1580, DOI 10.1603/0022-0493-93.6.1580; Heckel DG, 2007, J INVERTEBR PATHOL, V95, P192, DOI 10.1016/j.jip.2007.03.008; Hernandez CS, 2005, APPL ENVIRON MICROB, V71, P5627, DOI 10.1128/AEM.71.9.5627-5629.2005; Hutchison WD, 2010, SCIENCE, V330, P222, DOI 10.1126/science.1190242; Jackson RE, 2006, J ECON ENTOMOL, V99, P1790, DOI 10.1603/0022-0493-99.5.1790; Jackson RE, 2004, J ECON ENTOMOL, V97, P1719, DOI 10.1603/0022-0493-97.5.1719; James C., 2013, ISAAA BRIEFS; Jurat-Fuentes JL, 2012, INSECT PATHOLOGY, 2ND EDITION, P265, DOI 10.1016/B978-0-12-384984-7.00008-7; LI JD, 1991, NATURE, V353, P815, DOI 10.1038/353815a0; Lu YH, 2012, NATURE, V487, P362, DOI 10.1038/nature11153; Matten, 2012, REGULATION AGR BIOTE, P1752267; MCKENZIE JA, 1994, TRENDS ECOL EVOL, V9, P166, DOI 10.1016/0169-5347(94)90079-5; National Research Council, 2010, IMP GEN ENG CROPS FA; NELSON R R, 1972, Journal of Environmental Quality, V1, P220, DOI 10.2134/jeq1972.00472425000100030004x; Nguyen HT, 2009, J AGR FOOD CHEM, V57, P9990, DOI 10.1021/jf901115m; Onstad DW, 2010, J ECON ENTOMOL, V103, P849, DOI 10.1603/EC09199; Pardo-Lopez L, 2013, FEMS MICROBIOL REV, V37, P3, DOI 10.1111/j.1574-6976.2012.00341.x; Pigott CR, 2007, MICROBIOL MOL BIOL R, V71, P255, DOI 10.1128/MMBR.00034-06; Roush RT, 1998, PHILOS T R SOC B, V353, P1777, DOI 10.1098/rstb.1998.0330; Shi GM, 2013, NAT BIOTECHNOL, V31, P111, DOI 10.1038/nbt.2496; Siebert MW, 2012, J ECON ENTOMOL, V105, P1825, DOI 10.1603/EC12155; Sisterson MS, 2004, J ECON ENTOMOL, V97, P1413, DOI 10.1603/0022-0493-97.4.1413; Sivasupramaniam S, 2008, J ECON ENTOMOL, V101, P546, DOI 10.1603/0022-0493(2008)101[546:TACOCE]2.0.CO;2; Tabashnik BE, 2004, J EVOLUTION BIOL, V17, P904, DOI 10.1111/j.1420-9101.2004.00695.x; Tabashnik BE, 1996, APPL ENVIRON MICROB, V62, P2839, DOI 10.1128/AEM.62.8.2839-2844.1996; Tabashnik BE, 2002, APPL ENVIRON MICROB, V68, P3790, DOI 10.1128/AEM.68.8.3790-3794.2002; Tabashnik BE, 2008, NAT BIOTECHNOL, V26, P199, DOI 10.1038/nbt1382; Tabashnik BE, 2014, J ECON ENTOMOL, V107, P496, DOI 10.1603/EC13458; Tabashnik BE, 2013, NAT BIOTECHNOL, V31, P510, DOI 10.1038/nbt.2597; Tabashnik BE, 2012, J ECON ENTOMOL, V105, P767, DOI 10.1603/EC12080; Tabashnik BE, 2010, NAT BIOTECHNOL, V28, P1304, DOI 10.1038/nbt.1704; Tabashnik BE, 2009, J ECON ENTOMOL, V102, P2011, DOI 10.1603/029.102.0601; US Environmental Protection Agency, 1998, FIN REP SUBP BAC THU; US Environmental Protection Agency, 2011, CURR PREV REG SECT 3; US EPA, 2007, PEST NEWS STOR EPA A; (US EPA) U. S. Environmental Protection Agency, 1998, ENV PROT AG WHIT PAP; van Frankenhuyzen K, 2013, J INVERTEBR PATHOL, V114, P76, DOI 10.1016/j.jip.2013.05.010; Williams JL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021863; Wolfenbarger LL, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002118; Wu KM, 2008, SCIENCE, V321, P1676, DOI 10.1126/science.1160550; Zhao JZ, 2005, P NATL ACAD SCI USA, V102, P8426, DOI 10.1073/pnas.0409324102	75	208	225	2	161	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1087-0156	1546-1696		NAT BIOTECHNOL	Nat. Biotechnol.	FEB	2015	33	2					161	168		10.1038/nbt.3099	http://dx.doi.org/10.1038/nbt.3099			8	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	CA8VK	25599179				2022-12-27	WOS:000349198800021
J	Sanchez, MA				Sanchez, Miguel A.			Conflict of interests and evidence base for GM crops food/feed safety research	NATURE BIOTECHNOLOGY			English	Letter							FOOD		ChileBio, Santiago, Chile		Sanchez, MA (corresponding author), ChileBio, Santiago, Chile.	masanchez@chilebio.cl						Diels J, 2011, FOOD POLICY, V36, P197, DOI 10.1016/j.foodpol.2010.11.016; Nicolia A, 2014, CRIT REV BIOTECHNOL, V34, P77, DOI 10.3109/07388551.2013.823595; Nielsen KM, 2013, PLOS BIOL, V11, DOI 10.1371/journal.pbio.1001499; Robinson C, 2013, J EPIDEMIOL COMMUN H, V67, P717, DOI 10.1136/jech-2012-202185; Vain P, 2007, NAT BIOTECHNOL, V25, P624, DOI 10.1038/nbt0607-624b	5	11	11	2	76	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156	1546-1696		NAT BIOTECHNOL	Nat. Biotechnol.	FEB	2015	33	2					135	137		10.1038/nbt.3133	http://dx.doi.org/10.1038/nbt.3133			3	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	CA8VK	25658276				2022-12-27	WOS:000349198800013
J	Kling, J				Kling, Jim			Labeling for better or worse	NATURE BIOTECHNOLOGY			English	News Item																		European Commission Directorate General for Health and Consumers (DG SANCO), 2010, EV EU LEG FRAM FIELD; Handel L., 2014, WILL VERMONTS GMO LA; Leibtag E, 2008, CORN PRICES NEAR REC; Revkin A. C., 2014, NY TIMES; Ruanjan P, 2007, BIOL PLANTARUM, V51, P517, DOI 10.1007/s10535-007-0110-0; Speath B., 2011, CROPS REAPING BENEFI	6	6	6	0	1	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156	1546-1696		NAT BIOTECHNOL	Nat. Biotechnol.	DEC	2014	32	12					1180	1183		10.1038/nbt.3087	http://dx.doi.org/10.1038/nbt.3087			4	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	AW3AD	25489830				2022-12-27	WOS:000346156800014
J	Brennan, TA; Wilson, JM				Brennan, Troyen A.; Wilson, James M.			The special case of gene therapy pricing	NATURE BIOTECHNOLOGY			English	Article							HEMOPHILIA-B	Gene therapy companies that pursue high, one-time payments for their products risk a backlash from payors. A better solution may lie in a pay-for-performance model.	[Brennan, Troyen A.] CVS Caremark, Woonsocket, RI 02895 USA; [Wilson, James M.] Univ Penn, Dept Pathol & Lab Med, Perelman Sch Med, Philadelphia, PA USA	University of Pennsylvania; Pennsylvania Medicine	Brennan, TA (corresponding author), CVS Caremark, Woonsocket, RI 02895 USA.	troyen.brennan@cvscaremark.com	Wilson, James M/F-9220-2011	Wilson, James M/0000-0002-9630-3131				[Anonymous], 2014, JEFF 2014 GLOB HEALT; Berndt ER, 2005, HEALTH AFFAIR, V24, P653, DOI 10.1377/hlthaff.24.3.653; Bordonaro G., 2009, HARTFORD BUSINESS J; Brennan T, 2014, JAMA-J AM MED ASSOC, V312, P593, DOI 10.1001/jama.2014.8897; Bryant LR, 2013, PERS CONTIN PHILOS, P55; Buchlis G, 2012, BLOOD, V119, P3038, DOI 10.1182/blood-2011-09-382317; Gostin L.O., 2014, LAW HLTH SYSTEM CASE; Kesselheim AS, 2011, MILBANK Q, V89, P450, DOI 10.1111/j.1468-0009.2011.00636.x; Kohn DB, 2013, BIOL BLOOD MARROW TR, V19, pS64, DOI 10.1016/j.bbmt.2012.09.021; KREMER M, 2001, INNOVATION POLICY EC; Maguire AM, 2008, NEW ENGL J MED, V358, P2240, DOI 10.1056/NEJMoa0802315; Nathan DG, 2009, GENOME MED, V1, DOI 10.1186/gm114; Nathwani AC, 2011, NEW ENGL J MED, V365, P2357, DOI 10.1056/NEJMoa1108046; National Library of Medicine, 2014, GEN HOM REF; Wilson J.M., 2013, GENET ENG NEWS, V33, P62; Xiao PJ, 2012, THER DELIV, V3, P835, DOI 10.4155/TDE.12.63	16	48	49	0	4	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156	1546-1696		NAT BIOTECHNOL	Nat. Biotechnol.	SEP	2014	32	9					874	876		10.1038/nbt.3003	http://dx.doi.org/10.1038/nbt.3003			3	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	AQ2FD	25203033				2022-12-27	WOS:000342600300022
J	Su, ZQ; Labaj, PP; Li, S; Thierry-Mieg, J; Thierry-Mieg, D; Shi, W; Wang, C; Schroth, GP; Setterquist, RA; Thompson, JF; Jones, WD; Xiao, WH; Xu, WH; Jensen, RV; Kelly, R; Xu, J; Conesa, A; Furlanello, C; Gao, HL; Hong, HX; Jafari, N; Letovsky, S; Liao, Y; Lu, F; Oakeley, EJ; Peng, ZY; Praul, CA; Santoyo-Lopez, J; Scherer, A; Shi, T; Smyth, GK; Staedtler, F; Sykacek, P; Tan, XX; Thompson, EA; Vandesompele, J; Wang, MD; Wang, J; Wolfinger, RD; Zavadil, J; Auerbach, SS; Bao, WJ; Binder, H; Blomquist, T; Brilliant, MH; Bushel, PR; Cain, WM; Catalano, JG; Chang, CW; Chen, T; Chen, G; Chen, R; Chierici, M; Chu, TM; Clevert, DA; Deng, YP; Derti, A; Devanarayan, V; Dong, ZR; Dopazo, J; Du, TT; Fang, H; Fang, YX; Fasold, M; Fernandez, A; Fischer, M; Furio-Tari, P; Fuscoe, JC; Caiment, F; Gaj, S; Gandara, J; Gao, H; Ge, WG; Gondo, Y; Gong, BS; Gong, MH; Gong, ZL; Green, B; Guo, C; Guo, L; Guo, LW; Hadfield, J; Hellemans, J; Hochreiter, S; Jia, MW; Jian, M; Johnson, CD; Kay, S; Kleinjans, J; Lababidi, S; Levy, S; Li, QZ; Li, L; Li, L; Li, P; Li, Y; Li, HQ; Li, JY; Li, SY; Lin, SM; Lopez, FJ; Lu, X; Luo, H; Ma, XW; Meehan, J; Megherbi, DB; Mei, N; Mu, B; Ning, BT; Pandey, A; Perez-Florido, J; Perkins, RG; Peters, R; Phan, JH; Pirooznia, M; Qian, F; Qing, T; Rainbow, L; Rocca-Serra, P; Sambourg, L; Sansone, SA; Schwartz, S; Shah, R; Shen, J; Smith, TM; Stegle, O; Stralis-Pavese, N; Stupka, E; Suzuki, Y; Szkotnicki, LT; Tinning, M; Tu, BM; van Deft, J; Vela-Boza, A; Venturini, E; Walker, SJ; Wan, LQ; Wang, W; Wang, JH; Wang, J; Wieben, ED; Willey, JC; Wu, PY; Xuan, J; Yang, Y; Ye, Z; Yin, Y; Yu, Y; Yuan, YC; Zhang, J; Zhang, KK; Zhang, WQ; Zhang, WW; Zhang, YY; Zhao, C; Zheng, YT; Zhou, YM; Zumbo, P; Tong, WD; Kreil, DP; Mason, CE; Shi, LM				Su, Zhenqiang; Labaj, Pawel P.; Li, Sheng; Thierry-Mieg, Jean; Thierry-Mieg, Danielle; Shi, Wei; Wang, Charles; Schroth, Gary P.; Setterquist, Robert A.; Thompson, John F.; Jones, Wendell D.; Xiao, Wenzhong; Xu, Weihong; Jensen, Roderick V.; Kelly, Reagan; Xu, Joshua; Conesa, Ana; Furlanello, Cesare; Gao, Hanlin; Hong, Huixiao; Jafari, Nadereh; Letovsky, Stan; Liao, Yang; Lu, Fei; Oakeley, Edward J.; Peng, Zhiyu; Praul, Craig A.; Santoyo-Lopez, Javier; Scherer, Andreas; Shi, Tieliu; Smyth, Gordon K.; Staedtler, Frank; Sykacek, Peter; Tan, Xin-Xing; Thompson, E. Aubrey; Vandesompele, Jo; Wang, May D.; Wang, Jian; Wolfinger, Russell D.; Zavadil, Jiri; Auerbach, Scott S.; Bao, Wenjun; Binder, Hans; Blomquist, Thomas; Brilliant, Murray H.; Bushel, Pierre R.; Cain, Weimin; Catalano, Jennifer G.; Chang, Ching-Wei; Chen, Tao; Chen, Geng; Chen, Rong; Chierici, Marco; Chu, Tzu-Ming; Clevert, Djork-Arne; Deng, Youping; Derti, Adnan; Devanarayan, Viswanath; Dong, Zirui; Dopazo, Joaquin; Du, Tingting; Fang, Hong; Fang, Yongxiang; Fasold, Mario; Fernandez, Anita; Fischer, Matthias; Furio-Tari, Pedro; Fuscoe, James C.; Caiment, Florian; Gaj, Stan; Gandara, Jorge; Gao, Huan; Ge, Weigong; Gondo, Yoichi; Gong, Binsheng; Gong, Meihua; Gong, Zhuolin; Green, Bridgett; Guo, Chao; Guo, Lei; Guo, Li-Wu; Hadfield, James; Hellemans, Jan; Hochreiter, Sepp; Jia, Meiwen; Jian, Min; Johnson, Charles D.; Kay, Suzanne; Kleinjans, Jos; Lababidi, Samir; Levy, Shawn; Li, Quan-Zhen; Li, Li; Li, Li; Li, Peng; Li, Yan; Li, Haiqing; Li, Jianying; Li, Shiyong; Lin, Simon M.; Lopez, Francisco J.; Lu, Xin; Luo, Heng; Ma, Xiwen; Meehan, Joseph; Megherbi, Dalila B.; Mei, Nan; Mu, Bing; Ning, Baitang; Pandey, Akhilesh; Perez-Florido, Javier; Perkins, Roger G.; Peters, Ryan; Phan, John H.; Pirooznia, Mehdi; Qian, Feng; Qing, Tao; Rainbow, Lucille; Rocca-Serra, Philippe; Sambourg, Laure; Sansone, Susanna-Assunta; Schwartz, Scott; Shah, Ruchir; Shen, Jie; Smith, Todd M.; Stegle, Oliver; Stralis-Pavese, Nancy; Stupka, Elia; Suzuki, Yutaka; Szkotnicki, Lee T.; Tinning, Matthew; Tu, Bimeng; van Deft, Joost; Vela-Boza, Alicia; Venturini, Elisa; Walker, Stephen J.; Wan, Liqing; Wang, Wei; Wang, Jinhui; Wang, Jun; Wieben, Eric D.; Willey, James C.; Wu, Po-Yen; Xuan, Jiekun; Yang, Yong; Ye, Zhan; Yin, Ye; Yu, Ying; Yuan, Yate-Ching; Zhang, John; Zhang, Ke K.; Zhang, Wenqian; Zhang, Wenwei; Zhang, Yanyan; Zhao, Chen; Zheng, Yuanting; Zhou, Yiming; Zumbo, Paul; Tong, Weida; Kreil, David P.; Mason, Christopher E.; Shi, Leming			A comprehensive assessment of RNA-seq accuracy, reproducibility and information content by the Sequencing Quality Control Consortium	NATURE BIOTECHNOLOGY			English	Article							DIFFERENTIAL GENE-EXPRESSION; GENOME ANNOTATION; TRANSCRIPTOME; ARRAYS; BIAS; PCR	We present primary results from the Sequencing Quality Control (SEQC) project, coordinated by the US Food and Drug Administration. Examining Illumina HiSeq, Life Technologies SOLiD and Roche 454 platforms at multiple laboratory sites using reference RNA samples with built-in controls, we assess RNA sequencing (RNA-seq) performance for junction discovery and differential expression profiling and compare it to microarray and quantitative PCR (qPCR) data using complementary metrics. At all sequencing depths, we discover unannotated exon-exon junctions, with >80% validated by qPCR. We find that measurements of relative expression are accurate and reproducible across sites and platforms if specific-filters are used. In contrast, RNA-seq and microarrays do not provide accurate absolute measurements, and gene-specific biases are observed for all examined platforms, including qPCR. Measurement performance depends on the platform and data analysis pipeline, and variation is large for transcript-level profiling. The complete SEQC data sets, comprising >100 billion reads (10Tb), provide unique resources for evaluating RNA-seq analyses for clinical and regulatory settings.	[Su, Zhenqiang; Kelly, Reagan; Xu, Joshua; Hong, Huixiao; Chang, Ching-Wei; Chen, Tao; Fang, Hong; Fuscoe, James C.; Ge, Weigong; Gong, Binsheng; Green, Bridgett; Guo, Lei; Guo, Li-Wu; Li, Yan; Meehan, Joseph; Mei, Nan; Ning, Baitang; Perkins, Roger G.; Qian, Feng; Shen, Jie; Wan, Liqing; Xuan, Jiekun; Zhang, Wenqian; Tong, Weida; Shi, Leming] US FDA, Natl Ctr Toxicol Res, Jefferson, AR 72079 USA; [Labaj, Pawel P.; Sykacek, Peter; Stralis-Pavese, Nancy; Kreil, David P.] Boku Univ Vienna, Chair Bioinformat Res Grp, Vienna, Austria; [Li, Sheng; Gandara, Jorge; Zumbo, Paul; Mason, Christopher E.] Weill Cornell Med Coll, Dept Physiol & Biophys, New York, NY USA; [Li, Sheng; Zumbo, Paul; Mason, Christopher E.] Weill Cornell Med Coll, HRH Prince Alwaleed Bin Talal Bin Abdulaziz Alsau, New York, NY USA; [Thierry-Mieg, Jean; Thierry-Mieg, Danielle] NCBI, NIH, Bethesda, MD USA; [Shi, Wei; Liao, Yang; Smyth, Gordon K.] Walter & Eliza Hall Inst Med Res, Bioinformat Div, Parkville, Vic, Australia; [Shi, Wei] Univ Melbourne, Dept Comp & Informat Syst, Parkville, Vic 3052, Australia; [Wang, Charles] Loma Linda Univ, Ctr Genom, Sch Med, Loma Linda, CA 92350 USA; [Wang, Charles] Loma Linda Univ, Div Microbiol & Mol Genet, Sch Med, Loma Linda, CA 92350 USA; [Schroth, Gary P.] Illumina Inc, Hayward, CA USA; [Setterquist, Robert A.] Life Technol Corp, Austin, TX USA; [Thompson, John F.] Claritas Genom, Cambridge, MA USA; [Jones, Wendell D.] Express Anal Inc, Durham, NC USA; [Xiao, Wenzhong] Harvard Univ, Massachusetts Gen Hosp, Sch Med, Boston, MA USA; [Xiao, Wenzhong; Xu, Weihong] Stanford Genome Technol Ctr, Palo Alto, CA USA; [Jensen, Roderick V.] Virginia Tech, Dept Biol Sci, Blacksburg, VA USA; [Conesa, Ana; Dopazo, Joaquin; Furio-Tari, Pedro] Ctr Invest Principe Felipe, Computat Genom Program, Valencia, Spain; [Furlanello, Cesare; Chierici, Marco] Fdn Bruno Kessler, Trento, Trento, Italy; [Gao, Hanlin; Wang, Jinhui] City Hope Natl Med Ctr, DNA Sequencing Solexa Core, Beckman Res Inst, City Hope Comprehens Canc Ctr, Duarte, CA 91010 USA; [Jafari, Nadereh] Northwestern Univ, Ctr Genet Med, Feinberg Sch Med, Chicago, IL 60611 USA; [Letovsky, Stan] SynapDx Corp, Lexington, MA USA; [Liao, Yang] Univ Melbourne, Dept Med Biol, Parkville, Vic 3052, Australia; [Lu, Fei; Tan, Xin-Xing; Szkotnicki, Lee T.] GE Healthcare SeqWright Genom Serv, Houston, TX USA; [Oakeley, Edward J.; Staedtler, Frank; Fernandez, Anita] Novartis Inst Biomed Res, Basel, Switzerland; [Peng, Zhiyu; Dong, Zirui; Gao, Huan; Gong, Meihua; Gong, Zhuolin; Jian, Min; Li, Shiyong; Tu, Bimeng; Wang, Jun; Yin, Ye; Zhang, Wenqian; Zhang, Wenwei; Zhang, Yanyan] BGI Shenzhen, Bei Shan Ind Zone, Shenzhen, Guangdong, Peoples R China; [Praul, Craig A.] Penn State Univ, University Pk, PA 16802 USA; [Santoyo-Lopez, Javier; Lopez, Francisco J.; Perez-Florido, Javier; Vela-Boza, Alicia] Genom & Bioinformat Platform Andalusia, Med Genome Project, Seville, Spain; [Santoyo-Lopez, Javier] Univ Edinburgh, Edinburgh Genom, Edinburgh, Midlothian, Scotland; [Scherer, Andreas; Tinning, Matthew] Australian Genome Res Facil Ltd, Walter & Eliza Hall Inst Med Res, Parkville, Vic, Australia; [Scherer, Andreas] Spheromics, Kontiolahti, Finland; [Shi, Tieliu; Chen, Geng; Li, Peng; Zhao, Chen] E China Normal Univ, Inst Biomed Sci, Ctr Bioinformat & Computat Biol, Shanghai Key Lab Regulatory Biol, Shanghai 200062, Peoples R China; [Shi, Tieliu; Chen, Geng; Li, Peng; Zhao, Chen] E China Normal Univ, Sch Life Sci, Shanghai 200062, Peoples R China; [Smyth, Gordon K.] Univ Melbourne, Dept Math & Stat, Parkville, Vic 3052, Australia; [Thompson, E. Aubrey] Mayo Clin Jacksonville, Dept Canc Biol, Jacksonville, FL 32224 USA; [Vandesompele, Jo; Hellemans, Jan] Biogazelle, Zwijnaarde, Belgium; [Wang, May D.; Phan, John H.] GeorgiaTech, Dept Biomed Engn, Atlanta, GA USA; [Wang, May D.; Phan, John H.] Emory Univ, Atlanta, GA 30322 USA; [Wang, Jian; Yang, Yong] Eli Lilly & Co, Lilly Corp Ctr, Res Informat, Indianapolis, IN 46285 USA; [Wolfinger, Russell D.; Bao, Wenjun; Chu, Tzu-Ming; Li, Li] SAS Inst Inc, Cary, NC USA; [Zavadil, Jiri; Venturini, Elisa] NYU, Langone Med Ctr, NYU Genome Technol Ctr, New York, NY USA; [Zavadil, Jiri] NYU, Langone Med Ctr, NYU Ctr Hlth Informat & Bioinformat, Dept Pathol, New York, NY USA; [Zavadil, Jiri] Int Agcy Res Canc, Mol Mech & Biomarkers Grp, F-69372 Lyon, France; [Auerbach, Scott S.; Bushel, Pierre R.; Li, Jianying] NIEHS, NIH, Res Triangle Pk, NC 27709 USA; [Binder, Hans] Univ Leipzig, Interdisciplinary Ctr Bioinformat, D-04109 Leipzig, Germany; [Blomquist, Thomas; Willey, James C.] Univ Toledo, Div Pulm & Crit Care Med, Dept Med, Med Coll Ohio, Toledo, OH 43606 USA; [Brilliant, Murray H.] Marshfield Clin Res Fdn, Ctr Human Genet, Marshfield, WI USA; [Cain, Weimin; Du, Tingting; Jia, Meiwen; Qing, Tao; Yu, Ying; Zheng, Yuanting] Fudan Univ, Sch Pharm, Shanghai 200433, Peoples R China; [Catalano, Jennifer G.] US FDA, Off Cellular Tissue & Gene Therapies, CBER, Bethesda, MD 20014 USA; [Chen, Rong; Li, Li] Icahn Sch Med Mt Sinai, Dept Genet & Genom Sci, Icahn Inst Genom & Multiscale Biol, New York, NY 10029 USA; [Clevert, Djork-Arne; Hochreiter, Sepp] Johannes Kepler Univ Linz, Inst Bioinformat, A-4040 Linz, Austria; [Deng, Youping] Rush Univ, Ctr Canc, Dept Internal Med, Chicago, IL 60612 USA; [Derti, Adnan] Novartis Inst Biomed Res, Cambridge, MA USA; [Devanarayan, Viswanath] AbbVie Inc, Global Pharmaceut R&D, Souderton, PA USA; [Dopazo, Joaquin] CIBER Enfermedades Raras CIBERER, Valencia, Spain; [Dopazo, Joaquin] CIPF, Funct Genom Node INB, Valencia, Spain; [Fang, Yongxiang; Kay, Suzanne; Rainbow, Lucille] Univ Liverpool, Ctr Genom Res, Liverpool L69 3BX, Merseyside, England; [Fasold, Mario] ecSeq Bioinformat, Leipzig, Germany; [Fischer, Matthias] Univ Cologne, Dept Pediat Oncol & Hematol, D-50931 Cologne, Germany; [Fischer, Matthias] Univ Cologne, Ctr Mol Med CMMC, D-50931 Cologne, Germany; [Caiment, Florian; Gaj, Stan; Kleinjans, Jos; van Deft, Joost] Maastricht Univ, Dept Toxicogenom, Maastricht, Netherlands; [Gondo, Yoichi] RIKEN BioResource Ctr, Tsukuba, Ibaraki, Japan; [Guo, Chao] City Hope Natl Med Ctr, Beckman Res Inst, Funct Genom Core, Duarte, CA 91010 USA; [Hadfield, James] Univ Cambridge, Li Ka Shing Ctr, Canc Res UK Cambridge Inst, Cambridge, England; [Johnson, Charles D.; Schwartz, Scott] Texas A&M AgriLife Res, College Stn, TX USA; [Lababidi, Samir] US FDA, CBER, Rockville, MD 20857 USA; [Levy, Shawn] HudsonAlpha Inst Biotechnol, Huntsville, AL USA; [Li, Quan-Zhen] Univ Texas SW Med Ctr Dallas, UTSW, Dallas, TX 75390 USA; [Li, Haiqing; Mu, Bing; Yuan, Yate-Ching] City Hope Natl Med Ctr, Beckman Res Inst, Bioinformat Core, Duarte, CA 91010 USA; [Lin, Simon M.] Nationwide Childrens Hosp, Res Inst, Columbus, OH USA; [Lu, Xin] AbbVie Inc, Global Pharmaceut R&D, N Chicago, IL USA; [Luo, Heng] Univ Arkansas, UALR UAMS Joint Bioinformat Grad Program, Little Rock, AR 72204 USA; [Ma, Xiwen] Eli Lilly & Co, Lilly Corp Ctr, Discovery Stat, Indianapolis, IN 46285 USA; [Megherbi, Dalila B.] Univ Massachusetts, Dept Elect & Comp Engn, CMINDS Res Ctr, Lowell, MA USA; [Pandey, Akhilesh] Johns Hopkins Univ, Sch Med, McKusick Nathans Inst Genet Med, Baltimore, MD USA; [Pandey, Akhilesh] Inst Bioinformat, Bangalore, Karnataka, India; [Peters, Ryan] Partek Inc, St Louis, MO USA; [Pirooznia, Mehdi] Johns Hopkins Univ, Sch Med, Dept Psychiat, Baltimore, MD 21205 USA; [Rocca-Serra, Philippe; Sansone, Susanna-Assunta] Univ Oxford, Oxford e Res Ctr, Oxford, England; [Sambourg, Laure] UJF Grenoble, CNRS TIMC IMAG 1, UMR 5525, Computat & Math Biol BCM, Grenoble, France; [Shah, Ruchir] SRA Int Inc, Durham, NC USA; [Smith, Todd M.] Geospiza Inc, Seattle, WA USA; [Stegle, Oliver] European Bioinformat Inst, European Mol Biol Lab, Cambridge, England; [Stupka, Elia] Ist Sci San Raffaele, Ctr Translat Genom & Bioinformat, I-20132 Milan, Italy; [Suzuki, Yutaka] Univ Tokyo, Dept Med Genome Sci, Chiba, Japan; [Walker, Stephen J.] Wake Forest Univ, Wake Forest Inst Regenerat Med, Winston Salem, NC 27109 USA; [Wang, Wei] Princeton Univ, Lewis Sigler Inst Integrat Genom, Princeton, NJ 08544 USA; [Wang, Jun] Univ Copenhagen, Dept Biol, Copenhagen, Denmark; [Wang, Jun] King Abdulaziz Univ, Jeddah 21413, Saudi Arabia; [Wang, Jun] Univ Copenhagen, Novo Nordisk Fdn Ctr Basic Metab Res, Copenhagen, Denmark; [Wieben, Eric D.] Mayo Clin, Dept Biochem & Mol Biol, Rochester, MN USA; [Wu, Po-Yen] Georgia Inst Technol, Sch Elect & Comp Engn, Atlanta, GA 30332 USA; [Ye, Zhan] Marshfield Clin Res Fdn, Biomed Informat Res Ctr, Marshfield, WI USA; [Zhang, John] Zhejiang Univ Technol, Zhijiang Coll, Ctr Big Data Res, Hangzhou, Zhejiang, Peoples R China; [Zhang, Ke K.] Univ N Dakota, Sch Med, Dept Pathol, Grand Forks, ND 58202 USA; [Zhou, Yiming] Digomics LLC, Brookline, MA USA; [Kreil, David P.] Univ Warwick, Coventry CV4 7AL, W Midlands, England; [Shi, Leming] Fudan Univ, State Key Lab Genet Engn, Shanghai 200433, Peoples R China; [Shi, Leming] Fudan Univ, Sch Life Sci, MOE Key Lab Contemporary Anthropol, Shanghai 200433, Peoples R China; [Shi, Leming] Fudan Univ, Sch Pharm, Shanghai 200433, Peoples R China; [Shi, Leming] Fudan Zhangjiang Ctr Clin Genom, Shanghai, Peoples R China; [Shi, Leming] Zhanjiang Ctr Translat Med, Shanghai, Peoples R China	US Food & Drug Administration (FDA); University of Natural Resources & Life Sciences, Vienna; Cornell University; Cornell University; National Institutes of Health (NIH) - USA; Walter & Eliza Hall Institute; University of Melbourne; Loma Linda University; Loma Linda University; Illumina; Thermo Fisher Scientific; Harvard University; Harvard Medical School; Massachusetts General Hospital; Stanford University; Virginia Polytechnic Institute & State University; Prince Felipe Research Center; Fondazione Bruno Kessler; City of Hope; Beckman Research Institute of City of Hope; Northwestern University; Feinberg School of Medicine; University of Melbourne; General Electric; Novartis; Beijing Genomics Institute (BGI); Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; University of Edinburgh; Walter & Eliza Hall Institute; East China Normal University; East China Normal University; University of Melbourne; Mayo Clinic; Emory University; Eli Lilly; SAS Institute Inc; New York University; NYU Langone Medical Center; New York University; NYU Langone Medical Center; World Health Organization; International Agency for Research on Cancer (IARC); National Institutes of Health (NIH) - USA; NIH National Institute of Environmental Health Sciences (NIEHS); Leipzig University; University System of Ohio; University of Toledo; Fudan University; US Food & Drug Administration (FDA); Icahn School of Medicine at Mount Sinai; Johannes Kepler University Linz; Rush University; Novartis; AbbVie; CIBER - Centro de Investigacion Biomedica en Red; CIBERER; Prince Felipe Research Center; University of Liverpool; University of Cologne; University of Cologne; Maastricht University; RIKEN; City of Hope; Beckman Research Institute of City of Hope; Cancer Research UK; CRUK Cambridge Institute; University of Cambridge; Texas A&M University System; Texas A&M University College Station; Texas A&M AgriLife Research; US Food & Drug Administration (FDA); HudsonAlpha Institute for Biotechnology; University of Texas System; University of Texas Southwestern Medical Center Dallas; City of Hope; Beckman Research Institute of City of Hope; University System of Ohio; Ohio State University; Nationwide Childrens Hospital; Research Institute at Nationwide Children's Hospital; AbbVie; University of Arkansas System; University of Arkansas Fayetteville; University of Arkansas Little Rock; Eli Lilly; University of Massachusetts System; University of Massachusetts Lowell; Johns Hopkins University; Johns Hopkins University; University of Oxford; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute for Engineering & Systems Sciences (INSIS); UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Institut National Polytechnique de Grenoble; Universite Grenoble Alpes (UGA); SRA International; European Molecular Biology Laboratory (EMBL); Vita-Salute San Raffaele University; IRCCS Ospedale San Raffaele; University of Tokyo; Wake Forest University; Princeton University; University of Copenhagen; King Abdulaziz University; Novo Nordisk Foundation; University of Copenhagen; Mayo Clinic; University System of Georgia; Georgia Institute of Technology; Zhejiang University of Technology; University of North Dakota Grand Forks; University of Warwick; Fudan University; Fudan University; Fudan University	Shi, LM (corresponding author), US FDA, Natl Ctr Toxicol Res, Jefferson, AR 72079 USA.	david.krell@boku.ac.at; chm2042@med.cornell.edu; leming.shi@gmail.com	Clevert, Djork Arne/AAT-1782-2021; Jones, Wendell/AAM-4831-2021; Łabaj, Paweł/N-5425-2014; Pirooznia, Mehdi/AAG-1878-2019; Qing, Tao/J-3107-2019; Stegle, Oliver/AAU-9177-2020; Smyth, Gordon/B-5276-2008; Mei, Nan/E-8915-2011; Scherer, Andreas/ABD-8660-2020; Kleinjans, Jos C.S./E-7241-2015; Guo, Chao/B-2647-2010; Luo, Heng/D-3616-2016; Kreil, D/O-1783-2013; caiment, florian/N-7623-2015; Wang, May Dongmei/AAF-2065-2021; Hochreiter, Sepp/AAI-5904-2020; Vandesompele, Jo/W-3411-2018; Santoyo-Lopez, Javier/AHE-5002-2022; THIERRY-MIEG, Jean/F-1975-2017; Shi, Leming/B-3150-2010; Peng, Zhiyu/GXV-5301-2022; Santoyo-Lopez, Javier/C-9714-2012; Cegarra, Ana V Conesa/A-9559-2014; Gondo, Yoichi/A-5375-2016; DONG, Elvis/AAM-9274-2020; Xu, Weihong/C-4175-2012; Zavadil, Jiri/ABG-1780-2020; Gong, Binsheng/E-2306-2015; Mason, Christopher/HCH-3977-2022; Chierici, Marco/P-9949-2019; Wang, Jun/C-8434-2016; Wang, Jun/B-9503-2016; Binder, Hans/U-5519-2018	Pirooznia, Mehdi/0000-0002-4210-6458; Stegle, Oliver/0000-0002-8818-7193; Smyth, Gordon/0000-0001-9221-2892; Mei, Nan/0000-0002-3501-9014; Guo, Chao/0000-0002-6673-0933; Luo, Heng/0000-0001-5192-8878; Kreil, D/0000-0001-7538-2056; Wang, May Dongmei/0000-0003-3961-3608; Hochreiter, Sepp/0000-0001-7449-2528; Vandesompele, Jo/0000-0001-6274-0184; Santoyo-Lopez, Javier/0000-0003-1988-5059; THIERRY-MIEG, Jean/0000-0002-0396-6789; Shi, Leming/0000-0002-7143-2033; Santoyo-Lopez, Javier/0000-0003-1988-5059; Cegarra, Ana V Conesa/0000-0001-9597-311X; Gondo, Yoichi/0000-0003-2184-6489; DONG, Elvis/0000-0002-3626-6500; Xu, Weihong/0000-0002-3988-3571; Zavadil, Jiri/0000-0003-0640-5562; Gong, Binsheng/0000-0002-8724-5435; Chierici, Marco/0000-0001-9791-9301; xiao, wenzhong/0000-0003-4944-6380; Zhang, Yanyan/0000-0001-7801-0215; Wang, Jun/0000-0002-8540-8931; Johnson, Charles/0000-0003-3892-7082; Clevert, Djork-Arne/0000-0003-4191-2156; Perez Florido, Javier/0000-0002-0223-9889; Wang, Jun/0000-0002-2113-5874; Sykacek, Peter/0000-0001-8800-8354; Caiment, Florian/0000-0002-3325-0466; gao, huan/0000-0001-7561-606X; Scherer, Andreas/0000-0002-4254-7122; Levy, Shawn/0000-0002-1369-5740; Ning, Baitang/0000-0003-0798-0331; Stupka, Elia/0000-0003-3154-4011; Li, Shiyong/0000-0003-0416-526X; Labaj, Pawel/0000-0002-4994-0234; guo, lei/0000-0002-0402-4152; Peng, Zhiyu/0000-0003-2349-750X; Hong, Huixiao/0000-0001-8087-3968; Deng, Youping/0000-0002-5951-8213; Thompson, John/0000-0001-8568-3311; Sansone, Susanna-Assunta/0000-0001-5306-5690; Thierry-Mieg, Danielle/0000-0001-9568-4211; Binder, Hans/0000-0002-2242-4678; , Yang/0000-0002-9746-2839; Jones, Wendell/0000-0002-9676-5387	China's Program of Global Experts; US National Institutes of Health (NIH) [R01CA163256, R01HG006798, R01NS076465, R44HG005297, U54CA119338, PO1HG00205, R24GM102656]; Intramural Research Program of the NIH, National Library of Medicine, National Institute of Environmental Health Sciences (NIEHS) [Z01 ES102345-04]; Shriners Research Grant [85500]; Australia National Health and Medical Research Council (NHMRC) [1023454]; Victorian State Government Operational Infrastructure Support (Australia); National 973 Key Basic Research Program of China [2010CB945401]; National Natural Science Foundation of China [31240038, 31071162]; Science and Technology Commission of Shanghai Municipality [11DZ2260300]; NATIONAL CANCER INSTITUTE [R01CA163256, P30CA015083, U54CA119338] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL109054] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [P01HG000205, R01HG006798, R44HG005297] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [Z01ES102345, ZIAES102345] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R24GM102656, P50GM021700] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS076465] Funding Source: NIH RePORTER; Biotechnology and Biological Sciences Research Council [BB/J020265/1, BB/I025840/1, BBS/E/D/20310000, BB/I000771/1] Funding Source: researchfish; BBSRC [BB/I025840/1, BBS/E/D/20310000, BB/I000771/1, BB/J020265/1] Funding Source: UKRI	China's Program of Global Experts; US National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Intramural Research Program of the NIH, National Library of Medicine, National Institute of Environmental Health Sciences (NIEHS); Shriners Research Grant; Australia National Health and Medical Research Council (NHMRC)(National Health and Medical Research Council (NHMRC) of Australia); Victorian State Government Operational Infrastructure Support (Australia); National 973 Key Basic Research Program of China(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Science and Technology Commission of Shanghai Municipality(Science & Technology Commission of Shanghai Municipality (STCSM)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	All SEQC (MAQC-III) participants freely donated their time and reagents for the completion and analyses of the project. Many participants contributed to the sometimes-heated discussions on the topic of this paper during numerous e-mail exchanges, teleconferences and face-to-face project meetings. The common conclusions and recommendations reported in this paper evolved from this extended discourse. The authors gratefully acknowledge support by the National Center for Biotechnology Information (NCBI)'s Supercomputing Center, the FDA's Supercomputing Center, China's National Supercomputing Center of Tianjin, the Vienna Scientific Cluster High Performance Computing Facility (VSC), the Vienna Science and Technology Fund (WWTF), Baxter, the Austrian Institute of Technology, and the Austrian Centre of Biopharmaceutical Technology. This work was supported in part by China's Program of Global Experts. This work was supported in part by the US National Institutes of Health (NIH) grants R01CA163256, R01HG006798, R01NS076465, R44HG005297, U54CA119338, PO1HG00205, R24GM102656 and the Intramural Research Program of the NIH, National Library of Medicine, National Institute of Environmental Health Sciences (NIEHS) Z01 ES102345-04, Shriners Research Grant 85500, an Australia National Health and Medical Research Council (NH&MRC) Project grant (1023454) and Victorian State Government Operational Infrastructure Support (Australia), the National 973 Key Basic Research Program of China (2010CB945401), the National Natural Science Foundation of China (31240038 and 31071162), and the Science and Technology Commission of Shanghai Municipality (11DZ2260300). We greatly appreciate SAS Institute, Inc. for kindly hosting several face-to-face meetings of the SEQC (MAQC-III) project.	Agarwal A, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-383; Aird D, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-2-r18; Baker SC, 2005, NAT METHODS, V2, P731, DOI 10.1038/nmeth1005-731; Benjamini Y, 2012, NUCLEIC ACIDS RES, V40, DOI 10.1093/nar/gks001; Chin L, 2008, NATURE, V455, P1061, DOI 10.1038/nature07385; Dai MH, 2005, NUCLEIC ACIDS RES, V33, DOI 10.1093/nar/gni179; Djebali S, 2012, NATURE, V489, P101, DOI 10.1038/nature11233; Dobin A, 2013, BIOINFORMATICS, V29, P15, DOI 10.1093/bioinformatics/bts635; Fasold M, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-207; Harrow J, 2012, GENOME RES, V22, P1760, DOI 10.1101/gr.135350.111; Hochreiter S, 2006, BIOINFORMATICS, V22, P943, DOI 10.1093/bioinformatics/btl033; Huber Wolfgang, 2002, Bioinformatics, V18 Suppl 1, pS96; Hudson TJ, 2010, NATURE, V464, P993, DOI 10.1038/nature08987; Kim D, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-4-r36; Labaj PP, 2011, BIOINFORMATICS, V27, pI383, DOI 10.1093/bioinformatics/btr247; Levin JZ, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-10-r115; Li S, 2014, NAT BIOTECHNOL, V32, P888, DOI 10.1038/nbt.3000; Li S, 2014, NAT BIOTECHNOL, V32, P915, DOI 10.1038/nbt.2972; Liao Y, 2013, NUCLEIC ACIDS RES, V41, DOI 10.1093/nar/gkt214; Liu S, 2011, NUCLEIC ACIDS RES, V39, P578, DOI 10.1093/nar/gkq817; Liu YC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066883; Marioni JC, 2008, GENOME RES, V18, P1509, DOI 10.1101/gr.079558.108; McIntyre LM, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-293; Mortazavi A, 2008, NAT METHODS, V5, P621, DOI 10.1038/nmeth.1226; Mueckstein U, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-35; Munro S., NAT COMMUNI IN PRESS; Pickrell JK, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001236; Pruitt KD, 2012, NUCLEIC ACIDS RES, V40, pD130, DOI 10.1093/nar/gkr1079; Qing T, 2013, SCI CHINA LIFE SCI, V56, P134, DOI 10.1007/s11427-013-4437-9; Raghavachari N, 2012, BMC MED GENOMICS, V5, DOI 10.1186/1755-8794-5-28; Rapaport F, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-9-r95; Robinson MD, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-3-r25; Shi LM, 2006, NAT BIOTECHNOL, V24, P1151, DOI 10.1038/nbt1239; Shippy R, 2006, NAT BIOTECHNOL, V24, P1123, DOI 10.1038/nbt1241; Smyth GK, 2005, STAT BIOL HEALTH, P397, DOI 10.1007/0-387-29362-0_23; Sykacek P, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-73; Thierry-Mieg D, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-s1-s12; Toung JM, 2011, GENOME RES, V21, P991, DOI 10.1101/gr.116335.110; Trapnell C, 2013, NAT BIOTECHNOL, V31, P46, DOI 10.1038/nbt.2450; VanGuilder HD, 2008, BIOTECHNIQUES, V44, P619, DOI 10.2144/000112776; Wang C, 2014, NAT BIOTECHNOL, V32, P926, DOI 10.1038/nbt.3001; Wang ET, 2008, NATURE, V456, P470, DOI 10.1038/nature07509; Wu ZJ, 2004, J AM STAT ASSOC, V99, P909, DOI 10.1198/016214504000000683; Xu J., SCI DATA IN PRESS; Xu WH, 2011, P NATL ACAD SCI USA, V108, P3707, DOI 10.1073/pnas.1019753108; Yu Y, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4230	46	566	574	11	298	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156	1546-1696		NAT BIOTECHNOL	Nat. Biotechnol.	SEP	2014	32	9					903	914		10.1038/nbt.2957	http://dx.doi.org/10.1038/nbt.2957			12	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	AQ2FD	25150838	Green Accepted			2022-12-27	WOS:000342600300030
J	De Ravin, SS; Reik, A; Liu, PQ; Li, LH; Wu, XL; Su, L; Raley, C; Theobald, N; Choi, U; Song, AH; Chan, A; Pearl, JR; Paschon, DE; Lee, J; Newcombe, H; Koontz, S; Sweeney, C; Shivak, DA; Zarember, KA; Peshwa, MV; Gregory, PD; Urnov, FD; Malech, HL				De Ravin, Suk See; Reik, Andreas; Liu, Pei-Qi; Li, Linhong; Wu, Xiaolin; Su, Ling; Raley, Castle; Theobald, Narda; Choi, Uimook; Song, Alexander H.; Chan, Andy; Pearl, Jocelynn R.; Paschon, David E.; Lee, Janet; Newcombe, Hannah; Koontz, Sherry; Sweeney, Colin; Shivak, David A.; Zarember, Kol A.; Peshwa, Madhusudan V.; Gregory, Philip D.; Urnov, Fyodor D.; Malech, Harry L.			Targeted gene addition in human CD34(+) hematopoietic cells for correction of X-linked chronic granulomatous disease	NATURE BIOTECHNOLOGY			English	Article							THERAPY; STEM; EXPRESSION; VECTORS; OXIDASE	Gene therapy with genetically modified human CD34(+) hematopoietic stem and progenitor cells (HSPCs) may be safer using targeted integration (TI) of transgenes into a genomic 'safe harbor' site rather than random viral integration. We demonstrate that temporally optimized delivery of zinc finger nuclease mRNA via electroporation and adeno-associated virus (AAV) 6 delivery of donor constructs in human HSPCs approaches clinically relevant levels of TI into the AAVS1 safe harbor locus. Up to 58% Venus(+) HSPCs with 6-16% human cell marking were observed following engraftment into mice. In HSPCs from patients with X-linked chronic granulomatous disease (X-CGD), caused by mutations in the gp91phox subunit of the NADPH oxidase, TI of a gp91phox transgene into AAVS1 resulted in similar to 15% gp91phox expression and increased NADPH oxidase activity in ex vivo-derived neutrophils. In mice transplanted with corrected HSPCs, 4-11% of human cells in the bone marrow expressed gp91phox. This method for TI into AAVS1 may be broadly applicable to correction of other monogenic diseases.	[De Ravin, Suk See; Theobald, Narda; Choi, Uimook; Lee, Janet; Newcombe, Hannah; Koontz, Sherry; Sweeney, Colin; Zarember, Kol A.; Malech, Harry L.] NIAID, Host Def Lab, NIH, 9000 Rockville Pike, Bethesda, MD 20892 USA; [Reik, Andreas; Liu, Pei-Qi; Song, Alexander H.; Chan, Andy; Pearl, Jocelynn R.; Paschon, David E.; Shivak, David A.; Gregory, Philip D.; Urnov, Fyodor D.] Sangamo BioSci Inc, Richmond, CA USA; [Li, Linhong] MaxCyte Inc, Gaithersburg, MD USA; [Wu, Xiaolin; Su, Ling; Raley, Castle; Peshwa, Madhusudan V.] Leidos Biomed Res Inc, Canc Res Technol Program, Frederick, MD USA; [Gregory, Philip D.] Blubird Bio, Cambridge, MA USA	National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); Sangamo Therapeutics, Inc.; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	Malech, HL (corresponding author), NIAID, Host Def Lab, NIH, 9000 Rockville Pike, Bethesda, MD 20892 USA.	hmalech@nih.gov		De Ravin, Suk See/0000-0002-9800-774X; Zarember, Kol/0000-0002-9624-7096; Malech, Harry/0000-0001-5874-5775; Gregory, Philip/0000-0001-9249-2468	intramural program of National Institute of Allergy and Infectious Diseases (NIAID), National Institutes of Health [1 ZIA AI000644]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [Z01AI000644, ZIAAI001151, ZIAAI000645, ZIAAI000644, ZIAAI000155, Z01AI000988, ZIAAI000988, ZIAAI000991] Funding Source: NIH RePORTER	intramural program of National Institute of Allergy and Infectious Diseases (NIAID), National Institutes of Health; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	These studies were supported in part by project 1 ZIA AI000644 of the intramural program of National Institute of Allergy and Infectious Diseases (NIAID), National Institutes of Health. Human CD34<SUP>+</SUP> HSPCs were obtained under NIAID IRB approved Protocol 94-I-0073 after written informed consent. Murine animal studies were performed under National Institutes of Allergy and Infectious Diseases (NIAID) Animal Care and Use Committee approved protocol Laboratory of Host Defenses (LHD) 3E.	Astrakhan A, 2012, BLOOD, V119, P4395, DOI 10.1182/blood-2011-03-340711; Biffi A, 2013, SCIENCE, V341, P864, DOI 10.1126/science.1233158; Brenner S, 2003, BLOOD, V102, P2789, DOI 10.1182/blood-2002-05-1482; Carroll D, 2014, METHODS, V69, P137, DOI 10.1016/j.ymeth.2014.03.026; Carroll D, 2014, ANNU REV BIOCHEM, V83, P409, DOI 10.1146/annurev-biochem-060713-035418; Cavazzana-Calvo M, 2000, SCIENCE, V288, P669, DOI 10.1126/science.288.5466.669; CHALLITA PM, 1995, J VIROL, V69, P748, DOI 10.1128/JVI.69.2.748-755.1995; DeKelver RC, 2010, GENOME RES, V20, P1133, DOI 10.1101/gr.106773.110; Gabriel R, 2011, NAT BIOTECHNOL, V29, P816, DOI 10.1038/nbt.1948; Genovese P, 2014, NATURE, V510, P235, DOI 10.1038/nature13420; Hacein-Bey-Abina S, 2003, NEW ENGL J MED, V348, P255, DOI 10.1056/NEJM200301163480314; Hacein-Bey-Abina S, 2010, NEW ENGL J MED, V363, P355, DOI 10.1056/NEJMoa1000164; Kuhns DB, 2010, NEW ENGL J MED, V363, P2600, DOI 10.1056/NEJMoa1007097; Langmead B, 2012, NAT METHODS, V9, P357, DOI [10.1038/NMETH.1923, 10.1038/nmeth.1923]; Marciano BE, 2015, CLIN INFECT DIS, V60, P1176, DOI 10.1093/cid/ciu1154; Moehle EA, 2007, P NATL ACAD SCI USA, V104, P3055, DOI 10.1073/pnas.0611478104; Orlando SJ, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkq512; Song LJ, 2013, CYTOTHERAPY, V15, P986, DOI 10.1016/j.jcyt.2013.04.003; Song LJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058757; Stein S, 2010, NAT MED, V16, P198, DOI 10.1038/nm.2088; Tebas P, 2014, NEW ENGL J MED, V370, P901, DOI 10.1056/NEJMoa1300662; Urnov FD, 2005, NATURE, V435, P646, DOI 10.1038/nature03556; Vierstra J, 2015, NAT METHODS, V12, P927, DOI [10.1038/NMETH.3554, 10.1038/nmeth.3554]; Wang JB, 2015, NAT BIOTECHNOL, V33, P1256, DOI 10.1038/nbt.3408	24	134	138	0	33	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156	1546-1696		NAT BIOTECHNOL	Nat. Biotechnol.	APR	2016	34	4					424	+		10.1038/nbt.3513	http://dx.doi.org/10.1038/nbt.3513			8	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	DI6NL	26950749	Green Accepted			2022-12-27	WOS:000373616100024
J	Elkins, JM; Fedele, V; Szklarz, M; Azeez, KRA; Salah, E; Mikolajczyk, J; Romanov, S; Sepetov, N; Huang, XP; Roth, BL; Zen, AA; Fourches, D; Muratov, E; Tropsha, A; Morris, J; Teicher, BA; Kunkel, M; Polley, E; Lackey, KE; Atkinson, FL; Overington, JP; Bamborough, P; Muller, S; Price, DJ; Willson, TM; Drewry, DH; Knapp, S; Zuercher, WJ				Elkins, Jonathan M.; Fedele, Vita; Szklarz, Marta; Azeez, Kamal R. Abdul; Salah, Eidarus; Mikolajczyk, Jowita; Romanov, Sergei; Sepetov, Nikolai; Huang, Xi-Ping; Roth, Bryan L.; Zen, Ayman Al Haj; Fourches, Denis; Muratov, Eugene; Tropsha, Alex; Morris, Joel; Teicher, Beverly A.; Kunkel, Mark; Polley, Eric; Lackey, Karen E.; Atkinson, Francis L.; Overington, John P.; Bamborough, Paul; Mueller, Susanne; Price, Daniel J.; Willson, Timothy M.; Drewry, David H.; Knapp, Stefan; Zuercher, William J.			Comprehensive characterization of the Published Kinase Inhibitor Set	NATURE BIOTECHNOLOGY			English	Article							DRUG DISCOVERY; PROTEIN-KINASE; POTENT INHIBITORS; INTERACTION MAP; IN-VITRO; SELECTIVITY; KINOME; CANCER; ANGIOGENESIS; SCREEN	Despite the success of protein kinase inhibitors as approved therapeutics, drug discovery has focused on a small subset of kinase targets. Here we provide a thorough characterization of the Published Kinase Inhibitor Set (PKIS), a set of 367 small molecule ATP-competitive kinase inhibitors that was recently made freely available with the aim of expanding research in this field and as an experiment in open-source target validation. We screen the set in activity assays with 224 recombinant kinases and 24 G protein-coupled receptors and in cellular assays of cancer cell proliferation and angiogenesis. We identify chemical starting points for designing new chemical probes of orphan kinases and illustrate the utility of these leads by developing a selective inhibitor for the previously untargeted kinases LOK and SLK. Our cellular screens reveal compounds that modulate cancer cell growth and angiogenesis in vitro. These reagents and associated data illustrate an efficient way forward to increasing understanding of the historically untargeted kinome.	[Elkins, Jonathan M.; Fedele, Vita; Szklarz, Marta; Azeez, Kamal R. Abdul; Salah, Eidarus; Mueller, Susanne; Knapp, Stefan] Univ Oxford, Nuffield Dept Clin Med, Struct Genom Consortium & Target Discovery Inst, Old Rd Campus, Oxford, England; [Mikolajczyk, Jowita; Romanov, Sergei; Sepetov, Nikolai] Nanosyn Inc, Santa Clara, CA USA; [Huang, Xi-Ping; Roth, Bryan L.] Univ N Carolina, Sch Med, Natl Inst Mental Hlth Psychoact Act Drug Screenin, NIMH PDSP,Dept Pharmacol, Chapel Hill, NC USA; [Huang, Xi-Ping; Roth, Bryan L.] Univ N Carolina, Sch Med, Div Chem Biol & Med Chem, Chapel Hill, NC USA; [Zen, Ayman Al Haj] Univ Oxford, Radcliffe Dept Med, Div Cardiovasc Med, British Heart Fdn Ctr Res Excellence, Oxford, England; [Fourches, Denis; Muratov, Eugene; Tropsha, Alex] Univ N Carolina, Div Chem Biol & Med Chem, UNC Eshelman Sch Pharm, Lab Mol Modeling, Chapel Hill, NC USA; [Morris, Joel; Teicher, Beverly A.; Kunkel, Mark; Polley, Eric] NCI, Div Canc Treatment & Diag, Rockville, MD USA; [Lackey, Karen E.] Med Univ S Carolina, Charleston, SC 29425 USA; [Atkinson, Francis L.; Overington, John P.] EMBL EBI, Wellcome Trust Genome Campus, Cambridge, England; [Bamborough, Paul] GlaxoSmithKline, Chem Sci, Stevenage, Herts, England; [Price, Daniel J.; Willson, Timothy M.; Drewry, David H.; Zuercher, William J.] GlaxoSmithKline, Chem Sci, Res Triangle Pk, NC USA; [Knapp, Stefan] Goethe Univ Frankfurt, Inst Pharmazeut Chem, Georg Voigt Str 14, Frankfurt, Germany; [Knapp, Stefan] Buchmann Inst Mol Life Sci BMLS, Frankfurt, Germany; [Overington, John P.; Willson, Timothy M.; Drewry, David H.; Zuercher, William J.] Novartis Vaccines & Diagnost, Holly Springs, NC USA; [Fourches, Denis] N Carolina State Univ, Dept Chem, Bioinformat Res Ctr, Box 8204, Raleigh, NC 27695 USA; [Overington, John P.] Stratified Med, London, England; [Drewry, David H.] Meryx Pharmaceut, Chapel Hill, NC USA; [Willson, Timothy M.; Zuercher, William J.] Univ N Carolina, UNC Eshelman Sch Pharm, SGC UNC, Div Chem Biol & Med Chem, Chapel Hill, NC USA	University of Oxford; National Institutes of Health (NIH) - USA; NIH National Institute of Mental Health (NIMH); University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine; University of Oxford; University of North Carolina; University of North Carolina Chapel Hill; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Medical University of South Carolina; European Molecular Biology Laboratory (EMBL); Wellcome Trust Sanger Institute; GlaxoSmithKline; GlaxoSmithKline; Goethe University Frankfurt; Novartis; University of North Carolina; North Carolina State University; University of North Carolina; University of North Carolina Chapel Hill	Drewry, DH; Zuercher, WJ (corresponding author), GlaxoSmithKline, Chem Sci, Res Triangle Pk, NC USA.; Knapp, S (corresponding author), Goethe Univ Frankfurt, Inst Pharmazeut Chem, Georg Voigt Str 14, Frankfurt, Germany.; Knapp, S (corresponding author), Buchmann Inst Mol Life Sci BMLS, Frankfurt, Germany.; Drewry, DH; Zuercher, WJ (corresponding author), Novartis Vaccines & Diagnost, Holly Springs, NC USA.	david.drewry@meryxpharma.com; knapp@pharmchem.uni-frankfurt.de; william.zuercher@unc.edu	Zen, Ayman Al Haj/D-9035-2012; Muratov, Eugene/C-4454-2014; Knapp, Stefan/AAG-2347-2019; feinstein, doug/M-9414-2019; Fourches, Denis/H-4336-2019; Roth, Bryan L/F-3928-2010; Tropsha, Alexander/AAB-8324-2020; Overington, John P/G-8607-2015; Roth, Bryan/ABE-7032-2020	Muratov, Eugene/0000-0003-4616-7036; Knapp, Stefan/0000-0001-5995-6494; Overington, John P/0000-0002-5859-1064; Roth, Bryan/0000-0002-0561-6520; Atkinson, Francis/0000-0003-4688-959X; Muller-Knapp, Susanne/0000-0003-2402-4157; Drewry, David Harold/0000-0001-5973-5798; Fourches, Denis/0000-0001-5642-8303; Al Haj Zen, Ayman/0000-0002-2145-2925; Elkins, Jon/0000-0003-2858-8929	AbbVie; Bayer Pharma AG; Boehringer Ingelheim; Canada Foundation for Innovation; Eshelman Institute for Innovation; Genome Canada; Innovative Medicines Initiative (EU/EFPIA); Janssen; Merck Co.; Novartis Pharma AG; Ontario Ministry of Economic Development and Innovation; Pfizer; Sao Paulo Research Foundation-FAPESP; Takeda; Wellcome Trust; BHF Centre of Research Excellence, Oxford [RE/13/1/30181]	AbbVie(AbbVie); Bayer Pharma AG; Boehringer Ingelheim(Boehringer Ingelheim); Canada Foundation for Innovation(Canada Foundation for InnovationCGIAR); Eshelman Institute for Innovation; Genome Canada(Genome Canada); Innovative Medicines Initiative (EU/EFPIA); Janssen(Johnson & JohnsonJohnson & Johnson USAJanssen Biotech Inc); Merck Co.(Merck & Company); Novartis Pharma AG; Ontario Ministry of Economic Development and Innovation; Pfizer(Pfizer); Sao Paulo Research Foundation-FAPESP(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); Takeda(Takeda Pharmaceutical Company Ltd); Wellcome Trust(Wellcome TrustEuropean Commission); BHF Centre of Research Excellence, Oxford	The Structural Genomics Consortium is a registered charity (number 1097737) that receives funds from AbbVie, Bayer Pharma AG, Boehringer Ingelheim, Canada Foundation for Innovation, Eshelman Institute for Innovation, Genome Canada, Innovative Medicines Initiative (EU/EFPIA), Janssen, Merck & Co., Novartis Pharma AG, Ontario Ministry of Economic Development and Innovation, Pfizer, Sao Paulo Research Foundation-FAPESP, Takeda, and Wellcome Trust. A.A.H.Z. acknowledges support from the BHF Centre of Research Excellence, Oxford (RE/13/1/30181).	Anastassiadis T, 2011, NAT BIOTECHNOL, V29, P1039, DOI 10.1038/nbt.2017; Ardini E, 2014, MOL ONCOL, V8, P1495, DOI 10.1016/j.molonc.2014.06.001; Arnaoutova I, 2010, NAT PROTOC, V5, P628, DOI 10.1038/nprot.2010.6; Atkinson JM, 2011, CANCER CELL, V20, P384, DOI 10.1016/j.ccr.2011.08.013; Bain J, 2007, BIOCHEM J, V408, P297, DOI 10.1042/BJ20070797; Bamborough P, 2012, EXPERT OPIN DRUG DIS, V7, P1053, DOI 10.1517/17460441.2012.724056; Bamborough P, 2008, J MED CHEM, V51, P7898, DOI 10.1021/jm8011036; Belkina NV, 2009, P NATL ACAD SCI USA, V106, P4707, DOI 10.1073/pnas.0805963106; Ciceri P, 2014, NAT CHEM BIOL, V10, P305, DOI 10.1038/nchembio.1471; Cohen P, 2013, ACS CHEM BIOL, V8, P96, DOI 10.1021/cb300610s; Conway JG, 2005, P NATL ACAD SCI USA, V102, P16078, DOI 10.1073/pnas.0502000102; Davies SP, 2000, BIOCHEM J, V351, P95, DOI 10.1042/0264-6021:3510095; Davis MI, 2011, NAT BIOTECHNOL, V29, P1046, DOI 10.1038/nbt.1990; Dranchak P, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057888; Drewry DH, 2014, CURR TOP MED CHEM, V14, P340, DOI 10.2174/1568026613666131127160819; Edwards AM, 2009, NAT CHEM BIOL, V5, P436, DOI 10.1038/nchembio0709-436; Ember SWJ, 2014, ACS CHEM BIOL, V9, P1160, DOI 10.1021/cb500072z; Fabian MA, 2005, NAT BIOTECHNOL, V23, P329, DOI 10.1038/nbt1068; Faivre S, 2007, NAT REV DRUG DISCOV, V6, P734, DOI 10.1038/nrd2380; Fedorov O, 2007, P NATL ACAD SCI USA, V104, P20523, DOI 10.1073/pnas.0708800104; Fedorov O, 2012, METHODS MOL BIOL, V795, P109, DOI 10.1007/978-1-61779-337-0_7; Fedorov O, 2010, NAT CHEM BIOL, V6, P166, DOI 10.1038/nchembio.297; Folkman J, 2007, NAT REV DRUG DISCOV, V6, P273, DOI 10.1038/nrd2115; Fourches D, 2013, MOL INFORM, V32, P827, DOI 10.1002/minf.201300076; Gao YH, 2013, BIOCHEM J, V451, P313, DOI 10.1042/BJ20121418; Guo KX, 2014, J BIOMOL SCREEN, V19, P538, DOI 10.1177/1087057113520325; Hasegawa M, 2007, J MED CHEM, V50, P4453, DOI 10.1021/jm0611051; Haystead TAJ, 2006, CURR TOP MED CHEM, V6, P1117; Huber KVM, 2014, NATURE, V508, P222, DOI 10.1038/nature13194; Jester BW, 2010, J AM CHEM SOC, V132, P11727, DOI 10.1021/ja104491h; Karaman MW, 2008, NAT BIOTECHNOL, V26, P127, DOI 10.1038/nbt1358; Knight ZA, 2005, CHEM BIOL, V12, P621, DOI 10.1016/j.chembiol.2005.04.011; Kuramochi S, 1997, J BIOL CHEM, V272, P22679, DOI 10.1074/jbc.272.36.22679; Metz JT, 2011, NAT CHEM BIOL, V7, P200, DOI 10.1038/NCHEMBIO.530; Miyazaki Y, 2007, BIOORG MED CHEM LETT, V17, P1773, DOI 10.1016/j.bmcl.2006.12.077; Olsson AK, 2006, NAT REV MOL CELL BIO, V7, P359, DOI 10.1038/nrm1911; Paolini GV, 2006, NAT BIOTECHNOL, V24, P805, DOI 10.1038/nbt1228; Posy SL, 2011, J MED CHEM, V54, P54, DOI 10.1021/jm101195a; Reinhold WC, 2012, CANCER RES, V72, P3499, DOI 10.1158/0008-5472.CAN-12-1370; Shoemaker RH, 2006, NAT REV CANCER, V6, P813, DOI 10.1038/nrc1951; Takle AK, 2006, BIOORG MED CHEM LETT, V16, P378, DOI 10.1016/j.bmcl.2005.09.072; Verheul HMW, 2007, NAT REV CANCER, V7, P475, DOI 10.1038/nrc2152; Viswanatha R, 2012, J CELL BIOL, V199, P969, DOI 10.1083/jcb.201207047; Weinstein JN, 1997, SCIENCE, V275, P343, DOI 10.1126/science.275.5298.343; Wilhelm S, 2006, NAT REV DRUG DISCOV, V5, P835, DOI 10.1038/nrd2130; Witherington J, 2003, BIOORG MED CHEM LETT, V13, P1581, DOI 10.1016/S0960-894X(03)00135-5; Workman P, 2010, CHEM BIOL, V17, P561, DOI 10.1016/j.chembiol.2010.05.013; Wu P, 2015, TRENDS PHARMACOL SCI, V36, P422, DOI 10.1016/j.tips.2015.04.005; Zhang JM, 2009, NAT REV CANCER, V9, P28, DOI 10.1038/nrc2559	49	196	200	1	68	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156	1546-1696		NAT BIOTECHNOL	Nat. Biotechnol.	JAN	2016	34	1					95	103		10.1038/nbt.3374	http://dx.doi.org/10.1038/nbt.3374			9	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	DB8HQ	26501955	Green Submitted, hybrid			2022-12-27	WOS:000368758200033
J	Kleinstiver, BP; Prew, MS; Tsai, SQ; Nguyen, NT; Topkar, VV; Zheng, ZL; Joung, JK				Kleinstiver, Benjamin P.; Prew, Michelle S.; Tsai, Shengdar Q.; Nguyen, Nhu T.; Topkar, Ved V.; Zheng, Zongli; Joung, J. Keith			Broadening the targeting range of Staphylococcus aureus CRISPR-Cas9 by modifying PAM recognition	NATURE BIOTECHNOLOGY			English	Article							CRYSTAL-STRUCTURE; GUIDE RNA; DUAL-RNA; CAS9; DNA; ENDONUCLEASE; NUCLEASES; EVOLUTION	CRISPR-Cas9 nucleases target specific DNA sequences using a guide RNA but also require recognition of a protospacer adjacent motif (PAM) by the Cas9 protein. Although longer PAMs can potentially improve the specificity of genome editing, they limit the range of sequences that Cas9 orthologs can target. One potential strategy to relieve this restriction is to relax the PAM recognition specificity of Cas9. Here we used molecular evolution to modify the NNGRRT PAM of Staphylococcus aureus Cas9 (SaCas9). One variant we identified, referred to as KKH SaCas9, showed robust genome editing activities at endogenous human target sites with NNNRRT PAMs, thereby increasing SaCas9 targeting range by two-to fourfold. Using GUIDE-seq, we show that wild-type and KKH SaCas9 induce comparable numbers of off-target effects in human cells. Our strategy for evolving PAM specificity does not require structural information and therefore should be applicable to a wide range of Cas9 orthologs.	[Kleinstiver, Benjamin P.; Prew, Michelle S.; Tsai, Shengdar Q.; Nguyen, Nhu T.; Topkar, Ved V.; Joung, J. Keith] Massachusetts Gen Hosp, Mol Pathol Unit, Charlestown, MA 02129 USA; [Kleinstiver, Benjamin P.; Prew, Michelle S.; Tsai, Shengdar Q.; Nguyen, Nhu T.; Topkar, Ved V.; Joung, J. Keith] Massachusetts Gen Hosp, Ctr Canc Res, Charlestown, MA USA; [Kleinstiver, Benjamin P.; Prew, Michelle S.; Tsai, Shengdar Q.; Nguyen, Nhu T.; Topkar, Ved V.; Joung, J. Keith] Massachusetts Gen Hosp, Ctr Computat & Integrat Biol, Charlestown, MA USA; [Kleinstiver, Benjamin P.; Tsai, Shengdar Q.; Joung, J. Keith] Harvard Univ, Sch Med, Dept Pathol, Boston, MA 02115 USA; [Zheng, Zongli] City Univ Hong Kong, Dept Biomed Sci, Hong Kong, Hong Kong, Peoples R China	Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; City University of Hong Kong	Joung, JK (corresponding author), Massachusetts Gen Hosp, Mol Pathol Unit, Charlestown, MA 02129 USA.	bkleinstiver@mgh.harvard.edu; jjoung@mgh.harvard.edu	zheng, zongli/C-7309-2008; Tsai, Shengdar Q./G-4600-2012; Kleinstiver, Benjamin/K-4498-2014; Zheng, Zongli/B-2917-2011	Tsai, Shengdar Q./0000-0001-9161-3993; Kleinstiver, Benjamin/0000-0002-5469-0655; Zheng, Zongli/0000-0003-4849-4903; Prew, Michelle/0000-0001-7247-3024	US National Institutes of Health (NIH) [DP1 GM105378]; NIH [R01 GM107427]; Jim and Ann Orr Research Scholar Award; Natural Sciences and Engineering Research Council of Canada; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM107427, DP1GM105378] Funding Source: NIH RePORTER	US National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Jim and Ann Orr Research Scholar Award; Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank D. Edgell (University of Western Ontario) for providing the bacterial strain and precursor plasmids related to the bacterial selections, T. Cathomen (Freiburg) for providing the U2OS cells, and J. Angstman for comments on the manuscript. This work was supported by a US National Institutes of Health (NIH) Director's Pioneer Award (DP1 GM105378) and NIH R01 GM107427 to J.K.J., the Jim and Ann Orr Research Scholar Award (to J.K.J.), and a Natural Sciences and Engineering Research Council of Canada Postdoctoral Fellowship (to B.P.K.). New reagents described in this work will be deposited with the nonprofit plasmid distribution service Addgene (http://www.addgene.org/crispr-cas).	Anders C, 2014, NATURE, V513, P569, DOI 10.1038/nature13579; Canver MC, 2015, NATURE, V527, P192, DOI 10.1038/nature15521; Chen ZL, 2005, NUCLEIC ACIDS RES, V33, DOI 10.1093/nar/gni148; Cong L, 2013, SCIENCE, V339, P819, DOI 10.1126/science.1231143; Courtney DG, 2016, GENE THER, V23, P108, DOI 10.1038/gt.2015.82; Deltcheva E, 2011, NATURE, V471, P602, DOI 10.1038/nature09886; Doudna JA, 2014, SCIENCE, V346, P1077, DOI 10.1126/science.1258096; Esvelt KM, 2013, NAT METHODS, V10, P1116, DOI [10.1038/NMETH.2681, 10.1038/nmeth.2681]; Fonfara I, 2014, NUCLEIC ACIDS RES, V42, P2577, DOI 10.1093/nar/gkt1074; Fu YF, 2014, NAT BIOTECHNOL, V32, P279, DOI 10.1038/nbt.2808; Fu YF, 2013, NAT BIOTECHNOL, V31, P822, DOI 10.1038/nbt.2623; Horvath P, 2008, J BACTERIOL, V190, P1401, DOI 10.1128/JB.01415-07; Hsu PD, 2014, CELL, V157, P1262, DOI 10.1016/j.cell.2014.05.010; Jiang WY, 2013, NAT BIOTECHNOL, V31, P233, DOI 10.1038/nbt.2508; Jinek M, 2014, SCIENCE, V343, P1215, DOI 10.1126/science.1247997; Jinek M, 2013, ELIFE, V2, DOI 10.7554/eLife.00471; Jinek M, 2012, SCIENCE, V337, P816, DOI 10.1126/science.1225829; Kleinstiver BP, 2015, NATURE, V523, P481, DOI 10.1038/nature14592; Kleinstiver BP, 2010, NUCLEIC ACIDS RES, V38, P2411, DOI 10.1093/nar/gkp1223; Lin YN, 2014, NUCLEIC ACIDS RES, V42, P7473, DOI 10.1093/nar/gku402; Mali P, 2013, SCIENCE, V339, P823, DOI 10.1126/science.1232033; Mojica FJM, 2009, MICROBIOL-SGM, V155, P733, DOI 10.1099/mic.0.023960-0; Nishimasu H, 2015, CELL, V162, P1113, DOI 10.1016/j.cell.2015.08.007; Nishimasu H, 2014, CELL, V156, P935, DOI 10.1016/j.cell.2014.02.001; Ran FA, 2015, NATURE, V520, P186, DOI 10.1038/nature14299; Reyon D, 2012, NAT BIOTECHNOL, V30, P460, DOI 10.1038/nbt.2170; Sander JD, 2014, NAT BIOTECHNOL, V32, P347, DOI 10.1038/nbt.2842; Sapranauskas R, 2011, NUCLEIC ACIDS RES, V39, P9275, DOI 10.1093/nar/gkr606; Shah SA, 2013, RNA BIOL, V10, P891, DOI 10.4161/rna.23764; Sternberg SH, 2014, NATURE, V507, P62, DOI 10.1038/nature13011; Tsai SQ, 2015, NAT BIOTECHNOL, V33, P187, DOI 10.1038/nbt.3117; Vierstra J, 2015, NAT METHODS, V12, P927, DOI [10.1038/NMETH.3554, 10.1038/nmeth.3554]; Zhang Y, 2013, MOL CELL, V50, P488, DOI 10.1016/j.molcel.2013.05.001	33	361	437	11	141	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156	1546-1696		NAT BIOTECHNOL	Nat. Biotechnol.	DEC	2015	33	12					1293	+		10.1038/nbt.3404	http://dx.doi.org/10.1038/nbt.3404			7	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	CY4OO	26524662	Green Accepted, Green Published			2022-12-27	WOS:000366387700022
J	Laursen, L				Laursen, Lucas			IBM debuts hyped 'cognitive cloud' biotech HQ in Cambridge	NATURE BIOTECHNOLOGY			English	News Item																			0	1	3	0	2	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156	1546-1696		NAT BIOTECHNOL	Nat. Biotechnol.	DEC	2015	33	12					1219	1220		10.1038/nbt1215-1219	http://dx.doi.org/10.1038/nbt1215-1219			2	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	CY4OO	26650000				2022-12-27	WOS:000366387700004
J	Dane, EL; Irvine, DJ				Dane, Eric L.; Irvine, Darrell J.			Big thinking for adjuvants	NATURE BIOTECHNOLOGY			English	Editorial Material							VACCINE ADJUVANTS; AGONISTS		[Dane, Eric L.; Irvine, Darrell J.] MIT, David H Koch Inst Integrat Canc Res, Cambridge, MA 02139 USA	Massachusetts Institute of Technology (MIT)	Dane, EL (corresponding author), MIT, David H Koch Inst Integrat Canc Res, 77 Massachusetts Ave, Cambridge, MA 02139 USA.	djirvine@mit.edu		Dane, Eric/0000-0002-4022-7264				Hanson MC, 2015, J CLIN INVEST, V125, P2532, DOI 10.1172/JCI79915; Kawai T, 2011, IMMUNITY, V34, P637, DOI 10.1016/j.immuni.2011.05.006; Kopecek J, 2010, ADV DRUG DELIVER REV, V62, P122, DOI 10.1016/j.addr.2009.10.004; Lizee G, 2013, ANNU REV MED, V64, P71, DOI 10.1146/annurev-med-112311-083918; Lynn GM, 2015, NAT BIOTECHNOL, V33, P1201, DOI 10.1038/nbt.3371; Park H, 2013, J IMMUNOL, V190, P4103, DOI 10.4049/jimmunol.1202958; Steinhagen F, 2011, VACCINE, V29, P3341, DOI 10.1016/j.vaccine.2010.08.002; Vasilakos JP, 2013, EXPERT REV VACCINES, V12, P809, DOI 10.1586/14760584.2013.811208; Wu TYH, 2014, SCI TRANSL MED, V6, DOI 10.1126/scitranslmed.3009980	9	14	15	2	34	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1087-0156	1546-1696		NAT BIOTECHNOL	Nat. Biotechnol.	NOV	2015	33	11					1146	1148		10.1038/nbt.3398	http://dx.doi.org/10.1038/nbt.3398			4	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	CW3TY	26544144				2022-12-27	WOS:000364916000017
J	Vallier, L				Vallier, Ludovic			Putting induced pluripotent stem cells to the test	NATURE BIOTECHNOLOGY			English	Editorial Material							LINES; DIFFERENTIATION		[Vallier, Ludovic] Univ Cambridge, Wellcome Trust, Cambridge, England; [Vallier, Ludovic] Univ Cambridge, MRC Stem Cell Inst, Cambridge, England; [Vallier, Ludovic] Univ Cambridge, Wellcome Trust, Sanger Inst, Dept Surg, Cambridge, England	University of Cambridge; Wellcome Trust Sanger Institute; University of Cambridge; University of Cambridge; Wellcome Trust Sanger Institute	Vallier, L (corresponding author), Univ Cambridge, Wellcome Trust, Cambridge, England.	lv225@cam.ac.uk		Vallier, Ludovic/0000-0002-3848-2602				Bock C, 2011, CELL, V144, P439, DOI 10.1016/j.cell.2010.12.032; Choi J, 2015, NAT BIOTECHNOL, V33, P1173, DOI 10.1038/nbt.3388; Dunham I, 2012, NATURE, V489, P57, DOI 10.1038/nature11247; Kajiwara M, 2012, P NATL ACAD SCI USA, V109, P12538, DOI 10.1073/pnas.1209979109; Kim K, 2010, NATURE, V467, P285, DOI 10.1038/nature09342; Osafune K, 2008, NAT BIOTECHNOL, V26, P313, DOI 10.1038/nbt1383; Rouhani F, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004432; Soares FAC, 2014, STEM CELL REP, V3, P931, DOI 10.1016/j.stemcr.2014.11.006; Stadtfeld M, 2010, NATURE, V465, P175, DOI 10.1038/nature09017; Takahashi K, 2007, CELL, V131, P861, DOI 10.1016/j.cell.2007.11.019; Vallier L, 2009, STEM CELLS, V27, P2655, DOI 10.1002/stem.199	11	4	5	0	6	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1087-0156	1546-1696		NAT BIOTECHNOL	Nat. Biotechnol.	NOV	2015	33	11					1145	1146		10.1038/nbt.3401	http://dx.doi.org/10.1038/nbt.3401			2	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	CW3TY	26544143				2022-12-27	WOS:000364916000016
J	[Anonymous]				[Anonymous]			Contesting estimates of cryopreserved embryos in the United States reply	NATURE BIOTECHNOLOGY			English	Letter																		Lomax GP, 2013, NAT BIOTECHNOL, V31, P288, DOI 10.1038/nbt.2541; Snow D, 2015, NAT BIOTECHNOL, V33, P909, DOI 10.1038/nbt.3342	2	0	0	0	0	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156	1546-1696		NAT BIOTECHNOL	Nat. Biotechnol.	SEP	2015	33	9					909	909		10.1038/nbt.3348	http://dx.doi.org/10.1038/nbt.3348			1	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	CR0EK	26348955	Bronze			2022-12-27	WOS:000360990900014
J	Morrison, C				Morrison, Chris			'Financial toxicity' looms as cancer combinations proliferate	NATURE BIOTECHNOLOGY			English	News Item																			0	7	7	0	9	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156	1546-1696		NAT BIOTECHNOL	Nat. Biotechnol.	AUG	2015	33	8					783	784		10.1038/nbt0815-783	http://dx.doi.org/10.1038/nbt0815-783			2	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	CO6OB	26252117				2022-12-27	WOS:000359274900002
J	Ratner, M				Ratner, Mark			Microbial cocktails join fecal transplants in IBD treatment trials	NATURE BIOTECHNOLOGY			English	News Item																		2014, NAT BIOTECHNOL, V32, P401; 2015, GASTROENTEROL, V149, P102; 2015, NAT BIOTECHNOL, V33, P228	3	22	23	1	15	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156	1546-1696		NAT BIOTECHNOL	Nat. Biotechnol.	AUG	2015	33	8					787	788		10.1038/nbt0815-787	http://dx.doi.org/10.1038/nbt0815-787			2	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	CO6OB	26252119				2022-12-27	WOS:000359274900004
J	[Anonymous]				[Anonymous]			Alnylam, Dicerna tussle over RNAi tech	NATURE BIOTECHNOLOGY			English	News Item																			0	0	0	0	1	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156	1546-1696		NAT BIOTECHNOL	Nat. Biotechnol.	AUG	2015	33	8					791	791		10.1038/nbt0815-791a	http://dx.doi.org/10.1038/nbt0815-791a			1	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	CO6OB	26252122	Bronze			2022-12-27	WOS:000359274900035
J	Citorik, RJ; Mimee, M; Lu, TK				Citorik, Robert J.; Mimee, Mark; Lu, Timothy K.			Sequence-specific antimicrobials using efficiently delivered RNA-guided nucleases	NATURE BIOTECHNOLOGY			English	Article							ESCHERICHIA-COLI; BACTERIOPHAGE; RESISTANCE; SYSTEMS; DNA; ENTEROBACTERIACEAE; VIRULENCE; IMMUNITY; GENES	Current antibiotics tend to be broad spectrum, leading to indiscriminate killing of commensal bacteria and accelerated evolution of drug resistance. Here, we use CRISPR-Cas technology to create antimicrobials whose spectrum of activity is chosen-by design. RNA-guided nucleases (RGNs) targeting specific DNA sequences are delivered efficiently to microbial populations using bacteriophage or bacteria carrying plasmids transmissible by conjugation. The DNA targets of RGNs can be undesirable genes or polymorphisms, including antibiotic resistance and virulence determinants in carbapenem-resistant Enterobacteriaceae and enterohemorrhagic Escherichia coli. Delivery of RGNs significantly improves survival in a Galleria mellonella infection model. We also show that RGNs enable modulation of complex bacterial populations by selective knockdown of targeted strains based on genetic signatures. RGNs constitute a class of highly discriminatory, customizable antimicrobials that enact selective pressure at the DNA level to reduce the prevalence of undesired genes, minimize off-target effects and enable programmable remodeling of microbiota.	[Citorik, Robert J.; Mimee, Mark; Lu, Timothy K.] MIT, Microbiol Program, Cambridge, MA 02139 USA; [Citorik, Robert J.; Mimee, Mark; Lu, Timothy K.] MIT, Synthet Biol Ctr, Cambridge, MA 02139 USA; [Lu, Timothy K.] MIT, Dept Biol Engn, Cambridge, MA 02139 USA; [Lu, Timothy K.] MIT, Dept Elect Engn & Comp Sci, Cambridge, MA 02139 USA; [Lu, Timothy K.] Harvard Univ, Harvard Biophys Program, Boston, MA 02115 USA; [Lu, Timothy K.] Broad Inst MIT & Harvard, Cambridge, MA USA	Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT); Harvard University; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute	Lu, TK (corresponding author), MIT, Microbiol Program, 77 Massachusetts Ave, Cambridge, MA 02139 USA.	timlu@mit.edu		Mimee, Mark/0000-0002-0749-8054; Citorik, Robert/0000-0002-6397-5417; /0000-0002-3083-2671	US National Institutes of Health (NIH) [1DP2OD008435]; NIH National Centers for Systems Biology [1P50GM098792]; Defense Threat Reduction Agency [HDTRA1-14-1-0007]; US Army Research Laboratory; US Army Research Office through the Institute for Soldier Nanotechnologies [W911NF13D0001]; NIH/National Institute of General Medical Sciences Interdepartmental Biotechnology Training Program [5T32 GM008334]; Fonds de recherche Sante Quebec Master's Training Award; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P50GM098792, T32GM008334] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [DP2OD008435] Funding Source: NIH RePORTER	US National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH National Centers for Systems Biology; Defense Threat Reduction Agency(United States Department of DefenseDefense Threat Reduction Agency); US Army Research Laboratory(United States Department of DefenseUS Army Research Laboratory (ARL)); US Army Research Office through the Institute for Soldier Nanotechnologies; NIH/National Institute of General Medical Sciences Interdepartmental Biotechnology Training Program; Fonds de recherche Sante Quebec Master's Training Award; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	We would like to thank R. Meyer (Institute for Cell and Molecular Biology, University of Texas Austin) for R1162, D.L. Court (Center for Cancer Research, National Cancer Institute at Frederick) for pSIM9, and A.R.M. Bradbury (Los Alamos National Laboratory) for M13cp. The authors thank J. Rubens for assistance with flow cytometry experiments and H. Gancz and D. Zurawski for assistance with the Galleria infection model. T.K.L. acknowledges support from the US National Institutes of Health (NIH) New Innovator Award (1DP2OD008435), an NIH National Centers for Systems Biology grant (1P50GM098792), the Defense Threat Reduction Agency (HDTRA1-14-1-0007), the US Army Research Laboratory and the US Army Research Office through the Institute for Soldier Nanotechnologies (W911NF13D0001) and the Henry L. and Grace Doherty Professorship in Ocean Utilization. R.J.C. is supported by funding from the NIH/National Institute of General Medical Sciences Interdepartmental Biotechnology Training Program (5T32 GM008334), and M.M. is a Howard Hughes Medical Institute International Student Research fellow and a recipient of a Fonds de recherche Sante Quebec Master's Training Award.	Barrangou R, 2007, SCIENCE, V315, P1709, DOI 10.1126/science.1138140; Bikard D, 2012, CELL HOST MICROBE, V12, P177, DOI 10.1016/j.chom.2012.06.003; CDC, 2013, ANTIBIOTIC RESISTANC; Deltcheva E, 2011, NATURE, V471, P602, DOI 10.1038/nature09886; Desbois AP, 2012, ADV APPL MICROBIOL, V78, P25, DOI 10.1016/B978-0-12-394805-2.00002-6; Duan FP, 2010, P NATL ACAD SCI USA, V107, P11260, DOI 10.1073/pnas.1001294107; Edgar R, 2012, APPL ENVIRON MICROB, V78, P744, DOI 10.1128/AEM.05741-11; Esvelt KM, 2014, ELIFE, V3, DOI 10.7554/eLife.03401; Garneau JE, 2010, NATURE, V468, P67, DOI 10.1038/nature09523; Gomaa AA, 2014, MBIO, V5, DOI 10.1128/mBio.00928-13; Hayes F, 2003, SCIENCE, V301, P1496, DOI 10.1126/science.1088157; Jacoby GA, 2005, CLIN INFECT DIS, V41, pS120, DOI 10.1086/428052; Jiang WY, 2013, NAT BIOTECHNOL, V31, P233, DOI 10.1038/nbt.2508; Jinek M, 2012, SCIENCE, V337, P816, DOI 10.1126/science.1225829; Kaper JB, 2004, NAT REV MICROBIOL, V2, P123, DOI 10.1038/nrmicro818; Lu TK, 2007, P NATL ACAD SCI USA, V104, P11197, DOI 10.1073/pnas.0704624104; Lu TK, 2009, P NATL ACAD SCI USA, V106, P4629, DOI 10.1073/pnas.0800442106; Lutz R, 1997, NUCLEIC ACIDS RES, V25, P1203, DOI 10.1093/nar/25.6.1203; Mali P, 2013, NAT METHODS, V10, P957, DOI [10.1038/NMETH.2649, 10.1038/nmeth.2649]; Mnif B, 2010, J ANTIMICROB CHEMOTH, V65, P1599, DOI 10.1093/jac/dkq181; Nordmann P, 2012, TRENDS MOL MED, V18, P263, DOI 10.1016/j.molmed.2012.03.003; Paddon CJ, 2013, NATURE, V496, P528, DOI 10.1038/nature12051; Pennington JM, 2007, NAT GENET, V39, P797, DOI 10.1038/ng2051; Perez-Mendoza D, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-71; Rasheed JK, 2013, EMERG INFECT DIS, V19, P870, DOI 10.3201/eid1906.121515; Rasheed JK, 2000, ANTIMICROB AGENTS CH, V44, P2382, DOI 10.1128/AAC.44.9.2382-2388.2000; Seed KD, 2013, NATURE, V494, P489, DOI 10.1038/nature11927; Sonnenburg JL, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3001626; Vercoe RB, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003454; Williams JJ, 2012, TRENDS MICROBIOL, V20, P291, DOI 10.1016/j.tim.2012.02.005	30	385	437	10	198	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156	1546-1696		NAT BIOTECHNOL	Nat. Biotechnol.	NOV	2014	32	11					1141	1145		10.1038/nbt.3011	http://dx.doi.org/10.1038/nbt.3011			5	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	AT5IL	25240928	Green Published, Green Accepted			2022-12-27	WOS:000344977000019
J	Castellana, M; Wilson, MZ; Xu, YF; Joshi, P; Cristea, IM; Rabinowitz, JD; Gitai, Z; Wingreen, NS				Castellana, Michele; Wilson, Maxwell Z.; Xu, Yifan; Joshi, Preeti; Cristea, Ileana M.; Rabinowitz, Joshua D.; Gitai, Zemer; Wingreen, Ned S.			Enzyme clustering accelerates processing of intermediates through metabolic channeling	NATURE BIOTECHNOLOGY			English	Article							ESCHERICHIA-COLI; SPATIAL-ORGANIZATION; INCLUSION-BODIES; COMPLEX; INACTIVATION; MOLECULES; SCAFFOLDS; PROTEINS	We present a quantitative model to demonstrate that coclustering multiple enzymes into compact agglomerates accelerates the processing of intermediates, yielding the same efficiency benefits as direct channeling, a well-known mechanism in which enzymes are funneled between enzyme active sites through a physical tunnel. The model predicts the separation and size of coclusters that maximize metabolic efficiency, and this prediction is in agreement with previously reported spacings between coclusters in mammalian cells. For direct validation, we study a metabolic branch point in Escherichia coli and experimentally confirm the model prediction that enzyme agglomerates can accelerate the processing of a shared intermediate by one branch, and thus regulate steady-state flux division. Our studies establish a quantitative framework to understand coclustering-mediated metabolic channeling and its application to both efficiency improvement and metabolic regulation.	[Castellana, Michele; Xu, Yifan; Rabinowitz, Joshua D.; Wingreen, Ned S.] Princeton Univ, Lewis Sigler Inst Integrat Genom, Princeton, NJ 08544 USA; [Wilson, Maxwell Z.; Xu, Yifan; Joshi, Preeti; Cristea, Ileana M.; Gitai, Zemer; Wingreen, Ned S.] Princeton Univ, Dept Mol Biol, Princeton, NJ 08544 USA; [Rabinowitz, Joshua D.] Princeton Univ, Dept Chem, Princeton, NJ 08544 USA	Princeton University; Princeton University; Princeton University	Wingreen, NS (corresponding author), Princeton Univ, Lewis Sigler Inst Integrat Genom, Princeton, NJ 08544 USA.	zgitai@princeton.edu; wingreen@princeton.edu	Gitai, Zemer/AAI-6989-2021; Rabinowitz, Joshua/GPP-4019-2022; xu, yifan/GWZ-7154-2022	Rabinowitz, Joshua/0000-0002-1247-4727; Wilson, Maxwell/0000-0003-0768-7004	National Science Foundation [PHY-0957573, PHY-1305525, GRFP DGE-1148900]; US National Institutes of Health [NIDA DP1DA026192, NIAID R21AI102187]; Human Frontiers Science Program; NJCCR postdoctoral fellowship; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R21AI102187] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [DP1DA026192] Funding Source: NIH RePORTER; Direct For Mathematical & Physical Scien [1305525] Funding Source: National Science Foundation	National Science Foundation(National Science Foundation (NSF)); US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Human Frontiers Science Program(Human Frontier Science Program); NJCCR postdoctoral fellowship; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission); Direct For Mathematical & Physical Scien(National Science Foundation (NSF)NSF - Directorate for Mathematical & Physical Sciences (MPS))	We thank S. Benkovic for valuable conversations and T. Silhavy for E. coli strains. We also thank K. Drescher, K. Papenfort and S. van Teeffelen for critical reading of the manuscript. Research supported by National Science Foundation grants PHY-0957573, PHY-1305525 and GRFP DGE-1148900, by US National Institutes of Health grants NIDA DP1DA026192 and NIAID R21AI102187, by Human Frontiers Science Program and by the NJCCR postdoctoral fellowship.	An SG, 2008, SCIENCE, V320, P103, DOI 10.1126/science.1152241; An S, 2010, P NATL ACAD SCI USA, V107, P12872, DOI 10.1073/pnas.1008451107; Baba T, 2006, MOL SYST BIOL, V2, DOI 10.1038/msb4100050; Bauler P, 2010, J PHYS CHEM LETT, V1, P1332, DOI 10.1021/jz1002007; Bernhard S.A., 1987, NATO ASI SER, V127, P143; Brangwynne CP, 2009, SCIENCE, V324, P1729, DOI 10.1126/science.1172046; Campanella ME, 2005, P NATL ACAD SCI USA, V102, P2402, DOI 10.1073/pnas.0409741102; CHEREPANOV PP, 1995, GENE, V158, P9, DOI 10.1016/0378-1119(95)00193-A; Datsenko KA, 2000, P NATL ACAD SCI USA, V97, P6640, DOI 10.1073/pnas.120163297; Delebecque CJ, 2012, NAT PROTOC, V7, P1797, DOI 10.1038/nprot.2012.102; Deng YJ, 2012, J BIOL CHEM, V287, P36201, DOI 10.1074/jbc.M112.407056; Dueber JE, 2009, NAT BIOTECHNOL, V27, P753, DOI 10.1038/nbt.1557; DUNN MF, 1990, BIOCHEMISTRY-US, V29, P8598, DOI 10.1021/bi00489a015; Erickson HP, 2009, BIOL PROCED ONLINE, V11, P32, DOI 10.1007/s12575-009-9008-x; Fahnert B, 2004, ADV BIOCHEM ENG BIOT, V89, P93; Fersht A., 1999, STRUCTURE MECH PROTE, DOI 10.1142/10574; French JB, 2013, P NATL ACAD SCI USA, V110, P2528, DOI 10.1073/pnas.1300173110; Friedrich P., 1984, SUPRAMOLECULAR ENZYM; Garcia-Fruitos E, 2005, MICROB CELL FACT, V4, DOI 10.1186/1475-2859-4-27; Garcia-Perez AI, 1999, ARCH BIOCHEM BIOPHYS, V362, P329, DOI 10.1006/abbi.1998.1051; GERHART JC, 1962, J BIOL CHEM, V237, P891; Gibson DG, 2009, NAT METHODS, V6, P343, DOI [10.1038/NMETH.1318, 10.1038/nmeth.1318]; GINSBURG A, 1970, ANNU REV BIOCHEM, V39, P429, DOI 10.1146/annurev.bi.39.070170.002241; GUILLOU F, 1992, BIOCHEMISTRY-US, V31, P1656, DOI 10.1021/bi00121a012; GUTNICK D, 1969, J BACTERIOL, V100, P215, DOI 10.1128/JB.100.1.215-219.1969; HRAZDINA G, 1992, ANNU REV PLANT PHYS, V43, P241, DOI 10.1146/annurev.pp.43.060192.001325; Huang XY, 2001, ANNU REV BIOCHEM, V70, P149, DOI 10.1146/annurev.biochem.70.1.149; James CL, 2002, BIOCHEMISTRY-US, V41, P3726, DOI 10.1021/bi0159074; Johnson S. G, 2010, NLOPT NONLINEAR OPTI; Joshi P, 2013, MOL SYST BIOL, V9, DOI 10.1038/msb.2013.26; Kramer T, 2011, J VIROL, V85, P6427, DOI 10.1128/JVI.02253-10; KUO LC, 1988, BIOCHEMISTRY-US, V27, P8823, DOI 10.1021/bi00424a021; Lee H, 2012, METAB ENG, V14, P242, DOI 10.1016/j.ymben.2011.09.003; Lu WY, 2010, ANAL CHEM, V82, P3212, DOI 10.1021/ac902837x; M_uller-Hill B., 1996, LAC OPERON SHORT HIS; Moon TS, 2010, METAB ENG, V12, P298, DOI 10.1016/j.ymben.2010.01.003; Narayanaswamy R, 2009, P NATL ACAD SCI USA, V106, P10147, DOI 10.1073/pnas.0812771106; PERHAM RN, 1975, PHILOS T ROY SOC B, V272, P123, DOI 10.1098/rstb.1975.0075; PRESCOTT LM, 1969, ANAL BIOCHEM, V32, P408, DOI 10.1016/S0003-2697(69)80008-4; Rappsilber J, 2007, NAT PROTOC, V2, P1896, DOI 10.1038/nprot.2007.261; Reaves ML, 2013, NATURE, V500, P237, DOI 10.1038/nature12445; REED LJ, 1974, ACCOUNTS CHEM RES, V7, P40, DOI 10.1021/ar50074a002; Rodriguez-Carmona E, 2010, MICROB CELL FACT, V9, DOI 10.1186/1475-2859-9-71; Schomburg I, 2013, NUCLEIC ACIDS RES, V41, pD764, DOI 10.1093/nar/gks1049; SHEPHERDSON M, 1960, J BIOL CHEM, V235, P3233; SMITH GK, 1980, BIOCHEMISTRY-US, V19, P4313, DOI 10.1021/bi00559a026; SRERE PA, 1974, ANNU REV MICROBIOL, V28, P61, DOI 10.1146/annurev.mi.28.100174.000425; SRERE PA, 1987, ANNU REV BIOCHEM, V56, P89, DOI 10.1146/annurev.bi.56.070187.000513; Taniguchi Y, 2010, SCIENCE, V329, P533, DOI 10.1126/science.1188308; Welch G.R., 1985, ORG MULTIENZYME SYST; WELCH GR, 1977, PROG BIOPHYS MOL BIO, V32, P103; Yeates TO, 2010, ANNU REV BIOPHYS, V39, P185, DOI 10.1146/annurev.biophys.093008.131418; Zhao A., 2013, PLOS ONE, V8, P2	53	241	245	6	123	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156	1546-1696		NAT BIOTECHNOL	Nat. Biotechnol.	OCT	2014	32	10					1011	+		10.1038/nbt.3018	http://dx.doi.org/10.1038/nbt.3018			10	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	AR7MM	25262299	Bronze, Green Accepted			2022-12-27	WOS:000343763800018
J	Li, S; Labaj, PP; Zumbo, P; Sykacek, P; Shi, W; Shi, LM; Phan, J; Wu, PY; Wang, M; Wang, C; Thierry-Mieg, D; Thierry-Mieg, J; Kreil, DP; Mason, CE				Li, Sheng; Labaj, Pawel P.; Zumbo, Paul; Sykacek, Peter; Shi, Wei; Shi, Leming; Phan, John; Wu, Po-Yen; Wang, May; Wang, Charles; Thierry-Mieg, Danielle; Thierry-Mieg, Jean; Kreil, David P.; Mason, Christopher E.			Detecting and correcting systematic variation in large-scale RNA sequencing data	NATURE BIOTECHNOLOGY			English	Article							QUALITY-CONTROL; GENE-EXPRESSION; DIFFERENTIAL EXPRESSION; UNWANTED VARIATION; MESSENGER-RNA; SEQ; NORMALIZATION; TRANSCRIPTS; ALGORITHMS; PACKAGE	High-throughput RNA sequencing (RNA-seq) enables comprehensive scans of entire transcriptomes, but best practices for analyzing RNA-seq data have not been fully defined, particularly for data collected with multiple sequencing platforms or at multiple sites. Here we used standardized RNA samples with built-in controls to examine sources of error in large-scale RNA-seq studies and their impact on the detection of differentially expressed genes (DEGs). Analysis of variations in guanine-cytosine content, gene coverage, sequencing error rate and insert size allowed identification of decreased reproducibility across sites. Moreover, commonly used methods for normalization (cqn, EDASeq, RUV2, sva, PEER) varied in their ability to remove these systematic biases, depending on sample complexity and initial data quality. Normalization methods that combine data from genes across sites are strongly recommended to identify and remove site-specific effects and can substantially improve RNA-seq studies.	[Li, Sheng; Zumbo, Paul; Mason, Christopher E.] Weill Cornell Med Coll, Dept Physiol & Biophys, New York, NY 10065 USA; [Li, Sheng; Zumbo, Paul; Mason, Christopher E.] Weill Cornell Med Coll, HRH Prince Alwaleed Bin Talal Bin Abdulaziz Alsau, New York, NY USA; [Labaj, Pawel P.; Sykacek, Peter; Kreil, David P.] Boku Univ Vienna, Bioinformat Res Grp, Vienna, Austria; [Shi, Wei] WEHI, Dept Bioinformat, Melbourne, Vic, Australia; [Shi, Leming] Fudan Univ, State Key Lab Genet Engn, Sch Life Sci, Shanghai 200433, Peoples R China; [Shi, Leming] Fudan Univ, MOE Key Lab Contemporary Anthropol, Sch Life Sci, Shanghai 200433, Peoples R China; [Shi, Leming] Fudan Univ, Sch Pharm, Shanghai 200433, Peoples R China; [Phan, John; Wu, Po-Yen; Wang, May] Georgia Inst Technol, Sch Elect & Comp Engn, Atlanta, GA 30332 USA; [Wang, Charles] Loma Linda Univ, Ctr Genom, Loma Linda, CA 92350 USA; [Wang, Charles] Loma Linda Univ, Sch Med, Div Microbiol & Mol Genet, Loma Linda, CA USA; [Thierry-Mieg, Danielle; Thierry-Mieg, Jean] Natl Ctr Biotechnol Informat, Bethesda, MD USA; [Kreil, David P.] Univ Warwick, Coventry CV4 7AL, W Midlands, England; [Mason, Christopher E.] Feil Family Brain & Mind Res Inst, New York, NY USA	Cornell University; Cornell University; University of Natural Resources & Life Sciences, Vienna; Fudan University; Fudan University; Fudan University; University System of Georgia; Georgia Institute of Technology; Loma Linda University; Loma Linda University; University of Warwick	Mason, CE (corresponding author), Weill Cornell Med Coll, Dept Physiol & Biophys, New York, NY 10065 USA.	david.kreil@boku.ac.at; chm2042@med.cornell.edu	Łabaj, Paweł/N-5425-2014; Shi, Leming/B-3150-2010; Mason, Christopher/HCH-3977-2022; Wang, May Dongmei/AAF-2065-2021; THIERRY-MIEG, Jean/F-1975-2017; Kreil, D/O-1783-2013	Shi, Leming/0000-0002-7143-2033; Wang, May Dongmei/0000-0003-3961-3608; THIERRY-MIEG, Jean/0000-0002-0396-6789; Kreil, D/0000-0001-7538-2056; Sykacek, Peter/0000-0001-8800-8354; Labaj, Pawel/0000-0002-4994-0234; Thierry-Mieg, Danielle/0000-0001-9568-4211	Vienna Scientific Cluster (VSC); Vienna Science and Technology Fund (WWTF); Baxter AG; Austrian Research Centres (ARC) Seibersdorf; Austrian Centre of Biopharmaceutical Technology (ACBT); National Institutes of Health (NIH) [R01HG006798, R01NS076465, R01CA149566]; Irma T. Hirschl Charitable Trust; Monique Weill-Caulier Charitable Trust; STARR Consortium [I7-A765]; NATIONAL CANCER INSTITUTE [U10CA180827, R01CA149566] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R01HG006798] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS076465] Funding Source: NIH RePORTER	Vienna Scientific Cluster (VSC); Vienna Science and Technology Fund (WWTF); Baxter AG; Austrian Research Centres (ARC) Seibersdorf(Australian Research Council); Austrian Centre of Biopharmaceutical Technology (ACBT); National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Irma T. Hirschl Charitable Trust; Monique Weill-Caulier Charitable Trust; STARR Consortium; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We would like to thank the vendors of the SEQC for contributing many of the resources and reagents needed for completing these projects, including the sequencing and primary data analysis. The Weill Cornell Medical College Epigenomics Core Facility provided support for use of their sequencing machines and technical assistance during sequencing. P.P.L., P.S. and D.P.K. acknowledge support by the Vienna Scientific Cluster (VSC), the Vienna Science and Technology Fund (WWTF), Baxter AG, Austrian Research Centres (ARC) Seibersdorf and the Austrian Centre of Biopharmaceutical Technology (ACBT). S.L. would like to thank C. Zhang and T. Vincent for the constructive discussion. This work was supported with funding from the National Institutes of Health (NIH), including R01HG006798, R01NS076465, R01CA149566, as well as funds from the Irma T. Hirschl and Monique Weill-Caulier Charitable Trusts and the STARR Consortium (I7-A765).	Aird D, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-2-r18; Anders S, 2015, BIOINFORMATICS, V31, P166, DOI 10.1093/bioinformatics/btu638; Baldi P, 2000, BIOINFORMATICS, V16, P412, DOI 10.1093/bioinformatics/16.5.412; Ball CA, 2006, OMICS, V10, P138, DOI 10.1089/omi.2006.10.138; Benjamini Y, 2012, NUCLEIC ACIDS RES, V40, DOI 10.1093/nar/gks001; Bernstein BE, 2010, NAT BIOTECHNOL, V28, P1045, DOI 10.1038/nbt1010-1045; Bragg LM, 2013, PLOS COMPUT BIOL, V9, DOI 10.1371/journal.pcbi.1003031; Bullard JH, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-94; Casciano DA, 2006, NAT BIOTECHNOL, V24, P1103, DOI 10.1038/nbt0906-1103; Cheung VG, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000480; DeLuca DS, 2012, BIOINFORMATICS, V28, P1530, DOI 10.1093/bioinformatics/bts196; Dobin A, 2013, BIOINFORMATICS, V29, P15, DOI 10.1093/bioinformatics/bts635; Dudley JT, 2009, MOL SYST BIOL, V5, DOI 10.1038/msb.2009.66; Gagnon-Bartsch JA, 2012, BIOSTATISTICS, V13, P539, DOI 10.1093/biostatistics/kxr034; Glenn TC, 2011, MOL ECOL RESOUR, V11, P759, DOI 10.1111/j.1755-0998.2011.03024.x; Goncalves A, 2011, BIOINFORMATICS, V27, P867, DOI 10.1093/bioinformatics/btr012; Hansen KD, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkq224; Hansen KD, 2012, BIOSTATISTICS, V13, P204, DOI 10.1093/biostatistics/kxr054; Hong F, 2011, RANKPROD RANK PRODUC; Irizarry RA, 2005, NAT METHODS, V2, P345, DOI 10.1038/nmeth756; Ji HL, 2006, NAT BIOTECHNOL, V24, P1112, DOI 10.1038/nbt0906-1112; Labaj PP, 2011, BIOINFORMATICS, V27, pI383, DOI 10.1093/bioinformatics/btr247; Lawrence M, 2013, PLOS COMPUT BIOL, V9, DOI 10.1371/journal.pcbi.1003118; Leek JT, 2007, PLOS GENET, V3, P1724, DOI 10.1371/journal.pgen.0030161; Leek JT, 2012, BIOINFORMATICS, V28, P882, DOI 10.1093/bioinformatics/bts034; Li H, 2010, BRIEF BIOINFORM, V11, P473, DOI 10.1093/bib/bbq015; Li S, 2014, NAT BIOTECHNOL, V32, P915, DOI 10.1038/nbt.2972; Li Y., 2011, P ACM SIGMOD INT C M, P445; Loman NJ, 2012, NAT BIOTECHNOL, V30, P434, DOI 10.1038/nbt.2198; Lonsdale J, 2013, NAT GENET, V45, P580, DOI 10.1038/ng.2653; Mooney M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061088; Pickrell JK, 2010, NATURE, V464, P768, DOI 10.1038/nature08872; Pipes L, 2013, NUCLEIC ACIDS RES, V41, pD906, DOI 10.1093/nar/gks1268; Purcell SM, 2014, NATURE, V506, P185, DOI 10.1038/nature12975; Risso D, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-480; Roberts A, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-3-r22; Robinson MD, 2010, BIOINFORMATICS, V26, P139, DOI 10.1093/bioinformatics/btp616; Schulze SK, 2012, BMC GENOMICS, V13, P1, DOI 10.1186/1471-2164-13-524; Shi LM, 2006, NAT BIOTECHNOL, V24, P1151, DOI 10.1038/nbt1239; Shi LM, 2010, NAT BIOTECHNOL, V28, P827, DOI 10.1038/nbt.1665; Stegle O, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000770; Su ZQ, 2014, NAT BIOTECHNOL, V32, P903, DOI 10.1038/nbt.2957; 't Hoen PAC, 2013, NAT BIOTECHNOL, V31, P1015, DOI 10.1038/nbt.2702; Thierry-Mieg D, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-s1-s12; Trapnell C, 2013, NAT BIOTECHNOL, V31, P46, DOI 10.1038/nbt.2450; Trapnell C, 2010, NAT BIOTECHNOL, V28, P511, DOI 10.1038/nbt.1621; Tripathi AK, 2014, MECH DEVELOP, V132, P79, DOI 10.1016/j.mod.2014.01.001; van Heesch S, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-4-r33; Wang HM, 2005, FIBER POLYM, V6, P6, DOI 10.1007/BF02875567; Wang K, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkq622; Wang LG, 2012, BIOINFORMATICS, V28, P2184, DOI 10.1093/bioinformatics/bts356; 2008, NAT BIOTECHNOL, V26, P1099	52	109	111	0	36	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156	1546-1696		NAT BIOTECHNOL	Nat. Biotechnol.	SEP	2014	32	9					888	895		10.1038/nbt.3000	http://dx.doi.org/10.1038/nbt.3000			8	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	AQ2FD	25150837	Green Accepted, Bronze			2022-12-27	WOS:000342600300028
J	Munafo, M; Noble, S; Browne, WJ; Brunner, D; Button, K; Ferreira, J; Holmans, P; Langbehn, D; Lewis, G; Lindquist, M; Tilling, K; Wagenmakers, EJ; Blumenstein, R				Munafo, Marcus; Noble, Simon; Browne, William J.; Brunner, Dani; Button, Katherine; Ferreira, Joaquim; Holmans, Peter; Langbehn, Douglas; Lewis, Glyn; Lindquist, Martin; Tilling, Kate; Wagenmakers, Eric-Jan; Blumenstein, Robi			Scientific rigor and the art of motorcycle maintenance	NATURE BIOTECHNOLOGY			English	Article							SAMPLE-SIZE; POWER	The reliability of scientific research is under scrutiny. A recently convened working group proposes cultural adjustments to incentivize better research practices.	[Munafo, Marcus; Browne, William J.; Button, Katherine; Tilling, Kate] Univ Bristol, Bristol, Avon, England; [Noble, Simon; Blumenstein, Robi] CHDI Management CHDI Fdn, New York, NY USA; [Brunner, Dani] PsychoGenics Inc, Tarrytown, NY USA; [Brunner, Dani] Columbia Univ, New York, NY USA; [Ferreira, Joaquim] Univ Lisbon, P-1699 Lisbon, Portugal; [Holmans, Peter] Cardiff Univ, Cardiff CF10 3AX, S Glam, Wales; [Langbehn, Douglas] Univ Iowa, Iowa City, IA USA; [Lewis, Glyn] UCL, London, England; [Lindquist, Martin] Johns Hopkins Univ, Baltimore, MD USA; [Wagenmakers, Eric-Jan] Univ Amsterdam, Amsterdam, Netherlands	University of Bristol; Columbia University; Universidade de Lisboa; Cardiff University; University of Iowa; University of London; University College London; Johns Hopkins University; University of Amsterdam	Munafo, M (corresponding author), Univ Bristol, Bristol, Avon, England.	simon.noble@chdifoundation.org	Browne, William J/A-8686-2010; Lewis, Glyn/E-9944-2012; Tilling, Kate/AAY-1578-2021; Munafo, Marcus/AAE-2306-2020; Holmans, Peter/F-4518-2015; Langbehn, Douglas/AFS-2143-2022; Wagenmakers, Eric-Jan/AAH-7065-2019	Browne, William J/0000-0002-6659-6885; Lewis, Glyn/0000-0001-5205-8245; Munafo, Marcus/0000-0002-4049-993X; Holmans, Peter/0000-0003-0870-9412; Wagenmakers, Eric-Jan/0000-0003-1596-1034; Langbehn, Douglas/0000-0002-7803-4679; Tilling, Kate/0000-0002-1010-8926; Button, Katherine/0000-0003-4332-8789	MRC [MC_UU_12013/6] Funding Source: UKRI; Medical Research Council [MR/L010305/1, MC_UU_12013/6] Funding Source: researchfish	MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)		[Anonymous], 2013, Nat Biotechnol, V31, P943, DOI 10.1038/nbt.2748; [Anonymous], 2013, NAT METHODS, V10, P367, DOI 10.1038/nmeth.2471; [Anonymous], 2001, B WORLD HEALTH ORGAN, V79, P373; Brunner D, 2012, BEHAV PROCESS, V89, P187, DOI 10.1016/j.beproc.2011.10.011; Button KS, 2013, NAT REV NEUROSCI, V14, P365, DOI 10.1038/nrn3475; EDWARDS AWF, 1986, BIOL REV, V61, P295, DOI 10.1111/j.1469-185X.1986.tb00656.x; GREENWALD AG, 1975, PSYCHOL BULL, V82, P1, DOI 10.1037/h0076157; Hirschhorn JN, 2009, NEW ENGL J MED, V360, P1699, DOI 10.1056/NEJMp0808934; Ioannidis JPA, 2013, J CLIN EPIDEMIOL, V66, P903, DOI 10.1016/j.jclinepi.2013.03.002; Ioannidis JPA, 2012, PERSPECT PSYCHOL SCI, V7, P645, DOI 10.1177/1745691612464056; Ioannidis JPA, 2001, NAT GENET, V29, P306, DOI 10.1038/ng749; Johnson G., 2014, NY TIMES; Kerr N L, 1998, Pers Soc Psychol Rev, V2, P196, DOI 10.1207/s15327957pspr0203_4; Kilkenny C, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000412; Liang F, 2008, J AM STAT ASSOC, V103, P410, DOI 10.1198/016214507000001337; Martinson BC, 2005, NATURE, V435, P737, DOI 10.1038/435737a; Menalled L, 2014, FIELD GUIDE WORKING; POCOCK SJ, 1987, NEW ENGL J MED, V317, P426, DOI 10.1056/NEJM198708133170706; Schulz KF, 2010, BMC MED, V8, DOI [10.1186/1741-7015-8-18, 10.1136/bmj.c332]; SEDLMEIER P, 1989, PSYCHOL BULL, V105, P309, DOI 10.1037/0033-2909.105.2.309; von Elm E, 2007, PLOS MED, V4, P1623, DOI [10.1371/journal.pmed.0040296, 10.1371/journal.pmed.0040297]; Wagenmakers EJ, 2014, CORTEX, V51, P105, DOI 10.1016/j.cortex.2013.09.010; Welch V, 2012, PLOS MED, V9, DOI 10.1371/journal.pmed.1001333	23	34	34	0	12	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1087-0156	1546-1696		NAT BIOTECHNOL	Nat. Biotechnol.	SEP	2014	32	9					871	873		10.1038/nbt.3004	http://dx.doi.org/10.1038/nbt.3004			3	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	AQ2FD	25203032				2022-12-27	WOS:000342600300021
J	Roberts, M; Wall, IB; Bingham, I; Icely, D; Reeve, B; Bure, K; French, A; Brindley, DA				Roberts, MacKenna; Wall, Ivan B.; Bingham, Ian; Icely, Dominic; Reeve, Brock; Bure, Kim; French, Anna; Brindley, David A.			The global intellectual property landscape of induced pluripotent stem cell technologies	NATURE BIOTECHNOLOGY			English	Editorial Material							PATENTS; LICENSES	Will freedom to research and innovate be restricted as the induced pluripotent stem cell field advances toward the clinic, or are concerns premature within a rapidly changing ecosystem?	[Roberts, MacKenna; Wall, Ivan B.; French, Anna; Brindley, David A.] Univ Oxford, Oxford Univ Coll London, Ctr Adv Sustainable Med Innovat, Oxford, England; [Wall, Ivan B.] UCL, Dept Biochem Engn, London, England; [Wall, Ivan B.] Dankook Univ, Dept Nanobiomed Sci, Global Res Ctr Regenerat Med, Cheonan, South Korea; [Wall, Ivan B.] Dankook Univ, Plus NBM BK21, Global Res Ctr Regenerat Med, Cheonan, South Korea; [Wall, Ivan B.] Dankook Univ, Dept Nanobiomed Sci, Biomat & Tissue Engn Lab, Cheonan, South Korea; [Wall, Ivan B.] Dankook Univ, World Class Univ Res Ctr, Cheonan, South Korea; [Bingham, Ian; Icely, Dominic] IP Asset LLP, Oxford, England; [Reeve, Brock; Brindley, David A.] Harvard Stem Cell Inst, Cambridge, MA USA; [Bure, Kim] Sartorius Stedim, Gottingen, Germany; [Brindley, David A.] Univ Oxford, Nuffield Dept Orthopaed Rheumatol & Musculoskelet, Nuffield Orthopaed Ctr, Oxford, England; [Brindley, David A.] UCL, UCL Sch Pharm, Ctr Behav Med, London, England	University of Oxford; University of London; University College London; Dankook University; Dankook University; Dankook University; Dankook University; Harvard University; Nuffield Orthopaedic Centre; University of Oxford; University of London; University College London; University of London School of Pharmacy	Roberts, M (corresponding author), Univ Oxford, Oxford Univ Coll London, Ctr Adv Sustainable Med Innovat, Oxford, England.	anna.french@casmi.org.uk; david.brindley@ndorms.ox.ac.uk			Centre for the Commercialization of Regenerative Medicine; Celgene Cellular Therapeutics; Cell Therapy Catapult; CIRM; Eisai; GE Healthcare; Lonza; SENS Research Foundation; Sartorius Stedim; MEDIPOST Co., Ltd.; MEDIPOST America Inc.; New York Stem Cell Foundation; US National Institutes of Health Center for Regenerative Medicine; UK Technology Strategy Board	Centre for the Commercialization of Regenerative Medicine; Celgene Cellular Therapeutics(Bristol-Myers SquibbCelgene Corporation); Cell Therapy Catapult; CIRM(California Institute for Regenerative Medicine); Eisai(Eisai Co Ltd); GE Healthcare(General ElectricGE Healthcare); Lonza; SENS Research Foundation; Sartorius Stedim; MEDIPOST Co., Ltd.; MEDIPOST America Inc.; New York Stem Cell Foundation; US National Institutes of Health Center for Regenerative Medicine; UK Technology Strategy Board	The authors thank B. Larner, F. Wattler and J. Evans (Thomson Reuters) for their invaluable assistance; A. Carr (University of Oxford) and J. Karp (Harvard University and Brigham and Women's Hospital) for their invaluable support and insights; and R. Barker (the Centre for the Advancement of Sustainable Medical Innovation (CASMI)) and M. Morys (CASMI) for their support of the CASMI Translational Stem Cell Consortium. The authors wish to express sincere thanks to the following organizations that have contributed to the consortium as funding and events partners: Centre for the Commercialization of Regenerative Medicine; Celgene Cellular Therapeutics; Cell Therapy Catapult; CIRM; Eisai; GE Healthcare; Lonza; SENS Research Foundation; TAP Biosystems (now Sartorius Stedim); MEDIPOST Co., Ltd.; MEDIPOST America Inc.; the New York Stem Cell Foundation and the US National Institutes of Health Center for Regenerative Medicine. Additionally, CASMI is a past recipient of funding from the UK Technology Strategy Board to support an investigation into cell therapy regulation. The content outlined herein represents the individual opinions of the authors and may not necessarily represent the viewpoints of their employers. D.B. is subject to the CFA Institute's codes, standards and guidelines and as such, must stress that this piece is provided for academic interest only and must not be construed in any way as an investment recommendation.	[Anonymous], 2010, US Patent Application Patent, Patent No. [12/703,015, 12703015]; [Anonymous], 2008, Japan Patent, Patent No. [2008-131577, 2008131577]; [Anonymous], 2013, INITIAL PUBLIC OFFER; Bergman K, 2007, NAT BIOTECHNOL, V25, P419, DOI 10.1038/nbt0407-419; BioInformant Worldwide, 2014, COMPL 2012 13 IND PL; Bubela T, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003490; Cyranoski D, 2013, NAT MED, V19, P510, DOI 10.1038/nm0513-510; Feldman R., 2010, STANFORD J LAW SCI P, V3, P17; Heller MA, 1998, SCIENCE, V280, P698, DOI 10.1126/science.280.5364.698; Hou PP, 2013, SCIENCE, V341, P651, DOI 10.1126/science.1239278; House of Commons Science and Technology Committee, 2013, 348 HC; Jaenisch R, 2010, Patent No. [US7682828, 7682828]; Mathews DJH, 2013, CELL STEM CELL, V12, P508, DOI 10.1016/j.stem.2013.04.015; Mathews DJH, 2011, SCIENCE, V331, P725, DOI 10.1126/science.1201382; Moran N, 2013, NAT BIOTECHNOL, V31, P376, DOI 10.1038/nbt0513-376; Rao MS, 2013, STEM CELL RES THER, V4, DOI [10.1186/1757-6512-4-98, 10.1186/scrt309]; Sakurada K, 2010, Patent No. [2450603, GB2450603]; Schwartz SD, 2012, LANCET, V379, P713, DOI 10.1016/S0140-6736(12)60028-2; Simon BM, 2010, NAT BIOTECHNOL, V28, P557, DOI 10.1038/nbt0610-557; Takahashi K, 2007, CELL, V131, P861, DOI 10.1016/j.cell.2007.11.019; The Hinxton Group, 2010, CONS STAT POL PRACT; UK Intellectual Property Office Patent Informatics Team, 2012, STEM CELLS UKSCN PAT; Webb S, 2009, NAT BIOTECHNOL, V27, P977, DOI 10.1038/nbt1109-977; Winickoff David E, 2009, Yale J Health Policy Law Ethics, V9, P52; Yu JY, 2007, SCIENCE, V318, P1917, DOI 10.1126/science.1151526	25	24	24	0	24	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156	1546-1696		NAT BIOTECHNOL	Nat. Biotechnol.	AUG	2014	32	8					742	749		10.1038/nbt.2975	http://dx.doi.org/10.1038/nbt.2975			8	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	AW7PF	25093884				2022-12-27	WOS:000346455900013
J	Parisi, C; Tillie, P; Rodriguez-Cerezo, E				Parisi, Claudia; Tillie, Pascal; Rodriguez-Cerezo, Emilio			The global pipeline of GM crops out to 2020	NATURE BIOTECHNOLOGY			English	Article								Although a few arable crops and agronomic traits will likely dominate commercial varieties for the foreseeable future, with many being stacked together, more quality traits and specialty crops are being introduced into the pipeline.	[Parisi, Claudia; Tillie, Pascal; Rodriguez-Cerezo, Emilio] European Commiss, Joint Res Ctr Inst Prospect Technol Studies, Seville, Spain		Parisi, C (corresponding author), European Commiss, Joint Res Ctr Inst Prospect Technol Studies, Seville, Spain.	Claudia.parisi@ec.europa.eu						[Anonymous], 2004, EPTD DISCUSSION PAPE; Cockburn A., 2004, Journal of Commercial Biotechnology, V10, P209, DOI 10.1057/palgrave.jcb.3040076; Conko G., 2012, IS THERE FUTURE GENE; De Schrijver A, 2007, TRENDS FOOD SCI TECH, V18, P101, DOI 10.1016/j.tifs.2006.09.002; De Steur H, 2015, NAT BIOTECHNOL, V33, P25, DOI 10.1038/nbt.3110; Dodo HW, 2008, PLANT BIOTECHNOL J, V6, P135, DOI 10.1111/j.1467-7652.2007.00292.x; EuropaBio, 2011, APPR GMOS EUR UN; European Commission, 2008, COEXTRA GM NONGM SUP; FAO, 2014, TECHN CONS LOW LEV G; Gil-Humanes J, 2010, P NATL ACAD SCI USA, V107, P17023, DOI 10.1073/pnas.1007773107; Graff GD, 2009, NAT BIOTECHNOL, V27, P702, DOI 10.1038/nbt0809-702; Grushkin D, 2013, NAT BIOTECHNOL, V31, P10, DOI 10.1038/nbt0113-10c; Harwood JL, 2013, EUR J LIPID SCI TECH, V115, P1239, DOI 10.1002/ejlt.201300257; Huang JK, 2002, SCIENCE, V295, P674, DOI 10.1126/science.1067226; ISAAA, 2013, POCK K 42 STACK TRAI; Kalaitzandonakes N, 2007, NAT BIOTECHNOL, V25, P509, DOI 10.1038/nbt0507-509; Kalaitzandonakes N, 2014, FOOD POLICY, V45, P146, DOI 10.1016/j.foodpol.2013.06.013; Koch A, 2013, P NATL ACAD SCI USA, V110, P19324, DOI 10.1073/pnas.1306373110; Lusser M., 2011, NEW PLANT BREEDING T, DOI DOI 10.2791/54761; Lusser M, 2012, NAT BIOTECHNOL, V30, P231, DOI 10.1038/nbt.2142; Mao YB, 2011, TRANSGENIC RES, V20, P665, DOI 10.1007/s11248-010-9450-1; Miller JK, 2010, NAT BIOTECHNOL, V28, P1012, DOI 10.1038/nbt1010-1012; Sithole-Niang, 2013, GENETICALLY MODIFIED; Stein A.J., 2009, GLOBAL PIPELINE NEW; Stein AJ, 2010, NAT BIOTECHNOL, V28, P23, DOI 10.1038/nbt0110-23b; Waltz E, 2015, NAT BIOTECHNOL, V33, P328, DOI 10.1038/nbt0415-328; Wolt JD, 2007, BIOMASS BIOENERG, V31, P831, DOI 10.1016/j.biombioe.2007.04.003	27	81	83	1	45	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1087-0156	1546-1696		NAT BIOTECHNOL	Nat. Biotechnol.	JAN	2016	34	1					31	36		10.1038/nbt.3449	http://dx.doi.org/10.1038/nbt.3449			6	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	DB8HQ	26744975				2022-12-27	WOS:000368758200020
J	Waltz, E				Waltz, Emily			A face-lift for biotech rules begins	NATURE BIOTECHNOLOGY			English	News Item																			0	13	13	0	5	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156	1546-1696		NAT BIOTECHNOL	Nat. Biotechnol.	DEC	2015	33	12					1221	1222		10.1038/nbt1215-1221	http://dx.doi.org/10.1038/nbt1215-1221			2	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	CY4OO	26650002				2022-12-27	WOS:000366387700006
J	Blancquaert, D; Van Daele, J; Strobbe, S; Kiekens, F; Storozhenko, S; De Steur, H; Gellynck, X; Lambert, W; Stove, C; Van Der Straeten, D				Blancquaert, Dieter; Van Daele, Jeroen; Strobbe, Simon; Kiekens, Filip; Storozhenko, Sergei; De Steur, Hans; Gellynck, Xavier; Lambert, Willy; Stove, Christophe; Van Der Straeten, Dominique			Improving folate (vitamin B-9) stability in biofortified rice through metabolic engineering	NATURE BIOTECHNOLOGY			English	Article							TIME QUANTITATIVE PCR; FOLIC-ACID; EXPRESSION; HEALTH; IMPACT; GENES; ENHANCEMENT; FRAMEWORK; SEQUENCE; CHINA	Biofortification of staple crops could help to alleviate micronutrient deficiencies in humans. We show that folates in stored rice grains are unstable, which reduces the potential benefits of folate biofortification. We obtain folate concentrations that are up to 150 fold higher than those of wild-type rice by complexing folate to folate-binding proteins to improve folate stability, thereby enabling long-term storage of biofortified high-folate rice grains.	[Blancquaert, Dieter; Strobbe, Simon; Storozhenko, Sergei; Van Der Straeten, Dominique] Univ Ghent, Dept Physiol, Lab Funct Plant Biol, B-9000 Ghent, Belgium; [Van Daele, Jeroen; Kiekens, Filip; Lambert, Willy; Stove, Christophe] Univ Ghent, Dept Bioanal, Lab Toxicol, B-9000 Ghent, Belgium; [De Steur, Hans; Gellynck, Xavier] Univ Ghent, Dept Agr Econ, Div Agrifood Mkt & Chain Management, B-9000 Ghent, Belgium	Ghent University; Ghent University; Ghent University	Van Der Straeten, D (corresponding author), Univ Ghent, Dept Physiol, Lab Funct Plant Biol, B-9000 Ghent, Belgium.	dominique.vanderstraeten@ugent.be	Strobbe, Simon/ABB-6163-2020; Van Der Straeten, Dominique/E-7385-2016; Stove, Christophe/B-6057-2008	Strobbe, Simon/0000-0003-0583-9406; Van Der Straeten, Dominique/0000-0002-7755-1420; Stove, Christophe/0000-0001-7126-348X; De Steur, Hans/0000-0003-1340-0882	Ghent University, Belgium, (Bijzonder Onderzoeksfonds) [BOF2004GOA012, BOF2009G0A004]; Research Foundation-Flanders (FWO) [3G012609, 35963]; Agency for Innovation by Science AMP; Technology (IWT); F.W.O	Ghent University, Belgium, (Bijzonder Onderzoeksfonds); Research Foundation-Flanders (FWO)(FWO); Agency for Innovation by Science AMP; Technology (IWT); F.W.O(FWO)	The authors thank O. Saracutu for excellent rice transformation work. D.V.D.S. and W.L. gratefully acknowledge financial support from Ghent University, Belgium, (Bijzonder Onderzoeksfonds, BOF2004GOA012 and BOF2009G0A004), and the Research Foundation-Flanders (FWO, projects 3G012609 and 35963). D.B. is indebted to F.W.O. for a postdoctoral fellowship. Simon Strobbe is supported by a PhD fellowship from the Agency for Innovation by Science & Technology (IWT).	Blancquaert D, 2014, J EXP BOT, V65, P895, DOI 10.1093/jxb/ert483; Blancquaert D, 2013, PLANT MOL BIOL, V83, P329, DOI 10.1007/s11103-013-0091-7; Blancquaert D, 2010, CRIT REV PLANT SCI, V29, P14, DOI 10.1080/07352680903436283; Counce PA, 2000, CROP SCI, V40, P436, DOI 10.2135/cropsci2000.402436x; De Brouwer V, 2007, PHYTOCHEM ANALYSIS, V18, P496, DOI 10.1002/pca.1006; De Brouwer V, 2010, J CHROMATOGR B, V878, P509, DOI 10.1016/j.jchromb.2009.12.032; de La Garza RID, 2007, P NATL ACAD SCI USA, V104, P4218, DOI 10.1073/pnas.0700409104; De Steur H, 2014, TRENDS FOOD SCI TECH, V39, P116, DOI 10.1016/j.tifs.2014.06.010; De Steur H, 2012, NEW BIOTECHNOL, V29, P432, DOI 10.1016/j.nbt.2011.11.012; De Steur H, 2010, NAT BIOTECHNOL, V28, P554, DOI 10.1038/nbt0610-554; Fitzpatrick TB, 2012, PLANT CELL, V24, P395, DOI 10.1105/tpc.111.093120; Hellemans J, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-2-r19; Iyer R, 2009, J FOOD SCI, V74, pR114, DOI 10.1111/j.1750-3841.2009.01359.x; Kiekens F, 2015, MOL NUTR FOOD RES, V59, P490, DOI 10.1002/mnfr.201400590; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Nakase M, 1996, GENE, V170, P223, DOI 10.1016/0378-1119(95)00887-X; Orsomando G, 2005, J BIOL CHEM, V280, P28877, DOI 10.1074/jbc.M504306200; RUEB S, 1994, PLANT CELL TISS ORG, V36, P259, DOI 10.1007/BF00037729; SAUBERLICH HE, 1987, AM J CLIN NUTR, V46, P1016, DOI 10.1093/ajcn/46.6.1016; Scarpella E, 2000, DEVELOPMENT, V127, P3655; Scott J, 2000, J SCI FOOD AGR, V80, P795, DOI [10.1002/(SICI)1097-0010(20000515)80:7&lt;795::AID-JSFA599&gt;3.0.CO;2-K, 10.1002/(SICI)1097-0010(20000515)80:7<795::AID-JSFA599>3.0.CO;2-K]; Storozhenko S, 2007, NAT BIOTECHNOL, V25, P1277, DOI 10.1038/nbt1351; TAKAIWA F, 1991, PLANT MOL BIOL, V17, P875, DOI 10.1007/BF00037068; Van Daele J, 2014, J AGR FOOD CHEM, V62, P3092, DOI 10.1021/jf500753v; Yang LJ, 2007, PLANT BIOTECHNOL J, V5, P815, DOI 10.1111/j.1467-7652.2007.00287.x	25	92	97	6	108	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156	1546-1696		NAT BIOTECHNOL	Nat. Biotechnol.	OCT	2015	33	10					1076	+		10.1038/nbt.3358	http://dx.doi.org/10.1038/nbt.3358			5	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	CT1JX	26389575				2022-12-27	WOS:000362555700027
J	Nuccio, ML; Wu, J; Mowers, R; Zhou, HP; Meghji, M; Primavesi, LF; Paul, MJ; Chen, X; Gao, Y; Haque, E; Basu, SS; Lagrimini, LM				Nuccio, Michael L.; Wu, Jeff; Mowers, Ron; Zhou, Hua-Ping; Meghji, Moez; Primavesi, Lucia F.; Paul, Matthew J.; Chen, Xi; Gao, Yan; Haque, Emdadul; Basu, Shib Sankar; Lagrimini, L. Mark			Expression of trehalose-6-phosphate phosphatase in maize ears improves yield in well-watered and drought conditions	NATURE BIOTECHNOLOGY			English	Article							ABIOTIC STRESS TOLERANCE; TREHALOSE 6-PHOSPHATE; KERNEL SET; CARBOHYDRATE-METABOLISM; TRANSGENIC RICE; GRAIN-YIELD; PLANTS; GENE; IDENTIFICATION; ACCUMULATION	Maize, the highest-yielding cereal crop worldwide, is particularly susceptible to drought during its 2- to 3-week flowering period. Many genetic engineering strategies for drought tolerance impinge on plant development, reduce maximum yield potential or do not translate from laboratory conditions to the field. We overexpressed a gene encoding a rice trehalose-6-phosphate phosphatase (TPP) in developing maize ears using a floral promoter. This reduced the concentration of trehalose-6-phosphate (T6P), a sugar signal that regulates growth and development, and increased the concentration of sucrose in ear spikelets. Overexpression of TPP increased both kernel set and harvest index. Field data at several sites and over multiple seasons showed that the engineered trait improved yields from 9% to 49% under non-drought or mild drought conditions, and from 31% to 123% under more severe drought conditions, relative to yields from nontransgenic controls.	[Nuccio, Michael L.; Zhou, Hua-Ping; Chen, Xi; Gao, Yan; Haque, Emdadul; Basu, Shib Sankar] Syngenta Crop Protect LLC, Res Triangle Pk, NC 27709 USA; [Wu, Jeff; Mowers, Ron; Meghji, Moez] Syngenta Seeds Inc, Slater, IA USA; [Primavesi, Lucia F.; Paul, Matthew J.] Rothamsted Res, Plant Biol & Crop Sci, Harpenden, Herts, England; [Lagrimini, L. Mark] Univ Nebraska, Dept Agron & Hort, Lincoln, NE USA	Syngenta; Syngenta; UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); Rothamsted Research; University of Nebraska System; University of Nebraska Lincoln	Nuccio, ML (corresponding author), Syngenta Crop Protect LLC, Res Triangle Pk, NC 27709 USA.	michael.nuccio@syngenta.com	Paul, Matthew J/R-6384-2016	Paul, Matthew J/0000-0002-2001-961X; Primavesi, Lucia/0000-0003-3719-4569	Biotechnological and Biological Sciences Research Council of the U.K.; Biotechnology and Biological Sciences Research Council [BBS/E/C/00005997, BBS/E/C/00005202] Funding Source: researchfish; BBSRC [BBS/E/C/00005202, BBS/E/C/00005997] Funding Source: UKRI	Biotechnological and Biological Sciences Research Council of the U.K.; Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	We thank E. Cates and M. Yarnall for technical assistance. L. Payan, C. Chaulk-Grace and L. Mansur managed the field trial locations. We also thank our Syngenta colleagues for their enthusiasm and support of this work. We thank M.-D. Chilton and the anonymous reviewers for helpful comments. Trehalose metabolite measurements were done by Metabolon. Rothamsted Research receives strategic funding from the Biotechnological and Biological Sciences Research Council of the U.K.	Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Araus JL, 2002, ANN BOT-LONDON, V89, P925, DOI 10.1093/aob/mcf049; Araus JL, 2012, FRONT PHYSIOL, V3, DOI 10.3389/fphys.2012.00305; Arora R, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-242; Barker T, 2005, PL BRED RE, V25, P173; Bartels D, 2001, PLANT PHYSIOL, V127, P1346, DOI 10.1104/pp.010765; BIANCHI G, 1993, PHYSIOL PLANTARUM, V87, P223, DOI 10.1111/j.1399-3054.1993.tb00146.x; Boyer JS, 2007, J EXP BOT, V58, P267, DOI 10.1093/jxb/erl177; Boyer JS, 2004, J EXP BOT, V55, P2385, DOI 10.1093/jxb/erh219; BOYER JS, 1982, SCIENCE, V218, P443, DOI 10.1126/science.218.4571.443; Campos H, 2004, FIELD CROP RES, V90, P19, DOI 10.1016/j.fcr.2004.07.003; Castiglioni P, 2008, PLANT PHYSIOL, V147, P446, DOI 10.1104/pp.108.118828; Cattivelli L, 2008, FIELD CROP RES, V105, P1, DOI 10.1016/j.fcr.2007.07.004; Cortina C, 2005, PLANT SCI, V169, P75, DOI 10.1016/j.plantsci.2005.02.026; Dreni L, 2007, PLANT J, V52, P690, DOI 10.1111/j.1365-313X.2007.03272.x; Elliott J., 2013, 1301 RDCEP GRANTH RE; Garg AK, 2002, P NATL ACAD SCI USA, V99, P15898, DOI 10.1073/pnas.252637799; Goff SA, 2002, SCIENCE, V296, P92, DOI 10.1126/science.1068275; Grassini P, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3918; Habben JE, 2014, PLANT BIOTECHNOL J, V12, P685, DOI 10.1111/pbi.12172; Holmstrom KO, 1996, NATURE, V379, P683, DOI 10.1038/379683a0; Ingham DJ, 2001, BIOTECHNIQUES, V31, P132, DOI 10.2144/01311rr04; Jang IC, 2003, PLANT PHYSIOL, V131, P516, DOI 10.1104/pp.007237; Jones B, 2011, WIRES COMPUT STAT, V3, P188, DOI 10.1002/wics.162; Karim S, 2007, PLANT MOL BIOL, V64, P371, DOI 10.1007/s11103-007-9159-6; Kim JY, 2000, PLANT PHYSIOL, V124, P71, DOI 10.1104/pp.124.1.71; Lee SB, 2003, MOL BREEDING, V11, P1, DOI 10.1023/A:1022100404542; Li HF, 2010, CELL RES, V20, P299, DOI 10.1038/cr.2009.143; Li HW, 2011, PLANTA, V234, P1007, DOI 10.1007/s00425-011-1458-0; Lopez-Dee ZP, 1999, DEV GENET, V25, P237, DOI 10.1002/(SICI)1520-6408(1999)25:3&lt;237::AID-DVG6&gt;3.0.CO;2-L; Martinez-Barajas E, 2011, PLANT PHYSIOL, V156, P373, DOI 10.1104/pp.111.174524; Masuka B, 2012, J INTEGR PLANT BIOL, V54, P238, DOI 10.1111/j.1744-7909.2012.01118.x; Miranda JA, 2007, PLANTA, V226, P1411, DOI 10.1007/s00425-007-0579-y; Moon YH, 1999, PLANT MOL BIOL, V40, P167, DOI 10.1023/A:1026429922616; Morsy M, 2015, J INVESTIG GENOMICS, V2, P2, DOI DOI 10.15406/JIG.2015.02.00015; Negrotto D, 2000, PLANT CELL REP, V19, P798, DOI 10.1007/s002999900187; Nelson DE, 2007, P NATL ACAD SCI USA, V104, P16450, DOI 10.1073/pnas.0707193104; Nuccio M, 2015, RECENT ADV GENE EXPR, P41, DOI DOI 10.1007/978-1-4939-2202-4_2; Nunes C, 2013, PLANT PHYSIOL, V162, P1720, DOI 10.1104/pp.113.220657; Nunes C, 2013, PLANT PHYSIOL BIOCH, V63, P89, DOI 10.1016/j.plaphy.2012.11.011; Paul MJ, 2008, ANNU REV PLANT BIOL, V59, P417, DOI 10.1146/annurev.arplant.59.032607.092945; Paul MJ, 2010, PLANT SIGNAL BEHAV, V5, P386, DOI 10.4161/psb.5.4.10792; Pelleschi S, 1997, PLANT CELL ENVIRON, V20, P493, DOI 10.1046/j.1365-3040.1997.d01-89.x; PILONSMITS EAH, 1995, PLANT PHYSIOL, V107, P125, DOI 10.1104/pp.107.1.125; Pramanik MHR, 2005, PLANT MOL BIOL, V58, P751, DOI 10.1007/s11103-005-7404-4; Ray DK, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066428; Richards RA, 2000, J EXP BOT, V51, P447, DOI 10.1093/jexbot/51.suppl_1.447; Romero C, 1997, PLANTA, V201, P293, DOI 10.1007/s004250050069; Ruan YL, 2010, MOL PLANT, V3, P942, DOI 10.1093/mp/ssq044; Saini H. S., 1999, ADV AGRON, V68, P59, DOI [10.1016/S0065-2113(08)60843-3, DOI 10.1016/S0065-2113(08)60843-3]; SAS Institute, 2009, JMP 8 STAT GRAPH GUI; Satoh-Nagasawa N, 2006, NATURE, V441, P227, DOI 10.1038/nature04725; Schluepmann H, 2003, P NATL ACAD SCI USA, V100, P6849, DOI 10.1073/pnas.1132018100; Schluepmann H., 2009, ARABIDOPSIS BOOK, V7, pe0122; Schluepmann H, 2012, J EXP BOT, V63, P3379, DOI 10.1093/jxb/err311; SCHUSSLER JR, 1995, CROP SCI, V35, P1074, DOI 10.2135/cropsci1995.0011183X003500040026x; SCHUSSLER JR, 1991, CROP SCI, V31, P1189, DOI 10.2135/cropsci1991.0011183X003100050023x; SCHUSSLER JR, 1991, CROP SCI, V31, P1196, DOI 10.2135/cropsci1991.0011183X003100050024x; Schwachtje J, 2006, P NATL ACAD SCI USA, V103, P12935, DOI 10.1073/pnas.0602316103; Shima S, 2007, FEBS J, V274, P1192, DOI 10.1111/j.1742-4658.2007.05658.x; Snedecor G.W., 1989, AMES IOWA STATE U PR; Van Houtte H, 2013, PLANT SIGNAL BEHAV, V8, DOI 10.4161/psb.23209; Virlouvet L, 2011, PLANT PHYSIOL, V157, P917, DOI 10.1104/pp.111.176818; Vogel G, 1998, PLANT J, V13, P673, DOI 10.1046/j.1365-313X.1998.00064.x; Xiao BZ, 2009, MOL PLANT, V2, P73, DOI 10.1093/mp/ssn068; Yadav UP, 2014, J EXP BOT, V65, P1051, DOI 10.1093/jxb/ert457; Yeo ET, 2000, MOL CELLS, V10, P263; Yu H, 2000, PLANT PHYSIOL, V123, P1325, DOI 10.1104/pp.123.4.1325; Zhang J, 2010, PLANT J, V64, P604, DOI 10.1111/j.1365-313X.2010.04354.x; Zhang YH, 2009, PLANT PHYSIOL, V149, P1860, DOI 10.1104/pp.108.133934; ZINSELMEIER C, 1995, CROP SCI, V35, P1390, DOI 10.2135/cropsci1995.0011183X003500050022x; ZINSELMEIER C, 1995, PLANT PHYSIOL, V107, P385, DOI 10.1104/pp.107.2.385	72	247	260	22	272	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156	1546-1696		NAT BIOTECHNOL	Nat. Biotechnol.	AUG	2015	33	8					862	+		10.1038/nbt.3277	http://dx.doi.org/10.1038/nbt.3277			13	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	CO6OB	26473199				2022-12-27	WOS:000359274900026
J	Park, YJ; Kellis, M				Park, Yongjin; Kellis, Manolis			Deep learning for regulatory genomics	NATURE BIOTECHNOLOGY			English	Editorial Material							REPRESENTATION		[Park, Yongjin; Kellis, Manolis] MIT, Comp Sci & Artificial Intelligence Lab, Cambridge, MA 02139 USA	Massachusetts Institute of Technology (MIT)	Park, YJ (corresponding author), MIT, Comp Sci & Artificial Intelligence Lab, 77 Massachusetts Ave, Cambridge, MA 02139 USA.	manoli@mit.edu	Kellis, Manolis/ABE-7385-2020	Kellis, Manolis/0000-0001-7113-9630				Alipanahi B, 2015, NAT BIOTECHNOL, V33, P831, DOI 10.1038/nbt.3300; Bengio Y, 2013, IEEE T PATTERN ANAL, V35, P1798, DOI 10.1109/TPAMI.2013.50; Dunham I, 2012, NATURE, V489, P57, DOI 10.1038/nature11247; Hinton GE, 2006, NEURAL COMPUT, V18, P1527, DOI 10.1162/neco.2006.18.7.1527; LeCun Y, 1989, NEURAL COMPUT, V1, P541, DOI 10.1162/neco.1989.1.4.541; LeCun Y, 2015, NATURE, V521, P436, DOI 10.1038/nature14539; Roadmap Epigenomics Consortium, 2015, Nature, V518, P317, DOI 10.1038/nature14248; Srivastava N, 2014, J MACH LEARN RES, V15, P1929; Stormo GD, 2000, BIOINFORMATICS, V16, P16, DOI 10.1093/bioinformatics/16.1.16; Weirauch MT, 2013, NAT BIOTECHNOL, V31, P126, DOI 10.1038/nbt.2486	10	93	96	2	62	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1087-0156	1546-1696		NAT BIOTECHNOL	Nat. Biotechnol.	AUG	2015	33	8					825	826		10.1038/nbt.3313	http://dx.doi.org/10.1038/nbt.3313			2	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	CO6OB	26252139				2022-12-27	WOS:000359274900017
J	Li, FG; Fan, GY; Lu, CR; Xiao, GH; Zou, CS; Kohel, RJ; Ma, ZY; Shang, HH; Ma, XF; Wu, JY; Liang, XM; Huang, G; Percy, RG; Liu, K; Yang, WH; Chen, WB; Du, XM; Shi, CC; Yuan, YL; Ye, WW; Liu, X; Zhang, XY; Liu, WQ; Wei, HL; Wei, SJ; Huang, GD; Zhang, XL; Zhu, SJ; Zhang, H; Sun, FM; Wang, XF; Liang, J; Wang, JH; He, Q; Huang, LH; Wang, J; Cui, JJ; Song, GL; Wang, KB; Xu, X; Yu, JZ; Zhu, YX; Yu, SX				Li, Fuguang; Fan, Guangyi; Lu, Cairui; Xiao, Guanghui; Zou, Changsong; Kohel, Russell J.; Ma, Zhiying; Shang, Haihong; Ma, Xiongfeng; Wu, Jianyong; Liang, Xinming; Huang, Gai; Percy, Richard G.; Liu, Kun; Yang, Weihua; Chen, Wenbin; Du, Xiongming; Shi, Chengcheng; Yuan, Youlu; Ye, Wuwei; Liu, Xin; Zhang, Xueyan; Liu, Weiqing; Wei, Hengling; Wei, Shoujun; Huang, Guodong; Zhang, Xianlong; Zhu, Shuijin; Zhang, He; Sun, Fengming; Wang, Xingfen; Liang, Jie; Wang, Jiahao; He, Qiang; Huang, Leihuan; Wang, Jun; Cui, Jinjie; Song, Guoli; Wang, Kunbo; Xu, Xun; Yu, John Z.; Zhu, Yuxian; Yu, Shuxun			Genome sequence of cultivated Upland cotton (Gossypium hirsutum TM-1) provides insights into genome evolution	NATURE BIOTECHNOLOGY			English	Article							TRANSPOSABLE ELEMENTS; FIBER; PREDICTION; ETHYLENE; SUGGESTS; PROGRAM; FINDER; MAP	Gossypium hirsutum has proven difficult to sequence owing to its complex allotetraploid (A(t)D(t)) genome. Here we produce a draft genome using 181-fold paired-end sequences assisted by fivefold BAC-to-BAC sequences and a high-resolution genetic map. In our assembly 88.5% of the 2,173-Mb scaffolds, which cover 89.6%similar to 96.7% of the A(t)D(t) genome, are anchored and oriented to 26 pseudochromosomes. Comparison of this Gossypium hirsutum A(t)D(t) genome with the already sequenced diploid Gossypium arboreum (AA) and Gossypium raimondii (DD) genomes revealed conserved gene order. Repeated sequences account for 67.2% of the AtDt genome, and transposable elements (TEs) originating from D-t seem more active than from A(t). Reduction in the A(t)D(t) genome size occurred after allopolyploidization. The A or A(t) genome may have undergone positive selection for fiber traits. Concerted evolution of different regulatory mechanisms for Cellulose synthase (CesA) and 1-Aminocyclopropane-1-carboxylic acid oxidase1 and 3 (ACO1,3) may be important for enhanced fiber production in Gossypium hirsutum.	[Li, Fuguang; Lu, Cairui; Zou, Changsong; Shang, Haihong; Ma, Xiongfeng; Wu, Jianyong; Liu, Kun; Yang, Weihua; Du, Xiongming; Yuan, Youlu; Ye, Wuwei; Zhang, Xueyan; Wei, Hengling; Wei, Shoujun; Cui, Jinjie; Song, Guoli; Wang, Kunbo; Yu, Shuxun] Chinese Acad Agr Sci, Inst Cotton Res, State Key Lab Cotton Biol, Anyang, Peoples R China; [Fan, Guangyi; Liang, Xinming; Chen, Wenbin; Shi, Chengcheng; Liu, Xin; Liu, Weiqing; Huang, Guodong; Zhang, He; Sun, Fengming; Liang, Jie; Wang, Jiahao; He, Qiang; Huang, Leihuan; Wang, Jun; Xu, Xun] BGI Shenzhen, Shenzhen, Peoples R China; [Xiao, Guanghui; Huang, Gai; Zhu, Yuxian] Peking Univ, Coll Life Sci, State Key Lab Prot & Plant Gene Res, Beijing 100871, Peoples R China; [Xiao, Guanghui; Huang, Gai; Zhu, Yuxian] Wuhan Univ, Inst Adv Studies, Wuhan 430072, Peoples R China; [Xiao, Guanghui; Huang, Gai; Zhu, Yuxian] Wuhan Univ, Coll Life Sci, Wuhan 430072, Peoples R China; [Kohel, Russell J.; Percy, Richard G.] USDA ARS, Crop Germplasm Res Unit, Southern Plains Agr Res Ctr, College Stn, TX USA; [Ma, Zhiying; Wang, Xingfen] Agr Univ Hebei, Key Lab Crop Germplasm Resources Hebei, Baoding, Peoples R China; [Zhang, Xianlong] Huazhong Agr Univ, Natl Key Lab Crop Genet Improvement, Wuhan, Peoples R China; [Zhu, Shuijin] Zhejiang Univ, Dept Agron, Hangzhou 310003, Zhejiang, Peoples R China	Chinese Academy of Agricultural Sciences; Institute of Cotton Research, CAAS; Beijing Genomics Institute (BGI); Peking University; Wuhan University; Wuhan University; United States Department of Agriculture (USDA); Hebei Agricultural University; Huazhong Agricultural University; Zhejiang University	Zhu, YX (corresponding author), Peking Univ, Coll Life Sci, State Key Lab Prot & Plant Gene Res, Beijing 100871, Peoples R China.	John.Yu@ars.usda.gov; zhuyx@whu.edu.cn; Yu@cricaas.com.cn	Du, Xiongming/AAI-9999-2020; Xu, Xun/AAI-6763-2020; Wang, Jun/C-8434-2016; Wang, Jun/B-9503-2016	Xu, Xun/0000-0002-5338-5173; Huang, Gai/0000-0003-0426-9691; Zhu, Yuxian/0000-0003-2371-5933; zou, changsong/0000-0001-6805-3545; Zhang, He/0000-0001-9294-1403; Wang, Jun/0000-0002-8540-8931; Wang, Jun/0000-0002-2113-5874; yu, shuxun/0000-0002-9715-3462; SHI, Chengcheng/0000-0003-2154-5491; Wu, Jianyong/0000-0003-1392-4790; Liu, Xin/0000-0003-3256-2940	Major Program of Joint Funds (Sinkiang) of the National Natural Science Foundation of China [U1303282]; National Natural Science Foundation of China [90717009]; 863 National High-Tech Research Development Program in China [2013AA102601]; United States Department of Agriculture, Agricultural Research Service (USDA-ARS project) [3091-21000-038-01]	Major Program of Joint Funds (Sinkiang) of the National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); 863 National High-Tech Research Development Program in China(National High Technology Research and Development Program of China); United States Department of Agriculture, Agricultural Research Service (USDA-ARS project)	We are grateful to Q. Li for his assistance with data analysis and with the early phase of manuscript preparation. This work was supported by the Major Program of Joint Funds (Sinkiang) of the National Natural Science Foundation of China (grant U1303282), the National Natural Science Foundation of China (grant 90717009) and the 863 National High-Tech Research Development Program in China (grant 2013AA102601), and United States Department of Agriculture, Agricultural Research Service (USDA-ARS project 3091-21000-038-01).	Arabidopsis Genome Initiative, 2000, Nature (London), V408, P796, DOI 10.1038/35048692; Argout X, 2011, NAT GENET, V43, P101, DOI 10.1038/ng.736; Arumuganathan K, 1991, PLANT MOL BIOL REP, V9, P208, DOI DOI 10.1007/BF02672069; Bennetzen JL, 2014, ANNU REV PLANT BIOL, V65, P505, DOI 10.1146/annurev-arplant-050213-035811; Benson G, 1999, NUCLEIC ACIDS RES, V27, P573, DOI 10.1093/nar/27.2.573; Birney E, 2004, GENOME RES, V14, P988, DOI 10.1101/gr.1865504; Boetzer M, 2011, BIOINFORMATICS, V27, P578, DOI 10.1093/bioinformatics/btq683; Chalhoub B, 2014, SCIENCE, V345, P950, DOI 10.1126/science.1253435; Chen Nansheng, 2004, Curr Protoc Bioinformatics, VChapter 4, DOI 10.1002/0471250953.bi0410s05; Chen ZJ, 2007, PLANT PHYSIOL, V145, P1303, DOI 10.1104/pp.107.107672; Edgar RC, 2005, BIOINFORMATICS, V21, pI152, DOI 10.1093/bioinformatics/bti1003; Elsik CG, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-1-r13; Finn RD, 2011, NUCLEIC ACIDS RES, V39, pW29, DOI 10.1093/nar/gkr367; Hendrix B, 2005, ANN BOT-LONDON, V95, P789, DOI 10.1093/aob/mci078; Jaillon O, 2007, NATURE, V449, P463, DOI 10.1038/nature06148; Jurka J, 2000, TRENDS GENET, V16, P418, DOI 10.1016/S0168-9525(00)02093-X; Kent WJ, 2002, GENOME RES, V12, P656, DOI [10.1101/gr.229202, 10.1101/gr.229202. Article published online before March 2002]; KOHEL R. J., 1970, J. Crop Science, V10, P670, DOI 10.2135/cropsci1970.0011183X001000060019x; Li FG, 2014, NAT GENET, V46, P567, DOI 10.1038/ng.2987; Li RQ, 2010, GENOME RES, V20, P265, DOI 10.1101/gr.097261.109; Li RQ, 2010, NATURE, V463, P311, DOI 10.1038/nature08696; Majoros WH, 2004, BIOINFORMATICS, V20, P2878, DOI 10.1093/bioinformatics/bth315; Mayer KFX, 2014, SCIENCE, V345, DOI 10.1126/science.1251788; McFarlane HE, 2014, ANNU REV PLANT BIOL, V65, P69, DOI 10.1146/annurev-arplant-050213-040240; Myburg AA, 2014, NATURE, V510, P356, DOI 10.1038/nature13308; Oliver KR, 2013, GENOME BIOL EVOL, V5, P1886, DOI 10.1093/gbe/evt141; Ossowski S, 2010, SCIENCE, V327, P92, DOI 10.1126/science.1180677; Pang CY, 2010, MOL CELL PROTEOMICS, V9, P2019, DOI 10.1074/mcp.M110.000349; Paterson AH, 2012, NATURE, V492, P423, DOI 10.1038/nature11798; Peng LC, 2002, SCIENCE, V295, P147, DOI 10.1126/science.1064281; Qin YM, 2007, PLANT CELL, V19, P3692, DOI 10.1105/tpc.107.054437; Qin YM, 2011, CURR OPIN PLANT BIOL, V14, P106, DOI 10.1016/j.pbi.2010.09.010; Remm M, 2001, J MOL BIOL, V314, P1041, DOI 10.1006/jmbi.2000.5197; Rozen S, 2003, NATURE, V423, P873, DOI 10.1038/nature01723; Schmutz J, 2010, NATURE, V463, P178, DOI 10.1038/nature08670; Shi YH, 2006, PLANT CELL, V18, P651, DOI 10.1105/tpc.105.040303; Small RL, 2002, MOL BIOL EVOL, V19, P597, DOI 10.1093/oxfordjournals.molbev.a004119; STAM P, 1993, PLANT J, V3, P739, DOI 10.1111/j.1365-313X.1993.00739.x; Stanke M, 2006, NUCLEIC ACIDS RES, V34, pW435, DOI 10.1093/nar/gkl200; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Tang HB, 2008, SCIENCE, V320, P486, DOI 10.1126/science.1153917; Tang HB, 2008, GENOME RES, V18, P1944, DOI 10.1101/gr.080978.108; Trapnell C, 2010, NAT BIOTECHNOL, V28, P511, DOI 10.1038/nbt.1621; Udall JA, 2005, GENETICS, V169, P967, DOI 10.1534/genetics.104.033209; Wang KB, 2012, NAT GENET, V44, P1098, DOI 10.1038/ng.2371; WENDEL JF, 1992, SYST BOT, V17, P115, DOI 10.2307/2419069; Wendel JF, 2003, ADV AGRON, V78, P139, DOI 10.1016/S0065-2113(02)78004-8; WENDEL JF, 1989, P NATL ACAD SCI USA, V86, P4132, DOI 10.1073/pnas.86.11.4132; Wendel Jonathan F., 2009, V3, P3, DOI 10.1007/978-0-387-70810-2_1; Wright RJ, 1998, GENETICS, V149, P1987; Xie WB, 2010, P NATL ACAD SCI USA, V107, P10578, DOI 10.1073/pnas.1005931107; Xu Z, 2007, NUCLEIC ACIDS RES, V35, pW265, DOI 10.1093/nar/gkm286; Yang ZH, 1997, COMPUT APPL BIOSCI, V13, P555; You MS, 2013, NAT GENET, V45, P220, DOI 10.1038/ng.2524; Yu J, 2005, PLOS BIOL, V3, P266, DOI 10.1371/journal.pbio.0030038; Yu JZ, 2012, G3-GENES GENOM GENET, V2, P43, DOI 10.1534/g3.111.001552; Zhang H, 2008, LECT NOTES ENG COMP, P1, DOI 10.1155/2008/742304; Zhang TZ, 2015, NAT BIOTECHNOL, V33, P531, DOI 10.1038/nbt.3207; Zhu YX, 2013, J INTEGR PLANT BIOL, V55, P570, DOI 10.1111/jipb.12076	59	681	795	11	295	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1087-0156	1546-1696		NAT BIOTECHNOL	Nat. Biotechnol.	MAY	2015	33	5					524	U242		10.1038/nbt.3208	http://dx.doi.org/10.1038/nbt.3208			9	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	CH8VP	25893780	hybrid			2022-12-27	WOS:000354314500034
J	Ernst, J; Kellis, M				Ernst, Jason; Kellis, Manolis			Large-scale imputation of epigenomic datasets for systematic annotation of diverse human tissues	NATURE BIOTECHNOLOGY			English	Article							HISTONE MODIFICATIONS; CHROMATIN-STRUCTURE; METHYLATION STATUS; DNA METHYLATION; DISCOVERY; GENE; RESOLUTION; BINDING; ENCODE; IDENTIFICATION	With hundreds of epigenomic maps, the opportunity arises to exploit the correlated nature of epigenetic signals, across both marks and samples, for large-scale prediction of additional datasets. Here, we undertake epigenome imputation by leveraging such correlations through an ensemble of regression trees. We impute 4,315 high-resolution signal maps, of which 26% are also experimentally observed. Imputed signal tracks show overall similarity to observed signals and surpass experimental datasets in consistency, recovery of gene annotations and enrichment for disease-associated variants. We use the imputed data to detect low-quality experimental datasets, to find genomic sites with unexpected epigenomic signals, to define high-priority marks for new experiments and to delineate chromatin states in 127 reference epigenomes spanning diverse tissues and cell types. Our imputed datasets provide the most comprehensive human regulatory region annotation to date, and our approach and the ChromImpute software constitute a useful complement to large-scale experimental mapping of epigenomic information.	[Ernst, Jason] Univ Calif Los Angeles, Dept Biol Chem, Los Angeles, CA 90024 USA; [Ernst, Jason] Univ Calif Los Angeles, Dept Comp Sci, Los Angeles, CA 90024 USA; [Ernst, Jason] Univ Calif Los Angeles, Eli & Edythe Broad Ctr Regenerat Med & Stem Cell, Los Angeles, CA USA; [Ernst, Jason] Univ Calif Los Angeles, Jonsson Comprehens Canc Ctr, Los Angeles, CA 90024 USA; [Ernst, Jason] Univ Calif Los Angeles, Inst Mol Biol, Los Angeles, CA 90024 USA; [Kellis, Manolis] MIT Comp Sci & Artificial Intelligence Lab, Cambridge, MA USA; [Kellis, Manolis] Broad Inst MIT & Harvard, Cambridge, MA USA	University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; UCLA Jonsson Comprehensive Cancer Center; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; Massachusetts Institute of Technology (MIT); Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute	Ernst, J (corresponding author), Univ Calif Los Angeles, Dept Biol Chem, Los Angeles, CA 90024 USA.	jason.ernst@ucla.edu; manoli@mit.edu	Kellis, Manolis/ABE-7385-2020	Kellis, Manolis/0000-0001-7113-9630	National Science Foundation CAREER Award [1254200]; Alfred P. Sloan Fellowship; US National Institutes of Health through National Human Genome Research Institute [RC1HG005334, R01HG004037]; Direct For Biological Sciences [1254200, 0644282] Funding Source: National Science Foundation; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R01HG004037, U41HG007000, U01HG007610, RC1HG005334, U54HG004570] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM113708] Funding Source: NIH RePORTER	National Science Foundation CAREER Award(National Science Foundation (NSF)); Alfred P. Sloan Fellowship(Alfred P. Sloan Foundation); US National Institutes of Health through National Human Genome Research Institute; Direct For Biological Sciences(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank A. Kundaje, W. Meuleman, M. Bilenky and members of the NIH Roadmap Epigenomics Data Analysis and Coordination Center for data processing. We thank P. Kheradpour for advice on the motif analysis. We thank M. Eaton for generating the chromatin state segmentation visualization. We thank T. Wang for hosting the imputed data on the WashU Epigenome Browser. We thank N. Rajagopal, B. Ren and members of the Kellis laboratory and Roadmap Epigenomics Consortium for discussions related to this work. We thank the NIH Roadmap Epigenomics and ENCODE consortia for generating the data used in this paper. Funding for this work provided by National Science Foundation CAREER Award # 1254200 and an Alfred P. Sloan Fellowship to J.E. and by US National Institutes of Health through National Human Genome Research Institute grants RC1HG005334 and R01HG004037 to M.K.	Nguyen AT, 2011, GENE DEV, V25, P1345, DOI 10.1101/gad.2057811; Barber MF, 2012, NATURE, V487, P114, DOI 10.1038/nature11043; Barski A, 2007, CELL, V129, P823, DOI 10.1016/j.cell.2007.05.009; Bernstein BE, 2006, CELL, V125, P315, DOI 10.1016/j.cell.2006.02.041; Bock C, 2006, PLOS GENET, V2, P243, DOI 10.1371/journal.pgen.0020026; Bolstad BM, 2003, BIOINFORMATICS, V19, P185, DOI 10.1093/bioinformatics/19.2.185; Capra JA, 2014, BIOINFORMATICS, V30, pI408, DOI 10.1093/bioinformatics/btu445; Das R, 2006, P NATL ACAD SCI USA, V103, P10713, DOI 10.1073/pnas.0602949103; Dunham I, 2012, NATURE, V489, P57, DOI 10.1038/nature11247; Ernst J, 2012, NAT METHODS, V9, P215, DOI 10.1038/nmeth.1906; Ernst J, 2011, NATURE, V473, P43, DOI 10.1038/nature09906; Ernst J, 2010, NAT BIOTECHNOL, V28, P817, DOI 10.1038/nbt.1662; Eskandarian HA, 2013, SCIENCE, V341, P525, DOI 10.1126/science.1238858; Fan SC, 2008, BIOCHEM BIOPH RES CO, V374, P559, DOI 10.1016/j.bbrc.2008.07.077; Fejes AP, 2008, BIOINFORMATICS, V24, P1729, DOI 10.1093/bioinformatics/btn305; Ferrari R, 2008, SCIENCE, V321, P1086, DOI 10.1126/science.1155546; Garber M, 2009, BIOINFORMATICS, V25, pI54, DOI 10.1093/bioinformatics/btp190; Hall M., 2009, SIGKDD EXPLORATIONS, V11, P10, DOI [10.1145/1656274.1656278, DOI 10.1145/1656274.1656278]; Harris RA, 2010, NAT BIOTECHNOL, V28, P1097, DOI 10.1038/nbt.1682; Harrow J, 2012, GENOME RES, V22, P1760, DOI 10.1101/gr.135350.111; Hastie T., 2009, UNSUPERVISED LEARNIN; Heintzman ND, 2009, NATURE, V459, P108, DOI 10.1038/nature07829; Hindorff LA, 2009, P NATL ACAD SCI USA, V106, P9362, DOI 10.1073/pnas.0903103106; Hoffman MM, 2012, NAT METHODS, V9, P473, DOI [10.1038/NMETH.1937, 10.1038/nmeth.1937]; Horwitz GA, 2008, SCIENCE, V321, P1084, DOI 10.1126/science.1155544; John S, 2011, NAT GENET, V43, P264, DOI 10.1038/ng.759; Karlic R, 2010, P NATL ACAD SCI USA, V107, P2926, DOI 10.1073/pnas.0909344107; Karolchik D, 2014, NUCLEIC ACIDS RES, V42, pD764, DOI 10.1093/nar/gkt1168; Kasowski M, 2013, SCIENCE, V342, P750, DOI 10.1126/science.1242510; Kheradpour P, 2014, NUCLEIC ACIDS RES, V42, P2976, DOI 10.1093/nar/gkt1249; Kilpinen H, 2013, SCIENCE, V342, P744, DOI 10.1126/science.1242463; Kouskouti A, 2005, EMBO J, V24, P347, DOI 10.1038/sj.emboj.7600516; Kundaje A, 2015, NATURE, V518, P317, DOI 10.1038/nature14248; Landt SG, 2012, GENOME RES, V22, P1813, DOI 10.1101/gr.136184.111; Lasserre J, 2013, PLOS COMPUT BIOL, V9, DOI 10.1371/journal.pcbi.1003168; Lindblad-Toh K, 2011, NATURE, V478, P476, DOI 10.1038/nature10530; Lister R, 2009, NATURE, V462, P315, DOI 10.1038/nature08514; Marchini J, 2010, NAT REV GENET, V11, P499, DOI 10.1038/nrg2796; Maurano MT, 2012, SCIENCE, V337, P1190, DOI 10.1126/science.1222794; McVicker G, 2013, SCIENCE, V342, P747, DOI 10.1126/science.1242429; Raney BJ, 2014, BIOINFORMATICS, V30, P1003, DOI 10.1093/bioinformatics/btt637; SANYANUSIN P, 1995, NAT GENET, V9, P358, DOI 10.1038/ng0495-358; Seligson DB, 2005, NATURE, V435, P1262, DOI 10.1038/nature03672; Song LY, 2011, GENOME RES, V21, P1757, DOI 10.1101/gr.121541.111; Stevens M, 2013, GENOME RES, V23, P1541, DOI 10.1101/gr.152231.112; Thurman RE, 2012, NATURE, V489, P75, DOI 10.1038/nature11232; Troyanskaya O, 2001, BIOINFORMATICS, V17, P520, DOI 10.1093/bioinformatics/17.6.520; Xie W, 2013, CELL, V153, P1134, DOI 10.1016/j.cell.2013.04.022; Yu H, 2008, GENOME RES, V18, P1314, DOI 10.1101/gr.073080.107; Yuan GC, 2009, J COMPUT BIOL, V16, P341, DOI 10.1089/cmb.2008.18TT; Zhang Y, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-9-r137; Zheng H, 2013, BMC MED GENOMICS, V6, DOI 10.1186/1755-8794-6-S1-S13; Zhou J, 2014, PLOS COMPUT BIOL, V10, DOI 10.1371/journal.pcbi.1003525; Zhou X, 2011, NAT METHODS, V8, P989, DOI 10.1038/nmeth.1772; Zhu J, 2013, CELL, V152, P642, DOI 10.1016/j.cell.2012.12.033; Ziller MJ, 2013, NATURE, V500, P477, DOI 10.1038/nature12433	57	209	211	0	24	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156	1546-1696		NAT BIOTECHNOL	Nat. Biotechnol.	APR	2015	33	4					364	U74		10.1038/nbt.3157	http://dx.doi.org/10.1038/nbt.3157			16	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	CF2AE	25690853	Green Submitted, hybrid, Green Accepted			2022-12-27	WOS:000352348500022
J	Wachsmuth, M; Conrad, C; Bulkescher, J; Koch, B; Mahen, R; Isokane, M; Pepperkok, R; Ellenberg, J				Wachsmuth, Malte; Conrad, Christian; Bulkescher, Jutta; Koch, Birgit; Mahen, Robert; Isokane, Mayumi; Pepperkok, Rainer; Ellenberg, Jan			High-throughput fluorescence correlation spectroscopy enables analysis of proteome dynamics in living cells	NATURE BIOTECHNOLOGY			English	Article							CROSS-CORRELATION SPECTROSCOPY; CHROMOSOMAL PASSENGER COMPLEX; AURORA-B; SYSTEMS BIOLOGY; PROTEINS; LOCALIZATION; MICROSCOPY; DIFFUSION; MOBILITY; MITOSIS	To understand the function of cellular protein networks, spatial and temporal context is essential. Fluorescence correlation spectroscopy (FCS) is a single-molecule method to study the abundance, mobility and interactions of fluorescence-labeled biomolecules in living cells. However, manual acquisition and analysis procedures have restricted live-cell FCS to short-term experiments of a few proteins. Here, we present high-throughput (HT)-FCS, which automates screening and time-lapse acquisition of FCS data at specific subcellular locations and subsequent data analysis(1,2). We demonstrate its utility by studying the dynamics of 53 nuclear proteins(3,4). We made 60,000 measurements in 10,000 living human cells, to obtain biophysical parameters that allowed us to classify proteins according to their chromatin binding and complex formation. We also analyzed the cell-cycle-dependent dynamics of the mitotic kinase complex Aurora B/INCENP5 and showed how a rise in Aurora concentration triggers two-step complex formation. We expect that throughput and robustness will make HT-FCS a broadly applicable technology for characterizing protein network dynamics in cells.	[Wachsmuth, Malte; Koch, Birgit; Mahen, Robert; Isokane, Mayumi; Pepperkok, Rainer; Ellenberg, Jan] European Mol Biol Lab, Cell Biol & Biophys Unit, Heidelberg, Germany; [Conrad, Christian; Bulkescher, Jutta; Pepperkok, Rainer] European Mol Biol Lab, Adv Light Microscopy Facil, Heidelberg, Germany; [Conrad, Christian] German Canc Res Ctr BioQuant, Theoret Bioinformat, Heidelberg, Germany	European Molecular Biology Laboratory (EMBL); European Molecular Biology Laboratory (EMBL); Ruprecht Karls University Heidelberg	Ellenberg, J (corresponding author), European Mol Biol Lab, Cell Biol & Biophys Unit, Heidelberg, Germany.	rainer.pepperkok@embl.de; jan.ellenberg@embl.de	Ellenberg, Jan/I-4688-2014	Ellenberg, Jan/0000-0001-5909-701X; Mahen, Robert/0000-0002-4748-3690; Koch, Birgit/0000-0003-4683-3115	EMBL; MitoSys; European Commission [FP7/2007-2013-241548, FP7/2007-2013-258068]	EMBL; MitoSys; European Commission(European CommissionEuropean Commission Joint Research Centre)	We thank F. Sieckmann and W. Knebel of Leica Microsystems for providing microscope hardware and for implementing FCS functionality in the HCS-A module of the LASAF software. We also thank the mechanical and the electronics workshop of EMBL for custom hardware and the Advanced Light Microscopy Facility of EMBL for microscopy support. We gratefully acknowledge S. Trautmann and M. Knop for fruitful discussions, J.-K. Heriche for advice on data analysis, Y. Cai for critically reading the manuscript and B. Kramer of PicoQuant for help with FCS acquisition hardware and software. We thank K. Rippe and D. Boeke for comments on and testing of software and J. Braumann for technical help. We are grateful for support from EMBL and from the MitoSys and the Systems Microscopy projects funded by the European Commission (FP7/2007-2013-241548 and FP7/2007-2013-258068). HeLa Kyoto cells stably expressing the chromatin-targeted FRET biosensor were provided by D. Gerlich (IMBA, Vienna, Austria).	AXELROD D, 1976, BIOPHYS J, V16, P1055, DOI 10.1016/S0006-3495(76)85755-4; Bancaud A, 2009, EMBO J, V28, P3785, DOI 10.1038/emboj.2009.340; Baum M, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5494; Beck M, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.82; Burrows AC, 2012, J BIOL CHEM, V287, P39021, DOI 10.1074/jbc.M112.390328; Capoulade J, 2011, NAT BIOTECHNOL, V29, P835, DOI 10.1038/nbt.1928; Carmena M, 2012, NAT REV MOL CELL BIO, V13, P789, DOI 10.1038/nrm3474; Carpenter AE, 2004, NAT REV GENET, V5, P11, DOI 10.1038/nrg1248; Conrad C, 2011, NAT METHODS, V8, P246, DOI [10.1038/nmeth.1558, 10.1038/NMETH.1558]; Digman MA, 2011, ANNU REV PHYS CHEM, V62, P645, DOI 10.1146/annurev-physchem-032210-103424; Ebert DH, 2013, NATURE, V499, P341, DOI 10.1038/nature12348; ELSON EL, 1974, BIOPOLYMERS, V13, P1, DOI 10.1002/bip.1974.360130102; Guo SM, 2012, ANAL CHEM, V84, P3880, DOI 10.1021/ac2034375; Hayashi-Takanaka Y, 2009, J CELL BIOL, V187, P781, DOI 10.1083/jcb.200904137; Held M, 2010, NAT METHODS, V7, P747, DOI 10.1038/nmeth.1486; Honda R, 2003, MOL BIOL CELL, V14, P3325, DOI 10.1091/mbc.E02-11-0769; Huang S, 2009, DEVELOPMENT, V136, P3853, DOI 10.1242/dev.035139; Hutchins JRA, 2010, SCIENCE, V328, P593, DOI 10.1126/science.1181348; Kaur G, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2657; Kiyomitsu T, 2010, J CELL BIOL, V188, P791, DOI 10.1083/jcb.200908096; LEWIS JD, 1992, CELL, V69, P905, DOI 10.1016/0092-8674(92)90610-O; Ma Z, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003721; Mahen R, 2014, MOL BIOL CELL, V25, P3610, DOI 10.1091/mbc.E14-06-1091; Milo R, 2010, NUCLEIC ACIDS RES, V38, pD750, DOI 10.1093/nar/gkp889; Muller KP, 2009, BIOPHYS J, V97, P2876, DOI 10.1016/j.bpj.2009.08.057; Pepperkok R, 2006, NAT REV MOL CELL BIO, V7, P690, DOI 10.1038/nrm1979; Regard JB, 2004, J NEUROSCI, V24, P4092, DOI 10.1523/JNEUROSCI.4252-03.2004; Ries J, 2010, OPT EXPRESS, V18, P11073, DOI 10.1364/OE.18.011073; Romano A, 2003, J CELL BIOL, V161, P229, DOI 10.1083/jcb.200207117; Sampath SC, 2004, CELL, V118, P187, DOI 10.1016/j.cell.2004.06.026; Sankaran J, 2010, OPT EXPRESS, V18, P25468, DOI 10.1364/OE.18.025468; Schmidt U, 2009, RNA, V15, P862, DOI 10.1261/rna.1387009; Schwille P, 1997, BIOPHYS J, V72, P1878, DOI 10.1016/S0006-3495(97)78833-7; Schwille P, 2000, P NATL ACAD SCI USA, V97, P151, DOI 10.1073/pnas.97.1.151; Simpson JC, 2000, EMBO REP, V1, P287, DOI 10.1093/embo-reports/kvd058; Simpson JC, 2001, HISTOCHEM CELL BIOL, V115, P23, DOI 10.1007/s004180000236; Sommer C, 2013, J CELL SCI, V126, P5529, DOI 10.1242/jcs.123604; STRYER L, 1978, ANNU REV BIOCHEM, V47, P819, DOI 10.1146/annurev.bi.47.070178.004131; Tokai N, 1996, EMBO J, V15, P457, DOI 10.1002/j.1460-2075.1996.tb00378.x; van der Waal MS, 2012, EMBO REP, V13, P847, DOI 10.1038/embor.2012.93; Wachsmuth M, 2000, J MOL BIOL, V298, P677, DOI 10.1006/jmbi.2000.3692; Wang FW, 2011, CURR BIOL, V21, P1061, DOI 10.1016/j.cub.2011.05.016; Weidemann T, 2003, J MOL BIOL, V334, P229, DOI 10.1016/j.jmb.2003.08.063; Weidemann T, 2013, METHOD ENZYMOL, V518, P43, DOI 10.1016/B978-0-12-388422-0.00003-0; Will CL, 2002, EMBO J, V21, P4978, DOI 10.1093/emboj/cdf480; Wood C, 2011, PROC SPIE, V7905, DOI 10.1117/12.873947; Wurzenberger C, 2012, J CELL BIOL, V198, P173, DOI 10.1083/jcb.201112112; Xu ZJ, 2009, J CELL BIOL, V187, P637, DOI 10.1083/jcb.200906053; Yu SR, 2009, NATURE, V461, P533, DOI 10.1038/nature08391	49	102	103	1	80	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156	1546-1696		NAT BIOTECHNOL	Nat. Biotechnol.	APR	2015	33	4					384	U91		10.1038/nbt.3146	http://dx.doi.org/10.1038/nbt.3146			8	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	CF2AE	25774713				2022-12-27	WOS:000352348500024
J	Zhou, ZK; Jiang, Y; Wang, Z; Gou, ZH; Lyu, J; Li, WY; Yu, YJ; Shu, LP; Zhao, YJ; Ma, YM; Fang, C; Shen, YT; Liu, TF; Li, CC; Li, Q; Wu, M; Wang, M; Wu, YS; Dong, Y; Wan, WT; Wang, X; Ding, ZL; Gao, YD; Xiang, H; Zhu, BG; Lee, SH; Wang, W; Tian, ZX				Zhou, Zhengkui; Jiang, Yu; Wang, Zheng; Gou, Zhiheng; Lyu, Jun; Li, Weiyu; Yu, Yanjun; Shu, Liping; Zhao, Yingjun; Ma, Yanming; Fang, Chao; Shen, Yanting; Liu, Tengfei; Li, Congcong; Li, Qing; Wu, Mian; Wang, Min; Wu, Yunshuai; Dong, Yang; Wan, Wenting; Wang, Xiao; Ding, Zhaoli; Gao, Yuedong; Xiang, Hui; Zhu, Baoge; Lee, Suk-Ha; Wang, Wen; Tian, Zhixi			Resequencing 302 wild and cultivated accessions identifies genes related to domestication and improvement in soybean	NATURE BIOTECHNOLOGY			English	Article							COPY NUMBER VARIATION; FLAVONOID 3'-HYDROXYLASE GENE; MAP-BASED CLONING; LINKAGE DISEQUILIBRIUM; GENOME ASSOCIATION; LEAFLET SHAPE; DIVERSITY; TRAITS; RICE; ALIGNMENT	Understanding soybean (Glycine max) domestication and improvement at a genetic level is important to inform future efforts to further improve a crop that provides the world's main source of oilseed. We detect 230 selective sweeps and 162 selected copy number variants by analysis of 302 resequenced wild, landrace and improved soybean accessions at > 11x depth. A genomewide association study using these new sequences reveals associations between 10 selected regions and 9 domestication or improvement traits, and identifies 13 previously uncharacterized loci for agronomic traits including oil content, plant height and pubescence form. Combined with previous quantitative trait loci (QTL) information, we find that, of the 230 selected regions, 96 correlate with reported oil QTLs and 21 contain fatty acid biosynthesis genes. Moreover, we observe that some traits and loci are associated with geographical regions, which shows that soybean populations are structured geographically. This study provides resources for genomics-enabled improvements in soybean breeding.	[Zhou, Zhengkui; Wang, Zheng; Li, Weiyu; Ma, Yanming; Fang, Chao; Shen, Yanting; Liu, Tengfei; Li, Congcong; Li, Qing; Wu, Mian; Wang, Min; Wu, Yunshuai; Zhu, Baoge; Tian, Zhixi] Chinese Acad Sci, Inst Genet & Dev Biol, State Key Lab Plant Cell & Chromosome Engn, Beijing, Peoples R China; [Jiang, Yu; Gou, Zhiheng; Lyu, Jun; Shu, Liping; Zhao, Yingjun; Dong, Yang; Wan, Wenting; Wang, Xiao; Ding, Zhaoli; Gao, Yuedong; Xiang, Hui; Wang, Wen] Chinese Acad Sci, Kunming Inst Zool, State Key Lab Genet Resources & Evolut, Kunming, Peoples R China; [Jiang, Yu] Northwest A&F Univ, Coll Anim Sci & Technol, Yangling, Peoples R China; [Gou, Zhiheng; Zhao, Yingjun; Fang, Chao; Shen, Yanting; Liu, Tengfei; Li, Congcong; Li, Qing; Wang, Min; Wang, Xiao] Univ Chinese Acad Sci, Beijing, Peoples R China; [Yu, Yanjun] Chinese Acad Sci, Inst Microbiol, Beijing, Peoples R China; [Lee, Suk-Ha] Seoul Natl Univ, Dept Plant Sci, Seoul, South Korea; [Lee, Suk-Ha] Seoul Natl Univ, Res Inst Agr & Life Sci, Seoul, South Korea	Chinese Academy of Sciences; Institute of Genetics & Developmental Biology, CAS; Chinese Academy of Sciences; Kunming Institute of Zoology; Northwest A&F University - China; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS; Chinese Academy of Sciences; Institute of Microbiology, CAS; Seoul National University (SNU); Seoul National University (SNU)	Tian, ZX (corresponding author), Chinese Acad Sci, Inst Genet & Dev Biol, State Key Lab Plant Cell & Chromosome Engn, Beijing, Peoples R China.	wwang@mail.kiz.ac.cn; zxtian@genetics.ac.cn	Fang, Chao/U-5365-2019; Wang, Wen/AAP-9873-2020; Ma, Yanming/ABE-8450-2020; Jiang, Yu/O-5114-2015	Jiang, Yu/0000-0003-4821-3585; Zhou, Zhengkui/0000-0002-5192-2465; Wang, Wen/0000-0002-7801-2066; Li, Qing/0000-0001-7010-7776; Fang, Chao/0000-0003-0555-8487	National Key Basic Research Program [2013CB835200]; National Natural Science Foundation of China [31222042]; "Strategic Priority Research Program" of the Chinese Academy of Sciences [XDA08020202]; "One-hundred talents" Startup Funds from Chinese Academy of Sciences	National Key Basic Research Program(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); "Strategic Priority Research Program" of the Chinese Academy of Sciences(Chinese Academy of Sciences); "One-hundred talents" Startup Funds from Chinese Academy of Sciences	We thank the USDA GRIN database, SoyBase, the Platform of National Crop Germplasm Resources of China, and L. Qiu for providing publicly available resources and R. Nelson at the University of Illinois for sharing some of the phenotype data. We thank X. Liu (BGI-Shenzhen) for helping to upload sequence data to NCBI. This work was supported by the National Key Basic Research Program (No. 2013CB835200), National Natural Science Foundation of China (grant no. 31222042), "Strategic Priority Research Program" of the Chinese Academy of Sciences (grant no. XDA08020202), and "One-hundred talents" Startup Funds from Chinese Academy of Sciences for Z.T.	ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; [Anonymous], 2004, SOYBEANS IMPROVEMENT; Benjamini Y, 2012, NUCLEIC ACIDS RES, V40, DOI 10.1093/nar/gks001; Bickhart DM, 2012, GENOME RES, V22, P778, DOI 10.1101/gr.133967.111; Chen H, 2010, GENOME RES, V20, P393, DOI 10.1101/gr.100545.109; Chen YW, 2004, CROP SCI, V44, P671, DOI 10.2135/cropsci2004.0671; Chung WH, 2014, DNA RES, V21, P153, DOI 10.1093/dnares/dst047; Clemente TE, 2009, PLANT PHYSIOL, V151, P1030, DOI 10.1104/pp.109.146282; Clough SJ, 2004, GENOME, V47, P819, DOI 10.1139/G04-049; Cook DE, 2012, SCIENCE, V338, P1206, DOI 10.1126/science.1228746; Doebley JF, 2006, CELL, V127, P1309, DOI 10.1016/j.cell.2006.12.006; Fang C, 2013, J GENET GENOMICS, V40, P93, DOI 10.1016/j.jgg.2013.01.002; Felsenstein J., 2005, PHYLIP PHYLOGENY INF, DOI DOI 10.1111/J.1096-0031.1989.TB00562.X; Foley JA, 2011, NATURE, V478, P337, DOI 10.1038/nature10452; Funatsuki H, 2009, JARQ-JPN AGR RES Q, V43, P95, DOI 10.6090/jarq.43.95; Grabherr MG, 2011, NAT BIOTECHNOL, V29, P644, DOI 10.1038/nbt.1883; Grant D, 2010, NUCLEIC ACIDS RES, V38, pD843, DOI 10.1093/nar/gkp798; Guo JA, 2010, ANN BOT-LONDON, V106, P505, DOI 10.1093/aob/mcq125; Huang XH, 2012, NATURE, V490, P497, DOI 10.1038/nature11532; Huang XH, 2010, NAT GENET, V42, P961, DOI 10.1038/ng.695; Hufford MB, 2012, NAT GENET, V44, P808, DOI 10.1038/ng.2309; Hyten DL, 2007, GENETICS, V175, P1937, DOI 10.1534/genetics.106.069740; Hyten DL, 2006, P NATL ACAD SCI USA, V103, P16666, DOI 10.1073/pnas.0604379103; Ingvarsson PK, 2011, NEW PHYTOL, V189, P909, DOI 10.1111/j.1469-8137.2010.03593.x; Jeong N, 2012, PLANT CELL, V24, P4807, DOI 10.1105/tpc.112.104968; Jiao YP, 2012, NAT GENET, V44, P812, DOI 10.1038/ng.2312; Kim JH, 2012, BIOINFORMATICS, V28, P1790, DOI 10.1093/bioinformatics/bts239; Kim MY, 2010, P NATL ACAD SCI USA, V107, P22032, DOI 10.1073/pnas.1009526107; Lam HM, 2010, NAT GENET, V42, P1053, DOI 10.1038/ng.715; Larson G, 2014, P NATL ACAD SCI USA, V111, P6139, DOI 10.1073/pnas.1323964111; Li H, 2009, BIOINFORMATICS, V25, P1094, DOI [10.1093/bioinformatics/btp100, 10.1093/bioinformatics/btp324]; Li YH, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-579; Li YH, 2008, THEOR APPL GENET, V117, P857, DOI 10.1007/s00122-008-0825-0; Lipka AE, 2012, BIOINFORMATICS, V28, P2397, DOI 10.1093/bioinformatics/bts444; Liu B, 2007, ANN BOT-LONDON, V100, P1027, DOI 10.1093/aob/mcm149; Liu BH, 2010, PLANT PHYSIOL, V153, P198, DOI 10.1104/pp.109.150607; Mather KA, 2007, GENETICS, V177, P2223, DOI 10.1534/genetics.107.079616; McKenna A, 2010, GENOME RES, V20, P1297, DOI 10.1101/gr.107524.110; MURRAY MG, 1980, NUCLEIC ACIDS RES, V8, P4321, DOI 10.1093/nar/8.19.4321; Pathan M. S., 2008, ADV SOYBEAN BREEDING; Price AL, 2006, NAT GENET, V38, P904, DOI 10.1038/ng1847; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Qi JJ, 2013, NAT GENET, V45, P1510, DOI 10.1038/ng.2801; Quinlan AR, 2010, BIOINFORMATICS, V26, P841, DOI 10.1093/bioinformatics/btq033; Ray DK, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066428; Sayama T, 2012, PLANT CELL, V24, P2123, DOI 10.1105/tpc.111.095174; Schmutz J, 2010, NATURE, V463, P178, DOI 10.1038/nature08670; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Tang H, 2005, GENET EPIDEMIOL, V28, P289, DOI 10.1002/gepi.20064; Tanksley SD, 1997, SCIENCE, V277, P1063, DOI 10.1126/science.277.5329.1063; Tilman D, 2011, P NATL ACAD SCI USA, V108, P20260, DOI 10.1073/pnas.1116437108; Toda K, 2005, CROP SCI, V45, P2212, DOI 10.2135/cropsci2004.0623; Toda K, 2002, PLANT MOL BIOL, V50, P187, DOI 10.1023/A:1016087221334; Todd JJ, 1996, PLANT CELL, V8, P687, DOI 10.1105/tpc.8.4.687; Tuteja JH, 2004, PLANT CELL, V16, P819, DOI 10.1105/tpc.021352; Wang K, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkq603; Watanabe S, 2011, GENETICS, V188, P395, DOI 10.1534/genetics.110.125062; Wilson, 2008, SOYBEAN MARKET DRIVE; Xia Z., 2013, THESCIENTIFICWORLDJO, V2013, P1; Xia ZJ, 2012, P NATL ACAD SCI USA, V109, pE2155, DOI 10.1073/pnas.1117982109; Yamada T, 2011, BREEDING SCI, V61, P480, DOI 10.1270/jsbbs.61.480; Young ND, 2011, NATURE, V480, P520, DOI 10.1038/nature10625; Zabala G, 2007, CROP SCI, V47, pS113, DOI 10.2135/cropsci2006.12.0838tpg	63	617	670	23	354	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1087-0156	1546-1696		NAT BIOTECHNOL	Nat. Biotechnol.	APR	2015	33	4					408	U125		10.1038/nbt.3096	http://dx.doi.org/10.1038/nbt.3096			9	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	CF2AE	25643055	hybrid			2022-12-27	WOS:000352348500028
J	Steinbeck, JA; Choi, SJ; Mrejeru, A; Ganat, Y; Deisseroth, K; Sulzer, D; Mosharov, EV; Studer, L				Steinbeck, Julius A.; Choi, Se Joon; Mrejeru, Ana; Ganat, Yosif; Deisseroth, Karl; Sulzer, David; Mosharov, Eugene V.; Studer, Lorenz			Optogenetics enables functional analysis of human embryonic stem cell-derived grafts in a Parkinson's disease model	NATURE BIOTECHNOLOGY			English	Article							STRIATAL SYNAPTIC PLASTICITY; DOPAMINERGIC-NEURONS; GLUTAMATE RECEPTORS; AMPA RECEPTOR; MODULATION; EXPRESSION; D1; APOMORPHINE; RECOVERY; RATS	Recent studies have shown evidence of behavioral recovery after transplantation of human pluripotent stem cell (PSC)-derived neural cells in animal models of neurological disease. However, little is known about the mechanisms underlying graft function. Here we use optogenetics to modulate in real time electrophysiological and neurochemical properties of mesencephalic dopaminergic (mesDA) neurons derived from human embryonic stem cells (hESCs). In mice that had recovered from lesion-induced Parkinsonian motor deficits, light-induced selective silencing of graft activity rapidly and reversibly re-introduced the motor deficits. The re-introduction of motor deficits was prevented by the dopamine agonist apomorphine. These results suggest that functionality depends on graft neuronal activity and dopamine release. Combining optogenetics, slice electrophysiology and pharmacological approaches, we further show that mesDA-rich grafts modulate host glutamatergic synaptic transmission onto striatal medium spiny neurons in a manner reminiscent of endogenous mesDA neurons. Thus, application of optogenetics in cell therapy can link transplantation, animal behavior and postmortem analysis to enable the identification of mechanisms that drive recovery.	[Steinbeck, Julius A.; Ganat, Yosif; Studer, Lorenz] Sloan Kettering Inst Canc Res, Ctr Stem Cell Biol, New York, NY 10065 USA; [Steinbeck, Julius A.; Ganat, Yosif; Studer, Lorenz] Sloan Kettering Inst Canc Res, Dev Biol Program, New York, NY USA; [Choi, Se Joon; Mrejeru, Ana; Sulzer, David; Mosharov, Eugene V.] Columbia Univ, Med Ctr, Dept Neurol, New York, NY USA; [Deisseroth, Karl] Stanford Univ, Dept Bioengn, Stanford, CA 94305 USA; [Deisseroth, Karl] Stanford Univ, Dept Psychiat, Stanford, CA 94305 USA; [Deisseroth, Karl] Stanford Univ, Howard Hughes Med Inst, Stanford, CA 94305 USA; [Sulzer, David] Columbia Univ, Med Ctr, Dept Psychiat, New York, NY USA; [Sulzer, David] Columbia Univ, Med Ctr, Dept Pharmacol, New York, NY USA	Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center; Columbia University; Stanford University; Stanford University; Howard Hughes Medical Institute; Stanford University; Columbia University; Columbia University	Studer, L (corresponding author), Sloan Kettering Inst Canc Res, Ctr Stem Cell Biol, New York, NY 10065 USA.	em706@columbia.edu; studerl@mskcc.org	Studer, Lorenz/ABH-1491-2021	Studer, Lorenz/0000-0003-0741-7987	Deutsche Forschungsgemeinschaft fellowship; US National Institutes of Health (NIH)/National Institute of Neurological Disorders and Stroke (NINDS) [NS052671]; NYSTEM [C028503]; NINDS/NIH [NS075222]; Parkinson's disease Foundation; Jeffry and Barbara Picower Foundation; Udall Center of Excellence; NATIONAL CANCER INSTITUTE [P30CA008748] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [T32MH015174] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS075222, R01NS052671] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [R01AA019801] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [P01DA010154, R01DA007418] Funding Source: NIH RePORTER	Deutsche Forschungsgemeinschaft fellowship(German Research Foundation (DFG)); US National Institutes of Health (NIH)/National Institute of Neurological Disorders and Stroke (NINDS)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NYSTEM; NINDS/NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); Parkinson's disease Foundation; Jeffry and Barbara Picower Foundation; Udall Center of Excellence; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	We thank S. Oh and K. Manova (MSKCC molecular cytology core), and M. Tomishima (SKI stem cell core) for excellent technical support. We further thank Y. Schmitz (Sulzer laboratory) for advice on the corridor test. J.A.S. was supported by a Deutsche Forschungsgemeinschaft fellowship. The work was supported in part by US National Institutes of Health (NIH)/National Institute of Neurological Disorders and Stroke (NINDS) grant NS052671 and NYSTEM contract C028503 to L.S. and by the NINDS/NIH grant NS075222 to E.V.M. This work was further supported by grants from the Parkinson's disease and Jeffry and Barbara Picower Foundations and the Udall Center of Excellence to D.S.	Andre VM, 2010, EUR J NEUROSCI, V31, P14, DOI 10.1111/j.1460-9568.2009.07047.x; Bamford NS, 2008, NEURON, V58, P89, DOI 10.1016/j.neuron.2008.01.033; Battista D, 2014, STEM CELL TRANSL MED, V3, P108, DOI 10.5966/sctm.2013-0084; CENCI MA, 1992, NEUROSCIENCE, V46, P943, DOI 10.1016/0306-4522(92)90196-9; CEPEDA C, 1993, P NATL ACAD SCI USA, V90, P9576, DOI 10.1073/pnas.90.20.9576; Chan WS, 2003, NEUROSIGNALS, V12, P302, DOI 10.1159/000075312; Chaudhury D, 2013, NATURE, V493, P532, DOI 10.1038/nature11713; Cummings BJ, 2005, P NATL ACAD SCI USA, V102, P14069, DOI 10.1073/pnas.0507063102; Dell'Anno MT, 2014, J CLIN INVEST, V124, P3215, DOI 10.1172/JCI74664; Dowd E, 2005, BRAIN RES BULL, V68, P24, DOI 10.1016/j.brainresbull.2005.08.009; DUNNETT SB, 1988, EXP BRAIN RES, V71, P411; Fujita S, 2013, SYNAPSE, V67, P363, DOI 10.1002/syn.21644; Ganat YM, 2012, J CLIN INVEST, V122, P2928, DOI 10.1172/JCI58767; Gradinaru V, 2010, CELL, V141, P154, DOI 10.1016/j.cell.2010.02.037; Gradinaru V, 2008, BRAIN CELL BIOL, V36, P129, DOI 10.1007/s11068-008-9027-6; Grealish S, 2010, EUR J NEUROSCI, V31, P2266, DOI 10.1111/j.1460-9568.2010.07265.x; Guzman JN, 2009, J NEUROSCI, V29, P11011, DOI 10.1523/JNEUROSCI.2519-09.2009; Johnson MA, 2007, J NEUROSCI, V27, P3069, DOI 10.1523/JNEUROSCI.4562-06.2007; Kim JH, 2002, NATURE, V418, P50, DOI 10.1038/nature00900; Kirkeby A, 2012, CELL REPORTS, V1, P703, DOI 10.1016/j.celrep.2012.04.009; Kish LJ, 1999, BRAIN RES, V833, P58, DOI 10.1016/S0006-8993(99)01496-1; Kravitz AV, 2010, NATURE, V466, P622, DOI 10.1038/nature09159; Kriks S, 2011, NATURE, V480, P547, DOI 10.1038/nature10648; Lindvall O, 2010, J CLIN INVEST, V120, P29, DOI 10.1172/JCI40543; Miller JD, 2013, CELL STEM CELL, V13, P691, DOI 10.1016/j.stem.2013.11.006; Nambu A, 2008, CURR OPIN NEUROBIOL, V18, P595, DOI 10.1016/j.conb.2008.11.001; Paille V, 2010, J NEUROSCI, V30, P14182, DOI 10.1523/JNEUROSCI.2149-10.2010; Pina-Crespo JC, 2012, J NEUROSCI, V32, P15837, DOI 10.1523/JNEUROSCI.3735-12.2012; Pothos E, 1996, J NEUROCHEM, V66, P629; Price CJ, 1999, J NEUROCHEM, V73, P2441, DOI 10.1046/j.1471-4159.1999.0732441.x; Roy NS, 2006, NAT MED, V12, P1259, DOI 10.1038/nm1495; Rylander D, 2013, P NATL ACAD SCI USA, V110, pE4375, DOI 10.1073/pnas.1311187110; Snyder GL, 2000, J NEUROSCI, V20, P4480, DOI 10.1523/JNEUROSCI.20-12-04480.2000; Song RS, 2013, P NATL ACAD SCI USA, V110, P15437, DOI 10.1073/pnas.1311783110; Sorensen AT, 2005, EUR J NEUROSCI, V21, P2793, DOI 10.1111/j.1460-9568.2005.04116.x; Steinbeck JA, 2012, CELL MOL LIFE SCI, V69, P461, DOI 10.1007/s00018-011-0759-6; Surmeier DJ, 2007, TRENDS NEUROSCI, V30, P228, DOI 10.1016/j.tins.2007.03.008; Tornero D, 2013, BRAIN, V136, P3561, DOI 10.1093/brain/awt278; Tukey DS, 2013, J BIOL CHEM, V288, P35297, DOI 10.1074/jbc.M113.516690; Umemiya M, 1997, J NEUROPHYSIOL, V78, P1248, DOI 10.1152/jn.1997.78.3.1248; Weick JP, 2010, STEM CELLS, V28, P2008, DOI 10.1002/stem.514; Yan Z, 1999, NAT NEUROSCI, V2, P13, DOI 10.1038/4516	42	193	201	1	100	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156	1546-1696		NAT BIOTECHNOL	Nat. Biotechnol.	FEB	2015	33	2					204	209		10.1038/nbt.3124	http://dx.doi.org/10.1038/nbt.3124			6	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	CA8VK	25580598	Green Accepted			2022-12-27	WOS:000349198800027
J	Mahalatchimy, A; Rial-Sebbag, E; Duguet, AM; Taboulet, F; Cambon-Thomsen, A				Mahalatchimy, Aurelie; Rial-Sebbag, Emmanuelle; Duguet, Anne-Marie; Taboulet, Florence; Cambon-Thomsen, Anne			The impact of European embryonic stem cell patent decisions on research strategies	NATURE BIOTECHNOLOGY			English	Editorial Material							COURT; PATENTABILITY		[Mahalatchimy, Aurelie; Rial-Sebbag, Emmanuelle; Duguet, Anne-Marie; Taboulet, Florence; Cambon-Thomsen, Anne] INSERM, UMR1027, Toulouse, France; [Mahalatchimy, Aurelie; Rial-Sebbag, Emmanuelle; Duguet, Anne-Marie; Taboulet, Florence; Cambon-Thomsen, Anne] Univ Toulouse 3, F-31062 Toulouse, France; [Mahalatchimy, Aurelie] Univ Sussex, Sch Global Studies, Ctr Global Hlth Policy, Brighton, E Sussex, England; [Mahalatchimy, Aurelie] Univ Toulouse 1, IRDEIC, F-31042 Toulouse, France	Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Toulouse; Universite Toulouse III - Paul Sabatier; University of Sussex; Universite de Toulouse; Universite Toulouse 1 Capitole	Mahalatchimy, A (corresponding author), INSERM, UMR1027, Toulouse, France.	aurelie.mahalatchimy@gmail.com	Mahalatchimy, Aurelie/D-2485-2018	Mahalatchimy, Aurelie/0000-0002-4365-2143				Bonadio E, 2012, EIPR, V34, P433; Court of Justice of the European Union, 2011, GRAND CHAMB BRUSTL G; EPO, 2008, ENL BOARD APP WARF G; EPO, 2014, BOARDS APP TECHN RES; European Council, 2006, POL AGR 7 RES FRAM P; Harmon SHE, 2013, EUR LAW REV, V38, P92; Klimanskaya I, 2006, NATURE, V444, P481, DOI 10.1038/nature05142; Koch NJ, 2011, CELL STEM CELL, V9, P499, DOI 10.1016/j.stem.2011.11.001; Mahalatchimy A., EUR INTELLE IN PRESS; Moran N, 2011, NAT BIOTECHNOL, V29, P1057, DOI 10.1038/nbt1211-1057; Paton M, 2011, EIPR, V33, P590; Schuster MI, 2012, IIC-INT REV INTELL P, V43, P626; Wilmut I, 2011, CELL STEM CELL, V9, P498, DOI 10.1016/j.stem.2011.11.002	13	4	5	1	9	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156	1546-1696		NAT BIOTECHNOL	Nat. Biotechnol.	JAN	2015	33	1					41	43		10.1038/nbt.3105	http://dx.doi.org/10.1038/nbt.3105			3	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	AY7AR	25574634	Green Accepted			2022-12-27	WOS:000347714200022
J	Schlaeger, TM; Daheron, L; Brickler, TR; Entwisle, S; Chan, K; Cianci, A; DeVine, A; Ettenger, A; Fitzgerald, K; Godfrey, M; Gupta, D; McPherson, J; Malwadkar, P; Gupta, M; Bell, B; Doi, A; Jung, N; Li, X; Lynes, MS; Brookes, E; Cherry, ABC; Demirbas, D; Tsankov, AM; Zon, LI; Rubin, LL; Feinberg, AP; Meissner, A; Cowan, CA; Daley, GQ				Schlaeger, Thorsten M.; Daheron, Laurence; Brickler, Thomas R.; Entwisle, Samuel; Chan, Karrie; Cianci, Amelia; DeVine, Alexander; Ettenger, Andrew; Fitzgerald, Kelly; Godfrey, Michelle; Gupta, Dipti; McPherson, Jade; Malwadkar, Prerana; Gupta, Manav; Bell, Blair; Doi, Akiko; Jung, Namyoung; Li, Xin; Lynes, Maureen S.; Brookes, Emily; Cherry, Anne B. C.; Demirbas, Didem; Tsankov, Alexander M.; Zon, Leonard I.; Rubin, Lee L.; Feinberg, Andrew P.; Meissner, Alexander; Cowan, Chad A.; Daley, George Q.			A comparison of non-integrating reprogramming methods	NATURE BIOTECHNOLOGY			English	Article							PLURIPOTENT STEM-CELLS; HUMAN SOMATIC-CELLS; HUMAN FIBROBLASTS; IPS CELLS; GENERATION; DIFFERENTIATION; DERIVATION; INDUCTION; VECTOR; MOUSE	Human induced pluripotent stem cells (hiPSCs(1-3)) are useful in disease modeling and drug discovery, and they promise to provide a new generation of cell-based therapeutics. To date there has been no systematic evaluation of the most widely used techniques for generating integration-free hiPSCs. Here we compare Sendai-viral (SeV)(4), episomal (Epi)(5) and mRNA transfection mRNA(6) methods using a number of criteria. All methods generated high-quality hiPSCs, but significant differences existed in aneuploidy rates, reprogramming efficiency, reliability and workload. We discuss the advantages and shortcomings of each approach, and present and review the results of a survey of a large number of human reprogramming laboratories on their independent experiences and preferences. Our analysis provides a valuable resource to inform the use of specific reprogramming methods for different laboratories and different applications, including clinical translation.	[Schlaeger, Thorsten M.; Chan, Karrie; Cianci, Amelia; DeVine, Alexander; Ettenger, Andrew; Fitzgerald, Kelly; Godfrey, Michelle; Gupta, Dipti; McPherson, Jade; Malwadkar, Prerana; Gupta, Manav; Bell, Blair; Brookes, Emily; Cherry, Anne B. C.; Zon, Leonard I.; Daley, George Q.] Boston Childrens Hosp, Dana Farber Canc Inst, Div Pediat Hematol Oncol, Boston, MA USA; [Schlaeger, Thorsten M.; Daheron, Laurence; Brickler, Thomas R.; Entwisle, Samuel; Lynes, Maureen S.; Tsankov, Alexander M.; Zon, Leonard I.; Rubin, Lee L.; Meissner, Alexander; Cowan, Chad A.; Daley, George Q.] Harvard Stem Cell Inst, Cambridge, MA USA; [Doi, Akiko; Jung, Namyoung; Li, Xin; Feinberg, Andrew P.] Johns Hopkins Univ, Sch Med, Ctr Epigenet, Baltimore, MD USA; [Doi, Akiko; Jung, Namyoung; Li, Xin; Feinberg, Andrew P.] Johns Hopkins Univ, Sch Med, Dept Med, Baltimore, MD USA; [Doi, Akiko] MIT, Dept Biol, Cambridge, MA 02139 USA; [Cherry, Anne B. C.; Daley, George Q.] Harvard Univ, Sch Med, Dept Biol Chem & Mol Pharmacol, Boston, MA USA; [Demirbas, Didem] Boston Childrens Hosp, Manton Ctr Orphan Dis Res, Div Genet & Genom, Boston, MA USA; [Tsankov, Alexander M.; Meissner, Alexander; Cowan, Chad A.] Broad Inst, Cambridge, MA USA; [Rubin, Lee L.; Cowan, Chad A.] Harvard Univ, Dept Stem Cell & Regenerat Biol, Cambridge, MA USA; [Cowan, Chad A.] Massachusetts Gen Hosp, Ctr Regenerat Med, Boston, MA 02114 USA; [Daley, George Q.] Childrens Hosp Boston, Howard Hughes Med Inst, Boston, MA USA; [Daley, George Q.] Dana Farber Canc Inst, Boston, MA 02115 USA	Harvard University; Boston Children's Hospital; Dana-Farber Cancer Institute; Harvard University; Johns Hopkins University; Johns Hopkins University; Massachusetts Institute of Technology (MIT); Harvard University; Harvard Medical School; Harvard University; Boston Children's Hospital; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Harvard University; Harvard University; Massachusetts General Hospital; Harvard University; Boston Children's Hospital; Howard Hughes Medical Institute; Harvard University; Dana-Farber Cancer Institute	Schlaeger, TM (corresponding author), Boston Childrens Hosp, Dana Farber Canc Inst, Div Pediat Hematol Oncol, Boston, MA USA.	thorsten.schlaeger@childrens.harvard.edu; george.daley@childrens.harvard.edu	Feinberg, Andrew/AAY-7666-2020; Li, Xin/A-4137-2011	Demirbas, Didem/0000-0003-2865-2708; DeVine, Alexander/0000-0001-7682-9526; Rubin, Lee/0000-0002-8658-841X; Gupta, Manav/0000-0001-5163-2911; Brookes, Emily/0000-0003-2175-4349; Schlaeger, Thorsten/0000-0002-1599-9908; Ettenger, Andrew/0000-0003-2258-4329; Li, Xin/0000-0001-8328-4894; Feinberg, Andrew/0000-0002-8364-1991; , Karrie/0000-0002-6515-4735	National Heart, Lung, and Blood Institute (NHLBI) Progenitor Cell Biology Consortium [R01HL75737, U01HL107440, UO1-HL100001, U01HL87402, U01HL100408]; National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) [R24DK092760]; National Institute of Neurological Disorders and Stroke (NINDS) [PO1NS066888]; SMA Foundation; Jerome Le Jeune Foundation; EMBO postdoctoral fellowship; Harvard Stem Cell Institute; NATIONAL CANCER INSTITUTE [R01CA054358] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR025758] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [U01HL100001, U01HL107440, R01HL048801, U01HL100408] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [F32DK095537, R24DK092760] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM107536] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P01NS066888] Funding Source: NIH RePORTER	National Heart, Lung, and Blood Institute (NHLBI) Progenitor Cell Biology Consortium; National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); National Institute of Neurological Disorders and Stroke (NINDS)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); SMA Foundation; Jerome Le Jeune Foundation; EMBO postdoctoral fellowship(European Molecular Biology Organization (EMBO)); Harvard Stem Cell Institute; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We would like to thank B. Hamilton (Stemgent) for miRNA reprogramming agents and protocols, G. Mostoslavsky (Boston University) for human STEMCCA lentiviral plasmid constructs, M. Armant (Boston Children's Hospital) for MRC5 and hCD34<SUP>+</SUP> cells, G. MacLean (Boston Children's Hospital) for advice on episomal blood reprogramming and S. D'Souza (Icahn School of Medicine at Mount Sinai) for a list of contacts for human cell reprogramming laboratories. This work was supported in part by grants R01HL75737, U01HL107440, UO1-HL100001, U01HL87402 and U01HL100408 (National Heart, Lung, and Blood Institute (NHLBI) Progenitor Cell Biology Consortium), R24DK092760 (the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)), PO1NS066888 (the National Institute of Neurological Disorders and Stroke (NINDS)), by the SMA Foundation, the Jerome Le Jeune Foundation, an EMBO postdoctoral fellowship (E. B.) and the Harvard Stem Cell Institute.	Awe JP, 2013, STEM CELL RES THER, V4, DOI 10.1186/scrt246; Bock C, 2011, CELL, V144, P439, DOI 10.1016/j.cell.2010.12.032; Buganim Y, 2014, CELL STEM CELL, V15, P295, DOI 10.1016/j.stem.2014.07.003; Carey BW, 2011, CELL STEM CELL, V9, P588, DOI 10.1016/j.stem.2011.11.003; Chan EM, 2009, NAT BIOTECHNOL, V27, P1033, DOI 10.1038/nbt.1580; Chen GK, 2011, NAT METHODS, V8, P424, DOI [10.1038/nmeth.1593, 10.1038/NMETH.1593]; Fusaki N, 2009, P JPN ACAD B-PHYS, V85, P348, DOI 10.2183/pjab.85.348; Goh PA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081622; Gore A, 2011, NATURE, V471, P63, DOI 10.1038/nature09805; Hansen KD, 2012, GENOME BIOL, V13, DOI [10.1186/gb-2012-13-10-r83, 10.1186/gb-2012-13-10-R83]; Hansen KD, 2011, NAT GENET, V43, P768, DOI 10.1038/ng.865; Hartung O., 2010, CURR PROTOC STEM CEL, V14; Hou PP, 2013, SCIENCE, V341, P651, DOI 10.1126/science.1239278; Jiang J, 2013, CELL RES, V23, P92, DOI 10.1038/cr.2012.157; Koyanagi-Aoi M, 2013, P NATL ACAD SCI USA, V110, P20569, DOI 10.1073/pnas.1319061110; Laurent LC, 2011, CELL STEM CELL, V8, P106, DOI 10.1016/j.stem.2010.12.003; Lieu Pauline T, 2013, Methods Mol Biol, V997, P45, DOI 10.1007/978-1-62703-348-0_5; Lister R, 2011, NATURE, V471, P68, DOI 10.1038/nature09798; MacArthur CC, 2012, STEM CELLS INT, V2012, DOI 10.1155/2012/564612; Manos P.D., 2011, CURR PROTOC STEM CEL, V19; Miller JD, 2011, METHODS MOL BIOL, V767, P55, DOI 10.1007/978-1-61779-201-4_5; Nakagawa M, 2014, SCI REP-UK, V4, DOI 10.1038/srep03594; Okita K, 2013, STEM CELLS, V31, P458, DOI 10.1002/stem.1293; Okita K, 2011, NAT METHODS, V8, P409, DOI [10.1038/NMETH.1591, 10.1038/nmeth.1591]; Park IH, 2008, NAT PROTOC, V3, P1180, DOI 10.1038/nprot.2008.92; Park IH, 2008, NATURE, V451, P141, DOI [10.1038/nature06534, 10.1038/natureO6534]; Park TS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042838; Ruiz S, 2012, P NATL ACAD SCI USA, V109, P16196, DOI 10.1073/pnas.1202352109; Somers A, 2010, STEM CELLS, V28, P1728, DOI 10.1002/stem.495; Su RJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064496; Takahashi K, 2007, CELL, V131, P861, DOI 10.1016/j.cell.2007.11.019; Wang Y, 2011, EMBO REP, V12, P373, DOI 10.1038/embor.2011.11; Warren L, 2012, SCI REP-UK, V2, DOI 10.1038/srep00657; Warren L, 2010, CELL STEM CELL, V7, P618, DOI 10.1016/j.stem.2010.08.012; Yu JY, 2007, SCIENCE, V318, P1917, DOI 10.1126/science.1151526; Yu JY, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017557; Yu JY, 2009, SCIENCE, V324, P797, DOI 10.1126/science.1172482	37	304	317	4	115	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156	1546-1696		NAT BIOTECHNOL	Nat. Biotechnol.	JAN	2015	33	1					58	U230		10.1038/nbt.3070	http://dx.doi.org/10.1038/nbt.3070			8	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	AY7AR	25437882	Green Accepted, Green Published			2022-12-27	WOS:000347714200028
J	Zuris, JA; Thompson, DB; Shu, Y; Guilinger, JP; Bessen, JL; Hu, JH; Maeder, ML; Joung, JK; Chen, ZY; Liu, DR				Zuris, John A.; Thompson, David B.; Shu, Yilai; Guilinger, John P.; Bessen, Jeffrey L.; Hu, Johnny H.; Maeder, Morgan L.; Joung, J. Keith; Chen, Zheng-Yi; Liu, David R.			Cationic lipid-mediated delivery of proteins enables efficient protein-based genome editing in vitro and in vivo	NATURE BIOTECHNOLOGY			English	Article							GENE; CRISPR; SIRNA; CAS9; THERAPY; THERAPEUTICS; TRAFFICKING; SPECIFICITY; EXPRESSION; PEPTIDES	Efficient intracellular delivery of proteins is needed to fully realize the potential of protein therapeutics. Current methods of protein delivery commonly suffer from low tolerance for serum, poor endosomal escape and limited in vivo efficacy. Here we report that common cationic lipid nucleic acid transfection reagents can potently deliver proteins that are fused to negatively supercharged proteins, that contain natural anionic domains or that natively bind to anionic nucleic acids. This approach mediates the potent delivery of nM concentrations of Cre recombinase, TALE- and Cas9-based transcription activators, and Cas9:sgRNA nuclease complexes into cultured human cells in media containing 10% serum. Delivery of unmodified Cas9:sgRNA complexes resulted in up to 80% genome modification with substantially higher specificity compared to DNA transfection. This approach also mediated efficient delivery of Cre recombinase and Cas9:sgRNA complexes into the mouse inner ear in vivo, achieving 90% Cre-mediated recombination and 20% Cas9-mediated genome modification in hair cells.	[Zuris, John A.; Thompson, David B.; Guilinger, John P.; Bessen, Jeffrey L.; Hu, Johnny H.; Liu, David R.] Harvard Univ, Dept Chem & Chem Biol, Cambridge, MA 02138 USA; [Zuris, John A.; Thompson, David B.; Guilinger, John P.; Bessen, Jeffrey L.; Hu, Johnny H.; Liu, David R.] Harvard Univ, Howard Hughes Med Inst, Cambridge, MA 02138 USA; [Shu, Yilai; Chen, Zheng-Yi] Harvard Univ, Sch Med, Dept Otol & Laryngol, Cambridge, MA 02138 USA; [Shu, Yilai; Chen, Zheng-Yi] Massachusetts Eye & Ear Infirm, Eaton Peabody Lab, Boston, MA 02114 USA; [Shu, Yilai] Fudan Univ, Eye Ear Nose & Throat Hosp, Shanghai Med Coll, Dept Otol & Skull Base Surg, Shanghai 200433, Peoples R China; [Shu, Yilai] Minist Hearing Med, Key Lab Hlth, Shanghai, Peoples R China; [Maeder, Morgan L.; Joung, J. Keith] Massachusetts Gen Hosp, Mol Pathol Unit, Charlestown, MA USA; [Maeder, Morgan L.; Joung, J. Keith] Massachusetts Gen Hosp, Ctr Canc Res, Charlestown, MA USA; [Maeder, Morgan L.; Joung, J. Keith] Massachusetts Gen Hosp, Ctr Computat & Integrat Biol, Charlestown, MA USA; [Maeder, Morgan L.; Joung, J. Keith] Harvard Univ, Sch Med, Dept Pathol, Cambridge, MA 02138 USA	Harvard University; Harvard University; Howard Hughes Medical Institute; Harvard University; Harvard University; Massachusetts Eye & Ear Infirmary; Fudan University; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University	Liu, DR (corresponding author), Harvard Univ, Dept Chem & Chem Biol, Cambridge, MA 02138 USA.	drliu@fas.harvard.edu	Liu, David R./HCH-3132-2022	Bessen, Jeffrey/0000-0002-0351-7393; Shu, Yilai/0000-0001-8893-434X	Ruth L. Kirchstein National Research Service Award [F32 GM 106601-2]; US National Institutes of Health (NIH) [R01 GM095501, R01 DC006908]; Defense Advanced Research Projects Agency [HR0011-11-2-0003, N66001-12-C-4207]; Howard Hughes Medical Institute (HHMI); Bertarelli Foundation; David-Shulsky Foundation; Frederick and Ines Yeatts Hair Cell Regeneration grant; National Nature Science Foundation of China [NSFC81300824]; National Science Foundation Graduate Research Fellowship Program [DGE1144152]; NIH Director's Pioneer Award [DP1 GM105378]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [F32GM106601, R01GM095501] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC006908] Funding Source: NIH RePORTER	Ruth L. Kirchstein National Research Service Award(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); US National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Defense Advanced Research Projects Agency(United States Department of DefenseDefense Advanced Research Projects Agency (DARPA)); Howard Hughes Medical Institute (HHMI)(Howard Hughes Medical Institute); Bertarelli Foundation; David-Shulsky Foundation; Frederick and Ines Yeatts Hair Cell Regeneration grant; National Nature Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Science Foundation Graduate Research Fellowship Program(National Science Foundation (NSF)); NIH Director's Pioneer Award(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	J.A.Z. is a Ruth L. Kirchstein National Research Service Awards Postdoctoral Fellow (F32 GM 106601-2) D.B.T., J.P.G. and J.L.B. were supported by US National Institutes of Health (NIH) R01 GM095501 (to D. R. L.), Defense Advanced Research Projects Agency HR0011-11-2-0003 (to D. R. L.) and N66001-12-C-4207 (to D. R. L.), and the Howard Hughes Medical Institute (HHMI). D.R.L. was supported as a HHMI Investigator. Z.-Y.C. was supported by US National Institutes of Health (R01 DC006908), the Bertarelli Foundation, and the David-Shulsky Foundation. Y.S. was supported by the Frederick and Ines Yeatts Hair Cell Regeneration grant and by The National Nature Science Foundation of China NSFC81300824. J.H.H. was supported by National Science Foundation Graduate Research Fellowship Program (DGE1144152). M.L.M. and J.K.J. were supported by an NIH Director's Pioneer Award (DP1 GM105378). We thank A. Lawson, M. Sonnett, R. Xiao, S. Wang and J. Gehrke for technical assistance. We thank A. Edge, Massachusetts Eye & Ear Infirmary, Boston, for mouse embryonic stem cell (ES) line Tau-GFP and J. Johnson, Southwestern Medical Center, University of Texas, for floxPtdTomato mice (The Jackson Laboratory).	Adrian JE, 2010, J CONTROL RELEASE, V144, P341, DOI 10.1016/j.jconrel.2010.03.003; Aguilera TA, 2009, INTEGR BIOL, V1, P371, DOI 10.1039/b904878b; Allen TM, 2013, ADV DRUG DELIVER REV, V65, P36, DOI 10.1016/j.addr.2012.09.037; Basha G, 2011, MOL THER, V19, P2186, DOI 10.1038/mt.2011.190; Bodles-Brakhop AM, 2009, MOL THER, V17, P585, DOI 10.1038/mt.2009.5; Coelho T, 2013, NEW ENGL J MED, V369, P819, DOI 10.1056/NEJMoa1208760; Colletier Jacques-Philippe, 2002, BMC Biotechnol, V2, P9, DOI 10.1186/1472-6750-2-9; Cronican JJ, 2010, ACS CHEM BIOL, V5, P747, DOI 10.1021/cb1001153; Daniels DS, 2007, J AM CHEM SOC, V129, P14578, DOI 10.1021/ja0772445; Fu YF, 2014, NAT BIOTECHNOL, V32, P279, DOI 10.1038/nbt.2808; Gilleron J, 2013, NAT BIOTECHNOL, V31, P638, DOI 10.1038/nbt.2612; Guilinger JP, 2014, NAT BIOTECHNOL, V32, P577, DOI 10.1038/nbt.2909; Guschin DY, 2010, METHODS MOL BIOL, V649, P247, DOI 10.1007/978-1-60761-753-2_15; Hartung SD, 2004, MOL THER, V9, P866, DOI 10.1016/j.ymthe.2004.03.011; Judge AD, 2006, MOL THER, V13, P494, DOI 10.1016/j.ymthe.2005.11.002; Kay MA, 2001, NAT MED, V7, P33, DOI 10.1038/83324; Kim S, 2014, GENOME RES, V24, P1012, DOI 10.1101/gr.171322.113; Lawrence MS, 2007, J AM CHEM SOC, V129, P10110, DOI 10.1021/ja071641y; Leader B, 2008, NAT REV DRUG DISCOV, V7, P21, DOI 10.1038/nrd2399; Liu J, 2014, PLOS ONE, V9, DOI [10.1371/journal.pone.0091606, 10.1371/journal.pone.0085755, 10.1371/journal.pone.0089315, 10.1371/journal.pone.0098300]; Lumpkin EA, 2003, GENE EXPR PATTERNS, V3, P389, DOI 10.1016/S1567-133X(03)00089-9; Maeder ML, 2013, NAT METHODS, V10, P977, DOI [10.1038/NMETH.2598, 10.1038/nmeth.2598]; Maeder ML, 2013, NAT METHODS, V10, P243, DOI [10.1038/nmeth.2366, 10.1038/NMETH.2366]; Mali P, 2013, SCIENCE, V339, P823, DOI 10.1126/science.1232033; McNaughton BR, 2009, P NATL ACAD SCI USA, V106, P6111, DOI 10.1073/pnas.0807883106; Midoux P, 2009, BRIT J PHARMACOL, V157, P166, DOI 10.1111/j.1476-5381.2009.00288.x; Morris MC, 2001, NAT BIOTECHNOL, V19, P1173, DOI 10.1038/nbt1201-1173; Mullen L, 2014, EXPERT OPIN DRUG DEL, V11, P101, DOI 10.1517/17425247.2014.863872; Pattanayak V, 2013, NAT BIOTECHNOL, V31, P839, DOI 10.1038/nbt.2673; Putney SD, 1998, NAT BIOTECHNOL, V16, P153, DOI 10.1038/nbt0298-153; Qi LS, 2013, CELL, V152, P1173, DOI 10.1016/j.cell.2013.02.022; Ramakrishna S, 2014, GENOME RES, V24, P1020, DOI 10.1101/gr.171264.113; Ran FA, 2013, CELL, V154, P1380, DOI 10.1016/j.cell.2013.08.021; Sander JD, 2014, NAT BIOTECHNOL, V32, P347, DOI 10.1038/nbt.2842; Shete HK, 2014, J NANOSCI NANOTECHNO, V14, P460, DOI 10.1166/jnn.2014.9082; Song EW, 2005, NAT BIOTECHNOL, V23, P709, DOI 10.1038/nbt1101; TESSAROLLO L, 1994, P NATL ACAD SCI USA, V91, P11844, DOI 10.1073/pnas.91.25.11844; Thompson DB, 2012, CHEM BIOL, V19, P831, DOI 10.1016/j.chembiol.2012.06.014; Thompson DB, 2012, METHOD ENZYMOL, V503, P293, DOI 10.1016/B978-0-12-396962-0.00012-4; Urnov FD, 2010, NAT REV GENET, V11, P636, DOI 10.1038/nrg2842; Wadia JS, 2004, NAT MED, V10, P310, DOI 10.1038/nm996; Wang HY, 2013, CELL, V153, P910, DOI 10.1016/j.cell.2013.04.025; Wang JH, 2008, NAT BIOTECHNOL, V26, P901, DOI 10.1038/nbt.1484; Yin H, 2014, NAT BIOTECHNOL, V32, P551, DOI 10.1038/nbt.2884; Zangi L, 2013, NAT BIOTECHNOL, V31, P898, DOI 10.1038/nbt.2682; Zelphati O, 2001, J BIOL CHEM, V276, P35103, DOI 10.1074/jbc.M104920200	46	897	1031	23	587	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156	1546-1696		NAT BIOTECHNOL	Nat. Biotechnol.	JAN	2015	33	1					73	80		10.1038/nbt.3081	http://dx.doi.org/10.1038/nbt.3081			8	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	AY7AR	25357182	Green Accepted, Green Submitted			2022-12-27	WOS:000347714200030
J	Prasain, N; Lee, MR; Vemula, S; Meador, JL; Yoshimoto, M; Ferkowicz, MJ; Fett, A; Gupta, M; Rapp, BM; Saadatzadeh, MR; Ginsberg, M; Elemento, O; Lee, Y; Voytik-Harbin, SL; Chung, HM; Hong, KS; Reid, E; O'Neill, CL; Medina, RJ; Stitt, AW; Murphy, MP; Rafii, S; Broxmeyer, HE; Yoder, MC				Prasain, Nutan; Lee, Man Ryul; Vemula, Sasidhar; Meador, Jonathan Luke; Yoshimoto, Momoko; Ferkowicz, Michael J.; Fett, Alexa; Gupta, Manav; Rapp, Brian M.; Saadatzadeh, Mohammad Reza; Ginsberg, Michael; Elemento, Olivier; Lee, Younghee; Voytik-Harbin, Sherry L.; Chung, Hyung Min; Hong, Ki Sung; Reid, Emma; O'Neill, Christina L.; Medina, Reinhold J.; Stitt, Alan W.; Murphy, Michael P.; Rafii, Shahin; Broxmeyer, Hal E.; Yoder, Mervin C.			Differentiation of human pluripotent stem cells to cells similar to cord-blood endothelial colony-forming cells	NATURE BIOTECHNOLOGY			English	Article							PROGENITOR CELLS; NEUROPILIN-1; TRANSPLANTATION; COMMITMENT; HIERARCHY; EXPANSION; OUTGROWTH; VEGF	The ability to differentiate human pluripotent stem cells into endothelial cells with properties of cord-blood endothelial colony forming cells (CB-ECFCs) may enable the derivation of clinically relevant numbers of highly proliferative blood vessel forming cells to restore endothelial function in patients with vascular disease. We describe a protocol to convert human induced pluripotent stem cells (hiPSCs) or embryonic stem cells (hESCs) into cells similar to CB-ECFCs at an efficiency of >10(8) ECFCs produced from each starting pluripotent stem cell. The CB-ECFC-like cells display a stable endothelial phenotype with high clonal proliferative potential and the capacity to form human vessels in mice and to repair the ischemic mouse retina and limb, and they lack teratoma formation potential. We identify Neuropilin-1 (NRP-1)-mediated activation of KDR signaling through VEGF(165) as a critical mechanism for the emergence and maintenance of CB-ECFC-like cells.	[Prasain, Nutan; Vemula, Sasidhar; Meador, Jonathan Luke; Yoshimoto, Momoko; Ferkowicz, Michael J.; Fett, Alexa; Gupta, Manav; Yoder, Mervin C.] Indiana Univ Sch Med, Dept Pediat, Indianapolis, IN 46202 USA; [Lee, Man Ryul; Broxmeyer, Hal E.] Indiana Univ Sch Med, Dept Microbiol & Immunol, Indianapolis, IN 46202 USA; [Rapp, Brian M.; Saadatzadeh, Mohammad Reza; Murphy, Michael P.] Indiana Univ Sch Med, Dept Surg, Indianapolis, IN 46202 USA; [Ginsberg, Michael; Rafii, Shahin] Weill Cornell Med Coll, Howard Hughes Med Inst, New York, NY USA; [Elemento, Olivier] Weill Cornell Med Coll, Dept Physiol & Biophys, New York, NY USA; [Lee, Younghee] Univ Chicago, Dept Med, Chicago, IL 60637 USA; [Voytik-Harbin, Sherry L.] Purdue Univ, Weldon Sch Biomed Engn, W Lafayette, IN 47907 USA; [Chung, Hyung Min] Konkuk Univ, Sch Med, Seoul, South Korea; [Hong, Ki Sung] CHA Univ, Stem Cell Res Lab, Seoul, South Korea; [O'Neill, Christina L.; Medina, Reinhold J.; Stitt, Alan W.] Queens Univ Belfast, Ctr Expt Med, Belfast, Antrim, North Ireland	Indiana University System; Indiana University Bloomington; Indiana University System; Indiana University Bloomington; Indiana University System; Indiana University Bloomington; Cornell University; Howard Hughes Medical Institute; Cornell University; University of Chicago; Purdue University System; Purdue University; Purdue University West Lafayette Campus; Konkuk University; Konkuk University Medical Center; Pochon Cha University; Queens University Belfast	Yoder, MC (corresponding author), Indiana Univ Sch Med, Dept Pediat, Indianapolis, IN 46202 USA.	myoder@iu.edu	Medina, Reinhold J/A-7949-2015; Stitt, Alan/A-9842-2009	Medina, Reinhold J/0000-0003-4351-7010; Stitt, Alan/0000-0002-8647-9918; Reid, Emma/0000-0002-2555-438X; Gupta, Manav/0000-0001-5163-2911; Yoder, Mervin/0000-0003-4354-7631	Riley Children's Foundation; AHA postdoctoral fellowship; Public Health Service [R01 HL109602, RO1 HL056416, RO1 HL067384, PO1 DK090948]; Bio & Medical Technology Development Program of the National Research Foundation (NRF); South Korean government (MEST) [2011-0019487]; Medical Research Council [G0801962] Funding Source: researchfish; The Sir Jules Thorn Charitable Trust [10JTA] Funding Source: researchfish; MRC [G0801962] Funding Source: UKRI; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [KL2TR000431] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL109602, R01HL112669, R01HL067384, R01HL056416] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [U54DK106846, P30DK090948, P30DK049218] Funding Source: NIH RePORTER	Riley Children's Foundation; AHA postdoctoral fellowship(American Heart Association); Public Health Service(United States Department of Health & Human ServicesUnited States Public Health Service); Bio & Medical Technology Development Program of the National Research Foundation (NRF)(National Research Foundation of Korea); South Korean government (MEST)(Ministry of Education, Science & Technology (MEST), Republic of Korea); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); The Sir Jules Thorn Charitable Trust; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	These studies were supported by funds provided by the Riley Children's Foundation (M.C.Y.), by an AHA postdoctoral fellowship (N.P.), and Public Health Service Grants R01 HL109602 (M.C.Y. and S.L.V.-H.), RO1 HL056416 (H.E.B.), RO1 HL067384 (H.E.B.), PO1 DK090948 (H.E.B. and M.C.Y.), and by the Bio & Medical Technology Development Program of the National Research Foundation (NRF), which is funded by the South Korean government (MEST; No. 2011-0019487). The authors thank H.P. Poudel (Indiana University Purdue University Indianapolis) for critical input in biostatistical analysis. The authors also thank H.J. Lee (CHA Stem Cell Institute, CHA University, South Korea) for HLI experiments.	Cho SW, 2007, CIRCULATION, V116, P2409, DOI 10.1161/CIRCULATIONAHA.106.687038; Choi KD, 2009, STEM CELLS, V27, P559, DOI 10.1634/stemcells.2008-0922; Cimato T, 2009, CIRCULATION, V119, P2170, DOI 10.1161/CIRCULATIONAHA.109.849596; Critser PJ, 2010, MICROVASC RES, V80, P23, DOI 10.1016/j.mvr.2010.03.001; Evseenko D, 2010, P NATL ACAD SCI USA, V107, P13742, DOI 10.1073/pnas.1002077107; Feng Q, 2010, STEM CELLS, V28, P704, DOI 10.1002/stem.321; Ginsberg M, 2012, CELL, V151, P559, DOI 10.1016/j.cell.2012.09.032; Goldman O, 2009, STEM CELLS, V27, P1750, DOI 10.1002/stem.100; Heo SC, 2014, STEM CELLS, V32, P779, DOI 10.1002/stem.1578; Herzog B, 2011, MOL BIOL CELL, V22, P2766, DOI 10.1091/mbc.E09-12-1061; Huang XT, 2013, J NEUROTRAUM, V30, P2080, DOI 10.1089/neu.2013.2996; Ingram DA, 2005, BLOOD, V105, P2783, DOI 10.1182/blood-2004-08-3057; Ingram DA, 2004, BLOOD, V104, P2752, DOI 10.1182/blood-2004-04-1396; James D, 2010, NAT BIOTECHNOL, V28, P161, DOI 10.1038/nbt.1605; Kang KT, 2013, ANGIOGENESIS, V16, P773, DOI 10.1007/s10456-013-9354-9; Kuilman T, 2010, GENE DEV, V24, P2463, DOI 10.1101/gad.1971610; Lin Y, 2000, J CLIN INVEST, V105, P71, DOI 10.1172/JCI8071; Lippmann ES, 2012, NAT BIOTECHNOL, V30, P783, DOI 10.1038/nbt.2247; Medina RJ, 2010, INVEST OPHTH VIS SCI, V51, P5906, DOI 10.1167/iovs.09-4951; Moubarik C, 2011, STEM CELL REV REP, V7, P208, DOI 10.1007/s12015-010-9157-y; Pan Q, 2007, CANCER CELL, V11, P53, DOI 10.1016/j.ccr.2006.10.018; Schwarz TM, 2012, ARTERIOSCL THROM VAS, V32, pE13, DOI 10.1161/ATVBAHA.111.239822; Sone M, 2007, ARTERIOSCL THROM VAS, V27, P2127, DOI 10.1161/ATVBAHA.107.143149; Stroncek JD, 2012, ACTA BIOMATER, V8, P201, DOI 10.1016/j.actbio.2011.09.002; Thomson JA, 1998, SCIENCE, V282, P1145, DOI 10.1126/science.282.5391.1145; Uniewicz KA, 2011, J BIOL CHEM, V286, P12, DOI 10.1074/jbc.M110.190801; Yoder MC, 2007, BLOOD, V109, P1801, DOI 10.1182/blood-2006-08-043471; Yu JY, 2009, SCIENCE, V324, P797, DOI 10.1126/science.1172482; Zachary IC, 2011, BIOCHEM SOC T, V39, P1583, DOI 10.1042/BST20110697	29	159	166	0	46	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156	1546-1696		NAT BIOTECHNOL	Nat. Biotechnol.	NOV	2014	32	11					1151	1157		10.1038/nbt.3048	http://dx.doi.org/10.1038/nbt.3048			7	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	AT5IL	25306246	Green Accepted, Green Published			2022-12-27	WOS:000344977000021
J	Ginart, P; Raj, A				Ginart, Paul; Raj, Arjun			RNA sequencing in situ	NATURE BIOTECHNOLOGY			English	Editorial Material							SINGLE; EXPRESSION; SEQ		[Ginart, Paul; Raj, Arjun] Univ Penn, Philadelphia, PA 19104 USA	University of Pennsylvania	Ginart, P (corresponding author), Univ Penn, Philadelphia, PA 19104 USA.	arjunrajlab@gmail.com		Raj, Arjun/0000-0002-2915-6960				Femino A, 1998, SCIENCE, V280, P585, DOI 10.1126/science.280.5363.585; Hansen CH, 2013, NAT METHODS, V10, P869, DOI [10.1038/NMETH.2601, 10.1038/nmeth.2601]; Jaitin DA, 2014, SCIENCE, V343, P776, DOI 10.1126/science.1247651; Lee JH, 2014, SCIENCE, V343, P1360, DOI 10.1126/science.1250212; Levesque MJ, 2013, NAT METHODS, V10, P865, DOI [10.1038/NMETH.2589, 10.1038/nmeth.2589]; Levesque MJ, 2013, NAT METHODS, V10, P246, DOI [10.1038/NMETH.2372, 10.1038/nmeth.2372]; Lubeck E, 2014, NAT METHODS, V11, P360, DOI 10.1038/nmeth.2892; Lubeck E, 2012, NAT METHODS, V9, P743, DOI [10.1038/NMETH.2069, 10.1038/nmeth.2069]; Raj A, 2008, NAT METHODS, V5, P877, DOI 10.1038/NMETH.1253; Shaffer SM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075120; Wang Z, 2009, NAT REV GENET, V10, P57, DOI 10.1038/nrg2484	11	6	15	2	27	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156	1546-1696		NAT BIOTECHNOL	Nat. Biotechnol.	JUN	2014	32	6					543	544		10.1038/nbt.2921	http://dx.doi.org/10.1038/nbt.2921			3	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	AI9EV	24911498				2022-12-27	WOS:000337233800015
J	Ji, Z; Song, RS; Huang, HL; Regev, A; Struhl, K				Ji, Zhe; Song, Ruisheng; Huang, Hailiang; Regev, Aviv; Struhl, Kevin			Transcriptome-scale RNase-footprinting of RNA-protein complexes	NATURE BIOTECHNOLOGY			English	Article							LONG NONCODING RNAS; IN-VIVO; NUCLEOTIDE RESOLUTION; BINDING PROTEIN; ELEMENTS; SITES; TRANSLATION; SPLICEOSOME; ANNOTATION; CLIP	Ribosome profiling is widely used to study translation in vivo, but not all sequence reads correspond to ribosome-protected RNA. Here we describe Rfoot, a computational pipeline that analyzes ribosomal profiling data and identifies native, nonribosomal RNA-protein complexes. We use Rfoot to precisely map RNase-protected regions within small nucleolar RNAs, spliceosomal RNAs, microRNAs, tRNAs, long noncoding (lnc) RNAs and 3' untranslated regions of mRNAs in human cells. We show that RNAs of the same class can show differential complex association. Although only a subset of lncRNAs show RNase footprints, many of these have multiple footprints, and the protected regions are evolutionarily conserved, suggestive of biological functions.	[Ji, Zhe; Song, Ruisheng; Struhl, Kevin] Harvard Univ, Sch Med, Dept Biol Chem & Mol Pharmacol, Boston, MA 02115 USA; [Ji, Zhe; Huang, Hailiang; Regev, Aviv] Broad Inst MIT & Harvard, Cambridge, MA USA; [Huang, Hailiang] Massachusetts Gen Hosp, Analyt & Translat Genet Unit, Boston, MA 02114 USA; [Regev, Aviv] MIT, Dept Biol, Cambridge, MA USA; [Regev, Aviv] Howard Hughes Med Inst, Chevy Chase, MD USA	Harvard University; Harvard Medical School; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Harvard University; Massachusetts General Hospital; Massachusetts Institute of Technology (MIT); Howard Hughes Medical Institute	Struhl, K (corresponding author), Harvard Univ, Sch Med, Dept Biol Chem & Mol Pharmacol, Boston, MA 02115 USA.; Regev, A (corresponding author), Broad Inst MIT & Harvard, Cambridge, MA USA.; Regev, A (corresponding author), MIT, Dept Biol, Cambridge, MA USA.; Regev, A (corresponding author), Howard Hughes Med Inst, Chevy Chase, MD USA.	aregev@broadinstitute.org; kevin@hms.harvard.edu	SONG, RUISHENG/W-4784-2019; Ji, Zhe/P-7094-2018; Ji, Zhe/U-8320-2018	SONG, RUISHENG/0000-0002-6856-4721; Ji, Zhe/0000-0002-1809-8099; Huang, Hailiang/0000-0003-1461-5762	National Institutes of Health [CA 107486]; NATIONAL CANCER INSTITUTE [R01CA107486, U24CA180922] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [P50HG006193] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))	This work was supported by grants to K.S. from the National Institutes of Health (CA 107486). A.R. is a Howard Hughes Investigator.	Baltz AG, 2012, MOL CELL, V46, P674, DOI 10.1016/j.molcel.2012.05.021; Batista PJ, 2013, CELL, V152, P1298, DOI 10.1016/j.cell.2013.02.012; Cabili MN, 2011, GENE DEV, V25, P1915, DOI 10.1101/gad.17446611; Diaz-Munoz MD, 2015, NAT IMMUNOL, V16, P415, DOI 10.1038/ni.3115; Eichhorn SW, 2014, MOL CELL, V56, P104, DOI 10.1016/j.molcel.2014.08.028; Freeberg MA, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-2-r13; Hafner M, 2010, CELL, V141, P129, DOI 10.1016/j.cell.2010.03.009; Hahn WC, 1999, NATURE, V400, P464, DOI 10.1038/22780; Harrow J, 2012, GENOME RES, V22, P1760, DOI 10.1101/gr.135350.111; Hendrickson TL, 2001, P NATL ACAD SCI USA, V98, P13473, DOI 10.1073/pnas.251549298; Hirsch HA, 2010, CANCER CELL, V17, P348, DOI 10.1016/j.ccr.2010.01.022; Iliopoulos D, 2009, CELL, V139, P693, DOI 10.1016/j.cell.2009.10.014; Ingolia NT, 2012, NAT PROTOC, V7, P1534, DOI 10.1038/nprot.2012.086; Ingolia NT, 2009, SCIENCE, V324, P218, DOI 10.1126/science.1168978; Ji Z, 2015, ELIFE, V4, DOI 10.7554/eLife.08890; Kiss-Laszlo Z, 1998, EMBO J, V17, P797, DOI 10.1093/emboj/17.3.797; Matera AG, 2007, NAT REV MOL CELL BIO, V8, P209, DOI 10.1038/nrm2124; PEATTIE DA, 1981, P NATL ACAD SCI-BIOL, V78, P2273, DOI 10.1073/pnas.78.4.2273; Rinn JL, 2012, ANNU REV BIOCHEM, V81, P145, DOI 10.1146/annurev-biochem-051410-092902; Russell AG, 2006, NATURE, V443, P863, DOI 10.1038/nature05228; Siepel A, 2005, GENOME RES, V15, P1034, DOI 10.1101/gr.3715005; Silverman IM, 2014, GENOME BIOL, V15, DOI 10.1186/gb-2014-15-1-r3; Trapnell C, 2009, BIOINFORMATICS, V25, P1105, DOI 10.1093/bioinformatics/btp120; Will CL, 2011, CSH PERSPECT BIOL, V3, DOI 10.1101/cshperspect.a003707; Zhang CL, 2011, NAT BIOTECHNOL, V29, P607, DOI 10.1038/nbt.1873	25	33	33	1	33	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156	1546-1696		NAT BIOTECHNOL	Nat. Biotechnol.	APR	2016	34	4					410	+		10.1038/nbt.3441	http://dx.doi.org/10.1038/nbt.3441			5	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	DI6NL	26900662	Green Submitted, Green Accepted			2022-12-27	WOS:000373616100021
J	Kvedar, JC; Fogel, AL; Elenko, E; Zohar, D				Kvedar, Joseph C.; Fogel, Alexander L.; Elenko, Eric; Zohar, Daphne			Digital medicine's march on chronic disease	NATURE BIOTECHNOLOGY			English	Editorial Material							UNITED-STATES; ADHERENCE; THERAPY; MEDICATION; TRIAL		[Kvedar, Joseph C.] Massachusetts Gen Hosp, Dept Dermatol, Boston, MA 02114 USA; [Kvedar, Joseph C.] Harvard Univ, Sch Med, Boston, MA USA; [Kvedar, Joseph C.] Partners Healthcare, Partners Connected Hlth, Boston, MA USA; [Fogel, Alexander L.] Stanford Univ, Grad Sch Business, Stanford, CA 94305 USA; [Fogel, Alexander L.] Stanford Univ, Sch Med, Stanford, CA 94305 USA; [Elenko, Eric; Zohar, Daphne] PureTech Hlth, Boston, MA USA	Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; Partners Healthcare System; Stanford University; Stanford University	Zohar, D (corresponding author), PureTech Hlth, Boston, MA USA.	DaphneNB@puretechhealth.com						Alzheimer's Association, 2015, 2015 ALZH DIS FACTS; Andersson G, 2014, WORLD PSYCHIATRY, V13, P288, DOI 10.1002/wps.20151; Anguera JA, 2013, NATURE, V501, P97, DOI 10.1038/nature12486; [Anonymous], 2015, 2015 EMPL BEN SURV; [Anonymous], CHRON OBSTR PULM DIS; [Anonymous], DIAB PREV REC PROGR; Au-Yeung KY, 2012, INT J TUBERC LUNG D, V16, P1498, DOI 10.5588/ijtld.11.0868; Belknap R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053373; Boland MV, 2014, JAMA OPHTHALMOL, V132, P845, DOI 10.1001/jamaophthalmol.2014.857; Brewer JA, 2011, DRUG ALCOHOL DEPEN, V119, P72, DOI 10.1016/j.drugalcdep.2011.05.027; Bricker JB, 2014, DRUG ALCOHOL DEPEN, V143, P87, DOI 10.1016/j.drugalcdep.2014.07.006; Centers for Disease Control and Prevention, 2014 NAT DIAB STAT R; Centers for Disease Control and Prevention, 2015, STROK FACTS; Centers for Disease Control and Prevention, 2015, CHRON DIS OV; Centers for Disease Control and Prevention, DEATHS AND MORT; Centers for Disease Control and Prevention, LEAD CAUS DEATH 1900; Centers for Disease Control and Prevention, ATT DEF HYP DIS ADHD; Centers for Disease Control and Prevention (CDC), 2016, AUT SPECTR DIS ASD; Centers for Disease Control and Prevention (US), SMOK TOB US; Crimmins EM, 2015, GERONTOLOGIST, V55, P901, DOI 10.1093/geront/gnv130; Cutler A., 2015, AM AC CHILD AD PSYCH; Delbanco S, PAYMENT REFORM LANDS; Elenko E, 2015, NAT BIOTECHNOL, V33, P697, DOI 10.1038/nbt.3284; Elenko E, 2015, NAT BIOTECHNOL, V33, P456, DOI 10.1038/nbt.3222; Gaskin DJ, 2012, J PAIN, V13, P715, DOI 10.1016/j.jpain.2012.03.009; Gerteis J, MULTIPLE CHRONIC CON; Iuga AO, 2014, RISK MANAG HEALTHC P, V7, P35, DOI 10.2147/RMHP.S19801; Kish LJ, 2015, NAT BIOTECHNOL, V33, P921, DOI 10.1038/nbt.3340; Knowler WC, 2002, NEW ENGL J MED, V346, P393, DOI 10.1056/NEJMoa012512; Nathan DM, 2007, DIABETES CARE, V30, P753, DOI 10.2337/dc07-9920; National Institute of Mental Health, AN TOT DIR IND COSTS; Osterberg L, 2005, NEW ENGL J MED, V353, P487, DOI 10.1056/NEJMra050100; Pew Research Center, 2013, BROADB TECHN FACT SH; Pew Research Center, 2014, MOB TECHN FACT SHEET; Quinn CC, 2011, DIABETES CARE, V34, P1934, DOI 10.2337/dc11-0366; Renders C.M., 2001, COCHRANE DB SYST REV, V2001; Rice JB, 2014, DIABETES CARE, V37, P651, DOI 10.2337/dc13-2176; Sepah SC, 2015, J MED INTERNET RES, V17, DOI 10.2196/jmir.4052; US Department of Health & Human Services, BETT SMART HLTH; Viswanathan M, 2012, ANN INTERN MED, V157, P785, DOI 10.7326/0003-4819-157-11-201212040-00538; Ward BW, 2014, PREV CHRONIC DIS, V11, DOI 10.5888/pcd11.130389	41	70	74	0	12	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156	1546-1696		NAT BIOTECHNOL	Nat. Biotechnol.	MAR	2016	34	3					239	246		10.1038/nbt.3495	http://dx.doi.org/10.1038/nbt.3495			8	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	DG1CJ	26963544	Bronze			2022-12-27	WOS:000371802600014
J	Hammond, A; Galizi, R; Kyrou, K; Simoni, A; Siniscalchi, C; Katsanos, D; Gribble, M; Baker, D; Marois, E; Russell, S; Burt, A; Windbichler, N; Crisanti, A; Nolan, T				Hammond, Andrew; Galizi, Roberto; Kyrou, Kyros; Simoni, Alekos; Siniscalchi, Carla; Katsanos, Dimitris; Gribble, Matthew; Baker, Dean; Marois, Eric; Russell, Steven; Burt, Austin; Windbichler, Nikolai; Crisanti, Andrea; Nolan, Tony			A CRISPR-Cas9 gene drive system-targeting female reproduction in the malaria mosquito vector Anopheles gambiae	NATURE BIOTECHNOLOGY			English	Article							HOMING ENDONUCLEASE GENES; DROSOPHILA; SPECIFICITY; EXPRESSION; NUCLEASES; GERMLINE; TOOLS	Gene drive systems that enable super-Mendelian inheritance of a transgene have the potential to modify insect populations over a timeframe of a few years. We describe CRISPR-Cas9 endonuclease constructs that function as gene drive systems in Anopheles gambiae, the main vector for malaria. We identified three genes (AGAP005958, AGAP011377 and AGAP007280) that confer a recessive female-sterility phenotype upon disruption, and inserted into each locus CRISPR-Cas9 gene drive constructs designed to target and edit each gene. For each targeted locus we observed a strong gene drive at the molecular level, with transmission rates to progeny of 91.4 to 99.6%. Population modeling and cage experiments indicate that a CRISPR-Cas9 construct targeting one of these loci, AGAP007280, meets the minimum requirement for a gene drive targeting female reproduction in an insect population. These findings could expedite the development of gene drives to suppress mosquito populations to levels that do not support malaria transmission.	[Hammond, Andrew; Galizi, Roberto; Kyrou, Kyros; Simoni, Alekos; Katsanos, Dimitris; Gribble, Matthew; Burt, Austin; Windbichler, Nikolai; Crisanti, Andrea; Nolan, Tony] Univ London Imperial Coll Sci Technol & Med, Dept Life Sci, London, England; [Siniscalchi, Carla] Univ Perugia, Ctr Genom Funz, Dipartimento Med Sperimentale, Via Gambuli, I-06100 Perugia, Italy; [Baker, Dean; Russell, Steven] Univ Cambridge, Dept Genet, Downing St, Cambridge CB2 3EH, England; [Marois, Eric] Univ Strasbourg, Inst Biol Mol & Cellulaire, INSERM U963, CNRS UPR9022, Strasbourg, France	Imperial College London; University of Perugia; University of Cambridge; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg	Windbichler, N; Crisanti, A; Nolan, T (corresponding author), Univ London Imperial Coll Sci Technol & Med, Dept Life Sci, London, England.	nikolai.windbichler@imperial.ac.uk; a.crisanti@imperial.ac.uk; t.nolan@imperial.ac.uk	Marois, Eric/H-9246-2016; Galizi, Roberto/H-5999-2019; Nolan, Tony/I-4925-2012; Marois, Eric/AAZ-5549-2021	Marois, Eric/0000-0003-4147-3747; Nolan, Tony/0000-0002-2982-8333; Marois, Eric/0000-0003-4147-3747; Kyrou, Kyros/0000-0002-4919-2459; Hammond, Andrew/0000-0002-1757-5009; Simoni, Alekos/0000-0001-8629-721X; Crisanti, Andrea/0000-0002-2406-4426; Burt, Austin/0000-0001-5146-9640; Galizi, Roberto/0000-0003-3134-7480	Foundation for the National Institutes of Health through the Vector-Based Control of Transmission: Discovery Research (VCTR) program of the Grand Challenges in Global Health initiative of the Bill & Melinda Gates Foundation; European Research Council under the European Union's Seventh Framework Programme ERC [335724]	Foundation for the National Institutes of Health through the Vector-Based Control of Transmission: Discovery Research (VCTR) program of the Grand Challenges in Global Health initiative of the Bill & Melinda Gates Foundation; European Research Council under the European Union's Seventh Framework Programme ERC(European Research Council (ERC))	We are grateful to C. Bamikole, A. Hall and D. Fabrigar for experimental assistance and to P. Papathanos and S. Fuchs for useful discussion. This work was supported by a grant from the Foundation for the National Institutes of Health through the Vector-Based Control of Transmission: Discovery Research (VCTR) program of the Grand Challenges in Global Health initiative of the Bill & Melinda Gates Foundation and by the European Research Council under the European Union's Seventh Framework Programme ERC grant no. 335724 to N.W.	Akbari OS, 2015, SCIENCE, V349, P927, DOI 10.1126/science.aac7932; Bae S, 2014, NAT METHODS, V11, P705, DOI 10.1038/nmeth.3015; Baker DA, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-296; Bateman JR, 2006, GENETICS, V173, P769, DOI 10.1534/genetics.106.056945; Burt A, 2003, P ROY SOC B-BIOL SCI, V270, P921, DOI 10.1098/rspb.2002.2319; Claycomb JM, 2004, DEV CELL, V6, P145, DOI 10.1016/S1534-5807(03)00398-8; Deredec A, 2008, GENETICS, V179, P2013, DOI 10.1534/genetics.108.089037; Deredec A, 2011, P NATL ACAD SCI USA, V108, pE874, DOI 10.1073/pnas.1110717108; DiCarlo JE, 2015, NAT BIOTECHNOL, V33, P1250, DOI 10.1038/nbt.3412; Esvelt KM, 2014, ELIFE, V3, DOI 10.7554/eLife.03401; Fu YF, 2014, NAT BIOTECHNOL, V32, P279, DOI 10.1038/nbt.2808; Gantz VM, 2015, SCIENCE, V348, P442, DOI 10.1126/science.aaa5945; Giraldo-Calderon GI, 2015, NUCLEIC ACIDS RES, V43, pD707, DOI 10.1093/nar/gku1117; Hong CC, 1996, GENETICS, V143, P1653; Hsu PD, 2013, NAT BIOTECHNOL, V31, P827, DOI 10.1038/nbt.2647; Jinek M, 2012, SCIENCE, V337, P816, DOI 10.1126/science.1225829; Konet DS, 2007, INSECT MOL BIOL, V16, P199, DOI 10.1111/j.1365-2583.2006.00714.x; Papathanos PA, 2009, BMC MOL BIOL, V10, DOI 10.1186/1471-2199-10-65; Port F, 2014, P NATL ACAD SCI USA, V111, pE2967, DOI 10.1073/pnas.1405500111; Simoni A, 2014, NUCLEIC ACIDS RES, V42, P7461, DOI 10.1093/nar/gku387; Thomas DD, 2000, SCIENCE, V287, P2474, DOI 10.1126/science.287.5462.2474; Windbichler N, 2011, NATURE, V473, P212, DOI 10.1038/nature09937	22	645	679	11	468	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156	1546-1696		NAT BIOTECHNOL	Nat. Biotechnol.	JAN	2016	34	1					78	83		10.1038/nbt.3439	http://dx.doi.org/10.1038/nbt.3439			6	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	DB8HQ	26641531	Green Accepted, Bronze, Green Submitted			2022-12-27	WOS:000368758200030
J	Kidd, BA; Wroblewska, A; Boland, MR; Agudo, J; Merad, M; Tatonetti, NP; Brown, BD; Dudley, JT				Kidd, Brian A.; Wroblewska, Aleksandra; Boland, Mary R.; Agudo, Judith; Merad, Miriam; Tatonetti, Nicholas P.; Brown, Brian D.; Dudley, Joel T.			Mapping the effects of drugs on the immune system	NATURE BIOTECHNOLOGY			English	Article							IMMUNOLOGICAL GENOME PROJECT; HIGH-THROUGHPUT SCREENS; GENE-EXPRESSION; ALZHEIMERS-DISEASE; SET ANALYSIS; CELLS; MOUSE; INHIBITORS; KINASE; CANCER	Understanding how drugs affect the immune system has consequences for treating disease and minimizing unwanted side effects. Here we present an integrative computational approach for predicting interactions between drugs and immune cells in a system-wide manner. The approach matches gene sets between transcriptional signatures to determine their similarity. We apply the method to model the interactions between 1,309 drugs and 221 immune cell types and predict 69,995 interactions. The resulting immune-cell pharmacology map is used to predict how five drugs influence four immune cell types in humans and mice. To validate the predictions, we analyzed patient records and examined cell population changes from in vivo experiments. Our method offers a tool for screening thousands of interactions to identify relationships between drugs and the immune system.	[Kidd, Brian A.; Wroblewska, Aleksandra; Agudo, Judith; Brown, Brian D.; Dudley, Joel T.] Icahn Sch Med Mt Sinai, Dept Genet & Genom Sci, New York, NY 10029 USA; [Kidd, Brian A.; Dudley, Joel T.] Icahn Sch Med Mt Sinai, lcahn Inst Genom & Multiscale Biol, New York, NY 10029 USA; [Boland, Mary R.; Tatonetti, Nicholas P.] Columbia Univ, Med Ctr, Dept Biomed Informat Syst Biol & Med, New York, NY USA; [Merad, Miriam] Icahn Sch Med Mt Sinai, Dept Oncol Sci, New York, NY 10029 USA; [Merad, Miriam; Brown, Brian D.] Icahn Sch Med Mt Sinai, Tisch Canc Inst, New York, NY 10029 USA; [Merad, Miriam; Brown, Brian D.] Icahn Sch Med Mt Sinai, Inst Immunol, New York, NY 10029 USA	Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai; Columbia University; Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai	Brown, BD; Dudley, JT (corresponding author), Icahn Sch Med Mt Sinai, Dept Genet & Genom Sci, New York, NY 10029 USA.; Dudley, JT (corresponding author), Icahn Sch Med Mt Sinai, lcahn Inst Genom & Multiscale Biol, New York, NY 10029 USA.; Brown, BD (corresponding author), Icahn Sch Med Mt Sinai, Tisch Canc Inst, New York, NY 10029 USA.; Brown, BD (corresponding author), Icahn Sch Med Mt Sinai, Inst Immunol, New York, NY 10029 USA.	brian.brown@mssm.edu; joel.dudley@mssm.edu		Tatonetti, Nicholas/0000-0002-2700-2597; Wroblewska, Aleksandra/0000-0003-2059-6158; Kidd, Brian/0000-0003-2110-1145	US National Institutes of Health [R01AI104848, R33CA182377, R01AI113221, U54CA189201, R01DK098242]; Jonathan E. Gray TCI Young Scientist Cancer Research Award; NATIONAL CANCER INSTITUTE [P30CA196521, R01CA190400, R33CA182377, R01CA173861, U54CA189201] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI113221, R01AI104848] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK020541, R01DK098242] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM107145] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Jonathan E. Gray TCI Young Scientist Cancer Research Award; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank G. Hoffman and B. Readhead for useful conversations about the computational methods and suggestions on the manuscript, L. Li for assistance with the electronic medical records from Mount Sinai, K. Oguntuyo for assistance with the qPCR reactions, and A. Rahman for sample preparation and acquisition on the CyTOF. This work was supported by the US National Institutes of Health grants R01AI104848, R33CA182377 and R01AI113221 (to B.D.B.), U54CA189201 and R01DK098242, and Jonathan E. Gray TCI Young Scientist Cancer Research Award (to J.T.D.).	ALVIR JMJ, 1993, NEW ENGL J MED, V329, P162, DOI 10.1056/NEJM199307153290303; Beghi E, 2011, EPILEPSIA, V52, P40, DOI 10.1111/j.1528-1167.2011.03035.x; Bellucci R, 2012, J CLIN INVEST, V122, P2369, DOI 10.1172/JCI58457; Benoist C, 2012, NAT REV IMMUNOL, V12, P734, DOI 10.1038/nri3300; Beyrau M, 2012, OPEN BIOL, V2, DOI 10.1098/rsob.120134; Cheng Y, 2014, NATURE, V515, P371, DOI 10.1038/nature13985; Cherny RA, 2001, NEURON, V30, P665, DOI 10.1016/S0896-6273(01)00317-8; Cipolletta D, 2012, NATURE, V486, P549, DOI 10.1038/nature11132; Devi S, 2013, J EXP MED, V210, P2321, DOI 10.1084/jem.20130056; Dudley JT, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3002648; Emert-Sedlak LA, 2013, CHEM BIOL, V20, P82, DOI 10.1016/j.chembiol.2012.11.005; Evans DC, 2005, CURR OPIN DRUG DISC, V8, P44; FAGIUS J, 1985, J NEUROL NEUROSUR PS, V48, P65, DOI 10.1136/jnnp.48.1.65; Fisahn A, 2002, NEURON, V33, P615, DOI 10.1016/S0896-6273(02)00587-1; Fortunati E, 2009, CLIN EXP IMMUNOL, V155, P559, DOI 10.1111/j.1365-2249.2008.03791.x; Fox RI, 1999, CLIN IMMUNOL, V93, P198, DOI 10.1006/clim.1999.4777; Goh KI, 2007, P NATL ACAD SCI USA, V104, P8685, DOI 10.1073/pnas.0701361104; Grossi C, 2009, J ALZHEIMERS DIS, V17, P423, DOI 10.3233/JAD-2009-1063; Heng TSP, 2008, NAT IMMUNOL, V9, P1091, DOI 10.1038/ni1008-1091; Iorio F, 2010, P NATL ACAD SCI USA, V107, P14621, DOI 10.1073/pnas.1000138107; Iorio F, 2009, J COMPUT BIOL, V16, P241, DOI 10.1089/cmb.2008.10TT; Jagtap P, 2005, NAT REV DRUG DISCOV, V4, P421, DOI 10.1038/nrd1718; Jahchan NS, 2013, CANCER DISCOV, V3, P1364, DOI 10.1158/2159-8290.CD-13-0183; Johannessen TCA, 2008, CANCER TREAT REV, V34, P558, DOI 10.1016/j.ctrv.2008.03.125; Jojic V, 2013, NAT IMMUNOL, V14, P633, DOI 10.1038/ni.2587; Kim YJ, 2014, ALLERGY ASTHMA IMMUN, V6, P156, DOI 10.4168/aair.2014.6.2.156; Kolar D., 2008, NEUROPSYCHIATRIC DIS, V4, P389, DOI 10.2147/NDT.S6985; Kronke J, 2014, SCIENCE, V343, P301, DOI 10.1126/science.1244851; Kuhn M, 2010, MOL SYST BIOL, V6, DOI 10.1038/msb.2009.98; Lamb J, 2006, SCIENCE, V313, P1929, DOI 10.1126/science.1132939; Lewis JD, 2008, GASTROENTEROLOGY, V134, P688, DOI 10.1053/j.gastro.2007.12.012; Lin S, 2014, P NATL ACAD SCI USA, V111, P17224, DOI 10.1073/pnas.1413624111; Maloney DG, 1997, BLOOD, V90, P2188; Maugeri-Sacca M, 2012, MOL CANCER THER, V11, P1627, DOI 10.1158/1535-7163.MCT-11-1040; Miller JC, 2012, NAT IMMUNOL, V13, P888, DOI 10.1038/ni.2370; Nam D, 2010, BIOINFORMATICS, V26, pi511, DOI 10.1093/bioinformatics/btq380; Novershtern N, 2011, CELL, V144, P296, DOI 10.1016/j.cell.2011.01.004; Qiu P, 2011, NAT BIOTECHNOL, V29, P886, DOI 10.1038/nbt.1991; Rahmatallah Y, 2014, BIOINFORMATICS, V30, P360, DOI 10.1093/bioinformatics/btt687; Robertson AL, 2014, SCI TRANSL MED, V6, DOI 10.1126/scitranslmed.3007672; Roge R, 2012, SCHIZOPHR RES, V140, P204, DOI 10.1016/j.schres.2012.06.020; Romano A, 2014, J ALLER CL IMM-PRACT, V2, P3, DOI 10.1016/j.jaip.2013.11.006; Rouleau M, 2010, NAT REV CANCER, V10, P293, DOI 10.1038/nrc2812; Salama A, 2009, EXPERT OPIN DRUG SAF, V8, P73, DOI [10.1517/14740330802577351 , 10.1517/14740330802577351, 10.1182/asheducation-2009.1.73]; Seok J, 2013, P NATL ACAD SCI USA, V110, P3507, DOI 10.1073/pnas.1222878110; Shay T, 2013, P NATL ACAD SCI USA, V110, P2946, DOI 10.1073/pnas.1222738110; Sicherer SH, 2014, J ALLERGY CLIN IMMUN, V133, P324, DOI 10.1016/j.jaci.2013.11.013; Sirota M, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3001318; Stepan AF, 2011, CHEM RES TOXICOL, V24, P1345, DOI 10.1021/tx200168d; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Summers C, 2010, TRENDS IMMUNOL, V31, P318, DOI 10.1016/j.it.2010.05.006; Suzuki R, 2006, BIOINFORMATICS, V22, P1540, DOI 10.1093/bioinformatics/btl117; Tatonetti NP, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003377; VEZINA C, 1975, J ANTIBIOT, V28, P721, DOI 10.7164/antibiotics.28.721; VOGELSANG GB, 1992, NEW ENGL J MED, V326, P1055, DOI 10.1056/NEJM199204163261604; Walker RG, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0001033; Ward KE, 2010, AM J HEALTH-SYST PH, V67, P206, DOI 10.2146/ajhp080603; Wu D, 2012, NUCLEIC ACIDS RES, V40, DOI 10.1093/nar/gks461; Yaari G, 2013, NUCLEIC ACIDS RES, V41, DOI 10.1093/nar/gkt660; Zhang X, 2002, INT IMMUNOPHARMACOL, V2, P1029, DOI 10.1016/S1567-5769(02)00057-7	60	54	55	1	33	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156	1546-1696		NAT BIOTECHNOL	Nat. Biotechnol.	JAN	2016	34	1					47	54		10.1038/nbt.3367	http://dx.doi.org/10.1038/nbt.3367			8	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	DB8HQ	26619012	Green Accepted, Bronze			2022-12-27	WOS:000368758200026
J	DeFrancesco, L				DeFrancesco, Laura			Ebola vaccine trial falls short of homerun	NATURE BIOTECHNOLOGY			English	News Item																		The Lancet, 2015, LANCET, V386, P830; 2015, LANCET, V386, P831; 2015, LANCET, V386, P857	3	0	0	0	9	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156	1546-1696		NAT BIOTECHNOL	Nat. Biotechnol.	OCT	2015	33	10					1011	1012						2	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	CT1JX	26448067				2022-12-27	WOS:000362555700003
J	MacPherson, CR; Scherf, A				MacPherson, Cameron Ross; Scherf, Artur			Flexible guide-RNA design for CRISPR applications using Protospacer Workbench	NATURE BIOTECHNOLOGY			English	Letter									Inst Pasteur, Biol Host Parasite Interact Unit, Paris, France; CNRS, ERL 9195, Paris, France; INSERM, U1201, Paris, France	Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Institut National de la Sante et de la Recherche Medicale (Inserm)		cameron.crm@gmail.com; artur.scherf@pasteur.fr		Scherf, Artur/0000-0003-2411-3328; MacPherson, Cameron/0000-0002-8945-9736				Doench JG, 2014, NAT BIOTECHNOL, V32, P1262, DOI 10.1038/nbt.3026; Ghorbal M, 2014, NAT BIOTECHNOL, V32, P819, DOI 10.1038/nbt.2925; Heigwer F, 2014, NAT METHODS, V11, P122, DOI 10.1038/nmeth.2812; Hsu PD, 2013, NAT BIOTECHNOL, V31, P827, DOI 10.1038/nbt.2647; Robinson JT, 2011, NAT BIOTECHNOL, V29, P24, DOI 10.1038/nbt.1754; Sander JD, 2007, NUCLEIC ACIDS RES, V35, pW599, DOI 10.1093/nar/gkm349; Xie SS, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0100448	7	56	59	0	19	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156	1546-1696		NAT BIOTECHNOL	Nat. Biotechnol.	AUG	2015	33	8					805	806		10.1038/nbt.3291	http://dx.doi.org/10.1038/nbt.3291			2	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	CO6OB	26121414				2022-12-27	WOS:000359274900010
J	Johnson-Buck, A; Su, X; Giraldez, MD; Zhao, MP; Tewari, M; Walter, NG				Johnson-Buck, Alexander; Su, Xin; Giraldez, Maria D.; Zhao, Meiping; Tewari, Muneesh; Walter, Nils G.			Kinetic fingerprinting to identify and count single nucleic acids	NATURE BIOTECHNOLOGY			English	Article							INTERNAL-REFLECTION FLUORESCENCE; MOLECULE DETECTION; MICRORNA; HYBRIDIZATION; SPECIFICITY; EXPRESSION; MICROSCOPY; ASSAY	MicroRNAs (miRNAs) have emerged as promising diagnostic biomarkers. We introduce a kinetic fingerprinting approach called single-molecule recognition through equilibrium Poisson sampling (SiMREPS) for the amplification-free counting of single unlabeled miRNA molecules, which circumvents thermodynamic limits of specificity and virtually eliminates false positives. We demonstrate high-confidence, single-molecule detection of synthetic and endogenous miRNAs in both buffer and minimally treated biofluids, as well as >500-fold discrimination between single nucleotide polymorphisms.	[Johnson-Buck, Alexander; Walter, Nils G.] Univ Michigan, Dept Chem, Single Mol Anal Grp, Ann Arbor, MI 48109 USA; [Su, Xin; Zhao, Meiping] Peking Univ, Coll Chem & Mol Engn, MOE Key Lab Bioorgan Chem & Mol Engn, Beijing Natl Lab Mol Sci, Beijing 100871, Peoples R China; [Giraldez, Maria D.; Tewari, Muneesh] Univ Michigan, Dept Internal Med, Div Hematol Oncol, Ann Arbor, MI 48109 USA; [Tewari, Muneesh] Univ Michigan, Dept Internal Med, Div Mol Med & Genet, Ann Arbor, MI 48109 USA; [Tewari, Muneesh] Univ Michigan, Dept Biomed Engn, Ann Arbor, MI 48109 USA; [Tewari, Muneesh] Univ Michigan, Ctr Computat Med & Bioinformat, Ann Arbor, MI 48109 USA; [Tewari, Muneesh] Univ Michigan, Biointerfaces Inst, Ann Arbor, MI 48109 USA	University of Michigan System; University of Michigan; Chinese Academy of Sciences; Peking University; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan	Walter, NG (corresponding author), Univ Michigan, Dept Chem, Single Mol Anal Grp, Ann Arbor, MI 48109 USA.	nwalter@umich.edu	Walter, Nils G/G-7504-2016; Walter, Nils/P-3163-2019; Giraldez, Maria D/E-7395-2018	Walter, Nils G/0000-0002-7301-1275; Walter, Nils/0000-0002-7301-1275; Giraldez, Maria D/0000-0001-6829-7603; Johnson-Buck, Alexander/0000-0003-3748-6000	Department of Defense MURI Award [W911NF-12-1-0420]; US National Institutes of Health [R0IDK085714]; China Scholarship Council; Rio Hortega Fellowship; Martin Escudero Fellowship; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK085714] Funding Source: NIH RePORTER	Department of Defense MURI Award(MURIUnited States Department of Defense); US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); China Scholarship Council(China Scholarship Council); Rio Hortega Fellowship; Martin Escudero Fellowship; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was funded in part by the Department of Defense MURI Award W911NF-12-1-0420 (to N.G.W.) and US National Institutes of Health Transformative R01 grant R0IDK085714 (to M.T.). X.S. acknowledges support from the China Scholarship Council. M.D.G. acknowledges initial support from a Rio Hortega Fellowship and later from a Martin Escudero Fellowship. The authors thank A.M. Chinnaiyan, M. Bitzer, A. Sahu, S. Pitchiaya, L.A. Heinicke and M.L. Kahlscheuer for helpful discussions. The authors acknowledge J.D. Hoff and the Single-Molecule Analysis in Real-Time (SMART) Center for instrumentation and assistance in TIRF microscopy measurements.	AXELROD D, 1984, ANNU REV BIOPHYS BIO, V13, P247, DOI 10.1146/annurev.bb.13.060184.001335; Baaske MD, 2014, NAT NANOTECHNOL, V9, P933, DOI [10.1038/nnano.2014.180, 10.1038/NNANO.2014.180]; Cisse II, 2012, NAT STRUCT MOL BIOL, V19, P623, DOI 10.1038/nsmb.2294; Dupuis NF, 2013, BIOPHYS J, V105, P756, DOI 10.1016/j.bpj.2013.05.061; Garcia-Schwarz G, 2013, ANGEW CHEM INT EDIT, V52, P11534, DOI 10.1002/anie.201305875; Geiss GK, 2008, NAT BIOTECHNOL, V26, P317, DOI 10.1038/nbt1385; Gunnarsson A, 2008, NANO LETT, V8, P183, DOI 10.1021/nl072401j; Ho SL, 2014, ANAL CHEM, V86, P9880, DOI 10.1021/ac5025182; Jungmann R, 2010, NANO LETT, V10, P4756, DOI 10.1021/nl103427w; Li L, 2011, ANAL CHIM ACTA, V685, P52, DOI 10.1016/j.aca.2010.11.012; Lu M, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003420; Mitchell PS, 2008, P NATL ACAD SCI USA, V105, P10513, DOI 10.1073/pnas.0804549105; Ruepp A, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-1-r6; Russo F, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047786; Schwarzenbach H, 2011, NAT REV CANCER, V11, P426, DOI 10.1038/nrc3066; Sorgenfrei S, 2011, NAT NANOTECHNOL, V6, P125, DOI 10.1038/nnano.2010.275; Walter NG, 2008, NAT METHODS, V5, P475, DOI 10.1038/nmeth.1215; Zhang DY, 2012, NAT CHEM, V4, P208, DOI [10.1038/NCHEM.1246, 10.1038/nchem.1246]	18	93	97	6	111	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156	1546-1696		NAT BIOTECHNOL	Nat. Biotechnol.	JUL	2015	33	7					730	732		10.1038/nbt.3246	http://dx.doi.org/10.1038/nbt.3246			3	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	CN4JJ	26098451	Green Accepted			2022-12-27	WOS:000358396100027
J	Liddicoat, J; Whitton, T; Nicol, D				Liddicoat, Johnathon; Whitton, Tess; Nicol, Dianne			Are the gene-patent storm clouds dissipating? A global snapshot	NATURE BIOTECHNOLOGY			English	Editorial Material							HUMAN GENOME; INTELLECTUAL PROPERTY; PROVISION; MYRIAD; ACCESS		[Liddicoat, Johnathon; Whitton, Tess; Nicol, Dianne] Univ Tasmania, Fac Law, Ctr Law & Genet, Hobart, Tas, Australia	University of Tasmania	Liddicoat, J (corresponding author), Univ Tasmania, Fac Law, Ctr Law & Genet, Hobart, Tas, Australia.	johnathon.liddicoat@utas.edu.au	Nicol, Dianne/J-7253-2014; Liddicoat, Johnathon/J-7156-2014	Nicol, Dianne/0000-0002-6553-2839; Whitton, Tess/0000-0001-6397-6965; Liddicoat, Johnathon/0000-0001-7370-3936				Baldwin AL, 2013, GENOME MED, V5, DOI 10.1186/gm412; Carbone J, 2010, NAT BIOTECHNOL, V28, P784, DOI 10.1038/nbt0810-784; Caulfield T, 2006, NAT BIOTECHNOL, V24, P1091, DOI 10.1038/nbt0906-1091; Cho MK, 2003, J MOL DIAGN, V5, P3, DOI 10.1016/S1525-1578(10)60444-8; Conley John M, 2014, N C J Law Technol, V15, P597; Cook-Deegan R, 2010, GENET MED, V12, pS15, DOI 10.1097/GIM.0b013e3181d5a67b; Cook-Deegan R, 2009, NATURE, V458, P405, DOI 10.1038/458405a; European Techno-Economic Policy Support, 2008, ROL PAT DEV CLIN US; EUROPEAN UNION COMMITTEE OF EXPERTS ON RARE DISEASES, 2012, 2012 REP STAT ART RA; Evaluation of Genomic Applications in Practice and Prevention (EGAPP) Working Group, 2011, GENET MED, V13, P67; Gaisser S, 2009, NATURE, V458, P407, DOI 10.1038/458407a; Gold ER, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3006849; Graff GD, 2013, NAT BIOTECHNOL, V31, P404, DOI 10.1038/nbt.2568; Haanes EJ, 2012, NAT BIOTECHNOL, V30, P758, DOI 10.1038/nbt.2318; Hawkins N, 2011, GENET MED, V13, P320, DOI 10.1097/GIM.0b013e3181fc50bc; Holman C.M., 2012, UMKC L REV, V563; Holman CM, 2012, NAT BIOTECHNOL, V30, P1054, DOI 10.1038/nbt.2407; Hopkins MM, 2007, NAT BIOTECHNOL, V25, P185, DOI 10.1038/nbt0207-185; Huys I, 2012, NAT REV GENET, V13, P440, DOI 10.1038/nrg3255; Huys I, 2009, NAT BIOTECHNOL, V27, P903, DOI 10.1038/nbt1009-903; Instrumentation Laboratory, 2009, INSTR LAB WINS PAT I; Jefferson OA, 2013, NAT BIOTECHNOL, V31, P1086, DOI 10.1038/nbt.2755; Jensen K, 2005, SCIENCE, V310, P239, DOI 10.1126/science.1120014; Kers JG, 2014, EUR J HUM GENET, V22, P1155, DOI 10.1038/ejhg.2013.305; Kujovich JL, 2011, GENET MED, V13, P1, DOI 10.1097/GIM.0b013e3181faa0f2; Lemley MA, 2005, J ECON PERSPECT, V19, P75, DOI 10.1257/0895330054048650; Matthijs G, 2013, NAT BIOTECHNOL, V31, P704, DOI 10.1038/nbt.2644; McKernan KJ, 2013, NAT BIOTECHNOL, V31, P884, DOI 10.1038/nbt.2703; Moore K., 2005, BERKELEY TECH LJ, V20, P1521; Nicol D, 2005, COMMUNITY GENET, V8, P228, DOI 10.1159/000087960; Nicol D., 2012, J LAW INF SCI, V22, P32; Nicol D, 2013, AUST HEALTH REV, V37, P281, DOI 10.1071/AH13029; Noonan K.E., 2015, GAME MYRIAD UPDATE; Pressman L., 2012, LIFE SCI LAW IND REP, V6, P329; Rosenfeld J, 2013, GENOME MED, V5, DOI 10.1186/gm431; Schauinger S., 2012, HUMAN GENE PATENT RE; Sherkow JS, 2014, NAT BIOTECHNOL, V32, P620, DOI 10.1038/nbt.2944; US Secretary's Advisory Committee on Genetics Health and Society, 2010, GEN PAT LIC PRACT TH; van Zimmeren E, 2014, GENET SOC, P151; World Intellectual Property Organization, 2013, 2013 WORLD INT PROP	40	10	10	1	16	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156	1546-1696		NAT BIOTECHNOL	Nat. Biotechnol.	APR	2015	33	4					347	352		10.1038/nbt.3182	http://dx.doi.org/10.1038/nbt.3182			6	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	CF2AE	25850055	Green Submitted			2022-12-27	WOS:000352348500017
J	Herrera, CG; Adamantidis, AR				Herrera, Carolina Gutierrez; Adamantidis, Antoine R.			An integrated microprobe for the brain	NATURE BIOTECHNOLOGY			English	Editorial Material							DYNAMICS; NEURONS		[Herrera, Carolina Gutierrez; Adamantidis, Antoine R.] Univ Bern, Dept Neurol, Inselspital Univ Hosp, Bern, Switzerland; [Adamantidis, Antoine R.] McGill Univ, Dept Psychiat, Douglas Inst, Montreal, PQ, Canada	University of Bern; University Hospital of Bern; McGill University	Herrera, CG (corresponding author), Univ Bern, Dept Neurol, Inselspital Univ Hosp, Bern, Switzerland.	antoine.adamantidis@dkf.unibe.ch		Adamantidis, Antoine/0000-0003-2531-5175; Gutierrez Herrera, Carolina/0000-0002-7916-3341				Canales A, 2015, NAT BIOTECHNOL, V33, P277, DOI 10.1038/nbt.3093; Cui GH, 2013, NATURE, V494, P238, DOI 10.1038/nature11846; Dufour S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057703; Grienberger C, 2012, NEURON, V73, P862, DOI 10.1016/j.neuron.2012.02.011; Gunaydin LA, 2014, CELL, V157, P1535, DOI 10.1016/j.cell.2014.05.017; Jennings JH, 2015, CELL, V160, P516, DOI 10.1016/j.cell.2014.12.026; Kim JD, 2014, FRONT PHYSIOL, V5, DOI 10.3389/fphys.2014.00480; LeChasseur Y, 2011, NAT METHODS, V8, P319, DOI 10.1038/NMETH.1572; van den Pol AN, 2012, NEURON, V76, P98, DOI 10.1016/j.neuron.2012.09.014; Ziv Y, 2013, NAT NEUROSCI, V16, P264, DOI 10.1038/nn.3329	10	2	2	0	17	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156	1546-1696		NAT BIOTECHNOL	Nat. Biotechnol.	MAR	2015	33	3					259	260		10.1038/nbt.3169	http://dx.doi.org/10.1038/nbt.3169			2	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	CD0ME	25748915				2022-12-27	WOS:000350766900019
J	Liu, YQ; Wu, H; Chen, H; Liu, YL; He, J; Kang, HY; Sun, ZG; Pan, G; Wang, Q; Hu, JL; Zhou, F; Zhou, KN; Zheng, XM; Ren, YL; Chen, LM; Wang, YH; Zhao, ZG; Lin, QB; Wu, FQ; Zhang, X; Guo, XP; Cheng, XI; Jiang, L; Wu, CY; Wang, HY; Wan, JM				Liu, Yuqiang; Wu, Han; Chen, Hong; Liu, Yanling; He, Jun; Kang, Haiyan; Sun, Zhiguang; Pan, Gen; Wang, Qi; Hu, Jinlong; Zhou, Feng; Zhou, Kunneng; Zheng, Xiaoming; Ren, Yulong; Chen, Liangming; Wang, Yihua; Zhao, Zhigang; Lin, Qibing; Wu, Fuqing; Zhang, Xin; Guo, Xiuping; Cheng, Xianian; Jiang, Ling; Wu, Chuanyin; Wang, Haiyang; Wan, Jianmin			A gene cluster encoding lectin receptor kinases confers broad-spectrum and durable insect resistance in rice	NATURE BIOTECHNOLOGY			English	Article							NILAPARVATA-LUGENS HOMOPTERA; ORYZA-SATIVA L.; BROWN PLANTHOPPER; ARABIDOPSIS; IDENTIFICATION; DELPHACIDAE; RESPONSES; SEQUENCE; PROTEIN; BAC	The brown planthopper (BPH) is the most destructive pest of rice (Oryza sativa) and a substantial threat to rice production, causing losses of billions of dollars annually(1,2). Breeding of resistant cultivars is currently hampered by the rapid breakdown of BPH resistance(2). Thus, there is an urgent need to identify more effective BPH-resistance genes. Here, we report molecular cloning and characterization of Bph3, a locus in rice identified more than 30 years ago that confers resistance to BPH. We show that Bph3 is a cluster of three genes encoding plasma membrane-localized lectin receptor kinases (OsLecRK1-OsLecRK3). Introgression of Bph3 into susceptible rice varieties by transgenic or marker-assisted selection strategies significantly enhanced resistance to both the BPH and the white back planthopper. Our results suggest that these lectin receptor kinase genes function together to confer broad-spectrum and durable insect resistance and provide a resource for molecular breeding of insect-resistant rice cultivars.	[Liu, Yuqiang; Wu, Han; Chen, Hong; Liu, Yanling; He, Jun; Kang, Haiyan; Sun, Zhiguang; Pan, Gen; Wang, Qi; Hu, Jinlong; Zhou, Feng; Zhou, Kunneng; Ren, Yulong; Chen, Liangming; Wang, Yihua; Zhao, Zhigang; Cheng, Xianian; Jiang, Ling; Wan, Jianmin] Nanjing Agr Univ, Jiangsu Plant Gene Engn Res Ctr, Natl Key Lab Crop Genet & Germplasm Enhancement, Nanjing, Jiangsu, Peoples R China; [Zheng, Xiaoming; Lin, Qibing; Wu, Fuqing; Zhang, Xin; Guo, Xiuping; Wu, Chuanyin; Wang, Haiyang; Wan, Jianmin] Chinese Acad Agr Sci, Inst Crop Sci, Natl Key Facil Crop Gene Resources & Genet Improv, Beijing 100193, Peoples R China	Nanjing Agricultural University; Chinese Academy of Agricultural Sciences; Institute of Crop Sciences, CAAS	Wan, JM (corresponding author), Nanjing Agr Univ, Jiangsu Plant Gene Engn Res Ctr, Natl Key Lab Crop Genet & Germplasm Enhancement, Nanjing, Jiangsu, Peoples R China.	wanjm@njau.edu.cn	Lin, Qibing/AAG-3882-2021; liu, yan/HCI-5542-2022; Ren, Yulong/HHC-8217-2022; liu, yan/HGV-1365-2022	chen, hong/0000-0002-7376-172X; Wang, Qi/0000-0002-2379-4814	333 Program [BRA2012126]; NSFC [31471470]; 863 Program of China [2012AA101101, 2011AA10A101, 2011BAD35B02-02]; National Science and Technology Supporting Program [2011BAD35B02-02]; National Key Transformation Program [2014ZX08001-001]; Jiangsu Science and Technology Development Program [BE2012303, BK2010016]; Jiangsu PAPD program	333 Program; NSFC(National Natural Science Foundation of China (NSFC)); 863 Program of China(National High Technology Research and Development Program of China); National Science and Technology Supporting Program; National Key Transformation Program; Jiangsu Science and Technology Development Program; Jiangsu PAPD program	This work was supported by Jiangsu 333 Program (BRA2012126), NSFC (31471470), 863 Program of China (2012AA101101, 2011AA10A101 and 2011BAD35B02-02), National Science and Technology Supporting Program (2011BAD35B02-02), National Key Transformation Program (2014ZX08001-001), Jiangsu Science and Technology Development Program (BE2012303, BK2010016), and the Jiangsu PAPD program. We thank R. Guan (Nanjing Agricultural University) and J. Wang (Chinese Academy of Agricultural Sciences) for statistical analysis, and J. Zhou (Chinese Academy of Sciences), W. Terzaghi (Wilkes University) and C. Lin (UC-LA) for proofreading the manuscript.	Abramovitch RB, 2006, NAT REV MOL CELL BIO, V7, P601, DOI 10.1038/nrm1984; Ashikari M, 2005, SCIENCE, V309, P741, DOI 10.1126/science.1113373; Belousov VV, 2006, NAT METHODS, V3, P281, DOI 10.1038/NMETH866; Bharathi M, 2002, RICE GENETICS, P255; Chen XW, 2006, PLANT J, V46, P794, DOI 10.1111/j.1365-313X.2006.02739.x; Chen Yan, 2013, Yingyong Shengtai Xuebao, V24, P190; Cheng XY, 2013, PLANT J, V76, P687, DOI 10.1111/tpj.12328; Cheng XY, 2013, MOL PLANT, V6, P621, DOI 10.1093/mp/sst030; Choi J, 2014, SCIENCE, V343, P290, DOI 10.1126/science.343.6168.290; Cook DE, 2012, SCIENCE, V338, P1206, DOI 10.1126/science.1228746; DellaPenna D, 2012, SCIENCE, V336, P1648, DOI 10.1126/science.1225473; Dodds PN, 2010, NAT REV GENET, V11, P539, DOI 10.1038/nrg2812; Du B, 2009, P NATL ACAD SCI USA, V106, P22163, DOI 10.1073/pnas.0912139106; Gallagher S.R., 1992, GUS PROTOCOLS USING, P47; Ghaffar MBAB, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022137; Gilardoni PA, 2011, PLANT CELL, V23, P3512, DOI 10.1105/tpc.111.088229; Gouhier-Darimont C, 2013, J EXP BOT, V64, P665, DOI 10.1093/jxb/ers362; Heinrichs E., 1985, GENETIC EVALUATION I; HIEI Y, 1994, PLANT J, V6, P271, DOI 10.1046/j.1365-313X.1994.6020271.x; Jones JDG, 2006, NATURE, V444, P323, DOI 10.1038/nature05286; JUNGTSUNG W, 1986, ENVIRON ENTOMOL, V15, P648, DOI 10.1093/ee/15.3.648; Kanzaki H, 2008, PLANTA, V228, P977, DOI 10.1007/s00425-008-0797-y; Lacombe S, 2010, NAT BIOTECHNOL, V28, P365, DOI 10.1038/nbt.1613; LAKSHMINARAYANA A, 1977, CROP SCI, V17, P96, DOI 10.2135/cropsci1977.0011183X001700010028x; Li Qing, 1997, Acta Entomologica Sinica, V40, P139; Lv WT, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-674; Madurangi S.A.P, 2010, P 15 INT FOR ENV S, P172; Nagata T., 1984, Chinese Journal of Entomology, V4, P117; Naito K, 2008, MOL PLANT MICROBE IN, V21, P1165, DOI 10.1094/MPMI-21-9-1165; Nelson BK, 2007, PLANT J, V51, P1126, DOI 10.1111/j.1365-313X.2007.03212.x; PATHAK PK, 1982, ENVIRON ENTOMOL, V11, P85, DOI 10.1093/ee/11.1.85; PATHAK PK, 1982, J ECON ENTOMOL, V75, P194, DOI 10.1093/jee/75.2.194; Cruz AP, 2011, ENTOMOL EXP APPL, V141, P245, DOI 10.1111/j.1570-7458.2011.01193.x; Piper R., 2011, PESTS GUIDE WORLDS M; Shen JunHui, 2003, Rice Science, V11, P57; Singh P, 2013, FRONT PLANT SCI, V4, DOI 10.3389/fpls.2013.00124; Singh P, 2012, PLANT CELL, V24, P1256, DOI 10.1105/tpc.112.095778; SONG WY, 1995, SCIENCE, V270, P1804, DOI 10.1126/science.270.5243.1804; Sun LH, 2005, BREEDING SCI, V55, P391, DOI 10.1270/jsbbs.55.391; Swofford D.L, 1998, PAUP 4 0 PHYLOGENETI; Tamura Y, 2014, SCI REP-UK, V4, DOI 10.1038/srep05872; Vaid N, 2012, PLANT MOL BIOL, V80, P365, DOI 10.1007/s11103-012-9952-8; Wang G.-L., 2009, ADV GENETICS GENOMIC; Wu H, 2014, MOL BREEDING, V33, P909, DOI 10.1007/s11032-013-0005-z; Xiong ZY, 2004, CHINESE SCI BULL, V49, P591, DOI 10.1360/03wc0533; Xu X, 2012, NAT BIOTECHNOL, V30, P105, DOI 10.1038/nbt.2050	46	200	258	11	196	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156	1546-1696		NAT BIOTECHNOL	Nat. Biotechnol.	MAR	2015	33	3					301	+		10.1038/nbt.3069	http://dx.doi.org/10.1038/nbt.3069			7	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	CD0ME	25485617				2022-12-27	WOS:000350766900028
J	Wicks, P; Lowe, M; Gabriel, S; Sikirica, S; Sasane, R; Arcona, S				Wicks, Paul; Lowe, Maria; Gabriel, Susan; Sikirica, Slaven; Sasane, Rahul; Arcona, Stephen			Increasing patient participation in drug development	NATURE BIOTECHNOLOGY			English	Letter									[Wicks, Paul; Lowe, Maria] PatientsLikeMe, Cambridge, MA 02141 USA; [Gabriel, Susan; Sikirica, Slaven; Sasane, Rahul; Arcona, Stephen] Novartis Hlth Econ & Outcomes Res, E Hanover, NJ 07936 USA		Wicks, P (corresponding author), PatientsLikeMe, 155 2nd St, Cambridge, MA 02141 USA.	pwicks@patientslikeme.com	Wicks, Paul/C-6128-2011	Wicks, Paul/0000-0002-2293-9284				ARNSTEIN SR, 1969, J AM I PLANNERS, V35, P216, DOI 10.1080/01944366908977225; de Wit MPT, 2013, PATIENT, V6, P179, DOI 10.1007/s40271-013-0017-0; Fleurence R, 2013, HEALTH AFFAIR, V32, P393, DOI 10.1377/hlthaff.2012.1176; Garces J. R. D., 2012, ELICITING PATIENT PE; Hibbard JH, 2007, HEALTH SERV RES, V42, P1443, DOI 10.1111/j.1475-6773.2006.00669.x; Hughes V, 2015, NAT BIOTECHNOL, V33, P14, DOI 10.1038/nbt.3106; Lavallee DC, 2014, EXPERT REV PHARM OUT, V14, P335, DOI 10.1586/14737167.2014.901890; Mullard Asher, 2013, Nat Rev Drug Discov, V12, P651, DOI 10.1038/nrd4104; Perlmutter J., 2011, BREAST DIS A YEAR B, V21, P21, DOI DOI 10.1016/J.BREASTDIS.2011.01.045; Wicks P, 2014, TRIALS, V15, DOI 10.1186/1745-6215-15-172	10	5	6	0	3	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156	1546-1696		NAT BIOTECHNOL	Nat. Biotechnol.	FEB	2015	33	2					134	135		10.1038/nbt.3145	http://dx.doi.org/10.1038/nbt.3145			2	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	CA8VK	25658275	Bronze			2022-12-27	WOS:000349198800012
J	Swiech, L; Heidenreich, M; Banerjee, A; Habib, N; Li, YQ; Trombetta, J; Sur, M; Zhang, F				Swiech, Lukasz; Heidenreich, Matthias; Banerjee, Abhishek; Habib, Naomi; Li, Yinqing; Trombetta, John; Sur, Mriganka; Zhang, Feng			In vivo interrogation of gene function in the mammalian brain using CRISPR-Cas9	NATURE BIOTECHNOLOGY			English	Article							CPG-BINDING PROTEIN-2; RETT-SYNDROME; DUAL-RNA; TRANSCRIPTION; MECP2; CAS9; EXPRESSION; REPRESSION; NEURONS; MODEL	Probing gene function in the mammalian brain can be greatly assisted with methods to manipulate the genome of neurons in vivo. The clustered, regularly interspaced, short palindromic repeats (CRISPR)-associated endonuclease (Cas) 9 from Streptococcus pyogenes (SpCas9) 1 can be used to edit single or multiple genes in replicating eukaryotic cells, resulting in frame-shifting insertion/deletion (indel) mutations and subsequent protein depletion. Here, we delivered SpCas9 and guide RNAs using adeno-associated viral (AAV) vectors to target single (Mecp2) as well as multiple genes (Dnmt1, Dnmt3a and Dnmt3b) in the adult mouse brain in vivo. We characterized the effects of genome modifications in postmitotic neurons using biochemical, genetic, electrophysiological and behavioral readouts. Our results demonstrate that AAV-mediated SpCas9 genome editing can enable reverse genetic studies of gene function in the brain.	[Swiech, Lukasz; Heidenreich, Matthias; Habib, Naomi; Li, Yinqing; Trombetta, John; Zhang, Feng] Broad Inst MIT & Harvard, Cambridge, MA 02142 USA; [Swiech, Lukasz; Heidenreich, Matthias; Habib, Naomi; Li, Yinqing; Zhang, Feng] MIT, McGovern Inst Brain Res, Dept Brain & Cognit Sci, Cambridge, MA 02139 USA; [Swiech, Lukasz; Heidenreich, Matthias; Habib, Naomi; Zhang, Feng] MIT, McGovern Inst Brain Res, Dept Biol Engn, Cambridge, MA 02139 USA; [Banerjee, Abhishek; Sur, Mriganka] MIT, Picower Inst Learning & Memory, Dept Brain & Cognit Sci, Cambridge, MA 02139 USA; [Li, Yinqing] MIT, Dept Elect Engn & Comp Sci, Cambridge, MA 02139 USA	Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT); Northwell Health; Massachusetts Institute of Technology (MIT)	Zhang, F (corresponding author), Broad Inst MIT & Harvard, Cambridge, MA 02142 USA.	zhang@broadinstitute.org	Macrae, Rhiannon/AAX-1536-2020; Habib, Naomi/AAA-8937-2020; Core, Vector/CAF-4832-2022	Li, Yinqing/0000-0002-9096-8482	Human Frontiers Scientific Program; NATIONAL EYE INSTITUTE [R01EY007023] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH085802, DP1MH100706] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS073124] Funding Source: NIH RePORTER	Human Frontiers Scientific Program; NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank A. Trevino and C. Le for technical assistance and the entire Zhang lab for technical support and critical discussions; we thank R. Platt (Broad Institute) and H. Worman (Columbia University) for sharing plasmids, R. Rikhye for providing a template for electrophysiology analysis; and X. Yu for statistical discussions. L. S. is a European Molecular Biology Organization (EMBO) Fellow and is supported by the Foundation for Polish Science. M. H. is supported by the Human Frontiers Scientific Program. A. B. holds a postdoctoral fellowship from the Simons Center for the Social Brain. N. H. is an EMBO Fellow and Y. L. is supported by Friends of the McGovern Institute Fellowship. M. S. is supported by grants from the US National Institutes of Health (NIH) (R01EY007023 and R01MH085802) and the Simons Foundation. F. Z. is supported by the National Institute of Mental Health (NIMH) through NIH Director's Pioneer Award (5DP1-MH100706), the NINDS through a NIH Transformative R01 grant (5R01-NS073124), the Keck, Merkin, Vallee, Damon Runyon, Searle Scholars, Klarman Family Foundation, Klingenstein, Poitras and Simons Foundations, and Bob Metcalfe. The authors plan on making the reagents widely available to the academic community through Addgene and to provide software tools via the Zhang lab website (http://www. genome-engineering.org/).	Banerjee Abhishek, 2012, Front Psychiatry, V3, P34, DOI 10.3389/fpsyt.2012.00034; BANKER G, 1988, NATURE, V336, P185, DOI 10.1038/336185a0; Bikard D, 2013, NUCLEIC ACIDS RES, V41, P7429, DOI 10.1093/nar/gkt520; Chahrour M, 2008, SCIENCE, V320, P1224, DOI 10.1126/science.1153252; Chahrour M, 2007, NEURON, V56, P422, DOI 10.1016/j.neuron.2007.10.001; Chao HT, 2007, NEURON, V56, P58, DOI 10.1016/j.neuron.2007.08.018; Chen RZ, 2001, NAT GENET, V27, P327, DOI 10.1038/85906; Cong L, 2013, SCIENCE, V339, P819, DOI 10.1126/science.1231143; Ding QR, 2014, CIRC RES, V115, P488, DOI 10.1161/CIRCRESAHA.115.304351; Esvelt KM, 2013, NAT METHODS, V10, P1116, DOI [10.1038/NMETH.2681, 10.1038/nmeth.2681]; Feng J, 2010, NAT NEUROSCI, V13, P423, DOI 10.1038/nn.2514; Fonfara I, 2014, NUCLEIC ACIDS RES, V42, P2577, DOI 10.1093/nar/gkt1074; Fu YF, 2013, NAT BIOTECHNOL, V31, P822, DOI 10.1038/nbt.2623; Fujita PA, 2011, NUCLEIC ACIDS RES, V39, pD876, DOI 10.1093/nar/gkq963; Gilbert LA, 2013, CELL, V154, P442, DOI 10.1016/j.cell.2013.06.044; Gray SJ, 2011, HUM GENE THER, V22, P1143, DOI 10.1089/hum.2010.245; Grindberg RV, 2013, P NATL ACAD SCI USA, V110, P19802, DOI 10.1073/pnas.1319700110; Hagihara Hideo, 2009, J Vis Exp, DOI 10.3791/1543; Hsu PD, 2014, CELL, V157, P1262, DOI 10.1016/j.cell.2014.05.010; Hsu PD, 2013, NAT BIOTECHNOL, V31, P827, DOI 10.1038/nbt.2647; Jinek M, 2012, SCIENCE, V337, P816, DOI 10.1126/science.1225829; Kheirbek MA, 2013, NEURON, V77, P955, DOI 10.1016/j.neuron.2012.12.038; Konermann S, 2013, NATURE, V500, P472, DOI 10.1038/nature12466; LEVITT N, 1989, GENE DEV, V3, P1019, DOI 10.1101/gad.3.7.1019; Li Y, 2013, CELL STEM CELL, V13, P446, DOI 10.1016/j.stem.2013.09.001; McClure C, 2011, JOVE-J VIS EXP, DOI 10.3791/3348; McGraw CM, 2011, SCIENCE, V333, P186, DOI 10.1126/science.1206593; Moretti P, 2006, J NEUROSCI, V26, P319, DOI 10.1523/JNEUROSCI.2623-05.2006; Ostlund C, 2009, J CELL SCI, V122, P4099, DOI 10.1242/jcs.057075; Picelli S, 2013, NAT METHODS, V10, P1096, DOI [10.1038/nmeth.2639, 10.1038/NMETH.2639]; Platt RJ, 2014, CELL, V159, P440, DOI 10.1016/j.cell.2014.09.014; Qi LS, 2013, CELL, V152, P1173, DOI 10.1016/j.cell.2013.02.022; Ran FA, 2013, NAT PROTOC, V8, P2281, DOI 10.1038/nprot.2013.143; Sapranauskas R, 2011, NUCLEIC ACIDS RES, V39, P9275, DOI 10.1093/nar/gkr606; SHOLL DA, 1953, J ANAT, V87, P387; Swiech L, 2011, J NEUROSCI, V31, P4555, DOI 10.1523/JNEUROSCI.6582-10.2011; Wood L, 2009, J NEUROSCI, V29, P12440, DOI 10.1523/JNEUROSCI.3321-09.2009; Wu ZJ, 2010, MOL THER, V18, P80, DOI 10.1038/mt.2009.255; Xue W, 2014, NATURE, V514, P380, DOI 10.1038/nature13589; Yin H, 2014, NAT BIOTECHNOL, V32, P551, DOI 10.1038/nbt.2884; Zhou ZL, 2006, NEURON, V52, P255, DOI 10.1016/j.neuron.2006.09.037	42	504	612	7	226	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156	1546-1696		NAT BIOTECHNOL	Nat. Biotechnol.	JAN	2015	33	1					102	U286		10.1038/nbt.3055	http://dx.doi.org/10.1038/nbt.3055			9	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	AY7AR	25326897	Green Accepted, Green Submitted			2022-12-27	WOS:000347714200034
J	Cameron, DE; Collins, JJ				Cameron, D. Ewen; Collins, James J.			Tunable protein degradation in bacteria	NATURE BIOTECHNOLOGY			English	Article							ESCHERICHIA-COLI; SYNTHETIC BIOLOGY; ALLELE REPLACEMENT; GENETIC CIRCUITS; TIGHT REGULATION; EXPRESSION; DESIGN; SYSTEM; SWITCH; RIBOREGULATORS	Tunable control of protein degradation in bacteria would provide a powerful research tool. Here we use components of the Mesoplasma florum transfer-messenger RNA system to create a synthetic degradation system that provides both independent control of steady-state protein level and inducible degradation of targeted proteins in Escherichia coli. We demonstrate application of this system in synthetic circuit development and control of core bacterial processes and antibacterial targets, and we transfer the system to Lactococcus lactis to establish its broad functionality in bacteria. We create a 238-member library of tagged essential proteins in E. coli that can serve as both a research tool to study essential gene function and an applied system for antibiotic discovery. Our synthetic protein degradation system is modular, does not require disruption of host systems and can be transferred to diverse bacteria with minimal modification.	[Cameron, D. Ewen; Collins, James J.] Boston Univ, Howard Hughes Med Inst, Boston, MA 02215 USA; [Cameron, D. Ewen; Collins, James J.] Boston Univ, Ctr Synthet Biol, Boston, MA 02215 USA; [Cameron, D. Ewen; Collins, James J.] Boston Univ, Dept Biomed Engn, Boston, MA 02215 USA; [Collins, James J.] Harvard Univ, Wyss Inst Biol Inspired Engn, Boston, MA 02115 USA	Boston University; Howard Hughes Medical Institute; Boston University; Boston University; Harvard University	Collins, JJ (corresponding author), Boston Univ, Howard Hughes Med Inst, Boston, MA 02215 USA.	jcollins@bu.edu			Office of Naval Research (ONR); Defense Threat Reduction Agency [HDTRA1-14-1-0006]; Howard Hughes Medical Institute; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [DP1OD003644] Funding Source: NIH RePORTER	Office of Naval Research (ONR)(Office of Naval Research); Defense Threat Reduction Agency(United States Department of DefenseDefense Threat Reduction Agency); Howard Hughes Medical Institute(Howard Hughes Medical Institute); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	We are grateful to C. Bashor, M. Lobritz, M. Khalil and D. Dwyer for helpful discussions and critical reviews of the manuscript. This work was supported by funding from the Office of Naval Research (ONR) MURI Program, Defense Threat Reduction Agency grant HDTRA1-14-1-0006 and the Howard Hughes Medical Institute.	Adams DW, 2009, NAT REV MICROBIOL, V7, P642, DOI 10.1038/nrmicro2198; Baba T, 2006, MOL SYST BIOL, V2, DOI 10.1038/msb4100050; Bonger KM, 2011, NAT CHEM BIOL, V7, P531, DOI [10.1038/NCHEMBIO.598, 10.1038/nchembio.598]; BROWN ED, 1995, J BACTERIOL, V177, P4194, DOI 10.1128/jb.177.14.4194-4197.1995; Callura JM, 2012, P NATL ACAD SCI USA, V109, P5850, DOI 10.1073/pnas.1203808109; Callura JM, 2010, P NATL ACAD SCI USA, V107, P15898, DOI 10.1073/pnas.1009747107; Cameron DE, 2014, NAT REV MICROBIOL, V12, P381, DOI 10.1038/nrmicro3239; Cormack BP, 1996, GENE, V173, P33, DOI 10.1016/0378-1119(95)00685-0; Datsenko KA, 2000, P NATL ACAD SCI USA, V97, P6640, DOI 10.1073/pnas.120163297; Davis JH, 2011, ACS CHEM BIOL, V6, P1205, DOI 10.1021/cb2001389; DeVito JA, 2002, NAT BIOTECHNOL, V20, P478, DOI 10.1038/nbt0502-478; Dieye Y, 2001, J BACTERIOL, V183, P4157, DOI 10.1128/JB.183.14.4157-4166.2001; Gardner TS, 2000, NATURE, V403, P339, DOI 10.1038/35002131; Ge ZY, 2009, MOL MICROBIOL, V74, P1083, DOI 10.1111/j.1365-2958.2009.06923.x; Gur E, 2008, P NATL ACAD SCI USA, V105, P16113, DOI 10.1073/pnas.0808802105; GUZMAN LM, 1995, J BACTERIOL, V177, P4121, DOI 10.1128/jb.177.14.4121-4130.1995; Holo H, 1995, Methods Mol Biol, V47, P195; Holtz WJ, 2010, CELL, V140, P19, DOI 10.1016/j.cell.2009.12.029; Huang D, 2012, J BIOL ENG, V6, DOI 10.1186/1754-1611-6-9; Isaacs FJ, 2004, NAT BIOTECHNOL, V22, P841, DOI 10.1038/nbt986; Janssen BD, 2012, ADV PROTEIN CHEM STR, V86, P151, DOI 10.1016/B978-0-12-386497-0.00005-0; Kim DH, 1996, BIOCHEMISTRY-US, V35, P4923, DOI 10.1021/bi952937w; Litcofsky KD, 2012, NAT METHODS, V9, P1077, DOI [10.1038/NMETH.2205, 10.1038/nmeth.2205]; Lou CB, 2012, NAT BIOTECHNOL, V30, P1137, DOI 10.1038/nbt.2401; Lutz R, 1997, NUCLEIC ACIDS RES, V25, P1203, DOI 10.1093/nar/25.6.1203; METCALF WW, 1994, GENE, V138, P1, DOI 10.1016/0378-1119(94)90776-5; Metcalf WW, 1996, PLASMID, V35, P1, DOI 10.1006/plas.1996.0001; Mierau I, 2005, APPL MICROBIOL BIOT, V68, P705, DOI 10.1007/s00253-005-0107-6; MULLERHILL B, 1968, P NATL ACAD SCI USA, V59, P1259, DOI 10.1073/pnas.59.4.1259; Neklesa TK, 2011, NAT CHEM BIOL, V7, P538, DOI [10.1038/NCHEMBIO.597, 10.1038/nchembio.597]; Peterson EJR, 2012, ASSAY DRUG DEV TECHN, V10, P260, DOI 10.1089/adt.2011.0409; Prindle A, 2014, NATURE, V508, P387, DOI 10.1038/nature13238; Roemer T, 2013, NAT CHEM BIOL, V9, P222, DOI [10.1038/NCHEMBIO.1205, 10.1038/nchembio.1205]; Salis HM, 2009, NAT BIOTECHNOL, V27, P946, DOI 10.1038/nbt.1568; Silversmith RE, 2010, CURR OPIN MICROBIOL, V13, P177, DOI 10.1016/j.mib.2010.01.004; Slusarczyk AL, 2012, NAT REV GENET, V13, P406, DOI 10.1038/nrg3227; VANDEGUCHTE M, 1992, FEMS MICROBIOL LETT, V88, P73, DOI 10.1016/0378-1097(92)90685-H; Weber W, 2012, NAT REV GENET, V13, P21, DOI 10.1038/nrg3094; Wei JR, 2011, P NATL ACAD SCI USA, V108, P4176, DOI 10.1073/pnas.1018301108; Zhou JD, 2013, NUCLEIC ACIDS RES, V41, pD613, DOI 10.1093/nar/gks1235; Zhu W, 2013, P NATL ACAD SCI USA, V110, P123, DOI 10.1073/pnas.1219899110	41	124	132	3	98	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156	1546-1696		NAT BIOTECHNOL	Nat. Biotechnol.	DEC	2014	32	12					1276	U149		10.1038/nbt.3053	http://dx.doi.org/10.1038/nbt.3053			8	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	AW3AD	25402616	Green Accepted, Green Submitted			2022-12-27	WOS:000346156800031
J	Leslie, DC; Waterhouse, A; Berthet, JB; Valentin, TM; Watters, AL; Jain, A; Kim, P; Hatton, BD; Nedder, A; Donovan, K; Super, EH; Howell, C; Johnson, CP; Vu, TL; Bolgen, DE; Rifai, S; Hansen, AR; Aizenberg, M; Super, M; Aizenberg, J; Ingber, DE				Leslie, Daniel C.; Waterhouse, Anna; Berthet, Julia B.; Valentin, Thomas M.; Watters, Alexander L.; Jain, Abhishek; Kim, Philseok; Hatton, Benjamin D.; Nedder, Arthur; Donovan, Kathryn; Super, Elana H.; Howell, Caitlin; Johnson, Christopher P.; Vu, Thy L.; Bolgen, Dana E.; Rifai, Sami; Hansen, Anne R.; Aizenberg, Michael; Super, Michael; Aizenberg, Joanna; Ingber, Donald E.			A bioinspired omniphobic surface coating on medical devices prevents thrombosis and biofouling	NATURE BIOTECHNOLOGY			English	Article							CARDIOPULMONARY BYPASS CIRCUITS; HEPARIN; BIOCOMPATIBILITY; ANTICOAGULATION; HEMODIALYSIS; PERFORMANCE; OXYGEN; PMEA	Thrombosis and biofouling of extracorporeal circuits and indwelling medical devices cause significant morbidity and mortality worldwide. We apply a bioinspired, omniphobic coating to tubing and catheters and show that it completely repels blood and suppresses biofilm formation. The coating is a covalently tethered, flexible molecular layer of perfluorocarbon, which holds a thin liquid film of medical-grade perfluorocarbon on the surface. This coating prevents fibrin attachment, reduces platelet adhesion and activation, suppresses biofilm formation and is stable under blood flow in vitro. Surface-coated medical-grade tubing and catheters, assembled into arteriovenous shunts and implanted in pigs, remain patent for at least 8 h without anticoagulation. This surface-coating technology could reduce the use of anticoagulants in patients and help to prevent thrombotic occlusion and biofouling of medical devices.	[Leslie, Daniel C.; Waterhouse, Anna; Berthet, Julia B.; Valentin, Thomas M.; Watters, Alexander L.; Jain, Abhishek; Kim, Philseok; Hatton, Benjamin D.; Super, Elana H.; Howell, Caitlin; Johnson, Christopher P.; Vu, Thy L.; Bolgen, Dana E.; Rifai, Sami; Aizenberg, Michael; Super, Michael; Aizenberg, Joanna; Ingber, Donald E.] Harvard Univ, Wyss Inst Biologically Inspired Engn, Boston, MA 02115 USA; [Leslie, Daniel C.; Kim, Philseok; Hatton, Benjamin D.; Howell, Caitlin; Johnson, Christopher P.; Vu, Thy L.; Aizenberg, Joanna; Ingber, Donald E.] Harvard Univ, Sch Engn & Appl Sci, Cambridge, MA 02138 USA; [Leslie, Daniel C.; Waterhouse, Anna; Berthet, Julia B.; Valentin, Thomas M.; Watters, Alexander L.; Jain, Abhishek; Hansen, Anne R.; Super, Michael; Ingber, Donald E.] Harvard Univ, Sch Med, Boston, MA USA; [Leslie, Daniel C.; Jain, Abhishek; Super, Michael; Ingber, Donald E.] Boston Childrens Hosp, Vasc Biol Program, Boston, MA USA; [Waterhouse, Anna; Berthet, Julia B.; Hansen, Anne R.] Boston Childrens Hosp, Div Newborn Med, Boston, MA USA; [Nedder, Arthur; Donovan, Kathryn] Boston Childrens Hosp, Boston, MA USA; [Aizenberg, Joanna] Harvard Univ, Dept Chem & Biol Chem, Boston, MA 02115 USA	Harvard University; Harvard University; Harvard University; Harvard Medical School; Harvard University; Boston Children's Hospital; Harvard University; Boston Children's Hospital; Harvard University; Boston Children's Hospital; Harvard University	Ingber, DE (corresponding author), Harvard Univ, Wyss Inst Biologically Inspired Engn, Boston, MA 02115 USA.	don.ingber@wyss.harvard.edu	Waterhouse, Anna/M-1681-2018; Howell, Caitlin/E-4274-2016; Super, Michael/AAW-7952-2021; Jain, Abhishek/M-6851-2019; Leslie, Dan/AAX-9698-2020; Ingber, Donald E/AAC-5894-2019; Waterhouse, Anna/E-2464-2011; Leslie, Daniel/O-1680-2014	Howell, Caitlin/0000-0002-9345-6642; Jain, Abhishek/0000-0003-2235-5139; Waterhouse, Anna/0000-0003-1498-9393; Leslie, Daniel/0000-0003-0606-792X; Hicks-Berthet, Julia/0000-0002-6549-8116; Aizenberg, Michael/0000-0002-2901-7012	Defense Advanced Research Projects Agency [N66001-11-1-4180, HR0011-13-C-0025]; Wyss Institute for Biologically Inspired Engineering at Harvard University; National Science Foundation [ECS-0335765]	Defense Advanced Research Projects Agency(United States Department of DefenseDefense Advanced Research Projects Agency (DARPA)); Wyss Institute for Biologically Inspired Engineering at Harvard University; National Science Foundation(National Science Foundation (NSF))	This work was supported by Defense Advanced Research Projects Agency grant N66001-11-1-4180 and contract HR0011-13-C-0025, and the Wyss Institute for Biologically Inspired Engineering at Harvard University. We thank D. Super, R. Cooper, E. Murray and J. Lee for phlebotomy, T. Ferrante for assistance with fluorescence microscopy, H. Kozakewich for assistance with histology evaluation and O. Ahanotu for assistance in preparing surfaces. Scanning electron microscopy and X-ray photoelectron spectroscopy were conducted at the Center for Nanoscale Systems at Harvard University, a member of the National Nanotechnology Infrastructure Network, which is supported by the National Science Foundation (ECS-0335765).	Amarnath LP, 2006, BIOMATERIALS, V27, P1416, DOI 10.1016/j.biomaterials.2005.08.008; Bannan S, 1997, ANN THORAC SURG, V63, P663, DOI 10.1016/S0003-4975(96)01054-5; Bohn HF, 2004, P NATL ACAD SCI USA, V101, P14138, DOI 10.1073/pnas.0405885101; Canaud B, 2005, J AM SOC NEPHROL, V16, P1819, DOI 10.1681/ASN.2004050361; Castro CI, 2010, ARTIF ORGANS, V34, P622, DOI 10.1111/j.1525-1594.2009.00944.x; CLARK LC, 1966, SCIENCE, V152, P1755, DOI 10.1126/science.152.3730.1755; CLARK LC, 1973, SCIENCE, V181, P680, DOI 10.1126/science.181.4100.680; Conn G, 2006, EXPERT REV MED DEVIC, V3, P245, DOI 10.1586/17434440.3.2.245; Cronin RE, 2010, SEMIN DIALYSIS, V23, P510, DOI 10.1111/j.1525-139X.2010.00770.x; Epstein AK, 2012, P NATL ACAD SCI USA, V109, P13182, DOI 10.1073/pnas.1201973109; Finkel KW, 2009, SEMIN DIALYSIS, V22, P155, DOI 10.1111/j.1525-139X.2008.00550.x; GOULD SA, 1986, NEW ENGL J MED, V314, P1653, DOI 10.1056/NEJM198606263142601; HARTMANN RC, 1952, J CLIN INVEST, V31, P685, DOI 10.1172/JCI102650; Kim P, 2013, NANO LETT, V13, P1793, DOI 10.1021/nl4003969; Kutay V, 2006, J CARDIAC SURG, V21, P572, DOI 10.1111/j.1540-8191.2006.00298.x; LARM O, 1983, BIOMATER ARTIF CELL, V11, P161, DOI 10.3109/10731198309118804; Liu F., 2011, COMPREHENSIVE BIOMAT; Lobato RL, 2010, J THORAC CARDIOV SUR, V139, P1665, DOI 10.1016/j.jtcvs.2010.02.038; McCarthy PM, 2002, SCIENCE, V295, P998, DOI 10.1126/science.1068555; Nilsson J, 2012, INTERACT CARDIOV TH, V15, P834, DOI 10.1093/icvts/ivs345; NILSSON L, 1990, ARTIF ORGANS, V14, P46; Palanzo DA, 2001, PERFUSION-UK, V16, P279, DOI 10.1177/026765910101600403; PEPPAS NA, 1994, SCIENCE, V263, P1715, DOI 10.1126/science.8134835; RATNER BD, 1995, BIOSENS BIOELECTRON, V10, P797, DOI 10.1016/0956-5663(95)99218-A; Reser D, 2012, PERFUSION-UK, V27, P530, DOI 10.1177/0267659112454558; Schroder K, 2001, CONTRIB PLASM PHYS, V41, P562, DOI 10.1002/1521-3986(200111)41:6<562::AID-CTPP562>3.0.CO;2-Y; Shen JI, 2013, NEPHROL DIAL TRANSPL, V28, P1589, DOI 10.1093/ndt/gft067; Shepherd G, 2012, ANN PHARMACOTHER, V46, P169, DOI 10.1345/aph.1P592; Smith RS, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3004120; Stark AY, 2013, P NATL ACAD SCI USA, V110, P6340, DOI 10.1073/pnas.1219317110; Strobel M, 1994, PLASMA SURFACE MODIF; Suhara H, 2001, ANN THORAC SURG, V71, P1603, DOI 10.1016/S0003-4975(01)02466-3; Tevaearai HT, 1999, INT J ARTIF ORGANS, V22, P629, DOI 10.1177/039139889902200907; Thiara AS, 2010, PERFUSION-UK, V25, P9, DOI 10.1177/0267659110362822; Toes GJ, 2002, BIOMATERIALS, V23, P255, DOI 10.1016/S0142-9612(01)00103-X; Vogel N, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3176; VONSEGESSER LK, 1994, ANN THORAC SURG, V58, P391; Werner C, 2007, J MATER CHEM, V17, P3376, DOI 10.1039/b703416b; Wong TS, 2011, NATURE, V477, P443, DOI 10.1038/nature10447; Zhang Z, 2013, LAB CHIP, V13, P1963, DOI 10.1039/c3lc50302j	40	451	468	45	648	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1087-0156	1546-1696		NAT BIOTECHNOL	Nat. Biotechnol.	NOV	2014	32	11					1134	1140		10.1038/nbt.3020	http://dx.doi.org/10.1038/nbt.3020			7	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	AT5IL	25306244	Green Submitted			2022-12-27	WOS:000344977000018
J	Wang, YP; Cheng, X; Shan, QW; Zhang, Y; Liu, JX; Gao, CX; Qiu, JL				Wang, Yanpeng; Cheng, Xi; Shan, Qiwei; Zhang, Yi; Liu, Jinxing; Gao, Caixia; Qiu, Jin-Long			Simultaneous editing of three homoeoalleles in hexaploid bread wheat confers heritable resistance to powdery mildew	NATURE BIOTECHNOLOGY			English	Article							ZINC-FINGER NUCLEASES; TARGETED MUTAGENESIS; PLANTS; GENE; ARABIDOPSIS; SYSTEM; SPECIFICITY; EFFECTORS; TALEN; RICE	Sequence-specific nucleases have been applied to engineer targeted modifications in polyploid genomes(1), but simultaneous modification of multiple homoeoalleles has not been reported. Here we use transcription activator like effector nuclease (TALEN)(2,3) and clustered, regularly interspaced, short palindromic repeats (CRISPR)-Cas9 (refs. 4,5) technologies in hexaploid bread wheat to introduce targeted mutations in the three homoeoalleles that encode MILDEW-RESISTANCE LOCUS (MLO) proteins(6). Genetic redundancy has prevented evaluation of whether mutation of all three MLO alleles in bread wheat might confer resistance to powdery mildew, a trait not found in natural populations(7). We show that TALEN-induced mutation of all three TaMLO homoeologs in the same plant confers heritable broad-spectrum resistance to powdery mildew. We further use CRISPR-Cas9 technology to generate transgenic wheat plants that carry mutations in the TaMLO-A1 allele. We also demonstrate the feasibility of engineering targeted DNA insertion in bread wheat through nonhomologous end joining of the double-strand breaks caused by TALENs. Our findings provide a methodological framework to improve polyploid crops.	[Wang, Yanpeng; Shan, Qiwei; Zhang, Yi; Liu, Jinxing; Gao, Caixia] Chinese Acad Sci, Inst Genet & Dev Biol, State Key Lab Plant Cell & Chromosome Engn, Beijing, Peoples R China; [Cheng, Xi; Qiu, Jin-Long] Chinese Acad Sci, Inst Microbiol, State Key Lab Plant Genom, Beijing, Peoples R China	Chinese Academy of Sciences; Institute of Genetics & Developmental Biology, CAS; Chinese Academy of Sciences; Institute of Microbiology, CAS	Gao, CX (corresponding author), Chinese Acad Sci, Inst Genet & Dev Biol, State Key Lab Plant Cell & Chromosome Engn, Beijing, Peoples R China.	cxgao@genetics.ac.cn; qiujl@im.ac.cn	Gao, Caixia/AAG-8577-2019; Wang, Yanpeng/ABE-8732-2020	Gao, Caixia/0000-0003-3169-8248; Zhang, Yi/0000-0002-0745-3497; Qiu, Jin-Long/0000-0001-8054-2552	Strategic Priority Research Program of the Chinese Academy of Sciences [XDB11030500]; National Basic Research Program of China (973 Program) [2011CB100702]; National Natural Science Foundation of China [31271795]	Strategic Priority Research Program of the Chinese Academy of Sciences(Chinese Academy of Sciences); National Basic Research Program of China (973 Program)(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	We thank D. Wang for critical reading of the manuscript and providing the E22 and B13 strains, Q. Shen for providing E09 strain, and T. Li for technical support in flow cytometry (all three are at the Institute of Genetics and Developmental Biology, Chinese Academy of Sciences). This work was supported by grants from the Strategic Priority Research Program of the Chinese Academy of Sciences (XDB11030500) and the National Basic Research Program of China (973 Program, 2011CB100702) to J.-L.Q. and a grant to C.G. from the National Natural Science Foundation of China (31271795).	Bai YL, 2008, MOL PLANT MICROBE IN, V21, P30, DOI 10.1094/MPMI-21-1-0030; Bibikova M, 2003, SCIENCE, V300, P764, DOI 10.1126/science.1079512; Boch J, 2009, SCIENCE, V326, P1509, DOI 10.1126/science.1178811; Buschges R, 1997, CELL, V88, P695, DOI 10.1016/S0092-8674(00)81912-1; Cermak T, 2011, NUCLEIC ACIDS RES, V39, DOI 10.1093/nar/gkr218; Christensen AH, 1996, TRANSGENIC RES, V5, P213, DOI 10.1007/BF01969712; Christian M, 2013, G3-GENES GENOM GENET, V3, P1697, DOI 10.1534/g3.113.007104; Cong L, 2013, SCIENCE, V339, P819, DOI 10.1126/science.1231143; Consonni C, 2006, NAT GENET, V38, P716, DOI 10.1038/ng1806; Dvorak J, 2009, PLANT GENET GENOMICS, V7, P685, DOI 10.1007/978-0-387-77489-3_23; Elliott C, 2002, MOL PLANT MICROBE IN, V15, P1069, DOI 10.1094/MPMI.2002.15.10.1069; Feng ZY, 2014, P NATL ACAD SCI USA, V111, P4632, DOI 10.1073/pnas.1400822111; Feng ZY, 2013, CELL RES, V23, P1229, DOI 10.1038/cr.2013.114; Kim H, 2014, NAT REV GENET, V15, P321, DOI 10.1038/nrg3686; Li T, 2012, NAT BIOTECHNOL, V30, P390, DOI 10.1038/nbt.2199; Mali P, 2013, SCIENCE, V339, P823, DOI 10.1126/science.1232033; McDonald BA, 2002, ANNU REV PHYTOPATHOL, V40, P349, DOI 10.1146/annurev.phyto.40.120501.101443; Moscou MJ, 2009, SCIENCE, V326, P1501, DOI 10.1126/science.1178817; Piffanelli P, 2004, NATURE, V430, P887, DOI 10.1038/nature02781; Shan QW, 2013, NAT BIOTECHNOL, V31, P686, DOI 10.1038/nbt.2650; Shan QW, 2013, MOL PLANT, V6, P1365, DOI 10.1093/mp/sss162; Slade AJ, 2005, NAT BIOTECHNOL, V23, P75, DOI 10.1038/nbt1043; Symington LS, 2011, ANNU REV GENET, V45, P247, DOI 10.1146/annurev-genet-110410-132435; Varallyay E, 2012, ARCH VIROL, V157, P1345, DOI 10.1007/s00705-012-1286-y; Voytas DF, 2014, PLOS BIOL, V12, DOI 10.1371/journal.pbio.1001877; Xie KB, 2013, MOL PLANT, V6, P1975, DOI 10.1093/mp/sst119; Zhang F, 2010, P NATL ACAD SCI USA, V107, P12028, DOI 10.1073/pnas.0914991107	27	1018	1176	44	795	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156	1546-1696		NAT BIOTECHNOL	Nat. Biotechnol.	SEP	2014	32	9					947	951		10.1038/nbt.2969	http://dx.doi.org/10.1038/nbt.2969			5	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	AQ2FD	25038773				2022-12-27	WOS:000342600300035
J	Nasto, B				Nasto, Barbara			Biotech patents surge from institutions off the beaten track	NATURE BIOTECHNOLOGY			English	News Item																		2011, NAT BIOTECHNOL, V29, P953	1	0	0	0	0	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156	1546-1696		NAT BIOTECHNOL	Nat. Biotechnol.	AUG	2014	32	8					708	708		10.1038/nbt0814-708	http://dx.doi.org/10.1038/nbt0814-708			1	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	AW7PF	25101730	Bronze			2022-12-27	WOS:000346455900034
J	Cadwell, CR; Palasantza, A; Jiang, XL; Berens, P; Deng, QL; Yilmaz, M; Reimer, J; Shen, S; Bethge, M; Tolias, KF; Sandberg, R; Tolias, AS				Cadwell, Cathryn R.; Palasantza, Athanasia; Jiang, Xiaolong; Berens, Philipp; Deng, Qiaolin; Yilmaz, Marlene; Reimer, Jacob; Shen, Shan; Bethge, Matthias; Tolias, Kimberley F.; Sandberg, Rickard; Tolias, Andreas S.			Electrophysiological, transcriptomic and morphologic profiling of single neurons using Patch-seq	NATURE BIOTECHNOLOGY			English	Article							CELL RNA-SEQ; CLAMP ANALYSIS; CORTICAL INTERNEURONS; EXCITATORY SYNAPSE; CEREBRAL-CORTEX; RT-PCR; EXPRESSION; MOUSE; SMART-SEQ2; DIVERSITY	Despite the importance of the mammalian neocortex for complex cognitive processes, we still lack a comprehensive description of its cellular components. To improve the classification of neuronal cell types and the functional characterization of single neurons, we present Patch-seq, a method that combines whole-cell electrophysiological patch-clamp recordings, single-cell RNA-sequencing and morphological characterization. Following electrophysiological characterization, cell contents are aspirated through the patch-clamp pipette and prepared for RNA-sequencing. Using this approach, we generate electrophysiological and molecular profiles of 58 neocortical cells and show that gene expression patterns can be used to infer the morphological and physiological properties such as axonal arborization and action potential amplitude of individual neurons. Our results shed light on the molecular underpinnings of neuronal diversity and suggest that Patch-seq can facilitate the classification of cell types in the nervous system.	[Cadwell, Cathryn R.; Jiang, Xiaolong; Berens, Philipp; Reimer, Jacob; Shen, Shan; Tolias, Kimberley F.; Tolias, Andreas S.] Baylor Coll Med, Dept Neurosci, Houston, TX 77030 USA; [Palasantza, Athanasia; Deng, Qiaolin; Yilmaz, Marlene; Sandberg, Rickard] Karolinska Inst, Dept Cell & Mol Biol, Stockholm, Sweden; [Palasantza, Athanasia; Deng, Qiaolin; Yilmaz, Marlene; Sandberg, Rickard] Ludwig Inst Canc Res, S-10401 Stockholm, Sweden; [Berens, Philipp; Bethge, Matthias; Tolias, Andreas S.] Bernstein Ctr Computat Neurosci, Tubingen, Germany; [Berens, Philipp] Univ Tubingen, Inst Ophthalm Res, Tubingen, Germany; [Berens, Philipp; Bethge, Matthias] Univ Tubingen, Werner Reichardt Ctr Integrat Neurosci, Tubingen, Germany; [Berens, Philipp; Bethge, Matthias] Univ Tubingen, Inst Theoret Phys, Tubingen, Germany; [Bethge, Matthias] Max Planck Inst Biol Cybernet, Spemannstr 38, D-72076 Tubingen, Germany; [Tolias, Kimberley F.] Baylor Coll Med, Verna & Marrs McLean Dept Biochem & Mol Biol, Houston, TX 77030 USA	Baylor College of Medicine; Karolinska Institutet; Ludwig Institute for Cancer Research; Eberhard Karls University of Tubingen; Eberhard Karls University Hospital; Eberhard Karls University of Tubingen; Eberhard Karls University of Tubingen; Max Planck Society; Baylor College of Medicine	Tolias, AS (corresponding author), Baylor Coll Med, Dept Neurosci, Houston, TX 77030 USA.; Sandberg, R (corresponding author), Karolinska Inst, Dept Cell & Mol Biol, Stockholm, Sweden.; Sandberg, R (corresponding author), Ludwig Inst Canc Res, S-10401 Stockholm, Sweden.; Tolias, AS (corresponding author), Bernstein Ctr Computat Neurosci, Tubingen, Germany.	rickard.sandberg@ki.se; astolias@bcm.edu	Deng, Qiaolin/AAD-6905-2020; Berens, Philipp/A-5653-2009; Cadwell, Cathryn/AAD-7800-2022	Berens, Philipp/0000-0002-0199-4727; Deng, Qiaolin/0000-0001-5934-7816; Cadwell, Cathryn/0000-0003-1963-8285; Shen, Shan/0000-0002-9621-0314; Sandberg, Rickard/0000-0001-6473-1740; Tolias, Kimberley/0000-0002-2092-920X	Swedish Research Council; Swedish Foundation for Strategic Research [FFL4]; McKnight Scholar Award; Arnold and Mabel Beckman Foundation Young Investigator Award; Deutsche Forschungsgemeinschaft (DFG) [EXC 307]; German Federal Ministry of Education and Research (BMBF; BCCN Tubingen) [FKZ 01GQ1002];  [DP1EY023176];  [P30EY002520];  [T32EY07001];  [DP1OD008301];  [R01MH103108];  [F30MH095440];  [T32GM007330];  [T32EB006350];  [R01NS062829]; NATIONAL EYE INSTITUTE [T32EY007001, P30EY002520] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [T32EB006350] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007330] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [F30MH095440, R01MH103108] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS062829] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [DP1OD008301] Funding Source: NIH RePORTER	Swedish Research Council(Swedish Research CouncilEuropean Commission); Swedish Foundation for Strategic Research(Swedish Foundation for Strategic Research); McKnight Scholar Award; Arnold and Mabel Beckman Foundation Young Investigator Award; Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG)); German Federal Ministry of Education and Research (BMBF; BCCN Tubingen)(Federal Ministry of Education & Research (BMBF)); ; ; ; ; ; ; ; ; ; NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	We thank A. Morgan for technical assistance. This study was supported by grants DP1EY023176, P30EY002520, T32EY07001, and DP1OD008301 to A.S.T.; grants from the Swedish Research Council and the Swedish Foundation for Strategic Research (FFL4) to R.S.; grant R01MH103108 to A.S.T. and K.F.T.; grant R01NS062829 to K.F.T.; the McKnight Scholar Award to A.S.T.; and the Arnold and Mabel Beckman Foundation Young Investigator Award to A.S.T. C.R.C. was supported by grants F30MH095440, T32GM007330 and T32EB006350. M.B. and P.B. were supported by the Deutsche Forschungsgemeinschaft (DFG, EXC 307) and the German Federal Ministry of Education and Research (BMBF; BCCN Tubingen, FKZ 01GQ1002).	Alcantara S, 1998, J NEUROSCI, V18, P7779; Ascoli GA, 2008, NAT REV NEUROSCI, V9, P557, DOI 10.1038/nrn2402; BIGNAMI A, 1972, BRAIN RES, V43, P429, DOI 10.1016/0006-8993(72)90398-8; Brennecke P, 2013, NAT METHODS, V10, P1093, DOI [10.1038/nmeth.2645, 10.1038/NMETH.2645]; Brose N, 2008, TRAFFIC, V9, P1403, DOI 10.1111/j.1600-0854.2008.00758.x; Burkhalter A, 2008, FRONT NEUROSCI-SWITZ, V2, P155, DOI 10.3389/neuro.01.026.2008; Chan CH, 2001, CEREB CORTEX, V11, P1191, DOI 10.1093/cercor/11.12.1191; Chao HT, 2010, NATURE, V468, P263, DOI 10.1038/nature09582; Clopper CJ, 1934, BIOMETRIKA, V26, P404, DOI 10.2307/2331986; CONNORS BW, 1990, TRENDS NEUROSCI, V13, P99, DOI 10.1016/0166-2236(90)90185-D; Darmanis S, 2015, P NATL ACAD SCI USA, V112, P7285, DOI 10.1073/pnas.1507125112; Dobin A, 2013, BIOINFORMATICS, V29, P15, DOI 10.1093/bioinformatics/bts635; Fishell G, 2013, NEURON, V80, P602, DOI 10.1016/j.neuron.2013.10.035; Fremeau RT, 2001, NEURON, V31, P247, DOI 10.1016/S0896-6273(01)00344-0; Friedman J, 2010, J STAT SOFTW, V33, P1, DOI 10.18637/jss.v033.i01; Jaitin DA, 2014, SCIENCE, V343, P776, DOI 10.1126/science.1247651; Jiang XL, 2015, SCIENCE, V350, DOI 10.1126/science.aac9462; Jiang XL, 2013, NAT NEUROSCI, V16, P210, DOI 10.1038/nn.3305; Kalashnikova E, 2010, NEURON, V65, P80, DOI 10.1016/j.neuron.2009.12.021; Kharchenko PV, 2014, NAT METHODS, V11, P740, DOI [10.1038/NMETH.2967, 10.1038/nmeth.2967]; Lin L, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3270; Ma J, 2014, CEREB CORTEX, V24, P2604, DOI 10.1093/cercor/bht114; Macintyre G, 2010, SCHIZOPHR RES, V120, P143, DOI 10.1016/j.schres.2010.04.002; MARSHAK DR, 1990, PROG BRAIN RES, V86, P169; McGinley MJ, 2015, NEURON, V87, P1143, DOI 10.1016/j.neuron.2015.09.012; Miyoshi G, 2010, J NEUROSCI, V30, P1582, DOI 10.1523/JNEUROSCI.4515-09.2010; NEHER E, 1976, NATURE, V260, P799, DOI 10.1038/260799a0; Olah S, 2009, NATURE, V461, P1278, DOI 10.1038/nature08503; Picelli S, 2014, GENOME RES, V24, P2033, DOI 10.1101/gr.177881.114; Picelli S, 2014, NAT PROTOC, V9, P171, DOI 10.1038/nprot.2014.006; Picelli S, 2013, NAT METHODS, V10, P1096, DOI [10.1038/nmeth.2639, 10.1038/NMETH.2639]; Qiu Shenfeng, 2012, Frontiers in Genetics, V3, P124, DOI 10.3389/fgene.2012.00124; Ramon y Cajal S., 2002, TEXTURE NERVOUS SYST; Ramskold D, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000598; Sandberg R, 2014, NAT METHODS, V11, P22, DOI 10.1038/nmeth.2764; Stanco A, 2014, NEURON, V84, P940, DOI 10.1016/j.neuron.2014.10.040; Stuhmer T, 2002, DEVELOPMENT, V129, P245; Subkhankulova T, 2010, FRONT MOL NEUROSCI, V3, DOI 10.3389/fnmol.2010.00010; SUCHER NJ, 1995, NEURON, V14, P1095, DOI 10.1016/0896-6273(95)90257-0; Sucher NJ, 2000, CELL TISSUE RES, V302, P295, DOI 10.1007/s004410000289; Tang FC, 2009, NAT METHODS, V6, P377, DOI [10.1038/NMETH.1315, 10.1038/nmeth.1315]; Ting JT, 2014, METHODS MOL BIOL, V1183, P221, DOI 10.1007/978-1-4939-1096-0_14; Toledo-Rodriguez M, 2014, METHODS MOL BIOL, V1183, P143, DOI 10.1007/978-1-4939-1096-0_8; Zeisel A, 2015, SCIENCE, V347, P1138, DOI 10.1126/science.aaa1934	44	268	269	2	83	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156	1546-1696		NAT BIOTECHNOL	Nat. Biotechnol.	FEB	2016	34	2					199	+		10.1038/nbt.3445	http://dx.doi.org/10.1038/nbt.3445			8	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	DD0OK	26689543	Green Accepted			2022-12-27	WOS:000369619100023
J	Kessel, M; Masella, R				Kessel, Mark; Masella, Robert			Preparing for crises	NATURE BIOTECHNOLOGY			English	Editorial Material									[Kessel, Mark; Masella, Robert] Shearman & Sterling LLP, New York, NY USA		Kessel, M (corresponding author), Shearman & Sterling LLP, New York, NY USA.	mark.kessel@shearman.com							0	0	0	0	1	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156	1546-1696		NAT BIOTECHNOL	Nat. Biotechnol.	FEB	2016	34	2					133	136		10.1038/nbt.3475	http://dx.doi.org/10.1038/nbt.3475			4	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	DD0OK	26849512	Bronze			2022-12-27	WOS:000369619100009
J	Schmidt, A; Kochanowski, K; Vedelaar, S; Ahrne, E; Volkmer, B; Callipo, L; Knoops, K; Bauer, M; Aebersold, R; Heinemann, M				Schmidt, Alexander; Kochanowski, Karl; Vedelaar, Silke; Ahrne, Erik; Volkmer, Benjamin; Callipo, Luciano; Knoops, Kevin; Bauer, Manuel; Aebersold, Ruedi; Heinemann, Matthias			The quantitative and condition-dependent Escherichia coli proteome	NATURE BIOTECHNOLOGY			English	Article							EVOLUTIONARY CONSERVATION; GROWTH; ACETYLATION; PROTEINS; REVEALS; PHOSPHOPROTEOME; QUANTIFICATION; IDENTIFICATION; COVERAGE; DATABASE	Measuring precise concentrations of proteins can provide insights into biological processes. Here we use efficient protein extraction and sample fractionation, as well as state-of-the-art quantitative mass spectrometry techniques to generate a comprehensive, condition-dependent protein-abundance map for Escherichia coli. We measure cellular protein concentrations for 55% of predicted E. coli genes (>2,300 proteins) under 22 different experimental conditions and identify methylation and N-terminal protein acetylations previously not known to be prevalent in bacteria. We uncover system-wide proteome allocation, expression regulation and post-translational adaptations. These data provide a valuable resource for the systems biology and broader E. coli research communities.	[Schmidt, Alexander; Ahrne, Erik; Bauer, Manuel] Univ Basel, Biozentrum, Basel, Switzerland; [Kochanowski, Karl; Volkmer, Benjamin; Callipo, Luciano; Aebersold, Ruedi; Heinemann, Matthias] Swiss Fed Inst Technol, Inst Mol Syst Biol, Zurich, Switzerland; [Vedelaar, Silke; Heinemann, Matthias] Univ Groningen, Groningen Biomol Sci & Biotechnol Inst, Mol Syst Biol, Groningen, Netherlands; [Knoops, Kevin] Univ Groningen, Groningen Biomol Sci & Biotechnol Inst, Mol Cell Biol, Groningen, Netherlands; [Aebersold, Ruedi] Univ Zurich, Fac Sci, Zurich, Switzerland	University of Basel; Swiss Federal Institutes of Technology Domain; ETH Zurich; University of Groningen; University of Groningen; University of Zurich	Schmidt, A (corresponding author), Univ Basel, Biozentrum, Basel, Switzerland.	alex.schmidt@unibas.ch; m.heinemann@rug.nl	Kochanowski, Karl/ABE-7236-2021; Knoops, Kèvin/F-6247-2012; Heinemann, Matthias/B-9421-2008	Heinemann, Matthias/0000-0002-5512-9077; Knoops, Kevin/0000-0002-7539-1160; Volkmer, Benjamin/0000-0002-9945-9772	Netherlands Organisation for Scientific Research (NWO) (VIDI grant) [864.11.001]; Dupont (Dupont Young Professorship Award); Swiss National Science Foundation [31003A_132428/1]; Commission of the European Communities through the PROSPECTS consortium (EU FP7 project) [201648]; PROMYS consortium (EU H2020 project) [613745]; Marie Curie Intra-European Fellowship (IEF) [330150]; European Research Council [ERC-2008-AdG 233226]	Netherlands Organisation for Scientific Research (NWO) (VIDI grant)(Netherlands Organization for Scientific Research (NWO)); Dupont (Dupont Young Professorship Award); Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Commission of the European Communities through the PROSPECTS consortium (EU FP7 project); PROMYS consortium (EU H2020 project); Marie Curie Intra-European Fellowship (IEF)(European Commission); European Research Council(European Research Council (ERC)European Commission)	Funding is acknowledged from the Netherlands Organisation for Scientific Research (NWO) (VIDI grant 864.11.001 to M.H.), Dupont (Dupont Young Professorship Award to M.H.), the Swiss National Science Foundation (31003A_132428/1 to M.B.) and the Commission of the European Communities through the PROSPECTS consortium (EU FP7 project 201648) (R.A.), the PROMYS consortium (EU H2020 project 613745) (M.H.) and for a Marie Curie Intra-European Fellowship (IEF) grant (330150) (K. Knoops) and the European Research Council (ERC-2008-AdG 233226) (R.A.) Further, the authors would like to thank J. Radzikowski for performing a number of experiments. We also like to thank D. Bumann and S. Marguerat for critical reading of the manuscript.	Ahrne E, 2013, PROTEOMICS, V13, P2567, DOI 10.1002/pmic.201300135; Ahrne E, 2011, J PROTEOME RES, V10, P2913, DOI 10.1021/pr200152g; Ahrne E, 2010, PROTEOMICS, V10, P671, DOI 10.1002/pmic.200900502; Aidelberg G, 2014, BMC SYST BIOL, V8, DOI 10.1186/s12918-014-0133-z; Akhtar MK, 2009, METAB ENG, V11, P139, DOI 10.1016/j.ymben.2009.01.002; Apweiler R, 2004, NUCLEIC ACIDS RES, V32, pD115, DOI 10.1093/nar/gkh131; Baba T, 2006, MOL SYST BIOL, V2, DOI 10.1038/msb4100050; Beck M, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.82; Blattner FR, 1997, SCIENCE, V277, P1453, DOI 10.1126/science.277.5331.1453; Bonissone S, 2013, MOL CELL PROTEOMICS, V12, P14, DOI 10.1074/mcp.M112.019075; BRUNSCHEDE H, 1977, J BACTERIOL, V129, P1020, DOI 10.1128/JB.129.2.1020-1033.1977; Colak G, 2013, MOL CELL PROTEOMICS, V12, P3509, DOI 10.1074/mcp.M113.031567; DENNIS PP, 1974, J BACTERIOL, V119, P270, DOI 10.1128/JB.119.1.270-281.1974; Dorman CJ, 2009, ADV APPL MICROBIOL, V67, P47, DOI 10.1016/S0065-2164(08)01002-2; Ehrenberg M, 2013, BIOCHIMIE, V95, P643, DOI 10.1016/j.biochi.2012.11.012; Galperin MY, 2015, NUCLEIC ACIDS RES, V43, pD261, DOI 10.1093/nar/gku1223; GAUSING K, 1977, J MOL BIOL, V115, P335, DOI 10.1016/0022-2836(77)90158-9; Gillette MA, 2013, NAT METHODS, V10, P28, DOI 10.1038/nmeth.2309; Hammar P, 2012, SCIENCE, V336, P1595, DOI 10.1126/science.1221648; Hu LI, 2010, MOL MICROBIOL, V77, P15, DOI 10.1111/j.1365-2958.2010.07204.x; Ishihama Y, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-102; Ishii N, 2007, SCIENCE, V316, P593, DOI 10.1126/science.1132067; Jones JD, 2011, PROTEOMICS, V11, P3012, DOI 10.1002/pmic.201000812; KOCH AL, 1988, CAN J MICROBIOL, V34, P421, DOI 10.1139/m88-074; Krug K, 2013, MOL CELL PROTEOMICS, V12, P3420, DOI 10.1074/mcp.M113.029165; Lee MV, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.48; Li GW, 2014, CELL, V157, P624, DOI 10.1016/j.cell.2014.02.033; Macek B, 2008, MOL CELL PROTEOMICS, V7, P299, DOI 10.1074/mcp.M700311-MCP200; Maddalo G, 2011, J PROTEOME RES, V10, P1848, DOI 10.1021/pr101105c; Malmstrom J, 2009, NATURE, V460, P762, DOI 10.1038/nature08184; Marguerat S, 2012, CELL, V151, P671, DOI 10.1016/j.cell.2012.09.019; Masuda T, 2009, MOL CELL PROTEOMICS, V8, P2770, DOI 10.1074/mcp.M900240-MCP200; Picotti P, 2009, CELL, V138, P795, DOI 10.1016/j.cell.2009.05.051; Salgado H, 2013, NUCLEIC ACIDS RES, V41, pD203, DOI 10.1093/nar/gks1201; Savas JN, 2011, TRENDS BIOCHEM SCI, V36, P388, DOI 10.1016/j.tibs.2011.04.005; SCHAECHTER M, 1958, J GEN MICROBIOL, V19, P592, DOI 10.1099/00221287-19-3-592; Schmidt A, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.37; Schwanhausser B, 2011, NATURE, V473, P337, DOI 10.1038/nature10098; Scott M, 2014, MOL SYST BIOL, V10, DOI 10.15252/msb.20145379; Shahab N, 1996, MICROBIOL-SGM, V142, P1927, DOI 10.1099/13500872-142-8-1927; Smith VF, 1996, PROTEIN SCI, V5, P488; Soares NC, 2013, J PROTEOME RES, V12, P2611, DOI 10.1021/pr3011843; Soppa J, 2010, ARCHAEA, V2010, DOI 10.1155/2010/820681; Soupene E, 2003, J BACTERIOL, V185, P5611, DOI 10.1128/JB.185.18.5611-5626.2003; STOUTHAMER AH, 1973, A VAN LEEUW J MICROB, V39, P545, DOI 10.1007/BF02578899; Tatusov RL, 2003, BMC BIOINFORMATICS, V4, DOI 10.1186/1471-2105-4-41; Vizcaino JA, 2013, NUCLEIC ACIDS RES, V41, pD1063, DOI 10.1093/nar/gks1262; Volkmer B, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023126; Weinert BT, 2013, MOL CELL, V51, P265, DOI 10.1016/j.molcel.2013.06.003; Wood TK, 2006, APPL MICROBIOL BIOT, V72, P361, DOI 10.1007/s00253-005-0263-8; Zhang JM, 2009, MOL CELL PROTEOMICS, V8, P215, DOI 10.1074/mcp.M800187-MCP200	51	389	391	5	149	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156	1546-1696		NAT BIOTECHNOL	Nat. Biotechnol.	JAN	2016	34	1					104	110		10.1038/nbt.3418	http://dx.doi.org/10.1038/nbt.3418			7	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	DB8HQ	26641532	Green Accepted, Green Published			2022-12-27	WOS:000368758200034
J	Garber, K				Garber, Ken			Tumor macrophage target fuels $1.7-billion deal	NATURE BIOTECHNOLOGY			English	News Item																			0	0	0	0	2	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156	1546-1696		NAT BIOTECHNOL	Nat. Biotechnol.	DEC	2015	33	12					1222	1222		10.1038/nbt1215-1222	http://dx.doi.org/10.1038/nbt1215-1222			1	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	CY4OO	26650003	Bronze			2022-12-27	WOS:000366387700007
J	Santilli, G; Thrasher, AJ				Santilli, Giorgia; Thrasher, Adrian J.			Patching up hematopoietic stem cells	NATURE BIOTECHNOLOGY			English	Editorial Material							CHRONIC GRANULOMATOUS-DISEASE; MUTATION; ANEMIA	An approach for efficient genome editing in human hematopoietic stem cells could be useful in the treatment of immunological disorders.	[Santilli, Giorgia; Thrasher, Adrian J.] UCL, Inst Child Hlth, Dept Mol & Cellular Immunol, London, England	University of London; University College London	Santilli, G (corresponding author), UCL, Inst Child Hlth, Dept Mol & Cellular Immunol, London, England.	a.thrasher@ucl.ac.uk		Thrasher, Adrian/0000-0002-6097-6115				Dreyer AK, 2015, BIOMATERIALS, V69, P191, DOI 10.1016/j.biomaterials.2015.07.057; Fares I, 2014, SCIENCE, V345, P1509, DOI 10.1126/science.1256337; Genovese P, 2014, NATURE, V510, P235, DOI 10.1038/nature13420; Hoban MD, 2015, BLOOD, V125, P2597, DOI 10.1182/blood-2014-12-615948; Merling RK, 2015, MOL THER, V23, P147, DOI 10.1038/mt.2014.195; Mussolino C, 2015, CURR OPIN PHARMACOL, V24, P105, DOI 10.1016/j.coph.2015.08.008; Rio P, 2014, EMBO MOL MED, V6, P835, DOI 10.15252/emmm.201303374; Sather BD, 2015, SCI TRANSL MED, V7, DOI 10.1126/scitranslmed.aac5530; Sebastiano V, 2011, STEM CELLS, V29, P1717, DOI 10.1002/stem.718; Tebas P, 2014, NEW ENGL J MED, V370, P901, DOI 10.1056/NEJMoa1300662; Wang JB, 2015, NAT BIOTECHNOL, V33, P1256, DOI 10.1038/nbt.3408	11	1	1	0	3	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156	1546-1696		NAT BIOTECHNOL	Nat. Biotechnol.	DEC	2015	33	12					1236	1238		10.1038/nbt.3425	http://dx.doi.org/10.1038/nbt.3425			3	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	CY4OO	26650009				2022-12-27	WOS:000366387700012
J	Royzman, I				Royzman, Irena			Biotechnology patents under fire	NATURE BIOTECHNOLOGY			English	Editorial Material									Patterson Belknap Webb & Tyler LLP, New York, NY 10036 USA		Royzman, I (corresponding author), Patterson Belknap Webb & Tyler LLP, New York, NY 10036 USA.	iroyzman@pbwt.com							0	1	1	1	10	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156	1546-1696		NAT BIOTECHNOL	Nat. Biotechnol.	SEP	2015	33	9					925	927		10.1038/nbt.3334	http://dx.doi.org/10.1038/nbt.3334			3	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	CR0EK	26348959				2022-12-27	WOS:000360990900017
J	Steinberg, D; Horwitz, G; Zohar, D				Steinberg, David; Horwitz, Geoffrey; Zohar, Daphne			Building a business model in digital medicine	NATURE BIOTECHNOLOGY			English	Article									[Steinberg, David; Horwitz, Geoffrey; Zohar, Daphne] PureTech, Boston, MA 02116 USA		Steinberg, D (corresponding author), PureTech, Boston, MA 02116 USA.	daphnenb@puretechhealth.com						[Anonymous], 2014, 4 ANN STUDY MHEALTH; [Anonymous], 2013, FORBES; Battelle Technology Partnership Practice, 2015, BIOPH IND SPONS CLIN; Chen C., 2015, GOOGLE DEV HLTH TRAC; Elenko E, 2015, NAT BIOTECHNOL, V33, P456, DOI 10.1038/nbt.3222; Fiegerman S., 2014, MASHABLE; Hay T., 2014, WALL STREET J; Makower J., 2010, FDA IMPACT US MEDICA; Moukheiber Z, 2014, FORBES; Nazar J, 2013, FORBES; Novet J., 2015, VENTUREBEAT     0624; Offf.ice of the Press Secretary, 2015, FACT SHEET PRESIDENT; Posada M, 2014, EVOLVING LANDSCAPE M; Qualcomm, 2015, QUALC ANN STRAT COLL; Quinn CC, 2011, DIABETES CARE, V34, P1934, DOI 10.2337/dc11-0366; Sepah SC, 2015, J MED INTERNET RES, V17, DOI 10.2196/jmir.4052; Tarakji KG, 2015, HEART RHYTHM, V12, P554, DOI 10.1016/j.hrthm.2014.11.015; Tufts Centre for the Study of Drug Development, 2014, BRIEF COST DEV NEW D; US Food & Drug Administration, 2010, AD DES CLIN TRIALS D; Walker Rob, 2003, NY TIMES	20	22	22	2	38	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156	1546-1696		NAT BIOTECHNOL	Nat. Biotechnol.	SEP	2015	33	9					910	920		10.1038/nbt.3339	http://dx.doi.org/10.1038/nbt.3339			11	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	CR0EK	26348957				2022-12-27	WOS:000360990900015
J	Chick, JM; Kolippakkam, D; Nusinow, DP; Zhai, B; Rad, R; Huttlin, EL; Gygi, SP				Chick, Joel M.; Kolippakkam, Deepak; Nusinow, David P.; Zhai, Bo; Rad, Ramin; Huttlin, Edward L.; Gygi, Steven P.			A mass-tolerant database search identifies a large proportion of unassigned spectra in shotgun proteomics as modified peptides	NATURE BIOTECHNOLOGY			English	Article							N-TERMINAL ACETYLTRANSFERASES; PROTEIN IDENTIFICATION; POSTTRANSLATIONAL MODIFICATIONS; SEQUENCE DATABASES; DYNAMIC-RANGE; SPECTROMETRY; ACCURACY; HYBRID; PHOSPHORYLATION; ACETYLATION	Fewer than half of all tandem mass spectrometry (MS/MS) spectra acquired in shotgun proteomics experiments are typically matched to a peptide with high confidence. Here we determine the identity of unassigned peptides using an ultra-tolerant Sequest database search that allows peptide matching even with modifications of unknown masses up to +/- 500 Da. In a proteome-wide data set on HEK293 cells (9,513 proteins and 396,736 peptides), this approach matched an additional 184,000 modified peptides, which were linked to biological and chemical modifications representing 523 distinct mass bins, including phosphorylation, glycosylation and methylation. We localized all unknown modification masses to specific regions within a peptide. Known modifications were assigned to the correct amino acids with frequencies >90%. We conclude that at least one-third of unassigned spectra arise from peptides with substoichiometric modifications.	[Chick, Joel M.; Kolippakkam, Deepak; Nusinow, David P.; Zhai, Bo; Rad, Ramin; Huttlin, Edward L.; Gygi, Steven P.] Harvard Univ, Sch Med, Dept Cell Biol, Boston, MA 02115 USA	Harvard University; Harvard Medical School	Gygi, SP (corresponding author), Harvard Univ, Sch Med, Dept Cell Biol, Boston, MA 02115 USA.	steven_gygi@hms.harvard.edu	Nusinow, David/AAJ-4284-2020	Nusinow, David/0000-0002-7819-5261; Huttlin, Edward/0000-0002-1822-1173	US National Institutes of Health [HG3456, GM67945]; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R01HG003456] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM067945] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank all members of S.P.G.'s lab for fruitful discussions about this work. This work was funded in part by US National Institutes of Health grants HG3456 and GM67945 to S.P.G.	Arnesen T, 2009, P NATL ACAD SCI USA, V106, P8157, DOI 10.1073/pnas.0901931106; Banerji S, 2012, NATURE, V486, P405, DOI 10.1038/nature11154; Beausoleil SA, 2006, NAT BIOTECHNOL, V24, P1285, DOI 10.1038/nbt1240; Beck M, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.82; Bern M, 2007, ANAL CHEM, V79, P1393, DOI 10.1021/ac0617013; Boyne MT, 2009, J PROTEOME RES, V8, P374, DOI 10.1021/pr800635m; Choudhary C, 2009, SCIENCE, V325, P834, DOI 10.1126/science.1175371; Creasy DM, 2002, PROTEOMICS, V2, P1426, DOI 10.1002/1615-9861(200210)2:10<1426::AID-PROT1426>3.0.CO;2-5; Dasari S, 2010, J PROTEOME RES, V9, P1716, DOI 10.1021/pr900850m; Elias JE, 2007, NAT METHODS, V4, P207, DOI 10.1038/nmeth1019; ENG JK, 1994, J AM SOC MASS SPECTR, V5, P976, DOI 10.1016/1044-0305(94)80016-2; Geiger T, 2012, MOL CELL PROTEOMICS, V11, DOI 10.1074/mcp.M111.014050; Helbig AO, 2010, MOL CELL PROTEOMICS, V9, P928, DOI 10.1074/mcp.M900463-MCP200; Huttlin EL, 2010, CELL, V143, P1174, DOI 10.1016/j.cell.2010.12.001; Jones S, 2008, SCIENCE, V321, P1801, DOI 10.1126/science.1164368; Kim S, 2009, MOL CELL PROTEOMICS, V8, P53, DOI 10.1074/mcp.M800103-MCP200; Kim W, 2011, MOL CELL, V44, P325, DOI 10.1016/j.molcel.2011.08.025; Li J, 2010, HUM MUTAT, V31, P219, DOI 10.1002/humu.21176; Liu C, 2006, BIOINFORMATICS, V22, pE307, DOI 10.1093/bioinformatics/btl226; Makarov A, 2006, ANAL CHEM, V78, P2113, DOI 10.1021/ac0518811; Makarov A, 2006, J AM SOC MASS SPECTR, V17, P977, DOI 10.1016/j.jasms.2006.03.006; MANN M, 1994, ANAL CHEM, V66, P4390, DOI 10.1021/ac00096a002; MOEHRING JM, 1980, P NATL ACAD SCI-BIOL, V77, P1010, DOI 10.1073/pnas.77.2.1010; MULLEN JR, 1989, EMBO J, V8, P2067, DOI 10.1002/j.1460-2075.1989.tb03615.x; Nagaraj N, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.81; Nielsen ML, 2006, MOL CELL PROTEOMICS, V5, P2384, DOI 10.1074/mcp.M600248-MCP200; Olsen JV, 2007, NAT METHODS, V4, P709, DOI 10.1038/NMETH1060; Olsen JV, 2005, MOL CELL PROTEOMICS, V4, P2010, DOI 10.1074/mcp.T500030-MCP200; Perkins DN, 1999, ELECTROPHORESIS, V20, P3551, DOI 10.1002/(SICI)1522-2683(19991201)20:18<3551::AID-ELPS3551>3.0.CO;2-2; Polevoda B, 2003, J MOL BIOL, V325, P595, DOI 10.1016/S0022-2836(02)01269-X; Renard BY, 2012, MOL CELL PROTEOMICS, V11, DOI 10.1074/mcp.M111.014167; Savitski MM, 2006, MOL CELL PROTEOMICS, V5, P935, DOI 10.1074/mcp.T500034-MCP200; Shilov IV, 2007, MOL CELL PROTEOMICS, V6, P1638, DOI 10.1074/mcp.T600050-MCP200; Sunyaev S, 2003, ANAL CHEM, V75, P1307, DOI 10.1021/ac026199a; Tabb DL, 2003, ANAL CHEM, V75, P6415, DOI 10.1021/ac0347462; Takeuchi H, 2012, J BIOL CHEM, V287, P33934, DOI 10.1074/jbc.M112.401315; Tsur D, 2005, NAT BIOTECHNOL, V23, P1562, DOI 10.1038/nbt1168; Washburn MP, 2001, NAT BIOTECHNOL, V19, P242, DOI 10.1038/85686; WHITEHEART SW, 1989, J BIOL CHEM, V264, P14334; Wolters DA, 2001, ANAL CHEM, V73, P5683, DOI 10.1021/ac010617e; Zhang J, 2012, MOL CELL PROTEOMICS, V11, DOI [10.1074/mcp.M111.010587, 10.1074/mcp.M111.015032]; Zhang YJ, 2013, NAT METHODS, V10, P981, DOI 10.1038/nmeth.2603; Zielinska DF, 2012, MOL CELL, V46, P542, DOI 10.1016/j.molcel.2012.04.031	43	251	260	7	99	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156	1546-1696		NAT BIOTECHNOL	Nat. Biotechnol.	JUL	2015	33	7					743	749		10.1038/nbt.3267	http://dx.doi.org/10.1038/nbt.3267			7	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	CN4JJ	26076430	Green Submitted, Green Accepted			2022-12-27	WOS:000358396100030
J	Tilgner, H; Jahanbani, F; Blauwkamp, T; Moshrefi, A; Jaeger, E; Chen, F; Harel, I; Bustamante, CD; Rasmussen, M; Snyder, MP				Tilgner, Hagen; Jahanbani, Fereshteh; Blauwkamp, Tim; Moshrefi, Ali; Jaeger, Erich; Chen, Feng; Harel, Itamar; Bustamante, Carlos D.; Rasmussen, Morten; Snyder, Michael P.			Comprehensive transcriptome analysis using synthetic long-read sequencing reveals molecular co-association of distant splicing events	NATURE BIOTECHNOLOGY			English	Article							MESSENGER-RNA; HUMAN GENOME; GENE; SEQ; LANDSCAPE; GENCODE	Alternative splicing shapes mammalian transcriptomes, with many RNA molecules undergoing multiple distant alternative splicing events. Comprehensive transcriptome analysis, including analysis of exon co-association in the same molecule, requires deep, long-read sequencing. Here we introduce an RNA sequencing method, synthetic long-read RNA sequencing (SLR-RNA-seq), in which small pools (<= 1,000 molecules/pool, <= 1 molecule/gene for most genes) of full-length cDNAs are amplified, fragmented and short-read-sequenced. We demonstrate that these RNA sequences reconstructed from the short reads from each of the pools are mostly close to full length and contain few insertion and deletion errors. We report many previously undescribed isoforms (human brain: similar to 13,800 affected genes, 14.5% of molecules; mouse brain similar to 8,600 genes, 18% of molecules) and up to 165 human distant molecularly associated exon pairs (dMAPs) and distant molecularly and mutually exclusive pairs (dMEPs). Of 16 associated pairs detected in the mouse brain, 9 are conserved in human. Our results indicate conserved mechanisms that can produce distant but phased features on transcript and proteome isoforms.	[Tilgner, Hagen; Jahanbani, Fereshteh; Harel, Itamar; Bustamante, Carlos D.; Rasmussen, Morten; Snyder, Michael P.] Stanford Univ, Dept Genet, Stanford, CA 94305 USA; [Blauwkamp, Tim; Moshrefi, Ali; Jaeger, Erich; Chen, Feng] Illumina Inc, San Francisco, CA USA	Stanford University; Illumina	Snyder, MP (corresponding author), Stanford Univ, Dept Genet, Stanford, CA 94305 USA.	mpsnyder@stanford.edu		Harel, Itamar/0000-0001-9749-8279; Bustamante, Carlos D./0000-0002-4187-7920; Snyder, Michael/0000-0003-0784-7987	Danish Council for Independent Research [12-131829];  [5U01HL10739304];  [1P50HG007735-01];  [5P01GM09913004]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [U01HL107393] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [P50HG007735, U54HG006996] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P01GM099130] Funding Source: NIH RePORTER	Danish Council for Independent Research(Det Frie Forskningsrad (DFF)); ; ; ; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank N. Spies and F.A. Bava for a thorough reading of this manuscript and valuable comments and S. Shringarpure, V. Kuleshov, CS. Foo and H. Tang for valuable comments on statistics. We thank A. Brunet for providing mice and S. Munro for valuable comments on this manuscript. We also thank the Genetics Bioinformatics Service Center at Stanford for providing a well-working computing cluster. M.R. is paid by grant 12-131829 from the Danish Council for Independent Research. This work was supported by grant 5U01HL10739304 (to M.S. as co-PI), 1P50HG007735-01 (to M.S. as co-PI) and 5P01GM09913004 (to M.S.).	Au KF, 2013, P NATL ACAD SCI USA, V110, pE4821, DOI 10.1073/pnas.1320101110; Baker SC, 2005, NAT METHODS, V2, P731, DOI 10.1038/nmeth1005-731; Barash Y, 2010, NATURE, V465, P53, DOI 10.1038/nature09000; Ben-Dov C, 2008, J BIOL CHEM, V283, P1229, DOI 10.1074/jbc.R700033200; Benjamini Y, 2001, ANN STAT, V29, P1165; Bonnal S, 2012, NAT REV DRUG DISCOV, V11, P847, DOI 10.1038/nrd3823; Braunschweig U, 2014, GENOME RES, V24, P1774, DOI 10.1101/gr.177790.114; Chen JK, 2014, INT J STRUCT STAB DY, V14, DOI 10.1142/S0219455413500715; CHENG JH, 1994, SCIENCE, V263, P1759, DOI 10.1126/science.7510905; Cho HH, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0108095; Derrien T, 2012, GENOME RES, V22, P1775, DOI 10.1101/gr.132159.111; Djebali S, 2012, NATURE, V489, P101, DOI 10.1038/nature11233; Dobin A, 2013, BIOINFORMATICS, V29, P15, DOI 10.1093/bioinformatics/bts635; Dujardin G, 2013, BBA-GENE REGUL MECH, V1829, P134, DOI 10.1016/j.bbagrm.2012.08.005; Dunham I, 2012, NATURE, V489, P57, DOI 10.1038/nature11247; Duret L, 2006, SCIENCE, V312, P1653, DOI 10.1126/science.1126316; Eid J, 2009, SCIENCE, V323, P133, DOI 10.1126/science.1162986; Fagnani M, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-6-r108; Harrow J, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-s1-s4; Harrow J, 2012, GENOME RES, V22, P1760, DOI 10.1101/gr.135350.111; Johnson JM, 2003, SCIENCE, V302, P2141, DOI 10.1126/science.1090100; Karolchik D, 2014, NUCLEIC ACIDS RES, V42, pD764, DOI 10.1093/nar/gkt1168; Koren S, 2012, NAT BIOTECHNOL, V30, P692, DOI 10.1038/nbt.2280; Kornblihtt AR, 2013, NAT REV MOL CELL BIO, V14, P153, DOI 10.1038/nrm3525; Kuleshov V, 2014, NAT BIOTECHNOL, V32, P261, DOI 10.1038/nbt.2833; Lareau LF, 2007, NATURE, V446, P926, DOI 10.1038/nature05676; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Li S, 2014, NAT BIOTECHNOL, V32, P915, DOI 10.1038/nbt.2972; McCoy RC, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0106689; Modrek B, 2001, NUCLEIC ACIDS RES, V29, P2850, DOI 10.1093/nar/29.13.2850; Mortazavi A, 2008, NAT METHODS, V5, P621, DOI 10.1038/nmeth.1226; Nagalakshmi U, 2008, SCIENCE, V320, P1344, DOI 10.1126/science.1158441; Nilsen TW, 2010, NATURE, V463, P457, DOI 10.1038/nature08909; Oesterreich FC, 2010, MOL CELL, V40, P571, DOI 10.1016/j.molcel.2010.11.004; Pan Q, 2008, NAT GENET, V40, P1413, DOI 10.1038/ng.259; Sharon D, 2013, NAT BIOTECHNOL, V31, P1009, DOI 10.1038/nbt.2705; Smith CWJ, 2000, TRENDS BIOCHEM SCI, V25, P381, DOI 10.1016/S0968-0004(00)01604-2; Steijger T, 2013, NAT METHODS, V10, P1177, DOI [10.1038/nmeth.2714, 10.1038/NMETH.2714]; Sultan M, 2008, SCIENCE, V321, P956, DOI 10.1126/science.1160342; Sun SY, 2010, NAT STRUCT MOL BIOL, V17, P306, DOI 10.1038/nsmb.1750; Tilgner H, 2014, P NATL ACAD SCI USA, V111, P9869, DOI 10.1073/pnas.1400447111; Tilgner H, 2013, G3-GENES GENOM GENET, V3, P387, DOI 10.1534/g3.112.004812; Tilgner H, 2012, GENOME RES, V22, P1616, DOI 10.1101/gr.134445.111; Trapnell C, 2010, NAT BIOTECHNOL, V28, P511, DOI 10.1038/nbt.1621; Vargas DY, 2011, CELL, V147, P1054, DOI 10.1016/j.cell.2011.10.024; Wang ET, 2008, NATURE, V456, P470, DOI 10.1038/nature07509; Waterston RH, 2002, NATURE, V420, P520, DOI 10.1038/nature01262; Wilhelm BT, 2008, NATURE, V453, P1239, DOI 10.1038/nature07002; Wu TD, 2005, BIOINFORMATICS, V21, P1859, DOI 10.1093/bioinformatics/bti310	49	120	125	3	29	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156	1546-1696		NAT BIOTECHNOL	Nat. Biotechnol.	JUL	2015	33	7					736	742		10.1038/nbt.3242	http://dx.doi.org/10.1038/nbt.3242			7	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	CN4JJ	25985263	Green Accepted			2022-12-27	WOS:000358396100029
J	Hilton, IB; D'Ippolito, AM; Vockley, CM; Thakore, PI; Crawford, GE; Reddy, TE; Gersbach, CA				Hilton, Isaac B.; D'Ippolito, Anthony M.; Vockley, Christopher M.; Thakore, Pratiksha I.; Crawford, Gregory E.; Reddy, Timothy E.; Gersbach, Charles A.			Epigenome editing by a CRISPR-Cas9-based acetyltransferase activates genes from promoters and enhancers	NATURE BIOTECHNOLOGY			English	Article							FINGER TRANSCRIPTION FACTORS; ENDOGENOUS GENES; IN-VIVO; TARGETING ENHANCERS; CHROMATIN; CRISPR; CAS9; EXPRESSION; SYSTEM; CELLS	Technologies that enable targeted manipulation of epigenetic marks could be used to precisely control cell phenotype or interrogate the relationship between the epigenome and transcriptional control. Here we describe a programmable, CRISPR-Cas9-based acetyltransferase consisting of the nuclease-null dCas9 protein fused to the catalytic core of the human acetyltransferase p300. The fusion protein catalyzes acetylation of histone H3 lysine 27 at its target sites, leading to robust transcriptional activation of target genes from promoters and both proximal and distal enhancers. Gene activation by the targeted acetyltransferase was highly specific across the genome. In contrast to previous dCas9-based activators, the acetyltransferase activates genes from enhancer regions and with an individual guide RNA. We also show that the core p300 domain can be fused to other programmable DNA-binding proteins. These results support targeted acetylation as a causal mechanism of transactivation and provide a robust tool for manipulating gene regulation.	[Hilton, Isaac B.; Thakore, Pratiksha I.; Gersbach, Charles A.] Duke Univ, Dept Biomed Engn, Durham, NC 27706 USA; [Hilton, Isaac B.; D'Ippolito, Anthony M.; Vockley, Christopher M.; Thakore, Pratiksha I.; Crawford, Gregory E.; Reddy, Timothy E.; Gersbach, Charles A.] Duke Univ, Ctr Genom & Computat Biol, Durham, NC 27708 USA; [D'Ippolito, Anthony M.] Duke Univ, Med Ctr, Univ Program Genet & Genom, Durham, NC USA; [Vockley, Christopher M.] Duke Univ, Med Ctr, Dept Cell Biol, Durham, NC 27710 USA; [Crawford, Gregory E.] Duke Univ, Med Ctr, Dept Pediat, Div Med Genet, Durham, NC 27710 USA; [Reddy, Timothy E.] Duke Univ, Med Ctr, Dept Biostat & Bioinformat, Durham, NC USA; [Gersbach, Charles A.] Duke Univ, Med Ctr, Dept Orthopaed Surg, Durham, NC USA	Duke University; Duke University; Duke University; Duke University; Duke University; Duke University; Duke University	Reddy, TE (corresponding author), Duke Univ, Ctr Genom & Computat Biol, Durham, NC 27708 USA.	tim.reddy@duke.edu; charles.gersbach@duke.edu	Thakore, Pratiksha I./HDM-5197-2022; Gersbach, Charles/Y-3412-2019	Hilton, Isaac/0000-0002-3064-8532	US National Institutes of Health (NIH) grant [R01DA036865, U01HG007900]; NIH Director's New Innovator Award [DP2OD008586]; National Science Foundation (NSF) Faculty Early Career Development (CAREER) Award [CBET-1151035]; NIH [P30AR066527]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [T32HD040372] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [U01HG007900] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [P30AR066527] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007754] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA036865] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [DP2OD008586] Funding Source: NIH RePORTER	US National Institutes of Health (NIH) grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH Director's New Innovator Award(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation (NSF) Faculty Early Career Development (CAREER) Award(National Science Foundation (NSF)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	P. Perez-Pinera, D. Kocak, D. Ousterout and D. Lim provided assistance with gRNA design, plasmid cloning, PCR primer validation, and/or RNA isolations. The gene encoding the ICAM1-targeted zinc finger protein was provided by C. Barbas, III. This work was supported by a US National Institutes of Health (NIH) grants to G.E.C., C.A.G. and T.E.R. (R01DA036865 and U01HG007900), a NIH Director's New Innovator Award (DP2OD008586) and National Science Foundation (NSF) Faculty Early Career Development (CAREER) Award (CBET-1151035) to C.A.G. and NIH grant P30AR066527.	Beerli RR, 2000, P NATL ACAD SCI USA, V97, P1495, DOI 10.1073/pnas.040552697; Bernstein BE, 2010, NAT BIOTECHNOL, V28, P1045, DOI 10.1038/nbt1010-1045; Carter D, 2002, NAT GENET, V32, P623, DOI 10.1038/ng1051; Chakraborty S, 2014, STEM CELL REP, V3, P940, DOI 10.1016/j.stemcr.2014.09.013; Chavez A, 2015, NAT METHODS, V12, P326, DOI [10.1038/nmeth.3312, 10.1038/NMETH.3312]; Chen JCJ, 2001, DEV DYNAM, V221, P274, DOI 10.1002/dvdy.1138; Chen JH, 2011, EPIGENETICS-US, V6, P957, DOI 10.4161/epi.6.8.16065; Chen LF, 2002, EMBO J, V21, P6539, DOI 10.1093/emboj/cdf660; Cheng AW, 2013, CELL RES, V23, P1163, DOI 10.1038/cr.2013.122; CHOY B, 1993, NATURE, V366, P531, DOI 10.1038/366531a0; Cong L, 2013, SCIENCE, V339, P819, DOI 10.1126/science.1231143; Delvecchio M, 2013, NAT STRUCT MOL BIOL, V20, P1040, DOI 10.1038/nsmb.2642; Deng WL, 2014, CELL, V158, P849, DOI 10.1016/j.cell.2014.05.050; Doench JG, 2014, NAT BIOTECHNOL, V32, P1262, DOI 10.1038/nbt.3026; Doudna JA, 2014, SCIENCE, V346, P1077, DOI 10.1126/science.1258096; Dunham I, 2012, NATURE, V489, P57, DOI 10.1038/nature11247; Esvelt KM, 2013, NAT METHODS, V10, P1116, DOI [10.1038/NMETH.2681, 10.1038/nmeth.2681]; Farzadfard F, 2013, ACS SYNTH BIOL, V2, P604, DOI 10.1021/sb400081r; Gao XF, 2014, NUCLEIC ACIDS RES, V42, DOI 10.1093/nar/gku836; Gao XF, 2013, STEM CELL REP, V1, P183, DOI 10.1016/j.stemcr.2013.06.002; Gibson DG, 2009, NAT METHODS, V6, P343, DOI [10.1038/NMETH.1318, 10.1038/nmeth.1318]; Gilbert LA, 2014, CELL, V159, P647, DOI 10.1016/j.cell.2014.09.029; Gilbert LA, 2013, CELL, V154, P442, DOI 10.1016/j.cell.2013.06.044; Hotta A, 2009, NAT METHODS, V6, P370, DOI [10.1038/NMETH.1325, 10.1038/nmeth.1325]; Hsu PD, 2014, CELL, V157, P1262, DOI 10.1016/j.cell.2014.05.010; Hu JB, 2014, NUCLEIC ACIDS RES, V42, P4375, DOI 10.1093/nar/gku109; Ji QZ, 2014, NUCLEIC ACIDS RES, V42, P6158, DOI 10.1093/nar/gku243; Jinek M, 2012, SCIENCE, V337, P816, DOI 10.1126/science.1225829; Keung AJ, 2014, CELL, V158, P110, DOI 10.1016/j.cell.2014.04.047; Kim YW, 2013, BBA-GENE REGUL MECH, V1829, P963, DOI 10.1016/j.bbagrm.2013.04.006; Konermann S, 2015, NATURE, V517, P583, DOI 10.1038/nature14136; Konermann S, 2013, NATURE, V500, P472, DOI 10.1038/nature12466; Kuscu C, 2014, NAT BIOTECHNOL, V32, P677, DOI 10.1038/nbt.2916; Langmead B, 2012, NAT METHODS, V9, P357, DOI [10.1038/NMETH.1923, 10.1038/nmeth.1923]; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Maeder ML, 2013, NAT BIOTECHNOL, V31, P1137, DOI 10.1038/nbt.2726; Maeder ML, 2013, NAT METHODS, V10, P977, DOI [10.1038/NMETH.2598, 10.1038/nmeth.2598]; Maeder ML, 2013, NAT METHODS, V10, P243, DOI [10.1038/nmeth.2366, 10.1038/NMETH.2366]; Magnenat L, 2004, J MOL BIOL, V341, P635, DOI 10.1016/j.jmb.2004.06.030; Mali P, 2013, NAT BIOTECHNOL, V31, P833, DOI 10.1038/nbt.2675; Mali P, 2013, SCIENCE, V339, P823, DOI 10.1126/science.1232033; Memedula S, 2003, CURR BIOL, V13, P241, DOI 10.1016/S0960-9822(03)00048-4; Mendenhall EM, 2013, NAT BIOTECHNOL, V31, P1133, DOI 10.1038/nbt.2701; Nordhoff V, 2001, MAMM GENOME, V12, P309, DOI 10.1007/s003350010279; Ogryzko VV, 1996, CELL, V87, P953, DOI 10.1016/S0092-8674(00)82001-2; Perez-Pinera P, 2013, NAT METHODS, V10, P973, DOI [10.1038/NMETH.2600, 10.1038/nmeth.2600]; Perez-Pinera P, 2013, NAT METHODS, V10, P239, DOI [10.1038/nmeth.2361, 10.1038/NMETH.2361]; Polstein LR, 2015, NAT CHEM BIOL, V11, P198, DOI 10.1038/nchembio.1753; Qi LS, 2013, CELL, V152, P1173, DOI 10.1016/j.cell.2013.02.022; Rada-Iglesias A, 2011, NATURE, V470, P279, DOI 10.1038/nature09692; Rivenbark AG, 2012, EPIGENETICS-US, V7, P350, DOI 10.4161/epi.19507; Schmittgen TD, 2008, NAT PROTOC, V3, P1101, DOI 10.1038/nprot.2008.73; Snowden AW, 2002, CURR BIOL, V12, P2159, DOI 10.1016/S0960-9822(02)01391-X; Su MY, 2013, J BIOL CHEM, V288, P8433, DOI 10.1074/jbc.M112.413260; Tanenbaum ME, 2014, CELL, V159, P635, DOI 10.1016/j.cell.2014.09.039; Visel A, 2009, NATURE, V457, P854, DOI 10.1038/nature07730; Wu XB, 2014, NAT BIOTECHNOL, V32, P670, DOI 10.1038/nbt.2889; Zetsche B, 2015, NAT BIOTECHNOL, V33, P139, DOI 10.1038/nbt.3149	58	1063	1142	14	437	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156	1546-1696		NAT BIOTECHNOL	Nat. Biotechnol.	MAY	2015	33	5					510	U225		10.1038/nbt.3199	http://dx.doi.org/10.1038/nbt.3199			10	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	CH8VP	25849900	Green Accepted			2022-12-27	WOS:000354314500032
J	Sherkow, JS				Sherkow, Jacob S.			Law, history and lessons in the CRISPR patent conflict	NATURE BIOTECHNOLOGY			English	Editorial Material									New York Law Sch, Inst Informat Law & Policy, New York, NY 10013 USA		Sherkow, JS (corresponding author), New York Law Sch, Inst Informat Law & Policy, New York, NY 10013 USA.	jacob.sherkow@nyls.edu		Sherkow, Jacob/0000-0002-9724-9261				[Anonymous], 2002, Madey v. Duke University, Patent No. 2013032589; [Anonymous], 2010, USC, V35, Patent No. 20140336133; Cong L, 2013, SCIENCE, V339, P819, DOI 10.1126/science.1231143; Feldman M. P., 2007, Intellectual property management in health and agricultural innovation: a handbook of best practices, Volumes 1 and 2, P1797; Fore Joe Jr, 2006, J Biomed Discov Collab, V1, P7, DOI 10.1186/1747-5333-1-7; Jinek M, 2012, SCIENCE, V337, P816, DOI 10.1126/science.1225829; Rojahn SY, 2014, MIT TECHNOLOGY REV; Zhang F., 2014, US Patent, Patent No. [8,697,359, 8697359]	8	25	26	1	22	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156	1546-1696		NAT BIOTECHNOL	Nat. Biotechnol.	MAR	2015	33	3					256	257		10.1038/nbt.3160	http://dx.doi.org/10.1038/nbt.3160			2	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	CD0ME	25748913	Green Published			2022-12-27	WOS:000350766900018
J	Mahoney, JE; Kim, CF				Mahoney, John E.; Kim, Carla F.			Tracing the potential of lung progenitors	NATURE BIOTECHNOLOGY			English	Editorial Material							STEM-CELLS; REGENERATION; MAINTENANCE; INFLUENZA; ALVEOLAR; REPAIR; AIRWAY		[Mahoney, John E.; Kim, Carla F.] Harvard Univ, Sch Med, Boston Childrens Hosp, Boston, MA 02163 USA; [Mahoney, John E.; Kim, Carla F.] Harvard Univ, Sch Med, Dept Genet, Boston, MA USA	Harvard University; Boston Children's Hospital; Harvard Medical School; Harvard University; Harvard Medical School	Mahoney, JE (corresponding author), Harvard Univ, Sch Med, Boston Childrens Hosp, Boston, MA 02163 USA.	carla.kim@childrens.harvard.edu		Mahoney, John (Jed)/0000-0001-9414-9110	NHLBI NIH HHS [R01 HL125821] Funding Source: Medline	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Barkauskas CE, 2013, J CLIN INVEST, V123, P3025, DOI 10.1172/JCI68782; Chapman HA, 2011, J CLIN INVEST, V121, P2855, DOI 10.1172/JCI57673; Hogan BLM, 2014, CELL STEM CELL, V15, P123, DOI 10.1016/j.stem.2014.07.012; Kumar PA, 2011, CELL, V147, P525, DOI 10.1016/j.cell.2011.10.001; Lau AN, 2012, MOL THER, V20, P1116, DOI 10.1038/mt.2012.37; Rawlins EL, 2009, CELL STEM CELL, V4, P525, DOI 10.1016/j.stem.2009.04.002; Sell S, 2014, VIRAL IMMUNOL, V27, P484, DOI 10.1089/vim.2014.0077; Van Keymeulen A, 2011, NATURE, V479, P189, DOI 10.1038/nature10573; Vaughan A. E., 2014, NATURE, DOI DOI 10.1038/NATURE14112; Zuo W., 2014, NATURE, DOI DOI 10.1038/NATURE13903	10	3	3	0	0	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156	1546-1696		NAT BIOTECHNOL	Nat. Biotechnol.	FEB	2015	33	2					152	154		10.1038/nbt.3139	http://dx.doi.org/10.1038/nbt.3139			3	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	CA8VK	25658282	Green Accepted			2022-12-27	WOS:000349198800019
J	Morrison, C				Morrison, Chris			Merck splashes on Cubist, antibiotics prospects brighten	NATURE BIOTECHNOLOGY			English	News Item																		2012, NAT BIOTECHNOL, V30, P735	1	1	1	0	0	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156	1546-1696		NAT BIOTECHNOL	Nat. Biotechnol.	FEB	2015	33	2					120	121		10.1038/nbt0215-120	http://dx.doi.org/10.1038/nbt0215-120			2	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	CA8VK	25658265				2022-12-27	WOS:000349198800006
J	Hanley, N				Hanley, Neil			Closing in on pancreatic beta cells	NATURE BIOTECHNOLOGY			English	Editorial Material							EMBRYONIC STEM-CELLS		[Hanley, Neil] Univ Manchester, Ctr Endocrinol & Diabet, Manchester M13 9PL, Lancs, England; [Hanley, Neil] Cent Manchester Univ Hosp NHS Fdn Trust, Manchester, Lancs, England	University of Manchester; University of Manchester	Hanley, N (corresponding author), Univ Manchester, Ctr Endocrinol & Diabet, Manchester M13 9PL, Lancs, England.	Neil.Hanley@manchester.ac.uk		Hanley, Neil/0000-0003-3234-4038	Wellcome Trust [088566] Funding Source: Medline	Wellcome Trust(Wellcome TrustEuropean Commission)		Aguayo-Mazzucato C, 2013, DIABETES, V62, P1569, DOI 10.2337/db12-0849; Assady S, 2001, DIABETES, V50, P1691, DOI 10.2337/diabetes.50.8.1691; Barton FB, 2012, DIABETES CARE, V35, P1436, DOI 10.2337/dc12-0063; Blum B, 2014, ELIFE, V3, DOI 10.7554/eLife.02809; Hebrok M, 2012, CSH PERSPECT MED, V2, DOI 10.1101/cshperspect.a007674; Jennings RE, 2013, DIABETES, V62, P3514, DOI 10.2337/db12-1479; Kroon E, 2008, NAT BIOTECHNOL, V26, P443, DOI 10.1038/nbt1393; Mukhi S, 2009, DEV BIOL, V328, P384, DOI 10.1016/j.ydbio.2009.01.038; Pagliuca FW, 2014, CELL, V159, P428, DOI 10.1016/j.cell.2014.09.040; Rezania A, 2014, NAT BIOTECHNOL, V32, P1121, DOI 10.1038/nbt.3033; Rezania A, 2012, DIABETES, V61, P2016, DOI 10.2337/db11-1711; Rezania A, 2011, DIABETES, V60, P239, DOI 10.2337/db10-0573; Solar M, 2009, DEV CELL, V17, P849, DOI 10.1016/j.devcel.2009.11.003; Stanger BZ, 2013, GASTROENTEROLOGY, V144, P1170, DOI 10.1053/j.gastro.2013.01.074	14	4	10	0	11	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156	1546-1696		NAT BIOTECHNOL	Nat. Biotechnol.	NOV	2014	32	11					1100	1102		10.1038/nbt.3064	http://dx.doi.org/10.1038/nbt.3064			3	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	AT5IL	25380444				2022-12-27	WOS:000344977000012
J	Silver, LL				Silver, Lynn L.			Antibacterials for any target	NATURE BIOTECHNOLOGY			English	Editorial Material									LL Silver Consulting, Springfield, NJ 07081 USA		Silver, LL (corresponding author), LL Silver Consulting, Springfield, NJ 07081 USA.	silverly@comcast.net	Silver, Lynn L/A-7789-2009	Silver, Lynn L/0000-0002-8416-0487				Bikard D, 2014, NAT BIOTECHNOL, V32, P1146, DOI 10.1038/nbt.3043; Citorik RJ, 2014, NAT BIOTECHNOL, V32, P1141, DOI 10.1038/nbt.3011; Gomaa A.A., MBIO, V5; Jinek M, 2012, SCIENCE, V337, P816, DOI 10.1126/science.1225829; Silver LL, 2011, CLIN MICROBIOL REV, V24, P71, DOI 10.1128/CMR.00030-10; The Pew Charitable Trusts, ANT CURR CLIN DEV	6	6	7	0	13	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156	1546-1696		NAT BIOTECHNOL	Nat. Biotechnol.	NOV	2014	32	11					1102	1104		10.1038/nbt.3060	http://dx.doi.org/10.1038/nbt.3060			3	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	AT5IL	25380445				2022-12-27	WOS:000344977000013
J	Francisco, M				Francisco, Michael			Second-quarter biotech job picture	NATURE BIOTECHNOLOGY			English	Editorial Material																		2014, NAT BIOTECHNOL, V32, P497	1	0	0	0	1	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156	1546-1696		NAT BIOTECHNOL	Nat. Biotechnol.	AUG	2014	32	8					843	843		10.1038/nbt.2991	http://dx.doi.org/10.1038/nbt.2991			1	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	AW7PF	25101749	Bronze			2022-12-27	WOS:000346455900046
J	Zheng, GXY; Lau, BT; Schnall-Levin, M; Jarosz, M; Bell, JM; Hindson, CM; Kyriazopoulou-Panagiotopoulou, S; Masquelier, DA; Merrill, L; Terry, JM; Mudivarti, PA; Wyatt, PW; Bharadwaj, R; Makarewicz, AJ; Li, Y; Belgrader, P; Price, AD; Lowe, AJ; Marks, P; Vurens, GM; Hardenbol, P; Montesclaros, L; Luo, M; Greenfield, L; Wong, A; Birch, DE; Short, SW; Bjornson, KP; Patel, P; Hopmans, ES; Wood, C; Kaur, S; Lockwood, GK; Stafford, D; Delaney, JP; Wu, I; Ordonez, HS; Grimes, SM; Greer, S; Lee, JY; Belhocine, K; Giorda, KM; Heaton, WH; McDermott, GP; Bent, ZW; Meschi, F; Kondov, NO; Wilson, R; Bernate, JA; Gauby, S; Kindwall, A; Bermejo, C; Fehr, AN; Chan, A; Saxonov, S; Ness, KD; Hindson, BJ; Ji, HP				Zheng, Grace X. Y.; Lau, Billy T.; Schnall-Levin, Michael; Jarosz, Mirna; Bell, John M.; Hindson, Christopher M.; Kyriazopoulou-Panagiotopoulou, Sofia; Masquelier, Donald A.; Merrill, Landon; Terry, Jessica M.; Mudivarti, Patrice A.; Wyatt, Paul W.; Bharadwaj, Rajiv; Makarewicz, Anthony J.; Li, Yuan; Belgrader, Phillip; Price, Andrew D.; Lowe, Adam J.; Marks, Patrick; Vurens, Gerard M.; Hardenbol, Paul; Montesclaros, Luz; Luo, Melissa; Greenfield, Lawrence; Wong, Alexander; Birch, David E.; Short, Steven W.; Bjornson, Keith P.; Patel, Pranav; Hopmans, Erik S.; Wood, Christina; Kaur, Sukhvinder; Lockwood, Glenn K.; Stafford, David; Delaney, Joshua P.; Wu, Indira; Ordonez, Heather S.; Grimes, Susan M.; Greer, Stephanie; Lee, Josephine Y.; Belhocine, Kamila; Giorda, Kristina M.; Heaton, William H.; McDermott, Geoffrey P.; Bent, Zachary W.; Meschi, Francesca; Kondov, Nikola O.; Wilson, Ryan; Bernate, Jorge A.; Gauby, Shawn; Kindwall, Alex; Bermejo, Clara; Fehr, Adrian N.; Chan, Adrian; Saxonov, Serge; Ness, Kevin D.; Hindson, Benjamin J.; Ji, Hanlee P.			Haplotyping germline and cancer genomes with high-throughput linked-read sequencing	NATURE BIOTECHNOLOGY			English	Article							EML4-ALK FUSION GENE; CELL LUNG-CANCER; STRUCTURAL VARIATION; PROXIMITY-LIGATION; IDENTIFICATION; FRAMEWORK; VARIANT; DISCOVERY; ALIGNMENT; MODEL	Haplotyping of human chromosomes is a prerequisite for cataloguing the full repertoire of genetic variation. We present a microfluidics-based, linked-read sequencing technology that can phase and haplotype germline and cancer genomes using nanograms of input DNA. This high-throughput platform prepares barcoded libraries for short-read sequencing and computationally reconstructs long-range haplotype and structural variant information. We generate haplotype blocks in a nuclear trio that are concordant with expected inheritance patterns and phase a set of structural variants. We also resolve the structure of the EML4-ALK gene fusion in the NCI-H2228 cancer cell line using phased exome sequencing. Finally, we assign genetic aberrations to specific megabase-scale haplotypes generated from whole-genome sequencing of a primary colorectal adenocarcinoma. This approach resolves haplotype information using up to 100 times less genomic DNA than some methods and enables the accurate detection of structural variants.	[Zheng, Grace X. Y.; Schnall-Levin, Michael; Jarosz, Mirna; Hindson, Christopher M.; Kyriazopoulou-Panagiotopoulou, Sofia; Masquelier, Donald A.; Merrill, Landon; Terry, Jessica M.; Mudivarti, Patrice A.; Wyatt, Paul W.; Bharadwaj, Rajiv; Makarewicz, Anthony J.; Li, Yuan; Belgrader, Phillip; Price, Andrew D.; Lowe, Adam J.; Marks, Patrick; Vurens, Gerard M.; Hardenbol, Paul; Montesclaros, Luz; Luo, Melissa; Greenfield, Lawrence; Wong, Alexander; Birch, David E.; Short, Steven W.; Bjornson, Keith P.; Patel, Pranav; Kaur, Sukhvinder; Lockwood, Glenn K.; Stafford, David; Delaney, Joshua P.; Wu, Indira; Ordonez, Heather S.; Lee, Josephine Y.; Belhocine, Kamila; Giorda, Kristina M.; Heaton, William H.; McDermott, Geoffrey P.; Bent, Zachary W.; Meschi, Francesca; Kondov, Nikola O.; Wilson, Ryan; Bernate, Jorge A.; Gauby, Shawn; Kindwall, Alex; Bermejo, Clara; Fehr, Adrian N.; Chan, Adrian; Saxonov, Serge; Ness, Kevin D.; Hindson, Benjamin J.] 10X Genom, Pleasanton, CA USA; [Lau, Billy T.; Bell, John M.; Hopmans, Erik S.; Grimes, Susan M.; Ji, Hanlee P.] Stanford Univ, Stanford Genome Technol Ctr, Palo Alto, CA 94304 USA; [Wood, Christina; Greer, Stephanie; Ji, Hanlee P.] Stanford Univ, Dept Med, Sch Med, Div Oncol, Stanford, CA 94305 USA	Stanford University; Stanford University	Hindson, BJ (corresponding author), 10X Genom, Pleasanton, CA USA.; Ji, HP (corresponding author), Stanford Univ, Stanford Genome Technol Ctr, Palo Alto, CA 94304 USA.; Ji, HP (corresponding author), Stanford Univ, Dept Med, Sch Med, Div Oncol, Stanford, CA 94305 USA.	ben@10xgenomics.com; genomics_ji@stanford.edu	Greenfield, Lawrence/K-2292-2019; Wong, Alexander/GZM-2929-2022; Lockwood, Glenn/N-7078-2013	Wong, Alexander/0000-0002-5295-2797; Marks, Patrick/0000-0002-3231-7163; Heaton, Haynes/0000-0002-9649-525X; Lockwood, Glenn/0000-0002-9241-9372	US National Institutes of Health [NHGRI P01HG000205, NCI R33CA174575, NHGRI R01HG006137]; American Cancer Society [RSG-13-297-01-TBG]; Doris Duke Clinical Foundation; Clayville Foundation; Seiler Foundation; Howard Hughes Medical Institute; NATIONAL CANCER INSTITUTE [U01CA151920, R33CA174575] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [P01HG000205, R01HG006137] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Cancer Society(American Cancer Society); Doris Duke Clinical Foundation(Doris Duke Charitable Foundation (DDCF)); Clayville Foundation; Seiler Foundation; Howard Hughes Medical Institute(Howard Hughes Medical Institute); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))	This work was supported by US National Institutes of Health grants NHGRI P01HG000205 (to B.T.L., E.S.H., S.M.G., J.M.B. and H.P.J.), NCI R33CA174575 (to J.M.B., S. Greer and H.P.J.) and NHGRI R01HG006137 (to H.P.J.). The American Cancer Society provided additional support to S. Greer and H.P.J. (Research Scholar grant, RSG-13-297-01-TBG). H.P.J. also received support from the Doris Duke Clinical Foundation, the Clayville Foundation, the Seiler Foundation and the Howard Hughes Medical Institute.	Abate AR, 2009, LAB CHIP, V9, P2628, DOI 10.1039/b909386a; Adey A, 2013, NATURE, V500, P207, DOI 10.1038/nature12064; Altshuler DM, 2012, NATURE, V491, P56, DOI 10.1038/nature11632; Amini S, 2014, NAT GENET, V46, P1343, DOI 10.1038/ng.3119; Borgstrom E, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8173; Chen K, 2009, NAT METHODS, V6, P677, DOI [10.1038/NMETH.1363, 10.1038/nmeth.1363]; Choi YL, 2008, CANCER RES, V68, P4971, DOI 10.1158/0008-5472.CAN-07-6158; Cleary JG, 2014, J COMPUT BIOL, V21, P405, DOI 10.1089/cmb.2014.0029; de Vree PJP, 2014, NAT BIOTECHNOL, V32, P1019, DOI 10.1038/nbt.2959; Duitama J, 2012, NUCLEIC ACIDS RES, V40, P2041, DOI 10.1093/nar/gkr1042; FEARON ER, 1990, CELL, V61, P759, DOI 10.1016/0092-8674(90)90186-I; Frampton GM, 2013, NAT BIOTECHNOL, V31, P1023, DOI 10.1038/nbt.2696; Hopmans ES, 2014, NUCLEIC ACIDS RES, V42, DOI 10.1093/nar/gku282; Jung Y, 2012, GENE CHROMOSOME CANC, V51, P590, DOI 10.1002/gcc.21945; Kaper F, 2013, P NATL ACAD SCI USA, V110, P5552, DOI 10.1073/pnas.1218696110; Kent WJ, 2002, GENOME RES, V12, P656, DOI [10.1101/gr.229202, 10.1101/gr.229202. Article published online before March 2002]; Kidd JM, 2008, NATURE, V453, P56, DOI 10.1038/nature06862; Kircher M, 2014, NAT GENET, V46, P310, DOI 10.1038/ng.2892; Kitzman JO, 2011, NAT BIOTECHNOL, V29, P59, DOI 10.1038/nbt.1740; Klein AM, 2015, CELL, V161, P1187, DOI 10.1016/j.cell.2015.04.044; Koivunen JP, 2008, CLIN CANCER RES, V14, P4275, DOI 10.1158/1078-0432.CCR-08-0168; Kuleshov V, 2014, NAT BIOTECHNOL, V32, P261, DOI 10.1038/nbt.2833; Layer RM, 2014, GENOME BIOL, V15, DOI 10.1186/gb-2014-15-6-r84; Li H, 2010, BIOINFORMATICS, V26, P589, DOI 10.1093/bioinformatics/btp698; Lipson D, 2012, NAT MED, V18, P382, DOI 10.1038/nm.2673; Macosko EZ, 2015, CELL, V161, P1202, DOI 10.1016/j.cell.2015.05.002; McKenna A, 2010, GENOME RES, V20, P1297, DOI 10.1101/gr.107524.110; Mills RE, 2011, NATURE, V470, P59, DOI 10.1038/nature09708; Muzny DM, 2012, NATURE, V487, P330, DOI 10.1038/nature11252; Myllykangas S, 2011, NAT BIOTECHNOL, V29, P1024, DOI 10.1038/nbt.1996; Pendleton M, 2015, NAT METHODS, V12, P780, DOI [10.1038/nmeth.3454, 10.1038/NMETH.3454]; Peters BA, 2012, NATURE, V487, P190, DOI 10.1038/nature11236; Regan JF, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0118270; Roach JC, 2011, AM J HUM GENET, V89, P382, DOI 10.1016/j.ajhg.2011.07.023; Schrider DR, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003242; Selvaraj S, 2013, NAT BIOTECHNOL, V31, P1111, DOI 10.1038/nbt.2728; Shen JJ, 2012, ANN APPL STAT, V6, P476, DOI 10.1214/11-AOAS517; Soda M, 2007, NATURE, V448, P561, DOI 10.1038/nature05945; Suk EK, 2011, GENOME RES, V21, P1672, DOI 10.1101/gr.125047.111; VOGELSTEIN B, 1988, NEW ENGL J MED, V319, P525, DOI 10.1056/NEJM198809013190901	40	366	459	2	98	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156	1546-1696		NAT BIOTECHNOL	Nat. Biotechnol.	MAR	2016	34	3					303	+		10.1038/nbt.3432	http://dx.doi.org/10.1038/nbt.3432			11	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	DG1CJ	26829319	Green Accepted			2022-12-27	WOS:000371802600027
J	DeFrancesco, L				DeFrancesco, Laura			Drug pipeline Q4 2015	NATURE BIOTECHNOLOGY			English	News Item																			0	4	4	0	1	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156	1546-1696		NAT BIOTECHNOL	Nat. Biotechnol.	FEB	2016	34	2					128	128		10.1038/nbt.3484	http://dx.doi.org/10.1038/nbt.3484			1	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	VI3OH	26849510				2022-12-27	WOS:000474638300007
J	Nomakuchi, TT; Rigo, F; Aznarez, I; Krainer, AR				Nomakuchi, Tomoki T.; Rigo, Frank; Aznarez, Isabel; Krainer, Adrian R.			Antisense oligonucleotide-directed inhibition of nonsense-mediated mRNA decay	NATURE BIOTECHNOLOGY			English	Article							STOP CODON READTHROUGH; EXON JUNCTION COMPLEX; MUTATIONS; THERAPEUTICS; NUCLEAR; GENE	Nonsense-mediated mRNA decay (NMD) is a cellular quality-control mechanism that is thought to exacerbate the phenotype of certain pathogenic nonsense mutations by preventing the expression of semi-functional proteins. NMD also limits the efficacy of read-through compound (RTC)-based therapies. Here, we report a gene-specific method of NMD inhibition using antisense oligonucleotides (ASOs) and combine this approach with an RTC to effectively restore the expression of full-length protein from a nonsense-mutant allele.	[Nomakuchi, Tomoki T.; Aznarez, Isabel; Krainer, Adrian R.] Cold Spring Harbor Lab, POB 100, Cold Spring Harbor, NY 11724 USA; [Nomakuchi, Tomoki T.] SUNY Stony Brook, Sch Med, Stony Brook, NY 11794 USA; [Rigo, Frank] ISIS Pharmaceut, Carslbad, CA USA	Cold Spring Harbor Laboratory; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; Isis Pharmaceuticals Inc	Aznarez, I; Krainer, AR (corresponding author), Cold Spring Harbor Lab, POB 100, Cold Spring Harbor, NY 11724 USA.	aznarez@cshl.edu; krainer@cshl.edu		Nomakuchi, Tomoki/0000-0001-7300-9311; Krainer, Adrian/0000-0001-9024-9501	US National Institutes of Health (NIH) [R21-NS081448, R37-GM042699]; University of Pennsylvania's Center for Orphan Disease Research and Therapy; NIH [T32GM008444, F31NS087747]; Cancer Center Support Grant [5P30CA045508]; NATIONAL CANCER INSTITUTE [P30CA045508] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008444, R37GM042699] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R21NS081448, F31NS087747] Funding Source: NIH RePORTER	US National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); University of Pennsylvania's Center for Orphan Disease Research and Therapy; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Cancer Center Support Grant; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank F. Bennett for helpful discussions. This work was supported by US National Institutes of Health (NIH) grants R21-NS081448 and R37-GM042699 and by a research grant from the University of Pennsylvania's Center for Orphan Disease Research and Therapy to A.R.K. T.T.N. was supported by NIH grants T32GM008444 and F31NS087747. We acknowledge assistance from Cold Spring Harbor Laboratory Shared Resources, funded in part by Cancer Center Support Grant 5P30CA045508.	Baker BF, 1997, J BIOL CHEM, V272, P11994, DOI 10.1074/jbc.272.18.11994; Bhuvanagiri M, 2014, EMBO MOL MED, V6, P1593, DOI 10.15252/emmm.201404461; Gardner LB, 2010, MOL CANCER RES, V8, P295, DOI 10.1158/1541-7786.MCR-09-0502; Giorgi C, 2007, SEMIN CELL DEV BIOL, V18, P186, DOI 10.1016/j.semcdb.2007.01.002; Goldmann T, 2012, EMBO MOL MED, V4, P1186, DOI 10.1002/emmm.201201438; Hossain M, 2012, GENE DEV, V26, P1797, DOI 10.1101/gad.197178.112; Jeong JY, 2012, APPL ENVIRON MICROB, V78, P5440, DOI 10.1128/AEM.00844-12; Jolly LA, 2013, HUM MOL GENET, V22, P4673, DOI 10.1093/hmg/ddt315; Karam R, 2012, RNA BIOL, V9, P22, DOI 10.4161/rna.9.1.18010; Keeling KM, 2014, ANNU REV GENOM HUM G, V15, P371, DOI 10.1146/annurev-genom-091212-153527; Keeling KM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060478; Keeling KM, 2011, WIRES RNA, V2, P837, DOI 10.1002/wrna.95; Kole R, 2012, NAT REV DRUG DISCOV, V11, P125, DOI 10.1038/nrd3625; Loughran G, 2014, NUCLEIC ACIDS RES, V42, P8928, DOI 10.1093/nar/gku608; Martin L, 2014, CANCER RES, V74, P3104, DOI 10.1158/0008-5472.CAN-13-2235; Mayeda A, 1999, METH MOL B, V118, P315; Mayeda A, 1999, METH MOL B, V118, P309; Ni JZ, 2007, GENE DEV, V21, P708, DOI 10.1101/gad.1525507; Pan Q, 2006, GENE DEV, V20, P153, DOI 10.1101/gad.1382806; Popp MWL, 2013, ANNU REV GENET, V47, P139, DOI 10.1146/annurev-genet-111212-133424; Rigo F, 2012, J CELL BIOL, V199, P21, DOI 10.1083/jcb.201207087; Shibuya T, 2004, NAT STRUCT MOL BIOL, V11, P346, DOI 10.1038/nsmb750; Trcek T, 2013, GENE DEV, V27, P541, DOI 10.1101/gad.209635.112; TRECARTIN RF, 1981, J CLIN INVEST, V68, P1012, DOI 10.1172/JCI110323; Winkler J, 2010, CHEMMEDCHEM, V5, P1344, DOI 10.1002/cmdc.201000156; Zhang Z, 2007, P NATL ACAD SCI USA, V104, P11574, DOI 10.1073/pnas.0704946104; Zheng W, 2008, GENETICS, V180, P1391, DOI 10.1534/genetics.108.095737	27	49	56	1	22	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156	1546-1696		NAT BIOTECHNOL	Nat. Biotechnol.	FEB	2016	34	2					164	+		10.1038/nbt.3427	http://dx.doi.org/10.1038/nbt.3427			4	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	DD0OK	26655495	Green Accepted			2022-12-27	WOS:000369619100018
J	Rajagopal, N; Srinivasan, S; Kooshesh, K; Guo, YC; Edwards, MD; Banerjee, B; Syed, T; Emons, BJM; Gifford, DK; Sherwood, RI				Rajagopal, Nisha; Srinivasan, Sharanya; Kooshesh, Kameron; Guo, Yuchun; Edwards, Matthew D.; Banerjee, Budhaditya; Syed, Tahin; Emons, Bart J. M.; Gifford, David K.; Sherwood, Richard I.			High-throughput mapping of regulatory DNA	NATURE BIOTECHNOLOGY			English	Article							ENHANCERS; DISSECTION; DOMAINS; GENES	Quantifying the effects of cis-regulatory DNA on gene expression is a major challenge. Here, we present the multiplexed editing regulatory assay (MERA), a high-throughput CRISPR-Cas9-based approach that analyzes the functional impact of the regulatory genome in its native context. MERA tiles thousands of mutations across similar to 40 kb of cis-regulatory genomic space and uses knock- in green fluorescent protein (GFP) reporters to read out gene activity. Using this approach, we obtain quantitative information on the contribution of cis-regulatory regions to gene expression. We identify proximal and distal regulatory elements necessary for expression of four embryonic stem cell-specific genes. We show a consistent contribution of neighboring gene promoters to gene expression and identify unmarked regulatory elements (UREs) that control gene expression but do not have typical enhancer epigenetic or chromatin features. We compare thousands of functional and nonfunctional genotypes at a genomic location and identify the base pair-resolution functional motifs of regulatory elements.	[Rajagopal, Nisha; Srinivasan, Sharanya; Guo, Yuchun; Edwards, Matthew D.; Syed, Tahin; Gifford, David K.] MIT, Comp Sci & Artificial Intelligence Lab, 77 Massachusetts Ave, Cambridge, MA 02139 USA; [Srinivasan, Sharanya; Kooshesh, Kameron; Banerjee, Budhaditya; Emons, Bart J. M.; Sherwood, Richard I.] Brigham & Womens Hosp, Dept Med, Div Genet, 75 Francis St, Boston, MA 02115 USA; [Srinivasan, Sharanya; Kooshesh, Kameron; Banerjee, Budhaditya; Emons, Bart J. M.; Sherwood, Richard I.] Harvard Univ, Sch Med, Boston, MA USA; [Kooshesh, Kameron] Harvard Univ, Dept Stem Cell & Regenerat Biol, Cambridge, MA 02138 USA; [Emons, Bart J. M.] Univ Utrecht, Program Canc Stem Cells & Dev Biol, Utrecht, Netherlands	Massachusetts Institute of Technology (MIT); Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School; Harvard University; Utrecht University	Gifford, DK (corresponding author), MIT, Comp Sci & Artificial Intelligence Lab, 77 Massachusetts Ave, Cambridge, MA 02139 USA.; Sherwood, RI (corresponding author), Brigham & Womens Hosp, Dept Med, Div Genet, 75 Francis St, Boston, MA 02115 USA.; Sherwood, RI (corresponding author), Harvard Univ, Sch Med, Boston, MA USA.	gifford@mit.edu; rsherwood@partners.org	Guo, Yuchun/A-4805-2011; Young, Richard A/F-6495-2012; Guo, Yuchun/Q-8587-2019	Guo, Yuchun/0000-0003-2357-1546; Young, Richard A/0000-0001-8855-8647; Guo, Yuchun/0000-0003-2357-1546	US National Institutes of Health [1U01HG007037, 1K01DK101684-01]; Harvard Stem Cell Institute's Sternlicht Director's Fund award; Brigham and Women's Hospital BRI Innovation Fund; Human Frontier Science Program; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R01HG008754, U01HG007037, R01HG008363] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [K01DK101684] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Harvard Stem Cell Institute's Sternlicht Director's Fund award; Brigham and Women's Hospital BRI Innovation Fund; Human Frontier Science Program(Human Frontier Science Program); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	The authors thank F. Zhang (Broad Institute of MIT and Harvard) for reagents, the MIT BiomicroCenter for high-throughput sequencing assistance, and Y. Qiu for flow cytometric assistance. The authors acknowledge funding from the US National Institutes of Health to D.K.G. (1U01HG007037) and to R.I.S. (1K01DK101684-01) and Harvard Stem Cell Institute's Sternlicht Director's Fund award, Brigham and Women's Hospital BRI Innovation Fund, and Human Frontier Science Program grants to R.I.S.	Arbab M, 2015, STEM CELL REP, V5, P908, DOI 10.1016/j.stemcr.2015.09.022; Arnold CD, 2013, SCIENCE, V339, P1074, DOI 10.1126/science.1232542; Ay F, 2014, GENOME RES, V24, P999, DOI 10.1101/gr.160374.113; Bernstein BE, 2006, CELL, V125, P315, DOI 10.1016/j.cell.2006.02.041; Breiman L., 2001, Machine Learning, V45, P5, DOI 10.1023/A:1010933404324; Chen SD, 2015, CELL, V160, P1246, DOI 10.1016/j.cell.2015.02.038; Cong L, 2013, SCIENCE, V339, P819, DOI 10.1126/science.1231143; Cradick TJ, 2013, NUCLEIC ACIDS RES, V41, P9584, DOI 10.1093/nar/gkt714; Creyghton MP, 2010, P NATL ACAD SCI USA, V107, P21931, DOI 10.1073/pnas.1016071107; Dixon JR, 2012, NATURE, V485, P376, DOI 10.1038/nature11082; Dostie J, 2006, GENOME RES, V16, P1299, DOI 10.1101/gr.5571506; Dunham I, 2012, NATURE, V489, P57, DOI 10.1038/nature11247; Fullwood MJ, 2009, NATURE, V462, P58, DOI 10.1038/nature08497; Guo YC, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002638; Heintzman ND, 2009, NATURE, V459, P108, DOI 10.1038/nature07829; Jenuwein T, 2001, SCIENCE, V293, P1074, DOI 10.1126/science.1063127; Jinek M, 2013, ELIFE, V2, DOI 10.7554/eLife.00471; Jinek M, 2012, SCIENCE, V337, P816, DOI 10.1126/science.1225829; John S, 2011, NAT GENET, V43, P264, DOI 10.1038/ng.759; Kent WJ, 2002, GENOME RES, V12, P996, DOI 10.1101/gr.229102; Koike-Yusa H, 2014, NAT BIOTECHNOL, V32, P267, DOI 10.1038/nbt.2800; Kwasnieski JC, 2014, GENOME RES, V24, P1595, DOI 10.1101/gr.173518.114; Li GL, 2012, CELL, V148, P84, DOI 10.1016/j.cell.2011.12.014; Lieberman-Aiden E, 2009, SCIENCE, V326, P289, DOI 10.1126/science.1181369; Mali P, 2013, SCIENCE, V339, P823, DOI 10.1126/science.1232033; Melnikov A, 2012, NAT BIOTECHNOL, V30, P271, DOI 10.1038/nbt.2137; NELDER JA, 1972, J R STAT SOC SER A-G, V135, P370, DOI 10.2307/2344614; Patwardhan RP, 2012, NAT BIOTECHNOL, V30, P265, DOI 10.1038/nbt.2136; Rada-Iglesias A, 2011, NATURE, V470, P279, DOI 10.1038/nature09692; Rajagopal N, 2013, PLOS COMPUT BIOL, V9, DOI 10.1371/journal.pcbi.1002968; Shalem O, 2014, SCIENCE, V343, P84, DOI 10.1126/science.1247005; Sherwood RI, 2014, NAT BIOTECHNOL, V32, P171, DOI 10.1038/nbt.2798; Simonis M, 2006, NAT GENET, V38, P1348, DOI 10.1038/ng1896; Tsai SQ, 2015, NAT BIOTECHNOL, V33, P187, DOI 10.1038/nbt.3117; Vierstra J, 2015, NAT METHODS, V12, P927, DOI [10.1038/NMETH.3554, 10.1038/nmeth.3554]; Wang T, 2014, SCIENCE, V343, P80, DOI 10.1126/science.1246981; Woo YH, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012158; Young RA, 2011, CELL, V144, P940, DOI 10.1016/j.cell.2011.01.032; Yue F, 2014, NATURE, V515, P355, DOI 10.1038/nature13992; Zhou YX, 2014, NATURE, V509, P487, DOI 10.1038/nature13166	40	153	159	0	81	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1087-0156	1546-1696		NAT BIOTECHNOL	Nat. Biotechnol.	FEB	2016	34	2					167	+		10.1038/nbt.3468	http://dx.doi.org/10.1038/nbt.3468			10	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	DD0OK	26807528	Green Published, Green Accepted, Green Submitted			2022-12-27	WOS:000369619100019
J	Agudo, J; Ruzo, A; Park, ES; Sweeney, R; Kana, V; Wu, M; Zhao, Y; Egli, D; Merad, M; Brown, BD				Agudo, Judith; Ruzo, Albert; Park, Eun Sook; Sweeney, Robert; Kana, Veronika; Wu, Meng; Zhao, Yong; Egli, Dieter; Merad, Miriam; Brown, Brian D.			GFP-specific CD8 T cells enable targeted cell depletion and visualization of T-cell interactions	NATURE BIOTECHNOLOGY			English	Article							CENTRAL-NERVOUS-SYSTEM; RECEPTOR TRANSGENIC MICE; IN-VIVO; EXPRESSION; TOLERANCE; MICROGLIA; MONOCYTES; DELETION; LINEAGE; TISSUE	There are numerous cell types with scarcely understood functions, whose interactions with the immune system are not well characterized. To facilitate their study, we generated a mouse bearing enhanced green fluorescent protein (EGFP)-specific CD8(+) T cells. Transfer of the T cells into EGFP reporter animals can be used to kill EGFP-expressing cells, allowing selective depletion of desired cell types, or to interrogate T-cell interactions with specific populations. Using this system, we eliminate a rare EGFP-expressing cell type in the heart and demonstrate its role in cardiac function. We also show that naive T cells are recruited into the mouse brain by antigen-expressing microglia, providing evidence of an immune surveillance pathway in the central nervous system. The just EGFP death-inducing (Jedi) T cells enable visualization of a T-cell antigen. They also make it possible to utilize hundreds of existing EGFP-expressing mice, tumors, pathogens and other tools, to study T-cell interactions with many different cell types, to model disease states and to determine the functions of poorly characterized cell populations.	[Agudo, Judith; Ruzo, Albert; Park, Eun Sook; Sweeney, Robert; Wu, Meng; Zhao, Yong; Brown, Brian D.] Icahn Sch Med Mt Sinai, Dept Genet & Genom Sci, New York, NY 10029 USA; [Kana, Veronika; Merad, Miriam] Icahn Sch Med Mt Sinai, Dept Oncol Sci, New York, NY 10029 USA; [Egli, Dieter] New York Stem Cell Fdn, Res Inst, New York, NY USA; [Merad, Miriam; Brown, Brian D.] Icahn Sch Med Mt Sinai, Mt Sinai Immunol Inst, New York, NY 10029 USA; [Merad, Miriam; Brown, Brian D.] Icahn Sch Med Mt Sinai, Tisch Canc Inst, New York, NY 10029 USA; [Brown, Brian D.] Icahn Sch Med Mt Sinai, Diabet Obes & Metab Inst, New York, NY 10029 USA	Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai; The New York Stem Cell Foundation; Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai	Brown, BD (corresponding author), Icahn Sch Med Mt Sinai, Dept Genet & Genom Sci, New York, NY 10029 USA.	brian.brown@mssm.edu	Wu, Meng/J-8515-2016	Wu, Meng/0000-0001-5512-9651; Kana, Veronika/0000-0002-9362-3156	US National Institutes of Health (NIH) [R01AI104848, R01AI113221]; Diabetes Research, Obesity and Metabolism Institute; Juvenile Diabetes Research Foundation (JDRF); NIH [1R01HL107376]; Robin Chemers Neustein Award; JDRF postdoctoral fellowship; Swiss National Foundation; NATIONAL CANCER INSTITUTE [R01CA190400, R01CA173861, P30CA196521] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [K02HL103597, R01HL107376] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI113221, R01AI104848] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK026687] Funding Source: NIH RePORTER	US National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Diabetes Research, Obesity and Metabolism Institute; Juvenile Diabetes Research Foundation (JDRF)(Juvenile Diabetes Research Foundation); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Robin Chemers Neustein Award; JDRF postdoctoral fellowship(Juvenile Diabetes Research Foundation); Swiss National Foundation(Swiss National Science Foundation (SNSF)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	We thank A. Annoni, L. Sherman, J. Brody, J. Lafaille, S. Lira, J. Blander and M. Feldmann for helpful discussions. We also thank K. Kelly and the Mouse Genetics and Mouse Targeting facility, and A. Rahman and the Flow Cytometry Core for technical assistance. B.D.B. and M.M. were supported by US National Institutes of Health (NIH) R01AI104848 and R01AI113221. B.D.B. was also supported by a Pilot Award from the Diabetes Research, Obesity and Metabolism Institute and an Innovation Award from the Juvenile Diabetes Research Foundation (JDRF). Y.Z. was supported by NIH1R01HL107376. J.A. was supported by the Robin Chemers Neustein Award, and a JDRF postdoctoral fellowship. V.K. was supported by a Swiss National Foundation Early Postdoc Mobility fellowship.	Agudo J, 2014, NAT IMMUNOL, V15, P54, DOI 10.1038/ni.2767; Ajami B, 2011, NAT NEUROSCI, V14, P1142, DOI 10.1038/nn.2887; BERG LJ, 1989, CELL, V58, P1035, DOI 10.1016/0092-8674(89)90502-3; Brown BD, 2007, NAT BIOTECHNOL, V25, P1457, DOI 10.1038/nbt1372; Bucchi A, 2012, FRONT PHYSIOL, V3, DOI 10.3389/fphys.2012.00240; Clarke SRM, 2000, IMMUNOL CELL BIOL, V78, P110, DOI 10.1046/j.1440-1711.2000.00889.x; EGLI D, 2006, J VIS EXP, V1, P116; Engelhardt B, 2012, TRENDS IMMUNOL, V33, P579, DOI 10.1016/j.it.2012.07.004; Fletcher AL, 2011, TRENDS IMMUNOL, V32, P12, DOI 10.1016/j.it.2010.11.002; Fontenot JD, 2005, IMMUNITY, V22, P329, DOI 10.1016/j.immuni.2005.01.016; Gambotto A, 2000, GENE THER, V7, P2036, DOI 10.1038/sj.gt.3301335; Gong SC, 2003, NATURE, V425, P917, DOI 10.1038/nature02033; Hara M, 2003, AM J PHYSIOL-ENDOC M, V284, pE177, DOI 10.1152/ajpendo.00321.2002; Herrmann S, 2012, BRIT J PHARMACOL, V166, P501, DOI 10.1111/j.1476-5381.2011.01798.x; Jung S, 2000, MOL CELL BIOL, V20, P4106, DOI 10.1128/MCB.20.11.4106-4114.2000; Jung S, 2002, IMMUNITY, V17, P211, DOI 10.1016/S1074-7613(02)00365-5; Kim JM, 2007, NAT IMMUNOL, V8, P191, DOI 10.1038/ni1428; Kirak O, 2010, SCIENCE, V328, P243, DOI 10.1126/science.1178590; KISIELOW P, 1988, NATURE, V333, P742, DOI 10.1038/333742a0; Lafaille JJ, 2004, J AUTOIMMUN, V22, P95, DOI 10.1016/j.jaut.2003.10.007; Mueller SN, 2009, NAT REV IMMUNOL, V9, P618, DOI 10.1038/nri2588; Norbury CC, 2002, NAT IMMUNOL, V3, P265, DOI 10.1038/ni762; Pamer E, 1998, ANNU REV IMMUNOL, V16, P323, DOI 10.1146/annurev.immunol.16.1.323; Parish IA, 2009, P NATL ACAD SCI USA, V106, P3901, DOI 10.1073/pnas.0810427106; Ransohoff RM, 2010, NATURE, V468, P253, DOI 10.1038/nature09615; Saito M, 2001, NAT BIOTECHNOL, V19, P746, DOI 10.1038/90795; Sandor N, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0112397; Schmidt E.F., 2013, COLD SPRING HARB PRO, DOI [10.1101/pdb.top03692, DOI 10.1101/PDB.TOP03692]; Van Thuan N, 2009, REPRODUCTION, V138, P309, DOI 10.1530/REP-08-0299; Wu M, 2014, GENESIS, V52, P134, DOI 10.1002/dvg.22730; Yamasaki R, 2014, J EXP MED, V211, P1533, DOI 10.1084/jem.20132477	31	350	361	4	48	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156	1546-1696		NAT BIOTECHNOL	Nat. Biotechnol.	DEC	2015	33	12					1287	+		10.1038/nbt.3386	http://dx.doi.org/10.1038/nbt.3386			8	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	CY4OO	26524661	Green Accepted			2022-12-27	WOS:000366387700021
J	Amiram, M; Haimovich, AD; Fan, CG; Wang, YS; Aerni, HR; Ntai, I; Moonan, DW; Ma, NJ; Rovner, AJ; Hong, SH; Kelleher, NL; Goodman, AL; Jewett, MC; Soll, D; Rinehart, J; Isaacs, FJ				Amiram, Miriam; Haimovich, Adrian D.; Fan, Chenguang; Wang, Yane-Shih; Aerni, Hans-Rudolf; Ntai, Ioanna; Moonan, Daniel W.; Ma, Natalie J.; Rovner, Alexis J.; Hong, Seok Hoon; Kelleher, Neil L.; Goodman, Andrew L.; Jewett, Michael C.; Soell, Dieter; Rinehart, Jesse; Isaacs, Farren J.			Evolution of translation machinery in recoded bacteria enables multi-site incorporation of nonstandard amino acids	NATURE BIOTECHNOLOGY			English	Article							TRANSFER-RNA SYNTHETASES; GENETIC-CODE; ESCHERICHIA-COLI; PROTEIN-SYNTHESIS; ORGANISMS; CELLS; BIOSYNTHESIS; REASSIGNMENT; LIGATION; SEQUENCE	Expansion of the genetic code with nonstandard amino acids (nsAAs) has enabled biosynthesis of proteins with diverse new chemistries. However, this technology has been largely restricted to proteins containing a single or few nsAA instances. Here we describe an in vivo evolution approach in a genomically recoded Escherichia coli strain for the selection of orthogonal translation systems capable of multi-site nsAA incorporation. We evolved chromosomal aminoacyl-tRNA synthetases (aaRSs) with up to 25-fold increased protein production for p-acetyl-l-phenylalanine and p-azido-l-phenylalanine (pAzF). We also evolved aaRSs with tunable specificities for 14 nsAAs, including an enzyme that efficiently charges pAzF while excluding 237 other nsAAs. These variants enabled production of elastin-like-polypeptides with 30 nsAA residues at high yields (similar to 50 mg/L) and high accuracy of incorporation (>95%). This approach to aaRS evolution should accelerate and expand our ability to produce functionalized proteins and sequence-defined polymers with diverse chemistries.	[Amiram, Miriam; Haimovich, Adrian D.; Moonan, Daniel W.; Ma, Natalie J.; Rovner, Alexis J.; Isaacs, Farren J.] Yale Univ, Dept Mol Cellular & Dev Biol, New Haven, CT 06520 USA; [Amiram, Miriam; Haimovich, Adrian D.; Aerni, Hans-Rudolf; Moonan, Daniel W.; Ma, Natalie J.; Rovner, Alexis J.; Rinehart, Jesse; Isaacs, Farren J.] Yale Univ, Syst Biol Inst, West Haven, CT USA; [Fan, Chenguang; Wang, Yane-Shih; Soell, Dieter] Yale Univ, Dept Mol Biophys & Biochem, New Haven, CT USA; [Aerni, Hans-Rudolf; Rinehart, Jesse] Yale Univ, Dept Cellular & Mol Physiol, New Haven, CT USA; [Ntai, Ioanna; Kelleher, Neil L.] Northwestern Univ, Dept Chem, Evanston, IL USA; [Hong, Seok Hoon; Jewett, Michael C.] Northwestern Univ, Dept Chem & Biol Engn, Evanston, IL USA; [Goodman, Andrew L.] Yale Univ, Sch Med, Dept Microbial Pathogenesis, New Haven, CT USA; [Goodman, Andrew L.] Yale Univ, Sch Med, Microbial Sci Inst, New Haven, CT USA; [Soell, Dieter] Yale Univ, Dept Chem, New Haven, CT USA	Yale University; Yale University; Yale University; Yale University; Northwestern University; Northwestern University; Yale University; Yale University; Yale University	Isaacs, FJ (corresponding author), Yale Univ, Dept Mol Cellular & Dev Biol, New Haven, CT 06520 USA.	dieter.soll@yale.edu; jesse.rinehart@yale.edu; farren.isaacs@yale.edu	Hong, Seok Hoon/AAF-7163-2021; Jewett, Michael C/E-3506-2010; Fan, Cheguang/O-9709-2016; , Miriam/ABF-6823-2020	Hong, Seok Hoon/0000-0003-2401-6368; Fan, Cheguang/0000-0003-0662-1185; Amiram, Miriam/0000-0001-5826-930X; Jewett, Michael/0000-0003-2948-6211; Wang, Yane-Shih/0000-0003-2356-9577	Defense Advanced Research Projects Agency [N66001-12-C-4020, N66001-12-C-4211]; U.S. Department of Energy [DE-FG02-02ER63445]; National Institute for General Medical Sciences [GM22854, GM67193]; Army Research Office [W911NF-11-1-0445]; David and Lucile Packard Foundation; Camille Dreyfus Teacher-Scholar Program; DuPont, Inc.; Arnold and Mabel Beckman Foundation;  [T32GM007205];  [1F30CA196191]; NATIONAL CANCER INSTITUTE [F30CA196191] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R37GM022854, T32GM007205, R01GM022854, R01GM067193, T32GM007223] Funding Source: NIH RePORTER	Defense Advanced Research Projects Agency(United States Department of DefenseDefense Advanced Research Projects Agency (DARPA)); U.S. Department of Energy(United States Department of Energy (DOE)); National Institute for General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Army Research Office; David and Lucile Packard Foundation(The David & Lucile Packard Foundation); Camille Dreyfus Teacher-Scholar Program; DuPont, Inc.; Arnold and Mabel Beckman Foundation; ; ; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank K. Bilguvar and J. Knight (Yale Center for Genome Analysis) for conducting next-generation sequencing experiments; T. Wu (Yale West Campus Analytical Core facility) for conducting intact MS experiments; B. Gassaway for assistance with shotgun MS experiments. We are grateful to members of the Isaacs laboratory, J. Ling and G. Church for critical discussions and feedback. This work was supported by the Defense Advanced Research Projects Agency contracts N66001-12-C-4020 and N66001-12-C-4211 to (F.J.I., J.R., D.S., and M.C.J.), U.S. Department of Energy (DE-FG02-02ER63445 to F.J.I.) grants GM22854 to D.S. and GM67193 to N.L.K. from the National Institute for General Medical Sciences, T32GM007205 and 1F30CA196191 (A.D.H.), Army Research Office (W911NF-11-1-0445 to M.C.J.), the David and Lucile Packard Foundation (M.C.J.), the Camille Dreyfus Teacher-Scholar Program (M.C.J.), DuPont, Inc. (F.J.I.) and the Arnold and Mabel Beckman Foundation (F.J.I.).	Aerni HR, 2015, NUCLEIC ACIDS RES, V43, DOI 10.1093/nar/gku1087; Bae JH, 2001, J MOL BIOL, V309, P925, DOI 10.1006/jmbi.2001.4699; Chin JW, 2014, ANNU REV BIOCHEM, V83, P379, DOI 10.1146/annurev-biochem-060713-035737; Chin JW, 2002, J AM CHEM SOC, V124, P9026, DOI 10.1021/ja027007w; Cooley RB, 2014, BIOCHEMISTRY-US, V53, P1916, DOI 10.1021/bi5001239; DeVito JA, 2008, NUCLEIC ACIDS RES, V36, DOI 10.1093/nar/gkm1084; Dieterich DC, 2006, P NATL ACAD SCI USA, V103, P9482, DOI 10.1073/pnas.0601637103; Furman JL, 2014, J AM CHEM SOC, V136, P8411, DOI 10.1021/ja502851h; Gallagher RR, 2014, NAT PROTOC, V9, P2301, DOI 10.1038/nprot.2014.082; Gibson DG, 2009, NAT METHODS, V6, P343, DOI [10.1038/NMETH.1318, 10.1038/nmeth.1318]; Guo LT, 2014, P NATL ACAD SCI USA, V111, P16724, DOI 10.1073/pnas.1419737111; Heinemann IU, 2012, FEBS LETT, V586, P3716, DOI 10.1016/j.febslet.2012.08.031; Isaacs FJ, 2011, SCIENCE, V333, P348, DOI 10.1126/science.1205822; Johnson DBF, 2011, NAT CHEM BIOL, V7, P779, DOI 10.1038/nchembio.657; Kang MC, 2014, CHEMBIOCHEM, V15, P822, DOI 10.1002/cbic.201300727; Kirshenbaum K, 2002, CHEMBIOCHEM, V3, P235, DOI 10.1002/1439-7633(20020301)3:2/3<235::AID-CBIC235>3.0.CO;2-7; Ko JH, 2013, FEBS LETT, V587, P3243, DOI 10.1016/j.febslet.2013.08.018; Kobayashi T, 2005, P NATL ACAD SCI USA, V102, P1366, DOI 10.1073/pnas.0407039102; KOTHAKOTA S, 1995, J AM CHEM SOC, V117, P536, DOI 10.1021/ja00106a064; Lajoie MJ, 2013, SCIENCE, V342, P361, DOI 10.1126/science.1241460; Lajoie MJ, 2013, SCIENCE, V342, P357, DOI 10.1126/science.1241459; Li X, 2014, CHEMBIOCHEM, V15, P2335, DOI 10.1002/cbic.201402159; Link AJ, 2003, CURR OPIN BIOTECH, V14, P603, DOI 10.1016/j.copbio.2003.10.011; Liu CC, 2010, ANNU REV BIOCHEM, V79, P413, DOI 10.1146/annurev.biochem.052308.105824; MacEwan SR, 2010, BIOPOLYMERS, V94, P60, DOI 10.1002/bip.21327; Mandell DJ, 2015, NATURE, V518, P55, DOI 10.1038/nature14121; Meyer DE, 2002, BIOMACROMOLECULES, V3, P357, DOI 10.1021/bm015630n; Meyer DE, 2004, BIOMACROMOLECULES, V5, P846, DOI 10.1021/bm034215n; Mukai T, 2010, NUCLEIC ACIDS RES, V38, P8188, DOI 10.1093/nar/gkq707; Murphy KC, 1998, J BACTERIOL, V180, P2063, DOI 10.1128/JB.180.8.2063-2071.1998; Nehring S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031992; Nishi Y, 2005, BIOCHEMISTRY-US, V44, P6034, DOI 10.1021/bi047887m; O'Donoghue P, 2013, NAT CHEM BIOL, V9, P594, DOI 10.1038/nchembio.1339; Odoi KA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057035; Park HS, 2011, SCIENCE, V333, P1151, DOI 10.1126/science.1207203; Pedelacq JD, 2006, NAT BIOTECHNOL, V24, P79, DOI 10.1038/nbt1172; Rovner AJ, 2015, NATURE, V518, P89, DOI 10.1038/nature14095; Schultz KC, 2006, J AM CHEM SOC, V128, P13984, DOI 10.1021/ja0636690; Seitchik JL, 2012, J AM CHEM SOC, V134, P2898, DOI 10.1021/ja2109745; Sharan SK, 2009, NAT PROTOC, V4, P206, DOI 10.1038/nprot.2008.227; Stokes AL, 2009, MOL BIOSYST, V5, P1032, DOI 10.1039/b904032c; Tian F, 2014, P NATL ACAD SCI USA, V111, P1766, DOI 10.1073/pnas.1321237111; Tinberg CE, 2013, NATURE, V501, P212, DOI 10.1038/nature12443; Umehara T, 2012, FEBS LETT, V586, P729, DOI 10.1016/j.febslet.2012.01.029; Wang F, 2012, ANGEW CHEM INT EDIT, V51, P10132, DOI 10.1002/anie.201204668; Wang HH, 2009, NATURE, V460, P894, DOI 10.1038/nature08187; Wang L, 2003, P NATL ACAD SCI USA, V100, P56, DOI 10.1073/pnas.0234824100; Wiltschi B, 2008, YEAST, V25, P775, DOI 10.1002/yea.1632; Wu IL, 2013, CHEMBIOCHEM, V14, P968, DOI 10.1002/cbic.201300069; Young DD, 2011, BIOCHEMISTRY-US, V50, P1894, DOI 10.1021/bi101929e; Young TS, 2010, J MOL BIOL, V395, P361, DOI 10.1016/j.jmb.2009.10.030; Yuet KP, 2014, ANN BIOMED ENG, V42, P299, DOI 10.1007/s10439-013-0878-3; Zaher HS, 2009, CELL, V136, P746, DOI 10.1016/j.cell.2009.01.036	53	167	179	14	131	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156	1546-1696		NAT BIOTECHNOL	Nat. Biotechnol.	DEC	2015	33	12					1272	+		10.1038/nbt.3372	http://dx.doi.org/10.1038/nbt.3372			11	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	CY4OO	26571098	Green Accepted, Green Submitted			2022-12-27	WOS:000366387700019
J	Levy, G; Bomze, D; Heinz, S; Ramachandran, SD; Noerenberg, A; Cohen, M; Shibolet, O; Sklan, E; Braspenning, J; Nahmias, Y				Levy, Gahl; Bomze, David; Heinz, Stefan; Ramachandran, Sarada Devi; Noerenberg, Astrid; Cohen, Merav; Shibolet, Oren; Sklan, Ella; Braspenning, Joris; Nahmias, Yaakov			Long-term culture and expansion of primary human hepatocytes	NATURE BIOTECHNOLOGY			English	Article							IMMORTALIZED HUMAN HEPATOCYTES; PLURIPOTENT STEM-CELLS; ADULT-RAT HEPATOCYTES; C VIRUS-INFECTION; HEPARG CELLS; LIVER-CELL; GENE-EXPRESSION; LIPID DROPLET; HEPG2 CELLS; METABOLISM	Hepatocytes have a critical role in metabolism, but their study is limited by the inability to expand primary hepatocytes in vitro while maintaining proliferative capacity and metabolic function. Here we describe the oncostatin M (OSM)-dependent expansion of primary human hepatocytes by low expression of the human papilloma virus (HPV) genes E6 and E7 coupled with inhibition of epithelial-to-mesenchymal transition. We show that E6 and E7 expression upregulates the OSM receptor gp130 and that OSM stimulation induces hepatocytes to expand for up to 40 population doublings, producing 1013 to 1016 cells from a single human hepatocyte isolate. OSM removal induces differentiation into metabolically functional, polarized hepatocytes with functional bile canaliculi. Differentiated hepatocytes show transcriptional and toxicity profiles and cytochrome P450 induction similar to those of primary human hepatocytes. Replication and infectivity of hepatitis C virus (HCV) in differentiated hepatocytes are similar to those of Huh7.5.1 human hepatoma cells. These results offer a means of expanding human hepatocytes of different genetic backgrounds for research, clinical applications and pharmaceutical development.	[Levy, Gahl; Bomze, David; Cohen, Merav; Nahmias, Yaakov] Hebrew Univ Jerusalem, Alexander Grass Ctr Bioengn, Jerusalem, Israel; [Heinz, Stefan; Noerenberg, Astrid] Upcyte Technol GmbH, Hamburg, Germany; [Ramachandran, Sarada Devi; Braspenning, Joris] Medicyte GmbH, Heidelberg, Germany; [Shibolet, Oren] Tel Aviv Med Ctr & Sch Med, Dept Gastroenterol, Liver Unit, Tel Aviv, Israel; [Shibolet, Oren] Tel Aviv Univ, IL-69978 Tel Aviv, Israel; [Sklan, Ella] Tel Aviv Univ, Sackler Fac Med, Dept Clin Microbiol & Immunol, IL-69978 Tel Aviv, Israel; [Cohen, Merav; Nahmias, Yaakov] Hebrew Univ Jerusalem, Dept Cell & Dev Biol, Jerusalem, Israel; [Braspenning, Joris] Fraunhofer Translat Ctr, Wurzburg, Germany	Hebrew University of Jerusalem; Tel Aviv University; Sackler Faculty of Medicine; Tel Aviv University; Tel Aviv University; Sackler Faculty of Medicine; Hebrew University of Jerusalem	Nahmias, Y (corresponding author), Hebrew Univ Jerusalem, Alexander Grass Ctr Bioengn, Jerusalem, Israel.	ynahmias@cs.huji.ac.il	Nahmias, Yaakov/H-4725-2013; Nahmias, Yaakov/AAM-3872-2020	Nahmias, Yaakov/0000-0002-6051-616X; Nahmias, Yaakov/0000-0002-6051-616X; Cohen, Merav/0000-0001-7802-0499; Bomze, David/0000-0003-2958-7055	Forderprogram Biotechnologie Baden-Wurtenberg [720.830-4-03]; European Research Council [242699]; European Commission [HEALTH-F5-2010-266777]; Cosmetics Europe, as part of the SEURAT-1 cluster [HEALTH-F5-2010-266777]	Forderprogram Biotechnologie Baden-Wurtenberg; European Research Council(European Research Council (ERC)European Commission); European Commission(European CommissionEuropean Commission Joint Research Centre); Cosmetics Europe, as part of the SEURAT-1 cluster	The authors wish to thank D. Kitsberg, E. Flashner and T. Golan-Lev for technical support. We also wish to thank M. Vinken, V. Rogiers, N. Benvenisty and S. Bhatia for their comments and suggestions. This work was funded by the Forderprogram Biotechnologie Baden-Wurtenberg (project 720.830-4-03; S.H., S.D.R., A.N. and J.B.), European Research Council Starting Grant TMIHCV (project 242699; G.L., D.B., M.C. and Y.N.), and HeMiBio: a jointly funded consortium by the European Commission and Cosmetics Europe, as part of the SEURAT-1 cluster (project HEALTH-F5-2010-266777).	Aly HH, 2007, J HEPATOL, V46, P26, DOI 10.1016/j.jhep.2006.08.018; Antherieu S, 2010, DRUG METAB DISPOS, V38, P516, DOI 10.1124/dmd.109.030197; ARLOTTO MP, 1991, METHOD ENZYMOL, V206, P454; Avior Y, 2015, HEPATOLOGY, V62, P265, DOI 10.1002/hep.27803; Bauknecht T, 1999, VIROLOGY, V258, P344, DOI 10.1006/viro.1999.9722; Behnia K, 2000, TISSUE ENG, V6, P467, DOI 10.1089/107632700750022125; Ben-David U, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5825; Burkard A, 2012, XENOBIOTICA, V42, P939, DOI 10.3109/00498254.2012.675093; Clayton RF, 2005, LIVER INT, V25, P389, DOI 10.1111/j.1478-3231.2005.01017.x; Dierssen U, 2008, J BIOL CHEM, V283, P9886, DOI 10.1074/jbc.M705483200; Donato MT, 2004, DRUG METAB DISPOS, V32, P699, DOI 10.1124/dmd.32.7.699; Ducy P, 2000, CELL, V100, P197, DOI 10.1016/S0092-8674(00)81558-5; Duncan AW, 2012, GASTROENTEROLOGY, V142, P25, DOI 10.1053/j.gastro.2011.10.029; Duncan AW, 2010, NATURE, V467, P707, DOI 10.1038/nature09414; EKINS S, 1995, DRUG METAB DISPOS, V23, P1274; Gerets HHJ, 2012, CELL BIOL TOXICOL, V28, P69, DOI 10.1007/s10565-011-9208-4; Guillouzo A, 2007, CHEM-BIOL INTERACT, V168, P66, DOI 10.1016/j.cbi.2006.12.003; HABIG WH, 1974, P NATL ACAD SCI USA, V71, P3879, DOI 10.1073/pnas.71.10.3879; Ishiji Takaoki, 2000, Journal of Dermatology (Tokyo), V27, P73; Kaplowitz N, 2005, NAT REV DRUG DISCOV, V4, P489, DOI 10.1038/nrd1750; Khetani SR, 2008, NAT BIOTECHNOL, V26, P120, DOI 10.1038/nbt1361; Kidambi S, 2009, P NATL ACAD SCI USA, V106, P15714, DOI 10.1073/pnas.0906820106; Klochendler A, 2012, DEV CELL, V23, P681, DOI 10.1016/j.devcel.2012.08.009; Mitaka T, 1998, INT J EXP PATHOL, V79, P393, DOI 10.1046/j.1365-2613.1998.00083.x; Miyanari Y, 2007, NAT CELL BIOL, V9, P1089, DOI 10.1038/ncb1631; Moody CA, 2010, NAT REV CANCER, V10, P550, DOI 10.1038/nrc2886; MUNGER K, 1989, J VIROL, V63, P4417; Nahmias Y, 2007, ADV BIOCHEM ENG BIOT, V103, P309, DOI 10.1007/10_029; Nakamura K, 2004, HEPATOLOGY, V39, P635, DOI 10.1002/hep.20086; Ndongo-Thiam N, 2011, HEPATOLOGY, V54, P406, DOI 10.1002/hep.24386; Nevo-Yassaf I, 2012, J VIROL, V86, P6491, DOI 10.1128/JVI.00496-12; NYBERG SL, 1994, ANN SURG, V220, P59; Parent R, 2004, GASTROENTEROLOGY, V126, P1147, DOI 10.1053/j.gastro.2004.01.002; Ploss A, 2010, P NATL ACAD SCI USA, V107, P3141, DOI 10.1073/pnas.0915130107; Pollack V, 2007, AM J PHYSIOL-RENAL, V293, pF1714, DOI 10.1152/ajprenal.00130.2007; Runge D, 2000, BIOCHEM BIOPH RES CO, V274, P1, DOI 10.1006/bbrc.2000.2912; Schaller T, 2007, J VIROL, V81, P4591, DOI 10.1128/JVI.02144-06; Schippers IJ, 1997, CELL BIOL TOXICOL, V13, P375, DOI 10.1023/A:1007404028681; Shan J, 2013, NAT CHEM BIOL, V9, P514, DOI 10.1038/nchembio.1270; SHIMAOKA S, 1987, EXP CELL RES, V172, P228, DOI 10.1016/0014-4827(87)90109-1; Si-Tayeb K, 2010, HEPATOLOGY, V51, P297, DOI 10.1002/hep.23354; Sivertsson L, 2010, DRUG METAB DISPOS, V38, P995, DOI 10.1124/dmd.110.032367; Szkolnicka D, 2014, STEM CELL TRANSL MED, V3, P141, DOI 10.5966/sctm.2013-0146; Takebe T, 2013, NATURE, V499, P481, DOI 10.1038/nature12271; Trautwein C, 1996, J BIOL CHEM, V271, P22262, DOI 10.1074/jbc.271.36.22262; Tsuruga Y, 2008, CELL TRANSPLANT, V17, P1083, DOI 10.3727/096368908786991542; Westerink WMA, 2007, TOXICOL IN VITRO, V21, P1581, DOI 10.1016/j.tiv.2007.05.014; Wilkening S, 2003, DRUG METAB DISPOS, V31, P1035, DOI 10.1124/dmd.31.8.1035; YAMAMOTO N, 1989, CELL STRUCT FUNCT, V14, P217, DOI 10.1247/csf.14.217; Yu H, 2014, NAT REV CANCER, V14, P736, DOI 10.1038/nrc3818; Zhong J, 2005, P NATL ACAD SCI USA, V102, P9294, DOI 10.1073/pnas.0503596102	51	93	103	0	49	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156	1546-1696		NAT BIOTECHNOL	Nat. Biotechnol.	DEC	2015	33	12					1264	+		10.1038/nbt.3377	http://dx.doi.org/10.1038/nbt.3377			10	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	CY4OO	26501953				2022-12-27	WOS:000366387700018
J	Guan, JC; Koch, KE				Guan, Jiahn-Chou; Koch, Karen E.			A time and a place for sugar in your ears	NATURE BIOTECHNOLOGY			English	Editorial Material							SUCROSE METABOLISM; EXPRESSION; DROUGHT; MECHANISMS		[Guan, Jiahn-Chou; Koch, Karen E.] Univ Florida, Dept Hort Sci, Gainesville, FL 32611 USA	State University System of Florida; University of Florida	Guan, JC (corresponding author), Univ Florida, Dept Hort Sci, Gainesville, FL 32611 USA.	kekoch@ufl.edu			Division Of Integrative Organismal Systems [1116561] Funding Source: National Science Foundation	Division Of Integrative Organismal Systems(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))		Andersen MN, 2002, PLANT PHYSIOL, V130, P591, DOI 10.1104/pp.005637; Berjak P, 2013, FRONT PLANT SCI, V4, DOI [10.3389/fpls.2013.00177, 10.3389/fpls.2013.00478]; Boyer JS, 2004, J EXP BOT, V55, P2385, DOI 10.1093/jxb/erh219; Kakumanu A, 2012, PLANT PHYSIOL, V160, P846, DOI 10.1104/pp.112.200444; Koch K, 2004, CURR OPIN PLANT BIOL, V7, P235, DOI 10.1016/j.pbi.2004.03.014; Li HW, 2011, PLANTA, V234, P1007, DOI 10.1007/s00425-011-1458-0; Nuccio ML, 2015, NAT BIOTECHNOL, V33, P862, DOI 10.1038/nbt.3277; Wobus U, 1999, BIOL CHEM, V380, P937, DOI 10.1515/BC.1999.116; Xu J, 1996, PLANT CELL, V8, P1209, DOI 10.1105/tpc.8.7.1209; Yadav UP, 2014, J EXP BOT, V65, P1051, DOI 10.1093/jxb/ert457	10	7	7	0	16	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1087-0156	1546-1696		NAT BIOTECHNOL	Nat. Biotechnol.	AUG	2015	33	8					827	828		10.1038/nbt.3315	http://dx.doi.org/10.1038/nbt.3315			2	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	CO6OB	26252140				2022-12-27	WOS:000359274900018
J	Sheridan, C				Sheridan, Cormac			New class PCSK9 blockers stride into cholesterol market	NATURE BIOTECHNOLOGY			English	News Item							STATIN THERAPY											2015, EUR HEART J, V36, P1012; 2012, NAT BIOTECHNOL, V30, P302; 2015, NEW ENGL J MED, V372, P2387; 2012, J AMER HEART ASSOC, V1, P1800	4	5	6	0	1	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156	1546-1696		NAT BIOTECHNOL	Nat. Biotechnol.	AUG	2015	33	8					785	786		10.1038/nbt0815-785	http://dx.doi.org/10.1038/nbt0815-785			2	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	CO6OB	26252118				2022-12-27	WOS:000359274900003
J	Maza, I; Caspi, I; Zviran, A; Chomsky, E; Rais, Y; Viukov, S; Geula, S; Buenrostro, JD; Weinberger, L; Krupalnik, V; Hanna, S; Zerbib, M; Dutton, JR; Greenleaf, WJ; Massarwa, R; Novershtern, N; Hanna, JH				Maza, Itay; Caspi, Inbal; Zviran, Asaf; Chomsky, Elad; Rais, Yoach; Viukov, Sergey; Geula, Shay; Buenrostro, Jason D.; Weinberger, Leehee; Krupalnik, Vladislav; Hanna, Suhair; Zerbib, Mirie; Dutton, James R.; Greenleaf, William J.; Massarwa, Rada; Novershtern, Noa; Hanna, Jacob H.			Transient acquisition of pluripotency during somatic cell transdifferentiation with iPSC reprogramming factors	NATURE BIOTECHNOLOGY			English	Article							MOUSE FIBROBLASTS; DIRECT CONVERSION; NANOG; HEPATOCYTES; ACTIVATION	Somatic cells can be transdifferentiated to other cell types without passing through a pluripotent state by ectopic expression of appropriate transcription factors(1,2). Recent reports have proposed an alternative transdifferentiation method in which fibroblasts are directly converted to various mature somatic cell types by brief expression of the induced pluripotent stem cell (iPSC) reprogramming factors Oct4, Sox2, Klf4 and c-Myc (OSKM) followed by cell expansion in media that promote lineage differentiation(3-6). Here we test this method using genetic lineage tracing for expression of endogenous Nanog and Oct4 and for X chromosome reactivation, as these events mark acquisition of pluripotency. We show that the vast majority of reprogrammed cardiomyocytes or neural stem cells obtained from mouse fibroblasts by OSKM-induced 'transdifferentiation' pass through a transient pluripotent state, and that their derivation is molecularly coupled to iPSC formation mechanisms. Our findings underscore the importance of defining trajectories during cell reprogramming by various methods.	[Maza, Itay; Caspi, Inbal; Zviran, Asaf; Chomsky, Elad; Rais, Yoach; Viukov, Sergey; Geula, Shay; Weinberger, Leehee; Krupalnik, Vladislav; Hanna, Suhair; Zerbib, Mirie; Massarwa, Rada; Novershtern, Noa; Hanna, Jacob H.] Weizmann Inst Sci, Dept Mol Genet, IL-76100 Rehovot, Israel; [Maza, Itay] Rambam Hlth Care Campus, Dept Gastroenterol, Haifa, Israel; [Maza, Itay; Hanna, Suhair] Technion Israel Inst Technol, Bruce Rappaport Sch Med, Haifa, Israel; [Buenrostro, Jason D.; Greenleaf, William J.] Stanford Univ, Sch Med, Dept Genet, Stanford, CA 94305 USA; [Hanna, Suhair] Rambam Hlth Care Campus, Dept Pediat, Haifa, Israel; [Hanna, Suhair] Rambam Hlth Care Campus, Pediat Immunol Unit, Haifa, Israel; [Dutton, James R.] Univ Minnesota, Stem Cell Inst, Minneapolis, MN USA	Weizmann Institute of Science; Rambam Health Care Campus; Technion Israel Institute of Technology; Rappaport Faculty of Medicine; Stanford University; Rambam Health Care Campus; Rambam Health Care Campus; University of Minnesota System; University of Minnesota Twin Cities	Hanna, JH (corresponding author), Weizmann Inst Sci, Dept Mol Genet, IL-76100 Rehovot, Israel.	rada.massarwa@weizmann.ac.il; noa.novershtern@weizmann.ac.il; jacob.hanna@weizmann.ac.il	Hanna, Jacob/K-1339-2012; Geula, Shay Yosef/Z-3789-2019	Hanna, Jacob/0000-0003-2042-9974; Geula, Shay Yosef/0000-0001-8111-4410; Maza, Itay/0000-0003-3877-6501; Novershtern, Noa/0000-0002-2244-6877	New York Stem Cell Foundation (NYSCF); FAMRI; Kimmel Innovator Research Award; ERC [StG-2011-281906]; Leona M. and Harry B. Helmsley Charitable Trust; Morass Cancer Institute; Israel Science Foundation Regular research program; ICRF Foundation; Helen and Martin Kimmel Institute for Stem Cell research (HMKISCR); Benoziyo Endowment fund; HFSPO research grant; Weizmann Institute management; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007790] Funding Source: NIH RePORTER	New York Stem Cell Foundation (NYSCF); FAMRI; Kimmel Innovator Research Award; ERC(European Research Council (ERC)European Commission); Leona M. and Harry B. Helmsley Charitable Trust; Morass Cancer Institute; Israel Science Foundation Regular research program; ICRF Foundation; Helen and Martin Kimmel Institute for Stem Cell research (HMKISCR); Benoziyo Endowment fund; HFSPO research grant; Weizmann Institute management; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	J.H.H. is supported by a generous gift from I. and P. Mantoux; the New York Stem Cell Foundation (NYSCF), FAMRI, the Kimmel Innovator Research Award, the ERC (StG-2011-281906), the Leona M. and Harry B. Helmsley Charitable Trust, Morass Cancer Institute, the Israel Science Foundation Regular research program, the ICRF Foundation, Helen and Martin Kimmel Institute for Stem Cell research (HMKISCR), the Benoziyo Endowment fund. J.H.H. and W.G. are supported by an HFSPO research grant. J.H.H. is a New York Stem Cell Foundation - Robertson Investigator. We thank K. Hochedlinger for mutual exchange of results and discussions before publication. We thank Weizmann Institute management for providing critical financial and infrastructural support.	Bar-Nur O, 2015, NAT BIOTECHNOL, V33, P761, DOI 10.1038/nbt.3247; Buenrostro JD, 2013, NAT METHODS, V10, P1213, DOI [10.1038/NMETH.2688, 10.1038/nmeth.2688]; Buganim Y, 2012, CELL, V150, P1209, DOI 10.1016/j.cell.2012.08.023; Carey BW, 2010, NAT METHODS, V7, P56, DOI [10.1038/NMETH.1410, 10.1038/nmeth.1410]; Carter AC, 2014, STEM CELL REP, V2, P119, DOI 10.1016/j.stemcr.2013.12.010; Chambers I, 2007, NATURE, V450, P1230, DOI 10.1038/nature06403; Efe JA, 2011, NAT CELL BIOL, V13, P215, DOI 10.1038/ncb2164; Festuccia N, 2012, CELL STEM CELL, V11, P477, DOI 10.1016/j.stem.2012.08.002; Gafni O, 2013, NATURE, V504, P282, DOI 10.1038/nature12745; Graf T, 2009, NATURE, V462, P587, DOI 10.1038/nature08533; Greder LV, 2012, STEM CELLS, V30, P2596, DOI 10.1002/stem.1216; Hadjantonakis AK, 2001, GENESIS, V29, P133, DOI 10.1002/gene.1016; Hanna J, 2008, CELL, V133, P250, DOI 10.1016/j.cell.2008.03.028; Hanna J, 2009, CELL STEM CELL, V4, P513, DOI 10.1016/j.stem.2009.04.015; Kim J, 2011, P NATL ACAD SCI USA, V108, P7838, DOI 10.1073/pnas.1103113108; Ko K, 2010, NAT PROTOC, V5, P921, DOI 10.1038/nprot.2010.44; Kurian L, 2013, NAT METHODS, V10, P77, DOI [10.1038/NMETH.2255, 10.1038/nmeth.2255]; Maherali N, 2007, CELL STEM CELL, V1, P55, DOI 10.1016/j.stem.2007.05.014; Marro S, 2011, CELL STEM CELL, V9, P374, DOI 10.1016/j.stem.2011.09.002; Mitsui K, 2003, CELL, V113, P631, DOI 10.1016/S0092-8674(03)00393-3; Papp B, 2013, CELL, V152, P1324, DOI 10.1016/j.cell.2013.02.043; Rodriguez-Ubreva J, 2012, NUCLEIC ACIDS RES, V40, P1954, DOI 10.1093/nar/gkr1015; Schwarz BA, 2014, CURR BIOL, V24, P347, DOI 10.1016/j.cub.2013.12.050; Silva J, 2009, CELL, V138, P722, DOI 10.1016/j.cell.2009.07.039; Szabo E, 2010, NATURE, V468, P521, DOI 10.1038/nature09591; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; Vierbuchen T, 2011, NAT BIOTECHNOL, V29, P892, DOI 10.1038/nbt.1946; Vierbuchen T, 2010, NATURE, V463, P1035, DOI 10.1038/nature08797; Yang JA, 2010, CELL STEM CELL, V7, P319, DOI 10.1016/j.stem.2010.06.022; Yuan X, 2011, STEM CELLS, V29, P549, DOI 10.1002/stem.594; Zhu SY, 2014, NATURE, V508, P93, DOI 10.1038/nature13020	31	99	99	2	21	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156	1546-1696		NAT BIOTECHNOL	Nat. Biotechnol.	JUL	2015	33	7					769	774		10.1038/nbt.3270	http://dx.doi.org/10.1038/nbt.3270			6	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	CN4JJ	26098448	Green Submitted, Green Accepted			2022-12-27	WOS:000358396100034
J	Nussinovitch, U; Gepstein, L				Nussinovitch, Udi; Gepstein, Lior			Optogenetics for in vivo cardiac pacing and resynchronization therapies	NATURE BIOTECHNOLOGY			English	Article							MESENCHYMAL STEM-CELLS; IMPLANTABLE DEFIBRILLATOR; OPTICAL CONTROL; MUSCLE	Abnormalities in the specialized cardiac conduction system may result in slow heart rate or mechanical dyssynchrony. Here we apply optogenetics, widely used to modulate neuronal excitability(1-4), for cardiac pacing and resynchronization. We used adeno-associated virus (AAV) 9 to express the Channelrhodopsin-2 (ChR2) transgene at one or more ventricular sites in rats. This allowed optogenetic pacing of the hearts at different beating frequencies with blue-light illumination both in vivo and in isolated perfused hearts. Optical mapping confirmed that the source of the new pacemaker activity was the site of ChR2 transgene delivery. Notably, diffuse illumination of hearts where the ChR2 transgene was delivered to several ventricular sites resulted in electrical synchronization and significant shortening of ventricular activation times. These findings highlight the unique potential of optogenetics for cardiac pacing and resynchronization therapies.	[Nussinovitch, Udi; Gepstein, Lior] Technion Israel Inst Technol, Rappaport Fac Med, Sohnis Lab Cardiac Electrophysiol & Regenerat Med, Haifa, Israel; [Nussinovitch, Udi; Gepstein, Lior] Technion Israel Inst Technol, Res Inst, Haifa, Israel; [Nussinovitch, Udi; Gepstein, Lior] Rambam Hlth Care Campus, Haifa, Israel	Technion Israel Institute of Technology; Rappaport Faculty of Medicine; Technion Israel Institute of Technology; Rambam Health Care Campus	Gepstein, L (corresponding author), Technion Israel Inst Technol, Rappaport Fac Med, Sohnis Lab Cardiac Electrophysiol & Regenerat Med, Haifa, Israel.	mdlior@tx.technion.ac.il	Core, Vector/CAF-4832-2022		NOFAR project from the Office of the Chief Scientist (OCS) in the Israel Ministry of Economy; Israel Science Foundation [1609/14]; Nancy & Stephen Grand Philanthropic Fund	NOFAR project from the Office of the Chief Scientist (OCS) in the Israel Ministry of Economy; Israel Science Foundation(Israel Science Foundation); Nancy & Stephen Grand Philanthropic Fund	This study was supported in part by the NOFAR project from the Office of the Chief Scientist (OCS) in the Israel Ministry of Economy, by the Israel Science Foundation (1609/14) and by the Nancy & Stephen Grand Philanthropic Fund. We thank C. Giridish for his technical help with the light sources. Also, we wish to thank I. Huber (from the Rappaport Faculty of Medicine, Technion), E. Suss-Toby, M. Holdengreber Shahar and L. Leiba (Imaging center at the Faculty of Medicine, Technion) and S. Ben Eliezer (Pathology Department, Rambam Health Center, Haifa, Israel) for their help with histological slide processing and their assistance with results analysis.	Arrenberg AB, 2010, SCIENCE, V330, P971, DOI 10.1126/science.1195929; Boyden ES, 2005, NAT NEUROSCI, V8, P1263, DOI 10.1038/nn1525; Boyle PM, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3370; Bristow MR, 2004, NEW ENGL J MED, V350, P2140, DOI 10.1056/NEJMoa032423; Bruegmann T, 2010, NAT METHODS, V7, P897, DOI 10.1038/nmeth.1512; Cho HC, 2010, CIRC RES, V106, P674, DOI 10.1161/CIRCRESAHA.109.212936; Deisseroth K, 2011, NAT METHODS, V8, P26, DOI 10.1038/NMETH.F.324; Inagaki K, 2006, MOL THER, V14, P45, DOI 10.1016/j.ymthe.2006.03.014; Jia ZH, 2011, CIRC-ARRHYTHMIA ELEC, V4, P753, DOI 10.1161/CIRCEP.111.964247; Kapoor N, 2013, NAT BIOTECHNOL, V31, P54, DOI 10.1038/nbt.2465; Kehat I, 2004, NAT BIOTECHNOL, V22, P1282, DOI 10.1038/nbt1014; Kravitz AV, 2011, CURR OPIN NEUROBIOL, V21, P433, DOI 10.1016/j.conb.2011.02.010; Lin JY, 2013, NAT NEUROSCI, V16, P1499, DOI 10.1038/nn.3502; Miake J, 2002, NATURE, V419, P132, DOI 10.1038/419132b; Nagel G, 2003, P NATL ACAD SCI USA, V100, P13940, DOI 10.1073/pnas.1936192100; Nussinovitch U, 2014, CARDIOVASC RES, V102, P176, DOI 10.1093/cvr/cvu037; Plotnikov AN, 2007, CIRCULATION, V116, P706, DOI 10.1161/CIRCULATIONAHA.107.703231; Plotnikov AN, 2004, CIRCULATION, V109, P506, DOI 10.1161/01.CIR.0000114527.10764.CC; Potapova I, 2004, CIRC RES, V94, P952, DOI 10.1161/01.RES.0000123827.60210.72; Rosen MR, 2011, NAT REV CARDIOL, V8, P656, DOI 10.1038/nrcardio.2011.120; Szobota S, 2010, ANNU REV BIOPHYS, V39, P329, DOI 10.1146/annurev.biophys.093008.131400; Wilkoff BL, 2002, JAMA-J AM MED ASSOC, V288, P3115	22	132	136	1	40	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156	1546-1696		NAT BIOTECHNOL	Nat. Biotechnol.	JUL	2015	33	7					750	754		10.1038/nbt.3268	http://dx.doi.org/10.1038/nbt.3268			5	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	CN4JJ	26098449				2022-12-27	WOS:000358396100031
J	van Rooyen, P				van Rooyen, Pieter			Bridging tech and biotech	NATURE BIOTECHNOLOGY			English	Editorial Material									Edico Genome, La Jolla, CA 92037 USA		van Rooyen, P (corresponding author), Edico Genome, La Jolla, CA 92037 USA.	pieter@edicogenome.com							0	1	1	0	2	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156	1546-1696		NAT BIOTECHNOL	Nat. Biotechnol.	JUN	2015	33	6					581	583		10.1038/nbt.3260	http://dx.doi.org/10.1038/nbt.3260			3	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	CK2DE	26057967	Bronze			2022-12-27	WOS:000356019700007
J	Faridani, OR; Sandberg, R				Faridani, Omid R.; Sandberg, Rickard			Putting cells in their place	NATURE BIOTECHNOLOGY			English	Editorial Material							IN-SITU; TISSUE		[Faridani, Omid R.] Ludwig Inst Canc Res, S-10401 Stockholm, Sweden; Karolinska Inst, Dept Cell & Mol Biol, Stockholm, Sweden	Ludwig Institute for Cancer Research; Karolinska Institutet	Faridani, OR (corresponding author), Ludwig Inst Canc Res, S-10401 Stockholm, Sweden.	omid.faridani@licr.ki.se; rickard.sandberg@ki.se		Faridani, Omid/0000-0001-9330-887X; Sandberg, Rickard/0000-0001-6473-1740				Achim K, 2015, NAT BIOTECHNOL, V33, P503, DOI 10.1038/nbt.3209; Chung K, 2013, NATURE, V497, P332, DOI 10.1038/nature12107; Crosetto N, 2015, NAT REV GENET, V16, P57, DOI 10.1038/nrg3832; Junker JP, 2014, CELL, V159, P662, DOI 10.1016/j.cell.2014.09.038; Ke RQ, 2013, NAT METHODS, V10, P857, DOI 10.1038/nmeth.2563; Lee JH, 2014, SCIENCE, V343, P1360, DOI 10.1126/science.1250212; Lein ES, 2007, NATURE, V445, P168, DOI 10.1038/nature05453; Lovatt D, 2014, NAT METHODS, V11, P190, DOI [10.1038/NMETH.2804, 10.1038/nmeth.2804]; Sandberg R, 2014, NAT METHODS, V11, P22, DOI 10.1038/nmeth.2764; Satija R, 2015, NAT BIOTECHNOL, V33, P495, DOI 10.1038/nbt.3192	10	3	3	0	15	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156	1546-1696		NAT BIOTECHNOL	Nat. Biotechnol.	MAY	2015	33	5					490	491		10.1038/nbt.3219	http://dx.doi.org/10.1038/nbt.3219			2	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	CH8VP	25965757				2022-12-27	WOS:000354314500027
J	Perkins, MD; Kessel, M				Perkins, Mark D.; Kessel, Mark			What Ebola tells us about outbreak diagnostic readiness	NATURE BIOTECHNOLOGY			English	Article							HEMORRHAGIC-FEVER; IMMUNOSORBENT-ASSAY; VIRUS; ANTIBODIES; CONGO; IGG; PCR		[Perkins, Mark D.; Kessel, Mark] FIND, Geneva, Switzerland	Foundation For Innovative New Diagnostics	Perkins, MD (corresponding author), FIND, Geneva, Switzerland.	mark.perkins@finddx.org						Becquart P., PLOS ONE, V5, pe9126; Bitar D, 2009, EUROSURVEILLANCE, V14; Bolkan H.A., 2014, J PLOS CURR, V6, DOI [10.1371/currents.dis.8b3c24217d80f3975618fc9d9228a144., DOI 10.1371/CURRENTS.DIS.8B3C24217D80F3975618FC9D9228A144]; Cho KS, 2014, EPIDEMIOL HEALTH, V36, DOI 10.4178/epih/e2014004; Fink S., 2015, THE NEW YORK TIMES; Formenty P, 2006, CLIN INFECT DIS, V42, P1521, DOI 10.1086/503836; Heffernan RT, 2005, J INFECT DIS, V191, P964, DOI 10.1086/427994; Kim J.Y., 2014, THE NEW YORK TIMES; KSIAZEK TG, 1992, J CLIN MICROBIOL, V30, P947, DOI 10.1128/JCM.30.4.947-950.1992; Ksiazek TG, 1999, J INFECT DIS, V179, pS177, DOI 10.1086/514321; Ksiazek TG, 1999, J INFECT DIS, V179, pS192, DOI 10.1086/514313; Kuan MM, 2010, INT J INFECT DIS, V14, pE693, DOI 10.1016/j.ijid.2009.12.010; Leroy EM, 2000, LANCET, V355, P2210, DOI 10.1016/S0140-6736(00)02405-3; Leroy EM, 2000, J MED VIROL, V60, P463, DOI 10.1002/(SICI)1096-9071(200004)60:4&lt;463::AID-JMV15&gt;3.0.CO;2-M; McBride WJH, 2010, AUST NZ J PUBL HEAL, V34, P5, DOI 10.1111/j.1753-6405.2010.00466.x; Priest PC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0014490; Saijo M, 2005, J MED VIROL, V76, P111, DOI 10.1002/jmv.20332; Schieffelin JS, 2014, NEW ENGL J MED, V371, P2092, DOI 10.1056/NEJMoa1411680; Towner JS, 2004, J VIROL, V78, P4330, DOI 10.1128/JVI.78.8.4330-4341.2004; WHO, 2013, WORLD MALARIA REPORT 2013, P1	20	29	32	0	4	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156	1546-1696		NAT BIOTECHNOL	Nat. Biotechnol.	MAY	2015	33	5					464	469		10.1038/nbt.3215	http://dx.doi.org/10.1038/nbt.3215			6	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	CH8VP	25965752	Bronze			2022-12-27	WOS:000354314500023
J	Scholz, C; Weinert, BT; Wagner, SA; Beli, P; Miyake, Y; Qi, J; Jensen, LJ; Streicher, W; McCarthy, AR; Westwood, NJ; Lain, S; Cox, J; Matthias, P; Mann, M; Bradner, JE; Choudhary, C				Scholz, Christian; Weinert, Brian T.; Wagner, Sebastian A.; Beli, Petra; Miyake, Yasuyuki; Qi, Jun; Jensen, Lars J.; Streicher, Werner; McCarthy, Anna R.; Westwood, Nicholas J.; Lain, Sonia; Cox, Juergen; Matthias, Patrick; Mann, Matthias; Bradner, James E.; Choudhary, Chunaram			Acetylation site specificities of lysine deacetylase inhibitors in human cells	NATURE BIOTECHNOLOGY			English	Article							CYTOSCAPE PLUG-IN; HISTONE DEACETYLASE; COHESIN ACETYLATION; HDAC INHIBITORS; GENE ONTOLOGY; PROTEIN; MECHANISMS; ESTABLISHMENT; PHYSIOLOGY; REGULATOR	Lysine deacetylases inhibitors (KDACIs) are used in basic research, and many are being investigated in clinical trials for treatment of cancer and other diseases. However, their specificities in cells are incompletely characterized. Here we used quantitative mass spectrometry (MS) to obtain acetylation signatures for 19 different KDACIs, covering all 18 human lysine deacetylases. Most KDACIs increased acetylation of a small, specific subset of the acetylome, including sites on histones and other chromatin-associated proteins. Inhibitor treatment combined with genetic deletion showed that the effects of the pan-sirtuin inhibitor nicotinamide are primarily mediated by SIRT1 inhibition. Furthermore, we confirmed that the effects of tubacin and bufexamac on cytoplasmic proteins result from inhibition of HDAC6. Bufexamac also triggered an HDAC6-independent, hypoxia-like response by stabilizing HIF1-alpha, providing a possible mechanistic explanation of its adverse, pro-inflammatory effects. Our results offer a systems view of KDACI specificities, providing a framework for studying function of acetylation and deacetylases.	[Scholz, Christian; Weinert, Brian T.; Wagner, Sebastian A.; Beli, Petra; Choudhary, Chunaram] Univ Copenhagen, Fac Hlth & Med Sci, Dept Prote, Novo Nordisk Fdn,Ctr Prot Res, Copenhagen, Denmark; [Miyake, Yasuyuki; Matthias, Patrick] Friedrich Miescher Inst Biomed Res, Basel, Switzerland; [Qi, Jun; Bradner, James E.] Harvard Univ, Sch Med, Dana Farber Canc Inst, Dept Med Oncol, Boston, MA 02115 USA; [Jensen, Lars J.] Univ Copenhagen, Fac Hlth Sci, Dept Prot Sci & Technol, Novo Nordisk Fdn,Ctr Prot Res, Copenhagen, Denmark; [Streicher, Werner] Univ Copenhagen, Fac Hlth Sci, Dept Dis Syst Biol, Novo Nordisk Fdn,Ctr Prot Res, Copenhagen, Denmark; [McCarthy, Anna R.; Lain, Sonia] Karolinska Inst, Dept Microbiol Tumor & Cell Biol, Stockholm, Sweden; [Westwood, Nicholas J.] Univ St Andrews, EaStCHEM, Sch Chem, St Andrews, Fife, Scotland; [Westwood, Nicholas J.] Univ St Andrews, EaStCHEM, St Andrews, Fife, Scotland; [Cox, Juergen; Mann, Matthias] Max Planck Inst Biochem, Dept Prote & Signal Transduct, D-82152 Martinsried, Germany	Novo Nordisk Foundation; University of Copenhagen; Friedrich Miescher Institute for Biomedical Research; Harvard University; Dana-Farber Cancer Institute; Harvard Medical School; Novo Nordisk Foundation; University of Copenhagen; Novo Nordisk Foundation; University of Copenhagen; Karolinska Institutet; University of St Andrews; University of St Andrews; Max Planck Society	Choudhary, C (corresponding author), Univ Copenhagen, Fac Hlth & Med Sci, Dept Prote, Novo Nordisk Fdn,Ctr Prot Res, Copenhagen, Denmark.	chuna.choudhary@cpr.ku.dk	Jensen, Lars Juhl/C-6492-2008; Schölz, Christian/K-2855-2014; Miyake, Yasuyuki/AAS-1504-2021; Lain, Sonia/B-6980-2014; Cox, Jurgen/B-9481-2008; choudhary, chunaram/ABE-6634-2020	Jensen, Lars Juhl/0000-0001-7885-715X; Schölz, Christian/0000-0002-1633-2072; Miyake, Yasuyuki/0000-0001-6250-0260; Lain, Sonia/0000-0001-9693-5246; Cox, Jurgen/0000-0001-8597-205X; choudhary, chunaram/0000-0002-9863-433X; Beli, Petra/0000-0001-9507-9820; Streicher, Werner/0000-0002-2425-5839; Weinert, Brian/0000-0002-1335-9915; Westwood, Nicholas/0000-0003-0630-0138	Novo Nordisk Foundation [NNF14CC0001]; Danish Research Council [FSS: 10-085134, FSS: 12-12610]; EMBO Young Investigator program; Doris Duke Charitable Foundation; Novo Nordisk Fonden [NNF14OC0008541, NNF15SA0018240] Funding Source: researchfish; Novo Nordisk Foundation Center for Protein Research [PI Matthias Mann, PI Chunaram Choudhary] Funding Source: researchfish	Novo Nordisk Foundation(Novo Nordisk FoundationNovocure Limited); Danish Research Council(Det Frie Forskningsrad (DFF)); EMBO Young Investigator program(European Molecular Biology Organization (EMBO)); Doris Duke Charitable Foundation(Doris Duke Charitable Foundation (DDCF)); Novo Nordisk Fonden(Novo Nordisk Foundation); Novo Nordisk Foundation Center for Protein Research	We thank the members of the department of proteomics at CPR for their helpful discussions. We thank T. Narita for providing help with bioinformatic analyses. We thank R. Lavallee, D. Bekker-Jensen, H.C. Grell and B. Smith for their technical support. We gratefully acknowledge M. W. McBurney for providing SIRT1 knockout MEFs, D. Reinberg for providing SIRT2 knockout MEFs, and R. Mostoslavsky for providing SIRT6 knockout MEFs. This work was supported by the Hallas Moller Investigator grant from the Novo Nordisk Foundation to C.C. S.A.W. and P.B. were supported by individual postdoctoral grants from the Danish Research Council (FSS: 10-085134, FSS: 12-12610). C.C. is supported by the EMBO Young Investigator program. The Center for Protein Research is supported by a generous grant from the Novo Nordisk Foundation (grant no. NNF14CC0001). J.E.B. is supported by a grant from the Doris Duke Charitable Foundation. We thank the PRIDE team for their support with data storage.	Anderson KA, 2012, ESSAYS BIOCHEM, V52, P23, DOI [10.1042/BSE0520023, 10.1042/bse0520023]; Archin NM, 2012, NATURE, V487, P482, DOI 10.1038/nature11286; Balasubramanian S, 2008, LEUKEMIA, V22, P1026, DOI 10.1038/leu.2008.9; Bantscheff M, 2011, NAT BIOTECHNOL, V29, P255, DOI 10.1038/nbt.1759; Ben-Shahar TR, 2008, SCIENCE, V321, P563, DOI 10.1126/science.1157774; Bindea G, 2009, BIOINFORMATICS, V25, P1091, DOI 10.1093/bioinformatics/btp101; Bitterman KJ, 2002, J BIOL CHEM, V277, P45099, DOI 10.1074/jbc.M205670200; Bolden JE, 2006, NAT REV DRUG DISCOV, V5, P769, DOI 10.1038/nrd2133; Bradner JE, 2010, NAT CHEM BIOL, V6, P238, DOI 10.1038/NCHEMBIO.313; Buggy JJ, 2006, MOL CANCER THER, V5, P1309, DOI 10.1158/1535-7163.MCT-05-0442; Chen Y, 2012, MOL CELL PROTEOMICS, V11, P1048, DOI 10.1074/mcp.M112.019547; Cheung WL, 2000, CURR OPIN CELL BIOL, V12, P326, DOI 10.1016/S0955-0674(00)00096-X; Choudhary C, 2009, SCIENCE, V325, P834, DOI 10.1126/science.1175371; Cline MS, 2007, NAT PROTOC, V2, P2366, DOI 10.1038/nprot.2007.324; Deardorff MA, 2012, NATURE, V489, P313, DOI 10.1038/nature11316; Dell'Aversana C, 2012, EXP CELL RES, V318, P1229, DOI 10.1016/j.yexcr.2012.01.025; Dokmanovic M, 2007, MOL CANCER RES, V5, P981, DOI 10.1158/1541-7786.MCR-07-0324; Drogaris P, 2012, SCI REP-UK, V2, DOI 10.1038/srep00220; Elias JE, 2007, NAT METHODS, V4, P207, DOI 10.1038/nmeth1019; Eltzschig HK, 2011, NEW ENGL J MED, V364, P656, DOI 10.1056/NEJMra0910283; Emerling BM, 2008, P NATL ACAD SCI USA, V105, P2622, DOI 10.1073/pnas.0706790105; Finkel T, 2009, NATURE, V460, P587, DOI 10.1038/nature08197; Fukuda H, 2012, J DERMATOL, V39, P405, DOI 10.1111/j.1346-8138.2011.01261.x; Garcia O, 2007, BIOINFORMATICS, V23, P394, DOI 10.1093/bioinformatics/btl605; Grabiec AM, 2011, CRIT REV IMMUNOL, V31, P233, DOI 10.1615/CritRevImmunol.v31.i3.40; Grunstein M, 1997, NATURE, V389, P349, DOI 10.1038/38664; Haberland M, 2009, NAT REV GENET, V10, P32, DOI 10.1038/nrg2485; Haggarty SJ, 2003, P NATL ACAD SCI USA, V100, P4389, DOI 10.1073/pnas.0430973100; He WJ, 2012, TRENDS ENDOCRIN MET, V23, P467, DOI 10.1016/j.tem.2012.07.004; Hirschey MD, 2011, COLD SH Q B, V76, P267, DOI 10.1101/sqb.2011.76.010850; Iyer A, 2012, IMMUNOL CELL BIOL, V90, P39, DOI 10.1038/icb.2011.99; Jeong JW, 2002, CELL, V111, P709, DOI 10.1016/S0092-8674(02)01085-1; Kazantsev AG, 2008, NAT REV DRUG DISCOV, V7, P854, DOI 10.1038/nrd2681; Kelstrup CD, 2012, J PROTEOME RES, V11, P3487, DOI 10.1021/pr3000249; Khan O, 2012, IMMUNOL CELL BIOL, V90, P85, DOI 10.1038/icb.2011.100; Kim SC, 2006, MOL CELL, V23, P607, DOI 10.1016/j.molcel.2006.06.026; Lain S, 2008, CANCER CELL, V13, P454, DOI 10.1016/j.ccr.2008.03.004; Marks PA, 2010, EXPERT OPIN INV DRUG, V19, P1049, DOI 10.1517/13543784.2010.510514; McBurney MW, 2003, MOL CELL BIOL, V23, P38, DOI 10.1128/MCB.23.1.38-54.2003; Michalski A, 2011, MOL CELL PROTEOMICS, V10, DOI 10.1074/mcp.M111.011015; Montgomery RL, 2009, P NATL ACAD SCI USA, V106, P7876, DOI 10.1073/pnas.0902750106; Mostoslavsky R, 2006, CELL, V124, P315, DOI 10.1016/J.CEL.2005.11.044; Nagaraj N, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.81; Ong SE, 2002, MOL CELL PROTEOMICS, V1, P376, DOI 10.1074/mcp.M200025-MCP200; Rappsilber J, 2007, NAT PROTOC, V2, P1896, DOI 10.1038/nprot.2007.261; Salisbury CM, 2007, P NATL ACAD SCI USA, V104, P1171, DOI 10.1073/pnas.0608659104; Sterner DE, 2000, MICROBIOL MOL BIOL R, V64, P435, DOI 10.1128/MMBR.64.2.435-459.2000; Szklarczyk D, 2011, NUCLEIC ACIDS RES, V39, pD561, DOI 10.1093/nar/gkq973; Tan JH, 2010, J HEMATOL ONCOL, V3, DOI 10.1186/1756-8722-3-5; Unal E, 2008, SCIENCE, V321, P566, DOI 10.1126/science.1157880; Uter W, 2011, CONTACT DERMATITIS, V64, P235, DOI 10.1111/j.1600-0536.2011.01883.x; Valenzuela-Fernandez A, 2008, TRENDS CELL BIOL, V18, P291, DOI 10.1016/j.tcb.2008.04.003; Vaquero A, 2006, GENE DEV, V20, P1256, DOI 10.1101/gad.1412706; Vizcaino JA, 2014, NAT BIOTECHNOL, V32, P223, DOI 10.1038/nbt.2839; Waanders LF, 2008, MOL CELL PROTEOMICS, V7, P1452, DOI 10.1074/mcp.M800141-MCP200; Wagner Gregory R, 2011, J Aging Res, V2011, P234875, DOI 10.4061/2011/234875; Weinert BT, 2013, CELL REP, V4, P842, DOI 10.1016/j.celrep.2013.07.024; Weinert Brian T, 2009, Cancer Immun, V9, P9; Xu WS, 2007, ONCOGENE, V26, P5541, DOI 10.1038/sj.onc.1210620; Yang HY, 2007, CELL, V130, P1095, DOI 10.1016/j.cell.2007.07.035; Yang XJ, 2008, MOL CELL, V31, P449, DOI 10.1016/j.molcel.2008.07.002; Zhang JL, 2008, MOL CELL, V31, P143, DOI 10.1016/j.molcel.2008.06.006; Zhang XH, 2007, MOL CELL, V27, P197, DOI 10.1016/j.molcel.2007.05.033; Zhang Y, 2008, MOL CELL BIOL, V28, P1688, DOI 10.1128/MCB.01154-06; Zhao SM, 2010, SCIENCE, V327, P1000, DOI 10.1126/science.1179689	65	186	191	2	113	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156	1546-1696		NAT BIOTECHNOL	Nat. Biotechnol.	APR	2015	33	4					415	U136		10.1038/nbt.3130	http://dx.doi.org/10.1038/nbt.3130			11	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	CF2AE	25751058	Green Accepted			2022-12-27	WOS:000352348500029
J	Fox, JL				Fox, Jeffrey L.			Agricultural probiotics enter spotlight	NATURE BIOTECHNOLOGY			English	News Item																		2014, NAT BIOTECHNOL, V32, P211	1	10	10	0	9	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156	1546-1696		NAT BIOTECHNOL	Nat. Biotechnol.	FEB	2015	33	2					122	122		10.1038/nbt0215-122	http://dx.doi.org/10.1038/nbt0215-122			1	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	CA8VK	25658267	Bronze			2022-12-27	WOS:000349198800007
J	Jin, L; Zhang, HN; Lu, YH; Yang, YH; Wu, KM; Tabashnik, BE; Wu, YD				Jin, Lin; Zhang, Haonan; Lu, Yanhui; Yang, Yihua; Wu, Kongming; Tabashnik, Bruce E.; Wu, Yidong			Large-scale test of the natural refuge strategy for delaying insect resistance to transgenic Bt crops	NATURE BIOTECHNOLOGY			English	Article							HELICOVERPA-ARMIGERA LEPIDOPTERA; FIELD-EVOLVED RESISTANCE; BACILLUS-THURINGIENSIS; COTTON BOLLWORM; PEST RESISTANCE; CRY1AC COTTON; TOXIN; NOCTUIDAE; MAIZE; POPULATIONS	The 'natural refuge strategy' for delaying insect resistance to transgenic cotton that produces insecticidal proteins from Bacillus thuringiensis (Bt) relies on refuges of host plants other than cotton that do not make Bt toxins. We tested this widely adopted strategy by comparing predictions from modeling with data from a four-year field study of cotton bollworm (Helicoverpa armigera) resistance to transgenic cotton producing Bt toxin Cry1Ac in six provinces of northern China. Bioassay data revealed that the percentage of resistant insects increased from 0.93% in 2010 to 5.5% in 2013. Modeling predicted that the percentage of resistant insects would exceed 98% in 2013 without natural refuges, but would increase to only 1.1% if natural refuges were as effective as non-Bt cotton refuges. Therefore, the results imply that natural refuges delayed resistance, but were not as effective as an equivalent area of non-Bt cotton refuges. The percentage of resistant insects with nonrecessive inheritance of resistance increased from 37% in 2010 to 84% in 2013. Switching to Bt cotton producing two or more toxins and integrating other control tactics could slow further increases in resistance.	[Jin, Lin; Zhang, Haonan; Yang, Yihua; Wu, Yidong] Nanjing Agr Univ, Coll Plant Protect, Nanjing, Jiangsu, Peoples R China; [Lu, Yanhui; Wu, Kongming] Chinese Acad Agr Sci, Inst Plant Protect, State Key Lab Biol Plant Dis & Insect Pests, Beijing 100193, Peoples R China; [Tabashnik, Bruce E.] Univ Arizona, Dept Entomol, Tucson, AZ 85721 USA	Nanjing Agricultural University; Chinese Academy of Agricultural Sciences; Institute of Plant Protection, CAAS; University of Arizona	Wu, YD (corresponding author), Nanjing Agr Univ, Coll Plant Protect, Nanjing, Jiangsu, Peoples R China.	wyd@njau.edu.cn	Zhang, Haonan/J-2245-2019; Jin, Lin/N-1361-2018; Wu, Yidong/E-9720-2012; ZHANG, HAONAN/N-6395-2018	Zhang, Haonan/0000-0003-1196-2750; Jin, Lin/0000-0002-5114-7139; Wu, Yidong/0000-0003-3456-3373; ZHANG, HAONAN/0000-0003-1196-2750; Lu, Yanhui/0000-0002-6552-0248	Ministry of Agriculture of China [2014ZX08012-004]; National Natural Science Foundation of China [31071983, 31321004]; 111 program of China [B07030]; US Department of Agriculture Biotechnology Risk Assessment Grants program [2011-33522-30729]	Ministry of Agriculture of China(Ministry of Agriculture & Rural Affairs); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); 111 program of China(Ministry of Education, China - 111 Project); US Department of Agriculture Biotechnology Risk Assessment Grants program	We thank M. Sisterson and three anonymous reviewers for their comments that improved the manuscript. This work was funded by grants from the Ministry of Agriculture of China (2014ZX08012-004), the National Natural Science Foundation of China (31071983 and 31321004), the 111 program of China (B07030) and the US Department of Agriculture Biotechnology Risk Assessment Grants program (2011-33522-30729). We thank M.P. Carey (Case Western Reserve University, USA) for providing activated Cry1Ac toxin.	Alyokhin A, 2011, NAT BIOTECHNOL, V29, P577, DOI 10.1038/nbt.1911; An JJ, 2010, J ECON ENTOMOL, V103, P2169, DOI 10.1603/EC10105; Bagla P, 2010, SCIENCE, V327, P1439, DOI 10.1126/science.327.5972.1439; Behere GT, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-117; Brevault T, 2012, EVOL APPL, V5, P53, DOI 10.1111/j.1752-4571.2011.00207.x; Carpenter JE, 2010, NAT BIOTECHNOL, V28, P319, DOI 10.1038/nbt0410-319; Carriere Y, 2001, P ROY SOC B-BIOL SCI, V268, P1475, DOI 10.1098/rspb.2001.1689; Comas C, 2014, TRANSGENIC RES, V23, P135, DOI 10.1007/s11248-013-9737-0; Downes S, 2010, EVOL APPL, V3, P574, DOI 10.1111/j.1752-4571.2010.00146.x; Edgerton MD, 2012, NAT BIOTECHNOL, V30, P493, DOI 10.1038/nbt.2259; Gassmann AJ, 2014, P NATL ACAD SCI USA, V111, P5141, DOI 10.1073/pnas.1317179111; Gilbert N, 2013, NATURE, V497, P24, DOI 10.1038/497024a; Gould F, 1998, ANNU REV ENTOMOL, V43, P701, DOI 10.1146/annurev.ento.43.1.701; Gould F, 2002, P NATL ACAD SCI USA, V99, P16581, DOI 10.1073/pnas.242382499; Gustafson DI, 2006, J ECON ENTOMOL, V99, P2116, DOI 10.1603/0022-0493-99.6.2116; Huang JK, 2002, SCIENCE, V295, P674, DOI 10.1126/science.1067226; Hutchison WD, 2010, SCIENCE, V330, P222, DOI 10.1126/science.1190242; James C., 2013, ISAAA BRIEFS; Jin L, 2013, EVOL APPL, V6, P1222, DOI 10.1111/eva.12099; Kathage J, 2012, P NATL ACAD SCI USA, V109, P11652, DOI 10.1073/pnas.1203647109; Li GP, 2007, ECOL ENTOMOL, V32, P366, DOI 10.1111/j.1365-2311.2007.00891.x; Li GP, 2010, ENVIRON ENTOMOL, V39, P1698, DOI 10.1603/EN10077; Liu FY, 2010, PEST MANAG SCI, V66, P155, DOI 10.1002/ps.1849; Liu YB, 1997, APPL ENVIRON MICROB, V63, P2218, DOI 10.1128/AEM.63.6.2218-2223.1997; Lu YH, 2012, NATURE, V487, P362, DOI 10.1038/nature11153; Mahon RJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039192; Mendelsohn M, 2003, NAT BIOTECHNOL, V21, P1003, DOI 10.1038/nbt0903-1003; Pardo-Lopez L, 2013, FEMS MICROBIOL REV, V37, P3, DOI 10.1111/j.1574-6976.2012.00341.x; Ravi KC, 2005, ENVIRON ENTOMOL, V34, P59, DOI 10.1603/0046-225X-34.1.59; Sanahuja G, 2011, PLANT BIOTECHNOL J, V9, P283, DOI 10.1111/j.1467-7652.2011.00595.x; Storer NP, 2012, J INVERTEBR PATHOL, V110, P294, DOI 10.1016/j.jip.2012.04.007; TABASHNIK BE, 1982, ENVIRON ENTOMOL, V11, P1137, DOI 10.1093/ee/11.6.1137; Tabashnik BE, 2005, P NATL ACAD SCI USA, V102, P15389, DOI 10.1073/pnas.0507857102; Tabashnik BE, 2008, NAT BIOTECHNOL, V26, P199, DOI 10.1038/nbt1382; Tabashnik BE, 2013, NAT BIOTECHNOL, V31, P510, DOI 10.1038/nbt.2597; Tabashnik BE, 2010, NAT BIOTECHNOL, V28, P1304, DOI 10.1038/nbt.1704; Tabashnik BE, 2009, J ECON ENTOMOL, V102, P2011, DOI 10.1603/029.102.0601; Tabashnik BE, 2008, P NATL ACAD SCI USA, V105, P19029, DOI 10.1073/pnas.0810763106; Tay WT, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080134; US Environmental Protection Agency, 2007, PEST NEWS STOR EPA A; Van den Berg J, 2013, CROP PROT, V54, P154, DOI 10.1016/j.cropro.2013.08.010; Wan P, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029975; Wu KM, 2005, ANNU REV ENTOMOL, V50, P31, DOI 10.1146/annurev.ento.50.071803.130349; Wu KM, 2002, J ECON ENTOMOL, V95, P832, DOI 10.1603/0022-0493-95.4.832; Wu KM, 2008, SCIENCE, V321, P1676, DOI 10.1126/science.1160550; Yang YJ, 2007, APPL ENVIRON MICROB, V73, P6939, DOI 10.1128/AEM.01703-07; Zhang HN, 2013, PESTIC BIOCHEM PHYS, V107, P148, DOI 10.1016/j.pestbp.2013.06.007; Zhang HN, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0053418; Zhang HN, 2012, P NATL ACAD SCI USA, V109, P10275, DOI 10.1073/pnas.1200156109; Zhang HN, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022874	50	129	157	5	181	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1087-0156	1546-1696		NAT BIOTECHNOL	Nat. Biotechnol.	FEB	2015	33	2					169	174		10.1038/nbt.3100	http://dx.doi.org/10.1038/nbt.3100			6	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	CA8VK	25503384				2022-12-27	WOS:000349198800022
J	Klavins, E				Klavins, Eric			Lightening the load in synthetic biology	NATURE BIOTECHNOLOGY			English	Editorial Material							NETWORKS		Univ Washington, Dept Elect Engn, Seattle, WA 98195 USA	University of Washington; University of Washington Seattle	Klavins, E (corresponding author), Univ Washington, Dept Elect Engn, Seattle, WA 98195 USA.	klavins@u.washington.edu						Daniel R, 2013, NATURE, V497, P619, DOI 10.1038/nature12148; Del Vecchio D, 2008, MOL SYST BIOL, V4, DOI 10.1038/msb4100204; Del Vecchio D, 2013, ANNU REV CONTROL, V37, P333, DOI 10.1016/j.arcontrol.2013.09.011; Del Vecchio D, 2012, PHYS BIOL, V9, DOI 10.1088/1478-3975/9/4/045008; Horowitz P., 2015, ART ELECT; Lu TK, 2009, NAT BIOTECHNOL, V27, P1139, DOI 10.1038/nbt.1591; Mishra D, 2014, NAT BIOTECHNOL, V32, P1268, DOI 10.1038/nbt.3044; Nilgiriwala K. S., 2014, ACS SYNTH BIOL, DOI [10.1021/sb5002533, DOI 10.1021/SB5002533]; Qi L, 2012, NAT BIOTECHNOL, V30, P1002, DOI 10.1038/nbt.2355	9	4	4	0	14	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156	1546-1696		NAT BIOTECHNOL	Nat. Biotechnol.	DEC	2014	32	12					1198	1200		10.1038/nbt.3089	http://dx.doi.org/10.1038/nbt.3089			4	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	AW3AD	25489836				2022-12-27	WOS:000346156800020
J	Li, S; Tighe, SW; Nicolet, CM; Grove, D; Levy, S; Farmerie, W; Viale, A; Wright, C; Schweitzer, PA; Gao, Y; Kim, D; Boland, J; Hicks, B; Kim, R; Chhangawala, S; Jafari, N; Raghavachari, N; Gandara, J; Garcia-Reyero, N; Hendrickson, C; Roberson, D; Rosenfeldr, J; Smith, T; Underwood, JG; Wang, M; Zumbo, P; Baldwin, DA; Grills, GS; Mason, CE				Li, Sheng; Tighe, Scull W.; Nicolet, Charles M.; Grove, Deborah; Levy, Shawn; Farmerie, William; Viale, Agnes; Wright, Chris; Schweitzer, Peter A.; Gao, Yuan; Kim, Dewey; Boland, Joe; Hicks, Belynda; Kim, Ryan; Chhangawala, Sagar; Jafari, Nadereh; Raghavachari, Nalini; Gandara, Jorge; Garcia-Reyero, Natalia; Hendrickson, Cynthia; Roberson, David; Rosenfeldr, Jeffrey; Smith, Todd; Underwood, Jason G.; Wang, May; Zumbo, Paul; Baldwin, Don A.; Grills, George S.; Mason, Christopher E.			Multi-platform assessment of transcriptome profiling using RNA-seq in the ABRF next-generation sequencing study	NATURE BIOTECHNOLOGY			English	Article							GENE-EXPRESSION; REPRODUCIBILITY; TECHNOLOGIES; GENOMES	High-throughput RNA sequencing (RNA-seq) greatly expands the potential for genomics discoveries, but the wide variety of platforms, protocols and performance capabilitites has created the need for comprehensive reference data. Here we describe the Association of Biomolecular Resource Facilities next-generation sequencing (ABRF-NGS) study on RNA-seq. We carried out replicate experiments across 15 laboratory sites using reference RNA standards to test four protocols (poly-A-selected, ribo-depleted, size-selected and degraded) on five sequencing platforms (Illumina HiSeq, Life Technologies PGM and Proton, Pacific Biosciences RS and Roche 454). The results show high intraplatform (Spearman rank R > 0.86) and inter-platform (R > 0.83) concordance for expression measures across the deep-count platforms, but highly variable efficiency and cost for splice junction and variant detection between all platforms. For intact RNA, gene expression profiles from rRNA-depletion and poly-A enrichment are similar. In addition, rRNA depletion enables effective analysis of degraded RNA samples. This study provides a broad foundation for cross-platform standardization, evaluation and improvement of RNA-seq.	[Li, Sheng; Chhangawala, Sagar; Gandara, Jorge; Zumbo, Paul; Mason, Christopher E.] Weill Cornell Med Coll, Dept Physiol & Biophys, New York, NY USA; [Li, Sheng; Chhangawala, Sagar; Gandara, Jorge; Zumbo, Paul; Mason, Christopher E.] Weill Cornell Med Coll, HRH Prince Alwaleed Bin Talal Bin Abdulaziz Alsau, New York, NY USA; [Tighe, Scull W.] Univ Vermont, Vermont Canc Ctr, Burlington, VT USA; [Nicolet, Charles M.] Univ So Calif, Keck Sch Med, Los Angeles, CA 90033 USA; [Grove, Deborah] Penn State Univ, Huck Inst Life Sci, University Pk, PA 16802 USA; [Levy, Shawn] HudsonAlpha Inst Biotechnol, Huntsville, AL USA; [Farmerie, William] Univ Florida, Interdisciplinary Ctr Biotechnol Res, Gainesville, FL USA; [Viale, Agnes] Mem Sloan Kettering Canc Ctr, New York, NY USA; [Wright, Chris] Univ Illinois, Roy J Carver Biotechnol Ctr, Urbana, IL 61801 USA; [Schweitzer, Peter A.; Grills, George S.] Cornell Univ, Inst Biotechnol, Biotechnol Resource Ctr, Ithaca, NY USA; [Gao, Yuan; Kim, Dewey] Johns Hopkins Univ, Dept Biomed Engn, Baltimore, MD USA; [Boland, Joe; Hicks, Belynda; Roberson, David] NIH NCI SAIC Frederick, Gaithersburg, MD USA; [Kim, Ryan] Univ Calif Davis, Genome Ctr, Davis, CA 95616 USA; [Jafari, Nadereh] Northwestern Univ, Ctr Genet Med, Chicago, IL 60611 USA; [Raghavachari, Nalini] NHLBI, NIH, Bethesda, MD 20892 USA; [Garcia-Reyero, Natalia] Mississippi State Univ, Inst Genom Biocomp & Biotechnol, Starkville, MS USA; [Rosenfeldr, Jeffrey] Univ Med & Dent New Jersey, Div High Performance & Res Comp, Newark, NJ 07103 USA; [Smith, Todd] PerkinElmer Inc, Seattle, WA USA; [Underwood, Jason G.] Univ Washington, Dept Genome Sci, Seattle, WA 98195 USA; [Wang, May] Georgia Inst Technol, Dept Biomed Engn, Atlanta, GA 30332 USA; [Wang, May] Emory Univ, Atlanta, GA 30322 USA; [Baldwin, Don A.] Pathonomics LLC, Philadelphia, PA 19104 USA; [Mason, Christopher E.] Fell Family Brain & Mind Res Inst, New York, NY USA	Cornell University; Cornell University; University of Vermont; University of Southern California; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; HudsonAlpha Institute for Biotechnology; State University System of Florida; University of Florida; Memorial Sloan Kettering Cancer Center; University of Illinois System; University of Illinois Urbana-Champaign; Cornell University; Johns Hopkins University; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Science Applications International Corporation (SAIC); SAIC-Frederick; University of California System; University of California Davis; Northwestern University; National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI); Mississippi State University; Rutgers State University New Brunswick; Rutgers State University Medical Center; University of Washington; University of Washington Seattle; University System of Georgia; Georgia Institute of Technology; Emory University	Baldwin, DA (corresponding author), Pathonomics LLC, Philadelphia, PA 19104 USA.	pathonomics@gmail.com; gsg34@cornell.edu; chm2042@med.cornell.edu	Wang, May Dongmei/AAF-2065-2021; Mason, Christopher/HCH-3977-2022	Wang, May Dongmei/0000-0003-3961-3608; Chhangawala, Sagar/0000-0001-9626-1034; Levy, Shawn/0000-0002-1369-5740	National Institutes of Health (NIH) [R01HG006798, R01NS076465, R24RR032341]; Irma T. Hirschl Charitable Trust; Monique Weill-Caulier Charitable Trust; STARR Consortium [I7-A765]; Illumina; Life Technologies; Pacific Biosciences; Roche Life Sciences; Association of Biomolecular Resource Facilities (ABRF); NATIONAL CANCER INSTITUTE [U10CA180827] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [R24RR032341] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R01HG006798] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS076465] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [R24OD011172] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Irma T. Hirschl Charitable Trust; Monique Weill-Caulier Charitable Trust; STARR Consortium; Illumina; Life Technologies; Pacific Biosciences; Roche Life Sciences; Association of Biomolecular Resource Facilities (ABRF); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	We greatly appreciate the contribution and distribution of reference sample RNA from L. Shi (FDA) and his valuable interactions to assist in the planning of this study. This work was supported with funding from the National Institutes of Health (NIH), including R01HG006798, R01NS076465, R24RR032341, as well as funds from the Irma T. Hirschl and Monique Weill-Caulier Charitable Trusts and the STARR Consortium (I7-A765).; We would also like to thank the platform vendors, Illumina, Life Technologies, Pacific Biosciences and Roche Life Sciences, for their support of this study, and their distinguished scientists for providing technical expertise and assistance in study designs, protocols, new methods development and significant contributions of reagents and sequencing kits. In particular, alphabetically by vendor: G. Schroth (Illumina); M. Gallad, J. Smith, T. Bittick, R. Setterquist and G. Scott (Life Technologies); J. Korlach, S. Turner and E. Tseng (Pacific Biosciences); and K. Fredrickson and C. Telling (Roche Life Sciences).; We are sincerely appreciative of the Association of Biomolecular Resource Facilities (ABRF) for supporting this study and the contributing ABRF Research Groups. Special thanks to our ABRF executive board liaison A. Perera (Stowers Institute for Medical Research).	Adiconis X, 2013, NAT METHODS, V10, P623, DOI 10.1038/nmeth.2483; Aird D, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-2-r18; Altshuler DM, 2012, NATURE, V491, P56, DOI 10.1038/nature11632; Angeletti RH, 1999, FASEB J, V13, P595; Baldi P, 2000, BIOINFORMATICS, V16, P412, DOI 10.1093/bioinformatics/16.5.412; Boland JF, 2013, HUM GENET, V132, P1153, DOI 10.1007/s00439-013-1321-4; Cui P, 2010, GENOMICS, V96, P259, DOI 10.1016/j.ygeno.2010.07.010; Dobin A, 2013, BIOINFORMATICS, V29, P15, DOI 10.1093/bioinformatics/bts635; Glenn TC, 2011, MOL ECOL RESOUR, V11, P759, DOI 10.1111/j.1755-0998.2011.03024.x; Haas BJ, 2010, NAT BIOTECHNOL, V28, P421, DOI 10.1038/nbt0510-421; Hansen KD, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkq224; Huang R, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027288; Jiang LC, 2011, GENOME RES, V21, P1543, DOI 10.1101/gr.121095.111; Katz Y, 2010, NAT METHODS, V7, P1009, DOI 10.1038/NMETH.1528; Krupp M, 2012, BIOINFORMATICS, V28, P1184, DOI 10.1093/bioinformatics/bts084; Labaj PP, 2011, BIOINFORMATICS, V27, pI383, DOI 10.1093/bioinformatics/btr247; Leek JT, 2012, BIOINFORMATICS, V28, P882, DOI 10.1093/bioinformatics/bts034; Li S, 2014, NAT BIOTECHNOL, V32, P888, DOI 10.1038/nbt.3000; Li S, 2014, ANNU REV GENOM HUM G, V15, P127, DOI 10.1146/annurev-genom-090413-025405; Liu L, 2012, J BIOMED BIOTECHNOL, DOI 10.1155/2012/251364; Liu S, 2011, NUCLEIC ACIDS RES, V39, P578, DOI 10.1093/nar/gkq817; Loman NJ, 2012, NAT BIOTECHNOL, V30, P434, DOI 10.1038/nbt.2198; Marioni JC, 2008, GENOME RES, V18, P1509, DOI 10.1101/gr.079558.108; McIntyre LM, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-293; McKenna A, 2010, GENOME RES, V20, P1297, DOI 10.1101/gr.107524.110; Moelans CB, 2011, J CLIN PATHOL, V64, P960, DOI 10.1136/jclinpath-2011-200152; Morlan JD, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042882; Mortazavi A, 2008, NAT METHODS, V5, P621, DOI 10.1038/nmeth.1226; Nagalakshmi U., 2010, CURR PROTOC MOL BIOL, V89; Opitz L, 2010, BMC MED GENOMICS, V3, DOI 10.1186/1755-8794-3-36; Pareek CS, 2011, J APPL GENET, V52, P413, DOI 10.1007/s13353-011-0057-x; Pipes L, 2013, NUCLEIC ACIDS RES, V41, pD906, DOI 10.1093/nar/gks1268; Quail MA, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-341; Ratan A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055089; Risso D, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-480; Roberts A, 2011, BIOINFORMATICS, V27, P2325, DOI 10.1093/bioinformatics/btr355; Sharon D, 2013, NAT BIOTECHNOL, V31, P1009, DOI 10.1038/nbt.2705; Shi LM, 2006, NAT BIOTECHNOL, V24, P1151, DOI 10.1038/nbt1239; Shi LM, 2010, NAT BIOTECHNOL, V28, P827, DOI 10.1038/nbt.1665; Smyth GK, 2005, STAT BIOL HEALTH, P397, DOI 10.1007/0-387-29362-0_23; Su ZQ, 2014, NAT BIOTECHNOL, V32, P903, DOI 10.1038/nbt.2957; 't Hoen PAC, 2013, NAT BIOTECHNOL, V31, P1015, DOI 10.1038/nbt.2702; Tarazona S, 2011, GENOME RES, V21, P2213, DOI 10.1101/gr.124321.111; Toung JM, 2011, GENOME RES, V21, P991, DOI 10.1101/gr.116335.110; Wang ET, 2008, NATURE, V456, P470, DOI 10.1038/nature07509; Wang Z, 2009, NAT REV GENET, V10, P57, DOI 10.1038/nrg2484; Wenger Y, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-204; Zook JM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041356	48	141	142	0	61	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156	1546-1696		NAT BIOTECHNOL	Nat. Biotechnol.	SEP	2014	32	9					915	925		10.1038/nbt.2972	http://dx.doi.org/10.1038/nbt.2972			11	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	AQ2FD	25150835	Green Accepted			2022-12-27	WOS:000342600300031
J	Quinn, JJ; Ilik, IA; Qu, K; Georgiev, P; Chu, C; Alchtar, A; Chang, HY				Quinn, Jeffrey J.; Ilik, Ibrahim A.; Qu, Kun; Georgiev, Plamen; Chu, Ci; Alchtar, Asifa; Chang, Howard Y.			Revealing long noncoding RNA architecture and functions using domain-specific chromatin isolation by RNA purification	NATURE BIOTECHNOLOGY			English	Article							DROSOPHILA X-CHROMOSOME; DOSAGE COMPENSATION; GENE-EXPRESSION; MSL COMPLEX; TRANSCRIPTION; BINDING; SITES; PRINCIPLES; PROTEIN; INACTIVATION	Little is known about the functional domain architecture of long noncoding RNAs (lncRNAs) because of a relative paucity of suitable methods to analyze RNA function at a domain level. Here we describe domain-specific chromatin isolation by RNA purification (dChIRP), a scalable technique to dissect pairwise RNA-RNA, RNA-protein and RNA-chromatin interactions at the level of individual RNA domains in living cells. dChIRP of roX1, a lncRNA essential for Drosophila melanogaster X-chromosome dosage compensation, reveals a 'three-fingered hand' ribonucleoprotein topology. Each RNA finger binds chromatin and the male-specific lethal (MSL) protein complex and can individually rescue male lethality in roX-null flies, thus defining a minimal RNA domain for chromosome-wide dosage compensation. dChIRP improves the RNA genomic localization signal by >20-fold relative to previous techniques, and these binding sites are correlated with chromosome conformation data, indicating that most roX-bound loci cluster in a nuclear territory. These results suggest dChIRP can reveal lncRNA architecture and function with high precision and sensitivity.	[Quinn, Jeffrey J.; Qu, Kun; Chu, Ci; Chang, Howard Y.] Stanford Univ, Howard Hughes Med Inst, Sch Med, Stanford, CA 94305 USA; [Quinn, Jeffrey J.; Qu, Kun; Chu, Ci; Chang, Howard Y.] Stanford Univ, Program Epithelial Biol, Sch Med, Stanford, CA 94305 USA; [Quinn, Jeffrey J.] Stanford Univ, Sch Med, Dept Bioengn, Stanford, CA 94305 USA; [Quinn, Jeffrey J.] Stanford Univ, Sch Engn, Stanford, CA 94305 USA; [Ilik, Ibrahim A.; Georgiev, Plamen; Alchtar, Asifa] Max Planck Inst Immunobiol & Epigenet, Freiburg, Germany	Howard Hughes Medical Institute; Stanford University; Stanford University; Stanford University; Stanford University; Max Planck Society	Chang, HY (corresponding author), Stanford Univ, Howard Hughes Med Inst, Sch Med, Stanford, CA 94305 USA.	howchang@stanford.edu	Qu, Kun/G-3359-2012	Ilik, Ibrahim Avsar/0000-0003-0966-9504	US National Institutes of Health [R01-CA118750, R01-ES023168]; Max Planck Society; Bio-X Fellowship; DFG [SFB992, SFB746]; EU; NATIONAL CANCER INSTITUTE [R01CA118750] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES023168] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Max Planck Society(Max Planck SocietyFoundation CELLEX); Bio-X Fellowship; DFG(German Research Foundation (DFG)); EU(European Commission); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	We thank members of the Chang and Akhtar labs, P. Sharp and X. Wu (Massachusetts Institute of Technology) for meaningful discussion and E. Larschan (Brown University) for CLAMP antibody. Supported by US National Institutes of Health R01-CA118750 and R01-ES023168 (H.Y.C.), Max Planck Society (A.A.) and Bio-X Fellowship (J.J.Q.). This work was supported by DFG-funded SFB992 and SFB746 and EU-funded EpiGeneSys awarded to A.A. H.Y.C. is an Early Career Scientist of the Howard Hughes Medical Institute; A.A. is part of the BIOSS excellence initiative.	Alekseyenko AA, 2008, CELL, V134, P599, DOI 10.1016/j.cell.2008.06.033; Bailey T L, 1994, Proc Int Conf Intell Syst Mol Biol, V2, P28; Batista PJ, 2013, CELL, V152, P1298, DOI 10.1016/j.cell.2013.02.012; Chu C, 2011, MOL CELL, V44, P667, DOI 10.1016/j.molcel.2011.08.027; Colak D, 2014, SCIENCE, V343, P1002, DOI 10.1126/science.1245831; Conrad T, 2012, NAT REV GENET, V13, P123, DOI 10.1038/nrg3124; Engreitz JM, 2013, SCIENCE, V341, P767, DOI 10.1126/science.1237973; Grimaud C, 2009, GENE DEV, V23, P2490, DOI 10.1101/gad.539509; Guttman M, 2012, NATURE, V482, P339, DOI 10.1038/nature10887; Guttman M, 2009, NATURE, V458, P223, DOI 10.1038/nature07672; Hafner M, 2010, CELL, V141, P129, DOI 10.1016/j.cell.2010.03.009; Helwak A, 2013, CELL, V153, P654, DOI 10.1016/j.cell.2013.03.043; Ilik IA, 2013, MOL CELL, V51, P156, DOI 10.1016/j.molcel.2013.07.001; Kelley RL, 2008, MECH DEVELOP, V125, P1009, DOI 10.1016/j.mod.2008.08.003; Kind J, 2008, CELL, V133, P813, DOI 10.1016/j.cell.2008.04.036; Lai F, 2013, NATURE, V494, P497, DOI 10.1038/nature11884; Lee JT, 2013, CELL, V152, P1308, DOI 10.1016/j.cell.2013.02.016; Maenner S, 2013, MOL CELL, V51, P174, DOI 10.1016/j.molcel.2013.06.011; Meller VH, 2002, EMBO J, V21, P1084, DOI 10.1093/emboj/21.5.1084; Mercer TR, 2009, NAT REV GENET, V10, P155, DOI 10.1038/nrg2521; Park SW, 2007, GENETICS, V177, P1429, DOI 10.1534/genetics.107.071001; Rossetto CC, 2013, J VIROL, V87, P5540, DOI 10.1128/JVI.03111-12; Sexton T, 2012, CELL, V148, P458, DOI 10.1016/j.cell.2012.01.010; Simon MD, 2013, NATURE, V504, P465, DOI 10.1038/nature12719; Simon MD, 2011, P NATL ACAD SCI USA, V108, P20497, DOI 10.1073/pnas.1113536108; Soruco MML, 2013, GENE DEV, V27, P1551, DOI 10.1101/gad.214585.113; Straub T, 2005, GENE DEV, V19, P2284, DOI 10.1101/gad.1343105; Stuckenholz C, 2003, GENETICS, V164, P1003; Ule J, 2005, METHODS, V37, P376, DOI 10.1016/j.ymeth.2005.07.018; Wang KC, 2011, NATURE, V472, P120, DOI 10.1038/nature09819; Yang LQ, 2013, NATURE, V500, P598, DOI 10.1038/nature12451; Zuker M, 2003, NUCLEIC ACIDS RES, V31, P3406, DOI 10.1093/nar/gkg595	32	119	127	1	66	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156	1546-1696		NAT BIOTECHNOL	Nat. Biotechnol.	SEP	2014	32	9					933	940		10.1038/nbt.2943	http://dx.doi.org/10.1038/nbt.2943			8	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	AQ2FD	24997788	Green Accepted			2022-12-27	WOS:000342600300033
J	Lane, SW; Williams, DA; Watt, FM				Lane, Steven W.; Williams, David A.; Watt, Fiona M.			Modulating the stem cell niche for tissue regeneration	NATURE BIOTECHNOLOGY			English	Article							BONE-MARROW-TRANSPLANTATION; SPINAL-CORD-INJURY; GROWTH FACTOR-BB; HEMATOPOIETIC STEM; SELF-RENEWAL; IN-VIVO; EXTRACELLULAR-MATRIX; LYMPHOID PROGENITORS; OSTEOBLASTIC CELLS; TARGET POPULATIONS	The field of regenerative medicine holds considerable promise for treating diseases that are currently intractable. Although many researchers are adopting the strategy of cell transplantation for tissue repair, an alternative approach to therapy is to manipulate the stem cell microenvironment, or niche, to facilitate repair by endogenous stem cells. The niche is highly dynamic, with multiple opportunities for intervention. These include administration of small molecules, biologics or biomaterials that target specific aspects of the niche, such as cell-cell and cell-extracellular matrix interactions, to stimulate expansion or differentiation of stem cells, or to cause reversion of differentiated cells to stem cells. Nevertheless, there are several challenges in targeting the niche therapeutically, not least that of achieving specificity of delivery and responses. We envisage that successful treatments in regenerative medicine will involve different combinations of factors to target stem cells and niche cells, applied at different times to effect recovery according to the dynamics of stem cell-niche interactions.	[Lane, Steven W.] Univ Queensland, Royal Brisbane Hosp, QIMR Berghofer Med Res Inst, Div Immunol, Herston, Qld, Australia; [Williams, David A.] Harvard Univ, Sch Med, Boston Childrens Hosp, Div Hematol Oncol, Boston, MA USA; [Williams, David A.] Harvard Univ, Sch Med, Dana Farber Canc Inst, Dept Pediat Oncol, Boston, MA 02115 USA; [Williams, David A.] Harvard Stem Cell Inst, Boston, MA USA; [Watt, Fiona M.] Kings Coll London, Guys Hosp, Ctr Stem Cells & Regenerat Med, London, England	QIMR Berghofer Medical Research Institute; Royal Brisbane & Women's Hospital; University of Queensland; Harvard University; Boston Children's Hospital; Harvard Medical School; Harvard University; Dana-Farber Cancer Institute; Harvard Medical School; Harvard University; Guy's & St Thomas' NHS Foundation Trust; University of London; King's College London	Watt, FM (corresponding author), Kings Coll London, Guys Hosp, Ctr Stem Cells & Regenerat Med, London, England.	fiona.watt@kcl.ac.uk	Lane, Steven/C-3215-2012; Watt, Fiona/AHB-0226-2022	Lane, Steven/0000-0002-8050-6209; Watt, Fiona/0000-0001-9151-5154	National Health and Medical Research Council; Leukaemia Foundation of Australia; Rhys Pengelly Fellowship in Leukaemia Research; National Institutes of Health [DK062757]; Medical Research Council; Wellcome Trust; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK062757] Funding Source: NIH RePORTER	National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia); Leukaemia Foundation of Australia; Rhys Pengelly Fellowship in Leukaemia Research; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Wellcome Trust(Wellcome Trust); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	We apologize for any omissions due to space constraints. S.W.L. is supported by research funding from the National Health and Medical Research Council, the Leukaemia Foundation of Australia and the Rhys Pengelly Fellowship in Leukaemia Research. D.A.W. is supported by National Institutes of Health DK062757. F.M.W. gratefully acknowledges the financial support of the Medical Research Council and the Wellcome Trust.	Abad M, 2013, NATURE, V502, P340, DOI 10.1038/nature12586; Abdul-Wahab A, 2012, IMMUNOTHERAPY-UK, V4, P1859, DOI [10.2217/imt.12.120, 10.2217/IMT.12.120]; Adams GB, 2007, NAT BIOTECHNOL, V25, P238, DOI 10.1038/nbt1281; Alexandre C, 2014, NATURE, V505, P180, DOI 10.1038/nature12879; Ambler CA, 2010, DEVELOPMENT, V137, P3569, DOI 10.1242/dev.050310; Arwert EN, 2010, P NATL ACAD SCI USA, V107, P19903, DOI 10.1073/pnas.1007404107; Ballen K, 2012, BIOL BLOOD MARROW TR, V18, P1851, DOI 10.1016/j.bbmt.2012.06.016; Barker N, 2007, NATURE, V449, P1003, DOI 10.1038/nature06196; Barker N, 2014, NAT REV MOL CELL BIO, V15, P19, DOI 10.1038/nrm3721; Belloni E, 1996, NAT GENET, V14, P353, DOI 10.1038/ng1196-353; Bretzner F, 2011, CELL STEM CELL, V8, P468, DOI 10.1016/j.stem.2011.04.012; Brizzi MF, 2012, CURR OPIN CELL BIOL, V24, P645, DOI 10.1016/j.ceb.2012.07.001; Butler JM, 2010, CELL STEM CELL, V6, P251, DOI 10.1016/j.stem.2010.02.001; Byron A, 2009, J CELL SCI, V122, P4009, DOI 10.1242/jcs.056770; Calvi LM, 2003, NATURE, V425, P841, DOI 10.1038/nature02040; Cianfarani F, 2006, BRIT J DERMATOL, V154, P34, DOI 10.1111/j.1365-2133.2005.06925.x; Coleman MA, 2013, BLOOD, V121, P1049, DOI 10.1182/blood-2012-06-434100; Collins CA, 2011, DEVELOPMENT, V138, P5189, DOI 10.1242/dev.064592; Connelly JT, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027259; Conover JC, 2008, CELL TISSUE RES, V331, P211, DOI 10.1007/s00441-007-0503-6; Czechowicz A, 2007, SCIENCE, V318, P1296, DOI 10.1126/science.1149726; Daley GQ, 2012, CELL STEM CELL, V10, P740, DOI 10.1016/j.stem.2012.05.010; Ding L, 2013, NATURE, V495, P231, DOI 10.1038/nature11885; Driessen RL, 2003, EXP HEMATOL, V31, P1284, DOI 10.1016/j.exphem.2003.08.015; Driskell RR, 2013, NATURE, V504, P277, DOI 10.1038/nature12783; Driskell RR, 2011, J CELL SCI, V124, P1179, DOI 10.1242/jcs.082446; Evans RD, 2003, J CELL BIOL, V160, P589, DOI 10.1083/jcb.200209016; Farrar CA, 2013, CSH PERSPECT MED, V3, DOI 10.1101/cshperspect.a015479; Festa E, 2011, CELL, V146, P761, DOI 10.1016/j.cell.2011.07.019; Fleming HE, 2008, CELL STEM CELL, V2, P274, DOI 10.1016/j.stem.2008.01.003; Forristal CE, 2013, BLOOD, V121, P759, DOI 10.1182/blood-2012-02-408419; Frisch BJ, 2012, BLOOD, V119, P540, DOI 10.1182/blood-2011-04-348151; Fuchs E, 2009, CELL STEM CELL, V4, P499, DOI 10.1016/j.stem.2009.05.001; Fujisaki J, 2011, NATURE, V474, P216, DOI 10.1038/nature10160; Fujiwara H, 2011, CELL, V144, P577, DOI 10.1016/j.cell.2011.01.014; Garber K, 2009, J NATL CANCER I, V101, P548, DOI 10.1093/jnci/djp084; Gay D, 2013, NAT MED, V19, P916, DOI 10.1038/nm.3181; Gilbert PM, 2010, SCIENCE, V329, P1078, DOI 10.1126/science.1191035; Gilbertson RJ, 2007, NAT REV CANCER, V7, P733, DOI 10.1038/nrc2246; Gobaa S, 2011, NAT METHODS, V8, P949, DOI [10.1038/NMETH.1732, 10.1038/nmeth.1732]; Goodman SL, 2012, TRENDS PHARMACOL SCI, V33, P405, DOI 10.1016/j.tips.2012.04.002; Green H, 2008, BIOESSAYS, V30, P897, DOI 10.1002/bies.20797; Greenbaum A, 2013, NATURE, V495, P227, DOI 10.1038/nature11926; Habib SJ, 2013, SCIENCE, V339, P1445, DOI 10.1126/science.1231077; HALL PA, 1989, DEVELOPMENT, V106, P619; Hartwell KA, 2013, NAT CHEM BIOL, V9, P840, DOI [10.1038/nchembio.1367, 10.1038/NCHEMBIO.1367]; Hayes HB, 2014, NEUROLOGY, V82, P104, DOI 10.1212/01.WNL.0000437416.34298.43; Holst J, 2010, NAT BIOTECHNOL, V28, P1123, DOI 10.1038/nbt.1687; Ito M, 2007, NATURE, V447, P316, DOI 10.1038/nature05766; Jaiswal S, 2009, CELL, V138, P271, DOI 10.1016/j.cell.2009.05.046; Janich P, 2013, CELL STEM CELL, V13, P745, DOI 10.1016/j.stem.2013.09.004; Kai TS, 2003, P NATL ACAD SCI USA, V100, P4633, DOI 10.1073/pnas.0830856100; Katayama Y, 2006, CELL, V124, P407, DOI 10.1016/j.cell.2005.10.041; Kiel MJ, 2005, CELL, V121, P1109, DOI 10.1016/j.cell.2005.05.026; Kilian KA, 2010, P NATL ACAD SCI USA, V107, P4872, DOI 10.1073/pnas.0903269107; Kimura W, 2012, CARDIOVASC DIAGN THE, V2, P278, DOI 10.3978/j.issn.2223-3652.2012.12.02; Ko IK, 2013, EXP MOL MED, V45, DOI 10.1038/emm.2013.118; Kode A, 2014, NATURE, V506, P240, DOI 10.1038/nature12883; Kunisaki Y, 2013, NATURE, V502, P637, DOI 10.1038/nature12612; Lai-Cheong JE, 2011, TRENDS MOL MED, V17, P140, DOI 10.1016/j.molmed.2010.11.003; Lampe KJ, 2012, NEUROSCI LETT, V519, P138, DOI 10.1016/j.neulet.2012.01.042; Lane SW, 2009, BLOOD, V114, P1150, DOI 10.1182/blood-2009-01-202606; Li WL, 2013, CELL STEM CELL, V13, P270, DOI 10.1016/j.stem.2013.08.002; Lo Celso C, 2009, NATURE, V457, P92, DOI 10.1038/nature07434; Lu BS, 2014, DRUG DISCOV TODAY, V19, P801, DOI 10.1016/j.drudis.2013.11.011; Lymperi S, 2008, BLOOD, V111, P1173, DOI 10.1182/blood-2007-03-082800; Mavilio F, 2006, NAT MED, V12, P1397, DOI 10.1038/nm1504; McBeath R, 2004, DEV CELL, V6, P483, DOI 10.1016/S1534-5807(04)00075-9; Mckay WF, 2007, INT ORTHOP, V31, P729, DOI 10.1007/s00264-007-0418-6; Mendez-Ferrer S, 2008, NATURE, V452, P442, DOI 10.1038/nature06685; Morris JP, 2010, NAT REV CANCER, V10, P683, DOI 10.1038/nrc2899; Morrison SJ, 2014, NATURE, V505, P327, DOI 10.1038/nature12984; Muscari C, 2013, J BIOMED SCI, V20, DOI 10.1186/1423-0127-20-63; North TE, 2009, CELL, V137, P736, DOI 10.1016/j.cell.2009.04.023; Oldershaw RA, 2012, INT J EXP PATHOL, V93, P389, DOI 10.1111/j.1365-2613.2012.00837.x; Olnes MJ, 2012, NEW ENGL J MED, V367, P11, DOI 10.1056/NEJMoa1200931; Olson TS, 2013, BLOOD, V121, P5238, DOI 10.1182/blood-2012-10-463414; Pasmooij AMG, 2012, DISCOV MED, V14, P167; Pellegrini G, 2014, STEM CELLS, V32, P26, DOI 10.1002/stem.1517; Plikus MV, 2008, NATURE, V451, P340, DOI 10.1038/nature06457; Psaila B, 2009, NAT REV CANCER, V9, P285, DOI 10.1038/nrc2621; Ramsden CM, 2013, DEVELOPMENT, V140, P2576, DOI 10.1242/dev.092270; Ren J., 2013, J BIOMED MATER RES A, DOI [10.1002/jbma.34985, DOI 10.1002/JBMA.34985]; Reya T, 2005, NATURE, V434, P843, DOI 10.1038/nature03319; Rompolas P, 2013, NATURE, V502, P513, DOI 10.1038/nature12602; ROSENFELD SJ, 1995, BLOOD, V85, P3058, DOI 10.1182/blood.V85.11.3058.bloodjournal85113058; Roth TL, 2014, NATURE, V505, P223, DOI 10.1038/nature12808; Rothenberg ME, 2012, GASTROENTEROLOGY, V142, P1195, DOI 10.1053/j.gastro.2012.02.006; Rudin CM, 2009, NEW ENGL J MED, V361, P1173, DOI 10.1056/NEJMoa0902903; Sabelstrom H, 2013, SCIENCE, V342, P637, DOI 10.1126/science.1242576; Sato T, 2011, NATURE, V469, P415, DOI 10.1038/nature09637; Schittenhelm MM, 2006, CANCER RES, V66, P473, DOI 10.1158/0008-5472.CAN-05-2050; SCHOFIELD R, 1978, BLOOD CELLS, V4, P7; Shin JW, 2014, CELL STEM CELL, V14, P81, DOI 10.1016/j.stem.2013.10.009; Shyh-Chang N, 2013, DEVELOPMENT, V140, P2535, DOI 10.1242/dev.091777; Siggins SL, 2009, BLOOD, V114, P995, DOI 10.1182/blood-2009-03-208330; Signer RAJ, 2013, CELL STEM CELL, V12, P152, DOI 10.1016/j.stem.2013.01.001; Silva-Vargas V, 2005, DEV CELL, V9, P121, DOI 10.1016/j.devcel.2005.04.013; Simman R, 2000, ANN PLAS SURG, V44, P451, DOI 10.1097/00000637-200044040-00019; Slove S, 2013, HYPERTENSION, V62, P794, DOI 10.1161/HYPERTENSIONAHA.113.01379; Solchaga LA, 2012, J TISSUE ENG, V3, DOI 10.1177/2041731412442668; Speder P, 2011, CURR OPIN CELL BIOL, V23, P724, DOI 10.1016/j.ceb.2011.08.004; Speth JM, 2014, BLOOD, V123, P203, DOI 10.1182/blood-2013-07-516336; Srinivasan S, 2012, DEVELOPMENT, V139, P1381, DOI 10.1242/dev.070052; Swift J, 2013, SCIENCE, V341, DOI 10.1126/science.1240104; Tamai K, 2011, P NATL ACAD SCI USA, V108, P6609, DOI 10.1073/pnas.1016753108; Tan DWM, 2014, CURR TOP DEV BIOL, V107, P77, DOI 10.1016/B978-0-12-416022-4.00003-2; Tang JY, 2012, NEW ENGL J MED, V366, P2180, DOI 10.1056/NEJMoa1113538; Tanimura S, 2011, CELL STEM CELL, V8, P177, DOI 10.1016/j.stem.2010.11.029; Tavazoie M, 2008, CELL STEM CELL, V3, P279, DOI 10.1016/j.stem.2008.07.025; Tian H, 2011, NATURE, V478, P255, DOI 10.1038/nature10408; To LB, 2011, BLOOD, V118, P4530, DOI 10.1182/blood-2011-06-318220; TOKSOZ D, 1992, P NATL ACAD SCI USA, V89, P7350, DOI 10.1073/pnas.89.16.7350; Tolar J, 2014, J INVEST DERMATOL, V134, P1246, DOI 10.1038/jid.2013.523; Uitto J, 2012, J INVEST DERMATOL, V132, P820, DOI [10.1038/jid.2011.389, 10.1038/skinbio.2012.6]; van Es JH, 2012, NAT CELL BIOL, V14, P1099, DOI 10.1038/ncb2581; Wagner JE, 2010, NEW ENGL J MED, V363, P629, DOI 10.1056/NEJMoa0910501; Watt FM, 2008, CURR OPIN CELL BIOL, V20, P171, DOI 10.1016/j.ceb.2008.01.010; Watt FM, 2013, NAT REV MOL CELL BIO, V14, P467, DOI 10.1038/nrm3620; Watt FM, 2009, EMBO MOL MED, V1, P260, DOI 10.1002/emmm.200900033; Watt FM, 2010, PHILOS T R SOC B, V365, P155, DOI 10.1098/rstb.2009.0149; Watt FM, 2000, SCIENCE, V287, P1427, DOI 10.1126/science.287.5457.1427; Wieman TJ, 1998, DIABETES CARE, V21, P822, DOI 10.2337/diacare.21.5.822; Willert K, 2012, CSH PERSPECT BIOL, V4, DOI 10.1101/cshperspect.a007864; Williams CK, 2008, CANCER RES, V68, P1889, DOI 10.1158/0008-5472.CAN-07-2181; WILLIAMS DA, 1991, NATURE, V352, P438, DOI 10.1038/352438a0; Winkler IG, 2012, NAT MED, V18, P1651, DOI 10.1038/nm.2969; Winkler IG, 2010, BLOOD, V116, P4815, DOI 10.1182/blood-2009-11-253534; Wirth E, 2011, CELL STEM CELL, V8, P476, DOI 10.1016/j.stem.2011.04.008; Wong T, 2008, J INVEST DERMATOL, V128, P2179, DOI 10.1038/jid.2008.78; Yanger K, 2013, GENE DEV, V27, P719, DOI 10.1101/gad.207803.112	131	367	378	22	212	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1087-0156	1546-1696		NAT BIOTECHNOL	Nat. Biotechnol.	AUG	2014	32	8					795	803		10.1038/nbt.2978	http://dx.doi.org/10.1038/nbt.2978			9	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	AW7PF	25093887	Green Accepted			2022-12-27	WOS:000346455900023
J	Azvolinsky, A; DeFrancesco, L; Waltz, E; Webb, S				Azvolinsky, Anna; DeFrancesco, Laura; Waltz, Emily; Webb, Sarah			20 years of Nature Biotechnology research tools	NATURE BIOTECHNOLOGY			English	Article							DNA; NANOPORE; RESOLUTION; MOLECULES											Baker M, 2006, NAT BIOTECHNOL, V24, P301, DOI 10.1038/nbt0306-301a; Baker M, 2011, NAT BIOTECHNOL, V29, P221, DOI 10.1038/nbt.1798; Ball MP, 2009, NAT BIOTECHNOL, V27, P361, DOI 10.1038/nbt.1533; BLANCO L, 1989, J BIOL CHEM, V264, P8935; Butler TZ, 2008, P NATL ACAD SCI USA, V105, P20647, DOI 10.1073/pnas.0807514106; Cherf GM, 2012, NAT BIOTECHNOL, V30, P344, DOI 10.1038/nbt.2147; Cho SW, 2013, NAT BIOTECHNOL, V31, P230, DOI 10.1038/nbt.2507; Cloonan N, 2008, NAT METHODS, V5, P613, DOI 10.1038/nmeth.1223; Cong L, 2013, SCIENCE, V339, P819, DOI 10.1126/science.1231143; Cox J, 2008, NAT BIOTECHNOL, V26, P1367, DOI 10.1038/nbt.1511; Deng J, 2009, NAT BIOTECHNOL, V27, P353, DOI 10.1038/nbt.1530; Derrington IM, 2015, NAT BIOTECHNOL, V33, P1073, DOI 10.1038/nbt.3357; Gasiunas G, 2012, P NATL ACAD SCI USA, V109, pE2579, DOI 10.1073/pnas.1208507109; Grabherr MG, 2011, NAT BIOTECHNOL, V29, P644, DOI 10.1038/nbt.1883; Gygi SP, 1999, NAT BIOTECHNOL, V17, P994, DOI 10.1038/13690; Haas BJ, 2013, NAT PROTOC, V8, P1494, DOI 10.1038/nprot.2013.084; Hwang WY, 2013, NAT BIOTECHNOL, V31, P227, DOI 10.1038/nbt.2501; Iyer SM, 2014, NAT BIOTECHNOL, V32, P274, DOI 10.1038/nbt.2834; Jiang WY, 2013, NAT BIOTECHNOL, V31, P233, DOI 10.1038/nbt.2508; Jinek M, 2013, ELIFE, V2, DOI 10.7554/eLife.00471; Jinek M, 2012, SCIENCE, V337, P816, DOI 10.1126/science.1225829; Kasianowicz JJ, 1996, P NATL ACAD SCI USA, V93, P13770, DOI 10.1073/pnas.93.24.13770; Langille MGI, 2013, NAT BIOTECHNOL, V31, P814, DOI 10.1038/nbt.2676; Laszlo AH, 2014, NAT BIOTECHNOL, V32, P829, DOI 10.1038/nbt.2950; Lieberman KR, 2010, J AM CHEM SOC, V132, P17961, DOI 10.1021/ja1087612; Lister R, 2008, CELL, V133, P523, DOI 10.1016/j.cell.2008.03.029; Lockhart DJ, 1996, NAT BIOTECHNOL, V14, P1675, DOI 10.1038/nbt1296-1675; Lu P, 2007, NAT BIOTECHNOL, V25, P117, DOI 10.1038/nbt1270; Mali P, 2013, SCIENCE, V339, P823, DOI 10.1126/science.1232033; Manrao EA, 2012, NAT BIOTECHNOL, V30, P349, DOI 10.1038/nbt.2171; Mortazavi A, 2008, NAT METHODS, V5, P621, DOI 10.1038/nmeth.1226; Nagalakshmi U, 2008, SCIENCE, V320, P1344, DOI 10.1126/science.1158441; Shaner NC, 2004, NAT BIOTECHNOL, V22, P1567, DOI 10.1038/nbt1037; Trapnell C, 2013, NAT BIOTECHNOL, V31, P46, DOI 10.1038/nbt.2450; Trapnell C, 2010, NAT BIOTECHNOL, V28, P511, DOI 10.1038/nbt.1621; Tyagi S, 1996, NAT BIOTECHNOL, V14, P303, DOI 10.1038/nbt0396-303; Zheng GF, 2005, NAT BIOTECHNOL, V23, P1294, DOI 10.1038/nbt1138	37	4	4	0	31	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156	1546-1696		NAT BIOTECHNOL	Nat. Biotechnol.	MAR	2016	34	3					256	261		10.1038/nbt.3507	http://dx.doi.org/10.1038/nbt.3507			6	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	DG1CJ	26963546				2022-12-27	WOS:000371802600016
J	Oxley, TJ; Opie, NL; John, SE; Rind, GS; Ronayne, SM; Wheeler, TL; Judy, JW; McDonald, AJ; Dornom, A; Lovell, TJH; Steward, C; Garrett, DJ; Moffat, BA; Lui, EH; Yassi, N; Campbell, BCV; Wong, YT; Fox, KE; Nurse, ES; Bennett, IE; Bauquier, SH; Liyanage, KA; van der Nagel, NR; Perucca, P; Ahnood, A; Gill, KP; Yan, B; Churilov, L; French, CR; Desmond, PM; Horne, MK; Kiers, L; Prawer, S; Davis, SM; Burkitt, AN; Mitchell, PJ; Grayden, DB; May, CN; O'Brien, TJ				Oxley, Thomas J.; Opie, Nicholas L.; John, Sam E.; Rind, Gil S.; Ronayne, Stephen M.; Wheeler, Tracey L.; Judy, Jack W.; McDonald, Alan J.; Dornom, Anthony; Lovell, Timothy J. H.; Steward, Christopher; Garrett, David J.; Moffat, Bradford A.; Lui, Elaine H.; Yassi, Nawaf; Campbell, Bruce C. V.; Wong, Yan T.; Fox, Kate E.; Nurse, Ewan S.; Bennett, Iwan E.; Bauquier, Sebastien H.; Liyanage, Kishan A.; van der Nagel, Nicole R.; Perucca, Piero; Ahnood, Arman; Gill, Katherine P.; Yan, Bernard; Churilov, Leonid; French, Christopher R.; Desmond, Patricia M.; Horne, Malcolm K.; Kiers, Lynette; Prawer, Steven; Davis, Stephen M.; Burkitt, Anthony N.; Mitchell, Peter J.; Grayden, David B.; May, Clive N.; O'Brien, Terence J.			Minimally invasive endovascular stent-electrode array for high-fidelity, chronic recordings of cortical neural activity	NATURE BIOTECHNOLOGY			English	Article							IDIOPATHIC INTRACRANIAL HYPERTENSION; SURFACE-BASED ANALYSIS; RANDOMIZED-TRIAL; LONG-TERM; STIMULATION; SINUS; EEG; CATHETER; TISSUE; PACEMAKER	High-fidelity intracranial electrode arrays for recording and stimulating brain activity have facilitated major advances in the treatment of neurological conditions over the past decade. Traditional arrays require direct implantation into the brain via open craniotomy, which can lead to inflammatory tissue responses, necessitating development of minimally invasive approaches that avoid brain trauma. Here we demonstrate the feasibility of chronically recording brain activity from within a vein using a passive stent-electrode recording array (stentrode). We achieved implantation into a superficial cortical vein overlying the motor cortex via catheter angiography and demonstrate neural recordings in freely moving sheep for up to 190 d. Spectral content and bandwidth of vascular electrocorticography were comparable to those of recordings from epidural surface arrays. Venous internal lumen patency was maintained for the duration of implantation. Stentrodes may have wide ranging applications as a neural interface for treatment of a range of neurological conditions.	[Oxley, Thomas J.; Opie, Nicholas L.; John, Sam E.; Rind, Gil S.; Ronayne, Stephen M.; Lovell, Timothy J. H.; Wong, Yan T.; Nurse, Ewan S.; Liyanage, Kishan A.; van der Nagel, Nicole R.; Gill, Katherine P.; Grayden, David B.; May, Clive N.] Univ Melbourne, Dept Med, Melbourne Brain Ctr, Vasc Bion Lab, Melbourne, Vic, Australia; [Oxley, Thomas J.; Opie, Nicholas L.; John, Sam E.; Rind, Gil S.; Ronayne, Stephen M.; Lovell, Timothy J. H.; Steward, Christopher; Yassi, Nawaf; Campbell, Bruce C. V.; Perucca, Piero; Yan, Bernard; French, Christopher R.; Kiers, Lynette; Davis, Stephen M.; O'Brien, Terence J.] Univ Melbourne, Royal Melbourne Hosp, Melbourne Brain Ctr, Dept Med, Melbourne, Vic 3050, Australia; [Oxley, Thomas J.; Opie, Nicholas L.; John, Sam E.; Rind, Gil S.; Ronayne, Stephen M.; Lovell, Timothy J. H.; Steward, Christopher; Yassi, Nawaf; Campbell, Bruce C. V.; Perucca, Piero; Yan, Bernard; French, Christopher R.; Kiers, Lynette; Davis, Stephen M.; O'Brien, Terence J.] Univ Melbourne, Royal Melbourne Hosp, Melbourne Brain Ctr, Dept Neurol, Melbourne, Vic 3050, Australia; [Oxley, Thomas J.; Opie, Nicholas L.; John, Sam E.; Rind, Gil S.; Ronayne, Stephen M.; McDonald, Alan J.; Dornom, Anthony; Lovell, Timothy J. H.; Churilov, Leonid; Horne, Malcolm K.; May, Clive N.] Univ Melbourne, Florey Inst Neurosci & Mental Hlth, Melbourne, Vic, Australia; [Oxley, Thomas J.; Opie, Nicholas L.; John, Sam E.; Wong, Yan T.; Nurse, Ewan S.; Burkitt, Anthony N.; Grayden, David B.] Univ Melbourne, Dept Elect & Elect Engn, NeuroEngn Lab, Melbourne, Vic, Australia; [Wheeler, Tracey L.] Craig H Neilsen Fdn, Encino, CA USA; [Judy, Jack W.] Univ Florida, Nanosci Inst Med & Engn Technol, Gainesville, FL USA; [Steward, Christopher; Moffat, Bradford A.; Lui, Elaine H.; Desmond, Patricia M.; Mitchell, Peter J.] Melbourne Hlth, Royal Melbourne Hosp, Dept Radiol, Melbourne, Vic, Australia; [Steward, Christopher; Moffat, Bradford A.; Lui, Elaine H.; Desmond, Patricia M.; Mitchell, Peter J.] Univ Melbourne, Dept Radiol, Melbourne, Vic, Australia; [Garrett, David J.; Fox, Kate E.; Ahnood, Arman; Prawer, Steven] Univ Melbourne, Sch Phys, Melbourne, Vic, Australia; [Garrett, David J.; Burkitt, Anthony N.; Grayden, David B.] Bion Inst, East Melbourne, Vic, Australia; [Moffat, Bradford A.] Univ Melbourne, Dept Anat & Neurosci, Melbourne, Vic, Australia; [Fox, Kate E.] RMIT Univ, Sch Aerosp Mech & Mfg Engn, Ctr Addit Mfg, Melbourne, Vic, Australia; [Bennett, Iwan E.] Univ Melbourne, Royal Melbourne Hosp, Dept Surg, Melbourne, Vic 3050, Australia; [Bauquier, Sebastien H.] Univ Melbourne, Fac Vet & Agr Sci, Vet Hosp, Translat Res & Clin Trials TRACTs, Melbourne, Vic, Australia; [Churilov, Leonid] RMIT Univ, Sch Math & Geospatial Sci, Melbourne, Vic, Australia; [Grayden, David B.] Univ Melbourne, Ctr Neural Engn, Melbourne, Vic, Australia	University of Melbourne; Royal Melbourne Hospital; University of Melbourne; Royal Melbourne Hospital; University of Melbourne; Florey Institute of Neuroscience & Mental Health; University of Melbourne; University of Melbourne; State University System of Florida; University of Florida; Royal Melbourne Hospital; University of Melbourne; University of Melbourne; Bionics Institute; University of Melbourne; Royal Melbourne Institute of Technology (RMIT); Royal Melbourne Hospital; University of Melbourne; University of Melbourne; Royal Melbourne Institute of Technology (RMIT); University of Melbourne	Oxley, TJ (corresponding author), Univ Melbourne, Dept Med, Melbourne Brain Ctr, Vasc Bion Lab, Melbourne, Vic, Australia.; Oxley, TJ (corresponding author), Univ Melbourne, Royal Melbourne Hosp, Melbourne Brain Ctr, Dept Med, Melbourne, Vic 3050, Australia.; Oxley, TJ (corresponding author), Univ Melbourne, Royal Melbourne Hosp, Melbourne Brain Ctr, Dept Neurol, Melbourne, Vic 3050, Australia.; Oxley, TJ (corresponding author), Univ Melbourne, Florey Inst Neurosci & Mental Hlth, Melbourne, Vic, Australia.; Oxley, TJ (corresponding author), Univ Melbourne, Dept Elect & Elect Engn, NeuroEngn Lab, Melbourne, Vic, Australia.	thomas.oxley@unimelb.edu.au	Moffat, Bradford/L-3777-2019; French, Chris/AHA-1801-2022; Campbell, Bruce/J-1220-2019; Gill, Katherine/AAT-9676-2020; Horne, Malcolm/AAL-5214-2020; Campbell, Bruce/AGY-4147-2022; Wong, Yan Tat/G-5408-2016; O'Brien, Terence/AAU-5525-2021; O'Brien, Terence/L-8102-2013; Gill, Katherine P./AAO-1339-2020; Nurse, Ewan/J-7600-2016; Ahnood, Arman/O-8450-2015; Davis, Stephen/L-5260-2013; Opie, Nicholas/M-3831-2017; John, Sam/E-6904-2012; Desmond, Patricia/D-1966-2014	Moffat, Bradford/0000-0002-0278-4801; Campbell, Bruce/0000-0003-3632-9433; Horne, Malcolm/0000-0001-9427-2100; Wong, Yan Tat/0000-0002-5281-8221; O'Brien, Terence/0000-0002-7198-8621; Gill, Katherine P./0000-0001-6084-0296; Nurse, Ewan/0000-0001-8981-0074; Oxley, Thomas/0000-0002-5569-3612; Ahnood, Arman/0000-0002-0253-7579; French, Christopher/0000-0002-1445-8704; Davis, Stephen/0000-0003-0962-2300; Yassi, Nawaf/0000-0002-0685-0060; Perucca, Piero/0000-0002-7855-7066; Garrett, David/0000-0002-4676-8387; Bauquier, Sebastien/0000-0001-7355-5590; PRAWER, STEVEN/0000-0002-4959-0828; Opie, Nicholas/0000-0002-0342-9457; John, Sam/0000-0003-3780-2210; Desmond, Patricia/0000-0002-4803-6323	US Defense Advanced Research Projects Agency (DARPA) Microsystems Technology Office [N66001-12-1-4045]; Office of Naval Research (ONR) Global [N62909-14-1-N020]; National Health and Medical Research Council of Australia (NHMRC) [APP1062532, APP1075117]; Defence Health Foundation, Australia; Defence Science Institute, Australia; Brain Foundation, Australia; Victorian Government; Royal Melbourne Hospital Neuroscience Foundation; Faculty of Medicine, University of Melbourne; Covidien (Medtronic)	US Defense Advanced Research Projects Agency (DARPA) Microsystems Technology Office(United States Department of DefenseDefense Advanced Research Projects Agency (DARPA)); Office of Naval Research (ONR) Global(Office of Naval Research); National Health and Medical Research Council of Australia (NHMRC)(National Health and Medical Research Council (NHMRC) of Australia); Defence Health Foundation, Australia; Defence Science Institute, Australia; Brain Foundation, Australia; Victorian Government; Royal Melbourne Hospital Neuroscience Foundation; Faculty of Medicine, University of Melbourne(University of Melbourne); Covidien (Medtronic)	The research was supported by US Defense Advanced Research Projects Agency (DARPA) Microsystems Technology Office contract N66001-12-1-4045; Office of Naval Research (ONR) Global N62909-14-1-N020; National Health and Medical Research Council of Australia (NHMRC) Project Grant APP1062532 and Development Grant APP1075117; Defence Health Foundation, Australia (Booster Grant); Defence Science Institute, Australia, grant; Brain Foundation, Australia, research gift; and the Victorian Government's Operational Infrastructure Support Program. T.J.O. acknowledges the support of the Royal Melbourne Hospital Neuroscience Foundation for the Warren Haynes Fellowship, as well as the Faculty of Medicine, University of Melbourne for the Leslie Eric Paddle Scholarship in Neurology. We thank Covidien (Medtronic) for provision of 30 Solitaire stentriever devices as a product research grant, K. Wilson and S. Cudennec for MRI data acquisition; C. Hall, A. Stevenson and A. Maksimenko for synchrotron acquisition; G. Sharma and S. Salinas for imaging analysis; H. Lau and T. Vale for surgical assistance; and L. Warne for anesthetic assistance. We acknowledge the facilities, and the scientific and technical assistance of the Australian National Imaging Facility at the Melbourne Brain Centre Imaging Unit, as well as the Imaging and Medical beamline at the Australian Synchrotron, Victoria, Australia.	Ahmed RM, 2011, AM J NEURORADIOL, V32, P1408, DOI 10.3174/ajnr.A2575; ALLISON T, 1989, J NEUROPHYSIOL, V62, P694, DOI 10.1152/jn.1989.62.3.694; [Anonymous], 1997, EVOKED POTENTIALS CL; Antiga L, 2008, MED BIOL ENG COMPUT, V46, P1097, DOI 10.1007/s11517-008-0420-1; Bagley C, 1922, ARCH NEURO PSYCHIATR, V7, P417, DOI 10.1001/archneurpsyc.1922.02190100002001; Berkhemer OA, 2015, NEW ENGL J MED, V372, P11, DOI 10.1056/NEJMoa1411587; Boniface SJ, 1997, J NEUROL NEUROSUR PS, V62, P193, DOI 10.1136/jnnp.62.2.193; Bower MR, 2013, J NEUROSCI METH, V214, P21, DOI 10.1016/j.jneumeth.2012.12.027; Bundy DT, 2014, J NEURAL ENG, V11, DOI 10.1088/1741-2560/11/1/016006; Campbell BCV, 2015, NEW ENGL J MED, V372, P1009, DOI 10.1056/NEJMoa1414792; Cedzich C, 1996, NEUROSURGERY, V38, P962, DOI 10.1097/00006123-199605000-00023; Chimowitz MI, 2011, NEW ENGL J MED, V365, P993, DOI 10.1056/NEJMoa1105335; Cook MJ, 2013, LANCET NEUROL, V12, P563, DOI 10.1016/S1474-4422(13)70075-9; Dale AM, 1999, NEUROIMAGE, V9, P179, DOI 10.1006/nimg.1998.0395; Deuschl G, 2006, NEW ENGL J MED, V355, P896, DOI 10.1056/NEJMoa060281; Dill T, 2003, CIRCULATION, V107, P845, DOI 10.1161/01.CIR.0000048146.81336.1D; DRILLER J, 1969, MED RES ENG, V8, P11; Fedorov A, 2012, MAGN RESON IMAGING, V30, P1323, DOI 10.1016/j.mri.2012.05.001; Fischl B, 1999, NEUROIMAGE, V9, P195, DOI 10.1006/nimg.1998.0396; Fortescue EB, 2004, HEART RHYTHM, V1, P150, DOI 10.1016/j.hrthm.2004.02.020; Franks W, 2005, IEEE T BIO-MED ENG, V52, P1295, DOI 10.1109/TBME.2005.847523; FURMAN S, 1959, NEW ENGL J MED, V261, P943, DOI 10.1056/NEJM195911052611904; Ghoshal N. G., 1967, Iowa St Univ Vet, V29, P19; Grovum WL, 1999, BRAIN RES, V851, P252, DOI 10.1016/S0006-8993(99)02083-1; Henle C, 2011, BIOMED MICRODEVICES, V13, P59, DOI 10.1007/s10544-010-9471-9; Ho JS, 2014, P NATL ACAD SCI USA, V111, P7974, DOI 10.1073/pnas.1403002111; Hochberg LR, 2006, NATURE, V442, P164, DOI 10.1038/nature04970; Hochberg LR, 2012, NATURE, V485, P372, DOI 10.1038/nature11076; Hoffmann A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092990; JOHNSON JI, 1974, J COMP NEUROL, V158, P81, DOI 10.1002/cne.901580106; Karumbaiah L, 2013, BIOMATERIALS, V34, P8061, DOI 10.1016/j.biomaterials.2013.07.016; Lukatch HS, 2005, CEREB CORTEX, V15, P1322, DOI 10.1093/cercor/bhi015; Mallet L, 2008, NEW ENGL J MED, V359, P2121, DOI 10.1056/NEJMoa0708514; Metscher Brian D., 2009, BMC Physiology, V9, P11, DOI 10.1186/1472-6793-9-11; Mikuni N, 1997, EPILEPSIA, V38, P472, DOI 10.1111/j.1528-1157.1997.tb01738.x; MIROWSKI M, 1980, NEW ENGL J MED, V303, P322, DOI 10.1056/NEJM198008073030607; Morlacchi S, 2011, ANN BIOMED ENG, V39, P2615, DOI 10.1007/s10439-011-0355-9; Morrell MJ, 2011, NEUROLOGY, V77, P1295, DOI 10.1212/WNL.0b013e3182302056; Muller R, 2014, ISSCC DIG TECH PAP I, V57, P412, DOI 10.1109/ISSCC.2014.6757492; Nieman K, 2003, HERZ, V28, P136, DOI 10.1007/s00059-003-2446-3; OGAWA T, 1992, CAN J ANAESTH, V39, P862, DOI 10.1007/BF03008298; Oostenveld R, 2011, COMPUT INTEL NEUROSC, V2011, DOI 10.1155/2011/156869; PALAHNIUK RJ, 1974, ANESTHESIOLOGY, V41, P82, DOI 10.1097/00000542-197407000-00021; PENN RD, 1973, J NEUROSURG, V38, P239, DOI 10.3171/jns.1973.38.2.0239; Polikov VS, 2005, J NEUROSCI METH, V148, P1, DOI 10.1016/j.jneumeth.2005.08.015; Puffer RC, 2013, J NEUROINTERV SURG, V5, P483, DOI 10.1136/neurintsurg-2012-010468; Rampil IJ, 1998, ANESTHESIOLOGY, V89, P980, DOI 10.1097/00000542-199810000-00023; Saxena T, 2013, BIOMATERIALS, V34, P4703, DOI 10.1016/j.biomaterials.2013.03.007; Shao Y, 2009, J CLIN NEUROSCI, V16, P421, DOI 10.1016/j.jocn.2008.02.024; Shimoda K, 2012, J NEURAL ENG, V9, DOI 10.1088/1741-2560/9/3/036015; Simpson S, 1911, Q J EXP PHYSIOL, V4, P53, DOI 10.1113/expphysiol.1911.sp000083; Stevenson AW, 2010, J SYNCHROTRON RADIAT, V17, P75, DOI 10.1107/S0909049509041788; STONEY WS, 1976, ANN THORAC SURG, V22, P166, DOI 10.1016/S0003-4975(10)63980-X; Sun J, 2011, AJNR Am J Neuroradiol, V32, pE191, DOI 10.3174/ajnr.A2308; Teplitzky BA, 2014, J NEURAL ENG, V11, DOI 10.1088/1741-2560/11/2/026011; THOMSON DJ, 1982, P IEEE, V70, P1055, DOI 10.1109/PROC.1982.12433; Valderrama AT, 2010, J NEUROSCI METH, V187, P270, DOI 10.1016/j.jneumeth.2010.01.019; VanBelle E, 1997, CIRCULATION, V95, P438; VANDERGIESSEN WJ, 1991, CIRCULATION, V83, P1788, DOI 10.1161/01.CIR.83.5.1788; Villeneuve MY, 2003, J NEUROSCI METH, V129, P19, DOI 10.1016/S0165-0270(03)00198-5; Wang W, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055344; Watanabe H, 2009, ELECTR COMMUN JPN, V92, P29, DOI 10.1002/ecj.10058; Weiland JD, 2011, OPHTHALMOLOGY, V118, P2227, DOI 10.1016/j.ophtha.2011.08.042; Williams JC, 2007, J NEURAL ENG, V4, P410, DOI 10.1088/1741-2560/4/4/007; WILSON BS, 1991, NATURE, V352, P236, DOI 10.1038/352236a0; Yanagisawa T, 2012, ANN NEUROL, V71, P353, DOI 10.1002/ana.22613; Yanagisawa T, 2009, NEUROIMAGE, V45, P1099, DOI 10.1016/j.neuroimage.2008.12.069	67	115	126	17	90	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156	1546-1696		NAT BIOTECHNOL	Nat. Biotechnol.	MAR	2016	34	3					320	+		10.1038/nbt.3428	http://dx.doi.org/10.1038/nbt.3428			11	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	DG1CJ	26854476				2022-12-27	WOS:000371802600029
J	Gaidatzis, D; Burger, L; Florescu, M; Stadler, MB				Gaidatzis, Dimos; Burger, Lukas; Florescu, Maria; Stadler, Michael B.			Analysis of intronic and exonic reads in RNA-seq data characterizes transcriptional and post-transcriptional regulation (vol 33, pg 722, 2015)	NATURE BIOTECHNOLOGY			English	Correction														Florescu, Maria/0000-0002-0564-5663				Gaidatzis D, 2015, NAT BIOTECHNOL, V33, P722, DOI 10.1038/nbt.3269	1	5	5	1	13	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156	1546-1696		NAT BIOTECHNOL	Nat. Biotechnol.	FEB	2016	34	2					210	210		10.1038/nbt0216-210a	http://dx.doi.org/10.1038/nbt0216-210a			1	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	DD0OK	26849524	Bronze			2022-12-27	WOS:000369619100025
J	Woo, JW; Kim, J; Kwon, SI; Corvalan, C; Cho, SW; Kim, H; Kim, SG; Kim, ST; Choe, S; Kim, JS				Woo, Je Wook; Kim, Jungeun; Kwon, Soon Il; Corvalan, Claudia; Cho, Seung Woo; Kim, Hyeran; Kim, Sang-Gyu; Kim, Sang-Tae; Choe, Sunghwa; Kim, Jin-Soo			DNA-free genome editing in plants with preassembled CRISPR-Cas9 ribonucleoproteins	NATURE BIOTECHNOLOGY			English	Article							TRANSIENT GENE-EXPRESSION; HUMAN-CELLS; RNA; ARABIDOPSIS; KNOCKOUT; SYSTEM; GUIDE	Editing plant genomes without introducing foreign DNA into cells may alleviate regulatory concerns related to genetically modified plants. We transfected preassembled complexes of purified Cas9 protein and guide RNA into plant protoplasts of Arabidopsis thaliana, tobacco, lettuce and rice and achieved targeted mutagenesis in regenerated plants at frequencies of up to 46%. The targeted sites contained germline-transmissible small insertions or deletions that are indistinguishable from naturally occurring genetic variation.	[Woo, Je Wook; Kwon, Soon Il; Choe, Sunghwa] Adv Inst Convergence Technol, Convergence Res Ctr Funct Plant Prod, Suwon, Gyeonggi Do, South Korea; [Kim, Jungeun; Kim, Hyeran; Kim, Sang-Gyu; Kim, Sang-Tae; Kim, Jin-Soo] Inst for Basic Sci Korea, Ctr Genome Engn, Seoul, South Korea; [Kim, Jungeun; Cho, Seung Woo; Kim, Jin-Soo] Seoul Natl Univ, Dept Chem, Seoul, South Korea; [Corvalan, Claudia; Choe, Sunghwa] Seoul Natl Univ, Coll Nat Sci, Sch Biol Sci, Seoul 151742, South Korea; [Choe, Sunghwa] Seoul Natl Univ, Plant Genom & Breeding Inst, Seoul, South Korea	Institute for Basic Science - Korea (IBS); Seoul National University (SNU); Seoul National University (SNU); Seoul National University (SNU)	Choe, S (corresponding author), Adv Inst Convergence Technol, Convergence Res Ctr Funct Plant Prod, Suwon, Gyeonggi Do, South Korea.	shchoe@snu.ac.kr; jskim01@snu.ac.kr	KIM, Jin-Soo/M-6918-2013; Kim, Sang-Tae/U-9457-2018; Kim, Sang-Tae/X-8917-2019; Kim, Hyeran/AAB-5165-2021; Kim, Sang-Gyu/T-5925-2017; Cho, Seung Woo/B-2441-2019; Choe, Sunghwa/K-5650-2013	KIM, Jin-Soo/0000-0003-4847-1306; Kim, Sang-Tae/0000-0003-1645-6021; Kim, Sang-Tae/0000-0003-1645-6021; Cho, Seung Woo/0000-0001-9091-0937; Choe, Sunghwa/0000-0001-5541-484X	Institute for Basic Science [IBS-R021-D1]; Next-Generation BioGreen21 Program [PJ01104501, PJ01104502]	Institute for Basic Science; Next-Generation BioGreen21 Program(Rural Development Administration (RDA), Republic of Korea)	This work was supported in part by grants from the Institute for Basic Science (IBS-R021-D1) and the Next-Generation BioGreen21 Program (PJ01104501 to S.C. and PJ01104502 to S.I.K.).	Bae S, 2014, BIOINFORMATICS, V30, P1473, DOI 10.1093/bioinformatics/btu048; Cho SW, 2014, GENOME RES, V24, P132, DOI 10.1101/gr.162339.113; Cho SW, 2013, GENETICS, V195, P1177, DOI 10.1534/genetics.113.155853; Cho SW, 2013, NAT BIOTECHNOL, V31, P230, DOI 10.1038/nbt.2507; Choe S, 2002, PLANT PHYSIOL, V130, P1506, DOI 10.1104/pp.010496; FREARSON EM, 1973, DEV BIOL, V33, P130, DOI 10.1016/0012-1606(73)90169-3; GAMBORG OL, 1968, EXP CELL RES, V50, P151, DOI 10.1016/0014-4827(68)90403-5; Jones HD, 2015, NAT PLANTS, V1, DOI [10.1038/nplants.2014.11, 10.1038/NPLANTS.2014.11]; Kanchiswamy CN, 2015, TRENDS BIOTECHNOL, V33, P489, DOI 10.1016/j.tibtech.2015.04.002; Kim D, 2015, NAT METHODS, V12, P237, DOI [10.1038/nmeth.3284, 10.1038/NMETH.3284]; Kim HJ, 2009, GENOME RES, V19, P1279, DOI 10.1101/gr.089417.108; Kim H, 2014, NAT REV GENET, V15, P321, DOI 10.1038/nrg3686; Kim JM, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4157; Kim S, 2014, GENOME RES, V24, P1012, DOI 10.1101/gr.171322.113; Lee HJ, 2010, GENOME RES, V20, P81, DOI 10.1101/gr.099747.109; Lelivelt CLC, 2005, PLANT MOL BIOL, V58, P763, DOI 10.1007/s11103-005-7704-8; Li JF, 2013, NAT BIOTECHNOL, V31, P688, DOI 10.1038/nbt.2654; MENCZEL L, 1981, THEOR APPL GENET, V59, P191, DOI 10.1007/BF00264975; Nekrasov V, 2013, NAT BIOTECHNOL, V31, P691, DOI 10.1038/nbt.2655; Shan QW, 2013, NAT BIOTECHNOL, V31, P686, DOI 10.1038/nbt.2650; Sung YH, 2014, GENOME RES, V24, P125, DOI 10.1101/gr.163394.113; Yoo SD, 2007, NAT PROTOC, V2, P1565, DOI 10.1038/nprot.2007.199; Zhang Y, 2011, PLANT METHODS, V7, DOI 10.1186/1746-4811-7-30	23	614	678	13	394	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1087-0156	1546-1696		NAT BIOTECHNOL	Nat. Biotechnol.	NOV	2015	33	11					1162	+		10.1038/nbt.3389	http://dx.doi.org/10.1038/nbt.3389			4	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	CW3TY	26479191				2022-12-27	WOS:000364916000023
J	Chal, J; Oginuma, M; Al Tanoury, Z; Gobert, B; Sumara, O; Hick, A; Bousson, F; Zidouni, Y; Mursch, C; Moncuquet, P; Tassy, O; Vincent, S; Miyanari, A; Bera, A; Garnier, JM; Guevara, G; Hestin, M; Kennedy, L; Hayashi, S; Drayton, B; Cherrier, T; Gayraud-Morel, B; Gussoni, E; Relaix, F; Tajbakhsh, S; Pourquie, O				Chal, Jerome; Oginuma, Masayuki; Al Tanoury, Ziad; Gobert, Benedicte; Sumara, Olga; Hick, Aurore; Bousson, Fanny; Zidouni, Yasmine; Mursch, Caroline; Moncuquet, Philippe; Tassy, Olivier; Vincent, Stephane; Miyanari, Ayako; Bera, Agata; Garnier, Jean-Marie; Guevara, Getzabel; Hestin, Marie; Kennedy, Leif; Hayashi, Shinichiro; Drayton, Bernadette; Cherrier, Thomas; Gayraud-Morel, Barbara; Gussoni, Emanuela; Relaix, Frederic; Tajbakhsh, Shahragim; Pourquie, Olivier			Differentiation of pluripotent stem cells to muscle fiber to model Duchenne muscular dystrophy	NATURE BIOTECHNOLOGY			English	Article							MOUSE; DERIVATION; PROGENITORS; GENERATION; GENES; EXPRESSION; MYOGENESIS; MESODERM; ES; HETEROGENEITY	During embryonic development, skeletal muscles arise from somites, which derive from the presomitic mesoderm (PSM). Using PSM development as a guide, we establish conditions for the differentiation of monolayer cultures of mouse embryonic stem (ES) cells into PSM-like cells without the introduction of transgenes or cell sorting. We show that primary and secondary skeletal myogenesis can be recapitulated in vitro from the PSM-like cells, providing an efficient, serum-free protocol for the generation of striated, contractile fibers from mouse and human pluripotent cells. The mouse ES cells also differentiate into Pax7(+) cells with satellite cell characteristics, including the ability to form dystrophin(+) fibers when grafted into muscles of dystrophin-deficient mdx mice, a model of Duchenne muscular dystrophy (DMD). Fibers derived from ES cells of mdx mice exhibit an abnormal branched phenotype resembling that described in vivo, thus providing an attractive model to study the origin of the pathological defects associated with DMD.	[Chal, Jerome; Oginuma, Masayuki; Al Tanoury, Ziad; Gobert, Benedicte; Sumara, Olga; Zidouni, Yasmine; Mursch, Caroline; Moncuquet, Philippe; Tassy, Olivier; Vincent, Stephane; Miyanari, Ayako; Bera, Agata; Garnier, Jean-Marie; Kennedy, Leif; Cherrier, Thomas; Pourquie, Olivier] Univ Strasbourg, Inserm U964, CNRS UMR 7104, IGBMC, Illkirch Graffenstaden, France; [Chal, Jerome; Pourquie, Olivier] Stowers Inst Med Res, Kansas City, MO USA; [Chal, Jerome; Guevara, Getzabel; Hestin, Marie] Brigham & Womens Hosp, Dept Pathol, Boston, MA 02115 USA; [Chal, Jerome; Guevara, Getzabel; Hestin, Marie; Pourquie, Olivier] Harvard Univ, Sch Med, Dept Genet, Boston, MA USA; [Chal, Jerome; Guevara, Getzabel; Hestin, Marie; Pourquie, Olivier] Harvard Stem Cell Inst, Boston, MA USA; [Hick, Aurore; Bousson, Fanny] Anagenesis Biotechnol, Illkirch Graffenstaden, France; [Hayashi, Shinichiro; Drayton, Bernadette; Relaix, Frederic] Univ Paris 06, INSERM, Avenir Team, Paris, France; [Hayashi, Shinichiro; Drayton, Bernadette; Relaix, Frederic] Inst Myol, Paris, France; [Gayraud-Morel, Barbara; Tajbakhsh, Shahragim] Inst Pasteur, CNRS URA 2578, Paris, France; [Gussoni, Emanuela] Boston Childrens Hosp, Div Genet & Genom, Boston, MA USA; [Pourquie, Olivier] Howard Hughes Med Inst, Kansas City, MO USA	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; Stowers Institute for Medical Research; Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School; Harvard University; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; UDICE-French Research Universities; Sorbonne Universite; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Harvard University; Boston Children's Hospital; Howard Hughes Medical Institute	Pourquie, O (corresponding author), Univ Strasbourg, Inserm U964, CNRS UMR 7104, IGBMC, Illkirch Graffenstaden, France.	pourquie@genetics.med.harvard.edu	Pourquié, Olivier/CAJ-5443-2022; Gussoni, Emanuela/AAL-6150-2021; Vincent, Stéphane D/M-2046-2013; CHERRIER, Thomas/F-8727-2018	Pourquié, Olivier/0000-0001-5189-1227; Gussoni, Emanuela/0000-0002-9915-3677; Vincent, Stéphane D/0000-0003-1638-9615; Hayashi, Shinichiro/0000-0001-5553-7698; Chal, Jerome/0000-0002-0468-7677; CHERRIER, Thomas/0000-0002-0707-9204; Relaix, Frederic/0000-0003-1270-1472; Sumara, Olga/0000-0002-0845-3720; Gayraud-Morel, Barbara/0000-0002-1168-8504	Howard Hughes Medical Institute Funding Source: Medline	Howard Hughes Medical Institute(Howard Hughes Medical Institute)		Abujarour R, 2014, STEM CELL TRANSL MED, V3, P149, DOI 10.5966/sctm.2013-0095; Albini S, 2013, CELL REP, V3, P661, DOI 10.1016/j.celrep.2013.02.012; Allen DG, 2011, INT J BIOCHEM CELL B, V43, P290, DOI 10.1016/j.biocel.2010.11.005; Biressi S, 2007, DEV BIOL, V308, P281, DOI 10.1016/j.ydbio.2007.06.006; Borchin B, 2013, STEM CELL REP, V1, P620, DOI 10.1016/j.stemcr.2013.10.007; Boulting GL, 2011, NAT BIOTECHNOL, V29, P279, DOI 10.1038/nbt.1783; BRAUN T, 1994, DEV BIOL, V164, P24, DOI 10.1006/dbio.1994.1177; Braun T, 1996, EMBO J, V15, P310, DOI 10.1002/j.1460-2075.1996.tb00361.x; Chan S, 2011, EXP PHYSIOL, V96, P564, DOI 10.1113/expphysiol.2010.056713; Chang H, 2009, FASEB J, V23, P1907, DOI 10.1096/fj.08-123661; Charge SBP, 2004, PHYSIOL REV, V84, P209, DOI 10.1152/physrev.00019.2003; CHENG TC, 1993, SCIENCE, V261, P215, DOI 10.1126/science.8392225; Collins CA, 2005, CELL, V122, P289, DOI 10.1016/j.cell.2005.05.010; CROSSLEY PH, 1995, DEVELOPMENT, V121, P439; Darabi R, 2008, NAT MED, V14, P134, DOI 10.1038/nm1705; Darabi R, 2012, CELL STEM CELL, V10, P610, DOI 10.1016/j.stem.2012.02.015; Dequeant ML, 2006, SCIENCE, V314, P1595, DOI 10.1126/science.1133141; Eiraku M, 2011, NATURE, V472, P51, DOI 10.1038/nature09941; Friedrich O, 2010, BIOPHYS J, V98, P606, DOI 10.1016/j.bpj.2009.11.005; Goodall MH, 2012, AM J PHYSIOL-CELL PH, V303, pC224, DOI 10.1152/ajpcell.00136.2012; Gouti M, 2014, PLOS BIOL, V12, DOI 10.1371/journal.pbio.1001937; HENRIQUE D, 1995, NATURE, V375, P787, DOI 10.1038/375787a0; Hosoyama T, 2014, STEM CELL TRANSL MED, V3, P564, DOI 10.5966/sctm.2013-0143; Hutcheson DA, 2009, GENE DEV, V23, P997, DOI 10.1101/gad.1769009; Hwang YS, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0072023, 10.1371/annotation/b02313dc-840f-4f03-91a2-77cb55a3a4c9]; Kazanskaya O, 2004, DEV CELL, V7, P525, DOI 10.1016/j.devcel.2004.07.019; Kress C, 1998, MAMM GENOME, V9, P998, DOI 10.1007/s003359900914; Li WW, 2011, FAMILY ENTERPRISE IN THE ASIA PACIFIC: EXPLORING TRANSGENERATIONAL ENTREPRENEURSHIP IN FAMILY FIRMS, P76; Mathew SJ, 2011, DEVELOPMENT, V138, P371, DOI 10.1242/dev.057463; MATSUDA R, 1995, J BIOCHEM-TOKYO, V118, P959, DOI 10.1093/jb/118.5.959; McCracken KW, 2014, NATURE, V516, P400, DOI 10.1038/nature13863; Merrick D, 2009, DIS MODEL MECH, V2, P374, DOI 10.1242/dmm.001008; Messina G, 2010, CELL, V140, P554, DOI 10.1016/j.cell.2010.01.027; Minami I, 2012, CELL REP, V2, P1448, DOI 10.1016/j.celrep.2012.09.015; Mizuno Y, 2010, FASEB J, V24, P2245, DOI 10.1096/fj.09-137174; Montarras D, 2005, SCIENCE, V309, P2064, DOI 10.1126/science.1114758; Mouly V, 2005, Acta Myol, V24, P128; Nagai T, 2002, NAT BIOTECHNOL, V20, P87, DOI 10.1038/nbt0102-87; NAGY A, 1993, P NATL ACAD SCI USA, V90, P8424, DOI 10.1073/pnas.90.18.8424; Niederreither K, 1999, NAT GENET, V21, P444, DOI 10.1038/7788; Ozbudak EM, 2010, P NATL ACAD SCI USA, V107, P4224, DOI 10.1073/pnas.0909375107; Pavlath GK, 2010, CELL ADHES MIGR, V4, P502, DOI 10.4161/cam.4.4.12291; Rahimov F, 2013, J CELL BIOL, V201, P499, DOI 10.1083/jcb.201212142; Reich M, 2006, NAT GENET, V38, P500, DOI 10.1038/ng0506-500; Relaix F, 2005, NATURE, V435, P948, DOI 10.1038/nature03594; Relaix F, 2003, GENE DEV, V17, P2950, DOI 10.1101/gad.281203; Rinaldi F, 2014, TRANSL RES, V163, P409, DOI 10.1016/j.trsl.2013.11.006; ROHWEDEL J, 1994, DEV BIOL, V164, P87, DOI 10.1006/dbio.1994.1182; Saga Y, 1997, GENE DEV, V11, P1827, DOI 10.1101/gad.11.14.1827; Sakurai H, 2008, STEM CELLS, V26, P1865, DOI 10.1634/stemcells.2008-0173; Sakurai H, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047078; Sakurai H, 2009, STEM CELL RES, V3, P157, DOI 10.1016/j.scr.2009.08.002; Salani S, 2012, J CELL MOL MED, V16, P1353, DOI 10.1111/j.1582-4934.2011.01498.x; Sambasivan R, 2007, SEMIN CELL DEV BIOL, V18, P870, DOI 10.1016/j.semcdb.2007.09.013; Sambasivan R, 2009, DEV CELL, V16, P810, DOI 10.1016/j.devcel.2009.05.008; Schindelin J, 2012, NAT METHODS, V9, P676, DOI [10.1038/nmeth.2019, 10.1038/NMETH.2019]; Shelton M, 2014, STEM CELL REP, V3, P516, DOI 10.1016/j.stemcr.2014.07.001; Tan JY, 2013, STEM CELLS DEV, V22, P1893, DOI 10.1089/scd.2012.0590; Tanaka A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061540; Tanaka M, 2009, STEM CELL RES, V3, P126, DOI 10.1016/j.scr.2009.07.001; Tassy O, 2014, NUCLEIC ACIDS RES, V42, pD882, DOI 10.1093/nar/gkt807; Thomson JA, 1998, SCIENCE, V282, P1145, DOI 10.1126/science.282.5391.1145; Tonegawa A, 1997, DEVELOPMENT, V124, P1975; White RB, 2010, BMC DEV BIOL, V10, DOI 10.1186/1471-213X-10-21; Wittler L, 2007, EMBO REP, V8, P784, DOI 10.1038/sj.embor.7401030; Xu C, 2013, CELL, V155, P909, DOI 10.1016/j.cell.2013.10.023; Yasuhiko Y, 2006, P NATL ACAD SCI USA, V103, P3651, DOI 10.1073/pnas.0508238103; Ying QL, 2008, NATURE, V453, P519, DOI 10.1038/nature06968; Zheng JK, 2006, CELL RES, V16, P713, DOI 10.1038/sj.cr.7310080	69	231	241	7	67	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156	1546-1696		NAT BIOTECHNOL	Nat. Biotechnol.	SEP	2015	33	9					962	U207		10.1038/nbt.3297	http://dx.doi.org/10.1038/nbt.3297			11	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	CR0EK	26237517	Green Submitted			2022-12-27	WOS:000360990900024
J	Westhof, E				Westhof, Eric			RNA structure from deep sequencing	NATURE BIOTECHNOLOGY			English	Editorial Material							SECONDARY STRUCTURE		Univ Strasbourg, CNRS, Inst Mol & Cellular Biol, Architecture & React RNA, Strasbourg, France	Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg	Westhof, E (corresponding author), Univ Strasbourg, CNRS, Inst Mol & Cellular Biol, Architecture & React RNA, Strasbourg, France.	e.westhof@ibmc-cnrs.unistra.fr						Ares Manuel Jr, 2014, Cold Spring Harb Protoc, V2014, P1139, DOI 10.1101/pdb.top083352; Ding YL, 2015, NAT PROTOC, V10, P1050, DOI 10.1038/nprot.2015.064; Kertesz M, 2010, NATURE, V467, P103, DOI 10.1038/nature09322; Leontis NB, 2001, RNA, V7, P499, DOI 10.1017/S1355838201002515; Ramani V, 2015, NAT BIOTECHNOL, V33, P980, DOI 10.1038/nbt.3289; Rice GM, 2014, RNA, V20, P846, DOI 10.1261/rna.043323.113	6	1	1	0	6	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156	1546-1696		NAT BIOTECHNOL	Nat. Biotechnol.	SEP	2015	33	9					928	929		10.1038/nbt.3338	http://dx.doi.org/10.1038/nbt.3338			2	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	CR0EK	26348961				2022-12-27	WOS:000360990900018
J	Yao, LX; Li, Y; Ghosh, S; Evans, JA; Rzhetsky, A				Yao, Lixia; Li, Ying; Ghosh, Soumitra; Evans, James A.; Rzhetsky, Andrey			Health ROI as a measure of misalignment of biomedical needs and resources	NATURE BIOTECHNOLOGY			English	Letter							DISEASES; BURDEN		[Yao, Lixia] Univ N Carolina, Dept Software & Informat Syst, Charlotte, NC 28223 USA; [Li, Ying] Columbia Univ, Dept Biomed Informat, New York, NY USA; [Ghosh, Soumitra] GlaxoSmithKline R&D, Dept Genet, King Of Prussia, PA USA; [Evans, James A.] Univ Chicago, Dept Sociol, Chicago, IL 60637 USA; [Evans, James A.; Rzhetsky, Andrey] Univ Chicago, Computat Inst, Chicago, IL 60637 USA; [Rzhetsky, Andrey] Univ Chicago, Dept Med, Inst Genom & Syst Biol, Chicago, IL 60637 USA; [Rzhetsky, Andrey] Univ Chicago, Dept Human Genet, Inst Genom & Syst Biol, Chicago, IL 60637 USA	University of North Carolina; University of North Carolina Charlotte; Columbia University; GlaxoSmithKline; University of Chicago; University of Chicago; University of Chicago; University of Chicago	Yao, LX (corresponding author), Univ N Carolina, Dept Software & Informat Syst, Charlotte, NC 28223 USA.	L.Yao@uncc.edu; arzhetsky@uchicago.edu	rzhetsky, andrey/B-6118-2012	rzhetsky, andrey/0000-0001-6959-7405	NHLBI NIH HHS [U01HL108634-01, R01 HL122712, K12 HL119995, U01 HL108634] Funding Source: Medline; NIGMS NIH HHS [R01 GM061372] Funding Source: Medline; NIMH NIH HHS [P50 MH094267, R01 MH110905, T32 MH020065, 1P50MH094267] Funding Source: Medline; NLM NIH HHS [R01 LM010132] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [U01HL108634, R01HL122712, K12HL119995] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM061372] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH110905, T32MH020065, P50MH094267] Funding Source: NIH RePORTER; NATIONAL LIBRARY OF MEDICINE [R01LM010132] Funding Source: NIH RePORTER; Direct For Social, Behav & Economic Scie [1158803] Funding Source: National Science Foundation	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NLM NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Library of Medicine (NLM)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL LIBRARY OF MEDICINE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Library of Medicine (NLM)); Direct For Social, Behav & Economic Scie(National Science Foundation (NSF)NSF - Directorate for Social, Behavioral & Economic Sciences (SBE))		BLACK F, 1973, J POLIT ECON, V81, P637, DOI 10.1086/260062; Evans JA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090147; Gillum LA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016837; Gross CP, 1999, NEW ENGL J MED, V340, P1881, DOI 10.1056/NEJM199906173402406; Kleinbaum D., 2013, APPL REGRESSION ANAL; MERTON RC, 1973, BELL J ECON, V4, P141, DOI 10.2307/3003143; MURRAY CJL, 1994, B WORLD HEALTH ORGAN, V72, P429; Reiss J., 2010, THEORIA-SPAIN, V24, P263; Sampat BN, 2013, MILBANK Q, V91, P163, DOI 10.1111/milq.12005; Vanderelst D, 2013, J INFORMETR, V7, P240, DOI 10.1016/j.joi.2012.10.004; Vanderelst D, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000576	11	16	16	0	8	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156	1546-1696		NAT BIOTECHNOL	Nat. Biotechnol.	AUG	2015	33	8					807	811		10.1038/nbt.3276	http://dx.doi.org/10.1038/nbt.3276			5	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	CO6OB	26252133	Green Accepted			2022-12-27	WOS:000359274900011
J	[Anonymous]				[Anonymous]			BGI goes head-to-head with Illumina	NATURE BIOTECHNOLOGY			English	News Item																			0	1	1	1	4	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156	1546-1696		NAT BIOTECHNOL	Nat. Biotechnol.	AUG	2015	33	8					792	792		10.1038/nbt0815-792b	http://dx.doi.org/10.1038/nbt0815-792b			1	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	CO6OB	26252125				2022-12-27	WOS:000359274900038
J	Weber, JS; Mule, JJ				Weber, Jeffrey S.; Mule, James J.			Cancer immunotherapy meets biomaterials	NATURE BIOTECHNOLOGY			English	Editorial Material							CELLS; PATIENT		[Weber, Jeffrey S.; Mule, James J.] H Lee Moffitt Canc Ctr & Res Inst, Tampa, FL 33612 USA	H Lee Moffitt Cancer Center & Research Institute	Weber, JS (corresponding author), H Lee Moffitt Canc Ctr & Res Inst, Tampa, FL 33612 USA.	jeffrey.weber@moffitt.org						Ali OA, 2009, SCI TRANSL MED, V1, DOI 10.1126/scitranslmed.3000359; Boissonnas A, 2010, IMMUNITY, V32, P266, DOI 10.1016/j.immuni.2009.11.015; Dieu-Nosjean MC, 2008, J CLIN ONCOL, V26, P4410, DOI 10.1200/JCO.2007.15.0284; Jones D, 2009, NAT REV DRUG DISCOV, V8, P600, DOI 10.1038/nrd2956; Kim J, 2015, NAT BIOTECHNOL, V33, P64, DOI 10.1038/nbt.3071; Melero I, 2014, NAT REV CLIN ONCOL, V11, P509, DOI 10.1038/nrclinonc.2014.111; Messina JL, 2012, SCI REP-UK, V2, DOI 10.1038/srep00765; Sharma MD, 2007, J CLIN INVEST, V117, P2570, DOI 10.1172/JCI31911; Stephan SB, 2015, NAT BIOTECHNOL, V33, P97, DOI 10.1038/nbt.3104; Tran E, 2014, SCIENCE, V344, P641, DOI 10.1126/science.1251102	10	33	33	1	50	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156	1546-1696		NAT BIOTECHNOL	Nat. Biotechnol.	JAN	2015	33	1					44	45		10.1038/nbt.3119	http://dx.doi.org/10.1038/nbt.3119			2	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	AY7AR	25574635				2022-12-27	WOS:000347714200023
J	Meade, BR; Gogoi, K; Hamil, AS; Palm-Apergi, C; van den Berg, A; Hagopian, JC; Springer, AD; Eguchi, A; Kacsinta, AD; Dowdy, CF; Presente, A; Lonn, P; Kaulich, M; Yoshioka, N; Gros, E; Cui, XS; Dowdy, SF				Meade, Bryan R.; Gogoi, Khirud; Hamil, Alexander S.; Palm-Apergi, Caroline; van den Berg, Arjen; Hagopian, Jonathan C.; Springer, Aaron D.; Eguchi, Akiko; Kacsinta, Apollo D.; Dowdy, Connor F.; Presente, Asaf; Loenn, Peter; Kaulich, Manuel; Yoshioka, Naohisa; Gros, Edwige; Cui, Xian-Shu; Dowdy, Steven F.			Efficient delivery of RNAi prodrugs containing reversible charge-neutralizing phosphotriester backbone modifications	NATURE BIOTECHNOLOGY			English	Article							SOLID-PHASE SYNTHESIS; CHEMICAL-MODIFICATION; SIRNA DELIVERY; INTERFERENCE; DESIGN; SATE; PHOSPHODIESTER; PHOSPHONATE; PROGRESS; DNA	RNA interference (RNAi) has great potential to treat human disease(1-3). However, in vivo delivery of short interfering RNAs (siRNAs), which are negatively charged double-stranded RNA macromolecules, remains a major hurdle(4-9). Current siRNA delivery has begun to move away from large lipid and synthetic nanoparticles to more defined molecular conjugates(9). Here we address this issue by synthesis of short interfering ribonucleic neutrals (siRNNs) whose phosphate backbone contains neutral phosphotriester groups, allowing for delivery into cells. Once inside cells, siRNNs are converted by cytoplasmic thioesterases into native, charged phosphodiester-backbone siRNAs, which induce robust RNAi responses. siRNNs have favorable drug-like properties, including high synthetic yields, serum stability and absence of innate immune responses. Unlike siRNAs, siRNNs avidly bind serum albumin to positively influence pharmacokinetic properties. Systemic delivery of siRNNs conjugated to a hepatocyte-specific targeting domain induced extended dose-dependent in vivo RNAi responses in mice. We believe that siRNNs represent a technology that will open new avenues for development of RNAi therapeutics.	[Meade, Bryan R.; Gogoi, Khirud; Hamil, Alexander S.; Palm-Apergi, Caroline; van den Berg, Arjen; Hagopian, Jonathan C.; Springer, Aaron D.; Eguchi, Akiko; Kacsinta, Apollo D.; Dowdy, Connor F.; Presente, Asaf; Loenn, Peter; Kaulich, Manuel; Yoshioka, Naohisa; Gros, Edwige; Cui, Xian-Shu; Dowdy, Steven F.] Univ Calif San Diego, Sch Med, Dept Cellular & Mol Med, La Jolla, CA 92093 USA; [Presente, Asaf] Univ Calif San Diego, Sch Med, Dept Med, Div Pulm & Crit Care, La Jolla, CA 92093 USA	University of California System; University of California San Diego; University of California System; University of California San Diego	Dowdy, SF (corresponding author), Univ Calif San Diego, Sch Med, Dept Cellular & Mol Med, La Jolla, CA 92093 USA.	sdowdy@ucsd.edu	Kaulich, Manuel/U-4523-2017; Eguchi, Akiko/E-3086-2010	Kaulich, Manuel/0000-0002-9528-8822; Palm Apergi, Caroline/0000-0003-2236-2099	Cancer Biology Training grant (NCI); San Diego Foundation; C.I.R.M. Fellowship; Knut and Alice Wallenberg Foundation; Sweden-America Foundation; CT2 training grant (N.C.I.); Swedish Research Council grant; IRACDA Training grant (N.I.H.); W.M. Keck Foundation; Department of Defense; Leukemia & Lymphoma Society; Pardee Foundation; Howard Hughes Medical Institute; NATIONAL CANCER INSTITUTE [T32CA121938, T32CA067754] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [K12GM068524] Funding Source: NIH RePORTER	Cancer Biology Training grant (NCI); San Diego Foundation; C.I.R.M. Fellowship; Knut and Alice Wallenberg Foundation(Knut & Alice Wallenberg Foundation); Sweden-America Foundation; CT2 training grant (N.C.I.); Swedish Research Council grant(Swedish Research Council); IRACDA Training grant (N.I.H.); W.M. Keck Foundation(W.M. Keck Foundation); Department of Defense(United States Department of Defense); Leukemia & Lymphoma Society(Leukemia and Lymphoma Society); Pardee Foundation; Howard Hughes Medical Institute(Howard Hughes Medical Institute); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank Y. Tor (UCSD) for critical input, Y. Su (UCSD) for help with mass spectrometry, and Z. Rudolph and L.D.F. Vasconcelos for technical assistance. B.R.M., A.S.H. and A.D.S. were supported by a T32 Cancer Biology Training grant (NCI); A.S.H. was also supported by a Blasker Award from The San Diego Foundation; A. P. was supported by a C.I.R.M. Fellowship; C.P.-A. was supported by fellowships from Knut and Alice Wallenberg Foundation and Sweden-America Foundation; J.C.H. was supported by the CT2 training grant (N.C.I.); P.L. was supported by a Swedish Research Council grant; A.D.K. was supported by a IRACDA Training grant (N.I.H.). This work was supported by the W.M. Keck Foundation (S.F.D.), the Department of Defense (S.F.D.), SCOR grant from the Leukemia & Lymphoma Society (S.F.D.), the Pardee Foundation (S.F.D.), a grant from an anonymous donor (S.F.D.) and the Howard Hughes Medical Institute (S.F.D.).	Beaucage SL, 2008, CURR OPIN DRUG DISC, V11, P203; Behlke MA, 2008, OLIGONUCLEOTIDES, V18, P305, DOI 10.1089/oli.2008.0164; Bologna JC, 1999, EUR J ORG CHEM, V1999, P2353; Bramsen JB, 2011, METHODS MOL BIOL, V721, P77, DOI 10.1007/978-1-61779-037-9_5; BRESLOW R, 1993, P NATL ACAD SCI USA, V90, P1201, DOI 10.1073/pnas.90.4.1201; Carthew RW, 2009, CELL, V136, P642, DOI 10.1016/j.cell.2009.01.035; Castanotto D, 2009, NATURE, V457, P426, DOI 10.1038/nature07758; Davidson BL, 2011, NAT REV GENET, V12, P329, DOI 10.1038/nrg2968; Dellinger DJ, 2003, J AM CHEM SOC, V125, P940, DOI 10.1021/ja027983f; Eguchi A, 2009, NAT BIOTECHNOL, V27, P567, DOI 10.1038/nbt.1541; Faraj A, 1999, NUCLEOS NUCLEOT, V18, P987, DOI 10.1080/15257779908041623; Gao S, 2009, MOL THER, V17, P1225, DOI 10.1038/mt.2009.91; Gates KS, 2009, CHEM RES TOXICOL, V22, P1747, DOI 10.1021/tx900242k; Grajkowski A, 2001, ORG LETT, V3, P1287, DOI 10.1021/ol0156852; Guzaev A, 1999, NUCLEOS NUCLEOT, V18, P1391, DOI 10.1080/07328319908044727; Joshua-Tor L, 2011, CSH PERSPECT BIOL, V3, DOI 10.1101/cshperspect.a003772; Judge AD, 2006, MOL THER, V13, P494, DOI 10.1016/j.ymthe.2005.11.002; Kanasty R, 2013, NAT MATER, V12, P967, DOI [10.1038/NMAT3765, 10.1038/nmat3765]; Krishna H, 2012, J AM CHEM SOC, V134, P11618, DOI 10.1021/ja3026714; KUIJPERS WHA, 1990, NUCLEIC ACIDS RES, V18, P5197, DOI 10.1093/nar/18.17.5197; LEFEBVRE I, 1995, J MED CHEM, V38, P3941, DOI 10.1021/jm00020a007; Lipinski CA, 2001, ADV DRUG DELIVER REV, V46, P3, DOI 10.1016/S0169-409X(00)00129-0; Meade Bryan R, 2009, Discov Med, V8, P253; Pecot CV, 2011, NAT REV CANCER, V11, P59, DOI 10.1038/nrc2966; PERIGAUD C, 1993, BIOORG MED CHEM LETT, V3, P2521, DOI 10.1016/S0960-894X(01)80709-5; Petersen S, 2014, USPTO, Patent No. [8,691,971, 8691971]; Peyrottes S, 2004, MINI-REV MED CHEM, V4, P395; Pon RT, 1997, NUCLEIC ACIDS RES, V25, P3629, DOI 10.1093/nar/25.18.3629; Reese CB, 2005, ORG BIOMOL CHEM, V3, P3851, DOI 10.1039/b510458k; Rettig GR, 2012, MOL THER, V20, P483, DOI 10.1038/mt.2011.263; Robbins M, 2009, OLIGONUCLEOTIDES, V19, P89, DOI 10.1089/oli.2009.0180; Sliedregt LAJM, 1999, J MED CHEM, V42, P609, DOI 10.1021/jm981078h; Tanabe K, 2011, TETRAHEDRON LETT, V52, P7135, DOI 10.1016/j.tetlet.2011.10.109; Tosquellas G, 1998, NUCLEIC ACIDS RES, V26, P2069, DOI 10.1093/nar/26.9.2069; van den Berg A, 2011, CURR OPIN BIOTECH, V22, P888, DOI 10.1016/j.copbio.2011.03.008; Wadia JS, 2004, NAT MED, V10, P310, DOI 10.1038/nm996; Whitehead KA, 2011, ANNU REV CHEM BIOMOL, V2, P77, DOI 10.1146/annurev-chembioeng-061010-114133; Zhou JH, 2013, PHARMACEUTICALS, V6, P85, DOI 10.3390/ph6010085	38	144	168	7	100	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156	1546-1696		NAT BIOTECHNOL	Nat. Biotechnol.	DEC	2014	32	12					1256	U122		10.1038/nbt.3078	http://dx.doi.org/10.1038/nbt.3078			8	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	AW3AD	25402614	Green Accepted			2022-12-27	WOS:000346156800028
J	Mullard, A				Mullard, Asher			EMA reconsiders 'read-through' drug against Duchenne muscular dystrophy following appeal	NATURE BIOTECHNOLOGY			English	News Item																		2013, NAT BIOTECHNOL, V31, P771; 2014, LANCET RESPIR MED, V2, P539	2	12	13	0	2	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156	1546-1696		NAT BIOTECHNOL	Nat. Biotechnol.	AUG	2014	32	8					706	706		10.1038/nbt0814-706	http://dx.doi.org/10.1038/nbt0814-706			1	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	AW7PF	25101726	Bronze			2022-12-27	WOS:000346455900032
J	Han, A; Glanville, J; Hansmann, L; Davis, MM				Han, Arnold; Glanville, Jacob; Hansmann, Leo; Davis, Mark M.			Linking T-cell receptor sequence to functional phenotype at the single-cell level	NATURE BIOTECHNOLOGY			English	Article							TUMOR-INFILTRATING LYMPHOCYTES; COLORECTAL-CANCER; TRANSCRIPTION FACTORS; ALLELIC EXCLUSION; BETA-CHAINS; TCR-ALPHA; CYTOMETRY; EXPRESSION; DIVERSITY; ANTIBODY	Although each T lymphocyte expresses a T-cell receptor (TCR) that recognizes cognate antigen and controls T-cell activation, different T cells bearing the same TCR can be functionally distinct. Each TCR is a heterodimer, and both alpha- and beta-chains contribute to determining TCR antigen specificity. Here we present a methodology enabling integration of information about TCR specificity with information about T cell function. This method involves sequencing of TCR alpha and TCR beta genes, and amplifying functional genes characteristic of different T cell subsets, in single T cells. Because this approach retains information about individual TCR alpha-TCRb beta pairs, TCRs of interest can be expressed and used in functional studies, for antigen discovery, or in therapeutic applications. We apply this approach to study the clonal ancestry and differentiation of T lymphocytes infiltrating a human colorectal carcinoma.	[Han, Arnold] Stanford Univ, Sch Med, Dept Med, Div Gastroenterol, Stanford, CA 94305 USA; [Han, Arnold; Hansmann, Leo; Davis, Mark M.] Stanford Univ, Sch Med, Dept Microbiol & Immunol, Stanford, CA 94305 USA; [Glanville, Jacob; Davis, Mark M.] Stanford Univ, Sch Med, Inst Immun Transplantat & Infect, Program Computat & Syst Immunol, Stanford, CA 94305 USA; [Davis, Mark M.] Stanford Univ, Sch Med, Howard Hughes Med Inst, Stanford, CA 94305 USA	Stanford University; Stanford University; Stanford University; Howard Hughes Medical Institute; Stanford University	Davis, MM (corresponding author), Stanford Univ, Sch Med, Dept Microbiol & Immunol, Stanford, CA 94305 USA.	mmdavis@stanford.edu	Hansmann, Leo/V-3748-2019	Hansmann, Leo/0000-0003-3790-0128; Davis, Mark/0000-0001-6868-657X	Simons Foundation; German Research Foundation (D.F.G.); US National Institutes of Health; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U19AI057229] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [K08DK100739, T32DK007056] Funding Source: NIH RePORTER	Simons Foundation; German Research Foundation (D.F.G.)(German Research Foundation (DFG)); US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	We thank members of the Davis laboratory and the Y.-H. Chien laboratory for helpful discussions. We thank E. Newell for critical reading of the manuscript and helpful suggestions. We thank C. Bolen for assistance with data analysis. We thank X. Ji for deep sequencing. Tissue was obtained through the Stanford University Tissue Bank. The Stanford Shared FACS Facility provided use of equipment and the Stanford Functional Genomics Facility provided deep sequencing services. A. H. is supported by a grant from the Simons Foundation. L. H. is supported by a fellowship from the German Research Foundation (D.F.G.). M. M. D. is funded by the US National Institutes of Health and is an investigator of the Howard Hughes Medical Institute.	Anderson P, 2008, NAT IMMUNOL, V9, P353, DOI 10.1038/ni1584; Assenmacher M., 2002, CURR PROTOC IMMUNOL, V46; Bendall SC, 2012, TRENDS IMMUNOL, V33, P323, DOI 10.1016/j.it.2012.02.010; Bentley DR, 2008, NATURE, V456, P53, DOI 10.1038/nature07517; Birnbaum ME, 2014, CELL, V157, P1073, DOI 10.1016/j.cell.2014.03.047; Blatner NR, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3004566; Collins A, 2009, NAT REV IMMUNOL, V9, P106, DOI 10.1038/nri2489; Dash P, 2011, J CLIN INVEST, V121, P288, DOI 10.1172/JCI44752; De Rosa SC, 2001, NAT MED, V7, P245, DOI 10.1038/84701; deLeeuw RJ, 2012, CLIN CANCER RES, V18, P3022, DOI 10.1158/1078-0432.CCR-11-3216; Fontenot JD, 2003, NAT IMMUNOL, V4, P330, DOI 10.1038/ni904; Galon J, 2006, SCIENCE, V313, P1960, DOI 10.1126/science.1129139; Gascoigne NRJ, 1999, SEMIN IMMUNOL, V11, P337, DOI 10.1006/smim.1999.0190; Gerlinger M, 2013, J PATHOL, V231, P424, DOI 10.1002/path.4284; Glanville J, 2009, P NATL ACAD SCI USA, V106, P20216, DOI 10.1073/pnas.0909775106; Gounaris E, 2009, CANCER RES, V69, P5490, DOI 10.1158/0008-5472.CAN-09-0304; Han A, 2013, P NATL ACAD SCI USA, V110, P13073, DOI 10.1073/pnas.1311861110; Hinrichs CS, 2013, NAT BIOTECHNOL, V31, P999, DOI 10.1038/nbt.2725; Kim SM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037338; Krogsgaard M, 2005, NAT IMMUNOL, V6, P239, DOI 10.1038/ni1173; Ladoire S, 2011, CANCER IMMUNOL IMMUN, V60, P909, DOI 10.1007/s00262-011-1046-y; Law JP, 2009, CYTOM PART A, V75A, P1040, DOI 10.1002/cyto.a.20815; MALISSEN M, 1992, IMMUNOL TODAY, V13, P315, DOI 10.1016/0167-5699(92)90044-8; Miyara M, 2009, IMMUNITY, V30, P899, DOI 10.1016/j.immuni.2009.03.019; Murphy K., 2011, JANEWAYS IMMUNOBIOLO, V8th ed.; Nakamura K, 2011, NUCLEIC ACIDS RES, V39, DOI 10.1093/nar/gkr344; Newell EW, 2014, NAT BIOTECHNOL, V32, P149, DOI 10.1038/nbt.2783; Newell EW, 2013, NAT BIOTECHNOL, V31, P623, DOI 10.1038/nbt.2593; Newell EW, 2012, IMMUNITY, V36, P142, DOI 10.1016/j.immuni.2012.01.002; Oestreich KJ, 2012, NAT REV IMMUNOL, V12, P799, DOI 10.1038/nri3321; Pages F, 2005, NEW ENGL J MED, V353, P2654, DOI 10.1056/NEJMoa051424; Ribas A, 2012, NEW ENGL J MED, V366, P2517, DOI 10.1056/NEJMe1205943; Sasada T, 2011, IMMUNOTHERAPY-UK, V3, P1235, DOI [10.2217/imt.11.106, 10.2217/IMT.11.106]; Scurr M, 2012, CELL IMMUNOL, V279, P21, DOI 10.1016/j.cellimm.2012.08.004; Shapiro E, 2013, NAT REV GENET, V14, P618, DOI 10.1038/nrg3542; Sherwood AM, 2013, CANCER IMMUNOL IMMUN, V62, P1453, DOI 10.1007/s00262-013-1446-2; Sliwkowski MX, 2013, SCIENCE, V341, P1192, DOI 10.1126/science.1241145; Spurgeon SL, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001662; Tosolini M, 2011, CANCER RES, V71, P1263, DOI 10.1158/0008-5472.CAN-10-2907; Vahedi G, 2013, IMMUNOLOGY, V139, P294, DOI 10.1111/imm.12113; Wills QF, 2013, NAT BIOTECHNOL, V31, P748, DOI 10.1038/nbt.2642; Wilson CB, 2009, NAT REV IMMUNOL, V9, P91, DOI 10.1038/nri2487; Wu AR, 2014, NAT METHODS, V11, P41, DOI 10.1038/nmeth.2694; YANAGI Y, 1985, P NATL ACAD SCI USA, V82, P3430, DOI 10.1073/pnas.82.10.3430; Zhou L, 2009, IMMUNITY, V30, P646, DOI 10.1016/j.immuni.2009.05.001	45	332	388	6	87	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156	1546-1696		NAT BIOTECHNOL	Nat. Biotechnol.	JUL	2014	32	7					684	+		10.1038/nbt.2938	http://dx.doi.org/10.1038/nbt.2938			12	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	AK8VE	24952902	Green Accepted			2022-12-27	WOS:000338705900035
J	Lepenies, B; Seeberger, PH				Lepenies, Bernd; Seeberger, Peter H.			Simply better glycoproteins	NATURE BIOTECHNOLOGY			English	Editorial Material							N-GLYCOSYLATION; CELL LINE; GLYCANS		[Lepenies, Bernd; Seeberger, Peter H.] Max Planck Inst Colloids & Interfaces, Dept Biomol Syst, Potsdam, Germany; [Seeberger, Peter H.] Univ Berlin, Inst Chem & Biochem, Berlin, Germany	Max Planck Society	Lepenies, B (corresponding author), Max Planck Inst Colloids & Interfaces, Dept Biomol Syst, Potsdam, Germany.	bernd.lepenies@mpikg.mpg.de; peter.seeberger@mpikg.mpg.de	Lepenies, Bernd/C-6509-2009	Lepenies, Bernd/0000-0001-9033-5522				Aumiller JJ, 2012, GLYCOBIOLOGY, V22, P417, DOI 10.1093/glycob/cwr160; Castilho A, 2011, GLYCOBIOLOGY, V21, P813, DOI 10.1093/glycob/cwr009; Hamilton SR, 2006, SCIENCE, V313, P1441, DOI 10.1126/science.1130256; Lepenies B, 2013, ADV DRUG DELIVER REV, V65, P1271, DOI 10.1016/j.addr.2013.05.007; Lepenies B, 2010, CURR OPIN CHEM BIOL, V14, P404, DOI 10.1016/j.cbpa.2010.02.016; Meuris L, 2014, NAT BIOTECHNOL, V32, P485, DOI 10.1038/nbt.2885; Reeves PJ, 2002, P NATL ACAD SCI USA, V99, P13419, DOI 10.1073/pnas.212519299; Rich JR, 2009, NAT CHEM BIOL, V5, P206, DOI 10.1038/nchembio.148; Schwarz F, 2010, NAT CHEM BIOL, V6, P264, DOI [10.1038/NCHEMBIO.314, 10.1038/nchembio.314]; Seeberger PH, 2007, NATURE, V446, P1046, DOI 10.1038/nature05819; Wang P, 2013, SCIENCE, V342, P1357, DOI 10.1126/science.1245095; Wang Z, 2013, SCIENCE, V341, P379, DOI 10.1126/science.1236231	12	22	23	0	46	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156	1546-1696		NAT BIOTECHNOL	Nat. Biotechnol.	MAY	2014	32	5					443	445		10.1038/nbt.2893	http://dx.doi.org/10.1038/nbt.2893			4	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	AH3PH	24811516				2022-12-27	WOS:000336036100017
J	Amit, I; Baker, D; Barker, R; Berger, B; Bertozzi, C; Bhatia, S; Biffi, A; Demichelis, F; Doudna, J; Dowdy, SF; Endy, D; Helmstaedter, M; Junca, H; June, C; Kamb, S; Khvorova, A; Kim, DH; Kim, JS; Krishnan, Y; Lakadamyali, M; Lappalainen, T; Lewin, S; Liao, J; Loman, N; Lundberg, E; Lynd, L; Martin, C; Mellman, I; Miyawaki, A; Mummery, C; Nelson, K; Paz, J; Peralta-Yahya, P; Picotti, P; Polyak, K; Prather, K; Qin, J; Quake, S; Regev, A; Rogers, JA; Shetty, R; Sommer, M; Stevens, M; Stolovitzky, G; Takahashi, M; Tang, F; Teichmann, S; Torres-Padilla, ME; Tripathi, L; Vemula, P; Verdine, G; Vollmer, F; Wang, J; Ying, JY; Zhang, F; Zhang, T				Amit, Ido; Baker, David; Barker, Roger; Berger, Bonnie; Bertozzi, Carolyn; Bhatia, Sangeeta; Biffi, Alessandra; Demichelis, Francesca; Doudna, Jennifer; Dowdy, Steven F.; Endy, Drew; Helmstaedter, Moritz; Junca, Howard; June, Carl; Kamb, Sasha; Khvorova, Anastasia; Kim, Dae-Hyeong; Kim, Jin-Soo; Krishnan, Yamuna; Lakadamyali, Melike; Lappalainen, Tuuli; Lewin, Sharon; Liao, James; Loman, Nick; Lundberg, Emma; Lynd, Lee; Martin, Cathie; Mellman, Ira; Miyawaki, Atsushi; Mummery, Christine; Nelson, Karen; Paz, Jeanne; Peralta-Yahya, Pamela; Picotti, Paola; Polyak, Kornelia; Prather, Kristala; Qin, Jun; Quake, Stephen; Regev, Aviv; Rogers, John A.; Shetty, Reshma; Sommer, Morten; Stevens, Molly; Stolovitzky, Gustavo; Takahashi, Masayo; Tang, Fuchou; Teichmann, Sarah; Torres-Padilla, Maria-Elena; Tripathi, Leena; Vemula, Praveen; Verdine, Greg; Vollmer, Frank; Wang, Jun; Ying, Jackie Y.; Zhang, Feng; Zhang, Tian			Voices of biotech	NATURE BIOTECHNOLOGY			English	Article									[Amit, Ido] Weizmann Inst Sci, IL-76100 Rehovot, Israel; [Baker, David] Univ Washington, Seattle, WA 98195 USA; [Barker, Roger] Univ Cambridge, Cambridge, England; MIT, 77 Massachusetts Ave, Cambridge, MA 02139 USA; [Bertozzi, Carolyn; Endy, Drew; Quake, Stephen] Stanford Univ, Stanford, CA 94305 USA; [Biffi, Alessandra; Polyak, Kornelia] Dana Farber Canc Inst, Cambridge, MA USA; [Biffi, Alessandra; Polyak, Kornelia; Regev, Aviv; Verdine, Greg] Harvard Univ, Cambridge, MA 02138 USA; [Demichelis, Francesca] Univ Trento, Trento, Italy; [Doudna, Jennifer] Univ Calif Berkeley, Berkeley, CA 94720 USA; [Dowdy, Steven F.] Univ Calif San Diego, San Diego, CA 92103 USA; [Helmstaedter, Moritz] Max Planck Inst Brain Res, Frankfurt, Germany; [Junca, Howard] Microbiomas Fdn, Chia, Colombia; [June, Carl] Univ Penn, Philadelphia, PA 19104 USA; [Kamb, Sasha] Amgen Inc, Thousand Oaks, CA USA; [Khvorova, Anastasia] Univ Massachusetts, Worcester, MA 01605 USA; [Kim, Dae-Hyeong; Kim, Jin-Soo] Seoul Natl Univ, Seoul, South Korea; [Krishnan, Yamuna] Univ Chicago, Chicago, IL 60637 USA; [Lakadamyali, Melike] Inst Photon Sci, Barcelona, Spain; [Lappalainen, Tuuli] New York Genome Ctr New York, New York, NY USA; [Lappalainen, Tuuli] Columbia Univ, New York, NY USA; [Lewin, Sharon] Peter Doherty Inst Infect & Immun, Melbourne, Vic, Australia; [Liao, James] Univ Calif Los Angeles, Los Angeles, CA USA; [Loman, Nick] Univ Birmingham, Birmingham, W Midlands, England; [Lundberg, Emma] KTH Royal Inst Technol, Stockholm, Sweden; [Lynd, Lee] Dartmouth Coll, Hanover, NH 03755 USA; [Martin, Cathie] John Innes Ctr, Norwich, Norfolk, England; [Mellman, Ira] Genentech Inc, San Francisco, CA 94080 USA; [Miyawaki, Atsushi] RIKEN, Brain Sci Inst, Wako, Saitama, Japan; [Mummery, Christine] Leiden Univ, Med Ctr, Leiden, Netherlands; [Nelson, Karen] J Craig Venter Inst, La Jolla, CA USA; [Nelson, Karen] Human Longev, San Diego, CA USA; [Paz, Jeanne] Univ Calif San Francisco, Gladstone Inst, San Francisco, CA 94143 USA; [Peralta-Yahya, Pamela] Georgia Inst Technol, Atlanta, GA 30332 USA; [Picotti, Paola] Swiss Fed Inst Technol, Zurich, Switzerland; [Qin, Jun] Beijing Proteome Res Ctr, Beijing, Peoples R China; [Qin, Jun] Baylor Coll Med, Houston, TX 77030 USA; [Rogers, John A.] Univ Illinois, Champaign, IL USA; [Shetty, Reshma] Ginkgo Bioworks, Boston, MA USA; [Sommer, Morten; Zhang, Tian] Tech Univ Denmark, Horsholm, Denmark; [Stevens, Molly] Univ London Imperial Coll Sci Technol & Med, London, England; [Stolovitzky, Gustavo] IBM Res Corp, Yorktown Hts, NY USA; [Stolovitzky, Gustavo] Icahn Sch Med Mt Sinai, New York, NY 10029 USA; [Takahashi, Masayo] RIKEN, Ctr Dev Biol, Kobe, Hyogo, Japan; [Tang, Fuchou] Peking Univ, Biodynam Opt Imaging Ctr, Beijing 100871, Peoples R China; [Teichmann, Sarah] Wellcome Trust Sanger Inst, Cambridge, England; [Torres-Padilla, Maria-Elena] Inst Genet & Biol Mol & Cellulaire, Strasbourg, France; [Torres-Padilla, Maria-Elena] Helmholtz Ctr, Inst Epigenet & Stem Cells, Munich, Germany; [Tripathi, Leena] Int Inst Trop Agr, Ibadan, Kenya; [Vemula, Praveen] Inst Stem Cell Biol & Regenerat Med, Bangalore, Karnataka, India; [Verdine, Greg] Warp Drive Bio, Cambridge, MA USA; [Verdine, Greg] FogPharma, Gloucester, MA USA; [Vollmer, Frank] Max Planck Inst Sci Light, Erlangen, Germany; [Wang, Jun] ICarbonX, Shenzhen, Peoples R China; [Ying, Jackie Y.] Inst Bioengn & Nanotechnol, Singapore, Singapore	Weizmann Institute of Science; University of Washington; University of Washington Seattle; University of Cambridge; Massachusetts Institute of Technology (MIT); Stanford University; Harvard University; Dana-Farber Cancer Institute; Harvard University; University of Trento; University of California System; University of California Berkeley; University of California System; University of California San Diego; Max Planck Society; University of Pennsylvania; Amgen; University of Massachusetts System; University of Massachusetts Worcester; Seoul National University (SNU); University of Chicago; Barcelona Institute of Science & Technology; Universitat Politecnica de Catalunya; Institut de Ciencies Fotoniques (ICFO); Columbia University; University of California System; University of California Los Angeles; University of Birmingham; Royal Institute of Technology; Dartmouth College; UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); John Innes Center; Roche Holding; Genentech; RIKEN; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; J. Craig Venter Institute; University of California System; University of California San Francisco; The J David Gladstone Institutes; University System of Georgia; Georgia Institute of Technology; Swiss Federal Institutes of Technology Domain; ETH Zurich; Baylor College of Medicine; University of Illinois System; University of Illinois Urbana-Champaign; Technical University of Denmark; Imperial College London; International Business Machines (IBM); Icahn School of Medicine at Mount Sinai; RIKEN; Peking University; Wellcome Trust Sanger Institute; Institut National de la Sante et de la Recherche Medicale (Inserm); Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; Department of Biotechnology (DBT) India; Institute for Stem Cell Biology & Regenerative Medicine - inStem; Max Planck Society; Agency for Science Technology & Research (A*STAR); A*STAR - Institute of Bioengineering & Bioimaging (IBB); A*STAR - Institute of Bioengineering & Nanotechnology (IBN)	Amit, I (corresponding author), Weizmann Inst Sci, IL-76100 Rehovot, Israel.		Rogers, John/L-2798-2016; Lappalainen, Tuuli/AAE-6532-2020; Mellman, Ira/ABG-5896-2020; Lundberg, Emma S K/F-3891-2010; Lynd, Lee R/N-1260-2013; Junca, Howard/K-5525-2014; huang, yonggang/O-6236-2019; Loman, Nicholas/Z-1573-2019; Biffi, Alessandra/AAA-8890-2019; KIM, Jin-Soo/M-6918-2013; Demichelis, Francesca/J-9829-2016; Miyawaki, Atsushi/K-3569-2014; Vollmer, Frank/J-4732-2013; Zhang, Tian/N-4696-2015; Ying, Jackie/A-8402-2012	Lappalainen, Tuuli/0000-0002-7746-8109; Lynd, Lee R/0000-0002-5642-668X; Junca, Howard/0000-0003-4546-6229; KIM, Jin-Soo/0000-0003-4847-1306; Demichelis, Francesca/0000-0002-8266-8631; Miyawaki, Atsushi/0000-0002-2329-3235; Kim, Dae-Hyeong/0000-0002-4722-1893; Stevens, Molly/0000-0002-7335-266X; Vollmer, Frank/0000-0003-0565-4671; Mummery, Christine/0000-0002-4549-6535; Loman, Nicholas/0000-0002-9843-8988; Kaller Lundberg, Emma/0000-0001-7034-0850; Zhang, Tian/0000-0003-3840-4839; Ying, Jackie/0000-0001-6938-2113; Lewin, Sharon Ruth/0000-0002-0330-8241; Sommer, Morten Otto Alexander/0000-0003-4005-5674	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM108803] Funding Source: NIH RePORTER; Biotechnology and Biological Sciences Research Council [BBS/E/J/00000153] Funding Source: Medline; Medical Research Council [MR/M501621/1] Funding Source: Medline; NIGMS NIH HHS [R01 GM108803] Funding Source: Medline; Biotechnology and Biological Sciences Research Council [BB/N005023/1, BB/L011719/1] Funding Source: researchfish; Lundbeck Foundation [R77-2010-6772, R140-2013-13496] Funding Source: researchfish; Novo Nordisk Fonden [NNF14OC0011335, NNF10CC1016517, NNF13SA0009311, NNF13SA0006019] Funding Source: researchfish; NNF Center for Biosustainability [Bioelectrochem. Systems, Bacterial Synthetic Biology] Funding Source: researchfish; BBSRC [BB/N005023/1, BB/L011719/1] Funding Source: UKRI	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Lundbeck Foundation(Lundbeckfonden); Novo Nordisk Fonden(Novo Nordisk Foundation); NNF Center for Biosustainability; BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))			0	3	3	2	114	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156	1546-1696		NAT BIOTECHNOL	Nat. Biotechnol.	MAR	2016	34	3					270	275		10.1038/nbt.3502	http://dx.doi.org/10.1038/nbt.3502			6	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	DG1CJ	26963549				2022-12-27	WOS:000371802600019
J	DeFrancesco, L; Schmidt, C; Waltz, E				DeFrancesco, Laura; Schmidt, Charles; Waltz, Emily			20 years of Nature Biotechnology bioengineering research	NATURE BIOTECHNOLOGY			English	Article							GENE; PIGS											Atsumi S, 2009, NAT BIOTECHNOL, V27, P1177, DOI 10.1038/nbt.1586; Baker M, 2006, NAT BIOTECHNOL, V24, P301, DOI 10.1038/nbt0306-301a; Baker M, 2011, NAT BIOTECHNOL, V29, P221, DOI 10.1038/nbt.1798; Castellana M, 2014, NAT BIOTECHNOL, V32, P1011, DOI 10.1038/nbt.3018; Curtin SJ, 2011, PLANT PHYSIOL, V156, P466, DOI 10.1104/pp.111.172981; Dai YF, 2002, NAT BIOTECHNOL, V20, P251, DOI 10.1038/nbt0302-251; Dueber JE, 2009, NAT BIOTECHNOL, V27, P753, DOI 10.1038/nbt.1557; Fiehn O, 2000, NAT BIOTECHNOL, V18, P1157, DOI 10.1038/81137; Kasuga M, 1999, NAT BIOTECHNOL, V17, P287, DOI 10.1038/7036; Lai LX, 2002, SCIENCE, V295, P1089, DOI 10.1126/science.1068228; Petters RM, 1997, NAT BIOTECHNOL, V15, P965, DOI 10.1038/nbt1097-965; Wall RJ, 2005, NAT BIOTECHNOL, V23, P445, DOI 10.1038/nbt1078; Wang YP, 2014, NAT BIOTECHNOL, V32, P947, DOI 10.1038/nbt.2969; Whitworth KM, 2016, NAT BIOTECHNOL, V34, P20, DOI 10.1038/nbt.3434	14	1	1	0	16	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156	1546-1696		NAT BIOTECHNOL	Nat. Biotechnol.	MAR	2016	34	3					267	269		10.1038/nbt.3508	http://dx.doi.org/10.1038/nbt.3508			3	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	DG1CJ	26963548				2022-12-27	WOS:000371802600018
J	Hodgson, J				Hodgson, John			When biotech goes bad	NATURE BIOTECHNOLOGY			English	Article									[Hodgson, John] Informa Business Informat, Pharma, London, England		Hodgson, J (corresponding author), Informa Business Informat, Pharma, London, England.	john.hodgson@informa.com							0	1	1	0	6	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156	1546-1696		NAT BIOTECHNOL	Nat. Biotechnol.	MAR	2016	34	3					284	291		10.1038/nbt.3510	http://dx.doi.org/10.1038/nbt.3510			8	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	DG1CJ	26963551				2022-12-27	WOS:000371802600021
J	Yang, Y; Wang, LL; Bell, P; McMenamin, D; He, ZN; White, J; Yu, HW; Xu, CY; Morizono, H; Musunuru, K; Batshaw, ML; Wilson, JM				Yang, Yang; Wang, Lili; Bell, Peter; McMenamin, Deirdre; He, Zhenning; White, John; Yu, Hongwei; Xu, Chenyu; Morizono, Hiroki; Musunuru, Kiran; Batshaw, Mark L.; Wilson, James M.			A dual AAV system enables the Cas9-mediated correction of a metabolic liver disease in newborn mice	NATURE BIOTECHNOLOGY			English	Article							HEPATIC GENE-TRANSFER; HUMAN ORNITHINE TRANSCARBAMYLASE; ADENOASSOCIATED VIRUS; TOLERANCE INDUCTION; RHESUS-MONKEYS; MOUSE-LIVER; WILD-TYPE; GENOME; DELIVERY; CRISPR-CAS9	Many genetic liver diseases in newborns cause repeated, often lethal, metabolic crises. Gene therapy using nonintegrating viruses such as adeno-associated virus (AAV) is not optimal in this setting because the nonintegrating genome is lost as developing hepatocytes proliferate(1,2). We reasoned that newborn liver may be an ideal setting for AAV-mediated gene correction using CRISPR-Cas9. Here we intravenously infuse two AAVs, one expressing Cas9 and the other expressing a guide RNA and the donor DNA, into newborn mice with a partial deficiency in the urea cycle disorder enzyme, ornithine transcarbamylase (OTC). This resulted in reversion of the mutation in 10% (6.7-20.1%) of hepatocytes and increased survival in mice challenged with a high-protein diet, which exacerbates disease. Gene correction in adult OTC-deficient mice was lower and accompanied by larger deletions that ablated residual expression from the endogenous OTC gene, leading to diminished protein tolerance and lethal hyperammonemia on a chow diet.	[Yang, Yang; Bell, Peter; McMenamin, Deirdre; He, Zhenning; White, John; Yu, Hongwei; Wilson, James M.] Univ Penn, Dept Med, Perelman Sch Med, Gene Therapy Program, Philadelphia, PA 19104 USA; [Yang, Yang] Sichuan Univ, West China Hosp, State Key Lab Biotherapy, Chengdu 610064, Sichuan, Peoples R China; [Yang, Yang] Sichuan Univ, West China Hosp, Ctr Canc, Chengdu 610064, Sichuan, Peoples R China; [Yang, Yang] Collaborat Innovat Ctr Biotherapy, Chengdu, Sichuan, Peoples R China; [Wang, Lili] Univ Penn, Dept Pathol & Lab Med, Perelman Sch Med, Gene Therapy Program, Philadelphia, PA USA; [Xu, Chenyu; Morizono, Hiroki; Batshaw, Mark L.] Childrens Natl Hlth Syst, Childrens Res Inst, Ctr Genet Med Res, Washington, DC USA; [Musunuru, Kiran] Harvard Univ, Harvard Stem Cell Inst, Dept Stem Cell & Regenerat Biol, Cambridge, MA 02138 USA; [Musunuru, Kiran] Brigham & Womens Hosp, Div Cardiovasc Med, 75 Francis St, Boston, MA 02115 USA	University of Pennsylvania; Pennsylvania Medicine; Sichuan University; Sichuan University; University of Pennsylvania; Pennsylvania Medicine; Children's National Health System; Harvard University; Harvard University; Brigham & Women's Hospital	Wilson, JM (corresponding author), Univ Penn, Dept Med, Perelman Sch Med, Gene Therapy Program, Philadelphia, PA 19104 USA.	wilsonjm@mail.med.upenn.edu	Wang, Lili/D-1093-2009; Wilson, Matthew H/K-3193-2013; Wilson, James M/F-9220-2011; Morizono, Hiroki/E-9737-2013	Wang, Lili/0000-0001-9347-3939; Wilson, James M/0000-0002-9630-3131; Morizono, Hiroki/0000-0002-9678-5564; YANG, YANG/0000-0002-8190-1825	National Institute of Child Health and Human Development [P01-HD057247]; Kettering Family Foundation; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [P01HD057247] Funding Source: NIH RePORTER	National Institute of Child Health and Human Development(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); Kettering Family Foundation; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	We thank Penn Vector Core for supplying vectors, Penn Bioinformatics Core for assistance on deep sequencing data analysis, Y. Zhu and M. Nayalat for help on immunohistochemistry analysis, and L. Mays for assistance on manuscript preparation. This work was supported by National Institute of Child Health and Human Development P01-HD057247 (J.M.W.) and the Kettering Family Foundation (M.L.B.).	Anguela XM, 2013, BLOOD, V122, P3283, DOI 10.1182/blood-2013-04-497354; Augustin L, 2000, PEDIATR RES, V48, P842, DOI 10.1203/00006450-200012000-00023; Barzel A, 2015, NATURE, V517, P360, DOI 10.1038/nature13864; Batshaw ML, 2014, MOL GENET METAB, V113, P127, DOI 10.1016/j.ymgme.2014.08.001; Cheng RR, 2014, FEBS LETT, V588, P3954, DOI 10.1016/j.febslet.2014.09.008; Cunningham SC, 2008, MOL THER, V16, P1081, DOI 10.1038/mt.2008.72; Daly Thomas M, 2004, Methods Mol Biol, V246, P195; Dingemanse MA, 1996, HEPATOLOGY, V24, P407; Doudna JA, 2014, SCIENCE, V346, P1077, DOI 10.1126/science.1258096; Friedland AE, 2015, GENOME BIOL, V16, DOI 10.1186/s13059-015-0817-8; Gao GP, 2002, P NATL ACAD SCI USA, V99, P11854, DOI 10.1073/pnas.182412299; Hinderer C, 2015, MOL THER, V23, P1298, DOI 10.1038/mt.2015.99; HODGES PE, 1989, P NATL ACAD SCI USA, V86, P4142, DOI 10.1073/pnas.86.11.4142; Hsu PD, 2014, CELL, V157, P1262, DOI 10.1016/j.cell.2014.05.010; Kleinstiver BP, 2015, NATURE, V523, P481, DOI 10.1038/nature14592; Lichter-Konecki U, GENEREVIEWS; Lock M, 2010, HUM GENE THER, V21, P1259, DOI 10.1089/hum.2010.055; LoDuca PA, 2009, CURR GENE THER, V9, P104, DOI 10.2174/156652309787909490; Mahiny AJ, 2015, NAT BIOTECHNOL, V33, P584, DOI 10.1038/nbt.3241; Mew NA, 2013, J PEDIATR-US, V162, P324, DOI 10.1016/j.jpeds.2012.06.065; Morizono H, 1997, BIOCHEM J, V322, P625, DOI 10.1042/bj3220625; Moscioni D, 2006, MOL THER, V14, P25, DOI 10.1016/j.ymthe.2006.03.009; Nivsarkar MS, 2015, J IMMUNOL RES, V2015, DOI 10.1155/2015/397879; Ran FA, 2015, NATURE, V520, P186, DOI 10.1038/nature14299; Ran FA, 2013, NAT PROTOC, V8, P2281, DOI 10.1038/nprot.2013.143; Schmidt F, 2015, BIOTECHNOL J, V10, P258, DOI 10.1002/biot.201400529; Sharma R, 2015, BLOOD, V126, P1777, DOI 10.1182/blood-2014-12-615492; Shi Y, 2013, GENE THER, V20, P987, DOI 10.1038/gt.2013.22; Tsai SQ, 2015, NAT BIOTECHNOL, V33, P187, DOI 10.1038/nbt.3117; Vasileva A, 2005, NAT REV MICROBIOL, V3, P837, DOI 10.1038/nrmicro1266; Wang D, 2015, HUM GENE THER, V26, P432, DOI 10.1089/hum.2015.087; Wang L, 2012, GENE THER, V19, P404, DOI 10.1038/gt.2011.111; Wang LL, 2012, HUM GENE THER, V23, P533, DOI 10.1089/hum.2011.183; Wang LL, 2011, MOL THER, V19, P2012, DOI 10.1038/mt.2011.151; Yang LH, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6507; Yin H, 2014, NAT BIOTECHNOL, V32, P551, DOI 10.1038/nbt.2884	36	338	375	11	119	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156	1546-1696		NAT BIOTECHNOL	Nat. Biotechnol.	MAR	2016	34	3					334	+		10.1038/nbt.3469	http://dx.doi.org/10.1038/nbt.3469			7	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	DG1CJ	26829317	Green Accepted, Green Submitted			2022-12-27	WOS:000371802600031
J	Yin, H; Song, CQ; Dorkin, JR; Zhu, LHJ; Li, YX; Wu, QQ; Park, A; Yang, J; Suresh, S; Bizhanova, A; Gupta, A; Bolukbasi, MF; Walsh, S; Bogorad, RL; Gao, GP; Weng, ZP; Dong, YZ; Koteliansky, V; Wolfe, SA; Langer, R; Xue, W; Anderson, DG				Yin, Hao; Song, Chun-Qing; Dorkin, Joseph R.; Zhu, Lihua J.; Li, Yingxiang; Wu, Qiongqiong; Park, Angela; Yang, Junghoon; Suresh, Sneha; Bizhanova, Aizhan; Gupta, Ankit; Bolukbasi, Mehmet F.; Walsh, Stephen; Bogorad, Roman L.; Gao, Guangping; Weng, Zhiping; Dong, Yizhou; Koteliansky, Victor; Wolfe, Scot A.; Langer, Robert; Xue, Wen; Anderson, Daniel G.			Therapeutic genome editing by combined viral and non-viral delivery of CRISPR system components in vivo	NATURE BIOTECHNOLOGY			English	Article							HOMOLOGY-DIRECTED REPAIR; MAMMALIAN-CELLS; MESSENGER-RNA; MOUSE MODEL; GENE; CAS9; MICE; DNA; NUCLEASES; CORRECTS	The combination of Cas9, guide RNA and repair template DNA can induce precise gene editing and the correction of genetic diseases in adult mammals. However, clinical implementation of this technology requires safe and effective delivery of all of these components into the nuclei of the target tissue. Here, we combine lipid nanoparticle-mediated delivery of Cas9 mRNA with adeno-associated viruses encoding a sgRNA and a repair template to induce repair of a disease gene in adult animals. We applied our delivery strategy to a mouse model of human hereditary tyrosinemia and show that the treatment generated fumarylacetoacetate hydrolase (Fah)-positive hepatocytes by correcting the causative Fah-splicing mutation. Treatment rescued disease symptoms such as weight loss and liver damage. The efficiency of correction was >6% of hepatocytes after a single application, suggesting potential utility of Cas9-based therapeutic genome editing for a range of diseases.	[Yin, Hao; Dorkin, Joseph R.; Wu, Qiongqiong; Yang, Junghoon; Suresh, Sneha; Walsh, Stephen; Bogorad, Roman L.; Langer, Robert; Anderson, Daniel G.] MIT, David H Koch Inst Integrat Canc Res, 77 Massachusetts Ave, Cambridge, MA 02139 USA; [Song, Chun-Qing; Park, Angela; Bizhanova, Aizhan; Xue, Wen] Univ Massachusetts, Sch Med, RNA Therapeut Inst, Worcester, MA USA; [Song, Chun-Qing; Zhu, Lihua J.; Xue, Wen] Univ Massachusetts, Sch Med, Program Mol Med, Worcester, MA USA; [Dorkin, Joseph R.] MIT, Dept Biol, 77 Massachusetts Ave, Cambridge, MA USA; [Zhu, Lihua J.; Gupta, Ankit; Bolukbasi, Mehmet F.; Wolfe, Scot A.; Xue, Wen] Univ Massachusetts, Sch Med, Dept Mol Cell & Canc Biol, Worcester, MA USA; [Zhu, Lihua J.; Weng, Zhiping] Univ Massachusetts, Sch Med, Program Bioinformat & Integrat Biol, Worcester, MA USA; [Li, Yingxiang] Tongji Univ, Sch Life Sci & Technol, Dept Bioinformat, Shanghai 200092, Peoples R China; [Bolukbasi, Mehmet F.; Wolfe, Scot A.] Univ Massachusetts, Sch Med, Dept Biochem & Mol Pharmacol, Worcester, MA USA; [Gao, Guangping] Univ Massachusetts, Sch Med, Gene Therapy Ctr, Worcester, MA USA; [Dong, Yizhou] Ohio State Univ, Coll Pharm, 500 W 12Th Ave, Columbus, OH 43210 USA; [Koteliansky, Victor] Skolkovo Inst Sci & Technol, Skolkovo, Russia; [Koteliansky, Victor] Moscow MV Lomonosov State Univ, Dept Chem, Leninskie Gory, Russia; [Langer, Robert; Anderson, Daniel G.] MIT, Dept Chem Engn, Cambridge, MA 02139 USA; [Langer, Robert; Anderson, Daniel G.] Harvard MIT Div Hlth Sci & Technol, Cambridge, MA USA; [Langer, Robert; Anderson, Daniel G.] MIT, Inst Med Engn & Sci, 77 Massachusetts Ave, Cambridge, MA 02139 USA	Massachusetts Institute of Technology (MIT); University of Massachusetts System; University of Massachusetts Worcester; University of Massachusetts System; University of Massachusetts Worcester; Massachusetts Institute of Technology (MIT); University of Massachusetts System; University of Massachusetts Worcester; University of Massachusetts System; University of Massachusetts Worcester; Tongji University; University of Massachusetts System; University of Massachusetts Worcester; University of Massachusetts System; University of Massachusetts Worcester; University System of Ohio; Ohio State University; Skolkovo Institute of Science & Technology; Lomonosov Moscow State University; Massachusetts Institute of Technology (MIT); Harvard University; Massachusetts Institute of Technology (MIT)	Anderson, DG (corresponding author), MIT, David H Koch Inst Integrat Canc Res, 77 Massachusetts Ave, Cambridge, MA 02139 USA.; Xue, W (corresponding author), Univ Massachusetts, Sch Med, RNA Therapeut Inst, Worcester, MA USA.; Xue, W (corresponding author), Univ Massachusetts, Sch Med, Program Mol Med, Worcester, MA USA.; Xue, W (corresponding author), Univ Massachusetts, Sch Med, Dept Mol Cell & Canc Biol, Worcester, MA USA.; Anderson, DG (corresponding author), MIT, Dept Chem Engn, Cambridge, MA 02139 USA.; Anderson, DG (corresponding author), Harvard MIT Div Hlth Sci & Technol, Cambridge, MA USA.; Anderson, DG (corresponding author), MIT, Inst Med Engn & Sci, 77 Massachusetts Ave, Cambridge, MA 02139 USA.	wen.xue@umassmed.edu; dgander@mit.edu	Dong, Yizhou/O-9057-2015; Bizhanova, Aizhan/ABA-6459-2020; Wilson, Matthew H/K-3193-2013; Bizhanova, Aizhan/ABF-1166-2021	Dong, Yizhou/0000-0001-5786-0659; Bizhanova, Aizhan/0000-0003-0644-5361; Walsh, Stephen/0000-0002-6999-8601; Suresh, Sneha/0000-0001-9545-6366; Zhu, Lihua/0000-0001-7416-0590	National Institutes of Health (NIH) [5R00CA169512]; Worcester Foundation; Skoltech Center; NIH Centers for Cancer Nanotechnology Excellence [5-U54-CA151884-04]; Harvard-MIT Center of Cancer Nanotechnology Excellence [5-U54-CA151884-04]; National Institute of Biomedical Imaging and Bioengineering [1F32EB017625]; Russian scientific fund [14-34-00017]; NIH [P30-CA14051];  [5P30EY012196-17]; NATIONAL CANCER INSTITUTE [U54CA151884, R00CA169512, P30CA014051] Funding Source: NIH RePORTER; NATIONAL EYE INSTITUTE [P30EY012196] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [F32EB017625] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Worcester Foundation; Skoltech Center; NIH Centers for Cancer Nanotechnology Excellence; Harvard-MIT Center of Cancer Nanotechnology Excellence; National Institute of Biomedical Imaging and Bioengineering(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); Russian scientific fund(Russian Science Foundation (RSF)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); ; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB))	We thank M. Grompe, S. Levine, T. Jacks, P. Sharp, E. Sontheimer, C. Mello, P. Zamore, M. Moore, T. Flotte, T. Tammela, F. Sanchez-Rivera, T. Papagiannakopoulos, D. Wang, J. Moore and A. Vegas for discussions and for sharing reagents, S. Hough for technical assistance and K. Cormier for histology. This work is supported by grants from the National Institutes of Health (NIH), 5R00CA169512 and Worcester Foundation (to W.X.). H.Y. is supported by Skoltech Center and 5-U54-CA151884-04 (NIH Centers for Cancer Nanotechnology Excellence and the Harvard-MIT Center of Cancer Nanotechnology Excellence). Y.D. acknowledges support from the National Institute of Biomedical Imaging and Bioengineering for his postdoctoral fellowship 1F32EB017625. V.K. acknowledges support from the Russian scientific fund, grant number 14-34-00017. This work is supported in part by Cancer Center Support (core) grant P30-CA14051 from the NIH. We thank the Swanson Biotechnology Center for technical support. We thank C. Wang at Boston Children's Hospital Viral Core for AAV prep (supported by core grant 5P30EY012196-17). The authors acknowledge the service to the MIT community of the late S. Collier.	Aponte JL, 2001, P NATL ACAD SCI USA, V98, P641, DOI 10.1073/pnas.98.2.641; Atabai K, 2005, MOL BIOL CELL, V16, P5528, DOI 10.1091/mbc.E05-02-0128; Azuma H, 2007, NAT BIOTECHNOL, V25, P903, DOI 10.1038/nbt1326; Barzel A, 2015, NATURE, V517, P360, DOI 10.1038/nature13864; Bolukbasi MF, 2015, NAT METHODS, V12, P1150, DOI 10.1038/nmeth.3624; Chen DL, 2012, J AM CHEM SOC, V134, P6948, DOI 10.1021/ja301621z; Chen HZ, 2012, NAT CELL BIOL, V14, P1192, DOI 10.1038/ncb2595; Cong L, 2013, SCIENCE, V339, P819, DOI 10.1126/science.1231143; Cox DBT, 2015, NAT MED, V21, P121, DOI 10.1038/nm.3793; Doudna JA, 2014, SCIENCE, V346, P1077, DOI 10.1126/science.1258096; Elliott B, 1998, MOL CELL BIOL, V18, P93, DOI 10.1128/MCB.18.1.93; Findlay GM, 2014, NATURE, V513, P120, DOI 10.1038/nature13695; Fu YF, 2013, NAT BIOTECHNOL, V31, P822, DOI 10.1038/nbt.2623; Gilbert LA, 2013, CELL, V154, P442, DOI 10.1016/j.cell.2013.06.044; Goldberg AD, 2010, CELL, V140, P678, DOI 10.1016/j.cell.2010.01.003; Hendel A, 2015, NAT BIOTECHNOL, V33, P985, DOI 10.1038/nbt.3290; Hsu PD, 2013, NAT BIOTECHNOL, V31, P827, DOI 10.1038/nbt.2647; Kauffman KJ, 2015, NANO LETT, V15, P7300, DOI 10.1021/acs.nanolett.5b02497; Kay MA, 2011, NAT REV GENET, V12, P316, DOI 10.1038/nrg2971; Khorsandi SE, 2008, CANCER GENE THER, V15, P225, DOI 10.1038/sj.cgt.7701119; Kim H, 2014, GENETICS, V197, P1069, DOI 10.1534/genetics.114.166389; Kormann MSD, 2011, NAT BIOTECHNOL, V29, P154, DOI 10.1038/nbt.1733; Li HJ, 2011, NATURE, V475, P217, DOI 10.1038/nature10177; Long CZ, 2014, SCIENCE, V345, P1184, DOI 10.1126/science.1254445; Love KT, 2010, P NATL ACAD SCI USA, V107, P1864, DOI 10.1073/pnas.0910603106; Mahiny AJ, 2015, NAT BIOTECHNOL, V33, P584, DOI 10.1038/nbt.3241; Mali P, 2013, NAT METHODS, V10, P957, DOI [10.1038/NMETH.2649, 10.1038/nmeth.2649]; Mali P, 2013, SCIENCE, V339, P823, DOI 10.1126/science.1232033; Paulk NK, 2010, HEPATOLOGY, V51, P1200, DOI 10.1002/hep.23481; Ran FA, 2015, NATURE, V520, P186, DOI 10.1038/nature14299; Sander JD, 2014, NAT BIOTECHNOL, V32, P347, DOI 10.1038/nbt.2842; Schwank G, 2013, CELL STEM CELL, V13, P653, DOI 10.1016/j.stem.2013.11.002; Semple SC, 2010, NAT BIOTECHNOL, V28, P172, DOI 10.1038/nbt.1602; Sundararajan S, 2012, DEVELOPMENT, V139, P4484, DOI 10.1242/dev.078790; Swiech L, 2015, NAT BIOTECHNOL, V33, P102, DOI 10.1038/nbt.3055; Tsai SQ, 2015, NAT BIOTECHNOL, V33, P187, DOI 10.1038/nbt.3117; Chu VT, 2015, NAT BIOTECHNOL, V33, P543, DOI 10.1038/nbt.3198; Wu XB, 2014, NAT BIOTECHNOL, V32, P670, DOI 10.1038/nbt.2889; Wu YX, 2013, CELL STEM CELL, V13, P659, DOI 10.1016/j.stem.2013.10.016; Xue W, 2014, NATURE, V514, P380, DOI 10.1038/nature13589; Yin H, 2014, NAT REV GENET, V15, P541, DOI 10.1038/nrg3763; Yin H, 2014, NAT BIOTECHNOL, V32, P551, DOI 10.1038/nbt.2884; Zhu LHJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0108424; Zhu LJ, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-237; Zhu Lihua Julie, 2015, [Frontiers in Biology, 生物学前沿], V10, P289; Zuris JA, 2015, NAT BIOTECHNOL, V33, P73, DOI 10.1038/nbt.3081	46	591	633	13	584	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156	1546-1696		NAT BIOTECHNOL	Nat. Biotechnol.	MAR	2016	34	3					328	+		10.1038/nbt.3471	http://dx.doi.org/10.1038/nbt.3471			7	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	DG1CJ	26829318	Green Submitted, Green Accepted			2022-12-27	WOS:000371802600030
J	Bongaerts, GPA; Severijnen, RSVM				Bongaerts, Ger P. A.; Severijnen, Rene S. V. M.			A reassessment of the PROPATRIA study and its implications for probiotic therapy	NATURE BIOTECHNOLOGY			English	Article							SEVERE ACUTE-PANCREATITIS; ENTERAL NUTRITION; ACIDOSIS; FAILURE	The PROPATRIA (Probiotics in Pancreatitis Trial) study was a multicenter, double-blind, placebo-controlled clinical trial that aimed to reduce infectious complications in patients with predicted severe acute pancreatitis by the enteral use of a multispecies probiotic preparation. An unprecedented 24 of 152 patients (16%) in the group receiving probiotics died versus 9 of 144 (6%) in the placebo group. This high mortality rate in the probiotic-treated group contrasts strongly with observations from a previous smaller study and from our observations regarding the effects of abundant intestinal lactobacilli in patients with short small bowel (SSB) syndrome. We argue here that a lethal combination of mainly proteolytic pancreas enzymes and probiotic therapy resulted in the high mortality rate of the PROPATRIA trial and that elevated levels of lactic acid produced by bacterial fermentation of carbohydrates were a key contributing factor. We suggest that probiotic therapy may not be counter-indicated for the prevention of secondary infections associated with acute pancreatitis, provided that future clinical studies (i) start probiotic therapy immediately after first onset of disease symptoms, (ii) limit the supply of fermentable carbohydrates, (iii) prevent bacterial (over)growth of patient's own intestinal flora and (iv) massively increase the dose of probiotic bacteria.	[Bongaerts, Ger P. A.] Radboud Univ Nijmegen, Radboud Inst Mol Life Sci, Lab Pediat Infect Dis, Dept Pediat,Med Ctr, NL-6525 ED Nijmegen, Netherlands; [Severijnen, Rene S. V. M.] Radboud Univ Nijmegen, Med Ctr, Div Pediat Surg, Dept Surg, NL-6525 ED Nijmegen, Netherlands	Radboud University Nijmegen; Radboud University Nijmegen	Bongaerts, GPA (corresponding author), Radboud Univ Nijmegen, Radboud Inst Mol Life Sci, Lab Pediat Infect Dis, Dept Pediat,Med Ctr, NL-6525 ED Nijmegen, Netherlands.	Ger.Bongaerts@radboudurnc.nl						Ammori BJ, 1999, J GASTROINTEST SURG, V3, P252, DOI 10.1016/S1091-255X(99)80067-5; Besselink MGH, 2008, LANCET, V371, P651, DOI 10.1016/S0140-6736(08)60207-X; Besselink Marc G H, 2004, BMC Surg, V4, P12, DOI 10.1186/1471-2482-4-12; Bongaerts G, 2000, J PEDIATR GASTR NUTR, V30, P288, DOI 10.1097/00005176-200003000-00014; BONGAERTS G, 1995, CLIN CHEM, V41, P107; Bongaerts G. P. A., 2007, INT J PROBIOTICS PRE, V1, P87; Bongaerts G. P. A., 2007, INT J PROBIOTICS PRE, V1, P83; Bongaerts GPA, 1997, MICROB PATHOGENESIS, V22, P285, DOI 10.1006/mpat.1996.0122; Bongaerts GPA, 2005, MED HYPOTHESES, V64, P1089, DOI 10.1016/j.mehy.2004.10.018; DEITCH EA, 1990, ARCH SURG-CHICAGO, V125, P403; Food and Agricultural Organization of the United Nations and World Health Organization, 2001, HLTH NUTR PROP PROB; Gou SM, 2014, CRIT CARE, V18, DOI 10.1186/cc13809; HIGUCHI S, 1994, LANCET, V343, P741, DOI 10.1016/S0140-6736(94)91629-2; Hooijmans CR, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048811; Johnson CD, 2005, GUT, V54, P1, DOI 10.1136/gut.200A.057026; KARTON M, 1987, JPEN-PARENTER ENTER, V11, P586, DOI 10.1177/0148607187011006586; Martin FPJ, 2008, MOL SYST BIOL, V4, DOI 10.1038/msb4100190; Olah A, 2002, BRIT J SURG, V89, P1103, DOI 10.1046/j.1365-2168.2002.02189.x; Putaala H, 2008, RES MICROBIOL, V159, P692, DOI 10.1016/j.resmic.2008.08.002; Severijnen Rene, 2005, Microbial Ecology in Health and Disease, V17, P88, DOI 10.1080/08910600510044831; Sneath P. H. A., 1986, BERGEYS MANUAL SYSTE, p[1065, 1209, 1418]; Tangerman A, 2002, J CLIN PATHOL, V55, P631, DOI 10.1136/jcp.55.8.631; Van Baal M. C. P. M., 2014, THESIS RADBOUD U; van Baal MC, 2014, PANCREATOLOGY, V14, P470, DOI 10.1016/j.pan.2014.10.002	24	38	45	0	22	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156	1546-1696		NAT BIOTECHNOL	Nat. Biotechnol.	JAN	2016	34	1					55	63		10.1038/nbt.3436	http://dx.doi.org/10.1038/nbt.3436			9	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	DB8HQ	26744983				2022-12-27	WOS:000368758200027
J	Derrington, IM; Craig, JM; Stava, E; Laszlo, AH; Ross, BC; Brinkerhoff, H; Nova, IC; Doering, K; Tickman, BI; Ronaghi, M; Mandell, JG; Gunderson, KL; Gundlach, JH				Derrington, Ian M.; Craig, Jonathan M.; Stava, Eric; Laszlo, Andrew H.; Ross, Brian C.; Brinkerhoff, Henry; Nova, Ian C.; Doering, Kenji; Tickman, Benjamin I.; Ronaghi, Mostafa; Mandell, Jeffrey G.; Gunderson, Kevin L.; Gundlach, Jens H.			Subangstrom single-molecule measurements of motor proteins using a nanopore	NATURE BIOTECHNOLOGY			English	Article							STRANDED-DNA; MSPA; POLYMERASE; HELICASE	Techniques for measuring the motion of single motor proteins, such as FRET and optical tweezers, are limited to a resolution of similar to 300 pm. We use ion current modulation through the protein nanopore MspA to observe translocation of helicase Hel308 on DNA with up to similar to 40 pm sensitivity. This approach should be applicable to any protein that translocates on DNA or RNA, including helicases, polymerases, recombinases and DNA repair enzymes.	[Derrington, Ian M.; Craig, Jonathan M.; Laszlo, Andrew H.; Ross, Brian C.; Brinkerhoff, Henry; Nova, Ian C.; Doering, Kenji; Tickman, Benjamin I.; Gundlach, Jens H.] Univ Washington, Dept Phys, Seattle, WA 98195 USA; [Stava, Eric; Ronaghi, Mostafa; Mandell, Jeffrey G.; Gunderson, Kevin L.] Illumina Inc, San Diego, CA USA	University of Washington; University of Washington Seattle; Illumina	Gundlach, JH (corresponding author), Univ Washington, Dept Phys, Seattle, WA 98195 USA.	jens@phys.washington.edu		Brinkerhoff, Henry/0000-0003-2735-8048; Laszlo, Andrew/0000-0002-7853-0533; Craig, Jonathan M/0000-0003-4791-5112; Gundlach, Jens Horst/0000-0002-0773-8038	National Institutes of Health National Human Genome Research Institute (NHGRI) grant [R01HG005115]; Illumina; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R01HG005115] Funding Source: NIH RePORTER	National Institutes of Health National Human Genome Research Institute (NHGRI) grant; Illumina; NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))	This work was supported at the University of Washington by the National Institutes of Health National Human Genome Research Institute (NHGRI) grant R01HG005115 and at Illumina through internal funding. We thank J.J. Bartlett, S. Klebanoff, M.T. Svet and M.T. Noakes for assisting in the data collection and C.-Y. Chen, A. Nikoomanzar and W. Chang for making Hel308 and testing its activity. M. Hopper, N. Sam-Soon and S. Marx performed the initial experiments that revealed Hel308's fractional steps and their ATP dependence.	Adam G., 1968, STRUCTURAL CHEM MOL, P198; Akeson M, 1999, BIOPHYS J, V77, P3227, DOI 10.1016/S0006-3495(99)77153-5; Bosco A, 2014, NUCLEIC ACIDS RES, V42, P2064, DOI 10.1093/nar/gkt1089; Buttner K, 2007, NAT STRUCT MOL BIOL, V14, P647, DOI 10.1038/nsmb1246; Butler TZ, 2008, P NATL ACAD SCI USA, V105, P20647, DOI 10.1073/pnas.0807514106; Cherf GM, 2012, NAT BIOTECHNOL, V30, P344, DOI 10.1038/nbt.2147; Derrington IM, 2010, P NATL ACAD SCI USA, V107, P16060, DOI 10.1073/pnas.1001831107; Ha T, 2012, ANNU REV BIOPHYS, V41, P295, DOI 10.1146/annurev-biophys-042910-155351; Henrickson SE, 2000, PHYS REV LETT, V85, P3057, DOI 10.1103/PhysRevLett.85.3057; Herbert KM, 2008, ANNU REV BIOCHEM, V77, P149, DOI 10.1146/annurev.biochem.77.073106.100741; Kasianowicz JJ, 1996, P NATL ACAD SCI USA, V93, P13770, DOI 10.1073/pnas.93.24.13770; Kim H, 2013, REP PROG PHYS, V76, DOI 10.1088/0034-4885/76/1/016601; Laszlo AH, 2014, NAT BIOTECHNOL, V32, P829, DOI 10.1038/nbt.2950; Laszlo AH, 2013, P NATL ACAD SCI USA, V110, P18904, DOI 10.1073/pnas.1310240110; Manrao EA, 2012, NAT BIOTECHNOL, V30, P349, DOI 10.1038/nbt.2171; Mathe J, 2004, BIOPHYS J, V87, P3205, DOI 10.1529/biophysj.104.047274; Myong S, 2007, SCIENCE, V317, P513, DOI 10.1126/science.1144130; Smith SB, 1996, SCIENCE, V271, P795, DOI 10.1126/science.271.5250.795; Woodman IL, 2011, BIOCHEM SOC T, V39, P140, DOI 10.1042/BST0390140	19	82	84	3	93	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156	1546-1696		NAT BIOTECHNOL	Nat. Biotechnol.	OCT	2015	33	10					1073	+		10.1038/nbt.3357	http://dx.doi.org/10.1038/nbt.3357			4	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	CT1JX	26414351	Green Accepted			2022-12-27	WOS:000362555700026
J	Kish, LJ; Topol, EJ				Kish, Leonard J.; Topol, Eric J.			Unpatients-why patients should own their medical data	NATURE BIOTECHNOLOGY			English	Article									[Kish, Leonard J.] Unpatient Org, Denver, CO 80202 USA; [Topol, Eric J.] Scripps Res Inst, La Jolla, CA 92037 USA; [Topol, Eric J.] Scripps Hlth, La Jolla, CA USA	Scripps Research Institute	Kish, LJ (corresponding author), Unpatient Org, Denver, CO 80202 USA.	etopol@scripps.edu			NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR001114] Funding Source: NIH RePORTER; NCATS NIH HHS [8 UL1 TR001114] Funding Source: Medline	NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NCATS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS))		Bachman Rachel, WALL STREET J; Beck M., 2015, WALL STREET J; Cannon W.B., 1932, WISDOM BODY; Chu S, IDIGITALTIMES   0202; Collins K., QUICK GUIDE WORST CO; Fickenscher KM, 2013, J AM MED INFORM ASSN, V20, P593, DOI 10.1136/amiajnl-2013-001768; HHMI, YOUR VIR INF HIST SI; Kish L., 2012, HL7 STANDARDS 0828; Mandl KD, 2015, CELL SYST, V1, P8, DOI 10.1016/j.cels.2015.05.001; O'Brien J., 2015, FORTUNE; Peck M. E., SPECTRUM IEEE; Robert Wood Johnson Foundation, 2013, IND ACC MED REC 50 S; The Office of the National Coordinator for Health Information Technology (ONC), REP C APR 2015 REP H; Topol E., 2015, PATIENT WILL SEE YOU; Topol EJ, 2014, CELL, V157, P241, DOI 10.1016/j.cell.2014.02.012; Xu GJ, 2015, SCIENCE, V348, DOI 10.1126/science.aaa0698	16	79	80	0	14	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156	1546-1696		NAT BIOTECHNOL	Nat. Biotechnol.	SEP	2015	33	9					921	924		10.1038/nbt.3340	http://dx.doi.org/10.1038/nbt.3340			4	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	CR0EK	26348958				2022-12-27	WOS:000360990900016
J	[Anonymous]				[Anonymous]			BEAM to fight antimicrobial resistance	NATURE BIOTECHNOLOGY			English	News Item																			0	2	2	0	0	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156	1546-1696		NAT BIOTECHNOL	Nat. Biotechnol.	SEP	2015	33	9					889	889						1	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	VB8EQ	26348940				2022-12-27	WOS:000418257000002
J	Herskowitz, O				Herskowitz, Orin			In house expertise	NATURE BIOTECHNOLOGY			English	Editorial Material									Columbia Univ, Columbia Technol Ventures, Tech Transfer & Intellectual Property, New York, NY 10027 USA	Columbia University	Herskowitz, O (corresponding author), Columbia Univ, Columbia Technol Ventures, Tech Transfer & Intellectual Property, New York, NY 10027 USA.	orin.herskowitz@columbia.edu							0	1	1	0	0	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156	1546-1696		NAT BIOTECHNOL	Nat. Biotechnol.	AUG	2015	33	8					801	804		10.1038/nbt.3302	http://dx.doi.org/10.1038/nbt.3302			4	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	CO6OB	26252131	Bronze			2022-12-27	WOS:000359274900009
J	Konopacki, C; Plitas, G; Rudensky, A				Konopacki, Catherine; Plitas, George; Rudensky, Alexander			Reigning in regulatory T-cell function	NATURE BIOTECHNOLOGY			English	Editorial Material							TGF-BETA; DIFFERENTIATION; TGF-BETA-1; CANCER; GROWTH		[Konopacki, Catherine; Plitas, George; Rudensky, Alexander] Mem Sloan Kettering Canc Ctr, Howard Hughes Med Inst, New York, NY 10021 USA; [Konopacki, Catherine; Plitas, George; Rudensky, Alexander] Mem Sloan Kettering Canc Ctr, Ludwig Ctr, Program Immunol, New York, NY 10021 USA; [Plitas, George] Mem Sloan Kettering Canc Ctr, Dept Surg, Breast Canc Serv, New York, NY 10021 USA	Howard Hughes Medical Institute; Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center	Konopacki, C (corresponding author), Mem Sloan Kettering Canc Ctr, Howard Hughes Med Inst, New York, NY 10021 USA.	rudenska@mskcc.org						Attia P, 2005, J IMMUNOTHER, V28, P582, DOI 10.1097/01.cji.0000175468.19742.10; Bos PD, 2013, J EXP MED, V210, P2435, DOI 10.1084/jem.20130762; Cuende J, 2015, SCI TRANSL MED, V7, DOI 10.1126/scitranslmed.aaa1983; Donkor MK, 2011, IMMUNITY, V35, P123, DOI 10.1016/j.immuni.2011.04.019; Edwards JP, 2014, J IMMUNOL, V193, P2843, DOI 10.4049/jimmunol.1401102; Edwards JP, 2013, J IMMUNOL, V190, P5506, DOI 10.4049/jimmunol.1300199; Gutcher I, 2011, IMMUNITY, V34, P396, DOI 10.1016/j.immuni.2011.03.005; Josefowicz SZ, 2012, ANNU REV IMMUNOL, V30, P531, DOI 10.1146/annurev.immunol.25.022106.141623; Li XR, 2010, EUR J IMMUNOL, V40, P3325, DOI 10.1002/eji.201041093; Massague J, 2008, CELL, V134, P215, DOI 10.1016/j.cell.2008.07.001; Morris JC, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090353; Teng MWL, 2010, CANCER RES, V70, P7800, DOI 10.1158/0008-5472.CAN-10-1681; Wan YY, 2007, IMMUNOL REV, V220, P199, DOI 10.1111/j.1600-065X.2007.00565.x; Worthington JJ, 2015, IMMUNITY, V42, P903, DOI 10.1016/j.immuni.2015.04.012	14	1	2	0	10	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156	1546-1696		NAT BIOTECHNOL	Nat. Biotechnol.	JUL	2015	33	7					718	719		10.1038/nbt.3285	http://dx.doi.org/10.1038/nbt.3285			2	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	CN4JJ	26154011				2022-12-27	WOS:000358396100024
J	Morrison, C				Morrison, Chris			Fresh from the biotech pipeline-2014	NATURE BIOTECHNOLOGY			English	Editorial Material																		Hay M, 2014, NAT BIOTECHNOL, V32, P40, DOI 10.1038/nbt.2786; Kling J, 2014, NAT BIOTECHNOL, V32, P121, DOI 10.1038/nbt.2811	2	4	4	0	4	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156	1546-1696		NAT BIOTECHNOL	Nat. Biotechnol.	FEB	2015	33	2					125	128		10.1038/nbt.3136	http://dx.doi.org/10.1038/nbt.3136			4	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	CA8VK	25658270				2022-12-27	WOS:000349198800008
J	Mick, E; Sorek, R				Mick, Eran; Sorek, Rotem			High-resolution metagenomics	NATURE BIOTECHNOLOGY			English	Editorial Material								The structure of complex microbial communities is resolved by considering co-variation of gene abundance.	[Mick, Eran] Harvard Univ, Sch Med, Dept Syst Biol, Boston, MA 02138 USA; [Sorek, Rotem] Weizmann Inst Sci, Dept Mol Genet, IL-76100 Rehovot, Israel	Harvard University; Harvard Medical School; Weizmann Institute of Science	Mick, E (corresponding author), Harvard Univ, Sch Med, Dept Syst Biol, Boston, MA 02138 USA.	eranmick@fas.harvard.edu; rotem.sorek@weizmann.ac.il						Albertsen M, 2013, NAT BIOTECHNOL, V31, P533, DOI 10.1038/nbt.2579; Eckburg PB, 2005, SCIENCE, V308, P1635, DOI 10.1126/science.1110591; Gogarten JP, 2005, NAT REV MICROBIOL, V3, P679, DOI 10.1038/nrmicro1204; Iverson V, 2012, SCIENCE, V335, P587, DOI 10.1126/science.1212665; Kashtan N, 2014, SCIENCE, V344, P416, DOI 10.1126/science.1248575; Lukjancenko O, 2010, MICROB ECOL, V60, P708, DOI 10.1007/s00248-010-9717-3; Nielsen HB, 2014, NAT BIOTECHNOL, V32, P822, DOI 10.1038/nbt.2939; Peterson J, 2009, GENOME RES, V19, P2317, DOI 10.1101/gr.096651.109; Qin JJ, 2010, NATURE, V464, P59, DOI 10.1038/nature08821; Shapiro BJ, 2014, TRENDS MICROBIOL, V22, P235, DOI 10.1016/j.tim.2014.02.006; Sunagawa S, 2013, NAT METHODS, V10, P1196, DOI [10.1038/NMETH.2693, 10.1038/nmeth.2693]; Wrighton KC, 2012, SCIENCE, V337, P1661, DOI 10.1126/science.1224041	12	12	12	3	11	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156	1546-1696		NAT BIOTECHNOL	Nat. Biotechnol.	AUG	2014	32	8					750	+		10.1038/nbt.2962	http://dx.doi.org/10.1038/nbt.2962			2	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	AW7PF	25101744				2022-12-27	WOS:000346455900037
J	Sherkow, JS; Scott, C				Sherkow, Jacob S.; Scott, Christopher			Myriad stands alone	NATURE BIOTECHNOLOGY			English	Article									[Sherkow, Jacob S.] New York Law Sch, New York, NY 10013 USA		Sherkow, JS (corresponding author), New York Law Sch, New York, NY 10013 USA.			Sherkow, Jacob/0000-0002-9724-9261					0	11	11	0	2	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156	1546-1696		NAT BIOTECHNOL	Nat. Biotechnol.	JUL	2014	32	7					620	620		10.1038/nbt.2944	http://dx.doi.org/10.1038/nbt.2944			1	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	AK8VE	25004225	Green Published, Bronze			2022-12-27	WOS:000338705900022
J	Peng, YJ				Peng, Yaojin			The patentability of human embryonic stem cell technology in China	NATURE BIOTECHNOLOGY			English	Editorial Material								Although China has in the past decade been reluctant to grant patents on human embryonic stem cell technology, it has recently changed its patent policy to loosen some restrictions.	[Peng, Yaojin] Maastricht Univ, IGIR, NL-6200 MD Maastricht, Netherlands	Maastricht University	Peng, YJ (corresponding author), Maastricht Univ, IGIR, NL-6200 MD Maastricht, Netherlands.	yaojin.peng@hotmail.com						[Anonymous], 1990, EPO Technical Board of Appeal 3.3.02. T19/90, Patent No. 25050; Bonetta L, 2008, CELL, V132, P514, DOI 10.1016/j.cell.2008.02.012; *DEP EX BUS MAN SI, 2006, AN INTRODUCTION TO T, V2, P220; Department of Examination and Business Management of the SIPO, 2006, INTELLECTUAL PROPERT, P220; EDWARDS RG, 1980, BRIT J OBSTET GYNAEC, V87, P737, DOI 10.1111/j.1471-0528.1980.tb04610.x; *EPO TECHN BOARD, 1990, T1990 EPO TECHN BOAR, P3; Hansson MG, 2007, STEM CELLS, V25, P1507, DOI 10.1634/stemcells.2006-0684; SIPO, 2010, TITLE ERROR; SIPO, 2012, Patent Reexamination Board, Patent No. [FS46359, 17820]; SIPO, 2009, FS4237, Patent No. FS17820; SIPO, 2010, CHINESE INTELLECTUAL, Patent No. FS25050; SIPO, 2010, AGREEMENT ON TRADE R; SIPO, 2010, GUIDELINES FOR PATEN; The Law Department of the SIPO, 2001, GUIDELINES FOR PATEN, P27; Thomson JA, 1998, SCIENCE, V282, P1145, DOI 10.1126/science.282.5391.1145; WTO, 1994, TITLE ERROR; 2012, Patent No. 46359	17	5	9	0	12	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156	1546-1696		NAT BIOTECHNOL	Nat. Biotechnol.	JAN	2016	34	1					37	39		10.1038/nbt.3417	http://dx.doi.org/10.1038/nbt.3417			3	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	DB8HQ	26744976				2022-12-27	WOS:000368758200021
J	Choi, J; Lee, S; Mallard, W; Clement, K; Tagliazucchi, GM; Lim, H; Choi, IY; Ferrari, F; Tsankov, AM; Pop, R; Lee, G; Rinn, JL; Meissner, A; Park, PJ; Hochedlinger, K				Choi, Jiho; Lee, Soohyun; Mallard, William; Clement, Kendell; Tagliazucchi, Guidantonio Malagoli; Lim, Hotae; Choi, In Young; Ferrari, Francesco; Tsankov, Alexander M.; Pop, Ramona; Lee, Gabsang; Rinn, John L.; Meissner, Alexander; Park, Peter J.; Hochedlinger, Konrad			A comparison of genetically matched cell lines reveals the equivalence of human iPSCs and ESCs	NATURE BIOTECHNOLOGY			English	Article							PLURIPOTENT STEM-CELLS; HISTONE DEACETYLASE SIRT6; EXPRESSION; GENERATION; SIGNATURES; INDUCTION; GENES	The equivalence of human induced pluripotent stem cells (hiPSCs) and human embryonic stem cells (hESCs) remains controversial. Here we use genetically matched hESC and hiPSC lines to assess the contribution of cellular origin (hESC vs. hiPSC), the Sendai virus (SeV) reprogramming method and genetic background to transcriptional and DNA methylation patterns while controlling for cell line clonality and sex. We find that transcriptional and epigenetic variation originating from genetic background dominates over variation due to cellular origin or SeV infection. Moreover, the 49 differentially expressed genes we detect between genetically matched hESCs and hiPSCs neither predict functional outcome nor distinguish an independently derived, larger set of unmatched hESC and hiPSC lines. We conclude that hESCs and hiPSCs are molecularly and functionally equivalent and cannot be distinguished by a consistent gene expression signature. Our data further imply that genetic background variation is a major confounding factor for transcriptional and epigenetic comparisons of pluripotent cell lines, explaining some of the previously observed differences between genetically unmatched hESCs and hiPSCs.	[Choi, Jiho; Hochedlinger, Konrad] Massachusetts Gen Hosp, Dept Mol Biol, Ctr Canc, Boston, MA 02114 USA; [Choi, Jiho; Hochedlinger, Konrad] Massachusetts Gen Hosp, Ctr Regenerat Med, Boston, MA 02114 USA; [Choi, Jiho; Clement, Kendell; Tsankov, Alexander M.; Pop, Ramona; Meissner, Alexander; Hochedlinger, Konrad] Harvard Stem Cell Inst, Cambridge, MA USA; [Choi, Jiho; Hochedlinger, Konrad] Howard Hughes Med Inst, Chevy Chase, MD USA; [Lee, Soohyun; Tagliazucchi, Guidantonio Malagoli; Ferrari, Francesco; Park, Peter J.] Harvard Univ, Sch Med, Dept Biomed Informat, Boston, MA 02114 USA; [Mallard, William; Clement, Kendell; Tsankov, Alexander M.; Pop, Ramona; Rinn, John L.; Meissner, Alexander] Broad Inst MIT & Harvard, Cambridge, MA USA; [Mallard, William; Clement, Kendell; Tsankov, Alexander M.; Pop, Ramona; Rinn, John L.; Meissner, Alexander] Harvard Univ, Dept Stem Cell & Regenerat Biol, Cambridge, MA 02138 USA; [Tagliazucchi, Guidantonio Malagoli] Univ Modena & Reggio Emilia, Dept Life Sci, Ctr Genome Res, Modena, Italy; [Lim, Hotae; Choi, In Young; Lee, Gabsang] Johns Hopkins Univ, Sch Med, Dept Neurol, Inst Cell Engn,Solomon H Snyder Dept Neurosci, Baltimore, MD 21205 USA; [Rinn, John L.] Beth Israel Deaconess Med Ctr, Boston, MA 02215 USA	Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Howard Hughes Medical Institute; Harvard University; Harvard Medical School; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Harvard University; Universita di Modena e Reggio Emilia; Johns Hopkins University; Harvard University; Beth Israel Deaconess Medical Center	Park, PJ (corresponding author), Harvard Univ, Sch Med, Dept Biomed Informat, Boston, MA 02114 USA.	peter_park@harvard.edu; khochedlinger@helix.mgh.harvard.edu	Tagliazucch, Guidantonio Malagoli/E-5026-2018; Ferrari, Francesco/H-5007-2012; Clement, Kendell/AAZ-6854-2021	Tagliazucch, Guidantonio Malagoli/0000-0001-5581-4851; Ferrari, Francesco/0000-0002-9811-3753; Rinn, John/0000-0002-7231-7539; Park, Peter/0000-0001-9378-960X; Choi, Jiho/0000-0001-8839-4056; Lee, Soohyun/0000-0002-3594-6213	New York Stem Cell Foundation; Maryland Stem Cell Research Fund (TEDCO); US National Institutes of Health (NIH) grant [P01GM099117]; Howard Hughes Medical Institute (HHMI); MGH startup funds; Gerald and Darlene Jordan Endowed Chair for Regenerative Medicine; NIH [P01GM099117]; Vranos Family Graduate Research Fellowship in Developmental & Regenerative Biology; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P01GM099117] Funding Source: NIH RePORTER	New York Stem Cell Foundation; Maryland Stem Cell Research Fund (TEDCO); US National Institutes of Health (NIH) grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Howard Hughes Medical Institute (HHMI)(Howard Hughes Medical Institute); MGH startup funds; Gerald and Darlene Jordan Endowed Chair for Regenerative Medicine; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Vranos Family Graduate Research Fellowship in Developmental & Regenerative Biology; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank members of the Hochedlinger and Park laboratories for productive discussions and a critical reading of the manuscript. We also thank M. Stadtfeld for his helpful discussions and D. Melton for his generous donation of HUES2 and HUES3 lines. We are grateful to K. Folz-Donahue, M. Weglarz and L. Prickett at the Massachusetts General Hospital (MGH)/Harvard Stem Cell Institute (HSCI) flow cytometry core for their constant assistance and support. We are also thankful to the members of the Tufts Genomics Core for performing RNA-seq. Work in the Lee laboratory was supported by grants from the Robertson Investigator Award of the New York Stem Cell Foundation and from the Maryland Stem Cell Research Fund (TEDCO). A. M. and J.L.R. are supported by US National Institutes of Health (NIH) grant P01GM099117. A. M. is a New York Stem Cell Foundation Robertson Investigator. Parts of this work were supported by the Howard Hughes Medical Institute (HHMI), MGH startup funds, the Gerald and Darlene Jordan Endowed Chair for Regenerative Medicine (to K.H.) and a pilot grant from the NIH (P01GM099117 to K.H.). J.C. was supported by the Vranos Family Graduate Research Fellowship in Developmental & Regenerative Biology.	Abyzov A, 2012, NATURE, V492, P438, DOI 10.1038/nature11629; Anders S, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-10-r106; Anguera MC, 2012, CELL STEM CELL, V11, P75, DOI 10.1016/j.stem.2012.03.008; Bock C, 2011, CELL, V144, P439, DOI 10.1016/j.cell.2010.12.032; Boyle P, 2012, GENOME BIOL, V13, DOI [10.1186/gb-2012-13-10-R92, 10.1186/gb-2012-13-10-r92]; Chambers SM, 2009, NAT BIOTECHNOL, V27, P275, DOI 10.1038/nbt.1529; Chin MH, 2010, CELL STEM CELL, V7, P263, DOI 10.1016/j.stem.2010.06.019; Chin MH, 2009, CELL STEM CELL, V5, P111, DOI 10.1016/j.stem.2009.06.008; Cohen DR, 2000, MECH DEVELOP, V91, P317, DOI 10.1016/S0925-4773(99)00263-4; Cowan CA, 2004, NEW ENGL J MED, V350, P1353, DOI 10.1056/NEJMsr040330; Dunn J.C., 1974, J CYBERNETICS, V4, P95, DOI 10.1080/01969727408546059; EVERSE J, 1973, ADV ENZYMOL RAMB, V37, P61; Fantin VR, 2006, CANCER CELL, V9, P425, DOI 10.1016/j.ccr.2006.04.023; Flicek P, 2014, NUCLEIC ACIDS RES, V42, pD749, DOI 10.1093/nar/gkt1196; Fusaki N, 2009, P JPN ACAD B-PHYS, V85, P348, DOI 10.2183/pjab.85.348; Girirajan S, 2013, AM J HUM GENET, V92, P221, DOI 10.1016/j.ajhg.2012.12.016; Guenther MG, 2010, CELL STEM CELL, V7, P249, DOI 10.1016/j.stem.2010.06.015; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Huang DW, 2009, NUCLEIC ACIDS RES, V37, P1, DOI 10.1093/nar/gkn923; Humpherys D, 2001, SCIENCE, V293, P95, DOI 10.1126/science.1061402; Koyanagi-Aoi M, 2013, P NATL ACAD SCI USA, V110, P20569, DOI 10.1073/pnas.1319061110; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Lee S, 2015, BMC BIOINFORMATICS, V16, DOI 10.1186/s12859-015-0704-z; Loewer S, 2010, NAT GENET, V42, P1113, DOI 10.1038/ng.710; Maherali N, 2008, CELL STEM CELL, V3, P340, DOI 10.1016/j.stem.2008.08.003; Mai V, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020647; Mallon BS, 2014, STEM CELL RES, V12, P376, DOI 10.1016/j.scr.2013.11.010; Marshall CR, 2008, AM J HUM GENET, V82, P477, DOI 10.1016/j.ajhg.2007.12.009; Matsumoto K, 2004, NAT NEUROSCI, V7, P605, DOI 10.1038/nn1249; MUECKLER M, 1985, SCIENCE, V229, P941, DOI 10.1126/science.3839598; Newman AM, 2010, CELL STEM CELL, V7, P258, DOI 10.1016/j.stem.2010.06.016; Park IH, 2008, CELL, V134, P877, DOI 10.1016/j.cell.2008.07.041; Phanstiel DH, 2011, NAT METHODS, V8, P821, DOI [10.1038/NMETH.1699, 10.1038/nmeth.1699]; Robinson MD, 2010, BIOINFORMATICS, V26, P139, DOI 10.1093/bioinformatics/btp616; Rouhani F, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004432; ROUSSEEUW PJ, 1987, J COMPUT APPL MATH, V20, P53, DOI 10.1016/0377-0427(87)90125-7; Ruiz S, 2012, P NATL ACAD SCI USA, V109, P16196, DOI 10.1073/pnas.1202352109; Sebastian C, 2012, CELL, V151, P1185, DOI 10.1016/j.cell.2012.10.047; Soldner F, 2011, CELL, V146, P318, DOI 10.1016/j.cell.2011.06.019; Soldner F, 2009, CELL, V136, P964, DOI 10.1016/j.cell.2009.02.013; Stadtfeld M, 2012, NAT GENET, V44, P398, DOI 10.1038/ng.1110; Stadtfeld M, 2010, NATURE, V465, P175, DOI 10.1038/nature09017; Takahashi K, 2007, CELL, V131, P861, DOI 10.1016/j.cell.2007.11.019; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; Tchieu J, 2010, CELL STEM CELL, V7, P329, DOI 10.1016/j.stem.2010.06.024; Teichroeb JH, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023436; Thorvaldsdottir H, 2013, BRIEF BIOINFORM, V14, P178, DOI 10.1093/bib/bbs017; Tsankov AM, 2015, NAT BIOTECHNOL, V33, P1182, DOI 10.1038/nbt.3387; Wang C, 2014, NAT BIOTECHNOL, V32, P926, DOI 10.1038/nbt.3001; Yu JY, 2007, SCIENCE, V318, P1917, DOI 10.1126/science.1151526; Zhang XQ, 2010, CELL STEM CELL, V7, P90, DOI 10.1016/j.stem.2010.04.017; Zhang Y, 2013, P NATL ACAD SCI USA, V110, P12361, DOI 10.1073/pnas.1309725110; Zhao SR, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0078644; Zhong L, 2010, CELL, V140, P280, DOI 10.1016/j.cell.2009.12.041; Zhou WY, 2012, EMBO J, V31, P2103, DOI 10.1038/emboj.2012.71	55	162	171	0	47	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1087-0156	1546-1696		NAT BIOTECHNOL	Nat. Biotechnol.	NOV	2015	33	11					1173	U102		10.1038/nbt.3388	http://dx.doi.org/10.1038/nbt.3388			11	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	CW3TY	26501951	Green Accepted, Green Submitted			2022-12-27	WOS:000364916000025
J	Cleary, B; Brito, IL; Huang, K; Gevers, D; Shea, T; Young, S; Alm, EJ				Cleary, Brian; Brito, Ilana Lauren; Huang, Katherine; Gevers, Dirk; Shea, Terrance; Young, Sarah; Alm, Eric J.			Detection of low-abundance bacterial strains in metagenomic datasets by eigengenome partitioning	NATURE BIOTECHNOLOGY			English	Article							DIVERSITY; ASSEMBLER; ACCURATE; COVERAGE; GENOMES; REVEAL; VELVET	Analyses of metagenomic datasets that are sequenced to a depth of billions or trillions of bases can uncover hundreds of microbial genomes, but naive assembly of these data is computationally intensive, requiring hundreds of gigabytes to terabytes of RAM. We present latent strain analysis (LSA), a scalable, de novo pre-assembly method that separates reads into biologically informed partitions and thereby enables assembly of individual genomes. LSA is implemented with a streaming calculation of unobserved variables that we call eigengenomes. Eigengenomes reflect covariance in the abundance of short, fixed-length sequences, or k-mers. As the abundance of each genome in a sample is reflected in the abundance of each k-mer in that genome, eigengenome analysis can be used to partition reads from different genomes. This partitioning can be done in fixed memory using tens of gigabytes of RAM, which makes assembly and downstream analyses of terabytes of data feasible on commodity hardware. Using LSA, we assemble partial and near-complete genomes of bacterial taxa present at relative abundances as low as 0.00001%. We also show that LSA is sensitive enough to separate reads from several strains of the same species.	[Cleary, Brian] MIT, Computat & Syst Biol Program, Cambridge, MA 02139 USA; [Cleary, Brian; Brito, Ilana Lauren; Huang, Katherine; Gevers, Dirk; Shea, Terrance; Young, Sarah; Alm, Eric J.] Broad Inst Harvard & MIT, Cambridge, MA 02142 USA; [Brito, Ilana Lauren; Alm, Eric J.] MIT, Dept Biol Engn, Cambridge, MA 02139 USA; [Brito, Ilana Lauren; Alm, Eric J.] MIT, Ctr Microbiome Informat & Therapeut, Cambridge, MA 02139 USA	Massachusetts Institute of Technology (MIT); Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT)	Alm, EJ (corresponding author), Broad Inst Harvard & MIT, Cambridge, MA 02142 USA.	ejalm@mit.edu	Gevers, Dirk/C-1451-2009; Brito, Ilana/W-1827-2017	Brito, Ilana/0000-0002-2250-3480	Rasmussen Family Foundation; National Human Genome Research Institute [U54HG003067]; Center for Environmental Health Sciences at MIT; Fijian Ministry of Health; Earth Institute at Columbia University; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [U54HG003067] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM087237] Funding Source: NIH RePORTER	Rasmussen Family Foundation; National Human Genome Research Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); Center for Environmental Health Sciences at MIT; Fijian Ministry of Health; Earth Institute at Columbia University; NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported in part by the Rasmussen Family Foundation. The Fiji Community Microbiome Project was supported by the National Human Genome Research Institute, grant number U54HG003067 to the Broad Institute; the Center for Environmental Health Sciences at MIT; and the Fijian Ministry of Health. I.L.B. was supported in part by the Earth Institute at Columbia University. We would like to thank S. Jupiter and W. Naisilisili at the Wildlife Conservation Society's Fiji Islands site office, and A. Jenkins at the Edith Cowan University.	Albertsen M, 2013, NAT BIOTECHNOL, V31, P533, DOI 10.1038/nbt.2579; Alneberg J, 2014, NAT METHODS, V11, P1144, DOI [10.1038/NMETH.3103, 10.1038/nmeth.3103]; Arumugam M, 2011, NATURE, V473, P174, DOI 10.1038/nature09944; Bates ST, 2013, ISME J, V7, P652, DOI 10.1038/ismej.2012.147; Boisvert S, 2012, GENOME BIOL, V13, DOI 10.1186/gb-2012-13-12-r122; Daniel R, 2005, NAT REV MICROBIOL, V3, P470, DOI 10.1038/nrmicro1160; Deloger M, 2009, J BACTERIOL, V191, P91, DOI 10.1128/JB.01202-08; DeSantis TZ, 2006, APPL ENVIRON MICROB, V72, P5069, DOI 10.1128/AEM.03006-05; Fierer N, 2007, APPL ENVIRON MICROB, V73, P7059, DOI 10.1128/AEM.00358-07; Gans J, 2005, SCIENCE, V309, P1387, DOI 10.1126/science.1112665; Gionis A, 1999, PROCEEDINGS OF THE TWENTY-FIFTH INTERNATIONAL CONFERENCE ON VERY LARGE DATA BASES, P518; Howe AC, 2014, P NATL ACAD SCI USA, V111, P4904, DOI 10.1073/pnas.1402564111; Imelfort M, 2014, PEERJ, V2, DOI 10.7717/peerj.603; Koren O, 2013, PLOS COMPUT BIOL, V9, DOI 10.1371/journal.pcbi.1002863; Kulis B, 2009, IEEE I CONF COMP VIS, P2130, DOI 10.1109/ICCV.2009.5459466; Li DH, 2015, BIOINFORMATICS, V31, P1674, DOI 10.1093/bioinformatics/btv033; Li H, 2008, GENOME RES, V18, P1851, DOI 10.1101/gr.078212.108; Liu B, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-S2-S4; Morowitz MJ, 2010, PEDIATRICS, V125, P777, DOI 10.1542/peds.2009-3149; Namiki T, 2012, NUCLEIC ACIDS RES, V40, DOI 10.1093/nar/gks678; Nielsen HB, 2014, NAT BIOTECHNOL, V32, P822, DOI 10.1038/nbt.2939; Pell J, 2012, P NATL ACAD SCI USA, V109, P13272, DOI 10.1073/pnas.1121464109; Peng Y, 2011, BIOINFORMATICS, V27, pI94, DOI 10.1093/bioinformatics/btr216; Peterson J, 2009, GENOME RES, V19, P2317, DOI 10.1101/gr.096651.109; Pop M, 2009, BRIEF BIOINFORM, V10, P354, DOI 10.1093/bib/bbp026; Rehurek R, 2010, P LREC 2010 WORKSH N, P46; Sharon I, 2013, GENOME RES, V23, P111, DOI 10.1101/gr.142315.112; Thomas Torsten, 2012, Microb Inform Exp, V2, P3, DOI 10.1186/2042-5783-2-3; TREANGEN T. J., 2011, GENOME BIOL, P25, DOI DOI 10.1186/gb-2011-12-s1-p25; Tringe SG, 2005, SCIENCE, V308, P554, DOI 10.1126/science.1107851; Wu M, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-10-r151; Zerbino DR, 2008, GENOME RES, V18, P821, DOI 10.1101/gr.074492.107	33	80	83	6	43	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156	1546-1696		NAT BIOTECHNOL	Nat. Biotechnol.	OCT	2015	33	10					1053	+		10.1038/nbt.3329	http://dx.doi.org/10.1038/nbt.3329			10	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	CT1JX	26368049	Bronze, Green Submitted, Green Accepted			2022-12-27	WOS:000362555700024
J	Jefferson, DJ; Graff, GD; Chi-Ham, CL; Bennett, AB				Jefferson, David J.; Graff, Gregory D.; Chi-Ham, Cecilia L.; Bennett, Alan B.			The emergence of agbiogenerics	NATURE BIOTECHNOLOGY			English	Editorial Material							BIOTECHNOLOGY; CROPS		[Jefferson, David J.; Chi-Ham, Cecilia L.; Bennett, Alan B.] Univ Calif Davis, Dept Plant Sci, PIPRA Publ Sect Intellectual Property Resource Ag, Davis, CA 95616 USA; [Graff, Gregory D.] Colorado State Univ, Dept Agr & Resource Econ, Ft Collins, CO 80523 USA	University of California System; University of California Davis; Colorado State University	Jefferson, DJ (corresponding author), Univ Calif Davis, Dept Plant Sci, PIPRA Publ Sect Intellectual Property Resource Ag, Davis, CA 95616 USA.	djjefferson@ucdavis.edu		Graff, Gregory/0000-0002-9140-0901; Jefferson, David/0000-0001-5156-3469				Allred J. S., 2013, SOC SCI RES NETWORK; American Seed Trade Association & Biotechnology Industry Organization, 2012, AC GEN EV MARK ACC A; [Anonymous], 2014, SEED QUEST; [Anonymous], 2015, AUTH CORR N MCKINNEY; [Anonymous], 2015, SOYA BEAN GMO COMPAS; Barry GF, 2006, Patent No. [US RE039247, 039247]; Biotechnology Industry Organization & American Seed Trade Association, 2013, ACC GEN EV MARK ACC, VFirst; Bradford KJ, 2005, NAT BIOTECHNOL, V23, P439, DOI 10.1038/nbt1084; Brants IO, 2000, US Patent, Patent No. 6083878; Chi-Ham CL, 2012, PLANT BIOTECHNOL J, V10, P501, DOI 10.1111/j.1467-7652.2011.00674.x; Coggio BD, 2002, FOOD DRUG LAW J, V57, P161; Comai L., 2000, US patent, Patent No. [6,051,753, 6051753]; Feng P. C. C., 2012, MODERN CROP PROTECTI, V1, P415; Graff G. D., INNOVATION AGR GENOM; Grushkin D, 2013, NAT BIOTECHNOL, V31, P10, DOI 10.1038/nbt0113-10c; Herrera-Estrella L., 1998, US patent, Patent No. [5,728,925, 5728925]; Herrera-Estrella L., 1998, US patent, Patent No. [5,717,084, 5717084]; Krieb R., 2007, US patent, Patent No. [7,306,909, 7306909]; Krieb R., 2010, US patent, Patent No. [7,718,373, 7718373, US 7,718,373 B2]; Lema M. A., 2008, BIORES, V2, P3; Monsanto, 2015, ROUND READ SOYB PAT; Rabesandratana T, 2014, SCIENCE, V346, P1280, DOI 10.1126/science.346.6215.1280; Redick T., 2010, AGR LAW UPDATE, V27, P2; Redick T. P., 2013, BIOTECH N AM SPEC CR, V226, P221; Schonenberg B.M, 2014, MARQUETTE LAW REV, V97, P1039; USDA, 2014, REC TRENDS GE AD	26	12	14	1	7	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156	1546-1696		NAT BIOTECHNOL	Nat. Biotechnol.	AUG	2015	33	8					819	823		10.1038/nbt.3306	http://dx.doi.org/10.1038/nbt.3306			5	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	CO6OB	26252137	Bronze			2022-12-27	WOS:000359274900016
J	Gaidatzis, D; Burger, L; Florescu, M; Stadler, MB				Gaidatzis, Dimos; Burger, Lukas; Florescu, Maria; Stadler, Michael B.			Analysis of intronic and exonic reads in RNA-seq data characterizes transcriptional and post-transcriptional regulation	NATURE BIOTECHNOLOGY			English	Article							DIFFERENTIAL EXPRESSION ANALYSIS; EMBRYONIC STEM-CELLS; PRE-MESSENGER-RNA; GENE-EXPRESSION; MAMMALIAN MICRORNAS; CELLULAR CONTEXTS; REVEALS; RECONSTRUCTION; LANDSCAPE; PRECISION	RNA-seq experiments generate reads derived not only from mature RNA transcripts but also from pre-mRNA. Here we present a computational approach called exon-intron split analysis (EISA) that measures changes in mature RNA and pre-mRNA reads across different experimental conditions to quantify transcriptional and post-transcriptional regulation of gene expression. We apply EISA to 17 diverse data sets to show that most intronic reads arise from nuclear RNA and changes in intronic read counts accurately predict changes in transcriptional activity. Furthermore, changes in post-transcriptional regulation can be predicted from differences between exonic and intronic changes. EISA reveals both transcriptional and post-transcriptional contributions to expression changes, increasing the amount of information that can be gained from RNA-seq data sets.	[Gaidatzis, Dimos; Burger, Lukas; Florescu, Maria; Stadler, Michael B.] Friedrich Miescher Inst Biomed Res, Basel, Switzerland; [Gaidatzis, Dimos; Burger, Lukas; Florescu, Maria; Stadler, Michael B.] Swiss Inst Bioinformat, Basel, Switzerland; [Florescu, Maria] Univ Basel, Basel, Switzerland	Friedrich Miescher Institute for Biomedical Research; Swiss Institute of Bioinformatics; University of Basel	Gaidatzis, D (corresponding author), Friedrich Miescher Inst Biomed Res, Basel, Switzerland.	d.gaidatzis@fmi.ch; lukas.burger@fmi.ch; michael.stadler@fmi.ch		Florescu, Maria/0000-0002-0564-5663	Novartis Research Foundation	Novartis Research Foundation	We thank D. Schubeler, A. Krebs, R. Ivanek and T.C. Roloff for feedback on the manuscript. We gratefully acknowledge funding from the Novartis Research Foundation.	Ameur A, 2011, NAT STRUCT MOL BIOL, V18, P1435, DOI 10.1038/nsmb.2143; Anders S, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-10-r106; Bhatt DM, 2012, CELL, V150, P279, DOI 10.1016/j.cell.2012.05.043; Bibel M, 2004, NAT NEUROSCI, V7, P1003, DOI 10.1038/nn1301; Birol I, 2009, BIOINFORMATICS, V25, P2872, DOI 10.1093/bioinformatics/btp367; Bussemaker HJ, 2001, NAT GENET, V27, P167, DOI 10.1038/84792; Cheng C, 2012, NUCLEIC ACIDS RES, V40, P553, DOI 10.1093/nar/gkr752; Core LJ, 2008, SCIENCE, V322, P1845, DOI 10.1126/science.1162228; Cui P, 2010, GENOMICS, V96, P259, DOI 10.1016/j.ygeno.2010.07.010; DeLuca DS, 2012, BIOINFORMATICS, V28, P1530, DOI 10.1093/bioinformatics/bts196; Derrien T, 2012, GENOME RES, V22, P1775, DOI 10.1101/gr.132159.111; Djebali S, 2012, NATURE, V489, P101, DOI 10.1038/nature11233; Dobin A, 2013, BIOINFORMATICS, V29, P15, DOI 10.1093/bioinformatics/bts635; Dong XJ, 2012, GENOME BIOL, V13, DOI 10.1186/gb-2012-13-9-r53; Farh KKH, 2005, SCIENCE, V310, P1817, DOI 10.1126/science.1121158; Grabherr MG, 2011, NAT BIOTECHNOL, V29, P644, DOI 10.1038/nbt.1883; Gray JM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089673; Guo HL, 2010, NATURE, V466, P835, DOI 10.1038/nature09267; Guttman M, 2010, NAT BIOTECHNOL, V28, P503, DOI 10.1038/nbt.1633; Hendriks GJ, 2014, MOL CELL, V53, P380, DOI 10.1016/j.molcel.2013.12.013; Jin FL, 2013, NATURE, V503, P290, DOI 10.1038/nature12644; Karlic R, 2010, P NATL ACAD SCI USA, V107, P2926, DOI 10.1073/pnas.0909344107; Katz Y, 2010, NAT METHODS, V7, P1009, DOI 10.1038/NMETH.1528; Khodor YL, 2011, GENE DEV, V25, P2502, DOI 10.1101/gad.178962.111; Kim TK, 2010, NATURE, V465, P182, DOI 10.1038/nature09033; Koike N, 2012, SCIENCE, V338, P349, DOI 10.1126/science.1226339; Krutzfeldt J, 2005, NATURE, V438, P685, DOI 10.1038/nature04303; Law CW, 2014, GENOME BIOL, V15, DOI 10.1186/gb-2014-15-2-r29; Lim LP, 2005, NATURE, V433, P769, DOI 10.1038/nature03315; Menet JS, 2012, ELIFE, V1, DOI 10.7554/eLife.00011; Mortazavi A, 2008, NAT METHODS, V5, P621, DOI 10.1038/nmeth.1226; Nam JW, 2014, MOL CELL, V53, P1031, DOI 10.1016/j.molcel.2014.02.013; Reddy TE, 2009, GENOME RES, V19, P2163, DOI 10.1101/gr.097022.109; Robinson MD, 2010, BIOINFORMATICS, V26, P139, DOI 10.1093/bioinformatics/btp616; Soneson C, 2013, BMC BIOINFORMATICS, V14, DOI 10.1186/1471-2105-14-91; Sood P, 2006, P NATL ACAD SCI USA, V103, P2746, DOI 10.1073/pnas.0511045103; Stadler MB, 2011, NATURE, V480, P490, DOI 10.1038/nature10716; STEIGER JH, 1980, PSYCHOL BULL, V87, P245, DOI 10.1037/0033-2909.87.2.245; Steijger T, 2013, NAT METHODS, V10, P1177, DOI [10.1038/nmeth.2714, 10.1038/NMETH.2714]; Storch KF, 2002, NATURE, V417, P78, DOI 10.1038/nature744; Sultan M, 2008, SCIENCE, V321, P956, DOI 10.1126/science.1160342; Tani H, 2012, GENOME RES, V22, P947, DOI 10.1101/gr.130559.111; Tippmann SC, 2012, MOL SYST BIOL, V8, DOI 10.1038/msb.2012.23; Trapnell C, 2010, NAT BIOTECHNOL, V28, P511, DOI 10.1038/nbt.1621; Vollmers C, 2012, CELL METAB, V16, P833, DOI 10.1016/j.cmet.2012.11.004; Wang ET, 2008, NATURE, V456, P470, DOI 10.1038/nature07509; Wang YL, 2002, P NATL ACAD SCI USA, V99, P5860, DOI 10.1073/pnas.092538799; WUARIN J, 1994, MOL CELL BIOL, V14, P7219, DOI 10.1128/MCB.14.11.7219; Zaghlool A, 2013, BMC BIOTECHNOL, V13, DOI 10.1186/1472-6750-13-99; Zeisel A, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.62	50	143	144	0	24	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156	1546-1696		NAT BIOTECHNOL	Nat. Biotechnol.	JUL	2015	33	7					722	729		10.1038/nbt.3269	http://dx.doi.org/10.1038/nbt.3269			8	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	CN4JJ	26098447	Bronze			2022-12-27	WOS:000358396100026
J	Possas, C; Antunes, AMD; Mendes, FML; Schumacher, SDR; Martins, RM; Homma, A				Possas, Cristina; de Souza Antunes, Adelaide Maria; Lins Mendes, Flavia Maria; Rodrigues Schumacher, Suzanne de Oliveira; Martins, Reinaldo Menezes; Homma, Akira			Access to new technologies in multipatented vaccines: challenges for Brazil	NATURE BIOTECHNOLOGY			English	Editorial Material							INTELLECTUAL PROPERTY; DEVELOPING-COUNTRIES; HEALTH; INDIA		[Possas, Cristina; Martins, Reinaldo Menezes; Homma, Akira] Fiocruz MS, Oswaldo Cruz Fdn, BR-21045900 Rio De Janeiro, Brazil; [de Souza Antunes, Adelaide Maria; Lins Mendes, Flavia Maria; Rodrigues Schumacher, Suzanne de Oliveira] Univ Fed Rio de Janeiro, Sch Chem, Rio De Janeiro, Brazil; [Possas, Cristina] Fiocruz MS, Evandro Chagas Natl Inst Infectol, BR-21045900 Rio De Janeiro, Brazil; [de Souza Antunes, Adelaide Maria] Natl Inst Ind Property, Rio De Janeiro, Brazil	Fundacao Oswaldo Cruz; Universidade Federal do Rio de Janeiro; Fundacao Oswaldo Cruz; Instituto Nacional da Propriedade Industrial (INPI)	Possas, C (corresponding author), Fiocruz MS, Oswaldo Cruz Fdn, BR-21045900 Rio De Janeiro, Brazil.	cristina.possas@bio.fiocruz.br	Possas, Cristina/AAJ-3840-2020; Martins, Reinaldo/I-3413-2015; Antunes, Adelaide M S/C-6328-2017	Martins, Reinaldo/0000-0002-0667-532X; Antunes, Adelaide/0000-0002-2245-7517				[Anonymous], 2013, REV PAT LAW INN SUPP; Basso M., 2006, International Journal of Intellectual Property Management, V1, P54, DOI 10.1504/IJIPM.2006.011022; Block F., 2011, STATE INNOVATION US; Brazilian National Confederation of Industry, 2014, INT PROP CHANG IND N; Geradin D., 2011, SANT CLAR U COMP HIG; Greenwood B, 2011, PHILOS T R SOC B, V366, P2733, DOI 10.1098/rstb.2011.0076; Homma A, 2013, VACCINE, V31, pB54, DOI 10.1016/j.vaccine.2012.11.084; Homma A, 2009, BIOLOGICALS, V37, P173, DOI 10.1016/j.biologicals.2009.02.011; Mahoney RT, 2004, VACCINE, V22, P786, DOI 10.1016/j.vaccine.2003.04.001; Mazzucato M, 2006, KNOWLEDGE ACCUMULATION AND INDUSTRY EVOLUTION: THE CASE OF PHARMA-BIOTECH, P1, DOI 10.2277/ 0521858224; Mazzucato M., 2013, ENTREPRENEURIAL STAT; Mbow ML, 2010, CURR OPIN IMMUNOL, V22, P411, DOI 10.1016/j.coi.2010.04.004; Milstien JB, 2007, VACCINE, V25, P7610, DOI 10.1016/j.vaccine.2007.09.007; Oliveira M.H., 2015, FACTO ABIFINA, V43, P18; Padmanabhan S, 2010, NAT BIOTECHNOL, V28, P671, DOI 10.1038/nbt0710-671; Rezaie R, 2008, NAT BIOTECHNOL, V26, P627, DOI 10.1038/nbt0608-627; Santos P.R., 2014, INTEL PROP RIGHTS, V2, P119; Sette A, 2010, IMMUNITY, V33, P530, DOI 10.1016/j.immuni.2010.09.017; US Patent and Trademark Office, 2015, ALL TECHN REP PAT TE	19	4	4	0	4	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156	1546-1696		NAT BIOTECHNOL	Nat. Biotechnol.	JUN	2015	33	6					599	604		10.1038/nbt.3244	http://dx.doi.org/10.1038/nbt.3244			6	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	CK2DE	26057975	Bronze			2022-12-27	WOS:000356019700016
J	Maruyama, T; Dougan, SK; Truttmann, MC; Bilate, AM; Ingram, JR; Ploegh, HL				Maruyama, Takeshi; Dougan, Stephanie K.; Truttmann, Matthias C.; Bilate, Angelina M.; Ingram, Jessica R.; Ploegh, Hidde L.			Increasing the efficiency of precise genome editing with CRISPR-Cas9 by inhibition of nonhomologous end joining	NATURE BIOTECHNOLOGY			English	Article							ONE-STEP GENERATION; DNA-LIGASE-IV; CELLS; MICE; RECOMBINATION; DEFICIENT; ABSENCE; REPAIR; KU70	Methods to introduce targeted double-strand breaks (DSBs) into DNA enable precise genome editing by increasing the rate at which externally supplied DNA fragments are incorporated into the genome through homologous recombination. The efficiency of these methods is limited by nonhomologous end joining (NHEJ), an alternative DNA repair pathway that competes with homology-directed repair (HDR). To promote HDR at the expense of NHEJ, we targeted DNA ligase IV, a key enzyme in the NHEJ pathway, using the inhibitor Scr7. Scr7 treatment increased the efficiency of HDR-mediated genome editing, using Cas9 in mammalian cell lines and in mice for all four genes examined, up to 19-fold. This approach should be applicable to other customizable endonucleases, such as zinc finger nucleases and transcription activator-like effector nucleases, and to nonmammalian cells with sufficiently conserved mechanisms of NHEJ and HDR.	[Maruyama, Takeshi; Dougan, Stephanie K.; Truttmann, Matthias C.; Bilate, Angelina M.; Ingram, Jessica R.; Ploegh, Hidde L.] Whitehead Inst Biomed Res, Cambridge, MA 02142 USA; [Ploegh, Hidde L.] MIT, Dept Biol, Cambridge, MA USA	Massachusetts Institute of Technology (MIT); Whitehead Institute; Massachusetts Institute of Technology (MIT)	Ploegh, HL (corresponding author), Whitehead Inst Biomed Res, 9 Cambridge Ctr, Cambridge, MA 02142 USA.	ploegh@wi.mit.edu	Maruyama, Takeshi/T-7568-2019; truttmann, matthias/ABC-2727-2021	Maruyama, Takeshi/0000-0003-0331-4702; truttmann, matthias/0000-0002-0536-7923	National Institutes of Health (RO1 grant) [AI087879-01]; Japan Society for the Promotion of Science; Japan Heart Foundation; AACR-Pancreatic Cancer Action Network; SNSF Early Postdoc Mobility fellowship; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI087879] Funding Source: NIH RePORTER	National Institutes of Health (RO1 grant)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Japan Heart Foundation; AACR-Pancreatic Cancer Action Network; SNSF Early Postdoc Mobility fellowship; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	We thank members of the Ploegh laboratory, especially N. Pishesha and F. Tafesse, for critical reading of the manuscript; P.A. Koenig, L.K. Swee, C.S. Shivalila, H. Wang, H. Yang and R. Jaenisch for discussions; T. Wang and D.M. Sabatini for pCW-Cas9; P. Thiru and G. Bell of BARC (WIBR) for assistance with statistical analysis; and F. Zhang (Addgene) for pX330. This work was supported by the National Institutes of Health (RO1 grant AI087879-01 to H.L.P.), Japan Society for the Promotion of Science (to T.M.), Japan Heart Foundation (to T.M.), AACR-Pancreatic Cancer Action Network (to S.K.D. and H.L.P.) and an SNSF Early Postdoc Mobility fellowship (to M.C.T.).	Adachi N, 2001, P NATL ACAD SCI USA, V98, P12109, DOI 10.1073/pnas.201271098; Beumer KJ, 2013, G3-GENES GENOM GENET, V3, P657, DOI 10.1534/g3.112.005439; Boboila C, 2010, J EXP MED, V207, P417, DOI 10.1084/jem.20092449; Christianson JC, 2008, NAT CELL BIOL, V10, P272, DOI 10.1038/ncb1689; Frank KM, 1998, NATURE, V396, P173, DOI 10.1038/24172; Frit P, 2014, DNA REPAIR, V17, P81, DOI 10.1016/j.dnarep.2014.02.007; Hailemariam TK, 2008, ARTERIOSCL THROM VAS, V28, P1519, DOI 10.1161/ATVBAHA.108.168682; Hovenden M, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003306; Jiang WY, 2013, NAT BIOTECHNOL, V31, P233, DOI 10.1038/nbt.2508; Kamentsky L, 2011, BIOINFORMATICS, V27, P1179, DOI 10.1093/bioinformatics/btr095; Lee CC, 2014, J BIOL CHEM, V289, P17124, DOI 10.1074/jbc.M114.571257; Mali P, 2013, SCIENCE, V339, P823, DOI 10.1126/science.1232033; Panier S, 2014, NAT REV MOL CELL BIO, V15, P7, DOI 10.1038/nrm3719; Pierce AJ, 2001, GENE DEV, V15, P3237, DOI 10.1101/gad.946401; Popp Maximilian Wei-Lin, 2009, Curr Protoc Protein Sci, VChapter 15, DOI 10.1002/0471140864.ps1503s56; Rinkevich Y, 2012, NAT CELL BIOL, V14, P1251, DOI 10.1038/ncb2610; Robinson JT, 2011, NAT BIOTECHNOL, V29, P24, DOI 10.1038/nbt.1754; Sander JD, 2014, NAT BIOTECHNOL, V32, P347, DOI 10.1038/nbt.2842; Sanyal S, 2013, CELL HOST MICROBE, V14, P510, DOI 10.1016/j.chom.2013.10.011; Shi JH, 2014, P NATL ACAD SCI USA, V111, P10131, DOI 10.1073/pnas.1409861111; Simsek D, 2010, NAT STRUCT MOL BIOL, V17, P410, DOI 10.1038/nsmb.1773; Singh P, 2015, GENETICS, V199, P1, DOI 10.1534/genetics.114.169771; So S, 2004, J BIOL CHEM, V279, P55433, DOI 10.1074/jbc.M409827200; Song L, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0509-9; Srivastava M, 2012, CELL, V151, P1474, DOI 10.1016/j.cell.2012.11.054; VANKAER L, 1992, CELL, V71, P1205, DOI 10.1016/S0092-8674(05)80068-6; Wang HY, 2013, CELL, V153, P910, DOI 10.1016/j.cell.2013.04.025; Wang T, 2014, SCIENCE, V343, P80, DOI 10.1126/science.1246981; Wiedenheft B, 2012, NATURE, V482, P331, DOI 10.1038/nature10886; Wu YX, 2013, CELL STEM CELL, V13, P659, DOI 10.1016/j.stem.2013.10.016; Yang H, 2013, CELL, V154, P1370, DOI 10.1016/j.cell.2013.08.022; Yin H, 2014, NAT BIOTECHNOL, V32, P551, DOI 10.1038/nbt.2884	32	710	810	6	259	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156	1546-1696		NAT BIOTECHNOL	Nat. Biotechnol.	MAY	2015	33	5					538	U260		10.1038/nbt.3190	http://dx.doi.org/10.1038/nbt.3190			8	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	CH8VP	25798939	Green Accepted, Green Submitted			2022-12-27	WOS:000354314500036
J	Paterson, AH; Wendel, JF				Paterson, Andrew H.; Wendel, Jonathan F.			Unraveling the fabric of polyploidy	NATURE BIOTECHNOLOGY			English	Editorial Material							GENOME SEQUENCE; COTTON; EVOLUTION		[Paterson, Andrew H.] Univ Georgia, Athens, GA 30602 USA; [Wendel, Jonathan F.] Iowa State Univ, Ames, IA USA	University System of Georgia; University of Georgia; Iowa State University	Paterson, AH (corresponding author), Univ Georgia, Athens, GA 30602 USA.	paterson@uga.edu						Bowers JE, 2003, NATURE, V422, P433, DOI 10.1038/nature01521; Carvalho MR, 2011, AM J BOT, V98, P1337, DOI 10.3732/ajb.1000539; Chalhoub B, 2014, SCIENCE, V345, P950, DOI 10.1126/science.1253435; Guo H, 2014, GENETICS, V197, P1153, DOI 10.1534/genetics.114.166124; Jiang CX, 1998, P NATL ACAD SCI USA, V95, P4419, DOI 10.1073/pnas.95.8.4419; Li FG, 2015, NAT BIOTECHNOL, V33, P524, DOI 10.1038/nbt.3208; Li FG, 2014, NAT GENET, V46, P567, DOI 10.1038/ng.2987; Liu B, 2001, GENOME, V44, P321, DOI 10.1139/gen-44-3-321; Paterson AH, 2012, NATURE, V492, P423, DOI 10.1038/nature11798; Rong J, 2012, HEREDITY, V108, P500, DOI 10.1038/hdy.2011.111; STEPHENS SG, 1949, GENETICS, V34, P627; Wang KB, 2012, NAT GENET, V44, P1098, DOI 10.1038/ng.2371; Wendel JF, 2003, ADV AGRON, V78, P139, DOI 10.1016/S0065-2113(02)78004-8; Yoo MJ, 2013, HEREDITY, V110, P171, DOI 10.1038/hdy.2012.94; Zhang TZ, 2015, NAT BIOTECHNOL, V33, P531, DOI 10.1038/nbt.3207	15	13	13	1	40	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1087-0156	1546-1696		NAT BIOTECHNOL	Nat. Biotechnol.	MAY	2015	33	5					491	493		10.1038/nbt.3217	http://dx.doi.org/10.1038/nbt.3217			4	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	CH8VP	25965758				2022-12-27	WOS:000354314500028
J	Zhang, TZ; Hu, Y; Jiang, WK; Fang, L; Guan, XY; Chen, JD; Zhang, JB; Saski, CA; Scheffler, BE; Stelly, DM; Hulse-Kemp, AM; Wan, Q; Liu, BL; Liu, CX; Wang, S; Pan, MQ; Wang, YK; Wang, DW; Ye, WX; Chang, LJ; Zhang, WP; Song, QX; Kirkbride, RC; Chen, XY; Dennis, E; Llewellyn, DJ; Peterson, DG; Thaxton, P; Jones, DC; Wang, Q; Xu, XY; Zhang, H; Wu, HT; Zhou, L; Mei, GF; Chen, SQ; Tian, Y; Xiang, D; Li, XH; Ding, J; Zuo, QY; Tao, LN; Liu, YC; Li, J; Lin, Y; Hui, YY; Cao, ZS; Cai, CP; Zhu, XF; Jiang, Z; Zhou, BL; Guo, WZ; Li, RQ; Chen, ZJ				Zhang, Tianzhen; Hu, Yan; Jiang, Wenkai; Fang, Lei; Guan, Xueying; Chen, Jiedan; Zhang, Jinbo; Saski, Christopher A.; Scheffler, Brian E.; Stelly, David M.; Hulse-Kemp, Amanda M.; Wan, Qun; Liu, Bingliang; Liu, Chunxiao; Wang, Sen; Pan, Mengqiao; Wang, Yangkun; Wang, Dawei; Ye, Wenxue; Chang, Lijing; Zhang, Wenpan; Song, Qingxin; Kirkbride, Ryan C.; Chen, Xiaoya; Dennis, Elizabeth; Llewellyn, Danny J.; Peterson, Daniel G.; Thaxton, Peggy; Jones, Don C.; Wang, Qiong; Xu, Xiaoyang; Zhang, Hua; Wu, Huaitong; Zhou, Lei; Mei, Gaofu; Chen, Shuqi; Tian, Yue; Xiang, Dan; Li, Xinghe; Ding, Jian; Zuo, Qiyang; Tao, Linna; Liu, Yunchao; Li, Ji; Lin, Yu; Hui, Yuanyuan; Cao, Zhisheng; Cai, Caiping; Zhu, Xiefei; Jiang, Zhi; Zhou, Baoliang; Guo, Wangzhen; Li, Ruiqiang; Chen, Z. Jeffrey			Sequencing of allotetraploid cotton (Gossypium hirsutum L. acc. TM-1) provides a resource for fiber improvement	NATURE BIOTECHNOLOGY			English	Article							GENOME SEQUENCE; GENE-EXPRESSION; BRASSICA-NAPUS; CELL-WALL; EVOLUTION; ARABIDOPSIS; PREDICTION; REVEALS; TOOL; ANNOTATION	Upland cotton is a model for polyploid crop domestication and transgenic improvement. Here we sequenced the allotetraploid Gossypium hirsutum L. acc. TM-1 genome by integrating whole-genome shotgun reads, bacterial artificial chromosome (BAC)-end sequences and genotype-by-sequencing genetic maps. We assembled and annotated 32,032 A-subgenome genes and 34,402 D-subgenome genes. Structural rearrangements, gene loss, disrupted genes and sequence divergence were more common in the A subgenome than in the D subgenome, suggesting asymmetric evolution. However, no genome-wide expression dominance was found between the subgenomes. Genomic signatures of selection and domestication are associated with positively selected genes (PSGs) for fiber improvement in the A subgenome and for stress tolerance in the D subgenome. This draft genome sequence provides a resource for engineering superior cotton lines.	[Zhang, Tianzhen; Hu, Yan; Fang, Lei; Guan, Xueying; Chen, Jiedan; Wan, Qun; Liu, Bingliang; Liu, Chunxiao; Wang, Sen; Pan, Mengqiao; Wang, Yangkun; Ye, Wenxue; Chang, Lijing; Zhang, Wenpan; Wang, Qiong; Xu, Xiaoyang; Zhang, Hua; Wu, Huaitong; Zhou, Lei; Mei, Gaofu; Chen, Shuqi; Tian, Yue; Xiang, Dan; Li, Xinghe; Ding, Jian; Cai, Caiping; Zhu, Xiefei; Zhou, Baoliang; Guo, Wangzhen; Chen, Z. Jeffrey] Nanjing Agr Univ, Cotton Hybrid R&D Engn Ctr, Minist Educ, State Key Lab Crop Genet & Germplasm Enhancement, Nanjing, Jiangsu, Peoples R China; [Jiang, Wenkai; Zhang, Jinbo; Wang, Dawei; Zuo, Qiyang; Tao, Linna; Liu, Yunchao; Li, Ji; Lin, Yu; Hui, Yuanyuan; Cao, Zhisheng; Jiang, Zhi; Li, Ruiqiang] Novogene Bioinformat Inst, Beijing, Peoples R China; [Fang, Lei; Song, Qingxin; Kirkbride, Ryan C.; Chen, Z. Jeffrey] Univ Texas Austin, Dept Mol Biosci, Ctr Computat Biol & Bioinformat, Austin, TX 78712 USA; [Fang, Lei; Guan, Xueying; Song, Qingxin; Kirkbride, Ryan C.; Chen, Z. Jeffrey] Univ Texas Austin, Dept Mol Biosci, Inst Cellular & Mol Biol, Austin, TX 78712 USA; [Saski, Christopher A.] Clemson Univ, Genom Inst, Clemson, SC USA; [Scheffler, Brian E.] ARS, USDA, MSA, Genom Lab, Stoneville, MS USA; [Stelly, David M.; Hulse-Kemp, Amanda M.] Texas A&M Univ, Dept Soil & Crop Sci, College Stn, TX 77843 USA; [Chen, Xiaoya] Chinese Acad Sci, Natl Key Lab Plant Mol Genet, Natl Plant Gene Res Ctr, Inst Plant Physiol & Ecol,Shanghai Inst Biol Sci, Shanghai, Peoples R China; [Dennis, Elizabeth; Llewellyn, Danny J.] Commonwealth Sci & Ind Res Org, Plant Ind, Black Mt, Australia; [Peterson, Daniel G.] Mississippi State Univ, Dept Plant & Soil Sci, Starkville, MS USA; [Thaxton, Peggy] Mississippi State Univ, Delta Res & Extens Ctr, Stoneville, MS USA; [Jones, Don C.] Cotton Inc, Cary, NC USA	Nanjing Agricultural University; University of Texas System; University of Texas Austin; University of Texas System; University of Texas Austin; Clemson University; United States Department of Agriculture (USDA); Texas A&M University System; Texas A&M University College Station; Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; Commonwealth Scientific & Industrial Research Organisation (CSIRO); Mississippi State University; Mississippi State University; Cotton Incorporated	Zhang, TZ (corresponding author), Nanjing Agr Univ, Cotton Hybrid R&D Engn Ctr, Minist Educ, State Key Lab Crop Genet & Germplasm Enhancement, Nanjing, Jiangsu, Peoples R China.	cotton@njau.edu.cn; moelab@njau.edu.cn; lirq@novogene.cn; zjchen@austin.utexas.edu	Song, Qingxin/AAB-2101-2021; Llewellyn, Danny J/D-5230-2009; zhang, jin/GXV-9154-2022; Stelly, David/ABC-7400-2020; Mei, Gaofu/AAG-7632-2020; Dennis, Elizabeth S/A-6074-2008	Song, Qingxin/0000-0001-7081-3339; Llewellyn, Danny J/0000-0001-9535-8707; Stelly, David/0000-0002-3468-4119; Dennis, Elizabeth S/0000-0002-7850-591X; ye, wenxue/0000-0001-9917-2176; Hulse-Kemp, Amanda/0000-0001-9670-9433; Scheffler, Brian/0000-0003-1968-8952; Peterson, Daniel/0000-0002-0274-5968; Chen, Xiaoya/0000-0002-2909-8414; Chen, Jiedan/0000-0002-5223-8243; Wang, Qiong/0000-0001-8843-7060	Major State Basic Research Development Program of China (973 Program) [2011CB109300]; National Natural Science Foundation of China [3133058, 31290213]; NSF [ISO1025947]; Fundamental Research Funds by the Central Universities [KYZ201201]; Cotton Incorporated [07-161, 14-371]; Priority Academic Program Development of Jiangsu Higher Education Institutions; 111 program; Direct For Biological Sciences [1444552] Funding Source: National Science Foundation; Division Of Integrative Organismal Systems [1025947] Funding Source: National Science Foundation; ARS [ARS-0425248] Funding Source: Federal RePORTER	Major State Basic Research Development Program of China (973 Program)(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); NSF(National Science Foundation (NSF)); Fundamental Research Funds by the Central Universities; Cotton Incorporated(Cotton R&D Corp); Priority Academic Program Development of Jiangsu Higher Education Institutions; 111 program(Ministry of Education, China - 111 Project); Direct For Biological Sciences(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO)); Division Of Integrative Organismal Systems(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO)); ARS(United States Department of Agriculture (USDA)USDA Agricultural Research Service)	This work was financially supported in part by grants from the Major State Basic Research Development Program of China (973 Program) (2011CB109300), National Natural Science Foundation of China (No. 3133058; No. 31290213), NSF (ISO1025947), The Fundamental Research Funds by the Central Universities (KYZ201201), Cotton Incorporated (07-161, 14-371), the Priority Academic Program Development of Jiangsu Higher Education Institutions and the 111 program.	Adams KL, 2003, P NATL ACAD SCI USA, V100, P4649, DOI 10.1073/pnas.0630618100; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Bairoch A, 1999, NUCLEIC ACIDS RES, V27, P49, DOI 10.1093/nar/27.1.49; Bateman A, 2004, NUCLEIC ACIDS RES, V32, pD138, DOI [10.1093/nar/gkt1223, 10.1093/nar/gkr1065, 10.1093/nar/gkp985]; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Birney E, 2004, GENOME RES, V14, P988, DOI 10.1101/gr.1865504; Brenchley R, 2012, NATURE, V491, P705, DOI 10.1038/nature11650; Brosche M, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004112; Buggs RJA, 2012, CURR BIOL, V22, P248, DOI 10.1016/j.cub.2011.12.027; Burge C, 1997, J MOL BIOL, V268, P78, DOI 10.1006/jmbi.1997.0951; Chalhoub B, 2014, SCIENCE, V345, P950, DOI 10.1126/science.1253435; Chen ZJ, 2007, PLANT PHYSIOL, V145, P1303, DOI 10.1104/pp.107.107672; Cheng F, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036442; Conesa A, 2005, BIOINFORMATICS, V21, P3674, DOI 10.1093/bioinformatics/bti610; Ding KY, 2005, MOL BIOL EVOL, V22, P148, DOI 10.1093/molbev/msh266; Endrizzi J. E., 1985, Advances in Genetics, V23, P271, DOI 10.1016/S0065-2660(08)60515-5; Feldman M, 1997, GENETICS, V147, P1381; Finn RD, 2011, NUCLEIC ACIDS RES, V39, pW29, DOI 10.1093/nar/gkr367; Gaeta RT, 2007, PLANT CELL, V19, P3403, DOI 10.1105/tpc.107.054346; Gan XC, 2011, NATURE, V477, P419, DOI 10.1038/nature10414; Goodstein DM, 2012, NUCLEIC ACIDS RES, V40, pD1178, DOI 10.1093/nar/gkr944; Gou JY, 2007, CELL RES, V17, P422, DOI 10.1038/sj.cr.7310150; Griffiths-Jones S, 2005, NUCLEIC ACIDS RES, V33, pD121, DOI 10.1093/nar/gki081; Grover CE, 2012, NEW PHYTOL, V196, P966, DOI 10.1111/j.1469-8137.2012.04365.x; Guan XY, 2014, TRENDS PLANT SCI, V19, P516, DOI 10.1016/j.tplants.2014.04.007; Guigo R, 1998, J COMPUT BIOL, V5, P681, DOI 10.1089/cmb.1998.5.681; Guo WZ, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-314; Haas BJ, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-1-r7; Haigler CH, 2012, FRONT PLANT SCI, V3, DOI 10.3389/fpls.2012.00104; Hunter S, 2012, NUCLEIC ACIDS RES, V40, pD306, DOI 10.1093/nar/gkr948; Jin JP, 2014, NUCLEIC ACIDS RES, V42, pD1182, DOI 10.1093/nar/gkt1016; Kagale S, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4706; Kanehisa M, 2014, NUCLEIC ACIDS RES, V42, pD199, DOI 10.1093/nar/gkt1076; Kent WJ, 2003, P NATL ACAD SCI USA, V100, P11484, DOI 10.1073/pnas.1932072100; Kim EB, 2011, NATURE, V479, P223, DOI 10.1038/nature10533; KOHEL R J, 1970, Crop Science, V10, P670; Korf I, 2004, BMC BIOINFORMATICS, V5, DOI 10.1186/1471-2105-5-59; Leach LJ, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-276; Li FG, 2015, NAT BIOTECHNOL, V33, P524, DOI 10.1038/nbt.3208; Li FG, 2014, NAT GENET, V46, P567, DOI 10.1038/ng.2987; Li H, 2009, BIOINFORMATICS, V25, P1094, DOI [10.1093/bioinformatics/btp100, 10.1093/bioinformatics/btp324]; Li RQ, 2010, GENOME RES, V20, P265, DOI 10.1101/gr.097261.109; Li XR, 2010, J EXP BOT, V61, P287, DOI 10.1093/jxb/erp299; Liu B, 2001, GENOME, V44, P321, DOI 10.1139/gen-44-3-321; Liu S, 2014, NAT PROD COMMUN, V9, P7, DOI 10.1038/ncomms4930; Lowe TM, 1997, NUCLEIC ACIDS RES, V25, P955, DOI 10.1093/nar/25.5.955; Majoros WH, 2004, BIOINFORMATICS, V20, P2878, DOI 10.1093/bioinformatics/bth315; Mayer KFX, 2014, SCIENCE, V345, DOI 10.1126/science.1251788; Motamayor JC, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-6-r53; Nawrocki EP, 2009, BIOINFORMATICS, V25, P1335, DOI 10.1093/bioinformatics/btp157; Nussbaumer T, 2013, NUCLEIC ACIDS RES, V41, pD1144, DOI 10.1093/nar/gks1153; Ooijen J.W., 2001, PLANT RES INT; Otto SP, 2007, CELL, V131, P452, DOI 10.1016/j.cell.2007.10.022; Paterson AH, 2012, NATURE, V492, P423, DOI 10.1038/nature11798; Puranik S, 2012, TRENDS PLANT SCI, V17, P369, DOI 10.1016/j.tplants.2012.02.004; Qin YM, 2011, CURR OPIN PLANT BIOL, V14, P106, DOI 10.1016/j.pbi.2010.09.010; Rodrigues SM, 2006, J EXP BOT, V57, P1909, DOI 10.1093/jxb/erj132; Senchina DS, 2003, MOL BIOL EVOL, V20, P633, DOI 10.1093/molbev/msg065; Sierro N, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4833; Soltis PS, 2009, ANNU REV PLANT BIOL, V60, P561, DOI 10.1146/annurev.arplant.043008.092039; Stanke M, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-62; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Thimm O, 2004, PLANT J, V37, P914, DOI 10.1111/j.1365-313X.2004.02016.x; Trapnell C, 2010, NAT BIOTECHNOL, V28, P511, DOI 10.1038/nbt.1621; Trapnell C, 2009, BIOINFORMATICS, V25, P1105, DOI 10.1093/bioinformatics/btp120; TURCOTTE EL, 1969, CROP SCI, V9, P653, DOI 10.2135/cropsci1969.0011183X000900050045x; Voorrips RE, 2002, J HERED, V93, P77, DOI 10.1093/jhered/93.1.77; Walford SA, 2011, PLANT J, V65, P785, DOI 10.1111/j.1365-313X.2010.04464.x; Wang JL, 2006, GENETICS, V172, P507, DOI 10.1534/genetics.105.047894; Wang K, 2012, THEOR APPL GENET, V124, P1173, DOI 10.1007/s00122-011-1777-3; Wang K, 2010, CHROMOSOMA, V119, P255, DOI 10.1007/s00412-009-0254-0; Wang KB, 2012, NAT GENET, V44, P1098, DOI 10.1038/ng.2371; Wang LK, 2010, BIOINFORMATICS, V26, P136, DOI 10.1093/bioinformatics/btp612; Wang S, 2004, PLANT CELL, V16, P2323, DOI 10.1105/tpc.104.024844; Wang XW, 2011, NAT GENET, V43, P1035, DOI 10.1038/ng.919; WENDEL JF, 1989, P NATL ACAD SCI USA, V86, P4132, DOI 10.1073/pnas.86.11.4132; Woodhouse MR, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000409; Yang ZH, 2002, MOL BIOL EVOL, V19, P908, DOI 10.1093/oxfordjournals.molbev.a004148; Yang ZH, 2007, MOL BIOL EVOL, V24, P1586, DOI 10.1093/molbev/msm088; Yoo MJ, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004073; Yu XJ, 2006, GENOMICS, V88, P745, DOI 10.1016/j.ygeno.2006.05.008	83	1032	1163	23	359	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1087-0156	1546-1696		NAT BIOTECHNOL	Nat. Biotechnol.	MAY	2015	33	5					531	U252		10.1038/nbt.3207	http://dx.doi.org/10.1038/nbt.3207			10	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	CH8VP	25893781	hybrid			2022-12-27	WOS:000354314500035
J	Dow, LE; Fisher, J; O'Rourke, KP; Muley, A; Kastenhuber, ER; Livshits, G; Tschaharganeh, DF; Socci, ND; Lowe, SW				Dow, Lukas E.; Fisher, Jonathan; O'Rourke, Kevin P.; Muley, Ashlesha; Kastenhuber, Edward R.; Livshits, Geulah; Tschaharganeh, Darjus F.; Socci, Nicholas D.; Lowe, Scott W.			Inducible in vivo genome editing with CRISPR-Cas9	NATURE BIOTECHNOLOGY			English	Article							ONE-STEP GENERATION; MICE; GENE; SYSTEM; CANCER; MOUSE; CELLS; CAS9; DIFFERENTIATION; TRANSCRIPTION	CRISPR-Cas9-based genome editing enables the rapid genetic manipulation of any genomic locus without the need for gene targeting by homologous recombination. Here we describe a conditional transgenic approach that allows temporal control of CRISPR-Cas9 activity for inducible genome editing in adult mice. We show that doxycycline-regulated Cas9 induction enables widespread gene disruption in multiple tissues and that limiting the duration of Cas9 expression or using a Cas9(D10A) (Cas9n) variant can regulate the frequency and size of target gene modifications, respectively. Further, we show that this inducible CRISPR (iCRISPR) system can be used effectively to create biallelic mutation in multiple target loci and, thus, provides a flexible and fast platform to study loss-of-function phenotypes in vivo.	[Dow, Lukas E.; Fisher, Jonathan; O'Rourke, Kevin P.; Kastenhuber, Edward R.; Livshits, Geulah; Tschaharganeh, Darjus F.; Lowe, Scott W.] Mem Sloan Kettering Canc Ctr, Canc Biol & Genet Program, New York, NY 10021 USA; [Dow, Lukas E.; Muley, Ashlesha] Weill Cornell Med Coll, Dept Med, Hematol Med Oncol Div, New York, NY USA; [O'Rourke, Kevin P.] Weill Cornell Rockefeller Sloan Kettering Triinst, New York, NY USA; [Kastenhuber, Edward R.] Gerstner Sloan Kettering Grad Sch Biomed Sci, New York, NY USA; [Socci, Nicholas D.] Mem Sloan Kettering Canc Ctr, Bioinformat Core Facil, New York, NY 10021 USA; [Lowe, Scott W.] Mem Sloan Kettering Canc Ctr, Howard Hughes Med Inst, New York, NY 10021 USA	Memorial Sloan Kettering Cancer Center; Cornell University; Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center; Howard Hughes Medical Institute; Memorial Sloan Kettering Cancer Center	Dow, LE (corresponding author), Mem Sloan Kettering Canc Ctr, Canc Biol & Genet Program, 1275 York Ave, New York, NY 10021 USA.	lud2005@med.cornell.edu; lowes@mskcc.org		Kastenhuber, Edward/0000-0002-1872-212X; Dow, Lukas/0000-0001-7048-1418	National Cancer Institute (NCI) [CA-013106]; NCI/ National Institutes of Health (NIH) [1K22CA181280-01]; National Institute of General Medical Sciences of the NIH [T32GM07739]; American Cancer Society postdoctoral fellowship [PF-13-037-01]; NIH F32 grant [1F32CA177072-01]; NATIONAL CANCER INSTITUTE [F31CA192835, R01CA195787, P01CA013106, F32CA177072, P30CA008748, P01CA087497, K22CA181280, P01CA129243] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007739] Funding Source: NIH RePORTER	National Cancer Institute (NCI)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI/ National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); National Institute of General Medical Sciences of the NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); American Cancer Society postdoctoral fellowship(American Cancer Society); NIH F32 grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank J. Simon for technical assistance with animal colonies, and other members of the Lowe laboratory for advice and discussions. We thank the MSKCC transgenic core facility for production of transgenic animals by blastocyst injection and the MSKCC Genomics core facility for library preparation and Illumina sequencing. This work was supported by a program project grant number CA-013106 from the National Cancer Institute (NCI). L.E.D. was supported by a K22 Career Development Award from the NCI/ National Institutes of Health (NIH) under award number 1K22CA181280-01. K.P.O'R. was supported by a Medical Scientist Training Program grant from the National Institute of General Medical Sciences of the NIH under award number T32GM07739 to the Weill Cornell/Rockefeller/Sloan-Kettering Tri-Institutional MD-PhD Program. G.L. was supported by an American Cancer Society postdoctoral fellowship PF-13-037-01 and NIH F32 grant 1F32CA177072-01. S.W.L. is an investigator of the Howard Hughes Medical Institute and the Geoffrey Beene Chair for Cancer Biology.	Cong L, 2013, SCIENCE, V339, P819, DOI 10.1126/science.1231143; Dow LE, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0095236; Dow LE, 2012, NAT PROTOC, V7, P374, DOI 10.1038/nprot.2011.446; Fu YF, 2013, NAT BIOTECHNOL, V31, P822, DOI 10.1038/nbt.2623; Gilbert LA, 2013, CELL, V154, P442, DOI 10.1016/j.cell.2013.06.044; Gonzalez F, 2014, CELL STEM CELL, V15, P215, DOI 10.1016/j.stem.2014.05.018; Hochedlinger K, 2005, CELL, V121, P465, DOI 10.1016/j.cell.2005.02.018; Li DL, 2013, NAT BIOTECHNOL, V31, P681, DOI 10.1038/nbt.2661; Maddalo D, 2014, NATURE, V516, P423, DOI 10.1038/nature13902; Mali P, 2013, SCIENCE, V339, P823, DOI 10.1126/science.1232033; MOSER AR, 1995, DEV DYNAM, V203, P422, DOI 10.1002/aja.1002030405; Platt RJ, 2014, CELL, V159, P440, DOI 10.1016/j.cell.2014.09.014; Premsrirut PK, 2011, CELL, V145, P145, DOI 10.1016/j.cell.2011.03.012; Qi LS, 2013, CELL, V152, P1173, DOI 10.1016/j.cell.2013.02.022; Ran FA, 2013, CELL, V154, P1380, DOI 10.1016/j.cell.2013.08.021; Reed KR, 2008, BMC CANCER, V8, DOI 10.1186/1471-2407-8-162; Sanchez-Rivera FJ, 2014, NATURE, V516, P428, DOI 10.1038/nature13906; Sanjana NE, 2012, NAT PROTOC, V7, P171, DOI 10.1038/nprot.2011.431; Sansom OJ, 2004, GENE DEV, V18, P1385, DOI 10.1101/gad.287404; Sato T, 2011, GASTROENTEROLOGY, V141, P1762, DOI 10.1053/j.gastro.2011.07.050; SU LK, 1992, SCIENCE, V256, P668, DOI 10.1126/science.1350108; Wang HY, 2013, CELL, V153, P910, DOI 10.1016/j.cell.2013.04.025; Wu XB, 2014, NAT BIOTECHNOL, V32, P670, DOI 10.1038/nbt.2889; Xue W, 2014, NATURE, V514, P380, DOI 10.1038/nature13589; Yang H, 2013, CELL, V154, P1370, DOI 10.1016/j.cell.2013.08.022	25	330	359	5	205	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156	1546-1696		NAT BIOTECHNOL	Nat. Biotechnol.	APR	2015	33	4					390	U98		10.1038/nbt.3155	http://dx.doi.org/10.1038/nbt.3155			7	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	CF2AE	25690852	Green Accepted			2022-12-27	WOS:000352348500025
J	Jarchum, I				Jarchum, Irene			What's in a stomach?	NATURE BIOTECHNOLOGY			English	Editorial Material																		McCracken K. W., 2014, NATURE          1029, DOI [10.1038/nature13863, DOI 10.1038/NATURE13863]	1	0	0	0	1	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156	1546-1696		NAT BIOTECHNOL	Nat. Biotechnol.	DEC	2014	32	12					1201	1201		10.1038/nbt.3092	http://dx.doi.org/10.1038/nbt.3092			1	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	AW3AD	25489838	Bronze			2022-12-27	WOS:000346156800021
J	De Smet, F; Christopoulos, A; Carmeliet, P				De Smet, Frederik; Christopoulos, Arthur; Carmeliet, Peter			Allosteric targeting of receptor tyrosine kinases	NATURE BIOTECHNOLOGY			English	Article							PROTEIN-COUPLED RECEPTORS; DRUG DISCOVERY; SMALL-MOLECULE; EGF RECEPTOR; BCR-ABL; LIGAND-BINDING; IN-VIVO; INHIBITORS; ACTIVATION; GROWTH	The drug discovery landscape has been transformed over the past decade by the discovery of allosteric modulators of all major mammalian receptor superfamilies. Allosteric ligands are a rich potential source of drugs and drug targets with clear therapeutic advantages. G protein coupled receptors, ligand-gated ion channels and intracellular nuclear hormone receptors have all been targeted by allosteric modulators. More recently, a receptor tyrosine kinase (RTK) has been targeted by an extracellular small-molecule allosteric modulator. Allosteric mechanisms of structurally distinct molecules that target the various receptor families are more alike than originally anticipated and include selectivity, orthosteric probe dependence and pathway-biased signaling.	[De Smet, Frederik] Univ Leuven, Dept Cellular & Mol Med, SWITCH Lab, Leuven, Belgium; [De Smet, Frederik] Flanders Inst Biotechnol VIB, SWITCH Lab, Leuven, Belgium; [Christopoulos, Arthur] Monash Univ, Monash Inst Pharmaceut Sci, Clayton, Vic 3800, Australia; [Christopoulos, Arthur] Monash Univ, Monash Inst Pharmaceut Sci, Dept Pharmacol, Clayton, Vic 3800, Australia; [Carmeliet, Peter] Univ Leuven, Vesalius Res Ctr, Dept Oncol, Lab Angiogenesis & Neurovasc Link, Leuven, Belgium; [Carmeliet, Peter] VIB, Vesalius Res Ctr, Lab Angiogenesis & Neurovasc Link, Leuven, Belgium	KU Leuven; Flanders Institute for Biotechnology (VIB); Monash University; Monash University; KU Leuven; Flanders Institute for Biotechnology (VIB)	Carmeliet, P (corresponding author), Univ Leuven, Vesalius Res Ctr, Dept Oncol, Lab Angiogenesis & Neurovasc Link, Leuven, Belgium.	peter.carmeliet@vib-kuleuven.be	Christopoulos, Arthur/B-6207-2013; De Smet, Frederik/Q-7808-2016; Carmeliet, Peter/AAQ-5140-2020	Christopoulos, Arthur/0000-0003-4442-3294; De Smet, Frederik/0000-0002-6669-3335; Carmeliet, Peter/0000-0001-7961-1821	Fund for Scientific Research (FWO), Flanders; FWO, Belgium [G.0789.11, G.00764.10]; Belgian Science Policy (IAP) [P7/03]; Leducq Network of Excellence; Flemish Government	Fund for Scientific Research (FWO), Flanders(FWO); FWO, Belgium(FWO); Belgian Science Policy (IAP)(Belgian Federal Science Policy Office); Leducq Network of Excellence; Flemish Government(European Commission)	F.D.S. is supported by the Fund for Scientific Research (FWO), Flanders. A.C. is a principal research fellow of the National Health and Medical Research Council of Australia. This work is supported by grant #G.0789.11 and #G.00764.10 from the FWO, Belgium; the Belgian Science Policy (IAP #P7/03); Leducq Network of Excellence; and long-term structural Methusalem funding by the Flemish Government to P.C.	Birdsall NJM, 2005, MINI-REV MED CHEM, V5, P523, DOI 10.2174/1389557054023251; Bono F, 2013, CANCER CELL, V23, P477, DOI 10.1016/j.ccr.2013.02.019; Burke JR, 2003, J BIOL CHEM, V278, P1450, DOI 10.1074/jbc.M209677200; Cazorla M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009777; Chaneton B, 2012, NATURE, V491, P458, DOI 10.1038/nature11540; Cherrin C, 2010, CANCER BIOL THER, V9, P493, DOI 10.4161/cbt.9.7.11100; Christopoulos A, 2002, NAT REV DRUG DISCOV, V1, P198, DOI 10.1038/nrd746; Conn PJ, 2009, NAT REV DRUG DISCOV, V8, P41, DOI 10.1038/nrd2760; Corbin JA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088684; De Amici M, 2010, MED RES REV, V30, P463, DOI 10.1002/med.20166; Endres NF, 2011, CURR OPIN STRUC BIOL, V21, P777, DOI 10.1016/j.sbi.2011.07.007; Estebanez-Perpina E, 2007, P NATL ACAD SCI USA, V104, P16074, DOI 10.1073/pnas.0708036104; Fleishman SJ, 2002, P NATL ACAD SCI USA, V99, P15937, DOI 10.1073/pnas.252640799; Grebien F, 2011, CELL, V147, P306, DOI 10.1016/j.cell.2011.08.046; Grunewald FS, 2010, BBA-PROTEINS PROTEOM, V1804, P567, DOI 10.1016/j.bbapap.2009.09.002; Gui DY, 2013, SCI SIGNAL, V6, DOI 10.1126/scisignal.2003925; Hantschel O, 2012, CANCER RES, V72, P4890, DOI 10.1158/0008-5472.CAN-12-1276; Hardy JA, 2004, CURR OPIN STRUC BIOL, V14, P706, DOI 10.1016/j.sbi.2004.10.009; He KY, 2013, SCI SIGNAL, V6, DOI 10.1126/scisignal.2003900; Herbert C, 2013, CANCER CELL, V23, P489, DOI 10.1016/j.ccr.2013.02.018; Hopkins AL, 2002, NAT REV DRUG DISCOV, V1, P727, DOI 10.1038/nrd892; Hyde CAC, 2012, MOL CELL BIOL, V32, P3802, DOI 10.1128/MCB.06787-11; Jaffe EK, 2013, CURR TOP MED CHEM, V13, P55; Jang SW, 2007, P NATL ACAD SCI USA, V104, P16329, DOI 10.1073/pnas.0706662104; Jura N, 2011, MOL CELL, V42, P9, DOI 10.1016/j.molcel.2011.03.004; Karaman MW, 2008, NAT BIOTECHNOL, V26, P127, DOI 10.1038/nbt1358; Kenakin T, 2013, NAT REV DRUG DISCOV, V12, P205, DOI 10.1038/nrd3954; Laine E, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002661; Landgraf KE, 2010, J BIOL CHEM, V285, P40362, DOI 10.1074/jbc.M110.179721; Leahy DJ, 2008, CANCER CELL, V13, P291, DOI 10.1016/j.ccr.2008.03.010; Lebakken CS, 2012, J BIOMOL SCREEN, V17, P813, DOI 10.1177/1087057112439889; Lee S, 2005, J CELL BIOL, V169, P681, DOI 10.1083/jcb.200409115; Lemmon MA, 2010, CELL, V141, P1117, DOI 10.1016/j.cell.2010.06.011; Leonard TA, 2011, CELL, V144, P55, DOI 10.1016/j.cell.2010.12.013; Leppanen VM, 2013, P NATL ACAD SCI USA, V110, P12960, DOI 10.1073/pnas.1301415110; Li E, 2010, CELL ADHES MIGR, V4, P249, DOI 10.4161/cam.4.2.10725; Lundstrom K, 2009, METHODS MOL BIOL, V552, P51, DOI 10.1007/978-1-60327-317-6_4; Macdonald-Obermann JL, 2009, J BIOL CHEM, V284, P13570, DOI 10.1074/jbc.M109.001487; McEwan IJ, 2012, MOL CELL ENDOCRINOL, V348, P345, DOI 10.1016/j.mce.2011.08.035; McTigue M, 2012, P NATL ACAD SCI USA, V109, P18281, DOI 10.1073/pnas.1207759109; Melancon BJ, 2012, J MED CHEM, V55, P1445, DOI 10.1021/jm201139r; Moore TW, 2010, MOL ENDOCRINOL, V24, P683, DOI 10.1210/me.2009-0362; Murakami M, 2008, CARDIOVASC RES, V78, P223, DOI 10.1093/cvr/cvm086; Neubig RR, 2003, PHARMACOL REV, V55, P597, DOI 10.1124/pr.55.4.4; O'Hayre M, 2013, NAT REV CANCER, V13, P412, DOI 10.1038/nrc3521; Overington JP, 2006, NAT REV DRUG DISCOV, V5, P993, DOI 10.1038/nrd2199; Perron MD, 2014, MOL PHARMACOL, V85, P553, DOI 10.1124/mol.113.089847; Shah DR, 2013, DRUG SAFETY, V36, P413, DOI 10.1007/s40264-013-0050-x; Suarez RM, 2013, EUR J MED CHEM, V61, P2, DOI 10.1016/j.ejmech.2012.06.005; Thiel KW, 2007, P NATL ACAD SCI USA, V104, P19238, DOI 10.1073/pnas.0703854104; Tvorogov D, 2010, CANCER CELL, V18, P630, DOI 10.1016/j.ccr.2010.11.001; Udugamasooriya DG, 2008, J AM CHEM SOC, V130, P5744, DOI 10.1021/ja711193x; Weisheit S, 2012, CELL SIGNAL, V24, P422, DOI 10.1016/j.cellsig.2011.09.010; Weisheit S, 2011, CELL SIGNAL, V23, P436, DOI 10.1016/j.cellsig.2010.10.018; Wootten D, 2013, NAT REV DRUG DISCOV, V12, P630, DOI 10.1038/nrd4052; Yang JS, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002612; Yang Y, 2008, P NATL ACAD SCI USA, V105, P7681, DOI 10.1073/pnas.0802896105; Yang Y, 2010, P NATL ACAD SCI USA, V107, P1906, DOI 10.1073/pnas.0914052107; Zhang JM, 2010, NATURE, V463, P501, DOI 10.1038/nature08675; Zhang JM, 2009, NAT REV CANCER, V9, P28, DOI 10.1038/nrc2559	60	57	58	0	34	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156	1546-1696		NAT BIOTECHNOL	Nat. Biotechnol.	NOV	2014	32	11					1113	1120		10.1038/nbt.3028	http://dx.doi.org/10.1038/nbt.3028			8	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	AT5IL	25380447				2022-12-27	WOS:000344977000016
J	Bhatia, SN; Ingber, DE				Bhatia, Sangeeta N.; Ingber, Donald E.			Microfluidic organs-on-chips	NATURE BIOTECHNOLOGY			English	Article							PRIMARY HUMAN HEPATOCYTES; PLURIPOTENT STEM-CELL; IN-VITRO MODEL; A-CHIP; BREAST-CANCER; HUMAN LIVER; EXTRACELLULAR-MATRIX; HEPATIC-CLEARANCE; ENDOTHELIAL-CELLS; GENE-EXPRESSION	An organ-on-a-chip is a microfluidic cell culture device created with microchip manufacturing methods that contains continuously perfused chambers inhabited by living cells arranged to simulate tissue-and organ-level physiology. By recapitulating the multicellular architectures, tissue-tissue interfaces, physicochemical microenvironments and vascular perfusion of the body, these devices produce levels of tissue and organ functionality not possible with conventional 2D or 3D culture systems. They also enable high-resolution, real-time imaging and in vitro analysis of biochemical, genetic and metabolic activities of living cells in a functional tissue and organ context. This technology has great potential to advance the study of tissue development, organ physiology and disease etiology. In the context of drug discovery and development, it should be especially valuable for the study of molecular mechanisms of action, prioritization of lead candidates, toxicity testing and biomarker identification.	[Bhatia, Sangeeta N.] MIT, Koch Inst, Dept Elect Engn & Comp Sci, Cambridge, MA 02139 USA; [Bhatia, Sangeeta N.] MIT, Inst Med Engn & Sci, Cambridge, MA 02139 USA; [Bhatia, Sangeeta N.] Broad Inst, Cambridge, MA USA; [Bhatia, Sangeeta N.] Brigham & Womens Hosp, Dept Med, Boston, MA 02115 USA; [Ingber, Donald E.] Harvard Univ, Wyss Inst Biol Inspired Engn, Boston, MA 02115 USA; [Ingber, Donald E.] Boston Childrens Hosp, Dept Pathol, Vasc Biol Program, Boston, MA USA; [Ingber, Donald E.] Boston Childrens Hosp, Dept Surg, Boston, MA USA; [Ingber, Donald E.] Harvard Univ, Sch Med, Boston, MA USA; [Ingber, Donald E.] Harvard Univ, Sch Engn & Appl Sci, Cambridge, MA 02138 USA	Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT); Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Harvard University; Brigham & Women's Hospital; Harvard University; Harvard University; Boston Children's Hospital; Harvard University; Boston Children's Hospital; Harvard University; Harvard Medical School; Harvard University	Ingber, DE (corresponding author), Harvard Univ, Wyss Inst Biol Inspired Engn, Boston, MA 02115 USA.	don.ingber@wyss.harvard.edu	Ingber, Donald E/AAC-5894-2019		Defense Advanced Research Projects Agency (DARPA) [W911NF-12-2-0036]; FDA [HHSF223201310079C]; US National Institutes of Health [UH3 EB017103, R01 DK85713, R01 EB008396]; Bill and Melinda Gates Foundation [OPP1023607, OPP1086223]; Wyss Institute for Biologically Inspired Engineering at Harvard University; US Department of Defense (DoD) Breast Cancer Innovator Award [BC074986]; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P30ES002109] Funding Source: NIH RePORTER	Defense Advanced Research Projects Agency (DARPA)(United States Department of DefenseDefense Advanced Research Projects Agency (DARPA)); FDA(United States Department of Health & Human Services); US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Bill and Melinda Gates Foundation(Bill & Melinda Gates Foundation); Wyss Institute for Biologically Inspired Engineering at Harvard University; US Department of Defense (DoD) Breast Cancer Innovator Award(United States Department of Defense); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	We thank H. Fleming, S. Khetani, D. Levner, G. Hamilton and T. Bahinski for their helpful input. This work was supported by grants from the Defense Advanced Research Projects Agency (DARPA) (W911NF-12-2-0036), the FDA (HHSF223201310079C), the US National Institutes of Health (UH3 EB017103, R01 DK85713, R01 EB008396), Bill and Melinda Gates Foundation (OPP1023607, OPP1086223) and the Wyss Institute for Biologically Inspired Engineering at Harvard University. S.N.B. is an investigator of the Howard Hughes Medical Institute; D.E.I. is a recipient of a US Department of Defense (DoD) Breast Cancer Innovator Award (BC074986).	Achyuta AKH, 2013, LAB CHIP, V13, P542, DOI 10.1039/c2lc41033h; Agarwal A, 2013, LAB CHIP, V13, P3599, DOI 10.1039/c3lc50350j; Allen JW, 2005, TOXICOL SCI, V84, P110, DOI 10.1093/toxsci/kfi052; Allen JW, 2003, BIOTECHNOL BIOENG, V82, P253, DOI 10.1002/bit.10569; Atac B, 2013, LAB CHIP, V13, P3555, DOI 10.1039/c3lc50227a; Baker BM, 2013, LAB CHIP, V13, P3246, DOI 10.1039/c3lc50493j; Baudoin R, 2007, BIOTECHNOL PROGR, V23, P1245, DOI 10.1021/bp0603513; Baudoin R, 2014, J PHARM SCI-US, V103, P706, DOI 10.1002/jps.23796; Baudoin R, 2013, XENOBIOTICA, V43, P140, DOI 10.3109/00498254.2012.706725; Bhatia SN, 1999, FASEB J, V13, P1883, DOI 10.1096/fasebj.13.14.1883; Bischel LL, 2013, BIOMATERIALS, V34, P1471, DOI 10.1016/j.biomaterials.2012.11.005; Booth R, 2012, LAB CHIP, V12, P1784, DOI 10.1039/c2lc40094d; Boudou T, 2012, TISSUE ENG PT A, V18, P910, DOI [10.1089/ten.TEA.2011.0341, 10.1089/ten.tea.2011.0341]; Carraro A, 2008, BIOMED MICRODEVICES, V10, P795, DOI 10.1007/s10544-008-9194-3; Chan TS, 2013, DRUG METAB DISPOS, V41, P2024, DOI 10.1124/dmd.113.053397; Chao P, 2009, BIOCHEM PHARMACOL, V78, P625, DOI 10.1016/j.bcp.2009.05.013; Chen AA, 2010, INTEGR BIOL-UK, V2, P517, DOI 10.1039/c0ib00054j; Chen CS, 1997, SCIENCE, V276, P1425, DOI 10.1126/science.276.5317.1425; Chen MB, 2013, INTEGR BIOL-UK, V5, P1262, DOI 10.1039/c3ib40149a; Chen S, 2010, INTEGR BIOL-UK, V2, P130, DOI 10.1039/b919392h; Cheng S, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-54; Cheng W, 2006, LAB CHIP, V6, P1424, DOI 10.1039/b608202e; Chiu DT, 2000, P NATL ACAD SCI USA, V97, P2408, DOI 10.1073/pnas.040562297; Choucha-Snouber L, 2013, BIOTECHNOL BIOENG, V110, P597, DOI 10.1002/bit.24707; Chung BG, 2005, LAB CHIP, V5, P401, DOI 10.1039/b417651k; Cimetta E, 2013, LAB CHIP, V13, P355, DOI 10.1039/c2lc40836h; Cimetta E, 2010, LAB CHIP, V10, P3277, DOI 10.1039/c0lc00033g; Domansky K, 2013, LAB CHIP, V13, P3956, DOI 10.1039/c3lc50558h; Domansky K, 2010, LAB CHIP, V10, P51, DOI 10.1039/b913221j; Douville NJ, 2010, ANAL CHEM, V82, P2505, DOI 10.1021/ac9029345; Duffy DC, 1998, ANAL CHEM, V70, P4974, DOI 10.1021/ac980656z; EHRMANN RL, 1956, J NATL CANCER I, V16, P1375; Eklund SE, 2009, SENSORS-BASEL, V9, P2117, DOI 10.3390/s90302117; Esch MB, 2012, BIOMED MICRODEVICES, V14, P895, DOI 10.1007/s10544-012-9669-0; Faley SL, 2009, LAB CHIP, V9, P2659, DOI 10.1039/b902083g; Feinberg AW, 2007, SCIENCE, V317, P1366, DOI 10.1126/science.1146885; Feinberg AW, 2013, STEM CELL REP, V1, P387, DOI 10.1016/j.stemcr.2013.10.004; Folch A, 1998, BIOTECHNOL PROGR, V14, P388, DOI 10.1021/bp980037b; Folch A, 1999, J BIOMECH ENG-T ASME, V121, P28, DOI 10.1115/1.2798038; Fritsche CS, 2009, INT J ARTIF ORGANS, V32, P701, DOI 10.1177/039139880903201001; Gerets HHJ, 2012, CELL BIOL TOXICOL, V28, P69, DOI 10.1007/s10565-011-9208-4; Giridharan GA, 2010, ANAL CHEM, V82, P7581, DOI 10.1021/ac1012893; Gopalan SM, 2003, BIOTECHNOL BIOENG, V81, P578, DOI 10.1002/bit.10506; Greek R, 2013, INT J MED SCI, V10, P206, DOI 10.7150/ijms.5529; Griep LM, 2013, BIOMED MICRODEVICES, V15, P145, DOI 10.1007/s10544-012-9699-7; Grosberg A, 2012, J PHARMACOL TOX MET, V65, P126, DOI 10.1016/j.vascn.2012.04.001; Grosberg A, 2011, LAB CHIP, V11, P4165, DOI 10.1039/c1lc20557a; Gunther A, 2010, LAB CHIP, V10, P2341, DOI 10.1039/c004675b; Han S, 2012, LAB CHIP, V12, P3861, DOI 10.1039/c2lc40445a; Han S, 2012, LAB CHIP, V12, P2305, DOI 10.1039/c2lc21285d; Harrison RG, 1910, J EXP ZOOL, V9, P787, DOI 10.1002/jez.1400090405; Hsu YH, 2013, LAB CHIP, V13, P2990, DOI 10.1039/c3lc50424g; Huh D, 2007, P NATL ACAD SCI USA, V104, P18886, DOI 10.1073/pnas.0610868104; Huh D, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3004249; Huh D, 2010, SCIENCE, V328, P1662, DOI 10.1126/science.1188302; Ingber DE, 2003, ANN MED, V35, P564, DOI 10.1080/07853890310016333; Jang KJ, 2013, INTEGR BIOL-UK, V5, P1119, DOI 10.1039/c3ib40049b; Jang KJ, 2010, LAB CHIP, V10, P36, DOI 10.1039/b907515a; Jeon JS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056910; Jeon NL, 2002, NAT BIOTECHNOL, V20, P826, DOI 10.1038/nbt712; Kane BJ, 2006, ANAL CHEM, V78, P4291, DOI 10.1021/ac051856v; Kane RS, 1999, BIOMATERIALS, V20, P2363, DOI 10.1016/S0142-9612(99)00165-9; Kaplowitz N, 2005, NAT REV DRUG DISCOV, V4, P489, DOI 10.1038/nrd1750; Khanal G, 2011, ANALYST, V136, P3519, DOI 10.1039/c0an00845a; Khetani SR, 2008, NAT BIOTECHNOL, V26, P120, DOI 10.1038/nbt1361; Khetani SR, 2013, TOXICOL SCI, V132, P107, DOI 10.1093/toxsci/kfs326; Kidambi S, 2009, P NATL ACAD SCI USA, V106, P15714, DOI 10.1073/pnas.0906820106; Kim HJ, 2013, INTEGR BIOL-UK, V5, P1130, DOI 10.1039/c3ib40126j; Kim HJ, 2012, LAB CHIP, V12, P2165, DOI 10.1039/c2lc40074j; Kroon E, 2008, NAT BIOTECHNOL, V26, P443, DOI 10.1038/nbt1393; Kunze A, 2013, INTEGR BIOL-UK, V5, P964, DOI 10.1039/c3ib40022k; Lancaster MA, 2013, NATURE, V501, P373, DOI 10.1038/nature12517; Lang JD, 2013, INTEGR BIOL-UK, V5, P807, DOI 10.1039/c3ib20265h; Lee PHU, 2013, TISSUE ENG PT A, V19, P2147, DOI [10.1089/ten.tea.2012.0597, 10.1089/ten.TEA.2012.0597]; Lee PJ, 2007, BIOTECHNOL BIOENG, V97, P1340, DOI 10.1002/bit.21360; Legendre A, 2013, J PHARM SCI-US, V102, P3264, DOI 10.1002/jps.23466; Li C. Y., TISSUE ENG IN PRESS; Li CY, 2013, LAB CHIP, V13, P1969, DOI 10.1039/c3lc41300d; Liu MC, 2013, LAB CHIP, V13, P1743, DOI 10.1039/c3lc41414k; Mahler GJ, 2009, BIOTECHNOL BIOENG, V104, P193, DOI 10.1002/bit.22366; Mammoto T, 2013, ANNU REV CELL DEV BI, V29, P27, DOI 10.1146/annurev-cellbio-101512-122340; March S, 2013, CELL HOST MICROBE, V14, P104, DOI 10.1016/j.chom.2013.06.005; McCain ML, 2013, P NATL ACAD SCI USA, V110, P9770, DOI 10.1073/pnas.1304913110; Montanez-Sauri SI, 2013, INTEGR BIOL-UK, V5, P631, DOI 10.1039/c3ib20225a; Moya ML, 2013, TISSUE ENG PART C-ME, V19, P730, DOI [10.1089/ten.tec.2012.0430, 10.1089/ten.TEC.2012.0430]; Mroue Rana, 2013, Methods Mol Biol, V945, P221, DOI 10.1007/978-1-62703-125-7_14; Muranen T, 2012, CANCER CELL, V21, P227, DOI 10.1016/j.ccr.2011.12.024; Nguyen DHT, 2013, P NATL ACAD SCI USA, V110, P6712, DOI 10.1073/pnas.1221526110; Novik E, 2010, BIOCHEM PHARMACOL, V79, P1036, DOI 10.1016/j.bcp.2009.11.010; O'Neill AT, 2008, CYTOTECHNOLOGY, V56, P197, DOI 10.1007/s10616-008-9149-9; Park HS, 2013, IEEE ENG MED BIO, P2833, DOI 10.1109/EMBC.2013.6610130; Park SH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046689; Peng CC, 2013, LAB CHIP, V13, P3239, DOI 10.1039/c3lc50388g; Ploss A, 2010, P NATL ACAD SCI USA, V107, P3141, DOI 10.1073/pnas.0915130107; Prentice-Mott HV, 2013, P NATL ACAD SCI USA, V110, P21006, DOI 10.1073/pnas.1317441110; Prot JM, 2011, INT J PHARMACEUT, V408, P67, DOI 10.1016/j.ijpharm.2011.01.054; Puleo CM, 2009, LAB CHIP, V9, P3221, DOI 10.1039/b908332d; Radisic M, 2005, AM J PHYSIOL-HEART C, V288, pH1278, DOI 10.1152/ajpheart.00787.2004; Rumsey JW, 2010, BIOMATERIALS, V31, P8218, DOI 10.1016/j.biomaterials.2010.07.027; Sato T, 2013, SCIENCE, V340, P1190, DOI 10.1126/science.1234852; Schimek K, 2013, LAB CHIP, V13, P3588, DOI 10.1039/c3lc50217a; Scott A, 2013, LAB CHIP, V13, P527, DOI 10.1039/c2lc40826k; Seidi A, 2011, BIOMICROFLUIDICS, V5, DOI 10.1063/1.3580756; Shan J, 2013, NAT CHEM BIOL, V9, P514, DOI 10.1038/nchembio.1270; Shayan G, 2011, BIOTECHNOL PROGR, V27, P1137, DOI 10.1002/btpr.620; Shayan G, 2011, EUR J PHARM SCI, V42, P148, DOI 10.1016/j.ejps.2010.11.005; Shi MJ, 2013, LAB CHIP, V13, P3008, DOI 10.1039/c3lc50249j; Shin M, 2004, BIOMED MICRODEVICES, V6, P269, DOI 10.1023/B:BMMD.0000048559.29932.27; Shintu L, 2012, ANAL CHEM, V84, P1840, DOI 10.1021/ac2011075; Silva PN, 2013, LAB CHIP, V13, P4374, DOI 10.1039/c3lc50680k; Sin A, 2004, BIOTECHNOL PROGR, V20, P338, DOI 10.1021/bp034077d; SINGHVI R, 1994, SCIENCE, V264, P696, DOI 10.1126/science.8171320; Sivaraman A, 2005, CURR DRUG METAB, V6, P569, DOI 10.2174/138920005774832632; Snouber LC, 2013, TOXICOL SCI, V132, P8, DOI 10.1093/toxsci/kfs230; Snouber LC, 2012, BIOTECHNOL PROGR, V28, P474, DOI 10.1002/btpr.743; Song JW, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005756; Sonntag F, 2010, J BIOTECHNOL, V148, P70, DOI 10.1016/j.jbiotec.2010.02.001; Spaeter D, 2013, NAT CELL BIOL, V15, P1098, DOI 10.1038/ncb2824; Sun YS, 2012, BIOMICROFLUIDICS, V6, DOI 10.1063/1.4750486; Sung JH, 2010, EXPERT OPIN DRUG MET, V6, P1063, DOI 10.1517/17425255.2010.496251; Sung JH, 2010, LAB CHIP, V10, P446, DOI 10.1039/b917763a; Sung JH, 2009, LAB CHIP, V9, P1385, DOI 10.1039/b901377f; Sung KE, 2011, INTEGR BIOL-UK, V3, P439, DOI 10.1039/c0ib00063a; Takayama S, 2001, NATURE, V411, P1016, DOI 10.1038/35082637; Tatosian DA, 2009, BIOTECHNOL BIOENG, V103, P187, DOI 10.1002/bit.22219; Tavana H, 2011, BIOMED MICRODEVICES, V13, P731, DOI 10.1007/s10544-011-9543-5; Thodeti CK, 2009, CIRC RES, V104, P1123, DOI 10.1161/CIRCRESAHA.108.192930; Thorneloe KS, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3004276; Nguyen TA, 2013, ANAL CHEM, V85, P11068, DOI 10.1021/ac402761s; Toh YC, 2009, LAB CHIP, V9, P2026, DOI 10.1039/b900912d; Torisawa YS, 2014, NAT METHODS, V11, P663, DOI [10.1038/NMETH.2938, 10.1038/nmeth.2938]; Trkov S, 2010, J TISSUE ENG REGEN M, V4, P205, DOI 10.1002/term.231; Tsantoulas C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080722; Tumarkin E, 2011, INTEGR BIOL-UK, V3, P653, DOI 10.1039/c1ib00002k; van der Meer AD, 2013, LAB CHIP, V13, P3562, DOI 10.1039/c3lc50435b; van Laake LW, 2010, CIRC RES, V107, P340, DOI 10.1161/CIRCRESAHA.109.215434; van Midwoud PM, 2010, LAB CHIP, V10, P2778, DOI [10.1039/c0lc00043d, 10.1039/c01c00043d]; Viravaidya K, 2004, BIOTECHNOL PROGR, V20, P590, DOI 10.1021/bp034238d; Wagner I, 2013, LAB CHIP, V13, P3538, DOI 10.1039/c3lc50234a; Wan CR, 2011, ANN BIOMED ENG, V39, P1840, DOI 10.1007/s10439-011-0275-8; Wang G, 2014, NAT MED, V20, P616, DOI 10.1038/nm.3545; Wang SS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056448; Westein E, 2013, P NATL ACAD SCI USA, V110, P1357, DOI 10.1073/pnas.1209905110; Wikswo JP, 2013, LAB CHIP, V13, P3496, DOI 10.1039/c3lc50243k; Wikswo JP, 2013, IEEE T BIO-MED ENG, V60, P682, DOI 10.1109/TBME.2013.2244891; Wilkening S, 2003, DRUG METAB DISPOS, V31, P1035, DOI 10.1124/dmd.31.8.1035; Wood DK, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3002738; Xiao RR, 2013, ANAL CHEM, V85, P7842, DOI 10.1021/ac4022055; Xu ZY, 2013, BIOMATERIALS, V34, P4109, DOI 10.1016/j.biomaterials.2013.02.045; Yang K, 2013, BIOMATERIALS, V34, P6607, DOI 10.1016/j.biomaterials.2013.05.067; Zervantonakis IK, 2012, P NATL ACAD SCI USA, V109, P13515, DOI 10.1073/pnas.1210182109; Zhang C, 2009, LAB CHIP, V9, P3185, DOI 10.1039/b915147h; Zhang WT, 2014, TISSUE ENG PART C-ME, V20, P663, DOI [10.1089/ten.TEC.2013.0490, 10.1089/ten.tec.2013.0490]; Zhang Y, 2011, INTEGR BIOL-UK, V3, P39, DOI 10.1039/c0ib00053a; Zhou MY, 2014, BIOMATERIALS, V35, P1390, DOI 10.1016/j.biomaterials.2013.10.070; Ziegler L, 2011, STEM CELL REV REP, V7, P394, DOI 10.1007/s12015-010-9198-2	156	1790	1844	100	1522	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156	1546-1696		NAT BIOTECHNOL	Nat. Biotechnol.	AUG	2014	32	8					760	772		10.1038/nbt.2989	http://dx.doi.org/10.1038/nbt.2989			13	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	AW7PF	25093883				2022-12-27	WOS:000346455900018
J	Cheloha, RW; Maeda, A; Dean, T; Gardella, TJ; Gellman, SH				Cheloha, Ross W.; Maeda, Akira; Dean, Thomas; Gardella, Thomas J.; Gellman, Samuel H.			Backbone modification of a polypeptide drug alters duration of action in vivo	NATURE BIOTECHNOLOGY			English	Article							ALPHA-HELIX MIMICRY; AMINO-ACID RESIDUES; PARATHYROID-HORMONE; RECEPTOR CONFORMATION; PROTEIN; PEPTIDES; ANALOGS; RECOGNITION; MECHANISM; CAMP	Systematic modification of the backbone of bioactive polypeptides through beta-amino acid residue incorporation could provide a strategy for generating molecules with improved drug properties, but such alterations can result in lower receptor affinity and potency. Using an agonist of parathyroid hormone receptor-1 (PTHR1), a G protein-coupled receptor in the B-family, we present an approach for alpha ->beta residue replacement that enables both high activity and improved pharmacokinetic properties in vivo.	[Cheloha, Ross W.; Gellman, Samuel H.] Univ Wisconsin, Dept Chem, Madison, WI 53706 USA; [Maeda, Akira; Dean, Thomas; Gardella, Thomas J.] Massachusetts Gen Hosp, Endocrine Unit, Boston, MA 02114 USA; [Maeda, Akira; Dean, Thomas; Gardella, Thomas J.] Harvard Univ, Sch Med, Boston, MA USA	University of Wisconsin System; University of Wisconsin Madison; Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School	Gardella, TJ (corresponding author), Massachusetts Gen Hosp, Endocrine Unit, Boston, MA 02114 USA.	gardella@helix.mgh.harvard.edu; gellman@chem.wisc.edu			US National Institutes of Health [GM056414, NIDDK-11794]; National Institutes of Health Biotechnology Training grant [T32 GM008349]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008349, R01GM056414] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institutes of Health Biotechnology Training grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This research was supported by the US National Institutes of Health (GM056414 (to S. H. G.) and NIDDK-11794 (to T.J.G.)). R. W. C. was supported in part by a National Institutes of Health Biotechnology Training grant (T32 GM008349).	Binkowski BF, 2011, ACS CHEM BIOL, V6, P1193, DOI 10.1021/cb200248h; Boersma MD, 2012, J AM CHEM SOC, V134, P315, DOI 10.1021/ja207148m; Chongsiriwatana NP, 2008, P NATL ACAD SCI USA, V105, P2794, DOI 10.1073/pnas.0708254105; Denton EV, 2013, ORG LETT, V15, P5318, DOI 10.1021/ol402568j; Feinstein TN, 2011, NAT CHEM BIOL, V7, P278, DOI 10.1038/nchembio.545; Hoare SRJ, 2001, J BIOL CHEM, V276, P7741, DOI 10.1074/jbc.M009395200; Horne WS, 2009, P NATL ACAD SCI USA, V106, P14751, DOI 10.1073/pnas.0902663106; Johnson LM, 2013, METHOD ENZYMOL, V523, P407, DOI 10.1016/B978-0-12-394292-0.00019-9; Kostenuik PJ, 2007, J BONE MINER RES, V22, P1534, DOI 10.1359/JBMR.070616; Okazaki M, 2008, P NATL ACAD SCI USA, V105, P16525, DOI 10.1073/pnas.0808750105; Peggion E, 2002, BIOCHEMISTRY-US, V41, P8162, DOI 10.1021/bi0200155; Pioszak AA, 2008, P NATL ACAD SCI USA, V105, P5034, DOI 10.1073/pnas.0801027105; Porter EA, 2000, NATURE, V404, P565, DOI 10.1038/35007145; Schievano E, 2003, BIOPOLYMERS, V70, P534, DOI 10.1002/bip.10508; Serada M, 2012, XENOBIOTICA, V42, P398, DOI 10.3109/00498254.2011.622811; Underwood CR, 2010, J BIOL CHEM, V285, P723, DOI 10.1074/jbc.M109.033829; UZAWA T, 1995, BONE, V16, P477; Vilardaga JP, 2011, CELL MOL LIFE SCI, V68, P1, DOI 10.1007/s00018-010-0465-9; WADE D, 1990, P NATL ACAD SCI USA, V87, P4761, DOI 10.1073/pnas.87.12.4761; Winer KK, 2008, J CLIN ENDOCR METAB, V93, P3389, DOI 10.1210/jc.2007-2552	20	86	88	1	64	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156	1546-1696		NAT BIOTECHNOL	Nat. Biotechnol.	JUL	2014	32	7					653	+		10.1038/nbt.2920	http://dx.doi.org/10.1038/nbt.2920			4	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	AK8VE	24929976	Green Accepted			2022-12-27	WOS:000338705900030
J	Korkmaz, G; Lopes, R; Ugalde, AP; Nevedomskaya, E; Han, RQ; Myacheva, K; Zwart, W; Elkon, R; Agami, R				Korkmaz, Gozde; Lopes, Rui; Ugalde, Alejandro P.; Nevedomskaya, Ekaterina; Han, Ruiqi; Myacheva, Ksenia; Zwart, Wilbert; Elkon, Ran; Agami, Reuven			Functional genetic screens for enhancer elements in the human genome using CRISPR-Cas9	NATURE BIOTECHNOLOGY			English	Article							HUMAN-CELLS; BREAST-CANCER; P53; TRANSCRIPTION; MECHANISMS; ALIGNMENT; THERAPY; BINDING; CAS9; RNAS	Systematic identification of noncoding regulatory elements has, to date, mainly relied on large-scale reporter assays that do not reproduce endogenous conditions. We present two distinct CRISPR-Cas9 genetic screens to identify and characterize functional enhancers in their native context. Our strategy is to target Cas9 to transcription factor binding sites in enhancer regions. We identified several functional enhancer elements and characterized the role of two of them in mediating p53 (TP53) and ERa (ESR1) gene regulation. Moreover, we show that a genomic CRISPR-Cas9 tiling screen can precisely map functional domains within enhancer elements. Our approach expands the utility of CRISPR-Cas9 to elucidate the functions of the noncoding genome	[Korkmaz, Gozde; Lopes, Rui; Ugalde, Alejandro P.; Han, Ruiqi; Myacheva, Ksenia; Elkon, Ran; Agami, Reuven] Netherlands Canc Inst, Div Biol Stress Response, Amsterdam, Netherlands; [Nevedomskaya, Ekaterina; Zwart, Wilbert] Netherlands Canc Inst, Div Mol Pathol, Amsterdam, Netherlands; [Agami, Reuven] Rotterdam Univ, Erasmus MC, Rotterdam, Netherlands	Netherlands Cancer Institute; Netherlands Cancer Institute; Erasmus University Rotterdam; Erasmus MC	Elkon, R; Agami, R (corresponding author), Netherlands Canc Inst, Div Biol Stress Response, Amsterdam, Netherlands.; Agami, R (corresponding author), Rotterdam Univ, Erasmus MC, Rotterdam, Netherlands.	r.elkon@nki.nl; r.agami@nki.nl	Korkmaz, Gozde/A-1456-2015; agami, reuven/GOG-8289-2022; Pineiro-Ugalde, Alejandro/AAB-5229-2020	Korkmaz, Gozde/0000-0002-3574-1015; Pineiro-Ugalde, Alejandro/0000-0003-2522-0627; Agami, Reuven/0000-0002-2848-2473; Zwart, Wilbert/0000-0002-9823-7289	Human Frontier Science Program [LT000640/2013]; NWO [NGI 93512001/2012]; enhReg ERC-AdV	Human Frontier Science Program(Human Frontier Science Program); NWO(Netherlands Organization for Scientific Research (NWO)); enhReg ERC-AdV	We would like to acknowledge K. Rooijers for help in bioinformatic analyses, insightful ideas and critical discussions. We thank W. de Laat, P. Krijger, B. Evers, M. Amendola and R. Maia for reagents and technical assistance. We also thank all members of the Agami group for helpful discussions. And we thank F. Zhang (MIT) for the gift of plasmid vector lentiCRISPRv2 and D. Root (MIT) for pLX304-GFP. R.L. is a fellow of the Fundacao para a Ciencia e Tecnologia de Portugal (SFRH/BD/74476/2010; POPH/FSE). This work was supported by funds of The Human Frontier Science Program (LT000640/2013) to A.P.U., and enhReg ERC-AdV and NWO (NGI 93512001/2012) to R.A.	Agami R, 2000, CELL, V102, P55, DOI 10.1016/S0092-8674(00)00010-6; Anders S, 2015, BIOINFORMATICS, V31, P166, DOI 10.1093/bioinformatics/btu638; Arnold A, 2005, J CLIN ONCOL, V23, P4215, DOI 10.1200/JCO.2005.05.064; Beelen K, 2012, NAT REV CLIN ONCOL, V9, P529, DOI 10.1038/nrclinonc.2012.121; Botcheva K, 2011, CELL CYCLE, V10, P4237, DOI 10.4161/cc.10.24.18383; Canver MC, 2015, NATURE, V527, P192, DOI 10.1038/nature15521; Cho SW, 2013, NAT BIOTECHNOL, V31, P230, DOI 10.1038/nbt.2507; Cunningham F, 2015, NUCLEIC ACIDS RES, V43, pD662, DOI 10.1093/nar/gku1010; Drost J, 2010, NAT CELL BIOL, V12, P380, DOI 10.1038/ncb2038; ELDEIRY WS, 1993, CELL, V75, P817, DOI 10.1016/0092-8674(93)90500-P; Fullwood MJ, 2009, NATURE, V462, P58, DOI 10.1038/nature08497; Kearns NA, 2015, NAT METHODS, V12, P401, DOI 10.1038/nmeth.3325; Kim D, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-4-r36; Kim TK, 2010, NATURE, V465, P182, DOI 10.1038/nature09033; Kleinstiver BP, 2015, NATURE, V523, P481, DOI 10.1038/nature14592; Kumar V, 2013, NAT BIOTECHNOL, V31, P615, DOI 10.1038/nbt.2596; Langmead B, 2012, NAT METHODS, V9, P357, DOI [10.1038/NMETH.1923, 10.1038/nmeth.1923]; Leveille N, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7520; Li WB, 2013, NATURE, V498, P516, DOI 10.1038/nature12210; Mali P, 2013, SCIENCE, V339, P823, DOI 10.1126/science.1232033; Mansour MR, 2014, SCIENCE, V346, P1373, DOI 10.1126/science.1259037; Melo CA, 2013, MOL CELL, V49, P524, DOI 10.1016/j.molcel.2012.11.021; Messeguer X, 2002, BIOINFORMATICS, V18, P333, DOI 10.1093/bioinformatics/18.2.333; Muller PAJ, 2013, NAT CELL BIOL, V15, P2, DOI 10.1038/ncb2641; Rashi-Elkeles S, 2014, SCI SIGNAL, V7, DOI 10.1126/scisignal.2005032; Ross-Innes CS, 2012, NATURE, V481, P389, DOI 10.1038/nature10730; Sanjana NE, 2014, NAT METHODS, V11, P783, DOI 10.1038/nmeth.3047; Schmitt CA, 2002, CELL, V109, P335, DOI 10.1016/S0092-8674(02)00734-1; Sexton T, 2015, CELL, V160, P1049, DOI 10.1016/j.cell.2015.02.040; Shalem O, 2014, SCIENCE, V343, P84, DOI 10.1126/science.1247005; Shi JW, 2014, MOL CELL, V54, P728, DOI 10.1016/j.molcel.2014.05.016; Sigoillot FD, 2011, ACS CHEM BIOL, V6, P47, DOI 10.1021/cb100358f; Smeenk L, 2008, NUCLEIC ACIDS RES, V36, P3639, DOI 10.1093/nar/gkn232; Vahedi G, 2015, NATURE, V520, P558, DOI 10.1038/nature14154; Voorhoeve PM, 2006, CELL, V124, P1169, DOI 10.1016/j.cell.2006.02.037; Wang T, 2014, SCIENCE, V343, P80, DOI 10.1126/science.1246981; Yang XP, 2011, NAT METHODS, V8, P659, DOI [10.1038/NMETH.1638, 10.1038/nmeth.1638]; Zhang Y, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-9-r137	38	259	276	6	140	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156	1546-1696		NAT BIOTECHNOL	Nat. Biotechnol.	FEB	2016	34	2					192	+		10.1038/nbt.3450	http://dx.doi.org/10.1038/nbt.3450			10	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	DD0OK	26751173				2022-12-27	WOS:000369619100022
J	Jarchum, I				Jarchum, Irene			Getting rid of PERVs	NATURE BIOTECHNOLOGY			English	Editorial Material																		Oldmixon BA, 2002, J VIROL, V76, P3045, DOI 10.1128/JVI.76.6.3045-3048.2002; Wang HY, 2013, CELL, V153, P910, DOI 10.1016/j.cell.2013.04.025; Yang LH, 2015, SCIENCE, V350, P1101, DOI 10.1126/science.aad1191	3	3	4	1	12	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156	1546-1696		NAT BIOTECHNOL	Nat. Biotechnol.	JAN	2016	34	1					46	46		10.1038/nbt.3448	http://dx.doi.org/10.1038/nbt.3448			1	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	DB8HQ	26744982	Bronze			2022-12-27	WOS:000368758200025
J	DeFrancesco, L				DeFrancesco, Laura			Drug pipeline: 3Q15	NATURE BIOTECHNOLOGY			English	Editorial Material																			0	0	0	0	1	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156	1546-1696		NAT BIOTECHNOL	Nat. Biotechnol.	NOV	2015	33	11					1126	1126		10.1038/nbt.3405	http://dx.doi.org/10.1038/nbt.3405			1	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	VC0TM	26544135				2022-12-27	WOS:000427300600001
J	Szalay, T; Golovchenko, JA				Szalay, Tamas; Golovchenko, Jene A.			De novo sequencing and variant calling with nanopores using PoreSeq	NATURE BIOTECHNOLOGY			English	Article							INDIVIDUAL DNA STRANDS; SINGLE; POLYMERASE; ALGORITHM; MOLECULES; READS	The accuracy of sequencing single DNA molecules with nanopores is continually improving, but de novo genome sequencing and assembly using only nanopore data remain challenging. Here we describe PoreSeq, an algorithm that identifies and corrects errors in nanopore sequencing data and improves the accuracy of de novo genome assembly with increasing coverage depth. The approach relies on modeling the possible sources of uncertainty that occur as DNA transits through the nanopore and finds the sequence that best explains multiple reads of the same region. PoreSeq increases nanopore sequencing read accuracy of M13 bacteriophage DNA from 85% to 99% at 100x coverage. We also use the algorithm to assemble Escherichia coli with 30x coverage and the lambda genome at a range of coverages from 3x to 50x. Additionally, we classify sequence variants at an order of magnitude lower coverage than is possible with existing methods.	[Szalay, Tamas; Golovchenko, Jene A.] Harvard Univ, Sch Engn & Appl Sci, Cambridge, MA 02138 USA; [Golovchenko, Jene A.] Harvard Univ, Dept Phys, Cambridge, MA 02138 USA	Harvard University; Harvard University	Golovchenko, JA (corresponding author), Harvard Univ, Sch Engn & Appl Sci, Cambridge, MA 02138 USA.	golovchenko@physics.harvard.edu		Szalay, Tamas/0000-0002-6539-7497	National Institutes of Health [R01HG003703]; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R01HG003703] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))	We would like to thank E. Brandin for molecule preparation, D. Branton for obtaining MinION sequencers, S. Fleming for helpful algorithmic discussions and Figure 1a, and A. Kuan and M. Burns for feedback on this manuscript. The computations in this paper were run on the Odyssey cluster supported by the Faculty of Arts and Sciences Division of Science, Research Computing Group at Harvard University, and the work was supported by the National Institutes of Health Award no. R01HG003703 to J.A. Golovchenko and D. Branton.	Ashton PM, 2015, NAT BIOTECHNOL, V33, P296, DOI 10.1038/nbt.3103; Bayley H, 2015, CLIN CHEM, V61, P25, DOI 10.1373/clinchem.2014.223016; Bellman R., 1957, DYNAMIC PROGRAMMING; Brudno M, 2002, CSB2002: IEEE COMPUTER SOCIETY BIOINFORMATICS CONFERENCE, P138, DOI 10.1109/CSB.2002.1039337; Butler TZ, 2008, P NATL ACAD SCI USA, V105, P20647, DOI 10.1073/pnas.0807514106; Cherf GM, 2012, NAT BIOTECHNOL, V30, P344, DOI 10.1038/nbt.2147; Chin CS, 2013, NAT METHODS, V10, P563, DOI [10.1038/NMETH.2474, 10.1038/nmeth.2474]; Gollnick B, 2015, SMALL, V11, P1273, DOI 10.1002/smll.201402686; Gotoh O, 1996, J MOL BIOL, V264, P823, DOI 10.1006/jmbi.1996.0679; Howorka S, 2001, NAT BIOTECHNOL, V19, P636, DOI 10.1038/90236; Jain M, 2015, NAT METHODS, V12, P351, DOI [10.1038/NMETH.3290, 10.1038/nmeth.3290]; Koren S, 2012, NAT BIOTECHNOL, V30, P692, DOI 10.1038/nbt.2280; Kurtz S, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-2-r12; Laszlo AH, 2014, NAT BIOTECHNOL, V32, P829, DOI 10.1038/nbt.2950; Lieberman KR, 2010, J AM CHEM SOC, V132, P17961, DOI 10.1021/ja1087612; Loman NJ, 2015, NAT METHODS, V12, P733, DOI [10.1038/NMETH.3444, 10.1038/nmeth.3444]; Loman NJ, 2014, BIOINFORMATICS, V30, P3399, DOI 10.1093/bioinformatics/btu555; Maglia G, 2008, P NATL ACAD SCI USA, V105, P19720, DOI 10.1073/pnas.0808296105; Manrao EA, 2012, NAT BIOTECHNOL, V30, P349, DOI 10.1038/nbt.2171; Manrao EA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025723; Quick J, 2014, GIGASCIENCE, V3, DOI 10.1186/2047-217X-3-22; Sachidanandam R, 2001, NATURE, V409, P928, DOI 10.1038/35057149; Schreiber J, 2013, P NATL ACAD SCI USA, V110, P18910, DOI 10.1073/pnas.1310615110; SMITH TF, 1981, J MOL BIOL, V147, P195, DOI 10.1016/0022-2836(81)90087-5; Timp W, 2012, BIOPHYS J, V102, pL37, DOI 10.1016/j.bpj.2012.04.009; Vintsyuk T. K, 1972, CYBERNETICS, V4, P52; VITERBI AJ, 1967, IEEE T INFORM THEORY, V13, P260, DOI 10.1109/TIT.1967.1054010; Wescoe ZL, 2014, J AM CHEM SOC, V136, P16582, DOI 10.1021/ja508527b	28	60	62	0	23	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156	1546-1696		NAT BIOTECHNOL	Nat. Biotechnol.	OCT	2015	33	10					1087	+		10.1038/nbt.3360	http://dx.doi.org/10.1038/nbt.3360			7	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	CT1JX	26352647	Green Accepted, Green Published, Green Submitted			2022-12-27	WOS:000362555700029
J	Birket, MJ; Ribeiro, MC; Verkerk, AO; Ward, D; Leitoguinho, AR; den Hartogh, SC; Orlova, VV; Devalla, HD; Schwach, V; Bellin, M; Passier, R; Mummery, CL				Birket, Matthew J.; Ribeiro, Marcelo C.; Verkerk, Arie O.; Ward, Dorien; Leitoguinho, Ana Rita; den Hartogh, Sabine C.; Orlova, Valeria V.; Devalla, Harsha D.; Schwach, Verena; Bellin, Milena; Passier, Robert; Mummery, Christine L.			Expansion and patterning of cardiovascular progenitors derived from human pluripotent stem cells	NATURE BIOTECHNOLOGY			English	Article							SECONDARY HEART FIELD; SMOOTH-MUSCLE; CARDIAC DIFFERENTIATION; ZEBRAFISH HEART; BMP; CARDIOMYOCYTE; INDUCTION; MOUSE; POPULATION; LINEAGES	The inability of multipotent cardiovascular progenitor cells (CPCs) to undergo multiple divisions in culture has precluded stable expansion of precursors of cardiomyocytes and vascular cells. This contrasts with neural progenitors, which can be expanded robustly and are a renewable source of their derivatives. Here we use human pluripotent stem cells bearing a cardiac lineage reporter to show that regulated MYC expression enables robust expansion of CPCs with insulin-like growth factor-1 (IGF-1) and a hedgehog pathway agonist. The CPCs can be patterned with morphogens, recreating features of heart field assignment, and controllably differentiated to relatively pure populations of pacemaker-like or ventricular-like cardiomyocytes. The cells are clonogenic and can be expanded for >40 population doublings while retaining the ability to differentiate into cardiomyocytes and vascular cells. Access to CPCs will allow precise recreation of elements of heart development in vitro and facilitate investigation of the molecular basis of cardiac fate determination. This technology is applicable for cardiac disease modeling, toxicology studies and tissue engineering.	[Birket, Matthew J.; Ribeiro, Marcelo C.; Ward, Dorien; Leitoguinho, Ana Rita; den Hartogh, Sabine C.; Orlova, Valeria V.; Devalla, Harsha D.; Schwach, Verena; Bellin, Milena; Passier, Robert; Mummery, Christine L.] Leiden Univ, Med Ctr, Leiden, Netherlands; [Verkerk, Arie O.] Amsterdam Med Ctr, Amsterdam, Netherlands	Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; University of Amsterdam; Academic Medical Center Amsterdam	Mummery, CL (corresponding author), Leiden Univ, Med Ctr, Leiden, Netherlands.	c.l.mummery@lumc.nl	Bellin, Milena/M-2311-2014; Devalla, Harsha D./GRF-0685-2022; Orlova, Valeria V/C-6065-2014; Birket, Matthew/P-1704-2017	Bellin, Milena/0000-0001-5380-6743; Devalla, Harsha D./0000-0001-5343-1021; Orlova, Valeria V/0000-0002-1169-2802; Verkerk, Arie/0000-0003-2140-834X; Birket, Matthew/0000-0002-5985-6626; Mummery, Christine/0000-0002-4549-6535; Catarino Ribeiro, Marcelo/0000-0003-0583-7443	Cardiovascular Research Netherlands (CVON HUSTCARE); Netherlands Institute of Regenerative Medicine (NIRM); European Research Council (ERCAdG) [323182]; Netherlands Organization for Scientific Research (NWO-FOM FOM) [09MMC02]; etherlands Organization for Scientific Research [ZonMW-TOP 40-00812-98-12086, ZonMW-MKMD 40-42600-98-036]; Rembrandt Institute of Cardiovascular Science; European Community [602423]; National Centre for the Replacement [NC/C013202/1, NC/C013105/1] Funding Source: researchfish	Cardiovascular Research Netherlands (CVON HUSTCARE); Netherlands Institute of Regenerative Medicine (NIRM); European Research Council (ERCAdG)(European Research Council (ERC)); Netherlands Organization for Scientific Research (NWO-FOM FOM); etherlands Organization for Scientific Research; Rembrandt Institute of Cardiovascular Science; European Community(European Commission); National Centre for the Replacement	We acknowledge the contributions of I. Marcuccio and S. Casini. Work in C.L.M.'s lab is supported by Cardiovascular Research Netherlands (CVON HUSTCARE), The Netherlands Institute of Regenerative Medicine (NIRM), the European Research Council (ERCAdG 323182 STEMCARDIOVASC) and The Netherlands Organization for Scientific Research (NWO-FOM FOM 09MMC02). Work in R.P.'s lab is supported by the Netherlands Organization for Scientific Research (ZonMW-TOP 40-00812-98-12086 and ZonMW-MKMD 40-42600-98-036) and the Rembrandt Institute of Cardiovascular Science. V.V.O. was supported by the European Community's Seventh Framework Programme (FP7/2007-2013) grant agreement 602423.	Ardehali R, 2013, P NATL ACAD SCI USA, V110, P3405, DOI 10.1073/pnas.1220832110; Barron M, 2000, DEV DYNAM, V218, P383, DOI 10.1002/(SICI)1097-0177(200006)218:2<383::AID-DVDY11>3.0.CO;2-P; Bellin M, 2013, EMBO J, V32, P3161, DOI 10.1038/emboj.2013.240; Bhave M, 2014, ONCOLOGY-NY, V28, P482; Birket MJ, 2015, DEV BIOL, V400, P169, DOI 10.1016/j.ydbio.2015.01.012; Birket MJ, 2013, STEM CELL REP, V1, P560, DOI 10.1016/j.stemcr.2013.11.008; Bu L, 2009, NATURE, V460, P113, DOI 10.1038/nature08191; Cai CL, 2003, DEV CELL, V5, P877, DOI 10.1016/S1534-5807(03)00363-0; Cai WQ, 2013, GENE DEV, V27, P2332, DOI 10.1101/gad.225144.113; de Pater E, 2012, CIRC RES, V110, P578, DOI 10.1161/CIRCRESAHA.111.261172; Den Hartogh SC, 2015, STEM CELLS, V33, P56, DOI 10.1002/stem.1842; Devalla HD, 2015, EMBO MOL MED, V7, P394, DOI 10.15252/emmm.201404757; Domian IJ, 2009, SCIENCE, V326, P426, DOI 10.1126/science.1177350; Drawnel FM, 2014, CELL REP, V9, P810, DOI 10.1016/j.celrep.2014.09.055; Dyer LA, 2010, DEV BIOL, V348, P167, DOI 10.1016/j.ydbio.2010.09.021; Elliott DA, 2011, NAT METHODS, V8, P1037, DOI [10.1038/NMETH.1740, 10.1038/nmeth.1740]; Goumans MJ, 2008, STEM CELL RES, V1, P138, DOI 10.1016/j.scr.2008.02.003; Groot ACGD, 2007, ANAT REC, V290, P115, DOI 10.1002/ar.20406; Gude N, 2006, CIRC RES, V99, P381, DOI 10.1161/01.RES.0000236754.21499.1c; Hao J, 2010, ACS CHEM BIOL, V5, P245, DOI 10.1021/cb9002865; Inman GJ, 2002, MOL PHARMACOL, V62, P65, DOI 10.1124/mol.62.1.65; JACKSON T, 1990, MOL CELL BIOL, V10, P3709, DOI 10.1128/MCB.10.7.3709; James D, 2010, NAT BIOTECHNOL, V28, P161, DOI 10.1038/nbt.1605; Kattman SJ, 2006, DEV CELL, V11, P723, DOI 10.1016/j.devcel.2006.10.002; Kattman SJ, 2011, CELL STEM CELL, V8, P228, DOI 10.1016/j.stem.2010.12.008; Keren-Politansky A, 2009, DEV BIOL, V335, P374, DOI 10.1016/j.ydbio.2009.09.012; Laugwitz KL, 2005, NATURE, V433, P647, DOI 10.1038/nature03215; Liang XQ, 2013, CIRC RES, V113, P399, DOI 10.1161/CIRCRESAHA.113.301588; Liberatore CM, 2002, DEV BIOL, V244, P243, DOI 10.1006/dbio.2002.0604; LINTS TJ, 1993, DEVELOPMENT, V119, P419; Lundy Scott D, 2014, Curr Treat Options Cardiovasc Med, V16, P319, DOI 10.1007/s11936-014-0319-0; Ma Q, 2008, DEV BIOL, V323, P98, DOI 10.1016/j.ydbio.2008.08.013; Maherali N, 2008, CELL STEM CELL, V3, P340, DOI 10.1016/j.stem.2008.08.003; Marques SR, 2008, DEV BIOL, V321, P397, DOI 10.1016/j.ydbio.2008.06.033; Matsa E, 2014, SCI TRANSL MED, V6, DOI 10.1126/scitranslmed.3008921; MIANO JM, 1994, CIRC RES, V75, P803, DOI 10.1161/01.RES.75.5.803; Milgrom-Hoffman M, 2011, DEVELOPMENT, V138, P4777, DOI 10.1242/dev.061192; Mommersteeg MTM, 2007, CIRC RES, V100, P354, DOI 10.1161/01.RES.0000258019.74591.b3; Moretti A, 2006, CELL, V127, P1151, DOI 10.1016/j.cell.2006.10.029; Moretti A, 2010, FASEB J, V24, P700, DOI 10.1096/fj.09-139477; Noseda M, 2011, CIRC RES, V108, P129, DOI 10.1161/CIRCRESAHA.110.223792; Qyang Y, 2007, CELL STEM CELL, V1, P165, DOI 10.1016/j.stem.2007.05.018; Rape AD, 2011, BIOMATERIALS, V32, P2043, DOI 10.1016/j.biomaterials.2010.11.044; Reifers F, 2000, DEVELOPMENT, V127, P225; Schultheiss TM, 1997, GENE DEV, V11, P451, DOI 10.1101/gad.11.4.451; Spaeter D, 2013, NAT CELL BIOL, V15, P1098, DOI 10.1038/ncb2824; Ueno S, 2007, P NATL ACAD SCI USA, V104, P9685, DOI 10.1073/pnas.0702859104; van Berlo JH, 2014, NATURE, V509, P337, DOI 10.1038/nature13309; Verkerk AO, 2009, INT J CARDIOL, V132, P318, DOI 10.1016/j.ijcard.2008.12.196; Vincent SD, 2010, CURR TOP DEV BIOL, V90, P1, DOI 10.1016/S0070-2153(10)90001-X; Waldo KL, 2001, DEVELOPMENT, V128, P3179; Wierstra I, 2008, ADV CANCER RES, V99, P113, DOI 10.1016/S0065-230X(07)99004-1; Wiese C, 2009, CIRC RES, V104, P388, DOI 10.1161/CIRCRESAHA.108.187062; Wu SM, 2006, CELL, V127, P1137, DOI 10.1016/j.cell.2006.10.028; Xi JY, 2010, FASEB J, V24, P2739, DOI 10.1096/fj.09-145177; Yang L, 2008, NATURE, V453, P524, DOI 10.1038/nature06894; Zhang QZ, 2011, CELL RES, V21, P579, DOI 10.1038/cr.2010.163	57	133	142	0	41	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156	1546-1696		NAT BIOTECHNOL	Nat. Biotechnol.	SEP	2015	33	9					970	U219		10.1038/nbt.3271	http://dx.doi.org/10.1038/nbt.3271			12	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	CR0EK	26192318				2022-12-27	WOS:000360990900025
J	Gupta, PK; Choudhary, B; Gheysen, G				Gupta, Pushpendra Kumar; Choudhary, Bhagirath; Gheysen, Godelieve			Removing Bt eggplant from the face of Indian regulators	NATURE BIOTECHNOLOGY			English	Letter							CROPS		[Gupta, Pushpendra Kumar] Chaudhary Charan Singh Univ, Dept Genet & Plant Breeding, Meerut, Uttar Pradesh, India; [Choudhary, Bhagirath; Gheysen, Godelieve] Univ Ghent, Fac Biosci Engn, Dept Mol Biotechnol, B-9000 Ghent, Belgium; [Choudhary, Bhagirath; Gheysen, Godelieve] Univ Ghent, Inst Plant Biotechnol Outreach, B-9000 Ghent, Belgium	Chaudhary Charan Singh University; Ghent University; Ghent University	Gupta, PK (corresponding author), Chaudhary Charan Singh Univ, Dept Genet & Plant Breeding, Meerut, Uttar Pradesh, India.	b.choudhary@cgiar.org						Alberts B, 2013, SCIENCE, V341, P1320, DOI 10.1126/science.1245017; [Anonymous], 2014, INDIAN EXPRESS; [Anonymous], 2010, HINDU; [Anonymous], BUSINESS STANDA 0811; Bagla P, 2012, SCIENCE, V337, P789, DOI 10.1126/science.337.6096.789; Bagla P, 2010, SCIENCE, V327, P767, DOI 10.1126/science.327.5967.767; Barik S., 2010, HINDU; Choudhary B, 2014, PLANT BIOTECHNOL J, V12, P135, DOI 10.1111/pbi.12155; Genetic Engineering Approval Committee, 2009, 97 M GEN ENG APPR CO; Indian Academy of Sciences, 2010, INT REP GM CROPS; Kumar S, 2015, NATURE, V521, P138, DOI 10.1038/521138a; Kurmanath K. V., 2013, HINDU BUSINESS  0606; Mendelsohn M, 2003, NAT BIOTECHNOL, V21, P1003, DOI 10.1038/nbt0903-1003; Ministry of Environment and Forests, 2011, CIT CLIENTS CHART 20; Ministry of Environment and Forests, 2006, 1533 GOV IND MIN ENV; Ministry of Environment and Forests, 2010, DEC COMM BT BRINJ; Seralini GE, 2012, FOOD CHEM TOXICOL, V50, P4221, DOI 10.1016/j.fct.2012.08.005; Shantharam S, 2010, CURR SCI INDIA, V98, P996; Shetty P., 2010, NATURE NEWS BLOG; Shiva Vandana, 2006, SEEDS SUICIDE ECOLOG	20	6	6	1	16	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156	1546-1696		NAT BIOTECHNOL	Nat. Biotechnol.	SEP	2015	33	9					904	907		10.1038/nbt.3331	http://dx.doi.org/10.1038/nbt.3331			5	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	CR0EK	26348953				2022-12-27	WOS:000360990900011
J	Tagliabue, G				Tagliabue, Giovanni			The nonsensical GMO pseudo-category and a precautionary rabbit hole	NATURE BIOTECHNOLOGY			English	Letter												giovanni.tagliabue@uniedi.com		Molteni Tagliabue, Giovanni/0000-0001-7115-0936				Convention on Biological Diversity, 2000, CONV BIOL DIV MONTR; European Commission, 2000, COMMUNICATION; Taleb NN, 2014, PRECAUTIONARY PRINCI; UN, 1992, UN C ENV DEV ANN 1 R	4	13	13	1	17	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156	1546-1696		NAT BIOTECHNOL	Nat. Biotechnol.	SEP	2015	33	9					907	908		10.1038/nbt.3333	http://dx.doi.org/10.1038/nbt.3333			3	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	CR0EK	26348954				2022-12-27	WOS:000360990900012
J	Brower, V				Brower, Vicki			NCI-MATCH pairs tumor mutations with matching drugs	NATURE BIOTECHNOLOGY			English	News Item							MEDICINE											2014, NAT REV DRUG DISC, V13, P407; 2014, NAT BIOTECHNOL, V32, P116; 2015, NAT BIOTECHNOL, V33, P325; 2014, NAT BIOTECHNOL, V32, P117	4	29	30	0	2	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156	1546-1696		NAT BIOTECHNOL	Nat. Biotechnol.	AUG	2015	33	8					790	791		10.1038/nbt0815-790	http://dx.doi.org/10.1038/nbt0815-790			2	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	CO6OB	26252121				2022-12-27	WOS:000359274900006
J	Yang, W				Yang, Walter			2Q15-Running of the biotech bulls	NATURE BIOTECHNOLOGY			English	Editorial Material									[Yang, Walter] BioCentury, Redwood City, CA 94065 USA		Yang, W (corresponding author), BioCentury, Redwood City, CA 94065 USA.								0	0	0	0	1	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156	1546-1696		NAT BIOTECHNOL	Nat. Biotechnol.	AUG	2015	33	8					794	794		10.1038/nbt.3311	http://dx.doi.org/10.1038/nbt.3311			1	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	VC0UT	26252128				2022-12-27	WOS:000427505100001
J	Garber, K				Garber, Ken			Drugging the gut microbiome	NATURE BIOTECHNOLOGY			English	Editorial Material							METABOLISM; DISEASE											Atarashi K, 2013, NATURE, V500, P232, DOI 10.1038/nature12331; Chang PV, 2014, P NATL ACAD SCI USA, V111, P2247, DOI 10.1073/pnas.1322269111; Donia MS, 2014, CELL, V158, P1402, DOI 10.1016/j.cell.2014.08.032; Hsiao EY, 2013, CELL, V155, P1451, DOI 10.1016/j.cell.2013.11.024; Mazmanian SK, 2005, CELL, V122, P107, DOI 10.1016/j.cell.2005.05.007; Trompette A, 2014, NAT MED, V20, P159, DOI 10.1038/nm.3444; van Nood E, 2013, NEW ENGL J MED, V368, P407, DOI 10.1056/NEJMoa1205037; Wang ZN, 2011, NATURE, V472, P57, DOI 10.1038/nature09922; Yoshimoto S, 2013, NATURE, V499, P97, DOI 10.1038/nature12347	9	37	41	0	43	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156	1546-1696		NAT BIOTECHNOL	Nat. Biotechnol.	MAR	2015	33	3					228	231		10.1038/nbt.3161	http://dx.doi.org/10.1038/nbt.3161			4	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	CD0ME	25748907				2022-12-27	WOS:000350766900012
J	Frock, RL; Hu, JZ; Meyers, RM; Ho, YJ; Kii, E; Alt, FW				Frock, Richard L.; Hu, Jiazhi; Meyers, Robin M.; Ho, Yu-Jui; Kii, Erina; Alt, Frederick W.			Genome-wide detection of DNA double-stranded breaks induced by engineered nucleases	NATURE BIOTECHNOLOGY			English	Article							RECURRENT CHROMOSOMAL TRANSLOCATIONS; SEQUENCING REVEALS; B-LYMPHOCYTES; CAS SYSTEMS; SPECIFICITY; INSTABILITY; MECHANISMS; CLEAVAGE; TALENS; CELLS	Although great progress has been made in the characterization of the off-target effects of engineered nucleases, sensitive and unbiased genome-wide methods for the detection of off-target cleavage events and potential collateral damage are still lacking. Here we describe a linear amplification-mediated modification of a previously published high-throughput, genome-wide, translocation sequencing (HTGTS) method that robustly detects DNA double-stranded breaks (DSBs) generated by engineered nucleases across the human genome based on their translocation to other endogenous or ectopic DSBs. HTGTS with different Cas9:sgRNA or TALEN nucleases revealed off-target hotspot numbers for given nucleases that ranged from a few or none to dozens or more, and extended the number of known off-targets for certain previously characterized nucleases more than tenfold. We also identified translocations between bona fide nuclease targets on homologous chromosomes, an undesired collateral effect that has not been described previously. Finally, HTGTS confirmed that the, Cas9D10A paired nickase approach suppresses off-target cleavage genome-wide.	[Frock, Richard L.; Hu, Jiazhi; Meyers, Robin M.; Ho, Yu-Jui; Kii, Erina; Alt, Frederick W.] Boston Childrens Hosp, Program Cellular & Mol Med, Boston, MA 02115 USA; [Frock, Richard L.; Hu, Jiazhi; Meyers, Robin M.; Ho, Yu-Jui; Kii, Erina; Alt, Frederick W.] Harvard Univ, Sch Med, Dept Genet, Boston, MA USA; [Frock, Richard L.; Hu, Jiazhi; Meyers, Robin M.; Ho, Yu-Jui; Kii, Erina; Alt, Frederick W.] Howard Hughes Med Inst, Boston, MA 02115 USA	Harvard University; Boston Children's Hospital; Program in Cellular & Molecular Medicine (PCMM); Harvard University; Harvard Medical School; Howard Hughes Medical Institute	Alt, FW (corresponding author), Boston Childrens Hosp, Program Cellular & Mol Med, Boston, MA 02115 USA.	alt@enders.tch.harvard.edu	Frock, Richard/I-6934-2019; Wilson, Matthew H/K-3193-2013	Frock, Richard/0000-0001-6963-4931; Hu, Jiazhi/0000-0002-6345-0039; Meyers, Robin/0000-0002-1802-7231; Ho, Yu-jui/0000-0002-7540-024X	National Institutes of Health [P01CA109901, P01AI076210, NRSA T32CA070083]; National Health Institutes of Health [NRSA T32AI007512]; Robertson Foundation/Cancer Research Institute Irvington Fellowship; NATIONAL CANCER INSTITUTE [P01CA109901, T32CA070083] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [T32AI007512, P01AI076210] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Health Institutes of Health; Robertson Foundation/Cancer Research Institute Irvington Fellowship; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work is supported by the National Institutes of Health Grants P01CA109901 and P01AI076210. R.L.F. was supported by the National Institutes of Health NRSA T32CA070083 and is supported by the National Health Institutes of Health NRSA T32AI007512. J.H. is supported by Robertson Foundation/Cancer Research Institute Irvington Fellowship. F.W.A. is an investigator of the Howard Hughes Medical Institute. A549 cells were provided by David Weinstock (Dana-Farber Cancer Institute).	Alt FW, 2013, CELL, V152, P417, DOI 10.1016/j.cell.2013.01.007; Asaithamby A, 2009, NUCLEIC ACIDS RES, V37, P3912, DOI 10.1093/nar/gkp237; Barlow JH, 2013, CELL, V152, P620, DOI 10.1016/j.cell.2013.01.006; Chiarle R, 2011, CELL, V147, P107, DOI 10.1016/j.cell.2011.07.049; Christian M, 2010, GENETICS, V186, P757, DOI 10.1534/genetics.110.120717; Cong L, 2013, SCIENCE, V339, P819, DOI 10.1126/science.1231143; Doyle EL, 2012, NUCLEIC ACIDS RES, V40, pW117, DOI 10.1093/nar/gks608; Franco S, 2006, MOL CELL, V21, P201, DOI 10.1016/j.molcel.2006.01.005; Fu YF, 2013, NAT BIOTECHNOL, V31, P822, DOI 10.1038/nbt.2623; Gabriel R, 2011, NAT BIOTECHNOL, V29, P816, DOI 10.1038/nbt.1948; Gostissa M, 2014, P NATL ACAD SCI USA, V111, P2644, DOI 10.1073/pnas.1324176111; Guilinger JP, 2014, NAT METHODS, V11, P429, DOI 10.1038/nmeth.2845; Hakim O, 2012, NATURE, V484, P69, DOI 10.1038/nature10909; Hastings PJ, 2009, NAT REV GENET, V10, P551, DOI 10.1038/nrg2593; Hsu PD, 2013, NAT BIOTECHNOL, V31, P827, DOI 10.1038/nbt.2647; Hu JZ, 2014, P NATL ACAD SCI USA, V111, P10269, DOI 10.1073/pnas.1410112111; Jiang WY, 2013, NAT BIOTECHNOL, V31, P233, DOI 10.1038/nbt.2508; Jinek M, 2013, ELIFE, V2, DOI 10.7554/eLife.00471; Jinek M, 2012, SCIENCE, V337, P816, DOI 10.1126/science.1225829; Kim H, 2014, NAT REV GENET, V15, P321, DOI 10.1038/nrg3686; Klein IA, 2011, CELL, V147, P95, DOI 10.1016/j.cell.2011.07.048; Krzywinski M, 2009, GENOME RES, V19, P1639, DOI 10.1101/gr.092759.109; Lee YN, 2014, J ALLERGY CLIN IMMUN, V133, P1099, DOI 10.1016/j.jaci.2013.10.007; Mali P, 2013, NAT BIOTECHNOL, V31, P833, DOI 10.1038/nbt.2675; Mali P, 2013, SCIENCE, V339, P823, DOI 10.1126/science.1232033; Manfred S, 2007, NAT METHODS, V4, P1051, DOI 10.1038/nmeth1103; Miller JC, 2011, NAT BIOTECHNOL, V29, P143, DOI 10.1038/nbt.1755; Mitelman F, 2007, NAT REV CANCER, V7, P233, DOI 10.1038/nrc2091; Munoz IG, 2011, NUCLEIC ACIDS RES, V39, P729, DOI 10.1093/nar/gkq801; Mussolino C, 2011, NUCLEIC ACIDS RES, V39, P9283, DOI 10.1093/nar/gkr597; Pattanayak V, 2013, NAT BIOTECHNOL, V31, P839, DOI 10.1038/nbt.2673; Petek LM, 2010, MOL THER, V18, P983, DOI 10.1038/mt.2010.35; Ramiro AR, 2006, NATURE, V440, P105, DOI 10.1038/nature04495; Ran FA, 2013, CELL, V154, P1380, DOI 10.1016/j.cell.2013.08.021; Reyon D, 2012, NAT BIOTECHNOL, V30, P460, DOI 10.1038/nbt.2170; Sander JD, 2014, NAT BIOTECHNOL, V32, P347, DOI 10.1038/nbt.2842; Stephens PJ, 2009, NATURE, V462, P1005, DOI 10.1038/nature08645; Sung YH, 2013, NAT BIOTECHNOL, V31, P23, DOI 10.1038/nbt.2477; Wood AJ, 2011, SCIENCE, V333, P307, DOI 10.1126/science.1207773; Xiao A, 2014, BIOINFORMATICS, V30, P1180, DOI 10.1093/bioinformatics/btt764; Yang H, 2013, CELL, V154, P1370, DOI 10.1016/j.cell.2013.08.022; Yin H, 2014, NAT BIOTECHNOL, V32, P551, DOI 10.1038/nbt.2884; Zhang Y, 2012, CELL, V148, P908, DOI 10.1016/j.cell.2012.02.002	43	444	482	4	152	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156	1546-1696		NAT BIOTECHNOL	Nat. Biotechnol.	FEB	2015	33	2					179	186		10.1038/nbt.3101	http://dx.doi.org/10.1038/nbt.3101			8	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	CA8VK	25503383	Green Submitted, Green Accepted			2022-12-27	WOS:000349198800024
J	Tsai, SQ; Zheng, Z; Nguyen, NT; Liebers, M; Topkar, VV; Thapar, V; Wyvekens, N; Khayter, C; Iafrate, AJ; Le, LP; Aryee, MJ; Joung, JK				Tsai, Shengdar Q.; Zheng, Zongli; Nguyen, Nhu T.; Liebers, Matthew; Topkar, Ved V.; Thapar, Vishal; Wyvekens, Nicolas; Khayter, Cyd; Iafrate, A. John; Le, Long P.; Aryee, Martin J.; Joung, J. Keith			GUIDE-seq enables genome-wide profiling of off-target cleavage by CRISPR-Cas nucleases	NATURE BIOTECHNOLOGY			English	Article							HUMAN-CELLS; DUAL-RNA; SPECIFICITY; DNA; SYSTEMS; REVEALS; ENDONUCLEASE; IDENTIFICATION; NICKASES; SITES	CRISPR RNA-guided nucleases (RGNs) are widely used genome-editing reagents, but methods to delineate their genome-wide, off-target cleavage activities have been lacking. Here we describe an approach for global detection of DNA double-stranded breaks (DSBs) introduced by RGNs and potentially other nucleases. This method, called genome-wide, unbiased identification of DSBs enabled by sequencing (GUIDE-seq), relies on capture of double-stranded oligodeoxynucleotides into DSBs. Application of GUIDE-seq to 13 RGNs in two human cell lines revealed wide variability in RGN off-target activities and unappreciated characteristics of off-target sequences. The majority of identified sites were not detected by existing computational methods or chromatin immunoprecipitation sequencing (ChIP-seq). GUIDE-seq also identified RGN-independent genomic breakpoint 'hotspots'. Finally, GUIDE-seq revealed that truncated guide RNAs exhibit substantially reduced RGN-induced, off-target DSBs. Our experiments define the most rigorous framework for genome-wide identification of RGN off-target effects to date and provide a method for evaluating the safety of these nucleases before clinical use.	[Tsai, Shengdar Q.; Zheng, Zongli; Nguyen, Nhu T.; Liebers, Matthew; Topkar, Ved V.; Thapar, Vishal; Wyvekens, Nicolas; Khayter, Cyd; Iafrate, A. John; Le, Long P.; Aryee, Martin J.; Joung, J. Keith] Massachusetts Gen Hosp, Mol Pathol Unit, Charlestown, MA 02129 USA; [Tsai, Shengdar Q.; Zheng, Zongli; Nguyen, Nhu T.; Liebers, Matthew; Topkar, Ved V.; Thapar, Vishal; Wyvekens, Nicolas; Khayter, Cyd; Iafrate, A. John; Le, Long P.; Aryee, Martin J.; Joung, J. Keith] Massachusetts Gen Hosp, Ctr Canc Res, Charlestown, MA USA; [Tsai, Shengdar Q.; Zheng, Zongli; Iafrate, A. John; Le, Long P.; Aryee, Martin J.; Joung, J. Keith] Harvard Univ, Sch Med, Dept Pathol, Boston, MA 02115 USA; [Tsai, Shengdar Q.; Zheng, Zongli] Karolinska Inst, Dept Med Epidemiol & Biostat, Stockholm, Sweden	Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; Karolinska Institutet	Joung, JK (corresponding author), Massachusetts Gen Hosp, Mol Pathol Unit, Charlestown, MA 02129 USA.	stsai4@mgh.harvard.edu; jjoung@mgh.harvard.edu	Tsai, Shengdar Q./G-4600-2012; zheng, zongli/C-7309-2008; Aryee, Martin/AAC-8113-2020; Zheng, Zongli/B-2917-2011	Tsai, Shengdar Q./0000-0001-9161-3993; Zheng, Zongli/0000-0003-4849-4903	National Institutes of Health (NIH) Director's Pioneer Award [DP1 GM105378]; NIH [R01 GM088040, R01 AR063070, F32 GM105189]; Jim and Ann Orr Massachusetts General Hospital (MGH) Research Scholar Award; US Army Research Laboratory; US Army Research Office [W911NF-11-2-0056]; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR063070] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM088040, DP1GM105378, F32GM105189] Funding Source: NIH RePORTER	National Institutes of Health (NIH) Director's Pioneer Award; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Jim and Ann Orr Massachusetts General Hospital (MGH) Research Scholar Award; US Army Research Laboratory(United States Department of DefenseUS Army Research Laboratory (ARL)); US Army Research Office; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank J. Angstman, B. Kleinstiver, Y. Fu, J. Gehrke and R. Coltman for helpful comments on the manuscript and M. Maeder and J. Foden for technical assistance. This work was funded by a National Institutes of Health (NIH) Director's Pioneer Award (DP1 GM105378), NIH R01 GM088040, NIH R01 AR063070, and the Jim and Ann Orr Massachusetts General Hospital (MGH) Research Scholar Award. S.Q.T. was supported by NIH F32 GM105189. This material is based upon work supported by, or in part by, the US Army Research Laboratory and the US Army Research Office under grant number W911NF-11-2-0056. Links to software and resources for analyzing GUIDE-seq data will be made available at: http://www.jounglab.org/guideseq.	Cencic R, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0109213; Cho SW, 2014, GENOME RES, V24, P132, DOI 10.1101/gr.162339.113; Choi PS, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4728; Cradick TJ, 2013, NUCLEIC ACIDS RES, V41, P9584, DOI 10.1093/nar/gkt714; Crosetto N, 2013, NAT METHODS, V10, P361, DOI 10.1038/nmeth.2408; Duan JZ, 2014, CELL RES, V24, P1009, DOI 10.1038/cr.2014.87; Fonfara I, 2014, NUCLEIC ACIDS RES, V42, P2577, DOI 10.1093/nar/gkt1074; Fu YF, 2014, NAT BIOTECHNOL, V32, P279, DOI 10.1038/nbt.2808; Fu YF, 2013, NAT BIOTECHNOL, V31, P822, DOI 10.1038/nbt.2623; Gabriel R, 2011, NAT BIOTECHNOL, V29, P816, DOI 10.1038/nbt.1948; Ghezraoui H, 2014, MOL CELL, V55, P829, DOI 10.1016/j.molcel.2014.08.002; Gostissa M, 2014, P NATL ACAD SCI USA, V111, P2644, DOI 10.1073/pnas.1324176111; Guilinger JP, 2014, NAT BIOTECHNOL, V32, P577, DOI 10.1038/nbt.2909; Heigwer F, 2014, NAT METHODS, V11, P122, DOI 10.1038/nmeth.2812; Hsu PD, 2014, CELL, V157, P1262, DOI 10.1016/j.cell.2014.05.010; Hsu PD, 2013, NAT BIOTECHNOL, V31, P827, DOI 10.1038/nbt.2647; Jiang WY, 2013, NAT BIOTECHNOL, V31, P233, DOI 10.1038/nbt.2508; Jinek M, 2012, SCIENCE, V337, P816, DOI 10.1126/science.1225829; Kuscu C, 2014, NAT BIOTECHNOL, V32, P677, DOI 10.1038/nbt.2916; Lin YN, 2014, NUCLEIC ACIDS RES, V42, P7473, DOI 10.1093/nar/gku402; Mali P, 2013, NAT BIOTECHNOL, V31, P833, DOI 10.1038/nbt.2675; Manfred S, 2007, NAT METHODS, V4, P1051, DOI 10.1038/nmeth1103; Marx V, 2014, NAT METHODS, V11, P1021, DOI 10.1038/nmeth.3108; Orlando SJ, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkq512; Osborn MJ, 2013, MOL THER, V21, P1151, DOI 10.1038/mt.2013.56; Pattanayak V, 2013, NAT BIOTECHNOL, V31, P839, DOI 10.1038/nbt.2673; Ran FA, 2013, NAT PROTOC, V8, P2281, DOI 10.1038/nprot.2013.143; Ran FA, 2013, CELL, V154, P1380, DOI 10.1016/j.cell.2013.08.021; Sander JD, 2014, NAT BIOTECHNOL, V32, P347, DOI 10.1038/nbt.2842; Sander JD, 2013, NUCLEIC ACIDS RES, V41, DOI 10.1093/nar/gkt716; Smith C, 2014, CELL STEM CELL, V15, P13, DOI 10.1016/j.stem.2014.06.011; Tsai SQ, 2014, CELL STEM CELL, V15, P3, DOI 10.1016/j.stem.2014.06.017; Tsai SQ, 2014, NAT BIOTECHNOL, V32, P569, DOI 10.1038/nbt.2908; Veres A, 2014, CELL STEM CELL, V15, P27, DOI 10.1016/j.stem.2014.04.020; Wu XB, 2014, NAT BIOTECHNOL, V32, P670, DOI 10.1038/nbt.2889	35	1206	1350	18	277	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156	1546-1696		NAT BIOTECHNOL	Nat. Biotechnol.	FEB	2015	33	2					187	197		10.1038/nbt.3117	http://dx.doi.org/10.1038/nbt.3117			11	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	CA8VK	25513782	Green Accepted, Green Submitted			2022-12-27	WOS:000349198800025
J	Hare, P				Hare, Peter			New plant species through grafting	NATURE BIOTECHNOLOGY			English	Editorial Material																		Fuentes I, 2014, NATURE, V511, P232, DOI 10.1038/nature13291	1	2	2	0	33	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156	1546-1696		NAT BIOTECHNOL	Nat. Biotechnol.	SEP	2014	32	9					887	887		10.1038/nbt.3010	http://dx.doi.org/10.1038/nbt.3010			1	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	AQ2FD	25203040				2022-12-27	WOS:000342600300027
J	Huang, KGL; Ertug, G				Huang, Kenneth Guang-Lih; Ertug, Gokhan			Mobility, retention and productivity of genomics scientists in the United States	NATURE BIOTECHNOLOGY			English	Editorial Material							HUMAN-GENETICS; INNOVATION; INDUSTRY; SCIENCE; IMPACT		[Huang, Kenneth Guang-Lih; Ertug, Gokhan] Singapore Management Univ, Lee Kong Chian Sch Business, Singapore 178902, Singapore	Singapore Management University	Huang, KGL (corresponding author), Singapore Management Univ, Lee Kong Chian Sch Business, Singapore 178902, Singapore.	kennethhuang@smu.edu.sg	ERTUG, Gokhan/D-2222-2010; HUANG, Kenneth Guang-Lih/D-2205-2010	HUANG, Kenneth Guang-Lih/0000-0002-4811-5638				Agrawal A, 2011, J URBAN ECON, V69, P43, DOI 10.1016/j.jue.2010.06.003; Allen T. J., 1977, MANAGING FLOW TECHNO; Azoulay P, 2007, NEW ENGL J MED, V357, P2049, DOI 10.1056/NEJMsa067417; Cook-Deegan R, 2010, ANNU REV GENOM HUM G, V11, P383, DOI 10.1146/annurev-genom-082509-141811; Ernst and Young, 2007, GLOB BIOT REP; Ernst and Young, 2006, GLOB BIOT REP; Etzkowitz H, 1998, RES POLICY, V27, P823, DOI 10.1016/S0048-7333(98)00093-6; Hockfield S., RESTARTING AM JOB CR; Huang KG, 2010, RES POLICY, V39, P567, DOI 10.1016/j.respol.2010.02.004; Huang KG, 2009, ACAD MANAGE J, V52, P1193, DOI 10.5465/AMJ.2009.47084665; JAFFE AB, 1993, Q J ECON, V108, P577, DOI 10.2307/2118401; Jensen K, 2005, SCIENCE, V310, P239, DOI 10.1126/science.1120014; Kaku's Universe Dr., 2011, HAS BRAIN DRAIN TOP; Kenney Martin, 1986, BIOTECHNOLOGY U IND; Lane J, 2009, SCIENCE, V324, P1273, DOI 10.1126/science.1175335; Murray F, 2002, RES POLICY, V31, P1389, DOI 10.1016/S0048-7333(02)00070-7; Patton D, 2005, R&D MANAGE, V35, P1, DOI 10.1111/j.1467-9310.2005.00368.x; Rai AK, 2012, NAT BIOTECHNOL, V30, P953, DOI 10.1038/nbt.2382; Rincon P, 2011, BBC NEWS; Sampat BN, 2013, MILBANK Q, V91, P163, DOI 10.1111/milq.12005; Sampat BN, 2004, GENOMIC PATENTING AC; Singh J, 2011, MANAGE SCI, V57, P129, DOI 10.1287/mnsc.1100.1253; Stuart TE, 2006, AM J SOCIOL, V112, P97, DOI 10.1086/502691; U.S. Department of Energy, 2013, POT BEN HGP RES; Wadhwa V, 2009, IS US BRAIN DRAIN HO; Webber A.M, 2004, US TODAY	26	7	7	0	14	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156	1546-1696		NAT BIOTECHNOL	Nat. Biotechnol.	SEP	2014	32	9					953	958		10.1038/nbt.3016	http://dx.doi.org/10.1038/nbt.3016			6	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	AQ2FD	25203045	Green Published			2022-12-27	WOS:000342600300043
J	Kang, J; Hsu, CH; Wu, Q; Liu, SS; Coster, AD; Posner, BA; Altschuler, SJ; Wu, LF				Kang, Jungseog; Hsu, Chien-Hsiang; Wu, Qi; Liu, Shanshan; Coster, Adam D.; Posner, Bruce A.; Altschuler, Steven J.; Wu, Lani F.			Improving drug discovery with high-content phenotypic screens by systematic selection of reporter cell lines	NATURE BIOTECHNOLOGY			English	Article							SMALL-MOLECULE; HIGH-THROUGHPUT; CANCER-CELLS; KINASE INHIBITORS; NATURAL-PRODUCTS; IDENTIFICATION; SIGNATURES; PROTEOMICS; FUTURE; PERSPECTIVES	High-content, image-based screens enable the identification of compounds that induce cellular responses similar to those of known drugs but through different chemical structures or targets. A central challenge in designing phenotypic screens is choosing suitable imaging biomarkers. Here we present a method for systematically identifying optimal reporter cell lines for annotating compound libraries (ORACLs), whose phenotypic profiles most accurately classify a training set of known drugs. We generate a library of fluorescently tagged reporter cell lines, and let analytical criteria determine which among them the ORACL-best classifies compounds into multiple, diverse drug classes. We demonstrate that an ORACL can functionally annotate large compound libraries across diverse drug classes in a single-pass screen and confirm high prediction accuracy by means of orthogonal, secondary validation assays. Our approach will increase the efficiency, scale and accuracy of phenotypic screens by maximizing their discriminatory power.	[Kang, Jungseog; Hsu, Chien-Hsiang; Wu, Qi; Liu, Shanshan; Coster, Adam D.; Altschuler, Steven J.; Wu, Lani F.] Univ Texas SW Med Ctr Dallas, Green Ctr Syst Biol, Dallas, TX 75390 USA; [Kang, Jungseog] New York Univ Shanghai, Dept Arts & Sci, Shanghai, Peoples R China; [Hsu, Chien-Hsiang] Univ Texas SW Med Ctr Dallas, Simmons Canc Ctr, Dallas, TX 75390 USA; [Hsu, Chien-Hsiang; Altschuler, Steven J.; Wu, Lani F.] Univ Calif San Francisco, Dept Pharmaceut Chem, San Francisco, CA USA; [Posner, Bruce A.] Univ Texas SW Med Ctr Dallas, Dept Biochem, Dallas, TX 75390 USA	University of Texas System; University of Texas Southwestern Medical Center Dallas; NYU Shanghai; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of California System; University of California San Francisco; University of Texas System; University of Texas Southwestern Medical Center Dallas	Altschuler, SJ; Wu, LF (corresponding author), Univ Texas SW Med Ctr Dallas, Green Ctr Syst Biol, Dallas, TX 75390 USA.; Altschuler, SJ; Wu, LF (corresponding author), Univ Calif San Francisco, Dept Pharmaceut Chem, San Francisco, CA USA.	steven.altschuler@ucsf.edu; lani.wu@ucsf.edu			US National Institutes of Health [CA133253, R01CA184984]; Institute of Computational Health Sciences at UCSF; NATIONAL CANCER INSTITUTE [P30CA142543, R01CA184984, R01CA133253] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Institute of Computational Health Sciences at UCSF; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We thank members of the Altschuler and Wu laboratories for critical feedback; U. Alon (Weizmann Institute of Science, Rehovot, Israel), and members of his laboratory for providing the CD tag plasmid and guidance on its use; G. DeMartino (University of Texas Southwestern Medical Center, Dallas) for useful conversations reagents for the proteasome validation and the Ub-R clone of HeLa cells; and S. Wei for help with HTS experiments. This research was partially supported by the US National Institutes of Health grants CA133253 (S.J.A.), R01CA184984 (L.F.W.) and the Institute of Computational Health Sciences at UCSF (S.J.A., L.F.W.).	Bakal C, 2007, SCIENCE, V316, P1753, DOI 10.1126/science.1140324; Bantscheff M, 2007, NAT BIOTECHNOL, V25, P1035, DOI 10.1038/nbt1328; Caie PD, 2010, MOL CANCER THER, V9, P1913, DOI 10.1158/1535-7163.MCT-09-1148; Chen BZ, 2009, NAT CHEM BIOL, V5, P100, DOI 10.1038/nchembio.137; Chen D, 2011, CURR CANCER DRUG TAR, V11, P239, DOI 10.2174/156800911794519752; Cohen AA, 2008, SCIENCE, V322, P1511, DOI 10.1126/science.1160165; Feng Y, 2009, NAT REV DRUG DISCOV, V8, P567, DOI 10.1038/nrd2876; Fuchs F, 2010, MOL SYST BIOL, V6, DOI 10.1038/msb.2010.25; Futamura Y, 2012, CHEM BIOL, V19, P1620, DOI 10.1016/j.chembiol.2012.10.014; Griffin JL, 2004, NAT REV CANCER, V4, P551, DOI 10.1038/nrc1390; Gustafsdottir SM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080999; Houle D, 2010, NAT REV GENET, V11, P855, DOI 10.1038/nrg2897; Inglese J, 2007, NAT CHEM BIOL, V3, P466, DOI 10.1038/nchembio.2007.17; Johnson R., 2007, APPL MULTIVARIATE ST; Kangas JD, 2014, BMC BIOINFORMATICS, V15, DOI 10.1186/1471-2105-15-143; Kawatani M, 2011, CHEM BIOL, V18, P743, DOI 10.1016/j.chembiol.2011.03.012; Kelloff GJ, 2012, NAT REV DRUG DISCOV, V11, P201, DOI 10.1038/nrd3651; Kim TS, 2006, MOL BIOL CELL, V17, P824, DOI 10.1091/mbc.E05-08-0713; King KR, 2007, LAB CHIP, V7, P77, DOI 10.1039/b612516f; Klebe G, 2006, DRUG DISCOV TODAY, V11, P580, DOI 10.1016/j.drudis.2006.05.012; Koehn Frank E., 2008, V65; Kolch W, 2010, NAT REV CANCER, V10, P618, DOI 10.1038/nrc2900; Kuhn DJ, 2007, BLOOD, V110, P3281, DOI 10.1182/blood-2007-01-065888; Lachance H, 2012, J MED CHEM, V55, P5989, DOI 10.1021/jm300288g; Lamb J, 2006, SCIENCE, V313, P1929, DOI 10.1126/science.1132939; Loo LH, 2007, NAT METHODS, V4, P445, DOI 10.1038/NMETH1032; MacDonald ML, 2006, NAT CHEM BIOL, V2, P329, DOI 10.1038/nchembio790; Martin CJ, 2008, J MED CHEM, V51, P2853, DOI 10.1021/jm701558c; Mayr LM, 2009, CURR OPIN PHARMACOL, V9, P580, DOI 10.1016/j.coph.2009.08.004; Moffat JG, 2014, NAT REV DRUG DISCOV, V13, P588, DOI 10.1038/nrd4366; Muroi M, 2010, CHEM BIOL, V17, P460, DOI 10.1016/j.chembiol.2010.03.016; Nielsen TE, 2008, ANGEW CHEM INT EDIT, V47, P48, DOI 10.1002/anie.200703073; O'Connor CJ, 2012, CHEM SOC REV, V41, P4444, DOI DOI 10.1039/C2CS35023H; Perlman ZE, 2004, SCIENCE, V306, P1194, DOI 10.1126/science.1100709; Potts MB, 2013, SCI SIGNAL, V6, DOI 10.1126/scisignal.2004657; Reddy P, 2004, P NATL ACAD SCI USA, V101, P3921, DOI 10.1073/pnas.0400380101; Roti G, 2012, BRIT J CANCER, V106, P254, DOI 10.1038/bjc.2011.543; Stegmaier K, 2004, NAT GENET, V36, P257, DOI 10.1038/ng1305; Sundberg SA, 2000, CURR OPIN BIOTECH, V11, P47, DOI 10.1016/S0958-1669(99)00051-8; Taylor DL, 2007, METH MOL B, V356, P3; Thomas RK, 2007, NAT GENET, V39, P347, DOI 10.1038/ng1975; van't Veer LJ, 2002, NATURE, V415, P530, DOI 10.1038/415530a; Wawer MJ, 2014, P NATL ACAD SCI USA, V111, P10911, DOI 10.1073/pnas.1410933111; Wilson CJ, 2006, J BIOMOL SCREEN, V11, P21, DOI 10.1177/1087057105280726; Wojcik C, 2006, MOL BIOL CELL, V17, P4606, DOI 10.1091/mbc.E06-05-0432; Young DW, 2008, NAT CHEM BIOL, V4, P59, DOI 10.1038/nchembio.2007.53; Zhang JM, 2009, NAT REV CANCER, V9, P28, DOI 10.1038/nrc2559	48	51	52	1	42	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156	1546-1696		NAT BIOTECHNOL	Nat. Biotechnol.	JAN	2016	34	1					70	77		10.1038/nbt.3419	http://dx.doi.org/10.1038/nbt.3419			8	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	DB8HQ	26655497	Green Accepted, Green Submitted			2022-12-27	WOS:000368758200029
J	Salter, AI; Riddell, SR				Salter, Alexander I.; Riddell, Stanley R.			A BiTE from cancer's intracellular menu	NATURE BIOTECHNOLOGY			English	Editorial Material							ANTIBODY		[Salter, Alexander I.; Riddell, Stanley R.] Fred Hutchinson Canc Res Ctr, Program Immunol, Seattle, WA 98104 USA; [Salter, Alexander I.; Riddell, Stanley R.] Univ Washington, Sch Med, Seattle, WA USA	Fred Hutchinson Cancer Center; University of Washington; University of Washington Seattle	Salter, AI (corresponding author), Fred Hutchinson Canc Res Ctr, Program Immunol, 1124 Columbia St, Seattle, WA 98104 USA.	sriddell@fredhutch.org		Salter, Alexander/0000-0003-3820-0895				Cameron BJ, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3006034; Chapuis AG, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3004916; Cheever MA, 2009, CLIN CANCER RES, V15, P5323, DOI 10.1158/1078-0432.CCR-09-0737; Dao T, 2015, NAT BIOTECHNOL, V33, P1079, DOI 10.1038/nbt.3349; Dao T, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3005661; Denkberg G, 2002, P NATL ACAD SCI USA, V99, P9421, DOI 10.1073/pnas.132285699; Offner S, 2006, MOL IMMUNOL, V43, P763, DOI 10.1016/j.molimm.2005.03.007; Schumacher TN, 2015, SCIENCE, V348, P69, DOI 10.1126/science.aaa4971; Topp MS, 2014, J CLIN ONCOL, V32, P4134, DOI 10.1200/JCO.2014.56.3247; Veomett N, 2014, CLIN CANCER RES, V20, P4036, DOI 10.1158/1078-0432.CCR-13-2756	10	3	3	0	7	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156	1546-1696		NAT BIOTECHNOL	Nat. Biotechnol.	OCT	2015	33	10					1040	1041						2	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	CT1JX	26448086				2022-12-27	WOS:000362555700020
J	Cho, J				Cho, Judy			The heritable immune system	NATURE BIOTECHNOLOGY			English	Editorial Material									Icahn Sch Med Mt Sinai, New York, NY 10029 USA	Icahn School of Medicine at Mount Sinai	Cho, J (corresponding author), Icahn Sch Med Mt Sinai, New York, NY 10029 USA.	judy.cho@mssm.edu						Brodin P, 2015, CELL, V160, P37, DOI 10.1016/j.cell.2014.12.020; Chambers JC, 2011, NAT GENET, V43, P1131, DOI 10.1038/ng.970; Farh KKH, 2015, NATURE, V518, P337, DOI 10.1038/nature13835; Fraga MF, 2005, P NATL ACAD SCI USA, V102, P10604, DOI 10.1073/pnas.0500398102; Hedl M, 2014, IMMUNITY, V40, P734, DOI 10.1016/j.immuni.2014.04.011; Kau AL, 2011, NATURE, V474, P327, DOI 10.1038/nature10213; Roederer M, 2015, CELL, V161, P387, DOI 10.1016/j.cell.2015.02.046	7	5	5	0	6	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156	1546-1696		NAT BIOTECHNOL	Nat. Biotechnol.	JUN	2015	33	6					608	609		10.1038/nbt.3256	http://dx.doi.org/10.1038/nbt.3256			2	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	CK2DE	26057979				2022-12-27	WOS:000356019700019
J	Bosley, KS; Botchan, M; Bredenoord, AL; Carroll, D; Charo, RA; Charpentier, E; Cohen, R; Corn, J; Doudna, J; Feng, GP; Greely, HT; Isasi, R; Ji, WZ; Kim, JS; Knoppers, B; Lanphier, E; Li, JS; Lovell-Badge, R; Martin, GS; Moreno, J; Naldini, L; Pera, M; Perry, ACF; Venter, JC; Zhang, F; Zhou, Q				Bosley, Katrine S.; Botchan, Michael; Bredenoord, Annelien L.; Carroll, Dana; Charo, R. Alta; Charpentier, Emmanuelle; Cohen, Ron; Corn, Jacob; Doudna, Jennifer; Feng, Guoping; Greely, Henry T.; Isasi, Rosario; Ji, Weihzi; Kim, Jin-Soo; Knoppers, Bartha; Lanphier, Edward; Li, Jinsong; Lovell-Badge, Robin; Martin, G. Steven; Moreno, Jonathan; Naldini, Luigi; Pera, Martin; Perry, Anthony C. F.; Venter, J. Craig; Zhang, Feng; Zhou, Qi			CRISPR germline engineering-the community speaks	NATURE BIOTECHNOLOGY			English	Article									[Bosley, Katrine S.] Editas Med, Cambridge, MA 02142 USA; [Botchan, Michael; Martin, G. Steven] Univ Calif Berkeley, Dept Mol & Cell Biol, Berkeley, CA 94720 USA; [Bredenoord, Annelien L.] Univ Med Ctr, Dept Med Humanities, Utrecht, Netherlands; [Carroll, Dana] Univ Utah, Sch Med, Dept Biochem, Salt Lake City, UT USA; [Charo, R. Alta] Univ Wisconsin, Sch Law, Madison, WI USA; [Charo, R. Alta] Univ Wisconsin, Sch Med & Publ Hlth, Dept Med Hist & Bioeth, Madison, WI USA; [Charpentier, Emmanuelle] Helmholtz Ctr Infect Res, Dept Regulat Infect Biol, Braunschweig, Germany; [Cohen, Ron] Acorda Therapeut, Ardsley, NY USA; [Corn, Jacob] Innovat Genom Initiat, Berkeley, CA USA; [Doudna, Jennifer] Univ Calif Berkeley, Dept Mol & Cell Biol & Chem, Berkeley, CA 94720 USA; [Feng, Guoping] MIT, Broad Inst, Stanley Ctr Psychiat Res, Dept Brain & Cognit Sci, Cambridge, MA USA; [Feng, Guoping] Harvard Univ, Cambridge, MA 02138 USA; [Greely, Henry T.] Stanford Law Sch, Stanford, CA USA; [Isasi, Rosario] McGill Univ, Dept Human Genet, Montreal, PQ, Canada; [Ji, Weihzi] Kunming Biomed Int & Natl Engn Res Ctr Biomed & A, Kunming, Peoples R China; [Kim, Jin-Soo] Inst for Basic Sci Korea, Ctr Genome Engn, Seoul, South Korea; [Kim, Jin-Soo] Seoul Natl Univ, Dept Chem, Seoul, South Korea; [Knoppers, Bartha] McGill Univ, Dept Human Genet, Montreal, PQ, Canada; [Lanphier, Edward] Sangamo Biosci, Richmond, CA USA; [Li, Jinsong] Chinese Acad Sci, Shanghai Inst Biol Sci, Inst Biochem & Cell Biol, Shanghai, Peoples R China; [Lovell-Badge, Robin] Francis Crick Inst, London, England; [Moreno, Jonathan] Univ Penn, Philadelphia, PA 19104 USA; [Naldini, Luigi] San Raffaele Telethon Inst Gene Therapy, Milan, Italy; [Pera, Martin] Univ Melbourne, Dept Anat & Neurosci, Melbourne, Vic, Australia; [Perry, Anthony C. F.] Univ Bath, Dept Biol & Biochem, Bath BA2 7AY, Avon, England; [Venter, J. Craig] J Craig Venter Inst, La Jolla, CA USA; [Zhang, Feng] MIT & Harvard, Broad Inst, Cambridge, MA USA; [Zhou, Qi] Chinese Acad Sci, Inst Zool, State Key Lab Reprod Biol, Beijing, Peoples R China	University of California System; University of California Berkeley; Utrecht University; Utrecht University Medical Center; Utah System of Higher Education; University of Utah; University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; Helmholtz Association; Helmholtz-Center for Infection Research; University of California System; University of California Berkeley; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Harvard University; Stanford University; McGill University; Institute for Basic Science - Korea (IBS); Seoul National University (SNU); McGill University; Sangamo Therapeutics, Inc.; Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; Francis Crick Institute; University of Pennsylvania; Fondazione Telethon; San Raffaele Telethon Institute For Gene Therapy (Sr-Tiget); University of Melbourne; University of Bath; J. Craig Venter Institute; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Chinese Academy of Sciences; Institute of Zoology, CAS	Bosley, KS (corresponding author), Editas Med, Cambridge, MA 02142 USA.		Feng, Guoping/Y-2827-2019; KIM, Jin-Soo/M-6918-2013; PERA, MARTIN/A-9812-2012	KIM, Jin-Soo/0000-0003-4847-1306; PERA, MARTIN/0000-0001-6239-0428; Perry, Tony/0000-0003-3136-5355; Corn, Jacob/0000-0002-7798-5309; Lovell-Badge, Robin/0000-0001-9364-4179; NALDINI, Luigi/0000-0002-7835-527X; Charo, Robin Alta/0000-0003-3710-1043; li, jin song/0000-0003-3456-662X	MRC [G1000839, MC_U117562207] Funding Source: UKRI; The Francis Crick Institute [10107] Funding Source: researchfish; Medical Research Council [MC_U117562207, G1000839] Funding Source: Medline; NIGMS NIH HHS [R01 GM078571] Funding Source: Medline	MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); The Francis Crick Institute; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))			0	96	98	25	200	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156	1546-1696		NAT BIOTECHNOL	Nat. Biotechnol.	MAY	2015	33	5					478	486		10.1038/nbt.3227	http://dx.doi.org/10.1038/nbt.3227			9	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	CH8VP	25965754	Green Published			2022-12-27	WOS:000354314500025
J	Fast, EM; Zon, LI				Fast, Eva M.; Zon, Len I.			Singling out blood development	NATURE BIOTECHNOLOGY			English	Editorial Material							HETEROGENEITY; CELLS		[Fast, Eva M.; Zon, Len I.] Harvard Univ, Dept Stem Cell & Regenerat Biol, Cambridge, MA 02138 USA	Harvard University	Fast, EM (corresponding author), Harvard Univ, Dept Stem Cell & Regenerat Biol, Cambridge, MA 02138 USA.	zon@enders.tch.harvard.edu		Fast, Eva/0000-0002-4261-5244	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL048801] Funding Source: NIH RePORTER; Howard Hughes Medical Institute Funding Source: Medline; NHLBI NIH HHS [R01 HL048801] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); Howard Hughes Medical Institute(Howard Hughes Medical Institute); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Buettner F, 2015, NAT BIOTECHNOL, V33, P155, DOI 10.1038/nbt.3102; Guo GJ, 2013, CELL STEM CELL, V13, P492, DOI 10.1016/j.stem.2013.07.017; Moignard V, 2015, NAT BIOTECHNOL, V33, P269, DOI 10.1038/nbt.3154; Moignard V, 2013, NAT CELL BIOL, V15, P363, DOI 10.1038/ncb2709; Pollen AA, 2014, NAT BIOTECHNOL, V32, P1053, DOI 10.1038/nbt.2967; Swiers G, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3924; Treutlein B, 2014, NATURE, V509, P371, DOI 10.1038/nature13173	7	0	0	0	7	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156	1546-1696		NAT BIOTECHNOL	Nat. Biotechnol.	MAR	2015	33	3					260	261		10.1038/nbt.3168	http://dx.doi.org/10.1038/nbt.3168			3	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	CD0ME	25748916	Green Accepted			2022-12-27	WOS:000350766900020
J	Kirkpatrick, L				Kirkpatrick, Lynn			Incubators for innovators	NATURE BIOTECHNOLOGY			English	Editorial Material									PHusis Therapeut, San Diego, CA 92121 USA		Kirkpatrick, L (corresponding author), PHusis Therapeut, San Diego, CA 92121 USA.	lkirkpatrick@phusistherapeutics.com						[Anonymous], 2013, BUSINESS FLORIDA; [Anonymous], 2014, GENET ENG BIOTECHNOL; Grens K., 2014, SCIENTIST; Hernandez Sherwood C., 2013, EMED; Hernandez Sherwood C., 2014, EMED	5	6	6	0	3	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156	1546-1696		NAT BIOTECHNOL	Nat. Biotechnol.	FEB	2015	33	2					129	132		10.1038/nbt.3137	http://dx.doi.org/10.1038/nbt.3137			4	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	CA8VK	25658271	Bronze			2022-12-27	WOS:000349198800009
J	Langer, LJ				Langer, Lynn Johnson			Nuances in the entrepreneurship training tool box reply	NATURE BIOTECHNOLOGY			English	Letter																			0	0	0	0	0	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156	1546-1696		NAT BIOTECHNOL	Nat. Biotechnol.	FEB	2015	33	2					134	134		10.1038/nbt.3135	http://dx.doi.org/10.1038/nbt.3135			1	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	CA8VK	25658274	Bronze			2022-12-27	WOS:000349198800011
J	Sheridan, C				Sheridan, Cormac			Pivotal trials for beta-secretase inhibitors in Alzheimer's	NATURE BIOTECHNOLOGY			English	News Item							TARGET											2014, ACTA NEUROPATHOL, V128, P609; 2014, ACTA NEUROPATHOL, V127, P803; 2014, CELL, V159, P721	3	8	9	0	12	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156	1546-1696		NAT BIOTECHNOL	Nat. Biotechnol.	FEB	2015	33	2					115	116		10.1038/nbt0215-115	http://dx.doi.org/10.1038/nbt0215-115			2	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	CA8VK	25658256				2022-12-27	WOS:000349198800003
J	Bonde, MT; Makransky, G; Wandall, J; Larsen, MV; Morsing, M; Jarmer, H; Sommer, MOA				Bonde, Mads T.; Makransky, Guido; Wandall, Jakob; Larsen, Mette V.; Morsing, Mikkel; Jarmer, Hanne; Sommer, Morten O. A.			Improving biotech education through gamified laboratory simulations	NATURE BIOTECHNOLOGY			English	Editorial Material							SCIENCE		[Bonde, Mads T.; Sommer, Morten O. A.] Tech Univ Denmark, Novo Nordisk Fdn Ctr Biosustainabil, Lyngby, Denmark; [Bonde, Mads T.; Sommer, Morten O. A.] Tech Univ Denmark, Dept Syst Biol, Lyngby, Denmark; [Larsen, Mette V.; Jarmer, Hanne] Tech Univ Denmark, Ctr Biol Sequence Anal, Dept Syst Biol, Lyngby, Denmark; [Makransky, Guido] Univ Southern Denmark, Dept Psychol, Odense, Denmark; [Wandall, Jakob] NordicMetrics, Copenhagen, Denmark; [Morsing, Mikkel] Univ Copenhagen, Dept Biol, DK-1168 Copenhagen, Denmark	Technical University of Denmark; Technical University of Denmark; Technical University of Denmark; University of Southern Denmark; University of Copenhagen	Bonde, MT (corresponding author), Tech Univ Denmark, Novo Nordisk Fdn Ctr Biosustainabil, Lyngby, Denmark.	mab@bio.dtu.dk; hanne@cbs.dtu.dk; msom@bio.dtu.dk		Sommer, Morten Otto Alexander/0000-0003-4005-5674; Morsing, Mikkel/0000-0001-8322-8796; Makransky, Guido/0000-0003-1862-7824	Novo Nordisk Fonden [NNF14OC0011335, NNF10CC1016517, NNF13SA0009311, NNF13SA0006019] Funding Source: researchfish	Novo Nordisk Fonden(Novo Nordisk Foundation)		ALEXANDER KL, 1985, AM SOCIOL REV, V50, P409, DOI 10.2307/2095549; Anderson R.D., 2002, J SCI TEACH EDUC, V13, P1, DOI DOI 10.1023/A:1015171124982; Barr R., 1995, CHANGE MAGAZINE HIGH, V27, P12, DOI [10.1080/00091383.1995.10544672, DOI 10.1080/00091383.1995.10544672]; Birnbaum A., 1968, STAT THEORIES MENTAL, P397; Business Higher education Forum, 2011, STEM INT PROF CHALL; de Jong T, 2013, SCIENCE, V340, P305, DOI 10.1126/science.1230579; Donnelly D, 2013, RES SCI EDUC, V43, P1571, DOI 10.1007/s11165-012-9322-1; Eastwood JL, 2013, COMPUT EDUC, V66, P11, DOI 10.1016/j.compedu.2013.02.003; Embretson S, 2000, MULTIVARIATE APPL BO; Gago JM, 2004, INCREASING HUMAN RES; Gelbart H, 2006, J BIOL EDUC, V40, P107, DOI 10.1080/00219266.2006.9656026; Gordon E.W., 2013, GORDON COMMISSION FU; Gormally C, 2011, J COLL SCI TEACH, V40, P45; Hays R. T., 1992, MIL PSYCHOL, V4, P63, DOI DOI 10.1207/S15327876MP0402_1; Heckman JJ, 2008, ECON INQ, V46, P289, DOI 10.1111/j.1465-7295.2008.00163.x; Hoffler TN, 2007, LEARN INSTR, V17, P722, DOI 10.1016/j.learninstruc.2007.09.013; Honey M., 2011, COMMITTEE SCI LEARNI; KELLER D, 1995, ASSESSMENT NATL ACAD; Kiboss J.K., 2004, J SCI EDUC TECHNOL, V13, P207, DOI [10.1023/B:JOST.0000031259.76872.f1, DOI 10.1023/B:JOST.0000031259.76872.F1]; Lanahan L., 2005, FUNDAMENTAL PROBLEMS, P1; Levin H.M., 2012, PROSPECTS, V42, P269, DOI [10.1007/s11125-012-9240-z, DOI 10.1007/S11125-012-9240-Z]; Mayer R. E., 2001, MULTIMEDIA LEARNING; Mayer RE., 2014, CAMBRIDGE HDB MULTIM, P345, DOI 10.1017/CBO9781139547369.017; Mislevy R. J, 2011, 800 CRESST; National Foundation for Educational Research, 2011, EXPL YOUNG PEOPL VIE; National Research Council, 2005, AM LAB REP INV HIGH, DOI [10.17226/11311, DOI 10.17226/11311]; NATRIELLO G, 1989, SOCIOL EDUC, V62, P109, DOI 10.2307/2112843; RALPH J, 1994, PHI DELTA KAPPAN, V76, P144; Rutten N, 2012, COMPUT EDUC, V58, P136, DOI 10.1016/j.compedu.2011.07.017; The US department of education's national education technology Plan, 2010, TRANSF AM ED LEARN P; Toth EE, 2009, INNOV HIGH EDUC, V33, P333, DOI 10.1007/s10755-008-9087-7; Wainer H, 2007, TESTLET RESPONSE THEORY AND ITS APPLICATIONS, P1, DOI 10.1017/CBO9780511618765; Zacharia ZC, 2008, J RES SCI TEACH, V45, P1021, DOI 10.1002/tea.20260	34	115	118	1	45	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156	1546-1696		NAT BIOTECHNOL	Nat. Biotechnol.	JUL	2014	32	7					694	697		10.1038/nbt.2955	http://dx.doi.org/10.1038/nbt.2955			4	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Biotechnology & Applied Microbiology	AK8VE	25004234	Green Submitted			2022-12-27	WOS:000338705900036
J	Yu, CN; Mannan, AM; Yvone, GM; Ross, KN; Zhang, YL; Marton, MA; Taylor, BR; Crenshaw, A; Gould, JZ; Tamayo, P; Weir, BA; Tsherniak, A; Wong, B; Garraway, LA; Shamji, AF; Palmer, MA; Foley, MA; Winckler, W; Schreiber, SL; Kung, AL; Golub, TR				Yu, Channing; Mannan, Aristotle M.; Yvone, Griselda Metta; Ross, Kenneth N.; Zhang, Yan-Ling; Marton, Melissa A.; Taylor, Bradley R.; Crenshaw, Andrew; Gould, Joshua Z.; Tamayo, Pablo; Weir, Barbara A.; Tsherniak, Aviad; Wong, Bang; Garraway, Levi A.; Shamji, Alykhan F.; Palmer, Michelle A.; Foley, Michael A.; Winckler, Wendy; Schreiber, Stuart L.; Kung, Andrew L.; Golub, Todd R.			High-throughput identification of genotype-specific cancer vulnerabilities in mixtures of barcoded tumor cell lines	NATURE BIOTECHNOLOGY			English	Article							KINASE INHIBITOR SELECTIVITY; DRUG-SENSITIVITY; RESISTANCE; RESOURCE; EFFICACY; GENE	Hundreds of genetically characterized cell lines are available for the discovery of genotype-specific cancer vulnerabilities. However, screening large numbers of compounds against large numbers of cell lines is currently impractical, and such experiments are often difficult to control(1-4). Here we report a method called PRISM that allows pooled screening of mixtures of cancer cell lines by labeling each cell line with 24-nucleotide barcodes. PRISM revealed the expected patterns of cell killing seen in conventional (unpooled) assays. In a screen of 102 cell lines across 8,400 compounds, PRISM led to the identification of BRD-7880 as a potent and highly specific inhibitor of aurora kinases B and C. Cell line pools also efficiently formed tumors as xenografts, and PRISM recapitulated the expected pattern of erlotinib sensitivity in vivo.	[Yu, Channing; Mannan, Aristotle M.; Yvone, Griselda Metta; Ross, Kenneth N.; Zhang, Yan-Ling; Marton, Melissa A.; Taylor, Bradley R.; Crenshaw, Andrew; Gould, Joshua Z.; Tamayo, Pablo; Weir, Barbara A.; Tsherniak, Aviad; Wong, Bang; Garraway, Levi A.; Shamji, Alykhan F.; Palmer, Michelle A.; Foley, Michael A.; Winckler, Wendy; Schreiber, Stuart L.; Golub, Todd R.] Broad Inst Harvard & MIT, Cambridge, MA USA; [Yu, Channing; Garraway, Levi A.; Kung, Andrew L.; Golub, Todd R.] Dana Farber Canc Inst, Boston, MA 02115 USA; [Yu, Channing; Garraway, Levi A.; Kung, Andrew L.; Golub, Todd R.] Harvard Univ, Sch Med, Boston, MA USA; [Schreiber, Stuart L.] Harvard Univ, Cambridge, MA 02138 USA; [Schreiber, Stuart L.; Golub, Todd R.] Howard Hughes Med Inst, Chevy Chase, MD USA; [Yvone, Griselda Metta] Univ Calif Los Angeles, Los Angeles, CA USA; [Ross, Kenneth N.] Massachusetts Gen Hosp, Boston, MA 02114 USA; [Palmer, Michelle A.] ImmunoGen, Waltham, MA USA; [Foley, Michael A.] Triinst Therapeut Discovery Inst, New York, NY USA; [Kung, Andrew L.] Columbia Univ, Med Ctr, New York, NY USA	Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Harvard University; Dana-Farber Cancer Institute; Harvard University; Harvard Medical School; Harvard University; Howard Hughes Medical Institute; University of California System; University of California Los Angeles; Harvard University; Massachusetts General Hospital; Columbia University	Golub, TR (corresponding author), Broad Inst Harvard & MIT, Cambridge, MA USA.; Golub, TR (corresponding author), Dana Farber Canc Inst, Boston, MA 02115 USA.; Golub, TR (corresponding author), Harvard Univ, Sch Med, Boston, MA USA.; Golub, TR (corresponding author), Howard Hughes Med Inst, Chevy Chase, MD USA.	golub@broadinstitute.org	Kung, Andrew/AAL-2384-2020; Kung, Andrew L/AEU-0826-2022	Kung, Andrew L/0000-0002-9091-488X; Yu, Channing/0000-0002-3231-2565; Tsherniak, Aviad/0000-0002-3797-1877; Metta Yvone, Griselda/0000-0003-4639-2372; Tamayo, Pablo/0000-0002-9360-4668	US National Institutes of Health (NIH) Genomics Based Drug Discovery consortium grants [RL1-CA133834, RL1-GM084437, UL1DE019585]; US National Cancer Institute Integrative Cancer Biology Program grant [U54CA112962]; Howard Hughes Medical Institute; Claudia Adams Barr Program in Cancer Research Innovative Basic Science Research Program Grant; American Society of Clinical Oncology Conquer Cancer Foundation Young Investigator Award; Prostate Cancer Foundation; NIH grant [RL1-HG004671]; NATIONAL CANCER INSTITUTE [RL1CA133834, U54CA112962] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [RL1HG004671] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH [UL1DE019585] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [RL1GM084437] Funding Source: NIH RePORTER	US National Institutes of Health (NIH) Genomics Based Drug Discovery consortium grants; US National Cancer Institute Integrative Cancer Biology Program grant; Howard Hughes Medical Institute(Howard Hughes Medical Institute); Claudia Adams Barr Program in Cancer Research Innovative Basic Science Research Program Grant; American Society of Clinical Oncology Conquer Cancer Foundation Young Investigator Award; Prostate Cancer Foundation; NIH grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank S. Kim, G. Bonamy, J. (J.) Che, J. Thibault, T. Huynh, I. Engels and A. Shipway at Novartis for sharing data before publication; A. Christie and T. Davis for technical assistance in animal studies; C. Hartland, S. Donovan, E. Rubin and E. Winchester for technical assistance in compound assays; J. Bittker, J. McGrath and G. Wendel for assistance in compound management; S. Le Quement and J. Duvall for assistance in compound synthesis; J. Gale for technical assistance in enzyme kinetic assays; S. Howell for assistance in curation of computational data sets; A. Koehler, S. Dandapani, B. Munoz, C. Scherer, D. Gray, D. Bachovchin, S. Santaguida and J. Elkins for expert scientific guidance; J. Barretina, N. Stransky, S. Nijman, B. Julian, W. Read-Button, J. Davis and D. Peck for technical advice; and members of the Golub laboratory for critical review of the manuscript. This work was supported in part by the US National Institutes of Health (NIH) Genomics Based Drug Discovery consortium grants RL1-CA133834, RL1-GM084437 and UL1DE019585 (administratively linked to NIH grant RL1-HG004671), US National Cancer Institute Integrative Cancer Biology Program grant U54CA112962, the Howard Hughes Medical Institute, the Claudia Adams Barr Program in Cancer Research Innovative Basic Science Research Program Grant, the American Society of Clinical Oncology Conquer Cancer Foundation Young Investigator Award and the Prostate Cancer Foundation.	Abaan OD, 2013, CANCER RES, V73, P4372, DOI 10.1158/0008-5472.CAN-12-3342; Andrews PD, 2003, CURR OPIN CELL BIOL, V15, P672, DOI 10.1016/j.ceb.2003.10.013; Barretina J, 2012, NATURE, V483, P603, DOI 10.1038/nature11003; Basu A, 2013, CELL, V154, P1151, DOI 10.1016/j.cell.2013.08.003; Carmena M, 2003, NAT REV MOL CELL BIO, V4, P842, DOI 10.1038/nrm1245; Comer E, 2011, P NATL ACAD SCI USA, V108, P6751, DOI 10.1073/pnas.1015255108; Davis MI, 2011, NAT BIOTECHNOL, V29, P1046, DOI 10.1038/nbt.1990; Ditchfield C, 2003, J CELL BIOL, V161, P267, DOI 10.1083/jcb.200208091; Du JY, 2009, NAT BIOTECHNOL, V27, P77, DOI 10.1038/nbt.1513; Flaherty KT, 2012, NEW ENGL J MED, V367, P107, DOI 10.1056/NEJMoa1203421; Garnett MJ, 2012, NATURE, V483, P570, DOI 10.1038/nature11005; Karaman MW, 2008, NAT BIOTECHNOL, V26, P127, DOI 10.1038/nbt1358; Koivunen JP, 2008, CLIN CANCER RES, V14, P4275, DOI 10.1158/1078-0432.CCR-08-0168; Korn JM, 2008, NAT GENET, V40, P1253, DOI 10.1038/ng.237; Lowe JT, 2012, J ORG CHEM, V77, P7187, DOI 10.1021/jo300974j; Marcaurelle LA, 2010, J AM CHEM SOC, V132, P16962, DOI 10.1021/ja105119r; McDermott U, 2007, P NATL ACAD SCI USA, V104, P19936, DOI 10.1073/pnas.0707498104; Muellner MK, 2011, NAT CHEM BIOL, V7, P787, DOI 10.1038/nchembio.695; Peck D, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-7-r61; Schreiber SL, 2010, NAT BIOTECHNOL, V28, P904, DOI 10.1038/nbt0910-904; Sharma SV, 2010, NAT REV CANCER, V10, P241, DOI 10.1038/nrc2820; Sos ML, 2009, J CLIN INVEST, V119, P1727, DOI 10.1172/JCI37127; Turner NC, 2012, LANCET ONCOL, V13, pE178, DOI 10.1016/S1470-2045(11)70335-7; Wilhelm SM, 2008, MOL CANCER THER, V7, P3129, DOI 10.1158/1535-7163.MCT-08-0013; Zhang XHD, 2011, J BIOMOL SCREEN, V16, P775, DOI 10.1177/1087057111405851	25	132	136	1	24	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156	1546-1696		NAT BIOTECHNOL	Nat. Biotechnol.	APR	2016	34	4					419	+		10.1038/nbt.3460	http://dx.doi.org/10.1038/nbt.3460			7	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	DI6NL	26928769	Green Accepted, Green Submitted			2022-12-27	WOS:000373616100023
J	Booth, BL				Booth, Bruce L.			This time may be different	NATURE BIOTECHNOLOGY			English	Article							DEVELOPMENT PRODUCTIVITY	The markets may be softening on biotech, but overall the sector remains in an incredibly strong environment.	[Booth, Bruce L.] Atlas Venture, Cambridge, MA USA		Booth, BL (corresponding author), Atlas Venture, Cambridge, MA USA.	bruce@atlasventure.com						Booth B., 2004, IMPROVING PHARM RES; Ernst & Young, 1992, ERNST YOUNG ANN BIOT; Ernst & Young, 2015, ERNST YOUNG ANN BIOT; Schulze U, 2014, NAT REV DRUG DISCOV, V13, P331, DOI 10.1038/nrd4320; Slud M., 2000, CNNMONEY        0222; Smietana K, 2015, NAT REV DRUG DISCOV, V14, P455, DOI 10.1038/nrd4650; Thomas D, 2015, EMERGING THERAPEUTIC	7	7	9	0	8	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156	1546-1696		NAT BIOTECHNOL	Nat. Biotechnol.	JAN	2016	34	1					25	30		10.1038/nbt.3452	http://dx.doi.org/10.1038/nbt.3452			6	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	DB8HQ	26744974				2022-12-27	WOS:000368758200019
J	Sia, SK; Owens, MP				Sia, Samuel K.; Owens, Matthew P.			Share and share alike	NATURE BIOTECHNOLOGY			English	Editorial Material									[Sia, Samuel K.; Owens, Matthew P.] Harlem Biospace & Synapt, New York, NY 10027 USA; [Sia, Samuel K.] Columbia Univ, Dept Biomed Engn, New York, NY 10027 USA	Columbia University	Sia, SK (corresponding author), Harlem Biospace & Synapt, New York, NY 10027 USA.	ss2735@columbia.edu						Aldridge S., 2010, NAT BIOTECHNOL, V28, P189; Benkler Y, 2004, YALE LAW J, V114, P273, DOI 10.2307/4135731; Daniels RJ, 2015, P NATL ACAD SCI USA, V112, P313, DOI 10.1073/pnas.1418761112; Dolgin E, 2013, NAT MED, V19, P1556, DOI 10.1038/nm1213-1556; Fleming JJ, 2015, HEALTH AFFAIR, V34, P271, DOI 10.1377/hlthaff.2014.1051; Ford D., NAT BIOTECHNOL, V32, P201; Ford D., NAT BIOTECHNOL, V32, P15; Gura T, 2015, SCIENCE, V348, P1196, DOI 10.1126/science.348.6240.1196; Hamari J., 2015, SHARING EC WHY PEOPL; Kirkpatrick L, 2015, NAT BIOTECHNOL, V33, P129, DOI 10.1038/nbt.3137; National Center for Science and Engineering Statistics, 2014, ACAD I PROF RANK TOT; National Science Board, 2014, AC RES DEV SCI ENG I	12	9	9	0	9	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156	1546-1696		NAT BIOTECHNOL	Nat. Biotechnol.	DEC	2015	33	12					1224	1228		10.1038/nbt.3422	http://dx.doi.org/10.1038/nbt.3422			5	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	CY4OO	26650005	Bronze			2022-12-27	WOS:000366387700009
J	Iyer, LR; Sriram, S				Iyer, Laxmi Ravi; Sriram, Sandhya			The right track for you in biotech and biomedical sciences	NATURE BIOTECHNOLOGY			English	Editorial Material									[Iyer, Laxmi Ravi; Sriram, Sandhya] Biotech Media Pte Ltd, Biotechin Asia, Singapore, Singapore; [Sriram, Sandhya] ASTAR, Singapore Bioimaging Consortium, Lab Metab Med, Fat Metab & Stem Cell Grp, Singapore, Singapore	Agency for Science Technology & Research (A*STAR); A*STAR - Institute of Bioengineering & Bioimaging (IBB); A*STAR - Singapore Bioimaging Consortium (SBIC)	Iyer, LR (corresponding author), Biotech Media Pte Ltd, Biotechin Asia, Singapore, Singapore.	admin@biotechin.asia						Lim S., 2015, COMMUNICATION   0827; Startup Health Insights, 2015, DIG HLTH FUND RANK 2; Wong W.H., 2015, STRAITS TIMES	3	1	1	0	2	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156	1546-1696		NAT BIOTECHNOL	Nat. Biotechnol.	OCT	2015	33	10					1110	1111		10.1038/nbt.3376	http://dx.doi.org/10.1038/nbt.3376			2	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	CT1JX	26448094				2022-12-27	WOS:000362555700036
J	Schmidt, C				Schmidt, Charlie			Suicidal thoughts end Amgen's blockbuster aspirations for psoriasis drug	NATURE BIOTECHNOLOGY			English	News Item																		2014, J APPL BIOPHARM PHAR, V2, P50; 2010, ARCH DERMATOLOGY, V146, P891	2	18	19	0	3	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156	1546-1696		NAT BIOTECHNOL	Nat. Biotechnol.	SEP	2015	33	9					894	895		10.1038/nbt0915-894b	http://dx.doi.org/10.1038/nbt0915-894b			3	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	CR0EK	26348946				2022-12-27	WOS:000360990900005
J	Sampaziotis, F; de Brito, MC; Madrigal, P; Bertero, A; Saeb-Parsy, K; Soares, FAC; Schrumpf, E; Melum, E; Karlsen, TH; Bradley, JA; Gelson, WTH; Davies, S; Baker, A; Kaser, A; Alexander, GJ; Hannan, NRF; Vallier, L				Sampaziotis, Fotios; de Brito, Miguel Cardoso; Madrigal, Pedro; Bertero, Alessandro; Saeb-Parsy, Kourosh; Soares, Filipa A. C.; Schrumpf, Elisabeth; Melum, Espen; Karlsen, Tom H.; Bradley, J. Andrew; Gelson, William T. H.; Davies, Susan; Baker, Alastair; Kaser, Arthur; Alexander, Graeme J.; Hannan, Nicholas R. F.; Vallier, Ludovic			Cholangiocytes derived from human induced pluripotent stem cells for disease modeling and drug validation	NATURE BIOTECHNOLOGY			English	Article							POLYCYSTIC LIVER-DISEASE; CYSTIC-FIBROSIS; PROGENITOR CELLS; RAT; PATHOPHYSIOLOGY; MECHANISMS; GENERATION; DISORDERS; DEVELOP	The study of biliary disease has been constrained by a lack of primary human cholangiocytes. Here we present an efficient, serum-free protocol for directed differentiation of human induced pluripotent stem cells into cholangiocyte-like cells (CLCs). CLCs show functional characteristics of cholangiocytes, including bile acids transfer, alkaline phosphatase activity,. gamma-glutamyl-transpeptidase activity and physiological responses to secretin, somatostatin and vascular endothelial growth factor. We use CLCs to model in vitro key features of Alagille syndrome, polycystic liver disease and cystic fibrosis (CF)-associated cholangiopathy. Furthermore, we use CLCs generated from healthy individuals and patients with polycystic liver disease to reproduce the effects of the drugs verapamil and octreotide, and we show that the experimental CF drug VX809 rescues the disease phenotype of CF cholangiopathy in vitro. Our differentiation protocol will facilitate the study of biological mechanisms controlling biliary development, as well as disease modeling and drug screening.	[Sampaziotis, Fotios; de Brito, Miguel Cardoso; Madrigal, Pedro; Bertero, Alessandro; Soares, Filipa A. C.; Hannan, Nicholas R. F.; Vallier, Ludovic] Univ Cambridge, Wellcome Trust Med Res Council Stem Cell Inst, Anne McLaren Lab, Dept Surg, Cambridge, England; [Sampaziotis, Fotios; Saeb-Parsy, Kourosh; Bradley, J. Andrew] Univ Cambridge, Dept Surg, Cambridge, England; [Sampaziotis, Fotios; Saeb-Parsy, Kourosh; Bradley, J. Andrew] NIHR Cambridge Biomed Res Ctr, Cambridge, England; [Madrigal, Pedro; Vallier, Ludovic] Wellcome Trust Sanger Inst, Hinxton, Cambs, England; [Schrumpf, Elisabeth; Melum, Espen; Karlsen, Tom H.] Univ Oslo, Rikshosp, Oslo Univ Hosp, Norwegian PSC Res Ctr,Div Canc Surg & Transplant, N-0027 Oslo, Norway; [Schrumpf, Elisabeth; Melum, Espen; Karlsen, Tom H.] Univ Oslo, Rikshosp, Oslo Univ Hosp, KG Jebsen Inflammat Res Ctr,Res Inst Internal Med, N-0027 Oslo, Norway; [Schrumpf, Elisabeth; Karlsen, Tom H.] Univ Oslo, Inst Clin Med, Oslo, Norway; [Sampaziotis, Fotios; Gelson, William T. H.] Cambridge Univ Hosp NHS Fdn Trust, Dept Hepatol, Cambridge, England; [Davies, Susan] Cambridge Univ Hosp NHS Fdn Trust, Dept Histopathol, Cambridge, England; [Baker, Alastair] Kings Hlth Partners, Child Hlth Clin Acad Grouping, London, England; [Kaser, Arthur] Univ Cambridge, Dept Med, Div Gastroenterol & Hepatol, Cambridge CB2 2QQ, England; [Alexander, Graeme J.] Univ Cambridge, Dept Med, Sch Clin Med, Cambridge CB2 2QQ, England	University of Cambridge; University of Cambridge; University of Cambridge; Wellcome Trust Sanger Institute; University of Oslo; National Hospital Norway; University of Oslo; National Hospital Norway; University of Oslo; University of Cambridge; University of Cambridge; University of London; King's College London; University of Cambridge; University of Cambridge	Vallier, L (corresponding author), Univ Cambridge, Wellcome Trust Med Res Council Stem Cell Inst, Anne McLaren Lab, Dept Surg, Cambridge, England.	lv225@cam.ac.uk	Hannan, Nicholas/ABG-6497-2020; Bertero, Alessandro/AAC-7409-2021; Madrigal, Pedro/AAG-8543-2019	Vallier, Ludovic/0000-0002-3848-2602; Bertero, Alessandro/0000-0002-4919-9087; Madrigal, Pedro/0000-0003-1959-8199; Saeb-Parsy, Kourosh/0000-0002-0633-3696; Hannan, Nicholas/0000-0002-9843-1559	European Research Council; Cambridge Hospitals National Institute for Health Research Biomedical Research Center; Evelyn Trust; European Union; Wellcome Trust; UK Medical Research Council; Addenbrooke's Charitable Trust Clinical Research Training Fellowship; UK Medical Research Council-Sparks Clinical Research Training Fellowship; Medical Research Council [G0800784, G1000847, MR/L016761/1] Funding Source: researchfish; Sparks Charity [14CAM01] Funding Source: researchfish; MRC [MR/L016761/1, G1000847, G0800784] Funding Source: UKRI	European Research Council(European Research Council (ERC)European Commission); Cambridge Hospitals National Institute for Health Research Biomedical Research Center; Evelyn Trust; European Union(European Commission); Wellcome Trust(Wellcome TrustEuropean Commission); UK Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Addenbrooke's Charitable Trust Clinical Research Training Fellowship; UK Medical Research Council-Sparks Clinical Research Training Fellowship(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); Sparks Charity; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	The authors would like to thank the Cambridge BRC hiPSCs core facility for the derivation of the cystic fibrosis hiPSC line, P.-A. Tsagkaraki for her help with the generation of the manuscript figures and statistical analyses, J. Skepper, L. Carter and the University of Cambridge Advanced Imaging Centre for their help with electron microscopy, C. McGee and the Wellcome Trust Sanger Institute for their help with microarray data processing and analysis, B. McLeod for IT support and S. Brown for technical support and advice. This work was funded by European Research Council starting grant Relieve IMDs (L.V., N.H.), the Cambridge Hospitals National Institute for Health Research Biomedical Research Center (L.V., N.H., F.S.), the Evelyn Trust (N.H.), the European Union FP7 grant TissuGEN (M.C.d.B.) and core support grant from the Wellcome Trust and UK Medical Research Council to the Wellcome Trust - Medical Research Council Cambridge Stem Cell Institute. F.S. has been supported by an Addenbrooke's Charitable Trust Clinical Research Training Fellowship and a joint UK Medical Research Council-Sparks Clinical Research Training Fellowship.	Antoniou A, 2009, GASTROENTEROLOGY, V136, P2325, DOI 10.1053/j.gastro.2009.02.051; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bray SJ, 2006, NAT REV MOL CELL BIO, V7, P678, DOI 10.1038/nrm2009; Caperna TJ, 2011, IN VITRO CELL DEV-AN, V47, P218, DOI 10.1007/s11626-010-9382-3; Caroli A, 2010, CLIN J AM SOC NEPHRO, V5, P783, DOI 10.2215/CJN.05380709; Chandok N, 2012, ANN HEPATOL, V11, P819, DOI 10.1016/S1665-2681(19)31406-1; Cizkova D, 2005, PHYSIOL RES, V54, P419, DOI 10.33549/physiolres.930674; Clancy JP, 2012, THORAX, V67, P12, DOI 10.1136/thoraxjnl-2011-200393; Clotman F, 2005, GENE DEV, V19, P1849, DOI 10.1101/gad.340305; Colombo C, 2007, CURR OPIN PULM MED, V13, P529, DOI 10.1097/MCP.0b013e3282f10a16; Davies JC, 2007, BMJ-BRIT MED J, V335, P1255, DOI 10.1136/bmj.39391.713229.AD; Dianat N, 2014, HEPATOLOGY, V60, P700, DOI 10.1002/hep.27165; Du P, 2008, BIOINFORMATICS, V24, P1547, DOI 10.1093/bioinformatics/btn224; Geisler F, 2015, HEPATOLOGY, V61, P382, DOI 10.1002/hep.27268; Gigliozzi A, 2000, GASTROENTEROLOGY, V119, P1113, DOI 10.1053/gast.2000.18156; Gong AY, 2003, AM J PHYSIOL-CELL PH, V284, pC1205, DOI 10.1152/ajpcell.00313.2002; Haack A, 2013, WORLD J GASTROENTERO, V19, P8552, DOI 10.3748/wjg.v19.i46.8552; Hannan NRF, 2015, STEM CELLS DEV, V24, P1680, DOI 10.1089/scd.2014.0512; Hannan NRF, 2013, STEM CELL REP, V1, P293, DOI 10.1016/j.stemcr.2013.09.003; Hannan NRF, 2013, NAT PROTOC, V8, P430, DOI 10.1038/nprot.2012.153; Kanno N, 2000, HEPATOLOGY, V31, P555, DOI 10.1002/hep.510310302; Lazaridis KN, 2004, GASTROENTEROLOGY, V127, P1565, DOI 10.1053/j.gastro.2004.08.006; Marinelli RA, 1999, AM J PHYSIOL-GASTR L, V276, pG280, DOI 10.1152/ajpgi.1999.276.1.G280; Masyuk TV, 2007, GASTROENTEROLOGY, V132, P1104, DOI 10.1053/j.gastro.2006.12.039; Minagawa N, 2006, WORLD J GASTROENTERO, V12, P3466, DOI 10.3748/wjg.v12.i22.3466; Murray KF, 2005, HEPATOLOGY, V41, P1407, DOI 10.1002/hep.20704; Pollheimer MJ, 2011, CLIN RES HEPATOL GAS, V35, P792, DOI 10.1016/j.clinre.2011.04.014; Ramsay J. O, 2006, FUNCTIONAL DATA ANAL; Rashid ST, 2010, J CLIN INVEST, V120, P3127, DOI 10.1172/JCI43122; Raynaud P, 2011, HEPATOLOGY, V53, P1959, DOI 10.1002/hep.24292; Robinton DA, 2012, NATURE, V481, P295, DOI 10.1038/nature10761; Rowe SM, 2005, NEW ENGL J MED, V352, P1992, DOI 10.1056/NEJMra043184; Sampaziotis F, 2015, HEPATOLOGY, V62, P303, DOI 10.1002/hep.27651; Saravanamuthu SS, 2009, DEV BIOL, V332, P166, DOI 10.1016/j.ydbio.2009.05.566; Shenoy A, 2011, PEDIATR RES, V70, P447, DOI 10.1203/PDR.0b013e31822f2448; Si-Tayeb K, 2010, DEV CELL, V18, P175, DOI 10.1016/j.devcel.2010.01.011; Smyth G.K., 2004, STAT APPL GENET MOL, V3, P3, DOI [DOI 10.2202/1544-6115.1027, 10.2202/1544-6115.1027]; Staufer K, 2014, INT J MOL SCI, V15, P13529, DOI 10.3390/ijms150813529; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; Tanimizu N, 2007, MOL BIOL CELL, V18, P1472, DOI 10.1091/mbc.E06-09-0848; Temmerman F, 2011, ALIMENT PHARM THER, V34, P702, DOI 10.1111/j.1365-2036.2011.04783.x; Turnpenny PD, 2012, EUR J HUM GENET, V20, P251, DOI 10.1038/ejhg.2011.181; Van Goor F, 2011, P NATL ACAD SCI USA, V108, P18843, DOI 10.1073/pnas.1105787108; WARD CL, 1994, J BIOL CHEM, V269, P25710; Xia XF, 2006, WORLD J GASTROENTERO, V12, P3553, DOI 10.3748/wjg.v12.i22.3553; Yanai M, 2008, DEV DYNAM, V237, P1268, DOI 10.1002/dvdy.21520; Zhao DX, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006468; Zong YW, 2009, DEVELOPMENT, V136, P1727, DOI 10.1242/dev.029140	48	227	233	3	57	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156	1546-1696		NAT BIOTECHNOL	Nat. Biotechnol.	AUG	2015	33	8					845	+		10.1038/nbt.3275	http://dx.doi.org/10.1038/nbt.3275			11	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	CO6OB	26167629	Green Accepted, Green Published			2022-12-27	WOS:000359274900024
J	Satija, R; Farrell, JA; Gennert, D; Schier, AF; Regev, A				Satija, Rahul; Farrell, Jeffrey A.; Gennert, David; Schier, Alexander F.; Regev, Aviv			Spatial reconstruction of single-cell gene expression data	NATURE BIOTECHNOLOGY			English	Article							IN-SITU HYBRIDIZATION; RNA-SEQ; ZEBRAFISH EMBRYO; GENOME; FATE; TRANSCRIPTOMICS; AMPLIFICATION; GASTRULATION; LINEAGE; MODELS	Spatial localization is a key determinant of cellular fate and behavior, but methods for spatially resolved, transcriptome-wide gene expression profiling across complex tissues are lacking. RNA staining methods assay only a small number of transcripts, whereas single-cell RNA-seq, which measures global gene expression, separates cells from their native spatial context. Here we present Seurat, a computational strategy to infer cellular localization by integrating single-cell RNA-seq data with in situ RNA patterns. We applied Seurat to spatially map 851 single cells from dissociated zebrafish (Danio rerio) embryos and generated a transcriptome-wide map of spatial patterning. We confirmed Seurat's accuracy using several experimental approaches, then used the strategy to identify a set of archetypal expression patterns and spatial markers. Seurat correctly localizes rare subpopulations, accurately mapping both spatially restricted and scattered groups. Seurat will be applicable to mapping cellular localization within complex patterned tissues in diverse systems.	[Satija, Rahul; Gennert, David; Schier, Alexander F.; Regev, Aviv] Broad Inst MIT & Harvard, Cambridge, MA 02142 USA; [Farrell, Jeffrey A.; Schier, Alexander F.] Harvard Univ, Dept Mol & Cell Biol, Cambridge, MA 02138 USA; [Schier, Alexander F.] Harvard Univ, Ctr Brain Sci, Cambridge, MA 02138 USA; [Schier, Alexander F.] Harvard Univ, Harvard Stem Cell Inst, Cambridge, MA 02138 USA; [Schier, Alexander F.] Harvard Univ, Ctr Syst Biol, Cambridge, MA 02138 USA; [Regev, Aviv] MIT, Howard Hughes Med Inst, Dept Biol, Cambridge, MA USA	Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Harvard University; Harvard University; Harvard University; Harvard University; Howard Hughes Medical Institute; Massachusetts Institute of Technology (MIT)	Schier, AF (corresponding author), Broad Inst MIT & Harvard, Cambridge, MA 02142 USA.	schier@fas.harvard.edu; aregev@broad.mit.edu	huang, dezhi/ABC-6566-2021; Satija, Rahul/AAF-9564-2019; Horwitz, Marshall/AAE-8376-2021	Farrell, Jeffrey/0000-0003-4774-1562; Schier, Alexander Franz/0000-0001-7645-5325	Jane Coffin Childs Memorial Fund for Medical Research; NIH; National Human Genome Research Institute; Center of Excellence in Genome Science [1P50HG006193]; Klarman Cell Observatory; Howard Hughes Medical Institute;  [F32 HD075541]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [F32HD075541] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [P50HG006193] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM056211] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [U01MH105960] Funding Source: NIH RePORTER	Jane Coffin Childs Memorial Fund for Medical Research; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Human Genome Research Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); Center of Excellence in Genome Science; Klarman Cell Observatory; Howard Hughes Medical Institute(Howard Hughes Medical Institute); ; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	We thank members of the Regev and Schier laboratories for helpful discussion, O. Wurtzel for assistance with the R markdown scripts, A. Pauli for sharing the aplnrb plasmid, K. Rogers for donating superior, unpublished in situ hybridizations. This work was supported by F32 HD075541 (R.S.), the Jane Coffin Childs Memorial Fund for Medical Research (J.A.F.), the NIH (A.F.S.), National Human Genome Research Institute, Center of Excellence in Genome Science 1P50HG006193, the Klarman Cell Observatory and Howard Hughes Medical Institute (A.R.).	Achim K, 2015, NAT BIOTECHNOL, V33, P503, DOI 10.1038/nbt.3209; Benaglia T, 2009, J STAT SOFTW, V32, P1; Bennett JT, 2007, DEV BIOL, V304, P525, DOI 10.1016/j.ydbio.2007.01.012; Brennecke P, 2013, NAT METHODS, V10, P1093, DOI [10.1038/nmeth.2645, 10.1038/NMETH.2645]; Chung NC, 2015, BIOINFORMATICS, V31, P545, DOI 10.1093/bioinformatics/btu674; Clay H, 2005, ZEBRAFISH, V2, P105, DOI 10.1089/zeb.2005.2.105; Combs PA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071820; Deng QL, 2014, SCIENCE, V343, P193, DOI 10.1126/science.1245316; Durruthy-Durruthy R, 2014, CELL, V157, P964, DOI 10.1016/j.cell.2014.03.036; Fodor E, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070053; Furthauer M, 1999, DEV BIOL, V214, P181, DOI 10.1006/dbio.1999.9401; Gerstein MB, 2010, SCIENCE, V330, P1775, DOI 10.1126/science.1196914; Graveley BR, 2011, NATURE, V471, P473, DOI 10.1038/nature09715; Grun D, 2014, NAT METHODS, V11, P637, DOI [10.1038/NMETH.2930, 10.1038/nmeth.2930]; Hashimshony T, 2012, CELL REP, V2, P666, DOI 10.1016/j.celrep.2012.08.003; HO RK, 1993, SCIENCE, V261, P109, DOI 10.1126/science.8316841; Howe DG, 2013, NUCLEIC ACIDS RES, V41, pD854, DOI 10.1093/nar/gks938; Islam S, 2011, GENOME RES, V21, P1160, DOI 10.1101/gr.110882.110; Jaitin DA, 2014, SCIENCE, V343, P776, DOI 10.1126/science.1247651; Junker JP, 2014, CELL, V159, P662, DOI 10.1016/j.cell.2014.09.038; Kawahara A, 2000, P NATL ACAD SCI USA, V97, P12121, DOI 10.1073/pnas.97.22.12121; Kharchenko PV, 2014, NAT METHODS, V11, P740, DOI [10.1038/NMETH.2967, 10.1038/nmeth.2967]; Kikuchi Y, 2001, GENE DEV, V15, P1493, DOI 10.1101/gad.892301; KIMMEL CB, 1990, DEVELOPMENT, V108, P581; KIMMEL CB, 1995, DEV DYNAM, V203, P253, DOI 10.1002/aja.1002030302; Kudoh T, 2001, GENOME RES, V11, P1979, DOI 10.1101/gr.209601; Le Guellec D, 2004, INT J DEV BIOL, V48, P217, DOI 10.1387/ijdb.15272388; Lee JH, 2014, SCIENCE, V343, P1360, DOI 10.1126/science.1250212; Lovatt D, 2014, NAT METHODS, V11, P190, DOI [10.1038/NMETH.2804, 10.1038/nmeth.2804]; McDavid A, 2013, BIOINFORMATICS, V29, P461, DOI 10.1093/bioinformatics/bts714; Pauli A, 2014, SCIENCE, V343, P746, DOI 10.1126/science.1248636; Pauli A, 2012, GENOME RES, V22, P577, DOI 10.1101/gr.133009.111; Pollen AA, 2014, NAT BIOTECHNOL, V32, P1053, DOI 10.1038/nbt.2967; Ramskold D, 2012, NAT BIOTECHNOL, V30, P777, DOI 10.1038/nbt.2282; Roussigne M, 2012, DEV NEUROBIOL, V72, P269, DOI 10.1002/dneu.20885; Schier AF, 2005, ANNU REV GENET, V39, P561, DOI 10.1146/annurev.genet.37.110801.143752; Schier AF, 2013, NATURE, V496, P443, DOI 10.1038/nature12094; Seo HC, 1998, MECH DEVELOP, V73, P45, DOI 10.1016/S0925-4773(98)00028-8; Shalek AK, 2014, NATURE, V510, P363, DOI 10.1038/nature13437; Shalek AK, 2013, NATURE, V498, P236, DOI 10.1038/nature12172; Solnica-Krezel L, 2012, ANNU REV CELL DEV BI, V28, P687, DOI 10.1146/annurev-cellbio-092910-154043; Soumillon M., 2014, PREPRINT; STACHEL SE, 1993, DEVELOPMENT, V117, P1261; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Thisse B, 2004, METHOD CELL BIOL, V77, P505; THISSE C, 1993, DEVELOPMENT, V119, P1203; Tibshirani R, 1996, J ROY STAT SOC B MET, V58, P267, DOI 10.1111/j.2517-6161.1996.tb02080.x; Trapnell C, 2014, NAT BIOTECHNOL, V32, P381, DOI 10.1038/nbt.2859; Treutlein B, 2014, NATURE, V509, P371, DOI 10.1038/nature13173; Yoon C, 1997, DEVELOPMENT, V124, P3157	50	1874	1923	35	246	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156	1546-1696		NAT BIOTECHNOL	Nat. Biotechnol.	MAY	2015	33	5					495	U206		10.1038/nbt.3192	http://dx.doi.org/10.1038/nbt.3192			14	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	CH8VP	25867923	Green Submitted, Green Accepted, Bronze			2022-12-27	WOS:000354314500030
J	Moncunill, V; Gonzalez, S; Bea, S; Andrieux, LO; Salaverria, I; Royo, C; Martinez, L; Puiggros, M; Segura-Wang, M; Stutz, AM; Navarro, A; Royo, R; Gelpi, JL; Gut, IG; Lopez-Otin, C; Orozco, M; Korbel, J; Campo, E; Puente, XS; Torrents, D				Moncunill, Valenti; Gonzalez, Santi; Bea, Silvia; Andrieux, Lise O.; Salaverria, Itziar; Royo, Cristina; Martinez, Laura; Puiggros, Montserrat; Segura-Wang, Maia; Stuetz, Adrian M.; Navarro, Alba; Royo, Romina; Gelpi, Josep L.; Gut, Ivo G.; Lopez-Otin, Carlos; Orozco, Modesto; Korbel, Jan; Campo, Elias; Puente, Xose S.; Torrents, David			Comprehensive characterization of complex structural variations in cancer by directly comparing genome sequence reads	NATURE BIOTECHNOLOGY			English	Article							PAIRED-END; MUTATIONS; REARRANGEMENTS; RESOLUTION; LANDSCAPE; EVOLUTION; LYMPHOMA	The development of high-throughput sequencing technologies has advanced our understanding of cancer. However, characterizing somatic structural variants in tumor genomes is still challenging because current strategies depend on the initial alignment of reads to a reference genome. Here, we describe SMUFIN (somatic mutation finder), a single program that directly compares sequence reads from normal and tumor genomes to accurately identify and characterize a range of somatic sequence variation, from single-nucleotide variants (SNV) to large structural variants at base pair resolution. Performance tests on modeled tumor genomes showed average sensitivity of 92% and 74% for SNVs and structural variants, with specificities of 95% and 91%, respectively. Analyses of aggressive forms of solid and hematological tumors revealed that SMUFIN identifies breakpoints associated with chromothripsis and chromoplexy with high specificity. SMUFIN provides an integrated solution for the accurate, fast and comprehensive characterization of somatic sequence variation in cancer.	[Moncunill, Valenti; Gonzalez, Santi; Andrieux, Lise O.; Martinez, Laura; Puiggros, Montserrat; Royo, Romina; Gelpi, Josep L.; Orozco, Modesto; Torrents, David] Barcelona Supercomp Ctr, Joint IRB BSC Program Computat Biol, Barcelona, Spain; [Bea, Silvia; Salaverria, Itziar; Royo, Cristina; Navarro, Alba; Campo, Elias] Univ Barcelona, Hosp Clin, Inst Invest Biomed August Pi & Sunyer IDIBAPS, Dept Pathol,Hematopathol Unit, Barcelona, Spain; [Puiggros, Montserrat; Royo, Romina; Gelpi, Josep L.] Natl Inst Bioinformat, Barcelona, Spain; [Stuetz, Adrian M.; Korbel, Jan] European Mol Biol Lab, Genome Biol Res Unit, D-69012 Heidelberg, Germany; [Gelpi, Josep L.; Orozco, Modesto] Univ Barcelona, Dept Biochem & Mol Biol, Barcelona, Spain; [Gut, Ivo G.] CNAG, Barcelona, Spain; [Lopez-Otin, Carlos; Puente, Xose S.] Univ Oviedo, IUOPA, Dept Bioquim & Biol Mol, Oviedo, Spain; [Orozco, Modesto] IRB Barcelona, Barcelona, Spain; [Campo, Elias; Torrents, David] ICREA, Barcelona, Spain	Barcelona Institute of Science & Technology; Institute for Research in Biomedicine - IRB Barcelona; Universitat Politecnica de Catalunya; Barcelona Supercomputer Center (BSC-CNS); University of Barcelona; Hospital Clinic de Barcelona; IDIBAPS; European Molecular Biology Laboratory (EMBL); University of Barcelona; University of Oviedo; Barcelona Institute of Science & Technology; Institute for Research in Biomedicine - IRB Barcelona; ICREA	Torrents, D (corresponding author), Barcelona Supercomp Ctr, Joint IRB BSC Program Computat Biol, Barcelona, Spain.	david.torrents@bsc.es	López-Otín, Carlos/AAB-2106-2020; Gut, Ivo/ABF-3188-2020; Campo, Elias/AAC-5593-2019; Puente, Xosé S./ADB-0672-2022; SALAVERRIA, ITZIAR/L-2246-2015; SALAVERRIA, ITZIAR/AAW-9019-2021; Royo, Cristina/H-3193-2015; bea, silvia/K-7699-2014; Gelpí, Josep Ll./M-6401-2013; Navarro, Alba/H-2611-2015; Campo, elias/O-7192-2016; Torrents, David/G-5785-2015	López-Otín, Carlos/0000-0001-6964-1904; Gut, Ivo/0000-0001-7219-632X; Campo, Elias/0000-0001-9850-9793; Puente, Xosé S./0000-0001-9525-1483; SALAVERRIA, ITZIAR/0000-0002-2427-9822; Royo, Cristina/0000-0002-1214-4656; bea, silvia/0000-0001-7192-2385; Gelpí, Josep Ll./0000-0002-0566-7723; Navarro, Alba/0000-0002-4041-0974; Campo, elias/0000-0001-9850-9793; Torrents, David/0000-0002-6086-9037; Stuetz, Adrian/0000-0001-7650-3470; Royo, Romina/0000-0003-3493-0874; Puiggros, Montserrat/0000-0001-5034-7924; Gonzalez Rosado, Santiago/0000-0001-5685-4580; Segura-Wang, Maia/0000-0003-2424-618X	Spanish Ministry of Economy and Competitiveness (MINECO) through the Instituto de Salud Carlos III (ISCIII); Red Tematica de Investigacion del Cancer (RTICC) of the ISCIII [RD12/0036/0036]; National Institute of Bioinformatics (INB); Ministerio de Economia y Competitividad; Secretaria De Estado De Investigacion; Desarrollo e Innovacion PLAN NACIONAL de I+D+i; Subprograma de Apoyo a Centros y Unidades de excelencia Severo Ochoa; Plan Nacional [SAF12/38432]; Generalitat de Catalunya AGAUR [2009-SGR-992]; Fondo de Investigaciones Sanitarias [PI11/01177]; Association for International Cancer Research [12-0142]; European Commission [Health-F2-2010-260791]; ICREA Funding Source: Custom; Worldwide Cancer Research [12-0142] Funding Source: researchfish	Spanish Ministry of Economy and Competitiveness (MINECO) through the Instituto de Salud Carlos III (ISCIII); Red Tematica de Investigacion del Cancer (RTICC) of the ISCIII; National Institute of Bioinformatics (INB); Ministerio de Economia y Competitividad(Spanish Government); Secretaria De Estado De Investigacion; Desarrollo e Innovacion PLAN NACIONAL de I+D+i; Subprograma de Apoyo a Centros y Unidades de excelencia Severo Ochoa; Plan Nacional; Generalitat de Catalunya AGAUR(Agencia de Gestio D'Ajuts Universitaris de Recerca Agaur (AGAUR)Generalitat de Catalunya); Fondo de Investigaciones Sanitarias(Instituto de Salud Carlos III); Association for International Cancer Research; European Commission(European CommissionEuropean Commission Joint Research Centre); ICREA(ICREA); Worldwide Cancer Research	The ICGC-CLL Genome Consortium is funded by the Spanish Ministry of Economy and Competitiveness (MINECO) through the Instituto de Salud Carlos III (ISCIII), Red Tematica de Investigacion del Cancer (RTICC) of the ISCIII (RD12/0036/0036) and National Institute of Bioinformatics (INB). This study was also supported by Ministerio de Economia y Competitividad, Secretaria De Estado De Investigacion, Desarrollo e Innovacion PLAN NACIONAL de I+D+i 2008-2011, Subprograma de Apoyo a Centros y Unidades de excelencia Severo Ochoa; and Plan Nacional SAF12/38432; Generalitat de Catalunya AGAUR 2009-SGR-992; Fondo de Investigaciones Sanitarias (PI11/01177); Association for International Cancer Research (12-0142). J.O.K. and M.S.W. were supported by the European Commission (Health-F2-2010-260791). C.L.-O. is an investigator of the Botin Foundation. E.C. and M.O. are ICREA Academia Researchers. We also thank S. Guijarro and C. Gomez for their excellent technical assistance.	Alexandrov LB, 2013, NATURE, V500, P415, DOI 10.1038/nature12477; Altshuler DM, 2012, NATURE, V491, P56, DOI 10.1038/nature11632; Baca SC, 2013, CELL, V153, P666, DOI 10.1016/j.cell.2013.03.021; Bea S, 2013, P NATL ACAD SCI USA, V110, P18250, DOI 10.1073/pnas.1314608110; Chen K, 2009, NAT METHODS, V6, P677, DOI [10.1038/NMETH.1363, 10.1038/nmeth.1363]; Cibulskis K, 2013, NAT BIOTECHNOL, V31, P213, DOI 10.1038/nbt.2514; Degner JF, 2009, BIOINFORMATICS, V25, P3207, DOI 10.1093/bioinformatics/btp579; Frampton GM, 2013, NAT BIOTECHNOL, V31, P1023, DOI 10.1038/nbt.2696; Gonzalez-Perez A, 2013, NAT METHODS, V10, P1081, DOI [10.1038/NMETH.2642, 10.1038/nmeth.2642]; Kandoth C, 2013, NATURE, V502, P333, DOI 10.1038/nature12634; Korbel JO, 2013, CELL, V152, P1226, DOI 10.1016/j.cell.2013.02.023; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Puente XS, 2011, NATURE, V475, P101, DOI 10.1038/nature10113; Rausch T, 2012, BIOINFORMATICS, V28, pI333, DOI 10.1093/bioinformatics/bts378; Rausch T, 2012, CELL, V148, P59, DOI 10.1016/j.cell.2011.12.013; Richter J, 2012, NAT GENET, V44, P1316, DOI 10.1038/ng.2469; Shen MM, 2013, CANCER CELL, V23, P567, DOI 10.1016/j.ccr.2013.04.025; Wang JM, 2011, NAT METHODS, V8, P652, DOI [10.1038/nmeth.1628, 10.1038/NMETH.1628]; Ye K, 2009, BIOINFORMATICS, V25, P2865, DOI 10.1093/bioinformatics/btp394	19	59	61	0	22	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156	1546-1696		NAT BIOTECHNOL	Nat. Biotechnol.	NOV	2014	32	11					1106	1112		10.1038/nbt.3027	http://dx.doi.org/10.1038/nbt.3027			7	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	AT5IL	25344728	Bronze			2022-12-27	WOS:000344977000015
J	Ma'ayan, A; Duan, QN				Ma'ayan, Avi; Duan, Qiaonan			A blueprint of cell identity	NATURE BIOTECHNOLOGY			English	Editorial Material							CONVERSION; NETWORK; BIOLOGY		[Ma'ayan, Avi; Duan, Qiaonan] Icahn Sch Med Mt Sinai, Dept Pharmacol & Syst Therapeut, New York, NY 10029 USA	Icahn School of Medicine at Mount Sinai	Ma'ayan, A (corresponding author), Icahn Sch Med Mt Sinai, Dept Pharmacol & Syst Therapeut, New York, NY 10029 USA.	avi.maayan@mssm.edu	Ma'ayan, Avi/AAG-3131-2019	Ma'ayan, Avi/0000-0002-6904-1017	NCI NIH HHS [U54 CA189201] Funding Source: Medline; NHLBI NIH HHS [U54 HL127624] Funding Source: Medline; NIGMS NIH HHS [R01 GM098316] Funding Source: Medline; NATIONAL CANCER INSTITUTE [U54CA189201] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [U54HL127624] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM098316] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Cahan P, 2014, CELL, V158, P903, DOI 10.1016/j.cell.2014.07.020; Dunn SJ, 2014, SCIENCE, V344, P1156, DOI 10.1126/science.1248882; Faith JJ, 2007, PLOS BIOL, V5, P54, DOI 10.1371/journal.pbio.0050008; Ma'ayan A, 2014, TRENDS PHARMACOL SCI, V35, P450, DOI 10.1016/j.tips.2014.07.001; Morris SA, 2014, CELL, V158, P889, DOI 10.1016/j.cell.2014.07.021; Qiu P, 2011, NAT BIOTECHNOL, V29, P886, DOI 10.1038/nbt.1991; Sekiya S, 2011, NATURE, V475, P390, DOI 10.1038/nature10263; Waddington C. H., 2014, STRATEGY GENES; Xu HL, 2014, PLOS COMPUT BIOL, V10, DOI 10.1371/journal.pcbi.1003777; Xu HL, 2010, WIRES SYST BIOL MED, V2, P708, DOI 10.1002/wsbm.93	10	2	2	0	4	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156	1546-1696		NAT BIOTECHNOL	Nat. Biotechnol.	OCT	2014	32	10					1007	1008		10.1038/nbt.3035	http://dx.doi.org/10.1038/nbt.3035			2	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	AR7MM	25299921	Green Accepted			2022-12-27	WOS:000343763800016
J	Gil-Humanes, J; Voytas, DF				Gil-Humanes, Javier; Voytas, Daniel F.			Wheat rescued from fungal disease	NATURE BIOTECHNOLOGY			English	Editorial Material							POWDERY MILDEW; RESISTANCE; PROTEIN		[Gil-Humanes, Javier] Univ Minnesota, Dept Genet Cell Biol & Dev, Minneapolis, MN 55404 USA; Univ Minnesota, Ctr Genome Engn, Minneapolis, MN USA	University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities	Gil-Humanes, J (corresponding author), Univ Minnesota, Dept Genet Cell Biol & Dev, Minneapolis, MN 55404 USA.	voytas@umn.edu	Gil-Humanes, Javier/AAU-4381-2020	Voytas, Daniel/0000-0002-4944-1224; Gil Humanes, Javier/0000-0002-7283-6945				Bai YL, 2008, MOL PLANT MICROBE IN, V21, P30, DOI 10.1094/MPMI-21-1-0030; Baltes NJ, 2014, PLANT CELL, V26, P151, DOI 10.1105/tpc.113.119792; Bockus W.W., 2010, COMPENDIUM WHEAT DIS; Collins NC, 2003, NATURE, V425, P973, DOI 10.1038/nature02076; Consonni C, 2006, NAT GENET, V38, P716, DOI 10.1038/ng1806; Ledford H, 2013, NATURE, V500, P389, DOI 10.1038/500389a; Mayer KFX, 2014, SCIENCE, V345, DOI 10.1126/science.1251788; Piffanelli P, 2004, NATURE, V430, P887, DOI 10.1038/nature02781; Voytas DF, 2013, ANNU REV PLANT BIOL, V64, P327, DOI 10.1146/annurev-arplant-042811-105552; Wang YP, 2014, NAT BIOTECHNOL, V32, P947, DOI 10.1038/nbt.2969	10	8	11	0	20	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156	1546-1696		NAT BIOTECHNOL	Nat. Biotechnol.	SEP	2014	32	9					886	887		10.1038/nbt.3013	http://dx.doi.org/10.1038/nbt.3013			2	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	AQ2FD	25203039				2022-12-27	WOS:000342600300026
J	Choi, SY; Park, SJ; Kim, WJ; Yang, JE; Lee, H; Shin, J; Lee, SY				Choi, So Young; Park, Si Jae; Kim, Won Jun; Yang, Jung Eun; Lee, Hyuk; Shin, Jihoon; Lee, Sang Yup			One-step fermentative production of poly(lactate-co-glycolate) from carbohydrates in Escherichia coli	NATURE BIOTECHNOLOGY			English	Article							GLYCOLIC ACID PRODUCTION; POLYLACTIC ACID; BIOSYNTHESIS; POLYESTERS; POLYHYDROXYALKANOATES; METABOLISM; COPOLYMERS; POLYMERS; SYNTHASE; PATHWAY	Poly(lactate-co-glycolate) (PLGA) is a widely used biodegradable and biocompatible synthetic polymer. Here we report one-step fermentative production of PLGA in engineered Escherichia coli harboring an evolved polyhydroxyalkanoate (PHA) synthase that polymerizes D-lactyl-CoA and glycolyl-CoA into PLGA. Introduction of the Dahms pathway enables production of glycolate from xylose. Deletion of ptsG enables simultaneous utilization of glucose and xylose. An evolved propionyl-CoA transferase converts D-lactate and glycolate to D-lactyl-CoA and glycolyl-CoA, respectively. Deletion of adhE, frdB, pflB and poxB prevents by-product formation. We also demonstrate modulation of the monomer fractions in PLGA by overexpressing ldhA and deleting dld to increase the proportion of D-lactate or by deleting aceB, glcB, glcD, glcE, glcF and glcG to increase the proportion of glycolate. Incorporation of 2-hydroxybutyrate is prevented by deleting ilvA or feeding strains with l-isoleucine. The utility of our approach for generating diverse forms of PLGA is shown by the production of copolymers containing 3-hydroxybutyrate, 4-hydroxybutyrate or 2-hydroxyisovalerate.	[Choi, So Young; Kim, Won Jun; Yang, Jung Eun; Lee, Sang Yup] Korea Adv Inst Sci & Technol, Ctr Syst & Synthet Biotechnol, Dept Chem & Biomol Engn,Plus Program BK21, Metab & Biomol Engn Natl Res Lab,BioProc Engn Res, Daejeon, South Korea; [Choi, So Young; Kim, Won Jun; Yang, Jung Eun; Lee, Sang Yup] Korea Adv Inst Sci & Technol, Inst BioCentury, Daejeon, South Korea; [Park, Si Jae] Myongji Univ, Dept Environm Engn & Energy, Yongin, Gyeonggido, South Korea; [Lee, Hyuk] Korea Res Inst Chem Technol, Div Drug Discovery Res, Daejeon, South Korea; [Shin, Jihoon] Korea Res Inst Chem Technol, Green Chem & Engn Div, Ctr Biobased Chem, Daejeon, South Korea	Korea Advanced Institute of Science & Technology (KAIST); Korea Advanced Institute of Science & Technology (KAIST); Myongji University; Korea Research Institute of Chemical Technology (KRICT); Korea Research Institute of Chemical Technology (KRICT)	Lee, SY (corresponding author), Korea Adv Inst Sci & Technol, Ctr Syst & Synthet Biotechnol, Dept Chem & Biomol Engn,Plus Program BK21, Metab & Biomol Engn Natl Res Lab,BioProc Engn Res, Daejeon, South Korea.; Lee, SY (corresponding author), Korea Adv Inst Sci & Technol, Inst BioCentury, Daejeon, South Korea.	leesy@kaist.ac.kr	Lee, Sang Yup/C-1526-2011; 양, 정은/ABV-6071-2022	Lee, Sang Yup/0000-0003-0599-3091; 	Technology Development Program to Solve Climate Changes (Systems Metabolic Engineering for Biorefineries) of the Ministry of Science, ICT and Future Planning (MSIP) through the National Research Foundation of Korea [NRF-2012M1A2A2026556, NRF-2012M1A2A2026557]	Technology Development Program to Solve Climate Changes (Systems Metabolic Engineering for Biorefineries) of the Ministry of Science, ICT and Future Planning (MSIP) through the National Research Foundation of Korea	We thank S. Choi for the pTrc99s4 plasmid. This work was supported by the Technology Development Program to Solve Climate Changes (Systems Metabolic Engineering for Biorefineries) of the Ministry of Science, ICT and Future Planning (MSIP) through the National Research Foundation of Korea ((NRF-2012M1A2A2026556 and NRF-2012M1A2A2026557) to S.Y.C., W.J.K., J.E.Y., S.J.P. and S.Y.L.).	BRAUNEGG G, 1978, EUR J APPL MICROBIOL, V6, P29, DOI 10.1007/BF00500854; Cao H, 2012, INT J MOL SCI, V13, P12232, DOI 10.3390/ijms131012232; Chambellon E, 2009, J BACTERIOL, V191, P873, DOI 10.1128/JB.01114-08; Choi JI, 1999, BIOTECHNOL BIOENG, V62, P546, DOI 10.1002/(SICI)1097-0290(19990305)62:5<546::AID-BIT6>3.0.CO;2-0; Datsenko KA, 2000, P NATL ACAD SCI USA, V97, P6640, DOI 10.1073/pnas.120163297; Jung YK, 2011, J BIOTECHNOL, V151, P94, DOI 10.1016/j.jbiotec.2010.11.009; Jung YK, 2010, BIOTECHNOL BIOENG, V105, P161, DOI 10.1002/bit.22548; Kataoka M, 2001, BIOSCI BIOTECH BIOCH, V65, P2265, DOI 10.1271/bbb.65.2265; Kim JM, 2008, FEMS MICROBIOL LETT, V278, P78, DOI 10.1111/j.1574-6968.2007.00981.x; Koivistoinen OM, 2013, MICROB CELL FACT, V12, DOI 10.1186/1475-2859-12-82; Le Meur S, 2013, MICROB CELL FACT, V12, DOI 10.1186/1475-2859-12-123; Lee SY, 2015, NAT BIOTECHNOL, V33, P1061, DOI 10.1038/nbt.3365; Li ZJ, 2010, METAB ENG, V12, P352, DOI 10.1016/j.ymben.2010.03.003; Lindenkamp N, 2013, APPL MICROBIOL BIOT, V97, P7699, DOI 10.1007/s00253-012-4624-9; Liu HW, 2013, APPL MICROBIOL BIOT, V97, P3409, DOI 10.1007/s00253-012-4618-7; Makadia HK, 2011, POLYMERS-BASEL, V3, P1377, DOI 10.3390/polym3031377; Martin CH, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2418; Matsumoto K, 2011, J BIOTECHNOL, V156, P214, DOI 10.1016/j.jbiotec.2011.07.040; Palmeros B, 2000, GENE, V247, P255, DOI 10.1016/S0378-1119(00)00075-5; Park JW, 2007, J MASS SPECTROM, V42, P1136, DOI 10.1002/jms.1240; Park SJ, 2013, METAB ENG, V20, P20, DOI 10.1016/j.ymben.2013.08.002; Park SJ, 2012, APPL MICROBIOL BIOT, V93, P273, DOI 10.1007/s00253-011-3530-x; PARK TG, 1995, BIOMATERIALS, V16, P1123, DOI 10.1016/0142-9612(95)93575-X; Sambrook J., 2001, MOL CLONING LAB MANU; Sodergard A, 2002, PROG POLYM SCI, V27, P1123, DOI 10.1016/s0079-6700(02)00012-6; Stephens C, 2007, J BACTERIOL, V189, P2181, DOI 10.1128/JB.01438-06; Taguchi S, 2008, P NATL ACAD SCI USA, V105, P17323, DOI 10.1073/pnas.0805653105; Woodruff MA, 2010, PROG POLYM SCI, V35, P1217, DOI 10.1016/j.progpolymsci.2010.04.002; Wu SJ, 2008, BIOTECHNOL BIOENG, V99, P717, DOI 10.1002/bit.21643; Wu XS, 2001, J BIOMAT SCI-POLYM E, V12, P21, DOI 10.1163/156856201744425; Yang JE, 2013, MICROB BIOTECHNOL, V6, P621, DOI 10.1111/1751-7915.12066; Yang TH, 2010, BIOTECHNOL BIOENG, V105, P150, DOI 10.1002/bit.22547; Zahoor A, 2014, J BIOTECHNOL, V192, P366, DOI 10.1016/j.jbiotec.2013.12.020; Zhang KC, 2008, P NATL ACAD SCI USA, V105, P20653, DOI 10.1073/pnas.0807157106	34	134	148	12	170	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156	1546-1696		NAT BIOTECHNOL	Nat. Biotechnol.	APR	2016	34	4					435	+		10.1038/nbt.3485	http://dx.doi.org/10.1038/nbt.3485			8	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	DI6NL	26950748				2022-12-27	WOS:000373616100026
J	Liu, LF; Sommermeyer, D; Cabanov, A; Kosasih, P; Hill, T; Riddell, SR				Liu, Lingfeng; Sommermeyer, Daniel; Cabanov, Alexandra; Kosasih, Paula; Hill, Tyler; Riddell, Stanley R.			Inclusion of Strep-tag II in design of antigen receptors for T-cell immunotherapy	NATURE BIOTECHNOLOGY			English	Article							RECOGNITION; LYMPHOCYTES; ANTIBODIES; ANTI-CD3; AFFINITY; CLONES; DOMAIN	Adoptive immunotherapy with genetically engineered T cells has the potential to treat cancer and other diseases. The introduction of Strep-tag II sequences into specific sites in synthetic chimeric antigen receptors or natural T-cell receptors of diverse specificities provides engineered T cells with a marker for identification and rapid purification, a method for tailoring spacer length of chimeric receptors for optimal function, and a functional element for selective antibodycoated, microbead-driven, large-scale expansion. These receptor designs facilitate cGMP manufacturing of pure populations of engineered T cells for adoptive T-cell therapies and enable in vivo tracking and retrieval of transferred cells for downstream research applications.	[Liu, Lingfeng; Sommermeyer, Daniel; Cabanov, Alexandra; Kosasih, Paula; Hill, Tyler; Riddell, Stanley R.] Fred Hutchinson Canc Res Ctr, Program Immunol, 1124 Columbia St, Seattle, WA 98104 USA; [Riddell, Stanley R.] Univ Washington, Dept Med, Seattle, WA USA; [Riddell, Stanley R.] Tech Univ Munich, Inst Adv Study, D-80290 Munich, Germany	Fred Hutchinson Cancer Center; University of Washington; University of Washington Seattle; Technical University of Munich	Riddell, SR (corresponding author), Fred Hutchinson Canc Res Ctr, Program Immunol, 1124 Columbia St, Seattle, WA 98104 USA.; Riddell, SR (corresponding author), Univ Washington, Dept Med, Seattle, WA USA.; Riddell, SR (corresponding author), Tech Univ Munich, Inst Adv Study, D-80290 Munich, Germany.	sriddell@fredhutch.org	Hill, Tyler/B-9138-2017	Hill, Tyler/0000-0002-9192-8327	Walker Immunotherapy Fellowship; Fred Hutchinson Cancer Research Center (FHCRC) Synergy Technology Fund; National Institute of Health (NIH) grants [CA136551, CA114536, P50 CA138293]; NATIONAL CANCER INSTITUTE [R01CA114536, R01CA136551, P50CA138293] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [U54DK106829] Funding Source: NIH RePORTER	Walker Immunotherapy Fellowship; Fred Hutchinson Cancer Research Center (FHCRC) Synergy Technology Fund; National Institute of Health (NIH) grants; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	The authors thank M. Comstock, L. Perkins and D.E. Parrilla for expertise in carrying out the mouse experiments, R.L. Lawler for conducting Luminex assays, B. Hoffstrom and N. Boiani for assistance in developing the anti-Strep-tag II monoclonal antibody, and D. Hamm in Adaptive Biotechnologies for analysis of TCR sequencing data. This work was supported by a Walker Immunotherapy Fellowship, the Fred Hutchinson Cancer Research Center (FHCRC) Synergy Technology Fund, and National Institute of Health (NIH) grants CA136551, CA114536 and P50 CA138293.	Brentjens RJ, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3005930; Hudecek M, 2015, CANCER IMMUNOL RES, V3, P125, DOI 10.1158/2326-6066.CIR-14-0127; Hudecek M, 2013, CLIN CANCER RES, V19, P3153, DOI 10.1158/1078-0432.CCR-13-0330; Kalamasz D, 2004, J IMMUNOTHER, V27, P405, DOI 10.1097/00002371-200409000-00010; Kieback E, 2008, P NATL ACAD SCI USA, V105, P623, DOI 10.1073/pnas.0710198105; Kochenderfer JN, 2015, J CLIN ONCOL, V33, P540, DOI 10.1200/JCO.2014.56.2025; Korndorfer IP, 2002, PROTEIN SCI, V11, P883, DOI 10.1110/ps.4150102; Kuball J, 2007, BLOOD, V109, P2331, DOI 10.1182/blood-2006-05-023069; Leisegang M, 2008, J MOL MED, V86, P573, DOI 10.1007/s00109-008-0317-3; Levine BL, 1996, SCIENCE, V272, P1939, DOI 10.1126/science.272.5270.1939; Maude SL, 2014, HEMATOL-AM SOC HEMAT, P559, DOI 10.1182/asheducation-2014.1.559; Maude SL, 2014, NEW ENGL J MED, V371, P1507, DOI 10.1056/NEJMoa1407222; Morgan RA, 2006, SCIENCE, V314, P126, DOI 10.1126/science.1129003; RIDDELL SR, 1990, J IMMUNOL METHODS, V128, P189, DOI 10.1016/0022-1759(90)90210-M; Robbins PF, 2015, CLIN CANCER RES, V21, P1019, DOI 10.1158/1078-0432.CCR-14-2708; Robins H, 2012, J IMMUNOL METHODS, V375, P14, DOI 10.1016/j.jim.2011.09.001; Robins HS, 2009, BLOOD, V114, P4099, DOI 10.1182/blood-2009-04-217604; Sommermeyer D, 2010, J IMMUNOL, V184, P6223, DOI 10.4049/jimmunol.0902055; Stemberger C, 2014, BLOOD, V124, P628, DOI 10.1182/blood-2013-12-547349; Wang W, 2006, CANCER RES, V66, P6826, DOI 10.1158/0008-5472.CAN-05-3529; Wang XL, 2011, BLOOD, V118, P1255, DOI 10.1182/blood-2011-02-337360; Yam PY, 2002, MOL THER, V5, P479, DOI 10.1006/mthe.2002.0558	22	39	52	1	24	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156	1546-1696		NAT BIOTECHNOL	Nat. Biotechnol.	APR	2016	34	4					430	+		10.1038/nbt.3461	http://dx.doi.org/10.1038/nbt.3461			7	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	DI6NL	26900664	Green Accepted			2022-12-27	WOS:000373616100025
J	Vegas, AJ; Veiseh, O; Doloff, JC; Ma, ML; Tam, HH; Bratlie, K; Li, J; Bader, AR; Langan, E; Olejnik, K; Fenton, P; Kang, JW; Hollister-Locke, J; Bochenek, MA; Chiu, A; Siebert, S; Tang, K; Jhunjhunwala, S; Aresta-Dasilva, S; Dholakia, N; Thakrar, R; Vietti, T; Chen, M; Cohen, J; Siniakowicz, K; Qi, MRG; McGarrigle, J; Lyle, S; Harlan, DM; Greiner, DL; Oberholzer, J; Weir, GC; Langer, R; Anderson, DG				Vegas, Arturo J.; Veiseh, Omid; Doloff, Joshua C.; Ma, Minglin; Tam, Hok Hei; Bratlie, Kaitlin; Li, Jie; Bader, Andrew R.; Langan, Erin; Olejnik, Karsten; Fenton, Patrick; Kang, Jeon Woong; Hollister-Locke, Jennifer; Bochenek, Matthew A.; Chiu, Alan; Siebert, Sean; Tang, Katherine; Jhunjhunwala, Siddharth; Aresta-Dasilva, Stephanie; Dholakia, Nimit; Thakrar, Raj; Vietti, Thema; Chen, Michael; Cohen, Josh; Siniakowicz, Karolina; Qi, Meirigeng; McGarrigle, James; Lyle, Stephen; Harlan, David M.; Greiner, Dale L.; Oberholzer, Jose; Weir, Gordon C.; Langer, Robert; Anderson, Daniel G.			Combinatorial hydrogel library enables identification of materials that mitigate the foreign body response in primates	NATURE BIOTECHNOLOGY			English	Article							ALGINATE-BASED MICROCAPSULES; INFLAMMATORY RESPONSES; CONFOCAL RAMAN; ISLETS; ENCAPSULATION; PURIFICATION; ACTIVATION; MECHANISMS; EFFICACY	The foreign body response is an immune-mediated reaction that can lead to the failure of implanted medical devices and discomfort for the recipient(1-6). There is a critical need for biomaterials that overcome this key challenge in the development of medical devices. Here we use a combinatorial approach for covalent chemical modification to generate a large library of variants of one of the most widely used hydrogel biomaterials, alginate. We evaluated the materials in vivo and identified three triazole-containing analogs that substantially reduce foreign body reactions in both rodents and, for at least 6 months, in non-human primates. The distribution of the triazole modification creates a unique hydrogel surface that inhibits recognition by macrophages and fibrous deposition. In addition to the utility of the compounds reported here, our approach may enable the discovery of other materials that mitigate the foreign body response.	[Vegas, Arturo J.; Veiseh, Omid; Doloff, Joshua C.; Ma, Minglin; Tam, Hok Hei; Bratlie, Kaitlin; Li, Jie; Bader, Andrew R.; Langan, Erin; Olejnik, Karsten; Fenton, Patrick; Chiu, Alan; Siebert, Sean; Tang, Katherine; Jhunjhunwala, Siddharth; Aresta-Dasilva, Stephanie; Dholakia, Nimit; Thakrar, Raj; Vietti, Thema; Chen, Michael; Langer, Robert; Anderson, Daniel G.] MIT, David H Koch Inst Integrat Canc Res, 77 Massachusetts Ave, Cambridge, MA 02139 USA; [Vegas, Arturo J.; Doloff, Joshua C.; Ma, Minglin; Li, Jie; Bader, Andrew R.; Langan, Erin; Olejnik, Karsten; Fenton, Patrick; Chiu, Alan; Siebert, Sean; Tang, Katherine; Jhunjhunwala, Siddharth; Aresta-Dasilva, Stephanie; Dholakia, Nimit; Thakrar, Raj; Vietti, Thema; Chen, Michael; Langer, Robert; Anderson, Daniel G.] Boston Childrens Hosp, Dept Anesthesiol, Boston, MA USA; [Veiseh, Omid; Tam, Hok Hei; Bratlie, Kaitlin; Langer, Robert; Anderson, Daniel G.] MIT, Dept Chem Engn, Cambridge, MA 02139 USA; [Kang, Jeon Woong] MIT, Spect Lab, 77 Massachusetts Ave, Cambridge, MA 02139 USA; [Hollister-Locke, Jennifer; Cohen, Josh; Siniakowicz, Karolina; Weir, Gordon C.] Joslin Diabet Ctr, Div Res, Sect Islet Cell & Regenerat Biol, 1 Joslin Pl, Boston, MA 02215 USA; [Bochenek, Matthew A.; Qi, Meirigeng; McGarrigle, James; Oberholzer, Jose] Univ Illinois, Dept Surg, Div Transplantat, Chicago, IL 60680 USA; [Lyle, Stephen] Univ Massachusetts, Sch Med, Dept Canc Biol, Worcester, MA USA; [Harlan, David M.; Greiner, Dale L.] Univ Massachusetts, Sch Med, Diabet Ctr Excellence, Worcester, MA USA; [Langer, Robert; Anderson, Daniel G.] MIT, Inst Med Engn & Sci, 77 Massachusetts Ave, Cambridge, MA 02139 USA; [Langer, Robert; Anderson, Daniel G.] MIT, Div Hlth Sci & Technol, Cambridge, MA 02139 USA; [Vegas, Arturo J.] Boston Univ, Dept Chem, 590 Commonwealth Ave, Boston, MA 02215 USA; [Ma, Minglin] Cornell Univ, Dept Biol & Environm Engn, Ithaca, NY USA; [Bratlie, Kaitlin] Iowa State Univ, Dept Mat Sci & Engn, Ames, IA USA; [Bratlie, Kaitlin] Iowa State Univ, Dept Chem & Biol Engn, Ames, IA USA; [Bader, Andrew R.] MIT, Dept Mech Engn, Cambridge, MA 02139 USA	Massachusetts Institute of Technology (MIT); Harvard University; Boston Children's Hospital; Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT); Harvard University; Joslin Diabetes Center, Inc.; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; University of Massachusetts System; University of Massachusetts Worcester; University of Massachusetts System; University of Massachusetts Worcester; Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT); Boston University; Cornell University; Iowa State University; Iowa State University; Massachusetts Institute of Technology (MIT)	Anderson, DG (corresponding author), MIT, David H Koch Inst Integrat Canc Res, 77 Massachusetts Ave, Cambridge, MA 02139 USA.; Anderson, DG (corresponding author), Boston Childrens Hosp, Dept Anesthesiol, Boston, MA USA.; Anderson, DG (corresponding author), MIT, Dept Chem Engn, Cambridge, MA 02139 USA.; Anderson, DG (corresponding author), MIT, Inst Med Engn & Sci, 77 Massachusetts Ave, Cambridge, MA 02139 USA.; Anderson, DG (corresponding author), MIT, Div Hlth Sci & Technol, Cambridge, MA 02139 USA.	dgander@mit.edu	Veiseh, Omid/GLS-9547-2022; Jhunjhunwala, Siddharth/K-1526-2013; Veiseh, Omid/N-1137-2019; Qi, Meirigeng/B-5446-2014	Veiseh, Omid/0000-0003-1153-8079; Jhunjhunwala, Siddharth/0000-0001-8046-2288; Qi, Meirigeng/0000-0002-8531-8733; Bochenek, Matthew/0000-0001-5283-7388; Chen, Michael/0000-0002-1590-768X; Doloff, Joshua/0000-0002-4323-3264; Bratlie, Kaitlin/0000-0002-5197-0176	JDRF [3-SRA-2014-285-M-R]; Leona M. and the Harry B. Helmsley Charitable Trust [3-SRA-2014-285-M-R]; National Institutes of Health (NIH) [EB000244, EB000351, DE013023, CA151884, R01DK093909, P30DK036836]; NIH NIBIB [P41EB015871-27]; MIT SkolTech initiative; JDRF; Department of Defense/Congressionally Directed Medical Research Programs (DOD/CDMRP) [3-2013-178, W81XWH-13-1-0215]; National Institutes of Health (NIH, Joslin Diabetes Research Center and its Advanced Microscopy Core); Diabetes Research and Wellness Foundation; National Institutes of Health (NIH/NIDDK) [R01DK091526]; Chicago Diabetes Project; Koch Institute from the National Cancer Institute [P30-CA14051]; NATIONAL CANCER INSTITUTE [U54CA151884, P30CA014051] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [R01EB000244, P41EB015871, R37EB000244, R01EB000351] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [R01DE013023] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK091526, R01DK093909, P30DK036836] Funding Source: NIH RePORTER	JDRF(Juvenile Diabetes Research Foundation); Leona M. and the Harry B. Helmsley Charitable Trust; National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH NIBIB(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); MIT SkolTech initiative; JDRF(Juvenile Diabetes Research Foundation); Department of Defense/Congressionally Directed Medical Research Programs (DOD/CDMRP); National Institutes of Health (NIH, Joslin Diabetes Research Center and its Advanced Microscopy Core); Diabetes Research and Wellness Foundation; National Institutes of Health (NIH/NIDDK)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); Chicago Diabetes Project; Koch Institute from the National Cancer Institute; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported jointly by the JDRF and Leona M. and the Harry B. Helmsley Charitable Trust (grant 3-SRA-2014-285-M-R), National Institutes of Health (NIH grants EB000244, EB000351, DE013023 and CA151884), NIH NIBIB (P41EB015871-27), MIT SkolTech initiative (J.W.K.), JDRF and the Department of Defense/Congressionally Directed Medical Research Programs (DOD/CDMRP postdoctoral fellowships 3-2013-178 and W81XWH-13-1-0215 for O.V.) and through a generous gift from the Tayebati Family Foundation. G.C.W. is supported by National Institutes of Health (NIH grants R01DK093909 and P30DK036836, the Joslin Diabetes Research Center and its Advanced Microscopy Core), as well as the Diabetes Research and Wellness Foundation. J.O. is supported by the National Institutes of Health (NIH/NIDDK) R01DK091526 and the Chicago Diabetes Project. This work was also supported in part by the Koch Institute Support (core) grant P30-CA14051 from the National Cancer Institute. We also thank the Koch Institute Swanson Biotechnology Center for technical support, specifically Tang Histology Facility, Microscopy, Flow Cytometry, Nanotechnology Materials, and Applied Therapeutics and Whole Animal Imaging. The authors would like to acknowledge the use of resources at W.M. Keck Biological Imaging Facility (Whitehead Institute).	Anderson JM, 2008, SEMIN IMMUNOL, V20, P86, DOI 10.1016/j.smim.2007.11.004; Bernhardt A, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0129205; Bratlie KM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010032; BRAUKER JH, 1995, J BIOMED MATER RES, V29, P1517, DOI 10.1002/jbm.820291208; Brocchini S, 1998, J BIOMED MATER RES, V42, P66, DOI 10.1002/(SICI)1097-4636(199810)42:1<66::AID-JBM9>3.0.CO;2-M; Christen T, 2009, CIRCULATION, V119, P1925, DOI 10.1161/CIRCULATIONAHA.108.796888; Dang TT, 2013, BIOMATERIALS, V34, P5792, DOI 10.1016/j.biomaterials.2013.04.016; de Haan BJ, 2011, J BIOMED MATER RES A, V98A, P394, DOI 10.1002/jbm.a.33123; de Vos P, 2006, BIOMATERIALS, V27, P5603, DOI 10.1016/j.biomaterials.2006.07.010; de Vos P, 2009, BIOMATERIALS, V30, P2559, DOI 10.1016/j.biomaterials.2009.01.014; Dusseault J, 2006, J BIOMED MATER RES A, V76A, P243, DOI 10.1002/jbm.a.30541; Duvivier-Kali VF, 2001, DIABETES, V50, P1698, DOI 10.2337/diabetes.50.8.1698; Grainger DW, 2013, NAT BIOTECHNOL, V31, P507, DOI 10.1038/nbt.2600; Gu MH, 2013, BIOMATERIALS, V34, P6133, DOI 10.1016/j.biomaterials.2013.04.051; Haller J, 2008, J APPL PHYSIOL, V104, P795, DOI 10.1152/japplphysiol.00959.2007; Harding JL, 2014, TRENDS BIOTECHNOL, V32, P140, DOI 10.1016/j.tibtech.2013.12.004; Hetrick EM, 2007, BIOMATERIALS, V28, P4571, DOI 10.1016/j.biomaterials.2007.06.036; Hofman K, 2011, ANAL BIOCHEM, V417, P289, DOI 10.1016/j.ab.2011.06.019; Jacobs-Tulleneers-Thevissen D, 2013, DIABETOLOGIA, V56, P1605, DOI 10.1007/s00125-013-2906-0; Kang JW, 2012, NANO LETT, V12, P6170, DOI 10.1021/nl302991y; Kang JW, 2011, BIOMED OPT EXPRESS, V2, P2484, DOI 10.1364/BOE.2.002484; Kearney CJ, 2013, NAT MATER, V12, P1004, DOI [10.1038/NMAT3758, 10.1038/nmat3758]; Kenneth Ward W, 2008, J Diabetes Sci Technol, V2, P768; Kharb R, 2011, J ENZYM INHIB MED CH, V26, P1, DOI 10.3109/14756360903524304; Kim K, 2010, J BIOMED MATER RES A, V92A, P103, DOI 10.1002/jbm.a.32338; King A, 2001, J BIOMED MATER RES, V57, P374, DOI 10.1002/1097-4636(20011205)57:3<374::AID-JBM1180>3.0.CO;2-L; Langer R, 2009, ADV MATER, V21, P3235, DOI 10.1002/adma.200902589; Lee KY, 2012, PROG POLYM SCI, V37, P106, DOI 10.1016/j.progpolymsci.2011.06.003; LIM F, 1980, SCIENCE, V210, P908, DOI 10.1126/science.6776628; Lindstedt R, 2009, INT J IMMUNOPATH PH, V22, P29, DOI 10.1177/039463200902200105; Liu M, 2007, LANGMUIR, V23, P9378, DOI 10.1021/la7002996; Madden LR, 2010, P NATL ACAD SCI USA, V107, P15211, DOI 10.1073/pnas.1006442107; Manoury B, 2006, INT J IMMUNOPATH PH, V19, P471, DOI 10.1177/039463200601900303; Menard M, 2010, J BIOMED MATER RES B, V93B, P333, DOI 10.1002/jbm.b.31570; Omer A, 2005, TRANSPLANTATION, V79, P52, DOI 10.1097/01.TP.0000149340.37865.46; Omer A, 2003, DIABETES, V52, P69, DOI 10.2337/diabetes.52.1.69; Orive G, 2006, BIOMATERIALS, V27, P3691, DOI 10.1016/j.biomaterials.2006.02.048; Paredes-Juarez GA, 2014, MATERIALS, V7, P2087, DOI 10.3390/ma7032087; Paredes-Juarez GA, 2013, J CONTROL RELEASE, V172, P983, DOI 10.1016/j.jconrel.2013.09.009; Qi MRG, 2011, J SURG RES, V168, pE117, DOI 10.1016/j.jss.2011.01.040; Ratner BD, 2002, J CONTROL RELEASE, V78, P211, DOI 10.1016/S0168-3659(01)00502-8; Robitaille R, 2005, BIOMATERIALS, V26, P4119, DOI 10.1016/j.biomaterials.2004.10.028; Rodriguez A, 2009, J BIOMED MATER RES A, V89A, P152, DOI 10.1002/jbm.a.31939; Rokstad AM, 2011, ACTA BIOMATER, V7, P2566, DOI 10.1016/j.actbio.2011.03.011; Sato M, 2003, J IMMUNOL, V171, P417, DOI 10.4049/jimmunol.171.1.417; Scharp DW, 2014, ADV DRUG DELIVER REV, V67-68, P35, DOI 10.1016/j.addr.2013.07.018; Stoppel WL, 2014, J BIOMED MATER RES B, V102, P877, DOI 10.1002/jbm.b.33070; Sussman EM, 2014, ANN BIOMED ENG, V42, P1508, DOI 10.1007/s10439-013-0933-0; Tuch BE, 2009, DIABETES CARE, V32, P1887, DOI 10.2337/dc09-0744; Vegas AJ, 2016, NAT MED, V22, P306, DOI 10.1038/nm.4030; Veiseh O, 2015, NAT MATER, V14, P643, DOI [10.1038/NMAT4290, 10.1038/nmat4290]; Weir GC, 2013, DIABETOLOGIA, V56, P1458, DOI 10.1007/s00125-013-2921-1; Wick G, 2013, ANNU REV IMMUNOL, V31, P107, DOI 10.1146/annurev-immunol-032712-095937; Williams DF, 2008, BIOMATERIALS, V29, P2941, DOI 10.1016/j.biomaterials.2008.04.023; Wynn TA, 2012, NAT MED, V18, P1028, DOI 10.1038/nm.2807; Zhang L, 2013, NAT BIOTECHNOL, V31, P553, DOI 10.1038/nbt.2580	56	296	311	14	319	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156	1546-1696		NAT BIOTECHNOL	Nat. Biotechnol.	MAR	2016	34	3					345	+		10.1038/nbt.3462	http://dx.doi.org/10.1038/nbt.3462			14	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	DG1CJ	26807527	Green Accepted, Green Published, Green Submitted			2022-12-27	WOS:000371802600033
J	Ying, TL; Prabakaran, P; Dimitrov, DS				Ying, Tianlei; Prabakaran, Ponraj; Dimitrov, Dimiter S.			A systems approach to HIV-1 vaccines	NATURE BIOTECHNOLOGY			English	Editorial Material								Understanding the full breadth of immune responses that protect against HIV-1 may speed vaccine development.	[Ying, Tianlei] Fudan Univ, Sch Basic Med Sci, Minist Educ, Key Lab Med Mol Virol, Shanghai 200433, Peoples R China; [Ying, Tianlei] Fudan Univ, Sch Basic Med Sci, Minist Hlth, Shanghai 200433, Peoples R China; [Prabakaran, Ponraj] Intrexon Corp, Germantown, GA USA; [Dimitrov, Dimiter S.] NCI, Ctr Canc Res, NIH, Bethesda, MD 20892 USA	Fudan University; Fudan University; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	Dimitrov, DS (corresponding author), NCI, Ctr Canc Res, NIH, Bethesda, MD 20892 USA.	dimiter.dimitrov@nih.gov	应, 天雷/P-5396-2019; Ponraj, Prabakaran/D-6325-2011	应, 天雷/0000-0002-9597-2843; Ponraj, Prabakaran/0000-0002-4049-4813	NATIONAL CANCER INSTITUTE [ZIABC011155] Funding Source: NIH RePORTER	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Caskey M, 2015, NATURE, V522, P487, DOI 10.1038/nature14411; Chung AW, 2015, CELL, V163, P988, DOI 10.1016/j.cell.2015.10.027; Chung AW, 2014, SCI TRANSL MED, V6, DOI 10.1126/scitranslmed.3007736; Corey L, 2015, SCI TRANSL MED, V7, DOI 10.1126/scitranslmed.aac7732; Dimitrov DS, 2010, MABS-AUSTIN, V2, P347, DOI 10.4161/mabs.2.3.11779; Haynes BF, 2012, NAT BIOTECHNOL, V30, P423, DOI 10.1038/nbt.2197; Haynes BF, 2012, NEW ENGL J MED, V366, P1275, DOI 10.1056/NEJMoa1113425; Rerks-Ngarm S, 2009, NEW ENGL J MED, V361, P2209, DOI 10.1056/NEJMoa0908492; Shibata R, 1999, NAT MED, V5, P204, DOI 10.1038/5568; Xiao XD, 2009, BIOCHEM BIOPH RES CO, V390, P404, DOI 10.1016/j.bbrc.2009.09.029; Yates NL, 2014, SCI TRANSL MED, V6, DOI 10.1126/scitranslmed.3007730	11	2	2	0	13	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156	1546-1696		NAT BIOTECHNOL	Nat. Biotechnol.	JAN	2016	34	1					44	46		10.1038/nbt.3456	http://dx.doi.org/10.1038/nbt.3456			3	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	DB8HQ	26744981	Bronze			2022-12-27	WOS:000368758200024
J	Sheridan, C				Sheridan, Cormac			Omics-driven startups challenge healthcare model	NATURE BIOTECHNOLOGY			English	News Item																		2012, CELL, V148, P1293; 2015, BMC MED, V13, P5; 2015, NAT BIOTECHNOL, V33, P689	3	5	5	0	4	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156	1546-1696		NAT BIOTECHNOL	Nat. Biotechnol.	SEP	2015	33	9					887	889		10.1038/nbt0915-887	http://dx.doi.org/10.1038/nbt0915-887			3	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	CR0EK	26348939				2022-12-27	WOS:000360990900002
J	Mandl, KD; Kohane, IS				Mandl, Kenneth D.; Kohane, Isaac S.			Federalist principles for healthcare data networks	NATURE BIOTECHNOLOGY			English	Article							ARCHITECTURE		[Mandl, Kenneth D.; Kohane, Isaac S.] Boston Childrens Hosp, Boston, MA 02115 USA; [Mandl, Kenneth D.; Kohane, Isaac S.] Harvard Univ, Sch Med, Boston, MA USA	Harvard University; Boston Children's Hospital; Harvard University; Harvard Medical School	Mandl, KD (corresponding author), Boston Childrens Hosp, Boston, MA 02115 USA.	kenneth_mandl@harvard.edu			NHLBI NIH HHS [U01 HL121518] Funding Source: Medline; NIGMS NIH HHS [R01 GM104303] Funding Source: Medline; NLM NIH HHS [R01 LM011185] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [U01HL121518] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM104303] Funding Source: NIH RePORTER; NATIONAL LIBRARY OF MEDICINE [R01LM011185] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NLM NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Library of Medicine (NLM)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL LIBRARY OF MEDICINE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Library of Medicine (NLM))		Berndt SI, 2013, NAT GENET, V45, P501, DOI 10.1038/ng.2606; Blumenthal D, 2010, NEW ENGL J MED, V362, P382, DOI 10.1056/NEJMp0912825; Dolgin E, 2011, NAT MED, V17, P1525, DOI 10.1038/nm1211-1525; Friedman CP, 2010, SCI TRANSL MED, V2, DOI 10.1126/scitranslmed.3001456; Kohane IS, 1996, J AM MED INFORM ASSN, V3, P191, DOI 10.1136/jamia.1996.96310633; Kohane IS, 2012, NEW ENGL J MED, V367, P2538, DOI 10.1056/NEJMe1213371; Mandl KD, 2014, J AM MED INFORM ASSN, V21, P615, DOI 10.1136/amiajnl-2014-002727; Mandl KD, 2012, J AM MED INFORM ASSN, V19, P597, DOI 10.1136/amiajnl-2011-000622; Masys DR, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3004032; McMurry AJ, 2007, J AM MED INFORM ASSN, V14, P527, DOI 10.1197/jamia.M2371; National Research Council (US) Committee on a framework for developing a new taxonomy of disease, 2011, PREC MED BUILD KNOWL; Natter MD, 2013, J AM MED INFORM ASSN, V20, P172, DOI 10.1136/amiajnl-2012-001042; Patten IS, 2012, NATURE, V485, P333, DOI 10.1038/nature11040; Weber GM, 2014, JAMA-J AM MED ASSOC, V311, P2479, DOI 10.1001/jama.2014.4228	14	32	32	0	1	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156	1546-1696		NAT BIOTECHNOL	Nat. Biotechnol.	APR	2015	33	4					360	363		10.1038/nbt.3180	http://dx.doi.org/10.1038/nbt.3180			4	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Biotechnology & Applied Microbiology	CF2AE	25850061	Green Accepted, Bronze			2022-12-27	WOS:000352348500021
J	Waltz, E				Waltz, Emily			Engineers of scent	NATURE BIOTECHNOLOGY			English	Editorial Material																			0	7	7	0	6	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156	1546-1696		NAT BIOTECHNOL	Nat. Biotechnol.	APR	2015	33	4					329	332		10.1038/nbt.3191	http://dx.doi.org/10.1038/nbt.3191			4	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	CF2AE	25850048				2022-12-27	WOS:000352348500011
J	Forster, SC; Lawley, TD				Forster, Samuel C.; Lawley, Trevor D.			Systematic discovery of probiotics	NATURE BIOTECHNOLOGY			English	Editorial Material							CLOSTRIDIUM-DIFFICILE; BACTERIOTHERAPY		[Forster, Samuel C.; Lawley, Trevor D.] Wellcome Trust Sanger Inst, Hinxton, England	Wellcome Trust Sanger Institute	Forster, SC (corresponding author), Wellcome Trust Sanger Inst, Wellcome Trust Genome Campus, Hinxton, England.	tl2@sanger.ac.uk	Forster, Samuel C/F-4206-2014	Forster, Samuel C/0000-0003-4144-2537				Borody TJ, 2004, J CLIN GASTROENTEROL, V38, P475, DOI 10.1097/01.mcg.0000128988.13808.dc; Buffie CG, 2015, NATURE, V517, P205, DOI 10.1038/nature13828; Lawley TD, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002995; Petrof EO, 2013, MICROBIOME, V1, DOI 10.1186/2049-2618-1-3; Reeves AE, 2012, INFECT IMMUN, V80, P3786, DOI 10.1128/IAI.00647-12; Theriot CM, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4114; TVEDE M, 1989, LANCET, V1, P1156; van Nood E, 2013, NEW ENGL J MED, V368, P407, DOI 10.1056/NEJMoa1205037; WILSON KH, 1982, J CLIN MICROBIOL, V15, P443, DOI 10.1128/JCM.15.3.443-446.1982	9	10	12	0	13	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156	1546-1696		NAT BIOTECHNOL	Nat. Biotechnol.	JAN	2015	33	1					47	U210		10.1038/nbt.3111	http://dx.doi.org/10.1038/nbt.3111			4	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	AY7AR	25574637				2022-12-27	WOS:000347714200025
J	Laszlo, AH; Derrington, IM; Ross, BC; Brinkerhoff, H; Adey, A; Nova, IC; Craig, JM; Langford, KW; Samson, JM; Daza, R; Doering, K; Shendure, J; Gundlach, JH				Laszlo, Andrew H.; Derrington, Ian M.; Ross, Brian C.; Brinkerhoff, Henry; Adey, Andrew; Nova, Ian C.; Craig, Jonathan M.; Langford, Kyle W.; Samson, Jenny Mae; Daza, Riza; Doering, Kenji; Shendure, Jay; Gundlach, Jens H.			Decoding long nanopore sequencing reads of natural DNA	NATURE BIOTECHNOLOGY			English	Article							SINGLE; MEMBRANE; RESOLUTION; FLUID	Nanopore sequencing of DNA is a single-molecule technique that may achieve long reads, low cost and high speed with minimal sample preparation and instrumentation. Here, we build on recent progress with respect to nanopore resolution and DNA control to interpret the procession of ion current levels observed during the translocation of DNA through the pore MspA. As approximately four nucleotides affect the ion current of each level, we measured the ion current corresponding to all 256 four-nucleotide combinations (quadromers). This quadromer map is highly predictive of ion current levels of previously unmeasured sequences derived from the bacteriophage phi X 174 genome. Furthermore, we show nanopore sequencing reads of phi X 174 up to 4,500 bases in length, which can be unambiguously aligned to the phi X 174 reference genome, and demonstrate proof-of-concept utility with respect to hybrid genome assembly and polymorphism detection. This work provides a foundation for nanopore sequencing of long, natural DNA strands.	[Laszlo, Andrew H.; Derrington, Ian M.; Ross, Brian C.; Brinkerhoff, Henry; Nova, Ian C.; Craig, Jonathan M.; Langford, Kyle W.; Samson, Jenny Mae; Doering, Kenji; Gundlach, Jens H.] Univ Washington, Dept Phys, Seattle, WA 98195 USA; [Adey, Andrew; Daza, Riza; Shendure, Jay] Univ Washington, Dept Genome Sci, Seattle, WA 98195 USA	University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle	Gundlach, JH (corresponding author), Univ Washington, Dept Phys, Seattle, WA 98195 USA.	gundlach@uw.edu	Daza, Riza M./HCH-4047-2022; Shendure, Jay/AAU-3684-2021	Ross, Brian/0000-0003-2432-4678; Brinkerhoff, Henry/0000-0003-2735-8048; Craig, Jonathan M/0000-0003-4791-5112; Gundlach, Jens Horst/0000-0002-0773-8038; Shendure, Jay/0000-0002-1516-1865; Laszlo, Andrew/0000-0002-7853-0533	National Institutes of Health, National Human Genome Research Institutes (NHGRI) Genome Program [R01HG005115, R01HG006321, R01HG006283]; National Science Foundation [DGE-0718124]; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R01HG006321, R01HG006283, R01HG005115] Funding Source: NIH RePORTER	National Institutes of Health, National Human Genome Research Institutes (NHGRI) Genome Program; National Science Foundation(National Science Foundation (NSF)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))	Thanks to J.J. Bartlett and B. Tickman for their help in data acquisition. This work was supported by the National Institutes of Health, National Human Genome Research Institutes (NHGRI) $1,000 Genome Program Grants R01HG005115, R01HG006321 and R01HG006283 and graduate research fellowship DGE-0718124 from the National Science Foundation (to A.A.).	Baaken G, 2008, LAB CHIP, V8, P938, DOI 10.1039/b800431e; Bashir A, 2012, NAT BIOTECHNOL, V30, P701, DOI 10.1038/nbt.2288; Branton D, 2008, NAT BIOTECHNOL, V26, P1146, DOI 10.1038/nbt.1495; Braslavsky I, 2003, P NATL ACAD SCI USA, V100, P3960, DOI 10.1073/pnas.0230489100; Butler TZ, 2008, P NATL ACAD SCI USA, V105, P20647, DOI 10.1073/pnas.0807514106; Cherf GM, 2012, NAT BIOTECHNOL, V30, P344, DOI 10.1038/nbt.2147; Collins FS, 2004, NATURE, V431, P931, DOI 10.1038/nature03001; de Bruijn N.G., 1946, KONINKLIJKE NEDERLAN, V49, P758; Derrington IM, 2010, P NATL ACAD SCI USA, V107, P16060, DOI 10.1073/pnas.1001831107; Durbin R., 2006, BIOL SEQUENCE ANAL; Eid J, 2009, SCIENCE, V323, P133, DOI 10.1126/science.1162986; Heitz BA, 2011, LANGMUIR, V27, P1882, DOI 10.1021/la1025944; Heitz BA, 2010, J AM CHEM SOC, V132, P7086, DOI 10.1021/ja100245d; Jain T, 2013, ANAL CHEM, V85, P3871, DOI 10.1021/ac302972c; Kasianowicz JJ, 1996, P NATL ACAD SCI USA, V93, P13770, DOI 10.1073/pnas.93.24.13770; Koren S, 2012, NAT BIOTECHNOL, V30, P692, DOI 10.1038/nbt.2280; Laszlo AH, 2013, P NATL ACAD SCI USA, V110, P18904, DOI 10.1073/pnas.1310240110; Levene MJ, 2003, SCIENCE, V299, P682, DOI 10.1126/science.1079700; Malmstadt N, 2006, NANO LETT, V6, P1961, DOI 10.1021/nl0611034; Manrao EA, 2012, NAT BIOTECHNOL, V30, P349, DOI 10.1038/nbt.2171; Manrao EA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025723; McCarthy JJ, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3005785; Mitra RD, 2003, ANAL BIOCHEM, V320, P55, DOI 10.1016/S0003-2697(03)00291-4; NEEDLEMAN SB, 1970, J MOL BIOL, V48, P443, DOI 10.1016/0022-2836(70)90057-4; Ribeiro FJ, 2012, GENOME RES, V22, P2270, DOI 10.1101/gr.141515.112; Schibel AEP, 2010, ANAL CHEM, V82, P7259, DOI 10.1021/ac101183j; Shendure J, 2005, SCIENCE, V309, P1728, DOI 10.1126/science.1117389; Shendure J, 2008, NAT BIOTECHNOL, V26, P1135, DOI 10.1038/nbt1486; Shendure J, 2012, NAT BIOTECHNOL, V30, P1084, DOI 10.1038/nbt.2421; Wallace EVB, 2010, CHEM COMMUN, V46, P8195, DOI 10.1039/c0cc02864a; Wanunu M, 2012, PHYS LIFE REV, V9, P125, DOI 10.1016/j.plrev.2012.05.010; Yusko EC, 2011, NAT NANOTECHNOL, V6, P253, DOI 10.1038/nnano.2011.12	32	272	285	11	234	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156	1546-1696		NAT BIOTECHNOL	Nat. Biotechnol.	AUG	2014	32	8					829	833		10.1038/nbt.2950	http://dx.doi.org/10.1038/nbt.2950			5	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	AW7PF	24964173	Green Accepted			2022-12-27	WOS:000346455900044
J	Sturgeon, CM; Ditadi, A; Awong, G; Kennedy, M; Keller, G				Sturgeon, Christopher M.; Ditadi, Andrea; Awong, Geneve; Kennedy, Marion; Keller, Gordon			Wnt signaling controls the specification of definitive and primitive hematopoiesis from human pluripotent stem cells	NATURE BIOTECHNOLOGY			English	Article							DIFFERENTIATION CULTURES; YOLK-SAC; HAEMOGENIC ENDOTHELIUM; WNT/BETA-CATENIN; IN-VITRO; PROGENITORS; BLOOD; PATHWAY; EMBRYO; INDUCTION	Efforts to derive hematopoietic stem cells (HSCs) from human pluripotent stem cells (hPSCs) are complicated by the fact that embryonic hematopoiesis consists of two programs, primitive and definitive, that differ in developmental potential. As only definitive hematopoiesis generates HSCs, understanding how this program develops is essential for being able to produce this cell population in vitro. Here we show that both hematopoietic programs transition through hemogenic endothelial intermediates and develop from KDR(+)CD34(-)CD144(-) progenitors that are distinguished by CD235a expression. Generation of primitive progenitors (KDR(+)CD235a(+)) depends on stage-specific activin-nodal signaling and inhibition of the Wnt-beta-catenin pathway, whereas specification of definitive progenitors (KDR(+)CD235a(-)) requires Wnt-beta-catenin signaling during this same time frame. Together, these findings establish simple selective differentiation strategies for the generation of primitive or definitive hematopoietic progenitors by Wnt-beta-catenin manipulation, and in doing so provide access to enriched populations for future studies on hPSC-derived hematopoietic development.	[Sturgeon, Christopher M.; Ditadi, Andrea; Awong, Geneve; Kennedy, Marion; Keller, Gordon] McEwen Ctr Regenerat Med, Univ Hlth Network, Toronto, ON, Canada	University of Toronto; University Toronto Affiliates; University Health Network Toronto	Keller, G (corresponding author), McEwen Ctr Regenerat Med, Univ Hlth Network, Toronto, ON, Canada.	gkeller@uhnresearch.ca	; Ditadi, Andrea/K-3461-2016	Keller, Gordon/0000-0001-9309-9297; Ditadi, Andrea/0000-0003-3283-8943; , Christopher/0000-0003-1508-4414	National Institutes of Health [U01 HL100395]; CIHR [MOP93569, HOP83070, MOP12927]; McMurrich Post-Doctoral Fellowship; Magna-Golftown Post-Doctoral Fellowship; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [U01HL100395] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); CIHR(Canadian Institutes of Health Research (CIHR)); McMurrich Post-Doctoral Fellowship; Magna-Golftown Post-Doctoral Fellowship; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	We would like to thank the SickKids-UHN Flow Cytometry Facility for their expert assistance with cell sorting, in particular A. Khandani. This work was supported by National Institutes of Health grants U01 HL100395 and CIHR MOP93569, HOP83070 and MOP12927. C. M. S. and A. D. were supported by the McMurrich Post-Doctoral Fellowship and the Magna-Golftown Post-Doctoral Fellowship, respectively.	Antas VI, 2013, INT J BIOCHEM CELL B, V45, P692, DOI 10.1016/j.biocel.2012.12.013; Bigas A, 2010, INT J DEV BIOL, V54, P1175, DOI 10.1387/ijdb.093049ab; Boiers C, 2013, CELL STEM CELL, V13, P535, DOI 10.1016/j.stem.2013.08.012; Chanda B, 2013, CELL, V155, P215, DOI 10.1016/j.cell.2013.08.055; Chen BZ, 2009, NAT CHEM BIOL, V5, P100, DOI 10.1038/nchembio.137; Choi K, 1998, DEVELOPMENT, V125, P725; Choi KD, 2012, CELL REP, V2, P553, DOI 10.1016/j.celrep.2012.08.002; Clarke RL, 2013, NAT CELL BIOL, V15, P502, DOI 10.1038/ncb2724; Davis RP, 2008, BLOOD, V111, P1876, DOI 10.1182/blood-2007-06-093609; Dubois NC, 2011, NAT BIOTECHNOL, V29, P1011, DOI 10.1038/nbt.2005; Fraser Stuart T, 2013, ISRN Hematol, V2013, P568928, DOI 10.1155/2013/568928; Gertow K, 2013, STEM CELL REP, V1, P53, DOI 10.1016/j.stemcr.2013.04.002; Huber TL, 2004, NATURE, V432, P625, DOI 10.1038/nature03122; Irion S, 2010, DEVELOPMENT, V137, P2829, DOI 10.1242/dev.042119; Jackson SA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010706; Jho EH, 2002, MOL CELL BIOL, V22, P1172, DOI 10.1128/MCB.22.4.1172-1183.2002; Jiang W, 2013, STEM CELL REP, V1, P46, DOI 10.1016/j.stemcr.2013.03.003; Kennedy M, 2007, BLOOD, V109, P2679, DOI 10.1182/blood-2006-09-047704; Kennedy M, 2012, CELL REP, V2, P1722, DOI 10.1016/j.celrep.2012.11.003; La Motte-Mohs RN, 2005, BLOOD, V105, P1431, DOI 10.1182/blood-2004-04-1293; Lancrin C, 2009, NATURE, V457, P892, DOI 10.1038/nature07679; Liu F, 2012, BLOOD, V119, P3295, DOI 10.1182/blood-2012-01-403766; Medvinsky A, 2011, DEVELOPMENT, V138, P1017, DOI 10.1242/dev.040998; Murry CE, 2008, CELL, V132, P661, DOI 10.1016/j.cell.2008.02.008; Nostro MC, 2008, CELL STEM CELL, V2, P60, DOI 10.1016/j.stem.2007.10.011; Paluru P, 2014, STEM CELL RES, V12, P441, DOI 10.1016/j.scr.2013.12.003; Park IH, 2008, NATURE, V451, P141, DOI [10.1038/nature06534, 10.1038/natureO6534]; Pearson S, 2008, DEVELOPMENT, V135, P1525, DOI 10.1242/dev.011767; PESCHLE C, 1984, P NATL ACAD SCI-BIOL, V81, P2416, DOI 10.1073/pnas.81.8.2416; PHILLIPS JH, 1992, J EXP MED, V175, P1055, DOI 10.1084/jem.175.4.1055; Polychronopoulos P, 2004, J MED CHEM, V47, P935, DOI 10.1021/jm031016d; Ruiz-Herguido C, 2012, J EXP MED, V209, P1457, DOI 10.1084/jem.20120225; Samokhvalov IM, 2007, NATURE, V446, P1056, DOI 10.1038/nature05725; Sankaran VG, 2010, BRIT J HAEMATOL, V149, P181, DOI 10.1111/j.1365-2141.2010.08105.x; Schmitt TM, 2004, NAT IMMUNOL, V5, P410, DOI 10.1038/ni1055; Slukvin II, 2013, CELL CYCLE, V12, P720, DOI 10.4161/cc.23823; Smith AG, 2001, ANNU REV CELL DEV BI, V17, P435, DOI 10.1146/annurev.cellbio.17.1.435; Sturgeon CM, 2012, DEV CELL, V23, P45, DOI 10.1016/j.devcel.2012.05.021; Sumi T, 2008, DEVELOPMENT, V135, P2969, DOI 10.1242/dev.021121; Tanaka Y, 2012, P NATL ACAD SCI USA, V109, P4515, DOI 10.1073/pnas.1115828109; Tavian M, 2001, IMMUNITY, V15, P487, DOI 10.1016/S1074-7613(01)00193-5; Thomson JA, 1998, SCIENCE, V282, P1145, DOI 10.1126/science.282.5391.1145; Vodyanik MA, 2006, BLOOD, V108, P2095, DOI 10.1182/blood-2006-02-003327; Yoshimoto M, 2012, BLOOD, V119, P5706, DOI 10.1182/blood-2011-12-397489	44	242	254	4	37	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156	1546-1696		NAT BIOTECHNOL	Nat. Biotechnol.	JUN	2014	32	6					554	+		10.1038/nbt.2915	http://dx.doi.org/10.1038/nbt.2915			9	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	AI9EV	24837661	Green Accepted			2022-12-27	WOS:000337233800018
J	Francisco, M				Francisco, Michael			First-quarter biotech job picture	NATURE BIOTECHNOLOGY			English	Editorial Material																		2014, NAT BIOTECHNOL, V32, P199	1	1	1	0	1	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156	1546-1696		NAT BIOTECHNOL	Nat. Biotechnol.	MAY	2014	32	5					497	497		10.1038/nbt.2901	http://dx.doi.org/10.1038/nbt.2901			1	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	AH3PH	24811521				2022-12-27	WOS:000336036100027
J	Jeck, WR; Sharpless, NE				Jeck, William R.; Sharpless, Norman E.			Detecting and characterizing circular RNAs	NATURE BIOTECHNOLOGY			English	Review							EXON REPETITION; MESSENGER-RNAS; GENE; TRANSCRIPTS; EXPRESSION; MOLECULES; DELETION; ABUNDANT; CIRCLES; SPONGES	Circular RNA transcripts were first identified in the early 1990s but knowledge of these species has remained limited, as their study through traditional methods of RNA analysis has been difficult. Now, novel bioinformatic approaches coupled with biochemical enrichment strategies and deep sequencing have allowed comprehensive studies of circular RNA species. Recent studies have revealed thousands of endogenous circular RNAs in mammalian cells, some of which are highly abundant and evolutionarily conserved. Evidence is emerging that some circRNAs might regulate microRNA (miRNA) function, and roles in transcriptional control have also been suggested. Therefore, study of this class of noncoding RNAs has potential implications for therapeutic and research applications. We believe the key future challenge for the field will be to understand the regulation and function of these unusual molecules.	[Jeck, William R.; Sharpless, Norman E.] Univ N Carolina, Sch Med, Dept Genet, Chapel Hill, NC 27599 USA; [Sharpless, Norman E.] Univ N Carolina, Sch Med, Dept Med, Chapel Hill, NC USA; [Sharpless, Norman E.] Univ N Carolina, Lineberger Comprehens Canc Ctr, Sch Med, Chapel Hill, NC 27599 USA	University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine	Sharpless, NE (corresponding author), Univ N Carolina, Sch Med, Dept Genet, Chapel Hill, NC 27599 USA.	nes@med.unc.edu		Jeck, William/0000-0003-0257-4529; Sharpless, Norman/0000-0001-7078-9455	National Institute on Aging [F30 AG041567-3, RO1 AG024379-11]; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P30ES010126] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [F30AG041567, R01AG024379] Funding Source: NIH RePORTER	National Institute on Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	The authors would like to acknowledge W. Marzluff for his assistance in preparing this manuscript, as well as funding from the National Institute on Aging, grants F30 AG041567-3 and RO1 AG024379-11.	ARNBERG AC, 1980, CELL, V19, P313, DOI 10.1016/0092-8674(80)90505-X; Brown JA, 2012, P NATL ACAD SCI USA, V109, P19202, DOI 10.1073/pnas.1217338109; Burd CE, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001233; CAPEL B, 1993, CELL, V73, P1019, DOI 10.1016/0092-8674(93)90279-Y; Caudevilla C, 1998, P NATL ACAD SCI USA, V95, P12185, DOI 10.1073/pnas.95.21.12185; Chao CW, 1998, MOL MED, V4, P614, DOI 10.1007/BF03401761; CHEN CY, 1995, SCIENCE, V268, P415, DOI 10.1126/science.7536344; COCQUERELLE C, 1992, EMBO J, V11, P1095, DOI 10.1002/j.1460-2075.1992.tb05148.x; COCQUERELLE C, 1993, FASEB J, V7, P155, DOI 10.1096/fasebj.7.1.7678559; Cocquet J, 2006, GENOMICS, V88, P127, DOI 10.1016/j.ygeno.2005.12.013; Danan M, 2012, NUCLEIC ACIDS RES, V40, P3131, DOI 10.1093/nar/gkr1009; Dubin RA, 1995, GENE, V167, P245, DOI 10.1016/0378-1119(95)00639-7; Ebert MS, 2007, NAT METHODS, V4, P721, DOI 10.1038/NMETH1079; Fonseca NA, 2012, BIOINFORMATICS, V28, P3169, DOI 10.1093/bioinformatics/bts605; Franco-Zorrilla JM, 2007, NAT GENET, V39, P1033, DOI 10.1038/ng2079; Frantz SA, 1999, P NATL ACAD SCI USA, V96, P5400, DOI 10.1073/pnas.96.10.5400; Gao KP, 2008, NUCLEIC ACIDS RES, V36, P2257, DOI 10.1093/nar/gkn073; GILBERT W, 1978, NATURE, V271, P501, DOI 10.1038/271501a0; Gualandi F, 2003, J MED GENET, V40, DOI 10.1136/jmg.40.8.e100; Hansen TB, 2013, CANCER RES, V73, P5609, DOI 10.1158/0008-5472.CAN-13-1568; Hansen TB, 2013, NATURE, V495, P384, DOI 10.1038/nature11993; Hansen TB, 2011, EMBO J, V30, P4414, DOI 10.1038/emboj.2011.359; Haupenthal J, 2006, BIOCHEM PHARMACOL, V71, P702, DOI 10.1016/j.bcp.2005.11.015; Hurowitz EH, 2004, GENOME BIOL, V5; Jeck WR, 2013, RNA, V19, P141, DOI 10.1261/rna.035667.112; KOS A, 1986, NATURE, V323, P558, DOI 10.1038/323558a0; Li XF, 1999, J BIOL CHEM, V274, P8153, DOI 10.1074/jbc.274.12.8153; Liu YC, 2013, INT J BIOCHEM CELL B, V45, P2643, DOI 10.1016/j.biocel.2013.09.003; McManus CJ, 2010, P NATL ACAD SCI USA, V107, P12975, DOI 10.1073/pnas.1007586107; Memczak S, 2013, NATURE, V495, P333, DOI 10.1038/nature11928; NIGRO JM, 1991, CELL, V64, P607, DOI 10.1016/0092-8674(91)90244-S; Pasman Z, 1996, RNA, V2, P603; Poliseno L, 2010, NATURE, V465, P1033, DOI 10.1038/nature09144; Rigatti R, 2004, NUCLEIC ACIDS RES, V32, P441, DOI 10.1093/nar/gkh197; Romeo T, 1998, MOL MICROBIOL, V29, P1321, DOI 10.1046/j.1365-2958.1998.01021.x; Salzman J, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003777; Salzman J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030733; SANGER HL, 1976, P NATL ACAD SCI USA, V73, P3852, DOI 10.1073/pnas.73.11.3852; SCHINDLER CW, 1982, PLASMID, V7, P263, DOI 10.1016/0147-619X(82)90007-5; Schwanhausser B, 2011, NATURE, V473, P337, DOI 10.1038/nature10098; Spitali P, 2012, CELL, V148, P1085, DOI 10.1016/j.cell.2012.02.014; Surono A, 1999, HUM MOL GENET, V8, P493, DOI 10.1093/hmg/8.3.493; Suzuki H, 2006, NUCLEIC ACIDS RES, V34, DOI 10.1093/nar/gkl151; TABAK HF, 1988, NUCLEIC ACIDS RES, V16, P6597, DOI 10.1093/nar/16.14.6597; Umekage S., 2012, INNOVATIONS BIOTECHN, P75; VANDERVEEN R, 1986, CELL, V44, P225, DOI 10.1016/0092-8674(86)90756-7; Wang K, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkq622; Wilusz JE, 2012, GENE DEV, V26, P2392, DOI 10.1101/gad.204438.112; Zaphiropoulos PG, 1997, MOL CELL BIOL, V17, P2985, DOI 10.1128/MCB.17.6.2985; Zaphiropoulos PG, 1996, P NATL ACAD SCI USA, V93, P6536, DOI 10.1073/pnas.93.13.6536; ZAPHIROPOULOS PG, 1993, BIOCHEM BIOPH RES CO, V192, P778, DOI 10.1006/bbrc.1993.1482; Zhang Y, 2013, MOL CELL, V51, P792, DOI 10.1016/j.molcel.2013.08.017	52	1671	1791	23	419	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156	1546-1696		NAT BIOTECHNOL	Nat. Biotechnol.	MAY	2014	32	5					453	461		10.1038/nbt.2890	http://dx.doi.org/10.1038/nbt.2890			9	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	AH3PH	24811520	Green Accepted, Green Submitted			2022-12-27	WOS:000336036100020
J	Zhou, YX; Wei, WS				Zhou, Yuexin; Wei, Wensheng			Mapping regulatory elements	NATURE BIOTECHNOLOGY			English	Editorial Material							HUMAN-CELLS; DISSECTION; ENHANCERS		[Zhou, Yuexin; Wei, Wensheng] Peking Tsinghua Ctr Life Sci, State Key Lab Prot & Plant Gene Res, Biodynam Optic Imaging Ctr BIOPIC, Beijing, Peoples R China; [Zhou, Yuexin; Wei, Wensheng] Peking Univ, Sch Life Sci, Beijing 100871, Peoples R China	Peking University	Wei, WS (corresponding author), Peking Tsinghua Ctr Life Sci, State Key Lab Prot & Plant Gene Res, Biodynam Optic Imaging Ctr BIOPIC, Beijing, Peoples R China.; Wei, WS (corresponding author), Peking Univ, Sch Life Sci, Beijing 100871, Peoples R China.	wswei@pku.edu.cn	Wei, Wensheng/AAF-1325-2020	Wei, Wensheng/0000-0002-8053-2423				Canver MC, 2015, NATURE, V527, P192, DOI 10.1038/nature15521; Koike-Yusa H, 2014, NAT BIOTECHNOL, V32, P267, DOI 10.1038/nbt.2800; Korkmaz G, 2016, NAT BIOTECHNOL, V34, P192, DOI 10.1038/nbt.3450; Mansour MR, 2014, SCIENCE, V346, P1373, DOI 10.1126/science.1259037; Melnikov A, 2012, NAT BIOTECHNOL, V30, P271, DOI 10.1038/nbt.2137; Patwardhan RP, 2012, NAT BIOTECHNOL, V30, P265, DOI 10.1038/nbt.2136; Rajagopal N, 2016, NAT BIOTECHNOL, V34, P167, DOI 10.1038/nbt.3468; Shalem O, 2014, SCIENCE, V343, P84, DOI 10.1126/science.1247005; Sharon E, 2012, NAT BIOTECHNOL, V30, P521, DOI 10.1038/nbt.2205; Vahedi G, 2015, NATURE, V520, P558, DOI 10.1038/nature14154; Wang T, 2014, SCIENCE, V343, P80, DOI 10.1126/science.1246981; Zhou YX, 2014, NATURE, V509, P487, DOI 10.1038/nature13166	12	2	2	0	18	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156	1546-1696		NAT BIOTECHNOL	Nat. Biotechnol.	FEB	2016	34	2					151	152		10.1038/nbt.3477	http://dx.doi.org/10.1038/nbt.3477			2	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	DD0OK	26849519				2022-12-27	WOS:000369619100015
J	Huggett, B				Huggett, Brady			Innovative academic startups 2015	NATURE BIOTECHNOLOGY			English	News Item																			0	2	2	0	0	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156	1546-1696		NAT BIOTECHNOL	Nat. Biotechnol.	JAN	2016	34	1					19	19		10.1038/nbt.3447	http://dx.doi.org/10.1038/nbt.3447			1	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	VI3OG	26744970	Bronze			2022-12-27	WOS:000474629800001
J	Wang, JB; Exline, CM; DeClercq, JJ; Llewellyn, GN; Hayward, SB; Li, PWL; Shivak, DA; Surosky, RT; Gregory, PD; Holmes, MC; Cannon, PM				Wang, Jianbin; Exline, Colin M.; DeClercq, Joshua J.; Llewellyn, G. Nicholas; Hayward, Samuel B.; Li, Patrick Wai-Lun; Shivak, David A.; Surosky, Richard T.; Gregory, Philip D.; Holmes, Michael C.; Cannon, Paula M.			Homology-driven genome editing in hematopoietic stem and progenitor cells using ZFN mRNA and AAV6 donors	NATURE BIOTECHNOLOGY			English	Article							TARGETED GENE ADDITION; ZINC-FINGER NUCLEASES; ADENOASSOCIATED VIRUS VECTORS; STRAND BREAK REPAIR; LENTIVIRAL VECTOR; LONG-TERM; T-CELLS; IN-VIVO; DNA; CCR5	Genome editing with targeted nucleases and DNA donor templates homologous to the break site has proven challenging in human hematopoietic stem and progenitor cells (HSPCs), and particularly in the most primitive, long-term repopulating cell population. Here we report that combining electroporation of zinc finger nuclease (ZFN) mRNA with donor template delivery by adeno-associated virus (AAV) serotype 6 vectors directs efficient genome editing in HSPCs, achieving site-specific insertion of a GFP cassette at the CCR5 and AAVS1 loci in mobilized peripheral blood CD34(+) HSPCs at mean frequencies of 17% and 26%, respectively, and in fetal liver HSPCs at 19% and 43%, respectively. Notably, this approach modified the CD34(+)CD133(+)CD90(+) cell population, a minor component of CD34(+) cells that contains long-term repopulating hematopoietic stem cells (HSCs). Genome-edited HSPCs also engrafted in immune-deficient mice long-term, confirming that HSCs are targeted by this approach. Our results provide a strategy for more robust application of genome-editing technologies in HSPCs.	[Wang, Jianbin; DeClercq, Joshua J.; Hayward, Samuel B.; Li, Patrick Wai-Lun; Shivak, David A.; Surosky, Richard T.; Gregory, Philip D.; Holmes, Michael C.] Sangamo BioSci Inc, Richmond, CA USA; [Exline, Colin M.; Llewellyn, G. Nicholas; Cannon, Paula M.] Univ So Calif, Keck Sch Med, Dept Mol Microbiol, Los Angeles, CA 90033 USA	Sangamo Therapeutics, Inc.; University of Southern California	Cannon, PM (corresponding author), Univ So Calif, Keck Sch Med, Dept Mol Microbiol, Los Angeles, CA 90033 USA.	mholmes@sangamo.com; pcannon@usc.edu		Gregory, Philip/0000-0001-9249-2468	California HIV/AIDS Research Program [12-USC-245, F10-USC-207]; US National Institutes of Health [P01 HL73104, R01 DE025167, U19 HL129902]; California Institute for Regenerative Medicine grant [RT3-07848]; James B. Pendleton Charitable Trust; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL073104, U19HL129902] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [R01DE025167] Funding Source: NIH RePORTER	California HIV/AIDS Research Program; US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); California Institute for Regenerative Medicine grant(California Institute for Regenerative Medicine); James B. Pendleton Charitable Trust; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))	This work was supported by funding from the California HIV/AIDS Research Program ID12-USC-245 and F10-USC-207, US National Institutes of Health grants P01 HL73104, R01 DE025167, and U19 HL129902, the California Institute for Regenerative Medicine grant RT3-07848, and the James B. Pendleton Charitable Trust. We thank L. Truong, G. Lee and Y. Lee for CD34<SUP>+</SUP> cells, E. Lopez, E. Seclen and J. Rathbun for assistance with humanized mice, E. Killingbeck and P. Cheung for MiSeq analysis, A. Goodwin, A. Kang, and H. Tran for AAV production, A. Reik and F. Urnov for AAVS1 ZFNs, and C. Wang for helpful discussions.	Aiuti A, 2002, SCIENCE, V296, P2410, DOI 10.1126/science.1070104; Aiuti A, 2013, SCIENCE, V341, P865, DOI 10.1126/science.1233151; BAUM CM, 1992, P NATL ACAD SCI USA, V89, P2804, DOI 10.1073/pnas.89.7.2804; Biffi A, 2013, SCIENCE, V341, P864, DOI 10.1126/science.1233158; Boczkowski D, 2000, CANCER RES, V60, P1028; Branzei D, 2008, NAT REV MOL CELL BIO, V9, P297, DOI 10.1038/nrm2351; Braun CJ, 2014, SCI TRANSL MED, V6, DOI 10.1126/scitranslmed.3007280; Brugmans L, 2007, MUTAT RES-FUND MOL M, V614, P95, DOI 10.1016/j.mrfmmm.2006.01.022; Cartier N, 2009, SCIENCE, V326, P818, DOI 10.1126/science.1171242; Cavazza A, 2013, HUM GENE THER, V24, P119, DOI 10.1089/hum.2012.203; Chen FQ, 2011, NAT METHODS, V8, P753, DOI 10.1038/nmeth.1653; CHEUNG AKM, 1980, J VIROL, V33, P739, DOI 10.1128/JVI.33.2.739-748.1980; Coluccio A, 2013, MOL THER, V21, P1695, DOI 10.1038/mt.2013.143; DeKelver RC, 2010, GENOME RES, V20, P1133, DOI 10.1101/gr.106773.110; Dick JE, 1997, STEM CELLS, V15, P204; Dick JE, 1997, STEM CELLS, V15, P199, DOI 10.1002/stem.5530150826; Dick JE, 2001, ANN NY ACAD SCI, V938, P184; Doulatov S, 2012, CELL STEM CELL, V10, P120, DOI 10.1016/j.stem.2012.01.006; Doyon Y, 2011, NAT METHODS, V8, P74, DOI 10.1038/NMETH.1539; Gabriel R, 2011, NAT BIOTECHNOL, V29, P816, DOI 10.1038/nbt.1948; Gaj T, 2013, TRENDS BIOTECHNOL, V31, P397, DOI 10.1016/j.tibtech.2013.04.004; Genovese P, 2014, NATURE, V510, P235, DOI 10.1038/nature13420; Gu A, 2014, HUM GENE THER METHOD, V25, P221, DOI 10.1089/hgtb.2014.043; Guilinger JP, 2014, NAT METHODS, V11, P429, DOI 10.1038/nmeth.2845; Hacein-Bey-Abina S, 2008, J CLIN INVEST, V118, P3132, DOI 10.1172/JCI35700; Hirata R, 2002, NAT BIOTECHNOL, V20, P735, DOI 10.1038/nbt0702-735; Hirsch ML, 2015, GENE THER, V22, P190, DOI 10.1038/gt.2014.109; Hoban MD, 2015, BLOOD, V125, P2597, DOI 10.1182/blood-2014-12-615948; Hofer U, 2013, J INFECT DIS, V208, pS160, DOI 10.1093/infdis/jit382; Hogan CJ, 2002, P NATL ACAD SCI USA, V99, P413, DOI 10.1073/pnas.012336799; Holt N, 2010, NAT BIOTECHNOL, V28, P839, DOI 10.1038/nbt.1663; Kim H, 2014, NAT REV GENET, V15, P321, DOI 10.1038/nrg3686; Kowalczykowski SC, 2000, TRENDS BIOCHEM SCI, V25, P156, DOI 10.1016/S0968-0004(00)01569-3; Langmead B, 2012, NAT METHODS, V9, P357, DOI [10.1038/NMETH.1923, 10.1038/nmeth.1923]; Li LJ, 2013, MOL THER, V21, P1259, DOI 10.1038/mt.2013.65; Lin YF, 2001, NUCLEIC ACIDS RES, V29, P3975, DOI 10.1093/nar/29.19.3975; Lin YF, 2001, GENETICS, V158, P1665; Lombardo A, 2007, NAT BIOTECHNOL, V25, P1298, DOI 10.1038/nbt1353; Lombardo A, 2011, NAT METHODS, V8, P861, DOI [10.1038/NMETH.1674, 10.1038/nmeth.1674]; Majeti R, 2007, CELL STEM CELL, V1, P635, DOI 10.1016/j.stem.2007.10.001; McKenzie JL, 2006, NAT IMMUNOL, V7, P1225, DOI 10.1038/ni1393; Meyer M, 2010, P NATL ACAD SCI USA, V107, P15022, DOI 10.1073/pnas.1009424107; Miller DG, 2006, NAT BIOTECHNOL, V24, P1022, DOI 10.1038/nbt1231; Miller DG, 2004, NAT GENET, V36, P767, DOI 10.1038/ng1380; Miller JC, 2007, NAT BIOTECHNOL, V25, P778, DOI 10.1038/nbt1319; Miller JC, 2015, NAT METHODS, V12, P465, DOI 10.1038/nmeth.3330; Moehle EA, 2007, P NATL ACAD SCI USA, V104, P3055, DOI 10.1073/pnas.0611478104; MURRAY L, 1995, BLOOD, V85, P368; Negrin RS, 2000, BIOL BLOOD MARROW TR, V6, P262, DOI 10.1016/S1083-8791(00)70008-5; Notta F, 2011, SCIENCE, V333, P218, DOI 10.1126/science.1201219; Pei Y, 2015, SCI REP-UK, V5, DOI 10.1038/srep09205; Perez EE, 2008, NAT BIOTECHNOL, V26, P808, DOI 10.1038/nbt1410; Ran FA, 2013, CELL, V154, P1380, DOI 10.1016/j.cell.2013.08.021; Rogers CS, 2008, J CLIN INVEST, V118, P1571, DOI 10.1172/JCI34773; Russell DW, 1998, NAT GENET, V18, P325, DOI 10.1038/ng0498-325; Smith JR, 2008, STEM CELLS, V26, P496, DOI 10.1634/stemcells.2007-0039; Song LJ, 2013, CYTOTHERAPY, V15, P986, DOI 10.1016/j.jcyt.2013.04.003; Song LJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058757; Sung P, 2006, NAT REV MOL CELL BIO, V7, P739, DOI 10.1038/nrm2008; Tebas P, 2014, NEW ENGL J MED, V370, P901, DOI 10.1056/NEJMoa1300662; Urnov FD, 2010, NAT REV GENET, V11, P636, DOI 10.1038/nrg2842; Veldwijk MR, 2010, CYTOTHERAPY, V12, P107, DOI 10.3109/14653240903348293; Vose JM, 2001, BIOL BLOOD MARROW TR, V7, P680, DOI 10.1053/bbmt.2001.v7.pm11787531; Wang JB, 2012, GENOME RES, V22, P1316, DOI 10.1101/gr.122879.111; Wyman C, 2006, ANNU REV GENET, V40, P363, DOI 10.1146/annurev.genet.40.110405.090451; Xiao X, 1998, J VIROL, V72, P2224, DOI 10.1128/JVI.72.3.2224-2232.1998; Xu J, 2013, P NATL ACAD SCI USA, V110, P6518, DOI 10.1073/pnas.1303976110	67	195	210	0	34	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156	1546-1696		NAT BIOTECHNOL	Nat. Biotechnol.	DEC	2015	33	12					1256	+		10.1038/nbt.3408	http://dx.doi.org/10.1038/nbt.3408			10	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	CY4OO	26551060	Green Accepted			2022-12-27	WOS:000366387700017
J	Francisco, M				Francisco, Michael			Third-quarter biotech job picture	NATURE BIOTECHNOLOGY			English	Editorial Material																			0	0	0	0	1	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1087-0156	1546-1696		NAT BIOTECHNOL	Nat. Biotechnol.	NOV	2015	33	11					1211	1211		10.1038/nbt.3406	http://dx.doi.org/10.1038/nbt.3406			1	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	CW3TY	26544148				2022-12-27	WOS:000364916000029
J	Elvidge, S				Elvidge, Suzanne			Blockbuster expectations for hepatitis B therapeutic vaccine	NATURE BIOTECHNOLOGY			English	News Item																		2012, CANC GENE THER, V19, P779; 2014, VACCINE, V32, P4925	2	6	8	1	7	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156	1546-1696		NAT BIOTECHNOL	Nat. Biotechnol.	AUG	2015	33	8					789	789		10.1038/nbt0815-789	http://dx.doi.org/10.1038/nbt0815-789			1	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	CO6OB	26252120				2022-12-27	WOS:000359274900005
J	Francisco, M				Francisco, Michael			Second-quarter biotech job picture	NATURE BIOTECHNOLOGY			English	Editorial Material																			0	0	0	0	1	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156	1546-1696		NAT BIOTECHNOL	Nat. Biotechnol.	AUG	2015	33	8					883	883		10.1038/nbt.3314	http://dx.doi.org/10.1038/nbt.3314			1	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	CO6OB	26252149	Bronze			2022-12-27	WOS:000359274900034
J	Zhang, SG; Wittig, B				Zhang, Shuguang; Wittig, Burghardt			Alexander Rich 1924-2015	NATURE BIOTECHNOLOGY			English	Article									[Zhang, Shuguang] MIT, Media Lab, Ctr Bits & Atoms, Cambridge, MA 02139 USA; [Wittig, Burghardt] Free Univ Berlin, Fdn Inst Mol Biol & Bioinformat, Berlin, Germany	Massachusetts Institute of Technology (MIT); Free University of Berlin	Zhang, SG (corresponding author), MIT, Media Lab, Ctr Bits & Atoms, Cambridge, MA 02139 USA.	shuguang@mit.edu; bw@zedat.fu-berlin.de		Zhang, Shuguang/0000-0002-3856-3752				[Anonymous], 1998, Nat Struct Biol, V5, P858; FULLER W, 1973, NATURE, V243, P114; KIM SH, 1974, SCIENCE, V185, P435, DOI 10.1126/science.185.4149.435; RICH A, PUBLICATION LIST; ROSENBERG JM, 1973, NATURE, V243, P150, DOI 10.1038/243150a0; WATSON JD, 1983, NATURE, V302, P651	6	2	2	0	10	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156	1546-1696		NAT BIOTECHNOL	Nat. Biotechnol.	JUN	2015	33	6					593	598		10.1038/nbt.3262	http://dx.doi.org/10.1038/nbt.3262			6	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	CK2DE	26057974				2022-12-27	WOS:000356019700015
J	Chu, VT; Weber, T; Wefers, B; Wurst, W; Sander, S; Rajewsky, K; Kuhn, R				Van Trung Chu; Weber, Timm; Wefers, Benedikt; Wurst, Wolfgang; Sander, Sandrine; Rajewsky, Klaus; Kuehn, Ralf			Increasing the efficiency of homology-directed repair for CRISPR-Cas9-induced precise gene editing in mammalian cells	NATURE BIOTECHNOLOGY			English	Article							DAMAGE RESPONSE; BREAK REPAIR; DNA; RECEPTOR; PROTEIN; KINASE; KU70	The insertion of precise genetic modifications by genome editing tools such as CRISPR-Cas9 is limited by the relatively low efficiency of homology-directed repair (HDR) compared with the higher efficiency of the nonhomologous end-joining (NHEJ) pathway. To enhance HDR, enabling the insertion of precise genetic modifications, we suppressed the NHEJ key molecules KU70, KU80 or DNA ligase IV by gene silencing, the ligase IV inhibitor SCR7 or the coexpression of adenovirus 4 E1B55K and E4orf6 proteins in a 'traffic light' and other reporter systems. Suppression of KU70 and DNA ligase IV promotes the efficiency of HDR 4-5-fold. When co-expressed with the Cas9 system, E1B55K and E4orf6 improved the efficiency of HDR up to eightfold and essentially abolished NHEJ activity in both human and mouse cell lines. Our findings provide useful tools to improve the frequency of precise gene modifications in mammalian cells.	[Van Trung Chu; Weber, Timm; Sander, Sandrine; Rajewsky, Klaus; Kuehn, Ralf] Max Delbruck Ctr Mol Med, Berlin, Germany; [Wefers, Benedikt; Wurst, Wolfgang; Kuehn, Ralf] Helmholtz Zentrum Munchen, German Res Ctr Environm Hlth, Neuherberg, Germany; [Wefers, Benedikt; Wurst, Wolfgang] Deutsch Zentrum Neurodegenerat Erkrankungen eV, Munich, Germany; [Wurst, Wolfgang] Univ Munich, Munich Cluster Syst Neurol SyNergy, Munich, Germany; [Kuehn, Ralf] Berlin Inst Hlth, Berlin, Germany	Helmholtz Association; Max Delbruck Center for Molecular Medicine; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; Helmholtz Association; German Center for Neurodegenerative Diseases (DZNE); University of Munich; Berlin Institute of Health	Kuhn, R (corresponding author), Max Delbruck Ctr Mol Med, Berlin, Germany.	klaus.rajewsky@mdc-berlin.de; ralf.kuehn@mdc-berlin.de	Kühn, Ralf/U-1278-2017	Kühn, Ralf/0000-0003-1694-9803; Chu, Van Trung/0000-0003-1327-8696; Rajewsky, Klaus/0000-0002-6633-6370; Wurst, Wolfgang/0000-0003-4422-7410; Sander, Sandrine/0000-0003-4645-3366	European Research Council (ERC advanced grant) [ERC-AG-LS6]; German Ministry of Education and Research within the VIP program [TAL-CUT 03V0261]; European Union within the EUCOMMTOOLS project [FP7-HEALTH-F4-2010-261492]	European Research Council (ERC advanced grant)(European Research Council (ERC)); German Ministry of Education and Research within the VIP program; European Union within the EUCOMMTOOLS project	We thank K. Petsch and H.P. Rahn from the FACS core facility for excellent technical support. This work was supported by the European Research Council (ERC advanced grant ERC-AG-LS6, to K.R.), the German Ministry of Education and Research within the VIP program (TAL-CUT 03V0261, to W.W. and R.K.) and the European Union within the EUCOMMTOOLS project (FP7-HEALTH-F4-2010-261492, to W.W.). The plasmids MSCV-IRES-mCherry and MSCV-IRES-BFP were kind gifts of F. Rosenbauer and M. Janz (Charite, Berlin). We are grateful to H. Ploegh for communicating to us unpublished results and support in coordinating publication.	Adam S, 2014, EXP CELL RES, V329, P148, DOI 10.1016/j.yexcr.2014.07.017; Benkx M, 2005, VIRUS TAXONOMY; Bozas A, 2009, GENETICS, V182, P641, DOI 10.1534/genetics.109.101329; Certo MT, 2011, NAT METHODS, V8, P671, DOI [10.1038/nmeth.1648, 10.1038/NMETH.1648]; Cheng CY, 2011, J VIROL, V85, P765, DOI 10.1128/JVI.01890-10; Com E, 2007, MOL CELL PROTEOMICS, V6, P1842, DOI 10.1074/mcp.M700119-MCP200; Cong L, 2013, SCIENCE, V339, P819, DOI 10.1126/science.1231143; Donnelly MLL, 2001, J GEN VIROL, V82, P1027, DOI 10.1099/0022-1317-82-5-1027; Filippo JS, 2008, ANNU REV BIOCHEM, V77, P229, DOI 10.1146/annurev.biochem.77.061306.125255; Forrester NA, 2011, J VIROL, V85, P2201, DOI 10.1128/JVI.01748-10; Frit P, 2014, DNA REPAIR, V17, P81, DOI 10.1016/j.dnarep.2014.02.007; Ghebremedhin B, 2014, EUR J MICROBIOL IMMU, V4, P26, DOI 10.1556/EuJMI.4.2014.1.2; Gonzalez F, 2014, CELL STEM CELL, V15, P215, DOI 10.1016/j.stem.2014.05.018; Hsu PD, 2014, CELL, V157, P1262, DOI 10.1016/j.cell.2014.05.010; Li BM, 2011, AGING-US, V3, P395, DOI 10.18632/aging.100308; Lieber MR, 2010, ANNU REV BIOCHEM, V79, P181, DOI 10.1146/annurev.biochem.052308.093131; Mao ZY, 2008, DNA REPAIR, V7, P1765, DOI 10.1016/j.dnarep.2008.06.018; Martinez JJ, 2005, CELL, V123, P1013, DOI 10.1016/j.cell.2005.08.046; Merzlyak EM, 2007, NAT METHODS, V4, P555, DOI 10.1038/NMETH1062; Munakata Y, 2005, BLOOD, V106, P3449, DOI 10.1182/blood-2005-02-0536; Muylaert I, 2007, J BIOL CHEM, V282, P10865, DOI 10.1074/jbc.M611834200; Panier S, 2013, NAT REV MOL CELL BIO, V14, P661, DOI 10.1038/nrm3659; SAMULSKI RJ, 1991, EMBO J, V10, P3941, DOI 10.1002/j.1460-2075.1991.tb04964.x; Shalem O, 2014, SCIENCE, V343, P84, DOI 10.1126/science.1247005; Singh P, 2015, GENETICS, V199, P1, DOI 10.1534/genetics.114.169771; Srinivasan L, 2009, CELL, V139, P573, DOI 10.1016/j.cell.2009.08.041; Srivastava M, 2012, CELL, V151, P1474, DOI 10.1016/j.cell.2012.11.054; Windhofer F, 2007, J CELL PHYSIOL, V213, P475, DOI 10.1002/jcp.21120; Zhu QZ, 2010, J CELL PHYSIOL, V223, P283, DOI 10.1002/jcp.22060	29	751	855	10	296	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156	1546-1696		NAT BIOTECHNOL	Nat. Biotechnol.	MAY	2015	33	5					543	U160		10.1038/nbt.3198	http://dx.doi.org/10.1038/nbt.3198			8	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	CH8VP	25803306	Green Accepted			2022-12-27	WOS:000354314500038
J	He, QY; Johnston, J; Zeitlinger, J				He, Qiye; Johnston, Jeff; Zeitlinger, Julia			ChIP-nexus enables improved detection of in vivo transcription factor binding footprints	NATURE BIOTECHNOLOGY			English	Article							DROSOPHILA-EMBRYO; DNA-BINDING; NUCLEOTIDE RESOLUTION; INITIATION-COMPLEXES; C-MYC; GENOME; MAX; PROTEIN; EXPRESSION; FEATURES	Understanding how eukaryotic enhancers are bound and regulated by specific combinations of transcription factors is still a major challenge. To better map transcription factor binding genome-wide at nucleotide resolution in vivo, we have developed a robust ChIP-exo protocol called ChIP-nexus (chromatin immunoprecipitation experiments with nucleotide resolution through exonuclease, unique barcode and single ligation), which utilizes an efficient DNA self-circularization step during library preparation. Application of ChIP-nexus to four proteins-human TBP and Drosophila NFkB, Twist and Max-shows that it outperforms existing ChIP protocols in resolution and specificity, pinpoints relevant binding sites within enhancers containing multiple binding motifs, and allows for the analysis of in vivo binding specificities. Notably, we show that Max frequently interacts with DNA sequences next to its motif, and that this binding pattern correlates with local DNA-sequence features such as DNA shape. ChIP-nexus will be broadly applicable to the study of in vivo transcription factor binding specificity and its relationship to cis-regulatory changes in humans and model organisms.	[He, Qiye; Johnston, Jeff; Zeitlinger, Julia] Stowers Inst Med Res, Kansas City, MO 64110 USA; [Zeitlinger, Julia] Univ Kansas, Med Ctr, Dept Pathol, Kansas City, KS 66103 USA	Stowers Institute for Medical Research; University of Kansas; University of Kansas Medical Center	Zeitlinger, J (corresponding author), Stowers Inst Med Res, Kansas City, MO 64110 USA.	jbz@stowers.org		Johnston, Jeff/0000-0002-8962-6186	US National Institutes of Health (New Innovator Award) [1DP2 OD004561]; Stowers Institute for Medical Research; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [DP2OD004561] Funding Source: NIH RePORTER	US National Institutes of Health (New Innovator Award)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Stowers Institute for Medical Research; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	We thank M. Blanchette and A. Stark for discussions and R. Krumlauf and R. Mohan for critical comments on the manuscript. This work was funded by the US National Institutes of Health (New Innovator Award 1DP2 OD004561 to J.Z.) and the Stowers Institute for Medical Research.	Bardet AF, 2013, BIOINFORMATICS, V29, P2705, DOI 10.1093/bioinformatics/btt470; BLACKWOOD EM, 1991, SCIENCE, V251, P1211, DOI 10.1126/science.2006410; Casbon JA, 2011, NUCLEIC ACIDS RES, V39, DOI 10.1093/nar/gkr217; Fakhouri WD, 2010, MOL SYST BIOL, V6, DOI 10.1038/msb.2009.97; Feng JX, 2012, NAT PROTOC, V7, P1728, DOI 10.1038/nprot.2012.101; FERREDAMARE AR, 1993, NATURE, V363, P38, DOI 10.1038/363038a0; Gentleman RC, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-10-r80; Gordan R, 2013, CELL REP, V3, P1093, DOI 10.1016/j.celrep.2013.03.014; He QY, 2011, NAT GENET, V43, P414, DOI 10.1038/ng.808; Hesselberth JR, 2009, NAT METHODS, V6, P283, DOI [10.1038/NMETH.1313, 10.1038/nmeth.1313]; HUANG JD, 1993, GENE DEV, V7, P694, DOI 10.1101/gad.7.4.694; IP YT, 1992, GENE DEV, V6, P1728, DOI 10.1101/gad.6.9.1728; Kivioja T, 2012, NAT METHODS, V9, P72, DOI [10.1038/nmeth.1778, 10.1038/NMETH.1778]; Konig J, 2010, NAT STRUCT MOL BIOL, V17, P909, DOI 10.1038/nsmb.1838; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Liu X, 2006, GENOME RES, V16, P1517, DOI 10.1101/gr.5655606; Martin M, 2011, EMBNET J, V17, P10, DOI [10.14806/ej.17.1.200, 10.10.14806/ej.17.1.200, DOI 10.14806/EJ.17.1.200]; Nair SK, 2003, CELL, V112, P193, DOI 10.1016/S0092-8674(02)01284-9; Ozdemir A, 2011, GENOME RES, V21, P566, DOI 10.1101/gr.104018.109; PRENDERGAST GC, 1991, CELL, V65, P395, DOI 10.1016/0092-8674(91)90457-A; R Development Core Team, 2013, R: A Language and Environment for Statistical Computing; Rhee Ho Sung, 2012, Curr Protoc Mol Biol, VChapter 21, DOI 10.1002/0471142727.mb2124s100; Rhee HS, 2012, NATURE, V483, P295, DOI 10.1038/nature10799; Rhee HS, 2011, CELL, V147, P1408, DOI 10.1016/j.cell.2011.11.013; Rohs R, 2009, NATURE, V461, P1248, DOI 10.1038/nature08473; Sandmann T, 2007, GENE DEV, V21, P436, DOI 10.1101/gad.1509007; Serandour AA, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-12-r147; Spitz F, 2012, NAT REV GENET, V13, P613, DOI 10.1038/nrg3207; SZYMANSKI P, 1995, EMBO J, V14, P2229, DOI 10.1002/j.1460-2075.1995.tb07217.x; Venters BJ, 2013, NATURE, V502, P53, DOI 10.1038/nature12535; Walhout AJM, 1997, NUCLEIC ACIDS RES, V25, P1493, DOI 10.1093/nar/25.8.1493; WECHSLER DS, 1994, MOL CELL BIOL, V14, P4097, DOI 10.1128/MCB.14.6.4097; White MA, 2013, P NATL ACAD SCI USA, V110, P11952, DOI 10.1073/pnas.1307449110; Yang L, 2014, NUCLEIC ACIDS RES, V42, pD148, DOI 10.1093/nar/gkt1087; Yen KY, 2012, CELL, V149, P1461, DOI 10.1016/j.cell.2012.04.036; Zeitlinger J, 2007, GENE DEV, V21, P385, DOI 10.1101/gad.1509607; Zhou TY, 2013, NUCLEIC ACIDS RES, V41, pW56, DOI 10.1093/nar/gkt437; Zhu LHJ, 2011, NUCLEIC ACIDS RES, V39, pD111, DOI 10.1093/nar/gkq858; Zinzen RP, 2006, CURR BIOL, V16, P1358, DOI 10.1016/j.cub.2006.05.044	40	136	142	0	32	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156	1546-1696		NAT BIOTECHNOL	Nat. Biotechnol.	APR	2015	33	4					395	U108		10.1038/nbt.3121	http://dx.doi.org/10.1038/nbt.3121			10	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	CF2AE	25751057	Green Accepted			2022-12-27	WOS:000352348500026
J	Huggett, B				Huggett, Brady			Academic partnerships 2014	NATURE BIOTECHNOLOGY			English	Editorial Material																			0	2	2	0	1	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156	1546-1696		NAT BIOTECHNOL	Nat. Biotechnol.	APR	2015	33	4					333	333		10.1038/nbt.3189	http://dx.doi.org/10.1038/nbt.3189			1	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	VB8MA	25850049	Bronze			2022-12-27	WOS:000419072300001
J	Zhou, K; Qiao, KJ; Edgar, S; Stephanopoulos, G				Zhou, Kang; Qiao, Kangjian; Edgar, Steven; Stephanopoulos, Gregory			Distributing a metabolic pathway among a microbial consortium enhances production of natural products	NATURE BIOTECHNOLOGY			English	Article							1ST OXYGENATION STEP; ESCHERICHIA-COLI; SACCHAROMYCES-CEREVISIAE; TAXOL BIOSYNTHESIS; FUNCTIONAL EXPRESSION; MOLECULAR-CLONING; SYNTHETASE GENE; MIXED CULTURE; ACETATE; OPTIMIZATION	Metabolic engineering of microorganisms such as Escherichia coli and Saccharomyces cerevisiae to produce high-value natural metabolites is often done through functional reconstitution of long metabolic pathways. Problems arise when parts of pathways require specialized environments or compartments for optimal function. Here we solve this problem through co-culture of engineered organisms, each of which contains the part of the pathway that it is best suited to hosting. In one example, we divided the synthetic pathway for the acetylated diol paclitaxel precursor into two modules, expressed in either S. cerevisiae or E. coli, neither of which can produce the paclitaxel precursor on their own. Stable co-culture in the same bioreactor was achieved by designing a mutualistic relationship between the two species in which a metabolic intermediate produced by E. coli was used and functionalized by yeast. This synthetic consortium produced 33 mg/L oxygenated taxanes, including a monoacetylated dioxygenated taxane. The same method was also used to produce tanshinone precursors and functionalized sesquiterpenes.	[Zhou, Kang; Qiao, Kangjian; Edgar, Steven; Stephanopoulos, Gregory] MIT, Dept Chem Engn, Cambridge, MA 02139 USA	Massachusetts Institute of Technology (MIT)	Stephanopoulos, G (corresponding author), MIT, Dept Chem Engn, Cambridge, MA 02139 USA.	gregstep@mit.edu	Zhou, Kang/AAQ-5730-2021; Zhou, Kang/AAI-9969-2021	Zhou, Kang/0000-0003-0606-7030; 	National Institutes of Health [1-R01-GM085323-01A1]; Singapore MIT Alliance; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM085323] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Singapore MIT Alliance(Singapore-MIT Alliance for Research & Technology Centre (SMART)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We acknowledge useful discussions and input from A. Ghaderi, F. Lam, H. Zhang, J. Avalos and W. Wang. This work was supported by National Institutes of Health grant 1-R01-GM085323-01A1 and the Singapore MIT Alliance.	Agapakis CM, 2012, NAT CHEM BIOL, V8, P527, DOI [10.1038/NCHEMBIO.975, 10.1038/nchembio.975]; Ajikumar PK, 2008, MOL PHARMACEUT, V5, P167, DOI 10.1021/mp700151b; Ajikumar PK, 2010, SCIENCE, V330, P70, DOI 10.1126/science.1191652; Alonso-Gutierrez J, 2013, METAB ENG, V19, P33, DOI 10.1016/j.ymben.2013.05.004; Artsatbanov VY, 2012, BIOCHEMISTRY-MOSCOW+, V77, P362, DOI 10.1134/S0006297912040074; Avalos JL, 2013, NAT BIOTECHNOL, V31, P335, DOI 10.1038/nbt.2509; Bayer TS, 2009, J AM CHEM SOC, V131, P6508, DOI 10.1021/ja809461u; Blazeck J, 2012, BIOTECHNOL BIOENG, V109, P2884, DOI 10.1002/bit.24552; Causey TB, 2003, P NATL ACAD SCI USA, V100, P825, DOI 10.1073/pnas.0337684100; Chang MCY, 2007, NAT CHEM BIOL, V3, P274, DOI 10.1038/nchembio875; Choi YJ, 2013, NATURE, V502, P571, DOI 10.1038/nature12536; Craft DL, 2003, APPL ENVIRON MICROB, V69, P5983, DOI 10.1128/AEM.69.10.5983-5991.2003; DAVISON BH, 1986, BIOTECHNOL BIOENG, V28, P1127, DOI 10.1002/bit.260280802; DEVIRGILIO C, 1992, YEAST, V8, P1043, DOI 10.1002/yea.320081207; Eiteman MA, 2006, TRENDS BIOTECHNOL, V24, P530, DOI 10.1016/j.tibtech.2006.09.001; Flagfeldt DB, 2009, YEAST, V26, P545, DOI 10.1002/yea.1705; FREDRICKSON AG, 1981, SCIENCE, V213, P972, DOI 10.1126/science.7268409; Guerra-Bubb J, 2012, NAT PROD REP, V29, P683, DOI 10.1039/c2np20021j; Guo J, 2013, P NATL ACAD SCI USA, V110, P12108, DOI 10.1073/pnas.1218061110; Hefferon K, 2013, BIOTECHNOL J, V8, P1193, DOI 10.1002/biot.201300162; Hefner J, 1996, CHEM BIOL, V3, P479, DOI 10.1016/S1074-5521(96)90096-4; Hom EFY, 2014, SCIENCE, V345, P94, DOI 10.1126/science.1253320; Jennewein S, 2004, CHEM BIOL, V11, P379, DOI 10.1016/j.chembiol.2004.02.022; Kratzer S, 1997, MOL MICROBIOL, V26, P631, DOI 10.1046/j.1365-2958.1997.5611937.x; Leber C, 2014, BIOTECHNOL BIOENG, V111, P347, DOI 10.1002/bit.25021; Melnik S, 2013, CURR MED CHEM, V20, P1038; Minami H, 2008, P NATL ACAD SCI USA, V105, P7393, DOI 10.1073/pnas.0802981105; Minty JJ, 2013, P NATL ACAD SCI USA, V110, P14592, DOI 10.1073/pnas.1218447110; Nowak MA, 2006, SCIENCE, V314, P1560, DOI 10.1126/science.1133755; Paddon CJ, 2013, NATURE, V496, P528, DOI 10.1038/nature12051; Pillai VC, 2011, CLIN EXP PHARMACOL P, V38, P846, DOI 10.1111/j.1440-1681.2011.05622.x; Reed James R, 2011, Drug Metab Lett, V5, P6; Rontein D, 2008, J BIOL CHEM, V283, P6067, DOI 10.1074/jbc.M708950200; Santos CNS, 2012, P NATL ACAD SCI USA, V109, P13538, DOI 10.1073/pnas.1206346109; Schoendorf A, 2001, P NATL ACAD SCI USA, V98, P1501, DOI 10.1073/pnas.98.4.1501; Smid EJ, 2013, CURR OPIN BIOTECH, V24, P148, DOI 10.1016/j.copbio.2012.11.007; Sun J, 2012, BIOTECHNOL BIOENG, V109, P2082, DOI 10.1002/bit.24481; Walker K, 2000, ARCH BIOCHEM BIOPHYS, V374, P371, DOI 10.1006/abbi.1999.1609; Wheeler AL, 2001, ARCH BIOCHEM BIOPHYS, V390, P265, DOI 10.1006/abbi.2001.2377; Xia T, 2012, MICROB CELL FACT, V11, DOI 10.1186/1475-2859-11-77; Xue JF, 2011, APPL ENVIRON MICROB, V77, P2399, DOI 10.1128/AEM.02341-10; Zhou K, 2013, BIOTECHNOL BIOENG, V110, P2556, DOI 10.1002/bit.24900; Zhou YJJ, 2012, J AM CHEM SOC, V134, P3234, DOI 10.1021/ja2114486; Zou RY, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079557	45	365	404	36	546	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156	1546-1696		NAT BIOTECHNOL	Nat. Biotechnol.	APR	2015	33	4					377	U157		10.1038/nbt.3095	http://dx.doi.org/10.1038/nbt.3095			9	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	CF2AE	25558867	Green Submitted, Green Accepted			2022-12-27	WOS:000352348500023
J	Boekel, J; Chilton, JM; Cooke, IR; Horvatovich, PL; Jagtap, PD; Kall, L; Lehtio, J; Lukasse, P; Moerland, PD; Griffin, TJ				Boekel, Jorrit; Chilton, John M.; Cooke, Ira R.; Horvatovich, Peter L.; Jagtap, Pratik D.; Kall, Lukas; Lehtio, Janne; Lukasse, Pieter; Moerland, Perry D.; Griffin, Timothy J.			Multi-omic data analysis using Galaxy	NATURE BIOTECHNOLOGY			English	Letter							PROTEOMICS; WORKFLOWS; TAVERNA		[Boekel, Jorrit; Lehtio, Janne] Karolinska Inst, Sci Life Lab, Dept Oncol Pathol, Stockholm, Sweden; [Boekel, Jorrit] BILS, Stockholm, Sweden; [Chilton, John M.; Jagtap, Pratik D.] Univ Minnesota, Minnesota Supercomp Inst, Minneapolis, MN USA; [Cooke, Ira R.] La Trobe Univ, La Trobe Inst Mol Sci, Dept Biochem, Melbourne, Vic, Australia; [Cooke, Ira R.] Life Sci Computat Ctr, Victorian Life Sci Computat Initiat, Melbourne, Vic, Australia; [Horvatovich, Peter L.] Univ Groningen, Dept Pharm, Groningen, Netherlands; [Jagtap, Pratik D.; Griffin, Timothy J.] Univ Minnesota, Dept Biochem, Minneapolis, MN 55455 USA; [Kall, Lukas] Royal Inst Technol KTH, Sci Life Lab, Sch Biotechnol, Stockholm, Sweden; [Lukasse, Pieter] Wageningen Univ & Res Ctr, Plant Res Int, Wageningen, Netherlands; [Moerland, Perry D.] Univ Amsterdam, Acad Med Ctr, Dept Clin Epidemiol Biostat & Bioinformat, Bioinformat Lab, NL-1105 AZ Amsterdam, Netherlands	Karolinska Institutet; University of Minnesota System; University of Minnesota Twin Cities; La Trobe University; University of Groningen; University of Minnesota System; University of Minnesota Twin Cities; Royal Institute of Technology; Wageningen University & Research; University of Amsterdam; Academic Medical Center Amsterdam	Boekel, J (corresponding author), Karolinska Inst, Sci Life Lab, Dept Oncol Pathol, Stockholm, Sweden.	tgriffin@umn.edu	Cooke, Ira R/B-4409-2008; Käll, Lukas/A-7334-2009; Horvatovich, P.L./J-2154-2012; Moerland, Perry/AAG-1425-2020	Käll, Lukas/0000-0001-5689-9797; Horvatovich, P.L./0000-0003-2218-1140; Moerland, Perry/0000-0002-2357-3659; Jagtap, Pratik/0000-0003-0984-0973; Lehtio, Janne/0000-0002-8100-9562; Chilton, John/0000-0002-6794-0756; Griffin, Timothy/0000-0001-6801-2559; Cooke, Ira/0000-0001-6520-1397				Abouelhoda M, 2012, BMC BIOINFORMATICS, V13, DOI 10.1186/1471-2105-13-77; Armengaud J, 2013, ENVIRON MICROBIOL, V15, P12, DOI 10.1111/j.1462-2920.2012.02811.x; Castellana NE, 2014, MOL CELL PROTEOMICS, V13, P157, DOI 10.1074/mcp.M113.031260; Goble CA, 2010, NUCLEIC ACIDS RES, V38, pW677, DOI 10.1093/nar/gkq429; Goecks J, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-8-r86; Hull D, 2006, NUCLEIC ACIDS RES, V34, pW729, DOI 10.1093/nar/gkl320; Hunter AA, 2012, SOURCE CODE BIOL MED, V7, DOI 10.1186/1751-0473-7-1; Jagla B, 2011, BIOINFORMATICS, V27, P2907, DOI 10.1093/bioinformatics/btr478; Junot C, 2014, MASS SPECTROM REV, V33, P471, DOI 10.1002/mas.21401; Kacsuk P, 2012, J GRID COMPUT, V10, P601, DOI 10.1007/s10723-012-9240-5; Lappalainen T, 2013, NATURE, V501, P506, DOI 10.1038/nature12531; Low TY, 2013, CELL REP, V5, P1469, DOI 10.1016/j.celrep.2013.10.041; Martinez-Outschoorn UE, 2011, CELL CYCLE, V10, P1271, DOI 10.4161/cc.10.8.15330; Palsson B, 2010, NAT CHEM BIOL, V6, P787, DOI 10.1038/nchembio.462	14	90	92	0	25	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156	1546-1696		NAT BIOTECHNOL	Nat. Biotechnol.	FEB	2015	33	2					137	139		10.1038/nbt.3134	http://dx.doi.org/10.1038/nbt.3134			3	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	CA8VK	25658277	Green Published			2022-12-27	WOS:000349198800014
J	Buettner, F; Natarajan, KN; Casale, FP; Proserpio, V; Scialdone, A; Theis, FJ; Teichmann, SA; Marioni, JC; Stegie, O				Buettner, Florian; Natarajan, Kedar N.; Casale, F. Paolo; Proserpio, Valentina; Scialdone, Antonio; Theis, Fabian J.; Teichmann, Sarah A.; Marioni, John C.; Stegie, Oliver			Computational analysis of cell-to-cell heterogeneity in single-cell RNA-sequencing data reveals hidden subpopulations of cells	NATURE BIOTECHNOLOGY			English	Article							EMBRYONIC STEM-CELLS; GENE-EXPRESSION; FATE DECISIONS; SEQ ANALYSIS; MODELS; NOISE; TRANSCRIPTOMICS; MECHANISMS; LANDSCAPE; CYCLE	Recent technical developments have enabled the transcriptomes of hundreds of cells to be assayed in an unbiased manner, opening up the possibility that new subpopulations of cells can be found. However, the effects of potential confounding factors, such as the cell cycle, on the heterogeneity of gene expression and therefore on the ability to robustly identify subpopulations remain unclear. We present and validate a computational approach that uses latent variable models to account for such hidden factors. We show that our single-cell latent variable model (scLVM) allows the identification of otherwise undetectable subpopulations of cells that correspond to different stages during the differentiation of naive T cells into T helper 2 cells. Our approach can be used not only to identify cellular subpopulations but also to tease apart different sources of gene expression heterogeneity in single-cell transcriptomes.	[Buettner, Florian; Theis, Fabian J.] Inst Computat Biol, Munchen German Res Ctr Environm Hlth, Helmholtz Zentrum Munchen, Neuherberg, Germany; [Buettner, Florian; Natarajan, Kedar N.; Casale, F. Paolo; Proserpio, Valentina; Scialdone, Antonio; Teichmann, Sarah A.; Marioni, John C.; Stegie, Oliver] European Bioinformat Inst, European Mol Biol Lab, Cambridge, England; [Natarajan, Kedar N.; Proserpio, Valentina; Scialdone, Antonio; Teichmann, Sarah A.; Marioni, John C.] Wellcome Trust Sanger Inst, Hinxton, England; [Theis, Fabian J.] Tech Univ Munich, Dept Math, D-80290 Munich, Germany	Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; European Molecular Biology Laboratory (EMBL); Wellcome Trust Sanger Institute; Technical University of Munich	Marioni, JC (corresponding author), European Bioinformat Inst, European Mol Biol Lab, Wellcome Trust Genome Campus, Cambridge, England.	marioni@ebi.ac.uk; stegle@ebLac.uk	Buettner, Florian/ABF-1230-2020; Stegle, Oliver/AAU-9177-2020; Theis, Fabian J/ABD-5212-2021; Proserpio, Valentina/AAB-3630-2019	Buettner, Florian/0000-0001-5587-6761; Stegle, Oliver/0000-0002-8818-7193; Theis, Fabian J/0000-0002-2419-1943; Proserpio, Valentina/0000-0003-2071-4206; Marioni, John/0000-0001-9092-0852; Natarajan, Kedar Nath/0000-0002-9264-1280; Scialdone, Antonio/0000-0002-4956-2843; Teichmann, Sarah/0000-0002-6294-6366	European Research Council [260507 thSWITCH, 253524]; Sanger-EBI Single Cell Centre; European Molecular Biology Organization	European Research Council(European Research Council (ERC)European Commission); Sanger-EBI Single Cell Centre; European Molecular Biology Organization(European Molecular Biology Organization (EMBO))	We thank S. Anders and A. Baud for helpful discussions. We also thank the Sanger-EBI Single Cell Centre for technical support. We acknowledge support of the European Research Council (Starting grant no. 260507 thSWITCH to S.A.T., Starting Grant LatentCauses to F.J.T., Marie Curie FP7 fellowship 253524 to O.S.), the Sanger-EBI Single Cell Centre (K.N.N. & A.S.) and the European Molecular Biology Organization (short-term fellowship to F.B.).	Betz BC, 2010, J EXP MED, V207, P933, DOI 10.1084/jem.20091548; Bird JJ, 1998, IMMUNITY, V9, P229, DOI 10.1016/S1074-7613(00)80605-6; Brennecke P, 2013, NAT METHODS, V10, P1093, DOI [10.1038/nmeth.2645, 10.1038/NMETH.2645]; Burton A, 2013, CELL REP, V5, P687, DOI 10.1016/j.celrep.2013.09.044; Chang CH, 2013, CELL, V153, P1239, DOI 10.1016/j.cell.2013.05.016; Chiang MK, 2003, DEV CELL, V4, P383, DOI 10.1016/S1534-5807(03)00035-2; Citri A, 2012, NAT PROTOC, V7, P118, DOI 10.1038/nprot.2011.430; Fox CJ, 2005, NAT REV IMMUNOL, V5, P844, DOI 10.1038/nri1710; Fusi N, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002330; Garcia-Sanz JA, 1998, FASEB J, V12, P299, DOI 10.1096/fasebj.12.3.299; Gold D, 2008, J COMPUT BIOL, V15, P611, DOI 10.1089/cmb.2007.0220; Grun D, 2014, NAT METHODS, V11, P637, DOI [10.1038/NMETH.2930, 10.1038/nmeth.2930]; Guo GJ, 2010, DEV CELL, V18, P675, DOI 10.1016/j.devcel.2010.02.012; Islam S, 2014, NAT METHODS, V11, P163, DOI [10.1038/NMETH.2772, 10.1038/nmeth.2772]; Islam S, 2011, GENOME RES, V21, P1160, DOI 10.1101/gr.110882.110; Jensen LJ, 2009, NUCLEIC ACIDS RES, V37, pD412, DOI 10.1093/nar/gkn760; Lawrence ND, 2004, ADV NEUR IN, V16, P329; Leek JT, 2007, PLOS GENET, V3, P1724, DOI 10.1371/journal.pgen.0030161; Levsky JM, 2002, SCIENCE, V297, P836, DOI 10.1126/science.1072241; Li S, 2014, NAT BIOTECHNOL, V32, P888, DOI 10.1038/nbt.3000; Lippert C, 2011, NAT METHODS, V8, P833, DOI [10.1038/nmeth.1681, 10.1038/NMETH.1681]; Liu J, 2003, ANAL CHEM, V75, P4718, DOI 10.1021/ac0346407; Luo L, 1999, NAT MED, V5, P117, DOI 10.1038/4806; Mahata B, 2014, CELL REP, V7, P1130, DOI 10.1016/j.celrep.2014.04.011; Marcus JS, 2006, ANAL CHEM, V78, P3084, DOI 10.1021/ac0519460; Nelms K, 1999, ANNU REV IMMUNOL, V17, P701, DOI 10.1146/annurev.immunol.17.1.701; Newman JRS, 2006, NATURE, V441, P840, DOI 10.1038/nature04785; Pollen AA, 2014, NAT BIOTECHNOL, V32, P1053, DOI 10.1038/nbt.2967; Raj A, 2008, NAT METHODS, V5, P877, DOI 10.1038/NMETH.1253; Sahoo A, 2011, J IMMUNOL, V186, P4098, DOI 10.4049/jimmunol.1002620; Sasagawa Y, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-4-r31; Shalek AK, 2013, NATURE, V498, P236, DOI 10.1038/nature12172; Singh AM, 2013, STEM CELL REP, V1, P532, DOI 10.1016/j.stemcr.2013.10.009; Stegle O., NAT REV GEN IN PRESS; Stegle O, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000770; Stritesky GL, 2011, IMMUNITY, V34, P39, DOI 10.1016/j.immuni.2010.12.013; Tang FC, 2010, CELL STEM CELL, V6, P468, DOI 10.1016/j.stem.2010.03.015; Tang FC, 2010, NAT PROTOC, V5, P516, DOI 10.1038/nprot.2009.236; Taniguchi Y, 2010, SCIENCE, V329, P533, DOI 10.1126/science.1188308; Trapnell C, 2014, NAT BIOTECHNOL, V32, P381, DOI 10.1038/nbt.2859; Wheeler AR, 2003, ANAL CHEM, V75, P3581, DOI 10.1021/ac0340758; Wilson CB, 2002, J INFECT DIS, V185, pS37, DOI 10.1086/338001; Xue ZG, 2013, NATURE, V500, P593, DOI 10.1038/nature12364; Yan LY, 2013, NAT STRUCT MOL BIOL, V20, P1131, DOI 10.1038/nsmb.2660; Zhou MX, 2007, J IMMUNOL, V178, P5496, DOI 10.4049/jimmunol.178.9.5496; Zhu JF, 2006, CELL RES, V16, P3, DOI 10.1038/sj.cr.7310002	46	667	675	10	138	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156	1546-1696		NAT BIOTECHNOL	Nat. Biotechnol.	FEB	2015	33	2					155	160		10.1038/nbt.3102	http://dx.doi.org/10.1038/nbt.3102			6	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	CA8VK	25599176	Bronze			2022-12-27	WOS:000349198800020
J	Khvorova, A; Osborn, MF; Hassler, MR				Khvorova, Anastasia; Osborn, Maire F.; Hassler, Matthew R.			Taking charge of siRNA delivery	NATURE BIOTECHNOLOGY			English	Editorial Material									[Khvorova, Anastasia; Osborn, Maire F.; Hassler, Matthew R.] Univ Massachusetts, Sch Med, RNA Therapeut Inst, Worcester, MA 01655 USA	University of Massachusetts System; University of Massachusetts Worcester	Khvorova, A (corresponding author), Univ Massachusetts, Sch Med, RNA Therapeut Inst, Worcester, MA 01655 USA.	Anastasia.Khvorova@umassmed.edu			NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM108803] Funding Source: NIH RePORTER; NIGMS NIH HHS [R01 GM108803] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		[Anonymous], 2014, RNAI ROUNDTABLE ADV; Eguchi A, 2009, NAT BIOTECHNOL, V27, P567, DOI 10.1038/nbt.1541; FAWELL S, 1994, P NATL ACAD SCI USA, V91, P664, DOI 10.1073/pnas.91.2.664; Gait MJ, 2003, CELL MOL LIFE SCI, V60, P844, DOI 10.1007/s00018-003-3044-5; HANGELAND JJ, 1995, BIOCONJUGATE CHEM, V6, P695, DOI 10.1021/bc00036a006; Meade BR, 2014, NAT BIOTECHNOL, V32, P1256, DOI 10.1038/nbt.3078; Morrissey DV, 2005, HEPATOLOGY, V41, P1349, DOI 10.1002/hep.20702; PERIGAUD C, 1993, BIOORG MED CHEM LETT, V3, P2521, DOI 10.1016/S0960-894X(01)80709-5; Wiesler WT, 1996, J ORG CHEM, V61, P4272, DOI 10.1021/jo960274y	9	17	19	1	33	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156	1546-1696		NAT BIOTECHNOL	Nat. Biotechnol.	DEC	2014	32	12					1197	1198		10.1038/nbt.3091	http://dx.doi.org/10.1038/nbt.3091			2	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	AW3AD	25489835				2022-12-27	WOS:000346156800019
J	Hockendorf, B; Lavis, LD; Keller, PJ				Hoeckendorf, Burkhard; Lavis, Luke D.; Keller, Philipp J.			Making biology transparent	NATURE BIOTECHNOLOGY			English	Editorial Material							RECONSTRUCTION; TISSUE; BRAIN		[Hoeckendorf, Burkhard; Lavis, Luke D.; Keller, Philipp J.] Howard Hughes Med Inst, Ashburn, VA 20147 USA	Howard Hughes Medical Institute	Hockendorf, B (corresponding author), Howard Hughes Med Inst, Janelia Res Campus, Ashburn, VA 20147 USA.	hoeckendorfb@janelia.hhmi.org; lavisl@janelia.hhmi.org; kellerp@janelia.hhmi.org		Lavis, Luke/0000-0002-0789-6343; Keller, Philipp/0000-0003-2896-4920				Becker K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033916; Chung K, 2013, NATURE, V497, P332, DOI 10.1038/nature12107; DENT JA, 1989, DEVELOPMENT, V105, P61; Hama H, 2011, NAT NEUROSCI, V14, P1481, DOI 10.1038/nn.2928; Ke MT, 2013, NAT NEUROSCI, V16, P1154, DOI 10.1038/nn.3447; Keller PJ, 2012, CURR OPIN NEUROBIOL, V22, P138, DOI 10.1016/j.conb.2011.08.003; Kuwajima T, 2013, DEVELOPMENT, V140, P1364, DOI 10.1242/dev.091844; Spalteholz W., 1914, DURCHSICHTIGMACHEN M; Susaki EA, 2014, CELL, V157, P726, DOI 10.1016/j.cell.2014.03.042; Tomer R, 2014, NAT PROTOC, V9, P1682, DOI 10.1038/nprot.2014.123; Wang J, 2013, J BIOMED OPT, V18, DOI 10.1117/1.JBO.18.6.061209; Yang B, 2014, CELL, V158, P945, DOI 10.1016/j.cell.2014.07.017	12	4	4	0	28	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156	1546-1696		NAT BIOTECHNOL	Nat. Biotechnol.	NOV	2014	32	11					1104	1105		10.1038/nbt.3061	http://dx.doi.org/10.1038/nbt.3061			2	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	AT5IL	25380446				2022-12-27	WOS:000344977000014
J	Mei, H; Irazoqui, PP				Mei, Henry; Irazoqui, Pedro P.			Miniaturizing wireless implants	NATURE BIOTECHNOLOGY			English	Editorial Material							POWER TRANSFER		[Mei, Henry; Irazoqui, Pedro P.] Purdue Univ, Ctr Implantable Devices, Weldon Sch Biomed Engn, W Lafayette, IN 47907 USA	Purdue University System; Purdue University; Purdue University West Lafayette Campus	Mei, H (corresponding author), Purdue Univ, Ctr Implantable Devices, Weldon Sch Biomed Engn, W Lafayette, IN 47907 USA.	pip@purdue.edu						Beck H, 2010, AM J CARDIOL, V106, P810, DOI 10.1016/j.amjcard.2010.04.043; Chow EY, 2009, IEEE T MICROW THEORY, V57, P2523, DOI 10.1109/TMTT.2009.2029954; Dagdeviren C, 2014, P NATL ACAD SCI USA, V111, P1927, DOI 10.1073/pnas.1317233111; Ha D, 2014, IEEE MTT S INT MICR; HEETDERKS WJ, 1988, IEEE T BIO-MED ENG, V35, P323, DOI 10.1109/10.1388; Ho JS, 2014, P NATL ACAD SCI USA, V111, P7974, DOI 10.1073/pnas.1403002111; Kurs A, 2007, SCIENCE, V317, P83, DOI 10.1126/science.1143254; Pandey J, 2010, IEEE T BIOMED CIRC S, V4, P454, DOI 10.1109/TBCAS.2010.2081989; Waters BH, 2012, P IEEE, V100, P138, DOI 10.1109/JPROC.2011.2165309; Yeager DJ, 2009, IEEE T BIOMED CIRC S, V3, P379, DOI 10.1109/TBCAS.2009.2031628	10	26	26	0	23	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156	1546-1696		NAT BIOTECHNOL	Nat. Biotechnol.	OCT	2014	32	10					1008	1010		10.1038/nbt.3038	http://dx.doi.org/10.1038/nbt.3038			4	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	AR7MM	25299922				2022-12-27	WOS:000343763800017
J	Snijder, B; Kandasamy, RK; Superti-Furga, G				Snijder, Berend; Kandasamy, Richard Kumaran; Superti-Furga, Giulio			Toward effective sharing of high-dimensional immunology data	NATURE BIOTECHNOLOGY			English	Article							GENE-EXPRESSION; MINIMUM INFORMATION; T-CELLS; SYSTEMS; SIGNATURES; PROFILES; VACCINES; NETWORK; DISEASE; LINEAGE	Immunology is on the cusp of a 'big data'-driven breakthrough, but strategies for standardizing and sharing high-dimensional data from independent laboratories are needed to ensure that data support the formation of new and robust hypotheses.	[Snijder, Berend; Kandasamy, Richard Kumaran; Superti-Furga, Giulio] Austrian Acad Sci, CeMM Res Ctr Mol Med, A-1010 Vienna, Austria	Austrian Academy of Sciences; CeMM Research Center for Molecular Medicine of the Austrian Academy of Sciences	Snijder, B (corresponding author), Austrian Acad Sci, CeMM Res Ctr Mol Med, A-1010 Vienna, Austria.	bsnijder@cemm.oeaw.ac.at; gsuperti@cemm.oeaw.ac.at	Kandasamy, Richard Kumaran/C-8981-2009; Snijder, Berend/M-2998-2017; Snijder, Berend/O-9206-2019; Superti-Furga, Giulio/AAE-5681-2019; Superti-Furga, Giulio/F-4755-2015	Kandasamy, Richard Kumaran/0000-0002-0894-1222; Snijder, Berend/0000-0003-3386-6583; Superti-Furga, Giulio/0000-0002-0570-1768				Amir ED, 2013, NAT BIOTECHNOL, V31, P545, DOI 10.1038/nbt.2594; Baker M, 2013, NATURE, V494, P416, DOI 10.1038/494416a; Bammler T, 2005, NAT METHODS, V2, P351, DOI 10.1038/nmeth0605-477a; Barrett T, 2007, NUCLEIC ACIDS RES, V35, pD760, DOI 10.1093/nar/gkl887; Bindea G, 2013, IMMUNITY, V39, P782, DOI 10.1016/j.immuni.2013.10.003; Brazma A, 2001, NAT GENET, V29, P365, DOI 10.1038/ng1201-365; Chattopadhyay PK, 2014, NAT IMMUNOL, V15, P128, DOI 10.1038/ni.2796; Gautier EL, 2012, NAT IMMUNOL, V13, P1118, DOI 10.1038/ni.2419; Georgiou G, 2014, NAT BIOTECHNOL, V32, P158, DOI 10.1038/nbt.2782; Han A, 2013, P NATL ACAD SCI USA, V110, P13073, DOI 10.1073/pnas.1311861110; Heinaniemi M, 2013, NAT METHODS, V10, P577, DOI [10.1038/nmeth.2445, 10.1038/NMETH.2445]; Kerrien S, 2012, NUCLEIC ACIDS RES, V40, pD841, DOI 10.1093/nar/gkr1088; Khatri P, 2013, J EXP MED, V210, P2205, DOI 10.1084/jem.20122709; Kidd BA, 2014, NAT IMMUNOL, V15, P118, DOI 10.1038/ni.2787; Li S, 2014, NAT IMMUNOL, V15, P195, DOI 10.1038/ni.2789; Maecker HT, 2012, NAT REV IMMUNOL, V12, P191, DOI 10.1038/nri3158; Marbach D, 2012, NAT METHODS, V9, P796, DOI [10.1038/nmeth.2016, 10.1038/NMETH.2016]; Miller JC, 2012, NAT IMMUNOL, V13, P888, DOI 10.1038/ni.2370; Newell EW, 2014, NAT BIOTECHNOL, V32, P149, DOI 10.1038/nbt.2783; Obermoser G, 2013, IMMUNITY, V38, P831, DOI 10.1016/j.immuni.2012.12.008; Pachon G, 2012, NAT REV IMMUNOL, V12, P396, DOI 10.1038/nri3158-c1; Parkinson H, 2009, NUCLEIC ACIDS RES, V37, pD868, DOI 10.1093/nar/gkn889; Piwowar H, 2013, NATURE, V493, P159, DOI 10.1038/493159a; Qiu P, 2011, NAT BIOTECHNOL, V29, P886, DOI 10.1038/nbt.1991; Snijder B, 2013, NAT METHODS, V10, P1089, DOI [10.1038/NMETH.2655, 10.1038/nmeth.2655]; Taylor CF, 2007, NAT BIOTECHNOL, V25, P887, DOI 10.1038/nbt1329; Valle A., 2012, REV IMMUNOL, V12, P191; Varjosalo M, 2013, NAT METHODS, V10, P307, DOI [10.1038/NMETH.2400, 10.1038/nmeth.2400]; Vizcaino JA, 2013, NUCLEIC ACIDS RES, V41, pD1063, DOI 10.1093/nar/gks1262; Woodsworth DJ, 2013, GENOME MED, V5, DOI 10.1186/gm502	30	6	6	0	10	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156	1546-1696		NAT BIOTECHNOL	Nat. Biotechnol.	AUG	2014	32	8					755	759		10.1038/nbt.2974	http://dx.doi.org/10.1038/nbt.2974			5	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	AW7PF	25101748	Bronze			2022-12-27	WOS:000346455900041
J	Carlson, R				Carlson, Robert			Estimating the biotech sector's contribution to the US economy	NATURE BIOTECHNOLOGY			English	Article									[Carlson, Robert] Bioecon Capital LLC, Seattle, WA USA; [Carlson, Robert] Biodesic LLC, Seattle, WA USA		Carlson, R (corresponding author), Bioecon Capital LLC, Seattle, WA USA.; Carlson, R (corresponding author), Biodesic LLC, Seattle, WA USA.	rob@biodesic.com			Homeland Security Institute; Defense Threat Reduction Agency; Biodesic, LLC.	Homeland Security Institute; Defense Threat Reduction Agency(United States Department of DefenseDefense Threat Reduction Agency); Biodesic, LLC.	I am grateful to R. Langer, R. Wehbring, M. Oliveira and E. Carlson for their excellent comments and questions. Early portions of this work were funded by the Homeland Security Institute, the Defense Threat Reduction Agency and Biodesic, LLC.	Aggarwal SR, 2014, NAT BIOTECHNOL, V32, P32, DOI 10.1038/nbt.2794; [Anonymous], 2014, NAT BIOTECHNOL, V32, P598, DOI 10.1038/nbt.2966; [Anonymous], 2014, EM POL ISS SYNTH BIO; [Anonymous], 2014, GENETICALLY ENG CROP; [Anonymous], 2013, ECONOMIST; Batchelor S., NEW OPPORTUNITIES RE; Battelle/BIO, 2014, BATT BIO STAT BIOSC; BenDor T, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0128339; Biotechnology Industry Organization, 2011, UNL PROM BIOT; Brookes Graham, 2013, GM Crops Food, V4, P74, DOI 10.4161/gmcr.24176; Campo-Flores A., 2013, WALL STREET J; Carlson R., 2013, B ATOMIC SCI; Carlson R, 2011, CAUSES CONSEQUENCES; Carlson R, 2012, CAUSES CONSEQUENCES; Carlson RH, 2010, BIOL IS TECHNOLOGY P; Carlson R, 2009, NAT BIOTECHNOL, V27, P984, DOI 10.1038/nbt1109-984a; Carlson Robert, 2003, Biosecur Bioterror, V1, P203, DOI 10.1089/153871303769201851; Carvalho DO, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0003864; Committee on the Impact of Biotechnology on Farm-Level Economics and Sustainability and The National Research Council T, 2010, IMP GEN ENG CROPS FA; European Commission, INN SUST GROWTH BIOE; Ezezika OC, 2010, TECHNOL SOC, V32, P331, DOI 10.1016/j.techsoc.2010.10.010; Gisbert C, 2003, BIOCHEM BIOPH RES CO, V303, P440, DOI 10.1016/S0006-291X(03)00349-8; Goodell J., 2013, ROLLING STONE   0620; International Federation of Pharmaceutical Manufacturers & Associations, 2012, PHARM IND GLOB HLTH; Klumper W, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0111629; La Merie Business Intelligence, 2012, BLOCKB BIOL 2012; Ledford H, 2010, NATURE, V467, P650, DOI 10.1038/467650a; Morrison C, 2015, NAT BIOTECHNOL, V33, P703, DOI 10.1038/nbt.3278; National Mining Association, 2012, EC CONTR US MIN; Office of the Chief Economist and Office of Energy Policy and New Uses, 2011, BIOB EC IND; Pimentel D, 2005, ECOL ECON, V52, P273, DOI 10.1016/j.ecolecon.2004.10.002; Sagal M, 2012, S AUSP NAT AC SCI 12; Solomon D, 2013, US C BRIEFING TOOLIN; US National Security Council, 2009, NAT STRAT COUNT BIOL; US Office of Management and Budget, 2014, FED REGISTER, V79, P29626; Williams V.J., 2010, J SUSTAINABLE DEV, V3, P29	36	73	75	0	37	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156	1546-1696		NAT BIOTECHNOL	Nat. Biotechnol.	MAR	2016	34	3					247	255		10.1038/nbt.3491	http://dx.doi.org/10.1038/nbt.3491			9	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Biotechnology & Applied Microbiology	DG1CJ	26963545				2022-12-27	WOS:000371802600015
J	Anikeeva, P				Anikeeva, Polina			Optogenetics unleashed	NATURE BIOTECHNOLOGY			English	Editorial Material							WIRELESS; BRAIN	Two recent studies report the development of miniaturized, fully-implantable devices that enable wireless optogenetic neuromodulation in peripheral nerves and spinal cord.	[Anikeeva, Polina] MIT, Dept Mat Sci & Engn & Res Lab Elect, 77 Massachusetts Ave, Cambridge, MA 02139 USA	Massachusetts Institute of Technology (MIT)	Anikeeva, P (corresponding author), MIT, Dept Mat Sci & Engn & Res Lab Elect, 77 Massachusetts Ave, Cambridge, MA 02139 USA.	anikeeva@mit.edu						Agudo J, 2015, NAT BIOTECHNOL, V33, P1287, DOI 10.1038/nbt.3386; Boyden ES, 2005, NAT NEUROSCI, V8, P1263, DOI 10.1038/nn1525; Bruegmann T, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8153; Jeong JW, 2015, CELL, V162, P662, DOI 10.1016/j.cell.2015.06.058; Kim TI, 2013, SCIENCE, V340, P211, DOI 10.1126/science.1232437; Lee ST, 2015, IEEE T NEUR SYS REH, V23, P655, DOI 10.1109/TNSRE.2015.2391282; Magown P, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9506; Montgomery KL, 2015, NAT METHODS, V12, P969, DOI [10.1038/NMETH.3536, 10.1038/nmeth.3536]; Nussinovitch U, 2015, NAT BIOTECHNOL, V33, P750, DOI 10.1038/nbt.3268; Yeh AJ, 2013, APPL PHYS LETT, V103, DOI 10.1063/1.4825272; Yizhar O, 2011, NEURON, V71, P9, DOI 10.1016/j.neuron.2011.06.004	11	5	5	0	38	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156	1546-1696		NAT BIOTECHNOL	Nat. Biotechnol.	JAN	2016	34	1					43	44		10.1038/nbt.3458	http://dx.doi.org/10.1038/nbt.3458			2	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	DB8HQ	26744980				2022-12-27	WOS:000368758200023
J	Kuleshov, V; Jiang, C; Zhou, WY; Jahanbani, F; Batzoglou, S; Snyder, M				Kuleshov, Volodymyr; Jiang, Chao; Zhou, Wenyu; Jahanbani, Fereshteh; Batzoglou, Serafim; Snyder, Michael			Synthetic long-read sequencing reveals intraspecies diversity in the human microbiome	NATURE BIOTECHNOLOGY			English	Article							GENOME; IDENTIFICATION; METAGENOMES; ASSEMBLIES; DROSOPHILA; COVERAGE; DATABASE; RARE	Identifying bacterial strains in metagenome and microbiome samples using computational analyses of short-read sequences remains a difficult problem. Here, we present an analysis of a human gut microbiome using TruSeq synthetic long reads combined with computational tools for metagenomic long-read assembly, variant calling and haplotyping (Nanoscope and Lens). Our analysis identifies 178 bacterial species, of which 51 were not found using shotgun reads alone. We recover bacterial contigs that comprise multiple operons, including 22 contigs of >1 Mbp. Furthermore, we observe extensive intraspecies variation within microbial strains in the form of haplotypes that span up to hundreds of Kbp. Incorporation of synthetic long-read sequencing technology with standard short-read approaches enables more precise and comprehensive analyses of metagenomic samples.	[Kuleshov, Volodymyr; Batzoglou, Serafim] Stanford Univ, Dept Comp Sci, Stanford, CA 94305 USA; [Kuleshov, Volodymyr; Jiang, Chao; Zhou, Wenyu; Jahanbani, Fereshteh; Snyder, Michael] Stanford Univ, Dept Genet, Sch Med, Stanford, CA 94305 USA	Stanford University; Stanford University	Kuleshov, V; Batzoglou, S (corresponding author), Stanford Univ, Dept Comp Sci, Stanford, CA 94305 USA.; Kuleshov, V; Batzoglou, S (corresponding author), Stanford Univ, Dept Genet, Sch Med, Stanford, CA 94305 USA.	kuleshov@stanford.edu; serafim@cs.stanford.edu; mpsnyder@stanford.edu	Jiang, Chao/AAG-2439-2021	Jiang, Chao/0000-0003-0260-7271; Snyder, Michael/0000-0003-0784-7987	US National Institutes of Health/National Human Genome Research Institute (NIH/NHGRI) [T32 HG000044]; Natural Sciences and Engineering Research Council of Canada (NSERC); NATIONAL HUMAN GENOME RESEARCH INSTITUTE [T32HG000044] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [U54DK102556] Funding Source: NIH RePORTER	US National Institutes of Health/National Human Genome Research Institute (NIH/NHGRI); Natural Sciences and Engineering Research Council of Canada (NSERC)(Natural Sciences and Engineering Research Council of Canada (NSERC)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by US National Institutes of Health/National Human Genome Research Institute (NIH/NHGRI) grant T32 HG000044. V.K. was supported by a Natural Sciences and Engineering Research Council of Canada (NSERC) post-graduate fellowship. We thank Illumina, Inc. for their assistance in sample preparation.	Albertsen M, 2013, NAT BIOTECHNOL, V31, P533, DOI 10.1038/nbt.2579; Alneberg J, 2014, NAT METHODS, V11, P1144, DOI [10.1038/NMETH.3103, 10.1038/nmeth.3103]; Berlin K, 2015, NAT BIOTECHNOL, V33, P623, DOI 10.1038/nbt.3238; Burton JN, 2014, G3-GENES GENOM GENET, V4, P1339, DOI 10.1534/g3.114.011825; Burton JN, 2013, NAT BIOTECHNOL, V31, P1119, DOI 10.1038/nbt.2727; Chen WH, 2012, NUCLEIC ACIDS RES, V40, pD901, DOI 10.1093/nar/gkr986; Cingolani P, 2012, FLY, V6, P80, DOI 10.4161/fly.19695; Daniel R, 2005, NAT REV MICROBIOL, V3, P470, DOI 10.1038/nrmicro1160; Di Rienzi SC, 2013, ELIFE, V2, DOI 10.7554/eLife.01102; Eid J, 2009, SCIENCE, V323, P133, DOI 10.1126/science.1162986; Fichot EB, 2013, MICROBIOME, V1, DOI 10.1186/2049-2618-1-10; GUSFIELD D, 1991, NETWORKS, V21, P19, DOI 10.1002/net.3230210104; Huttenhower C, 2012, NATURE, V486, P207, DOI 10.1038/nature11234; Iverson V, 2012, SCIENCE, V335, P587, DOI 10.1126/science.1212665; Kuleshov V, 2014, NAT BIOTECHNOL, V32, P261, DOI 10.1038/nbt.2833; Li RQ, 2010, GENOME RES, V20, P265, DOI 10.1101/gr.097261.109; Lieberman TD, 2011, NAT GENET, V43, P1275, DOI 10.1038/ng.997; Magoc T, 2013, BIOINFORMATICS, V29, P1718, DOI 10.1093/bioinformatics/btt273; Mao FL, 2009, NUCLEIC ACIDS RES, V37, pD459, DOI 10.1093/nar/gkn757; McCoy RC, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0106689; Myers EW, 2000, SCIENCE, V287, P2196, DOI 10.1126/science.287.5461.2196; Nielsen HB, 2014, NAT BIOTECHNOL, V32, P822, DOI 10.1038/nbt.2939; Parks DH, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-328; Rinke C, 2013, NATURE, V499, P431, DOI 10.1038/nature12352; Sharon I, 2015, GENOME RES, V25, P534, DOI 10.1101/gr.183012.114; Sommer DD, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-64; Thomas Torsten, 2012, Microb Inform Exp, V2, P3, DOI 10.1186/2042-5783-2-3; Venter JC, 2004, SCIENCE, V304, P66, DOI 10.1126/science.1093857; Zhu WH, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkq275	29	62	65	0	40	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156	1546-1696		NAT BIOTECHNOL	Nat. Biotechnol.	JAN	2016	34	1					64	69		10.1038/nbt.3416	http://dx.doi.org/10.1038/nbt.3416			6	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	DB8HQ	26655498	Green Accepted			2022-12-27	WOS:000368758200028
J	Huggett, B; Paisner, K				Huggett, Brady; Paisner, Kathryn			Research biotech patenting 2014	NATURE BIOTECHNOLOGY			English	Editorial Material									[Huggett, Brady] Nat Biotechnol, Berkeley, CA USA; [Paisner, Kathryn] IP Checkups Inc, Res & analyt, Berkeley, CA USA			kpaisner@ipcheckups.com							0	0	0	0	3	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156	1546-1696		NAT BIOTECHNOL	Nat. Biotechnol.	JUL	2015	33	7					684	684		10.1038/nbt.3288	http://dx.doi.org/10.1038/nbt.3288			1	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	CN4JJ	26154000	Bronze			2022-12-27	WOS:000358396100014
J	Estivill, X				Estivill, Xavier			Genetic variation and alternative splicing	NATURE BIOTECHNOLOGY			English	Editorial Material							RNA; TRANSCRIPTOME; MUTATIONS		[Estivill, Xavier] UPF, CRG, Barcelona, Spain; [Estivill, Xavier] Quiron Dexeus Univ Inst, Dexeus Womens Hlth, Barcelona, Spain	Barcelona Institute of Science & Technology; Pompeu Fabra University; Centre de Regulacio Genomica (CRG)	Estivill, X (corresponding author), UPF, CRG, Barcelona, Spain.	xavier.estivill@crg.cat	Estivill, Xavier/A-3125-2013	Estivill, Xavier/0000-0002-0723-2256				Ars E, 2000, HUM MOL GENET, V9, P237, DOI 10.1093/hmg/9.2.237; Brawand D, 2011, NATURE, V478, P343, DOI 10.1038/nature10532; CHILLON M, 1995, AM J HUM GENET, V56, P623; CHILLON M, 1995, NEW ENGL J MED, V332, P1475, DOI 10.1056/NEJM199506013322204; Irimia M, 2014, CELL, V159, P1511, DOI 10.1016/j.cell.2014.11.035; Kakaradov B, 2012, BMC BIOINFORMATICS, V13, DOI 10.1186/1471-2105-13-S6-S11; Katz Y, 2010, NAT METHODS, V7, P1009, DOI 10.1038/NMETH.1528; Lappalainen T, 2013, NATURE, V501, P506, DOI 10.1038/nature12531; Xiong HY, 2015, SCIENCE, V347, DOI 10.1126/science.1254806; Zhang Y, 2014, J NEUROSCI, V34, P11929, DOI [10.1523/JNEUROSCI.1860-14.2014, 10.11772/j.issn.1001-9081.2014.07.1929]	10	3	3	0	9	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156	1546-1696		NAT BIOTECHNOL	Nat. Biotechnol.	APR	2015	33	4					357	359		10.1038/nbt.3195	http://dx.doi.org/10.1038/nbt.3195			4	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	CF2AE	25850059				2022-12-27	WOS:000352348500020
J	Hogenhout, SA; Zipfel, C				Hogenhout, Saskia A.; Zipfel, Cyril			Engineering insect-free cereals	NATURE BIOTECHNOLOGY			English	Editorial Material							BROWN PLANTHOPPER; RESISTANCE; IMMUNITY; RICE		[Hogenhout, Saskia A.] John Innes Ctr, Dept Cell & Dev Biol, Norwich, Norfolk, England; [Zipfel, Cyril] Sainsbury Lab, Norwich, Norfolk, England	UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); John Innes Center; UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); John Innes Center	Hogenhout, SA (corresponding author), John Innes Ctr, Dept Cell & Dev Biol, Norwich Res Pk, Norwich, Norfolk, England.	cyril.zipfel@tsl.ac.uk	Hogenhout, Saskia A/D-9266-2012; ZIPFEL, CYRIL/ABD-5076-2021; ZIPFEL, CYRIL B/D-7103-2011	Hogenhout, Saskia A/0000-0003-1371-5606; ZIPFEL, CYRIL/0000-0003-4935-8583; ZIPFEL, CYRIL B/0000-0003-4935-8583	BBSRC [BB/G024936/1, BBS/E/J/000C0623] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BBS/E/J/000C0623, BB/G024936/1] Funding Source: Medline	BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))		Bonaventure G, 2012, PLANT BIOLOGY, V14, P872, DOI 10.1111/j.1438-8677.2012.00650.x; Cheng XY, 2013, MOL PLANT, V6, P621, DOI 10.1093/mp/sst030; Dangl JL, 2013, SCIENCE, V341, P746, DOI 10.1126/science.1236011; Du B, 2009, P NATL ACAD SCI USA, V106, P22163, DOI 10.1073/pnas.0912139106; Gouhier-Darimont C, 2013, J EXP BOT, V64, P665, DOI 10.1093/jxb/ers362; Huang PY, 2014, FRONT PLANT SCI, V5, DOI 10.3389/fpls.2014.00624; Lannoo N, 2014, FRONT PLANT SCI, V5, DOI 10.3389/fpls.2014.00397; Liu YQ, 2015, NAT BIOTECHNOL, V33, P301, DOI 10.1038/nbt.3069; Tamura Y, 2014, SCI REP-UK, V4, DOI 10.1038/srep05872; Zipfel C, 2014, TRENDS IMMUNOL, V35, P345, DOI 10.1016/j.it.2014.05.004	10	3	3	2	32	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156	1546-1696		NAT BIOTECHNOL	Nat. Biotechnol.	MAR	2015	33	3					262	263		10.1038/nbt.3162	http://dx.doi.org/10.1038/nbt.3162			2	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	CD0ME	25748917	Green Accepted			2022-12-27	WOS:000350766900021
J	Kuffner, R; Zach, N; Norel, R; Hawe, J; Schoenfeld, D; Wang, LX; Li, G; Fang, L; Mackey, L; Hardiman, O; Cudkowicz, M; Sherman, A; Ertaylan, G; Grosse-Wentrup, M; Hothorn, T; van Ligtenberg, J; Macke, JH; Meyer, T; Scholkopf, B; Tran, L; Vaughan, R; Stolovitzky, G; Leitner, ML				Kueffner, Robert; Zach, Neta; Norel, Raquel; Hawe, Johann; Schoenfeld, David; Wang, Liuxia; Li, Guang; Fang, Lilly; Mackey, Lester; Hardiman, Orla; Cudkowicz, Merit; Sherman, Alexander; Ertaylan, Gokhan; Grosse-Wentrup, Moritz; Hothorn, Torsten; van Ligtenberg, Jules; Macke, Jakob H.; Meyer, Timm; Schoelkopf, Bernhard; Tran, Linh; Vaughan, Rubio; Stolovitzky, Gustavo; Leitner, Melanie L.			Crowdsourced analysis of clinical trial data to predict amyotrophic lateral sclerosis progression	NATURE BIOTECHNOLOGY			English	Article							URIC-ACID LEVELS; BODY-MASS INDEX; FUNCTIONAL RATING-SCALE; ALSFRS-R SCORE; DISEASE PROGRESSION; PROGNOSTIC-FACTORS; BLOOD-PRESSURE; SURVIVAL; CREATININE; ALZHEIMERS	Amyotrophic lateral sclerosis (ALS) is a fatal neurodegenerative disease with substantial heterogeneity in its clinical presentation. This makes diagnosis and effective treatment difficult, so better tools for estimating disease progression are needed. Here, we report results from the DREAM-Phil Bowen ALS Prediction Prize4Life challenge. In this crowdsourcing competition, competitors developed algorithms for the prediction of disease progression of 1,822 ALS patients from standardized, anonymized phase 2/3 clinical trials. The two best algorithms outperformed a method designed by the challenge organizers as well as predictions by ALS clinicians. We estimate that using both winning algorithms in future trial designs could reduce the required number of patients by at least 20%. The DREAM-Phil Bowen ALS Prediction Prize4Life challenge also identified several potential nonstandard predictors of disease progression including uric acid, creatinine and surprisingly, blood pressure, shedding light on ALS pathobiology. This analysis reveals the potential of a crowdsourcing competition that uses clinical trial data for accelerating ALS research and development.	[Kueffner, Robert] German Res Ctr Environm Hlth, Inst Bioinformat & Syst Biol, Munich, Germany; [Kueffner, Robert; Hawe, Johann] Univ Munich, Dept Informat, Munich, Germany; [Zach, Neta; Leitner, Melanie L.] Prize4Life, Tel Aviv, Israel; [Zach, Neta; Leitner, Melanie L.] Prize4Life, Cambridge, MA USA; [Norel, Raquel] IBM TJ Watson Res Ctr, Yorktown Hts, NY USA; [Schoenfeld, David] Massachusetts Gen Hosp, MGH Biostat Ctr, Boston, MA 02114 USA; [Schoenfeld, David] Harvard Univ, Sch Med, Charlestown, MA USA; [Wang, Liuxia; Li, Guang] Sentrana Inc, Washington, DC USA; [Fang, Lilly] Latham&Watkins LLP, Silicon Valley, CA USA; [Mackey, Lester] Stanford Univ, Dept Stat, Stanford, CA 94305 USA; [Hardiman, Orla] Beaumont Hosp, Dept Neurosci, Dublin 9, Ireland; [Hardiman, Orla] Trinity Coll Dublin, Dublin, Ireland; [Cudkowicz, Merit; Sherman, Alexander] Massachusetts Gen Hosp, Neurol Clin Res Inst, Charlestown, MA USA; [Ertaylan, Gokhan] Univ Luxembourg, Esch Alzette, Luxembourg Ctr Syst Biomed, Luxembourg, Luxembourg; [Grosse-Wentrup, Moritz; Meyer, Timm; Schoelkopf, Bernhard] Max Planck Inst Intelligent Syst, Tubingen, Germany; [Hothorn, Torsten] Univ Zurich, Inst Social & Prevent Med, Zurich, Switzerland; [van Ligtenberg, Jules; Vaughan, Rubio] Orca XL Problem Solvers, Amsterdam, Netherlands; [Macke, Jakob H.] Max Planck Inst Biol Cybernet, Tubingen, Germany; [Macke, Jakob H.] Bernstein Ctr Computat Neurosci, Tubingen, Germany; [Tran, Linh] Univ Calif Berkeley, Berkeley Sch Publ Hlth, Berkeley, CA USA; [Leitner, Melanie L.] Biogen Idec Inc, ALS Innovat Hub, Cambridge, MA USA	Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; University of Munich; International Business Machines (IBM); Harvard University; Massachusetts General Hospital; Harvard University; Stanford University; Trinity College Dublin; Harvard University; Massachusetts General Hospital; ArcelorMittal; University of Luxembourg; Max Planck Society; University of Zurich; Max Planck Society; University of California System; University of California Berkeley; Biogen	Kuffner, R (corresponding author), German Res Ctr Environm Hlth, Inst Bioinformat & Syst Biol, Munich, Germany.	robert.kueffner@helmholtz-muenchen.de; nzach@prize4life.org	Norel, Raquel/ABB-3422-2021; Wang, Xin/AAN-8435-2021; wang, xl/Y-8251-2019; CUDKOWICZ, MERIT/GWM-6585-2022; Schölkopf, Bernhard/A-7570-2013; wang, xiao/HGB-7081-2022; Hardiman, Orla/Y-3441-2019	Norel, Raquel/0000-0001-7737-4172; Wang, Xin/0000-0002-4457-7376; CUDKOWICZ, MERIT/0000-0002-7075-1681; Schölkopf, Bernhard/0000-0002-8177-0925; wang, xiao/0000-0002-4088-3341; Hardiman, Orla/0000-0003-2610-1291; Mackey, Lester/0000-0002-1102-0387; Hawe, Johann/0000-0003-3890-303X; Ertaylan, Gokhan/0000-0001-5602-6435				Ascherio A, 2009, ARCH NEUROL-CHICAGO, V66, P1460, DOI 10.1001/archneurol.2009.247; Atassi N, 2014, NEUROLOGY, V83, P1719, DOI 10.1212/WNL.0000000000000951; Auinger P, 2010, MOVEMENT DISORD, V25, P224, DOI 10.1002/mds.22907; Baltadzhieva R, 2005, CURR OPIN NEUROL, V18, P487, DOI 10.1097/01.wco.0000183114.76056.0e; Cedarbaum JM, 1997, J NEUROL SCI, V152, pS1, DOI 10.1016/S0022-510X(97)00237-2; Cedarbaum JM, 1999, J NEUROL SCI, V169, P13, DOI 10.1016/S0022-510X(99)00210-5; Chahin N, 2009, MUSCLE NERVE, V40, P126, DOI 10.1002/mus.21310; Chen XP, 2014, NEUROL SCI, V35, P1591, DOI 10.1007/s10072-014-1807-4; Chio A, 2011, NEUROLOGY, V77, P1432, DOI 10.1212/WNL.0b013e318232ab9b; Costello JC, 2013, CLIN PHARMACOL THER, V93, P396, DOI 10.1038/clpt.2013.36; Cutter GR, 1999, BRAIN, V122, P871, DOI 10.1093/brain/122.5.871; Czaplinski A, 2006, MUSCLE NERVE, V34, P702, DOI 10.1002/mus.20658; de Lau LML, 2005, ANN NEUROL, V58, P797, DOI 10.1002/ana.20663; del Aguila MA, 2003, NEUROLOGY, V60, P813, DOI 10.1212/01.WNL.0000049472.47709.3B; Drigo D, 2013, NEUROEPIDEMIOLOGY, V41, P54, DOI 10.1159/000350015; Euser SM, 2009, BRAIN, V132, P377, DOI 10.1093/brain/awn316; Fujimura-Kiyono C, 2011, J NEUROL NEUROSUR PS, V82, P1244, DOI 10.1136/jnnp-2011-300141; Gomeni R, 2014, AMYOTROPH LAT SCL FR, V15, P119, DOI 10.3109/21678421.2013.838970; Grossman I, 2010, EPMA J, V1, P293, DOI 10.1007/s13167-010-0024-3; Hothorn T, 2014, AMYOTROPH LAT SCL FR, V15, P444, DOI 10.3109/21678421.2014.893361; Ikeda K, 2012, INTERNAL MED, V51, P1501, DOI 10.2169/internalmedicine.51.7465; Johnston CA, 2006, J NEUROL, V253, P1642, DOI 10.1007/s00415-006-0195-y; Kandinov B, 2012, AMYOTROPH LATERAL SC, V13, P509, DOI 10.3109/17482968.2012.662986; Kiernan MC, 2011, LANCET, V377, P942, DOI 10.1016/S0140-6736(10)61156-7; Kollewe K, 2008, J NEUROL SCI, V275, P69, DOI 10.1016/j.jns.2008.07.016; Lakhani KR, 2013, NAT BIOTECHNOL, V31, P108, DOI 10.1038/nbt.2495; Magnus T, 2002, MUSCLE NERVE, V25, P709, DOI 10.1002/mus.10090; Marbach D, 2012, NAT METHODS, V9, P796, DOI [10.1038/nmeth.2016, 10.1038/NMETH.2016]; Miller RG, 2007, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD001447.pub2; Miller RG, 2011, NEUROLOGY, V77, P973, DOI 10.1212/WNL.0b013e31822dc7a5; Murata Y, 1997, ACTA NEUROL SCAND, V96, P118; Ontaneda D, 2012, MULT SCLER J, V18, P1074, DOI 10.1177/1352458512451512; Paganoni S, 2012, J NEUROL, V259, P1923, DOI 10.1007/s00415-012-6440-7; Paganoni S, 2012, MUSCLE NERVE, V45, P612, DOI 10.1002/mus.22338; Paganoni S, 2011, MUSCLE NERVE, V44, P20, DOI 10.1002/mus.22114; Pastula DM, 2009, AMYOTROPH LATERAL SC, V10, P332, DOI 10.3109/17482960802320545; Pavlovic S, 2010, AMYOTROPH LATERAL SC, V11, P272, DOI 10.3109/17482960903390855; Qureshi MM, 2006, AMYOTROPH LATERAL SC, V7, P173, DOI 10.1080/14660820600640596; Qureshi M, 2008, AMYOTROPH LATERAL SC, V9, P369, DOI 10.1080/17482960802163614; R Core Team, 2021, R LANGUAGE ENV STAT; Rafiq M., 2013, J NEUROL NEUROSUR PS, V84, pe2; Reich-Slotky R, 2013, AMYOTROPH LAT SCL FR, V14, P212, DOI 10.3109/21678421.2013.770028; Rogers JA, 2012, J PHARMACOKINET PHAR, V39, P479, DOI 10.1007/s10928-012-9263-3; Romero K, 2009, CLIN PHARMACOL THER, V86, P365, DOI 10.1038/clpt.2009.165; Tangri N, 2011, JAMA-J AM MED ASSOC, V305, P1553, DOI 10.1001/jama.2011.451; Traynor BJ, 2004, NEUROLOGY, V63, P1933, DOI 10.1212/01.WNL.0000144345.49510.4E; Turner MR, 2010, AMYOTROPH LATERAL SC, V11, P369, DOI 10.3109/17482960903420140; Vender RL, 2007, AMYOTROPH LATERAL SC, V8, P36, DOI 10.1080/17482960600863951; Zoccolella S, 2008, J NEUROL NEUROSUR PS, V79, P33, DOI 10.1136/jnnp.2007.118018	49	128	131	2	18	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1087-0156	1546-1696		NAT BIOTECHNOL	Nat. Biotechnol.	JAN	2015	33	1					51	U292		10.1038/nbt.3051	http://dx.doi.org/10.1038/nbt.3051			9	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	AY7AR	25362243	Green Published, Bronze			2022-12-27	WOS:000347714200027
J	Walsh, G				Walsh, Gary			Biopharmaceutical benchmarks 2014	NATURE BIOTECHNOLOGY			English	Article							ANTIBODIES		[Walsh, Gary] Univ Limerick, Dept Chem & Environm Sci, Ind Biochem Program, Limerick, Ireland; [Walsh, Gary] Univ Limerick, Mat & Surface Sci Inst, Limerick, Ireland	University of Limerick; University of Limerick	Walsh, G (corresponding author), Univ Limerick, Dept Chem & Environm Sci, Ind Biochem Program, Limerick, Ireland.	gary.walsh@ul.ie	Walsh, Gary/X-1951-2019	Walsh, Gary/0000-0002-1300-8314				[Anonymous], 2013, MEIRE BIOL, V6, P3; Beck A, 2013, MABS-AUSTIN, V5, P621, DOI 10.4161/mabs.25864; Blackstone E., 2014, AM HLTH DRUG BE 0702; Brennan TA, 2014, NAT BIOTECHNOL, V32, P874, DOI 10.1038/nbt.3003; Broz A., 2013, GEN GENET ENG BIOTEC, V33, P32, DOI DOI 10.1089/gen.33.4.15; Dalgaard K, 2013, BIOSIMILARS 7 YEARS; Emerton D.A., 2013, BIOPROCESS INT, V11, P6; Goede V., 2013, 55 ASH ANN M EXP NEW; Kling J, 2014, NAT BIOTECHNOL, V32, P851, DOI 10.1038/nbt0914-851a; Kwon KC, 2013, ADV DRUG DELIVER REV, V65, P782, DOI 10.1016/j.addr.2012.10.005; Nielsen LS, 2010, MOL BIOTECHNOL, V45, P257, DOI 10.1007/s12033-010-9270-9; Olinger GG, 2012, P NATL ACAD SCI USA, V109, P18030, DOI 10.1073/pnas.1213709109; Perez HL, 2014, DRUG DISCOV TODAY, V19, P869, DOI 10.1016/j.drudis.2013.11.004; PhRMA, 2013, MED DEV BIOL; Qui X., 2014, NATURE          0829, DOI [10.1038/nature13777, DOI 10.1038/NATURE13777]; Rickwood S., 2013, SEARCHING TERRA FIRM; Walsh G, 2006, NAT BIOTECHNOL, V24, P769, DOI 10.1038/nbt0706-769; Walsh G, 2010, NAT BIOTECHNOL, V28, P917, DOI 10.1038/nbt0910-917	18	676	726	2	249	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156	1546-1696		NAT BIOTECHNOL	Nat. Biotechnol.	OCT	2014	32	10					992	1000		10.1038/nbt.3040	http://dx.doi.org/10.1038/nbt.3040			9	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	AR7MM	25299917				2022-12-27	WOS:000343763800013
J	Schachter, B				Schachter, Beth			Therapies of the state	NATURE BIOTECHNOLOGY			English	Article								What can governmental agencies do to lower the risk of cell therapies and the enterprises commercializing them?										Alliance for Regenerative Medicine, 2014, 2014 REG MED ANN IND; Giebel LB, 2005, NAT BIOTECHNOL, V23, P798, DOI 10.1038/nbt0705-798	2	14	14	0	8	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156	1546-1696		NAT BIOTECHNOL	Nat. Biotechnol.	AUG	2014	32	8					736	741		10.1038/nbt.2984	http://dx.doi.org/10.1038/nbt.2984			6	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	AW7PF	25093881				2022-12-27	WOS:000346455900012
J	Jiang, N; Zhang, SQ; Ma, KY				Jiang, Ning; Zhang, Shuqi; Ma, Keyue			An ID card for T cells	NATURE BIOTECHNOLOGY			English	Editorial Material							RECOGNITION		[Jiang, Ning] Univ Texas Austin, Cockrell Sch Engn, Dept Biomed Engn, Austin, TX 78712 USA; [Jiang, Ning; Ma, Keyue] Univ Texas Austin, Coll Nat Sci, Inst Cellular & Mol Biol, Austin, TX 78712 USA; [Zhang, Shuqi] Univ Texas Austin, Cockrell Sch Engn, McKetta Dept Chem Engn, Austin, TX 78712 USA	University of Texas System; University of Texas Austin; University of Texas System; University of Texas Austin; University of Texas System; University of Texas Austin	Jiang, N (corresponding author), Univ Texas Austin, Cockrell Sch Engn, Dept Biomed Engn, Austin, TX 78712 USA.	jiang@austin.utexas.edu	Jiang, Ning/M-5448-2017	Jiang, Ning/0000-0003-1103-5922				Arstila TP, 1999, SCIENCE, V286, P958, DOI 10.1126/science.286.5441.958; Bendall SC, 2012, NAT BIOTECHNOL, V30, P639, DOI 10.1038/nbt.2283; Birnbaum ME, 2014, CELL, V157, P1073, DOI 10.1016/j.cell.2014.03.047; DAVIS MM, 1988, NATURE, V334, P395, DOI 10.1038/334395a0; Han A, 2014, NAT BIOTECHNOL, V32, P684, DOI 10.1038/nbt.2938; Ladoire S, 2011, CANCER IMMUNOL IMMUN, V60, P909, DOI 10.1007/s00262-011-1046-y; Shapiro E, 2013, NAT REV GENET, V14, P618, DOI 10.1038/nrg3542; Turchaninova MA, 2013, EUR J IMMUNOL, V43, P2507, DOI 10.1002/eji.201343453; Weinstein JA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067624; Yosef N, 2013, NATURE, V496, P461, DOI 10.1038/nature11981	10	3	3	0	8	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156	1546-1696		NAT BIOTECHNOL	Nat. Biotechnol.	JUL	2014	32	7					639	640		10.1038/nbt.2953	http://dx.doi.org/10.1038/nbt.2953			2	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	AK8VE	25004230				2022-12-27	WOS:000338705900026
J	DeFrancesco, L				DeFrancesco, Laura			Behind closed doors	NATURE BIOTECHNOLOGY			English	Article							METAANALYSIS; RISK; LAW	Confidential business information is commonly used to hide data about industry products from public view. Researchers, regulators and companies are currently struggling to redefine who needs to know what about commercial products and when they need to know it.										[Anonymous], 2013, FED REG; Baker G., 2014, MAKING GRADE; Biotechnology Industry Organization, 2014, BIOPR CLIN TRIAL DAT; Butler D, 2014, NATURE, V508, P439, DOI 10.1038/508439a; Committee on the Environmental Impacts Associated with Commercialization of Transgenic Plants, 2002, ENV EFF TRANS PLANTS; Doshi P, 2013, JAMA INTERN MED, V173, DOI 10.1001/jamainternmed.2013.9989; EMA, 2011, QUEST ANSW REV ANG 2; European Medicines Agency, PUBL ACC CLIN TRIAL; Gymrek M, 2013, SCIENCE, V339, P321, DOI 10.1126/science.1229566; PhRMA, PRINC RESP CLIN TRIA; Rader R, CITIZEN PETITION REQ; Research America, NAT POLL CLIN RES; Rowe EA, 2011, IOWA LAW REV, V96, P791; Schoen DJ, 2008, BIOSCIENCE, V58, P71, DOI 10.1641/B580112; Singh S, 2008, JAMA-J AM MED ASSOC, V300, P1439, DOI 10.1001/jama.300.12.1439; Sipahi I, 2010, LANCET ONCOL, V11, P627, DOI 10.1016/S1470-2045(10)70106-6; Staton T., 2013, FIERCE PHARM    0404; US House of Representatives Committee on Oversight and Government Reform, 2012, REP CARD FED GOV EFF	18	1	1	0	4	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156	1546-1696		NAT BIOTECHNOL	Nat. Biotechnol.	JUN	2014	32	6					528	535		10.1038/nbt.2923	http://dx.doi.org/10.1038/nbt.2923			8	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	AI9EV	24911493	Bronze			2022-12-27	WOS:000337233800011
J	Wilbanks, J; Friend, SH				Wilbanks, John; Friend, Stephen H.			First, design for data sharing	NATURE BIOTECHNOLOGY			English	Article									[Wilbanks, John; Friend, Stephen H.] Sage Bionetworks, Seattle, WA USA		Friend, SH (corresponding author), Sage Bionetworks, Seattle, WA USA.	friend@sagebase.org		wilbanks, john/0000-0002-4510-0385				Biden Jr J., 2016, INSPIRING NEW GENERA; Bot BM, 2016, SCI DATA, V3, DOI 10.1038/sdata.2016.11; Forms C., 2016, FRAMINGHAM HEART STU; Goetz CG, 2003, MOVEMENT DISORD, V18, P738, DOI 10.1002/mds.10473; Irister A., 2016, NPJ PARKINSONS DIS, V2, DOI [10.1038/npjparkd.2016.6, DOI 10.1038/NPJPARKD.2016.6]; Longo DL, 2016, NEW ENGL J MED, V374, P276, DOI 10.1056/NEJMe1516564; Shabani M, 2015, PLOS BIOL, V13, DOI 10.1371/journal.pbio.1002339; Shabani M, 2015, EMBO MOL MED, V7, P507, DOI 10.15252/emmm.201405002	8	33	33	0	9	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156	1546-1696		NAT BIOTECHNOL	Nat. Biotechnol.	APR	2016	34	4					377	379		10.1038/nbt.3516	http://dx.doi.org/10.1038/nbt.3516			3	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	DI6NL	26939011	hybrid			2022-12-27	WOS:000373616100013
J	Lu, JF; Zhong, XF; Liu, HS; Hao, L; Huang, CTL; Sherafat, MA; Jones, J; Ayala, M; Li, LJ; Zhang, SC				Lu, Jianfeng; Zhong, Xuefei; Liu, Huisheng; Hao, Ling; Huang, Cindy Tzu-Ling; Sherafat, Mohammad Amin; Jones, Jeffrey; Ayala, Melvin; Li, Lingjun; Zhang, Su-Chun			Generation of serotonin neurons from human pluripotent stem cells	NATURE BIOTECHNOLOGY			English	Article							DOPAMINE NEURONS; HUMAN ES; FUNCTIONAL-CHARACTERIZATION; PARKINSONS-DISEASE; NEURAL PROGENITORS; IN-VITRO; SPECIFICATION; TRAMADOL; MIDBRAIN; RELEASE	Serotonin neurons located in the raphe nucleus of the hindbrain have crucial roles in regulating brain functions and have been implicated in various psychiatric disorders. Yet functional human serotonin neurons are not available for in vitro studies. Through manipulation of the WNT pathway, we demonstrate efficient differentiation of human pluripotent stem cells (hPSCs) to cells resembling central serotonin neurons, primarily those located in the rhombomeric segments 2-3 of the rostra! raphe, which participate in high-order brain functions. The serotonin neurons express a series of molecules essential for serotonergic development, including tryptophan hydroxylase 2, exhibit typical electrophysiological properties and release serotonin in an activity-dependent manner. When treated with the FDA-approved drugs tramadol and escitalopram oxalate, they release or uptake serotonin in a dose- and time-dependent manner, suggesting the utility of these cells for the evaluation of drug candidates.	[Lu, Jianfeng; Liu, Huisheng; Huang, Cindy Tzu-Ling; Sherafat, Mohammad Amin; Jones, Jeffrey; Ayala, Melvin; Zhang, Su-Chun] Univ Wisconsin, Waisman Ctr, Madison, WI 53705 USA; [Zhong, Xuefei; Hao, Ling; Li, Lingjun] Univ Wisconsin, Sch Pharm, 425 N Charter St, Madison, WI 53706 USA; [Li, Lingjun] Univ Wisconsin, Dept Chem, 1101 Univ Ave, Madison, WI 53706 USA; [Zhang, Su-Chun] Univ Wisconsin, Sch Med & Publ Hlth, Dept Neurosci, Madison, WI USA; [Zhang, Su-Chun] Univ Wisconsin, Dept Neurol, Sch Med & Publ Hlth, Madison, WI 53706 USA	University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison	Zhang, SC (corresponding author), Univ Wisconsin, Waisman Ctr, Madison, WI 53705 USA.; Zhang, SC (corresponding author), Univ Wisconsin, Sch Med & Publ Hlth, Dept Neurosci, Madison, WI USA.; Zhang, SC (corresponding author), Univ Wisconsin, Dept Neurol, Sch Med & Publ Hlth, Madison, WI 53706 USA.	Zhang@waisman.wisc.edu		hao, ling/0000-0002-0106-5266; Ayala, Melvin/0000-0002-8669-1046; Jones, Jeffrey/0000-0002-7570-2571	US National Institutes of Health (NIH) [NS045926, MH099587, MH100031, 1R01DK071801]; National Institute of Child Health and Human Development (NICHD) [P30 HD03352]; NIH shared instrument grant (NIH-National Center for Research Resources (NCRR)) [S10RR029531]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [P30HD003352, P01HD076892] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR029531] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK071801] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH099587, P50MH100031] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS076352, R24NS086604, R01NS045926] Funding Source: NIH RePORTER	US National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institute of Child Health and Human Development (NICHD)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NIH shared instrument grant (NIH-National Center for Research Resources (NCRR)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was partially supported by US National Institutes of Health (NIH) grants (NS045926, MH099587 and MH100031 to S.C.Z.; 1R01DK071801 to L.L.) and the National Institute of Child Health and Human Development (NICHD; P30 HD03352). The Q-Exactive Orbitrap mass spectrometer was purchased through the support of an NIH shared instrument grant (NIH-National Center for Research Resources (NCRR) S10RR029531 to L.L.). L.L. acknowledges an H.I. Romnes Faculty Research Fellowship. S.C.Z. acknowledges a Steenbock Professorship.	Alenina N, 2006, STEM CELL REV, V2, P5, DOI 10.1385/SCR:2:1:5; Alonso A, 2013, BRAIN STRUCT FUNCT, V218, P1229, DOI 10.1007/s00429-012-0456-8; Bang SJ, 2012, EUR J NEUROSCI, V35, P85, DOI 10.1111/j.1460-9568.2011.07936.x; Barberi T, 2003, NAT BIOTECHNOL, V21, P1200, DOI 10.1038/nbt870; Baumann MH, 2000, SYNAPSE, V36, P102, DOI 10.1002/(SICI)1098-2396(200005)36:2<102::AID-SYN3>3.0.CO;2-#; Calizo LH, 2011, NEUROPHARMACOLOGY, V61, P524, DOI 10.1016/j.neuropharm.2011.04.008; Chambers SM, 2009, NAT BIOTECHNOL, V27, P275, DOI 10.1038/nbt.1529; Chen J, 2008, DEV BIOL, V320, P30, DOI 10.1016/j.ydbio.2008.03.038; Deneris ES, 2012, NAT NEUROSCI, V15, P519, DOI 10.1038/nn.3039; DRIESSEN B, 1992, BRIT J PHARMACOL, V105, P147, DOI 10.1111/j.1476-5381.1992.tb14226.x; Goridis C, 2002, NAT REV NEUROSCI, V3, P531, DOI 10.1038/nrn871; Gouti M, 2014, PLOS BIOL, V12, DOI 10.1371/journal.pbio.1001937; Guthrie S, 2007, NAT REV NEUROSCI, V8, P859, DOI 10.1038/nrn2254; Hu BY, 2009, DEVELOPMENT, V136, P1443, DOI 10.1242/dev.029447; JACOBS BL, 1992, PHYSIOL REV, V72, P165, DOI 10.1152/physrev.1992.72.1.165; Kiecker C, 2001, DEVELOPMENT, V128, P4189; Kim JH, 2002, NATURE, V418, P50, DOI 10.1038/nature00900; Kirkeby A, 2012, CELL REPORTS, V1, P703, DOI 10.1016/j.celrep.2012.04.009; Kizilbash A, 2014, J PAIN RES, V7, P149, DOI 10.2147/JPR.S49502; Koch P, 2009, P NATL ACAD SCI USA, V106, P3225, DOI 10.1073/pnas.0808387106; Kriks S, 2011, NATURE, V480, P547, DOI 10.1038/nature10648; Kumar M, 2009, STEM CELLS DEV, V18, P615, DOI 10.1089/scd.2008.0181; Lee SH, 2000, NAT BIOTECHNOL, V18, P675, DOI 10.1038/76536; Li XJ, 2005, NAT BIOTECHNOL, V23, P215, DOI 10.1038/nbt1063; Lu JF, 2013, CELL REP, V3, P1580, DOI 10.1016/j.celrep.2013.04.004; Maury Y, 2015, NAT BIOTECHNOL, V33, P89, DOI 10.1038/nbt.3049; Pastoor D, 2014, EXPERT OPIN DRUG MET, V10, P121, DOI 10.1517/17425255.2014.863873; Pudovkina OL, 2003, SYNAPSE, V50, P77, DOI 10.1002/syn.10245; RAFFA RB, 1992, J PHARMACOL EXP THER, V260, P275; Rhinn M, 2001, CURR OPIN NEUROBIOL, V11, P34, DOI 10.1016/S0959-4388(00)00171-9; Rothman RB, 2002, PHARMACOL BIOCHEM BE, V71, P825, DOI 10.1016/S0091-3057(01)00669-4; Salli U, 2004, EXP NEUROL, V188, P351, DOI 10.1016/j.expneurol.2004.04.015; Scott MM, 2005, P NATL ACAD SCI USA, V102, P16472, DOI 10.1073/pnas.0504510102; Smidt MP, 2013, FRONT CELL NEUROSCI, V7, DOI 10.3389/fncel.2013.00200; Tokuyama Y, 2010, EXP BIOL MED, V235, P649, DOI 10.1258/ebm.2010.009307; Xi JJ, 2012, STEM CELLS, V30, P1655, DOI 10.1002/stem.1152; Ye WL, 1998, CELL, V93, P755, DOI 10.1016/S0092-8674(00)81437-3	37	95	99	2	35	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156	1546-1696		NAT BIOTECHNOL	Nat. Biotechnol.	JAN	2016	34	1					89	94		10.1038/nbt.3435	http://dx.doi.org/10.1038/nbt.3435			6	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	DB8HQ	26655496	Green Accepted			2022-12-27	WOS:000368758200032
J	Fernald, K; Claassen, E				Fernald, Kenneth; Claassen, Eric			Trade-sale exits in different biotech sectors	NATURE BIOTECHNOLOGY			English	Letter									[Fernald, Kenneth; Claassen, Eric] Vrije Univ Amsterdam, Athena Inst, Noord Holland, Netherlands	Vrije Universiteit Amsterdam	Fernald, K (corresponding author), Vrije Univ Amsterdam, Athena Inst, Noord Holland, Netherlands.	kenneth.fernald@gmail.com		Fernald, Kenneth/0000-0003-2406-9320				Fernald K.D.S., 2015, J COMMERC BIOTECHNOL, V21, P32, DOI DOI 10.5912/JCB704; Giniatullina A, 2013, NAT BIOTECHNOL, V31, pA1, DOI 10.1038/nbt.2533; van der Valk T, 2009, TECHNOVATION, V29, P247, DOI 10.1016/j.technovation.2008.09.005	3	0	0	0	4	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156	1546-1696		NAT BIOTECHNOL	Nat. Biotechnol.	DEC	2015	33	12					1229	1231		10.1038/nbt.3304	http://dx.doi.org/10.1038/nbt.3304			3	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	CY4OO	26650006				2022-12-27	WOS:000366387700010
J	Jefferson, OA; Kollhofer, D; Ehrich, TH; Jefferson, RA				Jefferson, Osmat A.; Koellhofer, Deniz; Ehrich, Thomas H.; Jefferson, Richard A.			The ownership question of plant gene and genome intellectual properties	NATURE BIOTECHNOLOGY			English	Editorial Material								The restructuring of the crop agriculture industry over the past two decades has enabled patent holders to exclude, prevent and deter others from using certain research tools and delay or block further follow-on inventions.	[Jefferson, Osmat A.; Koellhofer, Deniz; Ehrich, Thomas H.; Jefferson, Richard A.] Queensland Univ Technol, Brisbane, Qld 4001, Australia; [Jefferson, Osmat A.; Koellhofer, Deniz; Ehrich, Thomas H.; Jefferson, Richard A.] Cambia, Canberra, ACT, Australia	Queensland University of Technology (QUT)	Jefferson, OA (corresponding author), Queensland Univ Technol, Brisbane, Qld 4001, Australia.	osmat@cambia.org; raj@cambia.org		Jefferson, Osmat Azzam/0000-0002-0607-8728; Jefferson, Richard/0000-0001-5352-4498; Ehrich, Thomas/0000-0003-3475-4321				Abbott F.M., 2014, EMERGING MARKETS WOR, P3; Agris CH, 1999, NAT BIOTECHNOL, V17, P197, DOI 10.1038/6205; [Anonymous], 1985, USPQ, V227, P433; Atkinson RC, 2003, SCIENCE, V301, P174, DOI 10.1126/science.1085553; Curtin SJ, 2012, PLANT GENOME-US, V5, P42, DOI 10.3835/plantgenome2012.06.0008; Foote H., 2014, INT IP PROTECTION PL; Fuglie KO, 2014, AM J AGR ECON, V96, P862, DOI 10.1093/ajae/aat107; Howard Philip H., 2009, Sustainability, V1, P1266, DOI 10.3390/su1041266; Information and Media Relations Division of the WTO Secretariat, 2008, REVIEWS; Jefferson OA, 2015, NAT BIOTECHNOL, V33, P1033, DOI 10.1038/nbt.3364; Jefferson OA, 2013, NAT BIOTECHNOL, V31, P1086, DOI 10.1038/nbt.2755; Marco A.C., 2007, CUDARE WORKING PAPER, V1036; Moss D.L., 2014, WISCONSIN STATE L RE, V337, P338; USDA National Genetic Resources Program, 2014, GERMPL RES INF NETW; WIPO Committee on Development and Intellectual Property, 2014, 13 SESS GEN MAY 19 2, P7; World Intellectual Property Organization, 2014, QUEST EXC LIM PAT RI	16	18	19	1	12	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1087-0156	1546-1696		NAT BIOTECHNOL	Nat. Biotechnol.	NOV	2015	33	11					1138	1144		10.1038/nbt.3393	http://dx.doi.org/10.1038/nbt.3393			7	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	CW3TY	26544141	Green Published			2022-12-27	WOS:000364916000015
J	Shukla, SA; Rooney, MS; Rajasagi, M; Tiao, G; Dixon, PM; Lawrence, MS; Stevens, J; Lane, WJ; Dellagatta, JL; Steelman, S; Sougnez, C; Cibulskis, K; Kiezun, A; Hacohen, N; Brusic, V; Wu, CJ; Getz, G				Shukla, Sachet A.; Rooney, Michael S.; Rajasagi, Mohini; Tiao, Grace; Dixon, Philip M.; Lawrence, Michael S.; Stevens, Jonathan; Lane, William J.; Dellagatta, Jamie L.; Steelman, Scott; Sougnez, Carrie; Cibulskis, Kristian; Kiezun, Adam; Hacohen, Nir; Brusic, Vladimir; Wu, Catherine J.; Getz, Gad			Comprehensive analysis of cancer-associated somatic mutations in class I HLA genes	NATURE BIOTECHNOLOGY			English	Article							CHRONIC LYMPHOCYTIC-LEUKEMIA; TUMOR TYPES; T-CELLS; MOLECULES; DISCOVERY; RNA; IMMUNOTHERAPY; LANDSCAPE; CARCINOMA; ALLELE	Detection of somatic mutations in human leukocyte antigen (HLA) genes using whole-exome sequencing (WES) is hampered by the high polymorphism of the HLA loci, which prevents alignment of sequencing reads to the human reference genome. We describe a computational pipeline that enables accurate inference of germline alleles of class I HLA-A, B and C genes and subsequent detection of mutations in these genes using the inferred alleles as a reference. Analysis of WES data from 7,930 pairs of tumor and healthy tissue from the same patient revealed 298 nonsilent HLA mutations in tumors from 266 patients. These 298 mutations are enriched for likely functional mutations, including putative loss-of-function events. Recurrence of mutations suggested that these 'hotspot' sites were positively selected. Cancers with recurrent somatic HLA mutations were associated with upregulation of signatures of cytolytic activity characteristic of tumor infiltration by effector lymphocytes, supporting immune evasion by altered HLA function as a contributory mechanism in cancer.	[Shukla, Sachet A.; Rajasagi, Mohini; Brusic, Vladimir; Wu, Catherine J.] Dana Farber Canc Inst, Canc Vaccine Ctr, Boston, MA 02115 USA; [Shukla, Sachet A.; Rooney, Michael S.; Tiao, Grace; Lawrence, Michael S.; Steelman, Scott; Sougnez, Carrie; Cibulskis, Kristian; Kiezun, Adam; Hacohen, Nir; Wu, Catherine J.; Getz, Gad] Broad Inst MIT & Harvard, Cambridge, MA USA; [Shukla, Sachet A.; Dixon, Philip M.] Iowa State Univ, Dept Stat, Ames, IA USA; [Rooney, Michael S.] MIT, Harvard Mit Div Hlth Sci & Technol, Cambridge, MA 02139 USA; [Rajasagi, Mohini; Brusic, Vladimir; Wu, Catherine J.] Dana Farber Canc Inst, Dept Med Oncol, Boston, MA 02115 USA; [Stevens, Jonathan; Lane, William J.; Dellagatta, Jamie L.] Brigham & Womens Hosp, Dept Pathol, Boston, MA 02115 USA; [Lane, William J.] Harvard Univ, Sch Med, Boston, MA USA; [Hacohen, Nir; Wu, Catherine J.] Harvard Univ, Sch Med, Dept Med, Boston, MA USA; [Hacohen, Nir] Massachusetts Gen Hosp, Ctr Immunol & Inflammatory Dis, Boston, MA 02114 USA; [Hacohen, Nir] Massachusetts Gen Hosp, Dept Med, Boston, MA 02114 USA; [Getz, Gad] Massachusetts Gen Hosp, Ctr Canc, Boston, MA USA; [Getz, Gad] Dept Pathol, Boston, MA USA	Harvard University; Dana-Farber Cancer Institute; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Iowa State University; Harvard University; Massachusetts Institute of Technology (MIT); Harvard University; Dana-Farber Cancer Institute; Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital	Wu, CJ (corresponding author), Dana Farber Canc Inst, Canc Vaccine Ctr, Boston, MA 02115 USA.	cwu@partners.org; gadgetz@broadinstitute.org	Cibulskis, Kristian/AAC-7380-2019; Dixon, Philip Michael/I-4843-2019; Lawrence, Michael/AAC-8202-2020; Brusic, Vladimir/B-1478-2008	Dixon, Philip Michael/0000-0002-1778-0686; Cibulskis, Kristian/0000-0003-1343-1582; Brusic, Vladimir/0000-0003-0523-5266	Blavatnik Family Foundation; American Association for Cancer Research (AACR) (SU2C Innovative Research Grant); National Heart, Lung, and Blood Institute (NHLBI) [1RO1HL103532-01]; National Cancer Institute (NCI) [1R01CA155010-01A1]; NATIONAL CANCER INSTITUTE [U24CA143845, R01CA155010] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL103532] Funding Source: NIH RePORTER	Blavatnik Family Foundation; American Association for Cancer Research (AACR) (SU2C Innovative Research Grant); National Heart, Lung, and Blood Institute (NHLBI)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); National Cancer Institute (NCI)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	C.J.W. is a Scholar of the Leukemia and Lymphoma Society and acknowledges support from the Blavatnik Family Foundation, American Association for Cancer Research (AACR) (SU2C Innovative Research Grant), National Heart, Lung, and Blood Institute (NHLBI) (1RO1HL103532-01) and National Cancer Institute (NCI) (1R01CA155010-01A1). This work has made extensive use of data generated by TCGA, a project of the National Cancer Institute and National Human Genome Research Institute. We thank E. Hodis for providing access to the melanoma data. We would also like to thank C. McCowan (Broad Technology Labs), T. Shea (Broad Technology Labs), S. Young (Broad Technology Labs) and M. Weiand (Pacific Biosciences) for their help in setting up, performing and analyzing data using Pacific Biosciences RSII instruments. We are grateful to E. Fritsch for critical reading of the manuscript and providing valuable feedback.	Bai Y, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-325; Bass AJ, 2014, NATURE, V513, P202, DOI 10.1038/nature13480; Beck S, 1999, NATURE, V401, P921, DOI 10.1038/44853; BJORKMAN PJ, 1990, ANNU REV BIOCHEM, V59, P253, DOI 10.1146/annurev.bi.59.070190.001345; Boegel S, 2012, GENOME MED, V4, DOI 10.1186/gm403; Brady CS, 2000, TISSUE ANTIGENS, V55, P401, DOI 10.1034/j.1399-0039.2000.550502.x; Brown SD, 2014, GENOME RES, V24, P743, DOI 10.1101/gr.165985.113; Brusic V, 2002, IMMUNOL CELL BIOL, V80, P280, DOI 10.1046/j.1440-1711.2002.01088.x; Bubenik J, 2004, INT J ONCOL, V25, P487; Cao HZ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069388; Cibulskis K, 2013, NAT BIOTECHNOL, V31, P213, DOI 10.1038/nbt.2514; Danzer M, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-221; Engstrom PG, 2013, NAT METHODS, V10, P1185, DOI [10.1038/NMETH.2722, 10.1038/nmeth.2722]; Erlich RL, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-42; FAYEN J, 1995, MOL IMMUNOL, V32, P267, DOI 10.1016/0161-5890(94)00149-U; FERNANDEZVINA MA, 1992, HUM IMMUNOL, V33, P163, DOI 10.1016/0198-8859(92)90068-X; Gonzalez-Galarza FF, 2011, NUCLEIC ACIDS RES, V39, pD913, DOI 10.1093/nar/gkq1128; Hammerman PS, 2012, NATURE, V489, P519, DOI 10.1038/nature11404; Hodis E, 2012, CELL, V150, P251, DOI 10.1016/j.cell.2012.06.024; Irimia M, 2014, CSH PERSPECT BIOL, V6, DOI 10.1101/cshperspect.a016071; Jimenez P, 2001, IMMUNOGENETICS, V53, P606, DOI 10.1007/s002510100371; Kim HJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067885; Landau DA, 2013, CELL, V152, P714, DOI 10.1016/j.cell.2013.01.019; Lank SM, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-378; Lawrence MS, 2014, NATURE, V505, P495, DOI 10.1038/nature12912; Lohr JG, 2012, P NATL ACAD SCI USA, V109, P3879, DOI 10.1073/pnas.1121343109; Norgaard L, 1999, TISSUE ANTIGENS, V54, P370, DOI 10.1034/j.1399-0039.1999.540406.x; Omberg L, 2013, NAT GENET, V45, P1121, DOI 10.1038/ng.2761; Pardoll DM, 2012, NAT REV CANCER, V12, P252, DOI 10.1038/nrc3239; Pittet MJ, 2003, J IMMUNOL, V171, P1844, DOI 10.4049/jimmunol.171.4.1844; Purcell SM, 2014, NATURE, V506, P185, DOI 10.1038/nature12975; Roberts RJ, 2013, GENOME BIOL, V14, DOI [10.1186/gb-2013-14-7-405, 10.1186/gb-2013-14-6-405]; Robinson J, 2013, NUCLEIC ACIDS RES, V41, pD1222, DOI 10.1093/nar/gks949; Robinson JT, 2011, NAT BIOTECHNOL, V29, P24, DOI 10.1038/nbt.1754; Rooney MS, 2015, CELL, V160, P48, DOI 10.1016/j.cell.2014.12.033; RUPPERT J, 1993, CELL, V74, P929, DOI 10.1016/0092-8674(93)90472-3; Saunders CT, 2012, BIOINFORMATICS, V28, P1811, DOI 10.1093/bioinformatics/bts271; Schreiber RD, 2011, SCIENCE, V331, P1565, DOI 10.1126/science.1203486; Stransky N, 2011, SCIENCE, V333, P1157, DOI 10.1126/science.1208130; Szolek A, 2014, BIOINFORMATICS, V30, P3310, DOI 10.1093/bioinformatics/btu548; TIERCY JM, 1994, HUM IMMUNOL, V41, P207, DOI 10.1016/0198-8859(94)90038-8; TOWNSEND A, 1989, ANNU REV IMMUNOL, V7, P601, DOI 10.1146/annurev.iy.07.040189.003125; Wang CL, 2012, P NATL ACAD SCI USA, V109, P8676, DOI 10.1073/pnas.1206614109; Wang LL, 2011, NEW ENGL J MED, V365, P2497, DOI 10.1056/NEJMoa1109016; Warren RL, 2012, GENOME MED, V4, DOI 10.1186/gm396; Welsh K, 1999, Rev Immunogenet, V1, P157; Zou WP, 2006, NAT REV IMMUNOL, V6, P295, DOI 10.1038/nri1806	47	361	373	5	34	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1087-0156	1546-1696		NAT BIOTECHNOL	Nat. Biotechnol.	NOV	2015	33	11					1152	U71		10.1038/nbt.3344	http://dx.doi.org/10.1038/nbt.3344			10	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	CW3TY	26372948	Bronze, Green Submitted, Green Accepted			2022-12-27	WOS:000364916000020
J	Kessel, M				Kessel, Mark			Why microbial diagnostics need more than money	NATURE BIOTECHNOLOGY			English	Letter									FIND, Geneva, Switzerland	Foundation For Innovative New Diagnostics	Kessel, M (corresponding author), FIND, Geneva, Switzerland.	mark.kessel@shearman.com						Davies S., 2015, WISH 2015 POLICY BRI; Hwang TJ, 2015, NAT BIOTECHNOL, V33, P589, DOI 10.1038/nbt.3251; International Federation of Pharmaceutical Manufacturers and Associations, 2015, RETH WAY WE FIGHT BA; WHO, 2015, GLOB ACT PLAN ANT RE, DOI DOI 10.1128/MICROBE.10.354.1	4	3	3	0	6	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156	1546-1696		NAT BIOTECHNOL	Nat. Biotechnol.	SEP	2015	33	9					898	900		10.1038/nbt.3328	http://dx.doi.org/10.1038/nbt.3328			3	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	CR0EK	26348950				2022-12-27	WOS:000360990900008
J	Elenko, E; Speier, A; Zohar, D				Elenko, Eric; Speier, Austin; Zohar, Daphne			A regulatory framework emerges for digital medicine	NATURE BIOTECHNOLOGY			English	Editorial Material									[Elenko, Eric; Zohar, Daphne] PureTech, Boston, MA 02116 USA; [Speier, Austin] Precis Med, Bethesda, MD USA		Elenko, E (corresponding author), PureTech, Boston, MA 02116 USA.	DaphneNB@puretechhealth.com						Billings P., 2015, EXAMINER 0427; Elenko E, 2015, NAT BIOTECHNOL, V33, P456, DOI 10.1038/nbt.3222; European Commission, 2012, DG HLTH CONS GUID QU; Federal Trade Commission, 2015, FTC CRACKS MARK MEL; FTC, 2011, FTC APPR FIN SETTL O; FTC, 2015, FTC APPR FIN ORD BAR; HHS. FDA, 2015, MED DEV DAT SYST MED; HHS. FDA, 2011, GUID IND FDA STAFF C; HHS. FDA, 2015, GEN WELLN POL LOW RI; HHS. FDA, 2015, GUID CONT PREM SUBM; Lakemedelsverket Medical Products Agency, 2012, MED INF SYST GUID QU; Silver Spring, 2014, FDASIA HLTH IT REP P; U.S. Department of Health and Human Services Food and Drug Administration, 2015, MOB MED APPL GUID IN; U.S. Department of Health and Human Services (HHS) Food and Drug Administration (FDA) Center for Devices and Radiological Health Center for Biologics Evaluation and Research, 2002, GEN PRINC SOFTW VAL; US FDA, 2015, EX MMAS FDA REG	15	18	19	0	13	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156	1546-1696		NAT BIOTECHNOL	Nat. Biotechnol.	JUL	2015	33	7					697	702		10.1038/nbt.3284	http://dx.doi.org/10.1038/nbt.3284			6	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	CN4JJ	26154006				2022-12-27	WOS:000358396100020
J	Zeitoun, RI; Garst, AD; Degen, GD; Pines, G; Mansell, TJ; Glebes, TY; Boyle, NR; Gill, RT				Zeitoun, Ramsey I.; Garst, Andrew D.; Degen, George D.; Pines, Gur; Mansell, Thomas J.; Glebes, Tirzah Y.; Boyle, Nanette R.; Gill, Ryan T.			Multiplexed tracking of combinatorial genomic mutations in engineered cell populations	NATURE BIOTECHNOLOGY			English	Article							ESCHERICHIA-COLI; SYNTHETIC BIOLOGY; ETHANOL TOLERANCE; GENETIC SYSTEMS; EMULSION-PCR; EVOLUTION; IDENTIFICATION; STRATEGY; AMPLIFICATION; CONSTRUCTION	Multiplexed genome engineering approaches can be used to generate targeted genetic diversity in cell populations on laboratory timescales, but methods to track mutations and link them to phenotypes have been lacking. We present an approach for tracking combinatorial engineered libraries (TRACE) through the simultaneous mapping of millions of combinatorially engineered genomes at single-cell resolution. Distal genomic sites are assembled into individual DNA constructs that are compatible with next-generation sequencing strategies. We used TRACE to map growth selection dynamics for Escherichia coli combinatorial libraries created by recursive multiplex recombineering at a depth 10(4)-fold greater than before. TRACE was used to identify genotype-to-phenotype correlations and to map the evolutionary trajectory of two individual combinatorial mutants in E. coli. Combinatorial mutations in the human ES2 ovarian carcinoma cell line were also assessed with TRACE. TRACE completes the combinatorial engineering cycle and enables more sophisticated approaches to genome engineering in both bacteria and eukaryotic cells than are currently possible.	[Zeitoun, Ramsey I.; Garst, Andrew D.; Pines, Gur; Mansell, Thomas J.; Glebes, Tirzah Y.; Gill, Ryan T.] Univ Colorado, Dept Chem & Biol Engn, Boulder, CO 80309 USA; [Degen, George D.] Carnegie Mellon Univ, Dept Chem Engn, Pittsburgh, PA 15213 USA; [Boyle, Nanette R.] Colorado Sch Mines, Dept Chem & Biol Engn, Golden, CO 80401 USA	University of Colorado System; University of Colorado Boulder; Carnegie Mellon University; Colorado School of Mines	Gill, RT (corresponding author), Univ Colorado, Dept Chem & Biol Engn, Boulder, CO 80309 USA.	rtg@colorado.edu	Pines, Gur/X-7501-2019	Pines, Gur/0000-0002-1757-6722; MANSELL, THOMAS/0000-0001-8807-4570	DOE BER Genomic Sciences Program [DE-SC0008812]; C2B2/NSF REU Program (NSF) [1261303]	DOE BER Genomic Sciences Program; C2B2/NSF REU Program (NSF)	Special thanks to S.A. Lynch and W.C. Grau for support and advice on this work. We would like to thank J. Huntley and S. Gao at the Colorado Biofrontiers Advanced Sequencing Core Facility for assistance with high-throughput sequencing. We would like to thank J. Liddle for generously sharing the ES2 cancer cell line. This work was funded by DOE BER Genomic Sciences Program Award Number DE-SC0008812. We would also like to acknowledge the C2B2/NSF REU Program (NSF# 1261303) for funding G.D.D.	Alper H, 2005, NAT BIOTECHNOL, V23, P612, DOI 10.1038/nbt1083; Barrick JE, 2013, NAT REV GENET, V14, P827, DOI 10.1038/nrg3564; Caporaso JG, 2011, P NATL ACAD SCI USA, V108, P4516, DOI 10.1073/pnas.1000080107; Casini A, 2014, NUCLEIC ACIDS RES, V42, DOI 10.1093/nar/gkt915; Craig DW, 2008, NAT METHODS, V5, P887, DOI 10.1038/NMETH.1251; Datta S, 2008, P NATL ACAD SCI USA, V105, P1626, DOI 10.1073/pnas.0709089105; Eklund AC, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkp1116; Estep AL, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001279; Farasat I, 2014, MOL SYST BIOL, V10, DOI 10.15252/msb.20134955; Gevertz JL, 2005, BIOTECHNOL BIOENG, V92, P346, DOI 10.1002/bit.20617; Goodarzi H, 2010, MOL SYST BIOL, V6, DOI 10.1038/msb.2010.33; Jiang WY, 2013, NAT BIOTECHNOL, V31, P233, DOI 10.1038/nbt.2508; Kanagawa T, 2003, J BIOSCI BIOENG, V96, P317, DOI 10.1263/jbb.96.317; Khan AI, 2011, SCIENCE, V332, P1193, DOI 10.1126/science.1203801; Kosuri S, 2014, NAT METHODS, V11, P499, DOI [10.1038/NMETH.2918, 10.1038/nmeth.2918]; Krzywinski M, 2009, GENOME RES, V19, P1639, DOI 10.1101/gr.092759.109; Lee JW, 2012, NAT CHEM BIOL, V8, P536, DOI [10.1038/NCHEMBIO.970, 10.1038/nchembio.970]; Mamanova L, 2010, NAT METHODS, V7, P111, DOI 10.1038/nmeth.1419; Metzker ML, 2010, NAT REV GENET, V11, P31, DOI 10.1038/nrg2626; Minty JJ, 2011, MICROB CELL FACT, V10, DOI 10.1186/1475-2859-10-18; Miura F, 2005, BIOINFORMATICS, V21, P4363, DOI 10.1093/bioinformatics/bti716; Na D, 2013, NAT BIOTECHNOL, V31, P170, DOI 10.1038/nbt.2461; Navin N, 2011, NATURE, V472, P90, DOI 10.1038/nature09807; PAABO S, 1990, J BIOL CHEM, V265, P4718; Pal C, 2014, NAT REV GENET, V15, P504, DOI 10.1038/nrg3746; Phillips PC, 2008, NAT REV GENET, V9, P855, DOI 10.1038/nrg2452; Romero PA, 2009, NAT REV MOL CELL BIO, V10, P866, DOI 10.1038/nrm2805; Sandoval NR, 2012, P NATL ACAD SCI USA, V109, P10540, DOI 10.1073/pnas.1206299109; Sawitzke JA, 2011, J MOL BIOL, V407, P45, DOI 10.1016/j.jmb.2011.01.030; Tewhey R, 2009, NAT BIOTECHNOL, V27, P1025, DOI 10.1038/nbt.1583; Volkmer B, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023126; Wang BL, 2014, NAT BIOTECHNOL, V32, P473, DOI 10.1038/nbt.2857; Wang HH, 2012, NAT METHODS, V9, P591, DOI [10.1038/NMETH.1971, 10.1038/nmeth.1971]; Wang HH, 2011, METHOD ENZYMOL, V498, P409, DOI 10.1016/B978-0-12-385120-8.00018-8; Wang HH, 2009, NATURE, V460, P894, DOI 10.1038/nature08187; Wang X, 2013, P NATL ACAD SCI USA, V110, P4021, DOI 10.1073/pnas.1217958110; Warner JR, 2010, NAT BIOTECHNOL, V28, P856, DOI 10.1038/nbt.1653; Wetmur JG, 2005, NUCLEIC ACIDS RES, V33, P2615, DOI 10.1093/nar/gki556; Williams R, 2006, NAT METHODS, V3, P545, DOI 10.1038/NMETH896; Woodruff LBA, 2013, METAB ENG, V15, P124, DOI 10.1016/j.ymben.2012.10.007; Yoo SM, 2013, NAT PROTOC, V8, P1694, DOI 10.1038/nprot.2013.105	41	33	43	0	35	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156	1546-1696		NAT BIOTECHNOL	Nat. Biotechnol.	JUN	2015	33	6					631	+		10.1038/nbt.3177	http://dx.doi.org/10.1038/nbt.3177			10	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	CK2DE	25798935				2022-12-27	WOS:000356019700023
J	Mailly, L; Xiao, F; Lupberger, J; Wilson, GK; Aubert, P; Duong, FHT; Calabrese, D; Leboeuf, C; Fofana, I; Thumann, C; Bandiera, S; Lurgehetmann, M; Volz, T; Davis, C; Harris, HJ; Mee, CJ; Girardi, E; Chane-Woon-Ming, B; Ericsson, M; Fletcher, N; Bartenschlager, R; Pessaux, P; Vercauteren, K; Meuleman, P; Villa, P; Kaderali, L; Pfeffer, S; Heim, MH; Neunlist, M; Zeisel, MB; Dandri, M; McKeating, JA; Robinet, E; Baumert, TF				Mailly, Laurent; Xiao, Fei; Lupberger, Joachim; Wilson, Garrick K.; Aubert, Philippe; Duong, Franois H. T.; Calabrese, Diego; Leboeuf, Celine; Fofana, Isabel; Thumann, Christine; Bandiera, Simonetta; Luergehetmann, Marc; Volz, Tassilo; Davis, Christopher; Harris, Helen J.; Mee, Christopher J.; Girardi, Erika; Chane-Woon-Ming, Beatrice; Ericsson, Maria; Fletcher, Nicola; Bartenschlager, Ralf; Pessaux, Patrick; Vercauteren, Koen; Meuleman, Philip; Villa, Pascal; Kaderali, Lars; Pfeffer, Sebastien; Heim, Markus H.; Neunlist, Michel; Zeisel, Mirjam B.; Dandri, Maura; McKeating, Jane A.; Robinet, Eric; Baumert, Thomas F.			Clearance of persistent hepatitis C virus infection in humanized mice using a claudin-1-targeting monoclonal antibody	NATURE BIOTECHNOLOGY			English	Article							HUMAN HEPATOCYTES; NEUTRALIZING ANTIBODIES; ENTRY FACTORS; HUMAN LIVER; CELL ENTRY; IN-VIVO; RECEPTOR; CD81; CLAUDIN-1; EXPRESSION	Hepatitis C virus (HCV) infection is a leading cause of liver cirrhosis and cancer(1). Cell entry of HCV2 and other pathogens(3-5) is mediated by tight junction (TJ) proteins, but successful therapeutic targeting of TJ proteins has not been reported yet. Using a human liver-chimeric mouse model(6), we show that a monoclonal antibody specific for the TJ protein claudin-1 (ref. 7) eliminates chronic HCV infection without detectable toxicity. This antibody inhibits HCV entry, cell-cell transmission and virus-induced signaling events. Antibody treatment reduces the number of HCV-infected hepatocytes in vivo, highlighting the need for de novo infection by means of host entry factors to maintain chronic infection. In summary, we demonstrate that an antibody targeting a virus receptor can cure chronic viral infection and uncover TJ proteins as targets for antiviral therapy.	[Mailly, Laurent; Xiao, Fei; Lupberger, Joachim; Leboeuf, Celine; Fofana, Isabel; Thumann, Christine; Bandiera, Simonetta; Pessaux, Patrick; Zeisel, Mirjam B.; Robinet, Eric; Baumert, Thomas F.] Inst Rech Malad Virales & Hepat, Inst Natl Sante & Rech Med, U1110, Strasbourg, France; [Mailly, Laurent; Xiao, Fei; Lupberger, Joachim; Leboeuf, Celine; Fofana, Isabel; Thumann, Christine; Bandiera, Simonetta; Girardi, Erika; Chane-Woon-Ming, Beatrice; Pessaux, Patrick; Villa, Pascal; Pfeffer, Sebastien; Zeisel, Mirjam B.; Robinet, Eric; Baumert, Thomas F.] Univ Strasbourg, Strasbourg, France; [Wilson, Garrick K.; Davis, Christopher; Harris, Helen J.; Mee, Christopher J.; Fletcher, Nicola; McKeating, Jane A.] Univ Birmingham, Inst Biomed Res, Hepatitis C Res Grp, Birmingham, W Midlands, England; [Aubert, Philippe; Neunlist, Michel] Inst Natl Sante & Rech Med, U913, Nantes, France; [Aubert, Philippe; Neunlist, Michel] Univ Nantes, Nantes, France; [Aubert, Philippe; Neunlist, Michel] CHU Nantes, Hop Hotel Dieu, Inst Malad Appareil Digestif, F-44035 Nantes 01, France; [Duong, Franois H. T.; Calabrese, Diego; Heim, Markus H.] Univ Basel, Dept Biomed, Hepatol Lab, Basel, Switzerland; [Luergehetmann, Marc; Volz, Tassilo; Dandri, Maura] Univ Med Ctr Hamburg Eppendorf, Dept Internal Med, Hamburg, Germany; [Girardi, Erika; Chane-Woon-Ming, Beatrice; Pfeffer, Sebastien] CNRS, Inst Biol Mol & Cellulaire, Architecture & React ARN, Strasbourg, France; [Ericsson, Maria] Harvard Univ, Sch Med, Elect Microscopy Facil, Boston, MA 02115 USA; [Bartenschlager, Ralf] Heidelberg Univ, Dept Infect Dis, Mol Virol, Heidelberg, Germany; [Bartenschlager, Ralf] Heidelberg Univ, German Ctr Infect Res, Heidelberg, Germany; [Pessaux, Patrick; Baumert, Thomas F.] Hop Univ Strasbourg, Inst Hosp Univ, Pole Hepatodigestif, Strasbourg, France; [Vercauteren, Koen; Meuleman, Philip] Univ Ghent, Ctr Vaccinol, B-9000 Ghent, Belgium; [Villa, Pascal] UdS & FMTS, CNRS, Medalis, Plateforme Chim Biol Integrat Strasbourg,UMS 3286, Illkirch Graffenstaden, France; [Kaderali, Lars] Tech Univ Dresden, Fac Med, Inst Med Informat & Biometry, D-01062 Dresden, Germany	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; University of Birmingham; Institut National de la Sante et de la Recherche Medicale (Inserm); Nantes Universite; Nantes Universite; CHU de Nantes; University of Basel; University of Hamburg; University Medical Center Hamburg-Eppendorf; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; Harvard University; Harvard Medical School; Ruprecht Karls University Heidelberg; German Center for Infection Research; Ruprecht Karls University Heidelberg; CHU Strasbourg; UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; Ghent University; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Technische Universitat Dresden	Baumert, TF (corresponding author), Inst Rech Malad Virales & Hepat, Inst Natl Sante & Rech Med, U1110, Strasbourg, France.	thomas.baumert@unistra.fr	Volz, Tassilo/U-1942-2019; Pfeffer, Sébastien/H-3212-2019; Dandri, Maura/ABG-4773-2021; Villa, Pascal/GRE-9521-2022; Heim, Markus/A-7526-2008; Neunlist, Michel/K-2388-2015; Aubert, Philippe/K-2352-2015; Zeisel, Mirjam B/E-9205-2016; Baumert, Thomas/ABF-4718-2020; Lupberger, Joachim/AAL-7721-2020; Girardi, Erika/P-5748-2015; Meuleman, Philip/H-2899-2013; Bartenschlager, Ralf/L-2582-2015; Xiao, Fei/E-7133-2013	Pfeffer, Sébastien/0000-0002-8458-348X; Dandri, Maura/0000-0002-0073-6689; Villa, Pascal/0000-0003-3466-4852; Heim, Markus/0000-0002-7523-4894; Aubert, Philippe/0000-0001-7471-7694; Zeisel, Mirjam B/0000-0003-1606-0131; Baumert, Thomas/0000-0002-8864-2168; Lupberger, Joachim/0000-0003-3996-3907; Girardi, Erika/0000-0001-6871-6628; Meuleman, Philip/0000-0001-6821-234X; Bartenschlager, Ralf/0000-0001-5601-9307; DUONG, Hong Tuan Francois/0000-0003-0928-2123; davis, chris/0000-0002-7317-3266; Xiao, Fei/0000-0001-7353-2700; Fletcher, Nicola/0000-0001-5593-9742; Mee, Christopher/0000-0002-6359-2694; Kaderali, Lars/0000-0002-2359-2294; Aubert, Philippe/0000-0002-3126-6202; Mailly, Laurent/0000-0001-6957-7463; Bandiera, Simonetta/0000-0002-7368-8155; Calabrese, Diego/0000-0002-0259-8611; Eric, ROBINET/0000-0001-9765-805X; Volz, Tassilo/0000-0003-3120-8958; McKeating, Jane/0000-0002-7229-5886; Vercauteren, Koen O.A./0000-0003-1472-9938	European Union (INTERREG-IV-Rhin Superieur-FEDER-Hepato-Regio-Net) [ERC-2008-AdG-233130-HEPCENT, ERC-2010-StG-260767-ncRNAVIR]; ANRS (ANRS) [2009/183, 2009/136, 2011/132, 2012/239, 2013/108]; ANR (Laboratoires d'excellence) [ANR-10-LABX-0028_HEPSYS, ANR-10-LABX-36 netRNA)]; Fondation ARC pour la recherche (NanoISI and TheraHCC IHUARC) [IHU201301187]; Institut Hospitalo-Universitaire (IHU) Strasbourg; Wilhelm Sander Foundation; Wilhelm Sander Foundation, Region Alsace; Institut National du CancerInstitut National de la Sante et de la Recherche Medicale; Centre National de la Recherche Scientifique; Universite de Strasbourg; Ghent University [GOA 01G01712]; Research Foundation-Flanders [1500910N, G052112N]; GIS-IBiSA (Groupement d'Interet Scientifique - Infrastructure en Biologie Sante et Agronomie) program; MRC [G0400802, G0801976, G1100247] Funding Source: UKRI; Medical Research Council [G0801976, G1100247, G0400802] Funding Source: researchfish	European Union (INTERREG-IV-Rhin Superieur-FEDER-Hepato-Regio-Net); ANRS (ANRS)(French National Research Agency (ANR)); ANR (Laboratoires d'excellence)(French National Research Agency (ANR)); Fondation ARC pour la recherche (NanoISI and TheraHCC IHUARC); Institut Hospitalo-Universitaire (IHU) Strasbourg; Wilhelm Sander Foundation; Wilhelm Sander Foundation, Region Alsace(Region Grand-Est); Institut National du CancerInstitut National de la Sante et de la Recherche Medicale; Centre National de la Recherche Scientifique(Centre National de la Recherche Scientifique (CNRS)); Universite de Strasbourg; Ghent University(Ghent University); Research Foundation-Flanders(FWO); GIS-IBiSA (Groupement d'Interet Scientifique - Infrastructure en Biologie Sante et Agronomie) program; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This work was supported by the European Union (ERC-2008-AdG-233130-HEPCENT, ERC-2010-StG-260767-ncRNAVIR, INTERREG-IV-Rhin Superieur-FEDER-Hepato-Regio-Net 2009 and 2012), ANRS (ANRS 2009/183, 2009/136, 2011/132, 2012/239, 2013/108), ANR (Laboratoires d'excellence ANR-10-LABX-0028_HEPSYS and ANR-10-LABX-36 netRNA), Fondation ARC pour la recherche (NanoISI and TheraHCC IHUARC IHU201301187), Institut Hospitalo-Universitaire (IHU) Strasbourg, the Wilhelm Sander Foundation, Region Alsace, Institut National du Cancer, the Institut National de la Sante et de la Recherche Medicale, Centre National de la Recherche Scientifique, Universite de Strasbourg, the Ghent University (GOA 01G01712) and the Research Foundation-Flanders (projects 1500910N and G052112N). We are grateful to S. Ito (Harvard Medical School) for electron microscopy studies, F.-L. Cosset (Inserm U1111, ENS Lyon, France) and J. Ball (University of Nottingham, Nottingham, UK) for retroviral vectors for HCVpp production, F. Chisari (The Scripps Research Institute, La Jolla, CA, USA) for the gift of Huh7.5.1 cells, A. Patel (MRC Virology Unit, Glasgow, UK) for E2-specific mAb AP33 and Huh7.5-GFP cells, S. Foung (Stanford Blood Center, Palo Alto, CA, USA) for E2-specific mAb CHB-23 and C.M. Rice and M. Evans (Rockefeller University and Mount Sinai School of Medicine, New York) for providing human and mouse CLDN1 expression constructs as well as Huh7.5 cells. We acknowledge S. Durand, L. Heydmann, E. Soulier, J. Barths, N. Brignon, S. Pernot (Inserm U1110, Strasbourg), O. Wendling and N. Messadeq (Institut Clinique de la Souris - ICS, Illkirch), C. Valencia (PCBIS, Illkirch), S. Kallis (University of Heidelberg, Germany) for technical work, F. Grunert and J. Thompson (Aldevron, Freiburg) for helpful discussions, H. Jacob and M.F. Champy (ICS, Illkirch) for histopathological, hematological and biochemical analyzes, P. Bachellier (Strasbourg University Hospitals) for providing liver resections for isolation of primary human hepatocytes, the Laboratoire Schuh-groupement Bio67, Strasbourg and the Plateau Technique de Microbiologie, Laboratoire de Virologie (S. Fafi-Kremer and F. Stoll-Keller), University Hospital Strasbourg for performing viral load analyses, and the IGBMC (Institut de Genetique et de Biologie Moleculaire et Cellulaire) microarray and sequencing platform, member of the France Genomique program, for the sequencing of our libraries. Part of the animal experiments was carried out within the small animal exploration facility Cardiex (Nantes), which is supported by the GIS-IBiSA (Groupement d'Interet Scientifique - Infrastructure en Biologie Sante et Agronomie) program.	Brazzoli M, 2008, J VIROL, V82, P8316, DOI 10.1128/JVI.00665-08; Bukh J, 2010, J INFECT DIS, V201, P1381, DOI 10.1086/651579; Che PL, 2013, VIROLOGY, V446, P303, DOI 10.1016/j.virol.2013.08.009; Cohen CJ, 2001, P NATL ACAD SCI USA, V98, P15191, DOI 10.1073/pnas.261452898; Diao JY, 2012, J VIROL, V86, P10935, DOI 10.1128/JVI.00750-12; Dill MT, 2012, GASTROENTEROLOGY, V143, P777, DOI 10.1053/j.gastro.2012.05.044; Dubel S, 2014, HDB THERAPEUTIC ANTI; Evans MJ, 2007, NATURE, V446, P801, DOI 10.1038/nature05654; Fletcher NF, 2014, HEPATOLOGY, V59, P1320, DOI 10.1002/hep.26911; Fofana I, 2013, J VIROL, V87, P10405, DOI 10.1128/JVI.01691-13; Fofana I, 2012, GASTROENTEROLOGY, V143, P223, DOI 10.1053/j.gastro.2012.04.006; Fofana I, 2010, GASTROENTEROLOGY, V139, P953, DOI 10.1053/j.gastro.2010.05.073; Fukumatsu M, 2012, CELL HOST MICROBE, V11, P325, DOI 10.1016/j.chom.2012.03.001; Haid S, 2014, HEPATOLOGY, V59, P24, DOI 10.1002/hep.26567; Harris HJ, 2008, J VIROL, V82, P5007, DOI 10.1128/JVI.02286-07; Harris HJ, 2013, HEPATOLOGY, V57, P854, DOI 10.1002/hep.25910; Harris HJ, 2010, J BIOL CHEM, V285, P21092, DOI 10.1074/jbc.M110.104836; Koutsoudakis G, 2007, J VIROL, V81, P588, DOI 10.1128/JVI.01534-06; Krieger SE, 2010, HEPATOLOGY, V51, P1144, DOI 10.1002/hep.23445; Lan L, 2008, J IMMUNOL, V181, P4926, DOI 10.4049/jimmunol.181.7.4926; Law M, 2008, NAT MED, V14, P25, DOI 10.1038/nm1698; Lupberger J, 2011, NAT MED, V17, P589, DOI 10.1038/nm.2341; Menzel N, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002829; Mercer DF, 2001, NAT MED, V7, P927, DOI 10.1038/90968; Meuleman P, 2012, HEPATOLOGY, V55, P364, DOI 10.1002/hep.24692; Neumann AU, 1998, SCIENCE, V282, P103, DOI 10.1126/science.282.5386.103; Petersen J, 2008, NAT BIOTECHNOL, V26, P335, DOI 10.1038/nbt1389; Piche T, 2009, GUT, V58, P196, DOI 10.1136/gut.2007.140806; Pietschmann T, 2006, P NATL ACAD SCI USA, V103, P7408, DOI 10.1073/pnas.0504877103; Reynolds GM, 2008, HEPATOLOGY, V47, P418, DOI 10.1002/hep.22028; Shi N, 2013, GUT, V62, P1055, DOI 10.1136/gutjnl-2012-302600; Suh Y, 2013, ONCOGENE, V32, P4873, DOI 10.1038/onc.2012.505; Thomas DL, 2013, NAT MED, V19, P850, DOI 10.1038/nm.3184; Wakita T, 2005, NAT MED, V11, P791, DOI 10.1038/nm1268; Wieland S, 2014, HEPATOLOGY, V59, P2121, DOI 10.1002/hep.26770; Zahid MN, 2013, HEPATOLOGY, V57, P492, DOI 10.1002/hep.26097; Zona L, 2013, CELL HOST MICROBE, V13, P302, DOI 10.1016/j.chom.2013.02.006	37	101	104	1	36	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156	1546-1696		NAT BIOTECHNOL	Nat. Biotechnol.	MAY	2015	33	5					549	U169		10.1038/nbt.3179	http://dx.doi.org/10.1038/nbt.3179			8	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	CH8VP	25798937	Green Submitted, Green Accepted			2022-12-27	WOS:000354314500039
J	Ashton, PM; Nair, S; Dallman, T; Rubino, S; Rabsch, W; Mwaigwisya, S; Wain, J; O'Grady, J				Ashton, Philip M.; Nair, Satheesh; Dallman, Tim; Rubino, Salvatore; Rabsch, Wolfgang; Mwaigwisya, Solomon; Wain, John; O'Grady, Justin			MinION nanopore sequencing identifies the position and structure of a bacterial antibiotic resistance island	NATURE BIOTECHNOLOGY			English	Article							TYPHI	Short-read, high-throughput sequencing technology cannot identify the chromosomal position of repetitive insertion sequences that typically flank horizontally acquired genes such as bacterial virulence genes and antibiotic resistance genes. The MinION nanopore sequencer can produce long sequencing reads on a device similar in size to a USB memory stick. Here we apply a MinION sequencer to resolve the structure and chromosomal insertion site of a composite antibiotic resistance island in Salmonella Typhi Haplotype 58. Nanopore sequencing data from a single 18-h run was used to create a scaffold for an assembly generated from short-read Illumina data. Our results demonstrate the potential of the MinION device in clinical laboratories to fully characterize the epidemic spread of bacterial pathogens.	[Ashton, Philip M.; Nair, Satheesh; Dallman, Tim] Publ Hlth England, Gastrointestinal Bacteria Reference Unit, London, England; [Rubino, Salvatore] Univ Sassari, Dept Biomed Sci, I-07100 Sassari, Italy; [Rubino, Salvatore] King Faisal Specialist Hosp & Res Ctr, Dept Infect & Immun, Riyadh 11211, Saudi Arabia; [Rabsch, Wolfgang] Robert Koch Inst, Natl Reference Ctr Salmonellae & Other Enter, Wernigerode, Germany; [Mwaigwisya, Solomon; Wain, John; O'Grady, Justin] Univ E Anglia, Norwich Med Sch, Norwich NR4 7TJ, Norfolk, England	Public Health England; University of Sassari; King Faisal Specialist Hospital & Research Center; Robert Koch Institute; University of East Anglia	O'Grady, J (corresponding author), Univ E Anglia, Norwich Med Sch, Norwich NR4 7TJ, Norfolk, England.	tim.dallman@phe.gov.uk; justin.ogrady@uea.ac.uk	Rubino, Salvatore/AAC-5848-2022; Barac, Aleksandra/W-9785-2019; O'Grady, Justin/I-2982-2012; Dallman, Timothy J/ABD-6662-2021; Wain, John Richard/B-3446-2013	O'Grady, Justin/0000-0001-5412-7152; Nair, Satheesh/0000-0002-7297-1485; Wain, John Richard/0000-0002-1257-1148	University of East Anglia; Oxford Nanopore Technologies Ltd.	University of East Anglia; Oxford Nanopore Technologies Ltd.	M. Day (Salmonella Reference Unit, Public Health England) for antibiotic susceptibility tests. J.O'G. and J.W. were funded by the University of East Anglia. We would like to thank Oxford Nanopore Technologies Ltd. for including us in the MinION Access Programme. We would also like to thank L. Nederbragt for a thorough review and contributions toward the presentation of Figure 1.	Adey A, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-12-r119; Bankevich A, 2012, J COMPUT BIOL, V19, P455, DOI 10.1089/cmb.2012.0021; Buckle Geoffrey C, 2012, J Glob Health, V2, P010401, DOI 10.7189/jogh.02.010401; CALLOW B R, 1959, J Hyg (Lond), V57, P346; Chin CS, 2013, NAT METHODS, V10, P563, DOI [10.1038/NMETH.2474, 10.1038/nmeth.2474]; Clarke J, 2009, NAT NANOTECHNOL, V4, P265, DOI [10.1038/NNANO.2009.12, 10.1038/nnano.2009.12]; Cock PJA, 2009, BIOINFORMATICS, V25, P1422, DOI 10.1093/bioinformatics/btp163; Ewing B, 1998, GENOME RES, V8, P175, DOI 10.1101/gr.8.3.175; Frith MC, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-80; Grimont P., 2007, WHO COLLABORATING CT, Vninth; Holt KE, 2008, NAT GENET, V40, P987, DOI 10.1038/ng.195; Holt KE, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001490; Holt KE, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0001245; Holt KE, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0000929; Holt KE, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-36; Kariuki S, 2010, J CLIN MICROBIOL, V48, P2171, DOI 10.1128/JCM.01983-09; Kim K.E., 2014, PREPRINT; Le TAH, 2007, J CLIN MICROBIOL, V45, P3485, DOI 10.1128/JCM.00948-07; Livermore DM, 2013, INFECT CHEMOTHER, V45, P1, DOI 10.3947/ic.2013.45.1.1; Loman NJ, 2014, BIOINFORMATICS, V30, P3399, DOI 10.1093/bioinformatics/btu555; Mikheyev AS, 2014, MOL ECOL RESOUR, V14, P1097, DOI 10.1111/1755-0998.12324; Parkhill J, 2001, NATURE, V413, P848, DOI 10.1038/35101607; Phan MD, 2009, ANTIMICROB AGENTS CH, V53, P716, DOI 10.1128/AAC.00645-08; Quick J, 2014, GIGASCIENCE, V3, DOI 10.1186/2047-217X-3-22; Roumagnac P, 2006, SCIENCE, V314, P1301, DOI 10.1126/science.1134933; Szczepanowski R, 2005, MICROBIOL-SGM, V151, P1095, DOI 10.1099/mic.0.27773-0; Thomson N, 2004, J MOL BIOL, V339, P279, DOI 10.1016/j.jmb.2004.03.058; Underwood AP, 2013, J CLIN MICROBIOL, V51, P232, DOI 10.1128/JCM.01696-12; Wain J, 2015, LANCET, V385, P1136, DOI 10.1016/S0140-6736(13)62708-7; Wain J, 2013, EXPERT REV MOL DIAGN, V13, P225, DOI [10.1586/erm.13.8, 10.1586/ERM.13.8]; Watson M, 2015, BIOINFORMATICS, V31, P114, DOI 10.1093/bioinformatics/btu590	31	267	284	7	214	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156	1546-1696		NAT BIOTECHNOL	Nat. Biotechnol.	MAR	2015	33	3					296	+		10.1038/nbt.3103	http://dx.doi.org/10.1038/nbt.3103			7	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	CD0ME	25485618	Green Accepted			2022-12-27	WOS:000350766900027
J	Dolgin, E				Dolgin, Elie			Antidotes progress for new oral clotbusters	NATURE BIOTECHNOLOGY			English	News Item																		2014, N ENGL J MED, V371, P2141; 2014, NATURE REV DRUG DISC, V13, P571	2	5	5	0	2	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156	1546-1696		NAT BIOTECHNOL	Nat. Biotechnol.	FEB	2015	33	2					117	118		10.1038/nbt0215-117	http://dx.doi.org/10.1038/nbt0215-117			2	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	CA8VK	25658260				2022-12-27	WOS:000349198800004
J	Ratner, M				Ratner, Mark			Roche swallows Ariosa, grabs slice of prenatal test market	NATURE BIOTECHNOLOGY			English	News Item																			0	2	2	0	5	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156	1546-1696		NAT BIOTECHNOL	Nat. Biotechnol.	FEB	2015	33	2					113	114		10.1038/nbt0215-113	http://dx.doi.org/10.1038/nbt0215-113			2	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	CA8VK	25658255				2022-12-27	WOS:000349198800002
J	Wang, XL; Wang, YB; Wu, XW; Wang, JH; Wang, YJ; Qiu, ZJ; Chang, T; Huang, H; Lin, RJ; Yee, HK				Wang, Xiaoling; Wang, Yebo; Wu, Xiwei; Wang, Jinhui; Wang, Yingjia; Qiu, Zhaojun; Chang, Tammy; Huang, He; Lin, Ren-Jang; Yee, Jiing-Kuan			Unbiased detection of off-target cleavage by CRISPR-Cas9 and TALENs using integrase-defective lentiviral vectors	NATURE BIOTECHNOLOGY			English	Article							HUMAN-CELLS; NUCLEASE SPECIFICITY; CAS9; CRISPR/CAS; DNA; DELETIONS; NICKASES; SYSTEMS	The utility of CRISPR-Cas9 and TALENs for genome editing may be compromised by their off-target activity. We show that integrase-defective lentiviral vectors (IDLVs) can detect such off-target cleavage with a frequency as low as 1%. In the case of Cas9, we find frequent off-target sites with a one-base bulge or up to 13 mismatches between the single guide RNA (sgRNA) and its genomic target; which refines sgRNA design.	[Wang, Xiaoling; Wang, Yebo; Wang, Yingjia; Chang, Tammy; Yee, Jiing-Kuan] Beckman Res Inst City Hope, Dept Virol, Duarte, CA 91010 USA; [Wang, Yebo; Wang, Yingjia; Huang, He] Zhejiang Univ, Affiliated Hosp 1, Bone Marrow Transplantat Ctr, Hangzhou 310003, Zhejiang, Peoples R China; [Wu, Xiwei; Wang, Jinhui; Qiu, Zhaojun; Lin, Ren-Jang] Beckman Res Inst City Hope, Dept Mol & Cellular Biol, Duarte, CA USA	City of Hope; Beckman Research Institute of City of Hope; Zhejiang University; City of Hope; Beckman Research Institute of City of Hope	Yee, HK (corresponding author), Beckman Res Inst City Hope, Dept Virol, Duarte, CA 91010 USA.	jyee@coh.org	; Lin, Ren-Jang/G-2052-2014	huang, he/0000-0002-2723-1621; Lin, Ren-Jang/0000-0002-2738-2438	California Institute of Regenerative Medicine [RB3-02161]; Nesvig Foundation; Beckman Research Institute Excellence Award; China Scholarship Council; National Natural Science Foundation of China; Zhejiang Provincial Natural Science Foundation of China; Zhejiang Provincial Major Science and Technology Project	California Institute of Regenerative Medicine(California Institute for Regenerative Medicine); Nesvig Foundation; Beckman Research Institute Excellence Award; China Scholarship Council(China Scholarship Council); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Zhejiang Provincial Natural Science Foundation of China(Natural Science Foundation of Zhejiang Province); Zhejiang Provincial Major Science and Technology Project	This work is supported by a grant RB3-02161 from California Institute of Regenerative Medicine (J.-K.Y.), grants from Nesvig Foundation and Beckman Research Institute Excellence Award (R.-J.L.). Y.B.W. is support by a grant from China Scholarship Council and Y.J.W. was supported by grants from National Natural Science Foundation of China, Zhejiang Provincial Natural Science Foundation of China, Zhejiang Provincial Major Science and Technology Project and China Scholarship Council.	Cho SW, 2014, GENOME RES, V24, P132, DOI 10.1101/gr.162339.113; Cong L, 2013, SCIENCE, V339, P819, DOI 10.1126/science.1231143; Fu YF, 2013, NAT BIOTECHNOL, V31, P822, DOI 10.1038/nbt.2623; Gabriel R, 2011, NAT BIOTECHNOL, V29, P816, DOI 10.1038/nbt.1948; Hsu PD, 2013, NAT BIOTECHNOL, V31, P827, DOI 10.1038/nbt.2647; Lin YN, 2014, NUCLEIC ACIDS RES, V42, P7473, DOI 10.1093/nar/gku402; Mali P, 2013, NAT BIOTECHNOL, V31, P833, DOI 10.1038/nbt.2675; Osborn MJ, 2013, MOL THER, V21, P1151, DOI 10.1038/mt.2013.56; Pattanayak V, 2013, NAT BIOTECHNOL, V31, P839, DOI 10.1038/nbt.2673; Pattanayak V, 2011, NAT METHODS, V8, P765, DOI 10.1038/nmeth.1670; Perez-Pinera P, 2013, NAT METHODS, V10, P973, DOI [10.1038/NMETH.2600, 10.1038/nmeth.2600]; Ran FA, 2013, CELL, V154, P1380, DOI 10.1016/j.cell.2013.08.021; Shalem O, 2014, SCIENCE, V343, P84, DOI 10.1126/science.1247005; Wang T, 2014, SCIENCE, V343, P80, DOI 10.1126/science.1246981; Xiao A, 2013, NUCLEIC ACIDS RES, V41, DOI 10.1093/nar/gkt464	15	305	331	6	122	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156	1546-1696		NAT BIOTECHNOL	Nat. Biotechnol.	FEB	2015	33	2					175	178		10.1038/nbt.3127	http://dx.doi.org/10.1038/nbt.3127			4	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	CA8VK	25599175				2022-12-27	WOS:000349198800023
J	Costello, JC; Heiser, LM; Georgii, E; Gonen, M; Menden, MP; Wang, NJ; Bansal, M; Ammad-ud-din, M; Hintsanen, P; Khan, SA; Mpindi, JP; Kallioniemi, O; Honkela, A; Aittokallio, T; Wennerberg, K; Collins, JJ; Gallahan, D; Singer, D; Saez-Rodriguez, J; Kaski, S; Gray, JW; Stolovitzky, G				Costello, James C.; Heiser, Laura M.; Georgii, Elisabeth; Gonen, Mehmet; Menden, Michael P.; Wang, Nicholas J.; Bansal, Mukesh; Ammad-ud-din, Muhammad; Hintsanen, Petteri; Khan, Suleiman A.; Mpindi, John-Patrick; Kallioniemi, Olli; Honkela, Antti; Aittokallio, Tero; Wennerberg, Krister; Collins, James J.; Gallahan, Dan; Singer, Dinah; Saez-Rodriguez, Julio; Kaski, Samuel; Gray, Joe W.; Stolovitzky, Gustavo		NCI DREAM Community	A community effort to assess and improve drug sensitivity prediction algorithms	NATURE BIOTECHNOLOGY			English	Article							CANCER CELL-LINES; HUMAN BREAST; GENES; ARRAY; IDENTIFICATION; ENCYCLOPEDIA; SIGNATURES; RESPONSES; RESOURCE; WISDOM	Predicting the best treatment strategy from genomic information is a core goal of precision medicine. Here we focus on predicting drug response based on a cohort of genomic, epigenomic and proteomic profiling data sets measured in human breast cancer cell lines. Through a collaborative effort between the National Cancer Institute (NCI) and the Dialogue on Reverse Engineering Assessment and Methods (DREAM) project, we analyzed a total of 44 drug sensitivity prediction algorithms. The top-performing approaches modeled nonlinear relationships and incorporated biological pathway information. We found that gene expression microarrays consistently provided the best predictive power of the individual profiling data sets; however, performance was increased by including multiple, independent data sets. We discuss the innovations underlying the top-performing methodology, Bayesian multitask MKL, and we provide detailed descriptions of all methods. This study establishes benchmarks for drug sensitivity prediction and identifies approaches that can be leveraged for the development of new methods.	[Costello, James C.; Collins, James J.] Boston Univ, Howard Hughes Med Inst, Boston, MA 02215 USA; [Costello, James C.; Collins, James J.] Boston Univ, Dept Biomed Engn, Boston, MA 02215 USA; [Heiser, Laura M.; Wang, Nicholas J.; Gray, Joe W.] Oregon Hlth & Sci Univ, Dept Biomed Engn, Portland, OR 97201 USA; [Georgii, Elisabeth; Gonen, Mehmet; Ammad-ud-din, Muhammad; Khan, Suleiman A.; Kaski, Samuel] Aalto Univ, Helsinki Inst Informat Technol HIIT, Dept Informat & Comp Sci, Espoo, Finland; [Menden, Michael P.; Saez-Rodriguez, Julio] European Bioinformat Inst, European Mol Biol Lab, Cambridge, England; [Bansal, Mukesh] Columbia Univ, Dept Syst Biol, Ctr Computat Biol & Bioinformat, New York, NY USA; [Hintsanen, Petteri; Mpindi, John-Patrick; Kallioniemi, Olli; Aittokallio, Tero; Wennerberg, Krister] Univ Helsinki, Inst Mol Med Finland FIMM, Helsinki, Finland; [Honkela, Antti; Kaski, Samuel] Univ Helsinki, Dept Comp Sci, Helsinki Inst Informat Technol HIIT, SF-00510 Helsinki, Finland; [Collins, James J.] Harvard Univ, Wyss Inst Biol Inspired Engn, Boston, MA 02115 USA; [Gallahan, Dan; Singer, Dinah] NCI, NIH, Bethesda, MD 20892 USA; [Stolovitzky, Gustavo] IBM Corp, Thomas J Watson Res Ctr, Yorktown Hts, NY 10598 USA	Boston University; Howard Hughes Medical Institute; Boston University; Oregon Health & Science University; Aalto University; University of Helsinki; European Molecular Biology Laboratory (EMBL); Columbia University; University of Helsinki; Aalto University; University of Helsinki; Harvard University; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); International Business Machines (IBM)	Kaski, S (corresponding author), Aalto Univ, Helsinki Inst Informat Technol HIIT, Dept Informat & Comp Sci, Espoo, Finland.	samuel.kaski@aalto.fi; grayjo@ohsu.edu; gustavo@us.ibm.com	Wennerberg, Krister/AAH-2919-2022; Gray, Joe/AAX-9549-2020; Zhao, Junfei/J-1425-2018; Wang, Wen/E-6320-2012; Kaski, Samuel/B-6684-2008; Khan, Suleiman/F-3472-2017; Gönen, Mehmet/O-7322-2015; Wennerberg, Krister/AFM-0539-2022; Song, Lei/F-6946-2018; Cokelaer, Thomas/AAN-8240-2020; Di Camillo, Barbara/L-3202-2013; Overington, John P/G-8607-2015; Li, Jun/O-9911-2014; Saez-Rodriguez, Julio/H-7114-2019; Rajwa, Bartek/B-3169-2009; Ma, Jian/A-9838-2008; B, Krithika/H-7099-2019; wang, edwin/G-5372-2010; Li, Jun/AAE-4393-2022; Aittokallio, Tero/B-6583-2009; Coelho, Luis Pedro/D-1260-2009; Hwang, Woochang/AAU-8398-2020; Duren, Zhana/A-6425-2018; van Westen, Gerard JP/D-7432-2011; Wang, Difei/E-7066-2010; Bender, Andreas/C-6942-2009; Bhattacharjee, Madhuchhanda/ABI-3732-2020; Yuan, Yuan/H-4007-2013; Kallioniemi, Olli P/H-5111-2011; De Baets, Bernard/E-8877-2010; Walter, Thomas/B-9079-2015	Wennerberg, Krister/0000-0002-1352-4220; Wang, Wen/0000-0002-5812-6744; Kaski, Samuel/0000-0003-1925-9154; Khan, Suleiman/0000-0002-0823-4042; Gönen, Mehmet/0000-0002-2483-075X; Wennerberg, Krister/0000-0002-1352-4220; Cokelaer, Thomas/0000-0001-6286-1138; Di Camillo, Barbara/0000-0001-8415-4688; Overington, John P/0000-0002-5859-1064; Li, Jun/0000-0002-1171-7141; Saez-Rodriguez, Julio/0000-0002-8552-8976; Rajwa, Bartek/0000-0001-7540-8236; Ma, Jian/0000-0002-4202-5834; B, Krithika/0000-0003-4015-7056; Li, Jun/0000-0002-1171-7141; Aittokallio, Tero/0000-0002-0886-9769; Coelho, Luis Pedro/0000-0002-9280-7885; Hwang, Woochang/0000-0003-0876-7305; Duren, Zhana/0000-0003-4685-811X; van Westen, Gerard JP/0000-0003-0717-1817; Bender, Andreas/0000-0002-6683-7546; Bhattacharjee, Madhuchhanda/0000-0002-8700-376X; Yuan, Yuan/0000-0003-4706-7897; Kallioniemi, Olli P/0000-0002-3231-0332; Abbuehl, Jean-Paul/0000-0003-3135-6969; Costello, James/0000-0003-3158-9682; De Baets, Bernard/0000-0002-3876-620X; IJzerman, Ad/0000-0002-1182-2259; Sadanandam, Anguraj/0000-0001-8485-5150; MOONEY, SEAN D/0000-0003-2654-0833; Grau, Michael/0000-0003-1909-0133; Walter, Thomas/0000-0001-7419-7879; Peng, Jian/0000-0002-1736-2978; Vert, Jean-Philippe/0000-0001-9510-8441; Han, Leng/0000-0002-7380-2640; Bansal, Mukesh/0000-0003-1481-6767; Boehm, Frederick/0000-0002-1644-5931; varoquaux, Nelle/0000-0002-8748-6546; Lee, Junehawk/0000-0001-8908-0884; Gusev, Yuriy/0000-0001-7371-4715; Wegner, Jorg Kurt/0000-0002-1852-9434; Califano, Andrea/0000-0003-4742-3679; Homicsko, Krisztian/0000-0003-0912-6198; Ha, Min Jin/0000-0002-5165-1642; Altman, Russ/0000-0003-3859-2905; Pal, Ranadip/0000-0002-9311-5901; Dundar, Murat/0000-0001-5752-468X	MaGNeT grant [5U54CA121852-08]; National Institutes of Health, National Cancer Institute [U54 CA 112970]; Stand Up To Cancer-American Association for Cancer Research Dream Team Translational Cancer Research [SU2C-AACR-DT0409]; Prospect Creek Foundation; Howard Hughes Medical Institute (HHMI); Academy of Finland (Finnish Center of Excellence in Computational Inference Research COIN) [251170, 140057]; NATIONAL CANCER INSTITUTE [U54CA121852, P30CA016672, P50CA058207, U54CA112970] Funding Source: NIH RePORTER	MaGNeT grant; National Institutes of Health, National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Stand Up To Cancer-American Association for Cancer Research Dream Team Translational Cancer Research; Prospect Creek Foundation; Howard Hughes Medical Institute (HHMI)(Howard Hughes Medical Institute); Academy of Finland (Finnish Center of Excellence in Computational Inference Research COIN); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	The data were kindly provided before publication for this challenge by J.W.G. We acknowledge the contributions of all participants in the co-organized NCI and DREAM Summit held on April 23, 2012, for the development of the challenge (http://www.the-dream-project.org/sites/the-dream-project.org/files/documents/dream7/dream_participant_list.docx). This work is supported in part by the following: MaGNeT grant (5U54CA121852-08); National Institutes of Health, National Cancer Institute grant U54 CA 112970; Stand Up To Cancer-American Association for Cancer Research Dream Team Translational Cancer Research grant SU2C-AACR-DT0409; Prospect Creek Foundation; Howard Hughes Medical Institute (HHMI); and The Academy of Finland (Finnish Center of Excellence in Computational Inference Research COIN, grant nos. 251170 and 140057).	Barretina J, 2012, NATURE, V483, P603, DOI 10.1038/nature11003; Bengtsson H, 2009, BIOINFORMATICS, V25, P2149, DOI 10.1093/bioinformatics/btp371; Breiman L., 2001, Machine Learning, V45, P5, DOI 10.1023/A:1010933404324; Bussey KJ, 2006, MOL CANCER THER, V5, P853, DOI 10.1158/1535-7163.MCT-05-0155; Caruana R, 1997, MACH LEARN, V28, P41, DOI 10.1023/A:1007379606734; Costello JC, 2013, CLIN PHARMACOL THER, V93, P396, DOI 10.1038/clpt.2013.36; Curtis C, 2012, NATURE, V486, P346, DOI 10.1038/nature10983; Daemen A, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-10-r110; Fackler MJ, 2011, CANCER RES, V71, P6195, DOI 10.1158/0008-5472.CAN-11-1630; Fallahi-Sichani M, 2013, NAT CHEM BIOL, V9, P708, DOI [10.1038/nchembio.1337, 10.1038/NCHEMBIO.1337]; Friedman J, 2010, J STAT SOFTW, V33, P1, DOI 10.18637/jss.v033.i01; Garnett MJ, 2012, NATURE, V483, P570, DOI 10.1038/nature11005; Gonen M, 2011, J MACH LEARN RES, V12, P2211; Griffith M, 2010, NAT METHODS, V7, P843, DOI [10.1038/NMETH.1503, 10.1038/nmeth.1503]; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Harrell FE, 2001, REGRESSION MODELING; Heiser LM, 2012, P NATL ACAD SCI USA, V109, P2724, DOI 10.1073/pnas.1018854108; Howlander N, 2013, SEER CANC STAT REV, P1975; Hudson TJ, 2010, NATURE, V464, P993, DOI 10.1038/nature08987; Kao J, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006146; Koboldt DC, 2012, NATURE, V490, P61, DOI 10.1038/nature11412; Kuo WL, 2009, BMC MED, V7, DOI 10.1186/1741-7015-7-77; Kwong LN, 2012, NAT MED, V18, P1503, DOI 10.1038/nm.2941; Lamb J, 2006, SCIENCE, V313, P1929, DOI 10.1126/science.1132939; Leiserson MDM, 2013, PLOS COMPUT BIOL, V9, DOI 10.1371/journal.pcbi.1003054; Liberzon A, 2011, BIOINFORMATICS, V27, P1739, DOI 10.1093/bioinformatics/btr260; Marbach D, 2012, NAT METHODS, V9, P796, DOI [10.1038/nmeth.2016, 10.1038/NMETH.2016]; Margolin AA, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3006112; Masica DL, 2013, CANCER RES, V73, P1699, DOI 10.1158/0008-5472.CAN-12-3122; Menden MP, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061318; MONKS A, 1991, J NATL CANCER I, V83, P757, DOI 10.1093/jnci/83.11.757; Neve RM, 2006, CANCER CELL, V10, P515, DOI 10.1016/j.ccr.2006.10.008; Ogata H, 1999, NUCLEIC ACIDS RES, V27, P29, DOI 10.1093/nar/27.1.29; Rantala L. M., 2013, MICROARRAYS, V2, P97; Reis JS, 2011, LANCET, V378, P1812, DOI 10.1016/S0140-6736(11)61539-0; Shawe-Taylor J, 2004, KERNEL METHODS PATTE; Shoemaker RH, 2006, NAT REV CANCER, V6, P813, DOI 10.1038/nrc1951; Sorlie T, 2001, P NATL ACAD SCI USA, V98, P10869, DOI 10.1073/pnas.191367098; Stephens PJ, 2012, NATURE, V486, P400, DOI 10.1038/nature11017; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Tibes R, 2006, MOL CANCER THER, V5, P2512, DOI 10.1158/1535-7163.MCT-06-0334; van't Veer LJ, 2002, NATURE, V415, P530, DOI 10.1038/415530a; Vaske CJ, 2010, BIOINFORMATICS, V26, pi237, DOI 10.1093/bioinformatics/btq182; Venkatraman ES, 2007, BIOINFORMATICS, V23, P657, DOI 10.1093/bioinformatics/btl646; Wilson TR, 2012, NATURE, V487, P505, DOI 10.1038/nature11249; Wood LD, 2007, SCIENCE, V318, P1108, DOI 10.1126/science.1145720; Wu J, 2012, ONCOGENE, V31, P333, DOI 10.1038/onc.2011.227; Yang WJ, 2013, NUCLEIC ACIDS RES, V41, pD955, DOI 10.1093/nar/gks1111	49	432	434	4	71	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1087-0156	1546-1696		NAT BIOTECHNOL	Nat. Biotechnol.	DEC	2014	32	12					1202	U57		10.1038/nbt.2877	http://dx.doi.org/10.1038/nbt.2877			13	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	AW3AD	24880487	Green Published, Green Accepted, Bronze, Green Submitted			2022-12-27	WOS:000346156800022
J	Feng, YH; De Franceschi, G; Kahraman, A; Soste, M; Melnik, A; Boersema, PJ; de Laureto, PP; Nikolaev, Y; Oliveira, AP; Picotti, P				Feng, Yuehan; De Franceschi, Giorgia; Kahraman, Abdullah; Soste, Martin; Melnik, Andre; Boersema, Paul J.; de laureto, Patrizia Polverino; Nikolaev, Yaroslav; Oliveira, Ana Paula; Picotti, Paola			Global analysis of protein structural changes in complex proteomes	NATURE BIOTECHNOLOGY			English	Article							CONFORMATIONAL-CHANGES; LIMITED PROTEOLYSIS; MASS-SPECTROMETRY; SACCHAROMYCES-CEREVISIAE; TARGETED PROTEOMICS; SECONDARY STRUCTURE; MOLTEN GLOBULE; YEAST; SCALE; PHOSPHORYLATION	Changes in protein conformation can affect protein function, but methods to probe these structural changes on a global scale in cells have been lacking. To enable large-scale analyses of protein conformational changes directly in their biological matrices, we present a method that couples limited proteolysis with a targeted proteomics workflow. Using our method, we assessed the structural features of more than 1,000 yeast proteins simultaneously and detected altered conformations for similar to 300 proteins upon a change of nutrients. We find that some branches of carbon metabolism are transcriptionally regulated whereas others are regulated by enzyme conformational changes. We detect structural changes in aggregation-prone proteins and show the functional relevance of one of these proteins to the metabolic switch. This approach enables probing of both subtle and pronounced structural changes of proteins on a large scale.	[Feng, Yuehan; De Franceschi, Giorgia; Kahraman, Abdullah; Soste, Martin; Melnik, Andre; Boersema, Paul J.; Picotti, Paola] ETH, Inst Biochem, Dept Biol, Zurich, Switzerland; [De Franceschi, Giorgia; de laureto, Patrizia Polverino] Univ Padua, CRIBI Biotechnol Ctr, Padua, Italy; [Nikolaev, Yaroslav] ETH, Inst Mol Biol & Biophys, Dept Biol, Zurich, Switzerland; [Oliveira, Ana Paula] ETH, Inst Mol Syst Biol, Dept Biol, Zurich, Switzerland	Swiss Federal Institutes of Technology Domain; ETH Zurich; University of Padua; Swiss Federal Institutes of Technology Domain; ETH Zurich; Swiss Federal Institutes of Technology Domain; ETH Zurich	Picotti, P (corresponding author), ETH, Inst Biochem, Dept Biol, Zurich, Switzerland.	paola.picotti@bc.biol.ethz.ch	Oliveira, Ana Paula/B-8366-2009; Nikolaev, Yaroslav/I-1976-2013	Oliveira, Ana Paula/0000-0003-3787-9138; Nikolaev, Yaroslav/0000-0002-1479-7474; Kahraman, Abdullah/0000-0003-3523-4467				ACETO A, 1995, INT J BIOCHEM CELL B, V27, P1033, DOI 10.1016/1357-2725(95)00081-Y; Aebersold R, 2003, NATURE, V422, P198, DOI 10.1038/nature01511; Amemiya T, 2011, J MOL BIOL, V408, P568, DOI 10.1016/j.jmb.2011.02.058; Antonini E., 1971, HEMOGLOBIN MYOGLOBIN; Apweiler R, 2004, NUCLEIC ACIDS RES, V32, pD115, DOI 10.1093/nar/gkh131; Berman HM, 2000, NUCLEIC ACIDS RES, V28, P235, DOI 10.1093/nar/28.1.235; Bu ZM, 2011, ADV PROTEIN CHEM STR, V83, P163, DOI 10.1016/B978-0-12-381262-9.00005-7; Chambers MC, 2012, NAT BIOTECHNOL, V30, P918, DOI 10.1038/nbt.2377; Chechik G, 2008, NAT BIOTECHNOL, V26, P1251, DOI 10.1038/nbt.1499; Chiti F, 2006, ANNU REV BIOCHEM, V75, P333, DOI 10.1146/annurev.biochem.75.101304.123901; Choi M, 2014, BIOINFORMATICS, V30, P2524, DOI 10.1093/bioinformatics/btu305; Costenoble R, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2010.122; COX S, 1994, CURR OPIN STRUC BIOL, V4, P893, DOI 10.1016/0959-440X(94)90272-0; Crooks GE, 2004, GENOME RES, V14, P1188, DOI 10.1101/gr.849004; De Franceschi G, 2009, J MOL BIOL, V394, P94, DOI 10.1016/j.jmb.2009.09.008; de Laureto PP, 2003, J MOL BIOL, V334, P129, DOI 10.1016/j.jmb.2003.09.024; DeRisi JL, 1997, SCIENCE, V278, P680, DOI 10.1126/science.278.5338.680; Dieckmann R, 1999, J MOL BIOL, V288, P129, DOI 10.1006/jmbi.1999.2671; EFTINK MR, 1991, METHOD BIOCHEM ANAL, V35, P127; Elias JE, 2007, NAT METHODS, V4, P207, DOI 10.1038/nmeth1019; Eliezer D, 1996, J MOL BIOL, V263, P531, DOI 10.1006/jmbi.1996.0596; Fendt SM, 2010, MOL SYST BIOL, V6, DOI 10.1038/msb.2010.11; Fink AL, 2005, CURR OPIN STRUC BIOL, V15, P35, DOI 10.1016/j.sbi.2005.01.002; Flikweert MT, 1996, YEAST, V12, P247, DOI 10.1002/(SICI)1097-0061(19960315)12:3<247::AID-YEA911>3.0.CO;2-I; Fontana A, 2004, ACTA BIOCHIM POL, V51, P299; Ghaemmaghami S, 2003, NATURE, V425, P737, DOI 10.1038/nature02046; Glatter T, 2012, J PROTEOME RES, V11, P5145, DOI 10.1021/pr300273g; Goh CS, 2004, CURR OPIN STRUC BIOL, V14, P104, DOI 10.1016/j.sbi.2004.01.005; Halfmann R, 2010, SCIENCE, V330, P629, DOI 10.1126/science.1191081; Heintz D, 2012, J PROTEOME RES, V11, P1228, DOI 10.1021/pr201127u; Herzog F, 2012, SCIENCE, V337, P1348, DOI 10.1126/science.1221483; Heyduk T, 2002, CURR OPIN BIOTECH, V13, P292, DOI 10.1016/S0958-1669(02)00332-4; Hwang H, 2010, PROTEINS, V78, P3111, DOI 10.1002/prot.22830; Ilari Andrea, 2008, V452, P63, DOI 10.1007/978-1-60327-159-2_3; KABSCH W, 1983, BIOPOLYMERS, V22, P2577, DOI 10.1002/bip.360221211; KENDREW JC, 1958, NATURE, V181, P662, DOI 10.1038/181662a0; KIRTLEY ME, 1977, MOL CELL BIOCHEM, V18, P141, DOI 10.1007/BF00280279; Kleifeld O, 2010, NAT BIOTECHNOL, V28, P281, DOI 10.1038/nbt.1611; KORN ED, 1987, SCIENCE, V238, P638, DOI 10.1126/science.3672117; Krissinel E, 2007, J MOL BIOL, V372, P774, DOI 10.1016/j.jmb.2007.05.022; Leibundgut M, 2007, SCIENCE, V316, P288, DOI 10.1126/science.1138249; LeVine H, 1999, METHOD ENZYMOL, V309, P274; Lomenick B, 2009, P NATL ACAD SCI USA, V106, P21984, DOI 10.1073/pnas.0910040106; Lozza J., 2010, THESIS ETH ZURICH; MacLean B, 2010, BIOINFORMATICS, V26, P966, DOI 10.1093/bioinformatics/btq054; Mischerikow N, 2011, PROTEOMICS, V11, P571, DOI 10.1002/pmic.201000397; Narayanaswamy R, 2009, P NATL ACAD SCI USA, V106, P10147, DOI 10.1073/pnas.0812771106; Oliveira AP, 2012, MOL SYST BIOL, V8, DOI 10.1038/msb.2012.55; Olsen JV, 2006, CELL, V127, P635, DOI 10.1016/j.cell.2006.09.026; Pelton JT, 2000, ANAL BIOCHEM, V277, P167, DOI 10.1006/abio.1999.4320; PENG ZY, 1994, BIOCHEMISTRY-US, V33, P2136, DOI 10.1021/bi00174a021; Picotti P, 2009, CELL, V138, P795, DOI 10.1016/j.cell.2009.05.051; Pieper U, 2011, NUCLEIC ACIDS RES, V39, pD465, DOI 10.1093/nar/gkq1091; Rabiller M, 2010, ARCH PHARM, V343, P193, DOI 10.1002/ardp.201000028; Rice P, 2000, TRENDS GENET, V16, P276, DOI 10.1016/S0168-9525(00)02024-2; Sakakibara D, 2009, NATURE, V458, P102, DOI 10.1038/nature07814; Sherman F, 2002, METHOD ENZYMOL, V350, P3, DOI 10.1016/S0076-6879(02)50954-X; Storey JD, 2002, J ROY STAT SOC B, V64, P479, DOI 10.1111/1467-9868.00346; TEALE FWJ, 1959, BIOCHIM BIOPHYS ACTA, V35, P543, DOI 10.1016/0006-3002(59)90407-X; Thakur SS, 2011, MOL CELL PROTEOMICS, V10, DOI 10.1074/mcp.M110.003699; Uversky VN, 2007, J NEUROCHEM, V103, P17, DOI 10.1111/j.1471-4159.2007.04764.x; Veisova D, 2010, BIOCHEMISTRY-US, V49, P3853, DOI 10.1021/bi100273k; Vilar M, 2008, P NATL ACAD SCI USA, V105, P8637, DOI 10.1073/pnas.0712179105; WINSTON F, 1995, YEAST, V11, P53, DOI 10.1002/yea.320110107; Wrabl JO, 2011, BIOPHYS CHEM, V159, P129, DOI 10.1016/j.bpc.2011.05.020; Xie XL, 2010, ELECTROPHORESIS, V31, P1842, DOI 10.1002/elps.200900752; Xu YF, 2012, MOL CELL, V48, P52, DOI 10.1016/j.molcel.2012.07.013; Zacharias M, 2010, CURR OPIN STRUC BIOL, V20, P180, DOI 10.1016/j.sbi.2010.02.001; Zhang QC, 2012, NATURE, V490, P556, DOI 10.1038/nature11503	69	193	198	5	111	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156	1546-1696		NAT BIOTECHNOL	Nat. Biotechnol.	OCT	2014	32	10					1036	+		10.1038/nbt.2999	http://dx.doi.org/10.1038/nbt.2999			13	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	AR7MM	25218519				2022-12-27	WOS:000343763800021
J	Sinha, G				Sinha, Gunjan			Cell presses	NATURE BIOTECHNOLOGY			English	News Item																		Jakab K, 2010, BIOFABRICATION, V2, DOI 10.1088/1758-5082/2/2/022001; Koch L, 2012, BIOTECHNOL BIOENG, V109, P1855, DOI 10.1002/bit.24455; Mueller D, 2014, TOXICOL IN VITRO, V28, P104, DOI 10.1016/j.tiv.2013.06.024; Reichert JC, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003720; Reiffel AJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056506; Robbins J. B., 2013, EXP BIOL BOST APR 20; Zopf DA, 2013, NEW ENGL J MED, V368, P2043, DOI 10.1056/NEJMc1206319	7	5	7	0	3	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156	1546-1696		NAT BIOTECHNOL	Nat. Biotechnol.	AUG	2014	32	8					716	719		10.1038/nbt.2983	http://dx.doi.org/10.1038/nbt.2983			4	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	AW7PF	25093885				2022-12-27	WOS:000346455900007
J	Zakrzewski, JL; van den Brink, MRM; Hubbell, JA				Zakrzewski, Johannes L.; van den Brink, Marcel R. M.; Hubbell, Jeffrey A.			Overcoming immunological barriers in regenerative medicine	NATURE BIOTECHNOLOGY			English	Article							VERSUS-HOST-DISEASE; MESENCHYMAL STEM-CELLS; REGULATORY T-CELLS; MAJOR HISTOCOMPATIBILITY COMPLEX; ANTIGEN-SPECIFIC TOLERANCE; DONOR-SPECIFIC TOLERANCE; REFRACTORY ACUTE GVHD; DENDRITIC CELLS; INTRATHYMIC INJECTION; MYCOPHENOLATE-MOFETIL	Regenerative therapies that use allogeneic cells are likely to encounter immunological barriers similar to those that occur with transplantation of solid organs and allogeneic hematopoietic stem cells (HSCs). Decades of experience in clinical transplantation hold valuable lessons for regenerative medicine, offering approaches for developing tolerance-induction treatments relevant to cell therapies. Outside the field of solid-organ and allogeneic HSC transplantation, new strategies are emerging for controlling the immune response, such as methods based on biomaterials or mimicry of antigen-specific peripheral tolerance. Novel biomaterials can alter the behavior of cells in tissue-engineered constructs and can blunt host immune responses to cells and biomaterial scaffolds. Approaches to suppress autoreactive immune cells may also be useful in regenerative medicine. The most innovative solutions will be developed through closer collaboration among stem cell biologists, transplantation immunologists and materials scientists.	[Zakrzewski, Johannes L.] Mem Sloan Kettering Canc Ctr, Dept Pediat, New York, NY 10021 USA; [van den Brink, Marcel R. M.] Mem Sloan Kettering Canc Ctr, Dept Med, New York, NY 10021 USA; [van den Brink, Marcel R. M.] Mem Sloan Kettering Canc Ctr, Dept Immunol, New York, NY 10021 USA; [Hubbell, Jeffrey A.] Ecole Polytech Fed Lausanne, Sch Life Sci, Inst Bioengn, Lausanne, Switzerland; [Hubbell, Jeffrey A.] Ecole Polytech Fed Lausanne, Sch Engn, Lausanne, Switzerland; [Hubbell, Jeffrey A.] Univ Chicago, Inst Mol Engn, Chicago, IL 60637 USA	Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center; Swiss Federal Institutes of Technology Domain; Ecole Polytechnique Federale de Lausanne; Swiss Federal Institutes of Technology Domain; Ecole Polytechnique Federale de Lausanne; University of Chicago	Zakrzewski, JL (corresponding author), Mem Sloan Kettering Canc Ctr, Dept Pediat, 1275 York Ave, New York, NY 10021 USA.	zakrzewj@mskcc.org	van den Brink, Marcel R. M./HGB-9434-2022		NCI NIH HHS [P30 CA008748, K08 CA160659, P30 CA072720] Funding Source: Medline; NHLBI NIH HHS [R01 HL069929] Funding Source: Medline; NATIONAL CANCER INSTITUTE [K08CA160659, P30CA008748, P30CA072720] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL069929] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Adkins D, 2009, TRANSPLANTATION, V88, P198, DOI 10.1097/TP.0b013e3181abfbf7; Allison AC, 2000, IMMUNOPHARMACOLOGY, V47, P85, DOI 10.1016/S0162-3109(00)00188-0; Araki R, 2013, NATURE, V494, P100, DOI 10.1038/nature11807; Asberg A, 2006, TRANSPLANTATION, V82, P62, DOI 10.1097/01.tp.0000225803.04995.2b; Berman DM, 2010, DIABETES, V59, P2558, DOI 10.2337/db10-0136; Beyersdorf N, 2008, BLOOD, V112, P4328, DOI 10.1182/blood-2008-03-146662; Blazar BR, 2012, NAT REV IMMUNOL, V12, P443, DOI 10.1038/nri3212; Bour-Jordan H, 2011, IMMUNOL REV, V241, P180, DOI 10.1111/j.1600-065X.2011.01011.x; Brady AC, 2013, TISSUE ENG PT A, V19, P2544, DOI [10.1089/ten.tea.2012.0686, 10.1089/ten.TEA.2012.0686]; BUSUTTIL RW, 1994, NEW ENGL J MED, V331, P1110; CALNE RY, 1978, LANCET, V2, P1323; Chen WJ, 1998, J IMMUNOL, V160, P1504; Choi J, 2010, BLOOD, V116, P129, DOI 10.1182/blood-2009-12-257253; Christopeit M, 2009, BLOOD, V113, P3130, DOI 10.1182/blood-2009-01-200527; Chung B, 2007, BLOOD, V110, P2803, DOI 10.1182/blood-2006-11-055673; Cicciarelli J.C., 2012, IMMUNOLOGICAL BARRIE, P147; Clark RA, 2005, J CLIN INVEST, V115, P3239, DOI 10.1172/JCI24731; Cober SR, 1999, J SURG RES, V85, P204, DOI 10.1006/jsre.1999.5688; Crop MJ, 2009, TRANSPLANTATION, V87, P896, DOI 10.1097/TP.0b013e31819b3d72; Cui H, 2009, TRANSPLANTATION, V88, P160, DOI 10.1097/TP.0b013e3181abbfc1; Czechowicz A, 2007, SCIENCE, V318, P1296, DOI 10.1126/science.1149726; Dane KY, 2011, J CONTROL RELEASE, V156, P154, DOI 10.1016/j.jconrel.2011.08.009; DIIANNI M, 2011, BLOOD, V117, P3921, DOI [DOI 10.1182/blood-2010-10-311894, DOI 10.1182/BLOOD-2010-10-311894]; Djamali A, 2004, TRANSPL INT, V17, P301, DOI 10.1111/j.1432-2277.2004.tb00447.x; Drobyski WR, 2011, BIOL BLOOD MARROW TR, V17, P1862, DOI 10.1016/j.bbmt.2011.07.001; Eggenhofer E, 2011, TRANSPL IMMUNOL, V24, P157, DOI 10.1016/j.trim.2010.12.002; Evenou JP, 2009, J PHARMACOL EXP THER, V330, P792, DOI 10.1124/jpet.109.153205; Ezzelarab MB, 2013, AM J TRANSPLANT, V13, P1989, DOI 10.1111/ajt.12310; Fan HM, 2011, SEMIN IMMUNOL, V23, P453, DOI 10.1016/j.smim.2011.08.012; Fife BT, 2006, J EXP MED, V203, P2737, DOI 10.1084/jem.20061577; Fuchimoto Y, 2000, J CLIN INVEST, V105, P1779, DOI 10.1172/JCI8721; Garcia-Cadenas I, 2013, BIOL BLOOD MARROW TR, V19, P435, DOI 10.1016/j.bbmt.2012.11.012; Getts DR, 2012, NAT BIOTECHNOL, V30, P1217, DOI 10.1038/nbt.2434; Ghobadi A., 2013, 55 AM SOC HEM ANN M; Gill RG, 2010, CURR OPIN IMMUNOL, V22, P649, DOI 10.1016/j.coi.2010.09.005; Glowacki AJ, 2013, P NATL ACAD SCI USA, V110, P18525, DOI 10.1073/pnas.1302829110; Gordon JR, 2014, FRONT IMMUNOL, V5, DOI 10.3389/fimmu.2014.00007; Highfill SL, 2010, BLOOD, V116, P5738, DOI 10.1182/blood-2010-06-287839; Hippen KL, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3001809; Hirosue S, 2014, J IMMUNOL, V192, P5002, DOI 10.4049/jimmunol.1302492; Hoda D, 2010, BONE MARROW TRANSPL, V45, P1347, DOI 10.1038/bmt.2009.343; Jacobson P, 1998, BONE MARROW TRANSPL, V22, P217, DOI 10.1038/sj.bmt.1701331; Jang MS, 2008, TRANSPLANTATION, V85, P1051, DOI 10.1097/TP.0b013e31816846f6; Joffre O, 2004, BLOOD, V103, P4216, DOI 10.1182/blood-2004-01-0005; Josefowicz SZ, 2012, ANNU REV IMMUNOL, V30, P531, DOI 10.1146/annurev.immunol.25.022106.141623; Kawai T, 2008, NEW ENGL J MED, V358, P353, DOI 10.1056/NEJMoa071074; Kheradmand T, 2011, BIOMATERIALS, V32, P4517, DOI 10.1016/j.biomaterials.2011.03.009; Kim N, 2013, ANN HEMATOL, V92, P1295, DOI 10.1007/s00277-013-1796-z; Komori J, 2012, NAT BIOTECHNOL, V30, P976, DOI 10.1038/nbt.2379; Kontos S, 2013, P NATL ACAD SCI USA, V110, pE60, DOI 10.1073/pnas.1216353110; Koreth J, 2011, NEW ENGL J MED, V365, P2055, DOI 10.1056/NEJMoa1108188; Koreth J, 2009, BLOOD, V114, P3956, DOI 10.1182/blood-2009-07-231092; Lakkis FG, 2013, CSH PERSPECT MED, V3, DOI 10.1101/cshperspect.a014993; Larsen CP, 1996, NATURE, V381, P434, DOI 10.1038/381434a0; Le Blanc K, 2004, LANCET, V363, P1439, DOI 10.1016/S0140-6736(04)16104-7; LeBlanc K, 2008, LANCET, V371, P1579, DOI 10.1016/S0140-6736(08)60690-X; Leveson-Gower DB, 2011, BLOOD, V117, P3220, DOI 10.1182/blood-2010-08-303008; Levine JE, 2008, BLOOD, V111, P2470, DOI 10.1182/blood-2007-09-112987; Li DP, 2012, J EXP MED, V209, P109, DOI 10.1084/jem.20110399; Li J, 2011, BIOL BLOOD MARROW TR, V17, P962, DOI 10.1016/j.bbmt.2011.01.018; Li N, 2010, CELL MOL IMMUNOL, V7, P133, DOI 10.1038/cmi.2009.120; Li S, 2006, J SURG RES, V136, P238, DOI 10.1016/j.jss.2006.05.032; LIM F, 1980, SCIENCE, V210, P908, DOI 10.1126/science.6776628; Liu K, 2002, J EXP MED, V196, P1091, DOI 10.1084/jem.20021215; Logan AC, 2012, CURR OPIN IMMUNOL, V24, P640, DOI 10.1016/j.coi.2012.08.002; Lund AW, 2012, CELL REP, V1, P191, DOI 10.1016/j.celrep.2012.01.005; Luo XR, 2008, P NATL ACAD SCI USA, V105, P14527, DOI 10.1073/pnas.0805204105; Lutterotti A, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3006168; Lutz MB, 2012, FRONT IMMUNOL, V3, DOI 10.3389/fimmu.2012.00123; Magro L, 2009, BLOOD, V114, P719, DOI 10.1182/blood-2009-02-204750; Mai HL, 2014, J CLIN INVEST, V124, P1723, DOI 10.1172/JCI66287; Maltzman JS, 2012, AM J TRANSPLANT, V12, P2269, DOI 10.1111/j.1600-6143.2012.04185.x; Mapara MY, 2001, BIOL BLOOD MARROW TR, V7, P646, DOI 10.1053/bbmt.2001.v7.pm11787527; Marodon G, 2006, BLOOD, V108, P2972, DOI 10.1182/blood-2006-03-010900; Martin AJ, 2010, J IMMUNOL, V185, P3326, DOI 10.4049/jimmunol.1000802; Martin MJ, 2005, NAT MED, V11, P228, DOI 10.1038/nm1181; Mukherjee G, 2013, INT IMMUNOL, V25, P651, DOI 10.1093/intimm/dxt031; Muraoka N, 2014, ANNU REV PHYSIOL, V76, P21, DOI 10.1146/annurev-physiol-021113-170301; Neufeld T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070150; Page A, 2012, AM J TRANSPLANT, V12, P115, DOI 10.1111/j.1600-6143.2011.03737.x; Penack O, 2010, JNCI-J NATL CANCER I, V102, P894, DOI 10.1093/jnci/djq172; Perez VL, 2011, DIABETOLOGIA, V54, P1121, DOI 10.1007/s00125-011-2091-y; Perico N, 2011, CLIN J AM SOC NEPHRO, V6, P412, DOI 10.2215/CJN.04950610; Petersdorf EW, 2013, BLOOD, V122, P1863, DOI 10.1182/blood-2013-05-355982; Pillai AB, 2007, J IMMUNOL, V178, P6242, DOI 10.4049/jimmunol.178.10.6242; Poznansky MC, 2000, NAT BIOTECHNOL, V18, P729, DOI 10.1038/77288; Pruett TL, 2009, TRANSPL P, V41, P3655, DOI 10.1016/j.transproceed.2009.06.226; Reddy P, 2008, J CLIN INVEST, V118, P2562, DOI 10.1172/JCI34712; Rossi Robert J, 2012, Methods Mol Biol, V900, P471, DOI 10.1007/978-1-60761-720-4_23; Sachs DH, 2014, CSH PERSPECT MED, V4, DOI 10.1101/cshperspect.a015529; Sagoo P, 2012, FRONT IMMUNOL, V3, DOI 10.3389/fimmu.2012.00184; Schlitt HJ, 2001, LANCET, V357, P587, DOI 10.1016/S0140-6736(00)04055-1; Schneidawind D, 2013, BLOOD, V122, P3116, DOI 10.1182/blood-2013-08-453126; Schub N, 2011, BONE MARROW TRANSPL, V46, P143, DOI 10.1038/bmt.2010.68; Seach N, 2010, TISSUE ENG PART C-ME, V16, P543, DOI [10.1089/ten.tec.2009.0135, 10.1089/ten.TEC.2009.0135]; Shapiro AMJ, 2006, NEW ENGL J MED, V355, P1318, DOI 10.1056/NEJMoa061267; Shapiro AMJ, 2000, NEW ENGL J MED, V343, P230, DOI 10.1056/NEJM200007273430401; Shields JD, 2010, SCIENCE, V328, P749, DOI 10.1126/science.1185837; Shimabukuro-Vornhagen A, 2008, BLOOD, V112, P1544, DOI 10.1182/blood-2008-04-149609; Shin HJ, 2011, BLOOD, V118, P2342, DOI 10.1182/blood-2010-10-313684; Shono Y, 2014, CANCER DISCOV, V4, P578, DOI 10.1158/2159-8290.CD-13-0585; Shtrichman R, 2013, CURR MOL MED, V13, P792, DOI 10.2174/1566524011313050010; Stenger EO, 2012, BLOOD, V119, P5088, DOI 10.1182/blood-2011-11-364091; Stern JNH, 2010, P NATL ACAD SCI USA, V107, P17280, DOI 10.1073/pnas.1010263107; Strioga MM, 2013, CRIT REV IMMUNOL, V33, P489; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; Tang Chad, 2013, Methods Mol Biol, V1029, P17, DOI 10.1007/978-1-62703-478-4_2; Tang QZ, 2013, CSH PERSPECT MED, V3, DOI 10.1101/cshperspect.a015552; Tao R, 2007, NAT MED, V13, P1299, DOI 10.1038/nm1652; Taylor PA, 2005, BLOOD, V105, P3372, DOI 10.1182/blood-2004-10-3869; Tolar J, 2010, STEM CELLS, V28, P1446, DOI 10.1002/stem.459; Trzonkowski P, 2009, CLIN IMMUNOL, V133, P22, DOI 10.1016/j.clim.2009.06.001; Tsai SE, 2010, IMMUNITY, V32, P568, DOI 10.1016/j.immuni.2010.03.015; Tuckett AZ, 2014, BLOOD, V123, P2797, DOI 10.1182/blood-2013-10-535401; Vijayakrishnan L, 2011, TRENDS PHARMACOL SCI, V32, P25, DOI 10.1016/j.tips.2010.10.004; Vodanovic-Jankovic S, 2006, BLOOD, V107, P827, DOI 10.1182/blood-2005-05-1820; Wabbijn Marike, 2004, Exp Clin Transplant, V2, P201; WALLACE PM, 1994, TRANSPLANTATION, V58, P602, DOI 10.1097/00007890-199409150-00013; Wood KJ, 2012, NAT REV IMMUNOL, V12, P417, DOI 10.1038/nri3227; Wu SM, 2011, NAT CELL BIOL, V13, P497, DOI 10.1038/ncb0511-497; Xhaard A, 2012, BIOL BLOOD MARROW TR, V18, P406, DOI 10.1016/j.bbmt.2011.06.012; Yap WT, 2013, TISSUE ENG PT A, V19, P2361, DOI [10.1089/ten.tea.2013.0033, 10.1089/ten.TEA.2013.0033]; Zhao TB, 2011, NATURE, V474, P212, DOI 10.1038/nature10135	123	91	91	0	55	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156	1546-1696		NAT BIOTECHNOL	Nat. Biotechnol.	AUG	2014	32	8					786	794		10.1038/nbt.2960	http://dx.doi.org/10.1038/nbt.2960			9	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	AW7PF	25093888	Green Accepted			2022-12-27	WOS:000346455900019
J	Daley, J; Shiu, A				Daley, John; Shiu, Alicia			Access all areas	NATURE BIOTECHNOLOGY			English	Editorial Material									[Daley, John] OneStart, London, England; [Shiu, Alicia] Oxbridge Biotech Roundtable, London, England		Daley, J (corresponding author), OneStart, London, England.	john.daley@oxbridgebiotech.com; ashiu@stanford.edu							0	1	1	0	0	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156	1546-1696		NAT BIOTECHNOL	Nat. Biotechnol.	JUL	2014	32	7					614	616		10.1038/nbt.2941	http://dx.doi.org/10.1038/nbt.2941			3	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	AK8VE	25004223	Bronze			2022-12-27	WOS:000338705900020
J	Rai, AK; Sherkow, JS				Rai, Arti K.; Sherkow, Jacob S.			The changing life science patent landscape	NATURE BIOTECHNOLOGY			English	Editorial Material									[Rai, Arti K.] Duke Univ, Sch Law, Ctr Innovat Policy, Durham, NC 27706 USA; [Sherkow, Jacob S.] New York Law Sch, Innovat Ctr Law & Technol, New York, NY USA	Duke University	Rai, AK (corresponding author), Duke Univ, Sch Law, Ctr Innovat Policy, Durham, NC 27706 USA.	rai@law.duke.edu; jacob.sherkow@nyls.edu		Sherkow, Jacob/0000-0002-9724-9261				[Anonymous], 2015, COMMUNICATION; [Anonymous], 2014, FED REGISTER, V79, P59776; Cook-Deegan R, 2013, EUR J HUM GENET, V21, P585, DOI 10.1038/ejhg.2012.217; Cook-Deegan R, 2009, NATURE, V458, P405, DOI 10.1038/458405a; DiMasi J.A., 2014, INNOVATION PHARM IND; Eisenberg Rebecca S., 2015, MICH TELECOMM TECH L, V21, P197; Grabowski H, 2012, FOOD DRUG LAW J, V67, P373; Heller MA, 1998, SCIENCE, V280, P698, DOI 10.1126/science.280.5364.698; Hemphill CS, 2013, SCIENCE, V339, P1386, DOI 10.1126/science.1235857; Hemphill T.P., 2015, REGULATION, V38, P6; Kapczynski A, 2015, NEW ENGL J MED, V373, P201, DOI 10.1056/NEJMp1506158; Merges RP., 2012, BERKELEY TECH LJ, V27, P1023; Micheel C., 2012, EVOLUTION TRANSLATIO; Price WN, 2015, SCIENCE, V348, P188, DOI 10.1126/science.aab1684; Rai AK, 2012, DUKE LAW J, V61, P1237; Reichman JH, 2009, J LAW MED ETHICS, V37, P247, DOI 10.1111/j.1748-720X.2009.00369.x; Sharfstein J, 2015, JAMA-J AM MED ASSOC, V313, P667, DOI 10.1001/jama.2014.18135; Sherkow JS, 2015, WASH LAW REV, V90, P205; USPTO, 2014, FED REG, V97, P74618	19	12	12	2	20	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156	1546-1696		NAT BIOTECHNOL	Nat. Biotechnol.	MAR	2016	34	3					292	294		10.1038/nbt.3504	http://dx.doi.org/10.1038/nbt.3504			3	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Biotechnology & Applied Microbiology	DG1CJ	26963552	Green Published			2022-12-27	WOS:000371802600022
J	Norman-Burgdolf, HL; Vanderford, NL				Norman-Burgdolf, Heather L.; Vanderford, Nathan L.			Preparing future professionals by enhancing workforce readiness	NATURE BIOTECHNOLOGY			English	Editorial Material							BIOMEDICAL-RESEARCH; GRADUATE-EDUCATION; PHD; RECOMMENDATIONS	A new course aims to help combat the absence of sufficient workforce preparedness for graduate students and postdoctoral fellows.	[Norman-Burgdolf, Heather L.] Univ Kentucky, Coll Med, Dept Pharmacol & Nutr Sci, Lexington, KY USA; [Vanderford, Nathan L.] Univ Kentucky, Coll Med, Markey Canc Ctr, Lexington, KY USA; [Vanderford, Nathan L.] Univ Kentucky, Coll Med, Dept Toxicol & Canc Biol, Lexington, KY USA	University of Kentucky; University of Kentucky; University of Kentucky	Vanderford, NL (corresponding author), Univ Kentucky, Coll Med, Markey Canc Ctr, Lexington, KY USA.; Vanderford, NL (corresponding author), Univ Kentucky, Coll Med, Dept Toxicol & Canc Biol, Lexington, KY USA.	nathan.vanderford@uky.edu			NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [T32DK007778] Funding Source: NIH RePORTER; NIDDK NIH HHS [T32 DK007778] Funding Source: Medline	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Alberts B, 2014, P NATL ACAD SCI USA, V111, P5773, DOI 10.1073/pnas.1404402111; Bourne HR, 2013, ELIFE, V2, DOI 10.7554/eLife.01139; Callier V., 2015, TECHNOLOGY TRANSFER, V2, P51; Callier V, 2014, NAT BIOTECHNOL, V32, P593, DOI 10.1038/nbt.2928; Daniels RJ, 2015, P NATL ACAD SCI USA, V112, P313, DOI 10.1073/pnas.1418761112; Fuhrmann CN, 2011, CBE-LIFE SCI EDUC, V10, P239, DOI 10.1187/cbe.11-02-0013; Gibbs KD, 2013, CBE-LIFE SCI EDUC, V12, P711, DOI 10.1187/cbe.13-02-0021; Golde C., 2001, CROSS PURPOSES WHAT; Helm M, 2012, J FACULTY DEV, V26, P5; Hobin JA, 2014, CBE-LIFE SCI EDUC, V13, P49, DOI 10.1187/cbe-13-04-0085; Juliano RL, 2001, ACAD MED, V76, P1005, DOI 10.1097/00001888-200110000-00007; Kimble J, 2015, ELIFE, V4, DOI 10.7554/eLife.09305; Koblinsky SA, 2015, AM J PUBLIC HEALTH, V105, pS125, DOI 10.2105/AJPH.2014.302509; McDowell Gary S, 2014, F1000Res, V3, P291, DOI 10.12688/f1000research.5878.2; National Institutes of Health, 2012, BIOM RES WORKF WORK; Pickett CL, 2015, P NATL ACAD SCI USA, V112, P10832, DOI 10.1073/pnas.1509901112; Russo Gene, 2011, Nature, V475, P533; Sauermann H, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036307; Schillebeeckx M, 2013, NAT BIOTECHNOL, V31, P938, DOI 10.1038/nbt.2706; Vanderford NL, 2013, NAT BIOTECHNOL, V31, P1149, DOI 10.1038/nbt.2767; Vanderford NL, 2012, NAT BIOTECHNOL, V30, P113, DOI 10.1038/nbt.2091	21	4	4	0	12	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156	1546-1696		NAT BIOTECHNOL	Nat. Biotechnol.	JAN	2016	34	1					111	113		10.1038/nbt.3459	http://dx.doi.org/10.1038/nbt.3459			3	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	DB8HQ	26744984	Green Accepted			2022-12-27	WOS:000368758200035
J	Pfleger, BF; Prather, KLJ				Pfleger, Brian F.; Prather, Kristala L. J.			Biological synthesis unbounded?	NATURE BIOTECHNOLOGY			English	Editorial Material							YEAST; OPIOIDS		[Pfleger, Brian F.] Univ Wisconsin, Madison, WI 53705 USA; [Prather, Kristala L. J.] MIT, Dept Chem Engn, Cambridge, MA 02139 USA	University of Wisconsin System; University of Wisconsin Madison; Massachusetts Institute of Technology (MIT)	Pfleger, BF (corresponding author), Univ Wisconsin, Madison, WI 53705 USA.	pfleger@engr.wisc.edu; kljp@mit.edu	Pfleger, Brian Frederick/AAA-2559-2022	Pfleger, Brian Frederick/0000-0002-9232-9959; Prather, Kristala/0000-0003-0437-3157				Alper H, 2009, NAT REV MICROBIOL, V7, P715, DOI 10.1038/nrmicro2186; DeLoache WC, 2015, NAT CHEM BIOL, V11, P465, DOI 10.1038/nchembio.1816; Ehrenberg R, 2015, NATURE, V521, P267, DOI 10.1038/251267a; Fossati E, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0124459; Galanie S, 2015, SCIENCE, V349, P1095, DOI 10.1126/science.aac9373; Hsu PD, 2014, CELL, V157, P1262, DOI 10.1016/j.cell.2014.05.010; National Rearch Council, IND BIOL ROADM ACC A; Thodey K, 2014, NAT CHEM BIOL, V10, P837, DOI [10.1038/NCHEMBIO.1613, 10.1038/nchembio.1613]; Yim H, 2011, NAT CHEM BIOL, V7, P445, DOI [10.1038/NCHEMBIO.580, 10.1038/nchembio.580]	9	9	9	0	16	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1087-0156	1546-1696		NAT BIOTECHNOL	Nat. Biotechnol.	NOV	2015	33	11					1148	1149		10.1038/nbt.3399	http://dx.doi.org/10.1038/nbt.3399			3	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	CW3TY	26544145				2022-12-27	WOS:000364916000018
J	Kyung, T; Lee, S; Kim, JE; Cho, T; Park, H; Jeong, YM; Kim, D; Shin, A; Kim, S; Baek, J; Kim, J; Kim, NY; Woo, D; Chae, S; Kim, CH; Shin, HS; Han, YM; Kim, D; Heo, WD				Kyung, Taeyoon; Lee, Sangkyu; Kim, Jung Eun; Cho, Taesup; Park, Hyerim; Jeong, Yun-Mi; Kim, Dongkyu; Shin, Anna; Kim, Sungsoo; Baek, Jinhee; Kim, Jihoon; Kim, Na Yeon; Woo, Doyeon; Chae, Sujin; Kim, Cheol-Hee; Shin, Hee-Sup; Han, Yong-Mahn; Kim, Daesoo; Heo, Won Do			Optogenetic control of endogenous Ca2+ channels in vivo	NATURE BIOTECHNOLOGY			English	Article							CRAC CHANNELS; NEURONAL-ACTIVITY; BLUE-LIGHT; STEM-CELLS; PROTEIN; CALCIUM; STIM1; SIGNALS; TRANSCRIPTION; ACTIVATION	Calcium (Ca2+) signals that are precisely modulated in space and time mediate a myriad of cellular processes, including contraction, excitation, growth, differentiation and apoptosis(1). However, study of Ca2+ responses has been hampered by technological limitations of existing Ca2+-modulating tools. Here we present OptoSTIM1, an optogenetic tool for manipulating intracellular Ca2+ levels through activation of Ca2+-selective endogenous Ca2+ release-activated Ca2+ (CRAC) channels. Using OptoSTIM1, which combines a plant photoreceptor(2,3) and the CRAC channel regulator STIM1 (ref. 4), we quantitatively and qualitatively controlled intracellular Ca2+ levels in various biological systems, including zebrafish embryos and human embryonic stem cells. We demonstrate that activating OptoSTIM1 in the CA1 hippocampal region of mice selectively reinforced contextual memory formation. The broad utility of OptoSTIM1 will expand our mechanistic understanding of numerous Ca2+-associated processes and facilitate screening for drug candidates that antagonize Ca2+ signals.	[Kyung, Taeyoon; Kim, Jung Eun; Park, Hyerim; Kim, Dongkyu; Shin, Anna; Kim, Sungsoo; Kim, Jihoon; Kim, Na Yeon; Woo, Doyeon; Han, Yong-Mahn; Kim, Daesoo; Heo, Won Do] Korea Adv Inst Sci & Technol, Dept Biol Sci, Daejeon, South Korea; [Lee, Sangkyu; Cho, Taesup; Baek, Jinhee; Shin, Hee-Sup; Heo, Won Do] Inst for Basic Sci Korea, Ctr Cognit & Social, Daejeon, South Korea; [Jeong, Yun-Mi; Kim, Cheol-Hee] Chungnam Natl Univ, Dept Biol, Daejeon, South Korea; [Baek, Jinhee; Shin, Hee-Sup] Korea Adv Inst Sci & Technol, Dept Bio & Brain Engn, Daejeon, South Korea; [Chae, Sujin; Heo, Won Do] Korea Adv Inst Sci & Technol, KAIST Inst BioCentury, Daejeon, South Korea; [Heo, Won Do] Korea Adv Inst Sci & Technol, KAIST Inst BioCentury, Canc Metastasis Control Ctr, Daejeon, South Korea	Korea Advanced Institute of Science & Technology (KAIST); Institute for Basic Science - Korea (IBS); Chungnam National University; Korea Advanced Institute of Science & Technology (KAIST); Korea Advanced Institute of Science & Technology (KAIST); Korea Advanced Institute of Science & Technology (KAIST)	Han, YM (corresponding author), Korea Adv Inst Sci & Technol, Dept Biol Sci, Daejeon, South Korea.	ymhan57@kaist.ac.kr; daesoo@kaist.ac.kr; wondo@kaist.ac.kr	Kim, Daesoo/C-1625-2011; Heo, Won-Do/C-1696-2011; Han, Yong-Mahn/C-1652-2011	Kim, Daesoo/0000-0001-9915-1463; Baek, Jinhee/0000-0002-0998-0047; KIM, SUNGSOO/0000-0003-0949-4214; Kim, Cheol-Hee/0000-0002-3019-0699; Lee, Sangkyu/0000-0002-6916-3372	Institute for Basic Science [IBS-R001-G1]; NRF Stem Cell Program - MSIP, KAIST Institute for the BioCentury [2011-0019509]; National Leading Research Laboratory Program - Ministry of Science, ICT and Future Planning, Republic of Korea [2011-0028772]	Institute for Basic Science; NRF Stem Cell Program - MSIP, KAIST Institute for the BioCentury; National Leading Research Laboratory Program - Ministry of Science, ICT and Future Planning, Republic of Korea	We thank C.L. Tucker (University of Colorado) for cDNA encoding CRY2PHR-mCherry, T.Inoue (Johns Hopkins University) for cDNA encoding Tom20-FRB, P. Gardner (Stanford University) for cDNA encoding NFATc1-GFP, D.Lee for fruitful discussions and N.Kim for advice on data analysis. This work was supported by the Institute for Basic Science (IBS-R001-G1), the NRF Stem Cell Program (2011-0019509) funded by MSIP, KAIST Institute for the BioCentury, and the National Leading Research Laboratory Program by the Ministry of Science, ICT and Future Planning (2011-0028772 to Daesoo K.), Republic of Korea.	Apati A, 2012, MOL CELL ENDOCRINOL, V353, P57, DOI 10.1016/j.mce.2011.08.038; Berridge MJ, 2000, NAT REV MOL CELL BIO, V1, P11, DOI 10.1038/35036035; Bugaj LJ, 2013, NAT METHODS, V10, P249, DOI 10.1038/nmeth.2360; Chin-Smith EC, 2014, FRONT PHYSIOL, V5, DOI 10.3389/fphys.2014.00169; Ellis-Davies GCR, 2007, NAT METHODS, V4, P619, DOI 10.1038/NMETH1072; Fenno L, 2011, ANNU REV NEUROSCI, V34, P389, DOI 10.1146/annurev-neuro-061010-113817; Fukuda N, 2014, ACS CHEM BIOL, V9, P1197, DOI 10.1021/cb400849n; Goshen I, 2011, CELL, V147, P678, DOI 10.1016/j.cell.2011.09.033; Grigoriev I, 2008, CURR BIOL, V18, P177, DOI 10.1016/j.cub.2007.12.050; Gunaydin LA, 2010, NAT NEUROSCI, V13, P387, DOI 10.1038/nn.2495; Hooper R, 2014, SCI SIGNAL, V7, DOI 10.1126/scisignal.2005556; Hoover PJ, 2011, P NATL ACAD SCI USA, V108, P13299, DOI 10.1073/pnas.1101664108; Kaech S, 2006, NAT PROTOC, V1, P2406, DOI 10.1038/nprot.2006.356; Kennedy MJ, 2010, NAT METHODS, V7, P973, DOI 10.1038/NMETH.1524; Kim N, 2014, CHEM BIOL, V21, P903, DOI 10.1016/j.chembiol.2014.05.013; Komatsu T, 2010, NAT METHODS, V7, P206, DOI [10.1038/nmeth.1428, 10.1038/NMETH.1428]; Korzeniowski MK, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.2001122; LeDoux JE, 2000, ANNU REV NEUROSCI, V23, P155, DOI 10.1146/annurev.neuro.23.1.155; Lee S, 2014, NAT METHODS, V11, P633, DOI [10.1038/nmeth.2940, 10.1038/NMETH.2940]; Liu HT, 2008, SCIENCE, V322, P1535, DOI 10.1126/science.1163927; McNally BA, 2012, NATURE, V482, P241, DOI 10.1038/nature10752; Muto A, 2013, CURR BIOL, V23, P307, DOI 10.1016/j.cub.2012.12.040; Parekh AB, 2010, NAT REV DRUG DISCOV, V9, P399, DOI 10.1038/nrd3136; Park CY, 2009, CELL, V136, P876, DOI 10.1016/j.cell.2009.02.014; Pham E, 2011, CHEM BIOL, V18, P880, DOI 10.1016/j.chembiol.2011.04.014; Prakriya M, 2006, NATURE, V443, P230, DOI 10.1038/nature05122; Prevarskaya N, 2011, NAT REV CANCER, V11, P609, DOI 10.1038/nrc3105; Riedl J, 2008, NAT METHODS, V5, P605, DOI 10.1038/nmeth.1220; Rothbauer U, 2006, NAT METHODS, V3, P887, DOI 10.1038/NMETH953; Schmittgen TD, 2008, NAT PROTOC, V3, P1101, DOI 10.1038/nprot.2008.73; Shcherbakova DM, 2013, NAT METHODS, V10, P751, DOI 10.1038/nmeth.2521; Soboloff J, 2012, NAT REV MOL CELL BIO, V13, P549, DOI 10.1038/nrm3414; Taslimi A, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5925; Tomida T, 2003, EMBO J, V22, P3825, DOI 10.1093/emboj/cdg381; Tsutajima J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0083129; Vig M, 2006, CURR BIOL, V16, P2073, DOI 10.1016/j.cub.2006.08.085; West AE, 2002, NAT REV NEUROSCI, V3, P921, DOI 10.1038/nrn987; Wong RCB, 2004, STEM CELLS, V22, P883, DOI 10.1634/stemcells.22-6-883; Zhang F, 2007, NATURE, V446, P633, DOI 10.1038/nature05744; Zhao YX, 2011, SCIENCE, V333, P1888, DOI 10.1126/science.1208592	40	106	110	1	41	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156	1546-1696		NAT BIOTECHNOL	Nat. Biotechnol.	OCT	2015	33	10					1092	+		10.1038/nbt.3350	http://dx.doi.org/10.1038/nbt.3350			8	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	CT1JX	26368050				2022-12-27	WOS:000362555700030
J	Parthasarathy, H; Fishburne, L				Parthasarathy, Hemai; Fishburne, Lindy			Philanthropy's role in translating scientific innovation	NATURE BIOTECHNOLOGY			English	Editorial Material								How can nonprofit funders help launch your biotech startup?	[Parthasarathy, Hemai; Fishburne, Lindy] Breakout Labs, San Francisco, CA 94129 USA		Parthasarathy, H (corresponding author), Breakout Labs, San Francisco, CA 94129 USA.	hemai@thielfoundation.org						Kearney S., 2014, STANFORD SOC INN FAL; Pfeiffer S, 2015, BOSTON GLOBE; Risser D., 2014, BLOOMBERG BUSIN 1119; Van Noorden R., NATURE	4	4	4	0	10	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156	1546-1696		NAT BIOTECHNOL	Nat. Biotechnol.	OCT	2015	33	10					1022	+		10.1038/nbt.3369	http://dx.doi.org/10.1038/nbt.3369			5	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	CT1JX	26448079				2022-12-27	WOS:000362555700014
J	DeFrancesco, L				DeFrancesco, Laura			To share is human	NATURE BIOTECHNOLOGY			English	Editorial Material																		2008, SCIENCE, V322, P44; 2008, NATURE, V452, P872; 2015, NAT BIOT, V33, P675	3	3	3	0	0	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156	1546-1696		NAT BIOTECHNOL	Nat. Biotechnol.	AUG	2015	33	8					796	800		10.1038/nbt.3309	http://dx.doi.org/10.1038/nbt.3309			5	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	CO6OB	26252130				2022-12-27	WOS:000359274900008
J	Morrison, C; Lahteenmaki, R				Morrison, Chris; Lahteenmaki, Riku			Public biotech in 2014-the numbers	NATURE BIOTECHNOLOGY			English	Article																			0	10	10	0	6	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156	1546-1696		NAT BIOTECHNOL	Nat. Biotechnol.	JUL	2015	33	7					703	709		10.1038/nbt.3278	http://dx.doi.org/10.1038/nbt.3278			7	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	CN4JJ	26154007				2022-12-27	WOS:000358396100021
J	Wong, SCK; Sasportas, LS; Richardson, K; Gordon, BR; Jayatunga, MKP; Shalizi, A; Pfister, SX; Stanzl, EG; Chui, C; Mathur, M; Thomsen, SK; Shetty, C; Pliuskys, L; Mehra, A; Bahar, H; Godec, J; Jong, S; Perez, DA				Wong, Sybil C. K.; Sasportas, Laura S.; Richardson, Katie; Gordon, Brian R.; Jayatunga, Madura K. P.; Shalizi, Aryaman; Pfister, Sophia X.; Stanzl, Erika G.; Chui, Cecilia; Mathur, Melina; Thomsen, Soren K.; Shetty, Charvi; Pliuskys, Laurynas; Mehra, Akhil; Bahar, Hila; Godec, Jernej; Jong, Simcha; Perez, Daniel A.			Keys to the kingdom	NATURE BIOTECHNOLOGY			English	Editorial Material									[Wong, Sybil C. K.; Perez, Daniel A.] Oxbridge Biotech Roundtable, London, England; [Sasportas, Laura S.; Mathur, Melina] Stanford Univ, Dept Bioengn, Stanford, CA 94305 USA; [Sasportas, Laura S.] Stanford Univ, Dept Radiol, Stanford, CA 94305 USA; [Richardson, Katie] Univ Oxford, Dept Physiol Anat & Genet, Oxford, England; [Gordon, Brian R.] BRGordon Partners, San Francisco, CA USA; [Jayatunga, Madura K. P.] Univ Oxford, Dept Organ Chem, Chem Res Lab, Oxford, England; [Shalizi, Aryaman] Stanford Univ, Dept Pathol, Stanford, CA 94305 USA; [Pfister, Sophia X.] CRUK MRC Oxford Inst Radiat Oncol, Oxford, England; [Stanzl, Erika G.] Stanford Univ, Dept Chem, Stanford, CA 94305 USA; [Chui, Cecilia] Univ Oxford, Oxford, England; [Thomsen, Soren K.] Univ Oxford, Oxford Ctr Diabet Endocrinol & Metab, Oxford, England; [Shetty, Charvi] KNOX Med Diagnost Inc, San Francisco, CA USA; [Pliuskys, Laurynas] Univ Oxford, Doctoral Training Ctr, Oxford, England; [Mehra, Akhil] Univ Calif San Francisco, Dept Anthropol Hist & Social Med, San Francisco, CA 94143 USA; [Bahar, Hila] Massachusetts Gen Hosp, Endocrine Unit, Boston, MA 02114 USA; [Bahar, Hila] Harvard Univ, Sch Med, Boston, MA USA; [Godec, Jernej] Dana Farber Canc Inst, Dept Pediat Oncol, Boston, MA 02115 USA; [Godec, Jernej] Harvard Univ, Sch Med, Dept Microbiol & Immunol, Boston, MA USA; [Jong, Simcha] UCL, Dept Management Sci & Innovat, London, England; [Perez, Daniel A.] Univ Oxford, Dept Biochem, Glycobiol Inst, Oxford OX1 3QU, England	Stanford University; Stanford University; University of Oxford; University of Oxford; Stanford University; Stanford University; University of Oxford; University of Oxford; University of Oxford; University of California System; University of California San Francisco; Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; Harvard University; Dana-Farber Cancer Institute; Harvard University; Harvard Medical School; University of London; University College London; University of Oxford	Wong, SCK (corresponding author), Oxbridge Biotech Roundtable, London, England.	dan@oxbridgebiotech.com		Jong, Simcha/0000-0002-3281-5381; Wong, Sybil/0000-0001-5238-2109; Shalizi, Aryaman/0000-0001-9226-0800; Thomsen, Soren Krogsgaard/0000-0001-8894-2868				Decter M, 2007, TECHNOVATION, V27, P145, DOI 10.1016/j.technovation.2006.02.001; Gavetti G, 2012, ORGAN SCI, V23, P267, DOI 10.1287/orsc.1110.0644; Huggett B., 2014, NAT BIOTECHNOL, V32, P1085; Jain S, 2009, RES POLICY, V38, P922, DOI 10.1016/j.respol.2009.02.007; Teece DJ, 2007, STRATEGIC MANAGE J, V28, P1319, DOI 10.1002/smj.640; Williams E., 2005, TOO FEW U SPIN OUT C	6	2	2	0	7	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156	1546-1696		NAT BIOTECHNOL	Nat. Biotechnol.	MAR	2015	33	3					232	236		10.1038/nbt.3159	http://dx.doi.org/10.1038/nbt.3159			5	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	CD0ME	25748908	Bronze			2022-12-27	WOS:000350766900013
J	Henry, BD; Neill, DR; Becker, KA; Gore, S; Bricio-Moreno, L; Ziobro, R; Edwards, MJ; Muhlemann, K; Steinmann, J; Kleuser, B; Japtok, L; Luginbuhl, M; Wolfmeier, H; Scherag, A; Gulbins, E; Kadioglu, A; Draeger, A; Babiychuk, EB				Henry, Brian D.; Neill, Daniel R.; Becker, Katrin Anne; Gore, Suzanna; Bricio-Moreno, Laura; Ziobro, Regan; Edwards, Michael J.; Muehlemann, Kathrin; Steinmann, Joerg; Kleuser, Burkhard; Japtok, Lukasz; Luginbuehl, Miriam; Wolfmeier, Heidi; Scherag, Andre; Gulbins, Erich; Kadioglu, Aras; Draeger, Annette; Babiychuk, Eduard B.			Engineered liposomes sequester bacterial exotoxins and protect from severe invasive infections in mice	NATURE BIOTECHNOLOGY			English	Article							PORE-FORMING TOXINS; ANTIBIOTIC-RESISTANCE; CHOLESTEROL; VIRULENCE; PNEUMOLYSIN; SPHINGOLIPIDS; DYNAMICS; SEPSIS; FAMILY; RAFTS	Gram-positive bacterial pathogens that secrete cytotoxic pore-forming toxins, such as Staphylococcus aureus and Streptococcus pneumoniae, cause a substantial burden of disease. Inspired by the principles that govern natural toxin-host interactions, we have engineered artificial liposomes that are tailored to effectively compete with host cells for toxin binding. Liposome-bound toxins are unable to lyse mammalian cells in vitro. We use these artificial liposomes as decoy targets to sequester bacterial toxins that are produced during active infection in vivo. Administration of artificial liposomes within 10 h after infection rescues mice from septicemia caused by S. aureus and S. pneumoniae, whereas untreated mice die within 24-33 h. Furthermore, liposomes protect mice against invasive pneumococcal pneumonia. Composed exclusively of naturally occurring lipids, tailored liposomes are not bactericidal and could be used therapeutically either alone or in conjunction with antibiotics to combat bacterial infections and to minimize toxin-induced tissue damage that occurs during bacterial clearance. npg (C) 2015 Nature America, Inc. All rights reserved.	[Henry, Brian D.; Becker, Katrin Anne; Ziobro, Regan; Gulbins, Erich] Univ Duisburg Essen, Inst Mol Biol, Essen, Germany; [Henry, Brian D.; Ziobro, Regan; Edwards, Michael J.; Gulbins, Erich] Univ Cincinnati, Dept Surg, Cincinnati, OH 45267 USA; [Neill, Daniel R.; Gore, Suzanna; Bricio-Moreno, Laura; Kadioglu, Aras] Univ Liverpool, Inst Infect & Global Hlth, Dept Clin Infect Microbiol & Immunol, Liverpool L69 3BX, Merseyside, England; [Muehlemann, Kathrin] Univ Bern, Inst Infect Dis, Bern, Switzerland; [Steinmann, Joerg] Univ Duisburg Essen, Inst Med Microbiol, Essen, Germany; [Kleuser, Burkhard; Japtok, Lukasz] Univ Potsdam, Inst Nutr Sci, Dept Toxicol, Potsdam, Germany; [Luginbuehl, Miriam; Wolfmeier, Heidi; Draeger, Annette; Babiychuk, Eduard B.] Univ Bern, Inst Anat, Bern, Switzerland; [Scherag, Andre] Jena Univ Hosp, CSCC, Clin Epidemiol Integrated Res & Treatment Ctr, Jena, Germany	University of Duisburg Essen; University System of Ohio; University of Cincinnati; University of Liverpool; University of Bern; University of Duisburg Essen; University of Potsdam; University of Bern; Friedrich Schiller University of Jena	Babiychuk, EB (corresponding author), Univ Bern, Inst Anat, Bern, Switzerland.	edik@ana.unibe.ch	Bricio-Moreno, Laura/AAD-2781-2019; Neill, Daniel/Q-6290-2019; Babiychuk, Eduard/AAV-7223-2021	Neill, Daniel/0000-0002-7911-8153; Bricio Moreno, Laura/0000-0002-4956-7142; Scherag, Andre/0000-0002-9406-4704; Wolfmeier, Heidi/0000-0003-2474-3717; Babiychuk, Eduard/0000-0003-1786-0085; kadioglu, aras/0000-0003-1137-6321; Lim, Suzanna/0000-0002-1753-1954; Kleuser, Burkhard/0000-0002-1888-9595	University of Bern, Commission for Technology and Innovation (CTI) [16001.1 PFLS-LS]; Deutsche Forschungsgemeinschaft (DFG) [GU 335/16-2, SFB 1112]; Federal Ministry of Education and Research (BMBF) (FKZ) [01EO1002]; Institute of Infection & Global Health, University of Liverpool; MRC [MC_PC_13068] Funding Source: UKRI; Medical Research Council [MC_PC_13068] Funding Source: researchfish	University of Bern, Commission for Technology and Innovation (CTI); Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG)); Federal Ministry of Education and Research (BMBF) (FKZ); Institute of Infection & Global Health, University of Liverpool; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	We gratefully acknowledge the financial support of the University of Bern, Commission for Technology and Innovation (CTI) (16001.1 PFLS-LS to A.D. and E.B.B.), Deutsche Forschungsgemeinschaft (DFG GU 335/16-2 to E.G. and SFB 1112 to B.K.), Federal Ministry of Education and Research (BMBF) (FKZ: 01EO1002 to A.S.) and the Institute of Infection & Global Health, University of Liverpool to A.K.	Alksne LE, 2000, CURR OPIN BIOTECH, V11, P625, DOI 10.1016/S0958-1669(00)00155-5; Allen RC, 2014, NAT REV MICROBIOL, V12, P300, DOI 10.1038/nrmicro3232; Babiychuk EB, 2009, CELL DEATH DIFFER, V16, P1126, DOI 10.1038/cdd.2009.30; Bakker-Woudenberg IAJM, 2001, ANTIMICROB AGENTS CH, V45, P1487, DOI 10.1128/AAC.45.5.1487-1492.2001; BRISSEAU GF, 1994, ANTIMICROB AGENTS CH, V38, P2671, DOI 10.1128/AAC.38.11.2671; BROWN DA, 1992, CELL, V68, P533, DOI 10.1016/0092-8674(92)90189-J; Bush K, 2011, NAT REV MICROBIOL, V9, P894, DOI 10.1038/nrmicro2693; Clinical and Laboratory Standards Institute, 2009, M07A8 CLSI; Dietschy JM, 2004, J LIPID RES, V45, P1375, DOI 10.1194/jlr.R400004-JLR200; Drulis-Kawa Z, 2010, INT J PHARMACEUT, V387, P187, DOI 10.1016/j.ijpharm.2009.11.033; Gonzalez MR, 2008, CELL MOL LIFE SCI, V65, P493, DOI 10.1007/s00018-007-7434-y; Harder T, 1997, CURR OPIN CELL BIOL, V9, P534, DOI 10.1016/S0955-0674(97)80030-0; Huang JY, 1999, BBA-BIOMEMBRANES, V1417, P89, DOI 10.1016/S0005-2736(98)00260-0; Huttunen R, 2011, J INFECTION, V63, P407, DOI 10.1016/j.jinf.2011.08.004; Ikonen E, 2008, NAT REV MOL CELL BIO, V9, P125, DOI 10.1038/nrm2336; Kadioglu A, 2008, NAT REV MICROBIOL, V6, P288, DOI 10.1038/nrmicro1871; Klose C, 2010, J BIOL CHEM, V285, P30224, DOI 10.1074/jbc.M110.123554; Linhartova I, 2010, FEMS MICROBIOL REV, V34, P1076, DOI 10.1111/j.1574-6976.2010.00231.x; McNeela EA, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001191; Merrill AH, 2005, METHODS, V36, P207, DOI 10.1016/j.ymeth.2005.01.009; Mesmin B, 2009, BBA-MOL CELL BIOL L, V1791, P636, DOI 10.1016/j.bbalip.2009.03.002; Moore CL, 2011, ANTIMICROB AGENTS CH, V55, P4581, DOI 10.1128/AAC.00115-11; MORTON DB, 1985, NATURE, V317, P106, DOI 10.1038/317106a0; Olsen I, 2001, ANAEROBE, V7, P103, DOI 10.1006/anae.2001.0376; Parker MW, 2005, PROG BIOPHYS MOL BIO, V88, P91, DOI 10.1016/j.pbiomolbio.2004.01.009; Rittirsch D, 2008, NAT REV IMMUNOL, V8, P776, DOI 10.1038/nri2402; SHAH H, 2011, NATL J PHYSL PHARM P, V1, P35, DOI DOI 10.4103/0976; Simons K, 1997, NATURE, V387, P569, DOI 10.1038/42408; Simons K, 2010, NAT REV MOL CELL BIO, V11, P688, DOI 10.1038/nrm2977; Spreer A, 2003, ANTIMICROB AGENTS CH, V47, P2649, DOI 10.1128/AAC.47.8.2649-2654.2003; Stefani S, 2010, INT J INFECT DIS, V14, pS19, DOI 10.1016/j.ijid.2010.05.009; Stringaris AK, 2002, NEUROBIOL DIS, V11, P355, DOI 10.1006/nbdi.2002.0561; Timmer AM, 2009, J BIOL CHEM, V284, P862, DOI 10.1074/jbc.M804632200; TITBALL RW, 1993, MICROBIOL REV, V57, P347, DOI 10.1128/MMBR.57.2.347-366.1993; Tweten RK, 2005, INFECT IMMUN, V73, P6199, DOI 10.1128/IAI.73.10.6199-6209.2005; Valeva A, 2006, J BIOL CHEM, V281, P26014, DOI 10.1074/jbc.M601960200; Wall EC, 2012, CLIN INFECT DIS, V54, P701, DOI 10.1093/cid/cir926; Wardenburg JB, 2007, NAT MED, V13, P1405, DOI 10.1038/nm1207-1405	38	139	142	3	118	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156	1546-1696		NAT BIOTECHNOL	Nat. Biotechnol.	JAN	2015	33	1					81	U295		10.1038/nbt.3037	http://dx.doi.org/10.1038/nbt.3037			11	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	AY7AR	25362245				2022-12-27	WOS:000347714200031
J	Stephan, SB; Taber, AM; Jileaeva, I; Pegues, EP; Sentman, CL; Stephan, MT				Stephan, Sirkka B.; Taber, Alexandria M.; Jileaeva, Ilona; Pegues, Ericka P.; Sentman, Charles L.; Stephan, Matthias T.			Biopolymer implants enhance the efficacy of adoptive T-cell therapy	NATURE BIOTECHNOLOGY			English	Article							PHASE-I; IMMUNOTHERAPY; VIVO; SUPERAGONIST; RECEPTOR; PATIENT; IL-15	Although adoptive T-cell therapy holds promise for the treatment of many cancers, its clinical utility has been limited by problems in delivering targeted lymphocytes to tumor sites, and the cells' inefficient expansion in the immunosuppressive tumor microenvironment. Here we describe a bioactive polymer implant capable of delivering, expanding and dispersing tumor-reactive T cells. The approach can be used to treat inoperable or incompletely removed tumors by situating implants near them or at resection sites. Using a mouse breast cancer resection model, we show that the implants effectively support tumor-targeting T cells throughout resection beds and associated lymph nodes, and reduce tumor relapse compared to conventional delivery modalities. In a multifocal ovarian cancer model, we demonstrate that polymer-delivered T cells trigger regression, whereas injected tumor-reactive lymphocytes have little curative effect. Scaffold-based T-cell delivery may provide a viable treatment option for inoperable tumors and reduce the rate of metastatic relapse after surgery. npg (C) 2015 Nature America, Inc. All rights reserved.	[Stephan, Sirkka B.; Taber, Alexandria M.; Stephan, Matthias T.] Fred Hutchinson Canc Res Ctr, Div Clin Res, Seattle, WA 98104 USA; [Jileaeva, Ilona; Pegues, Ericka P.; Stephan, Matthias T.] Fred Hutchinson Canc Res Ctr, Technol Access Fdn TAF Acad, Seattle, WA 98104 USA; [Sentman, Charles L.] Geisel Sch Med Dartmouth, Dept Microbiol & Immunol, Lebanon, NH USA; [Stephan, Matthias T.] Univ Washington, Dept Bioengn & Mol Engn, Seattle, WA 98195 USA; [Stephan, Matthias T.] Univ Washington, Inst Sci, Seattle, WA 98195 USA; [Stephan, Matthias T.] Univ Washington, Dept Med, Div Med Oncol, Seattle, WA 98195 USA	Fred Hutchinson Cancer Center; Fred Hutchinson Cancer Center; Dartmouth College; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle	Stephan, MT (corresponding author), Fred Hutchinson Canc Res Ctr, Div Clin Res, 1124 Columbia St, Seattle, WA 98104 USA.	mstephan@fhcrc.org		Stephan, Matthias/0000-0001-8310-0100; Taber, Alexandria/0000-0002-9510-3517	Bezos Family Foundation; NATIONAL CANCER INSTITUTE [P50CA138293, P50CA083636, R01CA181413] Funding Source: NIH RePORTER	Bezos Family Foundation; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We thank D. Ehlert (cognitionstudio. com) for the design of the illustration in Figure 1. This work was supported in part by the Fred Hutchinson Cancer Research Center's Immunotherapy Initiative with funds provided by the Bezos Family Foundation, the National Cancer Institute (NCI; RO1 CA181413), the George and Margaret McLane Foundation, the Breast Cancer Development Research Program funded by the Safeway Foundation and the Seattle Cancer Consortium Breast SPORE (NCI P50 CA138293, PI: Peggy Porter) and the Pacific Ovarian Cancer Research Consortium (NCI P50 CA83636, PI: Nicole Urban). We thank K. Roby (University of Kansas Medical Center, Kansas City, KS, USA) for giving us the murine ovarian cancer cell line ID8. SFG-CBR-luc (expressing click beetle red luciferase), SFG-F-luc (expressing firefly luciferase), and SFG-B7.1 and SFG-4-1BBL (encoding the costimulatory ligands B7.1 and 4-1BBL) vectors were kindly provided by M. Sadelain (Memorial Sloan-Kettering Cancer Center, New York).	Ali OA, 2009, SCI TRANSL MED, V1, DOI 10.1126/scitranslmed.3000359; Baldwin AD, 2010, BIOPOLYMERS, V94, P128, DOI 10.1002/bip.21334; Boontheekul T, 2005, BIOMATERIALS, V26, P2455, DOI 10.1016/j.biomaterials.2004.06.044; Charles KA, 2009, J CLIN INVEST, V119, P3011, DOI 10.1172/JCI39065; Conejo-Garcia JR, 2004, NAT MED, V10, P950, DOI 10.1038/nm1097; Erskine CL, 2012, JOVE-J VIS EXP, DOI 10.3791/3683; Hinrichs CS, 2014, AM J CLIN ONCOL-CANC, V32, P3008, DOI DOI 10.1200/JCO.2014.32.18_SUPPL.LBA3008; Hori Y, 2008, BIOMATERIALS, V29, P3671, DOI 10.1016/j.biomaterials.2008.05.033; Janat-Amsbury MM, 2006, ANTICANCER RES, V26, P2785; Kandalaft LE, 2012, J TRANSL MED, V10, DOI 10.1186/1479-5876-10-157; Kauer TM, 2012, NAT NEUROSCI, V15, P197, DOI 10.1038/nn.3019; Kershaw MH, 2006, CLIN CANCER RES, V12, P6106, DOI 10.1158/1078-0432.CCR-06-1183; Krebs S, 2013, FRONT ONCOL, V3, DOI 10.3389/fonc.2013.00322; Lamers CHJ, 2013, MOL THER, V21, P904, DOI 10.1038/mt.2013.17; Mamaeva V, 2013, ADV DRUG DELIVER REV, V65, P689, DOI 10.1016/j.addr.2012.07.018; Maus MV, 2002, NAT BIOTECHNOL, V20, P143, DOI 10.1038/nbt0202-143; Miller MJ, 2003, P NATL ACAD SCI USA, V100, P2604, DOI 10.1073/pnas.2628040100; Peres E, 2008, NEUROPEDIATRICS, V39, P151, DOI 10.1055/s-0028-1093333; Pule MA, 2008, NAT MED, V14, P1264, DOI 10.1038/nm.1882; Robbins PF, 2011, J CLIN ONCOL, V29, P917, DOI 10.1200/JCO.2010.32.2537; Rosenberg SA, 2011, NAT REV CLIN ONCOL, V8, P577, DOI 10.1038/nrclinonc.2011.116; Rosenberg SA, 2011, CLIN CANCER RES, V17, P4550, DOI 10.1158/1078-0432.CCR-11-0116; Rubinstein MP, 2006, P NATL ACAD SCI USA, V103, P9166, DOI 10.1073/pnas.0600240103; Scarlett UK, 2012, J EXP MED, V209, P495, DOI 10.1084/jem.20111413; Sentman CL, 2014, CANCER J, V20, P156, DOI 10.1097/PPO.0000000000000029; Stone JD, 2012, BIOTECHNOL PROGR, V28, P1588, DOI 10.1002/btpr.1631; Tran E, 2014, SCIENCE, V344, P641, DOI 10.1126/science.1251102; Tumeh PC, 2010, J IMMUNOTHER, V33, P759, DOI 10.1097/CJI.0b013e3181f1d644; Wojtowicz AM, 2010, BIOMATERIALS, V31, P2574, DOI 10.1016/j.biomaterials.2009.12.008; Yaghoubi SS, 2009, NAT CLIN PRACT ONCOL, V6, P53, DOI 10.1038/ncponc1278	30	244	264	9	157	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156	1546-1696		NAT BIOTECHNOL	Nat. Biotechnol.	JAN	2015	33	1					97	U277		10.1038/nbt.3104	http://dx.doi.org/10.1038/nbt.3104			7	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	AY7AR	25503382	Green Accepted			2022-12-27	WOS:000347714200033
J	Som, A; Charanya, T; Linderman, SW; Siegel, JS				Som, Avik; Charanya, Tauseef; Linderman, Stephen W.; Siegel, Joshua S.			Bridging the gap between invention and commercialization in medical devices	NATURE BIOTECHNOLOGY			English	Editorial Material									[Som, Avik] Washington Univ, Mallinckrodt Inst Radiol, Dept Biomed Engn, Med Scientist Training Program, St Louis, MO 63130 USA; [Charanya, Tauseef] Washington Univ, Mallinckrodt Inst Radiol, Dept Biomed Engn, St Louis, MO USA; [Linderman, Stephen W.] Washington Univ, Dept Orthoped Surg, Dept Biomed Engn, Med Scientist Training Program, St Louis, MO USA; [Siegel, Joshua S.] Washington Univ, Dept Neurol, Med Scientist Training Program, St Louis, MO USA	Washington University (WUSTL); Washington University (WUSTL); Washington University (WUSTL); Washington University (WUSTL)	Som, A (corresponding author), Washington Univ, Mallinckrodt Inst Radiol, Dept Biomed Engn, Med Scientist Training Program, St Louis, MO 63130 USA.	soma@wustl.edu	Linderman, Stephen/GQB-4770-2022	Linderman, Stephen/0000-0002-1797-5870; Siegel, Joshua/0000-0002-5752-3641	NATIONAL CANCER INSTITUTE [F30CA189435] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [T32AR060719] Funding Source: NIH RePORTER; NCI NIH HHS [F30 CA189435] Funding Source: Medline; NIAMS NIH HHS [T32 AR060719] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIAMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))		Ledford H, 2013, NATURE, V501, P471, DOI 10.1038/501471a; Leuthardt EC, 2013, NEUROSURGERY, V72, pA182, DOI 10.1227/NEU.0b013e318270cfec; Morris ZS, 2011, J ROY SOC MED, V104, P510, DOI 10.1258/jrsm.2011.110180; Schillebeeckx M, 2013, NAT BIOTECHNOL, V31, P938, DOI 10.1038/nbt.2706; Tilghman S., 2012, BIOMEDICAL RES WORKF; Yazdi Y, 2013, ANN BIOMED ENG, V41, P1822, DOI 10.1007/s10439-013-0869-4; Yock PG, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3002222	7	7	7	1	9	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156	1546-1696		NAT BIOTECHNOL	Nat. Biotechnol.	OCT	2014	32	10					1063	1065		10.1038/nbt.3041	http://dx.doi.org/10.1038/nbt.3041			3	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	AR7MM	25299924	Green Accepted			2022-12-27	WOS:000343763800025
J	Streets, AM; Huang, YY				Streets, Aaron M.; Huang, Yanyi			How deep is enough in single-cell RNA-seq?	NATURE BIOTECHNOLOGY			English	Editorial Material							TRANSCRIPTOME; NOISE		[Streets, Aaron M.; Huang, Yanyi] Peking Univ, Biodynam Opt Imaging Ctr BIOPIC, Beijing 100871, Peoples R China; [Streets, Aaron M.; Huang, Yanyi] Peking Univ, Coll Engn, Beijing 100871, Peoples R China	Peking University; Peking University	Streets, AM (corresponding author), Peking Univ, Biodynam Opt Imaging Ctr BIOPIC, Beijing 100871, Peoples R China.	yanyi@pku.edu.cn	Huang, Yanyi/D-1832-2009	Huang, Yanyi/0000-0002-7297-1266				Brennecke P, 2013, NAT METHODS, V10, P1093, DOI [10.1038/nmeth.2645, 10.1038/NMETH.2645]; Grun D, 2014, NAT METHODS, V11, P637, DOI [10.1038/NMETH.2930, 10.1038/nmeth.2930]; Islam S, 2014, NAT METHODS, V11, P163, DOI [10.1038/NMETH.2772, 10.1038/nmeth.2772]; Jaitin DA, 2014, SCIENCE, V343, P776, DOI 10.1126/science.1247651; Marinov GK, 2014, GENOME RES, V24, P496, DOI 10.1101/gr.161034.113; Pollen AA, 2014, NAT BIOTECHNOL, V32, P1053, DOI 10.1038/nbt.2967; Shalek AK, 2014, NATURE, V510, P363, DOI 10.1038/nature13437; Streets AM, 2014, P NATL ACAD SCI USA, V111, P7048, DOI 10.1073/pnas.1402030111; Treutlein B, 2014, NATURE, V509, P371, DOI 10.1038/nature13173; Wu AR, 2014, NAT METHODS, V11, P41, DOI 10.1038/nmeth.2694; Yan LY, 2013, NAT STRUCT MOL BIOL, V20, P1131, DOI 10.1038/nsmb.2660; Zhang Y, 2014, J NEUROSCI, V34, P11929, DOI [10.1523/JNEUROSCI.1860-14.2014, 10.11772/j.issn.1001-9081.2014.07.1929]	12	22	23	1	34	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156	1546-1696		NAT BIOTECHNOL	Nat. Biotechnol.	OCT	2014	32	10					1005	1006		10.1038/nbt.3039	http://dx.doi.org/10.1038/nbt.3039			2	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	AR7MM	25299920				2022-12-27	WOS:000343763800015
J	Hare, P				Hare, Peter			Genomics separates the sheep from the goats	NATURE BIOTECHNOLOGY			English	Editorial Material																		Jiang Y, 2014, SCIENCE, V344, P1168, DOI 10.1126/science.1252806	1	0	0	0	7	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156	1546-1696		NAT BIOTECHNOL	Nat. Biotechnol.	AUG	2014	32	8					754	754		10.1038/nbt.2985	http://dx.doi.org/10.1038/nbt.2985			1	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	AW7PF	25101747	Bronze			2022-12-27	WOS:000346455900040
J	Murphy, SV; Atala, A				Murphy, Sean V.; Atala, Anthony			3D bioprinting of tissues and organs	NATURE BIOTECHNOLOGY			English	Review							STEM-CELL LINES; IN-VITRO; DEVELOPMENTAL BIOLOGY; FREEFORM FABRICATION; PRINTING TECHNIQUE; CONTRAST AGENT; HYDROGELS; BIOMATERIALS; DEPOSITION; DIFFERENTIATION	Additive manufacturing, otherwise known as three-dimensional (3D) printing, is driving major innovations in many areas, such as engineering, manufacturing, art, education and medicine. Recent advances have enabled 3D printing of biocompatible materials, cells and supporting components into complex 3D functional living tissues. 3D bioprinting is being applied to regenerative medicine to address the need for tissues and organs suitable for transplantation. Compared with non-biological printing, 3D bioprinting involves additional complexities, such as the choice of materials, cell types, growth and differentiation factors, and technical challenges related to the sensitivities of living cells and the construction of tissues. Addressing these complexities requires the integration of technologies from the fields of engineering, biomaterials science, cell biology, physics and medicine. 3D bioprinting has already been used for the generation and transplantation of several tissues, including multilayered skin, bone, vascular grafts, tracheal splints, heart tissue and cartilaginous structures. Other applications include developing high-throughput 3D-bioprinted tissue models for research, drug discovery and toxicology.	[Murphy, Sean V.; Atala, Anthony] Wake Forest Univ, Bowman Gray Sch Med, Wake Forest Inst Regenerat Med, Winston Salem, NC 27106 USA	Wake Forest University; Wake Forest Baptist Medical Center	Atala, A (corresponding author), Wake Forest Univ, Bowman Gray Sch Med, Wake Forest Inst Regenerat Med, Winston Salem, NC 27106 USA.	aatala@wakehealth.edu						Alajati A, 2008, NAT METHODS, V5, P439, DOI [10.1038/nmeth.1198, 10.1038/NMETH.1198]; Allard T., 2005, P 6 INT S VIRT REAL; AMBESIIMPIOMBATO FS, 1980, P NATL ACAD SCI-BIOL, V77, P3455, DOI 10.1073/pnas.77.6.3455; Ananthanarayanan A, 2011, TRENDS BIOTECHNOL, V29, P110, DOI 10.1016/j.tibtech.2010.10.006; Bailey MJ, 1998, CURR OPIN STRUC BIOL, V8, P202, DOI 10.1016/S0959-440X(98)80039-0; Baptista PM, 2009, IEEE ENG MED BIO, P6526, DOI 10.1109/IEMBS.2009.5333145; Barron JA, 2004, THIN SOLID FILMS, V453, P383, DOI 10.1016/j.tsf.2003.11.161; Barron JA, 2004, BIOMED MICRODEVICES, V6, P139, DOI 10.1023/B:BMMD.0000031751.67267.9f; Behonick DJ, 2003, MECH DEVELOP, V120, P1327, DOI 10.1016/j.mod.2003.05.002; BOHANDY J, 1986, J APPL PHYS, V60, P1538, DOI 10.1063/1.337287; Campbell PG, 2005, BIOMATERIALS, V26, P6762, DOI 10.1016/j.biomaterials.2005.04.032; Censi R, 2011, J BIOMED MATER RES A, V97A, P219, DOI 10.1002/jbm.a.33048; Chang CC, 2011, J BIOMED MATER RES B, V98B, P160, DOI 10.1002/jbm.b.31831; Chang R, 2008, TISSUE ENG PART C-ME, V14, P157, DOI 10.1089/ten.tec.2007.0392; Chang R, 2008, TISSUE ENG PT A, V14, P41, DOI 10.1089/ten.a.2007.0004; Chen SB, 2004, J AM CHEM SOC, V126, P410, DOI 10.1021/ja037390k; Chen S, 2009, NAT CHEM BIOL, V5, P258, DOI 10.1038/nchembio.154; Chrisey DB, 2000, SCIENCE, V289, P879, DOI 10.1126/science.289.5481.879; Chun SY, 2007, BIOMATERIALS, V28, P4251, DOI 10.1016/j.biomaterials.2007.05.020; Cohen DL, 2006, TISSUE ENG, V12, P1325, DOI 10.1089/ten.2006.12.1325; Colina M, 2005, BIOSENS BIOELECTRON, V20, P1638, DOI 10.1016/j.bios.2004.08.047; Cui XF, 2012, TISSUE ENG PT A, V18, P1304, DOI [10.1089/ten.tea.2011.0543, 10.1089/ten.TEA.2011.0543]; Cui Xiaofeng, 2012, Recent Pat Drug Deliv Formul, V6, P149; Cui XF, 2010, BIOTECHNOL BIOENG, V106, P963, DOI 10.1002/bit.22762; De Coppi P, 2007, NAT BIOTECHNOL, V25, P100, DOI 10.1038/nbt1274; Demirci U, 2007, LAB CHIP, V7, P1139, DOI 10.1039/b704965j; Derby B, 2012, SCIENCE, V338, P921, DOI 10.1126/science.1226340; DIMRI GP, 1995, P NATL ACAD SCI USA, V92, P9363, DOI 10.1073/pnas.92.20.9363; Dinca V, 2008, NANO LETT, V8, P538, DOI 10.1021/nl072798r; Ding S, 2003, P NATL ACAD SCI USA, V100, P7632, DOI 10.1073/pnas.0732087100; Discher DE, 2005, SCIENCE, V310, P1139, DOI 10.1126/science.1116995; Dominici M, 2006, CYTOTHERAPY, V8, P315, DOI 10.1080/14653240600855905; Duan B, 2013, J BIOMED MATER RES A, V101, P1255, DOI 10.1002/jbm.a.34420; Duocastella M, 2010, SENSOR ACTUAT B-CHEM, V145, P596, DOI 10.1016/j.snb.2009.11.055; Fang Y, 2012, TISSUE ENG PART C-ME, V18, P647, DOI [10.1089/ten.tec.2011.0709, 10.1089/ten.TEC.2011.0709]; Fedorovich NE, 2009, BIOMACROMOLECULES, V10, P1689, DOI 10.1021/bm801463q; FRIEDENSTEIN AJ, 1974, EXP HEMATOL, V2, P83; Gillette BM, 2010, ADV MATER, V22, P686, DOI 10.1002/adma.200902265; Goldmann T, 2000, J BIOCHEM BIOPH METH, V42, P105, DOI 10.1016/S0165-022X(99)00049-4; Gonzalez-Gomez J., 2012, ADV AUTONOMOUS MINI, P49, DOI [10.1007/978-3-642-27482-4_8, DOI 10.1007/978-3-642-27482-4_8]; Gruene M, 2011, TISSUE ENG PART C-ME, V17, P79, DOI [10.1089/ten.tec.2010.0359, 10.1089/ten.TEC.2010.0359]; Gunther A, 2010, LAB CHIP, V10, P2341, DOI 10.1039/c004675b; Guillemot F, 2010, ACTA BIOMATER, V6, P2494, DOI 10.1016/j.actbio.2009.09.029; Guillemot F, 2010, NANOMEDICINE-UK, V5, P507, DOI [10.2217/nnm.10.14, 10.2217/NNM.10.14]; Guillotin B, 2011, TRENDS BIOTECHNOL, V29, P183, DOI 10.1016/j.tibtech.2010.12.008; Guillotin B, 2010, BIOMATERIALS, V31, P7250, DOI 10.1016/j.biomaterials.2010.05.055; Guvendiren M, 2012, SOFT MATTER, V8, P260, DOI 10.1039/c1sm06513k; Hamm A, 2002, TISSUE ENG, V8, P235, DOI 10.1089/107632702753725003; Harrison BS, 2007, BIOMATERIALS, V28, P4628, DOI 10.1016/j.biomaterials.2007.07.003; Heller TB, 1991, Google patent, Patent No. [WO1991012120A1, 1991012120, WO 1991012120 A1]; Hennink WE, 2012, ADV DRUG DELIVER REV, V64, P223, DOI 10.1016/j.addr.2012.09.009; Hersel U, 2003, BIOMATERIALS, V24, P4385, DOI 10.1016/S0142-9612(03)00343-0; Hollister SJ, 2005, NAT MATER, V4, P518, DOI 10.1038/nmat1421; Hopp B, 2005, TISSUE ENG, V11, P1817, DOI 10.1089/ten.2005.11.1817; Hopp B, 2012, OPT ENG, V51, DOI 10.1117/1.OE.51.1.014302; Horn Timothy J., 2012, Science Progress, V95, P255, DOI 10.3184/003685012X13420984463047; Huh D, 2012, LAB CHIP, V12, P2156, DOI 10.1039/c2lc40089h; Huh D, 2010, SCIENCE, V328, P1662, DOI 10.1126/science.1188302; Hull CW, 1986, US Patent, Patent No. [4575330A, 4575330, 4,575,330]; Hunt NC, 2010, BIOTECHNOL LETT, V32, P733, DOI 10.1007/s10529-010-0221-0; Hutmacher DW, 2000, BIOMATERIALS, V21, P2529, DOI 10.1016/S0142-9612(00)00121-6; Hutmacher DW, 2004, TRENDS BIOTECHNOL, V22, P354, DOI 10.1016/j.tibtech.2004.05.005; Ingber DE, 2006, TISSUE ENG, V12, P3265, DOI 10.1089/ten.2006.12.3265; Iwami K, 2010, BIOFABRICATION, V2, DOI 10.1088/1758-5082/2/1/014108; Jakab K, 2006, BIORHEOLOGY, V43, P509; Johnson WK, 1996, MAGN RESON IMAGING, V14, P43, DOI 10.1016/0730-725X(95)02044-T; Jones N, 2012, NATURE, V487, P22, DOI 10.1038/487022a; Kamei M, 2006, NATURE, V442, P453, DOI 10.1038/nature04923; Karp JM, 2007, LAB CHIP, V7, P786, DOI 10.1039/b705085m; Kasza KE, 2007, CURR OPIN CELL BIOL, V19, P101, DOI 10.1016/j.ceb.2006.12.002; Kattamis NT, 2007, APPL PHYS LETT, V91, DOI 10.1063/1.2799877; Kelm JM, 2010, J BIOTECHNOL, V148, P46, DOI 10.1016/j.jbiotec.2010.03.002; Keriquel V, 2010, BIOFABRICATION, V2, DOI 10.1088/1758-5082/2/1/014101; Khalil S, 2007, MAT SCI ENG C-BIO S, V27, P469, DOI 10.1016/j.msec.2006.05.023; Kim JD, 2010, POLYMER, V51, P2147, DOI 10.1016/j.polymer.2010.03.038; KLEBE RJ, 1988, EXP CELL RES, V179, P362, DOI 10.1016/0014-4827(88)90275-3; Koch L, 2010, TISSUE ENG PART C-ME, V16, P847, DOI [10.1089/ten.tec.2009.0397, 10.1089/ten.TEC.2009.0397]; Kruth J.P., 1991, CIRP ANN-MANUF TECHN, V40, P603, DOI DOI 10.1016/S0007-8506(07)61136-6; Li XJ, 2008, STEM CELLS, V26, P886, DOI 10.1634/stemcells.2007-0620; Li ZX, 2011, J ARTIF ORGANS, V14, P163, DOI 10.1007/s10047-011-0585-5; Limpanuphap S, 2002, J MATER SCI-MATER M, V13, P1163, DOI 10.1023/A:1021146106442; Malda J, 2013, ADV MATER, V25, P5011, DOI 10.1002/adma.201302042; Malone E, 2007, RAPID PROTOTYPING J, V13, P245, DOI 10.1108/13552540710776197; MANKOVICH NJ, 1994, OTOLARYNG CLIN N AM, V27, P875; Marga F, 2012, IFMBE PROC, V37, P27; Marga F, 2012, BIOFABRICATION, V4, DOI 10.1088/1758-5082/4/2/022001; Marga Francoise, 2007, Birth Defects Research, V81, P320, DOI 10.1002/bdrc.20109; Matsumoto Y, 2013, FEBS LETT, V587, P1021, DOI 10.1016/j.febslet.2013.01.044; MEGIBOW AJ, 1980, AM J ROENTGENOL, V134, P1273, DOI 10.2214/ajr.134.6.1273; Michael S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057741; Michelson RC, 2004, P I MECH ENG G-J AER, V218, P363, DOI 10.1243/0954410042794911; Miller JS, 2012, NAT MATER, V11, P768, DOI [10.1038/NMAT3357, 10.1038/nmat3357]; Mironov V, 2009, BIOFABRICATION, V1, DOI 10.1088/1758-5082/1/2/022001; Mironov V, 2011, CURR OPIN BIOTECH, V22, P667, DOI 10.1016/j.copbio.2011.02.006; Mironov V, 2009, BIOMATERIALS, V30, P2164, DOI 10.1016/j.biomaterials.2008.12.084; Murphy S., 2010, CURR PROTOC STEM CEL, p1E6; Murphy SV, 2013, J BIOMED MATER RES A, V101, P272, DOI 10.1002/jbm.a.34326; Nair Kalyani, 2009, Biotechnology Journal, V4, P1168, DOI 10.1002/biot.200900004; Nakamura M, 2005, TISSUE ENG, V11, P1658, DOI 10.1089/ten.2005.11.1658; Nakamura M, 2010, BIOFABRICATION, V2, DOI 10.1088/1758-5082/2/1/014110; Norotte C, 2009, BIOMATERIALS, V30, P5910, DOI 10.1016/j.biomaterials.2009.06.034; Okamoto T, 2000, NAT BIOTECHNOL, V18, P438, DOI 10.1038/74507; Okumura N, 2009, INVEST OPHTH VIS SCI, V50, P3680, DOI 10.1167/iovs.08-2634; Ott HC, 2008, NAT MED, V14, P213, DOI 10.1038/nm1684; Peltola SM, 2008, ANN MED, V40, P268, DOI 10.1080/07853890701881788; Perez-Pomares JM, 2006, ANAT REC PART A, V288A, P700, DOI 10.1002/ar.a.20338; Phillippi JA, 2008, STEM CELLS, V26, P127, DOI 10.1634/stemcells.2007-0520; Pittenger MF, 1999, SCIENCE, V284, P143, DOI 10.1126/science.284.5411.143; Price RL, 2003, MED BIOL ENG COMPUT, V41, P372, DOI 10.1007/BF02348445; PYKETT IL, 1982, RADIOLOGY, V143, P157, DOI 10.1148/radiology.143.1.7038763; Reed EJ, 2009, PHILOS T R SOC A, V367, P1571, DOI 10.1098/rsta.2009.0010; Reubinoff BE, 2000, NAT BIOTECHNOL, V18, P399, DOI 10.1038/74447; Ringeisen BR, 2004, TISSUE ENG, V10, P483, DOI 10.1089/107632704323061843; Salehi-Nik N, 2013, BIOMED RES INT, V2013, DOI 10.1155/2013/762132; Saunders R, 2004, EUR CELLS MATER, V7, P84; Saunders RE, 2008, BIOMATERIALS, V29, P193, DOI 10.1016/j.biomaterials.2007.09.032; Schuurman W, 2011, BIOFABRICATION, V3, DOI 10.1088/1758-5082/3/2/021001; Schuurman W, 2013, MACROMOL BIOSCI, V13, P551, DOI 10.1002/mabi.201200471; Sekitani T, 2008, P NATL ACAD SCI USA, V105, P4976, DOI 10.1073/pnas.0708340105; Shimizu TS, 2000, NAT CELL BIOL, V2, P792, DOI 10.1038/35041030; Shor L, 2009, BIOFABRICATION, V1, DOI 10.1088/1758-5082/1/1/015003; Singh M, 2010, ADV MATER, V22, P673, DOI 10.1002/adma.200901141; Skardal A, 2010, TISSUE ENG PT A, V16, P2675, DOI 10.1089/ten.TEA.2009.0798; Skardal A, 2012, STEM CELL TRANSL MED, V1, P792, DOI 10.5966/sctm.2012-0088; Skardal A, 2010, ADV MATER, V22, P4736, DOI 10.1002/adma.201001436; Skardal A, 2010, BIOMATERIALS, V31, P6173, DOI 10.1016/j.biomaterials.2010.04.045; Smith CM, 2004, TISSUE ENG, V10, P1566, DOI 10.1089/1076327042500274; Smith CM, 2007, TISSUE ENG, V13, P373, DOI 10.1089/ten.2006.0101; Sonntag F, 2010, J BIOTECHNOL, V148, P70, DOI 10.1016/j.jbiotec.2010.02.001; Spiller KL, 2011, TISSUE ENG PART B-RE, V17, P281, DOI [10.1089/ten.TEB.2011.0077, 10.1089/ten.teb.2011.0077]; Steer DL, 2004, AM J PHYSIOL-RENAL, V286, pF1, DOI 10.1152/ajprenal.00167.2003; Stevens MM, 2005, SCIENCE, V310, P1135, DOI 10.1126/science.1106587; Sullivan DC, 2012, BIOMATERIALS, V33, P7756, DOI 10.1016/j.biomaterials.2012.07.023; Sun J, 2012, GREEN CHEM, V14, P654, DOI 10.1039/c2gc16335g; Sun W, 2002, COMPUT METH PROG BIO, V67, P85, DOI 10.1016/S0169-2607(01)00116-X; Symes MD, 2012, NAT CHEM, V4, P349, DOI [10.1038/NCHEM.1313, 10.1038/nchem.1313]; Talbot EL, 2012, PHYS REV E, V85, DOI 10.1103/PhysRevE.85.061604; Tan Q, 2007, EUR J CARDIO-THORAC, V31, P806, DOI 10.1016/j.ejcts.2007.01.045; Tasoglu S, 2013, TRENDS BIOTECHNOL, V31, P10, DOI 10.1016/j.tibtech.2012.10.005; Teixeira AI, 2004, J BIOMED MATER RES A, V71A, P369, DOI 10.1002/jbm.a.30089; Tekin E, 2008, SOFT MATTER, V4, P703, DOI 10.1039/b711984d; Visconti RP, 2010, EXPERT OPIN BIOL TH, V10, P409, DOI 10.1517/14712590903563352; Visser J, 2013, BIOFABRICATION, V5, DOI 10.1088/1758-5082/5/3/035007; West JL, 1999, MACROMOLECULES, V32, P241, DOI 10.1021/ma981296k; Williams DF, 2008, BIOMATERIALS, V29, P2941, DOI 10.1016/j.biomaterials.2008.04.023; WOLF GL, 1989, RADIOLOGY, V172, P709, DOI 10.1148/radiology.172.3.2672095; Xu F, 2011, BIOTECHNOL J, V6, P204, DOI 10.1002/biot.201000340; Xu T, 2006, BIOMATERIALS, V27, P3580, DOI 10.1016/j.biomaterials.2006.01.048; Xu T, 2005, BIOMATERIALS, V26, P93, DOI 10.1016/j.biomaterials.2004.04.011; Xu T., 2008, J MANUF SCI E-T ASME, V130; Xu T., 2008, J MANUF SCI E-T ASME, V130; Xu T, 2013, BIOFABRICATION, V5, DOI 10.1088/1758-5082/5/1/015001; Xu T, 2013, BIOMATERIALS, V34, P130, DOI 10.1016/j.biomaterials.2012.09.035; Yu ZY, 2012, NEUROCHEM INT, V61, P1114, DOI 10.1016/j.neuint.2012.08.003; Zagoria R J, 1994, Neuroimaging Clin N Am, V4, P1; ZHANG SG, 1995, BIOMATERIALS, V16, P1385, DOI 10.1016/0142-9612(95)96874-Y; Zopf DA, 2013, NEW ENGL J MED, V368, P2043, DOI 10.1056/NEJMc1206319; Zuk PA, 2002, MOL BIOL CELL, V13, P4279, DOI 10.1091/mbc.E02-02-0105	158	3569	3811	226	5340	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156	1546-1696		NAT BIOTECHNOL	Nat. Biotechnol.	AUG	2014	32	8					773	785		10.1038/nbt.2958	http://dx.doi.org/10.1038/nbt.2958			13	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	AW7PF	25093879				2022-12-27	WOS:000346455900025
J	Ratner, M				Ratner, Mark			Next-generation AMD drugs to wed blockbusters	NATURE BIOTECHNOLOGY			English	News Item																		2011, NAT BIOTECHNOL, V29, P560	1	10	13	0	4	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156	1546-1696		NAT BIOTECHNOL	Nat. Biotechnol.	AUG	2014	32	8					701	702		10.1038/nbt0814-701	http://dx.doi.org/10.1038/nbt0814-701			2	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	AW7PF	25101720				2022-12-27	WOS:000346455900029
J	Yoder, MC				Yoder, Mervin C.			Inducing definitive hematopoiesis in a dish	NATURE BIOTECHNOLOGY			English	Editorial Material							STEM-CELLS; YOLK-SAC; ACQUISITION; EMERGENCE		Indiana Univ, Sch Med, Herman B Wells Ctr Pediat Res, Dept Pediat, Indianapolis, IN 46204 USA	Indiana University System; Indiana University-Purdue University Indianapolis	Yoder, MC (corresponding author), Indiana Univ, Sch Med, Herman B Wells Ctr Pediat Res, Dept Pediat, Indianapolis, IN 46204 USA.	myoder@iu.edu		Yoder, Mervin/0000-0003-4354-7631				Boiers C, 2013, CELL STEM CELL, V13, P535, DOI 10.1016/j.stem.2013.08.012; Chong DC, 2011, DEV DYNAM, V240, P2153, DOI 10.1002/dvdy.22706; Corada M, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3609; Kennedy M, 2012, CELL REP, V2, P1722, DOI 10.1016/j.celrep.2012.11.003; Lancrin C, 2009, NATURE, V457, P892, DOI 10.1038/nature07679; Lucitti JL, 2007, DEVELOPMENT, V134, P3317, DOI 10.1242/dev.02883; Palis J, 2014, FRONT PHYSIOL, V5, DOI 10.3389/fphys.2014.00003; Schulz C, 2012, SCIENCE, V336, P86, DOI 10.1126/science.1219179; Slukvin II, 2013, BLOOD, V122, P4035, DOI 10.1182/blood-2013-07-474825; Sturgeon CM, 2014, NAT BIOTECHNOL, V32, P554, DOI 10.1038/nbt.2915; Swiers G, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3924; Yoshimoto M, 2012, BLOOD, V119, P5706, DOI 10.1182/blood-2011-12-397489	12	27	27	0	8	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156	1546-1696		NAT BIOTECHNOL	Nat. Biotechnol.	JUN	2014	32	6					539	541		10.1038/nbt.2929	http://dx.doi.org/10.1038/nbt.2929			3	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	AI9EV	24911496				2022-12-27	WOS:000337233800013
J	Chang, MT; Asthana, S; Gao, SP; Lee, BH; Chapman, JS; Kandoth, C; Gao, JJ; Socci, ND; Solit, DB; Olshen, AB; Schultz, N; Taylor, BS				Chang, Matthew T.; Asthana, Saurabh; Gao, Sizhi Paul; Lee, Byron H.; Chapman, Jocelyn S.; Kandoth, Cyriac; Gao, JianJiong; Socci, Nicholas D.; Solit, David B.; Olshen, Adam B.; Schultz, Nikolaus; Taylor, Barry S.			Identifying recurrent mutations in cancer reveals widespread lineage diversity and mutational specificity	NATURE BIOTECHNOLOGY			English	Article							ACUTE LYMPHOBLASTIC-LEUKEMIA; LUNG-CANCER; TUMOR TYPES; METASTATIC MELANOMA; SIGNALING PATHWAYS; BREAST CANCERS; PROTEIN TC21; CELL-LINE; RAS; SENSITIVITY	Mutational hotspots indicate selective pressure across a population of tumor samples, but their prevalence within and across cancer types is incompletely characterized. An approach to detect significantly mutated residues, rather than methods that identify recurrently mutated genes, may uncover new biologically and therapeutically relevant driver mutations. Here, we developed a statistical algorithm to identify recurrently mutated residues in tumor samples. We applied the algorithm to 11,119 human tumors, spanning 41 cancer types, and identified 470 somatic substitution hotspots in 275 genes. We find that half of all human tumors possess one or more mutational hotspots with widespread lineage-, position-and mutant allele-specific differences, many of which are likely functional. In total, 243 hotspots were novel and appeared to affect a broad spectrum of molecular function, including hotspots at paralogous residues of Ras-related small GTPases RAC1 and RRAS2. Redefining hotspots at mutant amino acid resolution will help elucidate the allele-specific differences in their function and could have important therapeutic implications.	[Chang, Matthew T.; Gao, Sizhi Paul; Solit, David B.; Taylor, Barry S.] Mem Sloan Kettering Canc Ctr, Human Oncol & Pathogenesis Program, 1275 York Ave, New York, NY 10021 USA; [Chang, Matthew T.; Schultz, Nikolaus; Taylor, Barry S.] Mem Sloan Kettering Canc Ctr, Dept Epidemiol & Biostat, New York, NY 10021 USA; [Chang, Matthew T.] Univ Calif San Francisco, Dept Bioengn, San Francisco, CA 94143 USA; [Chang, Matthew T.] Univ Calif San Francisco, Dept Therapeut Sci, San Francisco, CA 94143 USA; [Asthana, Saurabh] Univ Calif San Francisco, Dept Med, San Francisco, CA USA; [Lee, Byron H.] Mem Sloan Kettering Canc Ctr, Dept Surg, 1275 York Ave, New York, NY 10021 USA; [Chapman, Jocelyn S.] Univ Calif San Francisco, Dept Obstet Gynecol & Reprod Sci, San Francisco, CA USA; [Kandoth, Cyriac; Gao, JianJiong; Socci, Nicholas D.; Solit, David B.; Schultz, Nikolaus; Taylor, Barry S.] Mem Sloan Kettering Canc Ctr, Marie Josee & Henry R Kravis Ctr Mol Oncol, 1275 York Ave, New York, NY 10021 USA; [Socci, Nicholas D.] Mem Sloan Kettering Canc Ctr, Bioinformat Core, 1275 York Ave, New York, NY 10021 USA; [Solit, David B.] Mem Sloan Kettering Canc Ctr, Dept Med, 1275 York Ave, New York, NY 10021 USA; [Solit, David B.] Cornell Univ, Weill Cornel Med Coll, New York, NY 10021 USA; [Olshen, Adam B.] Univ Calif San Francisco, Epidemiol & Biostat, San Francisco, CA 94143 USA; [Olshen, Adam B.] Univ Calif San Francisco, Helen Diller Family Comprehens Canc Ctr, San Francisco, CA 94143 USA	Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; Memorial Sloan Kettering Cancer Center; University of California System; University of California San Francisco; Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center; Cornell University; University of California System; University of California San Francisco; University of California System; University of California San Francisco; UCSF Medical Center; UCSF Helen Diller Family Comprehensive Cancer Center	Taylor, BS (corresponding author), Mem Sloan Kettering Canc Ctr, Human Oncol & Pathogenesis Program, 1275 York Ave, New York, NY 10021 USA.; Taylor, BS (corresponding author), Mem Sloan Kettering Canc Ctr, Dept Epidemiol & Biostat, New York, NY 10021 USA.; Taylor, BS (corresponding author), Mem Sloan Kettering Canc Ctr, Marie Josee & Henry R Kravis Ctr Mol Oncol, 1275 York Ave, New York, NY 10021 USA.	taylorb@mskcc.org	wang, edwin/G-5372-2010; Solit, David B./AAC-5309-2019; Schultz, Nikolaus/ABE-6347-2020; Gao, JianJiong/B-5673-2016	Gao, JianJiong/0000-0002-5739-1781; Lee, Byron/0000-0002-8755-9688; Kandoth, Cyriac/0000-0002-1345-3573; Solit, David/0000-0002-6614-802X	US National Institutes of Health (NIH) [T32 GM007175]; NIH [P30 CA82103]; NIH Core Grant [P30 CA008748]; Josie Robertson Foundation; Prostate Cancer Foundation; Sontag Foundation; Cycle for Survival; NATIONAL CANCER INSTITUTE [P30CA082103, P30CA008748] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007175] Funding Source: NIH RePORTER	US National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH Core Grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Josie Robertson Foundation; Prostate Cancer Foundation; Sontag Foundation; Cycle for Survival; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We would like to thank the members of the Taylor and Schultz laboratories and members of the Marie-Josee and Henry R. Kravis Center for Molecular Oncology for useful discussions throughout this work. M.T.C. was supported by the US National Institutes of Health (NIH) training grant T32 GM007175 and A.B.O. was supported by NIH grant P30 CA82103. This work has been further supported by an NIH Core Grant (P30 CA008748, PI: Thompson); the Josie Robertson and Prostate Cancer Foundations (N.S. and B.S.T.), the Sontag Foundation and Cycle for Survival (B.S.T.).	Al-Ahmadie H, 2014, CANCER DISCOV, V4, P1014, DOI 10.1158/2159-8290.CD-14-0380; Alexandrov LB, 2013, NATURE, V500, P415, DOI 10.1038/nature12477; Bao L, 2014, BIOINFORMATICS, V30, P1056, DOI 10.1093/bioinformatics/btt759; Barker KT, 1998, BRIT J CANCER, V78, P296, DOI 10.1038/bjc.1998.490; Benjamini Y, 2001, ANN STAT, V29, P1165; Burd CE, 2014, CANCER DISCOV, V4, P1418, DOI 10.1158/2159-8290.CD-14-0729; Cerami E, 2012, CANCER DISCOV, V2, P401, DOI 10.1158/2159-8290.CD-12-0095; Cheng DT, 2015, J MOL DIAGN, V17, P251, DOI 10.1016/j.jmoldx.2014.12.006; Cheung LWT, 2014, CANCER CELL, V26, P479, DOI 10.1016/j.ccell.2014.08.017; Clark GJ, 1996, ONCOGENE, V12, P169; de Bruin EC, 2014, SCIENCE, V346, P251, DOI 10.1126/science.1253462; Ehrhardt A, 2002, EXP HEMATOL, V30, P1089, DOI 10.1016/S0301-472X(02)00904-9; Erdogan M, 2007, J BIOL CHEM, V282, P27713, DOI 10.1074/jbc.M703037200; Forbes SA, 2015, NUCLEIC ACIDS RES, V43, pD805, DOI 10.1093/nar/gku1075; Gao JJ, 2013, SCI SIGNAL, V6, DOI 10.1126/scisignal.2004088; Garassino MC, 2011, ANN ONCOL, V22, P235, DOI 10.1093/annonc/mdq680; Garraway LA, 2013, CELL, V153, P17, DOI 10.1016/j.cell.2013.03.002; Getz G, 2013, NATURE, V497, P67, DOI 10.1038/nature12113; Gonzalez-Perez A, 2013, NAT METHODS, V10, P1081, DOI [10.1038/NMETH.2642, 10.1038/nmeth.2642]; Grabiner BC, 2014, CANCER DISCOV, V4, P554, DOI 10.1158/2159-8290.CD-13-0929; Hart T, 2014, MOL SYST BIOL, V10, DOI 10.15252/msb.20145216; Hodis E, 2012, CELL, V150, P251, DOI 10.1016/j.cell.2012.06.024; HUANG Y, 1995, ONCOGENE, V11, P1255; Ihle NT, 2012, JNCI-J NATL CANCER I, V104, P228, DOI 10.1093/jnci/djr523; Iyer G, 2012, SCIENCE, V338, P221, DOI 10.1126/science.1226344; Jaiswal BS, 2013, CANCER CELL, V23, P603, DOI 10.1016/j.ccr.2013.04.012; Janakiraman M, 2010, CANCER RES, V70, P5901, DOI 10.1158/0008-5472.CAN-10-0192; Kandoth C, 2013, NATURE, V502, P333, DOI 10.1038/nature12634; Karolchik D, 2014, NUCLEIC ACIDS RES, V42, pD764, DOI 10.1093/nar/gkt1168; Krauthammer M, 2012, NAT GENET, V44, P1006, DOI 10.1038/ng.2359; Lawrence MS, 2014, NATURE, V505, P495, DOI 10.1038/nature12912; Lawrence MS, 2013, NATURE, V499, P214, DOI 10.1038/nature12213; Lee CS, 2014, NAT GENET, V46, P1060, DOI 10.1038/ng.3091; McLaren W, 2010, BIOINFORMATICS, V26, P2069, DOI 10.1093/bioinformatics/btq330; Menzies AM, 2012, CLIN CANCER RES, V18, P3242, DOI 10.1158/1078-0432.CCR-12-0052; Mullighan CG, 2011, NATURE, V471, P235, DOI 10.1038/nature09727; Muzny DM, 2012, NATURE, V487, P330, DOI 10.1038/nature11252; Nik-Zainal S, 2012, CELL, V149, DOI 10.1016/j.cell.2012.04.023; Rong R, 2002, ONCOGENE, V21, P1062, DOI 10.1038/sj.onc.1205154; Rosario M, 1999, EMBO J, V18, P1270, DOI 10.1093/emboj/18.5.1270; Rosario M, 2001, MOL CELL BIOL, V21, P3750, DOI 10.1128/MCB.21.11.3750-3762.2001; Santarius T, 2010, NAT REV CANCER, V10, P59, DOI 10.1038/nrc2771; Tamborero D, 2013, SCI REP-UK, V3, DOI 10.1038/srep02650; Van Allen EM, 2014, CANCER DISCOV, V4, P94, DOI 10.1158/2159-8290.CD-13-0617; Vivanco I, 2012, CANCER DISCOV, V2, P458, DOI 10.1158/2159-8290.CD-11-0284; Vogelstein B, 2013, SCIENCE, V339, P1546, DOI 10.1126/science.1235122; Watson IR, 2014, CANCER RES, V74, P4845, DOI 10.1158/0008-5472.CAN-14-1232-T; Weinstein JN, 2014, NATURE, V507, P315, DOI 10.1038/nature12965; Weng AP, 2004, SCIENCE, V306, P269, DOI 10.1126/science.1102160; Westcott PMK, 2015, NATURE, V517, P489, DOI 10.1038/nature13898; Whitehall VLJ, 2012, INT J CANCER, V131, P813, DOI 10.1002/ijc.26440; Yu HA, 2015, J THORAC ONCOL, V10, P431, DOI 10.1097/JTO.0000000000000432	52	464	469	1	39	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156	1546-1696		NAT BIOTECHNOL	Nat. Biotechnol.	FEB	2016	34	2					155	+		10.1038/nbt.3391	http://dx.doi.org/10.1038/nbt.3391			11	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	DD0OK	26619011	Green Accepted, Bronze, Green Submitted			2022-12-27	WOS:000369619100017
J	Guerrini, CJ; Majumder, MA; McGuire, AL				Guerrini, Christi J.; Majumder, Mary A.; McGuire, Amy L.			Persistent confusion and controversy surrounding gene patents	NATURE BIOTECHNOLOGY			English	Editorial Material							PRIMARY-CARE; HUMAN GENOME; EDUCATION		[Guerrini, Christi J.; Majumder, Mary A.; McGuire, Amy L.] Baylor Coll Med, Ctr Med Eth & Hlth Policy, Houston, TX 77030 USA	Baylor College of Medicine	Guerrini, CJ (corresponding author), Baylor Coll Med, Ctr Med Eth & Hlth Policy, Houston, TX 77030 USA.	guerrini@bcm.edu	Guerrini, Christi/HGF-0227-2022	Guerrini, Christi/0000-0003-4430-2740	NHGRI NIH HHS [R01-HG006460, R01 HG006460] Funding Source: Medline; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R01HG006460] Funding Source: NIH RePORTER	NHGRI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))		[Anonymous], 2011, STAT, V125, P284; Christensen KD, 2016, CLIN GENET, V89, P228, DOI 10.1111/cge.12626; Collier R, 2012, CAN MED ASSOC J, V184, pE467, DOI 10.1503/cmaj.109-4188; Cook-Deegan R, 2014, J LAW MED ETHICS, V42, P42, DOI 10.1111/jlme.12161; Curnutte MA, 2014, NAT BIOTECHNOL, V32, P980, DOI 10.1038/nbt.3030; Demmer LA, 2014, ANNU REV GENOM HUM G, V15, P507, DOI 10.1146/annurev-genom-090413-025522; Dressler LG, 2014, GENET TEST MOL BIOMA, V18, P131, DOI 10.1089/gtmb.2013.0366; DuBois JM, 2009, J RES ADMIN, V40, P49; Haanes E. J., 2015, DEV PATENT STRATEGY, P43; Holzapfel H, 2008, IDEA, V48, P123; Hurle B, 2013, GENET MED, V15, P658, DOI 10.1038/gim.2013.14; Korf BR, 2014, GENET MED, V16, P804, DOI 10.1038/gim.2014.35; Shen Dongbiao, 2014, BERKELEY TECHNOLOGY, V29, P545; Srinivasan M, 2011, GENET MED, V13, P553, DOI 10.1097/GIM.0b013e31820e279a; United States Patent and Trademark Office (USPTO), 2014, FED REGISTER, V79, P74618; USPTO, 2014, NAT BAS PROD EX; USPTO, 2015, ABSTR ID EX	17	5	5	1	5	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156	1546-1696		NAT BIOTECHNOL	Nat. Biotechnol.	FEB	2016	34	2					145	147		10.1038/nbt.3470	http://dx.doi.org/10.1038/nbt.3470			3	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	DD0OK	26849516	Green Accepted			2022-12-27	WOS:000369619100013
J	Gaspar, P; Nedelec, S				Gaspar, Patricia; Nedelec, Stephane			Serotonin neurons in a dish	NATURE BIOTECHNOLOGY			English	Editorial Material							SYSTEM	A method for generating serotonin raphe neurons in vitro will aid the study of genetic variants and drugs that modulate serotonin activity.	[Gaspar, Patricia] INSERM UMRS 839, Inst Fer Moulin, Paris, France; [Nedelec, Stephane] AFM, INSERM UEVE UMR 861, I STEM, Evry, France	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Saclay	Gaspar, P (corresponding author), INSERM UMRS 839, Inst Fer Moulin, Paris, France.	patricia.gaspar@inserm.fr	Gaspar, Patricia/G-8892-2011; Nedelec, Stéphane/G-8469-2017	Gaspar, Patricia/0000-0003-4217-5717; Nedelec, Stéphane/0000-0001-8044-2498				Deneris ES, 2012, NAT NEUROSCI, V15, P519, DOI 10.1038/nn.3039; Dias JM, 2014, NEURON, V84, P927, DOI 10.1016/j.neuron.2014.10.033; Eley TC, 2004, MOL PSYCHIATR, V9, P908, DOI 10.1038/sj.mp.4001546; Fernandez SP, 2016, BRAIN STRUCT FUNCT, V221, P4007, DOI 10.1007/s00429-015-1142-4; Kiyasova V, 2011, EUR J NEUROSCI, V34, P1553, DOI 10.1111/j.1460-9568.2011.07910.x; Lu JF, 2016, NAT BIOTECHNOL, V34, P89, DOI 10.1038/nbt.3435; Maury Y, 2015, NAT BIOTECHNOL, V33, P89, DOI 10.1038/nbt.3049; Okaty BW, 2015, NEURON, V88, P774, DOI 10.1016/j.neuron.2015.10.007; Vadodaria KC, 2016, MOL PSYCHIATR, V21, P49, DOI 10.1038/mp.2015.161; Waider J, 2011, PSYCHONEUROENDOCRINO, V36, P393, DOI 10.1016/j.psyneuen.2010.12.012; Xu Z, 2016, MOL PSYCHIATR, V21, P62, DOI 10.1038/mp.2015.101	11	4	4	0	9	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156	1546-1696		NAT BIOTECHNOL	Nat. Biotechnol.	JAN	2016	34	1					41	42		10.1038/nbt.3455	http://dx.doi.org/10.1038/nbt.3455			2	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	DB8HQ	26744978				2022-12-27	WOS:000368758200022
J	Lynn, GM; Laga, R; Darrah, PA; Ishizuka, AS; Balaci, AJ; Dulcey, AE; Pechar, M; Pola, R; Gerner, MY; Yamamoto, A; Buechler, CR; Quinn, KM; Smelkinson, MG; Vanek, O; Cawood, R; Hills, T; Vasalatiy, O; Kastenmuller, K; Francica, JR; Stutts, L; Tom, JK; Ryu, KA; Esser-Kahn, AP; Etrych, T; Fisher, KD; Seymour, LW; Seder, RA				Lynn, Geoffrey M.; Laga, Richard; Darrah, Patricia A.; Ishizuka, Andrew S.; Balaci, Alexandra J.; Dulcey, Andres E.; Pechar, Michal; Pola, Robert; Gerner, Michael Y.; Yamamoto, Ayako; Buechler, Connor R.; Quinn, Kylie M.; Smelkinson, Margery G.; Vanek, Ondrej; Cawood, Ryan; Hills, Thomas; Vasalatiy, Olga; Kastenmueller, Kathrin; Francica, Joseph R.; Stutts, Lalisa; Tom, Janine K.; Ryu, Keun Ah; Esser-Kahn, Aaron P.; Etrych, Tomas; Fisher, Kerry D.; Seymour, Leonard W.; Seder, Robert A.			In vivo characterization of the physicochemical properties of polymer-linked TLR agonists that enhance vaccine immunogenicity	NATURE BIOTECHNOLOGY			English	Article							T-CELL IMMUNITY; DENDRITIC CELLS; INNATE IMMUNITY; LYMPH-NODES; ADJUVANT; RESPONSES; ANTIGEN; PROTECTION; ACTIVATION; COPOLYMERS	The efficacy of vaccine adjuvants such as Toll-like receptor agonists (TLRa) can be improved through formulation and delivery approaches. Here, we attached small molecule TLR-7/8a to polymer scaffolds (polymer-TLR-7/8a) and evaluated how different physicochemical properties of the TLR-7/8a and polymer carrier influenced the location, magnitude and duration of innate immune activation in vivo. Particle formation by polymer-TLR-7/8a was the most important factor for restricting adjuvant distribution and prolonging activity in draining lymph nodes. The improved pharmacokinetic profile by particulate polymer-TLR-7/8a was also associated with reduced morbidity and enhanced vaccine immunogenicity for inducing antibodies and T cell immunity. We extended these findings to the development of a modular approach in which protein antigens are site-specifically linked to temperature-responsive polymer-TLR-7/8a adjuvants that self-assemble into immunogenic particles at physiologic temperatures in vivo. Our findings provide a chemical and structural basis for optimizing adjuvant design to elicit broad-based antibody and T cell responses with protein antigens.	[Lynn, Geoffrey M.; Darrah, Patricia A.; Ishizuka, Andrew S.; Balaci, Alexandra J.; Yamamoto, Ayako; Buechler, Connor R.; Quinn, Kylie M.; Kastenmueller, Kathrin; Francica, Joseph R.; Seder, Robert A.] NIAID, Vaccine Res Ctr, NIH, Bethesda, MD 20892 USA; [Lynn, Geoffrey M.; Laga, Richard; Cawood, Ryan; Hills, Thomas; Fisher, Kerry D.; Seymour, Leonard W.] Univ Oxford, Dept Oncol, Oxford, England; [Laga, Richard; Pechar, Michal; Pola, Robert; Etrych, Tomas] Acad Sci Czech Republic, Inst Macromol Chem, Prague, Czech Republic; [Dulcey, Andres E.; Vasalatiy, Olga] NHLBI, Imaging Probe Dev Ctr, NIH, Rockville, MD USA; [Gerner, Michael Y.] NIAID, Lymphocyte Biol Sect, Lab Syst Biol, NIH, Bethesda, MD 20892 USA; [Smelkinson, Margery G.] NIAID, Biol Imaging Sect, Res Technol Branch, NIH, Bethesda, MD 20892 USA; [Vanek, Ondrej] Charles Univ Prague, Fac Sci, Dept Biochem, Prague, Czech Republic; [Stutts, Lalisa; Tom, Janine K.; Ryu, Keun Ah; Esser-Kahn, Aaron P.] Univ Calif Irvine, Dept Chem, Irvine, CA 92717 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); University of Oxford; Czech Academy of Sciences; Institute of Macromolecular Chemistry of the Czech Academy of Sciences; National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI); National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); Charles University Prague; University of California System; University of California Irvine	Seder, RA (corresponding author), NIAID, Vaccine Res Ctr, NIH, 9000 Rockville Pike, Bethesda, MD 20892 USA.	rseder@mail.nih.gov	Quinn, Kylie/AAJ-5066-2021; Laga, Richard/G-3627-2014; Pechar, Michal/G-6423-2014; Pola, Robert/G-5723-2014; Etrych, Tomas/G-3420-2014; Vaněk, Ondřej/I-7022-2016	Pola, Robert/0000-0003-0025-2016; Etrych, Tomas/0000-0001-5908-5182; Vaněk, Ondřej/0000-0003-1190-8535; Gerner, Michael/0000-0001-5406-8308; Ryu, Keun Ah/0000-0001-6244-0878; Hills, Thomas/0000-0003-0322-5822; Smelkinson, Margery/0000-0001-7777-5574; Ishizuka, Andrew/0000-0002-3024-7536; Quinn, Kylie/0000-0002-0417-3625; seymour, len/0000-0003-3825-0841	BIOPOL project (Ministry of Education, Youth and Sports of the Czech Republic) [EE2.3.30.0029]; Czech Science Foundation [15-15181S]; Charles University [UNCE 204025/2012]; Cancer Research UK [C552/A17720]; Office of AIDS Research of the US National Institutes of Health; National Institute of Allergy and Infectious Diseases of the US National Institutes of Health; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [K22AI108628] Funding Source: NIH RePORTER; Cancer Research UK [17720] Funding Source: researchfish	BIOPOL project (Ministry of Education, Youth and Sports of the Czech Republic); Czech Science Foundation(Grant Agency of the Czech Republic); Charles University; Cancer Research UK(Cancer Research UK); Office of AIDS Research of the US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institute of Allergy and Infectious Diseases of the US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Cancer Research UK(Cancer Research UK)	The authors wish to acknowledge M. Dillon, K. Wuddie and C. Chiedi at the Vaccine Research Center and B. Klaunberg and V. Diaz at the Mouse Imaging Facility (MIF) for their valuable support and assistance with the animal studies. We would also like to thank K. Ulbrich, R. Swenson and G. Griffiths for their support and helpful insights. This work was supported in part by the BIOPOL project (Grant of the Ministry of Education, Youth and Sports of the Czech Republic, no. EE2.3.30.0029); by the Czech Science Foundation (15-15181S); by Charles University (UNCE 204025/2012); by a Cancer Research UK grant (C552/A17720); and by the Office of AIDS Research and the National Institute of Allergy and Infectious Diseases of the US National Institutes of Health.	Andersen P, 2014, TRENDS IMMUNOL, V35, P387, DOI 10.1016/j.it.2014.04.006; Arens R, 2013, SEMIN IMMUNOL, V25, P182, DOI 10.1016/j.smim.2013.04.008; Bachmann MF, 2010, NAT REV IMMUNOL, V10, P787, DOI 10.1038/nri2868; Blander JM, 2006, NATURE, V440, P808, DOI 10.1038/nature04596; Brito LA, 2014, J CONTROL RELEASE, V190, P563, DOI 10.1016/j.jconrel.2014.06.027; Chou HY, 2010, J IMMUNOL, V185, P5468, DOI 10.4049/jimmunol.1001875; Coffman RL, 2010, IMMUNITY, V33, P492, DOI 10.1016/j.immuni.2010.10.002; Darrah PA, 2007, NAT MED, V13, P843, DOI 10.1038/nm1592; de Titta A, 2013, P NATL ACAD SCI USA, V110, P19902, DOI 10.1073/pnas.1313152110; Epstein JE, 2011, SCIENCE, V334, P475, DOI 10.1126/science.1211548; Fox CB, 2013, VACCINE, V31, P5848, DOI 10.1016/j.vaccine.2013.09.069; Gerner MY, 2012, IMMUNITY, V37, P364, DOI 10.1016/j.immuni.2012.07.011; Gerster JF, 2005, J MED CHEM, V48, P3481, DOI 10.1021/jm049211v; Gorden KB, 2005, J IMMUNOL, V174, P1259, DOI 10.4049/jimmunol.174.3.1259; Guy B, 2007, NAT REV MICROBIOL, V5, P505, DOI 10.1038/nrmicro1681; Hruby M, 2007, J CONTROL RELEASE, V119, P25, DOI 10.1016/j.jconrel.2007.02.009; Ilyinskii PO, 2014, VACCINE, V32, P2882, DOI 10.1016/j.vaccine.2014.02.027; Iwasaki A, 2004, NAT IMMUNOL, V5, P987, DOI 10.1038/ni1112; Jewell CM, 2011, P NATL ACAD SCI USA, V108, P15745, DOI 10.1073/pnas.1105200108; Jing P, 2008, BIOMACROMOLECULES, V9, P2438, DOI 10.1021/bm800459v; Kastenmuller K, 2011, J CLIN INVEST, V121, P1782, DOI 10.1172/JCI45416; Kasturi SP, 2011, NATURE, V470, P543, DOI 10.1038/nature09737; Kourtis IC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061646; KRIEG AM, 1995, ANTISENSE RES DEV, V5, P241, DOI 10.1089/ard.1995.5.241; Lahoud MH, 2012, P NATL ACAD SCI USA, V109, P16270, DOI 10.1073/pnas.1208796109; Liu HP, 2014, NATURE, V507, P519, DOI 10.1038/nature12978; Liu HP, 2011, ANGEW CHEM INT EDIT, V50, P7052, DOI 10.1002/anie.201101266; Liu XM, 2010, ADV DRUG DELIVER REV, V62, P258, DOI 10.1016/j.addr.2009.10.006; Manolova V, 2008, EUR J IMMUNOL, V38, P1404, DOI 10.1002/eji.200737984; Moon JJ, 2012, P NATL ACAD SCI USA, V109, P1080, DOI 10.1073/pnas.1112648109; Nair-Gupta P, 2014, CELL, V158, P506, DOI 10.1016/j.cell.2014.04.054; Nordly P, 2009, EXPERT OPIN DRUG DEL, V6, P657, DOI 10.1517/17425240903018863; Pechar M, 2013, BIOTECHNOL ADV, V31, P90, DOI 10.1016/j.biotechadv.2012.01.003; Plotkin SA, 2010, CLIN VACCINE IMMUNOL, V17, P1055, DOI 10.1128/CVI.00131-10; Pockros PJ, 2007, J HEPATOL, V47, P174, DOI 10.1016/j.jhep.2007.02.025; Quinn KM, 2013, J IMMUNOL, V190, P2720, DOI 10.4049/jimmunol.1202861; Reddy ST, 2006, J CONTROL RELEASE, V112, P26, DOI 10.1016/j.jconrel.2006.01.006; Russo C, 2011, BLOOD, V117, P5683, DOI 10.1182/blood-2010-12-328138; Ryu KA, 2014, J AM CHEM SOC, V136, P10823, DOI 10.1021/ja412314j; Savage P, 1996, BRIT J CANCER, V74, P1482, DOI 10.1038/bjc.1996.569; Scott EA, 2012, BIOMATERIALS, V33, P6211, DOI 10.1016/j.biomaterials.2012.04.060; Seder RA, 2008, NAT REV IMMUNOL, V8, P247, DOI 10.1038/nri2274; Seymour LW, 2002, J CLIN ONCOL, V20, P1668, DOI 10.1200/JCO.2002.20.6.1668; SEYMOUR LW, 1987, J BIOMED MATER RES, V21, P1341, DOI 10.1002/jbm.820211106; Shakya AK, 2013, VACCINE, V31, P3519, DOI 10.1016/j.vaccine.2013.05.084; Sharp FA, 2009, P NATL ACAD SCI USA, V106, P870, DOI 10.1073/pnas.0804897106; Shi HS, 2012, CARBOHYD POLYM, V89, P1101, DOI 10.1016/j.carbpol.2012.03.073; Shukla NM, 2011, BIOORG MED CHEM LETT, V21, P3232, DOI 10.1016/j.bmcl.2011.04.050; Shukla NM, 2010, J MED CHEM, V53, P4450, DOI 10.1021/jm100358c; Skeiky YAW, 2002, VACCINE, V20, P3292, DOI 10.1016/S0264-410X(02)00302-X; Smirnov D, 2011, VACCINE, V29, P5434, DOI 10.1016/j.vaccine.2011.05.061; Subr V, 2006, REACT FUNCT POLYM, V66, P1525, DOI 10.1016/j.reactfunctpolym.2006.05.002; Tyring S.K., 2009, J DRUGS DERMATOL, V8, P467; Vecchi S, 2014, EUR J PHARM BIOPHARM, V87, P310, DOI 10.1016/j.ejpb.2014.01.002; Wille-Reece U, 2005, P NATL ACAD SCI USA, V102, P15190, DOI 10.1073/pnas.0507484102; Wu CCN, 2007, P NATL ACAD SCI USA, V104, P3990, DOI 10.1073/pnas.0611624104; Wu TYH, 2014, SCI TRANSL MED, V6, DOI 10.1126/scitranslmed.3009980	58	284	289	14	243	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1087-0156	1546-1696		NAT BIOTECHNOL	Nat. Biotechnol.	NOV	2015	33	11					1201	+		10.1038/nbt.3371	http://dx.doi.org/10.1038/nbt.3371			13	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	CW3TY	26501954	Green Accepted			2022-12-27	WOS:000364916000028
J	Ren, X; Moser, PT; Gilpin, SE; Okamoto, T; Wu, T; Tapias, LF; Mercier, FE; Xiong, LJ; Ghawi, R; Scadden, DT; Mathisen, DJ; Ott, HC				Ren, Xi; Moser, Philipp T.; Gilpin, Sarah E.; Okamoto, Tatsuya; Wu, Tong; Tapias, Luis F.; Mercier, Francois E.; Xiong, Linjie; Ghawi, Raja; Scadden, David T.; Mathisen, Douglas J.; Ott, Harald C.			Engineering pulmonary vasculature in decellularized rat and human lungs	NATURE BIOTECHNOLOGY			English	Article							PLURIPOTENT STEM-CELLS; ORTHOTOPIC TRANSPLANTATION; LUMEN FORMATION; MATRIX; PERMEABILITY; PROGENITORS; TISSUE; DIFFERENTIATION; MORPHOGENESIS; REGENERATION	Bioengineered lungs produced from patient-derived cells may one day provide an alternative to donor lungs for transplantation therapy. Here we report the regeneration of functional pulmonary vasculature by repopulating the vascular compartment of decellularized rat and human lung scaffolds with human cells, including endothelial and perivascular cells derived from induced pluripotent stem cells. We describe improved methods for delivering cells into the lung scaffold and for maturing newly formed endothelium through co-seeding of endothelial and perivascular cells and a two-phase culture protocol. Using these methods we achieved similar to 75% endothelial coverage in the rat lung scaffold relative to that of native lung. The regenerated endothelium showed reduced vascular resistance and improved barrier function over the course of in vitro culture and remained patent for 3 days after orthotopic transplantation in rats. Finally, we scaled our approach to the human lung lobe and achieved efficient cell delivery, maintenance of cell viability and establishment of perfusable vascular lumens.	[Ren, Xi; Moser, Philipp T.; Gilpin, Sarah E.; Okamoto, Tatsuya; Wu, Tong; Tapias, Luis F.; Mercier, Francois E.; Xiong, Linjie; Ghawi, Raja; Scadden, David T.; Ott, Harald C.] Massachusetts Gen Hosp, Ctr Regenerat Med, Boston, MA 02114 USA; [Ren, Xi; Moser, Philipp T.; Gilpin, Sarah E.; Okamoto, Tatsuya; Wu, Tong; Tapias, Luis F.; Mercier, Francois E.; Xiong, Linjie; Ghawi, Raja; Scadden, David T.; Mathisen, Douglas J.; Ott, Harald C.] Harvard Univ, Sch Med, Boston, MA USA; [Tapias, Luis F.; Mathisen, Douglas J.; Ott, Harald C.] Massachusetts Gen Hosp, Dept Surg, Div Thorac Surg, Boston, MA 02114 USA; [Ghawi, Raja] Harvard Univ, Cambridge, MA USA; [Scadden, David T.; Ott, Harald C.] Harvard Stem Cell Inst, Cambridge, MA USA	Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; Harvard University; Massachusetts General Hospital; Harvard University; Harvard University	Ott, HC (corresponding author), Massachusetts Gen Hosp, Ctr Regenerat Med, Boston, MA 02114 USA.	hott@mgh.harvard.edu		Gilpin, Sarah/0000-0003-3560-6910	United Therapeutics Corporation; National Institutes of Health (NIH) Director's New Innovator Award [DP2-OD008749-01]; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [DP2OD008749] Funding Source: NIH RePORTER	United Therapeutics Corporation; National Institutes of Health (NIH) Director's New Innovator Award(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This study was supported by the United Therapeutics Corporation and the National Institutes of Health (NIH) Director's New Innovator Award (DP2-OD008749-01). The authors thank the HSCI/MGH Flow Cytometry Core Facility for analysis and purification of hiPSC differentiation, the MGH Center for Skeletal Research Core (NIH P30 AR066261) for histological processing and MGH Wellman Center for Photomedicine for transmission electron microscopy.	Au P, 2008, BLOOD, V111, P4551, DOI 10.1182/blood-2007-10-118273; Baptista PM, 2011, HEPATOLOGY, V53, P604, DOI 10.1002/hep.24067; Bayless KJ, 2000, AM J PATHOL, V156, P1673, DOI 10.1016/S0002-9440(10)65038-9; Bonvillain RW, 2013, JOVE-J VIS EXP, DOI 10.3791/50825; Booth AJ, 2012, AM J RESP CRIT CARE, V186, P866, DOI 10.1164/rccm.201204-0754OC; Carter EP, 1998, BIOPHYS J, V74, P2121, DOI 10.1016/S0006-3495(98)77919-6; Crisan M, 2008, CELL STEM CELL, V3, P301, DOI 10.1016/j.stem.2008.07.003; Forster C, 2005, J PHYSIOL-LONDON, V565, P475, DOI 10.1113/jphysiol.2005.084038; Gavard J, 2009, MOL CELL BIOL, V29, P2469, DOI 10.1128/MCB.01304-08; Ghaedi M, 2013, J CLIN INVEST, V123, P4950, DOI 10.1172/JCI68793; Gilpin SE, 2014, J HEART LUNG TRANSPL, V33, P298, DOI 10.1016/j.healun.2013.10.030; Herbert SP, 2011, NAT REV MOL CELL BIO, V12, P551, DOI 10.1038/nrm3176; Huang SXL, 2014, NAT BIOTECHNOL, V32, P84, DOI 10.1038/nbt.2754; James D, 2010, NAT BIOTECHNOL, V28, P161, DOI 10.1038/nbt.1605; Kim SH, 2012, BLOOD, V120, P4892, DOI 10.1182/blood-2012-05-428243; Longmire TA, 2012, CELL STEM CELL, V10, P398, DOI 10.1016/j.stem.2012.01.019; MACKERSIE RC, 1987, J SURG RES, V43, P495, DOI 10.1016/0022-4804(87)90122-3; Matthay MA, 2002, PHYSIOL REV, V82, P569, DOI 10.1152/physrev.00003.2002; Melero-Martin JM, 2007, BLOOD, V109, P4761, DOI 10.1182/blood-2006-12-062471; MEYRICK B, 1978, LAB INVEST, V38, P188; Mou HM, 2012, CELL STEM CELL, V10, P385, DOI 10.1016/j.stem.2012.01.018; Nichols JE, 2013, TISSUE ENG PT A, V19, P2045, DOI [10.1089/ten.tea.2012.0250, 10.1089/ten.TEA.2012.0250]; O'Neill JD, 2013, ANN THORAC SURG, V96, P1046, DOI 10.1016/j.athoracsur.2013.04.022; Ott HC, 2008, NAT MED, V14, P213, DOI 10.1038/nm1684; Ott HC, 2010, NAT MED, V16, P927, DOI 10.1038/nm.2193; Petersen TH, 2010, SCIENCE, V329, P538, DOI 10.1126/science.1189345; Prasain N, 2014, NAT BIOTECHNOL, V32, P1151, DOI 10.1038/nbt.3048; Price AP, 2015, TISSUE ENG PART C-ME, V21, P94, DOI [10.1089/ten.tec.2013.0756, 10.1089/ten.TEC.2013.0756]; Ren X, 2015, BIOMATERIALS, V52, P103, DOI 10.1016/j.biomaterials.2015.01.061; Rock JR, 2011, P NATL ACAD SCI USA, V108, pE1475, DOI 10.1073/pnas.1117988108; Sahara M, 2014, CELL RES, V24, P820, DOI 10.1038/cr.2014.59; Salvagiotto G, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017829; Song JJ, 2013, NAT MED, V19, P646, DOI 10.1038/nm.3154; STONE KC, 1992, AM REV RESPIR DIS, V146, P454, DOI 10.1164/ajrccm/146.2.454; Strilic B, 2009, DEV CELL, V17, P505, DOI 10.1016/j.devcel.2009.08.011; Uygun BE, 2010, NAT MED, V16, P814, DOI 10.1038/nm.2170; Wagner DE, 2014, BIOMATERIALS, V35, P3281, DOI 10.1016/j.biomaterials.2013.12.103; Wong AP, 2012, NAT BIOTECHNOL, V30, P876, DOI 10.1038/nbt.2328	39	140	143	0	51	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156	1546-1696		NAT BIOTECHNOL	Nat. Biotechnol.	OCT	2015	33	10					1097	+		10.1038/nbt.3354	http://dx.doi.org/10.1038/nbt.3354			10	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	CT1JX	26368048				2022-12-27	WOS:000362555700031
J	Cheema, T; Kamens, J				Cheema, Tooba; Kamens, Joanne			MASS AWIS: Supporting women in science for over a decade	NATURE BIOTECHNOLOGY			English	Editorial Material									[Cheema, Tooba] Unum Therapeut, Cambridge, MA 02142 USA; [Kamens, Joanne] Addgene, Cambridge, MA USA		Cheema, T (corresponding author), Unum Therapeut, Cambridge, MA 02142 USA.	joanne.kamens@addgene.org		Kamens, Joanne/0000-0002-7000-1477				Beck J, 2015, ATLANTIC; Fridkis-Hareli M, 2011, NAT BIOTECHNOL, V29, P287, DOI 10.1038/nbt.1799; Jaschik S., 2015, INSIDE HIGHER ED; Kamens J., 2014, ADDGENE BLOG BETTER; National Girls Collaborative Project, 2013, STAT GIRLS WOM STEM; Savonick D., 2015, HASTAC BLOG     0626	6	3	3	0	2	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156	1546-1696		NAT BIOTECHNOL	Nat. Biotechnol.	SEP	2015	33	9					1005	1006		10.1038/nbt.3347	http://dx.doi.org/10.1038/nbt.3347			2	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	CR0EK	26348966	Bronze			2022-12-27	WOS:000360990900030
J	Wroblewska, L; Kitada, T; Endo, K; Siciliano, V; Stillo, B; Saito, H; Weiss, R				Wroblewska, Liliana; Kitada, Tasuku; Endo, Kei; Siciliano, Velia; Stillo, Breanna; Saito, Hirohide; Weiss, Ron			Mammalian synthetic circuits with RNA binding proteins for RNA-only delivery	NATURE BIOTECHNOLOGY			English	Article							NONCYTOPATHIC REPLICATION; GENE-EXPRESSION; REPLICONS; BIOLOGY; DESIGN; SWITCH; VIRUS; CELLS	Synthetic regulatory circuits encoded in RNA rather than DNA could provide a means to control cell behavior while avoiding potentially harmful genomic integration in therapeutic applications. We create post-transcriptional circuits using RNA-binding proteins, which can be wired in a plug-and-play fashion to create networks of higher complexity. We show that the circuits function in mammalian cells when encoded in modified mRNA or self-replicating RNA.	[Wroblewska, Liliana; Kitada, Tasuku; Siciliano, Velia; Stillo, Breanna; Weiss, Ron] MIT, Synthet Biol Ctr, Dept Biol Engn, Cambridge, MA 02139 USA; [Endo, Kei; Saito, Hirohide] Kyoto Univ, Ctr iPS Cell Res & Applicat, Dept Life Sci Frontiers, Kyoto, Japan; [Saito, Hirohide] Kyoto Univ, Hakubi Ctr Adv Res, Kyoto, Japan	Massachusetts Institute of Technology (MIT); Kyoto University; Kyoto University	Saito, H (corresponding author), Kyoto Univ, Ctr iPS Cell Res & Applicat, Dept Life Sci Frontiers, Kyoto, Japan.	hirohide.saito@cira.kyoto-u.ac.jp; rweiss@mit.edu	Siciliano, Velia/D-5671-2018; Kitada, Tasuku/B-8121-2009; Endo, Kei/C-7325-2015; Endo, Kei/AAT-2169-2020	Siciliano, Velia/0000-0001-7734-9153; Kitada, Tasuku/0000-0003-2265-3363; Endo, Kei/0000-0003-1020-7884; Endo, Kei/0000-0003-1020-7884; DiAndreth, Breanna/0000-0002-0302-6834	Defense Advanced Research Projects Agency [DARPA-BAA-11-23]; US National Institutes of Health [P50-GM098792, 5-R01-CA155320-03]; National Science Foundation GRFP [1122374]; JSPS KAKENHI [23681042, 24104002]; Research Center Network for Realization of Regenerative Medicine from the Japan Science and Technology Agency; NATIONAL CANCER INSTITUTE [R01CA173712, R01CA155320] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P50GM098792] Funding Source: NIH RePORTER; Grants-in-Aid for Scientific Research [15H05722, 15H02774] Funding Source: KAKEN	Defense Advanced Research Projects Agency(United States Department of DefenseDefense Advanced Research Projects Agency (DARPA)); US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation GRFP(National Science Foundation (NSF)); JSPS KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Research Center Network for Realization of Regenerative Medicine from the Japan Science and Technology Agency; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	We thank K. Hayashi and N. Nishimura (Kyoto University) for supporting modified mRNA experiments. We also thank A.C. Goldstrohm and C. Weidmann (University of Michigan Medical School) for sharing Drosophila constructs containing MS2-fused repressors and the corresponding reporter, X. Zhang (MIT) and O. Andries (Ghent University) for assisting in VEE replicon construction, T.E. Wagner, D. Densmore (Boston University) and S. Payne (MIT) for communicating results before publication, W.M. Gelbart, C.M. Knobler, A. Berk, O. Azizgolshani and J.M. Parker (University of California, Los Angeles) for sharing replicon constructs and expertise, as well as A. Graziano (MIT) for supporting pDNA experiments and H. Chung (Harvard University) for designing the intronic mKate construct. This work was supported by Defense Advanced Research Projects Agency DARPA-BAA-11-23, US National Institutes of Health grants no. P50-GM098792, 5-R01-CA155320-03, National Science Foundation GRFP grant no. 1122374 (R.W.) and JSPS KAKENHI grant numbers 23681042, 24104002, and Research Center Network for Realization of Regenerative Medicine from the Japan Science and Technology Agency (H. S.).	An CI, 2006, RNA, V12, P710, DOI 10.1261/rna.2299306; [Anonymous], 2013, MATLAB STAT TOOLB RE; Aubel D, 2010, BIOESSAYS, V32, P332, DOI 10.1002/bies.200900149; Auslander S, 2014, NAT METHODS, V11, P1154, DOI [10.1038/NMETH.3136, 10.1038/nmeth.3136]; Auslander S, 2012, NATURE, V487, P123, DOI 10.1038/nature11149; Azizgolshani O, 2013, VIROLOGY, V441, P12, DOI 10.1016/j.virol.2013.03.001; Beal J, 2015, ACS SYNTH BIOL, V4, P48, DOI 10.1021/sb500173f; Culler SJ, 2010, SCIENCE, V330, P1251, DOI 10.1126/science.1192128; Frolov I, 1999, J VIROL, V73, P3854, DOI 10.1128/JVI.73.5.3854-3865.1999; Gardner TS, 2000, NATURE, V403, P339, DOI 10.1038/35002131; Green AA, 2014, CELL, V159, P925, DOI 10.1016/j.cell.2014.10.002; Khalil AS, 2010, NAT REV GENET, V11, P367, DOI 10.1038/nrg2775; Kramer BP, 2004, NAT BIOTECHNOL, V22, P867, DOI 10.1038/nbt980; LUSTIG S, 1988, J VIROL, V62, P2329, DOI 10.1128/JVI.62.7.2329-2336.1988; Mortimer I, 1999, GENE THER, V6, P403, DOI 10.1038/sj.gt.3300837; Petrakova O, 2005, J VIROL, V79, P7597, DOI 10.1128/JVI.79.12.7597-7608.2005; Qian L, 2011, SCIENCE, V332, P1196, DOI 10.1126/science.1200520; Rodrigo G, 2012, P NATL ACAD SCI USA, V109, P15271, DOI 10.1073/pnas.1203831109; Sahin U, 2014, NAT REV DRUG DISCOV, V13, P759, DOI 10.1038/nrd4278; Saito H, 2010, NAT CHEM BIOL, V6, P71, DOI [10.1038/NCHEMBIO.273, 10.1038/nchembio.273]; Stewart SA, 2003, RNA, V9, P493, DOI 10.1261/rna.2192803; STRAUSS JH, 1994, MICROBIOL REV, V58, P491, DOI 10.1128/MMBR.58.3.491-562.1994; Szymczak AL, 2004, NAT BIOTECHNOL, V22, P589, DOI 10.1038/nbt957; Tavernier G, 2011, J CONTROL RELEASE, V150, P238, DOI 10.1016/j.jconrel.2010.10.020; Van Etten J, 2012, J BIOL CHEM, V287, P36370, DOI 10.1074/jbc.M112.373522; Xie Z, 2011, SCIENCE, V333, P1307, DOI 10.1126/science.1205527	26	121	129	5	76	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156	1546-1696		NAT BIOTECHNOL	Nat. Biotechnol.	AUG	2015	33	8					839	+		10.1038/nbt.3301	http://dx.doi.org/10.1038/nbt.3301			5	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	CO6OB	26237515	Green Accepted, Green Submitted			2022-12-27	WOS:000359274900022
J	Craft, AM; Rockel, JS; Nartiss, Y; Kandel, RA; Alman, BA; Keller, GM				Craft, April M.; Rockel, Jason S.; Nartiss, Yulia; Kandel, Rita A.; Alman, Benjamin A.; Keller, Gordon M.			Generation of articular chondrocytes from human pluripotent stem cells	NATURE BIOTECHNOLOGY			English	Article							CARTILAGE FORMATION; IN-VITRO; ENDOCHONDRAL OSSIFICATION; SYNOVIAL JOINT; II RECEPTOR; MOUSE LIMB; DIFFERENTIATION; COLLAGEN; BETA; BONE	The replacement of articular cartilage through transplantation of chondrogenic cells or preformed cartilage tissue represents a potential new avenue for the treatment of degenerative joint diseases. Although many studies have described differentiation of human pluripotent stem cells (hPSCs) to the chondrogenic lineage, the generation of chondrocytes able to produce stable articular cartilage in vivo has not been demonstrated. Here we show that activation of the TGF beta pathway in hPSC-derived chondrogenic progenitors promotes the efficient development of articular chondrocytes that can form stable cartilage tissue in vitro and in vivo. In contrast, chondrocytes specified by BMP4 signaling display characteristics of hypertrophy and give rise to cartilage tissues that initiate the endochondral ossification process in vivo. These findings provide a simple serum-free and efficient approach for the routine generation of hPSC-derived articular chondrocytes for modeling diseases of the joint and developing cell therapy approaches to treat them.	[Craft, April M.; Nartiss, Yulia; Keller, Gordon M.] McEwen Ctr Regenerat Med, Univ Hlth Network, Toronto, ON, Canada; [Craft, April M.; Nartiss, Yulia; Keller, Gordon M.] Princess Margaret Canc Ctr, Toronto, ON, Canada; [Rockel, Jason S.; Alman, Benjamin A.] Hosp Sick Children, Dev & Stem Cell Biol, Toronto, ON M5G 1X8, Canada; [Kandel, Rita A.] Mt Sinai Hosp, Lunenfeld Tanenbaum Res Inst, Toronto, ON M5G 1X5, Canada; [Keller, Gordon M.] Univ Toronto, Dept Med Biophys, Toronto, ON, Canada	University of Toronto; University Toronto Affiliates; University Health Network Toronto; University of Toronto; University Toronto Affiliates; University Health Network Toronto; Princess Margaret Cancer Centre; University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Toronto; University Toronto Affiliates; Sinai Health System Toronto; Lunenfeld Tanenbaum Research Institute; University of Toronto	Craft, AM (corresponding author), Harvard Univ, Sch Med, Dept Orthoped Surg, Boston Childrens Hosp,Orthoped Res Labs, Boston, MA 02115 USA.	april.craft@childrens.harvard.edu; gkeller@uhnresearch.ca	Kandel, Rita/AAU-9908-2021; Kandel, Rita/E-2149-2017	Kandel, Rita/0000-0003-4047-3913; Kandel, Rita/0000-0003-4047-3913; Keller, Gordon/0000-0001-9309-9297	Canadian Institutes of Health Research [MOP 219710]	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR))	We thank D. Taylor for providing primary human chondrocyte samples, H. Whetstone for histological expertise and helpful discussions, and A. Grigoriadis, F. Beier and members of the Keller laboratory for critical reading of the manuscript. We thank T. Araki and B. Neel (Ontario Cancer Institute, Toronto) for the iBJ hiPSC line and M. Warman (Boston Children's Hospital) and G. Jay (Lifespan Health System, RI) for the lubricin antibody. This work was supported by a grant from Canadian Institutes of Health Research (MOP 219710) to B. A. A. and G.M.K., and a generous contribution from the Krembil Foundation to A.M.C. and G.M.K.	Archer Charles W., 2003, Birth Defects Research, V69, P144, DOI 10.1002/bdrc.10015; Bernardo BC, 2011, J BIOL CHEM, V286, P37758, DOI 10.1074/jbc.M111.248039; Colnot C, 2005, J CELL BIOCHEM, V95, P688, DOI 10.1002/jcb.20449; Craft AM, 2013, DEVELOPMENT, V140, P2597, DOI 10.1242/dev.087890; Enomoto-Iwamoto M, 1998, J CELL BIOL, V140, P409, DOI 10.1083/jcb.140.2.409; Evseenko D, 2010, P NATL ACAD SCI USA, V107, P13742, DOI 10.1073/pnas.1002077107; Farrell E, 2011, BMC MUSCULOSKEL DIS, V12, DOI 10.1186/1471-2474-12-31; Fukunaga T, 2003, BONE, V33, P911, DOI 10.1016/j.bone.2003.07.010; Goldring MB, 2011, EUR CELLS MATER, V21, P202, DOI 10.22203/eCM.v021a16; Guo SZ, 2010, CELL MOL BIOL LETT, V15, P153, DOI 10.2478/s11658-009-0040-2; Hwang NS, 2008, P NATL ACAD SCI USA, V105, P20641, DOI 10.1073/pnas.0809680106; Iwamoto M, 2007, DEV BIOL, V305, P40, DOI 10.1016/j.ydbio.2007.01.037; Janicki P, 2010, ACTA BIOMATER, V6, P3292, DOI 10.1016/j.actbio.2010.01.037; Kattman SJ, 2011, CELL STEM CELL, V8, P228, DOI 10.1016/j.stem.2010.12.008; Kennedy M, 2007, BLOOD, V109, P2679, DOI 10.1182/blood-2006-09-047704; Koch M, 2004, J BIOL CHEM, V279, P22514, DOI 10.1074/jbc.M400536200; Koyama E, 2008, DEV BIOL, V316, P62, DOI 10.1016/j.ydbio.2008.01.012; Kronenberg H M, 2001, Novartis Found Symp, V232, P144; Kronenberg HM, 2001, NOVART FDN SYMP, V232, P152; Li TS, 2013, STEM CELLS DEV, V22, P1342, DOI 10.1089/scd.2012.0207; Mackay AM, 1998, TISSUE ENG, V4, P415, DOI 10.1089/ten.1998.4.415; Murry CE, 2008, CELL, V132, P661, DOI 10.1016/j.cell.2008.02.008; Oldershaw RA, 2010, NAT BIOTECHNOL, V28, P1221, DOI 10.1038/nbt.1683; Pacifici M, 2006, ANN NY ACAD SCI, V1068, P74, DOI 10.1196/annals.1346.010; Park IH, 2008, NATURE, V451, P141, DOI [10.1038/nature06534, 10.1038/natureO6534]; Pelttari K, 2006, ARTHRITIS RHEUM-US, V54, P3254, DOI 10.1002/art.22136; Pelttari K, 2008, INJURY, V39, pS58, DOI 10.1016/j.injury.2008.01.038; ROARK EF, 1994, DEV DYNAM, V200, P103, DOI 10.1002/aja.1002000203; Saeed AI, 2003, BIOTECHNIQUES, V34, P374, DOI 10.2144/03342mt01; Sasano Y, 1996, ANAT EMBRYOL, V194, P247; Scotti C, 2013, P NATL ACAD SCI USA, V110, P3997, DOI 10.1073/pnas.1220108110; Serra R, 1997, J CELL BIOL, V139, P541, DOI 10.1083/jcb.139.2.541; Spagnoli A, 2007, J CELL BIOL, V177, P1105, DOI 10.1083/jcb.200611031; Steinert AF, 2007, ARTHRITIS RES THER, V9, DOI 10.1186/ar2195; Tanaka M, 2009, STEM CELL RES, V3, P126, DOI 10.1016/j.scr.2009.07.001; Toh WS, 2010, BIOMATERIALS, V31, P6968, DOI 10.1016/j.biomaterials.2010.05.064; Umeda K, 2012, SCI REP-UK, V2, DOI 10.1038/srep00455; Volk SW, 1998, J BONE MINER RES, V13, P1521, DOI 10.1359/jbmr.1998.13.10.1521; Wang X, 2011, INT J MOL MED, V27, P583, DOI 10.3892/ijmm.2011.611; Witty AD, 2014, NAT BIOTECHNOL, V32, P1026, DOI 10.1038/nbt.3002; Yang L, 2008, NATURE, V453, P524, DOI 10.1038/nature06894; Zhang QY, 2011, GENESIS, V49, P75, DOI 10.1002/dvg.20702	42	111	117	0	46	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156	1546-1696		NAT BIOTECHNOL	Nat. Biotechnol.	JUN	2015	33	6					638	+		10.1038/nbt.3210	http://dx.doi.org/10.1038/nbt.3210			9	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	CK2DE	25961409				2022-12-27	WOS:000356019700024
J	Risso, D; Ngai, J; Speed, TP; Dudoit, S				Risso, Davide; Ngai, John; Speed, Terence P.; Dudoit, Sandrine			Normalization of RNA-seq data using factor analysis of control genes or samples	NATURE BIOTECHNOLOGY			English	Article							LOCALLY WEIGHTED REGRESSION; MESSENGER-RNA; DIFFERENTIAL EXPRESSION; MICROARRAY DATA; SINGLE	Normalization of RNA-sequencing (RNA-seq) data has proven essential to ensure accurate inference of expression levels. Here, we show that usual normalization approaches mostly account for sequencing depth and fail to correct for library preparation and other more complex unwanted technical effects. We evaluate the performance of the External RNA Control Consortium (ERCC) spike-in controls and investigate the possibility of using them directly for normalization. We show that the spike-ins are not reliable enough to be used in standard global-scaling or regression-based normalization procedures. We propose a normalization strategy, called remove unwanted variation (RUV), that adjusts for nuisance technical effects by performing factor analysis on suitable sets of control genes (e.g., ERCC spike-ins) or samples (e.g., replicate libraries). Our approach leads to more accurate estimates of expression fold-changes and tests of differential expression compared to state-of-the-art normalization methods. In particular, RUV promises to be valuable for large collaborative projects involving multiple laboratories, technicians, and/or sequencing platforms.	[Risso, Davide; Speed, Terence P.; Dudoit, Sandrine] Univ Calif Berkeley, Dept Stat, Berkeley, CA 94720 USA; [Ngai, John] Univ Calif Berkeley, Dept Mol & Cell Biol, Berkeley, CA 94720 USA; [Ngai, John] Univ Calif Berkeley, Helen Wills Neurosci Inst, Berkeley, CA 94720 USA; [Ngai, John] Univ Calif Berkeley, Funct Genom Lab, Berkeley, CA 94720 USA; [Speed, Terence P.] Royal Melbourne Hosp, Walter & Eliza Hall Inst Med Res, Bioinformat Div, Parkville, Vic 3050, Australia; [Speed, Terence P.] Univ Melbourne, Dept Math & Stat, Melbourne, Vic 3010, Australia; [Dudoit, Sandrine] Univ Calif Berkeley, Div Biostat, Berkeley, CA 94720 USA	University of California System; University of California Berkeley; University of California System; University of California Berkeley; University of California System; University of California Berkeley; University of California System; University of California Berkeley; Royal Melbourne Hospital; Walter & Eliza Hall Institute; University of Melbourne; University of California System; University of California Berkeley	Risso, D (corresponding author), Univ Calif Berkeley, Dept Stat, Berkeley, CA 94720 USA.	davide.risso@berkeley.edu; sandrine@stat.berkeley.edu	Risso, Davide/H-5351-2019	Risso, Davide/0000-0001-8508-5012	National Health and Medical Research Council (NHMRC) Australia; National Institute on Deafness and Other Communication Disorders; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC007235] Funding Source: NIH RePORTER	National Health and Medical Research Council (NHMRC) Australia(National Health and Medical Research Council (NHMRC) of Australia); National Institute on Deafness and Other Communication Disorders(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	We thank the SEQC Consortium for granting us early access to the SEQC pilot data, L. Jacob for his help with the RUV methodology and its software implementation, and J. Gagnon-Bartsch, J. Choi, and W Shi for helpful discussions. J.N. was supported by a grant from the National Institute on Deafness and Other Communication Disorders. T.P.S. was supported by a National Health and Medical Research Council (NHMRC) Australia Fellowship.	Baker SC, 2005, NAT METHODS, V2, P731, DOI 10.1038/nmeth1005-731; Bolstad BM, 2003, BIOINFORMATICS, V19, P185, DOI 10.1093/bioinformatics/19.2.185; Brennecke P, 2013, NAT METHODS, V10, P1093, DOI [10.1038/nmeth.2645, 10.1038/NMETH.2645]; Bullard JH, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-94; Canales RD, 2006, NAT BIOTECHNOL, V24, P1115, DOI 10.1038/nbt1236; Chin L, 2008, NATURE, V455, P1061, DOI 10.1038/nature07385; CLEVELAND WS, 1979, J AM STAT ASSOC, V74, P829, DOI 10.2307/2286407; CLEVELAND WS, 1988, J AM STAT ASSOC, V83, P596, DOI 10.2307/2289282; Dillies MA, 2013, BRIEF BIOINFORM, V14, P671, DOI 10.1093/bib/bbs046; Feingold EA, 2004, SCIENCE, V306, P636, DOI 10.1126/science.1105136; Ferreira T, 2014, NEURON, V81, P847, DOI 10.1016/j.neuron.2014.01.001; Gagnon-Bartsch JA, 2012, BIOSTATISTICS, V13, P539, DOI 10.1093/biostatistics/kxr034; Hansen KD, 2012, BIOSTATISTICS, V13, P204, DOI 10.1093/biostatistics/kxr054; Jacob L., 2013, 818 U CAL DEP STAT; Jiang LC, 2011, GENOME RES, V21, P1543, DOI 10.1101/gr.121095.111; Leek JT, 2007, PLOS GENET, V3, P1724, DOI 10.1371/journal.pgen.0030161; Loven J, 2012, CELL, V151, P476, DOI 10.1016/j.cell.2012.10.012; Oshlack A, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-1-r2; Qing T, 2013, SCI CHINA LIFE SCI, V56, P134, DOI 10.1007/s11427-013-4437-9; Risso D, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-480; Risso D, 2009, BIOINFORMATICS, V25, P2685, DOI 10.1093/bioinformatics/btp443; Robinson MD, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-3-r25; SPEED T. P, 2013, 820 U CAL DEP STAT; Su ZQ, 2014, NAT BIOTECHNOL, V32, P903, DOI 10.1038/nbt.2957; Sun ZN, 2012, BIOINFORMATICS, V28, P2584, DOI 10.1093/bioinformatics/bts497; 't Hoen PAC, 2013, NAT BIOTECHNOL, V31, P1015, DOI 10.1038/nbt.2702; Tang FC, 2011, NAT METHODS, V8, pS6, DOI [10.1038/NMETH.1557, 10.1038/nmeth.1557]; Wu D, 2013, RNA, V19, P876, DOI 10.1261/rna.035055.112; Yang YH, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/30.4.e15	29	857	868	5	87	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156	1546-1696		NAT BIOTECHNOL	Nat. Biotechnol.	SEP	2014	32	9					896	902		10.1038/nbt.2931	http://dx.doi.org/10.1038/nbt.2931			7	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	AQ2FD	25150836	Green Accepted, Green Published, Bronze			2022-12-27	WOS:000342600300029
J	Trainor, N; Pietak, A; Smith, T				Trainor, Nuala; Pietak, Alexis; Smith, Tim			Rethinking clinical delivery of adult stem cell therapies	NATURE BIOTECHNOLOGY			English	Article							FDA		[Trainor, Nuala; Pietak, Alexis; Smith, Tim] Octane Biotech Inc, Kingston, ON, Canada		Trainor, N (corresponding author), Octane Biotech Inc, Kingston, ON, Canada.	info@octaneco.com						Abdallah BM, 2008, GENE THER, V15, P109, DOI 10.1038/sj.gt.3303067; [Anonymous], 2010, INBOUND LOGISTICS, V30, P75; Atoui R, 2012, STEM CELL TRANSL MED, V1, P200, DOI 10.5966/sctm.2011-0012; Cosh E, 2007, J COMMER BIOTECHNOL, V13, P263, DOI DOI 10.1057/PALGRAVE.JCB.3050062; Denault J., 2008, BIOPROCESS INT, V6, P14; Freeman M, 2012, J TRANSL MED, V10, DOI 10.1186/1479-5876-10-60; Glotzbach JP, 2011, CURR PROB SURG, V48, P148, DOI 10.1067/j.cpsurg.2010.11.002; Hakimian R, 2004, JAMA-J AM MED ASSOC, V292, P2500, DOI 10.1001/jama.292.20.2500; Halme DG, 2006, NEW ENGL J MED, V355, P1730, DOI 10.1056/NEJMhpr063086; Huang XP, 2010, CIRCULATION, V122, P2419, DOI 10.1161/CIRCULATIONAHA.110.955971; Martin I, 2009, TRENDS BIOTECHNOL, V27, P495, DOI 10.1016/j.tibtech.2009.06.002; O'Brien J., 2012, FORTUNE; Porter DL, 2011, HEMATOL-AM SOC HEMAT, P292, DOI 10.1182/asheducation-2011.1.292; Santoro R, 2010, BIOMATERIALS, V31, P8946, DOI 10.1016/j.biomaterials.2010.08.009; Thomas R., 2009, PHARMATECH, V33, P74; US Food and Drug Administration, 2007, GUID IND CELL SEL DE	16	37	41	0	22	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156	1546-1696		NAT BIOTECHNOL	Nat. Biotechnol.	AUG	2014	32	8					729	735		10.1038/nbt.2970	http://dx.doi.org/10.1038/nbt.2970			7	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	AW7PF	25093878				2022-12-27	WOS:000346455900011
J	Deverman, BE; Pravdo, PL; Simpson, BP; Kumar, SR; Chan, KY; Banerjee, A; Wu, WL; Yang, B; Huber, N; Pasca, SP; Gradinaru, V				Deverman, Benjamin E.; Pravdo, Piers L.; Simpson, Bryan P.; Kumar, Sripriya Ravindra; Chan, Ken Y.; Banerjee, Abhik; Wu, Wei-Li; Yang, Bin; Huber, Nina; Pasca, Sergiu P.; Gradinaru, Viviana			Cre-dependent selection yields AAV variants for widespread gene transfer to the adult brain	NATURE BIOTECHNOLOGY			English	Article							ADENOASSOCIATED VIRUS TYPE-2; IN-VIVO; NEUTRALIZING ANTIBODIES; DIRECTED EVOLUTION; NONHUMAN-PRIMATES; RECOMBINANT AAV; NERVOUS-SYSTEM; VIRAL-VECTORS; SPINAL-CORD; THERAPY	Recombinant adeno-associated viruses (rAAVs) are commonly used vehicles for in vivo gene transfer(1-6). However, the tropism repertoire of naturally occurring AAVs is limited, prompting a search for novel AAV capsids with desired characteristics(7-13). Here we describe a capsid selection method, called Cre recombination-based AAV targeted evolution (CREATE), that enables the development of AAV capsids that more efficiently transduce defined Cre-expressing cell populations in vivo. We use CREATE to generate AAV variants that efficiently and widely transduce the adult mouse central nervous system (CNS) after intravenous injection. One variant, AAV-PHP.B, transfers genes throughout the CNS with an efficiency that is at least 40-fold greater than that of the current standard, AAV9 (refs. 14-17), and transduces the majority of astrocytes and neurons across multiple CNS regions. In vitro, it transduces human neurons and astrocytes more efficiently than does AAV9, demonstrating the potential of CREATE to produce customized AAV vectors for biomedical applications.	[Deverman, Benjamin E.; Pravdo, Piers L.; Simpson, Bryan P.; Kumar, Sripriya Ravindra; Chan, Ken Y.; Banerjee, Abhik; Wu, Wei-Li; Yang, Bin; Gradinaru, Viviana] CALTECH, Div Biol & Biol Engn, Pasadena, CA 91125 USA; [Huber, Nina; Pasca, Sergiu P.] Stanford Univ, Sch Med, Dept Psychiat & Behav Sci, Stanford, CA 94305 USA	California Institute of Technology; Stanford University	Deverman, BE; Gradinaru, V (corresponding author), CALTECH, Div Biol & Biol Engn, Pasadena, CA 91125 USA.	bd@caltech.edu; viviana@caltech.edu	Wu, Wei-Li/ADY-3311-2022; Pasca, Sergiu/AAY-3949-2021	Pasca, Sergiu/0000-0002-3216-3248; Deverman, Benjamin/0000-0002-6223-9303; Chan, Ken/0000-0002-8853-5186; Simpson, Bryan/0000-0003-0192-6027	Hereditary Disease Foundation; Caltech-City of Hope Biomedical Initiative; National Institutes of Health (NIH) Director's New Innovator [1DP2NS087949]; NIH/National Institute on Aging (NIA) [1R01AG047664]; Beckman Institute for CLARITY, Optogenetics and Vector Engineering Research; Gordon and Betty Moore Foundation [GBMF2809]; Caltech Programmable Molecular Technology Initiative; NIH BRAIN [1U01NS090577]; NIH/National Institute of Mental Health (NIMH) [1R21MH103824-01]; Pew Charitable Trust; Sloan Foundation; Kimmel Foundation; Human Frontiers in Science Program; Caltech-GIST; NIMH [1R01MH100900, 1R01MH100900-02S1]; NIMH BRAINS [R01MH107800]; California Institute of Regenerative Medicine (CIRM); MQ Fellow Award; Donald E. and Delia B. Baxter Foundation Scholar Award; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH100900, R21MH103824, R01MH107800] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [U01NS090577, DP2NS087949] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG047664] Funding Source: NIH RePORTER	Hereditary Disease Foundation; Caltech-City of Hope Biomedical Initiative; National Institutes of Health (NIH) Director's New Innovator(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH/National Institute on Aging (NIA)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); Beckman Institute for CLARITY, Optogenetics and Vector Engineering Research; Gordon and Betty Moore Foundation(Gordon and Betty Moore Foundation); Caltech Programmable Molecular Technology Initiative; NIH BRAIN(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH/National Institute of Mental Health (NIMH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); Pew Charitable Trust; Sloan Foundation(Alfred P. Sloan Foundation); Kimmel Foundation; Human Frontiers in Science Program(Human Frontier Science Program); Caltech-GIST; NIMH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NIMH BRAINS; California Institute of Regenerative Medicine (CIRM)(California Institute for Regenerative Medicine); MQ Fellow Award; Donald E. and Delia B. Baxter Foundation Scholar Award; NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This article and the naming of the novel AAV clones are dedicated to the memory of Paul H. Patterson (P.H.P.), who passed away during the preparation of this manuscript. We wish to thank L. Rodriguez and P. Anguiano for administrative assistance, A. Balazs and S. Cassenaer and the entire Gradinaru and Patterson laboratories for helpful discussions, and A. Choe for helpful comments on the manuscript. We thank the University of Pennsylvania vector core for the AAV2/9 Rep-Cap plasmid, A. Balazs and D. Baltimore for the AAV genome plasmid, and the Biological Imaging Facility, supported by the Caltech Beckman Institute and the Arnold and Mabel Beckman Foundation, for use of imaging equipment. This work was supported by grants from the Hereditary Disease Foundation and the Caltech-City of Hope Biomedical Initiative (to P. H. P.) and from the National Institutes of Health (NIH) Director's New Innovator 1DP2NS087949; NIH/National Institute on Aging (NIA) 1R01AG047664; Beckman Institute for CLARITY, Optogenetics and Vector Engineering Research; and the Gordon and Betty Moore Foundation through grant GBMF2809 to the Caltech Programmable Molecular Technology Initiative (to V.G.). Work in the Gradinaru laboratory is also funded by the following awards (to V.G.): NIH BRAIN 1U01NS090577; NIH/National Institute of Mental Health (NIMH) 1R21MH103824-01; Pew Charitable Trust; Sloan Foundation; Kimmel Foundation; Human Frontiers in Science Program; Caltech-GIST; Caltech-City of Hope Biomedical Initiative. Work in the Pasca laboratory is supported by a NIMH 1R01MH100900 and 1R01MH100900-02S1, the NIMH BRAINS Award (R01MH107800), the California Institute of Regenerative Medicine (CIRM), the MQ Fellow Award and the Donald E. and Delia B. Baxter Foundation Scholar Award (to S.P.P.).	ALBERT H, 1995, PLANT J, V7, P649, DOI 10.1046/j.1365-313X.1995.7040649.x; Ayuso E, 2010, GENE THER, V17, P503, DOI 10.1038/gt.2009.157; Bartlett JS, 1999, NAT BIOTECHNOL, V17, P181, DOI 10.1038/6185; Bartlett JS, 1998, HUM GENE THER, V9, P1181, DOI 10.1089/hum.1998.9.8-1181; Belmonte JCI, 2015, NEURON, V86, P617, DOI 10.1016/j.neuron.2015.03.021; Betley JN, 2011, HUM GENE THER, V22, P669, DOI 10.1089/hum.2010.204; Bevan AK, 2011, MOL THER, V19, P1971, DOI 10.1038/mt.2011.157; Borel F, 2014, MOL THER, V22, P692, DOI 10.1038/mt.2013.285; Boutin S, 2010, HUM GENE THER, V21, P704, DOI 10.1089/hum.2009.182; Calcedo R, 2009, J INFECT DIS, V199, P381, DOI 10.1086/595830; Chakrabarty P, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067680; Chiorini JA, 1999, J VIROL, V73, P1309, DOI 10.1128/JVI.73.2.1309-1319.1999; Dalkara D, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3005708; Denise A, 2004, NAT NEUROSCI, V7, P1233, DOI 10.1038/nn1340; Dufour BD, 2014, MOL THER, V22, P797, DOI 10.1038/mt.2013.289; Excoffon KJDA, 2009, P NATL ACAD SCI USA, V106, P3865, DOI 10.1073/pnas.0813365106; Farris KD, 2008, HUM GENE THER, V19, P1421, DOI 10.1089/hgt.2008.118; Foust KD, 2009, NAT BIOTECHNOL, V27, P59, DOI 10.1038/nbt.1515; Gaudet D, 2010, ATHEROSCLEROSIS SUPP, V11, P55, DOI 10.1016/j.atherosclerosissup.2010.03.004; Gray SJ, 2011, CURR PROTOC NEUROS S, V57; Gray SJ, 2011, MOL THER, V19, P1058, DOI 10.1038/mt.2011.72; Grimm D, 2008, J VIROL, V82, P5887, DOI 10.1128/JVI.00254-08; Guenthner CJ, 2013, NEURON, V78, P773, DOI 10.1016/j.neuron.2013.03.025; HANCOCK JF, 1991, EMBO J, V10, P4033, DOI 10.1002/j.1460-2075.1991.tb04979.x; High KH, 2014, HAEMOPHILIA, V20, P43, DOI 10.1111/hae.12411; Kaplitt MG, 2007, LANCET, V369, P2097, DOI 10.1016/S0140-6736(07)60982-9; Kawashima T, 2013, NAT METHODS, V10, P889, DOI [10.1038/NMETH.2559, 10.1038/nmeth.2559]; LEVITT N, 1989, GENE DEV, V3, P1019, DOI 10.1101/gad.3.7.1019; Lisowski L, 2014, NATURE, V506, P382, DOI 10.1038/nature12875; Maguire AM, 2008, NEW ENGL J MED, V358, P2240, DOI 10.1056/NEJMoa0802315; Maguire C, 2014, NEUROTHERAPEUTICS, V11, P817, DOI 10.1007/s13311-014-0299-5; Maheshri N, 2006, NAT BIOTECHNOL, V24, P198, DOI 10.1038/nbt1182; Muller OJ, 2003, NAT BIOTECHNOL, V21, P1040, DOI 10.1038/nbt856; Nathwani AC, 2011, MOL THER, V19, P876, DOI 10.1038/mt.2010.274; Ojala DS, 2015, NEUROSCIENTIST, V21, P84, DOI 10.1177/1073858414521870; Pasca AM, 2015, NAT METHODS, V12, P671, DOI [10.1038/nmeth.3415, 10.1038/NMETH.3415]; Pulicherla N, 2011, MOL THER, V19, P1070, DOI 10.1038/mt.2011.22; Samaranch L, 2012, HUM GENE THER, V23, P382, DOI 10.1089/hum.2011.200; Shaner NC, 2013, NAT METHODS, V10, P407, DOI [10.1038/NMETH.2413, 10.1038/nmeth.2413]; Sonntag F, 2010, P NATL ACAD SCI USA, V107, P10220, DOI 10.1073/pnas.1001673107; Treweek JB, 2015, NAT PROTOC, V10, P1860, DOI 10.1038/nprot.2015.122; van der Marel S, 2011, INFLAMM BOWEL DIS, V17, P2436, DOI 10.1002/ibd.21673; Wall NR, 2010, P NATL ACAD SCI USA, V107, P21848, DOI 10.1073/pnas.1011756107; Wang HY, 2014, HUM MOL GENET, V23, P668, DOI 10.1093/hmg/ddt454; Wobus CE, 2000, J VIROL, V74, P9281, DOI 10.1128/JVI.74.19.9281-9293.2000; Wu ZJ, 2006, MOL THER, V14, P316, DOI 10.1016/j.ymthe.2006.05.009; Xie J, 2011, MOL THER, V19, P526, DOI 10.1038/mt.2010.279; Yang B, 2014, CELL, V158, P945, DOI 10.1016/j.cell.2014.07.017; Ying Y, 2010, GENE THER, V17, P980, DOI 10.1038/gt.2010.44; Zolotukhin S, 1999, GENE THER, V6, P973, DOI 10.1038/sj.gt.3300938	50	500	556	12	115	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156	1546-1696		NAT BIOTECHNOL	Nat. Biotechnol.	FEB	2016	34	2					204	+		10.1038/nbt.3440	http://dx.doi.org/10.1038/nbt.3440			8	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	DD0OK	26829320	Green Accepted			2022-12-27	WOS:000369619100024
J	Huggett, B				Huggett, Brady			Top US universities, institutes for life sciences in 2014	NATURE BIOTECHNOLOGY			English	Editorial Material																			0	3	3	0	0	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1087-0156	1546-1696		NAT BIOTECHNOL	Nat. Biotechnol.	NOV	2015	33	11					1131	1131		10.1038/nbt.3394	http://dx.doi.org/10.1038/nbt.3394			1	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	CW3TY	26544138	Bronze			2022-12-27	WOS:000364916000030
J	Brown, CT				Brown, C. Titus			Strain recovery from metagenomes	NATURE BIOTECHNOLOGY			English	Editorial Material							GENOMES		Univ Calif Davis, Sch Vet Med, Davis, CA 95616 USA	University of California System; University of California Davis	Brown, CT (corresponding author), Univ Calif Davis, Sch Vet Med, Davis, CA 95616 USA.	ctbrown@ucdavis.edu		Brown, C. Titus/0000-0001-6001-2677				Abubucker S, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002358; Alneberg J, 2014, NAT METHODS, V11, P1144, DOI [10.1038/NMETH.3103, 10.1038/nmeth.3103]; Bankevich A, 2012, J COMPUT BIOL, V19, P455, DOI 10.1089/cmb.2012.0021; Cleary B, 2015, NAT BIOTECHNOL, V33, P1053, DOI 10.1038/nbt.3329; Imelfort M, 2014, PEERJ, V2, DOI 10.7717/peerj.603; Iverson V, 2012, SCIENCE, V335, P587, DOI 10.1126/science.1212665; Pell J, 2012, P NATL ACAD SCI USA, V109, P13272, DOI 10.1073/pnas.1121464109; Rimmer A, 2014, NAT GENET, V46, P912, DOI 10.1038/ng.3036; Segata N, 2012, NAT METHODS, V9, P811, DOI [10.1038/NMETH.2066, 10.1038/nmeth.2066]; Shakya M, 2013, ENVIRON MICROBIOL, V15, P1882, DOI 10.1111/1462-2920.12086; Sharon I, 2013, GENOME RES, V23, P111, DOI 10.1101/gr.142315.112	12	10	10	1	8	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156	1546-1696		NAT BIOTECHNOL	Nat. Biotechnol.	OCT	2015	33	10					1041	1043						4	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	CT1JX	26448087				2022-12-27	WOS:000362555700021
J	Humphrey, SJ; Azimifar, SB; Mann, M				Humphrey, Sean J.; Azimifar, S. Babak; Mann, Matthias			High-throughput phosphoproteomics reveals in vivo insulin signaling dynamics	NATURE BIOTECHNOLOGY			English	Article							LARGE-SCALE ANALYSIS; PHOSPHORYLATION DYNAMICS; PROTEIN-PHOSPHORYLATION; KINASE; QUANTIFICATION; ACTIVATION; AKT/PKB	Mass spectrometry has enabled the study of cellular signaling on a systems-wide scale, through the quantification of post-translational modifications, such as protein phosphorylation(1). Here we describe EasyPhos, a scalable phosphoproteomics platform that now allows rapid quantification of hundreds of phosphoproteomes in diverse cells and tissues at a depth of >10,000 sites. We apply this technology to generate time-resolved maps of insulin signaling in the mouse liver. Our results reveal that insulin affects similar to 10% of the liver phosphoproteome and that many known functional phosphorylation sites, and an even larger number of unknown sites, are modified at very early time points (<15 s after insulin delivery). Our kinetic data suggest that the flow of signaling information from the cell surface to the nucleus can occur on very rapid timescales of less than 1 min in vivo. EasyPhos facilitates high-throughput phosphoproteomics studies, which should improve our understanding of dynamic cell signaling networks and how they are regulated and dysregulated in disease.	[Humphrey, Sean J.; Azimifar, S. Babak; Mann, Matthias] Max Planck Inst Biochem, Dept Prote & Signal Transduct, D-82152 Martinsried, Germany	Max Planck Society	Mann, M (corresponding author), Max Planck Inst Biochem, Dept Prote & Signal Transduct, Klopferspitz 18A, D-82152 Martinsried, Germany.	mmann@biochem.mpg.de	Humphrey, Sean/AAC-1425-2019	Humphrey, Sean/0000-0002-2666-9744	EMBO (European Molecular Biology Organization) Long Term fellowship; Virtual Liver Network of the German Federal Ministry of Education and Research (BMBF) [0315748]	EMBO (European Molecular Biology Organization) Long Term fellowship(European Molecular Biology Organization (EMBO)); Virtual Liver Network of the German Federal Ministry of Education and Research (BMBF)(Federal Ministry of Education & Research (BMBF))	We thank I. Paron, K. Mayr and G. Sowa for mass spectrometry technical assistance, J. Cox for bioinformatic tools and support, and E.S. Humphrey, M.Y. Hein, N. Kulak, G. Pichler and N. Nagaraj for helpful discussions. S.J.H. is supported by an EMBO (European Molecular Biology Organization) Long Term fellowship, and the project was supported by the Virtual Liver Network (grant 0315748) of the German Federal Ministry of Education and Research (BMBF).	Alessi DR, 1997, CURR BIOL, V7, P261, DOI 10.1016/S0960-9822(06)00122-9; Berglund ED, 2009, ENDOCRINOLOGY, V150, P4084, DOI 10.1210/en.2009-0221; Brunet A, 2002, J CELL BIOL, V156, P817, DOI 10.1083/jcb.200112059; Cox J, 2014, MOL CELL PROTEOMICS, V13, P2513, DOI 10.1074/mcp.M113.031591; de Graaf EL, 2014, MOL CELL PROTEOMICS, V13, P2426, DOI 10.1074/mcp.O113.036608; Dickhut C, 2014, J PROTEOME RES, V13, P2761, DOI 10.1021/pr401181y; Dubois F, 2009, MOL CELL PROTEOMICS, V8, P2487, DOI 10.1074/mcp.M800544-MCP200; Ferrell JE, 2014, TRENDS BIOCHEM SCI, V39, P556, DOI 10.1016/j.tibs.2014.09.003; Frias MA, 2006, CURR BIOL, V16, P1865, DOI 10.1016/j.cub.2006.08.001; Hsu PP, 2011, SCIENCE, V332, P1317, DOI 10.1126/science.1199498; Humphrey SJ, 2013, CELL METAB, V17, P1009, DOI 10.1016/j.cmet.2013.04.010; Huttlin EL, 2010, CELL, V143, P1174, DOI 10.1016/j.cell.2010.12.001; Kanshin E, 2015, CELL REP, V10, P1202, DOI 10.1016/j.celrep.2015.01.052; Kouhara H, 1997, CELL, V89, P693, DOI 10.1016/S0092-8674(00)80252-4; Liu PD, 2014, NATURE, V508, P541, DOI 10.1038/nature13079; Lundby A, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1871; Matsumoto M, 2007, CELL METAB, V6, P208, DOI 10.1016/j.cmet.2007.08.006; Mok J, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.2000482; Monetti M, 2011, NAT METHODS, V8, P655, DOI [10.1038/nmeth.1647, 10.1038/NMETH.1647]; Narvekar P, 2009, DIABETES, V58, P1040, DOI 10.2337/db08-1184; Olsen JV, 2006, CELL, V127, P635, DOI 10.1016/j.cell.2006.09.026; Olsen JV, 2013, MOL CELL PROTEOMICS, V12, P3444, DOI 10.1074/mcp.O113.034181; Ortiz-Padilla C, 2013, ONCOGENE, V32, P2696, DOI 10.1038/onc.2012.271; Purvis JE, 2013, CELL, V152, P945, DOI 10.1016/j.cell.2013.02.005; Russell WK, 2001, ANAL CHEM, V73, P2682, DOI 10.1021/ac001332p; Sarbassov DD, 2005, SCIENCE, V307, P1098, DOI 10.1126/science.1106148; Vaga S, 2014, MOL SYST BIOL, V10, DOI 10.15252/msb.20145112; Villen J, 2007, P NATL ACAD SCI USA, V104, P1488, DOI 10.1073/pnas.0609836104; Wang HX, 2005, J PROTEOME RES, V4, P2397, DOI 10.1021/pr050160f; Wilson-Grady JT, 2013, METHODS, V61, P277, DOI 10.1016/j.ymeth.2013.03.031; Wisniewski JR, 2010, J PROTEOME RES, V9, P3280, DOI 10.1021/pr1002214	31	287	292	9	155	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156	1546-1696		NAT BIOTECHNOL	Nat. Biotechnol.	SEP	2015	33	9					990	U142		10.1038/nbt.3327	http://dx.doi.org/10.1038/nbt.3327			7	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	CR0EK	26280412				2022-12-27	WOS:000360990900028
J	Mullard, A				Mullard, Asher			Celgene samples from science smorgasbord	NATURE BIOTECHNOLOGY			English	News Item																			0	0	0	0	1	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156	1546-1696		NAT BIOTECHNOL	Nat. Biotechnol.	SEP	2015	33	9					892	893		10.1038/nbt0915-892	http://dx.doi.org/10.1038/nbt0915-892			2	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	CR0EK	26348944				2022-12-27	WOS:000360990900004
J	[Anonymous]				[Anonymous]			UK biotech smashes financing record	NATURE BIOTECHNOLOGY			English	News Item																			0	0	0	0	0	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156	1546-1696		NAT BIOTECHNOL	Nat. Biotechnol.	SEP	2015	33	9					889	889						1	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	VB8EQ	26348941	Bronze			2022-12-27	WOS:000418257000001
J	Zetsche, B; Volz, SE; Zhang, F				Zetsche, Bernd; Volz, Sara E.; Zhang, Feng			A split-Cas9 architecture for inducible genome editing and transcription modulation	NATURE BIOTECHNOLOGY			English	Letter							RNA; CRISPR		[Zetsche, Bernd; Volz, Sara E.; Zhang, Feng] Broad Inst MIT & Harvard, Cambridge, MA 02142 USA; [Zetsche, Bernd; Volz, Sara E.; Zhang, Feng] MIT, McGovern Inst Brain Res, Cambridge, MA USA; [Zetsche, Bernd; Volz, Sara E.; Zhang, Feng] MIT, Dept Brain & Cognit Sci, Cambridge, MA USA; [Zetsche, Bernd; Volz, Sara E.; Zhang, Feng] MIT, Dept Biol Engn, Cambridge, MA USA; [Zetsche, Bernd] Bonn Med Sch, Inst Pathol, Dept Dev Pathol, Bonn, Germany	Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT); University of Bonn	Zhang, F (corresponding author), Broad Inst MIT & Harvard, Cambridge, MA 02142 USA.	zhang@broadinstitute.org	Macrae, Rhiannon/AAX-1536-2020		NATIONAL INSTITUTE OF MENTAL HEALTH [DP1MH100706] Funding Source: NIH RePORTER; NIMH NIH HHS [DP1 MH100706] Funding Source: Medline	NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		Banaszynski LA, 2005, J AM CHEM SOC, V127, P4715, DOI 10.1021/ja043277y; Cong L, 2013, SCIENCE, V339, P819, DOI 10.1126/science.1231143; Fu YF, 2014, NAT BIOTECHNOL, V32, P279, DOI 10.1038/nbt.2808; Gilbert LA, 2014, CELL, V159, P647, DOI 10.1016/j.cell.2014.09.029; Hsu PD, 2013, NAT BIOTECHNOL, V31, P827, DOI 10.1038/nbt.2647; Konermann S, 2015, NATURE, V517, P583, DOI 10.1038/nature14136; Konermann S, 2013, NATURE, V500, P472, DOI 10.1038/nature12466; Mali P, 2013, SCIENCE, V339, P823, DOI 10.1126/science.1232033; Nishimasu H, 2014, CELL, V156, P935, DOI 10.1016/j.cell.2014.02.001; Perez-Pinera P, 2013, NAT METHODS, V10, P973, DOI [10.1038/NMETH.2600, 10.1038/nmeth.2600]; Qi LS, 2013, CELL, V152, P1173, DOI 10.1016/j.cell.2013.02.022	11	445	554	5	147	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156	1546-1696		NAT BIOTECHNOL	Nat. Biotechnol.	FEB	2015	33	2					139	142		10.1038/nbt.3149	http://dx.doi.org/10.1038/nbt.3149			4	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	CA8VK	25643054	Green Accepted, Green Submitted			2022-12-27	WOS:000349198800015
J	Fournier, C; Glass, JD				Fournier, Christina; Glass, Jonathan D.			Modeling the course of amyotrophic lateral sclerosis	NATURE BIOTECHNOLOGY			English	Editorial Material							ALS		[Fournier, Christina; Glass, Jonathan D.] Emory Univ, Sch Med, Atlanta, GA 30322 USA	Emory University	Fournier, C (corresponding author), Emory Univ, Sch Med, Atlanta, GA 30322 USA.	jglas03@emory.edu			NATIONAL INSTITUTE ON AGING [R01AG037212] Funding Source: NIH RePORTER	NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		Abramson V, 2011, CLIN CANCER RES, V17, P952, DOI 10.1158/1078-0432.CCR-09-1947; Atassi N, 2014, NEUROLOGY, V83, P1719, DOI 10.1212/WNL.0000000000000951; Bedlack RS, 2008, AMYOTROPH LATERAL SC, V9, P257, DOI 10.1080/17482960802195913; Glass JD, 2012, EXP NEUROL, V233, P112, DOI 10.1016/j.expneurol.2011.10.007; Kuffner R, 2015, NAT BIOTECHNOL, V33, P51, DOI 10.1038/nbt.3051	5	15	15	0	7	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156	1546-1696		NAT BIOTECHNOL	Nat. Biotechnol.	JAN	2015	33	1					45	47		10.1038/nbt.3118	http://dx.doi.org/10.1038/nbt.3118			4	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	AY7AR	25574636				2022-12-27	WOS:000347714200024
J	Wang, L; Czedik-Eysenberg, A; Mertz, RA; Si, YQ; Tohge, T; Nunes-Nesi, A; Arrivault, S; Dedow, LK; Bryant, DW; Zhou, W; Xu, JJ; Weissmann, S; Studer, A; Li, PH; Zhang, CK; Larue, T; Shao, Y; Ding, ZH; Sun, Q; Patel, RV; Turgeon, R; Zhu, XG; Provart, NJ; Mockler, TC; Fernie, AR; Stitt, M; Liu, P; Brutnell, TP				Wang, Lin; Czedik-Eysenberg, Angelika; Mertz, Rachel A.; Si, Yaqing; Tohge, Takayuki; Nunes-Nesi, Adriano; Arrivault, Stephanie; Dedow, Lauren K.; Bryant, Douglas W.; Zhou, Wen; Xu, Jiajia; Weissmann, Sarit; Studer, Anthony; Li, Pinghua; Zhang, Cankui; LaRue, Therese; Shao, Ying; Ding, Zehong; Sun, Qi; Patel, Rohan V.; Turgeon, Robert; Zhu, Xinguang; Provart, Nicholas J.; Mockler, Todd C.; Fernie, Alisdair R.; Stitt, Mark; Liu, Peng; Brutnell, Thomas P.			Comparative analyses of C-4 and C-3 photosynthesis in developing leaves of maize and rice	NATURE BIOTECHNOLOGY			English	Article							CIS-REGULATORY ELEMENTS; LEAF DEVELOPMENTAL GRADIENT; BUNDLE-SHEATH; TRANSCRIPTION FACTORS; APOPLASTIC BARRIERS; GRASS LEAF; SUBERIN; ARABIDOPSIS; EXPRESSION; GENES	C-4 and C-3 photosynthesis differ in the efficiency with which they consume water and nitrogen. Engineering traits of the more efficient C-4 photosynthesis into C-3 crops could substantially increase crop yields in hot, arid conditions. To identify differences between C-4 and C-3 photosynthetic mechanisms, we profiled metabolites and gene expression in the developing leaves of Zea mays (maize), a C-4 plant, and Oryza sativa (rice), a C-3 plant, using a statistical method named the unified developmental model (UDM). Candidate cis-regulatory elements and transcription factors that might regulate photosynthesis were identified, together with differences between C-4 and C-3 nitrogen and carbon metabolism. The UDM algorithms could be applied to analyze and compare development in other species. These data sets together with community viewers to access and mine them provide a resource for photosynthetic research that will inform efforts to engineer improvements in carbon fixation in economically valuable grass crops.	[Wang, Lin; Mertz, Rachel A.; Dedow, Lauren K.; Bryant, Douglas W.; Weissmann, Sarit; Studer, Anthony; Shao, Ying; Mockler, Todd C.; Brutnell, Thomas P.] Donald Danforth Plant Sci Ctr, St Louis, MO 63132 USA; [Czedik-Eysenberg, Angelika; Tohge, Takayuki; Nunes-Nesi, Adriano; Arrivault, Stephanie; Fernie, Alisdair R.; Stitt, Mark] Max Planck Inst Mol Plant Physiol, Potsdam, Germany; [Si, Yaqing; Zhou, Wen; Liu, Peng] Iowa State Univ, Dept Stat, Ames, IA USA; [Xu, Jiajia; Zhu, Xinguang] Chinese Acad Sci, Shanghai Inst Biol Sci, Max Planck Soc Partner Inst Computat Biol, Shanghai, Peoples R China; [Li, Pinghua; Ding, Zehong] Chinese Acad Trop Agr Sci, Inst Trop Biosci & Biotechnol, Hainan, Haikou, Peoples R China; [Zhang, Cankui; Turgeon, Robert] Purdue Univ, Dept Agron, W Lafayette, IN 47907 USA; [LaRue, Therese] Skidmore Coll, Dept Biol, Saratoga Springs, NY 12866 USA; [Sun, Qi] Cornell Univ, Life Sci Core Labs Ctr, Computat Biol Serv Unit, Ithaca, NY USA; [Patel, Rohan V.; Provart, Nicholas J.] Univ Toronto, Ctr Anal Genome Evolut & Funct, Dept Cell & Syst Biol, Toronto, ON, Canada; [Brutnell, Thomas P.] Henan Agr Univ, Collaborat Innovat Ctr Henan Grain Crops, Zhengzhou, Peoples R China; [Brutnell, Thomas P.] Henan Agr Univ, Natl Key Lab Wheat & Maize Crop Sci, Zhengzhou, Peoples R China	Donald Danforth Plant Science Center; Max Planck Society; Iowa State University; Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; Max Planck Society; Chinese Academy of Tropical Agricultural Sciences; Purdue University System; Purdue University; Purdue University West Lafayette Campus; Skidmore College; Cornell University; University of Toronto; Henan Agricultural University; Henan Agricultural University	Brutnell, TP (corresponding author), Donald Danforth Plant Sci Ctr, St Louis, MO 63132 USA.	tbrutnell@danforthcenter.org	xu, jia/GSD-6347-2022; Li, Ping/GYV-4914-2022; Tohge, Takayuki/G-7924-2017; Mockler, Todd C/L-2609-2013; Brutnell, Thomas/M-2840-2013; Studer, Anthony/V-2570-2019; Nunes-Nesi, Adriano/D-6430-2013; Stitt, Mark/GVT-1242-2022	Tohge, Takayuki/0000-0001-5555-5650; Mockler, Todd C/0000-0002-0462-5775; Brutnell, Thomas/0000-0002-3581-8211; Weissmann, Sarit/0000-0001-9608-0866; Stitt, Mark/0000-0002-4900-1763; Nunes-Nesi, Adriano/0000-0002-9581-9355	National Science Foundation [IOS-1127017]; National Sciences and Engineering Research Council of Canada; Max-Planck Society; European Union Framework 7 Program; Direct For Biological Sciences [1127017] Funding Source: National Science Foundation	National Science Foundation(National Science Foundation (NSF)); National Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)); Max-Planck Society(Max Planck SocietyFoundation CELLEX); European Union Framework 7 Program; Direct For Biological Sciences(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	We thank J. Schnable for helpful comments and uploading the original sequencing data to the NCBI SRA (SRP018823). This research was supported by the National Science Foundation (IOS-1127017 to T.P.B., T.C.M., P. Liu and R.T.), the National Sciences and Engineering Research Council of Canada (to N.J.P.) and The Max-Planck Society and the European Union Framework 7 Program (3to4) (to A.R.F. and MS.).	Alexa A, 2006, BIOINFORMATICS, V22, P1600, DOI 10.1093/bioinformatics/btl140; Beisson F, 2007, PLANT CELL, V19, P351, DOI 10.1105/tpc.106.048033; Chang YM, 2012, PLANT PHYSIOL, V160, P165, DOI 10.1104/pp.112.203810; Compagnon V, 2009, PLANT PHYSIOL, V150, P1831, DOI 10.1104/pp.109.141408; Conceicao P, 2009, THIRD WORLD Q, V30, P1159, DOI 10.1080/01436590903037473; CORPET F, 1988, NUCLEIC ACIDS RES, V16, P10881, DOI 10.1093/nar/16.22.10881; Davuluri RV, 2003, BMC BIOINFORMATICS, V4, DOI 10.1186/1471-2105-4-25; EASTMAN PAK, 1988, PROTOPLASMA, V142, P92, DOI 10.1007/BF01290867; Evert RF, 1996, INT J PLANT SCI, V157, P247, DOI 10.1086/297344; Franke R, 2005, PHYTOCHEMISTRY, V66, P2643, DOI 10.1016/j.phytochem.2005.09.027; Gou JY, 2009, P NATL ACAD SCI USA, V106, P18855, DOI 10.1073/pnas.0905555106; Hatch MD, 1976, TRANSPORT PLANTS 3 E, V3, P144, DOI DOI 10.1007/978-3-642-66417-5_5; Hedges SB, 2006, BIOINFORMATICS, V22, P2971, DOI 10.1093/bioinformatics/btl505; Hibberd JM, 2010, ANNU REV PLANT BIOL, V61, P181, DOI 10.1146/annurev-arplant-042809-112238; Isaacson T, 2009, PLANT J, V60, P363, DOI 10.1111/j.1365-313X.2009.03969.x; Javelle M, 2010, PLANT PHYSIOL, V154, P273, DOI 10.1104/pp.109.150540; Kajala K, 2012, PLANT J, V69, P47, DOI 10.1111/j.1365-313X.2011.04769.x; Kotula L, 2009, J EXP BOT, V60, P2155, DOI 10.1093/jxb/erp089; Leakey ADB, 2009, P ROY SOC B-BIOL SCI, V276, P2333, DOI 10.1098/rspb.2008.1517; Li PH, 2010, NAT GENET, V42, P1060, DOI 10.1038/ng.703; LOIS R, 1989, EMBO J, V8, P1641, DOI 10.1002/j.1460-2075.1989.tb03554.x; Lyons E, 2008, PLANT J, V53, P661, DOI 10.1111/j.1365-313X.2007.03326.x; Mallmann J, 2014, ELIFE, V3, DOI 10.7554/eLife.02478; Mehrotra R, 2005, J GENET, V84, P183, DOI 10.1007/BF02715844; MIRANDA V, 1981, NEW PHYTOL, V88, P595, DOI 10.1111/j.1469-8137.1981.tb01735.x; Mitchell PL, 2006, NEW PHYTOL, V171, P688, DOI 10.1111/j.1469-8137.2006.01855.x; Mockler TC, 2007, COLD SPRING HARB SYM, V72, P353, DOI 10.1101/sqb.2007.72.006; Molina I, 2009, PLANT PHYSIOL, V151, P1317, DOI 10.1104/pp.109.144907; Mustroph A, 2009, P NATL ACAD SCI USA, V106, P18843, DOI 10.1073/pnas.0906131106; Naseer S, 2012, P NATL ACAD SCI USA, V109, P10101, DOI 10.1073/pnas.1205726109; Nelson T, 2011, J EXP BOT, V62, P3039, DOI 10.1093/jxb/err072; Nomura M, 2005, PLANT CELL PHYSIOL, V46, P754, DOI 10.1093/pcp/pci078; Nunes-Nesi A, 2010, MOL PLANT, V3, P973, DOI 10.1093/mp/ssq049; OBRIEN TP, 1975, AUST J BOT, V23, P783, DOI 10.1071/BT9750783; Palaniswamy SK, 2006, PLANT PHYSIOL, V140, P818, DOI 10.1104/pp.105.072280; Pick TR, 2011, PLANT CELL, V23, P4208, DOI 10.1105/tpc.111.090324; PRIOUL JL, 1980, PLANT PHYSIOL, V66, P770, DOI 10.1104/pp.66.4.770; Ranathunge K, 2011, PLANT SCI, V180, P399, DOI 10.1016/j.plantsci.2010.11.003; Rushton PJ, 1996, EMBO J, V15, P5690, DOI 10.1002/j.1460-2075.1996.tb00953.x; Sage RF, 2012, ANNU REV PLANT BIOL, V63, P19, DOI 10.1146/annurev-arplant-042811-105511; Schnable PS, 2009, SCIENCE, V326, P1112, DOI 10.1126/science.1178534; Schreiber L, 2005, J EXP BOT, V56, P1427, DOI 10.1093/jxb/eri144; Smith AM, 2005, ANNU REV PLANT BIOL, V56, P73, DOI 10.1146/annurev.arplant.56.032604.144257; STITT M, 1985, BIOCHIM BIOPHYS ACTA, V808, P400, DOI 10.1016/0005-2728(85)90148-3; Tilman D, 2011, P NATL ACAD SCI USA, V108, P20260, DOI 10.1073/pnas.1116437108; Vandepoele K, 2009, PLANT PHYSIOL, V150, P535, DOI 10.1104/pp.109.136028; von Caemmerer S, 2012, SCIENCE, V336, P1671, DOI 10.1126/science.1220177; Wang L, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026426; Wang L, 2011, NEW PHYTOL, V190, P9, DOI 10.1111/j.1469-8137.2011.03649.x; Weissmann S, 2012, CURR OPIN BIOTECH, V23, P298, DOI 10.1016/j.copbio.2011.12.018; Wheeler T, 2013, SCIENCE, V341, P508, DOI 10.1126/science.1239402; Wingler A, 1999, PLANT PHYSIOL, V120, P539, DOI 10.1104/pp.120.2.539; Winter D, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000718; Xu GH, 2012, ANNU REV PLANT BIOL, V63, P153, DOI 10.1146/annurev-arplant-042811-105532; Yanagisawa S, 1999, PLANT J, V17, P209, DOI 10.1046/j.1365-313X.1999.00363.x; Yeats TH, 2012, NAT CHEM BIOL, V8, P609, DOI [10.1038/NCHEMBIO.960, 10.1038/nchembio.960]; Yilmaz A, 2009, PLANT PHYSIOL, V149, P171, DOI 10.1104/pp.108.128579; Zeier J, 1999, PLANTA, V209, P1, DOI 10.1007/s004250050601; Zhong RQ, 2008, PLANT CELL, V20, P2763, DOI 10.1105/tpc.108.061325; Zhou JL, 2009, PLANT CELL, V21, P248, DOI 10.1105/tpc.108.063321; Zinger L, 2009, APPL ENVIRON MICROB, V75, P5863, DOI 10.1128/AEM.00748-09	61	162	163	18	166	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1087-0156	1546-1696		NAT BIOTECHNOL	Nat. Biotechnol.	NOV	2014	32	11					1158	1165		10.1038/nbt.3019	http://dx.doi.org/10.1038/nbt.3019			8	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	AT5IL	25306245				2022-12-27	WOS:000344977000022
J	de Vree, PJP; de Wit, E; Yilmaz, M; de Heijning, MV; Klous, P; Verstegen, MJAM; Wan, Y; Teunissen, H; Krijger, PHL; Geeven, G; Eijk, PP; Sie, D; Ylstra, B; Hulsman, LOM; van Dooren, MF; van Zutven, LJCM; van den Ouweland, A; Verbeek, S; van Dijk, KW; Cornelissen, M; Das, AT; Ben Berkhout,; Sikkema-Raddatz, B; van den Berg, E; van der Vlies, P; Weening, D; den Dunnen, JT; Matusiak, M; Lamkanfi, M; Ligtenberg, MJL; ter Brugge, P; Jonkers, J; Foekens, JA; Martens, JW; van der Luijt, R; van Amstel, HKP; van Min, M; Splinter, E; de Laat, W				de Vree, Paula J. P.; de Wit, Elzo; Yilmaz, Mehmet; de Heijning, Monique van; Klous, Petra; Verstegen, Marjon J. A. M.; Wan, Yi; Teunissen, Hans; Krijger, Peter H. L.; Geeven, Geert; Eijk, Paul P.; Sie, Daoud; Ylstra, Bauke; Hulsman, Lorette O. M.; van Dooren, Marieke F.; van Zutven, Laura J. C. M.; van den Ouweland, Ans; Verbeek, Sjef; van Dijk, Ko Willems; Cornelissen, Marion; Das, Atze T.; Ben Berkhout; Sikkema-Raddatz, Birgit; van den Berg, Eva; van der Vlies, Pieter; Weening, Desiree; den Dunnen, Johan T.; Matusiak, Magdalena; Lamkanfi, Mohamed; Ligtenberg, Marjolijn J. L.; ter Brugge, Petra; Jonkers, Jos; Foekens, John A.; Martens, John W.; van der Luijt, Rob; van Amstel, Hans Kristian Ploos; van Min, Max; Splinter, Erik; de Laat, Wouter			Targeted sequencing by proximity ligation for comprehensive variant detection and local haplotyping	NATURE BIOTECHNOLOGY			English	Article							COMPLEX CHROMOSOMAL REARRANGEMENTS; INFLAMMASOME ACTIVATION; GENETIC-VARIATION; 4C TECHNOLOGY; GENOME; DISEASE; TUMORS; CONFORMATION; ENRICHMENT; EXPRESSION	Despite developments in targeted gene sequencing and whole-genome analysis techniques, the robust detection of all genetic variation, including structural variants, in and around genes of interest and in an allele-specific manner remains a challenge. Here we present targeted locus amplification (TLA), a strategy to selectively amplify and sequence entire genes on the basis of the crosslinking of physically proximal sequences. We show that, unlike other targeted re-sequencing methods, TLA works without detailed prior locus information, as one or a few primer pairs are sufficient for sequencing tens to hundreds of kilobases of surrounding DNA. This enables robust detection of single nucleotide variants, structural variants and gene fusions in clinically relevant genes, including BRCA1 and BRCA2, and enables haplotyping. We show that TLA can also be used to uncover insertion sites and sequences of integrated transgenes and viruses. TLA therefore promises to be a useful method in genetic research and diagnostics when comprehensive or allele-specific genetic information is needed.	[de Vree, Paula J. P.; de Wit, Elzo; Verstegen, Marjon J. A. M.; Wan, Yi; Teunissen, Hans; Krijger, Peter H. L.; Geeven, Geert; de Laat, Wouter] KNAW, Hubrecht Inst, Utrecht, Netherlands; [de Vree, Paula J. P.; de Wit, Elzo; Verstegen, Marjon J. A. M.; Wan, Yi; Teunissen, Hans; Krijger, Peter H. L.; Geeven, Geert; de Laat, Wouter] Univ Med Ctr Utrecht, Utrecht, Netherlands; [de Wit, Elzo; Yilmaz, Mehmet; de Heijning, Monique van; Klous, Petra; van Min, Max; Splinter, Erik; de Laat, Wouter] Cergentis BV, Utrecht, Netherlands; [Eijk, Paul P.; Sie, Daoud; Ylstra, Bauke] Vrije Univ Amsterdam Med Ctr, Dept Pathol, Amsterdam, Netherlands; [Hulsman, Lorette O. M.; van Dooren, Marieke F.; van Zutven, Laura J. C. M.] Erasmus MC, Dept Clin Genet, Rotterdam, Netherlands; [Verbeek, Sjef; van Dijk, Ko Willems] Leiden Univ, Med Ctr, Dept Human Genet, Leiden, Netherlands; [Verbeek, Sjef; van Dijk, Ko Willems] Leiden Univ, Med Ctr, Dept Endocrinol, Leiden, Netherlands; [Cornelissen, Marion; Das, Atze T.; Ben Berkhout] Univ Amsterdam, Acad Med Ctr, Ctr Infect & Immun Amsterdam CINIMA, Dept Med Microbiol,Lab Expt Virol, NL-1105 AZ Amsterdam, Netherlands; [Sikkema-Raddatz, Birgit; van den Berg, Eva; van der Vlies, Pieter; Weening, Desiree] Univ Groningen, Univ Med Ctr Groningen, Dept Genet, Groningen, Netherlands; [den Dunnen, Johan T.] Leiden Univ, Med Ctr, Ctr Human & Clin Genet, Leiden Genome Technol Ctr, Leiden, Netherlands; [Matusiak, Magdalena; Lamkanfi, Mohamed] VIB, Dept Med Prot Res, Ghent, Belgium; [Matusiak, Magdalena; Lamkanfi, Mohamed] Univ Ghent, Dept Biochem, B-9000 Ghent, Belgium; [Ligtenberg, Marjolijn J. L.] Radboud Univ Nijmegen, Med Ctr, Dept Human Genet, NL-6525 ED Nijmegen, Netherlands; [ter Brugge, Petra; Jonkers, Jos] Netherlands Canc Inst, Div Mol Pathol, Amsterdam, Netherlands; [ter Brugge, Petra; Jonkers, Jos] Netherlands Canc Inst, Canc Genom Ctr, Amsterdam, Netherlands; [Foekens, John A.; Martens, John W.] Erasmus Univ, Med Ctr, Erasmus MC Canc Inst, Dept Med Oncol, Rotterdam, Netherlands; [van der Luijt, Rob; van Amstel, Hans Kristian Ploos] Univ Med Ctr Utrecht, Dept Med Genet, Utrecht, Netherlands	Royal Netherlands Academy of Arts & Sciences; Hubrecht Institute (KNAW); Utrecht University; Utrecht University Medical Center; Vrije Universiteit Amsterdam; VU UNIVERSITY MEDICAL CENTER; Erasmus University Rotterdam; Erasmus MC; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; University of Amsterdam; Academic Medical Center Amsterdam; University of Groningen; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Flanders Institute for Biotechnology (VIB); Ghent University; Radboud University Nijmegen; Netherlands Cancer Institute; Netherlands Cancer Institute; Erasmus University Rotterdam; Erasmus MC; Erasmus MC Cancer Institute; Utrecht University; Utrecht University Medical Center	Splinter, E (corresponding author), Cergentis BV, Utrecht, Netherlands.	erik.splinter@cergentis.com; w.delaat@hubrecht.eu	van Dijk, Ko Willems/A-1798-2008; Jonkers, Jos/AAG-3246-2019; dunnen, johan den/ABH-4228-2020; van Dijk, Ko Willems/AAT-4681-2021; Ylstra, Bauke/D-2906-2012; Ligtenberg, Marjolijn/N-9666-2013	van Dijk, Ko Willems/0000-0002-2172-7394; Jonkers, Jos/0000-0002-9264-9792; dunnen, johan den/0000-0002-6304-1710; van Dijk, Ko Willems/0000-0002-2172-7394; Ylstra, Bauke/0000-0001-9479-3010; Ligtenberg, Marjolijn/0000-0003-1290-1474; Sie, Daoud/0000-0001-6762-2582; van der Luijt, Rob/0000-0002-0018-1089; de Laat, Wouter/0000-0002-6393-595X; de Wit, Elzo/0000-0003-2883-1415; Geeven, Geert/0000-0002-5603-0095; Krijger, Peter/0000-0003-1702-348X	Netherlands Genomics Initiative (NGI) [93608003, 93611010]; Cancer Genomics Center (CGC); Dutch Cancer Foundation [2009-4459]	Netherlands Genomics Initiative (NGI); Cancer Genomics Center (CGC); Dutch Cancer Foundation(KWF Kankerbestrijding)	We thank T. P. Driessen for figure graphics. This work was supported by the Netherlands Genomics Initiative (NGI) pre-seed grants 93608003 and 93611010 and a proof of concept grant from the Cancer Genomics Center (CGC) to W.d.L. and an Innovation Credit from NL Agency to Cergentis. P.J.P.d.V. is supported by a Dutch Cancer Foundation grant KWF (2009-4459 to J.A.F., J.W.M. and W.d.L.).	Altmuller J, 2014, BIOL CHEM, V395, P231, DOI 10.1515/hsz-2013-0199; Altshuler DM, 2012, NATURE, V491, P56, DOI 10.1038/nature11632; Bolzer A, 2005, PLOS BIOL, V3, P826, DOI 10.1371/journal.pbio.0030157; Burton JN, 2013, NAT BIOTECHNOL, V31, P1119, DOI 10.1038/nbt.2727; de Vree PJP, 2009, MOL CYTOGENET, V2, DOI 10.1186/1755-8166-2-15; Dekker J, 2002, SCIENCE, V295, P1306, DOI 10.1126/science.1067799; Evers B, 2010, CLIN CANCER RES, V16, P99, DOI 10.1158/1078-0432.CCR-09-2434; Fong PC, 2009, NEW ENGL J MED, V361, P123, DOI 10.1056/NEJMoa0900212; Frank TS, 1998, J CLIN ONCOL, V16, P2417, DOI 10.1200/JCO.1998.16.7.2417; Harakalova M, 2011, NAT PROTOC, V6, P1870, DOI 10.1038/nprot.2011.396; Homminga I, 2011, CANCER CELL, V19, P484, DOI 10.1016/j.ccr.2011.02.008; Kaplan N, 2013, NAT BIOTECHNOL, V31, P1143, DOI 10.1038/nbt.2768; Katsanis SH, 2013, NAT REV GENET, V14, P415, DOI 10.1038/nrg3493; Kayagaki N, 2011, NATURE, V479, P117, DOI 10.1038/nature10558; Kleinjan DA, 2005, AM J HUM GENET, V76, P8, DOI 10.1086/426833; Koudijs MJ, 2011, GENOME RES, V21, P2181, DOI 10.1101/gr.112763.110; LANGE B, 1987, BLOOD, V70, P192; Leary RJ, 2010, SCI TRANSL MED, V2, DOI 10.1126/scitranslmed.3000702; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Lieberman-Aiden E, 2009, SCIENCE, V326, P289, DOI 10.1126/science.1181369; Lightfield KL, 2008, NAT IMMUNOL, V9, P1171, DOI 10.1038/ni.1646; Mamanova L, 2010, NAT METHODS, V7, P111, DOI 10.1038/nmeth.1419; Maurano MT, 2012, SCIENCE, V337, P1190, DOI 10.1126/science.1222794; MCKEITHAN TW, 1986, P NATL ACAD SCI USA, V83, P6636, DOI 10.1073/pnas.83.17.6636; Meyer C, 2013, LEUKEMIA, V27, P2165, DOI 10.1038/leu.2013.135; Nagel JHA, 2012, BREAST CANCER RES TR, V132, P439, DOI 10.1007/s10549-011-1588-x; PERSYN JP, 1980, EUR J CANCER, V16, P1513; Rippe K, 2001, TRENDS BIOCHEM SCI, V26, P733, DOI 10.1016/S0968-0004(01)01978-8; Selvaraj S, 2013, NAT BIOTECHNOL, V31, P1111, DOI 10.1038/nbt.2728; Sherry ST, 2001, NUCLEIC ACIDS RES, V29, P308, DOI 10.1093/nar/29.1.308; Simonis M, 2006, NAT GENET, V38, P1348, DOI 10.1038/ng1896; Simonis M, 2009, NAT METHODS, V6, P837, DOI [10.1038/NMETH.1391, 10.1038/nmeth.1391]; SMITH SD, 1988, BLOOD, V71, P395; Splinter E, 2012, METHODS, V58, P221, DOI 10.1016/j.ymeth.2012.04.009; Untergasser A, 2012, NUCLEIC ACIDS RES, V40, DOI 10.1093/nar/gks596; Uren AG, 2009, NAT PROTOC, V4, P789, DOI 10.1038/nprot.2009.64; van de Werken HJG, 2012, METHOD ENZYMOL, V513, P89, DOI 10.1016/B978-0-12-391938-0.00004-5; VANDENMAAGDENBERG AMJM, 1993, J BIOL CHEM, V268, P10540; Weischenfeldt J, 2013, NAT REV GENET, V14, P125, DOI 10.1038/nrg3373	39	140	144	1	37	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156	1546-1696		NAT BIOTECHNOL	Nat. Biotechnol.	OCT	2014	32	10					1019	+		10.1038/nbt.2959	http://dx.doi.org/10.1038/nbt.2959			9	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	AR7MM	25129690				2022-12-27	WOS:000343763800019
J	Eriksson, D; Stymne, S; Schjoerring, JK				Eriksson, Dennis; Stymne, Sten; Schjoerring, Jan K.			The slippery slope of cisgenesis	NATURE BIOTECHNOLOGY			English	Letter							GENETICALLY-MODIFIED ORGANISMS; PLANTS		[Eriksson, Dennis; Schjoerring, Jan K.] Univ Copenhagen, Dept Plant & Environm Sci, Frederiksberg, Denmark; [Stymne, Sten] Swedish Univ Agr Sci, Dept Plant Breeding, Alnarp, Sweden	University of Copenhagen; Swedish University of Agricultural Sciences	Eriksson, D (corresponding author), Univ Copenhagen, Dept Plant & Environm Sci, Frederiksberg, Denmark.	der@plen.ku.dk	Schjoerring, Jan K./M-4044-2019; Eriksson, Dennis/ABF-5510-2020; Schjoerring, Jan K./A-5387-2009; Eriksson, Dennis/J-4592-2012	Schjoerring, Jan K./0000-0002-2852-3298; Eriksson, Dennis/0000-0002-5205-3396; Schjoerring, Jan K./0000-0002-2852-3298; 				Editorial, 2013, NAT BIOTECHNOL, V31, P767; Holme IB, 2013, PLANT BIOTECHNOL J, V11, P395, DOI 10.1111/pbi.12055; Jacobsen E, 2008, POTATO RES, V51, P75, DOI 10.1007/s11540-008-9097-y; Jacobsen E, 2007, TRENDS BIOTECHNOL, V25, P219, DOI 10.1016/j.tibtech.2007.03.008; Mielby H, 2013, PUBLIC UNDERST SCI, V22, P155, DOI 10.1177/0963662511430577; Ramessar K, 2007, TRANSGENIC RES, V16, P261, DOI 10.1007/s11248-007-9083-1; Schouten HJ, 2006, EMBO REP, V7, P750, DOI 10.1038/sj.embor.7400769; Schouten HJ, 2006, NAT BIOTECHNOL, V24, P753, DOI 10.1038/nbt0706-753; Woo HJ, 2011, BIOTECHNOL BIOPROC E, V16, P1053, DOI 10.1007/s12257-011-0519-3	9	8	8	0	17	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156	1546-1696		NAT BIOTECHNOL	Nat. Biotechnol.	AUG	2014	32	8					727	727		10.1038/nbt.2980	http://dx.doi.org/10.1038/nbt.2980			1	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	AW7PF	25101741	Bronze			2022-12-27	WOS:000346455900035
J	Lawrence, RT; Villen, J				Lawrence, Robert T.; Villen, Judit			Drafts of the human proteome	NATURE BIOTECHNOLOGY			English	Editorial Material								Two studies catalog nearly all human proteins and their abundance throughout the body.	[Lawrence, Robert T.; Villen, Judit] Univ Washington, Dept Genome Sci, Seattle, WA 98195 USA	University of Washington; University of Washington Seattle	Lawrence, RT (corresponding author), Univ Washington, Dept Genome Sci, Seattle, WA 98195 USA.	jvillen@u.washington.edu		Villen, Judit/0000-0002-1005-1739				Desiere F, 2006, NUCLEIC ACIDS RES, V34, pD655, DOI [10.1093/nar/gkj040, 10.1007/978-1-60761-444-9_19]; Dunham I, 2012, NATURE, V489, P57, DOI 10.1038/nature11247; Kim MS, 2014, NATURE, V509, P575, DOI 10.1038/nature13302; Lander ES, 2001, NATURE, V409, P860, DOI 10.1038/35057062; Legrain P, 2011, MOL CELL PROTEOMICS, V10, DOI 10.1074/mcp.M111.009993; Uhlen M, 2010, NAT BIOTECHNOL, V28, P1248, DOI 10.1038/nbt1210-1248; Venter JC, 2001, SCIENCE, V291, P1304, DOI 10.1126/science.1058040; Wilhelm M, 2014, NATURE, V509, P582, DOI 10.1038/nature13319; Wu C, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-11-r130	9	3	3	1	11	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156	1546-1696		NAT BIOTECHNOL	Nat. Biotechnol.	AUG	2014	32	8					752	753		10.1038/nbt.2982	http://dx.doi.org/10.1038/nbt.2982			2	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	AW7PF	25101745				2022-12-27	WOS:000346455900039
J	Kalutkiewicz, MJ; Ehman, RL				Kalutkiewicz, Michael J.; Ehman, Richard L.			Patents as proxies: NIH hubs of innovation	NATURE BIOTECHNOLOGY			English	Editorial Material							CITATIONS		[Kalutkiewicz, Michael J.] Acad Radiol Res, Washington, DC 20036 USA; [Ehman, Richard L.] Mayo Clin, Dept Radiol, Rochester, MN USA	Mayo Clinic	Kalutkiewicz, MJ (corresponding author), Acad Radiol Res, Washington, DC 20036 USA.	mkalutkiewicz@acadrad.org						Ehrlich E., 2012, NIHS ROLE SUSTAINING; Families USA's Global Health Initiative, 2008, YOUR OWN BACKY NIH F; Hall B.H., 2007, ACAD MANAG P, V2007, P1, DOI [10.5465/ambpp.2007.26530853, DOI 10.5465/AMBPP.2007.26530853]; Hall BH, 2005, RAND J ECON, V36, P16; Harhoff D, 2004, INT J IND ORGAN, V22, P443, DOI 10.1016/j.ijindorg.2004.01.001; Harhoff D., 1997, 49726 FS WISS; Rothwell J., 2013, PATENTING PROSPERITY; Sarewitz D, 2010, NATURE, V468, P135, DOI 10.1038/468135a; TRAJTENBERG M, 1990, RAND J ECON, V21, P172, DOI 10.2307/2555502; White House, 2012, NAT BIOEC BLUEPR; Zeints J.D., 2012, COMMUNICATION	11	7	8	0	9	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156	1546-1696		NAT BIOTECHNOL	Nat. Biotechnol.	JUN	2014	32	6					536	538		10.1038/nbt.2917	http://dx.doi.org/10.1038/nbt.2917			3	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Biotechnology & Applied Microbiology	AI9EV	24911494				2022-12-27	WOS:000337233800012
J	Acharya, A; Bingham, K; Bradner, J; Burke, W; Charo, RA; Cherry, J; Choulika, A; Coles, T; Cook-Deegan, R; Crook, ST; Diaz, E; Erickson, B; Giddings, LV; Giwa, SE; Greenwood, JC; Gulati, V; Hall, S; Harris, J; Heywood, J; Hill, C; Levin, J; Mangubat, A; Maraganore, J; Mariggi, G; Mazur, BJ; McGuire, AL; Moll, N; Moreno, J; Naughton, G; Nelsen, L; Osbourn, J; Perez, D; Reed, J; Schmidt, E; Seyfert-Margolis, V; Stoffels, P; Thorball, J; O'Toole, T; Vainu, I; van Deventer, S; Zerhouni, E; Zohar, D				Acharya, Anu; Bingham, Kate; Bradner, Jay; Burke, Wylie; Charo, R. Alta; Cherry, Joel; Choulika, Andre; Coles, Tony; Cook-Deegan, Robert; Crook, Stanley T.; Diaz, Emilia; Erickson, Brent; Giddings, L. Val; Giwa, Sebastian Eriksson; Greenwood, James C.; Gulati, Vishal; Hall, Sam; Harris, John; Heywood, Jamie; Hill, Colin; Levin, Jeremy; Mangubat, Adina; Maraganore, John; Mariggi, Giovanni; Mazur, Barbara J.; McGuire, Amy L.; Moll, Nathalie; Moreno, Jonathan; Naughton, Gail; Nelsen, Lita; Osbourn, Jane; Perez, Daniel; Reed, John; Schmidt, Eric; Seyfert-Margolis, Vicki; Stoffels, Paul; Thorball, Jorgen; O'Toole, Tara; Vainu, Indrek; van Deventer, Sander; Zerhouni, Elias; Zohar, Daphne			Community crystal gazing	NATURE BIOTECHNOLOGY			English	Article									[Acharya, Anu] Mapmygenome, Hyderabad, Andhra Pradesh, India; [Bingham, Kate] SV Life Sci, London, England; [Bradner, Jay] Novartis Inst Biomed Res, Cambridge, MA USA; [Burke, Wylie] Univ Washington, Seattle, WA 98195 USA; [Charo, R. Alta] Univ Wisconsin, Madison, WI USA; [Cherry, Joel] Amyris, Emeryville, CA USA; [Choulika, Andre] Cellectis, Paris, France; [Coles, Tony] Yuman Therapeut, Cambridge, MA USA; [Cook-Deegan, Robert] Duke Univ, Durham, NC USA; [Crook, Stanley T.] Ionis Pharmaceut, Carlsbad, CA USA; [Diaz, Emilia] Kaitek Labs, Santiago, Chile; [Erickson, Brent; Greenwood, James C.] Biotechnol Innovat Org, Washington, DC USA; [Giddings, L. Val] Informat Technol & Innovat Fdn, Washington, DC USA; [Giwa, Sebastian Eriksson] Organ Preservat Alliance, Ossium & Sylvat Biotech, New York, NY USA; [Gulati, Vishal] Draper Espirit, London, England; [Hall, Sam] Apple Tree Partners, New York, NY USA; [Harris, John] Univ Manchester, Manchester, Lancs, England; [Heywood, Jamie] PatientsLikeMe & AOBiome, Boston, MA USA; [Hill, Colin] GNS Healthcare, Cambridge, MA USA; [Levin, Jeremy] Ovid Therapeut, New York, NY USA; [Mangubat, Adina] Spiral Genet, Seattle, WA USA; [Maraganore, John] Alnylam, Cambridge, MA USA; [Mariggi, Giovanni] Medicxi Ventures, Geneva, Switzerland; [Mazur, Barbara J.] DuPont Pioneer, Wilmington, DE USA; [McGuire, Amy L.] Baylor Coll Med, Houston, TX 77030 USA; [Moll, Nathalie] EuropaBio, Brussels, Belgium; [Moreno, Jonathan] Univ Penn, Philadelphia, PA 19104 USA; [Naughton, Gail] Histogen, San Diego, CA USA; [Nelsen, Lita] MIT, 77 Massachusetts Ave, Cambridge, MA 02139 USA; [Osbourn, Jane] BioInd Assoc, London, England; [Perez, Daniel] Oxbridge Biotech Roundtable, London, England; [Reed, John] Roche, Basel, Switzerland; [Schmidt, Eric] SG Cowan, New York, NY USA; [Seyfert-Margolis, Vicki] MyOwnMed, Chevy Chase, MD USA; [Stoffels, Paul] Johnson & Johnson, New Brunswick, NJ USA; [Thorball, Jorgen] XOventure Int, Luzern, Switzerland; [O'Toole, Tara] In Q Tel, Arlington, VA USA; [Vainu, Indrek] Xpressomics, Tallinn, Estonia; [van Deventer, Sander] Forb Capital Partners, Naarden, Netherlands; [Zerhouni, Elias] Sanofi, Paris, France; [Zohar, Daphne] PureTech Hlth, Cambridge, MA USA	Novartis; University of Washington; University of Washington Seattle; University of Wisconsin System; University of Wisconsin Madison; Duke University; Ionis Pharmaceuticals, Inc.; University of Manchester; DuPont; Baylor College of Medicine; University of Pennsylvania; Massachusetts Institute of Technology (MIT); Roche Holding; Johnson & Johnson; Johnson & Johnson USA; Sanofi-Aventis; Sanofi France	Acharya, A (corresponding author), Mapmygenome, Hyderabad, Andhra Pradesh, India.			Cook-Deegan, Robert/0000-0002-8251-4237; Charo, Robin Alta/0000-0003-3710-1043; Thorball, Jorgen/0000-0002-2915-1625					0	1	1	0	14	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156	1546-1696		NAT BIOTECHNOL	Nat. Biotechnol.	MAR	2016	34	3					276	283		10.1038/nbt.3515	http://dx.doi.org/10.1038/nbt.3515			8	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	DG1CJ	26963550				2022-12-27	WOS:000371802600020
J	Yang, W				Yang, Walter			2015-another banner year for biotech	NATURE BIOTECHNOLOGY			English	News Item									[Yang, Walter] BioCentury, Redwood City, CA 94065 USA		Yang, W (corresponding author), BioCentury, Redwood City, CA 94065 USA.								0	1	1	0	2	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156	1546-1696		NAT BIOTECHNOL	Nat. Biotechnol.	FEB	2016	34	2					127	127		10.1038/nbt.3480	http://dx.doi.org/10.1038/nbt.3480			1	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	VI3OH	26849509	Bronze			2022-12-27	WOS:000474638300006
J	DiCarlo, JE; Chavez, A; Dietz, SL; Esvelt, KM; Church, GM				DiCarlo, James E.; Chavez, Alejandro; Dietz, Sven L.; Esvelt, Kevin M.; Church, George M.			Safeguarding CRISPR-Cas9 gene drives in yeast	NATURE BIOTECHNOLOGY			English	Article							DROSOPHILA; SYSTEM; CAS9; DNA; GENERATION; MUTATIONS; GERMLINE; REPAIR; TOOLS	RNA-guided gene drives capable of spreading genomic alterations made in laboratory organisms through wild populations could be used to address environmental and public health problems. However, the possibility of unintended genome editing occurring through the escape of strains from laboratories, coupled with the prospect of unanticipated ecological change, demands caution. We report the efficacy of CRISPR-Cas9 gene drive systems in wild and laboratory strains of the yeast Saccharomyces cerevisiae. Furthermore, we address concerns surrounding accidental genome editing by developing and validating methods of molecular confinement that minimize the risk of unwanted genome editing. We also present a drive system capable of overwriting the changes introduced by an earlier gene drive. These molecular safeguards should enable the development of safe CRISPR gene drives for diverse organisms.	[DiCarlo, James E.; Chavez, Alejandro; Dietz, Sven L.; Church, George M.] Harvard Univ, Sch Med, Dept Genet, Boston, MA USA; [DiCarlo, James E.; Chavez, Alejandro; Dietz, Sven L.; Esvelt, Kevin M.; Church, George M.] Harvard Univ, Sch Med, Boston, MA 02115 USA; [DiCarlo, James E.] Boston Univ, Dept Biomed Engn, Boston, MA 02215 USA; [Chavez, Alejandro; Dietz, Sven L.; Esvelt, Kevin M.; Church, George M.] Wyss Inst Biol Inspired Engn, Boston, MA USA; [Chavez, Alejandro] Massachusetts Gen Hosp, Dept Pathol, Boston, MA 02114 USA; [Dietz, Sven L.] Swiss Fed Inst Technol, Dept Biosyst Sci & Engn, Basel, Switzerland	Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Boston University; Harvard University; Massachusetts General Hospital; Swiss Federal Institutes of Technology Domain; ETH Zurich	Esvelt, KM (corresponding author), Harvard Univ, Sch Med, Boston, MA 02115 USA.	kevin.esvelt@wyss.harvard.edu; gmc@harvard.edu	DiCarlo, James/AAJ-1579-2021	DiCarlo, James/0000-0003-4728-3186; Esvelt, Kevin/0000-0001-8797-3945; church, george/0000-0001-6232-9969	Department of Energy (DOE) [DE-FG02-02ER63445]; National Science Foundation (NSF) [SynBERC SA5283-11210, MCB-1330914]; National Cancer Institute (NCI) [5T32CA009216-34]; National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) [1K99DK102669-01]; Wyss Institute for Biologically Inspired Engineering (Technology Development Fellowship); Direct For Biological Sciences [1330914] Funding Source: National Science Foundation; NATIONAL CANCER INSTITUTE [T32CA009216] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R00DK102669, K99DK102669] Funding Source: NIH RePORTER	Department of Energy (DOE)(United States Department of Energy (DOE)); National Science Foundation (NSF)(National Science Foundation (NSF)); National Cancer Institute (NCI)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); Wyss Institute for Biologically Inspired Engineering (Technology Development Fellowship); Direct For Biological Sciences(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	We are very grateful to S. Doris, D. Spatt and F. Winston for their incredible patience, generosity and expertise in tetrad dissection. We also thank F. Winston for providing us with SK1 strains and members of the Church laboratory for insightful discussions. This work was supported by grants from the Department of Energy (DOE) (DE-FG02-02ER63445 to G.M.C.), National Science Foundation (NSF) (SynBERC SA5283-11210 and MCB-1330914 to G.M.C.), National Cancer Institute (NCI) (5T32CA009216-34 to A.C.), National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) (1K99DK102669-01 to K.M.E.) and the Wyss Institute for Biologically Inspired Engineering (Technology Development Fellowship to K.M.E.).	Ablain J, 2015, DEV CELL, V32, P756, DOI 10.1016/j.devcel.2015.01.032; Akbari OS, 2015, SCIENCE, V349, P927, DOI 10.1126/science.aac7932; Burt A, 2004, CURR OPIN GENET DEV, V14, P609, DOI 10.1016/j.gde.2004.09.010; Burt A, 2003, P ROY SOC B-BIOL SCI, V270, P921, DOI 10.1098/rspb.2002.2319; Burt A., 2009, GENES CONFLICT BIOL; CHAMBERLAIN N, 1952, J GEN MICROBIOL, V7, P54, DOI 10.1099/00221287-7-1-2-54; Chan YS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054130; Chan YS, 2011, GENETICS, V188, P33, DOI 10.1534/genetics.111.127506; Cong L, 2013, SCIENCE, V339, P819, DOI 10.1126/science.1231143; Costantino L, 2014, SCIENCE, V343, P88, DOI 10.1126/science.1243211; DiCarlo JE, 2013, NUCLEIC ACIDS RES, V41, P4336, DOI 10.1093/nar/gkt135; Esvelt KM, 2014, ELIFE, V3, DOI 10.7554/eLife.03401; Friedland AE, 2013, NAT METHODS, V10, P741, DOI 10.1038/nmeth.2532; Gantz VM, 2015, SCIENCE, V348, P442, DOI 10.1126/science.aaa5945; Gratz SJ, 2013, GENETICS, V194, P1029, DOI 10.1534/genetics.113.152710; Henkel R. D., 2012, APPL BIOSAF, V17, P171, DOI [DOI 10.1177/153567601201700402, 10.1177/153567601201700402]; Jain S, 2009, GENE DEV, V23, P291, DOI 10.1101/gad.1751209; Jiang WZ, 2013, NUCLEIC ACIDS RES, V41, DOI 10.1093/nar/gkt780; Jinek M, 2013, ELIFE, V2, DOI 10.7554/eLife.00471; Kondo S, 2013, GENETICS, V195, P715, DOI 10.1534/genetics.113.156737; Looke M, 2011, BIOTECHNIQUES, V50, P325, DOI 10.2144/000113672; MACREADIE IG, 1985, CELL, V41, P395, DOI 10.1016/S0092-8674(85)80012-X; Mali P, 2013, SCIENCE, V339, P823, DOI 10.1126/science.1232033; Mao XD, 1996, MOL CELL BIOL, V16, P475; NOVITSKI E, 1981, GENETICS, V98, P257; Oye KA, 2014, SCIENCE, V345, P626, DOI 10.1126/science.1254287; Port F, 2014, P NATL ACAD SCI USA, V111, pE2967, DOI 10.1073/pnas.1405500111; Spitzer M, 2014, NAT METHODS, V11, P121, DOI 10.1038/nmeth.2811; Takeuchi R, 2014, P NATL ACAD SCI USA, V111, P4061, DOI 10.1073/pnas.1321030111; Wang HY, 2013, CELL, V153, P910, DOI 10.1016/j.cell.2013.04.025; Windbichler N, 2011, NATURE, V473, P212, DOI 10.1038/nature09937	31	185	194	2	170	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156	1546-1696		NAT BIOTECHNOL	Nat. Biotechnol.	DEC	2015	33	12					1250	+		10.1038/nbt.3412	http://dx.doi.org/10.1038/nbt.3412			8	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	CY4OO	26571100	Green Accepted, Green Submitted			2022-12-27	WOS:000366387700016
J	Morrison, C				Morrison, Chris			Trade pact blow for innovative drug developers	NATURE BIOTECHNOLOGY			English	News Item																			0	1	1	0	0	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156	1546-1696		NAT BIOTECHNOL	Nat. Biotechnol.	DEC	2015	33	12					1223	1223		10.1038/nbt1215-1223	http://dx.doi.org/10.1038/nbt1215-1223			1	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	CY4OO	26650004	Bronze			2022-12-27	WOS:000366387700008
J	Jefferson, OA; Kollhofer, D; Ehrich, TH; Jefferson, RA				Jefferson, Osmat A.; Koellhofer, Deniz; Ehrich, Thomas H.; Jefferson, Richard A.			Gene patent practice across plant and human genomes	NATURE BIOTECHNOLOGY			English	Editorial Material									[Jefferson, Osmat A.; Koellhofer, Deniz; Ehrich, Thomas H.; Jefferson, Richard A.] Queensland Univ Technol, Brisbane, Qld 4001, Australia; [Jefferson, Osmat A.; Koellhofer, Deniz; Ehrich, Thomas H.; Jefferson, Richard A.] Cambia, Canberra, ACT, Australia	Queensland University of Technology (QUT)	Jefferson, OA (corresponding author), Queensland Univ Technol, Brisbane, Qld 4001, Australia.	osmat@cambia.org; raj@cambia.org		Jefferson, Osmat Azzam/0000-0002-0607-8728; Ehrich, Thomas/0000-0003-3475-4321; Koellhofer, Deniz/0000-0003-0313-4672; Jefferson, Richard/0000-0001-5352-4498				Association of University Technology Managers the Council on Governmental Relations the Association of American Universities and the Association of Public and Land-grant Universities, 2014, COMM USPTOS GUID DET; Hayden EC, 2014, NATURE, V511, P138, DOI 10.1038/511138a; Holman CM, 2013, BIOTECHNOL LAW REP, V32, P289, DOI 10.1089/blr.2013.9883; Jefferson OA, 2013, NAT BIOTECHNOL, V31, P1086, DOI 10.1038/nbt.2755; Li H, 2010, BIOINFORMATICS, V26, P589, DOI 10.1093/bioinformatics/btp698; Moran N, 2014, NAT BIOTECHNOL, V32, P403, DOI 10.1038/nbt0514-403a; Nottenburg Carol, 2008, P699, DOI 10.1007/978-0-387-72290-0_20; Storz U, 2012, MABS-AUSTIN, V4, P274, DOI 10.4161/mabs.4.2.19253; The Association for Molecular Pathology, 2014, RE GUID DET SUBJ MAT; US Patent and Trademark Office, 2014, GUID DET SUBJ MATT E	10	2	2	0	7	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156	1546-1696		NAT BIOTECHNOL	Nat. Biotechnol.	OCT	2015	33	10					1033	1039						7	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	CT1JX	26448084	Green Published, Bronze			2022-12-27	WOS:000362555700019
J	Bustamante, CD; Rasmussen, M				Bustamante, Carlos D.; Rasmussen, Morten			Beyond the reference genome	NATURE BIOTECHNOLOGY			English	Editorial Material									[Bustamante, Carlos D.; Rasmussen, Morten] Stanford Univ, Sch Med, Dept Genet, Stanford, CA 94305 USA	Stanford University	Bustamante, CD (corresponding author), Stanford Univ, Sch Med, Dept Genet, Stanford, CA 94305 USA.	cdbustam@stanford.edu		Bustamante, Carlos D./0000-0002-4187-7920				Amini S, 2014, NAT GENET, V46, P1343, DOI 10.1038/ng.3119; Cao HZ, 2015, NAT BIOTECHNOL, V33, P617, DOI 10.1038/nbt.3200; Chaisson MJP, 2015, NATURE, V517, P608, DOI 10.1038/nature13907; Kitzman JO, 2011, NAT BIOTECHNOL, V29, P59, DOI 10.1038/nbt.1740; Kuleshov V, 2014, NAT BIOTECHNOL, V32, P261, DOI 10.1038/nbt.2833; Levy S, 2007, PLOS BIOL, V5, P2113, DOI 10.1371/journal.pbio.0050254; Roach JC, 2010, SCIENCE, V328, P636, DOI 10.1126/science.1186802; Suk EK, 2011, GENOME RES, V21, P1672, DOI 10.1101/gr.125047.111; Wang JB, 2012, CELL, V150, P402, DOI 10.1016/j.cell.2012.06.030	9	1	1	0	7	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156	1546-1696		NAT BIOTECHNOL	Nat. Biotechnol.	JUN	2015	33	6					605	606		10.1038/nbt.3249	http://dx.doi.org/10.1038/nbt.3249			2	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	CK2DE	26057977				2022-12-27	WOS:000356019700017
J	Lin, L; Finak, G; Ushey, K; Seshadri, C; Hawn, TR; Frahm, N; Scriba, TJ; Mahomed, H; Hanekom, W; Bart, PA; Pantaleo, G; Tomaras, GD; Rerks-Ngarm, S; Kaewkungwal, J; Nitayaphan, S; Pitisuttithum, P; Michael, NL; Kim, JH; Robb, ML; O'Connell, RJ; Karasavvas, N; Gilbert, P; De Rosa, SC; McElrath, MJ; Gottardo, R				Lin, Lin; Finak, Greg; Ushey, Kevin; Seshadri, Chetan; Hawn, Thomas R.; Frahm, Nicole; Scriba, Thomas J.; Mahomed, Hassan; Hanekom, Willem; Bart, Pierre-Alexandre; Pantaleo, Giuseppe; Tomaras, Georgia D.; Rerks-Ngarm, Supachai; Kaewkungwal, Jaranit; Nitayaphan, Sorachai; Pitisuttithum, Punnee; Michael, Nelson L.; Kim, Jerome H.; Robb, Merlin L.; O'Connell, Robert J.; Karasavvas, Nicos; Gilbert, Peter; De Rosa, Stephen C.; McElrath, M. Juliana; Gottardo, Raphael			COMPASS identifies T-cell subsets correlated with clinical outcomes	NATURE BIOTECHNOLOGY			English	Article							FLOW-CYTOMETRY DATA; TUBERCULOSIS INFECTION; IMMUNE-RESPONSE; SOUTH-AFRICA; VACCINE; VIRUS; IMMUNIZATION; ASSAYS; TRIAL	Advances in flow cytometry and other single-cell technologies have enabled high-dimensional, high-throughput measurements of individual cells as well as the interrogation of cell population heterogeneity. However, in many instances, computational tools to analyze the wealth of data generated by these technologies are lacking. Here, we present a computational framework for unbiased combinatorial polyfunctionality analysis of antigen-specific T-cell subsets (COMPASS). COMPASS uses a Bayesian hierarchical framework to model all observed cell subsets and select those most likely to have antigen-specific responses. Cell-subset responses are quantified by posterior probabilities, and human subject-level responses are quantified by two summary statistics that describe the quality of an individual's polyfunctional response and can be correlated directly with clinical outcome. Using three clinical data sets of cytokine production, we demonstrate how COMPASS improves characterization of antigen-specific T cells and reveals cellular 'correlates of protection/immunity' in the RV144 HIV vaccine efficacy trial that are missed by other methods. COMPASS is available as open-source software.	[Lin, Lin; Finak, Greg; Ushey, Kevin; Frahm, Nicole; Gilbert, Peter; De Rosa, Stephen C.; McElrath, M. Juliana; Gottardo, Raphael] Fred Hutchinson Canc Res Ctr, Vaccine & Infect Dis Div, Seattle, WA 98104 USA; [Seshadri, Chetan; Hawn, Thomas R.; McElrath, M. Juliana] Univ Washington, Div Allergy & Infect Dis, Seattle, WA 98195 USA; [Scriba, Thomas J.; Mahomed, Hassan; Hanekom, Willem] Univ Cape Town, Inst Infect Dis & Mol Med, South African TB Vaccine Initiat, ZA-7925 Cape Town, South Africa; [Mahomed, Hassan; Hanekom, Willem] Univ Cape Town, Sch Child & Adolescent Hlth, ZA-7925 Cape Town, South Africa; [Bart, Pierre-Alexandre; Pantaleo, Giuseppe] Univ Vaudois, Ctr Hosp, Lausanne, Switzerland; [Tomaras, Georgia D.] Duke Univ, Med Ctr, Duke Human Vaccine Inst, Durham, NC USA; [Rerks-Ngarm, Supachai] Minist Publ Hlth, Dept Dis Control, Nonthaburi, Thailand; [Kaewkungwal, Jaranit] Mahidol Univ, Fac Trop Med, Data Management Unit, Bangkok, Thailand; [Nitayaphan, Sorachai] Thai Component, Armed Forces Res Inst Med Sci, Bangkok, Thailand; [Pitisuttithum, Punnee] Mahidol Univ, Fac Trop Med, Vaccine Trials Ctr, Bangkok, Thailand; [Michael, Nelson L.; Kim, Jerome H.] Walter Reed Army Inst Res, US Mil HIV Res Program, Silver Spring, MD USA; [Robb, Merlin L.] Henry M Jackson Fdn, Walter Reed Army Inst Res, US Army Mil HIV Res Program, Bethesda, MD USA; [O'Connell, Robert J.; Karasavvas, Nicos] Armed Forces Res Inst Med Sci, US Army Med Component, Bangkok 10400, Thailand; [De Rosa, Stephen C.; McElrath, M. Juliana] Univ Washington, Dept Lab Med, Seattle, WA 98195 USA	Fred Hutchinson Cancer Center; University of Washington; University of Washington Seattle; University of Cape Town; University of Cape Town; Duke University; Ministry of Public Health - Thailand; Mahidol University; United States Department of Defense; United States Army; Walter Reed Army Institute of Research (WRAIR); Armed Forces Research Institute of Medical Science (AFRIMS); Mahidol University; United States Department of Defense; United States Army; Walter Reed Army Institute of Research (WRAIR); Henry M. Jackson Foundation for the Advancement of Military Medicine, Inc; United States Department of Defense; United States Army; Walter Reed Army Institute of Research (WRAIR); United States Department of Defense; United States Army; Walter Reed Army Institute of Research (WRAIR); Armed Forces Research Institute of Medical Science (AFRIMS); University of Washington; University of Washington Seattle	Gottardo, R (corresponding author), Fred Hutchinson Canc Res Ctr, Vaccine & Infect Dis Div, 1124 Columbia St, Seattle, WA 98104 USA.	rgottard@fredhutch.org	Scriba, Thomas/AAH-9413-2020; Scriba, Thomas/GPX-2573-2022; Pantaleo, Giuseppe/K-6163-2016; Gottardo, Raphael/HCH-3169-2022; Tomaras, Georgia/J-5041-2016	Scriba, Thomas/0000-0002-0641-1359; Hanekom, Willem/0000-0003-3070-6154; Finak, Greg/0000-0003-4341-9090; Gottardo, Raphael/0000-0002-3867-0232; Kaewkungwal, Jaranit/0000-0001-7916-8460; Lin, Lin/0000-0002-7464-1172	National Institute of Health grants [R01 EB008400, UM1 AI068635, UM1 AI068618]; Human Immunology Phenotyping Consortium [U19 AI089986]; Collaboration for AIDS Vaccine Discovery [OPP1032325]; US Army Medical Research and Material Command [Y1-AI-2642-12]; National Institutes of Allergy and Infectious Diseases [Y1-AI-2642-12]; Henry M. Jackson Foundation for the Advancement of Military Medicine, Inc. [W81XWH-07-2-0067]; US Department of Defense [W81XWH-07-2-0067]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [UM1AI068635, N01AI002642, UM1AI068618, U19AI089986, UM1AI068614] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [R01EB008400] Funding Source: NIH RePORTER	National Institute of Health grants(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Human Immunology Phenotyping Consortium; Collaboration for AIDS Vaccine Discovery; US Army Medical Research and Material Command(United States Department of DefenseUnited States ArmyU.S. Army Medical Research & Materiel Command (USAMRMC)); National Institutes of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Henry M. Jackson Foundation for the Advancement of Military Medicine, Inc.; US Department of Defense(United States Department of Defense); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB))	This work was funded by National Institute of Health grants (R01 EB008400), and grants (UM1 AI068635) and (UM1 AI068618) to the HIV Vaccine Trials Network (HVTN) and the Statistical Data Management Center (SDMC), the Human Immunology Phenotyping Consortium (U19 AI089986), and the Collaboration for AIDS Vaccine Discovery (OPP1032325). The work was also supported in part by an Interagency Agreement Y1-AI-2642-12 between the US Army Medical Research and Material Command and the National Institutes of Allergy and Infectious Diseases and by a cooperative agreement (W81XWH-07-2-0067) between the Henry M. Jackson Foundation for the Advancement of Military Medicine, Inc., and the US Department of Defense. We also acknowledge G. Peterson for technical assistance with all assays related to the TB data set.	Aghaeepour N, 2013, NAT METHODS, V10, P228, DOI [10.1038/NMETH.2365, 10.1038/nmeth.2365]; Attig S, 2009, CANCER RES, V69, P8412, DOI 10.1158/0008-5472.CAN-09-0852; Bart P, 2012, RETROVIROLOGY, V9, DOI 10.1186/1742-4690-9-S2-O72; Bart PA, 2014, J CLIN INVEST, V124, P4843, DOI 10.1172/JCI75894; Ciuffreda D, 2008, EUR J IMMUNOL, V38, P2665, DOI 10.1002/eji.200838336; Darrah PA, 2007, NAT MED, V13, P843, DOI 10.1038/nm1592; De Rosa SC, 2004, J IMMUNOL, V173, P5372, DOI 10.4049/jimmunol.173.9.5372; De Rosa SC, 2012, CYTOM PART A, V81A, P1019, DOI 10.1002/cyto.a.22218; Derrick SC, 2011, VACCINE, V29, P2902, DOI 10.1016/j.vaccine.2011.02.010; Ewer KJ, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3836; Finak G, 2014, BIOSTATISTICS, V15, P87, DOI 10.1093/biostatistics/kxt024; Hawkridge T, 2008, J INFECT DIS, V198, P544, DOI 10.1086/590185; Haynes BF, 2012, NEW ENGL J MED, V366, P1275, DOI 10.1056/NEJMoa1113425; Horton H, 2007, J IMMUNOL METHODS, V323, P39, DOI 10.1016/j.jim.2007.03.002; Larsen M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042403; Lo K, 2008, CYTOM PART A, V73A, P321, DOI 10.1002/cyto.a.20531; Mahomed H, 2011, INT J TUBERC LUNG D, V15, P331; McElrath MJ, 2010, IMMUNITY, V33, P542, DOI 10.1016/j.immuni.2010.09.011; Nason M, 2006, J BIOPHARM STAT, V16, P483, DOI 10.1080/10543400600719426; Newton MA, 2004, BIOSTATISTICS, V5, P155, DOI 10.1093/biostatistics/5.2.155; Overstreet MG, 2008, IMMUNOL REV, V225, P272, DOI 10.1111/j.1600-065X.2008.00671.x; Pai M, 2014, CLIN MICROBIOL REV, V27, P3, DOI 10.1128/CMR.00034-13; Precopio ML, 2007, J EXP MED, V204, P1405, DOI 10.1084/jem.20062363; Proschan MA, 2009, BIOMETRICS, V65, P316, DOI 10.1111/j.1541-0420.2008.01053.x; Reddy TBK, 2009, NUCLEIC ACIDS RES, V37, pD499, DOI 10.1093/nar/gkn652; Rerks-Ngarm S, 2009, NEW ENGL J MED, V361, P2209, DOI 10.1056/NEJMoa0908492; Rodrigue-Gervais IG, 2010, J IMMUNOL, V184, P3134, DOI 10.4049/jimmunol.0902522; Roederer M, 2011, CYTOM PART A, V79A, P167, DOI 10.1002/cyto.a.21015; Scott JG, 2010, ANN STAT, V38, P2587, DOI 10.1214/10-AOS792; Trigona WL, 2003, J INTERF CYTOK RES, V23, P369, DOI 10.1089/107999003322226023	30	162	165	0	12	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156	1546-1696		NAT BIOTECHNOL	Nat. Biotechnol.	JUN	2015	33	6					610	+		10.1038/nbt.3187	http://dx.doi.org/10.1038/nbt.3187			9	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	CK2DE	26006008	Green Submitted, Green Accepted, Bronze			2022-12-27	WOS:000356019700020
J	Huggett, B				Huggett, Brady			Biotech's wellspring-a survey of the health of the private sector in 2014	NATURE BIOTECHNOLOGY			English	Article									Nat Biotechnol, New York, NY 10013 USA		Huggett, B (corresponding author), Nat Biotechnol, New York, NY 10013 USA.								0	9	9	0	0	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156	1546-1696		NAT BIOTECHNOL	Nat. Biotechnol.	MAY	2015	33	5					470	477		10.1038/nbt.3218	http://dx.doi.org/10.1038/nbt.3218			8	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	CH8VP	25965753				2022-12-27	WOS:000354314500024
J	Najafabadi, HS; Mnaimneh, S; Schmitges, FW; Garton, M; Lam, KN; Yang, A; Albu, M; Weirauch, MT; Radovani, E; Kim, PM; Greenblatt, J; Frey, BJ; Hughes, TR				Najafabadi, Hamed S.; Mnaimneh, Sanie; Schmitges, Frank W.; Garton, Michael; Lam, Kathy N.; Yang, Ally; Albu, Mihai; Weirauch, Matthew T.; Radovani, Ernest; Kim, Philip M.; Greenblatt, Jack; Frey, Brendan J.; Hughes, Timothy R.			C2H2 zinc finger proteins greatly expand the human regulatory lexicon	NATURE BIOTECHNOLOGY			English	Article							TRANSCRIPTION-FACTOR-BINDING; DNA-BINDING; MOLECULAR-DYNAMICS; SPECIFICITY; RECOGNITION; ELEMENTS; SYSTEM; MODEL; VISUALIZATION; SIMULATION	Cys2-His2 zinc finger (C2H2-ZF) proteins represent the largest class of putative human transcription factors. However, for most C2H2-ZF proteins it is unknown whether they even bind DNA or, if they do, to which sequences. Here, by combining data from a modified bacterial one-hybrid system with protein-binding microarray and chromatin immunoprecipitation analyses, we show that natural C2H2-ZFs encoded in the human genome bind DNA both in vitro and in vivo, and we infer the DNA recognition code using DNA-binding data for thousands of natural C2H2-ZF domains. In vivo binding data are generally consistent with our recognition code and indicate that C2H2-ZF proteins recognize more motifs than all other human transcription factors combined. We provide direct evidence that most KRAB-containing C2H2-ZF proteins bind specific endogenous retroelements (EREs), ranging from currently active to ancient families. The majority of C2H2-ZF proteins, including KRAB proteins, also show widespread binding to regulatory regions, indicating that the human genome contains an extensive and largely unstudied adaptive C2H2-ZF regulatory network that targets a diverse range of genes and pathways.	[Najafabadi, Hamed S.; Mnaimneh, Sanie; Schmitges, Frank W.; Garton, Michael; Yang, Ally; Albu, Mihai; Kim, Philip M.; Greenblatt, Jack; Frey, Brendan J.; Hughes, Timothy R.] Univ Toronto, Donnelly Ctr Cellular & Biomol Res, Toronto, ON, Canada; [Lam, Kathy N.; Radovani, Ernest; Kim, Philip M.; Greenblatt, Jack; Hughes, Timothy R.] Univ Toronto, Dept Mol Genet, Toronto, ON, Canada; [Weirauch, Matthew T.] Cincinnati Childrens Hosp Med Ctr, CAGE, Cincinnati, OH 45229 USA; [Weirauch, Matthew T.] Cincinnati Childrens Hosp Med Ctr, Div Biomed Informat, Cincinnati, OH 45229 USA; [Weirauch, Matthew T.] Cincinnati Childrens Hosp Med Ctr, Div Dev Biol, Cincinnati, OH 45229 USA; [Weirauch, Matthew T.; Frey, Brendan J.; Hughes, Timothy R.] Canadian Inst Adv Res, Toronto, ON, Canada; [Kim, Philip M.; Frey, Brendan J.] Univ Toronto, Dept Comp Sci, Toronto, ON, Canada; [Frey, Brendan J.] Univ Toronto, Dept Elect & Comp Engn, Toronto, ON, Canada	University of Toronto; University of Toronto; Cincinnati Children's Hospital Medical Center; Cincinnati Children's Hospital Medical Center; Cincinnati Children's Hospital Medical Center; Canadian Institute for Advanced Research (CIFAR); University of Toronto; University of Toronto	Hughes, TR (corresponding author), Univ Toronto, Donnelly Ctr Cellular & Biomol Res, Toronto, ON, Canada.	t.hughes@utoronto.ca	Weirauch, Matthew/M-5459-2019	Najafabadi, Hamed/0000-0003-2735-4231; Lam, Kathy/0000-0003-1543-0161; Yang, Ally/0000-0002-8678-0946	Canadian Institutes of Health Research [MOP-77721, MOP-111007, MOP-272138]; Canadian Institutes for Advanced Research; Canadian Institutes of Health Research Banting Fellowship; European Molecular Biology Organization postdoctoral fellowship; Natural Science and Engineering Research Council CGS-M	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Canadian Institutes for Advanced Research; Canadian Institutes of Health Research Banting Fellowship(Canadian Institutes of Health Research (CIHR)); European Molecular Biology Organization postdoctoral fellowship; Natural Science and Engineering Research Council CGS-M	We are grateful to S. Wolfe for providing B1H reagents and protocols, F. Aidoo, H. Zheng, H. Tang, P. Young, T. Kanagalingam, D. Torti and the Donnelly Sequencing Centre for technical support, and E. Chan, H. van Bakel and X. Chen for computational support and analyses. This work was supported by grants from the Canadian Institutes of Health Research (MOP-77721 and MOP-111007 to T.R.H., MOP-272138 to T.R.H., J.G. and Andrew Emili), and funding from the Canadian Institutes for Advanced Research to T.R.H., B.J.F. and M.T.W.H.S.N. was supported by a Canadian Institutes of Health Research Banting Fellowship, F.W.S. by a European Molecular Biology Organization postdoctoral fellowship, and K.N.L. by a Natural Science and Engineering Research Council CGS-M.	Ayyanathan K, 2003, GENE DEV, V17, P1855, DOI 10.1101/gad.1102803; Bailey TL, 2012, NUCLEIC ACIDS RES, V40, DOI 10.1093/nar/gks433; Bailey TL, 2009, NUCLEIC ACIDS RES, V37, pW202, DOI 10.1093/nar/gkp335; BERENDSEN HJC, 1984, J CHEM PHYS, V81, P3684, DOI 10.1063/1.448118; Berger MF, 2006, NAT BIOTECHNOL, V24, P1429, DOI 10.1038/nbt1246; Brayer KJ, 2008, CELL BIOCHEM BIOPHYS, V51, P9, DOI 10.1007/s12013-008-9007-6; Brayer KJ, 2008, CELL BIOCHEM BIOPHYS, V50, P111, DOI 10.1007/s12013-008-9008-5; Breiman L., 2001, Machine Learning, V45, P5, DOI 10.1023/A:1010933404324; Carlson KA, 2004, J IMMUNOL, V172, P381, DOI 10.4049/jimmunol.172.1.381; Carroll SB, 2008, CELL, V134, P25, DOI 10.1016/j.cell.2008.06.030; Case DA, 2005, J COMPUT CHEM, V26, P1668, DOI 10.1002/jcc.20290; Chen GI, 2008, J BIOL CHEM, V283, P29273, DOI 10.1074/jbc.M803443200; Cheng YD, 2010, CANCER RES, V70, P6516, DOI 10.1158/0008-5472.CAN-09-4566; Clark AG, 2007, NATURE, V450, P203, DOI 10.1038/nature06341; Day DS, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-6-r69; Dermitzakis ET, 2002, MOL BIOL EVOL, V19, P1114, DOI 10.1093/oxfordjournals.molbev.a004169; Dunham I, 2012, NATURE, V489, P57, DOI 10.1038/nature11247; Efron B, 2004, ANN STAT, V32, P407, DOI 10.1214/009053604000000067; Emerson RO, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000325; Feig M, 2004, J MOL GRAPH MODEL, V22, P377, DOI 10.1016/j.jmgm.2003.12.005; Frey BJ, 2007, SCIENCE, V315, P972, DOI 10.1126/science.1136800; Grant CE, 2011, BIOINFORMATICS, V27, P1017, DOI 10.1093/bioinformatics/btr064; Guerois R, 2002, J MOL BIOL, V320, P369, DOI 10.1016/S0022-2836(02)00442-4; Gupta A, 2014, NUCLEIC ACIDS RES, V42, P4800, DOI 10.1093/nar/gku132; Gupta A, 2012, NAT METHODS, V9, P588, DOI [10.1038/NMETH.1994, 10.1038/nmeth.1994]; Hamilton AT, 2006, GENOME RES, V16, P584, DOI 10.1101/gr.4843906; Hornak V, 2006, PROTEINS, V65, P712, DOI 10.1002/prot.21123; Isalan M, 1997, P NATL ACAD SCI USA, V94, P5617, DOI 10.1073/pnas.94.11.5617; Iuchi S, 2001, CELL MOL LIFE SCI, V58, P625, DOI 10.1007/PL00000885; Jacobs FMJ, 2014, NATURE, V516, P242, DOI 10.1038/nature13760; Jolma A, 2013, CELL, V152, P327, DOI 10.1016/j.cell.2012.12.009; Karolchik D, 2004, NUCLEIC ACIDS RES, V32, pD493, DOI 10.1093/nar/gkh103; Kharchenko PV, 2008, NAT BIOTECHNOL, V26, P1351, DOI 10.1038/nbt.1508; Kleefstra T, 2004, J MED GENET, V41, P394, DOI 10.1136/jmg.2003.016972; Klug Aaron, 2010, Annu Rev Biochem, V79, P213, DOI 10.1146/annurev-biochem-010909-095056; Kunarso G, 2010, NAT GENET, V42, P631, DOI 10.1038/ng.600; Lam KN, 2011, NUCLEIC ACIDS RES, V39, P4680, DOI 10.1093/nar/gkq1303; Lander ES, 2001, NATURE, V409, P860, DOI 10.1038/35057062; Landt SG, 2012, GENOME RES, V22, P1813, DOI 10.1101/gr.136184.111; Langmead B, 2012, NAT METHODS, V9, P357, DOI [10.1038/NMETH.1923, 10.1038/nmeth.1923]; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Li H, 2009, BIOINFORMATICS, V25, P1094, DOI [10.1093/bioinformatics/btp100, 10.1093/bioinformatics/btp324]; Lu XJ, 2003, NUCLEIC ACIDS RES, V31, P5108, DOI 10.1093/nar/gkg680; Machanick P, 2011, BIOINFORMATICS, V27, P1696, DOI 10.1093/bioinformatics/btr189; Mackay DJG, 2008, NAT GENET, V40, P949, DOI 10.1038/ng.187; Matsui T, 2010, NATURE, V464, P927, DOI 10.1038/nature08858; McLean CY, 2010, NAT BIOTECHNOL, V28, P495, DOI 10.1038/nbt.1630; Meng XD, 2005, NAT BIOTECHNOL, V23, P988, DOI 10.1038/nbt1120; Meng X, 2006, NAT PROTOC, V1, P30, DOI 10.1038/nprot.2006.6; Moffat J, 2006, CELL, V124, P1283, DOI 10.1016/j.cell.2006.01.040; Nowick K, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021553; Noyes MB, 2008, NUCLEIC ACIDS RES, V36, P2547, DOI 10.1093/nar/gkn048; Odom DT, 2007, NAT GENET, V39, P730, DOI 10.1038/ng2047; Pang YP, 2001, PROTEINS, V45, P183, DOI 10.1002/prot.1138; Perez A, 2007, BIOPHYS J, V92, P3817, DOI 10.1529/biophysj.106.097782; Persikov AV, 2014, NUCLEIC ACIDS RES, V42, P97, DOI 10.1093/nar/gkt890; Petrey D, 2003, PROTEINS, V53, P430, DOI 10.1002/prot.10550; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Ray D, 2013, NATURE, V499, P172, DOI 10.1038/nature12311; Rowe HM, 2011, VIROLOGY, V411, P273, DOI 10.1016/j.virol.2010.12.007; Rowe HM, 2010, NATURE, V463, P237, DOI 10.1038/nature08674; RYCKAERT JP, 1977, J COMPUT PHYS, V23, P327, DOI 10.1016/0021-9991(77)90098-5; Sanges R, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-7-r56; Schmidt D, 2009, METHODS, V48, P240, DOI 10.1016/j.ymeth.2009.03.001; She XW, 2008, NAT GENET, V40, P909, DOI 10.1038/ng.172; Sheffield NC, 2013, GENOME RES, V23, P777, DOI 10.1101/gr.152140.112; Siepel A, 2005, GENOME RES, V15, P1034, DOI 10.1101/gr.3715005; Skarra DV, 2011, PROTEOMICS, V11, P1508, DOI 10.1002/pmic.201000770; Stormo GD, 2010, NAT REV GENET, V11, P751, DOI 10.1038/nrg2845; Stubbs L, 2011, SUBCELL BIOCHEM, V52, P75, DOI 10.1007/978-90-481-9069-0_4; SWIRNOFF AH, 1995, MOL CELL BIOL, V15, P2275; Thomas JH, 2011, GENOME RES, V21, P1800, DOI 10.1101/gr.121749.111; Tonikian R, 2007, NAT PROTOC, V2, P1368, DOI 10.1038/nprot.2007.151; Toukmaji A, 2000, J CHEM PHYS, V113, P10913, DOI 10.1063/1.1324708; Umm-e-Kalsoom, 2013, J MED GENET, V50, P47, DOI 10.1136/jmedgenet-2012-101219; Vaquerizas JM, 2009, NAT REV GENET, V10, P252, DOI 10.1038/nrg2538; VRIEND G, 1990, J MOL GRAPHICS, V8, P52, DOI 10.1016/0263-7855(90)80070-V; Wang H, 2005, J MOL BIOL, V354, P994, DOI 10.1016/j.jmb.2005.09.085; Wang J, 2012, GENOME RES, V22, P1798, DOI 10.1101/gr.139105.112; Weirauch MT, 2014, CELL, V158, P1431, DOI 10.1016/j.cell.2014.08.009; Weirauch MT, 2011, SUBCELL BIOCHEM, V52, P25, DOI 10.1007/978-90-481-9069-0_3; Wolf D, 2009, NATURE, V458, P1201, DOI 10.1038/nature07844; Wolfe SA, 2001, STRUCTURE, V9, P717, DOI 10.1016/S0969-2126(01)00632-3; Wolfe SA, 2000, ANNU REV BIOPH BIOM, V29, P183, DOI 10.1146/annurev.biophys.29.1.183; Wunderlich Z, 2009, TRENDS GENET, V25, P434, DOI 10.1016/j.tig.2009.08.003; Zhang Y, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-9-r137	86	191	192	2	57	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1087-0156	1546-1696		NAT BIOTECHNOL	Nat. Biotechnol.	MAY	2015	33	5					555	U181		10.1038/nbt.3128	http://dx.doi.org/10.1038/nbt.3128			12	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	CH8VP	25690854				2022-12-27	WOS:000354314500040
J	Kim, J; Li, WA; Choi, Y; Lewin, SA; Verbeke, CS; Dranoff, G; Mooney, DJ				Kim, Jaeyun; Li, Weiwei Aileen; Choi, Youngjin; Lewin, Sarah A.; Verbeke, Catia S.; Dranoff, Glenn; Mooney, David J.			Injectable, spontaneously assembling, inorganic scaffolds modulate immune cells in vivo and increase vaccine efficacy	NATURE BIOTECHNOLOGY			English	Article							MESOPOROUS SILICA NANOPARTICLES; DENDRITIC CELLS; NALP3 INFLAMMASOME; DRUG-DELIVERY; T-FH; ANTIGEN; RESPONSES; INNATE; BIOMATERIALS; DEGRADATION	Implanting materials in the body to program host immune cells is a promising alternative to transplantation of cells manipulated ex vivo to direct an immune response, but doing so requires a surgical procedure. Here we demonstrate that high-aspect-ratio, mesoporous silica rods (MSRs) injected with a needle spontaneously assemble in vivo to form macroporous structures that provide a 3D cellular microenvironment for host immune cells. In mice, substantial numbers of dendritic cells are recruited to the pores between the scaffold rods. The recruitment of dendritic cells and their subsequent homing to lymph nodes can be modulated by sustained release of inflammatory signals and adjuvants from the scaffold. Moreover, injection of an MSR-based vaccine formulation enhances systemic helper T cells T(H)1 and T(H)2 serum antibody and cytotoxic T-cell levels compared to bolus controls. These findings suggest that injectable MSRs may serve as a multifunctional vaccine platform to modulate host immune cell function and provoke adaptive immune responses.	[Kim, Jaeyun; Li, Weiwei Aileen; Verbeke, Catia S.; Mooney, David J.] Harvard Univ, Sch Engn & Appl Sci, Cambridge, MA 02138 USA; [Kim, Jaeyun; Li, Weiwei Aileen; Lewin, Sarah A.; Verbeke, Catia S.; Mooney, David J.] Harvard Univ, Wyss Inst Biologically Inspired Engn, Boston, MA 02115 USA; [Kim, Jaeyun; Choi, Youngjin] Sungkyunkwan Univ, Sch Chem Engn, Suwon, South Korea; [Dranoff, Glenn] Dana Farber Canc Inst, Boston, MA 02115 USA; [Dranoff, Glenn] Harvard Univ, Sch Med, Boston, MA USA	Harvard University; Harvard University; Sungkyunkwan University (SKKU); Harvard University; Dana-Farber Cancer Institute; Harvard University; Harvard Medical School	Mooney, DJ (corresponding author), Harvard Univ, Sch Engn & Appl Sci, Cambridge, MA 02138 USA.	mooneyd@seas.harvard.edu	Kim, Jaeyun/E-2915-2015	Kim, Jaeyun/0000-0002-4687-6732; Li, Aileen/0000-0002-1056-5932; Mooney, David/0000-0001-6299-1194	National Institutes of Health (NIH) [1R01EB015498]; National Science Foundation (NSF) Graduate Research Fellowship Program (GRFP); Wyss Institute for Biologically Inspired Engineering at Harvard University; National Research Foundation (NRF) - National Research Foundation under the Ministry of Science, ICT & Future Planning, Korea [2012R1A1A1042735, 2010-0027955]; NIH [UL1 TR001102]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR001102] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [R01EB015498] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation (NSF) Graduate Research Fellowship Program (GRFP)(National Science Foundation (NSF)NSF - Office of the Director (OD)); Wyss Institute for Biologically Inspired Engineering at Harvard University; National Research Foundation (NRF) - National Research Foundation under the Ministry of Science, ICT & Future Planning, Korea; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB))	This work was supported by the National Institutes of Health (NIH) (1R01EB015498), the National Science Foundation (NSF) Graduate Research Fellowship Program (GRFP), the Wyss Institute for Biologically Inspired Engineering at Harvard University, and National Research Foundation (NRF) grants (2012R1A1A1042735, 2010-0027955) funded by the National Research Foundation under the Ministry of Science, ICT & Future Planning, Korea. We also thank Dana-Farber/Harvard Cancer Center (DF/HCC) Research Pathology Core and R. Bronson for the examination of the histology slides and J. Weaver from the Wyss Institute of Biologically Inspired Engineering for his help with scanning electron microscopy (SEM). Lastly, we thank R. Betensky from the Department of Biostatistics, Harvard School of Public Health and the Harvard Catalyst for her help with statistical analysis; Harvard Catalyst is supported, in part, by the NIH (UL1 TR001102).	Ali OA, 2009, SCI TRANSL MED, V1, DOI 10.1126/scitranslmed.3000359; Ali OA, 2009, NAT MATER, V8, P151, DOI [10.1038/NMAT2357, 10.1038/nmat2357]; Banchereau J, 1998, NATURE, V392, P245, DOI 10.1038/32588; Bhattacharya P, 2011, J LEUKOCYTE BIOL, V89, P235, DOI 10.1189/jlb.0310154; Cauda V, 2010, MICROPOR MESOPOR MAT, V132, P60, DOI 10.1016/j.micromeso.2009.11.015; Crotty S, 2011, ANNU REV IMMUNOL, V29, P621, DOI 10.1146/annurev-immunol-031210-101400; Dieu MC, 1998, J EXP MED, V188, P373, DOI 10.1084/jem.188.2.373; Dostert C, 2008, SCIENCE, V320, P674, DOI 10.1126/science.1156995; Engelmayr GC, 2008, NAT MATER, V7, P1003, DOI 10.1038/nmat2316; Faulkner L, 2000, IMMUNOLOGY, V99, P523, DOI 10.1046/j.1365-2567.2000.00018.x; FREED LE, 1994, BIO-TECHNOL, V12, P689, DOI 10.1038/nbt0794-689; Garcia-Bennett AE, 2011, NANOMEDICINE-UK, V6, P867, DOI [10.2217/NNM.11.82, 10.2217/nnm.11.82]; He QJ, 2010, MICROPOR MESOPOR MAT, V131, P314, DOI 10.1016/j.micromeso.2010.01.009; Hornung V, 2008, NAT IMMUNOL, V9, P847, DOI 10.1038/ni.1631; Hudson SP, 2008, BIOMATERIALS, V29, P4045, DOI 10.1016/j.biomaterials.2008.07.007; Jahnisch H, 2010, CLIN DEV IMMUNOL, DOI 10.1155/2010/517493; John ALS, 2012, NAT MATER, V11, P250, DOI [10.1038/NMAT3222, 10.1038/nmat3222]; Kim J, 2008, ANGEW CHEM INT EDIT, V47, P8438, DOI 10.1002/anie.200802469; Klinman DM, 2004, NAT REV IMMUNOL, V4, P248, DOI 10.1038/nri1329; Li ZX, 2012, CHEM SOC REV, V41, P2590, DOI 10.1039/c1cs15246g; Lu AH, 2004, CHEM-EUR J, V10, P6085, DOI 10.1002/chem.200400180; Lutolf MP, 2005, NAT BIOTECHNOL, V23, P47, DOI 10.1038/nbt1055; Medzhitov R, 1997, CURR OPIN IMMUNOL, V9, P4, DOI 10.1016/S0952-7915(97)80152-5; Meng HA, 2010, J AM CHEM SOC, V132, P12690, DOI 10.1021/ja104501a; Moon JJ, 2012, P NATL ACAD SCI USA, V109, P1080, DOI 10.1073/pnas.1112648109; Moon JJ, 2011, NAT MATER, V10, P243, DOI 10.1038/NMAT2960; Park J, 2012, NAT MATER, V11, P895, DOI [10.1038/NMAT3355, 10.1038/nmat3355]; Petushkov A, 2010, ADV MOLEC TOXICOL, V4, P223, DOI 10.1016/S1872-0854(10)04007-5; Place ES, 2009, CHEM SOC REV, V38, P1139, DOI 10.1039/b811392k; Porter DL, 2011, NEW ENGL J MED, V365, P725, DOI 10.1056/NEJMoa1103849; Rabinovich GA, 2007, ANNU REV IMMUNOL, V25, P267, DOI 10.1146/annurev.immunol.25.022106.141609; Randolph GJ, 2008, ANNU REV IMMUNOL, V26, P293, DOI 10.1146/annurev.immunol.26.021607.090254; Reddy ST, 2007, NAT BIOTECHNOL, V25, P1159, DOI [10.1038/nbt1332, 10.1038/nbtl332]; Russell B., 2010, Temporal release of growth factors from 3d micro rod scaffolds for tissue regeneration, Patent No. [EP 2170419 A1, 2170419]; Schmidt-Winkel P, 1999, ADV MATER, V11, P303, DOI 10.1002/(SICI)1521-4095(199903)11:4<303::AID-ADMA303>3.3.CO;2-D; Sharp FA, 2009, P NATL ACAD SCI USA, V106, P870, DOI 10.1073/pnas.0804897106; STEINMAN RM, 1991, ANNU REV IMMUNOL, V9, P271, DOI 10.1146/annurev.iy.09.040191.001415; Stephan MT, 2010, NAT MED, V16, P1035, DOI 10.1038/nm.2198; Uto T, 2011, BIOMATERIALS, V32, P5206, DOI 10.1016/j.biomaterials.2011.03.052; Victora GD, 2012, ANNU REV IMMUNOL, V30, P429, DOI 10.1146/annurev-immunol-020711-075032; Xia TA, 2009, ACS NANO, V3, P3273, DOI 10.1021/nn900918w; Yamada Y, 2004, TISSUE ENG, V10, P955, DOI 10.1089/1076327041348284; Yang PP, 2012, CHEM SOC REV, V41, P3679, DOI 10.1039/c2cs15308d; Yuen WW, 2010, P NATL ACAD SCI USA, V107, P17933, DOI 10.1073/pnas.1001192107; Zhang HY, 2012, J AM CHEM SOC, V134, P15790, DOI 10.1021/ja304907c; Zhang SG, 2003, NAT BIOTECHNOL, V21, P1171, DOI 10.1038/nbt874; Zhang XQ, 2007, J IMMUNOTHER, V30, P469, DOI 10.1097/CJI.0b013e31802fd8c6; Zhao DY, 1998, J AM CHEM SOC, V120, P6024, DOI 10.1021/ja974025i; Zou WP, 2005, NAT REV CANCER, V5, P263, DOI 10.1038/nrc1586	50	326	338	13	326	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156	1546-1696		NAT BIOTECHNOL	Nat. Biotechnol.	JAN	2015	33	1					64	U241		10.1038/nbt.3071	http://dx.doi.org/10.1038/nbt.3071			11	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	AY7AR	25485616	Green Accepted, Green Submitted			2022-12-27	WOS:000347714200029
J	Scott, CT; DeFrancesco, L				Scott, Christopher Thomas; DeFrancesco, Laura			Selling long life	NATURE BIOTECHNOLOGY			English	Article							SEARCH											Britt R.R., 2005, INFUSION YOUNG BLOOD; de Cabo R, 2014, CELL, V157, P1515, DOI 10.1016/j.cell.2014.05.031; Garber K, 2008, NAT BIOTECHNOL, V26, P371, DOI 10.1038/nbt0408-371; KENYON C, 1993, NATURE, V366, P461, DOI 10.1038/366461a0; McCay CM, 1935, J NUTR, V10, P63, DOI 10.1093/jn/10.1.63; OLSHANSKY SJ, 1990, SCIENCE, V250, P634, DOI 10.1126/science.2237414; Partridge L, 2010, PHILOS T R SOC B, V365, P147, DOI 10.1098/rstb.2009.0222; Rochon J, 2011, J GERONTOL A-BIOL, V66, P97, DOI 10.1093/gerona/glq168; Steakley L., 2014, EXPT TREATS EACH PER; Stipp D, 2010, YOUTH PILL SCI BRINK	10	14	14	0	20	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156	1546-1696		NAT BIOTECHNOL	Nat. Biotechnol.	JAN	2015	33	1					31	40		10.1038/nbt.3108	http://dx.doi.org/10.1038/nbt.3108			10	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	AY7AR	25574633				2022-12-27	WOS:000347714200021
J	Bikard, D; Euler, CW; Jiang, WY; Nussenzweig, PM; Goldberg, GW; Duportet, X; Fischetti, VA; Marraffini, LA				Bikard, David; Euler, Chad W.; Jiang, Wenyan; Nussenzweig, Philip M.; Goldberg, Gregory W.; Duportet, Xavier; Fischetti, Vincent A.; Marraffini, Luciano A.			Exploiting CRISPR-Cas nucleases to produce sequence-specific antimicrobials	NATURE BIOTECHNOLOGY			English	Article							STAPHYLOCOCCUS-AUREUS; GENOME SEQUENCE; RNA; GENE; EXPRESSION; ENCODES	Antibiotics target conserved bacterial cellular pathways or growth functions and therefore cannot selectively kill specific members of a complex microbial population. Here, we develop programmable, sequence-specific antimicrobials using the RNA-guided nuclease Cas9 (refs.1,2) delivered by a bacteriophage. We show that Cas9, reprogrammed to target virulence genes, kills virulent, but not avirulent, Staphylococcus aureus. Reprogramming the nuclease to target antibiotic resistance genes destroys staphylococcal plasmids that harbor antibiotic resistance genes(3,4) and immunizes avirulent staphylococci to prevent the spread of plasmid-borne resistance genes. We also show that CRISPR-Cas9 antimicrobials function in vivo to kill S. aureus in a mouse skin colonization model. This technology creates opportunities to manipulate complex bacterial populations in a sequence-specific manner.	[Bikard, David; Jiang, Wenyan; Nussenzweig, Philip M.; Goldberg, Gregory W.; Marraffini, Luciano A.] Rockefeller Univ, Bacteriol Lab, New York, NY 10021 USA; [Euler, Chad W.; Fischetti, Vincent A.] Rockefeller Univ, Lab Bacterial Pathogenesis & Immunol, New York, NY 10021 USA; [Duportet, Xavier] INRIA Paris Rocquencourt, Rocquencourt, France; [Duportet, Xavier] MIT, Synthet Biol Ctr, Dept Biol Engn, Cambridge, MA 02139 USA	Rockefeller University; Rockefeller University; Massachusetts Institute of Technology (MIT)	Marraffini, LA (corresponding author), Rockefeller Univ, Bacteriol Lab, 1230 York Ave, New York, NY 10021 USA.	david.bikard@pasteur.fr; marraffini@rockefeller.edu	Bikard, David/L-2971-2015; Bikard, David/AAZ-3752-2021	Bikard, David/0000-0002-5729-1211; Bikard, David/0000-0002-5729-1211; Goldberg, Gregory/0000-0002-5022-9976	Bettencourt Schuller Foundation; Searle Scholars Program; Rita Allen Scholars Program; Irma T. Hirschl Award; Sinsheimer Foundation Award; NIH Director's New Innovator Award [1DP2AI104556-01]; NIH Grant [AI057472]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [DP2AI104556, T32AI070084] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007739] Funding Source: NIH RePORTER	Bettencourt Schuller Foundation; Searle Scholars Program; Rita Allen Scholars Program; Irma T. Hirschl Award; Sinsheimer Foundation Award; NIH Director's New Innovator Award(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH Grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We would like to thank A. Raz for providing plasmid pCN57 and D. Mucida for assistance with flow cytometry experiments. D.B. is supported by the Bettencourt Schuller Foundation. L.A.M. is supported by the Searle Scholars Program, the Rita Allen Scholars Program, an Irma T. Hirschl Award, a Sinsheimer Foundation Award and a NIH Director's New Innovator Award (1DP2AI104556-01). VAR is supported by NIH Grant AI057472.	Agarwal R, 2013, THER DELIV, V4, P705, DOI [10.4155/TDE.13.37, 10.4155/tde.13.37]; Baba T, 2008, J BACTERIOL, V190, P300, DOI 10.1128/JB.01000-07; Bikard D, 2013, NUCLEIC ACIDS RES, V41, P7429, DOI 10.1093/nar/gkt520; Bikard D, 2012, CELL HOST MICROBE, V12, P177, DOI 10.1016/j.chom.2012.06.003; Charpentier E, 2004, APPL ENVIRON MICROB, V70, P6076, DOI 10.1128/AEM.70.10.6076-6085.2004; Deltcheva E, 2011, NATURE, V471, P602, DOI 10.1038/nature09886; Dethlefsen L, 2008, PLOS BIOL, V6, P2383, DOI 10.1371/journal.pbio.0060280; Diep BA, 2006, LANCET, V367, P731, DOI 10.1016/S0140-6736(06)68231-7; Gasiunas G, 2012, P NATL ACAD SCI USA, V109, pE2579, DOI 10.1073/pnas.1208507109; Gomaa AA, 2014, MBIO, V5, DOI 10.1128/mBio.00928-13; Grice EA, 2009, SCIENCE, V324, P1190, DOI 10.1126/science.1171700; HORINOUCHI S, 1982, J BACTERIOL, V150, P815, DOI 10.1128/JB.150.2.815-825.1982; Isnard C, 2013, ANTIMICROB AGENTS CH, V57, P4463, DOI 10.1128/AAC.01030-13; Jiang WY, 2013, NAT BIOTECHNOL, V31, P233, DOI 10.1038/nbt.2508; Jinek M, 2012, SCIENCE, V337, P816, DOI 10.1126/science.1225829; KREISWIRTH BN, 1983, NATURE, V305, P709, DOI 10.1038/305709a0; Kugelberg E, 2005, ANTIMICROB AGENTS CH, V49, P3435, DOI 10.1128/AAC.49.8.3435-3441.2005; Lowy FD, 1998, NEW ENGL J MED, V339, P520, DOI 10.1056/NEJM199808203390806; Mazmanian SK, 2008, NATURE, V453, P620, DOI 10.1038/nature07008; MELNIKOV AA, 1984, GENE, V28, P29, DOI 10.1016/0378-1119(84)90084-2; Pastagia M, 2011, ANTIMICROB AGENTS CH, V55, P738, DOI 10.1128/AAC.00890-10; Qi LS, 2013, CELL, V152, P1173, DOI 10.1016/j.cell.2013.02.022; Round JL, 2011, SCIENCE, V332, P974, DOI 10.1126/science.1206095; Seed KD, 2013, NATURE, V494, P489, DOI 10.1038/nature11927; UBUKATA K, 1989, J BACTERIOL, V171, P2882, DOI 10.1128/jb.171.5.2882-2885.1989; Weigel LM, 2003, SCIENCE, V302, P1569, DOI 10.1126/science.1090956	26	463	519	12	258	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156	1546-1696		NAT BIOTECHNOL	Nat. Biotechnol.	NOV	2014	32	11					1146	1150		10.1038/nbt.3043	http://dx.doi.org/10.1038/nbt.3043			5	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	AT5IL	25282355	Green Accepted			2022-12-27	WOS:000344977000020
J	Kessel, M				Kessel, Mark			Restoring the pharmaceutical industry's reputation COMMENTARY	NATURE BIOTECHNOLOGY			English	Article									[Kessel, Mark] FIND, New York, NY 10001 USA; [Kessel, Mark] Shearman & Sterling LLP, New York, NY USA; [Kessel, Mark] Symphony Capital LLP, New York, NY USA		Kessel, M (corresponding author), FIND, New York, NY 10001 USA.	mark@symphonycapital.com						Bach P, 2012, NY TIMES; Baum S., 2013, MEDCITY NEWS; Brigham Alexander F., 2010, FORBES; Denning Steve., 2014, FORBES; Drews J, 2003, DRUG DISCOV TODAY, V8, P411, DOI 10.1016/S1359-6446(03)02690-4; Gaines-Ross, 2008, CORPORATE REPUTATION; Grogan K., 2014, PHARMATIMES ONLINE; Harrison K., 2014, CUTTING EDGE PR; Interactive Harris, 2013, HARR POLL 2013 RQ; Pew Charitable Trusts, 2013, PERS PRESCR PHARM IN; Porter Eduardo, 2014, NY TIMES; Reputation Institute, 2012, CORP REP MAIN DRIV B; Surowiecki J, 2014, NEW YORKER; Ward A., 2014, FINANC TIMES	14	40	41	0	8	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156	1546-1696		NAT BIOTECHNOL	Nat. Biotechnol.	OCT	2014	32	10					983	990		10.1038/nbt.3036	http://dx.doi.org/10.1038/nbt.3036			8	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	AR7MM	25299916	Bronze			2022-12-27	WOS:000343763800012
J	Karpinski, J; Hauber, I; Chemnitz, J; Schafer, C; Paszkowski-Rogacz, M; Chakraborty, D; Beschorner, N; Hofmann-Sieber, H; Lange, UC; Grundhoff, A; Hackmann, K; Schrock, E; Abi-Ghanem, J; Pisabarro, MT; Surendranath, V; Schambach, A; Lindner, C; van Lunzen, J; Hauber, J; Buchholz, F				Karpinski, Janet; Hauber, Ilona; Chemnitz, Jan; Schaefer, Carola; Paszkowski-Rogacz, Maciej; Chakraborty, Deboyoti; Beschorner, Niklas; Hofmann-Sieber, Helga; Lange, Ulrike C.; Grundhoff, Adam; Hackmann, Karl; Schrock, Evelin; Abi-Ghanem, Josephine; Pisabarro, M. Teresa; Surendranath, Vineeth; Schambach, Axel; Lindner, Christoph; van Lunzen, Jan; Hauber, Joachim; Buchholz, Frank			Directed evolution of a recombinase that excises the provirus of most HIV-1 primary isolates with high specificity	NATURE BIOTECHNOLOGY			English	Article							ZINC-FINGER-NUCLEASES; SITE-SPECIFIC RECOMBINATION; OFF-TARGET CLEAVAGE; CD4(+) T-CELLS; CRE RECOMBINASE; ANTIRETROVIRAL THERAPY; DRUG-RESISTANCE; GENE-THERAPY; IN-VITRO; DNA	Current combination antiretroviral therapies (cART) efficiently suppress HIV-1 reproduction in humans, but the virus persists as integrated proviral reservoirs in small numbers of cells. To generate an antiviral agent capable of eradicating the provirus from infected cells, we employed 145 cycles of substrate-linked directed evolution to evolve a recombinase (Brec1) that site-specifically recognizes a 34-bp sequence present in the long terminal repeats (LTRs) of the majority of the clinically relevant HIV-1 strains and subtypes. Brec1 efficiently, precisely and safely removes the integrated provirus from infected cells and is efficacious on clinical HIV-1 isolates in vitro and in vivo, including in mice humanized with patient-derived cells. Our data suggest that Brec1 has potential for clinical application as a curative HIV-1 therapy.	[Karpinski, Janet; Paszkowski-Rogacz, Maciej; Chakraborty, Deboyoti; Buchholz, Frank] Tech Univ Dresden, Med Fac Carl Gustav Carus, UCC, Med Syst Biol, Dresden, Germany; [Karpinski, Janet; Hauber, Ilona; Chemnitz, Jan; Schaefer, Carola; Beschorner, Niklas; Hofmann-Sieber, Helga; Lange, Ulrike C.; Grundhoff, Adam; van Lunzen, Jan; Hauber, Joachim] Leibniz Inst Expt Virol, Heinrich Pette Inst, Hamburg, Germany; [Schaefer, Carola; Hofmann-Sieber, Helga; Lange, Ulrike C.; Grundhoff, Adam; van Lunzen, Jan; Hauber, Joachim] German Ctr Infect Res DZIF, Partner Site Hamburg, Braunschweig, Germany; [Lange, Ulrike C.] Univ Med Ctr Hamburg Eppendorf, Dept Anesthesiol, Hamburg, Germany; [Hackmann, Karl; Schrock, Evelin] Tech Univ Dresden, Univ Hosp, Inst Clin Genet, Dresden, Germany; [Hackmann, Karl; Schrock, Evelin] Tech Univ Dresden, Med Fac Carl Gustav Carus, Dresden, Germany; [Abi-Ghanem, Josephine; Pisabarro, M. Teresa] BIOTEC TU Dresden, Struct Bioinformat, Dresden, Germany; [Surendranath, Vineeth; Buchholz, Frank] Max Planck Inst Mol Cell Biol & Genet, Dresden, Germany; [Schambach, Axel] Hannover Med Sch, Inst Expt Hematol, Hannover, Germany; [Lindner, Christoph] Agaples Diakonieklinikum, Gynecol, Hamburg, Germany; [van Lunzen, Jan] Univ Med Ctr Hamburg Eppendorf, Infect Dis Unit, Hamburg, Germany	Technische Universitat Dresden; Carl Gustav Carus University Hospital; University of Hamburg; University Medical Center Hamburg-Eppendorf; Heinrich Pette Institute; German Center for Infection Research; University of Hamburg; University Medical Center Hamburg-Eppendorf; Technische Universitat Dresden; Carl Gustav Carus University Hospital; Technische Universitat Dresden; Carl Gustav Carus University Hospital; Technische Universitat Dresden; Max Planck Society; Hannover Medical School; University of Hamburg; University Medical Center Hamburg-Eppendorf	Buchholz, F (corresponding author), Tech Univ Dresden, Med Fac Carl Gustav Carus, UCC, Med Syst Biol, Dresden, Germany.; Hauber, J (corresponding author), Leibniz Inst Expt Virol, Heinrich Pette Inst, Hamburg, Germany.; Hauber, J (corresponding author), German Ctr Infect Res DZIF, Partner Site Hamburg, Braunschweig, Germany.; Buchholz, F (corresponding author), Max Planck Inst Mol Cell Biol & Genet, Dresden, Germany.	joachim.hauber@hpi.uni-hamburg.de; frank.buchholz@tu-dresden.de	Chakraborty, Debojyoti/Y-7627-2018; Buchholz, Frank/B-4700-2017; /F-4368-2012; Pisabarro, M. Teresa/D-4270-2012; Chakraborty, Debojyoti/GRI-9445-2022; Schambach, Axel/C-5491-2011	Chakraborty, Debojyoti/0000-0003-1460-7594; Buchholz, Frank/0000-0002-4577-3344; /0000-0003-0351-4579; Abi Ghanem, josephine/0000-0002-8281-1266; Chakraborty, Debojyoti/0000-0002-2300-4333; Grundhoff, Adam/0000-0003-0940-7045	DFG [BU 1400/7-1]; BMBF [GO-Bio FKZ 0315090]; Else Kroner-Fresenius-Stiftung [2010_A82]; "Viral Latency" program at the Heinrich Pette Institute-Leibniz Institute for Experimental Virology, Hamburg	DFG(German Research Foundation (DFG)); BMBF(Federal Ministry of Education & Research (BMBF)); Else Kroner-Fresenius-Stiftung; "Viral Latency" program at the Heinrich Pette Institute-Leibniz Institute for Experimental Virology, Hamburg	The authors are indebted to M. Karimova (TU Dresden; TUD) for providing reagents, R. Kuhnert (TUD) for help with mouse work, A. Kassner-Frensel (TUD) for SKY analyses, R. Naumann (Max Planck Institute for Molecular Cell Biology and Genetics; MPI-CBG) for the generation of transgenic mice, S. Winkler (MPI-CBG) and A. Dahl (DFG-Forschungszentrum fur Regenerative Therapien Dresden) for DNA sequencing, D. Dubrau (Heinrich Pette Institute) for initial ASLV-vector construction, G. Pilnitz-Stolze, B. Weseloh and B. Abel (Heinrich Pette Institute) for technical assistance, and D. Indenbirken and M. Alawi (Heinrich Pette Institute) for next-generation sequencing of nrLAM-PCR products. This work was supported by the DFG (BU 1400/7-1), the BMBF (GO-Bio FKZ 0315090), the Else Kroner-Fresenius-Stiftung (2010_A82), and the "Viral Latency" program at the Heinrich Pette Institute-Leibniz Institute for Experimental Virology, Hamburg. The reporter plasmid pCAGGS-loxP-mCherry-loxP-EGFP, where a floxed mCherry gene was inserted between the CAG enhancer/promoter module and the EGFP gene, was a generous gift from E.M. Tanaka (DFG-Forschungszentrum fur Regenerative Therapien Dresden). The mammalian expression vector pCAGGS-IRES-puro was a generous gift from K. Anastassiadis (TUD).	Abi-Ghanem J, 2013, NUCLEIC ACIDS RES, V41, P2394, DOI 10.1093/nar/gks1308; Akay C, 2014, J NEUROVIROL, V20, P39, DOI 10.1007/s13365-013-0227-1; Anastassiadis K, 2009, DIS MODEL MECH, V2, P508, DOI 10.1242/dmm.003087; Archin NM, 2012, NATURE, V487, P482, DOI 10.1038/nature11286; Battistini A, 2014, VIRUSES-BASEL, V6, P1715, DOI 10.3390/v6041715; Beltran LM, 2015, VASC HEALTH RISK MAN, V11, P35, DOI 10.2147/VHRM.S65885; Blankson JN, 2014, INFECT DIS CLIN N AM, V28, P633, DOI 10.1016/j.idc.2014.08.007; Buchholz F, 2001, NAT BIOTECHNOL, V19, P1047, DOI 10.1038/nbt1101-1047; Buchholz F, 2011, METHODS, V53, P102, DOI 10.1016/j.ymeth.2010.06.014; Caskey M, 2015, NATURE, V522, P487, DOI 10.1038/nature14411; Chomont N, 2009, NAT MED, V15, P893, DOI 10.1038/nm.1972; Chun TW, 1999, NATURE, V401, P874, DOI 10.1038/44755; Crowell TA, 2015, J INFECT DIS, V211, P1692, DOI 10.1093/infdis/jiu809; Deeks SG, 2012, NATURE, V487, P439, DOI 10.1038/487439a; Ebina H, 2013, SCI REP-UK, V3, DOI 10.1038/srep02510; Ennifar E, 2003, NUCLEIC ACIDS RES, V31, P5449, DOI 10.1093/nar/gkg732; Fauci AS, 2014, JAMA-J AM MED ASSOC, V312, P335, DOI 10.1001/jama.2014.4754; Gabriel R, 2011, NAT BIOTECHNOL, V29, P816, DOI 10.1038/nbt.1948; Hauber I, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003587; Herrera-Carrillo E, 2015, VIRUSES-BASEL, V7, P3910, DOI 10.3390/v7072804; Holt N, 2010, NAT BIOTECHNOL, V28, P839, DOI 10.1038/nbt.1663; Hu WH, 2014, P NATL ACAD SCI USA, V111, P11461, DOI 10.1073/pnas.1405186111; Josefsson L, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003432; Josefsson L, 2011, P NATL ACAD SCI USA, V108, P11199, DOI 10.1073/pnas.1107729108; Karimova M, 2013, NUCLEIC ACIDS RES, V41, DOI 10.1093/nar/gks1037; Katlama C, 2013, LANCET, V381, P2109, DOI 10.1016/S0140-6736(13)60104-X; Kim H, 2014, NAT REV GENET, V15, P321, DOI 10.1038/nrg3686; Langmead B, 2012, NAT METHODS, V9, P357, DOI [10.1038/NMETH.1923, 10.1038/nmeth.1923]; Li H, 2009, BIOINFORMATICS, V25, P2078, DOI 10.1093/bioinformatics/btp352; Maartens G, 2014, LANCET, V384, P258, DOI 10.1016/S0140-6736(14)60164-1; Mbonye U, 2014, VIROLOGY, V454, P328, DOI 10.1016/j.virol.2014.02.008; Munch RC, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7246; Nachega Jean B., 2011, Infectious Disorders - Drug Targets, V11, P167; Passaes CP, 2014, VIROLOGY, V454, P340, DOI 10.1016/j.virol.2014.02.021; Pattanayak V, 2011, NAT METHODS, V8, P765, DOI 10.1038/nmeth.1670; Perez EE, 2008, NAT BIOTECHNOL, V26, P808, DOI 10.1038/nbt1410; Petoumenos K, 2012, J INT AIDS SOC, V15, DOI 10.7448/IAS.15.2.17426; Pinoges L, 2015, JAIDS-J ACQ IMM DEF, V68, P527, DOI 10.1097/QAI.0000000000000513; Prufer K, 2008, BIOINFORMATICS, V24, P1530, DOI 10.1093/bioinformatics/btn223; Qu XY, 2013, NUCLEIC ACIDS RES, V41, P7771, DOI 10.1093/nar/gkt571; Rappold M, 2014, J INT AIDS SOC, V17, P167, DOI 10.7448/IAS.17.4.19768; Richman DD, 2006, ANTIVIR RES, V71, P117, DOI 10.1016/j.antiviral.2006.03.004; Ringrose L, 1999, EMBO J, V18, P6630, DOI 10.1093/emboj/18.23.6630; Santarosa M, 2004, BBA-REV CANCER, V1654, P105, DOI 10.1016/j.bbcan.2004.01.001; Santoro SW, 2002, P NATL ACAD SCI USA, V99, P4185, DOI 10.1073/pnas.022039799; Sarkar I, 2007, SCIENCE, V316, P1912, DOI 10.1126/science.1141453; Sauer B, 2004, NUCLEIC ACIDS RES, V32, P6086, DOI 10.1093/nar/gkh941; Schackman BR, 2006, MED CARE, V44, P990, DOI 10.1097/01.mlr.0000228021.89490.2a; Scherer LJ, 2011, HUM MOL GENET, V20, pR100, DOI 10.1093/hmg/ddr160; Suerth JD, 2010, J VIROL, V84, P6626, DOI 10.1128/JVI.00182-10; Surendranath V, 2010, NUCLEIC ACIDS RES, V38, pW293, DOI 10.1093/nar/gkq523; Suzuki E, 2011, NUCLEIC ACIDS RES, V39, DOI 10.1093/nar/gkq1280; Taylor BS, 2008, NEW ENGL J MED, V358, P1590, DOI 10.1056/NEJMra0706737; Tebas P, 2014, NEW ENGL J MED, V370, P901, DOI 10.1056/NEJMoa1300662; Tsai SQ, 2015, NAT BIOTECHNOL, V33, P187, DOI 10.1038/nbt.3117; Van Duyne GD, 2001, ANNU REV BIOPH BIOM, V30, P87, DOI 10.1146/annurev.biophys.30.1.87; Wang XL, 2015, NAT BIOTECHNOL, V33, P175, DOI 10.1038/nbt.3127; Waterhouse AM, 2009, BIOINFORMATICS, V25, P1189, DOI 10.1093/bioinformatics/btp033; Whitney JB, 2014, NATURE, V512, P74, DOI 10.1038/nature13594	59	78	100	0	41	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156	1546-1696		NAT BIOTECHNOL	Nat. Biotechnol.	APR	2016	34	4					401	+		10.1038/nbt.3467	http://dx.doi.org/10.1038/nbt.3467			13	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	DI6NL	26900663				2022-12-27	WOS:000373616100020
J	Richardson, CD; Ray, GJ; DeWitt, MA; Curie, GL; Corn, JE				Richardson, Christopher D.; Ray, Graham J.; DeWitt, Mark A.; Curie, Gemma L.; Corn, Jacob E.			Enhancing homology-directed genome editing by catalytically active and inactive CRISPR-Cas9 using asymmetric donor DNA	NATURE BIOTECHNOLOGY			English	Article							DOUBLE-STRAND BREAK; ZINC-FINGER NUCLEASES; BACTERIAL IMMUNITY; TARGET DNA; CAS9; RNA; REPAIR; CELLS; ENDONUCLEASE; INTERROGATION	Targeted genomic manipulation by Cas9 can efficiently generate knockout cells and organisms via error-prone nonhomologous end joining (NHEJ), but the efficiency of precise sequence replacement by homology-directed repair (HDR) is substantially lower(1,2). Here we investigate the interaction of Cas9 with target DNA and use our findings to improve HDR efficiency. We show that dissociation of Cas9 from double-stranded DNA (dsDNA) substrates is slow (lifetime similar to 6 h) but that, before complete dissociation, Cas9 asymmetrically releases the 3 end of the cleaved DNA strand that is not complementary to the sgRNA (nontarget strand). By rationally designing single-stranded DNA (ssDNA) donors of the optimal length complementary to the strand that is released first, we increase the rate of HDR in human cells when using Cas9 or nickase variants to up to 60%. We also demonstrate HDR rates of up to 0.7% using a catalytically inactive Cas9 mutant (dCas9), which binds DNA without cleaving it.	[Richardson, Christopher D.; Ray, Graham J.; DeWitt, Mark A.; Curie, Gemma L.; Corn, Jacob E.] Univ Calif Berkeley, Innovat Genom Initiat, Berkeley, CA 94720 USA; [Richardson, Christopher D.; Ray, Graham J.; DeWitt, Mark A.; Curie, Gemma L.; Corn, Jacob E.] Univ Calif Berkeley, Dept Mol & Cell Biol, 229 Stanley Hall, Berkeley, CA 94720 USA	University of California System; University of California Berkeley; University of California System; University of California Berkeley	Corn, JE (corresponding author), Univ Calif Berkeley, Innovat Genom Initiat, Berkeley, CA 94720 USA.; Corn, JE (corresponding author), Univ Calif Berkeley, Dept Mol & Cell Biol, 229 Stanley Hall, Berkeley, CA 94720 USA.	jcorn@berkeley.edu		Richardson, Chris/0000-0003-3122-4851; Ray, Graham/0000-0002-1245-8428; Corn, Jacob/0000-0002-7798-5309	Li Ka Shing Foundation	Li Ka Shing Foundation	We thank J. Doudna, M. Botchan, and members of the Corn laboratory for critical reading of the manuscript. We thank the Doudna lab for the gift of wtCas9 expression plasmids and the Berkeley Macrolab for support with protein expression and purification. This work was supported by the Li Ka Shing Foundation. Reagents described in this work are available on Addgene (https://www.addgene.org/Jacob_Corn/), and detailed protocols are available on protocols.io (https://www.protocols.io/g/innovative-genomics-initiative).	Abdiche Y, 2008, ANAL BIOCHEM, V377, P209, DOI 10.1016/j.ab.2008.03.035; Anders C, 2014, METHOD ENZYMOL, V546, P1, DOI 10.1016/B978-0-12-801185-0.00001-5; Anders C, 2014, NATURE, V513, P569, DOI 10.1038/nature13579; Aparicio O, 2005, CURR PROTOC MOL BIOL, V69; Bitinaite J, 1998, P NATL ACAD SCI USA, V95, P10570, DOI 10.1073/pnas.95.18.10570; Carroll D, 2011, GENETICS, V188, P773, DOI 10.1534/genetics.111.131433; Cathomen T, 2010, METHODS MOL BIOL, V649, P227, DOI 10.1007/978-1-60761-753-2_13; Chen FQ, 2011, NAT METHODS, V8, P753, DOI 10.1038/nmeth.1653; Davis L, 2014, P NATL ACAD SCI USA, V111, pE924, DOI 10.1073/pnas.1400236111; DeWitt M., 2015, CA9 RNP NUCLEOFECTIO, DOI 10.17504/protocols.io.dm649d; Doudna JA, 2014, SCIENCE, V346, P1077, DOI 10.1126/science.1258096; Gaj T, 2013, TRENDS BIOTECHNOL, V31, P397, DOI 10.1016/j.tibtech.2013.04.004; Genovese P, 2014, NATURE, V510, P235, DOI 10.1038/nature13420; Heler R, 2015, NATURE, V519, P199, DOI 10.1038/nature14245; Jiang WY, 2015, ANNU REV MICROBIOL, V69, P209, DOI 10.1146/annurev-micro-091014-104441; Jinek M, 2012, SCIENCE, V337, P816, DOI 10.1126/science.1225829; Kim S, 2014, GENOME RES, V24, P1012, DOI 10.1101/gr.171322.113; Knight SC, 2015, SCIENCE, V350, P823, DOI 10.1126/science.aac6572; Lin S, 2014, ELIFE, V3, DOI 10.7554/eLife.04766; Mali P, 2013, NAT BIOTECHNOL, V31, P833, DOI 10.1038/nbt.2675; Maruyama T, 2015, NAT BIOTECHNOL, V33, P538, DOI 10.1038/nbt.3190; McVey M, 2008, TRENDS GENET, V24, P529, DOI 10.1016/j.tig.2008.08.007; METZGER L, 1991, INT J RADIAT BIOL, V59, P1325, DOI 10.1080/09553009114551201; Nishimasu H, 2014, CELL, V156, P935, DOI 10.1016/j.cell.2014.02.001; Ran FA, 2013, CELL, V154, P1380, DOI 10.1016/j.cell.2013.08.021; Sfeir A, 2015, TRENDS BIOCHEM SCI, V40, P701, DOI 10.1016/j.tibs.2015.08.006; Sternberg SH, 2014, NATURE, V507, P62, DOI 10.1038/nature13011; Storici F, 2006, MOL CELL BIOL, V26, P7645, DOI 10.1128/MCB.00672-06; Trevino AE, 2014, METHOD ENZYMOL, V546, P161, DOI 10.1016/B978-0-12-801185-0.00008-8; Tsai SQ, 2014, NAT BIOTECHNOL, V32, P569, DOI 10.1038/nbt.2908; Chu VT, 2015, NAT BIOTECHNOL, V33, P543, DOI 10.1038/nbt.3198; Yang LH, 2013, NUCLEIC ACIDS RES, V41, P9049, DOI 10.1093/nar/gkt555; Yin H, 2014, NAT BIOTECHNOL, V32, P551, DOI 10.1038/nbt.2884	33	600	666	12	190	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156	1546-1696		NAT BIOTECHNOL	Nat. Biotechnol.	MAR	2016	34	3					339	+		10.1038/nbt.3481	http://dx.doi.org/10.1038/nbt.3481			7	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	DG1CJ	26789497				2022-12-27	WOS:000371802600032
J	Alphey, L				Alphey, Luke			Can CRISPR-Cas9 gene drives curb malaria?	NATURE BIOTECHNOLOGY			English	Editorial Material							MOSQUITO; VECTOR; POPULATIONS; EFFICIENT; SYSTEM		[Alphey, Luke] Pirbright Inst, Ash Rd, Woking, Surrey, England; [Alphey, Luke] Univ Oxford, Dept Zool, S Parks Rd, Oxford, England	UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); Pirbright Institute; University of Oxford	Alphey, L (corresponding author), Pirbright Inst, Ash Rd, Woking, Surrey, England.; Alphey, L (corresponding author), Univ Oxford, Dept Zool, S Parks Rd, Oxford, England.	luke.alphey@pirbright.ac.uk		Alphey, Luke/0000-0002-2916-3802	BBSRC [BBS/E/I/00001892] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BBS/E/I/00001892] Funding Source: researchfish	BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))		Alphey L, 2014, ANNU REV ENTOMOL, V59, P205, DOI 10.1146/annurev-ento-011613-162002; Burt A, 2003, P ROY SOC B-BIOL SCI, V270, P921, DOI 10.1098/rspb.2002.2319; Burt A, 2006, GENES CONFLICT BIOL; Carvalho DO, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0003864; Davis S, 2001, J THEOR BIOL, V212, P83, DOI 10.1006/jtbi.2001.2357; Deredec A, 2008, GENETICS, V179, P2013, DOI 10.1534/genetics.108.089037; Galizi R, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4977; Gantz VM, 2015, P NATL ACAD SCI USA, V112, pE6736, DOI 10.1073/pnas.1521077112; Gantz VM, 2015, SCIENCE, V348, P442, DOI 10.1126/science.aaa5945; Hammond A, 2016, NAT BIOTECHNOL, V34, P78, DOI 10.1038/nbt.3439	10	36	38	2	94	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156	1546-1696		NAT BIOTECHNOL	Nat. Biotechnol.	FEB	2016	34	2					149	150		10.1038/nbt.3473	http://dx.doi.org/10.1038/nbt.3473			2	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	DD0OK	26849518	Green Submitted			2022-12-27	WOS:000369619100014
J	Fuzik, J; Zeisel, A; Mate, Z; Calvigioni, D; Yanagawa, Y; Szabo, G; Linnarsson, S; Harkany, T				Fuzik, Janos; Zeisel, Amit; Mate, Zoltan; Calvigioni, Daniela; Yanagawa, Yuchio; Szabo, Gabor; Linnarsson, Sten; Harkany, Tibor			Integration of electrophysiological recordings with single-cell RNA-seq data identifies neuronal subtypes	NATURE BIOTECHNOLOGY			English	Article							VESICULAR GLUTAMATE TRANSPORTERS; GENE-EXPRESSION; GABAERGIC INTERNEURONS; RECEPTORS; DIVERSITY; RESOLUTION; SYNAPSES; DYNAMICS; FEATURES; CORTEX	Traditionally, neuroscientists have defined the identity of neurons by the cells' location, morphology, connectivity and excitability. However, the direct relationship between these parameters and the molecular phenotypes has remained largely unexplored. Here, we present a method for obtaining full transcriptome data from single neocortical pyramidal cells and interneurons after whole-cell patch-clamp recordings in mouse brain slices. In our approach, termed Patch-seq, a patch-clamp stimulus protocol is followed by the aspiration of the entire somatic compartment into the recording pipette, reverse transcription of RNA including addition of unique molecular identifiers, cDNA amplification, Illumina library preparation and sequencing. We show that Patch-seq reveals a close link between electrophysiological characteristics, responses to acute chemical challenges and RNA expression of neurotransmitter receptors and channels. Moreover, it distinguishes neuronal subpopulations that correspond to both well-established and, to our knowledge, hitherto undescribed neuronal subtypes. Our findings demonstrate the ability of Patch-seq to precisely map neuronal subtypes and predict their network contributions in the brain.	[Fuzik, Janos; Zeisel, Amit; Calvigioni, Daniela; Linnarsson, Sten; Harkany, Tibor] Karolinska Inst, Dept Med Biochem & Biophys, Stockholm, Sweden; [Fuzik, Janos; Calvigioni, Daniela; Harkany, Tibor] Med Univ Vienna, Dept Mol Neurosci, Ctr Brain Res, Vienna, Austria; [Mate, Zoltan; Szabo, Gabor] Hungarian Acad Sci, Inst Expt Med, Budapest, Hungary; [Yanagawa, Yuchio] Gunma Univ, Grad Sch Med, Dept Genet & Behav Neurosci, Maebashi, Gunma 371, Japan	Karolinska Institutet; Medical University of Vienna; Eotvos Lorand Research Network; Hungarian Academy of Sciences; Hungarian Institute of Experimental Medicine; Gunma University	Linnarsson, S; Harkany, T (corresponding author), Karolinska Inst, Dept Med Biochem & Biophys, Stockholm, Sweden.	sten.linnarsson@ki.se; tibor.harkany@ki.se	Szabo, Gabor/A-5087-2008; Linnarsson, Sten/HCH-3909-2022	Szabo, Gabor/0000-0001-5438-5151; Harkany, Tibor/0000-0002-6637-5900	European Research Council (BRAINCELL) [261063]; Swedish Research Council; Human Frontier Science Program; European Commission 7th Framework Program (PAINCAGE); Hjarnfonden; NovoNordisk Foundation; Alzheimers Research UK [ART-EG2009A-1] Funding Source: researchfish; Novo Nordisk Fonden [NNF15OC0015964, NNF14OC0010695] Funding Source: researchfish	European Research Council (BRAINCELL); Swedish Research Council(Swedish Research CouncilEuropean Commission); Human Frontier Science Program(Human Frontier Science Program); European Commission 7th Framework Program (PAINCAGE); Hjarnfonden; NovoNordisk Foundation(Novo Nordisk Foundation); Alzheimers Research UK(Alzheimer&apos;s Research UK (ARUK)); Novo Nordisk Fonden(Novo Nordisk Foundation)	We thank A. Jureus for DNA sequencing, and the CLICK Imaging Facility at Karolinska Institutet for making the Imaris software package available for neuronal reconstructions, T. Klausberger and E. Borok for discussions and assistance with Neurolucida reconstructions. This work was supported by the European Research Council (BRAINCELL 261063, to S.L.), the Swedish Research Council (to S.L. and T.H.); Human Frontier Science Program (to A.Z.), the European Commission 7th Framework Program (PAINCAGE, to T.H.), Hjarnfonden (to T.H.) and the NovoNordisk Foundation (to T.H.).	Angulo MC, 1997, J NEUROSCI, V17, P6685; Arganda S, 2007, NAT NEUROSCI, V10, P1467, DOI 10.1038/nn1982; Ascoli GA, 2008, NAT REV NEUROSCI, V9, P557, DOI 10.1038/nrn2402; Baranauskas G, 2003, NAT NEUROSCI, V6, P258, DOI 10.1038/nn1019; Caiati MD, 2013, FRONT CELL NEUROSCI, V7, DOI 10.3389/fncel.2013.00063; Cauli B, 1997, J NEUROSCI, V17, P3894; Cauli B, 2000, P NATL ACAD SCI USA, V97, P6144, DOI 10.1073/pnas.97.11.6144; Chaudhry FA, 1998, J NEUROSCI, V18, P9733; Citri A, 2012, NAT PROTOC, V7, P118, DOI 10.1038/nprot.2011.430; Ferezou I, 2002, J NEUROSCI, V22, P7389; Fishell G, 2008, NEURON, V57, P333, DOI 10.1016/j.neuron.2008.01.018; Fremeau RT, 2001, NEURON, V31, P247, DOI 10.1016/S0896-6273(01)00344-0; Freund TF, 2003, TRENDS NEUROSCI, V26, P489, DOI 10.1016/S0166-2236(03)00227-3; Freund TF, 1996, HIPPOCAMPUS, V6, P347, DOI 10.1002/(SICI)1098-1063(1996)6:4<347::AID-HIPO1>3.0.CO;2-I; Gupta A, 2000, SCIENCE, V287, P273, DOI 10.1126/science.287.5451.273; Hashimoto T, 2008, MOL PSYCHIATR, V13, P147, DOI 10.1038/sj.mp.4002011; Holt CE, 2013, NEURON, V80, P648, DOI 10.1016/j.neuron.2013.10.036; Islam S, 2014, NAT METHODS, V11, P163, DOI [10.1038/NMETH.2772, 10.1038/nmeth.2772]; Islam S, 2012, NAT PROTOC, V7, P813, DOI 10.1038/nprot.2012.022; Kaneko T, 2002, J COMP NEUROL, V444, P39, DOI 10.1002/cne.10129; Katona I, 1999, J NEUROSCI, V19, P4544; Kawaguchi Y, 1998, NEUROSCIENCE, V85, P677, DOI 10.1016/S0306-4522(97)00685-4; Kirischuk S, 2012, TRENDS NEUROSCI, V35, P497, DOI 10.1016/j.tins.2012.04.003; Klausberger T, 2008, SCIENCE, V321, P53, DOI 10.1126/science.1149381; Markram H, 2006, NAT REV NEUROSCI, V7, P153, DOI 10.1038/nrn1848; Mate Z, 2013, CELL TISSUE RES, V352, P199, DOI 10.1007/s00441-013-1552-7; Mindell JA, 2001, GENOME BIOL, V2; Morozov YM, 2003, NEUROSCIENCE, V120, P923, DOI 10.1016/S0306-4522(03)00409-3; Munoz-Manchado AB, 2016, CEREB CORTEX, V26, P96, DOI 10.1093/cercor/bhu179; Okaty BW, 2011, J NEUROSCI, V31, P6939, DOI 10.1523/JNEUROSCI.0626-11.2011; Okaty BW, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016493; Qiu Shenfeng, 2012, Frontiers in Genetics, V3, P124, DOI 10.3389/fgene.2012.00124; Rakic P, 2006, CEREB CORTEX, V16, pI3, DOI 10.1093/cercor/bhk036; Rakic P, 2009, NAT REV NEUROSCI, V10, P724, DOI 10.1038/nrn2719; Romanov RA, 2015, EMBO J, V34, P36, DOI 10.15252/embj.201488977; Schmidt MJ, 2014, MOL PSYCHIATR, V19, P580, DOI 10.1038/mp.2013.167; Schwanhausser B, 2011, NATURE, V473, P337, DOI 10.1038/nature10098; Subkhankulova T, 2010, FRONT MOL NEUROSCI, V3, DOI 10.3389/fnmol.2010.00010; Susaki EA, 2014, CELL, V157, P726, DOI 10.1016/j.cell.2014.03.042; Tainaka K, 2014, CELL, V159, P911, DOI 10.1016/j.cell.2014.10.034; Tamamaki N, 2003, J COMP NEUROL, V467, P60, DOI 10.1002/cne.10905; Tamas G, 2000, NAT NEUROSCI, V3, P366, DOI 10.1038/73936; Tomer R, 2014, NAT PROTOC, V9, P1682, DOI 10.1038/nprot.2014.123; Tricoire L, 2011, J NEUROSCI, V31, P10948, DOI 10.1523/JNEUROSCI.0323-11.2011; Tsou K, 1998, NEUROSCIENCE, V83, P393, DOI 10.1016/S0306-4522(97)00436-3; Usoskin D, 2015, NAT NEUROSCI, V18, P145, DOI 10.1038/nn.3881; Varga V, 2009, SCIENCE, V326, P449, DOI 10.1126/science.1178307; Veys K, 2012, J NEUROSCI METH, V209, P227, DOI 10.1016/j.jneumeth.2012.06.008; Zeisel A, 2015, SCIENCE, V347, P1138, DOI 10.1126/science.aaa1934; Zivraj KH, 2010, J NEUROSCI, V30, P15464, DOI 10.1523/JNEUROSCI.1800-10.2010	50	223	225	3	99	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156	1546-1696		NAT BIOTECHNOL	Nat. Biotechnol.	FEB	2016	34	2					175	+		10.1038/nbt.3443	http://dx.doi.org/10.1038/nbt.3443			11	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	DD0OK	26689544	Green Accepted			2022-12-27	WOS:000369619100020
J	DeFrancesco, L				DeFrancesco, Laura			23andMe protects consumers' data	NATURE BIOTECHNOLOGY			English	News Item																		2015, NAT BIOTECH, V33, P435	1	2	2	0	8	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156	1546-1696		NAT BIOTECHNOL	Nat. Biotechnol.	DEC	2015	33	12					1220	1220		10.1038/nbt1215-1220	http://dx.doi.org/10.1038/nbt1215-1220			1	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	CY4OO	26650001	Bronze			2022-12-27	WOS:000366387700005
J	Huggett, B; Paisner, K				Huggett, Brady; Paisner, Kathryn			Top 20 translational researchers of 2014	NATURE BIOTECHNOLOGY			English	Editorial Material									[Paisner, Kathryn] IP Checkups, Berkeley, CA USA			kpaisner@ipcheckups.com							0	0	0	0	0	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156	1546-1696		NAT BIOTECHNOL	Nat. Biotechnol.	SEP	2015	33	9					897	897		10.1038/nbt.3335	http://dx.doi.org/10.1038/nbt.3335			1	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	VB7JD	26349903	Bronze			2022-12-27	WOS:000416885400001
J	Gross, AM; Ideker, T				Gross, Andrew M.; Ideker, Trey			Molecular networks in context	NATURE BIOTECHNOLOGY			English	Editorial Material							DISEASE GENES; CELLNET; BIOLOGY		[Gross, Andrew M.] Univ Calif San Diego, Bioinformat Program, San Diego, CA 92103 USA; Univ Calif San Diego, Dept Med, San Diego, CA 92103 USA	University of California System; University of California San Diego; University of California System; University of California San Diego	Gross, AM (corresponding author), Univ Calif San Diego, Bioinformat Program, San Diego, CA 92103 USA.	tideker@ucsd.edu		Ideker, Trey/0000-0002-1708-8454				Cahan P, 2014, CELL, V158, P903, DOI 10.1016/j.cell.2014.07.020; Ganegoda GU, 2014, BMC SYST BIOL, V8, DOI 10.1186/1752-0509-8-S3-S3; Greene CS, 2015, NAT GENET, V47, P569, DOI 10.1038/ng.3259; Ideker T, 2012, MOL SYST BIOL, V8, DOI 10.1038/msb.2011.99; Lee I, 2011, GENOME RES, V21, P1109, DOI 10.1101/gr.118992.110; Magger O, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002690; Morris SA, 2014, CELL, V158, P889, DOI 10.1016/j.cell.2014.07.021	7	8	8	0	16	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156	1546-1696		NAT BIOTECHNOL	Nat. Biotechnol.	JUL	2015	33	7					720	721		10.1038/nbt.3283	http://dx.doi.org/10.1038/nbt.3283			2	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	CN4JJ	26154012				2022-12-27	WOS:000358396100025
J	Muindi, F; Keller, JB				Muindi, Fanuel; Keller, Joseph B.			Emerging network of resources for exploring paths beyond academia	NATURE BIOTECHNOLOGY			English	Editorial Material							GRADUATE-EDUCATION; CAREER; SCIENCE; SCIENTIST; PHDS		[Muindi, Fanuel; Keller, Joseph B.] MIT, Dept Brain & Cognit Sci, Cambridge, MA 02139 USA	Massachusetts Institute of Technology (MIT)	Muindi, F (corresponding author), MIT, Dept Brain & Cognit Sci, E25-618, Cambridge, MA 02139 USA.	fmuindi@mit.edu		/0000-0002-1998-1449				AAAS, FAQ S T POL FELL; Alberts B, 2008, SCIENCE, V320, P155, DOI 10.1126/science.1158519; Alberts B, 2014, P NATL ACAD SCI USA, V111, P5773, DOI 10.1073/pnas.1404402111; Austin J, 2014, SCIENCE, V344, P934, DOI 10.1126/science.344.6186.934; Callier V., 2014, F1000 RES, V279, P1; Carpenter S, 2010, SCI CAREERS     0115; Cyranoski D, 2011, NATURE, V472, P276, DOI 10.1038/472276a; Davenport TH, 2012, HARVARD BUS REV, V90, P70; Evans E, 2014, STANFORD DAILY  1201; Fuhrmann CN, 2011, CBE-LIFE SCI EDUC, V10, P239, DOI 10.1187/cbe.11-02-0013; Gibbs KD, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0114736; Golde C., 2001, CROSS PURPOSES WHAT; Hobin J.A., 2011, SCI CAREERS     0907; Hobin JA, 2014, CBE-LIFE SCI EDUC, V13, P49, DOI 10.1187/cbe-13-04-0085; Kamens J, 2015, NAT BIOTECHNOL, V33, P668, DOI 10.1038/nbt.3259; Kittinger JN, 2014, SCIENCE, V345, P110, DOI 10.1126/science.345.6192.110; Larson RC, 2014, SYST RES BEHAV SCI, V31, P745, DOI 10.1002/sres.2210; Manyika J., BIG DATA NEXT FRONTI; MASON MA, 2009, ACADEME, V95, P11; McCook A, 2011, NATURE, V472, P280, DOI 10.1038/472280a; McDowell GS, 2015, F1000RESEARCH, V3, P291, DOI DOI 10.12688/F1000; Muindi F, 2015, NATURE, V518, P35, DOI 10.1038/518035e; Mukherjee R, 2014, SCIENCE, V346, P1026, DOI 10.1126/science.346.6212.1026; National Academy of Sciences and National Academy of Engineering and Institute of Medicine, 2014, POSTD EXP REV; National Institutes of Health, 2012, BIOM RES WORKF WORK; Polka J., 2014, NATURE, V511, P256; Polka JK, 2015, MOL BIOL CELL, V26, P1413, DOI 10.1091/mbc.E14-10-1432; Polka JK, 2014, SCIENCE, V346, P1422, DOI 10.1126/science.346.6215.1422; Sauermann H, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036307; Schillebeeckx M, 2013, NAT BIOTECHNOL, V31, P938, DOI 10.1038/nbt.2706; Stanford Biosciences, 2013, STANF BIOSC STUD DEV; Tsang C, 2011, NATURE, V480, P576; Vanderford NL, 2013, NAT BIOTECHNOL, V31, P1149, DOI 10.1038/nbt.2767	33	5	5	2	31	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156	1546-1696		NAT BIOTECHNOL	Nat. Biotechnol.	JUL	2015	33	7					775	778		10.1038/nbt.3282	http://dx.doi.org/10.1038/nbt.3282			4	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	CN4JJ	26154014				2022-12-27	WOS:000358396100035
J	Skinner, OS; Kelleher, NL				Skinner, Owen S.; Kelleher, Neil L.			Illuminating the dark matter of shotgun proteomics	NATURE BIOTECHNOLOGY			English	Editorial Material									[Skinner, Owen S.; Kelleher, Neil L.] Northwestern Univ, Dept Chem, Evanston, IL 60208 USA; [Kelleher, Neil L.] Northwestern Univ, Dept Mol Biosci, Evanston, IL USA	Northwestern University; Northwestern University	Skinner, OS (corresponding author), Northwestern Univ, Dept Chem, Evanston, IL 60208 USA.	n-kelleher@northwestern.edu		Skinner, Owen/0000-0002-5023-0029				Chick JM, 2015, NAT BIOTECHNOL, V33, P743, DOI 10.1038/nbt.3267; LeDuc R.D., 2007, CURR PROTOC BIOINFOR, V19; Link AJ, 1999, NAT BIOTECHNOL, V17, P676, DOI 10.1038/10890; Nielsen ML, 2006, MOL CELL PROTEOMICS, V5, P2384, DOI 10.1074/mcp.M600248-MCP200; Smith LM, 2013, NAT METHODS, V10, P186, DOI 10.1038/nmeth.2369	5	24	24	0	27	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156	1546-1696		NAT BIOTECHNOL	Nat. Biotechnol.	JUL	2015	33	7					717	718		10.1038/nbt.3287	http://dx.doi.org/10.1038/nbt.3287			2	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	CN4JJ	26154010				2022-12-27	WOS:000358396100023
J	Bromberg, JS				Bromberg, Jonathan S.			Islet implantation in a pocket	NATURE BIOTECHNOLOGY			English	Editorial Material							TRANSPLANTATION		[Bromberg, Jonathan S.] Univ Maryland, Sch Med, Ctr Inflammatory & Vasc Dis, Dept Surg, Baltimore, MD 21201 USA; [Bromberg, Jonathan S.] Univ Maryland, Sch Med, Ctr Inflammatory & Vasc Dis, Dept Microbiol & Immunol, Baltimore, MD 21201 USA	University System of Maryland; University of Maryland Baltimore; University System of Maryland; University of Maryland Baltimore	Bromberg, JS (corresponding author), Univ Maryland, Sch Med, Ctr Inflammatory & Vasc Dis, Dept Surg, Baltimore, MD 21201 USA.	jbromberg@smail.umaryland.edu						Feng S, 2012, JAMA-J AM MED ASSOC, V307, P283, DOI 10.1001/jama.2011.2014; Harlan DM, 2009, DIABETES, V58, P2175, DOI 10.2337/db09-0476; Hlavaty KA, 2014, AM J TRANSPLANT, V14, P1523, DOI 10.1111/ajt.12742; Luan NM, 2014, AM J TRANSPLANT, V14, P1533, DOI 10.1111/ajt.12739; Maffi P, 2013, DIABETES, V62, P3523, DOI 10.2337/db13-0465; Pepper AR, 2015, NAT BIOTECHNOL, V33, P518, DOI 10.1038/nbt.3211; Russell SJ, 2014, NEW ENGL J MED, V371, P313, DOI 10.1056/NEJMoa1314474; Ryan EA, 2005, DIABETES, V54, P2060, DOI 10.2337/diabetes.54.7.2060; Schneeberger S, 2011, TRANSPL INT, V24, P760, DOI 10.1111/j.1432-2277.2011.01261.x; Shapiro AMJ, 2000, NEW ENGL J MED, V343, P230, DOI 10.1056/NEJM200007273430401; Tomei AA, 2014, P NATL ACAD SCI USA, V111, P10514, DOI 10.1073/pnas.1402216111	11	4	4	0	6	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156	1546-1696		NAT BIOTECHNOL	Nat. Biotechnol.	MAY	2015	33	5					493	494		10.1038/nbt.3216	http://dx.doi.org/10.1038/nbt.3216			3	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	CH8VP	25965759				2022-12-27	WOS:000354314500029
J	Chen, YJ; Xiong, M; Zhang, SC				Chen, Yuejun; Xiong, Man; Zhang, Su-Chun			Illuminating Parkinson's therapy with optogenetics	NATURE BIOTECHNOLOGY			English	Editorial Material							PROTEIN-COUPLED RECEPTORS; OPTICAL CONTROL; NEURONS; MICE		[Chen, Yuejun; Xiong, Man; Zhang, Su-Chun] Univ Wisconsin, Waisman Ctr, Madison, WI 53705 USA	University of Wisconsin System; University of Wisconsin Madison	Chen, YJ (corresponding author), Univ Wisconsin, Waisman Ctr, Madison, WI 53705 USA.	zhang@waisman.wisc.edu	chen, yuejun/AAL-4070-2020	Chen, Yuejun/0000-0002-4625-2604	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS076352, R24NS086604] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [P51OD011106] Funding Source: NIH RePORTER; NIH HHS [P51 OD011106] Funding Source: Medline; NINDS NIH HHS [R01 NS076352, R24 NS086604] Funding Source: Medline	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Alexander GM, 2009, NEURON, V63, P27, DOI 10.1016/j.neuron.2009.06.014; Armbruster BN, 2007, P NATL ACAD SCI USA, V104, P5163, DOI 10.1073/pnas.0700293104; Boyden ES, 2005, NAT NEUROSCI, V8, P1263, DOI 10.1038/nn1525; Bryson JB, 2014, SCIENCE, V344, P94, DOI 10.1126/science.1248523; Steinbeck JA, 2015, NAT BIOTECHNOL, V33, P204, DOI 10.1038/nbt.3124; Sternson SM, 2014, ANNU REV NEUROSCI, V37, DOI 10.1146/annurev-neuro-071013-014048; Umemiya M, 1997, J NEUROPHYSIOL, V78, P1248, DOI 10.1152/jn.1997.78.3.1248; Urban DJ, 2015, ANNU REV PHARMACOL, V55, P399, DOI 10.1146/annurev-pharmtox-010814-124803; Weick JP, 2011, P NATL ACAD SCI USA, V108, P20189, DOI 10.1073/pnas.1108487108; Weick JP, 2010, STEM CELLS, V28, P2008, DOI 10.1002/stem.514	10	19	23	1	41	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156	1546-1696		NAT BIOTECHNOL	Nat. Biotechnol.	FEB	2015	33	2					149	150		10.1038/nbt.3140	http://dx.doi.org/10.1038/nbt.3140			2	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	CA8VK	25658280	Green Accepted			2022-12-27	WOS:000349198800017
J	Hughes, V				Hughes, Virginia			Social storm	NATURE BIOTECHNOLOGY			English	Editorial Material																		Davies M, 2008, LISTNING CONSUMERS H; Health I.M.S, 2014, ENG PAT SOC MED; Pew Research Internet Project, SOC NETW FACT SHEET	3	1	1	0	1	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156	1546-1696		NAT BIOTECHNOL	Nat. Biotechnol.	JAN	2015	33	1					14	17		10.1038/nbt.3106	http://dx.doi.org/10.1038/nbt.3106			4	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	AY7AR	25574625				2022-12-27	WOS:000347714200014
J	Rezania, A; Bruin, JE; Arora, P; Rubin, A; Batushansky, I; Asadi, A; O'Dwyer, S; Quiskamp, N; Mojibian, M; Albrecht, T; Yang, YHC; Johnson, JD; Kieffer, TJ				Rezania, Alireza; Bruin, Jennifer E.; Arora, Payal; Rubin, Allison; Batushansky, Irina; Asadi, Ali; O'Dwyer, Shannon; Quiskamp, Nina; Mojibian, Majid; Albrecht, Tobias; Yang, Yu Hsuan Carol; Johnson, James D.; Kieffer, Timothy J.			Reversal of diabetes with insulin-producing cells derived in vitro from human pluripotent stem cells	NATURE BIOTECHNOLOGY			English	Article							PANCREATIC PROGENITOR CELLS; MAFA TRANSCRIPTION FACTOR; AIR-LIQUID INTERFACE; BETA-CELL; ISLET TRANSPLANTATION; DIFFERENTIATION; GLUCOSE; SECRETION; ENDODERM; GENERATION	Transplantation of pancreatic progenitors or insulin-secreting cells derived from human embryonic stem cells (hESCs) has been proposed as a therapy for diabetes. We describe a seven-stage protocol that efficiently converts hESCs into insulin-producing cells. Stage (S) 7 cells expressed key markers of mature pancreatic beta cells, including MAFA, and displayed glucose-stimulated insulin secretion similar to that of human islets during static incubations in vitro. Additional characterization using single-cell imaging and dynamic glucose stimulation assays revealed similarities but also notable differences between S7 insulin-secreting cells and primary human beta cells. Nevertheless, S7 cells rapidly reversed diabetes in mice within 40 days, roughly four times faster than pancreatic progenitors. Therefore, although S7 cells are not funk equivalent to mature beta cells, their capacity for glucose-responsive insulin secretion and rapid reversal of diabetes in vivo makes them a promising alternative to pancreatic progenitor cells or cadaveric islets for the treatment of diabetes.	[Rezania, Alireza; Arora, Payal; Rubin, Allison; Batushansky, Irina] Janssen R&D LLC, BetaL Venture, Raritan, NJ 08869 USA; [Bruin, Jennifer E.; Asadi, Ali; O'Dwyer, Shannon; Quiskamp, Nina; Mojibian, Majid; Albrecht, Tobias; Yang, Yu Hsuan Carol; Johnson, James D.; Kieffer, Timothy J.] Univ British Columbia, Inst Life Sci, Dept Cellular & Physiol Sci, Vancouver, BC V5Z 1M9, Canada; [Johnson, James D.; Kieffer, Timothy J.] Univ British Columbia, Dept Surg, Vancouver, BC V5Z 1M9, Canada	Johnson & Johnson; Janssen Pharmaceuticals; University of British Columbia; University of British Columbia	Kieffer, TJ (corresponding author), Janssen R&D LLC, BetaL Venture, Raritan, NJ 08869 USA.	ARezani@its.jnj.com; tim.kieffer@ubc.ca		asadi, ali/0000-0002-6224-9982; Bruin, Jennifer/0000-0003-2326-7819; Yang, Yu Hsuan Carol/0000-0001-6663-0302	JDRF; Canadian Institutes of Health Research (CIHR) Regenerative Medicine and Nanomedicine Initiative; Stem Cell Network (SCN); L'Oreal Canada; NSERC Post Graduate Scholarship; Mitacs Elevate Postdoctoral Fellowship; CIHR Transplantation Training Program; Stem Cell Technologies; JDRF postdoctoral fellowship	JDRF(Juvenile Diabetes Research Foundation); Canadian Institutes of Health Research (CIHR) Regenerative Medicine and Nanomedicine Initiative(Canadian Institutes of Health Research (CIHR)); Stem Cell Network (SCN); L'Oreal Canada; NSERC Post Graduate Scholarship(Natural Sciences and Engineering Research Council of Canada (NSERC)); Mitacs Elevate Postdoctoral Fellowship; CIHR Transplantation Training Program(Canadian Institutes of Health Research (CIHR)); Stem Cell Technologies; JDRF postdoctoral fellowship(Juvenile Diabetes Research Foundation)	This work was supported in part by funding from the JDRF, the Canadian Institutes of Health Research (CIHR) Regenerative Medicine and Nanomedicine Initiative, and the Stem Cell Network (SCN). J.E.B. was funded by a JDRF postdoctoral fellowship and L'Oreal Canada for Women in Science Research Excellence Fellowship. Y.H.C.Y. was the recipient of an NSERC Post Graduate Scholarship and M.M. was the recipient of a Mitacs Elevate Postdoctoral Fellowship. The CIHR Transplantation Training Program provided funding for J.E.B., N.Q. and M.M. We also thank Stem Cell Technologies for their financial support, T. Webber, S. Karuna and B. Hu for their technical assistance, and G. Warnock and Z. Ao from the Irving K. Barber Human Islet Isolation Laboratory (Vancouver, BC) for providing human islets.	Aguayo-Mazzucato C, 2011, DIABETOLOGIA, V54, P583, DOI 10.1007/s00125-010-2026-z; Aguayo-Mazzucato C, 2013, DIABETES, V62, P1569, DOI 10.2337/db12-0849; Aguayo-Mazzucato C, 2010, NAT REV ENDOCRINOL, V6, P139, DOI 10.1038/nrendo.2009.274; Apelqvist A, 1999, NATURE, V400, P877, DOI 10.1038/23716; Barton FB, 2012, DIABETES CARE, V35, P1436, DOI 10.2337/dc12-0063; Basford CL, 2012, DIABETOLOGIA, V55, P358, DOI 10.1007/s00125-011-2335-x; Bruin JE, 2014, STEM CELL RES, V12, P194, DOI 10.1016/j.scr.2013.10.003; Bruin JE, 2013, DIABETOLOGIA, V56, P1987, DOI 10.1007/s00125-013-2955-4; Chen S, 2009, NAT CHEM BIOL, V5, P258, DOI 10.1038/nchembio.154; Cho CHH, 2012, DIABETOLOGIA, V55, P3284, DOI 10.1007/s00125-012-2687-x; Choi KM, 2008, J BIOSCI BIOENG, V105, P586, DOI 10.1263/jbb.105.586; Cortijo C, 2012, CELL REP, V2, P1593, DOI 10.1016/j.celrep.2012.10.016; D'Amour KA, 2005, NAT BIOTECHNOL, V23, P1534, DOI 10.1038/nbt1163; D'Amour KA, 2006, NAT BIOTECHNOL, V24, P1392, DOI 10.1038/nbt1259; DAVALLI AM, 1995, TRANSPLANTATION, V59, P817, DOI 10.1097/00007890-199503270-00003; Haase TN, 2013, DIABETOLOGIA, V56, P763, DOI 10.1007/s00125-012-2821-9; Halban PA, 2001, DIABETES, V50, P2181, DOI 10.2337/diabetes.50.10.2181; Hang Y, 2014, DIABETES, V63, P1994, DOI 10.2337/db13-1001; Harmon JS, 2009, ENDOCRINOLOGY, V150, P4855, DOI 10.1210/en.2009-0708; Harmon JS, 2005, J BIOL CHEM, V280, P11107, DOI 10.1074/jbc.M410345200; Heinis M, 2010, DIABETES, V59, P662, DOI 10.2337/db09-0891; Johansson KA, 2007, DEV CELL, V12, P457, DOI 10.1016/j.devcel.2007.02.010; Jorgensen MC, 2007, ENDOCR REV, V28, P685, DOI 10.1210/er.2007-0016; Kelly OG, 2011, NAT BIOTECHNOL, V29, P750, DOI 10.1038/nbt.1931; Kinkel MD, 2009, BIOESSAYS, V31, P139, DOI 10.1002/bies.200800123; Kroon E, 2008, NAT BIOTECHNOL, V26, P443, DOI 10.1038/nbt1393; Kumar M, 2003, CURR OPIN GENET DEV, V13, P401, DOI 10.1016/S0959-437X(03)00089-3; Luciani DS, 2005, MOL CELL ENDOCRINOL, V241, P88, DOI 10.1016/j.mce.2005.06.006; Mahadevan J, 2013, DIABETES, V62, P3582, DOI 10.2337/db13-0357; Matsuoka T, 2004, P NATL ACAD SCI USA, V101, P2930, DOI 10.1073/pnas.0306233101; Merani S, 2008, BRIT J SURG, V95, P1449, DOI 10.1002/bjs.6391; MISLER S, 1992, DIABETES, V41, P1221, DOI 10.2337/diabetes.41.10.1221; Murtaugh LC, 2003, P NATL ACAD SCI USA, V100, P14920, DOI 10.1073/pnas.2436557100; NAUCK MA, 1986, J CLIN ENDOCR METAB, V63, P492, DOI 10.1210/jcem-63-2-492; Nelson SB, 2007, DEVELOPMENT, V134, P2491, DOI 10.1242/dev.002691; Nostro MC, 2011, DEVELOPMENT, V138, P861, DOI 10.1242/dev.055236; Nostro MC, 2012, SEMIN CELL DEV BIOL, V23, P701, DOI 10.1016/j.semcdb.2012.06.010; Pezzulo AA, 2011, AM J PHYSIOL-LUNG C, V300, pL25, DOI 10.1152/ajplung.00256.2010; Piper K, 2004, J ENDOCRINOL, V181, P11, DOI 10.1677/joe.0.1810011; Pisania A, 2010, LAB INVEST, V90, P1661, DOI 10.1038/labinvest.2010.124; PRUNIERAS M, 1983, J INVEST DERMATOL, V81, pS28, DOI 10.1111/1523-1747.ep12540324; Rezania A, 2013, STEM CELLS, V31, P2432, DOI 10.1002/stem.1489; Rezania A, 2012, DIABETES, V61, P2016, DOI 10.2337/db11-1711; Rezania A, 2011, DIABETES, V60, P239, DOI 10.2337/db10-0573; Rukstalis JM, 2009, ISLETS, V1, P177, DOI 10.4161/isl.1.3.9877; Sander M, 2000, DEVELOPMENT, V127, P5533; Schiesser JV, 2014, ANN NY ACAD SCI, V1311, P124, DOI 10.1111/nyas.12369; Schulz TC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037004; Seymour PA, 2007, P NATL ACAD SCI USA, V104, P1865, DOI 10.1073/pnas.0609217104; Shi YG, 2003, CELL, V113, P685, DOI 10.1016/S0092-8674(03)00432-X; Shim JH, 2007, DIABETOLOGIA, V50, P1228, DOI 10.1007/s00125-007-0634-z; Street CN, 2004, DIABETES, V53, P3107, DOI 10.2337/diabetes.53.12.3107; TUCH BE, 1991, TRANSPLANTATION, V51, P557, DOI 10.1097/00007890-199103000-00002; TUCH BE, 1991, TRANSPLANTATION, V51, P1156, DOI 10.1097/00007890-199106000-00003; Wang H, 2007, DIABETOLOGIA, V50, P348, DOI 10.1007/s00125-006-0490-2; Warnock GL, 2008, TRANSPLANTATION, V86, P1762, DOI 10.1097/TP.0b013e318190b052; Wells JM, 1999, ANNU REV CELL DEV BI, V15, P393, DOI 10.1146/annurev.cellbio.15.1.393; Xu XF, 2011, MECH DEVELOP, V128, P412, DOI 10.1016/j.mod.2011.08.001; Zhang C, 2005, MOL CELL BIOL, V25, P4969, DOI 10.1128/MCB.25.12.4969-4976.2005	59	902	987	16	251	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156	1546-1696		NAT BIOTECHNOL	Nat. Biotechnol.	NOV	2014	32	11					1121	1133		10.1038/nbt.3033	http://dx.doi.org/10.1038/nbt.3033			13	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	AT5IL	25211370				2022-12-27	WOS:000344977000017
J	Li, YH; Zhou, GY; Ma, JX; Jiang, WK; Jin, LG; Zhang, ZH; Guo, Y; Zhang, JB; Sui, Y; Zheng, LT; Zhang, SS; Zuo, QY; Shi, XH; Li, YF; Zhang, WK; Hu, YY; Kong, GY; Hong, HL; Tan, B; Song, J; Liu, ZX; Wang, YS; Ruan, H; Yeung, CKL; Liu, J; Wang, HL; Zhang, LJ; Guan, RX; Wang, KJ; Li, WB; Chen, SY; Chang, RZ; Jiang, Z; Jackson, SA; Li, RQ; Qiu, LJ				Li, Ying-hui; Zhou, Guangyu; Ma, Jianxin; Jiang, Wenkai; Jin, Long-guo; Zhang, Zhouhao; Guo, Yong; Zhang, Jinbo; Sui, Yi; Zheng, Liangtao; Zhang, Shan-shan; Zuo, Qiyang; Shi, Xue-hui; Li, Yan-fei; Zhang, Wan-ke; Hu, Yiyao; Kong, Guanyi; Hong, Hui-long; Tan, Bing; Song, Jian; Liu, Zhang-xiong; Wang, Yaoshen; Ruan, Hang; Yeung, Carol K. L.; Liu, Jian; Wang, Hailong; Zhang, Li-juan; Guan, Rong-xia; Wang, Ke-jing; Li, Wen-bin; Chen, Shou-yi; Chang, Ru-zhen; Jiang, Zhi; Jackson, Scott A.; Li, Ruiqiang; Qiu, Li-juan			De novo assembly of soybean wild relatives for pan-genome analysis of diversity and agronomic traits	NATURE BIOTECHNOLOGY			English	Article							DISEASE RESISTANCE; GENETIC DIVERSITY; OPEN SOFTWARE; MOSAIC-VIRUS; GLYCINE-SOJA; SEQUENCE; ALIGNMENT; IDENTIFICATION; EXPRESSION; DOMESTICATION	Wild relatives of crops are an important source of genetic diversity for agriculture, but their gene repertoire remains largely unexplored. We report the establishment and analysis of a pan-genome of Glycine soja, the wild relative of cultivated soybean Glycine max, by sequencing and de novo assembly of seven phylogenetically and geographically representative accessions. Intergenomic comparisons identified lineage-specific genes and genes with copy number variation or large-effect mutations, some of which show evidence of positive selection and may contribute to variation of agronomic traits such as biotic resistance, seed composition, flowering and maturity time, organ size and final biomass. Approximately 80% of the pan-genome was present in all seven accessions (core), whereas the rest was dispensable and exhibited greater variation than the core genome, perhaps reflecting a role in adaptation to diverse environments. This work will facilitate the harnessing of untapped genetic diversity from wild soybean for enhancement of elite cultivars.	[Li, Ying-hui; Jin, Long-guo; Guo, Yong; Sui, Yi; Zhang, Shan-shan; Shi, Xue-hui; Li, Yan-fei; Hong, Hui-long; Tan, Bing; Song, Jian; Liu, Zhang-xiong; Zhang, Li-juan; Guan, Rong-xia; Wang, Ke-jing; Chang, Ru-zhen; Qiu, Li-juan] Chinese Acad Agr Sci, Inst Crop Sci, Natl Key Facil Crop Gene Resources & Genet Improv, Beijing 100193, Peoples R China; [Li, Ying-hui; Jin, Long-guo; Guo, Yong; Sui, Yi; Zhang, Shan-shan; Shi, Xue-hui; Li, Yan-fei; Hong, Hui-long; Tan, Bing; Song, Jian; Liu, Zhang-xiong; Zhang, Li-juan; Guan, Rong-xia; Wang, Ke-jing; Chang, Ru-zhen; Qiu, Li-juan] Chinese Acad Agr Sci, Inst Crop Sci, MOA, Key Lab Crop Gene Resource & Germplasm Enhancemen, Beijing 100193, Peoples R China; [Li, Ying-hui; Jin, Long-guo; Guo, Yong; Sui, Yi; Zhang, Shan-shan; Shi, Xue-hui; Li, Yan-fei; Hong, Hui-long; Tan, Bing; Song, Jian; Liu, Zhang-xiong; Zhang, Li-juan; Guan, Rong-xia; Wang, Ke-jing; Chang, Ru-zhen; Qiu, Li-juan] Chinese Acad Agr Sci, Inst Crop Sci, MOA, Key Lab Soybean Biol Beijing, Beijing 100193, Peoples R China; [Zhou, Guangyu; Jiang, Wenkai; Zhang, Zhouhao; Zhang, Jinbo; Zheng, Liangtao; Zuo, Qiyang; Hu, Yiyao; Kong, Guanyi; Wang, Yaoshen; Ruan, Hang; Yeung, Carol K. L.; Liu, Jian; Wang, Hailong; Jiang, Zhi; Li, Ruiqiang] Novogene Bioinformat Inst, Beijing, Peoples R China; [Ma, Jianxin] Purdue Univ, Dept Agron, W Lafayette, IN 47907 USA; [Zhang, Wan-ke; Chen, Shou-yi] Chinese Acad Sci, Inst Genet & Dev Biol, State Key Lab Plant Genom, Beijing, Peoples R China; [Li, Wen-bin] Northeast Agr Univ, Key Lab Soybean Biol, Chinese Minist Educ, Harbin, Peoples R China; [Jackson, Scott A.] Univ Georgia, Ctr Appl Genet Technol, Athens, GA 30602 USA; [Li, Ruiqiang] Peking Univ, Biodynam Opt Imaging Ctr, Peking Tsinghua Ctr Life Sci, Beijing 100871, Peoples R China; [Li, Ruiqiang] Peking Univ, Sch Life Sci, Beijing 100871, Peoples R China	Chinese Academy of Agricultural Sciences; Institute of Crop Sciences, CAAS; Chinese Academy of Agricultural Sciences; Institute of Crop Sciences, CAAS; Chinese Academy of Agricultural Sciences; Institute of Crop Sciences, CAAS; Purdue University System; Purdue University; Purdue University West Lafayette Campus; Chinese Academy of Sciences; Institute of Genetics & Developmental Biology, CAS; Northeast Agricultural University - China; University System of Georgia; University of Georgia; Peking University; Peking University	Qiu, LJ (corresponding author), Chinese Acad Agr Sci, Inst Crop Sci, Natl Key Facil Crop Gene Resources & Genet Improv, Beijing 100193, Peoples R China.	sjackson@uga.edu; lirq@novogene.cn; qiulijuan@caas.cn	zhang, jin/GXV-9154-2022; Ruan, Hang/AAI-7367-2021; Zhang, Li/GWM-7501-2022; Shanshan, Zhang/AAH-9471-2021; Song, Jian/HGD-2320-2022	Ruan, Hang/0000-0001-7506-3805; jackson, scott/0000-0002-3172-1607; Wang, Yaoshen/0000-0003-2034-3855; Zheng, Liangtao/0000-0001-9795-3198	National Natural Science Foundation of China [31271753]; State Key Basic Research and Development Plan of China (973) [2010CB125903, 2009CB118404]; International Science and Technology Cooperation and Exchanges Projects [2008DFA30550]; Platform of National Crop Germplasm Resources of China [2012-004, 2013-004]; US National Science Foundation [DBI 0822258]; Division Of Integrative Organismal Systems [1229956] Funding Source: National Science Foundation	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); State Key Basic Research and Development Plan of China (973)(National Basic Research Program of China); International Science and Technology Cooperation and Exchanges Projects; Platform of National Crop Germplasm Resources of China; US National Science Foundation(National Science Foundation (NSF)); Division Of Integrative Organismal Systems(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	This research was supported by the National Natural Science Foundation of China (no. 31271753), the State Key Basic Research and Development Plan of China (973) (no. 2010CB125903 and 2009CB118404), the International Science and Technology Cooperation and Exchanges Projects (no. 2008DFA30550), the Platform of National Crop Germplasm Resources of China (nos. 2012-004 and 2013-004) and US National Science Foundation (no. DBI 0822258). We thank R. Stupar for critical reading of this manuscript and valuable suggestions. We also thank H. Zhu, Y. Xin, X. Meng and many additional staff at Novogene Bioinformatics Institute who contributed to this teamwork.	ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Angiuoli SV, 2011, BIOINFORMATICS, V27, P334, DOI 10.1093/bioinformatics/btq665; Arakaki M, 2011, P NATL ACAD SCI USA, V108, P8379, DOI 10.1073/pnas.1100628108; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Ashikari M, 2005, SCIENCE, V309, P741, DOI 10.1126/science.1113373; Bateman A, 2004, NUCLEIC ACIDS RES, V32, pD138, DOI [10.1093/nar/gkt1223, 10.1093/nar/gkr1065, 10.1093/nar/gkp985]; Birney E, 2004, GENOME RES, V14, P988, DOI 10.1101/gr.1865504; Butler J, 2008, GENOME RES, V18, P810, DOI 10.1101/gr.7337908; Cai JJ, 2010, GENOME BIOL EVOL, V2, P393, DOI 10.1093/gbe/evq019; Chanda B, 2011, NAT GENET, V43, P421, DOI 10.1038/ng.798; Claros Manuel Gonzalo, 2012, Biology (Basel), V1, P439, DOI 10.3390/biology1020439; Doebley JF, 2006, CELL, V127, P1309, DOI 10.1016/j.cell.2006.12.006; Donati C, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-10-r107; Du JC, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-113; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Eskandari M, 2013, THEOR APPL GENET, V126, P1839, DOI 10.1007/s00122-013-2096-7; Feys BJ, 2005, PLANT CELL, V17, P2601, DOI 10.1105/tpc.105.033910; FUKUDA YASONA, 1933, JAP JOUR BOT, V6, P489; Haas BJ, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-1-r7; Hirsch CN, 2014, PLANT CELL, V26, P121, DOI 10.1105/tpc.113.119982; Hufford MB, 2012, NAT GENET, V44, P808, DOI 10.1038/ng.2309; Hyten DL, 2006, P NATL ACAD SCI USA, V103, P16666, DOI 10.1073/pnas.0604379103; Innes RW, 2008, PLANT PHYSIOL, V148, P1740, DOI 10.1104/pp.108.127902; Jiao YP, 2012, NAT GENET, V44, P812, DOI 10.1038/ng.2312; Johnson K, 2011, NEW PHYTOL, V191, P319, DOI 10.1111/j.1469-8137.2011.03737.x; Kachroo A, 2009, ANNU REV PHYTOPATHOL, V47, P153, DOI 10.1146/annurev-phyto-080508-081820; Kanehisa M, 2000, NUCLEIC ACIDS RES, V28, P27, DOI 10.1093/nar/28.1.27; Kang YJ, 2012, BMC PLANT BIOL, V12, DOI 10.1186/1471-2229-12-139; Kim D, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-4-r36; Kim KH, 2011, DNA RES, V18, P483, DOI 10.1093/dnares/dsr033; Kim MY, 2010, P NATL ACAD SCI USA, V107, P22032, DOI 10.1073/pnas.1009526107; Kong FJ, 2010, PLANT PHYSIOL, V154, P1220, DOI 10.1104/pp.110.160796; Krylov DM, 2003, GENOME RES, V13, P2229, DOI 10.1101/gr.1589103; Kurtz S, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-2-r12; Lam HM, 2010, NAT GENET, V42, P1053, DOI 10.1038/ng.715; Lee GA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026720; Li H, 2009, BIOINFORMATICS, V25, P1094, DOI [10.1093/bioinformatics/btp100, 10.1093/bioinformatics/btp324]; Li L, 2003, GENOME RES, V13, P2178, DOI 10.1101/gr.1224503; Li RQ, 2010, GENOME RES, V20, P265, DOI 10.1101/gr.097261.109; Li RQ, 2010, NAT BIOTECHNOL, V28, P57, DOI 10.1038/nbt.1596; Li YH, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-579; Li YH, 2010, NEW PHYTOL, V188, P242, DOI 10.1111/j.1469-8137.2010.03344.x; Li-Beisson Yonghua, 2010, Arabidopsis Book, V8, pe0133, DOI [10.1199/tab.0133, 10.1199/tab.0161]; Lintala M, 2007, PLANT J, V49, P1041, DOI 10.1111/j.1365-313X.2006.03014.x; Liu B., 2012, ESTIMATION GENOMIC C; Liu B, 2008, GENETICS, V180, P995, DOI 10.1534/genetics.108.092742; McHale LK, 2012, PLANT PHYSIOL, V159, P1295, DOI 10.1104/pp.112.194605; Medini D, 2005, CURR OPIN GENET DEV, V15, P589, DOI 10.1016/j.gde.2005.09.006; Monteros MJ, 2010, THEOR APPL GENET, V121, P1023, DOI 10.1007/s00122-010-1368-8; Myers EW, 2000, SCIENCE, V287, P2196, DOI 10.1126/science.287.5461.2196; Prufer K, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-41; Qi ZM, 2011, EUPHYTICA, V179, P499, DOI 10.1007/s10681-011-0386-1; Qiu LJ, 2013, PLANT MOL BIOL, V83, P41, DOI 10.1007/s11103-013-0076-6; Read BA, 2013, NATURE, V499, P209, DOI 10.1038/nature12221; Rice P, 2000, TRENDS GENET, V16, P276, DOI 10.1016/S0168-9525(00)02024-2; Schmutz J, 2010, NATURE, V463, P178, DOI 10.1038/nature08670; Shoji T, 2004, PLANT PHYSIOL, V136, P3933, DOI 10.1104/pp.104.051748; Smit A, 1996, REPEATMASKER OPEN 30; SMITH TF, 1981, J MOL BIOL, V147, P195, DOI 10.1016/0022-2836(81)90087-5; Stanke M, 2003, BIOINFORMATICS, V19, pII215, DOI 10.1093/bioinformatics/btg1080; Suh SJ, 2011, PLANT GENOME-US, V4, P55, DOI 10.3835/plantgenome2010.11.0024; Swanson-Wagner RA, 2010, GENOME RES, V20, P1689, DOI 10.1101/gr.109165.110; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Tettelin H, 2005, P NATL ACAD SCI USA, V102, P13950, DOI 10.1073/pnas.0506758102; Trapnell C, 2012, NAT PROTOC, V7, P562, DOI 10.1038/nprot.2012.016; Varshney RK, 2012, NAT BIOTECHNOL, V30, P83, DOI 10.1038/nbt.2022; Wang D, 2004, THEOR APPL GENET, V108, P458, DOI 10.1007/s00122-003-1449-z; Wang K, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkq603; Watanabe S, 2009, GENETICS, V182, P1251, DOI 10.1534/genetics.108.098772; Weise A, 2000, PLANT CELL, V12, P1345, DOI 10.1105/tpc.12.8.1345; Wen RH, 2013, MOL PLANT MICROBE IN, V26, P203, DOI 10.1094/MPMI-06-12-0156-R; Xin DW, 2008, EUPHYTICA, V162, P155, DOI 10.1007/s10681-008-9652-2; Xu B., 1993, JINLIN AGR SCI, V2, P1; Yang SM, 2010, P NATL ACAD SCI USA, V107, P18735, DOI 10.1073/pnas.1011957107; Yang Y, 2011, PLANT PHYSIOL, V156, P873, DOI 10.1104/pp.111.175950; Yang ZH, 1997, COMPUT APPL BIOSCI, V13, P555; Zhang JQ, 2013, THEOR APPL GENET, V126, P1555, DOI 10.1007/s00122-013-2073-1	78	352	384	27	199	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1087-0156	1546-1696		NAT BIOTECHNOL	Nat. Biotechnol.	OCT	2014	32	10					1045	+		10.1038/nbt.2979	http://dx.doi.org/10.1038/nbt.2979			10	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	AR7MM	25218520	hybrid			2022-12-27	WOS:000343763800022
J	Kratz, A; Carninci, P				Kratz, Anton; Carninci, Piero			The devil in the details of RNA-seq	NATURE BIOTECHNOLOGY			English	Editorial Material								Large-scale consortium efforts provide a thorough understanding of RNA-seq.	[Kratz, Anton; Carninci, Piero] RIKEN, Ctr Life Sci Technol, Div Genom Technol, Yokohama, Kanagawa, Japan	RIKEN	Kratz, A (corresponding author), RIKEN, Ctr Life Sci Technol, Div Genom Technol, Yokohama, Kanagawa, Japan.	anton.kratz@riken.jp; carninci@riken.jp	Carninci, Piero/K-1568-2014	Carninci, Piero/0000-0001-7202-7243; Kratz, Anton/0000-0002-6262-4404				[Anonymous], 2014, NAT BIOTECHNOL, V32, P903, DOI [10.1038/nbt.2957, DOI 10.1038/NBT.2957]; Faulkner GJ, 2009, NAT GENET, V41, P563, DOI 10.1038/ng.368; Forrest ARR, 2014, NATURE, V507, P462, DOI 10.1038/nature13182; Hoheisel JD, 2006, NAT REV GENET, V7, P200, DOI 10.1038/nrg1809; Itoh M., 2012, PLOS ONE; Li S, 2014, NAT BIOTECHNOL, V32, P888, DOI 10.1038/nbt.3000; Li S, 2014, NAT BIOTECHNOL, V32, P915, DOI 10.1038/nbt.2972; Risso D, 2014, NAT BIOTECHNOL, V32, P896, DOI 10.1038/nbt.2931; Rung J, 2013, NAT REV GENET, V14, P89, DOI 10.1038/nrg3394; Wang C, 2014, NAT BIOTECHNOL, V32, P926, DOI 10.1038/nbt.3001	10	24	24	0	44	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156	1546-1696		NAT BIOTECHNOL	Nat. Biotechnol.	SEP	2014	32	9					882	884		10.1038/nbt.3015	http://dx.doi.org/10.1038/nbt.3015			3	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	AQ2FD	25203036				2022-12-27	WOS:000342600300024
J	Sinha, G				Sinha, Gunjan			Shire gobbles up Lumena and its fatty liver pills	NATURE BIOTECHNOLOGY			English	News Item																		2014, NAT BIOTECHNOL, V32, P207	1	0	0	0	2	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156	1546-1696		NAT BIOTECHNOL	Nat. Biotechnol.	AUG	2014	32	8					705	705		10.1038/nbt0814-705	http://dx.doi.org/10.1038/nbt0814-705			1	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	AW7PF	25101725	Bronze			2022-12-27	WOS:000346455900031
J	Drakeman, DL				Drakeman, Donald L.			Benchmarking biotech and pharmaceutical product development	NATURE BIOTECHNOLOGY			English	Article									[Drakeman, Donald L.] Univ Cambridge, Ctr Hlth Leadership & Enterprise, Judge Business Sch, Cambridge, England; [Drakeman, Donald L.] Advent Venture Partners, London, England	University of Cambridge	Drakeman, DL (corresponding author), Univ Cambridge, Ctr Hlth Leadership & Enterprise, Judge Business Sch, Trumpington St, Cambridge, England.	don.drakeman@adventventures.com						[Anonymous], 2008, PHARMALIVE; [Anonymous], 2006, PHARM EXECUTIVE MAGA, P80; [Anonymous], 2005, PHARM EXECUTIVE MAGA, P85; [Anonymous], 2006, PHARMALIVE; [Anonymous], 2007, PHARMALIVE; [Anonymous], 2011, PHARMALIVE; [Anonymous], 2008, PHARM EXECUTIVE MAGA, P75; [Anonymous], 2010, PHARMALIVE; [Anonymous], 2005, PHARMALIVE; [Anonymous], 2007, PHARM EXECUTIVE MAGA, P100; [Anonymous], GUID IND EXP PROGR S; Brichacek A., 2000, PHARM EXECUTIVE MAGA, P63; Cacciotti J., 2011, PHARM EXECUTIVE MAGA, P42; Clinton P., 2010, PHARM EXECUTIVE MAGA, P70; Clinton P., 2012, PHARM EXECUTIVE MAGA, P26; Ernst & Young, 2013, BORD MATT EV; Ernst & Young, 2013, BORD GLOB BIT IND RE; Kneller R, 2010, NAT REV DRUG DISCOV, V9, P867, DOI 10.1038/nrd3251; Munos B, 2009, NAT REV DRUG DISCOV, V8, P959, DOI 10.1038/nrd2961; Noor W., 2013, PHARM EXECUTIVE MAGA, P20; Pharm Exec Staff, 2009, PHARM EXECUTIVE MAGA, P69; Sellers L.J., 2004, PHARM EXECUTIVE MAGA, P61; Sellers L.J., 2003, PHARM EXECUTIVE MAGA, P43; Sellers L. J., 2002, PHARM EXECUTIVE MAGA, P61; Sellers L.J., 1999, PHARM EXECUTIVE MAGA, P63; Trusheim MR, 2010, NBER WORKING PAPERS, V13, P1; US Congressional Budget Office, 2006, RES DEV PHARM IND; US Food and Drug Administration, 2013, RES DEV PHARM IND	28	8	8	0	9	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156	1546-1696		NAT BIOTECHNOL	Nat. Biotechnol.	JUL	2014	32	7					621	625		10.1038/nbt.2947	http://dx.doi.org/10.1038/nbt.2947			5	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	AK8VE	25004226	Bronze			2022-12-27	WOS:000338705900023
J	Garber, K				Garber, Ken			Predictive biomarkers for checkpoints, first tests approved	NATURE BIOTECHNOLOGY			English	News Item																			0	12	13	0	3	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156	1546-1696		NAT BIOTECHNOL	Nat. Biotechnol.	DEC	2015	33	12					1217	1218		10.1038/nbt1215-1217	http://dx.doi.org/10.1038/nbt1215-1217			2	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	CY4OO	26649999				2022-12-27	WOS:000366387700003
J	Park, SI; Brenner, DS; Shin, G; Morgan, CD; Copits, BA; Chung, HU; Pullen, MY; Noh, KN; Davidson, S; Oh, SJ; Yoon, J; Jang, KI; Samineni, VK; Norman, M; Grajales-Reyes, JG; Vogt, SK; Sundaram, SS; Wilson, KM; Ha, JS; Xu, RX; Pan, TS; Kim, TI; Huang, YG; Montana, MC; Golden, JP; Bruchas, MR; Gereau, RW; Rogers, JA				Park, Sung Il; Brenner, Daniel S.; Shin, Gunchul; Morgan, Clinton D.; Copits, Bryan A.; Chung, Ha Uk; Pullen, Melanie Y.; Noh, Kyung Nim; Davidson, Steve; Oh, Soong Ju; Yoon, Jangyeol; Jang, Kyung-In; Samineni, Vijay K.; Norman, Megan; Grajales-Reyes, Jose G.; Vogt, Sherri K.; Sundaram, Saranya S.; Wilson, Kellie M.; Ha, Jeong Sook; Xu, Renxiao; Pan, Taisong; Kim, Tae-il; Huang, Yonggang; Montana, Michael C.; Golden, Judith P.; Bruchas, Michael R.; Gereau, Robert W.; Rogers, John A.			Soft, stretchable, fully implantable miniaturized optoelectronic systems for wireless optogenetics	NATURE BIOTECHNOLOGY			English	Article							GENE-THERAPY; PAIN; ACTIVATION; CIRCUITS; MICE	Optogenetics allows rapid, temporally specific control of neuronal activity by targeted expression and activation of light-sensitive proteins. Implementation typically requires remote light sources and fiber-optic delivery schemes that impose considerable physical constraints on natural behaviors. In this report we bypass these limitations using technologies that combine thin, mechanically soft neural interfaces with fully implantable, stretchable wireless radio power and control systems. The resulting devices achieve optogenetic modulation of the spinal cord and peripheral nervous system. This is demonstrated with two form factors; stretchable film appliques that interface directly with peripheral nerves, and flexible filaments that insert into the narrow confines of the spinal epidural space. These soft, thin devices are minimally invasive, and histological tests suggest they can be used in chronic studies. We demonstrate the power of this technology by modulating peripheral and spinal pain circuitry, providing evidence for the potential widespread use of these devices in research and future clinical applications of optogenetics outside the brain.	[Park, Sung Il; Shin, Gunchul; Chung, Ha Uk; Noh, Kyung Nim; Oh, Soong Ju; Yoon, Jangyeol; Jang, Kyung-In; Rogers, John A.] Univ Illinois, Dept Mat Sci & Engn, Urbana, IL 61801 USA; [Park, Sung Il; Shin, Gunchul; Chung, Ha Uk; Noh, Kyung Nim; Yoon, Jangyeol; Jang, Kyung-In; Rogers, John A.] Univ Illinois, Frederick Seitz Mat Res Lab, Urbana, IL USA; [Brenner, Daniel S.; Morgan, Clinton D.; Copits, Bryan A.; Pullen, Melanie Y.; Davidson, Steve; Samineni, Vijay K.; Norman, Megan; Grajales-Reyes, Jose G.; Vogt, Sherri K.; Sundaram, Saranya S.; Wilson, Kellie M.; Montana, Michael C.; Golden, Judith P.; Bruchas, Michael R.; Gereau, Robert W.] Washington Univ, Sch Med, Pain Ctr, St Louis, MO USA; [Brenner, Daniel S.; Morgan, Clinton D.; Copits, Bryan A.; Pullen, Melanie Y.; Davidson, Steve; Samineni, Vijay K.; Norman, Megan; Grajales-Reyes, Jose G.; Vogt, Sherri K.; Sundaram, Saranya S.; Wilson, Kellie M.; Montana, Michael C.; Golden, Judith P.; Bruchas, Michael R.; Gereau, Robert W.] Washington Univ, Sch Med, Dept Anesthesiol, St Louis, MO 63110 USA; [Oh, Soong Ju] Korea Univ, Dept Mat Sci & Engn, Seoul, South Korea; [Yoon, Jangyeol; Ha, Jeong Sook] Korea Univ, Dept Chem & Biol Engn, Seoul, South Korea; [Xu, Renxiao; Pan, Taisong; Huang, Yonggang] Northwestern Univ, Dept Mech Engn, Chicago, IL 60611 USA; [Kim, Tae-il] Sungkyunkwan Univ SKKU, Sch Chem Engn, Suwon, South Korea	University of Illinois System; University of Illinois Urbana-Champaign; University of Illinois System; University of Illinois Urbana-Champaign; Washington University (WUSTL); Washington University (WUSTL); Korea University; Korea University; Northwestern University; Sungkyunkwan University (SKKU)	Rogers, JA (corresponding author), Univ Illinois, Dept Mat Sci & Engn, Urbana, IL 61801 USA.	gereaur@wustl.edu; jrogers@illinois.edu	Kim, Tae-il/C-4769-2015; Bruchas, Michael/G-7616-2012; Oh, Soong Ju/C-8842-2015; Ha, Jeong Sook/F-6918-2013; Xu, Renxiao/ABA-5985-2020; Huang, Yonggang/B-6998-2009; Rogers, John/L-2798-2016; Park, Sung Il/GSJ-1455-2022; PAN, TAISONG/K-1252-2012; huang, yonggang/O-6236-2019	Kim, Tae-il/0000-0002-6667-5356; Oh, Soong Ju/0000-0003-1434-8844; PAN, TAISONG/0000-0003-1576-3409; Morgan, Clinton/0000-0002-7511-0488; Park, Sung Il/0000-0003-0001-8967; Golden, Judith/0000-0002-5168-8525; Samineni, Vijay/0000-0002-9491-2793; Williford, Kellie/0000-0002-7405-6459; Davidson, Steve/0000-0003-2944-1144	US National Institutes of Health (NIH) [NS081707]; NIH Ruth L. Kirschstein F31 Predoctoral Fellowship [1F31NS078852]; Howard Hughes Medical Institute (HHMI) Medical Research Fellowship; W.M. Keck Fellowship in Molecular Medicine;  [TR32 GM108539];  [T32 GM007067];  [NS076324]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM108539] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [F32NS076324, R01NS081707, F31NS078852] Funding Source: NIH RePORTER	US National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH Ruth L. Kirschstein F31 Predoctoral Fellowship(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Howard Hughes Medical Institute (HHMI) Medical Research Fellowship; W.M. Keck Fellowship in Molecular Medicine; ; ; ; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by a US National Institutes of Health (NIH) Director's Transformative Research Award (NS081707) to R.W.G., J.A.R. and M.R.B. D.S.B. was supported by an NIH Ruth L. Kirschstein F31 Predoctoral Fellowship (1F31NS078852). C.D.M. was supported by a Howard Hughes Medical Institute (HHMI) Medical Research Fellowship. B.A.C. was supported by a W.M. Keck Fellowship in Molecular Medicine and TR32 GM108539. M.Y.P. was supported by T32 GM007067. S.D. was supported by NS076324. Illustrations created by J. Sinn-Hanlon and P. Focken, University of Illinois. The authors appreciate the gifts of heterozygous SNS-cre mice from R. Kuner (University of Heidelberg), heterozygous TrpV1-cre mice from M. Hoon (NIH/National Institute of Dental and Craniofacial Research) and heterozygous Advillin-cre mice from F. Wang (Duke University). We would also like to think R.E. Schmidt for the expertise he provided in neuropathological examination of tissue.	Agarwal N, 2004, GENESIS, V38, P122, DOI 10.1002/gene.20010; [Anonymous], 2005, C9512005 IEEE; BENNETT GJ, 1988, PAIN, V33, P87, DOI 10.1016/0304-3959(88)90209-6; da Silva S, 2011, P NATL ACAD SCI USA, V108, P3395, DOI 10.1073/pnas.1014411108; Daou I, 2013, J NEUROSCI, V33, P18631, DOI 10.1523/JNEUROSCI.2424-13.2013; Fink DJ, 2011, PAIN MANAG, V1, P379, DOI 10.2217/PMT.11.49; Fink DJ, 2011, ANN NEUROL, V70, P207, DOI 10.1002/ana.22446; Folcher M, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6392; Golden JP, 2013, J NEUROSCI, V 33, P17095, DOI 10.1523/JNEUROSCI.0890-13.2013; Golden JP, 2010, J NEUROSCI, V30, P3983, DOI 10.1523/JNEUROSCI.5930-09.2010; Harrington R. F., 2001, TIME HARMONIC ELECTR; Harrison M, 2013, NEUROIMAGE, V68, P22, DOI 10.1016/j.neuroimage.2012.11.048; Hasegawa H, 2007, J NEUROSCI, V27, P14404, DOI 10.1523/JNEUROSCI.4908-07.2007; Iyer SM, 2014, NAT BIOTECHNOL, V32, P274, DOI 10.1038/nbt.2834; Jang KI, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5779; Kim DH, 2011, SCIENCE, V333, P838, DOI 10.1126/science.1206157; Kim TI, 2013, SCIENCE, V340, P211, DOI 10.1126/science.1232437; Kozai TDY, 2012, NAT MATER, V11, P1065, DOI [10.1038/NMAT3468, 10.1038/nmat3468]; Madisen L, 2012, NAT NEUROSCI, V15, P793, DOI 10.1038/nn.3078; Mishra SK, 2011, EMBO J, V30, P582, DOI 10.1038/emboj.2010.325; Miyazato M, 2010, J UROLOGY, V184, P1204, DOI 10.1016/j.juro.2010.04.066; Montana MC, 2009, J PHARMACOL EXP THER, V330, P834, DOI 10.1124/jpet.109.154138; Montgomery KL, 2015, NAT METHODS, V12, P969, DOI [10.1038/NMETH.3536, 10.1038/nmeth.3536]; Pleticha J, 2014, MOL PAIN, V10, DOI 10.1186/1744-8069-10-54; Sparta DR, 2012, NAT PROTOC, V7, P12, DOI 10.1038/nprot.2011.413; Towne C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072691; Xu S, 2014, SCIENCE, V344, P70, DOI 10.1126/science.1250169; Yokoyama H, 2009, HUM GENE THER, V20, P63, DOI 10.1089/hum.2008.094	28	193	199	16	272	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156	1546-1696		NAT BIOTECHNOL	Nat. Biotechnol.	DEC	2015	33	12					1280	+		10.1038/nbt.3415	http://dx.doi.org/10.1038/nbt.3415			9	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	CY4OO	26551059	Green Accepted			2022-12-27	WOS:000366387700020
J	Lee, SY; Kim, HU				Lee, Sang Yup; Kim, Hyun Uk			Systems strategies for developing industrial microbial strains	NATURE BIOTECHNOLOGY			English	Article							ESCHERICHIA-COLI; SYNTHETIC BIOLOGY; METABOLIC PATHWAY; MANNHEIMIA-SUCCINICIPRODUCENS; ACID; DESIGN; TOLERANCE; CHEMICALS; MODEL; BIOSYNTHESIS	Industrial strain development requires system-wide engineering and optimization of cellular metabolism while considering industrially relevant fermentation and recovery processes. It can be conceptualized as several strategies, which may be implemented in an iterative fashion and in different orders. The key challenges have been the time-, cost- and labor-intensive processes of strain development owing to the difficulties in understanding complex interactions among the metabolic, gene regulatory and signaling networks at the cell level, which are collectively represented as overall system performance under industrial fermentation conditions. These challenges can be overcome by taking systems approaches through the use of state-of-the-art tools of systems biology, synthetic biology and evolutionary engineering in the context of industrial bioprocess. Major systems metabolic engineering achievements in recent years include microbial production of amino acids (L-valine, L-threonine, L-lysine and L-arginine), bulk chemicals (1,4-butanediol, 1,4-diaminobutane, 1,5-diaminopentane, 1,3-propanediol, butanol, isobutanol and succinic acid) and drugs (artemisinin).	[Lee, Sang Yup; Kim, Hyun Uk] Korea Adv Inst Sci & Technol, Metab & Biomol Engn Natl Res Lab, Dept Chem & Biomol Engn, Plus Program BK21,Ctr Syst & Synthet Biotechnol,I, Daejeon, South Korea; [Lee, Sang Yup; Kim, Hyun Uk] Korea Adv Inst Sci & Technol, BioInformat Res Ctr, Daejeon, South Korea; [Lee, Sang Yup] Korea Adv Inst Sci & Technol, BioProc Engn Res Ctr, Daejeon, South Korea; [Lee, Sang Yup; Kim, Hyun Uk] Tech Univ Denmark, Novo Nordisk Fdn Ctr Biosustainabil, Horsholm, Denmark	Korea Advanced Institute of Science & Technology (KAIST); Korea Advanced Institute of Science & Technology (KAIST); Korea Advanced Institute of Science & Technology (KAIST); Technical University of Denmark	Lee, SY (corresponding author), Korea Adv Inst Sci & Technol, Metab & Biomol Engn Natl Res Lab, Dept Chem & Biomol Engn, Plus Program BK21,Ctr Syst & Synthet Biotechnol,I, Daejeon, South Korea.	leesy@kaist.ac.kr	Lee, Sang Yup/C-1526-2011; Kim, Hyun Uk/F-4509-2018	Lee, Sang Yup/0000-0003-0599-3091; Kim, Hyun Uk/0000-0001-7224-642X	Technology Development Program [NRF-2012M1A2A2026556]; Intelligent Synthetic Biology Center through the Global Frontier Project from the Ministry of Science, ICT and Future Planning (MSIP) through the National Research Foundation (NRF) of Korea [2011-0031963]; Novo Nordisk Foundation; Novo Nordisk Fonden [NNF10CC1016517] Funding Source: researchfish; NNF Center for Biosustainability [New Bioactive Compounds] Funding Source: researchfish	Technology Development Program; Intelligent Synthetic Biology Center through the Global Frontier Project from the Ministry of Science, ICT and Future Planning (MSIP) through the National Research Foundation (NRF) of Korea; Novo Nordisk Foundation(Novo Nordisk FoundationNovocure Limited); Novo Nordisk Fonden(Novo Nordisk Foundation); NNF Center for Biosustainability	We thank Seok Hyun Park, Sol Choi, Joungmin Lee, Chan Woo Song, Jae Ho Shin and Won Jun Kim for thoughtful discussions. This work was supported by the Technology Development Program to Solve Climate Changes on Systems Metabolic Engineering for Biorefineries (NRF-2012M1A2A2026556) and by Intelligent Synthetic Biology Center through the Global Frontier Project (2011-0031963) from the Ministry of Science, ICT and Future Planning (MSIP) through the National Research Foundation (NRF) of Korea. This work was also supported by the Novo Nordisk Foundation.	Anbarasan P, 2012, NATURE, V491, P235, DOI 10.1038/nature11594; Antoniewicz MR, 2013, CURR OPIN BIOTECH, V24, P1116, DOI 10.1016/j.copbio.2013.02.003; BAILEY JE, 1991, SCIENCE, V252, P1668, DOI 10.1126/science.2047876; Becker J, 2013, BIOTECHNOL BIOENG, V110, P3013, DOI 10.1002/bit.24963; Becker J, 2011, METAB ENG, V13, P159, DOI 10.1016/j.ymben.2011.01.003; Bonneau R, 2007, CELL, V131, P1354, DOI 10.1016/j.cell.2007.10.053; Borodina I, 2015, METAB ENG, V27, P57, DOI 10.1016/j.ymben.2014.10.003; Burgard AP, 2003, BIOTECHNOL BIOENG, V84, P647, DOI 10.1002/bit.10803; Caspeta L, 2014, SCIENCE, V346, P75, DOI 10.1126/science.1258137; Choi S, 2013, METAB ENG, V20, P73, DOI 10.1016/j.ymben.2013.09.001; Choi YJ, 2013, NATURE, V502, P571, DOI 10.1038/nature12536; Cobb RE, 2015, ACS SYNTH BIOL, V4, P723, DOI 10.1021/sb500351f; Cobb RE, 2012, CURR OPIN CHEM BIOL, V16, P285, DOI 10.1016/j.cbpa.2012.05.186; Croughan MS, 2015, BIOTECHNOL BIOENG, V112, P648, DOI 10.1002/bit.25529; Dahl RH, 2013, NAT BIOTECHNOL, V31, P1039, DOI 10.1038/nbt.2689; Dellomonaco C, 2011, NATURE, V476, P355, DOI 10.1038/nature10333; Dunlop MJ, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.21; Esvelt KM, 2013, MOL SYST BIOL, V9, DOI 10.1038/msb.2012.66; Galanie S, 2015, SCIENCE, V349, P1095, DOI 10.1126/science.aac9373; Guan YF, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000698; Hollinshead W, 2014, FRONT MICROBIOL, V5, DOI 10.3389/fmicb.2014.00344; Hong KK, 2012, CELL MOL LIFE SCI, V69, P2671, DOI 10.1007/s00018-012-0945-1; HSIAO TY, 1994, BIOTECHNOL BIOENG, V44, P1228, DOI 10.1002/bit.260441010; Jantama K, 2008, BIOTECHNOL BIOENG, V101, P881, DOI 10.1002/bit.22005; Jiang M, 2013, METAB ENG, V19, P42, DOI 10.1016/j.ymben.2013.05.005; Karr JR, 2012, CELL, V150, P389, DOI 10.1016/j.cell.2012.05.044; Kim HU, 2008, MOL BIOSYST, V4, P113, DOI 10.1039/b712395g; Kim J, 2012, P NATL ACAD SCI USA, V109, pE2856, DOI 10.1073/pnas.1208509109; Kim TY, 2015, METAB ENG, V28, P63, DOI 10.1016/j.ymben.2014.11.012; Kind S, 2014, METAB ENG, V25, P113, DOI 10.1016/j.ymben.2014.05.007; King ZA, 2014, METAB ENG, V24, P117, DOI 10.1016/j.ymben.2014.05.009; Lam FH, 2014, SCIENCE, V346, P71, DOI 10.1126/science.1257859; Lee BR, 2013, MOL CELLS, V35, P359, DOI 10.1007/s10059-013-0127-5; Lee JW, 2012, NAT CHEM BIOL, V8, P536, DOI [10.1038/NCHEMBIO.970, 10.1038/nchembio.970]; Lee JW, 2011, CURR OPIN BIOTECH, V22, P758, DOI 10.1016/j.copbio.2011.02.011; Lee JW, 2011, TRENDS BIOTECHNOL, V29, P370, DOI 10.1016/j.tibtech.2011.04.001; Lee JW, 2010, APPL MICROBIOL BIOT, V88, P905, DOI 10.1007/s00253-010-2825-7; Lee KH, 2007, MOL SYST BIOL, V3, DOI 10.1038/msb4100196; Lee SJ, 2006, APPL ENVIRON MICROB, V72, P1939, DOI 10.1128/AEM.72.3.1939-1948.2006; Lee SY, 1996, TRENDS BIOTECHNOL, V14, P98, DOI 10.1016/0167-7799(96)80930-9; Lee SY, 2005, TRENDS BIOTECHNOL, V23, P349, DOI 10.1016/j.tibtech.2005.05.003; Lewis NE, 2012, NAT REV MICROBIOL, V10, P291, DOI 10.1038/nrmicro2737; Ling H, 2014, CURR OPIN BIOTECH, V29, P99, DOI 10.1016/j.copbio.2014.03.005; Medema MH, 2012, NAT REV MICROBIOL, V10, P191, DOI 10.1038/nrmicro2717; Na D, 2013, NAT BIOTECHNOL, V31, P170, DOI 10.1038/nbt.2461; Paddon CJ, 2013, NATURE, V496, P528, DOI 10.1038/nature12051; Paddon CJ, 2014, NAT REV MICROBIOL, V12, P355, DOI 10.1038/nrmicro3240; Park JH, 2007, P NATL ACAD SCI USA, V104, P7797, DOI 10.1073/pnas.0702609104; Park JH, 2011, BIOTECHNOL BIOENG, V108, P1140, DOI 10.1002/bit.23044; Park JH, 2011, BIOTECHNOL BIOENG, V108, P934, DOI 10.1002/bit.22995; Park SH, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5618; Pronk JT, 2015, NAT BIOTECHNOL, V33, P237, DOI 10.1038/nbt.3171; Rellos P, 1997, PROTEIN EXPRES PURIF, V9, P83, DOI 10.1006/prep.1996.0673; Sagt CMJ, 2013, APPL MICROBIOL BIOT, V97, P2319, DOI 10.1007/s00253-013-4738-8; Shin JH, 2013, BIOTECHNOL ADV, V31, P925, DOI 10.1016/j.biotechadv.2012.12.008; Smanski MJ, 2014, NAT BIOTECHNOL, V32, P1241, DOI 10.1038/nbt.3063; Song CW, 2015, BIOTECHNOL J, V10, P56, DOI 10.1002/biot.201400057; Tong YJ, 2015, ACS SYNTH BIOL, V4, P1020, DOI 10.1021/acssynbio.5b00038; Trinh CT, 2009, APPL MICROBIOL BIOT, V81, P813, DOI 10.1007/s00253-008-1770-1; Utrilla J, 2012, METAB ENG, V14, P469, DOI 10.1016/j.ymben.2012.07.007; Van Dien S, 2013, CURR OPIN BIOTECH, V24, P1061, DOI 10.1016/j.copbio.2013.03.002; Wang HH, 2012, NAT METHODS, V9, P591, DOI [10.1038/NMETH.1971, 10.1038/nmeth.1971]; Wang HH, 2009, NATURE, V460, P894, DOI 10.1038/nature08187; Warner JR, 2010, NAT BIOTECHNOL, V28, P856, DOI 10.1038/nbt.1653; Xia JX, 2014, PLANT SIGNAL BEHAV, V9, DOI 10.4161/psb.28717; Yadav VG, 2012, METAB ENG, V14, P233, DOI 10.1016/j.ymben.2012.02.001; Yim H, 2011, NAT CHEM BIOL, V7, P445, DOI [10.1038/NCHEMBIO.580, 10.1038/nchembio.580]; Yin J, 2014, APPL MICROBIOL BIOT, V98, P8987, DOI 10.1007/s00253-014-5959-1; Yoo SM, 2013, NAT PROTOC, V8, P1694, DOI 10.1038/nprot.2013.105; Yu JL, 2014, BIOTECHNOL BIOENG, V111, P2580, DOI 10.1002/bit.25293; Zhang KC, 2010, P NATL ACAD SCI USA, V107, P6234, DOI 10.1073/pnas.0912903107; Zhuang KH, 2015, METAB ENG, V31, P1, DOI 10.1016/j.ymben.2015.05.007	72	303	318	22	331	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156	1546-1696		NAT BIOTECHNOL	Nat. Biotechnol.	OCT	2015	33	10					1061	1072		10.1038/nbt.3365	http://dx.doi.org/10.1038/nbt.3365			12	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	CT1JX	26448090				2022-12-27	WOS:000362555700025
J	Garber, K				Garber, Ken			RIKEN suspends first clinical trial involving induced pluripotent stem cells	NATURE BIOTECHNOLOGY			English	News Item																		2012, NATURE, V471, P46	1	130	133	0	24	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156	1546-1696		NAT BIOTECHNOL	Nat. Biotechnol.	SEP	2015	33	9					890	891		10.1038/nbt0915-890	http://dx.doi.org/10.1038/nbt0915-890			2	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	CR0EK	26348942				2022-12-27	WOS:000360990900003
J	Winter, DR; Ledergor, G; Amit, I				Winter, Deborah R.; Ledergor, Guy; Amit, Ido			From mass cytometry to cancer prognosis	NATURE BIOTECHNOLOGY			English	Editorial Material							ACUTE MYELOID-LEUKEMIA; CELL RNA-SEQ; AML		[Winter, Deborah R.; Ledergor, Guy; Amit, Ido] Weizmann Inst Sci, Dept Immunol, IL-76100 Rehovot, Israel	Weizmann Institute of Science	Winter, DR (corresponding author), Weizmann Inst Sci, Dept Immunol, IL-76100 Rehovot, Israel.	deborah.winter@weizmann.ac.il; guy.ledergor@weizmann.ac.il; ido.amit@weizmann.ac.il	Winter, Deborah R./AAQ-9253-2020	Winter, Deborah R./0000-0003-1806-673X; Ledergor, Guy/0000-0003-0443-6066				Ding L, 2012, NATURE, V481, P506, DOI 10.1038/nature10738; Dombret H, 2015, BLOOD, V126, P291, DOI 10.1182/blood-2015-01-621664; Eppert K, 2011, NAT MED, V17, P1086, DOI 10.1038/nm.2415; Etzrodt M, 2014, CELL STEM CELL, V15, P546, DOI 10.1016/j.stem.2014.10.015; Ferrara F, 2013, LANCET, V381, P484, DOI 10.1016/S0140-6736(12)61727-9; Jaitin DA, 2014, SCIENCE, V343, P776, DOI 10.1126/science.1247651; Levine JH, 2015, CELL, V162, P184, DOI 10.1016/j.cell.2015.05.047; Levis M, 2011, BLOOD, V117, P3294, DOI 10.1182/blood-2010-08-301796; Patel JP, 2012, NEW ENGL J MED, V366, P1079, DOI 10.1056/NEJMoa1112304; Taussig DC, 2010, BLOOD, V115, P1976, DOI 10.1182/blood-2009-02-206565; Zeisel A, 2015, SCIENCE, V347, P1138, DOI 10.1126/science.aaa1934	11	3	4	1	16	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156	1546-1696		NAT BIOTECHNOL	Nat. Biotechnol.	SEP	2015	33	9					931	932		10.1038/nbt.3346	http://dx.doi.org/10.1038/nbt.3346			2	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	CR0EK	26348963				2022-12-27	WOS:000360990900020
J	Alipanahi, B; Delong, A; Weirauch, MT; Frey, BJ				Alipanahi, Babak; Delong, Andrew; Weirauch, Matthew T.; Frey, Brendan J.			Predicting the sequence specificities of DNA- and RNA-binding proteins by deep learning	NATURE BIOTECHNOLOGY			English	Article							TERT PROMOTER MUTATIONS; TRANSCRIPTION FACTORS; RECOGNITION; COMPLEXITY; NETWORKS; SEARCH; MODELS; CANCER; SITES	Knowing the sequence specificities of DNA- and RNA-binding proteins is essential for developing models of the regulatory processes in biological systems and for identifying causal disease variants. Here we show that sequence specificities can be ascertained from experimental data with 'deep learning' techniques, which offer a scalable, flexible and unified computational approach for pattern discovery. Using a diverse array of experimental data and evaluation metrics, we find that deep learning outperforms other state-of-the-art methods, even when training on in vitro data and testing on in vivo data. We call this approach DeepBind and have built a stand-alone software tool that is fully automatic and handles millions of sequences per experiment. Specificities determined by DeepBind are readily visualized as a weighted ensemble of position weight matrices or as a 'mutation map' that indicates how variations affect binding within a specific sequence.	[Alipanahi, Babak; Delong, Andrew; Frey, Brendan J.] Univ Toronto, Dept Elect & Comp Engn, Toronto, ON, Canada; [Alipanahi, Babak; Frey, Brendan J.] Univ Toronto, Donnelly Ctr Cellular & Biomol Res, Toronto, ON, Canada; [Weirauch, Matthew T.; Frey, Brendan J.] Canadian Inst Adv Res, Program Genet Networks, Toronto, ON, Canada; [Weirauch, Matthew T.; Frey, Brendan J.] Canadian Inst Adv Res, Program Neural Computat, Toronto, ON, Canada; [Weirauch, Matthew T.] Cincinnati Childrens Hosp Med Ctr, Ctr Autoimmune Genom & Etiol, Cincinnati, OH 45229 USA; [Weirauch, Matthew T.] Cincinnati Childrens Hosp Med Ctr, Div Biomed Informat, Cincinnati, OH 45229 USA; [Weirauch, Matthew T.] Cincinnati Childrens Hosp Med Ctr, Div Dev Biol, Cincinnati, OH 45229 USA	University of Toronto; University of Toronto; Canadian Institute for Advanced Research (CIFAR); Canadian Institute for Advanced Research (CIFAR); Cincinnati Children's Hospital Medical Center; University System of Ohio; University of Cincinnati; Cincinnati Children's Hospital Medical Center; Cincinnati Children's Hospital Medical Center	Frey, BJ (corresponding author), Univ Toronto, Dept Elect & Comp Engn, Toronto, ON, Canada.	frey@psi.toronto.edu	Weirauch, Matthew/M-5459-2019	Alipanahi, Babak/0000-0001-8216-7178	Canadian Institutes of Health Research [OGP-106690]; John C. Polanyi Fellowship Grant; Canadian Institutes for Advanced Research; Autism Research Training and NeuroDevNet Fellowship; Natural Science and Engineering Research Council of Canada	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); John C. Polanyi Fellowship Grant; Canadian Institutes for Advanced Research; Autism Research Training and NeuroDevNet Fellowship; Natural Science and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC))	We are grateful to K.B. Cook, Q.D. Morris and T.R. Hughes for helpful discussions. This work was supported by a grant from the Canadian Institutes of Health Research (OGP-106690) to B.J.F., a John C. Polanyi Fellowship Grant to B.J.F., and funding from the Canadian Institutes for Advanced Research to B.J.F. and M.T.W.B.A. was supported by a joint Autism Research Training and NeuroDevNet Fellowship. A.D. was supported by a Fellowship from the Natural Science and Engineering Research Council of Canada..	Badis G, 2009, SCIENCE, V324, P1720, DOI 10.1126/science.1162327; Bae BI, 2014, SCIENCE, V343, P764, DOI 10.1126/science.1244392; Bell RJA, 2015, SCIENCE, V348, P1036, DOI 10.1126/science.aab0015; Berger MF, 2006, NAT BIOTECHNOL, V24, P1429, DOI 10.1038/nbt1246; Bergstra J, 2012, J MACH LEARN RES, V13, P281; Chen XY, 2007, BIOINFORMATICS, V23, pI72, DOI 10.1093/bioinformatics/btm224; Cotter A., 2011, P NEURIPS GRAN SPAIN; Daubner GM, 2013, CURR OPIN STRUC BIOL, V23, P100, DOI 10.1016/j.sbi.2012.11.006; De Castro-Oros I, 2011, HUM MUTAT, V32, P868, DOI 10.1002/humu.21520; De Gobbi M, 2006, SCIENCE, V312, P1215, DOI 10.1126/science.1126431; Del Gato-Konczak F, 2000, MOL CELL BIOL, V20, P6287, DOI 10.1128/MCB.20.17.6287-6299.2000; Foat BC, 2006, BIOINFORMATICS, V22, pE141, DOI 10.1093/bioinformatics/btl223; Fogel BL, 2012, HUM MOL GENET, V21, P4171, DOI 10.1093/hmg/dds240; Forbes SA, 2011, NUCLEIC ACIDS RES, V39, pD945, DOI 10.1093/nar/gkq929; Graves A, 2013, INT CONF ACOUST SPEE, P6645, DOI 10.1109/ICASSP.2013.6638947; Gupta A, 2011, J MOL BIOL, V409, P574, DOI 10.1016/j.jmb.2011.04.007; Han H, 2013, NATURE, V498, P241, DOI 10.1038/nature12270; Horn S, 2013, SCIENCE, V339, P959, DOI 10.1126/science.1230062; Huang FW, 2013, SCIENCE, V339, P957, DOI 10.1126/science.1229259; Jolma A, 2013, CELL, V152, P327, DOI 10.1016/j.cell.2012.12.009; Jolma A, 2010, GENOME RES, V20, P861, DOI 10.1101/gr.100552.109; Kazan H, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000832; Kharchenko PV, 2008, NAT BIOTECHNOL, V26, P1351, DOI 10.1038/nbt.1508; Kircher M, 2014, NAT GENET, V46, P310, DOI 10.1038/ng.2892; Krizhevsky A, 2017, COMMUN ACM, V60, P84, DOI 10.1145/3065386; Kyronlahti A, 2008, ENDOCRINOLOGY, V149, P5635, DOI 10.1210/en.2008-0148; Landt SG, 2012, GENOME RES, V22, P1813, DOI 10.1101/gr.136184.111; LeCun Y, 1989, NEURAL COMPUT, V1, P541, DOI 10.1162/neco.1989.1.4.541; Lee TI, 2013, CELL, V152, P1237, DOI 10.1016/j.cell.2013.02.014; Leonid TB, 2013, P NATL ACAD SCI USA, V110, P18602, DOI 10.1073/pnas.1316064110; Levitsky VG, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-80; Machanick P, 2011, BIOINFORMATICS, V27, P1696, DOI 10.1093/bioinformatics/btr189; Mathelier A, 2014, NUCLEIC ACIDS RES, V42, pD142, DOI 10.1093/nar/gkt997; Matys V, 2006, NUCLEIC ACIDS RES, V34, pD108, DOI 10.1093/nar/gkj143; Mukherjee S, 2004, NAT GENET, V36, P1331, DOI 10.1038/ng1473; Nutiu R, 2011, NAT BIOTECHNOL, V29, P659, DOI 10.1038/nbt.1882; Oberstrass FC, 2006, NAT STRUCT MOL BIOL, V13, P160, DOI 10.1038/nsmb1038; Pan Q, 2008, NAT GENET, V40, P1413, DOI 10.1038/ng.259; Pomerantz MM, 2009, NAT GENET, V41, P882, DOI 10.1038/ng.403; Ray D, 2013, NATURE, V499, P172, DOI 10.1038/nature12311; Ray D, 2009, NAT BIOTECHNOL, V27, P667, DOI 10.1038/nbt.1550; Rohs R, 2010, ANNU REV BIOCHEM, V79, P233, DOI 10.1146/annurev-biochem-060408-091030; Siggers T, 2014, NUCLEIC ACIDS RES, V42, P2099, DOI 10.1093/nar/gkt1112; Srivastava N, 2014, J MACH LEARN RES, V15, P1929; Stenson PD, 2014, HUM GENET, V133, P1, DOI 10.1007/s00439-013-1358-4; Stormo GD, 2000, BIOINFORMATICS, V16, P16, DOI 10.1093/bioinformatics/16.1.16; Ule J, 2006, NATURE, V444, P580, DOI 10.1038/nature05304; Wang J, 2012, GENOME RES, V22, P1798, DOI 10.1101/gr.139105.112; Weirauch MT, 2013, NAT BIOTECHNOL, V31, P126, DOI 10.1038/nbt.2486; Xue YC, 2009, MOL CELL, V36, P996, DOI 10.1016/j.molcel.2009.12.003; Zhao Y, 2011, NAT BIOTECHNOL, V29, P480, DOI 10.1038/nbt.1893	51	1289	1323	33	304	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156	1546-1696		NAT BIOTECHNOL	Nat. Biotechnol.	AUG	2015	33	8					831	+		10.1038/nbt.3300	http://dx.doi.org/10.1038/nbt.3300			9	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	CO6OB	26213851	Bronze			2022-12-27	WOS:000359274900021
J	McNamee, L; Ledley, F				McNamee, Laura; Ledley, Fred			What does the current biotech stock market value?	NATURE BIOTECHNOLOGY			English	Letter							IPO		[McNamee, Laura; Ledley, Fred] Bentley Univ, Ctr Integrat Sci & Ind, Waltham, MA 02452 USA	Bentley University	McNamee, L (corresponding author), Bentley Univ, Ctr Integrat Sci & Ind, Waltham, MA 02452 USA.	lmcnamee@bentley.edu						Booth BL, 2009, NAT BIOTECHNOL, V27, P705, DOI 10.1038/nbt0809-705; Christensen Clayton, 2003, INNOVATORS SOLUTION; DiMasi JA, 2010, CLIN PHARMACOL THER, V87, P272, DOI 10.1038/clpt.2009.295; Guedj I., 2004, 10933 NBER; McNamee L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082195; McNamee L, 2013, NAT BIOTECHNOL, V31, P969, DOI 10.1038/nbt.2711	6	1	1	0	12	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156	1546-1696		NAT BIOTECHNOL	Nat. Biotechnol.	AUG	2015	33	8					813	814		10.1038/nbt.3303	http://dx.doi.org/10.1038/nbt.3303			2	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	CO6OB	26252135				2022-12-27	WOS:000359274900014
J	Ogawa, M; Ogawa, S; Bear, CE; Ahmadi, S; Chin, S; Li, B; Grompe, M; Keller, G; Kamath, BM; Ghanekar, A				Ogawa, Mina; Ogawa, Shinichiro; Bear, Christine E.; Ahmadi, Saumel; Chin, Stephanie; Li, Bin; Grompe, Markus; Keller, Gordon; Kamath, Binita M.; Ghanekar, Anand			Directed differentiation of cholangiocytes from human pluripotent stem cells	NATURE BIOTECHNOLOGY			English	Article							HEPATIC PROGENITOR CELLS; BILE-DUCT DEVELOPMENT; ALAGILLE-SYNDROME; LIVER DEVELOPMENT; CYSTIC-FIBROSIS; IN-VITRO; TRANSCRIPTION FACTORS; NOTCH2 MUTATIONS; FATE DECISION; HEPATOCYTES	Although bile duct disorders are well-recognized causes of liver disease, the molecular and cellular events leading to biliary dysfunction are poorly understood. To enable modeling and drug discovery for biliary disease, we describe a protocol that achieves efficient differentiation of biliary epithelial cells (cholangiocytes) from human pluripotent stem cells (hPSCs) through delivery of developmentally relevant cues, including NOTCH signaling. Using three-dimensional culture, the protocol yields cystic and/or ductal structures that express mature biliary markers, including apical sodium-dependent bile acid transporter, secretin receptor, cilia and cystic fibrosis transmembrane conductance regulator (CFTR). We demonstrate that hPSC-derived cholangiocytes possess epithelial functions, including rhodamine efflux and CFTR-mediated fluid secretion. Furthermore, we show that functionally impaired hPSC-derived cholangiocytes from cystic fibrosis patients are rescued by CFTR correctors. These findings demonstrate that mature cholangiocytes can be differentiated from hPSCs and used for studies of biliary development and disease.	[Ogawa, Mina; Ogawa, Shinichiro; Keller, Gordon] Univ Hlth Network, McEwen Ctr Regenerat Med, Toronto, ON, Canada; [Ogawa, Mina; Ghanekar, Anand] Univ Hlth Network, Toronto Gen Res Inst, Toronto, ON, Canada; [Bear, Christine E.; Ahmadi, Saumel; Chin, Stephanie] Hosp Sick Children, Res Inst, Program Mol Struct & Funct, Toronto, ON M5G 1X8, Canada; [Li, Bin; Grompe, Markus] Oregon Hlth & Sci Univ, Dept Pediat, Portland, OR 97201 USA; [Keller, Gordon] Univ Hlth Network, Princess Margaret Canc Ctr, Toronto, ON, Canada; [Keller, Gordon] Univ Toronto, Dept Med Biophys, Toronto, ON, Canada; [Kamath, Binita M.] Hosp Sick Children, Div Gastroenterol Hepatol & Nutr, Toronto, ON M5G 1X8, Canada; [Kamath, Binita M.] Univ Toronto, Dept Pediat, Toronto, ON, Canada; [Ghanekar, Anand] Univ Hlth Network, Div Gen Surg, Toronto, ON, Canada; [Ghanekar, Anand] Univ Toronto, Dept Surg, Toronto, ON, Canada	University of Toronto; University Toronto Affiliates; University Health Network Toronto; University of Toronto; University Toronto Affiliates; University Health Network Toronto; Toronto General Hospital; University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); Oregon Health & Science University; University of Toronto; University Toronto Affiliates; University Health Network Toronto; Princess Margaret Cancer Centre; University of Toronto; University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Toronto; University of Toronto; University Toronto Affiliates; University Health Network Toronto; University of Toronto	Ghanekar, A (corresponding author), Univ Hlth Network, Toronto Gen Res Inst, Toronto, ON, Canada.	sogawa@uhnresearch.ca; anand.ghanekar@uhn.ca	Li, Bin/P-8992-2015; OGAWA, SHINICHIRO/G-2914-2019; Ahmadi, Saumel/O-3570-2018	Li, Bin/0000-0002-4884-6967; OGAWA, SHINICHIRO/0000-0002-4527-4764; Ahmadi, Saumel/0000-0002-5800-6945; Keller, Gordon/0000-0001-9309-9297; Grompe, Markus/0000-0002-6616-4345	McEwen Centre for Regenerative Medicine; Canadian Institutes of Health Research [MOP133620, MOP:97954, GPG:102171]; University Health Network Multi-Organ Transplant Program Academic Enrichment Fund; Astellas Pharma Canada; Alagille Syndrome Alliance; SickKids Research Institute; Rare Disease Foundation; Childhood Liver Disease Research and Education Network; National Institute of Diabetes, Digestive and Kidney Diseases [U01 DK062453]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [U01DK062453] Funding Source: NIH RePORTER	McEwen Centre for Regenerative Medicine; Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); University Health Network Multi-Organ Transplant Program Academic Enrichment Fund; Astellas Pharma Canada(Astellas Pharmaceuticals); Alagille Syndrome Alliance; SickKids Research Institute; Rare Disease Foundation; Childhood Liver Disease Research and Education Network; National Institute of Diabetes, Digestive and Kidney Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	We would like to thank J. Rossant, J. Ellis and A.P. Wong (Hospital for Sick Children, Toronto, ON, Canada) for providing CF patient iPSCs (C1 and GM00997). We thank members of the G.K. and A.G. laboratories for discussion and feedback on the manuscript. We would like to thank F. Xu (Advanced Optical Microscopy Facility, University Health Network) for technical assistance with the time-lapse video. In addition, we would also like to thank O. Adeyi and the members of Department Pathology, University Health Network for technical assistance with immunohistochemistry. H9 hESC was obtained from The Wicell Research Institute (Madison, WI, USA), and MSC-iPSC1 cells were obtained from G.Q. Daley (Harvard Stem Cell Institute). This work was supported by funding from the McEwen Centre for Regenerative Medicine and the Canadian Institutes of Health Research MOP133620, (G.K.), the University Health Network Multi-Organ Transplant Program Academic Enrichment Fund (sponsored by Astellas Pharma Canada), Alagille Syndrome Alliance, SickKids Research Institute, Rare Disease Foundation and the Childhood Liver Disease Research and Education Network, U01 DK062453 (Sokol) from the National Institute of Diabetes, Digestive and Kidney Diseases (B.M.K. and A.G.) and the Canadian Institutes of Health Research (MOP:97954 and GPG:102171 to C.E.B.).	Cardinale V, 2011, HEPATOLOGY, V54, P2159, DOI 10.1002/hep.24590; Clotman F, 2005, GENE DEV, V19, P1849, DOI 10.1101/gad.340305; Dekkers JF, 2013, NAT MED, V19, P939, DOI 10.1038/nm.3201; Dianat N, 2014, HEPATOLOGY, V60, P700, DOI 10.1002/hep.27165; Dorrell C, 2011, DIABETOLOGIA, V54, P2832, DOI 10.1007/s00125-011-2283-5; Eckford PDW, 2012, J BIOL CHEM, V287, P36639, DOI 10.1074/jbc.M112.393637; Fernandez-Sanchez V, 2011, BLOOD CELL MOL DIS, V47, P205, DOI 10.1016/j.bcmd.2011.08.003; Geisler F, 2008, HEPATOLOGY, V48, P607, DOI 10.1002/hep.22381; Gouon-Evans V, 2006, NAT BIOTECHNOL, V24, P1402, DOI 10.1038/nbt1258; Hofmann JJ, 2010, DEVELOPMENT, V137, P4061, DOI 10.1242/dev.052118; Hotta A, 2009, NAT PROTOC, V4, P1828, DOI 10.1038/nprot.2009.201; Irion S, 2007, NAT BIOTECHNOL, V25, P1477, DOI 10.1038/nbt1362; Kamath BM, 2012, LIVER TRANSPLANT, V18, P940, DOI 10.1002/lt.23437; Kamath BM, 2012, J MED GENET, V49, P138, DOI 10.1136/jmedgenet-2011-100544; Kennedy M, 2007, BLOOD, V109, P2679, DOI 10.1182/blood-2006-09-047704; Kodama Y, 2004, GASTROENTEROLOGY, V127, P1775, DOI 10.1053/j.gastro.2004.09.004; Leeuwen L, 2014, PAEDIATR RESPIR REV, V15, P69, DOI 10.1016/j.prrv.2013.05.001; Lehar SM, 2005, BLOOD, V105, P1440, DOI 10.1182/blood-2004-08-3257; Li LH, 1997, NAT GENET, V16, P243, DOI 10.1038/ng0797-243; Ludtke THW, 2009, HEPATOLOGY, V49, P969, DOI 10.1002/hep.22700; McDaniell R, 2006, AM J HUM GENET, V79, P169, DOI 10.1086/505332; Molinski S, 2012, FRONT PHARMACOL, V3, DOI 10.3389/fphar.2012.00160; Nostro MC, 2008, CELL STEM CELL, V2, P60, DOI 10.1016/j.stem.2007.10.011; Nostro MC, 2011, DEVELOPMENT, V138, P861, DOI 10.1242/dev.055236; O'Hara SP, 2013, J HEPATOL, V58, P575, DOI 10.1016/j.jhep.2012.10.011; Ogawa S, 2013, DEVELOPMENT, V140, P3285, DOI 10.1242/dev.090266; Okiyoneda T, 2013, NAT CHEM BIOL, V9, P444, DOI [10.1038/NCHEMBIO.1253, 10.1038/nchembio.1253]; Raynaud P, 2011, INT J BIOCHEM CELL B, V43, P245, DOI 10.1016/j.biocel.2009.07.020; Schmitt TM, 2002, IMMUNITY, V17, P749, DOI 10.1016/S1074-7613(02)00474-0; Si-Tayeb K, 2010, DEV CELL, V18, P175, DOI 10.1016/j.devcel.2010.01.011; Si-Tayeb K, 2010, HEPATOLOGY, V51, P297, DOI 10.1002/hep.23354; Suzuki A, 2008, DEVELOPMENT, V135, P1589, DOI 10.1242/dev.016634; Takayama K, 2014, DEVELOPMENT, V141, P91, DOI 10.1242/dev.103168; Takayama K, 2012, J HEPATOL, V57, P628, DOI 10.1016/j.jhep.2012.04.038; Tanimizu N, 2004, J CELL SCI, V117, P6425, DOI 10.1242/jcs.01572; Tanimizu N, 2004, J CELL SCI, V117, P3165, DOI 10.1242/jcs.01169; Touboul T, 2010, HEPATOLOGY, V51, P1754, DOI 10.1002/hep.23506; Turner R, 2011, HEPATOLOGY, V53, P1035, DOI 10.1002/hep.24157; Van Goor F, 2011, P NATL ACAD SCI USA, V108, P18843, DOI 10.1073/pnas.1105787108; Wong AP, 2012, NAT BIOTECHNOL, V30, P876, DOI 10.1038/nbt.2328; Yanagida A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067541; Zaret KS, 2008, SCIENCE, V322, P1490, DOI 10.1126/science.1161431; Zhao DX, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006468; Zong YW, 2009, DEVELOPMENT, V136, P1727, DOI 10.1242/dev.029140	44	185	189	4	51	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156	1546-1696		NAT BIOTECHNOL	Nat. Biotechnol.	AUG	2015	33	8					853	+		10.1038/nbt.3294	http://dx.doi.org/10.1038/nbt.3294			11	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	CO6OB	26167630				2022-12-27	WOS:000359274900025
J	Waltz, E				Waltz, Emily			Oxitec trials GM sterile moth to combat agricultural infestations	NATURE BIOTECHNOLOGY			English	News Item																		2015, PLOS NEGL TROP DIS, V9, P3864; 2012, J ECON ENTOM, V105, P1115; 2011, NAT BIOTECHNOL, V29, P9	3	2	2	0	5	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156	1546-1696		NAT BIOTECHNOL	Nat. Biotechnol.	AUG	2015	33	8					792	793		10.1038/nbt0815-792c	http://dx.doi.org/10.1038/nbt0815-792c			4	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	CO6OB	26252124				2022-12-27	WOS:000359274900007
J	Greenbaum, D				Greenbaum, Dov			Expanding ELSI to all areas of innovative science and technology	NATURE BIOTECHNOLOGY			English	Editorial Material							BIOETHICS; ETHICS; POLICY		[Greenbaum, Dov] Zvi Meitar Inst Legal Implicat Emerging Technol, Radzyner Law Sch, Interdisciplinary Ctr, Herzliyya, Israel; [Greenbaum, Dov] Yale Univ, Sch Med, Dept Mol Biophys & Biochem, New Haven, CT 06510 USA	Reichman University; Yale University	Greenbaum, D (corresponding author), Zvi Meitar Inst Legal Implicat Emerging Technol, Radzyner Law Sch, Interdisciplinary Ctr, Herzliyya, Israel.	dov.greenbaum@yale.edu	Greenbaum, Dov/ABG-8539-2021	Greenbaum, Dov/0000-0003-4440-3090				BERG P, 1975, P NATL ACAD SCI USA, V72, P1981, DOI 10.1073/pnas.72.6.1981; BERG P, 1995, P NATL ACAD SCI USA, V92, P9011, DOI 10.1073/pnas.92.20.9011; Booth JM, 2004, GENETICS, V168, P1111, DOI 10.1534/genetics.103.023077; Caulfield T, 2013, GENOME MED, V5, DOI 10.1186/gm425; Greenbaum D., 2008, VANDERBILT J ENTERTA, V11, P249; Greenbaum Dov, 2013, Frontiers in Genetics, V4, P158, DOI 10.3389/fgene.2013.00158; Guyer RL, 2004, AM J BIOETHICS, V4, pW14, DOI 10.1080/15265160490908022; Hyman S.E., 2010, AJOB NEUROSCI, V1, P9; Kathy W., 2015, AAAS QUESTIONNAIRE M; Klein E., 2010, AJOB NEUROSCIENCE, V1, P3, DOI DOI 10.1080/21507740.2010.510821; Miller J, 2012, CAMB Q HEALTHC ETHIC, V21, P409, DOI 10.1017/S0963180112000187; Pearce R., 2009, BIOSCIENCE ED, V13, P1, DOI [10.3108/beej.13.1, DOI 10.3108/BEEJ.13.1]; Schick A., 2014, THESIS MICHIGAN STAT; Seltzer D, 2011, J RES ADMIN, V42, P15; Turner L, 2003, NAT BIOTECHNOL, V21, P1282, DOI 10.1038/nbt1103-1282; Walker RL, 2012, GENET MED, V14, P259, DOI 10.1038/gim.2011.60; Yarborough M, 2013, CTS-CLIN TRANSL SCI, V6, P201, DOI 10.1111/cts.12035	17	8	8	0	8	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156	1546-1696		NAT BIOTECHNOL	Nat. Biotechnol.	APR	2015	33	4					425	426		10.1038/nbt.3193	http://dx.doi.org/10.1038/nbt.3193			2	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	CF2AE	25850063				2022-12-27	WOS:000352348500031
J	Yang, W				Yang, Walter			2014-the biotech bull rages on	NATURE BIOTECHNOLOGY			English	Editorial Material																			0	1	1	0	0	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156	1546-1696		NAT BIOTECHNOL	Nat. Biotechnol.	FEB	2015	33	2					123	123		10.1038/nbt.3151	http://dx.doi.org/10.1038/nbt.3151			1	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	VB8QK	25658268	Bronze			2022-12-27	WOS:000419589500001
J	Maury, Y; Come, J; Piskorowski, RA; Salah-Mohellibi, N; Chevaleyre, V; Peschanski, M; Martinat, C; Nedelec, S				Maury, Yves; Come, Julien; Piskorowski, Rebecca A.; Salah-Mohellibi, Nouzha; Chevaleyre, Vivien; Peschanski, Marc; Martinat, Cecile; Nedelec, Stephane			Combinatorial analysis of developmental cues efficiently converts human pluripotent stem cells into multiple neuronal subtypes	NATURE BIOTECHNOLOGY			English	Article							HUMAN ES; DOPAMINE NEURONS; MOTOR-NEURONS; SPECIFICATION; DIFFERENTIATION; INHIBITION; GENERATION; HINDBRAIN; REVEAL; MOTONEURONS	Specification of cell identity during development depends on exposure of cells to sequences of extrinsic cues delivered at precise times and concentrations. Identification of combinations of patterning molecules that control cell fate is essential for the effective use of human pluripotent stem cells (hPSCs) for basic and translational studies. Here we describe a scalable, automated approach to systematically test the combinatorial actions of small molecules for the targeted differentiation of hPSCs. Applied to the generation of neuronal subtypes, this analysis revealed an unappreciated role for canonical Wnt signaling in specifying motor neuron diversity from hPSCs and allowed us to define rapid (14 days), efficient procedures to generate spinal and cranial motor neurons as well as spinal interneurons and sensory neurons. Our systematic approach to improving hPSC-targeted differentiation should facilitate disease modeling studies and drug screening assays.	[Maury, Yves; Come, Julien] CECS, I STEM Inst Stem Cell Therapy & Explorat Monogen, AFM, Evry, France; [Piskorowski, Rebecca A.; Chevaleyre, Vivien] Sorbonne Paris Cite, Univ Paris Descartes, CNRS, UMR 8118, Paris, France; [Salah-Mohellibi, Nouzha; Peschanski, Marc; Martinat, Cecile; Nedelec, Stephane] INSERM, UEVE UMR 861, Evry, France	UDICE-French Research Universities; Universite Paris Saclay; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universite Paris Cite; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Saclay	Nedelec, S (corresponding author), INSERM, UEVE UMR 861, 1-STEM,AFM, Evry, France.	stephane.nedelec@inserm.fr	Peschanski, Marc/N-5769-2017; Piskorowski, Rebecca Ann/G-6610-2017; Nedelec, Stéphane/G-8469-2017; Martinat, Cécile S/F-6777-2010	Piskorowski, Rebecca Ann/0000-0003-0120-2360; Nedelec, Stéphane/0000-0001-8044-2498; Martinat, Cécile S/0000-0002-5234-1064; come, julien/0000-0001-9519-2436; Chevaleyre, Vivien/0000-0002-3679-4856	AFM	AFM(Association Francaise contre les Myopathies)	I-Stem is part of the Biotherapies Institute for Rare Diseases (BIRD) supported by the Association Fran~aise contre les Myopathies (AFM-Tlthon). This project was funded by AFM, INSERM and Laboratoire d'Excellence " Labex Revive" (Investissement d'Avenir; ANR-10-LABX-73). S. N. is currently supported by the " Labex Revive" and was previously supported by a fellowship from the Genopole. N. S.-M. was supported by the program INGESTEM (investissement d'avenir ANR-11-INBS-009-01). R. A. P. and V. C. are supported by ATIP-Avenir, Agence Nationale de la Recherche (ANR-12-BSV4-0021-01, ANR-13-JSV4-0002-01) and the Ville de Paris. We thank C. Varela and N. Lefort (I-STEM) for karyotyping the cell lines and L. Aubry (I-STEM) for providing the IMR90 hiPSC line. We thank H. Wichterle, F. Giudicelli, V. Ribes, E. O. Mazzoni and A. Rebsam for helpful discussion and critical review of the manuscript. We thank J.-F. Brunet for providing the Phox2b antibody, E. R. Lowry and H. Wichterle (Columbia University) for testing the sMN differentiation and for the Hb9oGFP-Neomycin plasmid. We thank D. Furling (Institute of Myology) for providing human primary myoblasts.	Amoroso MW, 2013, J NEUROSCI, V33, P574, DOI 10.1523/JNEUROSCI.0906-12.2013; Bialecka M, 2012, DEV BIOL, V371, P227, DOI 10.1016/j.ydbio.2012.08.018; Bonanomi D, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a001735; Bone HK, 2011, J CELL SCI, V124, P1992, DOI 10.1242/jcs.081679; Borghese L, 2010, STEM CELLS, V28, P955, DOI 10.1002/stem.408; Chambers SM, 2009, NAT BIOTECHNOL, V27, P275, DOI 10.1038/nbt.1529; Chen H, 2014, CELL STEM CELL, V14, P796, DOI 10.1016/j.stem.2014.02.004; Dasen JS, 2008, CELL, V134, P304, DOI 10.1016/j.cell.2008.06.019; Dasen JS, 2009, CURR TOP DEV BIOL, V88, P169, DOI 10.1016/S0070-2153(09)88006-X; Di Giorgio FP, 2008, CELL STEM CELL, V3, P637, DOI 10.1016/j.stem.2008.09.017; Elkabetz Y, 2008, GENE DEV, V22, P152, DOI 10.1101/gad.1616208; Gouti M, 2014, PLOS BIOL, V12, DOI 10.1371/journal.pbio.1001937; Guthrie S, 2007, NAT REV NEUROSCI, V8, P859, DOI 10.1038/nrn2254; Kanning KC, 2010, ANNU REV NEUROSCI, V33, P409, DOI 10.1146/annurev.neuro.051508.135722; Kirkeby A, 2012, CELL REPORTS, V1, P703, DOI 10.1016/j.celrep.2012.04.009; Kriks S, 2011, NATURE, V480, P547, DOI 10.1038/nature10648; Lee SK, 2003, NEURON, V38, P731, DOI 10.1016/S0896-6273(03)00296-4; Lefort N, 2008, NAT BIOTECHNOL, V26, P1364, DOI 10.1038/nbt.1509; Li XJ, 2005, NAT BIOTECHNOL, V23, P215, DOI 10.1038/nbt1063; Lumsden A, 1996, SCIENCE, V274, P1109, DOI 10.1126/science.274.5290.1109; Marklund U, 2014, STEM CELLS DEV, V23, P5, DOI 10.1089/scd.2013.0309; Marteyn A, 2011, CELL STEM CELL, V8, P434, DOI 10.1016/j.stem.2011.02.004; Masuda T, 2008, J NEUROSCI, V28, P10380, DOI 10.1523/JNEUROSCI.1926-08.2008; Mazzoni EO, 2013, NAT NEUROSCI, V16, P1191, DOI 10.1038/nn.3490; Mazzoni EO, 2013, NAT NEUROSCI, V16, P1219, DOI 10.1038/nn.3467; Mendjan S, 2014, CELL STEM CELL, V15, P310, DOI 10.1016/j.stem.2014.06.006; Merkle FT, 2013, CELL STEM CELL, V12, P656, DOI 10.1016/j.stem.2013.05.016; Miles GB, 2004, J NEUROSCI, V24, P7848, DOI 10.1523/JNEUROSCI.1972-04.2004; Nedelec S, 2012, J NEUROSCI, V32, P1496, DOI 10.1523/JNEUROSCI.4176-11.2012; Nimchinsky EA, 2000, J COMP NEUROL, V416, P112, DOI 10.1002/(SICI)1096-9861(20000103)416:1<112::AID-CNE9>3.0.CO;2-K; Nordstrom U, 2006, PLOS BIOL, V4, P1438, DOI 10.1371/journal.pbio.0040252; Pattyn A, 2000, DEVELOPMENT, V127, P1349; Peljto M, 2011, CURR OPIN NEUROBIOL, V21, P43, DOI 10.1016/j.conb.2010.09.012; Perrimon N, 2012, CSH PERSPECT BIOL, V4, DOI 10.1101/cshperspect.a005975; Ribes V, 2009, CSH PERSPECT BIOL, V1, DOI 10.1101/cshperspect.a002014; Sandoe J, 2013, NAT NEUROSCI, V16, P780, DOI 10.1038/nn.3425; Sathasivam S, 2008, ORPHANET J RARE DIS, V3, DOI 10.1186/1750-1172-3-9; Skromne I, 2007, DEVELOPMENT, V134, P2147, DOI 10.1242/dev.002980; Song MR, 2006, DEVELOPMENT, V133, P4945, DOI 10.1242/dev.02694; Sturgeon K, 2011, DEVELOPMENT, V138, P65, DOI 10.1242/dev.058727; Takahashi K, 2007, CELL, V131, P861, DOI 10.1016/j.cell.2007.11.019; Tzouanacou E, 2009, DEV CELL, V17, P365, DOI 10.1016/j.devcel.2009.08.002; VarelaEchavarria A, 1997, NEURON, V18, P193, DOI 10.1016/S0896-6273(00)80261-5; Wichterle H, 2002, CELL, V110, P385, DOI 10.1016/S0092-8674(02)00835-8; Wichterle H, 2010, NAT NEUROSCI, V13, P800, DOI 10.1038/nn.2577; Wilson V, 2009, DEVELOPMENT, V136, P1591, DOI 10.1242/dev.021246; Xi JJ, 2012, STEM CELLS, V30, P1655, DOI 10.1002/stem.1152; Yu JY, 2007, SCIENCE, V318, P1917, DOI 10.1126/science.1151526	48	206	213	1	76	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156	1546-1696		NAT BIOTECHNOL	Nat. Biotechnol.	JAN	2015	33	1					89	U270		10.1038/nbt.3049	http://dx.doi.org/10.1038/nbt.3049			10	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	AY7AR	25383599				2022-12-27	WOS:000347714200032
J	Peng, X; Alfoldi, J; Gori, K; Eisfeld, AJ; Tyler, SR; Tisoncik-Go, J; Brawand, D; Law, GL; Skunca, N; Hatta, M; Gasper, DJ; Kelly, SM; Chang, J; Thomas, MJ; Johnson, J; Berlin, AM; Lara, M; Russell, P; Swofford, R; Turner-Maier, J; Young, S; Hourlier, T; Aken, B; Searle, S; Sun, XS; Yi, YL; Suresh, M; Tumpey, TM; Siepel, A; Wisely, SM; Dessimoz, C; Kawaoka, Y; Birren, BW; Lindblad-Toh, K; Di Palma, F; Engelhardt, JF; Palermo, RE; Katze, MG				Peng, Xinxia; Alfoeldi, Jessica; Gori, Kevin; Eisfeld, Amie J.; Tyler, Scott R.; Tisoncik-Go, Jennifer; Brawand, David; Law, G. Lynn; Skunca, Nives; Hatta, Masato; Gasper, David J.; Kelly, Sara M.; Chang, Jean; Thomas, Matthew J.; Johnson, Jeremy; Berlin, Aaron M.; Lara, Marcia; Russell, Pamela; Swofford, Ross; Turner-Maier, Jason; Young, Sarah; Hourlier, Thibaut; Aken, Bronwen; Searle, Steve; Sun, Xingshen; Yi, Yaling; Suresh, M.; Tumpey, Terrence M.; Siepel, Adam; Wisely, Samantha M.; Dessimoz, Christophe; Kawaoka, Yoshihiro; Birren, Bruce W.; Lindblad-Toh, Kerstin; Di Palma, Federica; Engelhardt, John F.; Palermo, Robert E.; Katze, Michael G.			The draft genome sequence of the ferret (Mustela putorius furo) facilitates study of human respiratory disease	NATURE BIOTECHNOLOGY			English	Article							CYSTIC-FIBROSIS; INFLUENZA-VIRUS; RNA; EXPRESSION; TRACT; ANNOTATION; PHENOTYPE; INFECTION; IMMUNITY; MODELS	The domestic ferret (Mustela putorius furo) is an important animal model for multiple human respiratory diseases. It is considered the 'gold standard' for modeling human influenza virus infection and transmission(1-)4. Here we describe the 2.41 Gb draft genome assembly of the domestic ferret, constituting 2.28 Gb of sequence plus gaps. We annotated 19,910 protein-coding genes on this assembly using RNA-seq data from 21 ferret tissues. We characterized the ferret host response to two influenza virus infections by RNA-seq analysis of 42 ferret samples from influenza time-course data and showed distinct signatures in ferret trachea and lung tissues specific to 1918 or 2009 human pandemic influenza virus infections. Using microarray data from 16 ferret samples reflecting cystic fibrosis disease progression, we showed that transcriptional changes in the CFTR-knockout ferret lung reflect pathways of early disease that cannot be readily studied in human infants with cystic fibrosis disease.	[Peng, Xinxia; Tisoncik-Go, Jennifer; Law, G. Lynn; Kelly, Sara M.; Chang, Jean; Thomas, Matthew J.; Katze, Michael G.] Univ Washington, Dept Microbiol, Seattle, WA 98195 USA; [Alfoeldi, Jessica; Brawand, David; Johnson, Jeremy; Berlin, Aaron M.; Lara, Marcia; Russell, Pamela; Swofford, Ross; Turner-Maier, Jason; Young, Sarah; Birren, Bruce W.; Lindblad-Toh, Kerstin; Di Palma, Federica] Broad Inst MIT & Harvard, Cambridge, MA USA; [Gori, Kevin; Dessimoz, Christophe] European Bioinformat Inst, European Mol Biol Lab, Cambridge, England; [Eisfeld, Amie J.; Hatta, Masato; Gasper, David J.; Suresh, M.; Kawaoka, Yoshihiro] Univ Wisconsin, Sch Vet Med, Dept Pathobiol Sci, Madison, WI 53706 USA; [Tyler, Scott R.; Sun, Xingshen; Yi, Yaling; Engelhardt, John F.] Univ Iowa, Dept Anat & Cell Biol, Carver Coll Med, Iowa City, IA USA; [Tyler, Scott R.] Univ Iowa, Carver Coll Med, Mol & Cellular Biol Program, Iowa City, IA USA; [Skunca, Nives] ETH, Swiss Fed Inst Technol, Dept Comp Sci, Zurich, Switzerland; [Skunca, Nives] Swiss Inst Bioinformat, Zurich, Switzerland; [Hourlier, Thibaut; Aken, Bronwen; Searle, Steve] Wellcome Trust Sanger Inst, Cambridge, England; [Tumpey, Terrence M.] Ctr Dis Control & Prevent, Atlanta, GA USA; [Siepel, Adam] Cornell Univ, Dept Biol Stat & Computat Biol, Ithaca, NY USA; [Wisely, Samantha M.] Univ Florida, Dept Wildlife Ecol & Conservat, Gainesville, FL USA; [Dessimoz, Christophe] UCL, Dept Genet Evolut & Environm, London, England; [Dessimoz, Christophe] UCL, Dept Comp Sci, London, England; [Kawaoka, Yoshihiro] Japan Sci & Technol Agcy, ERATO Infect Induced Host Responses Project, Saitama, Japan; [Kawaoka, Yoshihiro] Univ Tokyo, Inst Med Sci, Dept Microbiol & Immunol, Div Virol, Tokyo, Japan; [Kawaoka, Yoshihiro] Univ Tokyo, Inst Med Sci, Int Res Ctr Infect Dis, Dept Special Pathogens,Minato Ku, Tokyo, Japan; [Kawaoka, Yoshihiro] Kyoto Univ, Inst Virus Res, Dept Biol Responses, Lab Bioresponses Regulat, Kyoto 606, Japan; [Lindblad-Toh, Kerstin] Uppsala Univ, Dept Med Biochem & Microbiol, Uppsala, Sweden; [Engelhardt, John F.] Univ Iowa, Carver Coll Med, Ctr Gene Therapy, Iowa City, IA USA; [Katze, Michael G.] Washington Natl Primate Res Ctr, Seattle, WA USA	University of Washington; University of Washington Seattle; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; European Molecular Biology Laboratory (EMBL); University of Wisconsin System; University of Wisconsin Madison; University of Iowa; University of Iowa; Swiss Federal Institutes of Technology Domain; ETH Zurich; Swiss Institute of Bioinformatics; Wellcome Trust Sanger Institute; Centers for Disease Control & Prevention - USA; Cornell University; State University System of Florida; University of Florida; University of London; University College London; University of London; University College London; Japan Science & Technology Agency (JST); University of Tokyo; University of Tokyo; Kyoto University; Uppsala University; University of Iowa	Katze, MG (corresponding author), Univ Washington, Dept Microbiol, Seattle, WA 98195 USA.	palermor@uw.edu; honey@uw.edu	Berlin, Aaron M/AFY-6549-2022; Dessimoz, Christophe/D-3678-2011	Berlin, Aaron M/0000-0002-0714-2808; Dessimoz, Christophe/0000-0002-2170-853X; Hourlier, Thibaut/0000-0003-4894-7773; Siepel, Adam/0000-0002-3557-7219; Di-Palma, Federica/0000-0002-4394-0102; Eisfeld, Amie/0000-0003-2231-3107; Aken, Bronwen/0000-0002-3032-4095; Gori, Kevin/0000-0001-7975-4275; Engelhardt, John/0000-0003-2389-9277; Russell, Pamela/0000-0003-2997-6392; Swofford, Ross/0000-0003-3676-8479; Brawand, David/0000-0002-0357-3520; Suresh, Marulasiddappa/0000-0003-1794-3358	National Institute of Allergy and Infectious Diseases, National Institutes of Health (NIH), Department of Health and Human Services [HHSN272200800060C, HHSN272201400005C, HHSN272200900018C]; Public Health Service Grant [P51OD010425]; NIH Office of the Director [9T32OD010423-06, 5T32RR023916-05]; NIH National Institute of Diabetes and Digestive and Kidney Diseases [R37 DK047967, R24 DK096518, P30 DK054759]; National Heart, Lung, and Blood Institute [R01 HL108902]; SNSF [136461]; NIH National Institute of General Medical Sciences [R01 GM102192]; EURYI ERC; BBSRC [BBS/E/T/000PR5885, BBS/E/T/000PR6193] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BBS/E/T/000PR5885, BBS/E/T/000PR6193] Funding Source: researchfish; NATIONAL CENTER FOR RESEARCH RESOURCES [T32RR023916] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL108902, R24HL123482] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U19AI110818] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R37DK047967, P30DK054759, R24DK096518] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P30ES005605] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM102192] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [P51OD010425, T32OD010423] Funding Source: NIH RePORTER	National Institute of Allergy and Infectious Diseases, National Institutes of Health (NIH), Department of Health and Human Services(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Public Health Service Grant(United States Department of Health & Human ServicesUnited States Public Health Service); NIH Office of the Director(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH National Institute of Diabetes and Digestive and Kidney Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); National Heart, Lung, and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); SNSF(Swiss National Science Foundation (SNSF)); NIH National Institute of General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); EURYI ERC; BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This project was funded in whole or in part with federal funds from the National Institute of Allergy and Infectious Diseases, National Institutes of Health (NIH), Department of Health and Human Services, under Contract Nos. HHSN272200800060C and HHSN272201400005C and Public Health Service Grant P51OD010425 (M.G.K.). For the Broad Institute of MIT and Harvard, this project was funded in whole or in part with federal funds from the National Institute of Allergy and Infectious Diseases, National Institutes of Health, Department of Health and Human Services, under Contract No. HHSN272200900018C. D.J.G. also received training grants 9T32OD010423-06 and 5T32RR023916-05 from the NIH Office of the Director. J.F.E., S.R.T., X.S. and Y.Y. (University of Iowa) were supported under the NIH National Institute of Diabetes and Digestive and Kidney Diseases grants R37 DK047967, R24 DK096518 and P30 DK054759, and National Heart, Lung, and Blood Institute grant R01 HL108902. C.D. acknowledges support by SNSF advanced researcher fellowship (#136461). A.S. receives support under NIH National Institute of General Medical Sciences R01 GM102192. For S.S., B.A. and T.H., the Wellcome Trust Sanger Institute is operated by Genome Research Limited, a charity registered in England with number 1021457 and a company registered in England with number 2742969. K.L.-T. also receives support under EURYI ERC. We thank Marshall Farms, New York, for providing three adult sable female ferrets (M. putorius furo; 421 days old).	Altenhoff AM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053786; Altenhoff AM, 2011, NUCLEIC ACIDS RES, V39, pD289, DOI 10.1093/nar/gkq1238; Apweiler R, 2013, NUCLEIC ACIDS RES, V41, pD43, DOI 10.1093/nar/gks1068; Belser JA, 2011, DIS MODEL MECH, V4, P575, DOI 10.1242/dmm.007823; BONFIELD TL, 1995, AM J RESP CRIT CARE, V152, P2111, DOI 10.1164/ajrccm.152.6.8520783; Cabili MN, 2011, GENE DEV, V25, P1915, DOI 10.1101/gad.17446611; Cavagna P, 2000, MAMM GENOME, V11, P866, DOI 10.1007/s003350010172; Ciofani M, 2012, CELL, V151, P289, DOI 10.1016/j.cell.2012.09.016; Ciofu O, 2013, CURR OPIN PULM MED, V19, P251, DOI 10.1097/MCP.0b013e32835f1afc; Curwen V, 2004, GENOME RES, V14, P942, DOI 10.1101/gr.1858004; Dobin A, 2013, BIOINFORMATICS, V29, P15, DOI 10.1093/bioinformatics/bts635; Gnerre S, 2011, P NATL ACAD SCI USA, V108, P1513, DOI 10.1073/pnas.1017351108; GONNET GH, 1992, SCIENCE, V256, P1443, DOI 10.1126/science.1604319; Grabherr MG, 2011, NAT BIOTECHNOL, V29, P644, DOI 10.1038/nbt.1883; Guindon S, 2010, SYST BIOL, V59, P307, DOI 10.1093/sysbio/syq010; Levin JZ, 2010, NAT METHODS, V7, P709, DOI [10.1038/NMETH.1491, 10.1038/nmeth.1491]; Marsolais D, 2009, P NATL ACAD SCI USA, V106, P1560, DOI 10.1073/pnas.0812689106; McCarthy DJ, 2012, NUCLEIC ACIDS RES, V40, P4288, DOI 10.1093/nar/gks042; Neill DR, 2010, NATURE, V464, P1367, DOI 10.1038/nature08900; Neumann G, 1999, P NATL ACAD SCI USA, V96, P9345, DOI 10.1073/pnas.96.16.9345; Ogilvie V, 2011, GENOMICS, V98, P327, DOI 10.1016/j.ygeno.2011.06.008; Olivier AK, 2012, J CLIN INVEST, V122, P3755, DOI 10.1172/JCI60610; Ouborg NJ, 2010, TRENDS GENET, V26, P177, DOI 10.1016/j.tig.2010.01.001; Ozawa M, 2011, J VIROL, V85, P4596, DOI 10.1128/JVI.00029-11; Rebhan M, 1997, TRENDS GENET, V13, P163, DOI 10.1016/S0168-9525(97)01103-7; Schrauwen EJA, 2011, EMERG INFECT DIS, V17, P200, DOI 10.3201/eid1702.101268; Stamatakis A, 2006, BIOINFORMATICS, V22, P2688, DOI 10.1093/bioinformatics/btl446; Su AI, 2004, P NATL ACAD SCI USA, V101, P6062, DOI 10.1073/pnas.0400782101; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Sun XS, 2014, AM J RESP CELL MOL, V50, P502, DOI 10.1165/rcmb.2013-0261OC; Sun XS, 2010, J CLIN INVEST, V120, P3149, DOI 10.1172/JCI43052; Trapnell C, 2010, NAT BIOTECHNOL, V28, P511, DOI 10.1038/nbt.1621; Tripp RA, 2009, CURR TOP MICROBIOL, V333, P397, DOI 10.1007/978-3-540-92165-3_19; van Riel D, 2006, SCIENCE, V312, P399, DOI 10.1126/science.1125548; van Riel D, 2007, AM J PATHOL, V171, P1215, DOI 10.2353/ajpath.2007.070248; Walsh KB, 2011, P NATL ACAD SCI USA, V108, P12018, DOI 10.1073/pnas.1107024108; Wang XD, 2006, CELL, V127, P803, DOI 10.1016/j.cell.2006.09.043; Watanabe T, 2009, P NATL ACAD SCI USA, V106, P588, DOI 10.1073/pnas.0806959106; Wisely SM, 2003, ZOO BIOL, V22, P287, DOI 10.1002/zoo.10089; Wisely SM, 2002, J HERED, V93, P231, DOI 10.1093/jhered/93.4.231; Wolk K, 2008, J LEUKOCYTE BIOL, V83, P1181, DOI 10.1189/jlb.0807525; Wu TD, 2005, BIOINFORMATICS, V21, P1859, DOI 10.1093/bioinformatics/bti310	42	82	83	0	15	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156	1546-1696		NAT BIOTECHNOL	Nat. Biotechnol.	DEC	2014	32	12					1250	U114		10.1038/nbt.3079	http://dx.doi.org/10.1038/nbt.3079			10	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	AW3AD	25402615	Green Published, hybrid, Green Accepted			2022-12-27	WOS:000346156800027
J	Lyon, RP; Setter, JR; Bovee, TD; Doronina, SO; Hunter, JH; Anderson, ME; Balasubramanian, CL; Duniho, SM; Leiske, CI; Li, F; Senter, PD				Lyon, Robert P.; Setter, Jocelyn R.; Bovee, Tim D.; Doronina, Svetlana O.; Hunter, Joshua H.; Anderson, Martha E.; Balasubramanian, Cindy L.; Duniho, Steven M.; Leiske, Chris I.; Li, Fu; Senter, Peter D.			Self-hydrolyzing maleimides improve the stability and pharmacological properties of antibody-drug conjugates	NATURE BIOTECHNOLOGY			English	Article							ANTITUMOR-ACTIVITY; CANCER-THERAPY; TRASTUZUMAB EMTANSINE; LINKER STABILITY; BREAST-CANCER; IN-VITRO; SITE; POTENT; PIPELINE; CYSTEINE	Many antibody-drug conjugates (ADCs) are unstable in vivo because they are formed from maleimide-containing components conjugated to reactive thiols. These thiosuccinimide linkages undergo two competing reactions in plasma: elimination of the maleimide through a retro-Michael reaction, which results in loss of drug-linker from the ADC, and hydrolysis of the thiosuccinimide ring, which results in a derivative that is resistant to the elimination reaction. In an effort to create linker technologies with improved stability characteristics, we used diaminopropionic acid (DPR) to prepare a drug-linker incorporating a basic amino group adjacent to the maleimide, positioned to provide intramolecular catalysis of thiosuccinimide ring hydrolysis. This basic group induces the thiosuccinimide to undergo rapid hydrolysis at neutral pH and room temperature. Once hydrolyzed, the drug-linker is no longer subject to maleimide elimination reactions, preventing nonspecific deconjugation. In vivo studies demonstrate that the increased stability characteristics can lead to improved ADC antitumor activity and reduced neutropenia.	[Lyon, Robert P.; Setter, Jocelyn R.; Bovee, Tim D.; Doronina, Svetlana O.; Hunter, Joshua H.; Anderson, Martha E.; Balasubramanian, Cindy L.; Duniho, Steven M.; Leiske, Chris I.; Li, Fu; Senter, Peter D.] Seattle Genet, Bothell, WA 98021 USA	Seattle Genetics	Lyon, RP (corresponding author), Seattle Genet, Bothell, WA 98021 USA.	rlyon@seagen.com						Agarwal P, 2013, P NATL ACAD SCI USA, V110, P46, DOI 10.1073/pnas.1213186110; Alley SC, 2008, BIOCONJUGATE CHEM, V19, P759, DOI 10.1021/bc7004329; Badescu G, 2014, BIOCONJUGATE CHEM, V25, P460, DOI 10.1021/bc400245v; Baldwin AD, 2011, BIOCONJUGATE CHEM, V22, P1946, DOI 10.1021/bc200148v; Chari RVJ, 2014, ANGEW CHEM INT EDIT, V53, P3796, DOI 10.1002/anie.201307628; Chudasama VL, 2012, CLIN PHARMACOL THER, V92, P520, DOI 10.1038/clpt.2012.153; Doronina SO, 2003, NAT BIOTECHNOL, V21, P778, DOI 10.1038/nbt832; Dubowchik GM, 2002, BIOCONJUGATE CHEM, V13, P855, DOI 10.1021/bc025536j; Francisco JA, 2003, BLOOD, V102, P1458, DOI 10.1182/blood-2003-01-0039; Hamblett KJ, 2004, CLIN CANCER RES, V10, P7063, DOI 10.1158/1078-0432.CCR-04-0789; Hermanson GT, 2008, BIOCONJUGATE TECHNIQUES, 2ND EDITION, P1, DOI 10.1016/B978-0-12-370501-3.00001-1; Jeffrey SC, 2013, BIOCONJUGATE CHEM, V24, P1256, DOI 10.1021/bc400217g; Kalia J, 2007, BIOORG MED CHEM LETT, V17, P6286, DOI 10.1016/j.bmcl.2007.09.002; KNIGHT P, 1979, BIOCHEM J, V179, P191, DOI 10.1042/bj1790191; Lyon RP, 2012, METHOD ENZYMOL, V502, P123, DOI 10.1016/B978-0-12-416039-2.00006-9; Mullard A, 2013, NAT REV DRUG DISCOV, V12, P329, DOI 10.1038/nrd4009; Okeley NM, 2014, HEMATOL ONCOL CLIN N, V28, P13, DOI 10.1016/j.hoc.2013.10.009; Peddi PF, 2013, FUTURE ONCOL, V9, P319, DOI [10.2217/fon.13.7, 10.2217/FON.13.7]; Ryan CP, 2011, CHEM COMMUN, V47, P5452, DOI 10.1039/c1cc11114k; Sanderson RJ, 2005, CLIN CANCER RES, V11, P843; Sassoon I, 2013, METHODS MOL BIOL, V1045, P1, DOI 10.1007/978-1-62703-541-5_1; Senter PD, 2012, NAT BIOTECHNOL, V30, P631, DOI 10.1038/nbt.2289; Shen BQ, 2012, NAT BIOTECHNOL, V30, P184, DOI 10.1038/nbt.2108; Sievers EL, 2013, ANNU REV MED, V64, P15, DOI 10.1146/annurev-med-050311-201823; Strop P, 2013, CHEM BIOL, V20, P161, DOI 10.1016/j.chembiol.2013.01.010; Sun MMC, 2005, BIOCONJUGATE CHEM, V16, P1282, DOI 10.1021/bc050201y; Tian F, 2014, P NATL ACAD SCI USA, V111, P1766, DOI 10.1073/pnas.1321237111; Toda N, 2013, ANGEW CHEM INT EDIT, V52, P12592, DOI 10.1002/anie.201306241; Wahl AF, 2002, CANCER RES, V62, P3736; Zolot RS, 2013, NAT REV DRUG DISCOV, V12, P259, DOI 10.1038/nrd3980	30	277	314	13	173	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156	1546-1696		NAT BIOTECHNOL	Nat. Biotechnol.	OCT	2014	32	10					1059	+		10.1038/nbt.2968	http://dx.doi.org/10.1038/nbt.2968			7	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	AR7MM	25194818				2022-12-27	WOS:000343763800024
J	Schouten, H				Schouten, Henk			The slippery slope of cisgenesis Reply	NATURE BIOTECHNOLOGY			English	Letter									Univ Wageningen & Res Ctr, Wageningen, Netherlands	Wageningen University & Research	Schouten, H (corresponding author), Univ Wageningen & Res Ctr, Wageningen, Netherlands.	henk.schouten@wur.nl						Andersson HC, 2012, EFSA J, V10, DOI 10.2903/j.efsa.2012.2561; [Anonymous], 2013, NAT BIOTECHNOL, V31, P767, DOI 10.1038/nbt.2700; Eriksson D, 2014, NAT BIOTECHNOL, V32, P727, DOI 10.1038/nbt.2980; Gaskell G., 2010, EUROPEANS BIOTECHNOL; Jochemsen H., 2000, TOETSEN BEGRENZEN ET; Laursen L, 2012, NAT BIOTECHNOL, V30, P562, DOI 10.1038/nbt0612-562c	6	6	6	0	10	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156	1546-1696		NAT BIOTECHNOL	Nat. Biotechnol.	AUG	2014	32	8					728	728		10.1038/nbt.2981	http://dx.doi.org/10.1038/nbt.2981			1	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	AW7PF	25101742				2022-12-27	WOS:000346455900036
J	[Anonymous]				[Anonymous]			Stabilizing prospects for a universal flu vaccine	NATURE BIOTECHNOLOGY			English	Editorial Material							HEMAGGLUTININ-STEM; INFLUENZA; VIRUS											Impagliazzo A, 2015, SCIENCE, V349, P1301, DOI 10.1126/science.aac7263; Kashyap AK, 2008, P NATL ACAD SCI USA, V105, P5986, DOI 10.1073/pnas.0801367105; Pica N, 2012, P NATL ACAD SCI USA, V109, P2573, DOI 10.1073/pnas.1200039109; Yassine HM, 2015, NAT MED, V21, P1065, DOI 10.1038/nm.3927	4	0	0	0	36	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156	1546-1696		NAT BIOTECHNOL	Nat. Biotechnol.	OCT	2015	33	10					1043	1044						3	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	CT1JX	26448088				2022-12-27	WOS:000362555700022
J	Yang, Z; Wang, SJ; Halim, A; Schulz, MA; Frodin, M; Rahman, SH; Vester-Christensen, MB; Behrens, C; Kristensen, C; Vakhrushev, SY; Bennett, EP; Wandall, HH; Clausen, H				Yang, Zhang; Wang, Shengjun; Halim, Adnan; Schulz, Morten Alder; Frodin, Morten; Rahman, Shamim H.; Vester-Christensen, Malene B.; Behrens, Carsten; Kristensen, Claus; Vakhrushev, Sergey Y.; Bennett, Eric Paul; Wandall, Hans H.; Clausen, Henrik			Engineered CHO cells for production of diverse, homogeneous glycoproteins	NATURE BIOTECHNOLOGY			English	Article							ZINC-FINGER NUCLEASES; RECOMBINANT ERYTHROPOIETIN; GLYCOSYLATION; LINES; FUT8	Production of glycoprotein therapeutics in Chinese hamster ovary (CHO) cells is limited by the cells' generic capacity for N-glycosylation, and production of glycoproteins with desirable homogeneous glycoforms remains a challenge. We conducted a comprehensive knockout screen of glycosyltransferase genes controlling N-glycosylation in CHO cells and constructed a design matrix that facilitates the generation of desired glycosylation, such as human-like alpha 2,6-linked sialic acid capping. This engineering approach will aid the production of glycoproteins with improved properties and therapeutic potential.	[Yang, Zhang; Wang, Shengjun; Halim, Adnan; Schulz, Morten Alder; Rahman, Shamim H.; Vester-Christensen, Malene B.; Kristensen, Claus; Vakhrushev, Sergey Y.; Bennett, Eric Paul; Wandall, Hans H.; Clausen, Henrik] Univ Copenhagen, Fac Hlth Sci, Ctr Glyc Cellular & Mol Med & Odontol, Copenhagen N, Denmark; [Yang, Zhang; Wang, Shengjun; Halim, Adnan; Clausen, Henrik] Danish Tech Univ, Novo Nordisk Fdn, Ctr Biosustainabil, Copenhagen, Denmark; [Frodin, Morten] Univ Copenhagen, Biotech Res & Innovat Ctr, Copenhagen, Denmark; [Rahman, Shamim H.; Vester-Christensen, Malene B.; Behrens, Carsten] Novo Nordisk AS, Malov, Denmark	University of Copenhagen; Novo Nordisk Foundation; Technical University of Denmark; University of Copenhagen; Novo Nordisk	Yang, Z (corresponding author), Univ Copenhagen, Fac Hlth Sci, Ctr Glyc Cellular & Mol Med & Odontol, Copenhagen N, Denmark.	yang@sund.ku.dk; hclau@sund.ku.dk	Bennett, Eric/AAG-6120-2020; Vakhrushev, Sergey Y/A-7638-2014; Kristensen, Claus/O-8047-2015; clausen, henrik/AAD-8016-2021; Yang, Zhang/I-8934-2016	Bennett, Eric/0000-0002-4976-0647; Vakhrushev, Sergey Y/0000-0002-0418-5765; Frodin, Morten/0000-0003-3691-9820; Kristensen, Claus/0000-0002-2594-7722; Clausen, Henrik/0000-0002-0915-5055; Yang, Zhang/0000-0002-4756-5813; Halim, Adnan/0000-0003-1629-187X; Wandall, Hans H./0000-0003-0240-9232	Novo Nordisk Foundation; Kirsten og Freddy Johansen Fonden; Mizutani Foundation; A.P. Moller og Hustru Chastine Mc-Kinney Mollers Fond til Almene Formaal; Copenhagen University Excellence Programme for Interdisciplinary Research [CDO2016]; Danish National Research Foundation [DNRF107]; Danish Councils for Strategic and Independent Research; Lundbeck Foundation [R108-2012-10312] Funding Source: researchfish; Novo Nordisk Fonden [NNF10CC1016517] Funding Source: researchfish	Novo Nordisk Foundation(Novo Nordisk FoundationNovocure Limited); Kirsten og Freddy Johansen Fonden; Mizutani Foundation; A.P. Moller og Hustru Chastine Mc-Kinney Mollers Fond til Almene Formaal; Copenhagen University Excellence Programme for Interdisciplinary Research; Danish National Research Foundation(Danmarks Grundforskningsfond); Danish Councils for Strategic and Independent Research; Lundbeck Foundation(Lundbeckfonden); Novo Nordisk Fonden(Novo Nordisk Foundation)	We would like to express our sincere gratitude to the SAFC Sigma team including K. Kayser and N. Sealover for their help with ZFN targeting constructs. We are also grateful to B. Palsson for help throughout this work and critical comments on the manuscript. We are grateful to M. Uhlen, L.E. Pedersen and B. Voldborg at the Novo Nordisk Foundation Center for Biosustainability, Danish Technical University, for RNA-seq analysis. This work was supported by the Novo Nordisk Foundation, Kirsten og Freddy Johansen Fonden, The Mizutani Foundation, A.P. Moller og Hustru Chastine Mc-Kinney Mollers Fond til Almene Formaal, Copenhagen University Excellence Programme for Interdisciplinary Research (CDO2016), the Danish National Research Foundation (DNRF107) and The Danish Councils for Strategic and Independent Research. All reagents and cell lines used in the study are available upon request for research purposes under a material transfer agreement.	Amado M, 1999, BBA-GEN SUBJECTS, V1473, P35, DOI 10.1016/S0304-4165(99)00168-3; Duda K, 2014, NUCLEIC ACIDS RES, V42, DOI 10.1093/nar/gku251; El Mai Nassimal, 2013, Methods Mol Biol, V988, P19, DOI 10.1007/978-1-62703-327-5_2; FUKUDA MN, 1989, BLOOD, V73, P84; Hamilton SR, 2006, SCIENCE, V313, P1441, DOI 10.1126/science.1130256; Lewis NE, 2013, NAT BIOTECHNOL, V31, P759, DOI 10.1038/nbt.2624; Malphettes L, 2010, BIOTECHNOL BIOENG, V106, P774, DOI 10.1002/bit.22751; Maresca M, 2013, GENOME RES, V23, P539, DOI 10.1101/gr.145441.112; Narimatsu H, 2006, CURR OPIN STRUC BIOL, V16, P567, DOI 10.1016/j.sbi.2006.09.001; North SJ, 2010, J BIOL CHEM, V285, P5759, DOI 10.1074/jbc.M109.068353; Patnaik SK, 2006, METHOD ENZYMOL, V416, P159, DOI 10.1016/S0076-6879(06)16011-5; SASAKI H, 1988, BIOCHEMISTRY-US, V27, P8618, DOI 10.1021/bi00423a017; Sinclair AM, 2005, J PHARM SCI-US, V94, P1626, DOI 10.1002/jps.20319; Steentoft C, 2014, GLYCOBIOLOGY, V24, P663, DOI 10.1093/glycob/cwu046; Walsh G, 2014, NAT BIOTECHNOL, V32, P992, DOI 10.1038/nbt.3040; Walsh G, 2010, DRUG DISCOV TODAY, V15, P773, DOI 10.1016/j.drudis.2010.06.009; Xu X, 2011, NAT BIOTECHNOL, V29, P735, DOI 10.1038/nbt.1932; Yamane-Ohnuki N, 2004, BIOTECHNOL BIOENG, V87, P614, DOI 10.1002/bit.20151; Yang Z, 2015, NUCLEIC ACIDS RES, V43, DOI 10.1093/nar/gkv126	19	163	169	3	85	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156	1546-1696		NAT BIOTECHNOL	Nat. Biotechnol.	AUG	2015	33	8					842	+		10.1038/nbt.3280	http://dx.doi.org/10.1038/nbt.3280			4	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	CO6OB	26192319				2022-12-27	WOS:000359274900023
J	Kupecz, A; Roox, K; Dekoninck, C; Schertenleib, D; Stief, M; Sanna, F; Orsingher, M; Miralles, S; Molina, E; Crosse, T; Gilbert, M; James, W				Kupecz, Andras; Roox, Kristof; Dekoninck, Christian; Schertenleib, Denis; Stief, Marco; Sanna, Fabrizio; Orsingher, Matteo; Miralles, Sergio; Molina, Elena; Crosse, Trevor; Gilbert, Mike; James, Will			Safe harbors in Europe: an update on the research and Bolar exemptions to patent infringement	NATURE BIOTECHNOLOGY			English	Editorial Material									[Kupecz, Andras] Kupecz Intellectual Property, Amsterdam, Netherlands; [Roox, Kristof; Dekoninck, Christian] Crowell & Moring LLP, Brussels, Belgium; [Schertenleib, Denis] Cabinet Schertenleib, Paris, France; [Stief, Marco] Maiwald Partnerschaftsgesell Patentanwalte Rechts, Munich, Germany; [Sanna, Fabrizio; Orsingher, Matteo] Orsingher Avvocati Associati, Milan, Italy; [Miralles, Sergio; Molina, Elena] Intangibles Legal SLP, Barcelona, Spain; [Crosse, Trevor; Gilbert, Mike; James, Will] Marks & Clerk Solicitors LLP, London, England		Kupecz, A (corresponding author), Kupecz Intellectual Property, Amsterdam, Netherlands.	andras@kupecz-ip.com						[Anonymous], SPAN REP Q202; [Anonymous], 2013, OJ C, V175, P1; De Jong P, 2014, TBH, V439; Holzapfel H., 2006, GRUR INT, V10; Hufnagel F, 2010, DIENERS REESE HDB PH, V14, P148; Hufnagel F., 2010, DIENERS REESE HDB PH; Krasser R, 2009, PATENTRECHT, V6th; Lemaire O., 2000, ING CONS, V436; Mignolet O., 2011, TRAITE DROIT PHARM; Ohly A., 2003, JZ, V545, P553; Pitz J., 2010, PATENTVERLETZUNGSV 4, p67c; Remiche B., 2010, DROIT BREVETS INVENT, P311; Van den Bulck P., 2006, ING CONS, V34; Van Gelder N., 2012, T GEZ, V214; Van Overwalle G., 2005, IRDI, V359; Van Overwalle G., 2006, CHIZAIKEN FORUM, V3; von Meibom W., 2005, FESTSCHRIFT KURT BAR	17	8	9	1	7	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156	1546-1696		NAT BIOTECHNOL	Nat. Biotechnol.	JUL	2015	33	7					710	716		10.1038/nbt.3273	http://dx.doi.org/10.1038/nbt.3273			7	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	CN4JJ	26154008				2022-12-27	WOS:000358396100022
J	Berlin, K; Koren, S; Chin, CS; Drake, JP; Landolin, JM; Phillippy, AM				Berlin, Konstantin; Koren, Sergey; Chin, Chen-Shan; Drake, James P.; Landolin, Jane M.; Phillippy, Adam M.			Assembling large genomes with single-molecule sequencing and locality-sensitive hashing	NATURE BIOTECHNOLOGY			English	Article							MICROBIAL GENOMES; IDENTIFICATION; CHROMOSOME; ALGORITHM; ALIGNMENT	Long-read, single-molecule real-time (SMRT) sequencing is routinely used to finish microbial genomes, but available assembly methods have not scaled well to larger genomes. We introduce the MinHash Alignment Process (MHAP) for overlapping noisy, long reads using probabilistic, locality-sensitive hashing. Integrating MHAP with the Celera Assembler enabled reference-grade de novo assemblies of Saccharomyces cerevisiae, Arabidopsis thaliana, Drosophila melanogaster and a human hydatidiform mole cell line (CHM1) from SMRT sequencing. The resulting assemblies are highly continuous, include fully resolved chromosome arms and close persistent gaps in these reference genomes. Our assembly of D. melanogaster revealed previously unknown heterochromatic and telomeric transition sequences, and we assembled low-complexity sequences from CHM1 that fill gaps in the human GRCh38 reference. Using MHAP and the Celera Assembler, single-molecule sequencing can produce de novo near-complete eukaryotic assemblies that are 99.99% accurate when compared with available reference genomes.	[Berlin, Konstantin] Univ Maryland, Dept Chem & Biochem, College Pk, MD 20742 USA; [Berlin, Konstantin] Univ Maryland, Inst Adv Comp Studies, College Pk, MD 20742 USA; [Berlin, Konstantin] Invincea Labs, Arlington, VA USA; [Koren, Sergey; Phillippy, Adam M.] Natl Biodefense Anal & Countermeasures Ctr, Frederick, MD USA; [Chin, Chen-Shan; Drake, James P.; Landolin, Jane M.] Pacif Biosci Calif Inc, Menlo Pk, CA USA	University System of Maryland; University of Maryland College Park; University System of Maryland; University of Maryland College Park	Koren, S (corresponding author), Univ Maryland, Dept Chem & Biochem, College Pk, MD 20742 USA.	korens@nbacc.net	Koren, Sergey/AAE-8314-2019; Phillippy, Adam M/U-5731-2018	Phillippy, Adam M/0000-0003-2983-8934; Chin, Chen-Shan/0000-0003-4394-2455	Department of Homeland Security Science and Technology Directorate (DHS/ST) [HSHQDC-07-C-00020]; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [ZIAHG200398] Funding Source: NIH RePORTER	Department of Homeland Security Science and Technology Directorate (DHS/ST)(United States Department of Homeland Security (DHS)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))	We are indebted to C. Bergman of the University of Manchester for his considered advice throughout this project and editing of an early version of this manuscript. We also thank Pacific Biosciences and all those involved in generating and freely releasing the data analyzed here. The contributions of S.K. and A.M.P. were funded under Agreement No. HSHQDC-07-C-00020 awarded by the Department of Homeland Security Science and Technology Directorate (DHS/S&T) for the management and operation of the National Biodefense Analysis and Countermeasures Center (NBACC), a Federally Funded Research and Development Center. The views and conclusions contained in this document are those of the authors and should not be interpreted as necessarily representing the official policies, either expressed or implied, of the US Department of Homeland Security. In no event shall the DHS, NBACC or Battelle National Biodefense Institute (BNBI) have any responsibility or liability for any use, misuse, inability to use, or reliance upon the information contained herein. The Department of Homeland Security does not endorse any products or commercial services mentioned in this publication.	Adams MD, 2000, SCIENCE, V287, P2185, DOI 10.1126/science.287.5461.2185; [Anonymous], 2011, ARXIV11115572; Anson EL, 1997, J COMPUT BIOL, V4, P369, DOI 10.1089/cmb.1997.4.369; Bankevich A, 2012, J COMPUT BIOL, V19, P455, DOI 10.1089/cmb.2012.0021; Beck S, 1999, NATURE, V401, P921, DOI 10.1038/44853; Blasco MA, 2005, NAT REV GENET, V6, P611, DOI 10.1038/nrg1656; Bohringer S., 2002, ONLINE J BIOINFORMAT, V1, P51; Broder AZ, 1998, COMPRESSION AND COMPLEXITY OF SEQUENCES 1997 - PROCEEDINGS, P21, DOI 10.1109/SEQUEN.1997.666900; Broder AZ, 2000, LECT NOTES COMPUT SC, V1848, P1; Buhler J, 2001, BIOINFORMATICS, V17, P419, DOI 10.1093/bioinformatics/17.5.419; Burton JN, 2013, NAT BIOTECHNOL, V31, P1119, DOI 10.1038/nbt.2727; Chaisson MJ, 2012, BMC BIOINFORMATICS, V13, DOI 10.1186/1471-2105-13-238; Chaisson MJP, 2015, NATURE, V517, P608, DOI 10.1038/nature13907; CHENG RCH, 1983, J ROY STAT SOC B MET, V45, P394; Chin CS, 2013, NAT METHODS, V10, P563, DOI [10.1038/NMETH.2474, 10.1038/nmeth.2474]; Chum O., 2008, BMVC, P812, DOI [DOI 10.5244/C.22.50, 10.5244/C.22.50]; Clarke J, 2009, NAT NANOTECHNOL, V4, P265, DOI [10.1038/NNANO.2009.12, 10.1038/nnano.2009.12]; Denton JF, 2014, PLOS COMPUT BIOL, V10, DOI 10.1371/journal.pcbi.1003998; Eid J, 2009, SCIENCE, V323, P133, DOI 10.1126/science.1162986; English AK, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041444; Ewing B, 1998, GENOME RES, V8, P175, DOI 10.1101/gr.8.3.175; George JA, 2006, GENOME RES, V16, P1231, DOI 10.1101/gr.5348806; Hoskins RA, 2007, SCIENCE, V316, P1625, DOI 10.1126/science.1139816; Huddleston J, 2014, GENOME RES, V24, P688, DOI 10.1101/gr.168450.113; Jurka J, 2005, CYTOGENET GENOME RES, V110, P462, DOI 10.1159/000084979; KAMINKER JS, 2002, GENOME BIOL, V0003; Kaplan N, 2013, NAT BIOTECHNOL, V31, P1143, DOI 10.1038/nbt.2768; Kaul S, 2000, NATURE, V408, P796, DOI 10.1038/35048692; Kim KE, 2014, SCI DATA, V1, DOI 10.1038/sdata.2014.45; Koch P, 2014, NUCLEIC ACIDS RES, V42, DOI 10.1093/nar/gku210; Koren S, 2015, CURR OPIN MICROBIOL, V23, P110, DOI 10.1016/j.mib.2014.11.014; Koren S, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-9-r101; Koren S, 2012, NAT BIOTECHNOL, V30, P692, DOI 10.1038/nbt.2280; Kurtz S, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-2-r12; Lam KK, 2014, BMC BIOINFORMATICS, V15, DOI 10.1186/1471-2105-15-S9-S4; Lander ES, 2001, NATURE, V409, P860, DOI 10.1038/35057062; Lee C, 2002, BIOINFORMATICS, V18, P452, DOI 10.1093/bioinformatics/18.3.452; Lee H., 2014, BIORXIV; Li H., 2013, ARXIV PREPRINT; MANBER U, 1993, SIAM J COMPUT, V22, P935, DOI 10.1137/0222058; McCoy RC, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0106689; Mewes HW, 1997, NATURE, V387, P7, DOI 10.1038/387s007; Miller JR, 2010, GENOMICS, V95, P315, DOI 10.1016/j.ygeno.2010.03.001; Myers EW, 1986, ALGORITHMICA, V1, P251, DOI 10.1007/BF01840446; Myers EW, 2000, SCIENCE, V287, P2196, DOI 10.1126/science.287.5461.2196; Myers G, 2014, LECT N BIOINFORMAT, V8701, P52, DOI 10.1007/978-3-662-44753-6_5; Nagarajan N, 2013, NAT REV GENET, V14, P157, DOI 10.1038/nrg3367; Narayanan M, 2004, LECT NOTES COMPUT SC, V3240, P74; PacBio, 2014, DAT REL PREL NOV HAP; PacBio DevNet, 2014, PAC BIOSC DEVNET DAT; Phillippy AM, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-3-r55; Quick J, 2014, GIGASCIENCE, V3, DOI 10.1186/2047-217X-3-22; Ralser M, 2012, OPEN BIOL, V2, DOI 10.1098/rsob.120093; Rasheed Z., 2013, SIAM INT C DAT MIN; Rasmussen KR, 2006, J COMPUT BIOL, V13, P296, DOI 10.1089/cmb.2006.13.296; Ribeiro FJ, 2012, GENOME RES, V22, P2270, DOI 10.1101/gr.141515.112; Roberts M, 2004, BIOINFORMATICS, V20, P3363, DOI 10.1093/bioinformatics/bth408; Ross MG, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-5-r51; Salzberg SL, 2012, GENOME RES, V22, P557, DOI 10.1101/gr.131383.111; Schatz MC, 2010, GENOME RES, V20, P1165, DOI 10.1101/gr.101360.109; SCHWARTZ DC, 1993, SCIENCE, V262, P110, DOI 10.1126/science.8211116; SMITH TF, 1981, J MOL BIOL, V147, P195, DOI 10.1016/0022-2836(81)90087-5; Steinberg KM, 2014, GENOME RES, V24, P2066, DOI 10.1101/gr.180893.114; UKKONEN E, 1992, THEOR COMPUT SCI, V92, P191, DOI 10.1016/0304-3975(92)90143-4; Venter JC, 2001, SCIENCE, V291, P1304, DOI 10.1126/science.1058040; Weber JL, 1997, GENOME RES, V7, P401, DOI 10.1101/gr.7.5.401; Weese D, 2012, BIOINFORMATICS, V28, P2592, DOI 10.1093/bioinformatics/bts505; Yang X, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-475	68	574	584	8	148	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156	1546-1696		NAT BIOTECHNOL	Nat. Biotechnol.	JUN	2015	33	6					623	+		10.1038/nbt.3238	http://dx.doi.org/10.1038/nbt.3238			11	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	CK2DE	26006009	Green Submitted			2022-12-27	WOS:000356019700022
J	Li, W; Cai, LS				Li, Wei; Cai, LiSheng			The scope of patent protection for gene technology in China	NATURE BIOTECHNOLOGY			English	Editorial Material									[Li, Wei; Cai, LiSheng] Zhejiang Univ, Ningbo Inst Technol, Ningbo, Zhejiang, Peoples R China	Zhejiang University	Li, W (corresponding author), Zhejiang Univ, Ningbo Inst Technol, Ningbo, Zhejiang, Peoples R China.	iprecht@126.com						Advanced Technology Industries Division of National Development and Reform Commission and Chinese Society of Biotechnology, 2012, CHIN BIOIND DEV REP; Cui G., 2012, PATENT LAW CASES PRI, P257; Fan Z., 2011, 2011 CHINA PATENT AT, P382; Feng Y., 2011, J BEIJING NORMAL U N, V5, P490; Han S.W., 2012, CHINA INTELLECTUAL P; Li Y., 2003, J ZHEJIANG U HUMANIT, V1, P134; State Intellect. Prop. Off, 2010, SIPO GUID PAT EX; Wang Z., 2008, GENE PATENT RES, P78; Zhang P.J., 2012, J PEKING U PHILOS SO, V3, P121; Zhu L., 2006, GUANGDONG AGR SCI, V10, P104	10	8	8	1	18	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156	1546-1696		NAT BIOTECHNOL	Nat. Biotechnol.	OCT	2014	32	10					1001	1003		10.1038/nbt.3031	http://dx.doi.org/10.1038/nbt.3031			3	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	AR7MM	25299918				2022-12-27	WOS:000343763800014
J	Brougher, J; Linnik, KM				Brougher, Joanna; Linnik, Konstantin M.			Patents or patients: who loses?	NATURE BIOTECHNOLOGY			English	Editorial Material							EXCLUSIVITY; INNOVATION	The unprecedented weakening of patent rights in the United States undermines necessary incentives for the discovery and development of innovative medicines.	[Linnik, Konstantin M.] Nutter McClennen Fish LLP, Boston, MA USA			joannabrougher@gmail.com; linnik@nutter.com						Grabowski H, 2008, NAT REV DRUG DISCOV, V7, P479, DOI 10.1038/nrd2532; Herper M, TRULY STAGGERING COS; Kesselheim AS, 2010, NEW ENGL J MED, V363, P1855, DOI 10.1056/NEJMhle1002961; Kowalski S, 2011, PATENT LITERATURE ME; Rader R, 2013, PATENT LAW LITIGATIO	5	5	5	0	0	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156	1546-1696		NAT BIOTECHNOL	Nat. Biotechnol.	SEP	2014	32	9					877	880		10.1038/nbt.3005	http://dx.doi.org/10.1038/nbt.3005			4	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	AQ2FD	25203034				2022-12-27	WOS:000342600300023
J	Heck, D; Kowalczyk, MS; Yudovich, D; Belizaire, R; Puram, RV; McConkey, ME; Thielke, A; Aster, JC; Regev, A; Ebert, BL				Heck, Dirk; Kowalczyk, Monika S.; Yudovich, David; Belizaire, Roger; Puram, Rishi V.; McConkey, Marie E.; Thielke, Anne; Aster, Jon C.; Regev, Aviv; Ebert, Benjamin L.			Generation of mouse models of myeloid malignancy with combinatorial genetic lesions using CRISPR-Cas9 genome editing	NATURE BIOTECHNOLOGY			English	Article							DIFFERENTIATION; INACTIVATION; MUTATIONS	Genome sequencing studies have shown that human malignancies often bear mutations in four or more driver genes(1), but it is difficult to recapitulate this degree of genetic complexity in mouse models using conventional breeding. Here we use the CRISPR-Cas9 system of genome editing(2-4) to overcome this limitation. By delivering combinations of small guide RNAs (sgRNAs) and Cas9 with a lentiviral vector, we modified up to five genes in a single mouse hematopoietic stem cell (HSC), leading to clonal outgrowth and myeloid malignancy. We thereby generated models of acute myeloid leukemia (AML) with cooperating mutations in genes encoding epigenetic modifiers, transcription factors and mediators of cytokine signaling, recapitulating the combinations of mutations observed in patients. Our results suggest that lentivirus-delivered sgRNA:Cas9 genome editing should be useful to engineer a broad array of in vivo cancer models that better reflect the complexity of human disease.	[Heck, Dirk; Yudovich, David; Belizaire, Roger; Puram, Rishi V.; McConkey, Marie E.; Ebert, Benjamin L.] Harvard Univ, Brigham & Womens Hosp, Dept Med, Div Hematol,Med Sch, Boston, MA 02115 USA; [Kowalczyk, Monika S.; Thielke, Anne; Regev, Aviv; Ebert, Benjamin L.] Broad Inst & Harvard, Cambridge, MA USA; [Belizaire, Roger; Aster, Jon C.] Harvard Univ, Brigham & Womens Hosp, Dept Pathol, Sch Med, Boston, MA 02115 USA; [Regev, Aviv] MIT, Howard Hughes Med Inst, Dept Biol, Cambridge, MA USA	Harvard University; Brigham & Women's Hospital; Harvard Medical School; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Harvard University; Brigham & Women's Hospital; Harvard Medical School; Howard Hughes Medical Institute; Massachusetts Institute of Technology (MIT)	Ebert, BL (corresponding author), Harvard Univ, Brigham & Womens Hosp, Dept Med, Div Hematol,Med Sch, Boston, MA 02115 USA.	bebert@partners.org	Yudovich, David/AAT-2685-2020; Heckl, Dirk/GMW-5407-2022; Yudovich, David/O-9971-2015	Yudovich, David/0000-0002-6580-0637; Yudovich, David/0000-0002-6580-0637; Belizaire, Roger/0000-0001-8496-287X	National Institutes of Health [P01 CA108631]; Leukemia and Lymphoma Society Scholar Award; SPARC consortium; National Human Genome Research Institute [5P50HG006193-02]; Klarman Family Foundation at The Broad Institute; German Cancer Foundation; NATIONAL CANCER INSTITUTE [P01CA066996] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL082945] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [P50HG006193] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007753] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Leukemia and Lymphoma Society Scholar Award(Leukemia and Lymphoma Society); SPARC consortium; National Human Genome Research Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); Klarman Family Foundation at The Broad Institute; German Cancer Foundation; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	The authors thank C. Morton and A. Hawkins from the Brigham and Women's Cytogenetics Core and R. Bronson from the DF/HCC Rodent Pathology Core for technical assistance and discussions. The authors thank F. Zhang for providing the CRISPR-Cas components. The authors also thank A. Schambach, E. Charpentier, J. Kroenke and A. Mullally for useful discussions, and thank S. Schwartz and B. Haas for assistance with analysis of sequencing data. C. Baum and A. Schambach of the Hannover Medical School, Hannover, Germany, kindly provided RRL. PPT.SFFV.IRES.eGFP.pre*, and D. Trono of EPFL, Lausanne, Switzerland, kindly provided both pMD2.G (Addgene plasmid 12259) and psPAX2.(Addgene plasmid 12260). This work was supported by funding from the National Institutes of Health (P01 CA108631), a Leukemia and Lymphoma Society Scholar Award, the SPARC consortium, a Center for Excellence in Genome Science grant (5P50HG006193-02 from the National Human Genome Research Institute) (A.R.) and Klarman Family Foundation at The Broad Institute (A.R.). D.H. was funded by the German Cancer Foundation (Mildred-Scheel Fellowship). M.S.K. is an EMBO and European Hematology Association Fellow.	[Anonymous], 2013, GEN EP LANDSC; Challen GA, 2012, NAT GENET, V44, P23, DOI 10.1038/ng.1009; Cong L, 2013, SCIENCE, V339, P819, DOI 10.1126/science.1231143; Friedland AE, 2013, NAT METHODS, V10, P741, DOI 10.1038/nmeth.2532; Fu YF, 2013, NAT BIOTECHNOL, V31, P822, DOI 10.1038/nbt.2623; Hsu PD, 2013, NAT BIOTECHNOL, V31, P827, DOI 10.1038/nbt.2647; Hwang WY, 2013, NAT BIOTECHNOL, V31, P227, DOI 10.1038/nbt.2501; Jinek M, 2012, SCIENCE, V337, P816, DOI 10.1126/science.1225829; Kelly LM, 2002, ANNU REV GENOM HUM G, V3, P179, DOI 10.1146/annurev.genom.3.032802.115046; Lee BH, 2007, CANCER CELL, V12, P367, DOI 10.1016/j.ccr.2007.08.031; Mali P, 2013, SCIENCE, V339, P823, DOI 10.1126/science.1232033; Mead AJ, 2013, CELL REP, V3, P1766, DOI 10.1016/j.celrep.2013.04.031; Moran-Crusio K, 2011, CANCER CELL, V20, P11, DOI 10.1016/j.ccr.2011.06.001; Quivoron C, 2011, CANCER CELL, V20, P25, DOI 10.1016/j.ccr.2011.06.003; Reyon D, 2012, NAT BIOTECHNOL, V30, P460, DOI 10.1038/nbt.2170; Sander JD, 2011, NAT BIOTECHNOL, V29, P697, DOI 10.1038/nbt.1934; Scuoppo C, 2012, NATURE, V487, P244, DOI 10.1038/nature11126; Shalem O, 2014, SCIENCE, V343, P84, DOI 10.1126/science.1247005; Shan QW, 2013, NAT BIOTECHNOL, V31, P686, DOI 10.1038/nbt.2650; Tanaka S, 2012, BLOOD, V120, P1107, DOI 10.1182/blood-2011-11-394932; Wang HY, 2013, CELL, V153, P910, DOI 10.1016/j.cell.2013.04.025; Wood AJ, 2011, SCIENCE, V333, P307, DOI 10.1126/science.1207773; Zender L, 2008, CELL, V135, P852, DOI 10.1016/j.cell.2008.09.061; Zhang YY, 2001, J CLIN INVEST, V108, P709, DOI 10.1172/JCI12758	24	346	376	0	90	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156	1546-1696		NAT BIOTECHNOL	Nat. Biotechnol.	SEP	2014	32	9					941	946		10.1038/nbt.2951	http://dx.doi.org/10.1038/nbt.2951			6	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	AQ2FD	24952903	Green Submitted, Green Accepted			2022-12-27	WOS:000342600300034
J	Bailey, AM; Mendicino, M; Au, P				Bailey, Alexander M.; Mendicino, Michael; Au, Patrick			An FDA perspective on preclinical development of cell-based regenerative medicine products	NATURE BIOTECHNOLOGY			English	Letter									[Bailey, Alexander M.; Mendicino, Michael; Au, Patrick] US FDA, Ctr Biol Evaluat & Res, Off Cellular Tissue & Gene Therapies, Silver Spring, MD 20993 USA; [Mendicino, Michael] US FDA, Off Commissioner, Off Chief Scientist, Off Regulatory Sci & Innovat, Silver Spring, MD USA	US Food & Drug Administration (FDA); US Food & Drug Administration (FDA)	Bailey, AM (corresponding author), US FDA, Ctr Biol Evaluat & Res, Off Cellular Tissue & Gene Therapies, Silver Spring, MD 20993 USA.	alexander.bailey@fda.hhs.gov; m.mendicino.phd@gmail.com; pakwai.au@fda.hhs.gov						Anatol R, 2014, PRINCIPLES OF TISSUE ENGINEERING, 4TH EDITION, P1781, DOI 10.1016/B978-0-12-398358-9.00086-0; Bailey AM, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003685; Mendicino M, 2014, CELL STEM CELL, V14, P141, DOI 10.1016/j.stem.2014.01.013; Robinson R, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3003394	4	47	50	0	14	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156	1546-1696		NAT BIOTECHNOL	Nat. Biotechnol.	AUG	2014	32	8					721	723		10.1038/nbt.2971	http://dx.doi.org/10.1038/nbt.2971			3	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	AW7PF	25093890				2022-12-27	WOS:000346455900008
J	Sheridan, C				Sheridan, Cormac			Cancer centers zero in on exceptional responders	NATURE BIOTECHNOLOGY			English	News Item							EVEROLIMUS											2014, CANCER DISCOV, V4, P546; 2014, ONCOTARGET, V5, P95; 2014, NATURE, V505, P495; 2014, NAT BIOTECHNOL, V32, P3; 2012, SCIENCE, V338, P221; 2014, NAT BIOTECHNOL, V32, P506	6	5	6	0	0	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156	1546-1696		NAT BIOTECHNOL	Nat. Biotechnol.	AUG	2014	32	8					703	704		10.1038/nbt0814-703	http://dx.doi.org/10.1038/nbt0814-703			2	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	AW7PF	25101721				2022-12-27	WOS:000346455900030
J	Velasco, R; Licciardello, C				Velasco, Riccardo; Licciardello, Concetta			A genealogy of the citrus family	NATURE BIOTECHNOLOGY			English	Editorial Material							GENOME; RUTACEAE; ORIGIN		[Velasco, Riccardo] Fdn Edmund Mach, Di San Michele A Adige, Trento, Italy; [Licciardello, Concetta] CRA ACM, Consiglio Ric & Sperimentaz Agr, Acireale, Italy	Fondazione Edmund Mach; Consiglio per la Ricerca in Agricoltura e L'analisi Dell'economia Agraria (CREA)	Velasco, R (corresponding author), Fdn Edmund Mach, Di San Michele A Adige, Trento, Italy.	riccardo.velasco@fmach.it	; Licciardello, Concetta/C-9296-2019	Velasco, Riccardo/0000-0002-8760-5031; Licciardello, Concetta/0000-0003-1380-6540				Bolger ME, 2014, CURR OPIN BIOTECH, V26, P31, DOI 10.1016/j.copbio.2013.08.019; Garcia-Lor A, 2013, ANN BOT-LONDON, V111, P1, DOI 10.1093/aob/mcs227; GMITTER FG, 1990, ECON BOT, V44, P267, DOI 10.1007/BF02860491; Gottwald TR, 2010, ANNU REV PHYTOPATHOL, V48, P119, DOI 10.1146/annurev-phyto-073009-114418; Salse J, 2012, CURR OPIN PLANT BIOL, V15, P122, DOI 10.1016/j.pbi.2012.01.001; Velasco R, 2010, NAT GENET, V42, P833, DOI 10.1038/ng.654; Wu GA, 2014, NAT BIOTECHNOL, V32, P656, DOI 10.1038/nbt.2906; Xu Q, 2013, NAT GENET, V45, P59, DOI 10.1038/ng.2472	8	38	39	0	28	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156	1546-1696		NAT BIOTECHNOL	Nat. Biotechnol.	JUL	2014	32	7					640	642		10.1038/nbt.2954	http://dx.doi.org/10.1038/nbt.2954			4	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	AK8VE	25004231				2022-12-27	WOS:000338705900027
J	Galdzicki, M; Clancy, KP; Oberortner, E; Pocock, M; Quinn, JY; Rodriguez, CA; Roehner, N; Wilson, ML; Adam, L; Anderson, JC; Bartley, BA; Beal, J; Chandran, D; Chen, J; Densmore, D; Endy, D; Grunberg, R; Hallinan, J; Hillson, NJ; Johnson, JD; Kuchinsky, A; Lux, M; Misirli, G; Peccoud, J; Plahar, HA; Sirin, E; Stan, GB; Villalobos, A; Wipat, A; Gennari, JH; Myers, CJ; Sauro, HM				Galdzicki, Michal; Clancy, Kevin P.; Oberortner, Ernst; Pocock, Matthew; Quinn, Jacqueline Y.; Rodriguez, Cesar A.; Roehner, Nicholas; Wilson, Mandy L.; Adam, Laura; Anderson, J. Christopher; Bartley, Bryan A.; Beal, Jacob; Chandran, Deepak; Chen, Joanna; Densmore, Douglas; Endy, Drew; Gruenberg, Raik; Hallinan, Jennifer; Hillson, Nathan J.; Johnson, Jeffrey D.; Kuchinsky, Allan; Lux, Matthew; Misirli, Goksel; Peccoud, Jean; Plahar, Hector A.; Sirin, Evren; Stan, Guy-Bart; Villalobos, Alan; Wipat, Anil; Gennari, John H.; Myers, Chris J.; Sauro, Herbert M.			The Synthetic Biology Open Language (SBOL) provides a community standard for communicating designs in synthetic biology	NATURE BIOTECHNOLOGY			English	Article							SYSTEMS; CIRCUITS; TOOL; SOFTWARE; FUTURE; MODELS	The re-use of previously validated designs is critical to the evolution of synthetic biology from a research discipline to an engineering practice. Here we describe the Synthetic Biology Open Language (SBOL), a proposed data standard for exchanging designs within the synthetic biology community. SBOL represents synthetic biology designs in a community-driven, formalized format for exchange between software tools, research groups and commercial service providers. The SBOL Developers Group has implemented SBOL as an XML/RDF serialization and provides software libraries and specification documentation to help developers implement SBOL in their own software. We describe early successes, including a demonstration of the utility of SBOL for information exchange between several different software tools and repositories from both academic and industrial partners. As a community-driven standard, SBOL will be updated as synthetic biology evolves to provide specific capabilities for different aspects of the synthetic biology workflow.	[Galdzicki, Michal; Gennari, John H.] Univ Washington, Seattle, WA 98195 USA; [Clancy, Kevin P.] Life Technol, Synthet Biol Unit, Carlsbad, CA USA; [Oberortner, Ernst; Densmore, Douglas] Boston Univ, Dept Elect & Comp Engn, Boston, MA 02215 USA; [Pocock, Matthew; Hallinan, Jennifer; Misirli, Goksel; Wipat, Anil] Newcastle Univ, Sch Comp Sci, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England; [Quinn, Jacqueline Y.; Rodriguez, Cesar A.; Chandran, Deepak] Autodesk, Autodesk Res, San Francisco, CA USA; [Roehner, Nicholas] Univ Utah, Salt Lake City, UT USA; [Wilson, Mandy L.; Adam, Laura] Virginia Tech, Virginia Bioinformat Inst, Blacksburg, VA USA; [Anderson, J. Christopher] Univ Calif Berkeley, Dept Bioengn, Berkeley, CA 94720 USA; [Bartley, Bryan A.; Sauro, Herbert M.] Univ Washington, Dept Bioengn, Seattle, WA 98195 USA; [Beal, Jacob] Raytheon BBN Technol, Cambridge, MA USA; [Chen, Joanna; Hillson, Nathan J.; Plahar, Hector A.] Joint Bioenergy Inst JBEI, Fuels Synth Div, Berkeley, CA USA; [Endy, Drew] Stanford Univ, Dept Bioengn, Stanford, CA 94305 USA; [Gruenberg, Raik] Univ Montreal, IRIC, Montreal, PQ, Canada; [Johnson, Jeffrey D.] Univ Calif Berkeley, Berkeley, CA 94720 USA; [Kuchinsky, Allan] Agilent Technol, Mol Tools Lab, Santa Clara, CA USA; [Sirin, Evren] Clark & Parsia, Arlington, MA USA; [Stan, Guy-Bart] Univ London Imperial Coll Sci Technol & Med, London, England; [Villalobos, Alan] DNA2 0, Menlo Pk, CA USA; [Myers, Chris J.] Univ Utah, Dept Elect & Comp Engn, Salt Lake City, UT USA	University of Washington; University of Washington Seattle; Thermo Fisher Scientific; Boston University; Newcastle University - UK; Autodesk, Inc.; Utah System of Higher Education; University of Utah; Virginia Polytechnic Institute & State University; University of California System; University of California Berkeley; University of Washington; University of Washington Seattle; Raytheon Technologies; Raytheon BBN Technologies; United States Department of Energy (DOE); Joint BioEnergy Institute - JBEI; Stanford University; Universite de Montreal; University of California System; University of California Berkeley; Agilent Technologies; Imperial College London; Utah System of Higher Education; University of Utah	Sauro, HM (corresponding author), Univ Washington, Dept Bioengn, Seattle, WA 98195 USA.	hsauro@uw.edu	Densmore, Douglas/AAC-7059-2020; Adam, Laura/J-2642-2014; Lux, Matthew/AFW-4004-2022; Misirli, Goksel/AAV-3983-2020; Lux, Matthew/A-3602-2010; Peccoud, Jean/A-2374-2008; Grünberg, Raik/A-1839-2011; Galdzicki, Michal/F-5682-2010	Misirli, Goksel/0000-0002-2454-7188; Peccoud, Jean/0000-0001-7649-6127; Grünberg, Raik/0000-0001-9532-6043; Gennari, John/0000-0001-8254-4957; Stan, Guy-Bart/0000-0002-5560-902X; Wilson, Mandy L/0000-0002-4778-5744; /0000-0002-8762-8444; Wipat, Anil/0000-0001-7310-4191; Endy, Drew/0000-0001-6952-8098; Galdzicki, Michal/0000-0002-8392-8183; Beal, Jacob/0000-0002-1663-5102	Microsoft Computational Challenges in Synthetic Biology Initiative; Autodesk, Inc.; National Science Foundation [0527023, 1147158, EF-0850100, CCF-1218095]; National Library of Medicine [R41 LM010745, T15 LM007442]; National Human Genome Research Institute [R42 HG006737]; Agilent Technologies' Applications and Core Technology University Research (ACT-UR) program; Defense Advanced Research Projects Agency (DARPA) [HR0011-10-C-0168]; Engineering and Physical Sciences Research Council EPSRC) - Flowers Consortium project [EP/J02175X/1]; EPSRC - Centre for Synthetic Biology and Innovation at Imperial College [EP/G036004/1]; Office of Science, Office of Biological and Environmental Research; US Department of Energy [DE-AC02-05CH11231]; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R42HG006737] Funding Source: NIH RePORTER; NATIONAL LIBRARY OF MEDICINE [T15LM007442, R41LM010745] Funding Source: NIH RePORTER; EPSRC [EP/J02175X/1, EP/K020617/1, EP/G036004/1] Funding Source: UKRI; Engineering and Physical Sciences Research Council [EP/J02175X/1, EP/K020617/1, EP/G036004/1] Funding Source: researchfish	Microsoft Computational Challenges in Synthetic Biology Initiative(Microsoft); Autodesk, Inc.; National Science Foundation(National Science Foundation (NSF)); National Library of Medicine(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Library of Medicine (NLM)); National Human Genome Research Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); Agilent Technologies' Applications and Core Technology University Research (ACT-UR) program; Defense Advanced Research Projects Agency (DARPA)(United States Department of DefenseDefense Advanced Research Projects Agency (DARPA)); Engineering and Physical Sciences Research Council EPSRC) - Flowers Consortium project(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); EPSRC - Centre for Synthetic Biology and Innovation at Imperial College(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); Office of Science, Office of Biological and Environmental Research(United States Department of Energy (DOE)); US Department of Energy(United States Department of Energy (DOE)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL LIBRARY OF MEDICINE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Library of Medicine (NLM)); EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC))	We acknowledge H. Huang for her technical support on augmenting the Clotho platform for SBOL compliance. This work was initiated by an award from the Microsoft Computational Challenges in Synthetic Biology Initiative (2006). Subsequently the effort was supported by a variety of funding sources including Autodesk, Inc., National Science Foundation (0527023, 1147158, EF-0850100 and CCF-1218095), National Library of Medicine (R41 LM010745, T15 LM007442), National Human Genome Research Institute (R42 HG006737), Agilent Technologies' Applications and Core Technology University Research (ACT-UR) program, Defense Advanced Research Projects Agency (DARPA; HR0011-10-C-0168), the Engineering and Physical Sciences Research Council EPSRC)-funded Flowers Consortium project (EP/J02175X/1) and EPSRC-funded Centre for Synthetic Biology and Innovation at Imperial College (EP/G036004/1). The portion of this work conducted by the Joint BioEnergy Institute was supported by the Office of Science, Office of Biological and Environmental Research, the US Department of Energy (contract no. DE-AC02-05CH11231). The views and conclusions contained in this document are those of the authors and not the US government or any agency thereof. We would like to dedicate this paper to the memory of Allan Kuchinsky, who made significant contributions to SBOL through his support at our workshop meetings and critically to the development of libSBOLj.	Beal J, 2012, 2012008 MIT CSAIL; Beal J, 2012, ACS SYNTH BIOL, V1, P317, DOI 10.1021/sb300030d; Beal J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022490; Benenson Y, 2012, NAT REV GENET, V13, P455, DOI 10.1038/nrg3197; Bilitchenko L, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018882; Cai YZ, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000529; Canton B, 2008, NAT BIOTECHNOL, V26, P787, DOI 10.1038/nbt1413; Chandran Deepak, 2009, J Biol Eng, V3, P19, DOI 10.1186/1754-1611-3-19; Chen J, 2012, J BIOL ENG, V6, DOI 10.1186/1754-1611-6-1; Demir E, 2010, NAT BIOTECHNOL, V28, P935, DOI 10.1038/nbt.1666; Eilbeck K, 2005, GENOME BIOL, V6, DOI 10.1186/gb-2005-6-5-r44; Faeder James R., 2009, V500, P113, DOI 10.1007/978-1-59745-525-1_5; Galdzicki M., 2012, 87126 BBF RFC; Galdzicki M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017005; Gardner TS, 2000, NATURE, V403, P339, DOI 10.1038/35002131; Ham TS, 2012, NUCLEIC ACIDS RES, V40, DOI 10.1093/nar/gks531; Hillson NJ, 2012, ACS SYNTH BIOL, V1, P14, DOI 10.1021/sb2000116; Hucka M, 2003, BIOINFORMATICS, V19, P524, DOI 10.1093/bioinformatics/btg015; Kahl LJ, 2013, J BIOL ENG, V7, DOI 10.1186/1754-1611-7-13; Keasling J, 2005, BRIDGE NATL ACAD ENG, V35, P18; Kelly Jason R, 2009, J Biol Eng, V3, P4, DOI 10.1186/1754-1611-3-4; Khalil AS, 2010, NAT REV GENET, V11, P367, DOI 10.1038/nrg2775; Le Novere N, 2006, NUCLEIC ACIDS RES, V34, pD689, DOI 10.1093/nar/gkj092; Le Novere N, 2009, NAT BIOTECHNOL, V27, P735, DOI 10.1038/nbt.1558; Lloyd CM, 2004, PROG BIOPHYS MOL BIO, V85, P433, DOI 10.1016/j.pbiomolbio.2004.01.004; Misirli G, 2011, BIOINFORMATICS, V27, P973, DOI 10.1093/bioinformatics/btr048; Muller KM, 2011, METHODS MOL BIOL, V813, P23, DOI 10.1007/978-1-61779-412-4_2; Mukherji S, 2009, NAT REV GENET, V10, P859, DOI 10.1038/nrg2697; Mungall CJ, 2011, J BIOMED INFORM, V44, P87, DOI 10.1016/j.jbi.2010.03.002; Myers CJ, 2009, BIOINFORMATICS, V25, P2848, DOI 10.1093/bioinformatics/btp457; Nandagopal N, 2011, SCIENCE, V333, P1244, DOI 10.1126/science.1207084; PEARSON WR, 1988, P NATL ACAD SCI USA, V85, P2444, DOI 10.1073/pnas.85.8.2444; Peccoud J, 2011, NAT BIOTECHNOL, V29, P22, DOI 10.1038/nbt.1753; Salis HM, 2009, NAT BIOTECHNOL, V27, P946, DOI 10.1038/nbt.1568; Slattery W.J., 1971, INDEX US VOLUNTARY E, V329; United States Standards Strategy Committee, 2010, US STAND STRAT; Villalobos A, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-285; Woolston BM, 2013, ANNU REV CHEM BIOMOL, V4, P259, DOI 10.1146/annurev-chembioeng-061312-103312; Xia B, 2011, METHOD ENZYMOL, V498, P97, DOI 10.1016/B978-0-12-385120-8.00005-X	39	172	176	6	81	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156	1546-1696		NAT BIOTECHNOL	Nat. Biotechnol.	JUN	2014	32	6					545	550		10.1038/nbt.2891	http://dx.doi.org/10.1038/nbt.2891			6	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	AI9EV	24911500	Bronze			2022-12-27	WOS:000337233800016
J	Monk, J; Nogales, J; Palsson, BO				Monk, Jonathan; Nogales, Juan; Palsson, Bernhard O.			Optimizing genome-scale network reconstructions	NATURE BIOTECHNOLOGY			English	Article							ESCHERICHIA-COLI K-12; GLOBAL RECONSTRUCTION; METABOLIC GENOTYPE; COMMUNITY APPROACH; HIGH-THROUGHPUT; MODEL; CYANOBACTERIA; OPTIMIZATION; PHYLOGENY; DISCOVERY		[Monk, Jonathan; Nogales, Juan; Palsson, Bernhard O.] Univ Calif San Diego, Dept Bioengn, La Jolla, CA 92093 USA	University of California System; University of California San Diego	Palsson, BO (corresponding author), Univ Calif San Diego, Dept Bioengn, La Jolla, CA 92093 USA.	palsson@ucsd.edu	Nogales, Juan/Y-8829-2019	Nogales, Juan/0000-0002-4961-0833; Palsson, Bernhard/0000-0003-2357-6785; Monk, Jonathan M./0000-0002-3895-8949	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM057089] Funding Source: NIH RePORTER	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Agren R, 2013, PLOS COMPUT BIOL, V9, DOI 10.1371/journal.pcbi.1002980; Baran R, 2013, ACS CHEM BIOL, V8, P189, DOI 10.1021/cb300477w; Bordbar A, 2014, NAT REV GENET, V15, P107, DOI 10.1038/nrg3643; Chang RL, 2013, SCIENCE, V340, P1220, DOI 10.1126/science.1234012; Chang RL, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.52; Charusanti P, 2011, BMC SYST BIOL, V5, DOI 10.1186/1752-0509-5-163; Chen LF, 2007, TRENDS BIOTECHNOL, V25, P343, DOI 10.1016/j.tibtech.2007.06.001; Covert MW, 2004, NATURE, V429, P92, DOI 10.1038/nature02456; Duarte NC, 2007, P NATL ACAD SCI USA, V104, P1777, DOI 10.1073/pnas.0610772104; Edwards JS, 2000, P NATL ACAD SCI USA, V97, P5528, DOI 10.1073/pnas.97.10.5528; Edwards JS, 1999, J BIOL CHEM, V274, P17410, DOI 10.1074/jbc.274.25.17410; Feist AM, 2007, MOL SYST BIOL, V3, DOI 10.1038/msb4100155; Feist AM, 2010, CURR OPIN MICROBIOL, V13, P344, DOI 10.1016/j.mib.2010.03.003; FLEISCHMANN RD, 1995, SCIENCE, V269, P496, DOI 10.1126/science.7542800; Forster J, 2003, GENOME RES, V13, P244, DOI 10.1101/gr.234503; Ganter M, 2013, BIOINFORMATICS, V29, P815, DOI 10.1093/bioinformatics/btt036; Hatzimanikatis V, 2005, BIOINFORMATICS, V21, P1603, DOI 10.1093/bioinformatics/bti213; Heavner BD, 2012, BMC SYST BIOL, V6, DOI 10.1186/1752-0509-6-55; Henry CS, 2010, NAT BIOTECHNOL, V28, P977, DOI 10.1038/nbt.1672; Herrgard MJ, 2008, NAT BIOTECHNOL, V26, P1155, DOI 10.1038/nbt1492; Hu PZ, 2009, PLOS BIOL, V7, P929, DOI 10.1371/journal.pbio.1000096; Janssen P, 2005, EMBO REP, V6, P397, DOI 10.1038/sj.embor.7400412; Kim TY, 2012, CURR OPIN BIOTECH, V23, P617, DOI 10.1016/j.copbio.2011.10.007; Kumar VS, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-212; KUMAR VS, 2009, PLOS COMPUT BIOL, V5, DOI DOI 10.1371/JOURNAL.PCBI.1000308; Lerman JA, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1928; Lespinet O, 2005, SCIENCE, V307, P42; Lewis NE, 2012, NAT REV MICROBIOL, V10, P291, DOI 10.1038/nrmicro2737; Li XY, 2010, CELL, V143, P639, DOI 10.1016/j.cell.2010.09.048; Liao YC, 2011, J BACTERIOL, V193, P1710, DOI 10.1128/JB.01218-10; Linster CL, 2013, NAT CHEM BIOL, V9, P72, DOI [10.1038/NCHEMBIO.1141, 10.1038/nchembio.1141]; McCloskey D, 2013, MOL SYST BIOL, V9, DOI 10.1038/msb.2013.18; Milne CB, 2011, BMC SYST BIOL, V5, DOI 10.1186/1752-0509-5-130; Nakahigashi K, 2009, MOL SYST BIOL, V5, DOI 10.1038/msb.2009.65; Nogales J, 2012, P NATL ACAD SCI USA, V109, P2678, DOI 10.1073/pnas.1117907109; Orth JD, 2012, BMC SYST BIOL, V6, DOI 10.1186/1752-0509-6-30; Orth JD, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.65; Osterlund T, 2012, BIOTECHNOL ADV, V30, P979, DOI 10.1016/j.biotechadv.2011.07.021; Pouliot Y, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-244; Rabinowitz JD, 2012, NAT CHEM BIOL, V8, P497, DOI 10.1038/nchembio.969; Reed JL, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-9-r54; Reed JL, 2003, J BACTERIOL, V185, P2692, DOI 10.1128/JB.185.9.2692-2699.2003; Riley M, 2006, NUCLEIC ACIDS RES, V34, P1, DOI 10.1093/nar/gkj405; Schnoes AM, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000605; Schomburg I, 2013, NUCLEIC ACIDS RES, V41, pD764, DOI 10.1093/nar/gks1049; Thiele I, 2013, NAT BIOTECHNOL, V31, P419, DOI 10.1038/nbt.2488; Thiele I, 2011, BMC SYST BIOL, V5, DOI 10.1186/1752-0509-5-8; Thiele I, 2010, MOL SYST BIOL, V6, DOI 10.1038/msb.2010.15; Thiele I, 2010, NAT PROTOC, V5, P93, DOI 10.1038/nprot.2009.203; Thiele I, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000312; Vitkin E, 2012, GENOME BIOL, V13, DOI 10.1186/gb-2012-13-11-r111; Wu DY, 2009, NATURE, V462, P1056, DOI 10.1038/nature08656; Zhao SW, 2013, NATURE, V502, P698, DOI 10.1038/nature12576	53	131	132	2	72	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156	1546-1696		NAT BIOTECHNOL	Nat. Biotechnol.	MAY	2014	32	5					447	452		10.1038/nbt.2870	http://dx.doi.org/10.1038/nbt.2870			6	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	AH3PH	24811519	Bronze			2022-12-27	WOS:000336036100019
J	Ford, D; Kohlbrenner, W				Ford, Dennis; Kohlbrenner, William			Aligning needs	NATURE BIOTECHNOLOGY			English	Article									[Ford, Dennis; Kohlbrenner, William] Life Sci Nation, Boston, MA USA		Ford, D (corresponding author), Life Sci Nation, Boston, MA USA.	dford@lifesciencenation.com							0	2	2	0	1	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156	1546-1696		NAT BIOTECHNOL	Nat. Biotechnol.	MAR	2016	34	3					226	230		10.1038/nbt.3497	http://dx.doi.org/10.1038/nbt.3497			5	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	DG1CJ	26963540	Bronze			2022-12-27	WOS:000371802600010
J	Pelossof, R; Singh, I; Yang, JL; Weirauch, MT; Hughes, TR; Leslie, CS				Pelossof, Raphael; Singh, Irtisha; Yang, Julie L.; Weirauch, Matthew T.; Hughes, Timothy R.; Leslie, Christina S.			Affinity regression predicts the recognition code of nucleic acid-binding proteins	NATURE BIOTECHNOLOGY			English	Article							TRANSCRIPTION-FACTOR-BINDING; FACTOR SEQUENCE SPECIFICITY; SUPPORT VECTOR MACHINES; DNA-BINDING; QUANTITATIVE-ANALYSIS; RNA RECOGNITION; K-MERS; MODELS; PREFERENCES; INFERENCE	Predicting the affinity profiles of nucleic acid-binding proteins directly from the protein sequence is a challenging problem. We present a statistical approach for learning the recognition code of a family of transcription factors or RNA-binding proteins (RBPs) from high-throughput binding data. Our method, called affinity regression, trains on protein binding microarray (PBM) or RNAcompete data to learn an interaction model between proteins and nucleic acids using only protein domain and probe sequences as inputs. When trained on mouse homeodomain PBM profiles, our model correctly identifies residues that confer DNA-binding specificity and accurately predicts binding motifs for an independent set of divergent homeodomains. Similarly, when trained on RNAcompete profiles for diverse RBPs, our model correctly predicts the binding affinities of held-out proteins and identifies key RNA-binding residues, despite the high level of sequence divergence across RBPs. We expect that the method will be broadly applicable to modeling and predicting paired macromolecular interactions in settings where high-throughput affinity data are available.	[Pelossof, Raphael; Singh, Irtisha; Yang, Julie L.; Leslie, Christina S.] Mem Sloan Kettering Canc Ctr, Computat Biol Program, New York, NY 10021 USA; [Singh, Irtisha; Yang, Julie L.] Weill Cornell Grad Coll, TriI Program Computat Biol & Med, New York, NY USA; [Weirauch, Matthew T.] Cincinnati Childrens Hosp Med Ctr, CAGE, Cincinnati, OH 45229 USA; [Weirauch, Matthew T.] Cincinnati Childrens Hosp Med Ctr, Div Biomed Informat, Cincinnati, OH 45229 USA; [Weirauch, Matthew T.; Hughes, Timothy R.] Univ Toronto, Donnelly Ctr, Toronto, ON, Canada	Memorial Sloan Kettering Cancer Center; Qatar Foundation (QF); Weill Cornell Medical College Qatar; Cincinnati Children's Hospital Medical Center; Cincinnati Children's Hospital Medical Center; University of Toronto	Leslie, CS (corresponding author), Mem Sloan Kettering Canc Ctr, Computat Biol Program, 1275 York Ave, New York, NY 10021 USA.	cleslie@cbio.mskcc.org	Singh, Irtisha/W-6182-2019; Weirauch, Matthew/M-5459-2019	Singh, Irtisha/0000-0002-9460-3587	Canadian Institute for Health Research grant [MOP-111007]; US National Institutes of Health [HG006798, CA143840]; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R01HG006798] Funding Source: NIH RePORTER	Canadian Institute for Health Research grant(Canadian Institutes of Health Research (CIHR)); US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))	We thank K. Cook for providing the PWM-Align-Z script and Q. Morris for suggestions on RBP analysis. This work was supported in part by Canadian Institute for Health Research grant MOP-111007 (T.R.H.) and US National Institutes of Health grants HG006798 and CA143840 (C.S.L.).	Agius P, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000916; Alleyne TM, 2009, BIOINFORMATICS, V25, P1012, DOI 10.1093/bioinformatics/btn645; Arvey A, 2012, GENOME RES, V22, P1723, DOI 10.1101/gr.127712.111; Auweter SD, 2006, EMBO J, V25, P163, DOI 10.1038/sj.emboj.7600918; Bellucci M, 2011, NAT METHODS, V8, P444, DOI 10.1038/nmeth.1611; Berger MF, 2008, CELL, V133, P1266, DOI 10.1016/j.cell.2008.05.024; Berger MF, 2006, NAT BIOTECHNOL, V24, P1429, DOI 10.1038/nbt1246; Brunner C, 2012, J MACH LEARN RES, V13, P2279; Buenrostro JD, 2014, NAT BIOTECHNOL, V32, P562, DOI 10.1038/nbt.2880; Burglin TR, 1997, NUCLEIC ACIDS RES, V25, P4173, DOI 10.1093/nar/25.21.4173; Chen XY, 2007, BIOINFORMATICS, V23, pI72, DOI 10.1093/bioinformatics/btm224; Christensen RG, 2012, BIOINFORMATICS, V28, pI84, DOI 10.1093/bioinformatics/bts202; Foat BC, 2009, MOL SYST BIOL, V5, DOI 10.1038/msb.2009.24; Golub G., 2013, MATRIX COMPUTATIONS; Gordan R, 2013, CELL REP, V3, P1093, DOI 10.1016/j.celrep.2013.03.014; Hirsch JA, 1995, EMBO J, V14, P6280, DOI 10.1002/j.1460-2075.1995.tb00318.x; Jolma A, 2013, CELL, V152, P327, DOI 10.1016/j.cell.2012.12.009; Jolma A, 2010, GENOME RES, V20, P861, DOI 10.1101/gr.100552.109; Kazan H, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000832; Lambert N, 2014, MOL CELL, V54, P887, DOI 10.1016/j.molcel.2014.04.016; Leslie C., 2002, PAC S BIOCOMPUTING, V2012, P564; Liu JJ, 2008, BIOINFORMATICS, V24, P1850, DOI 10.1093/bioinformatics/btn331; Maticzka D, 2014, GENOME BIOL, V15, DOI 10.1186/gb-2014-15-1-r17; Nagasaki H, 2001, PLANT CELL, V13, P2085, DOI 10.1105/tpc.13.9.2085; Noyes MB, 2008, CELL, V133, P1277, DOI 10.1016/j.cell.2008.05.023; Osmanbeyoglu HU, 2014, GENOME RES, V24, P1869, DOI 10.1101/gr.173039.114; Penrose R., 1955, MATH P CAMBRIDGE PHI, V51, P406, DOI [10.1017/S0305004100030401, DOI 10.1017/S0305004100030401]; Ray D, 2013, NATURE, V499, P172, DOI 10.1038/nature12311; Ray D, 2009, NAT BIOTECHNOL, V27, P667, DOI 10.1038/nbt.1550; Tenenbaum JB, 2000, NEURAL COMPUT, V12, P1247, DOI 10.1162/089976600300015349; Torrado M, 2009, J BIOL CHEM, V284, P23765, DOI 10.1074/jbc.M109.012054; Vert JP, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-S10-S8; Weirauch MT, 2014, CELL, V158, P1431, DOI 10.1016/j.cell.2014.08.009; Weirauch MT, 2013, NAT BIOTECHNOL, V31, P126, DOI 10.1038/nbt.2486; Zhao Y, 2011, NAT BIOTECHNOL, V29, P480, DOI 10.1038/nbt.1893; Zhao Y, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000590	36	32	32	0	13	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156	1546-1696		NAT BIOTECHNOL	Nat. Biotechnol.	DEC	2015	33	12					1242	+		10.1038/nbt.3343	http://dx.doi.org/10.1038/nbt.3343			9	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	CY4OO	26571099	Bronze, Green Accepted			2022-12-27	WOS:000366387700015
J	Senatore, V; Scott, CT; Sebastiano, V				Senatore, Vincenzo; Scott, Christopher Thomas; Sebastiano, Vittorio			Patenting parthenotes in the US and Europe	NATURE BIOTECHNOLOGY			English	Editorial Material							EMBRYONIC STEM-CELLS	The real nature of a parthenote determines its ultimate value.	[Senatore, Vincenzo] Guida Senatore & Associates Law Firm, Rome, Italy; [Senatore, Vincenzo; Scott, Christopher Thomas] Stanford Univ, Ctr Biomed Eth, Stanford, CA 94305 USA; [Sebastiano, Vittorio] Stanford Univ, Dept Obstet & Gynecol, Inst Stem Cell Biol & Regenerat Med, Stanford, CA 94305 USA	Stanford University; Stanford University	Senatore, V (corresponding author), Guida Senatore & Associates Law Firm, Rome, Italy.	cscott@stanford.edu; vsebast@stanford.edu						[Anonymous], 2010, US Patent, Patent No. [7,732,202, 7732202]; Chen ZS, 2009, STEM CELLS, V27, P2136, DOI 10.1002/stem.158; Eckardt S, 2007, GENE DEV, V21, P409, DOI 10.1101/gad.1524207; Hauzman EE, 2008, J PERINAT MED, V36, P175, DOI 10.1515/JPM.2008.028; Kuno N, 2004, BIRTH DEFECTS RES A, V70, P40, DOI 10.1002/bdra.10133; MCGRATH J, 1984, CELL, V37, P179, DOI 10.1016/0092-8674(84)90313-1; Porter G, 2006, NAT BIOTECHNOL, V24, P653, DOI 10.1038/nbt0606-653; Senatore V., 2015, AIPLA QJ, V43, P241; STRAIN L, 1995, NAT GENET, V11, P164, DOI 10.1038/ng1095-164; Wernig M, 2007, NATURE, V448, P318, DOI 10.1038/nature05944; Winberg J, 2010, AM J MED GENET A, V152A, P2277, DOI 10.1002/ajmg.a.33594; WISCONSIN ALUMNI RES, 2008, Patent No. 5843780	12	1	1	0	4	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156	1546-1696		NAT BIOTECHNOL	Nat. Biotechnol.	DEC	2015	33	12					1232	1234		10.1038/nbt.3421	http://dx.doi.org/10.1038/nbt.3421			3	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	CY4OO	26650007				2022-12-27	WOS:000366387700011
J	Sontheimer, EJ; Wolfe, SA				Sontheimer, Erik J.; Wolfe, Scot A.			Cas9 gets a classmate	NATURE BIOTECHNOLOGY			English	Editorial Material							IMMUNITY; ENDONUCLEASE; SYSTEM	Cpf1 is one of a growing number of class II CRISPR-Cas effectors that expand both our understanding of bacterial immunity and our genome-editing toolset.	[Sontheimer, Erik J.] Univ Massachusetts, Sch Med, Program Mol Med, RNA Therapeut Inst, Worcester, MA 01655 USA; [Wolfe, Scot A.] Univ Massachusetts, Sch Med, Dept Mol Cell & Canc Biol, Worcester, MA USA	University of Massachusetts System; University of Massachusetts Worcester; University of Massachusetts System; University of Massachusetts Worcester	Sontheimer, EJ (corresponding author), Univ Massachusetts, Sch Med, Program Mol Med, RNA Therapeut Inst, Worcester, MA 01655 USA.	erik.sontheimer@umassmed.edu; scot.wolfe@umassmed.edu						Esvelt KM, 2013, NAT METHODS, V10, P1116, DOI [10.1038/NMETH.2681, 10.1038/nmeth.2681]; Gasiunas G, 2012, P NATL ACAD SCI USA, V109, pE2579, DOI 10.1073/pnas.1208507109; Hendel A, 2015, NAT BIOTECHNOL, V33, P985, DOI 10.1038/nbt.3290; Jinek M, 2012, SCIENCE, V337, P816, DOI 10.1126/science.1225829; Makarova KS, 2015, NAT REV MICROBIOL, V13, P722, DOI 10.1038/nrmicro3569; Maresca M, 2013, GENOME RES, V23, P539, DOI 10.1101/gr.145441.112; Sapranauskas R, 2011, NUCLEIC ACIDS RES, V39, P9275, DOI 10.1093/nar/gkr606; Shmakov S, 2015, MOL CELL, V60, P385, DOI 10.1016/j.molcel.2015.10.008; Zetsche B, 2015, CELL, V163, P759, DOI 10.1016/j.cell.2015.09.038	9	3	4	0	29	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156	1546-1696		NAT BIOTECHNOL	Nat. Biotechnol.	DEC	2015	33	12					1240	1241		10.1038/nbt.3426	http://dx.doi.org/10.1038/nbt.3426			3	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	CY4OO	26650011				2022-12-27	WOS:000366387700014
J	Dao, T; Pankov, D; Scott, A; Korontsvit, T; Zakhaleva, V; Xu, YY; Xiang, JY; Yan, S; Guerreiro, MDD; Veomett, N; Dubrovsky, L; Curcio, M; Doubrovina, E; Ponomarev, V; Liu, C; O'Reilly, RJ; Scheinberg, DA				Dao, Tao; Pankov, Dmitry; Scott, Andrew; Korontsvit, Tatyana; Zakhaleva, Victoriya; Xu, Yiyang; Xiang, Jingyi; Yan, Su; Guerreiro, Manuel Direito de Morais; Veomett, Nicholas; Dubrovsky, Leonid; Curcio, Michael; Doubrovina, Ekaterina; Ponomarev, Vladimir; Liu, Cheng; O'Reilly, Richard J.; Scheinberg, David A.			Therapeutic bispecific T-cell engager antibody targeting the intracellular oncoprotein WT1	NATURE BIOTECHNOLOGY			English	Article							TUMOR-CELLS; CD4+T CELLS; CANCER; IMMUNOTHERAPY; BLOCKADE; PEPTIDE; IDENTIFICATION; LYMPHOCYTES; GENERATION; RESPONSES	Intracellular tumor antigens presented on the cell surface in the context of human leukocyte antigen (HLA) molecules have been targeted by T cell-based therapies, but there has been little progress in developing small-molecule drugs or antibodies directed to these antigens. Here we describe a bispecific T-cell engager (BiTE) antibody derived from a T-cell receptor (TCR)-mimic monoclonal antibody (mAb) ESK1, which binds a peptide derived from the intracellular oncoprotein WT1 presented on HLA-A*02:01. Despite the very low density of the complexes at the cell surface, ESK1-BiTE selectively activated and induced proliferation of cytolytic human T cells that killed cells from multiple leukemias and solid tumors in vitro and in mice. We also discovered that in an autologous in vitro setting, ESK1-BiTE induced a robust secondary CD8 T-cell response specific for tumor-associated antigens other than WT1. Our study provides an approach that targets tumor-specific intracellular antigens without using cell therapy and suggests that epitope spreading could contribute to the therapeutic efficacy of this BiTE.	[Dao, Tao; Pankov, Dmitry; Scott, Andrew; Korontsvit, Tatyana; Zakhaleva, Victoriya; Guerreiro, Manuel Direito de Morais; Veomett, Nicholas; Dubrovsky, Leonid; Curcio, Michael; Doubrovina, Ekaterina; Ponomarev, Vladimir; O'Reilly, Richard J.; Scheinberg, David A.] Mem Sloan Kettering Canc Ctr, New York, NY 10021 USA; [Scott, Andrew; Veomett, Nicholas; O'Reilly, Richard J.; Scheinberg, David A.] Weill Cornell Med Coll, New York, NY USA; [Xu, Yiyang; Xiang, Jingyi; Yan, Su; Liu, Cheng] Eureka Therapeut, Emeryville, CA USA	Memorial Sloan Kettering Cancer Center; Cornell University	Scheinberg, DA (corresponding author), Mem Sloan Kettering Canc Ctr, 1275 York Ave, New York, NY 10021 USA.	d-scheinberg@ski.mskcc.org		Scott, Andrew/0000-0002-3090-9704; Liu, Cheng/0000-0002-2219-1018; Direito de Morais Guerreiro, Manuel Nuno/0000-0001-5978-2578; Ponomarev, Vladimir/0000-0002-9119-9128	US National Institutes of Health [R01 CA 55349, P01 CA23766, P30 CA008748, MARF]; Memorial Sloan Kettering Cancer Center's (MSKCC's) Experimental Therapeutics Center; Lymphoma Foundation; Glades fund; Tudor fund; NATIONAL CANCER INSTITUTE [R01CA055349, T32CA062948, P30CA008748, P01CA023766] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Memorial Sloan Kettering Cancer Center's (MSKCC's) Experimental Therapeutics Center; Lymphoma Foundation; Glades fund; Tudor fund; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	The study was supported by US National Institutes of Health grant R01 CA 55349, P01 CA23766, MARF, P30 CA008748, Memorial Sloan Kettering Cancer Center's (MSKCC's) Experimental Therapeutics Center and the Lymphoma Foundation and Tudor and Glades funds. We thank D Levine, F. Dao and M. Mattar for their efforts and help in collecting clinical samples. We also thank the MSKCC Small-Animal Imaging Core Facility, R. Gejman for statistical analyses, T.-Y. Kuo for helpful discussions for Renilla transduction, A. Selvakumar and A. Yeh for their expert HLA typing.	Abes R, 2010, BLOOD, V116, P926, DOI 10.1182/blood-2009-10-248609; Brentjens RJ, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3005930; Brischwein K, 2006, MOL IMMUNOL, V43, P1129, DOI 10.1016/j.molimm.2005.07.034; Brischwein K, 2007, J IMMUNOTHER, V30, P798, DOI 10.1097/CJI.0b013e318156750c; Chapuis AG, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3004916; Cheever MA, 2009, CLIN CANCER RES, V15, P5323, DOI 10.1158/1078-0432.CCR-09-0737; Corbiere V, 2011, CANCER RES, V71, P1253, DOI 10.1158/0008-5472.CAN-10-2693; Coulie PG, 2014, NAT REV CANCER, V14, P135, DOI 10.1038/nrc3670; Curran KJ, 2012, J GENE MED, V14, P405, DOI 10.1002/jgm.2604; Dao T, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3005661; Dao T, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006730; Doubrovina E, 2012, BLOOD, V120, P1633, DOI 10.1182/blood-2011-11-394619; Doubrovina E, 2012, BLOOD, V119, P2644, DOI 10.1182/blood-2011-08-371971; Dubrovsky L, 2014, BLOOD, V123, P3296, DOI 10.1182/blood-2014-01-549022; Fan LC, 2012, BIOTECHNOL BIOENG, V109, P1007, DOI 10.1002/bit.24365; Frankel SR, 2013, CURR OPIN CHEM BIOL, V17, P385, DOI 10.1016/j.cbpa.2013.03.029; Gubin MM, 2014, NATURE, V515, P577, DOI 10.1038/nature13988; Hilchey SP, 2009, BLOOD, V113, P3809, DOI 10.1182/blood-2008-10-185280; Hoffmann P, 2005, INT J CANCER, V115, P98, DOI 10.1002/ijc.20908; Hunder NN, 2008, NEW ENGL J MED, V358, P2698, DOI 10.1056/NEJMoa0800251; Inoue K, 1997, BLOOD, V89, P1405, DOI 10.1182/blood.V89.4.1405; Kessler JH, 2001, J EXP MED, V193, P73, DOI 10.1084/jem.193.1.73; Mittendorf EA, 2008, CANCER IMMUNOL IMMUN, V57, P1511, DOI 10.1007/s00262-008-0540-3; Morris E, 2006, BLOOD REV, V20, P61, DOI 10.1016/j.blre.2005.05.001; Nagorsen D, 2011, EXP CELL RES, V317, P1255, DOI 10.1016/j.yexcr.2011.03.010; Oka Y, 2007, THESCIENTIFICWORLDJO, V7, P649, DOI 10.1100/tsw.2007.119; Ott PA, 2013, CLIN CANCER RES, V19, P5300, DOI 10.1158/1078-0432.CCR-13-0143; Pedersen AE, 2011, J IMMUNOTHER, V34, P629, DOI 10.1097/CJI.0b013e3182281381; Peralbo E, 2007, EXP GERONTOL, V42, P703, DOI 10.1016/j.exger.2007.05.002; Quintarelli C, 2011, BLOOD, V117, P3353, DOI 10.1182/blood-2010-08-300376; Sadelain M, 2013, CANCER DISCOV, V3, P388, DOI 10.1158/2159-8290.CD-12-0548; Selenko N, 2001, LEUKEMIA, V15, P1619, DOI 10.1038/sj.leu.2402226; Sergeeva A, 2011, BLOOD, V117, P4262, DOI 10.1182/blood-2010-07-299248; Tran E, 2014, SCIENCE, V344, P641, DOI 10.1126/science.1251102; Tumeh PC, 2014, NATURE, V515, P568, DOI 10.1038/nature13954; Veomett N, 2014, CLIN CANCER RES, V20, P4036, DOI 10.1158/1078-0432.CCR-13-2756	36	99	101	2	39	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156	1546-1696		NAT BIOTECHNOL	Nat. Biotechnol.	OCT	2015	33	10					1079	+		10.1038/nbt.3349	http://dx.doi.org/10.1038/nbt.3349			10	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	CT1JX	26389576	Green Accepted			2022-12-27	WOS:000362555700028
J	Luo, CW; Knight, R; Siljander, H; Knip, M; Xavier, RJ; Gevers, D				Luo, Chengwei; Knight, Rob; Siljander, Heli; Knip, Mikael; Xavier, Ramnik J.; Gevers, Dirk			ConStrains identifies microbial strains in metagenomic datasets	NATURE BIOTECHNOLOGY			English	Article							GENOME SEQUENCE	An important fraction of microbial diversity is harbored in strain individuality, so identification of conspecific bacterial strains is imperative for improved understanding of microbial community functions. Limitations in bioinformatics and sequencing technologies have to date precluded strain identification owing to difficulties in phasing short reads to faithfully recover the original strain-level genotypes, which have highly similar sequences. We present ConStrains, an open-source algorithm that identifies conspecific strains from metagenomic sequence data and reconstructs the phylogeny of these strains in microbial communities. The algorithm uses single-nucleotide polymorphism (SNP) patterns in a set of universal genes to infer within-species structures that represent strains. Applying ConStrains to simulated and host-derived datasets provides insights into microbial community dynamics.	[Luo, Chengwei; Xavier, Ramnik J.; Gevers, Dirk] Broad Inst Massachusetts Inst Technol MIT & Harva, Cambridge, MA 02142 USA; [Luo, Chengwei; Xavier, Ramnik J.] Massachusetts Gen Hosp, Gastrointestinal Unit, Boston, MA 02114 USA; [Luo, Chengwei; Xavier, Ramnik J.] Massachusetts Gen Hosp, Ctr Study Inflammatory Bowel Dis, Boston, MA 02114 USA; [Luo, Chengwei; Xavier, Ramnik J.] Harvard Univ, Sch Med, Boston, MA USA; [Luo, Chengwei; Xavier, Ramnik J.] Massachusetts Gen Hosp, Ctr Computat & Integrat Biol, Boston, MA 02114 USA; [Knight, Rob] Univ Colorado, Dept Chem & Biochem, Boulder, CO 80309 USA; [Knight, Rob] Univ Colorado, Howard Hughes Med Inst, Boulder, CO 80309 USA; [Siljander, Heli; Knip, Mikael] Univ Helsinki, Childrens Hosp, Helsinki, Finland; [Siljander, Heli; Knip, Mikael] Helsinki Univ Hosp, Helsinki, Finland; [Siljander, Heli] Univ Helsinki, Diabet & Obes, Res Programs Unit, Helsinki, Finland; [Knip, Mikael] Folkhalsan Res Ctr, Helsinki, Finland; [Knip, Mikael] Tampere Univ Hosp, Dept Pediat, Tampere, Finland; [Xavier, Ramnik J.] MIT, Ctr Microbiome Informat & Therapeut, Cambridge, MA 02139 USA	Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; Harvard University; Massachusetts General Hospital; University of Colorado System; University of Colorado Boulder; Howard Hughes Medical Institute; University of Colorado System; University of Colorado Boulder; University of Helsinki; University of Helsinki; Helsinki University Central Hospital; University of Helsinki; Folkhalsan Research Center; Tampere University; Tampere University Hospital; Massachusetts Institute of Technology (MIT)	Xavier, RJ (corresponding author), Broad Inst Massachusetts Inst Technol MIT & Harva, Cambridge, MA 02142 USA.	xavier@molbio.mgh.harvard.edu; dirk.gevers@gmail.com	Knip, Mikael/AAL-3773-2020; Knight, Rob/D-1299-2010; Gevers, Dirk/C-1451-2009	Knip, Mikael/0000-0003-0474-0033; Knight, Rob/0000-0002-0975-9019	Crohn's and Colitis Foundation of America; Leona M. and Harry B. Helmsley Charitable Trust; US National Institutes of Health [U54 DK102557, R01 DK092405]; Howard Hughes Medical Institute; Finnish Centre of Excellence in Molecular Systems Immunology and Physiology Research (Academy of Finland) [250114]; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R01HG004872] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [U54DK102557, R01DK092405, P30DK043351, P01DK078669] Funding Source: NIH RePORTER	Crohn's and Colitis Foundation of America; Leona M. and Harry B. Helmsley Charitable Trust; US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Howard Hughes Medical Institute(Howard Hughes Medical Institute); Finnish Centre of Excellence in Molecular Systems Immunology and Physiology Research (Academy of Finland); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	We thank N. Nedelsky for editorial support. This work was supported in part by the Crohn's and Colitis Foundation of America, the Leona M. and Harry B. Helmsley Charitable Trust, US National Institutes of Health grants U54 DK102557 (R.J.X.) and R01 DK092405 (R.J.X.)., the Howard Hughes Medical Institute (R.K.) and the Finnish Centre of Excellence in Molecular Systems Immunology and Physiology Research 2012-17 (Academy of Finland, Decision No. 250114; M.K.).	Ahn TH, 2015, BIOINFORMATICS, V31, P170, DOI 10.1093/bioinformatics/btu641; Beitel CW, 2014, PEERJ, V2, DOI 10.7717/peerj.415; Crost EH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076341; Darling AE, 2014, PEERJ, V2, DOI 10.7717/peerj.243; David LA, 2014, GENOME BIOL, V15, DOI 10.1186/gb-2014-15-7-r89; Di Gioia D, 2014, APPL MICROBIOL BIOT, V98, P563, DOI 10.1007/s00253-013-5405-9; Eren A.M., 2014, ISME J, P968; Eren AM, 2013, METHODS ECOL EVOL, V4, P1111, DOI 10.1111/2041-210X.12114; Faith JJ, 2013, SCIENCE, V341, P44, DOI 10.1126/science.1237439; Greenblum S, 2015, CELL, V160, P583, DOI 10.1016/j.cell.2014.12.038; Han DS, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0107371; Hong CJ, 2014, MICROBIOME, V2, DOI 10.1186/2049-2618-2-33; Huang WC, 2012, BIOINFORMATICS, V28, P593, DOI 10.1093/bioinformatics/btr708; Huttenhower C, 2012, NATURE, V486, P207, DOI 10.1038/nature11234; Imelfort M, 2014, PEERJ, V2, DOI 10.7717/peerj.603; Ivanova N, 2003, NATURE, V423, P87, DOI 10.1038/nature01582; Karlsson E, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0085417; Kashtan N, 2014, SCIENCE, V344, P416, DOI 10.1126/science.1248575; Langmead B, 2012, NAT METHODS, V9, P357, DOI [10.1038/NMETH.1923, 10.1038/nmeth.1923]; Lasken RS, 2014, NAT REV GENET, V15, P577, DOI 10.1038/nrg3785; Lee SM, 2013, NATURE, V501, P426, DOI 10.1038/nature12447; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Lieberman TD, 2014, NAT GENET, V46, P82, DOI 10.1038/ng.2848; Luo CW, 2012, ISME J, V6, P898, DOI 10.1038/ismej.2011.147; Luo CW, 2011, P NATL ACAD SCI USA, V108, P7200, DOI 10.1073/pnas.1015622108; Maslunka C, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0105390; Miller JR, 2010, GENOMICS, V95, P315, DOI 10.1016/j.ygeno.2010.03.001; Morgan XC, 2012, GENOME BIOL, V13, DOI 10.1186/gb-2012-13-9-r79; Nandi T, 2015, GENOME RES, V25, P129, DOI 10.1101/gr.177543.114; Nielsen HB, 2014, NAT BIOTECHNOL, V32, P822, DOI 10.1038/nbt.2939; Nijkamp JF, 2013, BIOINFORMATICS, V29, P2826, DOI 10.1093/bioinformatics/btt502; ROBINSON DF, 1981, MATH BIOSCI, V53, P131, DOI 10.1016/0025-5564(81)90043-2; Schell MA, 2002, P NATL ACAD SCI USA, V99, P14422, DOI 10.1073/pnas.212527599; Schloissnig S, 2013, NATURE, V493, P45, DOI 10.1038/nature11711; Segata N, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3304; Segata N, 2012, NAT METHODS, V9, P811, DOI [10.1038/NMETH.2066, 10.1038/nmeth.2066]; Sela DA, 2008, P NATL ACAD SCI USA, V105, P18964, DOI 10.1073/pnas.0809584105; Sharon I, 2013, GENOME RES, V23, P111, DOI 10.1101/gr.142315.112; Sokol H, 2008, P NATL ACAD SCI USA, V105, P16731, DOI 10.1073/pnas.0804812105; Sunagawa S, 2013, NAT METHODS, V10, P1196, DOI [10.1038/NMETH.2693, 10.1038/nmeth.2693]	40	149	154	2	53	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156	1546-1696		NAT BIOTECHNOL	Nat. Biotechnol.	OCT	2015	33	10					1045	+		10.1038/nbt.3319	http://dx.doi.org/10.1038/nbt.3319			10	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	CT1JX	26344404	Bronze, Green Submitted, Green Accepted			2022-12-27	WOS:000362555700023
J	Eduati, F; Mangravite, LM; Wang, T; Tang, H; Bare, JC; Huang, RL; Norman, T; Kellen, M; Menden, MP; Yang, JC; Zhan, XW; Zhong, R; Xiao, GH; Xia, MH; Abdo, N; Kosyk, O; Friend, S; Dearry, A; Simeonov, A; Tice, RR; Rusyn, I; Wright, FA; Stolovitzky, G; Xie, Y; Saez-Rodriguez, J; Aittokallio, T; Alaimo, S; Amadoz, A; Ammad-ud-din, M; Azencott, CA; Bacardit, J; Barron, P; Bernard, E; Beyer, A; Bin, S; van Bommel, A; Borgwardt, K; Brys, AM; Caffrey, B; Chang, J; Chang, J; Chheda, H; Christodoulou, EG; Clement-Ziza, M; Cohen, T; Cowherd, M; Demeyer, S; Dopazo, J; Elhard, JD; Falcao, AO; Ferro, A; Friedenberg, DA; Giugno, R; Gong, YG; Gorospe, JW; Granville, CA; Grimm, D; Heinig, M; Hernansaiz, RD; Hintsanen, P; Hochreiter, S; Huang, LC; Huska, M; Jaiswal, A; Jiao, YL; Kaski, S; Kaur, I; Khan, SA; Klambauer, G; Krasnogor, N; Kuhn, M; Kursa, MB; Kutum, R; Lazzarini, N; Lee, I; Leung, MKK; Lim, WK; Liu, C; Lopez, FL; Mammana, A; Mayr, A; Michoel, T; Mongiovi, M; Moore, JD; Mpindi, JP; Narasimhan, R; Opiyo, SO; Pandey, G; Peabody, AL; Perner, J; Poso, A; Pulvirenti, A; Rawlik, K; Reinhardt, S; Riffle, CG; Ruderfer, D; Sander, AJ; Savage, RS; Scornet, E; Sebastian-Leon, P; Sharan, R; Simon-Gabriel, CJ; Stoven, V; Sun, JC; Tang, J; Teixeira, AL; Tenesa, A; Vert, JP; Vingron, M; Walter, T; Wennerberg, K; Whalen, S; Wisniewska, Z; Wu, YH; Xu, H; Zhang, SH; Zhao, JF; Zheng, WJ; Dai, ZW				Eduati, Federica; Mangravite, Lara M.; Wang, Tao; Tang, Hao; Bare, J. Christopher; Huang, Ruili; Norman, Thea; Kellen, Mike; Menden, Michael P.; Yang, Jichen; Zhan, Xiaowei; Zhong, Rui; Xiao, Guanghua; Xia, Menghang; Abdo, Nour; Kosyk, Oksana; Friend, Stephen; Dearry, Allen; Simeonov, Anton; Tice, Raymond R.; Rusyn, Ivan; Wright, Fred A.; Stolovitzky, Gustavo; Xie, Yang; Saez-Rodriguez, Julio; Aittokallio, Tero; Alaimo, Salvatore; Amadoz, Alicia; Ammad-ud-din, Muhammad; Azencott, Chloe-Agathe; Bacardit, Jaume; Barron, Pelham; Bernard, Elsa; Beyer, Andreas; Bin, Shao; van Boemmel, Alena; Borgwardt, Karsten; Brys, April M.; Caffrey, Brian; Chang, Jeffrey; Chang, Jungsoo; Chheda, Himanshu; Christodoulou, Eleni G.; Clement-Ziza, Mathieu; Cohen, Trevor; Cowherd, Marianne; Demeyer, Sofie; Dopazo, Joaquin; Elhard, Joel D.; Falcao, Andre O.; Ferro, Alfredo; Friedenberg, David A.; Giugno, Rosalba; Gong, Yunguo; Gorospe, Jenni W.; Granville, Courtney A.; Grimm, Dominik; Heinig, Matthias; Hernansaiz, Rosa D.; Hintsanen, Petteri; Hochreiter, Sepp; Huang, Liang-Chin; Huska, Matthew; Jaiswal, Alok; Jiao, Yunlong; Kaski, Samuel; Kaur, Ismeet; Khan, Suleiman Ali; Klambauer, Guenter; Krasnogor, Natalio; Kuhn, Michael; Kursa, Miron Bartosz; Kutum, Rintu; Lazzarini, Nicola; Lee, Inhan; Leung, Michael K. K.; Lim, Weng Khong; Liu, Charlie; Lopez, Felipe Llinares; Mammana, Alessandro; Mayr, Andreas; Michoel, Tom; Mongiovi, Misael; Moore, Jonathan D.; Mpindi, John-Patrick; Narasimhan, Ravi; Opiyo, Stephen O.; Pandey, Gaurav; Peabody, Andrea L.; Perner, Juliane; Poso, Antti; Pulvirenti, Alfredo; Rawlik, Konrad; Reinhardt, Susanne; Riffle, Carol G.; Ruderfer, Douglas; Sander, Aaron J.; Savage, Richard S.; Scornet, Erwan; Sebastian-Leon, Patricia; Sharan, Roded; Simon-Gabriel, Carl Johann; Stoven, Veronique; Sun, Jingchun; Tang, Jing; Teixeira, Ana L.; Tenesa, Albert; Vert, Jean-Philippe; Vingron, Martin; Walter, Thomas; Wennerberg, Krister; Whalen, Sean; Wisniewska, Zofia; Wu, Yonghui; Xu, Hua; Zhang, Shihua; Zhao, Junfei; Zheng, W. Jim; Dai Ziwei		NIEHS-NCATS-UNC DREAM	Prediction of human population responses to toxic compounds by a collaborative competition	NATURE BIOTECHNOLOGY			English	Article							GENOME-WIDE ASSOCIATION; EXPRESSION; SENSITIVITY; KNOWLEDGE; LIBRARY; MODEL; SET	The ability to computationally predict the effects of toxic compounds on humans could help address the deficiencies of current chemical safety testing. Here, we report the results from a community-based DREAM challenge to predict toxicities of environmental compounds with potential adverse health effects for human populations. We measured the cytotoxicity of 156 compounds in 884 lymphoblastoid cell lines for which genotype and transcriptional data are available as part of the Tox21 1000 Genomes Project. The challenge participants developed algorithms to predict interindividual variability of toxic response from genomic profiles and population-level cytotoxicity data from structural attributes of the compounds. 179 submitted predictions were evaluated against an experimental data set to which participants were blinded. Individual cytotoxicity predictions were better than random, with modest correlations (Pearson's r < 0.28), consistent with complex trait genomic prediction. In contrast, predictions of population-level response to different compounds were higher (r < 0.66). The results highlight the possibility of predicting health risks associated with unknown compounds, although risk estimation accuracy remains suboptimal.	[Eduati, Federica; Menden, Michael P.; Saez-Rodriguez, Julio] European Bioinformat Inst, European Mol Biol Lab, Cambridge, England; [Mangravite, Lara M.; Bare, J. Christopher; Norman, Thea; Kellen, Mike; Friend, Stephen] Sage Bionetworks, Seattle, WA USA; [Wang, Tao; Tang, Hao; Yang, Jichen; Zhong, Rui; Xiao, Guanghua; Xie, Yang] Univ Texas SW Med Ctr Dallas, Dept Clin Sci, Quantitat Biomed Res Ctr, Dallas, TX 75390 USA; [Tang, Hao; Xie, Yang] Univ Texas SW Med Ctr Dallas, Simmons Comprehens Canc Ctr, Dallas, TX 75390 USA; [Huang, Ruili; Xia, Menghang; Simeonov, Anton] NIH, Div Preclin Innovat, Chem Genom Ctr, Natl Ctr Adv Translat Sci, Rockville, MD USA; [Zhan, Xiaowei] Univ Michigan, Dept Biostat, Ann Arbor, MI 48109 USA; [Abdo, Nour; Kosyk, Oksana; Rusyn, Ivan] Univ N Carolina, Dept Environm Sci & Engn, Chapel Hill, NC USA; [Abdo, Nour] Jordan Univ Sci & Technol, Fac Med, Dept Publ Hlth, Irbid, Jordan; [Dearry, Allen; Tice, Raymond R.] NIEHS, NIH, US Dept HHS, Res Triangle Pk, NC 27709 USA; [Wright, Fred A.] N Carolina State Univ, Bioinformat Res Ctr, Dept Stat & Biol Sci, Raleigh, NC 27695 USA; [Stolovitzky, Gustavo] IBM Corp, IBM TJ Watson Res Ctr, Yorktown Hts, NY USA; [Aittokallio, Tero; Chheda, Himanshu; Hintsanen, Petteri; Jaiswal, Alok; Mpindi, John-Patrick; Tang, Jing; Wennerberg, Krister] Univ Helsinki, Inst Mol Med Finland FIMM, Helsinki, Finland; [Alaimo, Salvatore; Mongiovi, Misael] Univ Catania, Dept Math & Comp Sci, Catania, Italy; [Amadoz, Alicia; Dopazo, Joaquin; Hernansaiz, Rosa D.; Sebastian-Leon, Patricia] CIPF, Computat Genom Dept, Valencia, Spain; [Ammad-ud-din, Muhammad; Kaski, Samuel; Khan, Suleiman Ali] Aalto Univ, Helsinki Inst Informat Technol, Dept Informat & Comp Sci, Espoo, Finland; [Azencott, Chloe-Agathe; Borgwardt, Karsten; Grimm, Dominik; Lopez, Felipe Llinares; Simon-Gabriel, Carl Johann] Max Planck Inst Dev Biol, Machine Learning & Computat Biol Res Grp, Tubingen, Germany; [Azencott, Chloe-Agathe; Borgwardt, Karsten; Grimm, Dominik; Lopez, Felipe Llinares; Simon-Gabriel, Carl Johann] Max Planck Inst Intelligent Syst, Machine Learning & Computat Biol Res Grp, Tubingen, Germany; [Bacardit, Jaume; Krasnogor, Natalio; Lazzarini, Nicola] Newcastle Univ, Interdisciplinary Comp & Complex BioSystems ICOS, Newcastle Upon Tyne, Tyne & Wear, England; [Barron, Pelham; Chang, Jungsoo; Cowherd, Marianne; Lee, Inhan] MiRcore, Ann Arbor, MI USA; [Bernard, Elsa; Jiao, Yunlong; Scornet, Erwan; Stoven, Veronique; Vert, Jean-Philippe; Walter, Thomas] Ctr Computat Biol, Mines ParisTech, Fontainebleau, France; [Bernard, Elsa; Jiao, Yunlong; Scornet, Erwan; Stoven, Veronique; Vert, Jean-Philippe; Walter, Thomas] Inst Curie, Paris, France; [Bernard, Elsa; Jiao, Yunlong; Scornet, Erwan; Stoven, Veronique; Vert, Jean-Philippe; Walter, Thomas] INSERM U900, Paris, France; [Beyer, Andreas; Christodoulou, Eleni G.; Clement-Ziza, Mathieu; Kuhn, Michael; Reinhardt, Susanne] Tech Univ Dresden, BIOTEC, Dresden, Germany; [Beyer, Andreas; Clement-Ziza, Mathieu] Univ Cologne, CECAD, Cologne, Germany; [Bin, Shao; Dai Ziwei] Peking Univ, Ctr Quantitat Biol, Beijing, Peoples R China; [van Boemmel, Alena; Caffrey, Brian; Heinig, Matthias; Huska, Matthew; Mammana, Alessandro; Perner, Juliane; Vingron, Martin] Max Planck Inst Mol Genet, Berlin, Germany; [Brys, April M.; Elhard, Joel D.; Friedenberg, David A.; Gorospe, Jenni W.; Granville, Courtney A.; Peabody, Andrea L.; Riffle, Carol G.; Sander, Aaron J.] Battelle Mem Inst, Columbus, OH USA; [Chang, Jeffrey; Cohen, Trevor; Gong, Yunguo; Huang, Liang-Chin; Sun, Jingchun; Wu, Yonghui; Xu, Hua; Zheng, W. Jim] Univ Texas Hlth Sci Ctr Houston, Sch Biomed Informat, Houston, TX 77030 USA; [Chang, Jeffrey] Univ Texas Hlth Sci Ctr Houston, Dept Integrat Biol & Pharmacol, Houston, TX 77030 USA; [Demeyer, Sofie; Michoel, Tom; Rawlik, Konrad; Tenesa, Albert] Univ Edinburgh, Roslin Inst, Div Genet & Genom, Edinburgh, Midlothian, Scotland; [Falcao, Andre O.; Teixeira, Ana L.] Univ Lisbon, Dept Informat, LaSIGE, Fac Ciencias, Lisbon, Portugal; [Ferro, Alfredo; Giugno, Rosalba; Pulvirenti, Alfredo] Univ Catania, Dept Clin & Mol Biomed, Catania, Italy; [Heinig, Matthias] Max Delbruck Ctr Mol Med, Berlin, Germany; [Hochreiter, Sepp; Klambauer, Guenter; Mayr, Andreas] Johannes Kepler Univ Linz, Inst Bioinformat, Linz, Austria; [Kaur, Ismeet] Adobe, San Jose, CA USA; [Kursa, Miron Bartosz; Wisniewska, Zofia] Univ Warsaw, Interdisciplinary Ctr Math & Computat Modelling, Warsaw, Poland; [Kutum, Rintu] CSIR, Inst Genom Integrat Biol, New Delhi, India; [Leung, Michael K. K.] Univ Toronto, Dept Elect & Comp Engn, Toronto, ON, Canada; [Lim, Weng Khong] Natl Canc Ctr Singapore, Singapore, Singapore; [Liu, Charlie] Stepping Stone Genom, Mclean, VA USA; [Moore, Jonathan D.; Savage, Richard S.] Univ Warwick, Syst Biol Ctr, Coventry, W Midlands, England; [Narasimhan, Ravi] Vital Connect Inc, Campbell, CA USA; [Opiyo, Stephen O.] Ohio State Univ, Mol & Mol Imaging Ctr, Columbus, OH 43210 USA; [Pandey, Gaurav; Ruderfer, Douglas; Whalen, Sean] Mt Sinai, New York, NY USA; [Poso, Antti] Univ Eastern Finland, Sch Pharm, Fac Hlth Sci, Kuopio, Finland; [Savage, Richard S.] Univ Warwick, Warwick Med Sch, Coventry, W Midlands, England; [Scornet, Erwan] Univ Paris 06, Paris, France; [Sharan, Roded] Tel Aviv Univ, Sch Comp Sci, Tel Aviv, Israel; [Teixeira, Ana L.] Univ Lisbon, Ctr Quim Bioquim, Fac Ciencias, Lisbon, Portugal; [Whalen, Sean] Gladstone Inst, San Francisco, CA USA; [Zhang, Shihua; Zhao, Junfei] Chinese Acad Sci, Acad Math & Syst Sci, Natl Ctr Math & Interdisciplinary Sci, Beijing, Peoples R China	European Molecular Biology Laboratory (EMBL); University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas; National Institutes of Health (NIH) - USA; NIH National Center for Advancing Translational Sciences (NCATS); University of Michigan System; University of Michigan; University of North Carolina; University of North Carolina Chapel Hill; Jordan University of Science & Technology; National Institutes of Health (NIH) - USA; NIH National Institute of Environmental Health Sciences (NIEHS); University of North Carolina; North Carolina State University; International Business Machines (IBM); University of Helsinki; University of Catania; Prince Felipe Research Center; Aalto University; University of Helsinki; Max Planck Society; Max Planck Society; Newcastle University - UK; UDICE-French Research Universities; PSL Research University Paris; MINES ParisTech; UDICE-French Research Universities; PSL Research University Paris; UNICANCER; Institut Curie; UDICE-French Research Universities; PSL Research University Paris; UNICANCER; Institut Curie; Institut National de la Sante et de la Recherche Medicale (Inserm); Technische Universitat Dresden; University of Cologne; Peking University; Max Planck Society; Battelle Memorial Institute; University of Texas System; University of Texas Health Science Center Houston; University of Texas System; University of Texas Health Science Center Houston; UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); Roslin Institute; University of Edinburgh; Universidade de Lisboa; University of Catania; Helmholtz Association; Max Delbruck Center for Molecular Medicine; Johannes Kepler University Linz; Adobe Systems Inc.; University of Warsaw; Interdisciplinary Centre for Mathematical & Computational Modelling; Council of Scientific & Industrial Research (CSIR) - India; CSIR - Institute of Genomics & Integrative Biology (IGIB); University of Toronto; National Cancer Centre Singapore (NCCS); University of Warwick; University System of Ohio; Ohio State University; University of Eastern Finland; University of Warwick; UDICE-French Research Universities; Sorbonne Universite; Tel Aviv University; Universidade de Lisboa; University of California System; University of California San Francisco; The J David Gladstone Institutes; Chinese Academy of Sciences; Academy of Mathematics & System Sciences, CAS	Saez-Rodriguez, J (corresponding author), Rhein Westfal TH Aachen, Joint Res Ctr Computat Biomed JRC COMBINE, Aachen, Germany.	Yang.Xie@utsouthwestern.edu; saezrodriguez@combine.rwth-aachen.de	Moore, Jonathan D/D-1796-2013; Beyer, Andreas/AAQ-5519-2020; Wennerberg, Krister/AAH-2919-2022; Lim, Weng Khong/Q-8661-2019; Rusyn, Ivan/S-2426-2016; Clément-Ziza, Mathieu/J-4146-2012; Ruderfer, Douglas M/M-5795-2016; SEBASTIAN-LEON, PATRICIA/AAA-8009-2020; Mongiovì, Misael/GNP-0059-2022; ALAIMO, Salvatore/K-4745-2017; Bernard, Elsa/AAD-8682-2020; Bacardit, Jaume/F-9293-2014; Pulvirenti, Alfredo/I-7272-2018; Saez-Rodriguez, Julio/H-7114-2019; Motsinger-Reif, Alison/I-4167-2018; Hochreiter, Sepp/AAI-5904-2020; Zhao, Junfei/J-1425-2018; Tang, Jing/H-4084-2012; SHAO, BIN/ABE-4975-2021; Tang, Jing/W-1764-2019; Kursa, Miron/B-4405-2013; tang, jing/HHR-9815-2022; Kaski, Samuel/B-6684-2008; Scornet, Erwan/AAE-7811-2020; Falcao, Andre O./A-3545-2010; Aittokallio, Tero/B-6583-2009; Wennerberg, Krister/AFM-0539-2022; Eduati, Federica/AAH-6526-2021; Wang, Tao/K-3518-2016; Amadoz, Alicia/A-9598-2014; Grimm, Dominik/L-9088-2019; yang, jichen/HDL-9203-2022; Walter, Thomas/B-9079-2015	Moore, Jonathan D/0000-0002-5486-0407; Beyer, Andreas/0000-0002-3891-2123; Wennerberg, Krister/0000-0002-1352-4220; Lim, Weng Khong/0000-0003-4391-1130; Clément-Ziza, Mathieu/0000-0003-2763-249X; Ruderfer, Douglas M/0000-0002-2365-386X; SEBASTIAN-LEON, PATRICIA/0000-0001-7299-3660; Mongiovì, Misael/0000-0003-0528-5490; ALAIMO, Salvatore/0000-0003-4825-7617; Bernard, Elsa/0000-0002-2057-7187; Bacardit, Jaume/0000-0002-2692-7205; Pulvirenti, Alfredo/0000-0002-9764-0295; Saez-Rodriguez, Julio/0000-0002-8552-8976; Motsinger-Reif, Alison/0000-0003-1346-2493; Hochreiter, Sepp/0000-0001-7449-2528; Tang, Jing/0000-0001-7480-7710; SHAO, BIN/0000-0001-8697-2174; Tang, Jing/0000-0001-7480-7710; Kursa, Miron/0000-0001-7672-648X; Kaski, Samuel/0000-0003-1925-9154; Falcao, Andre O./0000-0002-3588-8746; Aittokallio, Tero/0000-0002-0886-9769; Wennerberg, Krister/0000-0002-1352-4220; Eduati, Federica/0000-0002-7822-3867; Amadoz, Alicia/0000-0003-3915-0404; Grimm, Dominik/0000-0003-2085-4591; Demeyer, Sofie/0000-0002-8193-5734; Kutum, Rintu/0000-0001-8667-6199; Bare, J. Christopher/0000-0003-1006-1491; Hernansaiz Ballesteros, Rosa/0000-0001-8536-8848; Michoel, Tom/0000-0003-4749-4725; Rusyn, Ivan/0000-0001-9340-7384; Heinig, Matthias/0000-0002-5612-1720; Cowherd, Marianne/0000-0002-3165-4504; van Bommel, Alena/0000-0002-8434-8586; Dai, Ziwei/0000-0002-0858-638X; Vert, Jean-Philippe/0000-0001-9510-8441; Friedenberg, David/0000-0002-4404-8941; Poso, Antti/0000-0003-4196-4204; Azencott, Chloe-Agathe/0000-0003-1003-301X; Tenesa, Albert/0000-0003-4884-4475; Walter, Thomas/0000-0001-7419-7879; Giugno, Rosalba/0000-0001-9843-7638; Borgwardt, Karsten/0000-0001-7221-2393; Mangravite, Lara/0000-0001-7841-3612; Chang, Jungsoo/0000-0001-5901-6929	US National Institutes of Health (NIH); National Institute of Environmental Health Sciences (NIEHS) [Y2-ES-7020-01]; US Environmental Protection Agency [STAR RD83516601, RD83382501]; NIH [R01CA161608, R01HG006292, 5R01CA152301, 1R01CA172211]; European Molecular Biology Laboratory Interdisciplinary Post-Docs (EMBL EIPOD); Marie Curie Actions (COFUND); MRC [G0902104] Funding Source: UKRI; Medical Research Council [G0902104] Funding Source: researchfish; NATIONAL CANCER INSTITUTE [R01CA161608, R01CA172211, R01CA152301] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [ZIATR000038, ZICTR000040] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R01HG006292] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P42ES005948, T32ES007020] Funding Source: NIH RePORTER	US National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institute of Environmental Health Sciences (NIEHS)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); US Environmental Protection Agency(United States Environmental Protection Agency); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); European Molecular Biology Laboratory Interdisciplinary Post-Docs (EMBL EIPOD); Marie Curie Actions (COFUND); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This research was supported in part by the US National Institutes of Health (NIH), National Institute of Environmental Health Sciences (NIEHS). This work was made possible by US Environmental Protection Agency grants STAR RD83516601 and RD83382501, NIH grants R01CA161608 and R01HG006292, and through an interagency agreement (IAG #Y2-ES-7020-01) from NIEHS to NCATS. F.E. thanks European Molecular Biology Laboratory Interdisciplinary Post-Docs (EMBL EIPOD) and Marie Curie Actions (COFUND) for funding. Best performing team was funded by NIH grants 5R01CA152301 and 1R01CA172211.	Abdo N, 2015, ENVIRON HEALTH PERSP, V123, P458, DOI 10.1289/ehp.1408775; Altshuler D, 2010, NATURE, V467, P1061, DOI 10.1038/nature09534; Altshuler DM, 2012, NATURE, V491, P56, DOI 10.1038/nature11632; Brown CC, 2014, PHARMACOGENOMICS, V15, P137, DOI 10.2217/pgs.13.213; Burczynski ME, 2000, TOXICOL SCI, V58, P399, DOI 10.1093/toxsci/58.2.399; Caliskan M, 2011, HUM MOL GENET, V20, P1643, DOI 10.1093/hmg/ddr041; Chatterjee N, 2013, NAT GENET, V45, P400, DOI 10.1038/ng.2579; Choy E, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000287; Collins FS, 2008, SCIENCE, V319, P906, DOI 10.1126/science.1154619; Costello JC, 2014, NAT BIOTECHNOL, V32, P1202, DOI 10.1038/nbt.2877; Derry JMJ, 2012, NAT GENET, V44, P127, DOI 10.1038/ng.1089; Dorne JLCM, 2010, TOXICOLOGY, V268, P156, DOI 10.1016/j.tox.2009.11.004; Gamazon ER, 2013, BLOOD, V121, P4366, DOI 10.1182/blood-2012-10-464149; Gaulton A, 2012, NUCLEIC ACIDS RES, V40, pD1100, DOI 10.1093/nar/gkr777; Jacobs AC, 2013, VET PATHOL, V50, P324, DOI 10.1177/0300985812450727; Johnson WE, 2007, BIOSTATISTICS, V8, P118, DOI 10.1093/biostatistics/kxj037; Judson R, 2009, ENVIRON HEALTH PERSP, V117, P685, DOI 10.1289/ehp.0800168; Kanehisa M, 2014, NUCLEIC ACIDS RES, V42, pD199, DOI 10.1093/nar/gkt1076; Kleinstreuer NC, 2014, NAT BIOTECHNOL, V32, P583, DOI 10.1038/nbt.2914; Kuz'min VE, 2008, J COMPUT AID MOL DES, V22, P403, DOI 10.1007/s10822-008-9179-6; Lappalainen T, 2013, NATURE, V501, P506, DOI 10.1038/nature12531; Lipinski CA, 2001, ADV DRUG DELIVER REV, V46, P3, DOI 10.1016/S0169-409X(00)00129-0; Mangravite LM, 2013, NATURE, V502, P377, DOI 10.1038/nature12508; Marbach D, 2012, NAT METHODS, V9, P796, DOI [10.1038/nmeth.2016, 10.1038/NMETH.2016]; Margolin AA, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3006112; Meyer P, 2014, BMC SYST BIOL, V8, DOI 10.1186/1752-0509-8-13; Park JH, 2010, NAT GENET, V42, P570, DOI 10.1038/ng.610; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Rogers D, 2010, J CHEM INF MODEL, V50, P742, DOI 10.1021/ci100050t; Steinbeck C, 2003, J CHEM INF COMP SCI, V43, P493, DOI 10.1021/ci025584y; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Todeschini R., 2004, WEB VERSION, V3; Uehara T, 2011, TOXICOL APPL PHARM, V255, P297, DOI 10.1016/j.taap.2011.07.001; Wang YL, 2012, NUCLEIC ACIDS RES, V40, pD400, DOI [10.1093/nar/gkr1132, 10.1093/nar/gkr1293]; Xia M, 2008, ENVIRON HEALTH PERSP, V116, P284, DOI 10.1289/ehp.10727; Yang JA, 2010, NAT GENET, V42, P565, DOI 10.1038/ng.608; Zeise L, 2013, ENVIRON HEALTH PERSP, V121, P23, DOI 10.1289/ehp.1205687; Zheng WF, 2000, J CHEM INF COMP SCI, V40, P185, DOI 10.1021/ci980033m	38	68	69	1	26	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156	1546-1696		NAT BIOTECHNOL	Nat. Biotechnol.	SEP	2015	33	9					933	+		10.1038/nbt.3299	http://dx.doi.org/10.1038/nbt.3299			11	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	CR0EK	26258538	Green Published, hybrid, Green Accepted			2022-12-27	WOS:000360990900021
J	Nihongaki, Y; Kawano, F; Nakajima, T; Sato, M				Nihongaki, Yuta; Kawano, Fuun; Nakajima, Takahiro; Sato, Moritoshi			Photoactivatable CRISPR-Cas9 for optogenetic genome editing	NATURE BIOTECHNOLOGY			English	Article							NUCLEASE-INDUCED MUTATIONS; HUMAN-CELLS; TARGET DNA; GUIDE RNA; CAS9; PROTEIN; SPECIFICITY; SYSTEM; ENDONUCLEASE; ACTIVATION	We describe an engineered photoactivatable Cas9 (paCas9) that enables optogenetic control of CRISPR-Cas9 genome editing in human cells. paCas9 consists of split Cas9 fragments and photoinducible dimerization domains named Magnets. In response to blue light irradiation, paCas9 expressed in human embryonic kidney 293T cells induces targeted genome sequence modifications through both nonhomologous end joining and homology-directed repair pathways. Genome editing activity can be switched off simply by extinguishing the light. We also demonstrate activation of paCas9 in spatial patterns determined by the sites of irradiation. Optogenetic control of targeted genome editing should facilitate improved understanding of complex gene networks and could prove useful in biomedical applications.	[Nihongaki, Yuta; Kawano, Fuun; Nakajima, Takahiro; Sato, Moritoshi] Univ Tokyo, Grad Sch Arts & Sci, Meguro Ku, Tokyo, Japan	University of Tokyo	Sato, M (corresponding author), Univ Tokyo, Grad Sch Arts & Sci, Meguro Ku, Tokyo, Japan.	cmsato@mail.ecc.u-tokyo.ac.jp	Sato, Moritoshi/O-2735-2018; Kawano, Fuun/U-5777-2019	Sato, Moritoshi/0000-0002-3095-5831; Nihongaki, Yuta/0000-0002-9818-9344	Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT); Japan Society for the Promotion of Science (JSPS); Grants-in-Aid for Scientific Research [15J05897] Funding Source: KAKEN	Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Japan Society for the Promotion of Science (JSPS)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	We would like to thank J. Galipon for technical assistance. This work was supported by Platform for Dynamic Approaches to Living System from the Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT) and by grants from Japan Society for the Promotion of Science (JSPS).	Anders C, 2014, NATURE, V513, P569, DOI 10.1038/nature13579; Brieke C, 2012, ANGEW CHEM INT EDIT, V51, P8446, DOI 10.1002/anie.201202134; Bugaj LJ, 2013, NAT METHODS, V10, P249, DOI 10.1038/nmeth.2360; Cong L, 2013, SCIENCE, V339, P819, DOI 10.1126/science.1231143; DeRose R, 2013, PFLUG ARCH EUR J PHY, V465, P409, DOI 10.1007/s00424-012-1208-6; Dow LE, 2015, NAT BIOTECHNOL, V33, P390, DOI 10.1038/nbt.3155; Fu YF, 2013, NAT BIOTECHNOL, V31, P822, DOI 10.1038/nbt.2623; Gonzalez F, 2014, CELL STEM CELL, V15, P215, DOI 10.1016/j.stem.2014.05.018; Hsu PD, 2013, NAT BIOTECHNOL, V31, P827, DOI 10.1038/nbt.2647; Jinek M, 2013, ELIFE, V2, DOI 10.7554/eLife.00471; Kawano F, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7256; Kennedy MJ, 2010, NAT METHODS, V7, P973, DOI 10.1038/NMETH.1524; Kim H, 2011, NAT METHODS, V8, P941, DOI [10.1038/NMETH.1733, 10.1038/nmeth.1733]; Kim S, 2014, GENOME RES, V24, P1012, DOI 10.1101/gr.171322.113; Laplante M, 2012, CELL, V149, P274, DOI 10.1016/j.cell.2012.03.017; Lee HM, 2009, ACS CHEM BIOL, V4, P409, DOI 10.1021/cb900036s; Lin YC, 2013, ANGEW CHEM INT EDIT, V52, P6450, DOI 10.1002/anie.201301219; Mali P, 2013, NAT BIOTECHNOL, V31, P833, DOI 10.1038/nbt.2675; Mali P, 2013, SCIENCE, V339, P823, DOI 10.1126/science.1232033; Nihongaki Y, 2015, CHEM BIOL, V22, P169, DOI 10.1016/j.chembiol.2014.12.011; Nishimasu H, 2014, CELL, V156, P935, DOI 10.1016/j.cell.2014.02.001; Polstein LR, 2015, NAT CHEM BIOL, V11, P198, DOI 10.1038/nchembio.1753; Qi LS, 2013, CELL, V152, P1173, DOI 10.1016/j.cell.2013.02.022; Ramakrishna S, 2014, GENOME RES, V24, P1020, DOI 10.1101/gr.171264.113; Ramakrishna S, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4378; Ran FA, 2013, CELL, V154, P1380, DOI 10.1016/j.cell.2013.08.021; Shen ZF, 2014, DEV CELL, V30, P625, DOI 10.1016/j.devcel.2014.07.017; Voon DC, 2005, NUCLEIC ACIDS RES, V33, DOI 10.1093/nar/gni030; Zetsche B, 2015, NAT BIOTECHNOL, V33, P139, DOI 10.1038/nbt.3149; Zuris JA, 2015, NAT BIOTECHNOL, V33, P73, DOI 10.1038/nbt.3081	30	380	419	6	258	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156	1546-1696		NAT BIOTECHNOL	Nat. Biotechnol.	JUL	2015	33	7					755	760		10.1038/nbt.3245	http://dx.doi.org/10.1038/nbt.3245			6	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	CN4JJ	26076431				2022-12-27	WOS:000358396100032
J	Canales, A; Jia, XT; Froriep, UP; Koppes, RA; Tringides, CM; Selvidge, J; Lu, C; Hou, C; Wei, L; Fink, Y; Anikeeva, P				Canales, Andres; Jia, Xiaoting; Froriep, Ulrich P.; Koppes, Ryan A.; Tringides, Christina M.; Selvidge, Jennifer; Lu, Chi; Hou, Chong; Wei, Lei; Fink, Yoel; Anikeeva, Polina			Multifunctional fibers for simultaneous optical, electrical and chemical interrogation of neural circuits in vivo	NATURE BIOTECHNOLOGY			English	Article							TISSUE; BRAIN; ELECTRODE; NEURONS; DESIGN; PROBE; CHANNELRHODOPSIN-2; RECORDINGS; SYSTEMS; SURFACE	Brain function depends on simultaneous electrical, chemical and mechanical signaling at the cellular level. This multiplicity has confounded efforts to simultaneously measure or modulate these diverse signals in vivo. Here we present fiber probes that allow for simultaneous optical stimulation, neural recording and drug delivery in behaving mice with high resolution. These fibers are fabricated from polymers by means of a thermal drawing process that allows for the integration of multiple materials and interrogation modalities into neural probes. Mechanical, electrical, optical and microfluidic measurements revealed high flexibility and functionality of the probes under bending deformation. Long-term in vivo recordings, optogenetic stimulation, drug perturbation and analysis of tissue response confirmed that our probes can form stable brain-machine interfaces for at least 2 months. We expect that our multifunctional fibers will permit more detailed manipulation and analysis of neural circuits deep in the brain of behaving animals than achievable before.	[Canales, Andres; Tringides, Christina M.; Selvidge, Jennifer; Lu, Chi; Hou, Chong; Fink, Yoel; Anikeeva, Polina] MIT, Dept Mat Sci & Engn, Cambridge, MA 02139 USA; [Jia, Xiaoting; Froriep, Ulrich P.; Koppes, Ryan A.; Wei, Lei; Fink, Yoel; Anikeeva, Polina] MIT, Res Lab Elect, Cambridge, MA 02139 USA; [Froriep, Ulrich P.] MIT, Simons Ctr Social Brain, Cambridge, MA 02139 USA	Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT)	Anikeeva, P (corresponding author), MIT, Dept Mat Sci & Engn, Cambridge, MA 02139 USA.	anikeeva@mit.edu	Hou, Chong/E-7433-2015; Jia, Xiaoting/E-2669-2015; Wei, Lei/F-1596-2010; Koppes, Ryan/AAK-3044-2020	Hou, Chong/0000-0002-1975-0747; Jia, Xiaoting/0000-0003-4890-6103; Wei, Lei/0000-0003-0819-8325	National Science Foundation under a CAREER award [CBET-1253890]; Center for Materials Science and Engineering [DMR-0819762]; Center for Sensorimotor Neural Engineering [EEC-1028725]; McGovern Institute for Brain Research; US Army Research Laboratory; US Army Research Office through the Institute for Soldier Nanotechnologies [W911NF-13-D-0001]; Simons Foundation	National Science Foundation under a CAREER award; Center for Materials Science and Engineering; Center for Sensorimotor Neural Engineering(National Science Foundation (NSF)); McGovern Institute for Brain Research; US Army Research Laboratory(United States Department of DefenseUS Army Research Laboratory (ARL)); US Army Research Office through the Institute for Soldier Nanotechnologies; Simons Foundation	This work was supported in part by the National Science Foundation under a CAREER award to P.A. (CBET-1253890), the Center for Materials Science and Engineering (DMR-0819762), the Center for Sensorimotor Neural Engineering (EEC-1028725), the McGovern Institute for Brain Research, the US Army Research Laboratory and the US Army Research Office through the Institute for Soldier Nanotechnologies under contract number W911NF-13-D-0001, and a grant from the Simons Foundation to the Simons Center for the Social Brain at MIT. The authors are grateful to G. Feng for the generous donation of Thy1-ChR2-YFP mice, W. Jia and J. LaVine for initial help with microfluidic characterization and C. Moritz and L.H. Tsai for assistance with equipment.	Abouraddy AF, 2007, NAT MATER, V6, P336, DOI 10.1038/nmat1889; Aden M, 2010, J POLYM SCI POL PHYS, V48, P451, DOI 10.1002/polb.21906; Anikeeva P, 2012, NAT NEUROSCI, V15, P163, DOI 10.1038/nn.2992; Arenkiel BR, 2007, NEURON, V54, P205, DOI 10.1016/j.neuron.2007.03.005; Borschel GH, 2003, J SURG RES, V114, P133, DOI 10.1016/S0022-4804(03)00255-5; CAMPBELL PK, 1991, IEEE T BIO-MED ENG, V38, P758, DOI 10.1109/10.83588; Cardin JA, 2010, NAT PROTOC, V5, P247, DOI 10.1038/nprot.2009.228; Chow BY, 2010, NATURE, V463, P98, DOI 10.1038/nature08652; Ferguson JE, 2009, SENSOR ACTUAT A-PHYS, V156, P388, DOI 10.1016/j.sna.2009.10.001; GOFF D, 2002, FIBER OPTIC REFERENC; Gradinaru V, 2010, CELL, V141, P154, DOI 10.1016/j.cell.2010.02.037; Gradinaru V, 2009, SCIENCE, V324, P354, DOI 10.1126/science.1167093; Green MA, 2008, NMR BIOMED, V21, P755, DOI 10.1002/nbm.1254; Holtmaat A, 2009, NAT REV NEUROSCI, V10, P647, DOI 10.1038/nrn2699; Jog MS, 2002, J NEUROSCI METH, V117, P141, DOI 10.1016/S0165-0270(02)00092-4; Karumbaiah L, 2013, BIOMATERIALS, V34, P8061, DOI 10.1016/j.biomaterials.2013.07.016; KENNEDY PR, 1989, J NEUROSCI METH, V29, P181, DOI 10.1016/0165-0270(89)90142-8; Khanarian G, 2001, OPT ENG, V40, P1024, DOI 10.1117/1.1369411; Kim DH, 2010, NAT MATER, V9, P511, DOI [10.1038/NMAT2745, 10.1038/nmat2745]; Kozai TDY, 2012, NAT MATER, V11, P1065, DOI [10.1038/NMAT3468, 10.1038/nmat3468]; Kravitz AV, 2012, NAT NEUROSCI, V15, P816, DOI 10.1038/nn.3100; Kuo JTW, 2013, LAB CHIP, V13, P554, DOI 10.1039/c2lc40935f; LeChasseur Y, 2011, NAT METHODS, V8, P319, DOI 10.1038/NMETH.1572; Lee H, 2005, J NEURAL ENG, V2, P81, DOI 10.1088/1741-2560/2/4/003; Lind G, 2013, SCI REP-UK, V3, DOI 10.1038/srep02942; Mattis J, 2012, NAT METHODS, V9, P159, DOI [10.1038/nmeth.1808, 10.1038/NMETH.1808]; MCNAUGHTON BL, 1983, J NEUROSCI METH, V8, P391, DOI 10.1016/0165-0270(83)90097-3; Merolli A, 1999, J MATER SCI-MATER M, V10, P265, DOI 10.1023/A:1008949311714; Minev IR, 2013, ACTA BIOMATER, V9, P6936, DOI 10.1016/j.actbio.2013.02.048; Polikov VS, 2005, J NEUROSCI METH, V148, P1, DOI 10.1016/j.jneumeth.2005.08.015; Prasad A, 2012, J NEURAL ENG, V9, DOI 10.1088/1741-2560/9/5/056015; Quiroga RQ, 2004, NEURAL COMPUT, V16, P1661, DOI 10.1162/089976604774201631; Ramirez S, 2013, SCIENCE, V341, P387, DOI 10.1126/science.1239073; Rubehn B, 2013, LAB CHIP, V13, P579, DOI 10.1039/c2lc40874k; Saxena T, 2013, BIOMATERIALS, V34, P4703, DOI 10.1016/j.biomaterials.2013.03.007; Schmitzer-Torbert N, 2005, NEUROSCIENCE, V131, P1, DOI 10.1016/j.neuroscience.2004.09.066; Seymour JP, 2007, BIOMATERIALS, V28, P3594, DOI 10.1016/j.biomaterials.2007.03.024; Seymour JP, 2011, BIOMED MICRODEVICES, V13, P441, DOI 10.1007/s10544-011-9512-z; Steenland HW, 2008, J NEUROSCI, V28, P6826, DOI 10.1523/JNEUROSCI.1019-08.2008; Takeuchi S, 2004, J MICROMECH MICROENG, V14, P104, DOI 10.1088/0960-1317/14/1/014; Tye KM, 2012, NAT REV NEUROSCI, V13, P251, DOI 10.1038/nrn3171; Ward MP, 2009, BRAIN RES, V1282, P183, DOI 10.1016/j.brainres.2009.05.052; Williams JC, 2007, J NEURAL ENG, V4, P410, DOI 10.1088/1741-2560/4/4/007; Woolley AJ, 2013, J NEURAL ENG, V10, DOI 10.1088/1741-2560/10/2/026007; YALON M, 1988, J CATARACT REFR SURG, V14, P393, DOI 10.1016/S0886-3350(88)80145-7; Yaman M, 2011, NAT MATER, V10, P494, DOI [10.1038/NMAT3038, 10.1038/nmat3038]; Yizhar O, 2011, NEURON, V71, P9, DOI 10.1016/j.neuron.2011.06.004; Zhang F, 2007, NAT REV NEUROSCI, V8, P577, DOI 10.1038/nrn2192; Zhang JY, 2009, J NEURAL ENG, V6, DOI 10.1088/1741-2560/6/5/055007; Znamenskiy P, 2013, NATURE, V497, P482, DOI 10.1038/nature12077	50	383	390	21	351	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156	1546-1696		NAT BIOTECHNOL	Nat. Biotechnol.	MAR	2015	33	3					277	+		10.1038/nbt.3093	http://dx.doi.org/10.1038/nbt.3093			10	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	CD0ME	25599177				2022-12-27	WOS:000350766900024
J	Pertea, M; Pertea, GM; Antonescu, CM; Chang, TC; Mendell, JT; Salzberg, SL				Pertea, Mihaela; Pertea, Geo M.; Antonescu, Corina M.; Chang, Tsung-Cheng; Mendell, Joshua T.; Salzberg, Steven L.			StringTie enables improved reconstruction of a transcriptome from RNA-seq reads	NATURE BIOTECHNOLOGY			English	Article							ABUNDANCE ESTIMATION; ISOFORM DISCOVERY; REFERENCE GENOME; NONCODING RNAS; QUANTIFICATION; EXPRESSION; REVEALS; ANNOTATION	Methods used to sequence the transcriptome often produce more than 200 million short sequences. We introduce StringTie, a computational method that applies a network flow algorithm originally developed in optimization theory, together with optional de novo assembly, to assemble these complex data sets into transcripts. When used to analyze both simulated and real data sets, StringTie produces more complete and accurate reconstructions of genes and better estimates of expression levels, compared with other leading transcript assembly programs including Cufflinks, IsoLasso, Scripture and Traph. For example, on 90 million reads from human blood, StringTie correctly assembled 10,990 transcripts, whereas the next best assembly was of 7,187 transcripts by Cufflinks, which is a 53% increase in transcripts assembled. On a simulated data set, StringTie correctly assembled 7,559 transcripts, which is 20% more than the 6,310 assembled by Cufflinks. As well as producing a more complete transcriptome assembly, StringTie runs faster on all data sets tested to date compared with other assembly software, including Cufflinks.	[Pertea, Mihaela; Pertea, Geo M.; Antonescu, Corina M.; Salzberg, Steven L.] Johns Hopkins Univ, Ctr Computat Biol, Baltimore, MD 21218 USA; [Pertea, Mihaela; Pertea, Geo M.; Antonescu, Corina M.; Salzberg, Steven L.] Johns Hopkins Univ, McKusick Nathans Inst Genet Med, Baltimore, MD USA; [Chang, Tsung-Cheng; Mendell, Joshua T.] Univ Texas SW Med Ctr Dallas, Dept Med Biol, Dallas, TX 75390 USA; [Chang, Tsung-Cheng; Mendell, Joshua T.] Univ Texas SW Med Ctr Dallas, Ctr Regenerat Sci & Med, Dallas, TX 75390 USA; [Mendell, Joshua T.] Univ Texas SW Med Ctr Dallas, Simmons Canc Ctr, Dallas, TX 75390 USA; [Salzberg, Steven L.] Johns Hopkins Univ, Dept Biomed Engn, Baltimore, MD USA; [Salzberg, Steven L.] Johns Hopkins Univ, Dept Comp Sci, Baltimore, MD 21218 USA	Johns Hopkins University; Johns Hopkins University; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas; Johns Hopkins University; Johns Hopkins University	Salzberg, SL (corresponding author), Johns Hopkins Univ, Ctr Computat Biol, Baltimore, MD 21218 USA.	salzberg@jhu.edu	Salzberg, Steven/Q-6514-2019; Salzberg, Steven L/F-6162-2011; Pertea, Mihaela/AAT-2705-2021	Salzberg, Steven/0000-0002-8859-7432; Salzberg, Steven L/0000-0002-8859-7432; Pertea, Mihaela/0000-0003-0762-8637	US National Institutes of Health [R01-HG006677, R01-HG006102, R01-GM105705, R01-CA120185, P01-CA134292]; Cancer Prevention and Research Institute of Texas; NATIONAL CANCER INSTITUTE [P01CA134292, R01CA120185] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R01HG006102, R01HG006677] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM105705] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Cancer Prevention and Research Institute of Texas; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	These studies were supported in part by US National Institutes of Health grants R01-HG006677 (S.L.S.), R01-HG006102 (S.L.S.), R01-GM105705 (G.M.P.), R01-CA120185 (J.T.M.), P01-CA134292 (J.T.M.), and the Cancer Prevention and Research Institute of Texas (J.T.M.).	Behr J, 2013, BIOINFORMATICS, V29, P2529, DOI 10.1093/bioinformatics/btt442; Blencowe BJ, 2006, CELL, V126, P37, DOI 10.1016/j.cell.2006.06.023; Cabili MN, 2011, GENE DEV, V25, P1915, DOI 10.1101/gad.17446611; Dantzig G. B., 1962, LINEAR PROGRAMMING E; Dunham I, 2012, NATURE, V489, P57, DOI 10.1038/nature11247; Feng JX, 2011, J COMPUT BIOL, V18, P305, DOI 10.1089/cmb.2010.0243; Flicek P, 2014, NUCLEIC ACIDS RES, V42, pD749, DOI 10.1093/nar/gkt1196; Ford L. R. J., 1962, FLOWS NETWORKS; Garber M, 2011, NAT METHODS, V8, P469, DOI [10.1038/nmeth.1613, 10.1038/NMETH.1613]; GOLDBERG AV, 1988, J ACM, V35, P921, DOI 10.1145/48014.61051; GOLDBERG AV, 1991, MATH OPER RES, V16, P351, DOI 10.1287/moor.16.2.351; Grabherr MG, 2011, NAT BIOTECHNOL, V29, P644, DOI 10.1038/nbt.1883; Griebel T, 2012, NUCLEIC ACIDS RES, V40, P10073, DOI 10.1093/nar/gks666; Guttman M, 2010, NAT BIOTECHNOL, V28, P503, DOI 10.1038/nbt.1633; Hansen KD, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkq224; Karolchik D, 2014, NUCLEIC ACIDS RES, V42, pD764, DOI 10.1093/nar/gkt1168; Kim D, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-4-r36; Li B, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-323; Li JJ, 2011, P NATL ACAD SCI USA, V108, P19867, DOI 10.1073/pnas.1113972108; Li W, 2011, J COMPUT BIOL, V18, P1693, DOI 10.1089/cmb.2011.0171; Mezlini AM, 2013, GENOME RES, V23, P519, DOI 10.1101/gr.142232.112; Ponting CP, 2009, CELL, V136, P629, DOI 10.1016/j.cell.2009.02.006; Pruitt KD, 2009, NUCLEIC ACIDS RES, V37, pD32, DOI 10.1093/nar/gkn721; Rehrauer H, 2013, BMC BIOINFORMATICS, V14, DOI 10.1186/1471-2105-14-370; Roberts A, 2013, NAT METHODS, V10, P71, DOI [10.1038/NMETH.2251, 10.1038/nmeth.2251]; Salzberg Steven L, 2010, F1000 Biol Rep, V2, P64, DOI 10.3410/B2-64; Schulz MH, 2012, BIOINFORMATICS, V28, P1086, DOI 10.1093/bioinformatics/bts094; Steijger T, 2013, NAT METHODS, V10, P1177, DOI [10.1038/nmeth.2714, 10.1038/NMETH.2714]; Tomescu AI, 2013, BMC BIOINFORMATICS, V14, DOI 10.1186/1471-2105-14-S5-S15; Trapnell C, 2010, NAT BIOTECHNOL, V28, P511, DOI 10.1038/nbt.1621; Wang ET, 2008, NATURE, V456, P470, DOI 10.1038/nature07509; Wu TD, 2010, BIOINFORMATICS, V26, P873, DOI 10.1093/bioinformatics/btq057; Zhao QY, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-S14-S2; Zimin AV, 2013, BIOINFORMATICS, V29, P2669, DOI 10.1093/bioinformatics/btt476	34	4194	4303	71	519	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156	1546-1696		NAT BIOTECHNOL	Nat. Biotechnol.	MAR	2015	33	3					290	+		10.1038/nbt.3122	http://dx.doi.org/10.1038/nbt.3122			8	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	CD0ME	25690850	Green Accepted			2022-12-27	WOS:000350766900026
J	Rychlik, B				Rychlik, Bruce			Total target cash compensation shows a healthy increase at private life-science companies	NATURE BIOTECHNOLOGY			English	Editorial Material							NONFOUNDER EXECUTIVES; PAY INCREASES		Pk Sq Execut Search LLC, Cambridge, MA 02142 USA		Rychlik, B (corresponding author), Pk Sq Execut Search LLC, Cambridge, MA 02142 USA.	bruce@parksquare.com						Rychlik B, 2014, NAT BIOTECHNOL, V32, P393, DOI 10.1038/nbt.2878; Rychlik B, 2013, NAT BIOTECHNOL, V31, P259, DOI 10.1038/nbt.2526; Wasserman N, 2014, WALL STREET J; Wasserman N., 2012, FOUNDERS DILEMMAS AN, DOI DOI 10.2307/J.CTVCM4HQC	4	4	4	0	0	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156	1546-1696		NAT BIOTECHNOL	Nat. Biotechnol.	MAR	2015	33	3					313	316		10.1038/nbt.3166	http://dx.doi.org/10.1038/nbt.3166			4	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	CD0ME	25748919				2022-12-27	WOS:000350766900030
J	Bubela, T; Cook-Deegan, R				Bubela, Tania; Cook-Deegan, Robert			Keeping score, strengthening policy and fighting bad actors over access to research tools	NATURE BIOTECHNOLOGY			English	Editorial Material									[Bubela, Tania] Univ Alberta, Sch Publ Hlth, Edmonton, AB, Canada; [Cook-Deegan, Robert] Duke Univ, Sanford Sch Publ Policy, Durham, NC USA; [Cook-Deegan, Robert] Ctr Milken Inst, Washington, DC USA	University of Alberta; Duke University	Bubela, T (corresponding author), Univ Alberta, Sch Publ Hlth, Edmonton, AB, Canada.	tbubela@ualberta.ca	; Bubela, Tania/F-4860-2014	Cook-Deegan, Robert/0000-0002-8251-4237; Bubela, Tania/0000-0002-0807-2899	NHGRI NIH HHS [P50 HG003391, R01 HG006460] Funding Source: Medline; Alberta Innovates [201201154] Funding Source: researchfish; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R01HG006460, P50HG003391] Funding Source: NIH RePORTER	NHGRI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); Alberta Innovates; NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))		Association of University Technology Managers, 2007, PUBL INT 9 POINTS CO; Blischak M.P., 2007, IP LITIGATOR, P45; Broad Institute, 2015, INF LIC CRISPR CAS9; Cahoy DR, 2002, AM BUS LAW J, V40, P125; Caulfield T, 2006, NAT BIOTECHNOL, V24, P1091, DOI 10.1038/nbt0906-1091; Feldman R., 2013, PATENT TROLLING WHY; Fore Joe Jr, 2006, J Biomed Discov Collab, V1, P7, DOI 10.1186/1747-5333-1-7; Hsiao K, 1996, SCIENCE, V274, P99, DOI 10.1126/science.274.5284.99; Lemley M, 2008, MEDIA ENTERTAINMENT, V18, P611; Malani A, 2013, GEORGETOWN LAW J, V101, P637; Mishra A, 2014, OMICS, V18, P254, DOI 10.1089/omi.2013.0158; Nicol D., 2014, 8 U TASM CTR LAW GEN; President's Council of Economic Advisers. The National Economic Council and the Office of Science &Technology Policy, 2013, PAT ASS US INN; Radar R.R., 2013, NY TIMES; Riesenfeld SA, 1954, U PENN LAW REV, V102, P291, DOI 10.2307/3310038; Rimmer M. U., 2006, U OTTAWA LAW TEC DEC, P539; US Patent and Trademark Office, 2014, 2014 INT GUID PAT SU	17	4	4	0	2	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156	1546-1696		NAT BIOTECHNOL	Nat. Biotechnol.	FEB	2015	33	2					143	148		10.1038/nbt.3131	http://dx.doi.org/10.1038/nbt.3131			6	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Biotechnology & Applied Microbiology	CA8VK	25658278	Green Accepted, Bronze			2022-12-27	WOS:000349198800016
J	Kupecz, A				Kupecz, Andra			Who owns CRISPR-Cas9 in Europe?	NATURE BIOTECHNOLOGY			English	Editorial Material									Kupecz Intellectual Property, Amsterdam, Netherlands		Kupecz, A (corresponding author), Kupecz Intellectual Property, Amsterdam, Netherlands.	andras@kupecz-ip.com						Hsu PD, 2014, CELL, V157, P1262, DOI 10.1016/j.cell.2014.05.010; Jinek M, 2012, SCIENCE, V337, P816, DOI 10.1126/science.1225829; Letter of the applicant (the Broad Institute and MIT), 2014, [No title captured], Patent No. 2764103; Sheridan C, 2014, NAT BIOTECHNOL, V32, P599, DOI 10.1038/nbt0714-599; Zhang F., 2014, US Patent, Patent No. [8,697,359, 8697359]	5	7	7	2	20	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156	1546-1696		NAT BIOTECHNOL	Nat. Biotechnol.	DEC	2014	32	12					1194	1196		10.1038/nbt.3086	http://dx.doi.org/10.1038/nbt.3086			3	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	AW3AD	25489834				2022-12-27	WOS:000346156800018
J	Smanski, MJ; Bhatia, S; Zhao, DH; Park, Y; Woodruff, LBA; Giannoukos, G; Ciulla, D; Busby, M; Calderon, J; Nicol, R; Gordon, DB; Densmore, D; Voigt, CA				Smanski, Michael J.; Bhatia, Swapnil; Zhao, Dehua; Park, YongJin; Woodruff, Lauren B. A.; Giannoukos, Georgia; Ciulla, Dawn; Busby, Michele; Calderon, Johnathan; Nicol, Robert; Gordon, D. Benjamin; Densmore, Douglas; Voigt, Christopher A.			Functional optimization of gene clusters by combinatorial design and assembly	NATURE BIOTECHNOLOGY			English	Article							NITROGEN-FIXATION GENES; KLEBSIELLA-PNEUMONIAE; EXPRESSION; CONSTRUCTION; PROMOTERS; PROSPECTS; AMMONIUM; KINETICS; SEQUENCE; SITES	Large microbial gene clusters encode useful functions, including energy utilization and natural product biosynthesis, but genetic manipulation of such systems is slow, difficult and complicated by complex regulation. We exploit the modularity of a refactored Klebsiella oxytoca nitrogen fixation (nif) gene cluster (16 genes, 103 parts) to build genetic permutations that could not be achieved by starting from the wild-type cluster. Constraint-based combinatorial design and DNA assembly are used to build libraries of radically different cluster architectures by varying part choice, gene order, gene orientation and operon occupancy. We construct 84 variants of the nifUSVWZM operon, 145 variants of the nifHDKY operon, 155 variants of the nifHDKYENJ operon and 122 variants of the complete 16-gene pathway. The performance and behavior of these variants are characterized by nitrogenase assay and strand-specific RNA sequencing (RNA-seq), and the results are incorporated into subsequent design cycles. We have produced a fully synthetic cluster that recovers 57% of wild-type activity. Our approach allows the performance of genetic parts to be quantified simultaneously in hundreds of genetic contexts. This parallelized design-build-test-learn cycle, which can access previously unattainable regions of genetic space, should provide a useful, fast tool for genetic optimization and hypothesis testing.	[Smanski, Michael J.; Zhao, Dehua; Park, YongJin; Woodruff, Lauren B. A.; Calderon, Johnathan; Gordon, D. Benjamin; Voigt, Christopher A.] MIT, Dept Biol Engn, Synthet Biol Ctr, Cambridge, MA 02139 USA; [Bhatia, Swapnil; Densmore, Douglas] Boston Univ, Dept Elect & Comp Engn, Boston, MA 02215 USA; [Woodruff, Lauren B. A.; Giannoukos, Georgia; Ciulla, Dawn; Busby, Michele; Nicol, Robert; Gordon, D. Benjamin; Voigt, Christopher A.] Broad Inst MIT & Harvard, Broad Technol Labs, Cambridge, MA USA	Massachusetts Institute of Technology (MIT); Boston University; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute	Voigt, CA (corresponding author), MIT, Dept Biol Engn, Synthet Biol Ctr, 77 Massachusetts Ave, Cambridge, MA 02139 USA.	cavoigt@gmail.com	Densmore, Douglas/AAC-7059-2020	Nicol, Robert/0000-0003-1932-1392; Bhatia, Swapnil/0000-0003-1079-7570; Andrews, Lauren/0000-0003-1627-1430	US Defense Advanced Research Projects Agency (DARPA) [HR0011-12-C-0067]; US National Science Foundation Synthetic Biology Engineering Research Center (SynBERC) [SA5284-11210]; Institute for Collaborative Biotechnologies through from the US Army Research Office [W911NF-09-0001]; DARPA Living Foundries [HR0011-12-C-0067]; Samsung Scholarship	US Defense Advanced Research Projects Agency (DARPA)(United States Department of DefenseDefense Advanced Research Projects Agency (DARPA)); US National Science Foundation Synthetic Biology Engineering Research Center (SynBERC); Institute for Collaborative Biotechnologies through from the US Army Research Office; DARPA Living Foundries; Samsung Scholarship(Samsung)	M.J.S., D.Z.,J.C., R.N., D.B.G. and C.A.V. are supported by the US Defense Advanced Research Projects Agency (DARPA) Living Foundries grant HR0011-12-C-0067 and the US National Science Foundation Synthetic Biology Engineering Research Center (SynBERC) through grant SA5284-11210 and are also supported by the Institute for Collaborative Biotechnologies through contract W911NF-09-0001 from the US Army Research Office. The content of the information does not necessarily reflect the position or the policy of the US government, and no official endorsement should be inferred. S.B. and D.D. are supported by DARPA Living Foundries grant HR0011-12-C-0067. M.J.S. is an HHMI Fellow of the Damon Runyon Cancer Research Foundation, DRG-2129-12. Y.P. is supported by the Samsung Scholarship.	Alper H, 2005, P NATL ACAD SCI USA, V102, P12678, DOI 10.1073/pnas.0504604102; ARNOLD W, 1988, J MOL BIOL, V203, P715, DOI 10.1016/0022-2836(88)90205-7; Barnett DW, 2011, BIOINFORMATICS, V27, P1691, DOI 10.1093/bioinformatics/btr174; Beatty PH, 2011, SCIENCE, V333, P416, DOI 10.1126/science.1209467; BEYNON J, 1983, CELL, V34, P665, DOI 10.1016/0092-8674(83)90399-9; Bilitchenko L, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018882; CANNON FC, 1976, J GEN MICROBIOL, V93, P111, DOI 10.1099/00221287-93-1-111; Cardinale S, 2012, BIOTECHNOL J, V7, P856, DOI 10.1002/biot.201200085; Chan LY, 2005, MOL SYST BIOL, V1, DOI 10.1038/msb4100025; Chen YJ, 2013, NAT METHODS, V10, P659, DOI [10.1038/NMETH.2515, 10.1038/nmeth.2515]; Crook NC, 2011, NUCLEIC ACIDS RES, V39, DOI 10.1093/nar/gkr346; Czar MJ, 2009, TRENDS BIOTECHNOL, V27, P63, DOI 10.1016/j.tibtech.2008.10.007; Davis JH, 2011, NUCLEIC ACIDS RES, V39, P1131, DOI 10.1093/nar/gkq810; Densmore D., 2010, P 2010 IEEE ISCAS, DOI [10.1109/ISCAS.2010.5537540, DOI 10.1109/ISCAS.2010.5537540]; Dixon R, 1997, PLANT SOIL, V194, P193, DOI 10.1023/A:1004296703638; DIXON R, 1976, NATURE, V260, P268, DOI 10.1038/260268a0; DIXON RA, 1972, NATURE, V237, P102, DOI 10.1038/237102a0; Dukes P., 2008, BANFF INT RES STAT M; EADY RR, 1978, J GEN MICROBIOL, V104, P277, DOI 10.1099/00221287-104-2-277; Endy D, 2000, P NATL ACAD SCI USA, V97, P5375, DOI 10.1073/pnas.090101397; Fischbach M, 2010, BIOTECHNOL J, V5, P1277, DOI 10.1002/biot.201000181; Giannoukos G, 2012, GENOME BIOL, V13, DOI 10.1186/gb-2012-13-3-r23; Gibson DG, 2010, SCIENCE, V329, P52, DOI 10.1126/science.1190719; Gibson DG, 2009, NAT METHODS, V6, P343, DOI [10.1038/NMETH.1318, 10.1038/nmeth.1318]; Gorochowski TE, 2014, ACS SYNTH BIOL, V3, P129, DOI 10.1021/sb4001245; Hamilton TL, 2011, J BACTERIOL, V193, P4477, DOI 10.1128/JB.05099-11; JENG ST, 1990, J BIOL CHEM, V265, P3823; Kroger C, 2012, P NATL ACAD SCI USA, V109, pE1277, DOI 10.1073/pnas.1201061109; Li H, 2009, BIOINFORMATICS, V25, P1094, DOI [10.1093/bioinformatics/btp100, 10.1093/bioinformatics/btp324]; Liang LW, 2013, GENETICS, V193, P453, DOI 10.1534/genetics.112.147199; Lim HN, 2011, P NATL ACAD SCI USA, V108, P10626, DOI 10.1073/pnas.1105692108; LOWE DJ, 1984, BIOCHEM J, V224, P877, DOI 10.1042/bj2240877; May O., 2002, ENZYME CATALYSIS ORG; MCALLISTER WT, 1981, J MOL BIOL, V153, P527, DOI 10.1016/0022-2836(81)90406-X; Moser F, 2012, ACS SYNTH BIOL, V1, P555, DOI 10.1021/sb3000832; PLACKETT RL, 1946, BIOMETRIKA 4, V33, P305, DOI DOI 10.1093/BIOMET/33.4.305; Poza-Carrion C, 2014, J BACTERIOL, V196, P595, DOI 10.1128/JB.00942-13; Price MN, 2005, GENOME RES, V15, P809, DOI 10.1101/gr.3368805; Ran LA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011486; Salis HM, 2009, NAT BIOTECHNOL, V27, P946, DOI 10.1038/nbt.1568; Stacy G.S., 1992, BIOL NITROGEN FIXATI; STEWART WDP, 1967, SCIENCE, V158, P536, DOI 10.1126/science.158.3800.536; Stucken K, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009235; Suh MH, 2002, BIOCHEM BIOPH RES CO, V299, P233, DOI 10.1016/S0006-291X(02)02620-7; Temme K, 2012, NUCLEIC ACIDS RES, V40, P8773, DOI 10.1093/nar/gks597; Temme K, 2012, P NATL ACAD SCI USA, V109, P7085, DOI 10.1073/pnas.1120788109; von Dassow G, 2000, NATURE, V406, P188, DOI 10.1038/35018085; Wang X, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068677; Weber E, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016765; Yan YL, 2010, BMC GENOMICS, V11, DOI [10.1186/1471-2164-11-405, 10.1186/1471-2164-11-11]	50	233	249	5	165	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1087-0156	1546-1696		NAT BIOTECHNOL	Nat. Biotechnol.	DEC	2014	32	12					1241	U104		10.1038/nbt.3063	http://dx.doi.org/10.1038/nbt.3063			12	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	AW3AD	25419741				2022-12-27	WOS:000346156800026
J	Schmidt, C				Schmidt, Charles			Stepping into the sunshine	NATURE BIOTECHNOLOGY			English	News Item																		Bhandari M, 2004, CAN MED ASSOC J, V170, P477; Borrell B, SCI AM; Harris G., NY TIMES; Ornstein C., BOSTON GLOBE PROPUBL; Seiffert D., 2014, BOSTON BUSINESS J; Vox F, 2014, FORBES	6	4	4	0	0	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156	1546-1696		NAT BIOTECHNOL	Nat. Biotechnol.	SEP	2014	32	9					859	862		10.1038/nbt.3008	http://dx.doi.org/10.1038/nbt.3008			4	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	AQ2FD	25203027				2022-12-27	WOS:000342600300016
J	Andrews, PW; Cavagnaro, J; Deans, R; Feigal, E; Horowitz, E; Keating, A; Rao, M; Turner, M; Wilmut, I; Yamanaka, S				Andrews, Peter W.; Cavagnaro, Joy; Deans, Robert; Feigal, Ellen; Horowitz, Ed; Keating, Armand; Rao, Mahendra; Turner, Marc; Wilmut, Ian; Yamanaka, Shinya			Harmonizing standards for producing clinical-grade therapies from pluripotent stem cells	NATURE BIOTECHNOLOGY			English	Letter							CELLULAR THERAPY; INFORMED-CONSENT		[Andrews, Peter W.] Univ Sheffield, Dept Biomed Sci, Ctr Stem Cell Biol, Western Bank, Sheffield S10 2TN, S Yorkshire, England; [Andrews, Peter W.] Int Stem Cell Initiat, Harbor, ME USA; [Cavagnaro, Joy] Access BIO, Boyce, VA USA; [Deans, Robert] Alliance Regenerat Med Athersys, Cleveland, OH USA; [Feigal, Ellen] Calif Inst Regenerat Med, San Francisco, CA USA; [Horowitz, Ed] Int Soc Cell Therapy, Vancouver, BC, Canada; [Keating, Armand] Univ Toronto, Amer Soc Hematol, Toronto, ON, Canada; [Keating, Armand] Princess Margaret Canc Ctr, Toronto, ON, Canada; [Rao, Mahendra] NIH, Ctr Regenerat Med, Bethesda, MD 20892 USA; [Turner, Marc] Scottish Natl Blood Transfus Serv Headquarters, Edinburgh, Midlothian, Scotland; [Wilmut, Ian] Univ Edinburgh, Scottish Ctr Regenerat Med, Edinburgh BioQuarter, Edinburgh, Midlothian, Scotland; [Yamanaka, Shinya] Kyoto Univ, Kyoto Ctr iPS Cell Res & Applicat, Sakyo Ku, Kyoto, Japan; [Yamanaka, Shinya] Int Soc Stem Cell Res, Northbrook, IL USA	University of Sheffield; University of Toronto; University of Toronto; University Toronto Affiliates; University Health Network Toronto; Princess Margaret Cancer Centre; National Institutes of Health (NIH) - USA; University of Edinburgh; Kyoto University	Andrews, PW (corresponding author), Univ Sheffield, Dept Biomed Sci, Ctr Stem Cell Biol, Western Bank, Sheffield S10 2TN, S Yorkshire, England.	mrao@nyscf.org		Andrews, Peter/0000-0001-7215-4410				Ahrlund-Richter L, 2009, CELL STEM CELL, V4, P20, DOI 10.1016/j.stem.2008.11.012; Allison M, 2012, NAT BIOTECHNOL, V30, P304, DOI 10.1038/nbt0412-304; Bravery CA, 2013, CYTOTHERAPY, V15, P9, DOI 10.1016/j.jcyt.2012.10.008; Carpenter MK, 2010, REGEN MED, V5, P569, DOI [10.2217/rme.10.55, 10.2217/RME.10.55]; Clarke D, 2012, CYTOTHERAPY, V14, P1032, DOI 10.3109/14653249.2012.706709; Georgieva BP, 2010, REGEN MED, V5, P581, DOI 10.2217/RME.10.43; Lomax GP, 2013, STEM CELL TRANSL MED, V2, P727, DOI 10.5966/sctm.2013-0099; Lowenthal J, 2012, STEM CELL TRANSL MED, V1, P409, DOI 10.5966/sctm.2012-0029; Magnus D, 2010, J LAW MED ETHICS, V38, P267, DOI 10.1111/j.1748-720X.2010.00487.x; Obasogie Osagie K., 2012, STANFORD TECHNOLOGY, V16, P51; Rao MS, 2013, STEM CELL RES THER, V4, DOI [10.1186/1757-6512-4-98, 10.1186/scrt309]; Rao MM, 2012, ELECTROCHEM COMMUN, V17, P1, DOI 10.1016/j.elecom.2011.12.022; Rawley J., 2012, BIOPROCESS INT, V10, P16; Sipp D, 2012, SCIENCE, V338, P1296, DOI 10.1126/science.1229918; Turner M, 2013, CELL STEM CELL, V13, P382, DOI 10.1016/j.stem.2013.08.003; Yamanaka S, 2012, CELL STEM CELL, V10, P678, DOI 10.1016/j.stem.2012.05.005	16	46	47	0	15	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156	1546-1696		NAT BIOTECHNOL	Nat. Biotechnol.	AUG	2014	32	8					724	726		10.1038/nbt.2973	http://dx.doi.org/10.1038/nbt.2973			3	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	AW7PF	25093882				2022-12-27	WOS:000346455900009
J	Elvidge, S				Elvidge, Suzanne			Anti-CGRP antibodies for migraine turn industry heads	NATURE BIOTECHNOLOGY			English	News Item																			0	7	12	0	5	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156	1546-1696		NAT BIOTECHNOL	Nat. Biotechnol.	AUG	2014	32	8					707	707		10.1038/nbt0814-707a	http://dx.doi.org/10.1038/nbt0814-707a			1	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	AW7PF	25101728				2022-12-27	WOS:000346455900033
J	Naumova, AV; Modo, M; Moore, A; Murry, CE; Frank, JA				Naumova, Anna V.; Modo, Michel; Moore, Anna; Murry, Charles E.; Frank, Joseph A.			Clinical imaging in regenerative medicine	NATURE BIOTECHNOLOGY			English	Article							NEURAL STEM-CELLS; POSITRON-EMISSION-TOMOGRAPHY; HEMATOPOIETIC PROGENITOR CELLS; IRON-OXIDE NANOPARTICLES; MARROW MONONUCLEAR-CELLS; NORMAL ORGAN WEIGHTS; IN-VIVO; MAGNETIC-RESONANCE; MYOCARDIAL-INFARCTION; ISLET TRANSPLANTATION	In regenerative medicine, clinical imaging is indispensable for characterizing damaged tissue and for measuring the safety and efficacy of therapy. However, the ability to track the fate and function of transplanted cells with current technologies is limited. Exogenous contrast labels such as nanoparticles give a strong signal in the short term but are unreliable long term. Genetically encoded labels are good both short-and long-term in animals, but in the human setting they raise regulatory issues related to the safety of genomic integration and potential immunogenicity of reporter proteins. Imaging studies in brain, heart and islets share a common set of challenges, including developing novel labeling approaches to improve detection thresholds and early delineation of toxicity and function. Key areas for future research include addressing safety concerns associated with genetic labels and developing methods to follow cell survival, differentiation and integration with host tissue. Imaging may bridge the gap between cell therapies and health outcomes by elucidating mechanisms of action through longitudinal monitoring.	[Naumova, Anna V.] Univ Washington, Dept Radiol, Seattle, WA 98195 USA; [Naumova, Anna V.; Murry, Charles E.] Univ Washington, Ctr Cardiovasc Biol, Seattle, WA 98195 USA; [Naumova, Anna V.; Murry, Charles E.] Univ Washington, Inst Stem Cell & Regenerat Med, Seattle, WA 98195 USA; [Modo, Michel] Univ Pittsburgh, McGowan Inst Regenerat Med, Pittsburgh, PA USA; [Modo, Michel] Univ Pittsburgh, Ctr Neural Basis Cognit, Pittsburgh, PA USA; [Modo, Michel] Univ Pittsburgh, Dept Radiol, Pittsburgh, PA 15260 USA; [Modo, Michel] Univ Pittsburgh, Dept Bioengn, Pittsburgh, PA USA; [Moore, Anna] Massachusetts Gen Hosp, Athinoula A Martinos Ctr Biomed Imaging, Dept Radiol, Charlestown, MA USA; [Murry, Charles E.] Univ Washington, Dept Pathol, Seattle, WA 98195 USA; [Murry, Charles E.] Univ Washington, Dept Bioengn, Seattle, WA 98195 USA; [Murry, Charles E.] Univ Washington, Dept Med Cardiol, Seattle, WA 98195 USA; [Frank, Joseph A.] NIH, Bethesda, MD 20892 USA; [Frank, Joseph A.] Natl Inst Biomed Imaging & Bioengn, NIH, Bethesda, MD USA	University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Harvard University; Massachusetts General Hospital; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; National Institutes of Health (NIH) - USA; National Institutes of Health (NIH) - USA; NIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)	Murry, CE (corresponding author), Univ Washington, Ctr Cardiovasc Biol, Seattle, WA 98195 USA.	murry@uw.edu; jfrank@helix.nih.gov	Frank, Joseph/W-2021-2019	Modo, Michel/0000-0003-4436-735X	Commonwealth of Pennsylvania, Department of Health [4100061184]; NINDS [R01NS082226]; NIBIB [1R01EB016629]; US National Institutes of Health (NIH) [P01HL094374, R01HL084642, U01HL100405, P01GM81619]; intramural research program in the Clinical Center and National Institutes of Biomedical Imaging and Bioengineering at the US National Institutes of Health; NIH [R24 DK096465]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL084642, P01HL094374, U01HL100405] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [R01EB016629, P20EB007076] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK017047] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P01GM081619] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS082226] Funding Source: NIH RePORTER; CLINICAL CENTER [ZIACL090007] Funding Source: NIH RePORTER	Commonwealth of Pennsylvania, Department of Health; NINDS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NIBIB(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); US National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); intramural research program in the Clinical Center and National Institutes of Biomedical Imaging and Bioengineering at the US National Institutes of Health; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); CLINICAL CENTER	The authors would like to acknowledge Kristine Evers for proofreading of the manuscript and the following grant support: M.M. was supported by the Commonwealth of Pennsylvania, Department of Health (4100061184), NINDS (R01NS082226) and NIBIB (1R01EB016629). C.E.M. was supported by US National Institutes of Health (NIH) grants P01HL094374, R01HL084642, U01HL100405 and P01GM81619. J.A.F. was supported in part by the intramural research program in the Clinical Center and National Institutes of Biomedical Imaging and Bioengineering at the US National Institutes of Health. A.M. was supported in part by NIH grant R24 DK096465.	Ahrens ET, 2013, NAT REV IMMUNOL, V13, P755, DOI 10.1038/nri3531; Ahrens ET, 2013, NMR BIOMED, V26, P860, DOI 10.1002/nbm.2948; Amsalem Y, 2007, CIRCULATION, V116, pI38, DOI 10.1161/CIRCULATIONAHA.106.680231; Arbab AS, 2008, REGEN MED, V3, P199, DOI 10.2217/17460751.3.2.199; Arbab AS, 2006, EXPERT REV MED DEVIC, V3, P427, DOI 10.1586/17434440.3.4.427; Arbab AS, 2009, CURR MED IMAGING, V5, P19, DOI 10.2174/157340509787354697; Arbab AS, 2003, RADIOLOGY, V229, P838, DOI 10.1148/radiol.2293021215; Arbab AS, 2005, NMR BIOMED, V18, P553, DOI 10.1002/nbm.991; Arifin DR, 2011, DIABETES-METAB RES, V27, P761, DOI 10.1002/dmrr.1248; Arifin DR, 2011, RADIOLOGY, V260, P790, DOI 10.1148/radiol.11101608; Bar-Shir A, 2014, ACS CHEM BIOL, V9, P134, DOI 10.1021/cb400617q; Bar-Shir A, 2013, NAT PROTOC, V8, P2380, DOI 10.1038/nprot.2013.140; Bara C, 2006, J AM SOC ECHOCARDIOG, V19, P563, DOI 10.1016/j.echo.2006.02.002; Barnett BP, 2007, NAT MED, V13, P986, DOI 10.1038/nm1581; Barnett BP, 2011, CONTRAST MEDIA MOL I, V6, P251, DOI 10.1002/cmmi.424; Barnett BP, 2011, RADIOLOGY, V258, P182, DOI 10.1148/radiol.10092339; Barshes NR, 2005, J LEUKOCYTE BIOL, V77, P587, DOI 10.1189/jlb.1104649; Battistella V, 2011, REGEN MED, V6, P45, DOI 10.2217/RME.10.97; Berger C, 2006, BLOOD, V107, P2294, DOI 10.1182/blood-2005-08-3503; Bernard-Gauthier V, 2013, BIOORGAN MED CHEM, V21, P7816, DOI 10.1016/j.bmc.2013.10.012; Bianconi E, 2013, ANN HUM BIOL, V40, P463, DOI 10.3109/03014460.2013.807878; Bible E, 2012, BIOMATERIALS, V33, P2858, DOI 10.1016/j.biomaterials.2011.12.033; Bible E, 2009, NAT PROTOC, V4, P1440, DOI 10.1038/nprot.2009.156; Bible E, 2009, BIOMATERIALS, V30, P2985, DOI 10.1016/j.biomaterials.2009.02.012; Blum B, 2012, NAT BIOTECHNOL, V30, P261, DOI 10.1038/nbt.2141; Bonetto F, 2012, NMR BIOMED, V25, P1095, DOI 10.1002/nbm.2774; Bonetto F, 2011, INT J CANCER, V129, P365, DOI 10.1002/ijc.25672; Brenner W, 2004, J NUCL MED, V45, P512; Bulte JWM, 2009, AM J ROENTGENOL, V193, P314, DOI 10.2214/AJR.09.3107; Campan M, 2011, AM J PHYSIOL-HEART C, V300, pH2238, DOI 10.1152/ajpheart.00935.2010; Chan KWY, 2013, NAT MATER, V12, P268, DOI [10.1038/NMAT3525, 10.1038/nmat3525]; Chong JJH, 2014, NATURE, V510, P273, DOI 10.1038/nature13233; Chugh AR, 2012, CIRCULATION, V126, pS54, DOI 10.1161/CIRCULATIONAHA.112.092627; Chung YL, 2013, NEUROREPORT, V24, P1035, DOI 10.1097/WNR.0000000000000056; Crowe LA, 2011, AM J TRANSPLANT, V11, P1158, DOI 10.1111/j.1600-6143.2011.03559.x; Daar AS, 2007, J TISSUE ENG REGEN M, V1, P179, DOI 10.1002/term.20; Dahnke H, 2005, MAGNET RESON MED, V53, P1202, DOI 10.1002/mrm.20435; de Almeida PE, 2011, AM J PHYSIOL-HEART C, V301, pH663, DOI 10.1152/ajpheart.00337.2011; de Vries IJM, 2005, NAT BIOTECHNOL, V23, P1407, DOI 10.1038/nbt1154; Donovan T, 2003, BRIT J NEUROSURG, V17, P443, DOI 10.1080/02688690310001613844; Eich T, 2007, NEW ENGL J MED, V356, P2754, DOI 10.1056/NEJMc070201; Elhami E, 2013, EJNMMI RES, V3, DOI 10.1186/2191-219X-3-72; Eriksson O, 2009, AM J TRANSPLANT, V9, P2816, DOI 10.1111/j.1600-6143.2009.02844.x; Everaert BR, 2012, BMC BIOTECHNOL, V12, DOI 10.1186/1472-6750-12-93; EVERALL I, 1995, J NEUROVIROL, V1, P126, DOI 10.3109/13550289509111017; Evgenov NV, 2006, DIABETES, V55, P2419, DOI 10.2337/db06-0484; Evgenov NV, 2006, NAT MED, V12, P144, DOI 10.1038/nm1316; Fischer UM, 2009, STEM CELLS DEV, V18, P683, DOI 10.1089/scd.2008.0253; GEPTS W, 1965, DIABETES, V14, P619, DOI 10.2337/diab.14.10.619; Gerhard A, 2005, NEUROIMAGE, V24, P591, DOI 10.1016/j.neuroimage.2004.09.034; Grobner T, 2006, NEPHROL DIAL TRANSPL, V21, P1104, DOI 10.1093/ndt/gfk062; Gu E, 2012, THERANOSTICS, V2, P335, DOI 10.7150/thno.3666; Gupta N, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3004373; Gyongyosi M, 2008, CIRC-CARDIOVASC IMAG, V1, P94, DOI 10.1161/CIRCIMAGING.108.797449; Harting MT, 2009, J NEUROSURG, V110, P1189, DOI 10.3171/2008.9.JNS08158; HELLMAN B, 1959, NATURE, V184, P1498, DOI 10.1038/1841498a0; Husser O, 2013, INT J CARDIOVAS IMAG, V29, P1499, DOI 10.1007/s10554-013-0239-1; Josephson L, 2013, J NUCL MED, V54, P329, DOI 10.2967/jnumed.112.107615; Kang WJ, 2006, J NUCL MED, V47, P1295; Kefalopoulou Z, 2014, JAMA NEUROL, V71, P83, DOI 10.1001/jamaneurol.2013.4749; Kondziolka D, 2004, CELL TRANSPLANT, V13, P749, DOI 10.3727/000000004783983350; Kondziolka D, 2000, NEUROLOGY, V55, P565, DOI 10.1212/WNL.55.4.565; Kondziolka D, 2005, J NEUROSURG, V103, P38, DOI 10.3171/jns.2005.103.1.0038; Kordower JH, 1998, MOVEMENT DISORD, V13, P383, DOI 10.1002/mds.870130303; Kostura L, 2004, NMR BIOMED, V17, P513, DOI 10.1002/nbm.925; Kroon E, 2008, NAT BIOTECHNOL, V26, P443, DOI 10.1038/nbt1393; Kumar R, 2011, EUR J HEART FAIL, V13, P651, DOI 10.1093/eurjhf/hfr012; Laflamme MA, 2007, NAT BIOTECHNOL, V25, P1015, DOI 10.1038/nbt1327; Laskey WK, 2010, JACC-CARDIOVASC IMAG, V3, P517, DOI 10.1016/j.jcmg.2009.11.017; Lazaridou A, 2013, MOL MED REP, V8, P775, DOI 10.3892/mmr.2013.1603; Lee PH, 2008, CLIN PHARMACOL THER, V83, P723, DOI 10.1038/sj.clpt.6100386; LINDVALL O, 1990, SCIENCE, V247, P574, DOI 10.1126/science.2105529; Lubag AJM, 2011, P NATL ACAD SCI USA, V108, P18400, DOI 10.1073/pnas.1109649108; Makkar RR, 2012, LANCET, V379, P895, DOI 10.1016/S0140-6736(12)60195-0; Malliaras K, 2014, J AM COLL CARDIOL, V63, P110, DOI 10.1016/j.jacc.2013.08.724; Matveyenko AV, 2008, DIABETES OBES METAB, V10, P23, DOI 10.1111/j.1463-1326.2008.00939.x; McCall M., 2012, INTERFACE FOCUS, V3; McGill LA, 2012, J CARDIOVASC MAGN R, V14, DOI 10.1186/1532-429X-14-86; Medarova Z, 2006, NAT PROTOC, V1, P429, DOI 10.1038/nprot.2006.63; Mekkaoui C, 2012, J CARDIOVASC MAGN R, V14, DOI 10.1186/1532-429X-14-70; Meltzer CC, 2001, NEUROSURGERY, V49, P586, DOI 10.1097/00006123-200109000-00011; Mendez I, 2005, BRAIN, V128, P1498, DOI 10.1093/brain/awh510; Minger SL, 2007, REGEN MED, V2, P69, DOI 10.2217/17460751.2.1.69; Modo M, 2013, CONTRAST MEDIA MOL I, V8, P439, DOI 10.1002/cmmi.1547; Modo M, 2013, CURR OPIN NEUROL, V26, P626, DOI 10.1097/WCO.0000000000000031; Molina DK, 2012, AM J FOREN MED PATH, V33, P368, DOI 10.1097/PAF.0b013e31823d29ad; Molina DK, 2012, AM J FOREN MED PATH, V33, P362, DOI 10.1097/PAF.0b013e31823d298b; Moniche F, 2012, STROKE, V43, P2242, DOI 10.1161/STROKEAHA.112.659409; Moszczynska A, 2004, BRAIN, V127, P363, DOI 10.1093/brain/awh046; Muir KW, 2011, TRANSL STROKE RES, V2, P266, DOI 10.1007/s12975-011-0095-z; Naumova AV, 2014, J CARDIOVASC PHARM T, V19, P358, DOI 10.1177/1074248414525999; Naumova AV, 2012, NMR BIOMED, V25, P1187, DOI 10.1002/nbm.2788; Naumova AV, 2010, MOL IMAGING, V9, P201, DOI 10.2310/7290.2010.00020; Nguyen PK, 2014, CELL STEM CELL, V14, P431, DOI 10.1016/j.stem.2014.03.009; Nguyen PK, 2011, CIRC RES, V109, P962, DOI 10.1161/CIRCRESAHA.111.242909; OLIVETTI G, 1990, CIRC RES, V67, P23, DOI 10.1161/01.RES.67.1.23; Park KI, 2002, NAT BIOTECHNOL, V20, P1111, DOI 10.1038/nbt751; Partlow KC, 2007, FASEB J, V21, P1647, DOI 10.1096/fj.06-6505com; Pawelczyk E, 2008, STEM CELLS, V26, P1366, DOI 10.1634/stemcells.2007-0707; Pawelczyk E, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006712; Perin EC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022949; Piccini P, 1999, NAT NEUROSCI, V2, P1137, DOI 10.1038/16060; Politis M, 2012, PROG BRAIN RES, V200, P199, DOI 10.1016/B978-0-444-59575-1.00009-0; Politis M, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003391; Politis M, 2010, SCI TRANSL MED, V2, DOI 10.1126/scitranslmed.3000976; Progatzky F, 2013, INTERFACE FOCUS, V3, DOI 10.1098/rsfs.2013.0001; Qiao H, 2009, MOL IMAGING BIOL, V11, P408, DOI 10.1007/s11307-009-0222-3; Ramsden CM, 2013, DEVELOPMENT, V140, P2576, DOI 10.1242/dev.092270; REAVEN GM, 1988, DIABETES, V37, P1595, DOI 10.2337/diabetes.37.12.1595; Rezania A, 2012, DIABETES, V61, P2016, DOI 10.2337/db11-1711; Rigol M, 2008, TRANSPL P, V40, P3619, DOI 10.1016/j.transproceed.2008.05.084; Robey TE, 2008, J MOL CELL CARDIOL, V45, P567, DOI 10.1016/j.yjmcc.2008.03.009; Rosado-de-Castro PH, 2013, REGEN MED, V8, P145, DOI [10.2217/RME.13.2, 10.2217/rme.13.2]; Ross BD, 1999, NMR BIOMED, V12, P221, DOI 10.1002/(SICI)1099-1492(199906)12:4<221::AID-NBM582>3.0.CO;2-Q; Rother KI, 2004, J CLIN INVEST, V114, P877, DOI 10.1172/JC1200423235; Roura S, 2013, J CELL MOL MED, V17, P693, DOI 10.1111/jcmm.12018; Rueger MA, 2012, NEUROSCIENCE, V215, P174, DOI 10.1016/j.neuroscience.2012.04.036; Rueger MA, 2013, CURR PHARM DESIGN, V19, P6499, DOI 10.2174/1381612811319360010; Ryan EA, 2005, DIABETES, V54, P2060, DOI 10.2337/diabetes.54.7.2060; Saleh A, 2007, STROKE, V38, P2733, DOI 10.1161/STROKEAHA.107.481788; Saudek F, 2010, TRANSPLANTATION, V90, P1602, DOI 10.1097/TP.0b013e3181ffba5e; Schachinger V, 2008, CIRCULATION, V118, P1425, DOI 10.1161/CIRCULATIONAHA.108.777102; Schafer R, 2009, CYTOTHERAPY, V11, P68, DOI 10.1080/14653240802666043; Seggewiss R, 2006, BLOOD, V107, P3865, DOI 10.1182/blood-2005-10-4108; Shapiro AMJ, 2000, NEW ENGL J MED, V343, P230, DOI 10.1056/NEJM200007273430401; Shapiro EM, 2006, MAGN RESON MED, V55, P242, DOI 10.1002/mrm.20718; Shapiro EM, 2004, P NATL ACAD SCI USA, V101, P10901, DOI 10.1073/pnas.0403918101; Shiba Y, 2012, NATURE, V489, P322, DOI 10.1038/nature11317; So PW, 2010, CELL TRANSPLANT, V19, P419, DOI 10.3727/096368910X498250; Sosnovik DE, 2014, CIRCULATION, V129, P1731, DOI 10.1161/CIRCULATIONAHA.113.005841; Srinivas M, 2010, ADV DRUG DELIVER REV, V62, P1080, DOI 10.1016/j.addr.2010.08.009; Sztriha LK, 2012, STROKE, V43, P3124, DOI 10.1161/STROKEAHA.111.649244; Tai JH, 2006, DIABETES, V55, P2931, DOI 10.2337/db06-0393; Tannous BA, 2006, NAT METHODS, V3, P391, DOI 10.1038/NMETH875; Templin C, 2012, CIRCULATION, V126, P430, DOI 10.1161/CIRCULATIONAHA.111.087684; Terrovitis J, 2008, CIRCULATION, V117, P1555, DOI 10.1161/CIRCULATIONAHA.107.732073; Thu MS, 2012, NAT MED, V18, P463, DOI 10.1038/nm.2666; Toso C, 2008, AM J TRANSPLANT, V8, P701, DOI 10.1111/j.1600-6143.2007.02120.x; van der Bogt KEA, 2008, CIRCULATION, V118, pS121, DOI 10.1161/CIRCULATIONAHA.107.759480; Van Hoof Dennis, 2013, Methods Mol Biol, V997, P127, DOI 10.1007/978-1-62703-348-0_10; van Zijl PCM, 2011, MAGN RESON MED, V65, P927, DOI 10.1002/mrm.22761; Vrtovec B, 2013, CIRCULATION, V128, pS42, DOI 10.1161/CIRCULATIONAHA.112.000230; Vrtovec B, 2013, CIRC RES, V112, P165, DOI 10.1161/CIRCRESAHA.112.276519; Wagers AJ, 2012, CELL STEM CELL, V10, P362, DOI 10.1016/j.stem.2012.02.018; Walczak P, 2007, MAGN RESON MED, V58, P261, DOI 10.1002/mrm.21280; Ward KM, 2000, J MAGN RESON, V143, P79, DOI 10.1006/jmre.1999.1956; Wardlaw JM, 2013, J NEUROL NEUROSUR PS, V84, P1001, DOI 10.1136/jnnp-2012-304807; Weigert R, 2013, J CELL BIOL, V201, P969, DOI 10.1083/jcb.201212130; Willmann JK, 2009, RADIOLOGY, V252, P117, DOI 10.1148/radiol.2513081616; Wolfs E, 2013, J NUCL MED, V54, P447, DOI 10.2967/jnumed.112.108316; Wu CX, 2013, CLIN IMAG, V37, P28, DOI 10.1016/j.clinimag.2012.02.023; Yaghoubi SS, 2012, THERANOSTICS, V2, P374, DOI 10.7150/thno.3677; Yaghoubi SS, 2009, NAT CLIN PRACT ONCOL, V6, P53, DOI 10.1038/ncponc1278; Yannas IV, 2013, BIOMATERIALS, V34, P321, DOI 10.1016/j.biomaterials.2012.10.006; Zhang Y, 2008, CURR PHARM DESIGN, V14, P3835, DOI 10.2174/138161208786898662; Zhen ZP, 2012, THERANOSTICS, V2, P45, DOI 10.7150/thno.3448; Zhou JY, 2013, J MAGN RESON IMAGING, V38, P1119, DOI 10.1002/jmri.24067; Zhou JY, 2003, NAT MED, V9, P1085, DOI 10.1038/nm907; Zhu JH, 2006, NEW ENGL J MED, V355, P2376, DOI 10.1056/NEJMc055304	159	168	173	0	89	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156	1546-1696		NAT BIOTECHNOL	Nat. Biotechnol.	AUG	2014	32	8					804	U121		10.1038/nbt.2993	http://dx.doi.org/10.1038/nbt.2993			15	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	AW7PF	25093889	Green Accepted			2022-12-27	WOS:000346455900021
J	Cima, MJ				Cima, Michael J.			Next-generation wearable electronics	NATURE BIOTECHNOLOGY			English	Editorial Material									Koch Inst Integrat Canc Res, Dept Mat Sci & Engn, Lemelson MIT Program, Cambridge, MA 02139 USA		Cima, MJ (corresponding author), Koch Inst Integrat Canc Res, Dept Mat Sci & Engn, Lemelson MIT Program, Cambridge, MA 02139 USA.	mjcima@mit.edu						Chelly JE, 2005, EXPERT OPIN PHARMACO, V6, P1205, DOI 10.1517/14656566.6.7.1205; Pahor M, 2014, JAMA-J AM MED ASSOC, V311, P2387, DOI 10.1001/jama.2014.5616; Shafiq R., 2001, J AM GERIATR SOC, V49, P1539; Son D, 2014, NAT NANOTECHNOL, V9, P397, DOI [10.1038/nnano.2014.38, 10.1038/NNANO.2014.38]; Timmermans A.A., 2009, J NEUROENG REHABIL; Wang J, 2013, INT C REHAB ROBOT; Yeo WH, 2013, ADV MATER, V25, P2773, DOI 10.1002/adma.201204426	7	115	116	1	73	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1087-0156	1546-1696		NAT BIOTECHNOL	Nat. Biotechnol.	JUL	2014	32	7					642	643		10.1038/nbt.2952	http://dx.doi.org/10.1038/nbt.2952			3	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	AK8VE	25004232				2022-12-27	WOS:000338705900028
J	Hu, H; Roach, JC; Coon, H; Guthery, SL; Voelkerding, KV; Margraf, RL; Durtschi, JD; Tavtigian, SV; Shankaracharya; Wu, W; Scheet, P; Wang, SG; Xing, JC; Glusman, G; Hubley, R; Li, H; Garg, V; Moore, B; Hood, L; Galas, DJ; Srivastava, D; Reese, MG; Jorde, LB; Yandell, M; Huff, CD				Hu, Hao; Roach, Jared C.; Coon, Hilary; Guthery, Stephen L.; Voelkerding, Karl V.; Margraf, Rebecca L.; Durtschi, Jacob D.; Tavtigian, Sean V.; Shankaracharya; Wu, Wilfred; Scheet, Paul; Wang, Shuoguo; Xing, Jinchuan; Glusman, Gustavo; Hubley, Robert; Li, Hong; Garg, Vidu; Moore, Barry; Hood, Leroy; Galas, David J.; Srivastava, Deepak; Reese, Martin G.; Jorde, Lynn B.; Yandell, Mark; Huff, Chad D.			A unified test of linkage analysis and rare-variant association for analysis of pedigree sequence data	NATURE BIOTECHNOLOGY			English	Article							CHRONIC MUCOCUTANEOUS CANDIDIASIS; FUNCTION STAT1 MUTATIONS; DE-NOVO MUTATIONS; DIVERSITY; IDENTIFICATION	High-throughput sequencing of related individuals has become an important tool for studying human disease. However, owing to technical complexity and lack of available tools, most pedigree-based sequencing studies rely on an ad hoc combination of suboptimal analyses. Here we present pedigree-VAAST (pVAAST), a disease-gene identification tool designed for high-throughput sequence data in pedigrees. pVAAST uses a sequence-based model to perform variant and gene-based linkage analysis. Linkage information is then combined with functional prediction and rare variant case-control association information in a unified statistical framework. pVAAST outperformed linkage and rare-variant association tests in simulations and identified disease-causing genes from whole-genome sequence data in three human pedigrees with dominant, recessive and de novo inheritance patterns. The approach is robust to incomplete penetrance and locus heterogeneity and is applicable to a wide variety of genetic traits. pVAAST maintains high power across studies of monogenic, high-penetrance phenotypes in a single pedigree to highly polygenic, common phenotypes involving hundreds of pedigrees.	[Hu, Hao; Shankaracharya; Scheet, Paul; Huff, Chad D.] Univ Texas MD Anderson Canc Ctr, Dept Epidemiol, Houston, TX 77030 USA; [Roach, Jared C.; Glusman, Gustavo; Hubley, Robert; Li, Hong; Hood, Leroy] Inst Syst Biol, Seattle, WA USA; [Coon, Hilary] Univ Utah, Dept Psychiat, Salt Lake City, UT USA; [Guthery, Stephen L.] Univ Utah, Dept Pediat, Salt Lake City, UT USA; [Voelkerding, Karl V.] Univ Utah, Sch Med, Dept Pathol, Salt Lake City, UT USA; [Voelkerding, Karl V.; Margraf, Rebecca L.; Durtschi, Jacob D.] ARUP Labs, ARUP Inst Clin & Expt Pathol, Salt Lake City, UT USA; [Tavtigian, Sean V.] Univ Utah, Huntsman Canc Inst, Dept Oncol Sci, Salt Lake City, UT USA; [Wu, Wilfred; Moore, Barry; Jorde, Lynn B.; Yandell, Mark] Univ Utah, Dept Human Genet, Salt Lake City, UT 84112 USA; [Wu, Wilfred; Moore, Barry; Jorde, Lynn B.; Yandell, Mark] Univ Utah, USTAR Ctr Genet Discovery, Salt Lake City, UT USA; [Wang, Shuoguo; Xing, Jinchuan] Rutgers State Univ, Dept Genet, Piscataway, NJ USA; [Garg, Vidu] Ohio State Univ, Dept Pediat, Columbus, OH 43210 USA; [Garg, Vidu] Nationwide Childrens Hosp, Res Inst, Ctr Cardiovasc & Pulm Res, Columbus, OH USA; [Galas, David J.] Univ Luxembourg, Luxembourg Ctr Syst Biomed, Esch Sur Alzette, Luxembourg; [Galas, David J.] Pacific Northwest Diabet Res Inst, Seattle, WA USA; [Srivastava, Deepak] Gladstone Inst Cardiovasc Dis, San Francisco, CA USA; [Srivastava, Deepak] Univ Calif San Francisco, San Francisco, CA 94143 USA; [Reese, Martin G.] Omicia Inc, Oakland, CA USA	University of Texas System; UTMD Anderson Cancer Center; Institute for Systems Biology (ISB); Utah System of Higher Education; University of Utah; Utah System of Higher Education; University of Utah; Utah System of Higher Education; University of Utah; Utah System of Higher Education; University of Utah; ARUP Laboratories; Huntsman Cancer Institute; Utah System of Higher Education; University of Utah; Utah System of Higher Education; University of Utah; Utah System of Higher Education; University of Utah; Rutgers State University New Brunswick; University System of Ohio; Ohio State University; University System of Ohio; Ohio State University; Nationwide Childrens Hospital; Research Institute at Nationwide Children's Hospital; University of Luxembourg; Pacific Northwest Diabetes Research Institute (PNDRI); University of California System; University of California San Francisco; The J David Gladstone Institutes; University of California System; University of California San Francisco	Yandell, M (corresponding author), Univ Utah, Dept Human Genet, Salt Lake City, UT 84112 USA.	myandell@genetics.utah.edu; chad@hufflab.org	Garg, Vidu/E-3101-2011; Garg, Vidu/D-8240-2012	Garg, Vidu/0000-0002-3778-5927; , shankaracharya/0000-0001-5957-9828; Srivastava, Deepak/0000-0002-3480-5953; Coon, Hilary/0000-0002-8877-5446; Glusman, Gustavo/0000-0001-8060-5955	US National Institutes of Health [R01 GM104390, R01 DK091374, R01 CA164138, R44HG006579, R01 GM59290]; University of Luxembourg-Institute for Systems Biology Program; NHLBI [UO1 HL100406, U01 HL098179]; NIH [R01 MH094400, R01 MH099134, R00HG005846]; MD Anderson Cancer Center Odyssey Program; NATIONAL CANCER INSTITUTE [P30CA016672, R01CA164138] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR001425] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [U01HL098179, R01HL109758, U01HL100406] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R44HG006579, R00HG005846] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM059290, R01GM104390] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH094400, R01MH099134] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); University of Luxembourg-Institute for Systems Biology Program; NHLBI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); MD Anderson Cancer Center Odyssey Program; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	An allocation of computer time on the University of Texas MD Anderson Research Computing High Performance Computing (HPC) facility is gratefully acknowledged. This work was supported by US National Institutes of Health grants R01 GM104390 (M.Y., L.B.J., C. D. H. and H. H.), R01 DK091374 (S. L. G., C. D. H. and L.B.J.), R01 CA164138 (S. V. T. and C. D. H.), R44HG006579 (M. G. R. and M.Y.) and R01 GM59290 (L.B.J.) as well as the University of Luxembourg-Institute for Systems Biology Program. D. S. was supported by grants from the NHLBI (UO1 HL100406 and U01 HL098179) related to this project. H. C. was supported by NIH grants R01 MH094400 and R01 MH099134. H. H. was supported by the MD Anderson Cancer Center Odyssey Program. J.X. was supported by NIH grant R00HG005846.	Abecasis GR, 2002, NAT GENET, V30, P97, DOI 10.1038/ng786; Adzhubei IA, 2010, NAT METHODS, V7, P248, DOI 10.1038/nmeth0410-248; Altshuler D, 2010, NATURE, V467, P1061, DOI 10.1038/nature09534; Altshuler DM, 2012, NATURE, V491, P56, DOI 10.1038/nature11632; Boisson-Dupuis S, 2012, CURR OPIN IMMUNOL, V24, P364, DOI 10.1016/j.coi.2012.04.011; Borecki IB, 2008, ADV GENET, V60, P51, DOI 10.1016/S0065-2660(07)00403-8; Coon H, 2013, TRANSL PSYCHIAT, V3, DOI 10.1038/tp.2013.100; Domyan ET, 2014, CURR BIOL, V24, P459, DOI 10.1016/j.cub.2014.01.020; Dreszer TR, 2012, NUCLEIC ACIDS RES, V40, pD918, DOI 10.1093/nar/gkr1055; Drmanac R, 2010, SCIENCE, V327, P78, DOI 10.1126/science.1181498; ELSTON RC, 1971, HUM HERED, V21, P523, DOI 10.1159/000152448; Epstein MP, 2012, AM J HUM GENET, V91, P215, DOI 10.1016/j.ajhg.2012.06.004; Feng BJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023221; Fishelson M, 2002, Bioinformatics, V18 Suppl 1, pS189; Garg V, 2003, NATURE, V424, P443, DOI 10.1038/nature01827; Heinzen EL, 2012, NAT GENET, V44, P1030, DOI 10.1038/ng.2358; Hoischen A, 2010, NAT GENET, V42, P483, DOI 10.1038/ng.581; Hori T, 2012, J CLIN IMMUNOL, V32, P1213, DOI 10.1007/s10875-012-9744-6; Hu H, 2013, GENET EPIDEMIOL, V37, P622, DOI 10.1002/gepi.21743; Jung J, 2006, GENET EPIDEMIOL, V30, P652, DOI 10.1002/gepi.20177; Lee S, 2012, AM J HUM GENET, V91, P224, DOI 10.1016/j.ajhg.2012.06.007; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Li YR, 2010, NAT GENET, V42, P969, DOI 10.1038/ng.680; Liu LY, 2011, J EXP MED, V208, P1635, DOI 10.1084/jem.20110958; Madsen BE, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000384; Marchani EE, 2012, HUM HERED, V74, P153, DOI 10.1159/000346560; McKenna A, 2010, GENOME RES, V20, P1297, DOI 10.1101/gr.107524.110; METROPOLIS N, 1953, J CHEM PHYS, V21, P1087, DOI 10.1063/1.1699114; MULLER HJ, 1950, AM J HUM GENET, V2, P111; Neale BM, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1001322; Ng PC, 2006, ANNU REV GENOM HUM G, V7, P61, DOI 10.1146/annurev.genom.7.080505.115630; Oualkacha K, 2013, GENET EPIDEMIOL, V37, P366, DOI 10.1002/gepi.21725; Reese MG, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-8-r88; Roach JC, 2010, SCIENCE, V328, P636, DOI 10.1126/science.1186802; Rosner B., 2011, FUNDAMENTALS BIOSTAT; Schaid DJ, 2013, GENET EPIDEMIOL, V37, P409, DOI 10.1002/gepi.21727; Sebat J, 2007, SCIENCE, V316, P445, DOI 10.1126/science.1138659; Shapiro MD, 2013, SCIENCE, V339, P1063, DOI 10.1126/science.1230422; Soltesz B, 2013, J MED GENET, V50, P567, DOI 10.1136/jmedgenet-2013-101570; Takezaki S, 2012, J IMMUNOL, V189, P1521, DOI 10.4049/jimmunol.1200926; Uzel G, 2013, J ALLERGY CLIN IMMUN, V131, P1611, DOI 10.1016/j.jaci.2012.11.054; van de Veerdonk FL, 2011, NEW ENGL J MED, V365, P54, DOI 10.1056/NEJMoa1100102; Vigouroux Y, 2008, AM J BOT, V95, P1240, DOI 10.3732/ajb.0800097; Wang K, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkq603; Yandell M, 2011, GENOME RES, V21, P1529, DOI 10.1101/gr.123158.111; Zhao K, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1467	46	71	71	0	10	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156	1546-1696		NAT BIOTECHNOL	Nat. Biotechnol.	JUL	2014	32	7					663	+		10.1038/nbt.2895	http://dx.doi.org/10.1038/nbt.2895			10	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	AK8VE	24837662	Green Accepted			2022-12-27	WOS:000338705900032
J	Brooks, PJ; Tagle, DA; Groft, S				Brooks, Philip J.; Tagle, Danilo A.; Groft, Steve			Expanding rare disease drug trials based on shared molecular etiology	NATURE BIOTECHNOLOGY			English	Article							FAMILIAL DYSAUTONOMIA; CYSTIC-FIBROSIS; NONSENSE MUTATIONS; STORAGE DISORDERS; GENETIC-DISEASES; GAUCHER-DISEASE; SUPPRESSION; REPAIR; CHAPERONES; MECHANISM	Current clinical trial approaches in rare disease test one drug on one indication defined by a clinical phenotype. For targeted drugs, grouping patients by molecular etiology would make much more sense.	[Brooks, Philip J.; Groft, Steve] NIH, Off Rare Dis Res, Natl Ctr Adv Translat Sci, Bethesda, MD 20892 USA; [Tagle, Danilo A.] NIH, Off Special Initiat, Off Director, Natl Ctr Adv Translat Sci, Bethesda, MD USA	National Institutes of Health (NIH) - USA; NIH National Center for Advancing Translational Sciences (NCATS); National Institutes of Health (NIH) - USA; NIH National Center for Advancing Translational Sciences (NCATS)	Brooks, PJ (corresponding author), NIH, Off Rare Dis Res, Natl Ctr Adv Translat Sci, Bethesda, MD 20892 USA.	pjbrooks@mail.nih.gov			Intramural NIH HHS [Z99 TR999999] Funding Source: Medline	Intramural NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)		Amaral MD, 2013, CURR PHARM DESIGN, V19, P3497; Anderson SL, 2005, BIOCHEM BIOPH RES CO, V336, P150, DOI 10.1016/j.bbrc.2005.08.054; Appelqvist H, 2013, J MOL CELL BIOL, V5, P214, DOI 10.1093/jmcb/mjt022; Auld DS, 2009, P NATL ACAD SCI USA, V106, P3585, DOI 10.1073/pnas.0813345106; Axelrod FB, 2011, PEDIATR RES, V70, P480, DOI 10.1203/PDR.0b013e31822e1825; Balch WE, 2008, SCIENCE, V319, P916, DOI 10.1126/science.1141448; Bemporad F, 2012, CHEM BIOL, V19, P315, DOI 10.1016/j.chembiol.2012.02.003; Boone N, 2012, HUM MUTAT, V33, P530, DOI 10.1002/humu.22010; Cullen V, 2011, ANN NEUROL, V69, P940, DOI 10.1002/ana.22400; Dietz HC, 2010, NEW ENGL J MED, V363, P852, DOI 10.1056/NEJMra0907180; Du LT, 2009, J EXP MED, V206, P2285, DOI 10.1084/jem.20081940; Garber K, 2013, NAT BIOTECHNOL, V31, P189, DOI 10.1038/nbt0313-189; Hims MM, 2007, J MOL MED, V85, P149, DOI 10.1007/s00109-006-0137-2; Hoffman EP, 2013, DISCOV MED, V16, P233; Hruska KS, 2008, HUM MUTAT, V29, P567, DOI 10.1002/humu.20676; Huang RL, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3001862; Kazantsev AG, 2008, NAT REV DRUG DISCOV, V7, P854, DOI 10.1038/nrd2681; Keeling KM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060478; Keeling KM, 2011, WIRES RNA, V2, P837, DOI 10.1002/wrna.95; Kleta R, 2004, EXPERT OPIN PHARMACO, V5, P2255, DOI 10.1517/14656566.5.11.2255; Kulkarni A, 2008, AM J HUM GENET, V82, P539, DOI 10.1016/j.ajhg.2008.01.009; Kuschal C, 2013, P NATL ACAD SCI USA, V110, P19483, DOI 10.1073/pnas.1312088110; Kuzmiak HA, 2006, TRENDS MOL MED, V12, P306, DOI 10.1016/j.molmed.2006.05.005; Linde L, 2008, TRENDS GENET, V24, P552, DOI 10.1016/j.tig.2008.08.010; Lindquist SL, 2011, CSH PERSPECT BIOL, V3, DOI 10.1101/cshperspect.a004507; McElroy SP, 2013, PLOS BIOL, V11, DOI 10.1371/journal.pbio.1001593; Medina M, 2011, FRONT MOL NEUROSCI, V4, DOI 10.3389/fnmol.2011.00024; Mort M, 2008, HUM MUTAT, V29, P1037, DOI 10.1002/humu.20763; Mosse YP, 2013, LANCET ONCOL, V14, P472, DOI 10.1016/S1470-2045(13)70095-0; Mu TW, 2008, PLOS BIOL, V6, P253, DOI 10.1371/journal.pbio.0060026; Myerowitz R, 1997, HUM MUTAT, V9, P195, DOI 10.1002/(SICI)1098-1004(1997)9:3<195::AID-HUMU1>3.0.CO;2-7; Nakamura K, 2011, AM J MED GENET C, V157C, P63, DOI 10.1002/ajmg.c.30291; Nudelman I, 2009, J MED CHEM, V52, P2836, DOI 10.1021/jm801640k; Parenti G, 2009, EMBO MOL MED, V1, P268, DOI 10.1002/emmm.200900036; Peltz SW, 2013, ANNU REV MED, V64, P407, DOI 10.1146/annurev-med-120611-144851; Pichavant C, 2011, MOL THER, V19, P830, DOI 10.1038/mt.2011.59; Quintana-Gallego E, 2014, ARCH BRONCONEUMOL, V50, P146, DOI 10.1016/j.arbres.2013.07.013; Rymond B, 2007, NAT CHEM BIOL, V3, P533, DOI 10.1038/nchembio0907-533; Tuchman M, 2008, PEDIATR RES, V64, P213, DOI 10.1203/PDR.0b013e318179454b; Wang F, 2011, J BIOL CHEM, V286, P43454, DOI 10.1074/jbc.M111.274332; Wang GS, 2007, NAT REV GENET, V8, P749, DOI 10.1038/nrg2164; Wilschanski M, 2011, EUR RESPIR J, V38, P59, DOI 10.1183/09031936.00120910; Xu M, 2012, J BIOL CHEM, V287, DOI 10.1074/jbc.M112.357707; Yang CZ, 2014, P NATL ACAD SCI USA, V111, P249, DOI 10.1073/pnas.1321341111	44	14	15	0	5	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156	1546-1696		NAT BIOTECHNOL	Nat. Biotechnol.	JUN	2014	32	6					515	518		10.1038/nbt.2924	http://dx.doi.org/10.1038/nbt.2924			4	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	AI9EV	24911489	Green Accepted			2022-12-27	WOS:000337233800007
J	Kessel, M				Kessel, Mark			Diagnostics as the first line of defense in global health security	NATURE BIOTECHNOLOGY			English	Article								The creation of the Global Health Security Agenda is a key step in the goal of combatting outbreaks in an increasingly interconnected world. It is too bad that the initiative is so woefully underfunded.	[Kessel, Mark] Shearman & Sterling LLP, FIND, New York, NY 10022 USA; [Kessel, Mark] Symphony Capital LLP, New York, NY USA		Kessel, M (corresponding author), Shearman & Sterling LLP, FIND, New York, NY 10022 USA.	mark.kessel@shearman.com							0	3	3	0	1	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156	1546-1696		NAT BIOTECHNOL	Nat. Biotechnol.	JUN	2014	32	6					513	514		10.1038/nbt.2930	http://dx.doi.org/10.1038/nbt.2930			2	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	AI9EV	24911488	Bronze, Green Published			2022-12-27	WOS:000337233800006
J	Doench, JG; Fusi, N; Sullender, M; Hegde, M; Vaimberg, EW; Donovan, KF; Smith, I; Tothova, Z; Wilen, C; Orchard, R; Virgin, HW; Listgarten, J; Root, DE				Doench, John G.; Fusi, Nicolo; Sullender, Meagan; Hegde, Mudra; Vaimberg, Emma W.; Donovan, Katherine F.; Smith, Ian; Tothova, Zuzana; Wilen, Craig; Orchard, Robert; Virgin, Herbert W.; Listgarten, Jennifer; Root, David E.			Optimized sgRNA design to maximize activity and minimize off-target effects of CRISPR-Cas9	NATURE BIOTECHNOLOGY			English	Article							GENETIC SCREENS; CELL-LINE; GENOME; CAS9; DNA; RAF; IDENTIFICATION; ENDONUCLEASE; SPECIFICITY; RESISTANCE	CRISPR-Cas9-based genetic screens are a powerful new tool in biology. By simply altering the sequence of the single-guide RNA (sgRNA), one can reprogram Cas9 to target different sites in the genome with relative ease, but the on-target activity and off-target effects of individual sgRNAs can vary widely. Here, we use recently devised sgRNA design rules to create human and mouse genome-wide libraries, perform positive and negative selection screens and observe that the use of these rules produced improved results. Additionally, we profile the off-target activity of thousands of sgRNAs and develop a metric to predict off-target sites. We incorporate these findings from large-scale, empirical data to improve our computational design rules and create optimized sgRNA libraries that maximize on-target activity and minimize off-target effects to enable more effective and efficient genetic screens and genome engineering.	[Doench, John G.; Sullender, Meagan; Hegde, Mudra; Vaimberg, Emma W.; Donovan, Katherine F.; Smith, Ian; Tothova, Zuzana; Root, David E.] Broad Inst MIT & Harvard, Cambridge, MA USA; [Fusi, Nicolo; Listgarten, Jennifer] Microsoft Res New England, Cambridge, MA USA; [Tothova, Zuzana] Dana Farber Canc Inst, Div Hematol Malignancies, Boston, MA 02115 USA; [Wilen, Craig; Orchard, Robert; Virgin, Herbert W.] Washington Univ, Sch Med, Dept Pathol & Immunol, St Louis, MO USA	Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Microsoft; Harvard University; Dana-Farber Cancer Institute; Washington University (WUSTL)	Doench, JG; Root, DE (corresponding author), Broad Inst MIT & Harvard, Cambridge, MA USA.; Fusi, N; Listgarten, J (corresponding author), Microsoft Res New England, Cambridge, MA USA.	jdoench@broadinstitute.org; fusi@microsoft.com; jennl@microsoft.com; droot@broadinstitute.org	Doench, John G/HCI-9570-2022; Kim, Hyongbum Henry/D-5804-2019; ravegnini, gloria/K-1330-2016; Doench, John/ABE-6251-2020	Doench, John G/0000-0002-3707-9889; Kim, Hyongbum Henry/0000-0002-4693-738X; ravegnini, gloria/0000-0002-7774-402X; Doench, John/0000-0002-3707-9889; Virgin, Herbert/0000-0001-8580-7628; Wilen, Craig/0000-0003-2495-9403; Sullender, Meagan/0000-0001-6666-8650; Hegde, Mudra/0000-0003-4530-4633	NIH [5K12CA087723-12]; ASCO Young Investigator Award; LLS Special Fellow Award; Next Generation Fund at the Broad Institute of MIT and Harvard; NATIONAL CANCER INSTITUTE [K12CA087723] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [T32AI007163, U19AI109725] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); ASCO Young Investigator Award; LLS Special Fellow Award; Next Generation Fund at the Broad Institute of MIT and Harvard; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	We thank M. Tomko, M. Greene, A. Brown, D. Alan and T. Green for software engineering support, and T. Nguyen, N. Tran and X. Yang for library production support (Broad Institute). Z.T. is funded by NIH 5K12CA087723-12, ASCO Young Investigator Award, LLS Special Fellow Award. J.G.D. is a Merkin Institute Fellow and is supported by the Next Generation Fund at the Broad Institute of MIT and Harvard.	Bae S, 2014, NAT METHODS, V11, P705, DOI 10.1038/nmeth.3015; Bae S, 2014, BIOINFORMATICS, V30, P1473, DOI 10.1093/bioinformatics/btu048; Bae S, 2012, FEBS LETT, V586, P3057, DOI 10.1016/j.febslet.2012.07.022; Barretina J, 2012, NATURE, V483, P603, DOI 10.1038/nature11003; Ben-Hur A, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000173; BLASI E, 1987, EUR J IMMUNOL, V17, P1491, DOI 10.1002/eji.1830171016; Bollag G, 2010, NATURE, V467, P596, DOI 10.1038/nature09454; Brinkman EK, 2014, NUCLEIC ACIDS RES, V42, DOI 10.1093/nar/gku936; CASKEY CT, 1979, CELL, V16, P1, DOI 10.1016/0092-8674(79)90182-X; Chari R, 2015, NAT METHODS, V12, P823, DOI [10.1038/NMETH.3473, 10.1038/nmeth.3473]; Cheok MH, 2006, NAT REV CANCER, V6, P117, DOI 10.1038/nrc1800; Cock PJA, 2009, BIOINFORMATICS, V25, P1422, DOI 10.1093/bioinformatics/btp163; Cong L, 2013, SCIENCE, V339, P819, DOI 10.1126/science.1231143; Davies BR, 2007, MOL CANCER THER, V6, P2209, DOI 10.1158/1535-7163.MCT-07-0231; Doench JG, 2014, NAT BIOTECHNOL, V32, P1262, DOI 10.1038/nbt.3026; Fu YF, 2013, NAT BIOTECHNOL, V31, P822, DOI 10.1038/nbt.2623; Gamper AM, 2008, MOL CELL BIOL, V28, P2517, DOI 10.1128/MCB.01461-07; Gilbert LA, 2014, CELL, V159, P647, DOI 10.1016/j.cell.2014.09.029; Guilinger JP, 2014, NAT BIOTECHNOL, V32, P577, DOI 10.1038/nbt.2909; Hart T, 2014, MOL SYST BIOL, V10, DOI 10.15252/msb.20145216; Hartenian E, 2015, FEBS J, V282, P1383, DOI 10.1111/febs.13248; Heigwer F, 2014, NAT METHODS, V11, P122, DOI 10.1038/nmeth.2812; Hsu PD, 2013, NAT BIOTECHNOL, V31, P827, DOI 10.1038/nbt.2647; Jinek M, 2014, SCIENCE, V343, P1215, DOI 10.1126/science.1247997; Jinek M, 2013, ELIFE, V2, DOI 10.7554/eLife.00471; Jinek M, 2012, SCIENCE, V337, P816, DOI 10.1126/science.1225829; Johannessen CM, 2010, NATURE, V468, P968, DOI 10.1038/nature09627; Kampmann M, 2015, P NATL ACAD SCI USA, V112, pE3384, DOI 10.1073/pnas.1508821112; Koike-Yusa H, 2014, NAT BIOTECHNOL, V32, P267, DOI 10.1038/nbt.2800; Langmead B, 2012, NAT METHODS, V9, P357, DOI [10.1038/NMETH.1923, 10.1038/nmeth.1923]; Lawrence MS, 2014, NATURE, V505, P495, DOI 10.1038/nature12912; Le Novere N, 2001, BIOINFORMATICS, V17, P1226, DOI 10.1093/bioinformatics/17.12.1226; Li W, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0554-4; Liberzon A, 2011, BIOINFORMATICS, V27, P1739, DOI 10.1093/bioinformatics/btr260; Lin YN, 2014, NUCLEIC ACIDS RES, V42, P7473, DOI 10.1093/nar/gku402; Mali P, 2013, SCIENCE, V339, P823, DOI 10.1126/science.1232033; Ran FA, 2013, CELL, V154, P1380, DOI 10.1016/j.cell.2013.08.021; Sanjana NE, 2014, NAT METHODS, V11, P783, DOI 10.1038/nmeth.3047; Shalem O, 2014, SCIENCE, V343, P84, DOI 10.1126/science.1247005; Shi JW, 2015, NAT BIOTECHNOL, V33, P661, DOI 10.1038/nbt.3235; Stansley B, 2012, J NEUROINFLAMM, V9, DOI 10.1186/1742-2094-9-115; STEIGER JH, 1980, PSYCHOL BULL, V87, P245, DOI 10.1037/0033-2909.87.2.245; Stemmer M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0124633; Sternberg SH, 2014, NATURE, V507, P62, DOI 10.1038/nature13011; Storey JD, 2003, P NATL ACAD SCI USA, V100, P9440, DOI 10.1073/pnas.1530509100; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Tsai SQ, 2015, NAT BIOTECHNOL, V33, P187, DOI 10.1038/nbt.3117; Veres A, 2014, CELL STEM CELL, V15, P27, DOI 10.1016/j.stem.2014.04.020; Wang T, 2015, SCIENCE, V350, P1096, DOI 10.1126/science.aac7041; Wang T, 2014, SCIENCE, V343, P80, DOI 10.1126/science.1246981; Whittaker SR, 2013, CANCER DISCOV, V3, P350, DOI 10.1158/2159-8290.CD-12-0470; Xu H, 2015, GENOME RES, V25, P1147, DOI 10.1101/gr.191452.115; Zha MW, 2008, J MOL BIOL, V379, P568, DOI 10.1016/j.jmb.2008.04.006	53	1545	1623	31	519	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156	1546-1696		NAT BIOTECHNOL	Nat. Biotechnol.	FEB	2016	34	2					184	+		10.1038/nbt.3437	http://dx.doi.org/10.1038/nbt.3437			12	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	DD0OK	26780180	Green Accepted			2022-12-27	WOS:000369619100021
J	McDonald, A; Glusman, G; Price, ND				McDonald, Aniel; Glusman, Gustavo; Price, Nathan D.			Personalized nutrition through big data	NATURE BIOTECHNOLOGY			English	Editorial Material									[McDonald, Aniel; Glusman, Gustavo; Price, Nathan D.] Inst Syst Biol, Seattle, WA USA	Institute for Systems Biology (ISB)	Price, ND (corresponding author), Inst Syst Biol, Seattle, WA USA.	nprice@systemsbiology.org		Price, Nathan/0000-0002-4157-0267; Glusman, Gustavo/0000-0001-8060-5955				Ausiello D, 2015, BIG DATA, V3, P203, DOI 10.1089/big.2015.0016; Dodd H, 2011, AM J CLIN NUTR, V94, P992, DOI 10.3945/ajcn.111.012138; Hood L, 2014, SCI TRANSL MED, V6, DOI 10.1126/scitranslmed.3008665; Olle B, 2013, NAT BIOTECHNOL, V31, P309, DOI 10.1038/nbt.2548; Pedregosa F, 2011, J MACH LEARN RES, V12, P2825; Qin JJ, 2012, NATURE, V490, P55, DOI 10.1038/nature11450; Zeevi D, 2015, CELL, V163, P1079, DOI 10.1016/j.cell.2015.11.001; Zimmet P, 2001, NATURE, V414, P782, DOI 10.1038/414782a	8	13	15	1	26	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1087-0156	1546-1696		NAT BIOTECHNOL	Nat. Biotechnol.	FEB	2016	34	2					152	154		10.1038/nbt.3476	http://dx.doi.org/10.1038/nbt.3476			4	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	DD0OK	26849520				2022-12-27	WOS:000369619100016
J	Sheridan, C				Sheridan, Cormac			CETP inhibitors boost 'good' cholesterol to no avail	NATURE BIOTECHNOLOGY			English	News Item																		1988, ARTERIOSCLEROSIS, V8, P737	1	7	8	0	1	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156	1546-1696		NAT BIOTECHNOL	Nat. Biotechnol.	JAN	2016	34	1					5	+		10.1038/nbt0116-5	http://dx.doi.org/10.1038/nbt0116-5			2	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	DB8HQ	26744957				2022-12-27	WOS:000368758200003
J	Dahlman, JE; Abudayyeh, OO; Joung, J; Gootenberg, JS; Zhang, F; Konermann, S				Dahlman, James E.; Abudayyeh, Omar O.; Joung, Julia; Gootenberg, Jonathan S.; Zhang, Feng; Konermann, Silvana			Orthogonal gene knockout and activation with a catalytically active Cas9 nuclease	NATURE BIOTECHNOLOGY			English	Article							GUIDE RNA; GENOME; CRISPR-CAS9; SPECIFICITY; COMPLEX; DNA; TRANSCRIPTION; ENDONUCLEASE; IMMUNITY; CELLS	We have developed a CRISPR-based method that uses catalytically active Cas9 and distinct single guide (sgRNA) constructs to knock out and activate different genes in the same cell. These sgRNAs, with 14- to 15-bp target sequences and MS2 binding loops, can activate gene expression using an active Streptococcus pyogenes Cas9 nuclease, without inducing doublestranded breaks. We use these 'dead RNAs' to perform orthogonal gene knockout and transcriptional activation in human cells.	[Dahlman, James E.; Abudayyeh, Omar O.; Joung, Julia; Gootenberg, Jonathan S.; Zhang, Feng; Konermann, Silvana] Broad Inst MIT & Harvard, Cambridge, MA 02142 USA; [Dahlman, James E.] Georgia Inst Technol, Wallace H Coulter Dept Biomed Engn, Atlanta, GA 30332 USA; [Abudayyeh, Omar O.; Joung, Julia; Gootenberg, Jonathan S.; Zhang, Feng; Konermann, Silvana] MIT, McGovern Inst Brain Res, Cambridge, MA 02139 USA; [Abudayyeh, Omar O.; Joung, Julia; Gootenberg, Jonathan S.; Zhang, Feng; Konermann, Silvana] MIT, Dept Brain & Cognit Sci, Cambridge, MA 02139 USA; [Abudayyeh, Omar O.; Joung, Julia; Gootenberg, Jonathan S.; Zhang, Feng; Konermann, Silvana] MIT, Dept Biol Engn, Cambridge, MA 02139 USA; [Gootenberg, Jonathan S.] Harvard Univ, Sch Med, Dept Syst Biol, Boston, MA USA	Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; University System of Georgia; Georgia Institute of Technology; Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT); Harvard University; Harvard Medical School	Dahlman, JE (corresponding author), Broad Inst MIT & Harvard, Cambridge, MA 02142 USA.	james.dahlman@bme.gatech.edu; silvanakonermann@gmail.com	Gootenberg, Jonathan/AAY-8174-2021; Joung, Julia/HCH-8944-2022; Abudayyeh, Omar/ABF-1746-2020; Macrae, Rhiannon/AAX-1536-2020	Gootenberg, Jonathan/0000-0003-2757-2175; Abudayyeh, Omar/0000-0002-7979-3220; 	Life Science Research Foundation post-doctoral fellowship of the Cystic Fibrosis Foundation; Friends of the McGovern Institute Fellowship; Department of Energy (DOE) Computational Science Graduate Fellowship; National Institute of Mental Health (NIMH) [1DP1-MH100706]; David R. Cheng and Bob Metcalfe; Poitras Foundation; Vallee Foundation; Simons Foundation; Paul G. Allen Foundation; New York Stem Cell Foundation; NATIONAL INSTITUTE OF MENTAL HEALTH [DP1MH100706] Funding Source: NIH RePORTER	Life Science Research Foundation post-doctoral fellowship of the Cystic Fibrosis Foundation; Friends of the McGovern Institute Fellowship; Department of Energy (DOE) Computational Science Graduate Fellowship(United States Department of Energy (DOE)); National Institute of Mental Health (NIMH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); David R. Cheng and Bob Metcalfe; Poitras Foundation; Vallee Foundation; Simons Foundation; Paul G. Allen Foundation; New York Stem Cell Foundation; NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	The authors thank K. Zheng and I. Slaymaker for their support and input. J.E.D. is supported by a Life Science Research Foundation post-doctoral fellowship of the Cystic Fibrosis Foundation. O.O.A. is supported by a Friends of the McGovern Institute Fellowship. J.S.G. is supported by a Department of Energy (DOE) Computational Science Graduate Fellowship. F.Z. is supported by the National Institute of Mental Health (NIMH) (1DP1-MH100706), the Poitras, Vallee, Simons, Paul G. Allen and New York Stem Cell Foundations, and David R. Cheng and Bob Metcalfe. The authors plan to make the reagents widely available to the academic community through Addgene and to provide software tools via the Zhang laboratory website (http://www.genome-engineering.org/).	Briner AE, 2014, MOL CELL, V56, P333, DOI 10.1016/j.molcel.2014.09.019; Dow LE, 2015, NAT BIOTECHNOL, V33, P390, DOI 10.1038/nbt.3155; Esvelt KM, 2013, NAT METHODS, V10, P1116, DOI [10.1038/NMETH.2681, 10.1038/nmeth.2681]; Fu YF, 2014, NAT BIOTECHNOL, V32, P279, DOI 10.1038/nbt.2808; Gasiunas G, 2012, P NATL ACAD SCI USA, V109, pE2579, DOI 10.1073/pnas.1208507109; Gilbert LA, 2013, CELL, V154, P442, DOI 10.1016/j.cell.2013.06.044; Hilton IB, 2015, NAT BIOTECHNOL, V33, P510, DOI 10.1038/nbt.3199; Hsu PD, 2013, NAT BIOTECHNOL, V31, P827, DOI 10.1038/nbt.2647; Jinek M, 2012, SCIENCE, V337, P816, DOI 10.1126/science.1225829; Kiani S, 2015, NAT METHODS, V12, P1051, DOI [10.1038/NMETH.3580, 10.1038/nmeth.3580]; Konermann S, 2015, NATURE, V517, P583, DOI 10.1038/nature14136; Konermann S, 2013, NATURE, V500, P472, DOI 10.1038/nature12466; Li B, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-323; Maeder ML, 2013, NAT METHODS, V10, P977, DOI [10.1038/NMETH.2598, 10.1038/nmeth.2598]; Mali P, 2013, NAT BIOTECHNOL, V31, P833, DOI 10.1038/nbt.2675; Nishimasu H, 2014, CELL, V156, P935, DOI 10.1016/j.cell.2014.02.001; Perez-Pinera P, 2013, NAT METHODS, V10, P973, DOI [10.1038/NMETH.2600, 10.1038/nmeth.2600]; Platt RJ, 2014, CELL, V159, P440, DOI 10.1016/j.cell.2014.09.014; Ran FA, 2013, CELL, V154, P1380, DOI 10.1016/j.cell.2013.08.021; Shalem O, 2014, SCIENCE, V343, P84, DOI 10.1126/science.1247005; Wu XB, 2014, NAT BIOTECHNOL, V32, P670, DOI 10.1038/nbt.2889; Zalatan JG, 2015, CELL, V160, P339, DOI 10.1016/j.cell.2014.11.052	22	165	185	5	63	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1087-0156	1546-1696		NAT BIOTECHNOL	Nat. Biotechnol.	NOV	2015	33	11					1159	U147		10.1038/nbt.3390	http://dx.doi.org/10.1038/nbt.3390			4	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	CW3TY	26436575	Green Submitted, Green Accepted			2022-12-27	WOS:000364916000022
J	Picotti, P				Picotti, Paola			Phosphoproteomics takes it easy	NATURE BIOTECHNOLOGY			English	Editorial Material							PHOSPHORYLATION; ENRICHMENT		ETH, Inst Biochem, Dept Biol, Zurich, Switzerland	ETH Zurich	Picotti, P (corresponding author), ETH, Inst Biochem, Dept Biol, Zurich, Switzerland.	paola.picotti@bc.biol.ethz.ch						ANDERSSON L, 1986, ANAL BIOCHEM, V154, P250, DOI 10.1016/0003-2697(86)90523-3; Cohen P, 2000, TRENDS BIOCHEM SCI, V25, P596, DOI 10.1016/S0968-0004(00)01712-6; de Graaf EL, 2014, MOL CELL PROTEOMICS, V13, P2426, DOI 10.1074/mcp.O113.036608; Dephoure N, 2013, MOL BIOL CELL, V24, P535, DOI 10.1091/mbc.E12-09-0677; Dickhut C, 2014, J PROTEOME RES, V13, P2761, DOI 10.1021/pr401181y; Luber CA, 2010, IMMUNITY, V32, P279, DOI 10.1016/j.immuni.2010.01.013; Mann M., 2015, NAT BIOTECHNOL, V33, P862; Pinkse MWH, 2004, ANAL CHEM, V76, P3935, DOI 10.1021/ac0498617; Scheltema RA, 2014, MOL CELL PROTEOMICS, V13, P3698, DOI 10.1074/mcp.M114.043489; Soste M, 2014, NAT METHODS, V11, P1045, DOI [10.1038/NMETH.3101, 10.1038/nmeth.3101]; Tape CJ, 2014, ANAL CHEM, V86, P10296, DOI 10.1021/ac5025842	11	4	4	0	19	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156	1546-1696		NAT BIOTECHNOL	Nat. Biotechnol.	SEP	2015	33	9					929	930		10.1038/nbt.3345	http://dx.doi.org/10.1038/nbt.3345			3	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	CR0EK	26348962				2022-12-27	WOS:000360990900019
J	Shen, H; Zhong, XB; Zhao, FF; Wang, YM; Yan, BX; Li, Q; Chen, GY; Mao, BZ; Wang, JJ; Li, YS; Xiao, GY; He, YK; Xiao, H; Li, JM; He, ZH				Shen, Hui; Zhong, Xiangbin; Zhao, Fangfang; Wang, Yanmei; Yan, Bingxiao; Li, Qun; Chen, Genyun; Mao, Bizeng; Wang, Jianjun; Li, Yangsheng; Xiao, Guoying; He, Yuke; Xiao, Han; Li, Jianming; He, Zuhua			Overexpression of receptor-like kinase ERECTA improves thermotolerance in rice and tomato	NATURE BIOTECHNOLOGY			English	Article							WATER-USE EFFICIENCY; TRANSCRIPTION FACTOR; HEAT-STRESS; TEMPERATURE PERCEPTION; ARABIDOPSIS; GENE; PROTEIN; TOLERANCE; ADAPTATION; LEAF	The detrimental effects of global warming on crop productivity threaten to reduce the world's food supply(1-3). Although plant responses to changes in temperature have been studied(4), genetic modification of crops to improve thermotolerance has had little success to date. Here we demonstrate that overexpression of the Arabidopsis thaliana receptor-like kinase ERECTA (ER) in Arabidopsis, rice and tomato confers thermotolerance independent of water loss and that Arabidopsis er mutants are hypersensitive to heat. A loss-of-function mutation of a rice ER homolog and reduced expression of a tomato ER allele decreased thermotolerance of both species. Transgenic tomato and rice lines overexpressing Arabidopsis ER showed improved heat tolerance in the greenhouse and in field tests at multiple locations in China during several seasons. Moreover, ER-overexpressing transgenic Arabidopsis, tomato and rice plants had increased biomass. Our findings could contribute to engineering or breeding thermotolerant crops with no growth penalty.	[Shen, Hui; Zhong, Xiangbin; Zhao, Fangfang; Wang, Yanmei; Yan, Bingxiao; Li, Qun; Chen, Genyun; He, Yuke; Xiao, Han; He, Zuhua] Chinese Acad Sci, Natl Key Lab Plant Mol Genet, Shanghai, Peoples R China; [Shen, Hui; Zhong, Xiangbin; Zhao, Fangfang; Wang, Yanmei; Yan, Bingxiao; Li, Qun; Chen, Genyun; He, Yuke; Xiao, Han; He, Zuhua] Chinese Acad Sci, Shanghai Inst Biol Sci, Inst Plant Physiol & Ecol, Natl Ctr Plant Gene Res, Shanghai, Peoples R China; [Shen, Hui] Chinese Acad Sci, Shanghai Chenshan Bot Garden, Shanghai Chenshan Plant Sci Res Ctr, Shanghai, Peoples R China; [Mao, Bizeng] Zhejiang Univ, Coll Agr & Biotechnol, Hangzhou 310003, Zhejiang, Peoples R China; [Wang, Jianjun] Zhejiang Acad Agr Sci, Hangzhou, Zhejiang, Peoples R China; [Li, Yangsheng] Wuhan Univ, Coll Life Sci, Wuhan, Hubei, Peoples R China; [Xiao, Guoying] Chinese Acad Sci, Inst Subtrop Agr, Changsha, Hunan, Peoples R China; [Li, Jianming] Chinese Acad Sci, Shanghai Inst Biol Sci, Shanghai Ctr Plant Stress Biol, Shanghai, Peoples R China; [He, Zuhua] Chinese Acad Sci, Shanghai Inst Biol Sci, Inst Plant Physiol & Ecol, Collaborat Innovat Ctr Genet & Dev, Shanghai, Peoples R China	Chinese Academy of Sciences; Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; Zhejiang University; Zhejiang Academy of Agricultural Sciences; Wuhan University; Chinese Academy of Sciences; Institute of Subtropical Agriculture, CAS; Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS	He, ZH (corresponding author), Chinese Acad Sci, Natl Key Lab Plant Mol Genet, Shanghai, Peoples R China.	zhhe@sibs.ac.cn	Xiao, Han/AAH-1549-2022; li, yong/HDN-3885-2022; mao, bizeng/U-3958-2017; Xiao, Han/C-3295-2012; Li, Yang/GWM-7879-2022; Li, Jianming/O-1772-2014; Xiao, Han/AFL-9447-2022; Li, Yuan/GXV-1310-2022	mao, bizeng/0000-0001-9852-6171; Xiao, Han/0000-0001-5937-6510; Li, Jianming/0000-0003-3231-0778; He, Zuhua/0000-0002-6098-7893	National Key Basic Research and Development Program [2011CB100700, 2015CB150104]; National Natural Science Foundation of China [3130061]; Ministry of Science and Technology of China [2012AA10A302]; National GMO project [2013ZX08009-003-001]; National High Technology Research and Development Program of China [2012AA100104-6]; Chinese Academy of Sciences [KSCX2-EW-N-01, 2009OHTP07]; Shanghai Committee of Science and Technology [11PJ1410900]	National Key Basic Research and Development Program(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Ministry of Science and Technology of China(Ministry of Science and Technology, China); National GMO project; National High Technology Research and Development Program of China(National High Technology Research and Development Program of China); Chinese Academy of Sciences(Chinese Academy of Sciences); Shanghai Committee of Science and Technology(Shanghai Science & Technology Committee)	We thank J.-S. Jeon and C.Y. Wu for the rice T-DNA mutants, X.L. Wang for the er-105 line, X.G. Zhu, Y.J. Zhang and M.Z. Lv for help in statistical analysis, D.Y. Sun and H.X. Lin for helpful discussions, and L. Lin for help in experiments. This work was supported by the National Key Basic Research and Development Program (2011CB100700 to H.Z.), the National Natural Science Foundation of China (3130061 to H.Z.), the Ministry of Science and Technology of China (2012AA10A302 to Z.H.), the National GMO project (2013ZX08009-003-001 to Z.H.), the National High Technology Research and Development Program of China (2012AA100104-6 to H.X.), the Chinese Academy of Sciences (KSCX2-EW-N-01 to H.Z. and 2009OHTP07 to H.X.), the Shanghai Committee of Science and Technology (11PJ1410900 to H.X.), and the National Key Basic Research and Development Program (2015CB150104 to G.C.).	Burke JJ, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0122933; Charng YY, 2007, PLANT PHYSIOL, V143, P251, DOI 10.1104/pp.106.091322; Clough SJ, 1998, PLANT J, V16, P735, DOI 10.1046/j.1365-313x.1998.00343.x; Finka A, 2012, PLANT CELL, V24, P3333, DOI 10.1105/tpc.112.095844; Fitter AH, 2002, SCIENCE, V296, P1689, DOI 10.1126/science.1071617; Fournier-Level A, 2011, SCIENCE, V334, P86, DOI 10.1126/science.1209271; Grover A, 2013, PLANT SCI, V205, P38, DOI 10.1016/j.plantsci.2013.01.005; Guan QM, 2014, PLANT CELL, V26, P438, DOI 10.1105/tpc.113.118927; Hancock AM, 2011, SCIENCE, V334, P83, DOI 10.1126/science.1209244; Iba K, 2002, ANNU REV PLANT BIOL, V53, P225, DOI 10.1146/annurev.arplant.53.100201.160729; Ishikawa T, 2013, METHOD ENZYMOL, V527, P239, DOI 10.1016/B978-0-12-405882-8.00013-1; Jagadish SVK, 2010, J EXP BOT, V61, P143, DOI 10.1093/jxb/erp289; Karaba A, 2007, P NATL ACAD SCI USA, V104, P15270, DOI 10.1073/pnas.0707294104; Kim M, 2012, PLANT CELL, V24, P3349, DOI 10.1105/tpc.112.101006; Kumar SV, 2010, CELL, V140, P136, DOI 10.1016/j.cell.2009.11.006; Lee JS, 2012, GENE DEV, V26, P126, DOI 10.1101/gad.179895.111; Li SX, 2014, PLANT CELL, V26, P1764, DOI 10.1105/tpc.114.124883; Li XM, 2015, NAT GENET, V47, P827, DOI 10.1038/ng.3305; Lin L, 2012, PLANT J, V72, P707, DOI 10.1111/j.1365-313X.2012.05109.x; LISTER C, 1993, PLANT J, V4, P745, DOI 10.1046/j.1365-313X.1993.04040745.x; Lobell DB, 2007, ENVIRON RES LETT, V2, DOI 10.1088/1748-9326/2/1/014002; Long SP, 2010, CURR OPIN PLANT BIOL, V13, P241, DOI 10.1016/j.pbi.2010.04.008; Masle J, 2005, NATURE, V436, P866, DOI 10.1038/nature03835; Mickelbart MV, 2015, NAT REV GENET, V16, P237, DOI 10.1038/nrg3901; Parida AK, 2007, PLANT BIOTECHNOL REP, V1, P37, DOI 10.1007/s11816-006-0004-1; Penfield S, 2008, NEW PHYTOL, V179, P615, DOI 10.1111/j.1469-8137.2008.02478.x; Peng SB, 2004, P NATL ACAD SCI USA, V101, P9971, DOI 10.1073/pnas.0403720101; Pennycooke JC, 2008, PLANT MOL BIOL, V67, P483, DOI 10.1007/s11103-008-9333-5; Pose D, 2013, NATURE, V503, P414, DOI 10.1038/nature12633; Qi YP, 2004, PLANTA, V219, P270, DOI 10.1007/s00425-004-1248-z; Queitsch C, 2000, PLANT CELL, V12, P479, DOI 10.1105/tpc.12.4.479; Samach A, 2005, CURR OPIN PLANT BIOL, V8, P483, DOI 10.1016/j.pbi.2005.07.011; Sato S, 2012, NATURE, V485, P635, DOI 10.1038/nature11119; Shiu SH, 2004, PLANT CELL, V16, P1220, DOI 10.1105/tpc.020834; Shpak ED, 2005, SCIENCE, V309, P290, DOI 10.1126/science.1109710; Shpak ED, 2004, DEVELOPMENT, V131, P1491, DOI 10.1242/dev.01028; Tisne S, 2008, PLANT PHYSIOL, V148, P1117, DOI 10.1104/pp.108.124271; Torii KU, 1996, PLANT CELL, V8, P735, DOI 10.1105/tpc.8.4.735; Uchida N, 2012, P NATL ACAD SCI USA, V109, P6337, DOI 10.1073/pnas.1117537109; van Zanten M, 2009, TRENDS PLANT SCI, V14, P214, DOI 10.1016/j.tplants.2009.01.010; Villagarcia H, 2012, J EXP BOT, V63, P6493, DOI 10.1093/jxb/ers305; Wang E, 2008, NAT GENET, V40, P1370, DOI 10.1038/ng.220; Weng L, 2015, PLANT PHYSIOL, V167, P931, DOI 10.1104/pp.114.255174; Xing HT, 2011, PLANTA, V234, P229, DOI 10.1007/s00425-011-1389-9; Yan CS, 2006, PLANTA, V224, P889, DOI 10.1007/s00425-006-0272-6; Zhang HK, 2004, CELL RES, V14, P27, DOI 10.1038/sj.cr.7290199; Zhong SH, 2013, P NATL ACAD SCI USA, V110, P9171, DOI 10.1073/pnas.1219655110	47	108	123	14	182	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1087-0156	1546-1696		NAT BIOTECHNOL	Nat. Biotechnol.	SEP	2015	33	9					996	U153		10.1038/nbt.3321	http://dx.doi.org/10.1038/nbt.3321			11	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	CR0EK	26280413				2022-12-27	WOS:000360990900029
J	Wong, ASL; Choi, GCG; Cheng, AA; Purcell, O; Lu, TK				Wong, Alan S. L.; Choi, Gigi C. G.; Cheng, Allen A.; Purcell, Oliver; Lu, Timothy K.			Massively parallel high-order combinatorial genetics in human cells	NATURE BIOTECHNOLOGY			English	Article							MISSING HERITABILITY; INTERACTION NETWORKS; TARGET INTERACTIONS; MAMMALIAN-CELLS; BREAST-CANCER; RNA DECAY; MICRORNA; EXPRESSION; CRISPR-CAS9; RESISTANCE	The systematic functional analysis of combinatorial genetics has been limited by the throughput that can be achieved and the order of complexity that can be studied. To enable massively parallel characterization of genetic combinations in human cells, we developed a technology for rapid, scalable assembly of high-order barcoded combinatorial genetic libraries that can be quantified with high-throughput sequencing. We applied this technology, combinatorial genetics en masse (CombiGEM), to create high-coverage libraries of 1,521 two-wise and 51,770 three-wise barcoded combinations of 39 human microRNA (miRNA) precursors. We identified miRNA combinations that synergistically sensitize drug-resistant cancer cells to chemotherapy and/or inhibit cancer cell proliferation, providing insights into complex miRNA networks. More broadly, our method will enable high-throughput profiling of multifactorial genetic combinations that regulate phenotypes of relevance to biomedicine, biotechnology and basic science.	[Wong, Alan S. L.; Choi, Gigi C. G.; Cheng, Allen A.; Purcell, Oliver; Lu, Timothy K.] MIT, MIT Synthet Biol Ctr, Synthet Biol Grp, Cambridge, MA 02139 USA; [Wong, Alan S. L.; Choi, Gigi C. G.; Cheng, Allen A.; Purcell, Oliver; Lu, Timothy K.] MIT, Res Lab Elect, Cambridge, MA 02139 USA; [Wong, Alan S. L.; Choi, Gigi C. G.; Cheng, Allen A.; Purcell, Oliver; Lu, Timothy K.] MIT, Dept Biol Engn & Elect Engn & Comp Sci, Cambridge, MA 02139 USA	Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT)	Lu, TK (corresponding author), MIT, MIT Synthet Biol Ctr, Synthet Biol Grp, 77 Massachusetts Ave, Cambridge, MA 02139 USA.	timlu@mit.edu		Wong, Alan S.L./0000-0003-1790-3233	US National Institutes of Health [OD008435, P50 GM098792]; Office of Naval Research [N00014-13-1-0424]; Ellison Foundation New Scholar in Aging Award; Defense Advanced Research Projects Agency; Defense Threat Reduction Agency [HDTRA1-15-1-0050]; Croucher Foundation; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P50GM098792] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [DP2OD008435] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Office of Naval Research(Office of Naval Research); Ellison Foundation New Scholar in Aging Award; Defense Advanced Research Projects Agency(United States Department of DefenseDefense Advanced Research Projects Agency (DARPA)); Defense Threat Reduction Agency(United States Department of DefenseDefense Threat Reduction Agency); Croucher Foundation; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	We thank members of the Lu laboratory and H. Ding for helpful discussions. We thank S. Patnaik of the Roswell Park Cancer Institute for processing miRNA expression data from the ArrayExpress database of European Bioinformatics Institute, the Massachusetts Institute of Technology BioMicroCenter for technical support on Illumina HiSeq, J. Weis for assisting computational analysis of next-generation sequencing data and C. Cui for technical assistance on cell viability assays. This work was supported by the US National Institutes of Health (DP2 OD008435 and P50 GM098792), the Office of Naval Research (N00014-13-1-0424), the Ellison Foundation New Scholar in Aging Award, the Defense Advanced Research Projects Agency and the Defense Threat Reduction Agency (HDTRA1-15-1-0050). A.S.L.W. was supported by the Croucher Foundation. The pAWp6 vector backbone (pFUGW-UBCp-GFP) was a gift from L. Nissim of the T.K. Lu laboratory, MIT; miR-128 was a gift from M.F. Wilkinson, University of California San Diego, USA and miR-132 was a gift from R.H. Goodman, Oregon Health and Science University, USA; HOSE 11-12 and HOSE 17-1 cells were gifts from G.S.W. Tsao, University of Hong Kong, Hong Kong; OVCAR8 and OVCAR8-ADR cells were gifts from S.N. Bhatia, MIT, and T. Ochiya, Japanese National Cancer Center Research Institute, Japan, respectively.	Al-Lazikani B, 2012, NAT BIOTECHNOL, V30, P679, DOI 10.1038/nbt.2284; Andersson R, 2014, NATURE, V507, P455, DOI 10.1038/nature12787; Bassik MC, 2013, CELL, V152, P909, DOI 10.1016/j.cell.2013.01.030; Bhattacharya R, 2009, CANCER RES, V69, P9090, DOI 10.1158/0008-5472.CAN-09-2552; Blower PE, 2007, MOL CANCER THER, V6, P1483, DOI 10.1158/1535-7163.MCT-07-0009; Brown BD, 2009, NAT REV GENET, V10, P578, DOI 10.1038/nrg2628; Bruno IG, 2011, MOL CELL, V42, P500, DOI 10.1016/j.molcel.2011.04.018; Cheng AA, 2014, P NATL ACAD SCI USA, V111, P12462, DOI 10.1073/pnas.1400093111; Chia NY, 2010, NATURE, V468, P316, DOI 10.1038/nature09531; Creighton CJ, 2010, BREAST CANCER RES, V12, DOI 10.1186/bcr2594; Dixon SJ, 2009, ANNU REV GENET, V43, P601, DOI 10.1146/annurev.genet.39.073003.114751; Drees BL, 2005, GENOME BIOL, V6, DOI 10.1186/gb-2005-6-4-r38; Ebert MS, 2007, NAT METHODS, V4, P721, DOI 10.1038/NMETH1079; Eichler EE, 2010, NAT REV GENET, V11, P446, DOI 10.1038/nrg2809; Engler C, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003647; Forrest ARR, 2014, NATURE, V507, P462, DOI 10.1038/nature13182; Gaj T, 2013, TRENDS BIOTECHNOL, V31, P397, DOI 10.1016/j.tibtech.2013.04.004; Gandhi S, 2010, NAT NEUROSCI, V13, P789, DOI 10.1038/nn.2584; Gholami AM, 2013, CELL REP, V4, P609, DOI 10.1016/j.celrep.2013.07.018; Gibson DG, 2009, NAT METHODS, V6, P343, DOI [10.1038/NMETH.1318, 10.1038/nmeth.1318]; Gilbert LA, 2014, CELL, V159, P647, DOI 10.1016/j.cell.2014.09.029; Gobeil S, 2008, GENE DEV, V22, P2932, DOI 10.1101/gad.1714608; Guillamot M, 2011, SCI REP-UK, V1, DOI 10.1038/srep00189; Guttman M, 2011, NATURE, V477, P295, DOI 10.1038/nature10398; Honma K, 2008, NAT MED, V14, P939, DOI 10.1038/nm.1858; Hsu PD, 2014, CELL, V157, P1262, DOI 10.1016/j.cell.2014.05.010; Hsu SD, 2014, NUCLEIC ACIDS RES, V42, pD78, DOI 10.1093/nar/gkt1266; Huntzinger E, 2011, NAT REV GENET, V12, P99, DOI 10.1038/nrg2936; Jacobsen A, 2013, NAT STRUCT MOL BIOL, V20, P1325, DOI 10.1038/nsmb.2678; Johannessen CM, 2013, NATURE, V504, P138, DOI 10.1038/nature12688; Kampmann M, 2013, P NATL ACAD SCI USA, V110, pE2317, DOI 10.1073/pnas.1307002110; Kastl L, 2012, BREAST CANCER RES TR, V131, P445, DOI 10.1007/s10549-011-1424-3; Klein ME, 2007, NAT NEUROSCI, V10, P1513, DOI 10.1038/nn2010; Koike-Yusa H, 2014, NAT BIOTECHNOL, V32, P267, DOI 10.1038/nbt.2800; Krek A, 2005, NAT GENET, V37, P495, DOI 10.1038/ng1536; Lewis BP, 2005, CELL, V120, P15, DOI 10.1016/j.cell.2004.12.035; Manolio TA, 2009, NATURE, V461, P747, DOI 10.1038/nature08494; McLornan DP, 2014, NEW ENGL J MED, V371, P1725, DOI 10.1056/NEJMra1407390; Metzker ML, 2010, NAT REV GENET, V11, P31, DOI 10.1038/nrg2626; Miyamichi K, 2011, NATURE, V472, P191, DOI 10.1038/nature09714; Moffat J, 2006, NAT REV MOL CELL BIO, V7, P177, DOI 10.1038/nrm1860; Park J, 2013, NATURE, V498, P325, DOI 10.1038/nature12204; Patnaik SK, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049918; Peden JF, 2011, HUM MOL GENET, V20, pR198, DOI 10.1093/hmg/ddr384; Pierce SE, 2007, NAT PROTOC, V2, P2958, DOI 10.1038/nprot.2007.427; Ren Y, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003778; Shalem O, 2014, SCIENCE, V343, P84, DOI 10.1126/science.1247005; Storey JD, 2003, P NATL ACAD SCI USA, V100, P9440, DOI 10.1073/pnas.1530509100; Strezoska Z, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042341; Tong AHY, 2004, SCIENCE, V303, P808, DOI 10.1126/science.1091317; Vierbuchen T, 2012, MOL CELL, V47, P827, DOI 10.1016/j.molcel.2012.09.008; Voorhoeve PM, 2006, CELL, V124, P1169, DOI 10.1016/j.cell.2006.02.037; Wang T, 2014, SCIENCE, V343, P80, DOI 10.1126/science.1246981; Weinstein JN, 2013, NAT GENET, V45, P1113, DOI 10.1038/ng.2764; Xia L, 2008, INT J CANCER, V123, P372, DOI 10.1002/ijc.23501; Yoo AS, 2011, NATURE, V476, P228, DOI 10.1038/nature10323; Yu HY, 2011, NAT METHODS, V8, P478, DOI [10.1038/NMETH.1597, 10.1038/nmeth.1597]; Zelcbuch L, 2013, NUCLEIC ACIDS RES, V41, DOI 10.1093/nar/gkt151; Zhou YX, 2014, NATURE, V509, P487, DOI 10.1038/nature13166; Zhu FF, 2014, NUCLEIC ACIDS RES, V42, DOI 10.1093/nar/gkt1290; Zuk O, 2012, P NATL ACAD SCI USA, V109, P1193, DOI 10.1073/pnas.1119675109	61	36	37	0	26	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156	1546-1696		NAT BIOTECHNOL	Nat. Biotechnol.	SEP	2015	33	9					952	U196		10.1038/nbt.3326	http://dx.doi.org/10.1038/nbt.3326			13	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	CR0EK	26280411	Green Accepted, Green Published, Green Submitted			2022-12-27	WOS:000360990900023
J	[Anonymous]				[Anonymous]			21st Century Cures Act wins in US House	NATURE BIOTECHNOLOGY			English	News Item																			0	0	0	0	0	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156	1546-1696		NAT BIOTECHNOL	Nat. Biotechnol.	SEP	2015	33	9					891	891		10.1038/nbt0915-891	http://dx.doi.org/10.1038/nbt0915-891			1	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	VC0TL	26348943				2022-12-27	WOS:000427299800001
J	Kamens, J				Kamens, Joanne			Career coaching for scientists	NATURE BIOTECHNOLOGY			English	Editorial Material									Joanne Kamens Addgene, Cambridge, MA 02139 USA		Kamens, J (corresponding author), Joanne Kamens Addgene, Cambridge, MA 02139 USA.	joanne.kamens@addgene.org		Kamens, Joanne/0000-0002-7000-1477					0	3	3	0	10	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156	1546-1696		NAT BIOTECHNOL	Nat. Biotechnol.	JUN	2015	33	6					668	669		10.1038/nbt.3259	http://dx.doi.org/10.1038/nbt.3259			2	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	CK2DE	26057981				2022-12-27	WOS:000356019700028
J	Zentner, GE; Henikoff, S				Zentner, Gabriel E.; Henikoff, Steven			Epigenome editing made easy	NATURE BIOTECHNOLOGY			English	Editorial Material							ENHANCERS; FUSION; GENES		[Zentner, Gabriel E.] Fred Hutchinson Canc Res Ctr, Div Basic Sci, Seattle, WA 98104 USA; [Henikoff, Steven] Fred Hutchinson Canc Res Ctr, Howard Hughes Med Inst, Seattle, WA 98104 USA	Fred Hutchinson Cancer Center; Fred Hutchinson Cancer Center; Howard Hughes Medical Institute	Zentner, GE (corresponding author), Fred Hutchinson Canc Res Ctr, Div Basic Sci, 1124 Columbia St, Seattle, WA 98104 USA.	steveh@fredhutch.org		Henikoff, Steven/0000-0002-7621-8685; Zentner, Gabriel/0000-0002-0801-7646				Daigle SR, 2011, CANCER CELL, V20, P53, DOI 10.1016/j.ccr.2011.06.009; Hilton IB, 2015, NAT BIOTECHNOL, V33, P510, DOI 10.1038/nbt.3199; Hon GC, 2013, NAT GENET, V45, P1198, DOI 10.1038/ng.2746; Kearns NA, 2015, NAT METHODS, V12, P401, DOI 10.1038/nmeth.3325; Keung AJ, 2014, CELL, V158, P110, DOI 10.1016/j.cell.2014.04.047; Maeder ML, 2013, NAT BIOTECHNOL, V31, P1137, DOI 10.1038/nbt.2726; McKay DJ, 2015, DEV CELL, V32, P373, DOI 10.1016/j.devcel.2014.12.025; Mendenhall EM, 2013, NAT BIOTECHNOL, V31, P1133, DOI 10.1038/nbt.2701; Whyte WA, 2012, NATURE, V482, P221, DOI 10.1038/nature10805; Zentner GE, 2014, NAT REV GENET, V15, P814, DOI 10.1038/nrg3798	10	12	14	0	17	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156	1546-1696		NAT BIOTECHNOL	Nat. Biotechnol.	JUN	2015	33	6					606	607		10.1038/nbt.3248	http://dx.doi.org/10.1038/nbt.3248			3	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	CK2DE	26057978				2022-12-27	WOS:000356019700018
J	Achim, K; Pettit, JB; Saraiva, LR; Gavriouchkina, D; Larsson, T; Arendt, D; Marioni, JC				Achim, Kaia; Pettit, Jean-Baptiste; Saraiva, Luis R.; Gavriouchkina, Daria; Larsson, Tomas; Arendt, Detlev; Marioni, John C.			High-throughput spatial mapping of single-cell RNA-seq data to tissue of origin	NATURE BIOTECHNOLOGY			English	Article							ANNELID PLATYNEREIS-DUMERILII; EXPRESSION PATTERNS; MARINE ZOOPLANKTON; COMMON ORIGIN; IN-SITU; EVOLUTION; GENES; RESOLUTION; INSIGHTS; LARVAE	Understanding cell type identity in a multicellular organism requires the integration of gene expression profiles from individual cells with their spatial location in a particular tissue. Current technologies allow whole-transcriptome sequencing of spatially identified cells but lack the throughput needed to characterize complex tissues. Here we present a high-throughput method to identify the spatial origin of cells assayed by single-cell RNA-sequencing within a tissue of interest. Our approach is based on comparing complete, specificity-weighted mRNA profiles of a cell with positional gene expression profiles derived from a gene expression atlas. We show that this method allocates cells to precise locations in the brain of the marine annelid Platynereis dumerilii with a success rate of 81%. Our method is applicable to any system that has a reference gene expression database of sufficiently high resolution.	[Achim, Kaia; Pettit, Jean-Baptiste; Saraiva, Luis R.; Marioni, John C.] EMBL EBI, Hinxton, Cambs, England; [Achim, Kaia; Gavriouchkina, Daria; Larsson, Tomas; Arendt, Detlev; Marioni, John C.] EMBL, Dev Biol Unit, Heidelberg, Germany; [Saraiva, Luis R.; Marioni, John C.] Wellcome Trust Sanger Inst, Hinxton, Cambs, England	European Molecular Biology Laboratory (EMBL); European Molecular Biology Laboratory (EMBL); Wellcome Trust Sanger Institute	Arendt, D (corresponding author), EMBL, Dev Biol Unit, Heidelberg, Germany.	arendt@embl.de; marioni@ebi.ac.uk	Gavriouchkina, Daria/K-8471-2019; Gavriouchkina, Daria/K-8256-2019; Saraiva, Luis R./H-1712-2012	Gavriouchkina, Daria/0000-0002-7488-5898; Saraiva, Luis R./0000-0003-4079-0396; Achim, Kaia/0000-0003-3723-4065; Marioni, John/0000-0001-9092-0852	European Molecular Biology Laboratory; EMBL International PhD Programme; EMBL Interdisciplinary Postdoc Programme under Marie Curie Actions COFUND; Wellcome Trust Sanger Institute; European Union's Seventh Framework Programme [ERCEA-AdG-2011-294810_'BrainEvoDevo']	European Molecular Biology Laboratory; EMBL International PhD Programme; EMBL Interdisciplinary Postdoc Programme under Marie Curie Actions COFUND; Wellcome Trust Sanger Institute(Wellcome Trust); European Union's Seventh Framework Programme	The sequencing and expression analysis of P. dumerilii EST clones was carried out by H. Snyman and R. Tomer. K. Tessmar-Raible, K. Guy and M. A. Tosches provided the sequence data and plasmids for P. dumerilii Lhx3, Sepiapterin reductase, Eya and Pnr. H. Martinez-Vergara assisted with the image registration and averaging of the WMISH signal for Ten3, Cux1/2 and Fezf. We thank the members of the Marioni and Arendt groups for helpful discussions. We also thank D. Logan, the Sanger-EBI single-cell genomics centre and the EMBL Genomics core for technical support. The work was supported by the European Molecular Biology Laboratory (J.B.P., L.R.R., K.A., T.L., D.A., J.C.M.); the EMBL International PhD Programme (J.B.P., D.G.); the EMBL Interdisciplinary Postdoc Programme under Marie Curie Actions COFUND (K.A., T.L.); the Wellcome Trust Sanger Institute (L.R.R.) and by the European Union's Seventh Framework Programme project: ERCEA-AdG-2011-294810_'BrainEvoDevo' to D. A.	Anders S, 2015, BIOINFORMATICS, V31, P166, DOI 10.1093/bioinformatics/btu638; Arendt D, 2004, SCIENCE, V306, P869, DOI 10.1126/science.1099955; Arendt D, 2002, DEVELOPMENT, V129, P1143; Arendt D, 2008, NAT REV GENET, V9, P868, DOI 10.1038/nrg2416; Asadulina A, 2012, EVODEVO, V3, DOI 10.1186/2041-9139-3-27; Backfisch B, 2013, P NATL ACAD SCI USA, V110, P193, DOI 10.1073/pnas.1209657109; Battich N, 2013, NAT METHODS, V10, P1127, DOI 10.1038/nmeth.2657; Biffar L, 2014, DEV BIOL, V388, P103, DOI 10.1016/j.ydbio.2014.01.028; Christodoulou F, 2010, NATURE, V463, P1084, DOI 10.1038/nature08744; Conzelmann M, 2013, P NATL ACAD SCI USA, V110, P8224, DOI 10.1073/pnas.1220285110; Conzelmann M, 2012, EVODEVO, V3, DOI 10.1186/2041-9139-3-23; Conzelmann M, 2011, P NATL ACAD SCI USA, V108, pE1174, DOI 10.1073/pnas.1109085108; Denes AS, 2007, CELL, V129, P277, DOI 10.1016/j.cell.2007.02.040; Dray N, 2010, SCIENCE, V329, P339, DOI 10.1126/science.1188913; Durruthy-Durruthy R, 2014, CELL, V157, P964, DOI 10.1016/j.cell.2014.03.036; Ferrier DEK, 2012, DEVELOPMENT, V139, P2643, DOI 10.1242/dev.074724; Fonseca N.A., IRAP INTEGRATED RNA; Garcia-Solache M, 2010, DEV BIOL, V344, P306, DOI 10.1016/j.ydbio.2010.04.019; Grange P, 2014, P NATL ACAD SCI USA, V111, P5397, DOI 10.1073/pnas.1312098111; Jaitin DA, 2014, SCIENCE, V343, P776, DOI 10.1126/science.1247651; Jekely G, 2008, NATURE, V456, P395, DOI 10.1038/nature07590; Jekely G, 2007, BIOTECHNIQUES, V42, P751, DOI 10.2144/000112462; Jekely G, 2013, P NATL ACAD SCI USA, V110, P8702, DOI 10.1073/pnas.1221833110; Jiang LC, 2011, GENOME RES, V21, P1543, DOI 10.1101/gr.121095.111; Kerner P, 2006, DEV GENES EVOL, V216, P821, DOI 10.1007/s00427-006-0100-9; Kerner P, 2009, EVOL DEV, V11, P513, DOI 10.1111/j.1525-142X.2009.00359.x; Langmead B, 2012, NAT METHODS, V9, P357, DOI [10.1038/NMETH.1923, 10.1038/nmeth.1923]; Lee JH, 2014, SCIENCE, V343, P1360, DOI 10.1126/science.1250212; Lovatt D, 2014, NAT METHODS, V11, P190, DOI [10.1038/NMETH.2804, 10.1038/nmeth.2804]; Marlow H, 2014, BMC BIOL, V12, DOI 10.1186/1741-7007-12-7; Pani AM, 2012, NATURE, V483, P289, DOI 10.1038/nature10838; Pettit JB, 2014, PLOS COMPUT BIOL, V10, DOI 10.1371/journal.pcbi.1003824; Prud'homme B, 2002, CURR BIOL, V12, P1395, DOI 10.1016/S0960-9822(02)01068-0; Puniyani K, 2010, BIOINFORMATICS, V26, pi47, DOI 10.1093/bioinformatics/btq172; Raible F, 2005, SCIENCE, V310, P1325, DOI 10.1126/science.1119089; Randel N, 2013, INTEGR COMP BIOL, V53, P7, DOI 10.1093/icb/ict046; Satija R, 2015, NAT BIOTECHNOL, V33, P495, DOI 10.1038/nbt.3192; Schindelin J, 2012, NAT METHODS, V9, P676, DOI [10.1038/nmeth.2019, 10.1038/NMETH.2019]; Shapiro E, 2013, NAT REV GENET, V14, P618, DOI 10.1038/nrg3542; Simionato E, 2008, BMC EVOL BIOL, V8, DOI 10.1186/1471-2148-8-170; Stegle O, 2015, NAT REV GENET, V16, P133, DOI 10.1038/nrg3833; Steinmetz PRH, 2011, EVOL DEV, V13, P72, DOI 10.1111/j.1525-142X.2010.00457.x; Tan SJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064084; Tessmar-Raible K, 2005, BIOTECHNIQUES, V39, P460, DOI 10.2144/000112023; Tessmar-Raible K, 2007, CELL, V129, P1389, DOI 10.1016/j.cell.2007.04.041; Tomer R, 2010, CELL, V142, P800, DOI 10.1016/j.cell.2010.07.043; Tosches MA, 2014, CELL, V159, P46, DOI 10.1016/j.cell.2014.07.042	47	240	271	4	98	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156	1546-1696		NAT BIOTECHNOL	Nat. Biotechnol.	MAY	2015	33	5					503	U215		10.1038/nbt.3209	http://dx.doi.org/10.1038/nbt.3209			9	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	CH8VP	25867922	Bronze			2022-12-27	WOS:000354314500031
J	De Jonge, B; Louwaars, NP; Kinderlerer, J				De Jonge, Bram; Louwaars, Niels P.; Kinderlerer, Julian			A solution to the controversy on plant variety protection in Africa	NATURE BIOTECHNOLOGY			English	Editorial Material									[De Jonge, Bram; Louwaars, Niels P.] Wageningen Univ, Law & Governance Grp, NL-6700 AP Wageningen, Netherlands; [Louwaars, Niels P.] Plantum NL, Gouda, Netherlands; [Kinderlerer, Julian] Univ Cape Town, Dept Private Law, ZA-7925 Cape Town, South Africa	Wageningen University & Research; University of Cape Town	De Jonge, B (corresponding author), Wageningen Univ, Law & Governance Grp, NL-6700 AP Wageningen, Netherlands.	bram.dejonge@wur.nl							0	6	6	0	9	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156	1546-1696		NAT BIOTECHNOL	Nat. Biotechnol.	MAY	2015	33	5					487	489		10.1038/nbt.3213	http://dx.doi.org/10.1038/nbt.3213			3	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	CH8VP	25965755	Bronze			2022-12-27	WOS:000354314500026
J	Ebert, P; Bock, C				Ebert, Peter; Bock, Christoph			Improving reference epigenome catalogs by computational prediction	NATURE BIOTECHNOLOGY			English	Editorial Material							IMPUTATION; INFERENCE		[Ebert, Peter; Bock, Christoph] Max Planck Inst Informat, D-66123 Saarbrucken, Germany; [Ebert, Peter] Univ Saarland, Grad Sch Comp Sci, D-66123 Saarbrucken, Germany; [Bock, Christoph] Austrian Acad Sci, CeMM Res Ctr Mol Med, A-1010 Vienna, Austria; [Bock, Christoph] Med Univ Vienna, Dept Lab Med, Vienna, Austria	Max Planck Society; Saarland University; Austrian Academy of Sciences; CeMM Research Center for Molecular Medicine of the Austrian Academy of Sciences; Medical University of Vienna	Ebert, P (corresponding author), Max Planck Inst Informat, D-66123 Saarbrucken, Germany.	cbock@cemm.oeaw.ac.at	Bock, Christoph/AAE-7618-2019	Bock, Christoph/0000-0001-6091-3088; Ebert, Peter/0000-0001-7441-532X				Adams D, 2012, NAT BIOTECHNOL, V30, P224, DOI 10.1038/nbt.2153; Bernstein BE, 2010, NAT BIOTECHNOL, V28, P1045, DOI 10.1038/nbt1010-1045; Bock C, 2008, BIOINFORMATICS, V24, P1, DOI 10.1093/bioinformatics/btm546; Ernst J, 2015, NAT BIOTECHNOL, V33, P364, DOI 10.1038/nbt.3157; Farlik M, 2015, CELL REP, V10, P1386, DOI 10.1016/j.celrep.2015.02.001; Feingold EA, 2004, SCIENCE, V306, P636, DOI 10.1126/science.1105136; Marchini J, 2010, NAT REV GENET, V11, P499, DOI 10.1038/nrg2796; Smallwood SA, 2014, NAT METHODS, V11, P817, DOI [10.1038/nmeth.3035, 10.1038/NMETH.3035]; Stolovitzky G, 2007, ANN NY ACAD SCI, V1115, P1, DOI 10.1196/annals.1407.021; Teschendorff AE, 2012, GENOME MED, V4, DOI 10.1186/gm323	10	5	5	0	2	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156	1546-1696		NAT BIOTECHNOL	Nat. Biotechnol.	APR	2015	33	4					354	355		10.1038/nbt.3194	http://dx.doi.org/10.1038/nbt.3194			2	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	CF2AE	25850057				2022-12-27	WOS:000352348500018
J	Teruel, MN; Gu, B; Zhao, ML				Teruel, Mary N.; Gu, Bo; Zhao, Michael L.			A dynamic picture of protein behavior in cells	NATURE BIOTECHNOLOGY			English	Editorial Material							CORRELATION SPECTROSCOPY		[Teruel, Mary N.; Gu, Bo; Zhao, Michael L.] Stanford Univ, Dept Chem & Syst Biol, Stanford, CA 94305 USA	Stanford University	Teruel, MN (corresponding author), Stanford Univ, Dept Chem & Syst Biol, Stanford, CA 94305 USA.	mteruel@stanford.edu		Zhao, Michael/0000-0001-6614-9199; Teruel, Mary/0000-0002-2854-3598	NHGRI NIH HHS [T32 HG000044] Funding Source: Medline; NIDDK NIH HHS [R01 DK106241, R01 DK101743] Funding Source: Medline; NIGMS NIH HHS [P50 GM107615] Funding Source: Medline; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [T32HG000044] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK106241, R01DK101743] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P50GM107615] Funding Source: NIH RePORTER	NHGRI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Elson EL, 2011, BIOPHYS J, V101, P2855, DOI 10.1016/j.bpj.2011.11.012; Huang S, 2009, DEVELOPMENT, V136, P3853, DOI 10.1242/dev.035139; Kristensen AR, 2012, NAT METHODS, V9, P907, DOI 10.1038/nmeth.2131; Lippincott-Schwartz J, 2001, NAT REV MOL CELL BIO, V2, P444, DOI 10.1038/35073068; Wachsmuth M, 2015, NAT BIOTECHNOL, V33, P384, DOI 10.1038/nbt.3146; Weidemann T, 2013, METHOD ENZYMOL, V518, P43, DOI 10.1016/B978-0-12-388422-0.00003-0	6	0	0	0	12	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156	1546-1696		NAT BIOTECHNOL	Nat. Biotechnol.	APR	2015	33	4					356	357		10.1038/nbt.3196	http://dx.doi.org/10.1038/nbt.3196			2	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	CF2AE	25850058	Green Accepted			2022-12-27	WOS:000352348500019
J	Nugent, KL; Lindburg, L				Nugent, Kathy L.; Lindburg, Lori			Life sciences workforce trends evolve with the industry	NATURE BIOTECHNOLOGY			English	Editorial Material									[Nugent, Kathy L.] Univ Alabama Birmingham, Inst Innovat & Entrepreneurship, Birmingham, AL USA; [Lindburg, Lori] Lori Lindburg BayBio Inst, BioAlabama & Coalit State Biosc Inst, San Francisco, CA 94080 USA	University of Alabama System; University of Alabama Birmingham	Nugent, KL (corresponding author), Lori Lindburg BayBio Inst, BioAlabama & Coalit State Biosc Inst, San Francisco, CA 94080 USA.	knugent@uab.edu							0	2	2	0	3	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156	1546-1696		NAT BIOTECHNOL	Nat. Biotechnol.	JAN	2015	33	1					107	109		10.1038/nbt.3116	http://dx.doi.org/10.1038/nbt.3116			3	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	AY7AR	25574640				2022-12-27	WOS:000347714200035
J	Huggett, B				Huggett, Brady			Reinventing tech transfer	NATURE BIOTECHNOLOGY			English	Editorial Material																			0	14	14	0	4	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156	1546-1696		NAT BIOTECHNOL	Nat. Biotechnol.	DEC	2014	32	12					1184	1191		10.1038/nbt.3085	http://dx.doi.org/10.1038/nbt.3085			8	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	AW3AD	25489831	Bronze			2022-12-27	WOS:000346156800015
J	Mishra, D; Rivera, PM; Lin, A; Del Vecchio, D; Weiss, R				Mishra, Deepak; Rivera, Phillip M.; Lin, Allen; Del Vecchio, Domitilla; Weiss, Ron			A load driver device for engineering modularity in biological networks	NATURE BIOTECHNOLOGY			English	Article							SACCHAROMYCES-CEREVISIAE; GENE-EXPRESSION; ESCHERICHIA-COLI; COVALENT MODIFICATION; SIGNALING PATHWAYS; SYNTHETIC BIOLOGY; TOGGLE SWITCH; CELL BIOLOGY; YEAST; SYSTEMS	The behavior of gene modules in complex synthetic circuits is often unpredictable(1-4). After joining modules to create a circuit, downstream elements (such as binding sites for a regulatory protein) apply a load to upstream modules that can negatively affect circuit function(1,5). Here we devised a genetic device named a load driver that mitigates the impact of load on circuit function, and we demonstrate its behavior in Saccharomyces cerevisiae. The load driver implements the design principle of timescale separation: inclusion of the load driver's fast phosphotransfer processes restores the capability of a slower transcriptional circuit to respond to time-varying input signals even in the presence of substantial load. Without the load driver, we observed circuit behavior that suffered from a 76% delay in response time and a 25% decrease in system bandwidth due to load. With the addition of a load driver, circuit performance was almost completely restored. Load drivers will serve as fundamental building blocks in the creation of complex, higher-level genetic circuits.	[Mishra, Deepak; Weiss, Ron] MIT, Dept Biol Engn, Cambridge, MA 02139 USA; [Mishra, Deepak; Rivera, Phillip M.; Lin, Allen; Del Vecchio, Domitilla; Weiss, Ron] MIT, Synthet Biol Ctr, Cambridge, MA 02139 USA; [Rivera, Phillip M.; Del Vecchio, Domitilla] MIT, Dept Mech Engn, Cambridge, MA 02139 USA; [Lin, Allen; Weiss, Ron] MIT, Dept Elect Engn Comp Sci, Cambridge, MA 02139 USA	Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT)	Weiss, R (corresponding author), MIT, Dept Biol Engn, 77 Massachusetts Ave, Cambridge, MA 02139 USA.	ddv@mit.edu; rweiss@mit.edu			Eni-MIT Energy Research Fellowship; National Science Foundation (NSF) [DGE-1122374]; NSF [CCF-1058127]; NSF SynBERC [SA5284-11210]; USAFOSR [FA9550-12-1-0129]; USARO ICB [W911NF-09-D-0001]; US National Institutes of Health [P50 GM098792]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P50GM098792] Funding Source: NIH RePORTER; Direct For Biological Sciences [1330914] Funding Source: National Science Foundation; Direct For Computer & Info Scie & Enginr [0964646] Funding Source: National Science Foundation	Eni-MIT Energy Research Fellowship; National Science Foundation (NSF)(National Science Foundation (NSF)); NSF(National Science Foundation (NSF)); NSF SynBERC(National Science Foundation (NSF)); USAFOSR(United States Department of DefenseAir Force Office of Scientific Research (AFOSR)); USARO ICB; US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Direct For Biological Sciences(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO)); Direct For Computer & Info Scie & Enginr(National Science Foundation (NSF)NSF - Directorate for Computer & Information Science & Engineering (CISE))	We thank members of the labs of R. W. and D. D. V. for discussions, M.-T. Chen (Department of Electrical Engineering, Princeton University) for plasmids containing both STAT5-HKRR and JAK2, and the Synthetic Biology Center at Massachusetts Institute of Technology's cytometry facility. D.M. was supported by the Eni-MIT Energy Research Fellowship, and both D.M. and P.M.R. were supported by the National Science Foundation (NSF) Graduate Research Fellowship Plan under grant DGE-1122374. This research was supported by the NSF (CCF-1058127), NSF SynBERC (SA5284-11210), USAFOSR (FA9550-12-1-0129), USARO ICB (W911NF-09-D-0001) and the US National Institutes of Health (P50 GM098792).	Aaronson DS, 2002, SCIENCE, V296, P1653, DOI 10.1126/science.1071545; Alberti S, 2007, YEAST, V24, P913, DOI 10.1002/yea.1502; Alon U., 2013, INTRO SYSTEMS BIOL D; Ansaldi M, 2001, J BACTERIOL, V183, P2691, DOI 10.1128/JB.183.8.2691-2695.2001; Atkinson MR, 2003, CELL, V113, P597, DOI 10.1016/S0092-8674(03)00346-5; Bashor CJ, 2012, NAT BIOTECHNOL, V30, P1061, DOI 10.1038/nbt.2411; Brewster RC, 2014, CELL, V156, P1312, DOI 10.1016/j.cell.2014.02.022; Buchler NE, 2009, MOL SYST BIOL, V5, DOI 10.1038/msb.2009.30; Cardinale S, 2012, BIOTECHNOL J, V7, P856, DOI 10.1002/biot.201200085; Chen MT, 2005, NAT BIOTECHNOL, V23, P1551, DOI 10.1038/nbt1162; Del Vecchio D., 2014, BIOMOLECULAR FEEDBAC; Del Vecchio D, 2008, MOL SYST BIOL, V4, DOI 10.1038/msb4100204; Ellis T, 2009, NAT BIOTECHNOL, V27, P465, DOI 10.1038/nbt.1536; Elowitz MB, 2000, NATURE, V403, P335, DOI 10.1038/35002125; Endy D, 2005, NATURE, V438, P449, DOI 10.1038/nature04342; Escote X, 2004, NAT CELL BIOL, V6, P997, DOI 10.1038/ncb1174; Franklin G.F., 2010, FEEDBACK CONTROL DYN, V6th ed.; FUTCHER AB, 1984, J BACTERIOL, V157, P283, DOI 10.1128/JB.157.1.283-290.1984; Gardner TS, 2000, NATURE, V403, P339, DOI 10.1038/35002131; Gari E, 1997, YEAST, V13, P837, DOI 10.1002/(SICI)1097-0061(199707)13:9<837::AID-YEA145>3.0.CO;2-T; Ghaemmaghami S, 2003, NATURE, V425, P737, DOI 10.1038/nature02046; Gibson DG, 2009, NAT METHODS, V6, P343, DOI [10.1038/NMETH.1318, 10.1038/nmeth.1318]; GIETZ D, 1992, NUCLEIC ACIDS RES, V20, P1425, DOI 10.1093/nar/20.6.1425; GOLDBETER A, 1981, P NATL ACAD SCI-BIOL, V78, P6840, DOI 10.1073/pnas.78.11.6840; Gueldener U, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/30.6.e23; Guye P, 2013, NUCLEIC ACIDS RES, V41, DOI 10.1093/nar/gkt605; Gyorgy A, 2014, PLOS COMPUT BIOL, V10, DOI 10.1371/journal.pcbi.1003486; Hartwell LH, 1999, NATURE, V402, pC47, DOI 10.1038/35011540; Hooshangi S, 2005, P NATL ACAD SCI USA, V102, P3581, DOI 10.1073/pnas.0408507102; Janiak-Spens F, 2005, BIOCHEMISTRY-US, V44, P377, DOI 10.1021/bi048433s; Janke C, 2004, YEAST, V21, P947, DOI 10.1002/yea.1142; Jayanthi S, 2013, ACS SYNTH BIOL, V2, P431, DOI 10.1021/sb300098w; Jayanthi S, 2011, IEEE T AUTOMAT CONTR, V56, P748, DOI 10.1109/TAC.2010.2069631; Jiang P, 2011, SCI SIGNAL, V4, DOI 10.1126/scisignal.2002152; Kim Y, 2011, DEV CELL, V20, P880, DOI 10.1016/j.devcel.2011.05.009; Kim Y, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2010.121; Laub MT, 2007, ANNU REV GENET, V41, P121, DOI 10.1146/annurev.genet.41.042007.170548; Lauffenburger DA, 2000, P NATL ACAD SCI USA, V97, P5031, DOI 10.1073/pnas.97.10.5031; Lee ME, 2013, NUCLEIC ACIDS RES, V41, P10668, DOI 10.1093/nar/gkt809; Lee TH, 2012, MOL SYST BIOL, V8, DOI 10.1038/msb.2012.7; Lenssen E, 2007, EUKARYOT CELL, V6, P2251, DOI 10.1128/EC.00327-06; Lou CB, 2012, NAT BIOTECHNOL, V30, P1137, DOI 10.1038/nbt.2401; Millman J., 1987, MICROELECTRONICS; Nilgiriwala K. S., 2014, ACS SYNTH BIOL, DOI [10.1021/sb5002533, DOI 10.1021/SB5002533]; OTA IM, 1993, SCIENCE, V262, P566, DOI 10.1126/science.8211183; Perraud AL, 1999, TRENDS MICROBIOL, V7, P115, DOI 10.1016/S0966-842X(99)01458-4; Purnick PEM, 2009, NAT REV MOL CELL BIO, V10, P410, DOI 10.1038/nrm2698; Qi L, 2012, NAT BIOTECHNOL, V30, P1002, DOI 10.1038/nbt.2355; Reiser V, 2003, J CELL BIOL, V161, P1035, DOI 10.1083/jcb.200301099; Schaller G Eric, 2008, Arabidopsis Book, V6, pe0112, DOI 10.1199/tab.0112; Ventura AC, 2010, P NATL ACAD SCI USA, V107, P10032, DOI 10.1073/pnas.0913815107; Voth WP, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.12.e59; Whitaker WR, 2012, P NATL ACAD SCI USA, V109, P18090, DOI 10.1073/pnas.1209230109; Workentine ML, 2009, FEMS MICROBIOL LETT, V292, P50, DOI 10.1111/j.1574-6968.2008.01445.x	54	98	104	0	39	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156	1546-1696		NAT BIOTECHNOL	Nat. Biotechnol.	DEC	2014	32	12					1268	U141		10.1038/nbt.3044	http://dx.doi.org/10.1038/nbt.3044			11	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	AW3AD	25419739	Green Accepted, Green Submitted			2022-12-27	WOS:000346156800030
J	Wu, H; Wu, XJ; Shen, L; Zhang, Y				Wu, Hao; Wu, Xiaoji; Shen, Li; Zhang, Yi			Single-base resolution analysis of active DNA demethylation using methylase-assisted bisulfite sequencing	NATURE BIOTECHNOLOGY			English	Article							GENOME-WIDE ANALYSIS; CELL SELF-RENEWAL; TET PROTEINS; 5-METHYLCYTOSINE OXIDATION; 5-HYDROXYMETHYLCYTOSINE; 5-FORMYLCYTOSINE; 5-CARBOXYLCYTOSINE; REVEALS; SEQ; PLURIPOTENT	Active DNA demethylation in mammals involves TET-mediated iterative oxidation of 5-methylcytosine (5mC)/5-hydroxymethylcytosine (5hmC) and subsequent excision repair of highly oxidized cytosine bases 5-formylcytosine (5fC)/5-carboxylcytosine (5caC) by thymine DNA glycosylase (TDG). However, quantitative and high-resolution analysis of active DNA demethylation activity remains challenging. Here, we describe M. SssI methylase-assisted bisulfite sequencing (MAB-seq), a method that directly maps 5fC/5caC at single-base resolution. Genome-wide MAB-seq allows systematic identification of 5fC/5caC in Tdg-depleted embryonic stem cells, thereby generating a base-resolution map of active DNA demethylome. A comparison of 5fC/5caC and 5hmC distribution maps indicates that catalytic processivity of TET enzymes correlates with local chromatin accessibility. MAB-seq also reveals strong strand asymmetry of active demethylation within palindromic CpGs. Integrating MAB-seq with other base-resolution mapping methods enables quantitative measurement of cytosine modification states at key transitioning steps of the active DNA demethylation cascade and reveals a regulatory role of 5fC/5caC excision repair in this step-wise process.	[Wu, Hao; Wu, Xiaoji; Shen, Li; Zhang, Yi] Howard Hughes Med Inst, Boston, MA 02115 USA; [Wu, Hao; Wu, Xiaoji; Shen, Li; Zhang, Yi] Boston Childrens Hosp, Program Cellular & Mol Med, Boston, MA USA; [Wu, Hao; Wu, Xiaoji; Shen, Li; Zhang, Yi] Harvard Stem Cell Inst, Boston, MA USA; [Wu, Hao; Wu, Xiaoji; Shen, Li; Zhang, Yi] Harvard Univ, Sch Med, Dept Genet, Boston, MA USA	Howard Hughes Medical Institute; Harvard University; Boston Children's Hospital; Program in Cellular & Molecular Medicine (PCMM); Harvard University; Harvard University; Harvard Medical School	Zhang, Y (corresponding author), Howard Hughes Med Inst, Boston, MA 02115 USA.	haowu7@gmail.com; yzhang@genetics.med.harvard.edu	Wu, Hao/H-3899-2017	Wu, Hao/0000-0003-1269-7354; Wu, Hao/0000-0003-4395-6929	National Institutes of Health [U01DK089565]; Jane Coffin Childs Memorial Fund for Medical Research; National Human Genome Research Institute [K99HG007982]; China Scholarship Council; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [K99HG007982] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [U01DK089565] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Jane Coffin Childs Memorial Fund for Medical Research; National Human Genome Research Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); China Scholarship Council(China Scholarship Council); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	We thank S. Yamaguchi and F. Lu for generating and characterizing Tet mutant mouse ESCs. We also thank L.M. Tuesta and S. Yamaguchi for critical reading of the manuscript. This project is supported by National Institutes of Health grant U01DK089565. H.W. was supported by a postdoctoral fellowship from the Jane Coffin Childs Memorial Fund for Medical Research and is currently supported by the National Human Genome Research Institute (K99HG007982). X.W. was supported by the China Scholarship Council. Y.Z. is an investigator of the Howard Hughes Medical Institute.	Banaszynski LA, 2013, CELL, V155, P107, DOI 10.1016/j.cell.2013.08.061; Baylin SB, 2011, NAT REV CANCER, V11, P726, DOI 10.1038/nrc3130; Bestor TH, 2000, HUM MOL GENET, V9, P2395, DOI 10.1093/hmg/9.16.2395; Bird A, 2002, GENE DEV, V16, P6, DOI 10.1101/gad.947102; Blaschke K, 2013, NATURE, V500, P222, DOI 10.1038/nature12362; Bolger AM, 2014, BIOINFORMATICS, V30, P2114, DOI 10.1093/bioinformatics/btu170; Booth MJ, 2014, NAT CHEM, V6, P435, DOI [10.1038/NCHEM.1893, 10.1038/nchem.1893]; Booth MJ, 2012, SCIENCE, V336, P934, DOI 10.1126/science.1220671; Cedar H, 2012, ANNU REV BIOCHEM, V81, P97, DOI 10.1146/annurev-biochem-052610-091920; Cortazar D, 2011, NATURE, V470, P419, DOI 10.1038/nature09672; Cortellino S, 2011, CELL, V146, P67, DOI 10.1016/j.cell.2011.06.020; Creyghton MP, 2010, P NATL ACAD SCI USA, V107, P21931, DOI 10.1073/pnas.1016071107; Dunham I, 2012, NATURE, V489, P57, DOI 10.1038/nature11247; Hashimoto H, 2014, NATURE, V506, P391, DOI 10.1038/nature12905; He YF, 2011, SCIENCE, V333, P1303, DOI 10.1126/science.1210944; Hu GQ, 2013, CELL STEM CELL, V12, P180, DOI 10.1016/j.stem.2012.11.003; Hu LL, 2013, CELL, V155, P1545, DOI 10.1016/j.cell.2013.11.020; Inoue A, 2011, CELL RES, V21, P1670, DOI 10.1038/cr.2011.189; Inoue A, 2011, SCIENCE, V334, P194, DOI 10.1126/science.1212483; Ito S, 2011, SCIENCE, V333, P1300, DOI 10.1126/science.1210597; Ito S, 2010, NATURE, V466, P1129, DOI 10.1038/nature09303; Kriaucionis S, 2009, SCIENCE, V324, P929, DOI 10.1126/science.1169786; Krueger F, 2011, BIOINFORMATICS, V27, P1571, DOI 10.1093/bioinformatics/btr167; Ku M, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000242; Lister R, 2013, SCIENCE, V341, P629, DOI 10.1126/science.1237905; Liu YP, 2012, GENOME BIOL, V13, DOI 10.1186/gb-2012-13-7-r61; Lu XY, 2013, J AM CHEM SOC, V135, P9315, DOI 10.1021/ja4044856; Maiti A, 2011, J BIOL CHEM, V286, P35334, DOI 10.1074/jbc.C111.284620; Marson A, 2008, CELL, V134, P521, DOI 10.1016/j.cell.2008.07.020; Meissner A, 2008, NATURE, V454, P766, DOI 10.1038/nature07107; Mikkelsen TS, 2007, NATURE, V448, P553, DOI 10.1038/nature06008; Myers RM, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1001046; Nabel CS, 2012, NAT CHEM BIOL, V8, P751, DOI [10.1038/NCHEMBIO.1042, 10.1038/nchembio.1042]; Pastor WA, 2013, NAT REV MOL CELL BIO, V14, P341, DOI 10.1038/nrm3589; RENBAUM P, 1990, NUCLEIC ACIDS RES, V18, P1145, DOI 10.1093/nar/18.5.1145; Shen L, 2013, CELL, V153, P692, DOI 10.1016/j.cell.2013.04.002; Shen Y, 2012, NATURE, V488, P116, DOI 10.1038/nature11243; Song CX, 2013, CELL, V153, P678, DOI 10.1016/j.cell.2013.04.001; Sotiriou S, 2002, NAT MED, V8, P514, DOI 10.1038/nm0502-514; Stadler MB, 2011, NATURE, V480, P490, DOI 10.1038/nature10716; Tahiliani M, 2009, SCIENCE, V324, P930, DOI 10.1126/science.1170116; Whyte WA, 2013, CELL, V153, P307, DOI 10.1016/j.cell.2013.03.035; Wu H, 2014, CELL, V156, P45, DOI 10.1016/j.cell.2013.12.019; Wu H, 2011, NATURE, V473, P389, DOI 10.1038/nature09934; Wu H, 2011, GENE DEV, V25, P679, DOI 10.1101/gad.2036011; Yin RC, 2013, J AM CHEM SOC, V135, P10396, DOI 10.1021/ja4028346; Yu M, 2012, CELL, V149, P1368, DOI 10.1016/j.cell.2012.04.027	47	96	102	3	60	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156	1546-1696		NAT BIOTECHNOL	Nat. Biotechnol.	DEC	2014	32	12					1231	U92		10.1038/nbt.3073	http://dx.doi.org/10.1038/nbt.3073			13	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	AW3AD	25362244	Green Submitted, Green Accepted			2022-12-27	WOS:000346156800025
J	Fox, JL				Fox, Jeffrey L.			Technology comes to typing	NATURE BIOTECHNOLOGY			English	Editorial Material																		[Anonymous], 2014, FDA PUBL WORKSH ADV; Conlan S, 2014, SCI TRANSL MED, V6, DOI 10.1126/scitranslmed.3009845; Doughty EL, 2014, PEERJ, V2, DOI 10.7717/peerj.585; Loman NJ, 2013, JAMA-J AM MED ASSOC, V309, P1502, DOI 10.1001/jama.2013.3231; Wilson MR, 2014, NEW ENGL J MED, V370, P2408, DOI 10.1056/NEJMoa1401268	5	1	1	0	5	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156	1546-1696		NAT BIOTECHNOL	Nat. Biotechnol.	NOV	2014	32	11					1081	1084		10.1038/nbt.3067	http://dx.doi.org/10.1038/nbt.3067			4	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	AT5IL	25380436				2022-12-27	WOS:000344977000007
J	Langer, LJ				Langer, Lynn Johnson			Building a curriculum for bioentrepreneurs	NATURE BIOTECHNOLOGY			English	News Item									Johns Hopkins Univ, Enterprise & Regulatory Sci Programs, Ctr Biotechnol Educ, Adv Acad Programs, Rockville, MD 20850 USA	Johns Hopkins University	Langer, LJ (corresponding author), Johns Hopkins Univ, Enterprise & Regulatory Sci Programs, Ctr Biotechnol Educ, Adv Acad Programs, Rockville, MD 20850 USA.	ljlanger@jhu.edu						Berret D., 2013, CHRON HIGHER ED	1	4	4	0	6	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156	1546-1696		NAT BIOTECHNOL	Nat. Biotechnol.	SEP	2014	32	9					863	865		10.1038/nbt.3012	http://dx.doi.org/10.1038/nbt.3012			3	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	AQ2FD	25203028	Bronze			2022-12-27	WOS:000342600300017
J	Wang, C; Gong, BS; Bushel, PR; Thierry-Mieg, J; Thierry-Mieg, D; Xu, JS; Fang, H; Hong, HX; Shen, J; Su, ZQ; Meehan, J; Li, XJ; Yang, L; Li, HQ; Labaj, PP; Kreil, DP; Megherbi, D; Gaj, S; Caiment, F; van Delft, J; Kleinjans, J; Scherer, A; Devanarayan, V; Wang, J; Yang, Y; Qian, HR; Lancashire, LJ; Bessarabova, M; Nikolsky, Y; Furlanello, C; Chierici, M; Albanese, D; Jurman, G; Riccadonna, S; Filosi, M; Visintainer, R; Zhang, KK; Li, JY; Hsieh, JH; Svoboda, DL; Fuscoe, JC; Deng, YD; Shi, LM; Paules, RS; Auerbach, SS; Tong, WD				Wang, Charles; Gong, Binsheng; Bushel, Pierre R.; Thierry-Mieg, Jean; Thierry-Mieg, Danielle; Xu, Joshua; Fang, Hong; Hong, Huixiao; Shen, Jie; Su, Zhenqiang; Meehan, Joe; Li, Xiaojin; Yang, Lu; Li, Haiqing; Labaj, Pawel P.; Kreil, David P.; Megherbi, Dalila; Gaj, Stan; Caiment, Florian; van Delft, Joost; Kleinjans, Jos; Scherer, Andreas; Devanarayan, Viswanath; Wang, Jian; Yang, Yong; Qian, Hui-Rong; Lancashire, Lee J.; Bessarabova, Marina; Nikolsky, Yuri; Furlanello, Cesare; Chierici, Marco; Albanese, Davide; Jurman, Giuseppe; Riccadonna, Samantha; Filosi, Michele; Visintainer, Roberto; Zhang, Ke K.; Li, Jainying; Hsieh, Jui-Hua; Svoboda, Daniel L.; Fuscoe, James C.; Deng, Youping; Shi, Leming; Paules, Richard S.; Auerbach, Scott S.; Tong, Weida			The concordance between RNA-seq and microarray data depends on chemical treatment and transcript abundance	NATURE BIOTECHNOLOGY			English	Article							DIFFERENTIAL EXPRESSION ANALYSIS; GENE-EXPRESSION; REPRODUCIBILITY; CONSISTENCY; ARRAYS	The concordance of RNA-sequencing (RNA-seq) with microarrays for genome-wide analysis of differential gene expression has not been rigorously assessed using a range of chemical treatment conditions. Here we use a comprehensive study design to generate Illumina RNA-seq and Affymetrix microarray data from the same liver samples of rats exposed in triplicate to varying degrees of perturbation by 27 chemicals representing multiple modes of action (MOAs). The cross-platform concordance in terms of differentially expressed genes (DEGs) or enriched pathways is linearly correlated with treatment effect size (R-2 approximate to 0.8). Furthermore, the concordance is also affected by transcript abundance and biological complexity of the MOA. RNA-seq outperforms microarray (93% versus 75%) in DEG verification as assessed by quantitative PCR, with the gain mainly due to its improved accuracy for low-abundance transcripts. Nonetheless, classifiers to predict MOAs perform similarly when developed using data from either platform. Therefore, the endpoint studied and its biological complexity, transcript abundance and the genomic application are important factors in transcriptomic research and for clinical and regulatory decision making.	[Wang, Charles] Loma Linda Univ, Sch Med, Ctr Genom, Loma Linda, CA USA; [Wang, Charles] Loma Linda Univ, Sch Med, Div Microbiol & Mol Genet, Loma Linda, CA USA; [Gong, Binsheng; Xu, Joshua; Hong, Huixiao; Shen, Jie; Su, Zhenqiang; Meehan, Joe; Shi, Leming; Tong, Weida] US FDA, Div Bioinformat & Biostat, Natl Ctr Toxicol Res, Jefferson, AR 72079 USA; [Bushel, Pierre R.; Li, Jainying] NIEHS, Microarray & Genome Informat Grp, Res Triangle Pk, NC 27709 USA; [Bushel, Pierre R.] NIEHS, Biostat Branch, Res Triangle Pk, NC 27709 USA; [Thierry-Mieg, Jean; Thierry-Mieg, Danielle] Natl Lib Med, Nat Ctr Biotechnol Informat, NIH, Bethesda, MD USA; [Fang, Hong] US FDA, Off Sci Coordinat, Natl Ctr Toxicol Res, Jefferson, AR 72079 USA; [Li, Xiaojin; Yang, Lu; Li, Haiqing] City Hope Natl Med Ctr, Beckman Res Inst, Dept Mol Med, Funct Genom Core, Duarte, CA USA; [Labaj, Pawel P.; Kreil, David P.] Boku Univ Vienna, Chair Bioinformat Res Grp, Vienna, Austria; [Kreil, David P.] Univ Warwick, Coventry CV4 7AL, W Midlands, England; [Megherbi, Dalila] Univ Massachusetts, Dept Elect & Comp Engn, Francis Coll Engn, CMINDS Res Ctr, Lowell, MA USA; [Gaj, Stan; Caiment, Florian; van Delft, Joost; Kleinjans, Jos] Maastricht Univ, Dept Toxicogen, Maastricht, Netherlands; [Scherer, Andreas] Australian Genome Res Facil Ltd, Walter & Eliza Hall Inst Med Res, Melbourne, Vic, Australia; [Devanarayan, Viswanath] AbbVie Inc, N Chicago, IL USA; [Wang, Jian; Yang, Yong; Qian, Hui-Rong] Eli Lilly & Co, Lilly Corp Ctr, Res Informat & Stat, Indianapolis, IN 46285 USA; [Lancashire, Lee J.; Bessarabova, Marina] Thomson Reuters, IP & Sci, Carlsbad, CA USA; [Nikolsky, Yuri] Russian Acad Sci, Vavilov Inst Gen Genet, Moscow, Russia; [Furlanello, Cesare; Chierici, Marco; Albanese, Davide; Jurman, Giuseppe; Riccadonna, Samantha; Filosi, Michele; Visintainer, Roberto] Fdn Bruno Kessler, Trento, Italy; [Albanese, Davide; Riccadonna, Samantha] Fdn Edmund Mach, Computat Biol Dept, Res & Innovat Ctr, San Michele All Adige, Italy; [Zhang, Ke K.] Univ N Dakota, Dept Pathol, Bioinformat CORE, Grand Forks, ND 58201 USA; [Li, Jainying] Kelly Govt Solut Inc, Durham, NC USA; [Hsieh, Jui-Hua; Auerbach, Scott S.] NIEHS, Biomol Screening Branch, Div Natl Toxicol Program, Res Triangle Pk, NC 27709 USA; [Svoboda, Daniel L.] SRA Int, Durham, NC USA; [Fuscoe, James C.] US FDA, Div Syst Biol, Natl Ctr Toxicol Res, Jefferson, AR 72079 USA; [Deng, Youping] Rush Univ, Med Ctr, Dept Internal Med & Biochem, Chicago, IL 60612 USA; [Shi, Leming] Fudan Univ, State Key Lab Genet Engn, Shanghai 200433, Peoples R China; [Shi, Leming] Fudan Univ, MOE Key Lab Contemporary Anthropol, Sch Life Sci, Shanghai 200433, Peoples R China; [Shi, Leming] Fudan Univ, MOE Key Lab Contemporary Anthropol, Sch Pharm, Shanghai 200433, Peoples R China; [Paules, Richard S.] NIEHS, Lab Toxicol & Pharmacol, Res Triangle Pk, NC 27709 USA	Loma Linda University; Loma Linda University; US Food & Drug Administration (FDA); National Institutes of Health (NIH) - USA; NIH National Institute of Environmental Health Sciences (NIEHS); National Institutes of Health (NIH) - USA; NIH National Institute of Environmental Health Sciences (NIEHS); National Institutes of Health (NIH) - USA; NIH National Library of Medicine (NLM); US Food & Drug Administration (FDA); City of Hope; Beckman Research Institute of City of Hope; University of Natural Resources & Life Sciences, Vienna; University of Warwick; University of Massachusetts System; University of Massachusetts Lowell; Maastricht University; AbbVie; Eli Lilly; Clarivate; Russian Academy of Sciences; Vavilov Institute of General Genetics; Fondazione Bruno Kessler; Fondazione Edmund Mach; University of North Dakota Grand Forks; National Institutes of Health (NIH) - USA; NIH National Institute of Environmental Health Sciences (NIEHS); SRA International; US Food & Drug Administration (FDA); Rush University; Fudan University; Fudan University; Fudan University; National Institutes of Health (NIH) - USA; NIH National Institute of Environmental Health Sciences (NIEHS)	Tong, WD (corresponding author), US FDA, Div Bioinformat & Biostat, Natl Ctr Toxicol Res, Jefferson, AR 72079 USA.	bushel@niehs.nih.gov; AuerbachS@niehs.nih.gov; weida.tong@fda.hhs.gov	Gong, Binsheng/E-2306-2015; Jurman, Giuseppe/GRS-8221-2022; Scherer, Andreas/ABD-8660-2020; Kleinjans, Jos C.S./E-7241-2015; Kreil, D/O-1783-2013; Riccadonna, Samantha/H-7247-2019; Albanese, Davide/AAA-7295-2021; caiment, florian/N-7623-2015; Łabaj, Paweł/N-5425-2014; THIERRY-MIEG, Jean/F-1975-2017; yang, lu/D-5099-2015; Shi, Leming/B-3150-2010; Chierici, Marco/P-9949-2019	Gong, Binsheng/0000-0002-8724-5435; Kreil, D/0000-0001-7538-2056; Riccadonna, Samantha/0000-0002-9737-8274; Albanese, Davide/0000-0002-9493-3850; THIERRY-MIEG, Jean/0000-0002-0396-6789; Shi, Leming/0000-0002-7143-2033; Chierici, Marco/0000-0001-9791-9301; Jurman, Giuseppe/0000-0002-2705-5728; Scherer, Andreas/0000-0002-4254-7122; Deng, Youping/0000-0002-5951-8213; Filosi, Michele/0000-0002-3872-347X; Thierry-Mieg, Danielle/0000-0001-9568-4211; Meehan, Joe/0000-0001-9602-3394; Lancashire, Lee/0000-0003-4835-4847; Hong, Huixiao/0000-0001-8087-3968; Labaj, Pawel/0000-0002-4994-0234; Caiment, Florian/0000-0002-3325-0466; Paules, Richard S/0000-0001-9106-7486; Visintainer, Roberto/0000-0003-1289-6871	National Institutes of Health (NIH); National Institutes of Health (NIH), National Institute of Environmental Health Sciences (NIEHS) [ES102345-04, ES023026]; National Library of Medicine; Vienna Scientific Cluster (VSC); Vienna Science and Technology Fund (WWTF); Baxter AG; Austrian Research Centres (ARC) Seibersdorf; Austrian Centre of Biopharmaceutical Technology (ACBT); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [ZIAES102345] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institutes of Health (NIH), National Institute of Environmental Health Sciences (NIEHS)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); National Library of Medicine(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Library of Medicine (NLM)); Vienna Scientific Cluster (VSC); Vienna Science and Technology Fund (WWTF); Baxter AG; Austrian Research Centres (ARC) Seibersdorf(Australian Research Council); Austrian Centre of Biopharmaceutical Technology (ACBT); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	We thank M. Arana and D. Mendrick for their critical review of the manuscript. This research was supported, in part, by the Intramural Research Program of the National Institutes of Health (NIH), National Institute of Environmental Health Sciences (NIEHS) (ES102345-04 and ES023026) and National Library of Medicine. P.P.L. and D.P.K. acknowledge support by the Vienna Scientific Cluster (VSC), the Vienna Science and Technology Fund (WWTF), Baxter AG, Austrian Research Centres (ARC) Seibersdorf and the Austrian Centre of Biopharmaceutical Technology (ACBT).	Anders S, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-10-r106; Baker SC, 2005, NAT METHODS, V2, P731, DOI 10.1038/nmeth1005-731; Bottomly D, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017820; Bradford JR, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-282; Chen MJ, 2012, TOXICOL SCI, V130, P217, DOI 10.1093/toxsci/kfs223; Fan X, 2010, PHARMACOGENOMICS J, V10, P247, DOI 10.1038/tpj.2010.34; Giorgi FM, 2013, BIOINFORMATICS, V29, P717, DOI 10.1093/bioinformatics/btt053; Guo L, 2006, NAT BIOTECHNOL, V24, P1162, DOI 10.1038/nbt1238; Hamburg MA, 2011, SCIENCE, V331, P987, DOI 10.1126/science.1204432; Irizarry RA, 2003, NUCLEIC ACIDS RES, V31, DOI 10.1093/nar/gng015; Katz Y, 2010, NAT METHODS, V7, P1009, DOI 10.1038/NMETH.1528; Kupershmidt I, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013066; Labaj PP, 2011, BIOINFORMATICS, V27, pI383, DOI 10.1093/bioinformatics/btr247; Li C, 2001, P NATL ACAD SCI USA, V98, P31, DOI 10.1073/pnas.011404098; Loven J, 2012, CELL, V151, P476, DOI 10.1016/j.cell.2012.10.012; Lu J, 2013, GENE, V527, P616, DOI 10.1016/j.gene.2013.06.052; Malone JH, 2011, BMC BIOL, V9, DOI 10.1186/1741-7007-9-34; Marioni JC, 2008, GENOME RES, V18, P1509, DOI 10.1101/gr.079558.108; McIntyre LM, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-293; Merrick BA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061768; Mooney M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061088; Mortazavi A, 2008, NAT METHODS, V5, P621, DOI 10.1038/nmeth.1226; Nookaew I, 2012, NUCLEIC ACIDS RES, V40, P10084, DOI 10.1093/nar/gks804; Raghavachari N, 2012, BMC MED GENOMICS, V5, DOI 10.1186/1755-8794-5-28; Robinson MD, 2010, BIOINFORMATICS, V26, P139, DOI 10.1093/bioinformatics/btp616; Shi LM, 2006, NAT BIOTECHNOL, V24, P1151, DOI 10.1038/nbt1239; Shi LM, 2010, NAT BIOTECHNOL, V28, P827, DOI 10.1038/nbt.1665; Shi LM, 2005, BMC BIOINFORMATICS, V6, DOI 10.1186/1471-2105-6-S2-S11; Sirbu A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050986; Smyth GK, 2005, STAT BIOL HEALTH, P397, DOI 10.1007/0-387-29362-0_23; Su ZQ, 2014, NAT BIOTECHNOL, V32, P903, DOI 10.1038/nbt.2957; Su ZQ, 2011, CHEM RES TOXICOL, V24, P1486, DOI 10.1021/tx200103b; Subramaniam S, 2012, NAT IMMUNOL, V13, P199, DOI 10.1038/ni.2244; Sultan M, 2008, SCIENCE, V321, P956, DOI 10.1126/science.1160342; Thierry-Mieg D, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-s1-s12; Xiong YY, 2010, NAT GENET, V42, P1043, DOI 10.1038/ng.711; Xu WH, 2011, P NATL ACAD SCI USA, V108, P3707, DOI 10.1073/pnas.1019753108	37	295	305	2	102	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156	1546-1696		NAT BIOTECHNOL	Nat. Biotechnol.	SEP	2014	32	9					926	932		10.1038/nbt.3001	http://dx.doi.org/10.1038/nbt.3001			7	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	AQ2FD	25150839	Green Accepted			2022-12-27	WOS:000342600300032
J	Li, JH; Jia, HJ; Cai, XH; Zhong, HZ; Feng, Q; Sunagawa, S; Arumugam, M; Kultima, JR; Prifti, E; Nielsen, T; Juncker, AS; Manichanh, C; Chen, B; Zhang, WW; Levenez, F; Wang, J; Xu, X; Xiao, L; Liang, SS; Zhang, DY; Zhang, ZX; Chen, WN; Zhao, HL; Al-Aama, JY; Edris, S; Yang, HM; Wang, J; Hansen, T; Nielsen, HB; Brunak, S; Kristiansen, K; Guarner, F; Pedersen, O; Dore, J; Ehrlich, SD; Bork, P; Wang, J				Li, Junhua; Jia, Huijue; Cai, Xianghang; Zhong, Huanzi; Feng, Qiang; Sunagawa, Shinichi; Arumugam, Manimozhiyan; Kultima, Jens Roat; Prifti, Edi; Nielsen, Trine; Juncker, Agnieszka Sierakowska; Manichanh, Chaysavanh; Chen, Bing; Zhang, Wenwei; Levenez, Florence; Wang, Juan; Xu, Xun; Xiao, Liang; Liang, Suisha; Zhang, Dongya; Zhang, Zhaoxi; Chen, Weineng; Zhao, Hailong; Al-Aama, Jumana Yousuf; Edris, Sherif; Yang, Huanming; Wang, Jian; Hansen, Torben; Nielsen, Henrik Bjorn; Brunak, Soren; Kristiansen, Karsten; Guarner, Francisco; Pedersen, Oluf; Dore, Joel; Ehrlich, S. Dusko; Bork, Peer; Wang, Jun		MetaHIT Consortium	An integrated catalog of reference genes in the human gut microbiome	NATURE BIOTECHNOLOGY			English	Article							EUKARYOTIC DIVERSITY; FECAL MICROBIOTA; POPULATION-SIZE; METAGENOME; GENOMES; IMPACT; SETS	Many analyses of the human gut microbiome depend on a catalog of reference genes. Existing catalogs for the human gut microbiome are based on samples from single cohorts or on reference genomes or protein sequences, which limits coverage of global microbiome diversity. Here we combined 249 newly sequenced samples of the Metagenomics of the Human Intestinal Tract (MetaHit) project with 1,018 previously sequenced samples to create a cohort from three continents that is at least threefold larger than cohorts used for previous gene catalogs. From this we established the integrated gene catalog (IGC) comprising 9,879,896 genes. The catalog includes close-to-complete sets of genes for most gut microbes, which are also of considerably higher quality than in previous catalogs. Analyses of a group of samples from Chinese and Danish individuals using the catalog revealed country-specific gut microbial signatures. This expanded catalog should facilitate quantitative characterization of metagenomic, metatranscriptomic and metaproteomic data from the gut microbiome to understand its variation across populations in human health and disease.	[Li, Junhua; Jia, Huijue; Cai, Xianghang; Zhong, Huanzi; Feng, Qiang; Arumugam, Manimozhiyan; Chen, Bing; Zhang, Wenwei; Wang, Juan; Xu, Xun; Xiao, Liang; Liang, Suisha; Zhang, Dongya; Zhang, Zhaoxi; Chen, Weineng; Zhao, Hailong; Yang, Huanming; Wang, Jian; Wang, Jun] BGI Shenzhen, Shenzhen, Peoples R China; [Li, Junhua] BGI Hong Kong Res Inst, Hong Kong, Hong Kong, Peoples R China; [Li, Junhua] S China Univ Technol, Sch Biosci & Biotechnol, Guangzhou, Guangdong, Peoples R China; [Feng, Qiang; Kristiansen, Karsten; Wang, Jun] Univ Copenhagen, Dept Biol, Copenhagen, Denmark; [Sunagawa, Shinichi; Arumugam, Manimozhiyan; Kultima, Jens Roat; Bork, Peer] European Mol Biol Lab, D-69012 Heidelberg, Germany; [Arumugam, Manimozhiyan; Nielsen, Trine; Hansen, Torben; Pedersen, Oluf; Wang, Jun] Univ Copenhagen, Fac Hlth & Med Sci, Novo Nordisk Fdn Ctr Basic Metab Res, Copenhagen, Denmark; [Prifti, Edi; Levenez, Florence; Dore, Joel; Ehrlich, S. Dusko] INRA, Metagenopolis, Jouy En Josas, France; [Juncker, Agnieszka Sierakowska; Nielsen, Henrik Bjorn; Brunak, Soren] Tech Univ Denmark, Ctr Biol Sequence Anal, DK-2800 Lyngby, Denmark; [Manichanh, Chaysavanh] Univ Hosp Vall dHebron, Digest Syst Res Unit, Barcelona, Spain; [Al-Aama, Jumana Yousuf] King Abdulaziz Univ, Fac Med, Dept Med Genet, Jeddah 21413, Saudi Arabia; [Al-Aama, Jumana Yousuf; Edris, Sherif; Yang, Huanming; Wang, Jun] KAU, Fac Med, Princess Al Jawhara AlBrahim Ctr Excellence Res H, Jeddah, Saudi Arabia; [Edris, Sherif] King Abdulaziz Univ, Fac Sci, Dept Biol Sci, Jeddah, Saudi Arabia; [Yang, Huanming; Wang, Jian] James D Watson Inst Genome Sci, Hangzhou, Zhejiang, Peoples R China; [Dore, Joel] INRA, Unite Mixte Rech 14121, Microbiol Alimentat Serv Sante, Jouy En Josas, France; [Ehrlich, S. Dusko] Kings Coll London, Guys Hosp, Inst Dent, Cent Off,Ctr Host Microbiome Interact, London, England; [Bork, Peer] Max Delbruck Ctr Mol Med, Berlin, Germany; [Wang, Jun] Macau Univ Sci & Technol, Macau, Peoples R China	Beijing Genomics Institute (BGI); Beijing Genomics Institute (BGI); South China University of Technology; University of Copenhagen; European Molecular Biology Laboratory (EMBL); Novo Nordisk Foundation; University of Copenhagen; INRAE; UDICE-French Research Universities; Universite Paris Saclay; Technical University of Denmark; Hospital Universitari Vall d'Hebron; King Abdulaziz University; King Abdulaziz University; King Abdulaziz University; INRAE; UDICE-French Research Universities; Universite Paris Saclay; Guy's & St Thomas' NHS Foundation Trust; University of London; King's College London; Helmholtz Association; Max Delbruck Center for Molecular Medicine; Macau University of Science & Technology	Wang, J (corresponding author), BGI Shenzhen, Shenzhen, Peoples R China.	bork@embl.de; wangj@genomics.org.cn	Al-aama, Jumana/AAA-8653-2021; Dore, Joel/ABA-8921-2020; Tap, Julien/E-5760-2010; Xu, Xun/AAI-6763-2020; van Hylckama Vlieg, Johan/F-7887-2014; Li, Junhua/AAG-3919-2019; GUEDON, Eric/N-8624-2019; Borruel, Natalia/AFO-6891-2022; Kristiansen, Karsten/J-5148-2014; Guarner, Francisco/ABF-1192-2020; Ho, Igor Osorio/AAG-8616-2020; Knol, Jan/AAL-6487-2020; Guedon, Eric/S-5635-2016; Nielsen, Henrik/B-8961-2019; Edris, Sherif/I-8070-2012; Ehrlich, S./Y-2423-2019; Arumugam, Manimozhiyan/AAJ-2394-2020; Pedersen, Oluf/AAG-8015-2020; BLOTTIERE, Hervé M/C-6120-2011; Knol, Jan/A-2178-2010; Prifti, Edi/F-3967-2019; Veiga, Patrick/A-9862-2011; Sunagawa, Shinichi/Q-5950-2019; Edris, Sherif/GXZ-9995-2022; Bork, Peer/F-1813-2013; Arumugam, Manimozhiyan/E-1211-2011; Rescigno, Maria/J-9704-2012; Pedersen, Oluf/Z-1731-2019; Jia, Huijue/M-3991-2015; Xiao, Liang/L-5614-2016; Wang, Jun/C-8434-2016; Wang, Jun/B-9503-2016; Brunak, Soren/O-6621-2016	Tap, Julien/0000-0001-8998-5413; Xu, Xun/0000-0002-5338-5173; van Hylckama Vlieg, Johan/0000-0001-6656-8668; Li, Junhua/0000-0001-6784-1873; GUEDON, Eric/0000-0002-0901-4447; Borruel, Natalia/0000-0002-4449-2292; Kristiansen, Karsten/0000-0002-6024-0917; Guarner, Francisco/0000-0002-4051-0836; Knol, Jan/0000-0002-2103-5961; Guedon, Eric/0000-0002-0901-4447; Nielsen, Henrik/0000-0003-2281-5713; Edris, Sherif/0000-0002-2810-3736; Ehrlich, S./0000-0002-7563-4046; Arumugam, Manimozhiyan/0000-0002-0886-9101; BLOTTIERE, Hervé M/0000-0002-8390-0607; Knol, Jan/0000-0002-2103-5961; Prifti, Edi/0000-0001-8861-1305; Veiga, Patrick/0000-0001-6318-8547; Sunagawa, Shinichi/0000-0003-3065-0314; Edris, Sherif/0000-0002-2810-3736; Bork, Peer/0000-0002-2627-833X; Arumugam, Manimozhiyan/0000-0002-0886-9101; Rescigno, Maria/0000-0002-6464-509X; Pedersen, Oluf/0000-0002-3321-3972; Jia, Huijue/0000-0002-3592-126X; Pelletier, Eric/0000-0003-4228-1712; Hansen, Torben/0000-0001-8748-3831; Xiao, Liang/0000-0003-0836-4397; TORREJON, ANTONIO/0000-0002-3126-1532; Kennedy, Sean/0000-0002-3932-8922; Wang, Jun/0000-0002-8540-8931; Derrien, Muriel/0000-0001-8841-9153; Wang, Jun/0000-0002-2113-5874; Brunak, Soren/0000-0003-0316-5866; Nielsen, Trine/0000-0002-2066-7895; Chaysavanh, Manichanh/0000-0002-2287-4003; Kleerebezem, Michiel/0000-0001-8552-2235; Delorme, Christine/0000-0002-5208-7238; Varela Castro, Encarna/0000-0001-6334-9320; Liang, Suisha/0000-0003-0426-9827	European Commission [HEALTH-F4-2007-201052, HEALTH-F4-2010-261376]; Natural Science Foundation of China [30890032, 30725008, 30811130531, 31161130357]; Shenzhen Municipal Government of China [ZYC200903240080A, BGI20100001, CXB201108250096A, CXB201108250098A]; European Research Council CancerBiome [268985]; METACARDIS project [FP7-HEALTH-2012-INNOVATION-I-305312]; Danish Strategic Research Council [2106-07-0021]; Danish Natural Science Research Council; Solexa project [272-07-0196]; Lundbeck Foundation Centre for Applied Medical Genomics in Personalized Disease Prediction, Prevention and Care; Novo Nordisk Foundation Center for Basic Metabolic Research; Novo Nordisk Foundation; Metagenopolis grant [ANR-11-DPBS-0001]; Novo Nordisk Fonden [NNF10CC1016517] Funding Source: researchfish	European Commission(European CommissionEuropean Commission Joint Research Centre); Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Shenzhen Municipal Government of China; European Research Council CancerBiome; METACARDIS project; Danish Strategic Research Council(Danske Strategiske Forskningsrad (DSF)); Danish Natural Science Research Council(Danish Natural Science Research Council); Solexa project; Lundbeck Foundation Centre for Applied Medical Genomics in Personalized Disease Prediction, Prevention and Care; Novo Nordisk Foundation Center for Basic Metabolic Research(Novo Nordisk Foundation); Novo Nordisk Foundation(Novo Nordisk FoundationNovocure Limited); Metagenopolis grant; Novo Nordisk Fonden(Novo Nordisk Foundation)	This research was supported by the European Commission FP7 grant HEALTH-F4-2007-201052 and HEALTH-F4-2010-261376, Natural Science Foundation of China (30890032, 30725008, 30811130531 and 31161130357), the Shenzhen Municipal Government of China (ZYC200903240080A, BGI20100001, CXB201108250096A and CXB201108250098A), European Research Council CancerBiome grant (project reference 268985), METACARDIS project (FP7-HEALTH-2012-INNOVATION-I-305312), the Danish Strategic Research Council grant (2106-07-0021), the Ole Romer grant from Danish Natural Science Research Council and the Solexa project (272-07-0196). Additional funding came from the Lundbeck Foundation Centre for Applied Medical Genomics in Personalized Disease Prediction, Prevention and Care (http://www.lucamp.org/), the Novo Nordisk Foundation Center for Basic Metabolic Research (an independent research center at the University of Copenhagen partially funded by an unrestricted donation from the Novo Nordisk Foundation; http://www.metabol.ku.dk) and the Metagenopolis grant ANR-11-DPBS-0001. We are indebted to many additional faculty and staff of BGI-Shenzhen who contributed to this work.	Anuurad E, 2003, J OCCUP HEALTH, V45, P335, DOI 10.1539/joh.45.335; Arumugam M, 2011, NATURE, V473, P174, DOI 10.1038/nature09944; Arumugam M, 2010, BIOINFORMATICS, V26, P2977, DOI 10.1093/bioinformatics/btq536; CHAO A, 1987, BIOMETRICS, V43, P783, DOI 10.2307/2531532; Ciccarelli FD, 2006, SCIENCE, V311, P1283, DOI 10.1126/science.1123061; Clemente JC, 2012, CELL, V148, P1258, DOI 10.1016/j.cell.2012.01.035; David LA, 2014, NATURE, V505, P559, DOI 10.1038/nature12820; Erickson AR, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049138; Faith JJ, 2013, SCIENCE, V341, P44, DOI 10.1126/science.1237439; Fodor AA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041294; Forslund K, 2013, GENOME RES, V23, P1163, DOI 10.1101/gr.155465.113; Furet JP, 2009, FEMS MICROBIOL ECOL, V68, P351, DOI 10.1111/j.1574-6941.2009.00671.x; Hu YF, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3151; Kanehisa M, 2000, NUCLEIC ACIDS RES, V28, P27, DOI 10.1093/nar/28.1.27; Karlsson FH, 2013, NATURE, V498, P99, DOI 10.1038/nature12198; Kent WJ, 2002, GENOME RES, V12, P656, DOI [10.1101/gr.229202, 10.1101/gr.229202. Article published online before March 2002]; Ko GTC, 1999, INT J OBESITY, V23, P1136, DOI 10.1038/sj.ijo.0801043; Kultima JR, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047656; Kurokawa K, 2007, DNA RES, V14, P169, DOI 10.1093/dnares/dsm018; Le Chatelier E, 2013, NATURE, V500, P541, DOI 10.1038/nature12506; LEE SM, 1994, BIOMETRICS, V50, P88, DOI 10.2307/2533199; Li A, 2013, BIOTECHNOL BIOFUELS, V6, DOI 10.1186/1754-6834-6-3; Li J., 2014, GIGASCIENCE DATABASE, DOI [10.5524/100064, DOI 10.5524/100064]; Li RQ, 2010, GENOME RES, V20, P265, DOI 10.1101/gr.097261.109; Li RQ, 2009, BIOINFORMATICS, V25, P1966, DOI 10.1093/bioinformatics/btp336; Li WZ, 2006, BIOINFORMATICS, V22, P1658, DOI 10.1093/bioinformatics/btl158; Marchesi JR, 2010, ADV APPL MICROBIOL, V72, P43, DOI 10.1016/S0065-2164(10)72002-5; Markowitz VM, 2014, NUCLEIC ACIDS RES, V42, pD560, DOI 10.1093/nar/gkt963; Mende DR, 2013, NAT METHODS, V10, P881, DOI [10.1038/NMETH.2575, 10.1038/nmeth.2575]; Methe BA, 2012, NATURE, V486, P215, DOI 10.1038/nature11209; Minot S, 2011, GENOME RES, V21, P1616, DOI 10.1101/gr.122705.111; Modi SR, 2013, NATURE, V499, P219, DOI 10.1038/nature12212; Nelson KE, 2010, SCIENCE, V328, P994, DOI 10.1126/science.1183605; Nielsen HB, 2014, NAT BIOTECHNOL, V32, P822, DOI 10.1038/nbt.2939; Ning ZM, 2001, GENOME RES, V11, P1725, DOI 10.1101/gr.194201; Parfrey LW, 2011, FRONT MICROBIOL, V2, DOI 10.3389/fmicb.2011.00153; Powell S, 2012, NUCLEIC ACIDS RES, V40, pD284, DOI 10.1093/nar/gkr1060; Qin JJ, 2012, NATURE, V490, P55, DOI 10.1038/nature11450; Qin JJ, 2010, NATURE, V464, P59, DOI 10.1038/nature08821; Reyes A, 2012, NAT REV MICROBIOL, V10, P607, DOI 10.1038/nrmicro2853; Reyes A, 2010, NATURE, V466, P334, DOI 10.1038/nature09199; Scanlan PD, 2008, ISME J, V2, P1183, DOI 10.1038/ismej.2008.76; Schloss PD, 2009, APPL ENVIRON MICROB, V75, P7537, DOI 10.1128/AEM.01541-09; Sorek R, 2007, SCIENCE, V318, P1449, DOI 10.1126/science.1147112; Storey JD, 2002, J ROY STAT SOC B, V64, P479, DOI 10.1111/1467-9868.00346; Storey JD, 2003, P NATL ACAD SCI USA, V100, P9440, DOI 10.1073/pnas.1530509100; Sunagawa S, 2013, NAT METHODS, V10, P1196, DOI [10.1038/NMETH.2693, 10.1038/nmeth.2693]; Turnbaugh PJ, 2009, NATURE, V457, P480, DOI 10.1038/nature07540; Wang Q, 2007, APPL ENVIRON MICROB, V73, P5261, DOI 10.1128/AEM.00062-07; Wang XX, 2010, NAT COMMUN, V1, DOI 10.1038/ncomms1146; WHO/IASO/IOTF, 2000, ASIA PACIFIC PERSPEC; Xiong XJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036009; Zhu WH, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkq275	53	1040	1110	23	332	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1087-0156	1546-1696		NAT BIOTECHNOL	Nat. Biotechnol.	AUG	2014	32	8					834	841		10.1038/nbt.2942	http://dx.doi.org/10.1038/nbt.2942			8	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	AW7PF	24997786				2022-12-27	WOS:000346455900045
J	Huggett, B				Huggett, Brady			Biotech's wellspring: the health of private biotech in 2013 (vol 32, pg 428, 2014)	NATURE BIOTECHNOLOGY			English	Correction																		Huggett B, 2014, NAT BIOTECHNOL, V32, P428, DOI 10.1038/nbt.2905	1	3	3	0	4	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156	1546-1696		NAT BIOTECHNOL	Nat. Biotechnol.	JUN	2014	32	6					592	592		10.1038/nbt0614-592a	http://dx.doi.org/10.1038/nbt0614-592a			1	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	AI9EV	24911487	Bronze			2022-12-27	WOS:000337233800023
J	Peng, T; Hang, HC				Peng, Tao; Hang, Howard C.			SORTing out cellular proteomes in vivo	NATURE BIOTECHNOLOGY			English	Editorial Material									[Peng, Tao; Hang, Howard C.] Rockefeller Univ, Lab Chem Biol & Microbial Pathogenesis, New York, NY 10021 USA	Rockefeller University	Peng, T (corresponding author), Rockefeller Univ, Lab Chem Biol & Microbial Pathogenesis, 1230 York Ave, New York, NY 10021 USA.	hhang@rockefeller.edu						Cox J, 2011, ANNU REV BIOCHEM, V80, P273, DOI 10.1146/annurev-biochem-061308-093216; Elliott TS, 2014, NAT BIOTECHNOL, V32, P465, DOI 10.1038/nbt.2860; Ingolia NT, 2014, NAT REV GENET, V15, P205, DOI 10.1038/nrg3645; Lang K, 2014, CHEM REV, V114, P4764, DOI 10.1021/cr400355w; Liu CC, 2010, ANNU REV BIOCHEM, V79, P413, DOI 10.1146/annurev.biochem.052308.105824; Ngo JT, 2011, ACCOUNTS CHEM RES, V44, P677, DOI 10.1021/ar200144y; Yang J, 2012, ANGEW CHEM INT EDIT, V51, P7476, DOI 10.1002/anie.201202122	7	1	1	0	14	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156	1546-1696		NAT BIOTECHNOL	Nat. Biotechnol.	MAY	2014	32	5					445	446		10.1038/nbt.2898	http://dx.doi.org/10.1038/nbt.2898			3	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	AH3PH	24811517				2022-12-27	WOS:000336036100018
J	Sheridan, C				Sheridan, Cormac			Anti-CD20 antibody wows in multiple sclerosis	NATURE BIOTECHNOLOGY			English	News Item																		Hauser SL, 2015, MULT SCLER J, V21, P8, DOI 10.1177/1352458514561911; SELLEBJERG F, 2008, NEW ENGL J MED, V358, P676	2	4	4	0	9	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156	1546-1696		NAT BIOTECHNOL	Nat. Biotechnol.	DEC	2015	33	12					1215	1216		10.1038/nbt1215-1215	http://dx.doi.org/10.1038/nbt1215-1215			2	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	CY4OO	26649998				2022-12-27	WOS:000366387700002
J	Svenson, KL				Svenson, Karen L.			Scaling up phenotyping studies	NATURE BIOTECHNOLOGY			English	Editorial Material							MAMMALIAN GENE-FUNCTION; HUMAN KNOCKOUTS; CONSORTIUM; RESOURCE		Jackson Lab, Bar Harbor, ME 04609 USA	Jackson Laboratory	Svenson, KL (corresponding author), Jackson Lab, 600 Main St, Bar Harbor, ME 04609 USA.	karen.svenson@jax.org			NATIONAL HUMAN GENOME RESEARCH INSTITUTE [U54HG006332] Funding Source: NIH RePORTER; NHGRI NIH HHS [U54 HG006332] Funding Source: Medline	NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NHGRI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))		Bradley A, 2012, MAMM GENOME, V23, P580, DOI 10.1007/s00335-012-9422-2; Brown SDM, 2012, MAMM GENOME, V23, P632, DOI 10.1007/s00335-012-9427-x; Callaway E, 2014, NATURE, V514, P548, DOI 10.1038/514548a; de Angelis MH, 2015, NAT GENET, V47, P969, DOI 10.1038/ng.3360; Mallon AM, 2008, NUCLEIC ACIDS RES, V36, pD715, DOI 10.1093/nar/gkm728; Sulem P, 2015, NAT GENET, V47, P448, DOI 10.1038/ng.3243; White JK, 2013, CELL, V154, P452, DOI 10.1016/j.cell.2013.06.022	7	0	0	0	2	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1087-0156	1546-1696		NAT BIOTECHNOL	Nat. Biotechnol.	NOV	2015	33	11					1150	1151		10.1038/nbt.3400	http://dx.doi.org/10.1038/nbt.3400			2	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	CW3TY	26544146				2022-12-27	WOS:000364916000019
J	Blanco, E; Shen, H; Ferrari, M				Blanco, Elvin; Shen, Haifa; Ferrari, Mauro			Principles of nanoparticle design for overcoming biological barriers to drug delivery	NATURE BIOTECHNOLOGY			English	Article							ALBUMIN-BOUND PACLITAXEL; PHASE-III TRIAL; MULTIDRUG-RESISTANCE; SURFACE-CHARGE; BREAST-CANCER; GENE-THERAPY; IN-VIVO; MACROMOLECULAR THERAPEUTICS; TUMORITROPIC ACCUMULATION; SILICON MICROPARTICLES	Biological barriers to drug transport prevent successful accumulation of nanotherapeutics specifically at diseased sites, limiting efficacious responses in disease processes ranging from cancer to inflammation. Although substantial research efforts have aimed to incorporate multiple functionalities and moieties within the overall nanoparticle design, many of these strategies fail to adequately address these barriers. Obstacles, such as nonspecific distribution and inadequate accumulation of therapeutics, remain formidable challenges to drug developers. A reimagining of conventional nanoparticles is needed to successfully negotiate these impediments to drug delivery. Site-specific delivery of therapeutics will remain a distant reality unless nanocarrier design takes into account the majority, if not all, of the biological barriers that a particle encounters upon intravenous administration. By successively addressing each of these barriers, innovative design features can be rationally incorporated that will create a new generation of nanotherapeutics, realizing a paradigmatic shift in nanoparticle-based drug delivery.	[Blanco, Elvin; Shen, Haifa; Ferrari, Mauro] Houston Methodist Res Inst, Dept Nanomed, Houston, TX 77030 USA; [Shen, Haifa] Weill Cornell Med Coll, Dept Cell & Dev Biol, New York, NY USA; [Ferrari, Mauro] Weill Cornell Med Coll, Dept Med, New York, NY USA	The Methodist Hospital System; The Methodist Hospital - Houston; Cornell University; Cornell University	Ferrari, M (corresponding author), Houston Methodist Res Inst, Dept Nanomed, Houston, TX 77030 USA.	mferrari@HoustonMethodist.org			Department of Defense [W81XWH-12-1-0414]; US National Institutes of Health [NIH U54CA143837, NIH U54CA151668]; Susan G. Komen Breast Cancer Foundation [KG101394]; NATIONAL CANCER INSTITUTE [U54CA143837, U54CA151668] Funding Source: NIH RePORTER	Department of Defense(United States Department of Defense); US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Susan G. Komen Breast Cancer Foundation(Susan G. Komen Breast Cancer Foundation); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	M.F. is grateful for the Ernest Cockrell Jr. Distinguished Endowed Chair in the Department of Nanomedicine at the Houston Methodist Research Institute. The authors acknowledge financial support from Department of Defense grant W81XWH-12-1-0414, and US National Institutes of Health grants NIH U54CA143837 and NIH U54CA151668. E.B. is grateful for the support of the Susan G. Komen Breast Cancer Foundation (grant KG101394). The authors are grateful for the assistance of F.E. Cara, V. Segura-Ibarra and Suhong Wu in manuscript preparation. M.G. Landry is acknowledged for manuscript schematics.	Alexiou C, 2000, CANCER RES, V60, P6641; Alexis F, 2008, MOL PHARMACEUT, V5, P505, DOI 10.1021/mp800051m; Aller SG, 2009, SCIENCE, V323, P1718, DOI 10.1126/science.1168750; Anderson DJ, 2007, NAT CELL BIOL, V9, P1160, DOI 10.1038/ncb1636; Arvizo RR, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024374; Attia ABE, 2013, BIOMATERIALS, V34, P3132, DOI 10.1016/j.biomaterials.2013.01.042; Azzopardi EA, 2013, J ANTIMICROB CHEMOTH, V68, P257, DOI 10.1093/jac/dks379; Bareford LA, 2007, ADV DRUG DELIVER REV, V59, P748, DOI 10.1016/j.addr.2007.06.008; Barenholz Y, 2012, J CONTROL RELEASE, V160, P117, DOI 10.1016/j.jconrel.2012.03.020; Batrakova EV, 2008, J CONTROL RELEASE, V130, P98, DOI 10.1016/j.jconrel.2008.04.013; Bertrand N, 2014, ADV DRUG DELIVER REV, V66, P2, DOI 10.1016/j.addr.2013.11.009; Black KCL, 2014, ACS NANO, V8, P4385, DOI 10.1021/nn406258m; Braet F, 2007, MICROSC RES TECHNIQ, V70, P230, DOI 10.1002/jemt.20408; Cabral H, 2011, NAT NANOTECHNOL, V6, P815, DOI [10.1038/nnano.2011.166, 10.1038/NNANO.2011.166]; Champion JA, 2006, P NATL ACAD SCI USA, V103, P4930, DOI 10.1073/pnas.0600997103; Champion JA, 2009, PHARM RES-DORDR, V26, P244, DOI 10.1007/s11095-008-9626-z; Chauhan VP, 2012, NAT NANOTECHNOL, V7, P383, DOI [10.1038/NNANO.2012.45, 10.1038/nnano.2012.45]; CHEN LT, 1973, BLOOD, V41, P529, DOI 10.1182/blood.V41.4.529.529; Chen X, 2014, NATURE, V508, P103, DOI 10.1038/nature13119; Chiappini C, 2010, CHEMPHYSCHEM, V11, P1029, DOI 10.1002/cphc.200900914; Choi HS, 2007, NAT BIOTECHNOL, V25, P1165, DOI 10.1038/nbt1340; Chou LYT, 2011, CHEM SOC REV, V40, P233, DOI 10.1039/c0cs00003e; Christian DA, 2009, MOL PHARMACEUT, V6, P1343, DOI 10.1021/mp900022m; Cui JW, 2014, ADV MATER, V26, P7295, DOI 10.1002/adma.201402753; Dauty E, 2002, BIOCONJUGATE CHEM, V13, P831, DOI 10.1021/bc0255182; Dave B, 2014, P NATL ACAD SCI USA, V111, P8838, DOI 10.1073/pnas.1320769111; Dean M, 2005, NAT REV CANCER, V5, P275, DOI 10.1038/nrc1590; Decuzzi P, 2005, ANN BIOMED ENG, V33, P179, DOI 10.1007/s10439-005-8976-5; Decuzzi P, 2009, PHARM RES-DORD, V26, P235, DOI 10.1007/s11095-008-9697-x; Diop-Frimpong B, 2011, P NATL ACAD SCI USA, V108, P2909, DOI 10.1073/pnas.1018892108; Dobson J, 2006, GENE THER, V13, P283, DOI 10.1038/sj.gt.3302720; Docter D, 2014, NAT PROTOC, V9, P2030, DOI 10.1038/nprot.2014.139; Ferrari M, 2010, TRENDS BIOTECHNOL, V28, P181, DOI 10.1016/j.tibtech.2009.12.007; Fletcher JI, 2010, NAT REV CANCER, V10, P147, DOI 10.1038/nrc2789; Geng Y, 2007, NAT NANOTECHNOL, V2, P249, DOI 10.1038/nnano.2007.70; Gentile F, 2008, J BIOMECH, V41, P2312, DOI 10.1016/j.jbiomech.2008.03.021; Gottesman MM, 2002, NAT REV CANCER, V2, P48, DOI 10.1038/nrc706; Gould GW, 2009, NAT REV MOL CELL BIO, V10, P287, DOI 10.1038/nrm2652; Gradishar WJ, 2006, EXPERT OPIN PHARMACO, V7, P1041, DOI 10.1517/14656566.7.8.1041; Gradishar WJ, 2005, J CLIN ONCOL, V23, P7794, DOI 10.1200/JCO.2005.04.937; Gratton SEA, 2008, P NATL ACAD SCI USA, V105, P11613, DOI 10.1073/pnas.0801763105; Guo ST, 2011, J NANOMATER, V2011, DOI 10.1155/2011/742895; Hamilton A, 2002, ANN ONCOL, V13, P910, DOI 10.1093/annonc/mdf157; Harris JM, 2003, NAT REV DRUG DISCOV, V2, P214, DOI 10.1038/nrd1033; Hawkins MJ, 2008, ADV DRUG DELIVER REV, V60, P876, DOI 10.1016/j.addr.2007.08.044; Heldin CH, 2004, NAT REV CANCER, V4, P806, DOI 10.1038/nrc1456; Hobbs SK, 1998, P NATL ACAD SCI USA, V95, P4607, DOI 10.1073/pnas.95.8.4607; Hu CMJ, 2011, P NATL ACAD SCI USA, V108, P10980, DOI 10.1073/pnas.1106634108; Hu YX, 2013, ACS NANO, V7, P5376, DOI 10.1021/nn4012384; Ibrahim NK, 2005, J CLIN ONCOL, V23, P6019, DOI 10.1200/JCO.2005.11.013; Jain RK, 2013, J CLIN ONCOL, V31, P2205, DOI 10.1200/JCO.2012.46.3653; Jain RK, 2010, NAT REV CLIN ONCOL, V7, P653, DOI 10.1038/nrclinonc.2010.139; Kay MA, 2001, NAT MED, V7, P33, DOI 10.1038/83324; Kola I, 2004, NAT REV DRUG DISCOV, V3, P711, DOI 10.1038/nrd1470; Kreuter J, 2002, J DRUG TARGET, V10, P317, DOI 10.1080/10611860290031877; Le Roy C, 2005, NAT REV MOL CELL BIO, V6, P112, DOI 10.1038/nrm1571; Lechardeur D, 1999, GENE THER, V6, P482, DOI 10.1038/sj.gt.3300867; Lee Y, 2007, J AM CHEM SOC, V129, P5362, DOI 10.1021/ja071090b; Lee Y, 2008, BIOCONJUGATE CHEM, V19, P525, DOI 10.1021/bc700382z; Levine RM, 2013, LANGMUIR, V29, P9208, DOI 10.1021/la400859e; Li SD, 2009, BBA-BIOMEMBRANES, V1788, P2259, DOI 10.1016/j.bbamem.2009.06.022; Longmire M, 2008, NANOMEDICINE-UK, V3, P703, DOI 10.2217/17435889.3.5.703; Luo D, 2000, NAT BIOTECHNOL, V18, P33, DOI 10.1038/71889; Maeda H, 2000, J CONTROL RELEASE, V65, P271, DOI 10.1016/S0168-3659(99)00248-5; Maeda H, 2013, ADV DRUG DELIVER REV, V65, P71, DOI 10.1016/j.addr.2012.10.002; Martens TF, 2014, NANO TODAY, V9, P344, DOI 10.1016/j.nantod.2014.04.011; Marti CN, 2012, J AM COLL CARDIOL, V60, P1455, DOI 10.1016/j.jacc.2011.11.082; MATSUMURA Y, 1986, CANCER RES, V46, P6387; Merkel TJ, 2012, J CONTROL RELEASE, V162, P37, DOI 10.1016/j.jconrel.2012.06.009; Miller CR, 1998, BIOCHEMISTRY-US, V37, P12875, DOI 10.1021/bi980096y; Moghimi SM, 1998, ADV DRUG DELIVER REV, V32, P45, DOI 10.1016/S0169-409X(97)00131-2; Moghimi SM, 2001, PHARMACOL REV, V53, P283; Monsky WL, 1999, CANCER RES, V59, P4129; Mura S, 2013, NAT MATER, V12, P991, DOI [10.1038/nmat3776, 10.1038/NMAT3776]; Murphy EA, 2008, P NATL ACAD SCI USA, V105, P9343, DOI 10.1073/pnas.0803728105; Nel AE, 2009, NAT MATER, V8, P543, DOI [10.1038/NMAT2442, 10.1038/nmat2442]; O'Brien MER, 2004, ANN ONCOL, V15, P440, DOI 10.1093/annonc/mdh097; Osaka T, 2009, COLLOID SURFACE B, V71, P325, DOI 10.1016/j.colsurfb.2009.03.004; Park JH, 2009, SMALL, V5, P694, DOI 10.1002/smll.200801789; Park K, 2013, ACS NANO, V7, P7442, DOI 10.1021/nn404501g; Parodi A, 2013, NAT NANOTECHNOL, V8, P61, DOI 10.1038/nnano.2012.212; Patel NR, 2011, INT J PHARMACEUT, V416, P296, DOI 10.1016/j.ijpharm.2011.05.082; Pissuwan D, 2011, J CONTROL RELEASE, V149, P65, DOI 10.1016/j.jconrel.2009.12.006; Prapainop K, 2012, J AM CHEM SOC, V134, P4100, DOI 10.1021/ja300537u; Raices M, 2012, NAT REV MOL CELL BIO, V13, P687, DOI 10.1038/nrm3461; Rees DC, 2009, NAT REV MOL CELL BIO, V10, P218, DOI 10.1038/nrm2646; Rodriguez PL, 2013, SCIENCE, V339, P971, DOI 10.1126/science.1229568; Rocker C, 2009, NAT NANOTECHNOL, V4, P577, DOI [10.1038/NNANO.2009.195, 10.1038/nnano.2009.195]; Safra T, 2000, ANN ONCOL, V11, P1029, DOI 10.1023/A:1008365716693; Sahay G, 2010, J CONTROL RELEASE, V145, P182, DOI 10.1016/j.jconrel.2010.01.036; Salvati A, 2013, NAT NANOTECHNOL, V8, P137, DOI [10.1038/nnano.2012.237, 10.1038/NNANO.2012.237]; Serda RE, 2009, BIOMATERIALS, V30, P2440, DOI 10.1016/j.biomaterials.2009.01.019; Shah S, 2011, J NANOSCI NANOTECHNO, V11, P919, DOI 10.1166/jnn.2011.3536; Sheridan C, 2011, NAT BIOTECHNOL, V29, P121, DOI 10.1038/nbt.1769; Sica A, 2007, J CLIN INVEST, V117, P1155, DOI 10.1172/JCI31422; Sosnik A, 2013, ADV DRUG DELIVER REV, V65, P1828, DOI 10.1016/j.addr.2013.09.002; Szakacs G, 2006, NAT REV DRUG DISCOV, V5, P219, DOI 10.1038/nrd1984; Tan JF, 2013, MICROFLUID NANOFLUID, V14, P77, DOI 10.1007/s10404-012-1024-5; Tanaka T, 2010, CANCER RES, V70, P3687, DOI 10.1158/0008-5472.CAN-09-3931; Tasciotti E, 2008, NAT NANOTECHNOL, V3, P151, DOI 10.1038/nnano.2008.34; Tenzer S, 2013, NAT NANOTECHNOL, V8, P772, DOI 10.1038/nnano.2013.181; Thurston G, 1998, J CLIN INVEST, V101, P1401, DOI 10.1172/JCI965; Tian Y, 2007, J CONTROL RELEASE, V121, P137, DOI 10.1016/j.jconrel.2007.05.010; Torchilin VP, 2005, NAT REV DRUG DISCOV, V4, P145, DOI 10.1038/nrd1632; van de Ven AL, 2012, J CONTROL RELEASE, V158, P148, DOI 10.1016/j.jconrel.2011.10.021; van Nostrum CF, 2011, SOFT MATTER, V7, P3246, DOI 10.1039/c0sm00999g; Venditto VJ, 2013, ADV DRUG DELIVER REV, V65, P80, DOI 10.1016/j.addr.2012.09.038; von Maltzahn G, 2011, NAT MATER, V10, P545, DOI [10.1038/nmat3049, 10.1038/NMAT3049]; Wasungu L, 2006, J CONTROL RELEASE, V116, P255, DOI 10.1016/j.jconrel.2006.06.024; Wong HL, 2006, J CONTROL RELEASE, V116, P275, DOI 10.1016/j.jconrel.2006.09.007; Woollard KJ, 2010, NAT REV CARDIOL, V7, P77, DOI 10.1038/nrcardio.2009.228; Wu J, 2007, J PHARM PHARM SCI, V10, P350; Xiao K, 2011, BIOMATERIALS, V32, P3435, DOI 10.1016/j.biomaterials.2011.01.021; Xiong XB, 2011, ACS NANO, V5, P5202, DOI 10.1021/nn2013707; Yamamoto Y, 2001, J CONTROL RELEASE, V77, P27, DOI 10.1016/S0168-3659(01)00451-5; Yao C, 2014, ANAL CHEM, V86, P9749, DOI 10.1021/ac5023259; Yokoi K, 2014, CANCER RES, V74, P4239, DOI 10.1158/0008-5472.CAN-13-3494; Yokoi K, 2014, CANCER LETT, V345, P48, DOI 10.1016/j.canlet.2013.11.015; Yuan YY, 2012, ADV MATER, V24, P5476, DOI 10.1002/adma.201202296; Zhang L, 2008, CLIN PHARMACOL THER, V83, P761, DOI 10.1038/sj.clpt.6100400; Zhang L, 2012, ACS NANO, V6, P6681, DOI 10.1021/nn301159a	121	3612	3672	137	2065	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156	1546-1696		NAT BIOTECHNOL	Nat. Biotechnol.	SEP	2015	33	9					941	951		10.1038/nbt.3330	http://dx.doi.org/10.1038/nbt.3330			11	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	CR0EK	26348965	Green Accepted			2022-12-27	WOS:000360990900022
J	Touchot, N; Flume, M				Touchot, Nicolas; Flume, Mathias			The payers' perspective on gene therapies	NATURE BIOTECHNOLOGY			English	Letter							COST		[Touchot, Nicolas] groupH, Strategy Consulting, London, England; [Flume, Mathias] Kassenarztliche Vereinigung Westfalen Lippe, Prescript Management, Dortmund, Germany		Touchot, N (corresponding author), groupH, Strategy Consulting, London, England.	nicolas.touchot@therachallenges.com						Arons I., 2015, OPHTHALMOLOGIST, V0515, P601; Brennan TA, 2014, NAT BIOTECHNOL, V32, P874, DOI 10.1038/nbt.3003; Hanson SG, 2014, 2014 US ORGAN TISSUE; Hirschler B., 2015, REUTERS; Leleu H, 2015, J VIRAL HEPATITIS, V22, P376, DOI 10.1111/jvh.12311; Yla-Herttuala S, 2015, MOL THER, V23, P217, DOI 10.1038/mt.2014.248	6	19	19	1	3	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156	1546-1696		NAT BIOTECHNOL	Nat. Biotechnol.	SEP	2015	33	9					902	904		10.1038/nbt.3332	http://dx.doi.org/10.1038/nbt.3332			4	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	CR0EK	26348952				2022-12-27	WOS:000360990900010
J	Bar-Nur, O; Verheul, C; Sommer, AG; Brumbaugh, J; Schwarz, BA; Lipchina, I; Huebner, AJ; Mostoslavsky, G; Hochedlinger, K				Bar-Nur, Ori; Verheul, Cassandra; Sommer, Andreia G.; Brumbaugh, Justin; Schwarz, Benjamin A.; Lipchina, Inna; Huebner, Aaron J.; Mostoslavsky, Gustavo; Hochedlinger, Konrad			Lineage conversion induced by pluripotency factors involves transient passage through an iPSC stage	NATURE BIOTECHNOLOGY			English	Article							SMALL MOLECULES FACILITATE; MOUSE FIBROBLASTS; STEM-CELLS; GENERATION; NANOG	Brief expression of pluripotency-associated factors such as Oct4, Klf4, Sox2 and c-Myc (OKSM), in combination with differentiation-inducing signals, has been reported to trigger transdifferentiation of fibroblasts into other cell types. Here we show that OKSM expression in mouse fibroblasts gives rise to both induced pluripotent stem cells (iPSCs) and induced neural stem cells (iNSCs) under conditions previously shown to induce only iNSCs. Fibroblast-derived iNSC colonies silenced retroviral transgenes and reactivated silenced X chromosomes, both hallmarks of pluripotent stem cells. Moreover, lineage tracing with an Oct4-CreER labeling system demonstrated that virtually all iNSC colonies originated from cells transiently expressing Oct4, whereas ablation of Oct4(+) cells prevented iNSC formation. Lastly, an alternative transdifferentiation cocktail that lacks Oct4 and was reportedly unable to support induced pluripotency yielded iPSCs and iNSCs carrying the Oct4-CreER-derived lineage label. Together, these data suggest that iNSC generation from fibroblasts using OKSM and other pluripotency-related reprogramming factors requires passage through a transient iPSC state.	[Bar-Nur, Ori; Verheul, Cassandra; Brumbaugh, Justin; Schwarz, Benjamin A.; Lipchina, Inna; Huebner, Aaron J.; Hochedlinger, Konrad] Massachusetts Gen Hosp, Ctr Regenerat Med, Boston, MA 02114 USA; [Bar-Nur, Ori; Verheul, Cassandra; Brumbaugh, Justin; Schwarz, Benjamin A.; Lipchina, Inna; Huebner, Aaron J.; Hochedlinger, Konrad] Massachusetts Gen Hosp, Dept Mol Biol, Boston, MA 02114 USA; [Bar-Nur, Ori; Verheul, Cassandra; Brumbaugh, Justin; Schwarz, Benjamin A.; Lipchina, Inna; Huebner, Aaron J.; Hochedlinger, Konrad] Harvard Univ, Dept Stem Cell & Regenerat Biol, Cambridge, MA 02138 USA; [Bar-Nur, Ori; Verheul, Cassandra; Brumbaugh, Justin; Schwarz, Benjamin A.; Lipchina, Inna; Huebner, Aaron J.; Hochedlinger, Konrad] Howard Hughes Med Inst, Chevy Chase, MD USA; [Bar-Nur, Ori; Verheul, Cassandra; Brumbaugh, Justin; Schwarz, Benjamin A.; Lipchina, Inna; Huebner, Aaron J.; Hochedlinger, Konrad] Harvard Stem Cell Inst, Cambridge, MA USA; [Sommer, Andreia G.; Mostoslavsky, Gustavo] Boston Univ, Sch Med, Ctr Regenerat Med CReM, Boston, MA 02118 USA; [Sommer, Andreia G.; Mostoslavsky, Gustavo] Boston Med Ctr, Boston, MA USA	Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Howard Hughes Medical Institute; Harvard University; Boston University; Boston Medical Center	Hochedlinger, K (corresponding author), Massachusetts Gen Hosp, Ctr Regenerat Med, Boston, MA 02114 USA.	khochedlinger@mgh.harvard.edu	Bar-Nur, Ori/GWQ-5917-2022	Brumbaugh, Justin/0000-0002-9605-2010	EGL foundation; Postdoctoral Fellowship Award by MGH Executive Committee on Research Fund; US National Institutes of Health (NIH) [1F32HD078029-01A1, 1F32HD079225-01A1]; NIH [R01HD058013]; Howard Hughes Medical Institute;  [T32 (5-T32-CA-9216-33)]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [F32HD078029, F32HD079225, R01HD058013] Funding Source: NIH RePORTER; NATIONAL CANCER INSTITUTE [T32CA009216] Funding Source: NIH RePORTER	EGL foundation; Postdoctoral Fellowship Award by MGH Executive Committee on Research Fund; US National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Howard Hughes Medical Institute(Howard Hughes Medical Institute); ; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We thank members of the Hochedlinger laboratory for critical evaluation and discussion of this manuscript. We thank E. Apostolou and S. Cheloufi for helpful comments and N. Maherali for suggesting the idea of X chromosome reactivation. We are also grateful to B. Payer and J. Lee for providing tail-tip fibroblasts carrying an X-linked GFP reporter and to A. Brack for sharing Rosa26-lsl-DTA mice. We are grateful to L. Prickett, M. Weglarz and K. Folz-Donahue at the MGH/HSCI flow cytometry core for their constant assistance and support. O.B.-N, is supported by a Gruss-Lipper postdoctoral fellowship from the EGL foundation. B.A.S. has been supported by a T32 (5-T32-CA-9216-33) grant and through a Postdoctoral Fellowship Award by the MGH Executive Committee on Research Fund for Medical Discovery. J.B. and I.L. are supported by Ruth L. Kirschstein F32 Post-doctoral Fellowships from the US National Institutes of Health (NIH) (1F32HD078029-01A1 to J.B. and 1F32HD079225-01A1 to I.L.). Support to K.H. is from the NIH (R01HD058013) and Howard Hughes Medical Institute.	Bar-Nur O, 2014, NAT METHODS, V11, P1170, DOI [10.1038/nmeth.3142, 10.1038/NMETH.3142]; Capela A, 2002, NEURON, V35, P865, DOI 10.1016/S0896-6273(02)00835-8; Chambers I, 2003, CELL, V113, P643, DOI 10.1016/S0092-8674(03)00392-1; Chen JK, 2011, CELL RES, V21, P884, DOI 10.1038/cr.2011.51; DeVeale B, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003957; Efe JA, 2011, NAT CELL BIOL, V13, P215, DOI 10.1038/ncb2164; Esteban MA, 2010, CELL STEM CELL, V6, P71, DOI 10.1016/j.stem.2009.12.001; Greder LV, 2012, STEM CELLS, V30, P2596, DOI 10.1002/stem.1216; Han DW, 2012, CELL STEM CELL, V10, P465, DOI 10.1016/j.stem.2012.02.021; Kim J, 2011, P NATL ACAD SCI USA, V108, P7838, DOI 10.1073/pnas.1103113108; Li K, 2014, CELL STEM CELL, V14, P228, DOI 10.1016/j.stem.2014.01.006; Lujan E, 2012, P NATL ACAD SCI USA, V109, P2527, DOI 10.1073/pnas.1121003109; Maherali N, 2007, CELL STEM CELL, V1, P55, DOI 10.1016/j.stem.2007.05.014; Margariti A, 2012, P NATL ACAD SCI USA, V109, P13793, DOI 10.1073/pnas.1205526109; Maza I, 2015, NAT BIOTECHNOL, V33, P769, DOI 10.1038/nbt.3270; Orkin SH, 2011, CELL, V145, P835, DOI 10.1016/j.cell.2011.05.019; Polo JM, 2012, CELL, V151, P1617, DOI 10.1016/j.cell.2012.11.039; Schwarz BA, 2014, CURR BIOL, V24, P347, DOI 10.1016/j.cub.2013.12.050; Sommer CA, 2009, STEM CELLS, V27, P543, DOI 10.1634/stemcells.2008-1075; Stadtfeld M, 2008, CELL STEM CELL, V2, P230, DOI 10.1016/j.stem.2008.02.001; Stadtfeld M, 2010, NAT METHODS, V7, P53, DOI [10.1038/NMETH.1409, 10.1038/nmeth.1409]; Thier M, 2012, CELL STEM CELL, V10, P473, DOI 10.1016/j.stem.2012.03.003; van Oosten AL, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1822; Vierbuchen T, 2012, MOL CELL, V47, P827, DOI 10.1016/j.molcel.2012.09.008; Vierbuchen T, 2010, NATURE, V463, P1035, DOI 10.1038/nature08797; Weissbein U, 2014, CELL STEM CELL, V15, P687, DOI 10.1016/j.stem.2014.10.018; Zhu SY, 2014, NATURE, V508, P93, DOI 10.1038/nature13020	27	84	86	0	17	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156	1546-1696		NAT BIOTECHNOL	Nat. Biotechnol.	JUL	2015	33	7					761	768		10.1038/nbt.3247	http://dx.doi.org/10.1038/nbt.3247			8	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	CN4JJ	26098450	Green Accepted, Green Submitted			2022-12-27	WOS:000358396100033
J	DeFrancesco, L				DeFrancesco, Laura			Drug pipeline: 1Q15	NATURE BIOTECHNOLOGY			English	Editorial Material																			0	0	0	0	0	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156	1546-1696		NAT BIOTECHNOL	Nat. Biotechnol.	JUN	2015	33	6					580	580		10.1038/nbt.3261	http://dx.doi.org/10.1038/nbt.3261			1	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	VC0UG	26057966				2022-12-27	WOS:000427419800001
J	Bouchie, A; DeFrancesco, L				Bouchie, Aaron; DeFrancesco, Laura			Nature Biotechnology's academic spinouts of 2014	NATURE BIOTECHNOLOGY			English	Article																			0	8	8	0	9	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156	1546-1696		NAT BIOTECHNOL	Nat. Biotechnol.	MAR	2015	33	3					247	255		10.1038/nbt.3163	http://dx.doi.org/10.1038/nbt.3163			9	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	CD0ME	25748912				2022-12-27	WOS:000350766900017
J	Liu, MD; Maurano, MT; Wang, H; Qi, HY; Song, CZ; Navas, PA; Emery, DW; Stamatoyannopoulos, JA; Stamatoyannopoulos, G				Liu, Mingdong; Maurano, Matthew T.; Wang, Hao; Qi, Heyuan; Song, Chao-Zhong; Navas, Patrick A.; Emery, David W.; Stamatoyannopoulos, John A.; Stamatoyannopoulos, George			Genomic discovery of potent chromatin insulators for human gene therapy	NATURE BIOTECHNOLOGY			English	Article							PROTEIN CTCF; REGULATORY ELEMENTS; VECTOR INTEGRATION; LENTIVIRAL VECTORS; ERYTHROID-CELLS; CHS4 INSULATOR; SCID-X1; BINDING; GENOTOXICITY; ACTIVATION	Insertional mutagenesis and genotoxicity, which usually manifest as hematopoietic malignancy, represent major barriers to realizing the promise of gene therapy. Although insulator sequences that block transcriptional enhancers could mitigate or eliminate these risks, so far no human insulators with high functional potency have been identified: Here we describe a genomic approach for the identification of compact sequence elements that function as insulators. These elements are highly occupied by the insulator protein CTCF, are DNase I hypersensitive and represent only a small minority of the CTCF recognition sequences in the human genome. We show that the elements identified acted as potent enhancer blockers and substantially decreased the risk of tumor formation in a cancer-prone animal model. The elements are small, can be efficiently accommodated by viral vectors and have no detrimental effects on viral titers. The insulators we describe here are expected to increase the safety of gene therapy for genetic diseases.	[Liu, Mingdong; Qi, Heyuan; Song, Chao-Zhong; Navas, Patrick A.; Emery, David W.; Stamatoyannopoulos, George] Univ Washington, Div Med Genet, Seattle, WA 98195 USA; [Maurano, Matthew T.; Wang, Hao; Stamatoyannopoulos, John A.; Stamatoyannopoulos, George] Univ Washington, Dept Genome Sci, Seattle, WA 98195 USA; [Qi, Heyuan] Chinese Acad Sci, Beijing Inst Gen, Beijing, Peoples R China; [Song, Chao-Zhong; Emery, David W.] Univ Washington, Inst Stem Cell & Regenerat Med, Seattle, WA 98195 USA; [Stamatoyannopoulos, John A.] Univ Washington, Dept Med, Seattle, WA 98195 USA	University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; Chinese Academy of Sciences; Beijing Institute of Genomics, CAS; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle	Stamatoyannopoulos, G (corresponding author), Univ Washington, Div Med Genet, Seattle, WA 98195 USA.	gstam@uw.edu			US National Institutes of Health (NIH) [PO1 HL53750, R90 HG004152];  [U54 HG007010];  [UO1 ES017156];  [F31 MH 094073]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL053750] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [U54HG007010, R90HG004152] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [U01ES017156] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [F31MH094073] Funding Source: NIH RePORTER	US National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); ; ; ; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	This research was supported by US National Institutes of Health (NIH) grants PO1 HL53750 and R90 HG004152 to G.S., grants U54 HG007010 and UO1 ES017156 to J.A.S., and fellowship F31 MH 094073 to M.T.M.	Aiuti A, 2007, J CLIN INVEST, V117, P2233, DOI 10.1172/JCI31666; Aiuti A, 2009, NEW ENGL J MED, V360, P447, DOI 10.1056/NEJMoa0805817; Arumugam PI, 2007, MOL THER, V15, P1863, DOI 10.1038/sj.mt.6300259; Baum C, 2011, MOL THER, V19, P2103, DOI 10.1038/mt.2011.252; Baum C, 2011, STEM CELLS, V29, P1479, DOI 10.1002/stem.716; Bell AC, 1999, CELL, V98, P387, DOI 10.1016/S0092-8674(00)81967-4; Burgess-Beusse B, 2002, P NATL ACAD SCI USA, V99, P16433, DOI 10.1073/pnas.162342499; Cartier N, 2009, SCIENCE, V326, P818, DOI 10.1126/science.1171242; Cavazzana-Calvo M, 2010, NATURE, V467, P318, DOI 10.1038/nature09328; Chung JH, 1997, P NATL ACAD SCI USA, V94, P575, DOI 10.1073/pnas.94.2.575; CHUNG JH, 1993, CELL, V74, P505, DOI 10.1016/0092-8674(93)80052-G; Deichmann A, 2007, J CLIN INVEST, V117, P2225, DOI 10.1172/JCI31659; Dickson J, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000804; Dixon JR, 2012, NATURE, V485, P376, DOI 10.1038/nature11082; Dunbar CE, 2010, NAT MED, V16, P163, DOI 10.1038/nm0210-163; Emery DW, 2011, HUM GENE THER, V22, P761, DOI 10.1089/hum.2010.233; Emery DW, 2000, P NATL ACAD SCI USA, V97, P9150, DOI 10.1073/pnas.160159597; Evans-Galea MV, 2007, MOL THER, V15, P801, DOI 10.1038/sj.mt.6300103; Galy A, 2011, CURR OPIN ALLERGY CL, V11, P545, DOI 10.1097/ACI.0b013e32834c230c; Gaszner M, 2006, NAT REV GENET, V7, P703, DOI 10.1038/nrg1925; Giles KE, 2010, COLD SH Q B, V75, P79, DOI 10.1101/sqb.2010.75.006; Hacein-Bey-Abina S, 2008, J CLIN INVEST, V118, P3132, DOI 10.1172/JCI35700; Hacein-Bey-Abina S, 2010, NEW ENGL J MED, V363, P355, DOI 10.1056/NEJMoa1000164; Howe SJ, 2008, J CLIN INVEST, V118, P3143, DOI 10.1172/JCI35798; Kim TH, 2007, CELL, V128, P1231, DOI 10.1016/j.cell.2006.12.048; Kohn DB, 2009, NEW ENGL J MED, V360, P518, DOI 10.1056/NEJMe0809614; Li CL, 2009, MOL THER, V17, P716, DOI 10.1038/mt.2009.7; Li GL, 2012, CELL, V148, P84, DOI 10.1016/j.cell.2011.12.014; Nakahashi H, 2013, CELL REP, V3, P1678, DOI 10.1016/j.celrep.2013.04.024; Nienhuis AW, 2006, MOL THER, V13, P1031, DOI 10.1016/j.ymthe.2006.03.001; Ohlsson R, 2001, TRENDS GENET, V17, P520, DOI 10.1016/S0168-9525(01)02366-6; Parelho V, 2008, CELL, V132, P422, DOI 10.1016/j.cell.2008.01.011; Phillips JE, 2009, CELL, V137, P1194, DOI 10.1016/j.cell.2009.06.001; Renda M, 2007, J BIOL CHEM, V282, P33336, DOI 10.1074/jbc.M706213200; Ryu BY, 2008, BLOOD, V111, P1866, DOI 10.1182/blood-2007-04-085506; Ryu BY, 2007, BLOOD CELL MOL DIS, V39, P221, DOI 10.1016/j.bcmd.2007.05.003; Schmidt D, 2012, CELL, V148, P335, DOI 10.1016/j.cell.2011.11.058; Schwarzwaelder K, 2007, J CLIN INVEST, V117, P2241, DOI 10.1172/JCI31661; Seita J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040321; Song LY, 2011, GENOME RES, V21, P1757, DOI 10.1101/gr.121541.111; Stein S, 2010, NAT MED, V16, P198, DOI 10.1038/nm.2088; Uchida N, 2013, HUM GENE THER METHOD, V24, P117, DOI 10.1089/hgtb.2012.152; Wang H, 2012, GENOME RES, V22, P1680, DOI 10.1101/gr.136101.111; Wendt KS, 2008, NATURE, V451, P796, DOI 10.1038/nature06634; Xi HL, 2007, PLOS GENET, V3, P1377, DOI 10.1371/journal.pgen.0030136	45	67	71	1	23	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156	1546-1696		NAT BIOTECHNOL	Nat. Biotechnol.	FEB	2015	33	2					198	203		10.1038/nbt.3062	http://dx.doi.org/10.1038/nbt.3062			6	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	CA8VK	25580597				2022-12-27	WOS:000349198800026
J	Bansal, M; Yang, JC; Karan, C; Menden, MP; Costello, JC; Tang, H; Xiao, GH; Li, YJ; Allen, J; Zhong, R; Chen, BB; Kim, MS; Wang, T; Heiser, LM; Realubit, R; Mattioli, M; Alvarez, MJ; Shen, Y; Gallahan, D; Singer, D; Saez-Rodriguez, J; Xie, Y; Stolovitzky, G; Califano, A; Abbuehl, JP; Altman, RB; Balcome, S; Bell, A; Bender, A; Berger, B; Bernard, J; Bieberich, AA; Borboudakis, G; Chan, C; Chen, TH; Choi, J; Coelho, LP; Creighton, CJ; Dampier, W; Davisson, VJ; Deshpande, R; Diao, LX; Di Camillo, B; Dundar, M; Ertel, A; Goswami, CP; Gottlieb, A; Gould, MN; Goya, J; Grau, M; Gray, JW; Hejase, HA; Hoffmann, MF; Homicsko, K; Homilius, M; Hwang, W; Ijzerman, AP; Kallioniemi, O; Karacali, B; Kaski, S; Kim, J; Krishnan, A; Lee, J; Lee, YS; Lenselink, EB; Lenz, P; Li, L; Li, J; Liang, H; Mpindi, JP; Myers, CL; Newton, MA; Overington, JP; Parkkinen, J; Prill, RJ; Peng, J; Pestell, R; Qiu, P; Rajwa, B; Sadanandam, A; Sambo, F; Sridhar, A; Sun, W; Toffolo, GM; Tozeren, A; Troyanskaya, OG; Tsamardinos, I; van Vlijmen, HWT; Wang, W; Wegner, JK; Wennerberg, K; van Westen, GJP; Xia, T; Yang, Y; Yao, V; Yuan, Y; Zeng, HY; Zhang, SH; Zhao, JF; Zhou, J				Bansal, Mukesh; Yang, Jichen; Karan, Charles; Menden, Michael P.; Costello, James C.; Tang, Hao; Xiao, Guanghua; Li, Yajuan; Allen, Jeffrey; Zhong, Rui; Chen, Beibei; Kim, Minsoo; Wang, Tao; Heiser, Laura M.; Realubit, Ronald; Mattioli, Michela; Alvarez, Mariano J.; Shen, Yao; Gallahan, Daniel; Singer, Dinah; Saez-Rodriguez, Julio; Xie, Yang; Stolovitzky, Gustavo; Califano, Andrea; Abbuehl, Jean-Paul; Altman, Russ B.; Balcome, Shawn; Bell, Ana; Bender, Andreas; Berger, Bonnie; Bernard, Jonathan; Bieberich, Andrew A.; Borboudakis, Giorgos; Chan, Christina; Chen, Ting-Huei; Choi, Jaejoon; Coelho, Luis Pedro; Creighton, Chad J.; Dampier, Will; Davisson, V. Jo; Deshpande, Raamesh; Diao, Lixia; Di Camillo, Barbara; Dundar, Murat; Ertel, Adam; Goswami, Chirayu P.; Gottlieb, Assaf; Gould, Michael N.; Goya, Jonathan; Grau, Michael; Gray, Joe W.; Hejase, Hussein A.; Hoffmann, Michael F.; Homicsko, Krisztian; Homilius, Max; Hwang, Woochang; Ijzerman, Adriaan P.; Kallioniemi, Olli; Karacali, Bilge; Kaski, Samuel; Kim, Junho; Krishnan, Arjun; Lee, Junehawk; Lee, Young-Suk; Lenselink, Eelke B.; Lenz, Peter; Li, Lang; Li, Jun; Liang, Han; Mpindi, John-Patrick; Myers, Chad L.; Newton, Michael A.; Overington, John P.; Parkkinen, Juuso; Prill, Robert J.; Peng, Jian; Pestell, Richard; Qiu, Peng; Rajwa, Bartek; Sadanandam, Anguraj; Sambo, Francesco; Sridhar, Arvind; Sun, Wei; Toffolo, Gianna M.; Tozeren, Aydin; Troyanskaya, Olga G.; Tsamardinos, Ioannis; van Vlijmen, Herman W. T.; Wang, Wen; Wegner, Joerg K.; Wennerberg, Krister; van Westen, Gerard J. P.; Xia, Tian; Yang, Yang; Yao, Victoria; Yuan, Yuan; Zeng, Haoyang; Zhang, Shihua; Zhao, Junfei; Zhou, Jian		Cellworks Group; NCI-DREAM Community	A community computational challenge to predict the activity of pairs of compounds	NATURE BIOTECHNOLOGY			English	Article							DRUG-COMBINATIONS; SYSTEMS BIOLOGY; CANCER; THERAPY; NETWORK; CHEMOTHERAPY; MODELS; INHIBITION; EXPRESSION; RESISTANCE	Recent therapeutic successes have renewed interest in drug combinations, but experimental screening approaches are costly and often identify only small numbers of synergistic combinations. The DREAM consortium launched an open challenge to foster the development of in silico methods to computationally rank 91 compound pairs, from the most synergistic to the most antagonistic, based on gene-expression profiles of human B cells treated with individual compounds at multiple time points and concentrations. Using scoring metrics based on experimental dose-response curves, we assessed 32 methods (31 community-generated approaches and SynGen), four of which performed significantly better than random guessing. We highlight similarities between the methods. Although the accuracy of predictions was not optimal, we find that computational prediction of compound-pair activity is possible, and that community challenges can be useful to advance the field of in silico compound-synergy prediction.	[Bansal, Mukesh; Alvarez, Mariano J.; Shen, Yao; Califano, Andrea] Columbia Univ, Dept Syst Biol, New York, NY USA; [Bansal, Mukesh; Alvarez, Mariano J.; Shen, Yao; Califano, Andrea] Columbia Univ, Ctr Computat Biol & Bioinformat, New York, NY USA; [Yang, Jichen; Tang, Hao; Xiao, Guanghua; Allen, Jeffrey; Zhong, Rui; Chen, Beibei; Kim, Minsoo; Wang, Tao; Xie, Yang] Univ Texas SW Med Ctr Dallas, Quantitat Biomed Res Ctr, Dept Clin Sci, Dallas, TX 75390 USA; [Karan, Charles; Realubit, Ronald] Columbia Univ, Columbia Genome Ctr, High Throughput Screening Facil, New York, NY USA; [Menden, Michael P.; Saez-Rodriguez, Julio] European Bioinformat Inst, European Mol Biol Lab, Cambridge, England; [Costello, James C.] Boston Univ, Dept Biomed Engn, Howard Hughes Med Inst, Boston, MA 02215 USA; [Costello, James C.] Boston Univ, Howard Hughes Med Inst, Ctr Synthet Biol, Boston, MA 02215 USA; [Li, Yajuan] Univ Texas SW Med Ctr Dallas, Dept Immunol, Dallas, TX 75390 USA; [Kim, Minsoo; Xie, Yang] Univ Texas SW Med Ctr Dallas, Simmons Comprehens Canc Ctr, Dallas, TX USA; [Heiser, Laura M.] Oregon Hlth & Sci Univ, Dept Biomed Engn, Portland, OR 97201 USA; [Mattioli, Michela] Fdn Ist Italiano Tecnol IIT, Ctr Genom Sci IIT SEMM, Milan, Italy; [Gallahan, Daniel; Singer, Dinah] NCI, Div Canc Biol, Bethesda, MD 20892 USA; [Stolovitzky, Gustavo] IBM Corp, Thomas J Watson Res Ctr, IBM Computat Biol Ctr, Yorktown Hts, NY 10598 USA; [Califano, Andrea] Columbia Univ, Dept Biomed Informat, New York, NY USA; [Califano, Andrea] Columbia Univ, Dept Biochem & Mol Biophys, New York, NY USA; [Califano, Andrea] Columbia Univ, Inst Canc Genet, New York, NY USA; [Califano, Andrea] Columbia Univ, Herbert Irving Comprehens Canc Ctr, New York, NY USA; [Abbuehl, Jean-Paul; Bernard, Jonathan] Swiss Fed Inst Technol Lausanne EPFL, Swiss Inst Expt Canc Res ISREC, Lausanne, Switzerland; [Altman, Russ B.; Gottlieb, Assaf] Stanford Univ, Dept Genet, Stanford, CA 94305 USA; [Balcome, Shawn; Deshpande, Raamesh; Myers, Chad L.; Wang, Wen; Xia, Tian] Univ Minnesota, Minneapolis, MN USA; [Bell, Ana; Homilius, Max; Lee, Young-Suk; Troyanskaya, Olga G.; Yao, Victoria] Princeton Univ, Dept Comp Sci, Princeton, NJ 08544 USA; [Bell, Ana; Goya, Jonathan; Homilius, Max; Krishnan, Arjun; Lee, Young-Suk; Troyanskaya, Olga G.; Yao, Victoria; Zhou, Jian] Princeton Univ, Lewis Sigler Inst Integrat Genom, Princeton, NJ 08544 USA; [Bender, Andreas] Univ Cambridge, Unilever Ctr, Cambridge, England; [Berger, Bonnie; Peng, Jian; Zeng, Haoyang] MIT, Comp Sci & Artificial Intelligence Lab, 77 Massachusetts Ave, Cambridge, MA 02139 USA; [Bieberich, Andrew A.; Davisson, V. Jo] Purdue Univ, Dept Med Chem & Mol Pharmacol, W Lafayette, IN 47907 USA; [Borboudakis, Giorgos; Tsamardinos, Ioannis] Univ Crete, Dept Comp Sci, Iraklion, NE, Greece; [Borboudakis, Giorgos; Tsamardinos, Ioannis] FORTH, Inst Comp Sci, Iraklion, NE, Greece; [Chan, Christina; Hejase, Hussein A.] Michigan State Univ, Dept Comp Sci & Engn, E Lansing, MI 48824 USA; [Chan, Christina] Michigan State Univ, Dept Chem Engn & Mat Sci, E Lansing, MI 48824 USA; [Chan, Christina] Michigan State Univ, Dept Biochem & Mol Biol, E Lansing, MI 48824 USA; [Chen, Ting-Huei; Sun, Wei] Univ N Carolina, Dept Biostat, Chapel Hill, NC 27515 USA; [Choi, Jaejoon; Hwang, Woochang; Kim, Junho; Lee, Junehawk] Korea Adv Inst Sci & Technol, Daejeon, South Korea; [Coelho, Luis Pedro] Univ Lisbon, Inst Med Mol, Fac Med, Lisbon, Portugal; [Creighton, Chad J.] Baylor Coll Med, Dept Med, Dan L Duncan Ctr Div Biostat, Houston, TX 77030 USA; [Dampier, Will; Tozeren, Aydin] Drexel Univ, Ctr Integrated Bioinformat, Philadelphia, PA 19104 USA; [Diao, Lixia; Li, Jun; Liang, Han; Qiu, Peng; Yang, Yang; Yuan, Yuan] Univ Texas MD Anderson Canc Ctr, Dept Bioinformat & Computat Biol, Houston, TX 77030 USA; [Di Camillo, Barbara; Sambo, Francesco; Toffolo, Gianna M.] Univ Padua, Dept Informat Engn, Padua, Italy; [Dundar, Murat] IUPUI, Dept Comp & Informat Sci, Indianapolis, IN USA; [Ertel, Adam; Pestell, Richard] Jefferson Kimmel Canc Ctr, Philadelphia, PA USA; [Cellworks Group] Cellworks Grp Inc, San Jose, CA USA; [Goswami, Chirayu P.; Li, Lang] IU Sch Med, Ctr Computat Biol & Bioinformat, Indianapolis, IN USA; [Gould, Michael N.; Hoffmann, Michael F.] Univ Wisconsin, Dept Oncol & Carbone Canc Ctr, Madison, WI USA; [Grau, Michael; Lenz, Peter] Univ Marburg, Dept Phys, Marburg, Germany; [Ijzerman, Adriaan P.; Lenselink, Eelke B.] Leiden Univ, Leiden Acad Ctr Drug Res, Leiden, Netherlands; [Kallioniemi, Olli; Mpindi, John-Patrick; Wennerberg, Krister] Univ Helsinki, Inst Mol Med Finland FIMM, Helsinki, Finland; [Karacali, Bilge] Izmir Inst Technol, Izmir, Turkey; [Kaski, Samuel; Parkkinen, Juuso] Aalto Univ, Helsinki Inst Informat Technol, Dept Informat & Comp Sci, Espoo, Finland; [Kaski, Samuel] Univ Helsinki, Inst Informat Technol HIIT, Dept Comp Sci, Helsinki, Finland; [Lee, Junehawk] Korea Inst Sci & Technol Informat, Daejeon, South Korea; [Li, Jun] Chinese Acad Sci, Shanghai Inst Biol Sci, CAS MPG Partner Inst Computat Biol, Key Lab Computat Biol, Shanghai, Peoples R China; [Liang, Han; Yuan, Yuan] Baylor Coll Med, Grad Program Struct & Computat Biol & Mol Biophys, Houston, TX 77030 USA; [Newton, Michael A.] Univ Wisconsin, Dept Stat, Madison, WI USA; [Newton, Michael A.] Univ Wisconsin, Dept Biostat & Med Informat, Madison, WI USA; [Overington, John P.; van Westen, Gerard J. P.] Wellcome Trust Genome Campus, European Bioinformat Inst EMBL EBI, Cambridge, England; [Prill, Robert J.] IBM Almaden Res Ctr, San Jose, CA USA; [Rajwa, Bartek] Purdue Univ, Bindley Biosci Ctr, W Lafayette, IN 47907 USA; [Sridhar, Arvind] Swiss Fed Inst Technol Lausanne EPFL, Inst Elect Engn, Embedded Syst Lab ESL, Lausanne, Switzerland; [Sun, Wei] Univ N Carolina, Dept Genet, Chapel Hill, NC USA; [van Vlijmen, Herman W. T.; Wegner, Joerg K.] Janssen Pharmaceut, Beerse, Belgium; [Yang, Yang] Univ Texas Hlth Sci Ctr, Sch Publ Hlth, Div Biostat, Houston, TX USA; [Zhang, Shihua; Zhao, Junfei] Chinese Acad Sci, Acad Math & Syst Sci, Natl Ctr Math & Interdisciplinary Sci, Beijing, Peoples R China; [Qiu, Peng] Univ Colorado, Sch Med, Dept Pharmacol, Anschutz Med Campus, Aurora, CO USA; [Qiu, Peng] Georgia Inst Technol, Dept Biomed Engn, Atlanta, GA USA; [Qiu, Peng] Emory Univ, Atlanta, GA 30322 USA	Columbia University; Columbia University; University of Texas System; University of Texas Southwestern Medical Center Dallas; Columbia University; European Molecular Biology Laboratory (EMBL); Boston University; Howard Hughes Medical Institute; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas; Oregon Health & Science University; Istituto Italiano di Tecnologia - IIT; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); International Business Machines (IBM); Columbia University; Columbia University; Columbia University; Columbia University; Swiss Federal Institutes of Technology Domain; Ecole Polytechnique Federale de Lausanne; Swiss Institute Experimental Cancer Research; Stanford University; University of Minnesota System; University of Minnesota Twin Cities; Princeton University; Princeton University; University of Cambridge; Massachusetts Institute of Technology (MIT); Purdue University System; Purdue University; Purdue University West Lafayette Campus; University of Crete; Foundation for Research & Technology - Hellas (FORTH); Michigan State University; Michigan State University; Michigan State University; University of North Carolina; University of North Carolina Chapel Hill; Korea Advanced Institute of Science & Technology (KAIST); Universidade de Lisboa; Baylor College of Medicine; Drexel University; University of Texas System; UTMD Anderson Cancer Center; University of Padua; Indiana University System; Indiana University-Purdue University Indianapolis; Jefferson University; Indiana University System; Indiana University Bloomington; University of Wisconsin System; University of Wisconsin Madison; Philipps University Marburg; Leiden University; Leiden University - Excl LUMC; University of Helsinki; Izmir Institute of Technology; Aalto University; University of Helsinki; University of Helsinki; Korea Institute of Science & Technology Information (KISTI); Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; Max Planck Society; Baylor College of Medicine; University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; European Molecular Biology Laboratory (EMBL); Wellcome Trust Sanger Institute; International Business Machines (IBM); Purdue University System; Purdue University; Purdue University West Lafayette Campus; Swiss Federal Institutes of Technology Domain; Ecole Polytechnique Federale de Lausanne; University of North Carolina; University of North Carolina Chapel Hill; Johnson & Johnson; Janssen Pharmaceuticals; University of Texas System; University of Texas Health Science Center Houston; University of Texas School Public Health; Chinese Academy of Sciences; Academy of Mathematics & System Sciences, CAS; University of Colorado System; University of Colorado Anschutz Medical Campus; University System of Georgia; Georgia Institute of Technology; Emory University	Stolovitzky, G (corresponding author), IBM Corp, Thomas J Watson Res Ctr, IBM Computat Biol Ctr, Yorktown Hts, NY 10598 USA.	Yang.Xie@UTSouthwestern.edu; gustavo@us.ibm.com; califano@c2b2.columbia.edu	IJzerman, Ad/ABG-1353-2020; Rajwa, Bartek/B-3169-2009; Wennerberg, Krister/AFM-0539-2022; Dundar, M. Murat/C-3846-2011; Gray, Joe/AAX-9549-2020; Dundar, Murat/U-1837-2019; Bender, Andreas/C-6942-2009; Zhao, Junfei/J-1425-2018; Overington, John P/G-8607-2015; Saez-Rodriguez, Julio/H-7114-2019; Wang, Wen/E-6320-2012; Wang, Tao/K-3518-2016; Hwang, Woochang/AAU-8398-2020; Mattioli, Michela/K-3951-2013; Yao, Vicky/AAC-6183-2020; Homilius, Max/AAW-1251-2021; Di Camillo, Barbara/L-3202-2013; yang, jichen/HDL-9203-2022; He, Liye/C-8843-2015; Kallioniemi, Olli P/H-5111-2011; Coelho, Luis Pedro/D-1260-2009; van Westen, Gerard/HHZ-3762-2022; Yuan, Yuan/H-4007-2013; van Westen, Gerard JP/D-7432-2011; Kaski, Samuel/B-6684-2008; Wennerberg, Krister/AAH-2919-2022; Li, Jun/AAE-4393-2022	IJzerman, Ad/0000-0002-1182-2259; Rajwa, Bartek/0000-0001-7540-8236; Wennerberg, Krister/0000-0002-1352-4220; Bender, Andreas/0000-0002-6683-7546; Overington, John P/0000-0002-5859-1064; Saez-Rodriguez, Julio/0000-0002-8552-8976; Wang, Wen/0000-0002-5812-6744; Hwang, Woochang/0000-0003-0876-7305; Mattioli, Michela/0000-0002-1692-9178; Yao, Vicky/0000-0002-3201-9983; Homilius, Max/0000-0001-7240-0028; Di Camillo, Barbara/0000-0001-8415-4688; He, Liye/0000-0002-6632-2112; Kallioniemi, Olli P/0000-0002-3231-0332; Coelho, Luis Pedro/0000-0002-9280-7885; Yuan, Yuan/0000-0003-4706-7897; van Westen, Gerard JP/0000-0003-0717-1817; Kaski, Samuel/0000-0003-1925-9154; Wennerberg, Krister/0000-0002-1352-4220; Li, Jun/0000-0002-1171-7141; Dundar, Murat/0000-0001-5752-468X; Bansal, Mukesh/0000-0003-1481-6767; Borboudakis, Giorgos/0000-0001-7355-8871; Peng, Jian/0000-0002-1736-2978; Lee, Junehawk/0000-0001-8908-0884; Califano, Andrea/0000-0003-4742-3679; Lenz, Peter/0000-0001-7705-3950; Homicsko, Krisztian/0000-0003-0912-6198; Zeng, Haoyang/0000-0003-1057-2865; Sadanandam, Anguraj/0000-0001-8485-5150; Grau, Michael/0000-0003-1909-0133; Abbuehl, Jean-Paul/0000-0003-3135-6969; Wegner, Jorg Kurt/0000-0002-1852-9434; Altman, Russ/0000-0003-3859-2905; Troyanskaya, Olga/0000-0002-5676-5737; Costello, James/0000-0003-3158-9682	Multiscale Analysis of Genomic and Cellular Networks (MAGNet) [5U54CA121852-08]; Library of Integrated Network-based Cellular Signatures Program (LINCS) [1U01CA164184-02, 3U01HL111566-02]; National Institutes of Health (NIH) [5R01CA152301]; Cancer Prevention and Research Institute of Texas (CPRIT) [RP101251]; NIH, NCI [U54 CA112970]; NATIONAL CANCER INSTITUTE [P30CA016672, P50CA058207, U01CA168426, P50CA098258, R01CA152301, U01CA164184, U54CA121852, U54CA112970] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [U01HL111566] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [T32HG003284] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM071966, R01GM081871] Funding Source: NIH RePORTER; Direct For Computer & Info Scie & Enginr [1252648] Funding Source: National Science Foundation	Multiscale Analysis of Genomic and Cellular Networks (MAGNet); Library of Integrated Network-based Cellular Signatures Program (LINCS); National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Cancer Prevention and Research Institute of Texas (CPRIT); NIH, NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Direct For Computer & Info Scie & Enginr(National Science Foundation (NSF)NSF - Directorate for Computer & Information Science & Engineering (CISE))	The data for this challenge were kindly provided prepublication by A. Califano's laboratory. The general idea of the challenge was conceived in a workshop co-organized by National Cancer Institute (NCI) and Dialogue for Reverse Engineering Assessments and Methods (DREAM) on April 23, 2012. We acknowledge the contributions of all the participants in that summit, whose list of attendees can be accessed by the following link http://tinyurl.com/n3zp443. We would like to thank L. Pasqualucci and A. Holmes for processing the genetic profile of the OCI-LY3 cell line; W.K. Lim for normalizing GEPs; S. Dhindaw for proofreading the manuscript; F.M. Giorgi for helping with the figures of the manuscript; H. Li for tissue culture; P. Guarnieri, A. Ambesi, S. Anand, P. Subramaniam and S. Irshad for their valuable comments and feedback during the preparation of this manuscript. GeneTitan hybridizations were run at Rutgers University facility (Bionomics Research and Technology Center -BRTC). This work is supported in part by the Multiscale Analysis of Genomic and Cellular Networks (MAGNet) grant (5U54CA121852-08) and Library of Integrated Network-based Cellular Signatures Program (LINCS) grants (1U01CA164184-02 and 3U01HL111566-02) to A.C.; National Institutes of Health (NIH) grant (5R01CA152301) and Cancer Prevention and Research Institute of Texas (CPRIT) grant (RP101251) to Y.X. and NIH, NCI grant (U54 CA112970) to J.W.G.	Al-Lazikani B, 2012, NAT BIOTECHNOL, V30, P679, DOI 10.1038/nbt.2284; Alexe G, 2005, 2005 IEEE Computational Systems Bioinformatics Conference, Proceedings, P322, DOI 10.1109/CSB.2005.7; Araujo RP, 2005, BIOSYSTEMS, V80, P57, DOI 10.1016/j.biosystems.2004.10.002; Aytes A, 2014, CANCER CELL, V25, P638, DOI 10.1016/j.ccr.2014.03.017; Bokemeyer C, 2009, J CLIN ONCOL, V27, P663, DOI 10.1200/JCO.2008.20.8397; Borisy AA, 2003, P NATL ACAD SCI USA, V100, P7977, DOI 10.1073/pnas.1337088100; Carro MS, 2010, NATURE, V463, P318, DOI 10.1038/nature08712; Chen J. C., CELL IN PRESS; Chudnovsky Y, 2014, CELL REP, V6, P313, DOI 10.1016/j.celrep.2013.12.032; Cokol M, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.71; Di Camillo B, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032391; FERNANDES DJ, 1980, P NATL ACAD SCI-BIOL, V77, P5663, DOI 10.1073/pnas.77.10.5663; Fitzgerald JB, 2006, NAT CHEM BIOL, V2, P458, DOI 10.1038/nchembio817; Gottlieb A, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.26; Green MR, 2010, BLOOD, V116, P3268, DOI 10.1182/blood-2010-05-282780; Guyon I, 2002, MACH LEARN, V46, P389, DOI 10.1023/A:1012487302797; HANLEY JA, 1982, RADIOLOGY, V143, P29, DOI 10.1148/radiology.143.1.7063747; Harrell FE, 1996, STAT MED, V15, P361, DOI 10.1002/(SICI)1097-0258(19960229)15:4<361::AID-SIM168>3.0.CO;2-4; Helguera AM, 2013, EUR J MED CHEM, V59, P75, DOI 10.1016/j.ejmech.2012.10.035; Hoshida Y, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015543; Ibrahim YH, 2012, CANCER DISCOV, V2, P1036, DOI 10.1158/2159-8290.CD-11-0348; Jia J, 2009, NAT REV DRUG DISCOV, V8, P111, DOI 10.1038/nrd2683; Jin GX, 2011, BIOINFORMATICS, V27, pI310, DOI 10.1093/bioinformatics/btr202; Keith CT, 2005, NAT REV DRUG DISCOV, V4, P71, DOI 10.1038/nrd1609; Lefebvre C, 2010, MOL SYST BIOL, V6, DOI 10.1038/msb.2010.31; Lehar J, 2009, NAT BIOTECHNOL, V27, P659, DOI 10.1038/nbt.1549; Marbach D, 2012, NAT METHODS, V9, P796, DOI [10.1038/nmeth.2016, 10.1038/NMETH.2016]; Margolin AA, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3006112; Nelson HS, 2001, J ALLERGY CLIN IMMUN, V107, P397, DOI 10.1067/mai.2001.112939; Norel R, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.70; Olshen AB, 2004, BIOSTATISTICS, V5, P557, DOI 10.1093/biostatistics/kxh008; Pedregosa F, 2011, J MACH LEARN RES, V12, P2825; Piovan E, 2013, CANCER CELL, V24, P766, DOI 10.1016/j.ccr.2013.10.022; Prill RJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009202; Puri Neelu, 2008, J Carcinog, V7, P9; Rajendran P, 2011, CLIN CANCER RES, V17, P1425, DOI 10.1158/1078-0432.CCR-10-1123; Rawlinson R, 2014, BMC CANCER, V14, DOI 10.1186/1471-2407-14-483; Recht A, 1996, NEW ENGL J MED, V334, P1356, DOI 10.1056/NEJM199605233342102; Schlessinger A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004433; Shah MA, 2001, CLIN CANCER RES, V7, P2168; STEIN GE, 1984, CLIN PHARMACY, V3, P591; van Westen GJP, 2013, NAT METHODS, V10, P116, DOI 10.1038/nmeth.2339; Vermorken JB, 2008, NEW ENGL J MED, V359, P1116, DOI 10.1056/NEJMoa0802656; Vilar S, 2012, J AM MED INFORM ASSN, V19, P1066, DOI 10.1136/amiajnl-2012-000935; Weinstein IB, 2002, SCIENCE, V297, P63, DOI 10.1126/science.1073096; Yonesaka K, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3002442; Zhang J, 2013, P NATL ACAD SCI USA, V110, P1398, DOI 10.1073/pnas.1205299110; Zhao S, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3006548; Zhao XM, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1002323	49	175	177	3	37	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1087-0156	1546-1696		NAT BIOTECHNOL	Nat. Biotechnol.	DEC	2014	32	12					1213	+		10.1038/nbt.3052	http://dx.doi.org/10.1038/nbt.3052			12	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	AW3AD	25419740	Bronze, Green Accepted, Green Published			2022-12-27	WOS:000346156800023
J	Li, WD; Cavelti-Weder, C; Zhang, YY; Clement, K; Donovan, S; Gonzalez, G; Zhu, J; Stemann, M; Xu, K; Hashimoto, T; Yamada, T; Nakanishi, M; Zhang, YM; Zeng, S; Gifford, D; Meissner, A; Weir, G; Zhou, Q				Li, Weida; Cavelti-Weder, Claudia; Zhang, Yinying; Clement, Kendell; Donovan, Scott; Gonzalez, Gabriel; Zhu, Jiang; Stemann, Marianne; Xu, Ke; Hashimoto, Tatsu; Yamada, Takatsugu; Nakanishi, Mio; Zhang, Yuemei; Zeng, Samuel; Gifford, David; Meissner, Alexander; Weir, Gordon; Zhou, Qiao			Long-term persistence and development of induced pancreatic beta cells generated by lineage conversion of acinar cells	NATURE BIOTECHNOLOGY			English	Article							IN-VIVO; DEFINED FACTORS; FUNCTIONAL-NEURONS; INSULIN-SECRETION; EXOCRINE CELLS; ISLETS; FIBROBLASTS; GROWTH; CARDIOMYOCYTES; MICE	Direct lineage conversion is a promising approach to generate therapeutically important cell types for disease modeling and tissue repair. However, the survival and function of lineage-reprogrammed cells in vivo over the long term has not been examined. Here, using an improved method for in vivo conversion of adult mouse pancreatic acinar cells toward beta cells, we show that induced beta cells persist for up to 13 months (the length of the experiment), form pancreatic islet-like structures and support normoglycemia in diabetic mice. Detailed molecular analyses of induced beta cells over 7 months reveal that global DNA methylation changes occur within 10 d, whereas the transcriptional network evolves over 2 months to resemble that of endogenous beta cells and remains stable thereafter. Progressive gain of beta-cell function occurs over 7 months, as measured by glucose-regulated insulin release and suppression of hyperglycemia. These studies demonstrate that lineage-reprogrammed cells persist for > 1 year and undergo epigenetic, transcriptional, anatomical and functional development toward a beta-cell phenotype.	[Li, Weida; Zhang, Yinying; Clement, Kendell; Donovan, Scott; Gonzalez, Gabriel; Xu, Ke; Nakanishi, Mio; Zhang, Yuemei; Zeng, Samuel; Meissner, Alexander; Zhou, Qiao] Harvard Univ, Dept Stem Cell & Regenerat Biol, Cambridge, MA 02138 USA; [Cavelti-Weder, Claudia; Stemann, Marianne; Yamada, Takatsugu; Weir, Gordon] Joslin Diabet Ctr, Sect Islet Cell & Regenerat Biol, Boston, MA 02215 USA; [Zhang, Yinying; Clement, Kendell; Donovan, Scott; Zhu, Jiang; Meissner, Alexander] Broad Inst MIT & Harvard, Cambridge, MA USA; [Clement, Kendell] MIT, Div Hlth Sci & Technol, Cambridge, MA 02139 USA; [Gonzalez, Gabriel] Harvard Univ, Sch Med, West Roxbury, MA USA; [Zhu, Jiang] Massachusetts Gen Hosp, Ctr Syst Biol, Boston, MA 02114 USA; [Zhu, Jiang] Massachusetts Gen Hosp, Ctr Canc Res, Boston, MA 02114 USA; [Hashimoto, Tatsu; Gifford, David] MIT, Dept Elect Engn & Comp Sci, Cambridge, MA 02139 USA	Harvard University; Harvard University; Joslin Diabetes Center, Inc.; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Massachusetts Institute of Technology (MIT); Harvard University; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Massachusetts Institute of Technology (MIT)	Zhou, Q (corresponding author), Harvard Univ, Dept Stem Cell & Regenerat Biol, Cambridge, MA 02138 USA.	qiao_zhou@harvard.edu	Clement, Kendell/AAZ-6854-2021; Young, Richard A/F-6495-2012	Young, Richard A/0000-0001-8855-8647; Zhou, Qiao/0000-0002-0099-3909; Cavelti-Weder, Claudia/0000-0002-0650-6091; Zhang, Yuemei/0000-0003-3555-4524; Li, Weida/0000-0001-6578-6321; Gonzalez, Gabriel/0000-0003-1842-3119	US National Institutes of Health; Juvenile Diabetes Research Foundation; Swiss Science Foundation; Swiss Foundation for Grants in Biology and Medicine	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Juvenile Diabetes Research Foundation(Juvenile Diabetes Research Foundation); Swiss Science Foundation(Swiss National Science Foundation (SNSF)); Swiss Foundation for Grants in Biology and Medicine	We thank M. Shear, J. Brown, J. Hollister-Lock, and R. Zhao for technical assistance; H.-H. Chen for assistance with gene profiling; D. Yu and T. Fabbro for statistical analysis; Boston Children's Hospital core facility for an Illumina array; Joslin Specialized Assay Core for insulin measurement; members of the Zhou laboratory for advice and feedback; and D. Melton and D. Breault for discussion and reading of the manuscript. Q.Z. was supported by awards from the US National Institutes of Health. W.L. is supported by a postdoctoral fellowship from the Juvenile Diabetes Research Foundation. C.C.-W. is supported by postdoctoral fellowships from the Swiss Science Foundation and the Swiss Foundation for Grants in Biology and Medicine.	Akinci E, 2012, BIOCHEM J, V442, P539, DOI 10.1042/BJ20111678; Al-Hasani K, 2013, DEV CELL, V26, P86, DOI 10.1016/j.devcel.2013.05.018; Baeyens L, 2014, NAT BIOTECHNOL, V32, P76, DOI 10.1038/nbt.2747; Banga A, 2012, P NATL ACAD SCI USA, V109, P15336, DOI 10.1073/pnas.1201701109; Blum B, 2012, NAT BIOTECHNOL, V30, P261, DOI 10.1038/nbt.2141; Bonner-Weir S, 2000, TRENDS ENDOCRIN MET, V11, P375, DOI 10.1016/S1043-2760(00)00305-2; Brennand K, 2007, PLOS BIOL, V5, P1520, DOI 10.1371/journal.pbio.0050163; Cavelti-Weder C, 2014, METHODS MOL BIOL, V1150, P247, DOI 10.1007/978-1-4939-0512-6_17; Chen JX, 2012, CIRC RES, V111, P50, DOI 10.1161/CIRCRESAHA.112.270264; Chen YJ, 2014, CELL REP, V6, P1046, DOI 10.1016/j.celrep.2014.02.013; Dahl U, 1996, DEVELOPMENT, V122, P2895; Ginsberg M, 2012, CELL, V151, P559, DOI 10.1016/j.cell.2012.09.032; GOTOH M, 1987, TRANSPLANTATION, V43, P725, DOI 10.1097/00007890-198705000-00024; Graf T, 2009, NATURE, V462, P587, DOI 10.1038/nature08533; Gu HC, 2011, NAT PROTOC, V6, P468, DOI 10.1038/nprot.2010.190; Guo ZY, 2014, CELL STEM CELL, V14, P188, DOI 10.1016/j.stem.2013.12.001; HOPCROFT DW, 1985, ENDOCRINOLOGY, V117, P2073, DOI 10.1210/endo-117-5-2073; Ieda M, 2010, CELL, V142, P375, DOI 10.1016/j.cell.2010.07.002; JUANG JH, 1994, DIABETES, V43, P1334, DOI 10.2337/diabetes.43.11.1334; Konstantinova I, 2007, CELL, V129, P359, DOI 10.1016/j.cell.2007.02.044; Lee J, 2013, ELIFE, V2, DOI 10.7554/eLife.00940; Li WD, 2014, ELIFE, V3, DOI 10.7554/eLife.01846; MEDA P, 1990, J CLIN INVEST, V86, P759, DOI 10.1172/JCI114772; Meissner A, 2008, NATURE, V454, P766, DOI 10.1038/nature07107; MONTANA E, 1993, J CLIN INVEST, V91, P780, DOI 10.1172/JCI116297; MONTANA E, 1994, J CLIN INVEST, V93, P1577, DOI 10.1172/JCI117137; Ravier MA, 2005, DIABETES, V54, P1798, DOI 10.2337/diabetes.54.6.1798; Shaner NC, 2005, NAT METHODS, V2, P905, DOI 10.1038/NMETH819; Smyth G.K., 2004, STAT APPL GENET MOL, V3, P3, DOI [DOI 10.2202/1544-6115.1027, 10.2202/1544-6115.1027]; Teta M, 2005, DIABETES, V54, P2557, DOI 10.2337/diabetes.54.9.2557; Thorel F, 2010, NATURE, V464, P1149, DOI 10.1038/nature08894; Vierbuchen T, 2012, MOL CELL, V47, P827, DOI 10.1016/j.molcel.2012.09.008; Vierbuchen T, 2010, NATURE, V463, P1035, DOI 10.1038/nature08797; Zhou Q, 2008, NATURE, V455, P627, DOI 10.1038/nature07314	34	67	70	1	38	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156	1546-1696		NAT BIOTECHNOL	Nat. Biotechnol.	DEC	2014	32	12					1223	U79		10.1038/nbt.3082	http://dx.doi.org/10.1038/nbt.3082			10	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	AW3AD	25402613				2022-12-27	WOS:000346156800024
J	Van Keuren-Jensen, K; Keats, JJ; Craig, DW				Van Keuren-Jensen, Kendall; Keats, Jonathan J.; Craig, David W.			Bringing RNA-seq closer to the clinic	NATURE BIOTECHNOLOGY			English	Editorial Material							QUALITY	Several multicenter benchmark data sets represent valuable steps toward using RNA-seq as a diagnostic tool with clinical utility.	[Van Keuren-Jensen, Kendall; Craig, David W.] Translat Genom Res Inst, Neurogen Div, Phoenix, AZ 85004 USA; [Keats, Jonathan J.] Translat Genom Res Inst, Integrated Canc Genom Div, Phoenix, AZ USA	Translational Genomics Research Institute; Translational Genomics Research Institute	Van Keuren-Jensen, K (corresponding author), Translat Genom Res Inst, Neurogen Div, Phoenix, AZ 85004 USA.	dcraig@tgen.org	Craig, David Wesley/K-6961-2019	Craig, David Wesley/0000-0003-2040-1955; Keats, Jonathan/0000-0003-4375-7399				Gargis AS, 2012, NAT BIOTECHNOL, V30, P1033, DOI 10.1038/nbt.2403; Li S, 2014, NAT BIOTECHNOL, V32, P888, DOI 10.1038/nbt.3000; Li S, 2014, NAT BIOTECHNOL, V32, P915, DOI 10.1038/nbt.2972; Risso D, 2014, NAT BIOTECHNOL, V32, P896, DOI 10.1038/nbt.2931; Shi LM, 2010, NAT BIOTECHNOL, V28, P827, DOI 10.1038/nbt.1665; Su ZQ, 2014, NAT BIOTECHNOL, V32, P903, DOI 10.1038/nbt.2957; Wang C, 2014, NAT BIOTECHNOL, V32, P926, DOI 10.1038/nbt.3001	7	15	15	0	10	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156	1546-1696		NAT BIOTECHNOL	Nat. Biotechnol.	SEP	2014	32	9					884	+		10.1038/nbt.3017	http://dx.doi.org/10.1038/nbt.3017			2	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	AQ2FD	25203037				2022-12-27	WOS:000342600300025
J	Lawrence, S; Lahteenmaki, R				Lawrence, Stacy; Lahteenmaki, Riku			Public biotech 2013-the numbers	NATURE BIOTECHNOLOGY			English	Article																			0	13	13	0	5	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156	1546-1696		NAT BIOTECHNOL	Nat. Biotechnol.	JUL	2014	32	7					626	632		10.1038/nbt.2949	http://dx.doi.org/10.1038/nbt.2949			7	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	AK8VE	25004227				2022-12-27	WOS:000338705900024
J	Callier, V; Vanderford, NL				Callier, Viviane; Vanderford, Nathan L.			Mission possible: putting trainees at the center of academia's mission	NATURE BIOTECHNOLOGY			English	Editorial Material								Academia's pursuit of tokens of prestige has eclipsed trainees' well-being and career development. It is time for that to change.	[Callier, Viviane] Ronin Inst, Montclair, NJ 07043 USA; [Vanderford, Nathan L.] Univ Kentucky, Markey Canc Ctr, Lexington, KY USA; [Vanderford, Nathan L.] Integrat Acad Solut, Lexington, KY USA	University of Kentucky	Callier, V (corresponding author), Ronin Inst, Montclair, NJ 07043 USA.	nathan.vanderford@uky.edu						[Anonymous], 2010, ECONOMIST; Cavanaugh J.P., 1999, J HOPKINS MAGAZINE; Flaherty C., INSIDE HIGHER ED; Fogg P., 2009, CHRONICLE HIGHER ED; Gewin Virginia, 2012, Nature, V490, P299; Martin B, 2014, TIMES HIGHER ED; Mitchell J. S., 2013, 2013 CANADIAN POSTDO; Monroe R, 2013, BALTIMORE FISHB 1213; National Postdoctoral Association, 2013, STRAT PLAN 2013 2017; National Postdoctoral Association, 2012, NPA REC POSTD POL PR; Russo Gene, 2011, Nature, V475, P533; Sauermann H, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036307; Schillebeeckx M, 2013, NAT BIOTECHNOL, V31, P938, DOI 10.1038/nbt.2706; Schuman R, SLATE; Thornton C, 2013, JACOBIN         1216; Turley N, 2013, INSIDE HIGHER ED; US National Institutes of Health, 2012, BIOM RES WORKF WORK	17	3	3	0	9	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156	1546-1696		NAT BIOTECHNOL	Nat. Biotechnol.	JUN	2014	32	6					593	594		10.1038/nbt.2928	http://dx.doi.org/10.1038/nbt.2928			2	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	AI9EV	24911506	Bronze			2022-12-27	WOS:000337233800028
J	Westmoreland, C; Carmichael, PL				Westmoreland, Carl; Carmichael, Paul L.			Chemical safety without animals	NATURE BIOTECHNOLOGY			English	Editorial Material									[Westmoreland, Carl; Carmichael, Paul L.] Unilever Safety & Environm Assurance Ctr, Bedford, England	Unilever	Westmoreland, C (corresponding author), Unilever Safety & Environm Assurance Ctr, Bedford, England.	carl.westmoreland@unilever.com; paul.carmichael@unilever.com		Carmichael, Paul/0000-0003-1353-9032				Adeleye Y, 2015, TOXICOLOGY, V332, P102, DOI 10.1016/j.tox.2014.02.007; Adler S, 2011, ARCH TOXICOL, V85, P367, DOI 10.1007/s00204-011-0693-2; European Commission, 2003, OFF J EUR UNION, VL066, P26; Hall B, 2007, FOOD CHEM TOXICOL, V45, P2097, DOI 10.1016/j.fct.2007.06.017; Kavlock R, 2012, CHEM RES TOXICOL, V25, P1287, DOI 10.1021/tx3000939; Kleinstreuer NC, 2014, NAT BIOTECHNOL, V32, P583, DOI 10.1038/nbt.2914; Krewski D, 2010, J TOXICOL ENV HEAL B, V13, P51, DOI 10.1080/10937404.2010.483176; Organization for economic cooperation and development, 2011, REP WORKSH US MECH I, V138	8	4	4	0	5	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	0733-222X	1546-1696		NAT BIOTECHNOL	Nat. Biotechnol.	JUN	2014	32	6					541	543		10.1038/nbt.2922	http://dx.doi.org/10.1038/nbt.2922			4	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	AI9EV	24911497				2022-12-27	WOS:000337233800014
J	Kang, HW; Lee, SJ; Ko, IK; Kengla, C; Yoo, JJ; Atala, A				Kang, Hyun-Wook; Lee, Sang Jin; Ko, In Kap; Kengla, Carlos; Yoo, James J.; Atala, Anthony			A 3D bioprinting system to produce human-scale tissue constructs with structural integrity	NATURE BIOTECHNOLOGY			English	Article							IN-VITRO BIOCOMPATIBILITY; CELL-LADEN; HYDROGELS; ENCAPSULATION; SCAFFOLDS; CULTURE	A challenge for tissue engineering is producing three-dimensional (3D), vascularized cellular constructs of clinically relevant size, shape and structural integrity. We present an integrated tissue-organ printer (ITOP) that can fabricate stable, human-scale tissue constructs of any shape. Mechanical stability is achieved by printing cell-laden hydrogels together with biodegradable polymers in integrated patterns and anchored on sacrificial hydrogels. The correct shape of the tissue construct is achieved by representing clinical imaging data as a computer model of the anatomical defect and translating the model into a program that controls the motions of the printer nozzles, which dispense cells to discrete locations. The incorporation of microchannels into the tissue constructs facilitates diffusion of nutrients to printed cells, thereby overcoming the diffusion limit of 100-200 mm for cell survival in engineered tissues. We demonstrate capabilities of the ITOP by fabricating mandible and calvarial bone, cartilage and skeletal muscle. Future development of the ITOP is being directed to the production of tissues for human applications and to the building of more complex tissues and solid organs.	[Kang, Hyun-Wook; Lee, Sang Jin; Ko, In Kap; Kengla, Carlos; Yoo, James J.; Atala, Anthony] Wake Forest Sch Med, Wake Forest Inst Regenerat Med, Med Ctr Blvd, Winston Salem, NC USA	Wake Forest University	Atala, A (corresponding author), Wake Forest Sch Med, Wake Forest Inst Regenerat Med, Med Ctr Blvd, Winston Salem, NC USA.	aatala@wakehealth.edu	Kang, Hyun-Wook/AAY-1766-2021; Lee, Sang Jin/S-4056-2019; Yoo, James J./L-4850-2017; Kengla, Carlos/G-3418-2019	Lee, Sang Jin/0000-0002-3899-1909; Kengla, Carlos/0000-0001-8788-4221	Armed Forces Institute of Regenerative Medicine [W81XWH-08-2-0032]; Telemedicine and Advanced Technology Research Center at the US Army Medical Research and Material Command [W81XWH-07-1-0718]; Defense Threat Reduction Agency [N66001-13-C-2027]	Armed Forces Institute of Regenerative Medicine; Telemedicine and Advanced Technology Research Center at the US Army Medical Research and Material Command; Defense Threat Reduction Agency(United States Department of DefenseDefense Threat Reduction Agency)	This work was supported, in part, by grants from the Armed Forces Institute of Regenerative Medicine (W81XWH-08-2-0032), the Telemedicine and Advanced Technology Research Center at the US Army Medical Research and Material Command (W81XWH-07-1-0718) and the Defense Threat Reduction Agency (N66001-13-C-2027). We would like to thank D.M. Eckman for editorial comments on this manuscript, and H.S. Kim and G.V. Kulkarni for technical assistance.	Amini Ami R., 2012, Critical Reviews in Biomedical Engineering, V40, P363; Atala A, 2006, LANCET, V367, P1241, DOI 10.1016/S0140-6736(06)68438-9; Atala A, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3004890; Bian WN, 2012, TISSUE ENG PT A, V18, P957, DOI [10.1089/ten.tea.2011.0313, 10.1089/ten.TEA.2011.0313]; Bichara DA, 2012, TISSUE ENG PART B-RE, V18, P51, DOI [10.1089/ten.teb.2011.0326, 10.1089/ten.TEB.2011.0326]; Binder KW, 2010, J AM COLL SURGEONS, V211, pS76, DOI 10.1016/j.jamcollsurg.2010.06.198; Boland Thomas, 2006, Biotechnology Journal, V1, P910, DOI 10.1002/biot.200600081; Cabodi M, 2005, J AM CHEM SOC, V127, P13788, DOI 10.1021/ja054820t; Chang CC, 2011, J BIOMED MATER RES B, V98B, P160, DOI 10.1002/jbm.b.31831; Choi JS, 2008, BIOMATERIALS, V29, P2899, DOI 10.1016/j.biomaterials.2008.03.031; Cooper GM, 2010, TISSUE ENG PT A, V16, P1749, DOI [10.1089/ten.tea.2009.0650, 10.1089/ten.TEA.2009.0650]; Costa KD, 2003, TISSUE ENG, V9, P567, DOI 10.1089/107632703768247278; Cui XF, 2012, TISSUE ENG PT A, V18, P1304, DOI [10.1089/ten.tea.2011.0543, 10.1089/ten.TEA.2011.0543]; Cui XF, 2009, BIOMATERIALS, V30, P6221, DOI 10.1016/j.biomaterials.2009.07.056; da Graca B, 2011, AM J CARDIOL, V107, P141, DOI 10.1016/j.amjcard.2010.08.056; De Coppi P, 2007, NAT BIOTECHNOL, V25, P100, DOI 10.1038/nbt1274; Derby B, 2012, SCIENCE, V338, P921, DOI 10.1126/science.1226340; Duan B, 2013, J BIOMED MATER RES A, V101, P1255, DOI 10.1002/jbm.a.34420; Durmus NG, 2013, NAT MATER, V12, P478, DOI 10.1038/nmat3665; Fedorovich NE, 2008, TISSUE ENG PT A, V14, P127, DOI 10.1089/ten.a.2007.0158; Ferris CJ, 2013, APPL MICROBIOL BIOT, V97, P4243, DOI 10.1007/s00253-013-4853-6; Guillotin B, 2011, TRENDS BIOTECHNOL, V29, P183, DOI 10.1016/j.tibtech.2010.12.008; Hoffman AS, 2012, ADV DRUG DELIVER REV, V64, P18, DOI 10.1016/j.addr.2012.09.010; Ignatius AA, 1996, BIOMATERIALS, V17, P831, DOI 10.1016/0142-9612(96)81421-9; Ilkhanizadeh S, 2007, BIOMATERIALS, V28, P3936, DOI 10.1016/j.biomaterials.2007.05.018; Jain RK, 2005, NAT BIOTECHNOL, V23, P821, DOI 10.1038/nbt0705-821; Jakab K, 2004, P NATL ACAD SCI USA, V101, P2864, DOI 10.1073/pnas.0400164101; Jones N, 2012, NATURE, V487, P22, DOI 10.1038/487022a; Ker EDF, 2011, BIOMATERIALS, V32, P8097, DOI 10.1016/j.biomaterials.2011.07.025; Khalil S, 2009, J BIOMECH ENG-T ASME, V131, DOI 10.1115/1.3128729; Kim J, 2013, BIOMED MATER, V8, DOI 10.1088/1748-6041/8/1/014107; Ko IK, 2013, BIOMATERIALS, V34, P3246, DOI 10.1016/j.biomaterials.2013.01.029; Landers R, 2002, BIOMATERIALS, V23, P4437, DOI 10.1016/S0142-9612(02)00139-4; Lee SJ, 2011, BIOMACROMOLECULES, V12, P306, DOI 10.1021/bm100856g; Lee W, 2009, BIOMATERIALS, V30, P1587, DOI 10.1016/j.biomaterials.2008.12.009; Lee YB, 2010, EXP NEUROL, V223, P645, DOI 10.1016/j.expneurol.2010.02.014; Liao YS, 2001, INT J ADV MANUF TECH, V18, P579, DOI 10.1007/s001700170034; Ling Y, 2007, LAB CHIP, V7, P756, DOI 10.1039/b615486g; Lippens E, 2013, J BIOMATER APPL, V27, P828, DOI 10.1177/0885328211427774; Marga F, 2012, BIOFABRICATION, V4, DOI 10.1088/1758-5082/4/2/022001; Mikos AG, 2006, TISSUE ENG, V12, P3307, DOI 10.1089/ten.2006.12.3307; Mironov V, 2003, TRENDS BIOTECHNOL, V21, P157, DOI 10.1016/S0167-7799(03)00033-7; Mironov V, 2009, BIOMATERIALS, V30, P2164, DOI 10.1016/j.biomaterials.2008.12.084; Murphy SV, 2014, NAT BIOTECHNOL, V32, P773, DOI 10.1038/nbt.2958; Nicodemus GD, 2008, TISSUE ENG PT B-REV, V14, P149, DOI 10.1089/ten.teb.2007.0332; Norotte C, 2009, BIOMATERIALS, V30, P5910, DOI 10.1016/j.biomaterials.2009.06.034; Ostrovidov S, 2014, TISSUE ENG PART B-RE, V20, P403, DOI [10.1089/ten.teb.2013.0534, 10.1089/ten.TEB.2013.0534]; Park SC, 2000, COMPUT AIDED DESIGN, V32, P17, DOI 10.1016/S0010-4485(99)00080-9; Phillippi JA, 2008, STEM CELLS, V26, P127, DOI 10.1634/stemcells.2007-0520; Raya-Rivera A, 2011, LANCET, V377, P1175, DOI 10.1016/S0140-6736(10)62354-9; Raya-Rivera AM, 2014, LANCET, V384, P329, DOI 10.1016/S0140-6736(14)60542-0; Roy R, 2004, J BIOMED MATER RES A, V68A, P597, DOI 10.1002/jbm.a.10068; Schuurman W, 2011, BIOFABRICATION, V3, DOI 10.1088/1758-5082/3/2/021001; Serrano MC, 2004, BIOMATERIALS, V25, P5603, DOI 10.1016/j.biomaterials.2004.01.037; Shim JH, 2012, J MICROMECH MICROENG, V22, DOI 10.1088/0960-1317/22/8/085014; Skardal A, 2010, BIOMATERIALS, V31, P6173, DOI 10.1016/j.biomaterials.2010.04.045; Stachowiak AN, 2005, ADV MATER, V17, P399, DOI 10.1002/adma.200400507; Sun HF, 2006, BIOMATERIALS, V27, P1735, DOI 10.1016/j.biomaterials.2005.09.019; WAKELAM MJO, 1985, BIOCHEM J, V228, P1; Wang XH, 2010, TISSUE ENG PART B-RE, V16, P189, DOI [10.1089/ten.teb.2009.0576, 10.1089/ten.TEB.2009.0576]; Xu T, 2013, BIOFABRICATION, V5, DOI 10.1088/1758-5082/5/1/015001; Xu T, 2013, BIOMATERIALS, V34, P130, DOI 10.1016/j.biomaterials.2012.09.035; Xu T, 2009, BIOFABRICATION, V1, DOI 10.1088/1758-5082/1/3/035001; Zignani M, 2000, BIOMATERIALS, V21, P1773, DOI 10.1016/S0142-9612(00)00065-X	64	1439	1535	83	2087	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1087-0156	1546-1696		NAT BIOTECHNOL	Nat. Biotechnol.	MAR	2016	34	3					312	+		10.1038/nbt.3413	http://dx.doi.org/10.1038/nbt.3413			11	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	DG1CJ	26878319				2022-12-27	WOS:000371802600028
J	Kitzman, JO				Kitzman, Jacob O.			Haplotypes drop by drop	NATURE BIOTECHNOLOGY			English	Article									[Kitzman, Jacob O.] Univ Michigan, Dept Human Genet, Ann Arbor, MI 48109 USA; [Kitzman, Jacob O.] Univ Michigan, Dept Computat Med & Bioinformat, Ann Arbor, MI 48109 USA	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan	Kitzman, JO (corresponding author), Univ Michigan, Dept Human Genet, Ann Arbor, MI 48109 USA.; Kitzman, JO (corresponding author), Univ Michigan, Dept Computat Med & Bioinformat, Ann Arbor, MI 48109 USA.	kitzmanj@umich.edu		Kitzman, Jacob/0000-0002-6145-882X				Browning SR, 2011, NAT REV GENET, V12, P703, DOI 10.1038/nrg3054; Chaisson MJP, 2015, NATURE, V517, P608, DOI 10.1038/nature13907; Fan HC, 2012, NATURE, V487, P320, DOI 10.1038/nature11251; Jiang PY, 2015, P NATL ACAD SCI USA, V112, pE1317, DOI 10.1073/pnas.1500076112; Kitzman JO, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3004323; Kitzman JO, 2011, NAT BIOTECHNOL, V29, P59, DOI 10.1038/nbt.1740; Klein AM, 2015, CELL, V161, P1187, DOI 10.1016/j.cell.2015.04.044; Kuleshov V, 2016, NAT BIOTECHNOL, V34, P64, DOI 10.1038/nbt.3416; Sharon D, 2013, NAT BIOTECHNOL, V31, P1009, DOI 10.1038/nbt.2705; Snyder MW, 2015, NAT REV GENET, V16, P344, DOI 10.1038/nrg3903; Stephens PJ, 2011, CELL, V144, P27, DOI 10.1016/j.cell.2010.11.055; Tewhey R, 2011, NAT REV GENET, V12, P215, DOI 10.1038/nrg2950; Zheng GXY, 2016, NAT BIOTECHNOL, V34, P303, DOI 10.1038/nbt.3432	13	21	23	0	12	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156	1546-1696		NAT BIOTECHNOL	Nat. Biotechnol.	MAR	2016	34	3					296	298		10.1038/nbt.3500	http://dx.doi.org/10.1038/nbt.3500			4	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	DG1CJ	26963554				2022-12-27	WOS:000371802600024
J	Dodd, D; Tropini, C; Sonnenburg, JL				Dodd, Dylan; Tropini, Carolina; Sonnenburg, Justin L.			Your gut microbiome, deconstructed	NATURE BIOTECHNOLOGY			English	Editorial Material								Use of sophisticated reductionist and whole-system approaches are providing much-needed technologies to unravel the complex melange of microbiome functions.	[Dodd, Dylan] Stanford Univ, Dept Pathol, Sch Med, Stanford, CA 94305 USA; [Dodd, Dylan; Tropini, Carolina; Sonnenburg, Justin L.] Stanford Univ, Dept Microbiol & Immunol, Sch Med, Stanford, CA 94305 USA	Stanford University; Stanford University	Dodd, D (corresponding author), Stanford Univ, Dept Pathol, Sch Med, Stanford, CA 94305 USA.	jsonnenburg@stanford.edu	Tropini, Carolina/H-2992-2019	Tropini, Carolina/0000-0002-7542-1577; Dodd, Dylan/0000-0001-6210-6239				Atarashi K, 2013, NATURE, V500, P232, DOI 10.1038/nature12331; Bhatia SN, 2014, NAT BIOTECHNOL, V32, P760, DOI 10.1038/nbt.2989; Faith JJ, 2014, SCI TRANSL MED, V6, DOI 10.1126/scitranslmed.3008051; Goodman AL, 2011, P NATL ACAD SCI USA, V108, P6252, DOI 10.1073/pnas.1102938108; Goodman AL, 2009, CELL HOST MICROBE, V6, P279, DOI 10.1016/j.chom.2009.08.003; Jemielita M, 2014, MBIO, V5, DOI 10.1128/mBio.01751-14; Korem T, 2015, SCIENCE, V349, P1101, DOI 10.1126/science.aac4812; Lukovac S, 2014, MBIO, V5, DOI 10.1128/mBio.01438-14; Wu M, 2015, SCIENCE, V350, DOI 10.1126/science.aac5992	9	1	1	0	25	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156	1546-1696		NAT BIOTECHNOL	Nat. Biotechnol.	DEC	2015	33	12					1238	1240		10.1038/nbt.3431	http://dx.doi.org/10.1038/nbt.3431			4	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	CY4OO	26650010				2022-12-27	WOS:000366387700013
J	Tsankov, AM; Akopian, V; Pop, R; Chetty, S; Gifford, CA; Daheron, L; Tsankova, NM; Meissner, A				Tsankov, Alexander M.; Akopian, Veronika; Pop, Ramona; Chetty, Sundari; Gifford, Casey A.; Daheron, Laurence; Tsankova, Nadejda M.; Meissner, Alexander			A qPCRCR ScoreCard quantifies the differentiation potential of human pluripotent stem cells	NATURE BIOTECHNOLOGY			English	Article							HUMAN ES; SPECIFICATION; DISRUPTION; DYNAMICS; LINES	Research on human pluripotent stem cells has been hampered by the lack of a standardized, quantitative, scalable assay of pluripotency. We previously described an assay called ScoreCard that used gene expression signatures to quantify differentiation efficiency. Here we report an improved version of the assay based on qPCR that enables faster, more quantitative assessment of functional pluripotency. We provide an in-depth characterization of the revised signature panel (commercially available as the TaqMan hPSC Scorecard Assay) through embryoid body and directed differentiation experiments as well as a detailed comparison to the teratoma assay. We further show that the improved ScoreCard enables a wider range of applications, such as screening of small molecules, genetic perturbations and assessment of culture conditions. Our approach can be extended beyond stem cell applications to characterize and assess the utility of other cell types and lineages.	[Tsankov, Alexander M.; Akopian, Veronika; Pop, Ramona; Gifford, Casey A.; Meissner, Alexander] Broad Inst MIT & Harvard, Cambridge, MA 02142 USA; [Tsankov, Alexander M.; Akopian, Veronika; Pop, Ramona; Gifford, Casey A.; Daheron, Laurence; Meissner, Alexander] Harvard Stem Cell Inst, Cambridge, MA USA; [Tsankov, Alexander M.; Akopian, Veronika; Pop, Ramona; Chetty, Sundari; Gifford, Casey A.; Meissner, Alexander] Harvard Univ, Dept Stem Cell & Regenerat Biol, Cambridge, MA 02138 USA; [Tsankova, Nadejda M.] Columbia Univ, Med Ctr, Dept Pathol & Cell Biol, New York, NY USA; [Tsankova, Nadejda M.] Icahn Sch Med Mt Sinai, Dept Pathol, New York, NY 10029 USA; [Tsankova, Nadejda M.] Icahn Sch Med Mt Sinai, Dept Neurosci, New York, NY 10029 USA	Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Harvard University; Harvard University; Columbia University; Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai	Meissner, A (corresponding author), Broad Inst MIT & Harvard, Cambridge, MA 02142 USA.	alexander_meissner@harvard.edu		Gifford, Casey/0000-0002-7757-573X	NIH under Ruth L. Kirschstein National Research Service Award (NRSA) fellowship [5F32DK095537]; National Institute of General Medical Sciences (NIGMS) [P01GM099117]; National Human Genome Research Institute (NHGRI) [1P50HG006193]; New York Stem Cell Foundation; Life Technologies; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [P50HG006193] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [F32DK095537] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P01GM099117] Funding Source: NIH RePORTER	NIH under Ruth L. Kirschstein National Research Service Award (NRSA) fellowship(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institute of General Medical Sciences (NIGMS)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); National Human Genome Research Institute (NHGRI)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); New York Stem Cell Foundation; Life Technologies; NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We would like to thank all members of the Meissner laboratory as well as D. Tieberg and U. Lakshmipathy for their valuable support and insightful feedback, L. Solomon and L. Gaffney for graphical support, I.S. Kim and B. Bernstein for the JQ1 inhibitor molecule and insight, L. Rubin for the partially reprogrammed cell lines and C. MacGillivray (HSCI Histology core) for teratoma sectioning, fixation and histochemical staining for markers of the three germ layers. A.M.T. is supported by the NIH under Ruth L. Kirschstein National Research Service Award (NRSA) fellowship 5F32DK095537. This work was supported by the National Institute of General Medical Sciences (NIGMS) (P01GM099117), National Human Genome Research Institute (NHGRI) (1P50HG006193), the New York Stem Cell Foundation, and a research grant from Life Technologies. A.M. is a New York Stem Cell Foundation, Robertson Investigator.	Bock C, 2011, CELL, V144, P439, DOI 10.1016/j.cell.2010.12.032; Borowiak M, 2009, CELL STEM CELL, V4, P348, DOI 10.1016/j.stem.2009.01.014; Boulting GL, 2011, NAT BIOTECHNOL, V29, P279, DOI 10.1038/nbt.1783; Choi J, 2015, NAT BIOTECHNOL, V33, P1173, DOI 10.1038/nbt.3388; Daley GQ, 2012, CELL STEM CELL, V10, P740, DOI 10.1016/j.stem.2012.05.010; Dolgin E, 2010, NAT MED, V16, P1354, DOI 10.1038/nm1210-1354; Gifford CA, 2013, CELL, V153, P1149, DOI 10.1016/j.cell.2013.04.037; Liao J, 2015, NAT GENET, V47, P469, DOI 10.1038/ng.3258; Liptak T., 1958, MAGYAR TUD AKAD MAT, V3, P171; Loven J, 2013, CELL, V153, P320, DOI 10.1016/j.cell.2013.03.036; Muller FJ, 2011, NAT METHODS, V8, P315, DOI 10.1038/NMETH.1580; Muller FJ, 2010, CELL STEM CELL, V6, P412, DOI 10.1016/j.stem.2010.04.009; Pikkarainen S, 2004, CARDIOVASC RES, V63, P196, DOI 10.1016/j.cardiores.2004.03.025; Stouffer SA, 1949, AM SOLDIER ADJUSTMEN, V1; Takahashi K, 2007, CELL, V131, P861, DOI 10.1016/j.cell.2007.11.019; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; Teo AKK, 2011, GENE DEV, V25, P238, DOI 10.1101/gad.607311; Tsankov AM, 2015, NATURE, V518, P344, DOI 10.1038/nature14233; Wang Z, 2012, CELL STEM CELL, V10, P440, DOI 10.1016/j.stem.2012.02.016; Ziller MJ, 2015, NATURE, V518, P355, DOI 10.1038/nature13990	20	89	89	0	10	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1087-0156	1546-1696		NAT BIOTECHNOL	Nat. Biotechnol.	NOV	2015	33	11					1182	U117		10.1038/nbt.3387	http://dx.doi.org/10.1038/nbt.3387			15	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	CW3TY	26501952	Green Submitted, Green Accepted			2022-12-27	WOS:000364916000026
J	Xiao, L; Feng, Q; Liang, SS; Sonne, SB; Xia, ZK; Qiu, XM; Li, XP; Long, H; Zhang, JF; Zhang, DY; Liu, C; Fang, ZW; Chou, J; Glanville, J; Hao, Q; Kotowska, D; Colding, C; Licht, TR; Wu, DH; Yu, J; Sung, JJY; Liang, QY; Li, JH; Jia, HJ; Lan, Z; Tremaroli, V; Dworzynski, P; Nielsen, HB; Backhed, F; Dore, J; Le Chatelier, E; Ehrlich, SD; Lin, JC; Arumugam, M; Wang, J; Madsen, L; Kristiansen, K				Xiao, Liang; Feng, Qiang; Liang, Suisha; Sonne, Si Brask; Xia, Zhongkui; Qiu, Xinmin; Li, Xiaoping; Long, Hua; Zhang, Jianfeng; Zhang, Dongya; Liu, Chuan; Fang, Zhiwei; Chou, Joyce; Glanville, Jacob; Hao, Qin; Kotowska, Dorota; Colding, Camilla; Licht, Tine Rask; Wu, Donghai; Yu, Jun; Sung, Joseph Jao Yiu; Liang, Qiaoyi; Li, Junhua; Jia, Huijue; Lan, Zhou; Tremaroli, Valentina; Dworzynski, Piotr; Nielsen, H. Bjorn; Backhed, Fredrik; Dore, Joel; Le Chatelier, Emmanuelle; Ehrlich, S. Dusko; Lin, John C.; Arumugam, Manimozhiyan; Wang, Jun; Madsen, Lise; Kristiansen, Karsten			A catalog of the mouse gut metagenome	NATURE BIOTECHNOLOGY			English	Article							HIGH-FAT; MICROBIOTA; OBESITY; HOST; DIET; INFLAMMATION; ANNOTATION; GENERATION; HEALTH; IMPACT	We established a catalog of the mouse gut metagenome comprising similar to 2.6 million nonredundant genes by sequencing DNA from fecal samples of 184 mice. To secure high microbiome diversity, we used mouse strains of diverse genetic backgrounds, from different providers, kept in different housing laboratories and fed either a low-fat or high-fat diet. Similar to the human gut microbiome, >99% of the cataloged genes are bacterial. We identified 541 metagenomic species and defined a core set of 26 metagenomic species found in 95% of the mice. The mouse gut microbiome is functionally similar to its human counterpart, with 95.2% of its Kyoto Encyclopedia of Genes and Genomes (KEGG) orthologous groups in common. However, only 4.0% of the mouse gut microbial genes were shared (95% identity, 90% coverage) with those of the human gut microbiome. This catalog provides a useful reference for future studies.	[Xiao, Liang; Feng, Qiang; Liang, Suisha; Xia, Zhongkui; Qiu, Xinmin; Li, Xiaoping; Zhang, Jianfeng; Zhang, Dongya; Liu, Chuan; Fang, Zhiwei; Li, Junhua; Jia, Huijue; Lan, Zhou; Arumugam, Manimozhiyan; Madsen, Lise; Kristiansen, Karsten] Beijing Genom Inst BGI Shenzhen, Shenzhen, Peoples R China; [Feng, Qiang; Sonne, Si Brask; Hao, Qin; Kotowska, Dorota; Colding, Camilla; Wang, Jun; Madsen, Lise; Kristiansen, Karsten] Univ Copenhagen, Lab Genom & Mol Biomed, Dept Biol, Copenhagen, Denmark; [Long, Hua; Chou, Joyce; Glanville, Jacob; Lin, John C.] Pfizer Inc, Pfizer Expt Med, San Francisco, CA USA; [Colding, Camilla] Tech Univ Denmark, Natl Food Inst, Soborg, Denmark; [Wu, Donghai] Chinese Acad Sci, Guangzhou Inst Biomed & Hlth, Key Lab Regenerat Biol, Guangzhou 510530, Guangdong, Peoples R China; [Yu, Jun; Sung, Joseph Jao Yiu; Liang, Qiaoyi] Chinese Univ Hong Kong, Inst Digest Dis, Hong Kong, Hong Kong, Peoples R China; [Yu, Jun; Sung, Joseph Jao Yiu; Liang, Qiaoyi] Chinese Univ Hong Kong, Dept Med & Therapeut, State Key Lab Digest Dis, Li Ka Shing Inst Hlth Sci,Shenzhen Res Inst, Hong Kong, Hong Kong, Peoples R China; [Tremaroli, Valentina; Backhed, Fredrik] Univ Gothenburg, Wallenberg Lab, Dept Mol & Clin Med, Gothenburg, Sweden; [Dworzynski, Piotr; Nielsen, H. Bjorn] Tech Univ Denmark, Dept Syst Biol, DK-2800 Lyngby, Denmark; [Backhed, Fredrik; Arumugam, Manimozhiyan] Univ Copenhagen, Novo Nordisk Fdn Ctr Basic Metab Res, Copenhagen, Denmark; [Dore, Joel] Inst Natl Rech Agron Microbiol Aliment Serv Sante, Jouy En Josas, France; [Dore, Joel; Le Chatelier, Emmanuelle; Ehrlich, S. Dusko] INRA, Metagenopolis, Jouy En Josas, France; [Ehrlich, S. Dusko; Wang, Jun] Kings Coll London, Dent Inst Cent Off, Guys Hosp, Ctr Host Microbiome Interact, London, England; [Wang, Jun] King Abdulaziz Univ, Princess Al Jawhara Albrahim Ctr Excellence Res H, Jeddah 21413, Saudi Arabia; [Wang, Jun] Macau Univ Sci & Technol, Taipa, Macau, Peoples R China; [Madsen, Lise] Natl Inst Nutr & Seafood Res, Bergen, Norway	Beijing Genomics Institute (BGI); University of Copenhagen; Pfizer; Technical University of Denmark; Chinese Academy of Sciences; Guangzhou Institute of Biomedicine & Health, CAS; Chinese University of Hong Kong; Chinese University of Hong Kong; University of Gothenburg; Technical University of Denmark; Novo Nordisk Foundation; University of Copenhagen; INRAE; UDICE-French Research Universities; Universite Paris Saclay; INRAE; UDICE-French Research Universities; Universite Paris Saclay; Guy's & St Thomas' NHS Foundation Trust; University of London; King's College London; King Abdulaziz University; Macau University of Science & Technology	Kristiansen, K (corresponding author), Beijing Genom Inst BGI Shenzhen, Shenzhen, Peoples R China.	wangj@genomics.cn; Lise.Madsen@nifes.no; kk@bio.ku.dk	Backhed, Fredrik/ABE-6613-2020; Nielsen, Henrik/B-8961-2019; Jia, Huijue/M-3991-2015; Liang, Qiaoyi Jessie/G-9612-2019; Sonne, Si Brask/A-4851-2012; Sung, Joseph J. Y./R-3203-2018; Dore, Joel/ABA-8921-2020; Ehrlich, S./Y-2423-2019; Arumugam, Manimozhiyan/AAJ-2394-2020; Li, Junhua/AAG-3919-2019; Madsen, Lise/C-6246-2012; LE CHATELIER, Emmanuelle/O-1243-2017; Arumugam, Manimozhiyan/E-1211-2011; Kristiansen, Karsten/J-5148-2014; Tremaroli, Valentina/AAE-8001-2019; Yu, Jun/D-8569-2015; Xiao, Liang/L-5614-2016; Wang, Jun/B-9503-2016; Wang, Jun/C-8434-2016	Backhed, Fredrik/0000-0002-4871-8818; Nielsen, Henrik/0000-0003-2281-5713; Jia, Huijue/0000-0002-3592-126X; Liang, Qiaoyi Jessie/0000-0001-8496-3442; Sonne, Si Brask/0000-0003-3194-3805; Sung, Joseph J. Y./0000-0003-3125-5199; Ehrlich, S./0000-0002-7563-4046; Arumugam, Manimozhiyan/0000-0002-0886-9101; Li, Junhua/0000-0001-6784-1873; Madsen, Lise/0000-0003-4468-1947; LE CHATELIER, Emmanuelle/0000-0002-2724-0536; Arumugam, Manimozhiyan/0000-0002-0886-9101; Kristiansen, Karsten/0000-0002-6024-0917; Tremaroli, Valentina/0000-0002-9150-4233; Yu, Jun/0000-0001-5008-2153; Colding-Christensen, Camilla Skettrup/0000-0003-2777-6725; Xiao, Liang/0000-0003-0836-4397; Liu, Chuan/0000-0003-3716-7050; Wang, Jun/0000-0002-2113-5874; Dworzynski, Piotr/0000-0002-6717-8052; Wang, Jun/0000-0002-8540-8931; Liang, Suisha/0000-0003-0426-9827; Hao, Qin/0000-0002-6775-2181; Licht, Tine Rask/0000-0002-6399-9574	Danish Natural Science Research Foundation; Carlsberg Foundation; Danish Council for Strategic Research [11-116163]; National Basic Research Program of China (973 Program) [2013CB531400, 2011CB504004, 2010CB945500]; Shenzhen Municipal Government of China (the research and development of the novel personalized gut microbiota probiotic production) [CXZZ20150330171521403]; Theme-based Research Scheme of the Hong Kong Research Grants Council [T12-403-11]; Metagenopolis grant [ANR-11-DPBS-0001]; Knut and Alice Wallenberg Foundation; Swedish Research Council; Novo Nordisk foundation; Torsten Soderberg's foundation; ERC Consolidator Grant (European Research Council) [615362-METABASE]	Danish Natural Science Research Foundation(Danish Natural Science Research Council); Carlsberg Foundation(Carlsberg Foundation); Danish Council for Strategic Research(Danske Strategiske Forskningsrad (DSF)); National Basic Research Program of China (973 Program)(National Basic Research Program of China); Shenzhen Municipal Government of China (the research and development of the novel personalized gut microbiota probiotic production); Theme-based Research Scheme of the Hong Kong Research Grants Council; Metagenopolis grant; Knut and Alice Wallenberg Foundation(Knut & Alice Wallenberg Foundation); Swedish Research Council(Swedish Research CouncilEuropean Commission); Novo Nordisk foundation(Novo Nordisk FoundationNovocure Limited); Torsten Soderberg's foundation; ERC Consolidator Grant (European Research Council)(European Research Council (ERC))	We thank the sequencing and bioinformatics staff at BGI-Shenzhen for help and advice. This study was supported by the Danish Natural Science Research Foundation, the Carlsberg Foundation, The Danish Council for Strategic Research (grant 11-116163), the National Basic Research Program of China (973 Program, 2013CB531400, 2011CB504004 and 2010CB945500), the Shenzhen Municipal Government of China (the research and development of the novel personalized gut microbiota probiotic production, CXZZ20150330171521403), Theme-based Research Scheme of the Hong Kong Research Grants Council (T12-403-11), the Metagenopolis grant (ANR-11-DPBS-0001), Knut and Alice Wallenberg Foundation, Swedish Research Council, the Novo Nordisk foundation, Torsten Soderberg's foundation. F.B. is a recipient of ERC Consolidator Grant (European Research Council, Consolidator grant 615362-METABASE).	Ahern PP, 2014, IMMUNITY, V40, P815, DOI 10.1016/j.immuni.2014.05.012; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Anderson MJ, 2001, AUSTRAL ECOL, V26, P32, DOI 10.1046/j.1442-9993.2001.01070.x; Cantarel BL, 2009, NUCLEIC ACIDS RES, V37, pD233, DOI 10.1093/nar/gkn663; Cho I, 2012, NAT REV GENET, V13, P260, DOI 10.1038/nrg3182; Clemente JC, 2012, CELL, V148, P1258, DOI 10.1016/j.cell.2012.01.035; Cotillard A, 2013, NATURE, V500, P585, DOI 10.1038/nature12480; David LA, 2014, NATURE, V505, P559, DOI 10.1038/nature12820; Everard A, 2014, ISME J, V8, P2116, DOI 10.1038/ismej.2014.45; Faith JJ, 2014, SCI TRANSL MED, V6, DOI 10.1126/scitranslmed.3008051; Friswell MK, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008584; Gerlach W, 2011, NUCLEIC ACIDS RES, V39, DOI 10.1093/nar/gkr225; Hildebrand F, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-1-r4; Huttenhower C, 2014, IMMUNITY, V40, P843, DOI 10.1016/j.immuni.2014.05.013; Jensen LJ, 2008, NUCLEIC ACIDS RES, V36, pD250, DOI 10.1093/nar/gkm796; Kamada N, 2013, NAT REV IMMUNOL, V13, P321, DOI 10.1038/nri3430; Kanehisa M, 2000, NUCLEIC ACIDS RES, V28, P27, DOI 10.1093/nar/28.1.27; Kent WJ, 2002, GENOME RES, V12, P656, DOI [10.1101/gr.229202, 10.1101/gr.229202. Article published online before March 2002]; Lacombe A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067497; Le Chatelier E, 2013, NATURE, V500, P541, DOI 10.1038/nature12506; Ley RE, 2005, P NATL ACAD SCI USA, V102, P11070, DOI 10.1073/pnas.0504978102; Li JH, 2014, NAT BIOTECHNOL, V32, P834, DOI 10.1038/nbt.2942; Lombard V, 2014, NUCLEIC ACIDS RES, V42, pD490, DOI 10.1093/nar/gkt1178; Luo RB, 2012, GIGASCIENCE, V1, DOI 10.1186/2047-217X-1-18; McArdle BH, 2001, ECOLOGY, V82, P290, DOI 10.1890/0012-9658(2001)082[0290:FMMTCD]2.0.CO;2; Moriya Y, 2007, NUCLEIC ACIDS RES, V35, pW182, DOI 10.1093/nar/gkm321; Nielsen HB, 2014, NAT BIOTECHNOL, V32, P822, DOI 10.1038/nbt.2939; Parks BW, 2013, CELL METAB, V17, P141, DOI 10.1016/j.cmet.2012.12.007; Patrone V, 2012, MICROBIOL-SGM, V158, P983, DOI 10.1099/mic.0.054247-0; Qin JJ, 2012, NATURE, V490, P55, DOI 10.1038/nature11450; Qin JJ, 2010, NATURE, V464, P59, DOI 10.1038/nature08821; Ridaura VK, 2013, SCIENCE, V341, P1079, DOI 10.1126/science.1241214; Schwab C, 2014, ISME J, V8, P1101, DOI 10.1038/ismej.2013.223; Subramanian S, 2014, NATURE, V510, P417, DOI 10.1038/nature13421; Suez J, 2014, NATURE, V514, P181, DOI 10.1038/nature13793; Thaiss CA, 2014, CELL, V159, P514, DOI 10.1016/j.cell.2014.09.048; Tremaroli V, 2012, NATURE, V489, P242, DOI 10.1038/nature11552; Turnbaugh PJ, 2008, CELL HOST MICROBE, V3, P213, DOI 10.1016/j.chom.2008.02.015; Turnbaugh PJ, 2006, NATURE, V444, P1027, DOI 10.1038/nature05414; Turnbaugh PJ, 2009, SCI TRANSL MED, V1, DOI 10.1126/scitranslmed.3000322; Wu GD, 2011, SCIENCE, V334, P105, DOI 10.1126/science.1208344; Zhang CH, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3163; Zhang CH, 2012, ISME J, V6, P1848, DOI 10.1038/ismej.2012.27; Zhang CH, 2010, ISME J, V4, P232, DOI 10.1038/ismej.2009.112; Zhang X, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0040320, 10.1371/journal.pone.0042529]; Zhao LP, 2013, NAT REV MICROBIOL, V11, P639, DOI 10.1038/nrmicro3089	46	273	282	5	172	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156	1546-1696		NAT BIOTECHNOL	Nat. Biotechnol.	OCT	2015	33	10					1103	+		10.1038/nbt.3353	http://dx.doi.org/10.1038/nbt.3353			7	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	CT1JX	26414350				2022-12-27	WOS:000362555700032
J	Kotini, AG; Chang, CJ; Boussaad, I; Delrow, JJ; Dolezal, EK; Nagulapally, AB; Perna, F; Fishbein, GA; Klimek, VM; Hawkins, RD; Huangfu, D; Murry, CE; Graubert, T; Nimer, SD; Papapetrou, EP				Kotini, Andriana G.; Chang, Chan-Jung; Boussaad, Ibrahim; Delrow, Jeffrey J.; Dolezal, Emily K.; Nagulapally, Abhinav B.; Perna, Fabiana; Fishbein, Gregory A.; Klimek, Virginia M.; Hawkins, R. David; Huangfu, Danwei; Murry, Charles E.; Graubert, Timothy; Nimer, Stephen D.; Papapetrou, Eirini P.			Functional analysis of a chromosomal deletion associated with myelodysplastic syndromes using isogenic human induced pluripotent stem cells	NATURE BIOTECHNOLOGY			English	Article							METHYLTRANSFERASE GENE EZH2; TUMOR-SUPPRESSOR; MUTATIONS; GENERATION; IMPACT; 7Q; HAPLOINSUFFICIENCY; IDENTIFICATION; EVOLUTION; REVEALS	Chromosomal deletions associated with human diseases, such as cancer, are common, but synteny issues complicate modeling of these deletions in mice. We use cellular reprogramming and genome engineering to functionally dissect the loss of chromosome 7q (del(7q)), a somatic cytogenetic abnormality present in myelodysplastic syndromes (MDS). We derive del(7q)- and isogenic karyotypically normal induced pluripotent stem cells (iPSCs) from hematopoietic cells of MDS patients and show that the del(7q) iPSCs recapitulate disease-associated phenotypes, including impaired hematopoietic differentiation. These disease phenotypes are rescued by spontaneous dosage correction and can be reproduced in karyotypically normal cells by engineering hemizygosity of defined chr7q segments in a 20-Mb region. We use a phenotype-rescue screen to identify candidate haploinsufficient genes that might mediate the del(7q)-hematopoietic defect. Our approach highlights the utility of human iPSCs both for functional mapping of disease-associated large-scale chromosomal deletions and for discovery of haploinsufficient genes.	[Kotini, Andriana G.; Chang, Chan-Jung; Papapetrou, Eirini P.] Icahn Sch Med Mt Sinai, Dept Oncol Sci, New York, NY 10029 USA; [Kotini, Andriana G.; Chang, Chan-Jung; Papapetrou, Eirini P.] Icahn Sch Med Mt Sinai, Tisch Canc Inst, New York, NY 10029 USA; [Kotini, Andriana G.; Chang, Chan-Jung] Icahn Sch Med Mt Sinai, Black Family Stem Cell Inst, New York, NY 10029 USA; [Boussaad, Ibrahim; Papapetrou, Eirini P.] Univ Washington, Dept Med, Div Hematol, Seattle, WA 98195 USA; [Boussaad, Ibrahim; Nagulapally, Abhinav B.; Hawkins, R. David; Murry, Charles E.; Papapetrou, Eirini P.] Univ Washington, Inst Stem Cell & Regenerat Med, Seattle, WA 98195 USA; [Delrow, Jeffrey J.] Fred Hutchinson Canc Res Ctr, Genom Resource, Seattle, WA 98104 USA; [Dolezal, Emily K.; Nimer, Stephen D.] Univ Miami, Miller Sch Med, Sylvester Comprehens Canc Ctr, Miami, FL 33136 USA; [Nagulapally, Abhinav B.; Hawkins, R. David] Univ Washington, Dept Med, Div Med Genet, Seattle, WA 98195 USA; [Perna, Fabiana] Mem Sloan Kettering Canc Ctr, Mol Pharmacol & Chem Program, New York, NY 10021 USA; [Fishbein, Gregory A.] Univ Calif Los Angeles, David Geffen Sch Med, Dept Pathol & Lab Med, Los Angeles, CA 90095 USA; [Klimek, Virginia M.] Mem Sloan Kettering Canc Ctr, Dept Med, New York, NY 10021 USA; [Huangfu, Danwei] Sloan Kettering Inst, Dev Biol Program, New York, NY USA; [Murry, Charles E.; Papapetrou, Eirini P.] Univ Washington, Dept Pathol, Seattle, WA 98195 USA; [Murry, Charles E.] Univ Washington, Ctr Cardiovasc Biol, Seattle, WA 98195 USA; [Murry, Charles E.] Univ Washington, Dept Bioengn, Seattle, WA 98195 USA; [Murry, Charles E.] Univ Washington, Dept Med, Div Cardiol, Seattle, WA USA; [Graubert, Timothy] Massachusetts Gen Hosp, Ctr Canc, Boston, MA 02114 USA; [Papapetrou, Eirini P.] Icahn Sch Med Mt Sinai, Dept Med, Div Hematol & Med Oncol, New York, NY 10029 USA	Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; Fred Hutchinson Cancer Center; University of Miami; University of Washington; University of Washington Seattle; Memorial Sloan Kettering Cancer Center; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; Harvard University; Massachusetts General Hospital; Icahn School of Medicine at Mount Sinai	Papapetrou, EP (corresponding author), Icahn Sch Med Mt Sinai, Dept Oncol Sci, New York, NY 10029 USA.	eirini.papapetrou@mssm.edu	Boussaad, Ibrahim/GZH-0742-2022	Boussaad, Ibrahim/0000-0002-3512-3364; Huangfu, Danwei/0000-0002-1145-6199; KOTINI, ANDRIANA/0000-0001-9148-6015; Perna, Fabiana/0000-0002-3744-8672; Fishbein, Gregory/0000-0002-3632-5654; Graubert, Timothy/0000-0002-7710-1171	National Institutes of Health (NIH) [R00 DK087923, R01 HL121570, P30 CA15704]; University of Washington Royalty Research Fund; American Society of Hematology; Sidney Kimmel Foundation for Cancer Research; Aplastic Anemia & MDS International Foundation; Ellison Medical Foundation; Damon Runyon Cancer Research Foundation; John H. Tietze Stem Cell Scientist Award; NATIONAL CANCER INSTITUTE [R01CA166835, P30CA008748, P30CA015704] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL121570] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK096239, R00DK087923] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); University of Washington Royalty Research Fund(University of Washington); American Society of Hematology; Sidney Kimmel Foundation for Cancer Research; Aplastic Anemia & MDS International Foundation; Ellison Medical Foundation(Lawrence Ellison Foundation); Damon Runyon Cancer Research Foundation; John H. Tietze Stem Cell Scientist Award; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by the National Institutes of Health (NIH) grants R00 DK087923 (E.P.P.), R01 HL121570 (E.P.P.), P30 CA15704 and by awards from the University of Washington Royalty Research Fund (E.P.P.), the American Society of Hematology (E.P.P.), the Sidney Kimmel Foundation for Cancer Research (E.P.P.), the Aplastic Anemia & MDS International Foundation (E.P.P.), the Ellison Medical Foundation (E.P.P.), the Damon Runyon Cancer Research Foundation (E.P.P.) and a John H. Tietze Stem Cell Scientist Award (E.P.P.). We thank D. Russell and L. Li for sharing their expertise in AAV-mediated gene targeting and T. Papayannopoulou for sharing her expertise in assessment of May-Giemsa slides and for useful discussions. We thank C. Husser, C. Sather and R. Basom for excellent technical assistance and J. Overbey for statistical advice.	Abyzov A, 2012, NATURE, V492, P438, DOI 10.1038/nature11629; Alkan C, 2011, NAT REV GENET, V12, P363, DOI 10.1038/nrg2958; Amps K, 2011, NAT BIOTECHNOL, V29, P1132, DOI 10.1038/nbt.2051; Berger AH, 2011, NATURE, V476, P163, DOI 10.1038/nature10275; Beroukhim R, 2010, NATURE, V463, P899, DOI 10.1038/nature08822; Bolze A, 2013, SCIENCE, V340, P976, DOI 10.1126/science.1234864; Carette JE, 2009, SCIENCE, V326, P1231, DOI 10.1126/science.1178955; Chen C, 2014, CANCER CELL, V25, P652, DOI 10.1016/j.ccr.2014.03.016; Cibulskis K, 2013, NAT BIOTECHNOL, V31, P213, DOI 10.1038/nbt.2514; Davoli T, 2013, CELL, V155, P948, DOI 10.1016/j.cell.2013.10.011; Dohner K, 1998, BLOOD, V92, P4031, DOI 10.1182/blood.V92.11.4031.423k55_4031_4035; Ebert BL, 2008, NATURE, V451, P335, DOI 10.1038/nature06494; Ernst T, 2010, NAT GENET, V42, P722, DOI 10.1038/ng.621; Flores-Figueroa E, 1999, LEUKEMIA RES, V23, P385, DOI 10.1016/S0145-2126(98)00176-3; Gibson G, 2012, NAT REV GENET, V13, P135, DOI 10.1038/nrg3118; Gonzalez F, 2014, CELL STEM CELL, V15, P215, DOI 10.1016/j.stem.2014.05.018; Grskovic M, 2011, NAT REV DRUG DISCOV, V10, P915, DOI 10.1038/nrd3577; Hosono N, 2014, LEUKEMIA, V28, P1348, DOI 10.1038/leu.2014.25; Jerez A, 2012, BLOOD, V119, P6109, DOI 10.1182/blood-2011-12-397620; Kennedy M, 2012, CELL REP, V2, P1722, DOI 10.1016/j.celrep.2012.11.003; LeBeau MM, 1996, BLOOD, V88, P1930; Lewandoski M, 1997, NAT GENET, V17, P223, DOI 10.1038/ng1097-223; Li J, 1997, SCIENCE, V275, P1943, DOI 10.1126/science.275.5308.1943; Li LB, 2012, CELL STEM CELL, V11, P615, DOI 10.1016/j.stem.2012.08.004; Lindsley RC, 2013, BLOOD, V122, P3741, DOI 10.1182/blood-2013-06-460295; Lindsley RC, 2013, ANNU REV PATHOL-MECH, V8, P21, DOI 10.1146/annurev-pathol-011811-132436; Makishima H, 2010, LEUKEMIA, V24, P1799, DOI 10.1038/leu.2010.167; Matsumura H, 2007, NAT METHODS, V4, P23, DOI 10.1038/NMETH973; Narva E, 2010, NAT BIOTECHNOL, V28, P371, DOI 10.1038/nbt.1615; Nikoloski G, 2010, NAT GENET, V42, P665, DOI 10.1038/ng.620; Pang WW, 2011, P NATL ACAD SCI USA, V108, P20012, DOI 10.1073/pnas.1116110108; Papapetrou EP, 2011, NAT PROTOC, V6, P1251, DOI 10.1038/nprot.2011.374; Papapetrou EP, 2011, NAT BIOTECHNOL, V29, P73, DOI 10.1038/nbt.1717; Papapetrou EP, 2010, STEM CELLS, V28, P287, DOI 10.1002/stem.257; Papapetrou EP, 2009, P NATL ACAD SCI USA, V106, P12759, DOI 10.1073/pnas.0904825106; Sato T, 1998, LEUKEMIA, V12, P1187, DOI 10.1038/sj.leu.2401084; Shih AH, 2012, NAT REV CANCER, V12, P599, DOI 10.1038/nrc3343; Singh H, 2013, BLOOD CANCER J, V3, DOI 10.1038/bcj.2013.16; Soldner F, 2011, CELL, V146, P318, DOI 10.1016/j.cell.2011.06.019; Solimini NL, 2012, SCIENCE, V337, P104, DOI 10.1126/science.1219580; Starczynowski DT, 2010, NAT MED, V16, P49, DOI 10.1038/nm.2054; Sturgeon CM, 2013, NAT BIOTECHNOL, V31, P416, DOI 10.1038/nbt.2571; Tang YC, 2013, CELL, V152, P394, DOI 10.1016/j.cell.2012.11.043; Tennessen JA, 2012, SCIENCE, V337, P64, DOI 10.1126/science.1219240; Walter MJ, 2012, NEW ENGL J MED, V366, P1090, DOI 10.1056/NEJMoa1106968; Weischenfeldt J, 2013, NAT REV GENET, V14, P125, DOI 10.1038/nrg3373; Welch JS, 2012, CELL, V150, P264, DOI 10.1016/j.cell.2012.06.023; White JK, 2013, CELL, V154, P452, DOI 10.1016/j.cell.2013.06.022; Xue W, 2012, P NATL ACAD SCI USA, V109, P8212, DOI 10.1073/pnas.1206062109; Young MA, 2012, CELL STEM CELL, V10, P570, DOI 10.1016/j.stem.2012.03.002	50	107	114	0	20	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156	1546-1696		NAT BIOTECHNOL	Nat. Biotechnol.	JUN	2015	33	6					646	+		10.1038/nbt.3178	http://dx.doi.org/10.1038/nbt.3178			12	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	CK2DE	25798938	Green Accepted			2022-12-27	WOS:000356019700025
J	Elenko, E; Underwood, L; Zohar, D				Elenko, Eric; Underwood, Lindsay; Zohar, Daphne			Defining digital medicine	NATURE BIOTECHNOLOGY			English	Article									[Elenko, Eric; Underwood, Lindsay; Zohar, Daphne] PureTech, Boston, MA 02116 USA		Elenko, E (corresponding author), PureTech, Boston, MA 02116 USA.	DaphneNB@puretechhealth.com						Anguera JA, 2013, NATURE, V501, P97, DOI 10.1038/nature12486; Avery L, 2012, DIABETES CARE, V35, P2681, DOI 10.2337/dc11-2452; Barr A., 2014, WALL STREET J; Bloomberg J, 2014, FORBES; Chen R, 2012, CELL, V148, P1293, DOI 10.1016/j.cell.2012.02.009; Clifton L, 2014, IEEE J BIOMED HEALTH, V18, P722, DOI 10.1109/JBHI.2013.2293059; El-Khatib FH, 2010, SCI TRANSL MED, V2, DOI 10.1126/scitranslmed.3000619; Food and Drug Administration, 2012, 510 K SUMM KD 7964 F; Hafen E, 2014, METHOD INFORM MED, V53, P82, DOI 10.3414/ME13-02-0051; Kocher B., 2014, HARVARD BUS REV; Lim YY, 2014, ALZHEIMERS DEMENT, V10, P743, DOI 10.1016/j.jalz.2013.11.005; Lin JS, 2014, ANN INTERN MED, V161, P568, DOI 10.7326/M14-0130; Shaffer David Williamson, 2002, Stud Health Technol Inform, V80, P195; Topol EJ, 2015, JAMA-J AM MED ASSOC, V313, P353, DOI 10.1001/jama.2014.17125; US Food and Drug Administration, 2015, MOB MED APPL; Wicks P, 2011, NAT BIOTECHNOL, V29, P411, DOI 10.1038/nbt.1837; Williamson J.R., 2013, P IEEE INT C BOD SEN, P5, DOI DOI 10.1109/BSN.2013.6575523; Williamson JR, 2013, RESP PHYSIOL NEUROBI, V189, P223, DOI 10.1016/j.resp.2013.05.034	18	99	100	3	25	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156	1546-1696		NAT BIOTECHNOL	Nat. Biotechnol.	MAY	2015	33	5					456	461		10.1038/nbt.3222	http://dx.doi.org/10.1038/nbt.3222			6	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	CH8VP	25965750				2022-12-27	WOS:000354314500021
J	Gabriel, R; von Kalle, C; Schmidt, M				Gabriel, Richard; von Kalle, Christof; Schmidt, Manfred			Mapping the precision of genome editing	NATURE BIOTECHNOLOGY			English	Editorial Material							CRISPR-CAS; NUCLEASE SPECIFICITY; TARGET; BREAKS; CELLS		[Gabriel, Richard] Natl Ctr Tumor Dis, Heidelberg, Germany; German Canc Res Ctr, Heidelberg, Germany	Helmholtz Association; German Cancer Research Center (DKFZ); Ruprecht Karls University Heidelberg; Helmholtz Association; German Cancer Research Center (DKFZ)	Gabriel, R (corresponding author), Natl Ctr Tumor Dis, Heidelberg, Germany.	manfred.schmidt@nct-heidelberg.de						Carroll D, 2013, NAT BIOTECHNOL, V31, P807, DOI 10.1038/nbt.2684; Chiarle R, 2011, CELL, V147, P107, DOI 10.1016/j.cell.2011.07.049; Frock RL, 2015, NAT BIOTECHNOL, V33, P179, DOI 10.1038/nbt.3101; Fu YF, 2014, NAT BIOTECHNOL, V32, P279, DOI 10.1038/nbt.2808; Fu YF, 2013, NAT BIOTECHNOL, V31, P822, DOI 10.1038/nbt.2623; Gabriel R, 2011, NAT BIOTECHNOL, V29, P816, DOI 10.1038/nbt.1948; Gabriel R, 2009, NAT MED, V15, P1431, DOI 10.1038/nm.2057; Jinek M, 2012, SCIENCE, V337, P816, DOI 10.1126/science.1225829; Mali P, 2013, NAT BIOTECHNOL, V31, P833, DOI 10.1038/nbt.2675; Pattanayak V, 2011, NAT METHODS, V8, P765, DOI 10.1038/nmeth.1670; Tsai SQ, 2015, NAT BIOTECHNOL, V33, P187, DOI 10.1038/nbt.3117; Wang XL, 2015, NAT BIOTECHNOL, V33, P175, DOI 10.1038/nbt.3127	12	29	30	0	18	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156	1546-1696		NAT BIOTECHNOL	Nat. Biotechnol.	FEB	2015	33	2					150	152		10.1038/nbt.3142	http://dx.doi.org/10.1038/nbt.3142			3	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	CA8VK	25658281				2022-12-27	WOS:000349198800018
J	Jarchum, I; Jones, S				Jarchum, Irene; Jones, Susan			DREAMing of benchmarks	NATURE BIOTECHNOLOGY			English	Editorial Material							CHALLENGE; PREDICTION											Bansal M, 2014, NAT BIOTECHNOL, V32, P1213, DOI 10.1038/nbt.3052; Bilal E, 2013, PLOS COMPUT BIOL, V9, DOI 10.1371/journal.pcbi.1003047; Boutros PC, 2014, NAT GENET, V46, P318, DOI 10.1038/ng.2932; Costello JC, 2014, NAT BIOTECHNOL, V32, P1202, DOI 10.1038/nbt.2877; Kuffner R, 2015, NAT BIOTECHNOL, V33, P51, DOI 10.1038/nbt.3051; Margolin AA, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3006112; Plenge RM, 2013, NAT GENET, V45, P468, DOI 10.1038/ng.2623	7	7	7	0	4	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156	1546-1696		NAT BIOTECHNOL	Nat. Biotechnol.	JAN	2015	33	1					49	50		10.1038/nbt.3115	http://dx.doi.org/10.1038/nbt.3115			2	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	AY7AR	25574639				2022-12-27	WOS:000347714200026
J	van der Hoff, H				van der Hoff, Hilary			Antibody claims granted by the European Patent Office	NATURE BIOTECHNOLOGY			English	Editorial Material									Mewburn Ellis LLP, Cambridge, England		van der Hoff, H (corresponding author), Mewburn Ellis LLP, Cambridge, England.	hilary.vanderhoff@mewburn.com						Di Padova F, 2011, IL-17 antagonistic antibodies, Patent No. [EP 1776142, 1776142]; Fukuzawa H., 2010, Polypeptide having a delta 5 fatty acid unsaturating activity, poly-. nucleotide coding for the polypeptide and use thereof, Patent No. [EP1780275, 1780275]; Funaro A., 2011, Antibodies against human cytomegalovirus (HCMV), Patent No. [EP2126049, 2126049]; Gelber C., 2011, Ovarian cancer cell and myeloma cell surface glycoproteins, antibodies thereto, and uses thereof, Patent No. [EP1204683, 1204683]; Heinegard D., 2011, Method for determining a tissue degradation process by detection of COMP neoepitopes, Patent No. [EP1766411, 1766411]; Jacquemin M., 2011, Human inhibitory anti-factor VIII antibodies binding to the A2 domain, Patent No. [EP1910420, 1910420]; Klemt V., 2011, Method of detecting ProBNP with a monoclonal antibody binding to the amino acids 42-46, Patent No. [EP 1625164, 1625164]; Matsuo M., 2011, Anti-human soluble fibrin monoclonal antibody and immunological assay method using the antibody, Patent No. [EP1832654, 1832654]; Ohashi T., 2010, Hybridoma capable of producing a monoclonal antibody specific to tartrate-resistant acid phosphatase 5b (TRACP 5b), Patent No. [EP 1359161, 1359161]; Pilkington G., 2011, OVR110 antibody compositions and methods of use, Patent No. [EP1633784, 1633784]; Rinderknecht E., 2011, Linear VH-CH1-VH-CH1 heavy chain antibody fragment, Patent No. [EP1752465, 1752465]; Roschke V., 2011, Human G-protein chemokine receptor (CCR5) HDGNR10, Patent No. [EP 1366058, 1366058]; Salamone S., 2010, Doxorubicin immunoassay, Patent No. [EP 1864129, 1864129]; Shiver J., 2011, Human antibodies interacting with HIV gp41, Patent No. [EP1765398, 1765398]; Throsby M., 2011, Binding molecules capable of neutralizing West Nile virus and uses thereof, Patent No. [EP1828247, 1828247]; Wang X., 2010, Gene engineering recombinant anti-CEA. Anti-CD3 and anti-CD28 single-chain tri-specific antibody, Patent No. [EP1736484, 1736484]	16	1	2	0	3	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156	1546-1696		NAT BIOTECHNOL	Nat. Biotechnol.	NOV	2014	32	11					1094	1099	10.1038/nbt.3054	10.1038/nbt.3054	http://dx.doi.org/10.1038/nbt.3054			6	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	AT5IL	25380442				2022-12-27	WOS:000344977000011
J	Kleinstreuer, NC; Yang, J; Berg, EL; Knudsen, TB; Richard, AM; Martin, MT; Reif, DM; Judson, RS; Polokoff, M; Dix, DJ; Kavlock, RJ; Houck, KA				Kleinstreuer, Nicole C.; Yang, Jian; Berg, Ellen L.; Knudsen, Thomas B.; Richard, Ann M.; Martin, Matthew T.; Reif, David M.; Judson, Richard S.; Polokoff, Mark; Dix, David J.; Kavlock, Robert J.; Houck, Keith A.			Phenotypic screening of the ToxCast chemical library to classify toxic and therapeutic mechanisms	NATURE BIOTECHNOLOGY			English	Article							MAP KINASE INHIBITOR; DRUG DISCOVERY; PERFLUOROOCTANE SULFONATE; ENVIRONMENTAL CHEMICALS; RHEUMATOID-ARTHRITIS; PREDICTIVE MODELS; BIOLOGY APPROACH; BIOMAP ANALYSIS; BREAST-CANCER; RECEPTOR	Addressing the safety aspects of drugs and environmental chemicals has historically been undertaken through animal testing. However, the quantity of chemicals in need of assessment and the challenges of species extrapolation require the development of alternative approaches. Our approach, the US Environmental Protection Agency's ToxCast program, utilizes a large suite of in vitro and model organism assays to interrogate important chemical libraries and computationally analyze bioactivity profiles. Here we evaluated one component of the ToxCast program, the use of primary human cell systems, by screening for chemicals that disrupt physiologically important pathways. Chemical-response signatures for 87 endpoints covering molecular functions relevant to toxic and therapeutic pathways were generated in eight cell systems for 641 environmental chemicals and 135 reference pharmaceuticals and failed drugs. Computational clustering of the profiling data provided insights into the polypharmacology and potential off-target effects for many chemicals that have limited or no toxicity information. The endpoints measured can be closely linked to in vivo outcomes, such as the upregulation of tissue factor in endothelial cell systems by compounds linked to the risk of thrombosis in vivo. Our results demonstrate that assaying complex biological pathways in primary human cells can identify potential chemical targets, toxicological liabilities and mechanisms useful for elucidating adverse outcome pathways.	[Kleinstreuer, Nicole C.; Knudsen, Thomas B.; Richard, Ann M.; Martin, Matthew T.; Reif, David M.; Judson, Richard S.; Dix, David J.; Kavlock, Robert J.; Houck, Keith A.] US EPA, Natl Ctr Computat Toxicol, Off Res & Dev, Res Triangle Pk, NC 27711 USA; [Yang, Jian; Berg, Ellen L.; Polokoff, Mark] Div DiscoveRx Inc, BioSeek, San Francisco, CA USA	United States Environmental Protection Agency	Houck, KA (corresponding author), US EPA, Natl Ctr Computat Toxicol, Off Res & Dev, Res Triangle Pk, NC 27711 USA.	houck.keith@epa.gov	Houck, Keith/G-8654-2014; Berg, Ellen/T-8827-2019; Kleinstreuer, Nicole/F-7203-2019; Berg, Ellen/D-9076-2014	Houck, Keith/0000-0002-0055-2249; Kleinstreuer, Nicole/0000-0002-7914-3682; Reif, David/0000-0001-7815-6767; Berg, Ellen/0000-0001-5149-6665; Judson, Richard/0000-0002-2348-9633				AIZUYOKOTA E, 1994, CARCINOGENESIS, V15, P1875, DOI 10.1093/carcin/15.9.1875; Arredondo J, 2001, LAB INVEST, V81, P1653, DOI 10.1038/labinvest.3780379; Arrowsmith J, 2011, NAT REV DRUG DISCOV, V10, P1, DOI 10.1038/nrd3375; Attene-Ramos MS, 2013, DRUG DISCOV TODAY, V18, P716, DOI 10.1016/j.drudis.2013.05.015; Augustine-Rauch KA, 2004, BIRTH DEFECTS RES A, V70, P789, DOI 10.1002/bdra.20076; Ayala A, 1996, J BIOL CHEM, V271, P23105, DOI 10.1074/jbc.271.38.23105; Barna TM, 2001, J MOL BIOL, V310, P433, DOI 10.1006/jmbi.2001.4779; Barua RS, 2013, ARTERIOSCL THROM VAS, V33, P1460, DOI 10.1161/ATVBAHA.112.300154; Berg EL, 2005, IEE P SYST BIOL, V152, P201, DOI 10.1049/ip-syb:20050036; Berg Ellen L., 2006, Journal of Pharmacological and Toxicological Methods, V53, P67, DOI 10.1016/j.vascn.2005.06.003; Berg EL, 2013, J BIOMOL SCREEN, V18, P1260, DOI 10.1177/1087057113505324; Berg EL, 2010, J PHARMACOL TOX MET, V61, P3, DOI 10.1016/j.vascn.2009.10.001; Bogdanska J, 2011, TOXICOLOGY, V284, P54, DOI 10.1016/j.tox.2011.03.014; Bowes J, 2012, NAT REV DRUG DISCOV, V11, P909, DOI 10.1038/nrd3845; Camici GG, 2010, EUR HEART J, V31, P236, DOI 10.1093/eurheartj/ehp259; Chen Y, 2009, NAT CHEM BIOL, V5, P358, DOI 10.1038/nchembio.155; Clark RD, 2000, J MOL GRAPH MODEL, V18, P404, DOI 10.1016/S1093-3263(00)00065-6; Cohen SB, 2009, ARTHRITIS RHEUM, V60, P335, DOI 10.1002/art.24266; Cummings SR, 1999, JAMA-J AM MED ASSOC, V281, P2189, DOI 10.1001/jama.281.23.2189; Ding CH, 2006, CURR OPIN INVEST DR, V7, P1020; Dix DJ, 2007, TOXICOL SCI, V95, P5, DOI 10.1093/toxsci/kfl103; Fell MJ, 2010, NEUROPHARMACOLOGY, V58, P632, DOI 10.1016/j.neuropharm.2009.11.014; Houck KA, 2008, TOXICOL APPL PHARM, V227, P163, DOI 10.1016/j.taap.2007.10.022; Houck KA, 2009, J BIOMOL SCREEN, V14, P1054, DOI 10.1177/1087057109345525; Judson R, 2009, ENVIRON HEALTH PERSP, V117, P685, DOI 10.1289/ehp.0800168; Kavlock R, 2012, CHEM RES TOXICOL, V25, P1287, DOI 10.1021/tx3000939; Khaidakov M, 2009, BIOCHEM BIOPH RES CO, V387, P543, DOI 10.1016/j.bbrc.2009.07.057; Kirkiacharian S., 1999, Annales Pharmaceutiques Francaises, V57, P332; Kitchen DB, 2004, NAT REV DRUG DISCOV, V3, P935, DOI 10.1038/nrd1549; Kleinstreuer N, 2013, PLOS COMPUT BIOL, V9, DOI 10.1371/journal.pcbi.1002996; Kleinstreuer NC, 2011, ENVIRON HEALTH PERSP, V119, P1596, DOI 10.1289/ehp.1103412; Kohonen T, 2013, NEURAL NETWORKS, V37, P52, DOI 10.1016/j.neunet.2012.09.018; Kunkel EJ, 2004, ASSAY DRUG DEV TECHN, V2, P431, DOI 10.1089/1540658041850607; Kunkel EJ, 2004, FASEB J, V18, P1279, DOI 10.1096/fj.04-1538fje; Lau C, 2003, TOXICOL SCI, V74, P382, DOI 10.1093/toxsci/kfg122; LIPTON A, 1984, CANCER TREAT REP, V68, P887; Lounkine E, 2012, NATURE, V486, P361, DOI 10.1038/nature11159; Martin MT, 2011, BIOL REPROD, V85, P327, DOI 10.1095/biolreprod.111.090977; McCann FE, 2010, ARTHRITIS RES THER, V12, DOI 10.1186/ar3041; Melrose J, 1998, J IMMUNOL, V161, P2457; Murotani T, 2011, NEUROPHARMACOLOGY, V61, P228, DOI 10.1016/j.neuropharm.2011.04.003; National Research Council, 2007, TOX TEST 21 CENT VIS; Ouattara B, 2010, NEUROSCIENCE, V167, P1160, DOI 10.1016/j.neuroscience.2010.03.022; Owens AP, 2012, CURR ATHEROSCLER REP, V14, P394, DOI 10.1007/s11883-012-0269-5; Plavec I, 2004, P NATL ACAD SCI USA, V101, P1223, DOI 10.1073/pnas.0308221100; Robichaud A, 2002, BRIT J PHARMACOL, V135, P113, DOI 10.1038/sj.bjp.0704457; Sipes NS, 2011, TOXICOL SCI, V124, P109, DOI 10.1093/toxsci/kfr220; Thiede A, 2012, BBA-BIOENERGETICS, V1817, P1747, DOI 10.1016/j.bbabio.2012.02.034; Tice RR, 2013, ENVIRON HEALTH PERSP, V121, P756, DOI 10.1289/ehp.1205784; U.S. Environmental Protection Agency (EPA), 2021, PFAS STRAT ROADM EPA; Viguerie N, 2012, PHYSIOL GENOMICS, V44, P141, DOI 10.1152/physiolgenomics.00032.2011; Williams O, 2010, CHEM BIOL, V17, P123, DOI 10.1016/j.chembiol.2010.01.010	52	138	142	2	68	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156	1546-1696		NAT BIOTECHNOL	Nat. Biotechnol.	JUN	2014	32	6					583	+		10.1038/nbt.2914	http://dx.doi.org/10.1038/nbt.2914			12	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	AI9EV	24837663				2022-12-27	WOS:000337233800022
J	Elsner, M				Elsner, Markus			New PAMs for Cas	NATURE BIOTECHNOLOGY			English	Editorial Material							NUCLEASES							Elsner, Markus/0000-0001-7227-5212				Anders C, 2014, NATURE, V513, P569, DOI 10.1038/nature13579; Kleinstiver BP, 2015, NATURE, V523, P481, DOI 10.1038/nature14592; Tsai SQ, 2015, NAT BIOTECHNOL, V33, P187, DOI 10.1038/nbt.3117	3	1	1	1	3	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156	1546-1696		NAT BIOTECHNOL	Nat. Biotechnol.	AUG	2015	33	8					829	829		10.1038/nbt.3317	http://dx.doi.org/10.1038/nbt.3317			1	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	CO6OB	26252142	Bronze			2022-12-27	WOS:000359274900019
J	Jarchum, I				Jarchum, Irene			A flexible mesh to record the brain	NATURE BIOTECHNOLOGY			English	Editorial Material																		Liu J, 2015, NAT NANOTECHNOL, V10, P629, DOI [10.1038/NNANO.2015.115, 10.1038/nnano.2015.115]; Tian BZ, 2012, NAT MATER, V11, P986, DOI [10.1038/NMAT3404, 10.1038/nmat3404]	2	2	2	0	17	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156	1546-1696		NAT BIOTECHNOL	Nat. Biotechnol.	AUG	2015	33	8					830	830		10.1038/nbt.3316	http://dx.doi.org/10.1038/nbt.3316			1	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	CO6OB	26252143				2022-12-27	WOS:000359274900020
J	Lyon, RP; Bovee, TD; Doronina, SO; Burke, PJ; Hunter, JH; Neff-LaFord, HD; Jonas, M; Anderson, ME; Setter, JR; Senter, PD				Lyon, Robert P.; Bovee, Tim D.; Doronina, Svetlana O.; Burke, Patrick J.; Hunter, Joshua H.; Neff-LaFord, Haley D.; Jonas, Mechthild; Anderson, Martha E.; Setter, Jocelyn R.; Senter, Peter D.			Reducing hydrophobicity of homogeneous antibody-drug conjugates improves pharmacokinetics and therapeutic index	NATURE BIOTECHNOLOGY			English	Article							SITE-SPECIFIC CONJUGATION; LINKERS	The in vitro potency of antibody-drug conjugates (ADCs) increases with the drug-to-antibody ratio (DAR); however, ADC plasma clearance also increases with DAR, reducing exposure and in vivo efficacy. Here we show that accelerated clearance arises from ADC hydrophobicity, which can be modulated through drug-linker design. We exemplify this using hydrophilic auristatin drug linkers and PEGylated ADCs that yield uniform, high-DAR ADCs with superior in vivo performance.	[Lyon, Robert P.; Bovee, Tim D.; Doronina, Svetlana O.; Burke, Patrick J.; Hunter, Joshua H.; Setter, Jocelyn R.; Senter, Peter D.] Seattle Genet, Dept Chem, Bothell, WA 98021 USA; [Neff-LaFord, Haley D.] Seattle Genet, Dept Pharmacol & Toxicol, Bothell, WA USA; [Jonas, Mechthild] Seattle Genet, Dept Translat Res, Bothell, WA USA; [Anderson, Martha E.] Seattle Genet, Dept Preclin Res, Bothell, WA USA	Seattle Genetics; Seattle Genetics; Seattle Genetics; Seattle Genetics	Lyon, RP (corresponding author), Seattle Genet, Dept Chem, Bothell, WA 98021 USA.	rlyon@seagen.com						Hamblett KJ, 2004, CLIN CANCER RES, V10, P7063, DOI 10.1158/1078-0432.CCR-04-0789; Herbertson RA, 2009, CLIN CANCER RES, V15, P6709, DOI 10.1158/1078-0432.CCR-09-0536; Jeffrey SC, 2006, BIOCONJUGATE CHEM, V17, P831, DOI 10.1021/bc0600214; Jeffrey SC, 2013, BIOCONJUGATE CHEM, V24, P1256, DOI 10.1021/bc400217g; Junutula JR, 2008, NAT BIOTECHNOL, V26, P925, DOI 10.1038/nbt.1480; King HD, 2002, J MED CHEM, V45, P4336, DOI 10.1021/jm020149g; Lyori R.P., 2012, METHOD ENZYMOL, V502, P123; McDonagh CF, 2006, PROTEIN ENG DES SEL, V19, P299, DOI 10.1093/protein/gzl013; Miller ML, 2004, J MED CHEM, V47, P4802, DOI 10.1021/jm049705s; Moon SJ, 2008, J MED CHEM, V51, P6916, DOI 10.1021/jm800719t; Sievers EL, 2013, ANNU REV MED, V64, P15, DOI 10.1146/annurev-med-050311-201823; Strop P, 2013, CHEM BIOL, V20, P161, DOI 10.1016/j.chembiol.2013.01.010; Wang LT, 2005, PROTEIN SCI, V14, P2436, DOI 10.1110/ps.051478705; Zhao RY, 2011, J MED CHEM, V54, P3606, DOI 10.1021/jm2002958	14	279	296	11	128	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156	1546-1696		NAT BIOTECHNOL	Nat. Biotechnol.	JUL	2015	33	7					733	735		10.1038/nbt.3212	http://dx.doi.org/10.1038/nbt.3212			3	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	CN4JJ	26076429				2022-12-27	WOS:000358396100028
J	Cao, HZ; Wu, HL; Luo, RB; Huang, SJ; Sun, YH; Tong, X; Xie, YL; Liu, BH; Yang, HL; Zheng, HC; Li, J; Li, B; Wang, Y; Yang, F; Sun, P; Liu, SY; Gao, P; Huang, HD; Sun, J; Chen, D; He, GZ; Huang, WH; Huang, Z; Li, Y; Tellier, LCAM; Liu, X; Feng, Q; Xu, X; Zhang, XQ; Bolund, L; Krogh, A; Kristiansen, K; Drmanac, R; Drmanac, S; Nielsen, R; Li, SG; Wang, J; Yang, HM; Li, YR; Wong, GKS; Wang, J				Cao, Hongzhi; Wu, Honglong; Luo, Ruibang; Huang, Shujia; Sun, Yuhui; Tong, Xin; Xie, Yinlong; Liu, Binghang; Yang, Hailong; Zheng, Hancheng; Li, Jian; Li, Bo; Wang, Yu; Yang, Fang; Sun, Peng; Liu, Siyang; Gao, Peng; Huang, Haodong; Sun, Jing; Chen, Dan; He, Guangzhu; Huang, Weihua; Huang, Zheng; Li, Yue; Tellier, Laurent C. A. M.; Liu, Xiao; Feng, Qiang; Xu, Xun; Zhang, Xiuqing; Bolund, Lars; Krogh, Anders; Kristiansen, Karsten; Drmanac, Radoje; Drmanac, Snezana; Nielsen, Rasmus; Li, Songgang; Wang, Jian; Yang, Huanming; Li, Yingrui; Wong, Gane Ka-Shu; Wang, Jun			De novo assembly of a haplotype-resolved human genome	NATURE BIOTECHNOLOGY			English	Article							SEQUENCE; SNP; CANCER	The human genome is diploid, and knowledge of the variants on each chromosome is important for the interpretation of genomic information. Here we report the assembly of a haplotype-resolved diploid genome without using a reference genome. Our pipeline relies on fosmid pooling together with whole-genome shotgun strategies, based solely on next-generation sequencing and hierarchical assembly methods. We applied our sequencing method to the genome of an Asian individual and generated a 5.15-Gb assembled genome with a haplotype N50 of 484 kb. Our analysis identified previously undetected indels and 7.49 Mb of novel coding sequences that could not be aligned to the human reference genome, which include at least six predicted genes. This haplotype-resolved genome represents the most complete de novo human genome assembly to date. Application of our approach to identify individual haplotype differences should aid in translating genotypes to phenotypes for the development of personalized medicine.	[Cao, Hongzhi; Wu, Honglong; Luo, Ruibang; Huang, Shujia; Sun, Yuhui; Tong, Xin; Xie, Yinlong; Liu, Binghang; Yang, Hailong; Zheng, Hancheng; Li, Jian; Li, Bo; Wang, Yu; Yang, Fang; Sun, Peng; Liu, Siyang; Gao, Peng; Huang, Haodong; Sun, Jing; Chen, Dan; He, Guangzhu; Huang, Weihua; Huang, Zheng; Li, Yue; Tellier, Laurent C. A. M.; Liu, Xiao; Feng, Qiang; Xu, Xun; Zhang, Xiuqing; Bolund, Lars; Krogh, Anders; Kristiansen, Karsten; Nielsen, Rasmus; Li, Songgang; Wang, Jian; Yang, Huanming; Li, Yingrui; Wong, Gane Ka-Shu; Wang, Jun] BGI Shenzhen, Shenzhen, Peoples R China; [Cao, Hongzhi; Wu, Honglong] BGI Tianjin, Tianjin, Peoples R China; [Zheng, Hancheng; Li, Jian; Liu, Siyang; Tellier, Laurent C. A. M.; Liu, Xiao; Feng, Qiang; Krogh, Anders; Kristiansen, Karsten] Univ Copenhagen, Dept Biol, Copenhagen, Denmark; [Luo, Ruibang; Xie, Yinlong; Liu, Binghang] HKU BGI Bioinformat Algorithms & Core Technol Res, Hong Kong, Hong Kong, Peoples R China; [Huang, Shujia; Sun, Yuhui; Wang, Yu; Huang, Haodong] S China Univ Technol, Sch Biosci & Bioengn, Guangzhou 510641, Guangdong, Peoples R China; [Bolund, Lars] Univ Aarhus, Inst Biomed, Aarhus, Denmark; [Bolund, Lars] Danish Ctr Translat Breast Canc Res, Copenhagen, Denmark; [Drmanac, Radoje; Drmanac, Snezana] Complete Genom Inc, Mountain View, CA USA; [Nielsen, Rasmus] Univ Calif Berkeley, Dept Integrat Biol, Berkeley, CA 94720 USA; [Nielsen, Rasmus] Univ Calif Berkeley, Dept Stat, Berkeley, CA 94720 USA; [Wang, Jian; Yang, Huanming] James D Watson Inst Genome Sci, Hangzhou, Zhejiang, Peoples R China; [Yang, Huanming; Wang, Jun] King Abdulaziz Univ, Princess AI Jawhara Albrahim Ctr Excellence Res H, Jeddah 21413, Saudi Arabia; [Li, Yingrui] Univ Queensland, Inst Mol Biosci, Brisbane, Qld, Australia; [Wong, Gane Ka-Shu] Univ Alberta, Dept Biol Sci, Edmonton, AB, Canada; [Wong, Gane Ka-Shu] Univ Alberta, Dept Med, Edmonton, AB, Canada; [Wang, Jun] Macau Univ Sci & Technol, Taipa, Macau, Peoples R China; [Wang, Jun] Univ Hong Kong, Dept Med, Hong Kong, Hong Kong, Peoples R China; [Wang, Jun] Univ Hong Kong, State Key Lab Pharmaceut Biotechnol, Hong Kong, Hong Kong, Peoples R China	Beijing Genomics Institute (BGI); Beijing Genomics Institute (BGI); University of Copenhagen; University of Hong Kong; South China University of Technology; Aarhus University; University of California System; University of California Berkeley; University of California System; University of California Berkeley; King Abdulaziz University; University of Queensland; University of Alberta; University of Alberta; Macau University of Science & Technology; University of Hong Kong; University of Hong Kong	Wang, J (corresponding author), BGI Shenzhen, Shenzhen, Peoples R China.	liyr@genomics.cn; gane@ualberta.ca; wangj@genomics.cn	WONG, Gane Ka-Shu/G-5784-2013; Li, Yingrui/K-1064-2015; Liu, Xiao/P-2732-2015; Xu, Xun/AAI-6763-2020; Nielsen, Rasmus/D-4405-2009; Kristiansen, Karsten/J-5148-2014; yang, hailong/GXH-9625-2022; Huang, Shujia/GXG-8583-2022; Liu, Siyang/M-6127-2014; Krogh, Anders/M-1541-2014; Wang, Jun/B-9503-2016; Wang, Jun/C-8434-2016	WONG, Gane Ka-Shu/0000-0001-6108-5560; Liu, Xiao/0000-0002-8073-0534; Xu, Xun/0000-0002-5338-5173; Nielsen, Rasmus/0000-0003-0513-6591; Kristiansen, Karsten/0000-0002-6024-0917; Huang, Shujia/0000-0003-2100-2534; Liu, Siyang/0000-0001-6780-9419; Luo, Ruibang/0000-0001-9711-6533; Melchior Tellier, Laurent Christian Asker/0000-0003-3240-4926; Krogh, Anders/0000-0002-5147-6282; Wang, Jun/0000-0002-2113-5874; liu, bh/0000-0002-4948-2835; Wang, Jun/0000-0002-8540-8931	State Key Development Program for Basic Research of China-973 Program [2011CB809202]; Shenzhen Municipal Government of China [JC201005260191A]; International Science and Technology Cooperation Program of Shenzhen [GJHZ20130417140835564]; Tianjin Municipal Science and Technology special funds for Enterprise Development [14ZXLJSY00320]; Alberta Innovates Technology Futures; Lundbeck Foundation [R151-2013-14439] Funding Source: researchfish	State Key Development Program for Basic Research of China-973 Program(National Basic Research Program of ChinaState Key Development Program for Basic Research of China); Shenzhen Municipal Government of China; International Science and Technology Cooperation Program of Shenzhen; Tianjin Municipal Science and Technology special funds for Enterprise Development; Alberta Innovates Technology Futures; Lundbeck Foundation(Lundbeckfonden)	We wish to recognize BGI-Shenzhen's sequencing platform for generating the data in this study. We thank the faculty and staff at BGI-Shenzhen who contributed to this project especially to H. Jiang and B. Wang, who helped on the experimental part, D. Cao, L. Lin and M. Li, who helped on the validation part, and L. Goodman, W. Chen and H. Jia, who provided critical comments on the manuscript. This work was supported by the State Key Development Program for Basic Research of China-973 Program (no. 2011CB809202); the Shenzhen Municipal Government of China (no. JC201005260191A); International Science and Technology Cooperation Program of Shenzhen (GJHZ20130417140835564); Tianjin Municipal Science and Technology special funds for Enterprise Development (no. 14ZXLJSY00320). G.W. was also supported by Alberta Innovates Technology Futures.	Adey A, 2013, NATURE, V500, P207, DOI 10.1038/nature12064; Adzhubei IA, 2010, NAT METHODS, V7, P248, DOI 10.1038/nmeth0410-248; Aghaei M, 2005, CLIN BIOCHEM, V38, P887, DOI 10.1016/j.clinbiochem.2005.05.015; Ahn SM, 2009, GENOME RES, V19, P1622, DOI 10.1101/gr.092197.109; Alkan C, 2011, NAT REV GENET, V12, P363, DOI 10.1038/nrg2958; Altshuler D, 2005, NATURE, V437, P1299, DOI 10.1038/nature04226; Altshuler D, 2010, NATURE, V467, P1061, DOI 10.1038/nature09534; Altshuler DM, 2012, NATURE, V491, P56, DOI 10.1038/nature11632; Altshuler DM, 2010, NATURE, V467, P52, DOI 10.1038/nature09298; Audic S, 1997, GENOME RES, V7, P986, DOI 10.1101/gr.7.10.986; Bentley DR, 2008, NATURE, V456, P53, DOI 10.1038/nature07517; Browning SR, 2007, AM J HUM GENET, V81, P1084, DOI 10.1086/521987; Browning SR, 2011, NAT REV GENET, V12, P703, DOI 10.1038/nrg3054; Cao HZ, 2013, HUM MUTAT, V34, P1715, DOI 10.1002/humu.22439; Dapprich J, 2008, NUCLEIC ACIDS RES, V36, DOI 10.1093/nar/gkn345; DePristo MA, 2011, NAT GENET, V43, P491, DOI 10.1038/ng.806; Duitama J, 2012, NUCLEIC ACIDS RES, V40, P2041, DOI 10.1093/nar/gkr1042; Fan HC, 2011, NAT BIOTECHNOL, V29, P51, DOI 10.1038/nbt.1739; Han WL, 2001, BIOCHEM J, V357, P127, DOI 10.1042/0264-6021:3570127; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Huang DW, 2009, NUCLEIC ACIDS RES, V37, P1, DOI 10.1093/nar/gkn923; Khurana E, 2013, SCIENCE, V342, P84, DOI 10.1126/science.1235587; Kirin M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013996; Kitzman JO, 2011, NAT BIOTECHNOL, V29, P59, DOI 10.1038/nbt.1740; Lam HYK, 2012, NAT BIOTECHNOL, V30, P78, DOI 10.1038/nbt.2065; Lander ES, 2001, NATURE, V409, P860, DOI 10.1038/35057062; Levy S, 2007, PLOS BIOL, V5, P2113, DOI 10.1371/journal.pbio.0050254; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Li RQ, 2010, NAT BIOTECHNOL, V28, P57, DOI 10.1038/nbt.1596; Li RQ, 2009, GENOME RES, V19, P1124, DOI 10.1101/gr.088013.108; Li YR, 2011, NAT BIOTECHNOL, V29, P723, DOI 10.1038/nbt.1904; Li YR, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000533; Li Y, 2010, GENET EPIDEMIOL, V34, P816, DOI 10.1002/gepi.20533; Luo RB, 2012, GIGASCIENCE, V1, DOI 10.1186/2047-217X-1-18; Ng PC, 2003, NUCLEIC ACIDS RES, V31, P3812, DOI 10.1093/nar/gkg509; Pemberton TJ, 2012, AM J HUM GENET, V91, P275, DOI 10.1016/j.ajhg.2012.06.014; Peng ZY, 2012, NAT BIOTECHNOL, V30, P253, DOI 10.1038/nbt.2122; Peters BA, 2012, NATURE, V487, P190, DOI 10.1038/nature11236; Rusk N, 2012, NAT METHODS, V9, P36, DOI 10.1038/nmeth.1822; Schwartz S, 2003, GENOME RES, V13, P103, DOI 10.1101/gr.809403; Suk EK, 2011, GENOME RES, V21, P1672, DOI 10.1101/gr.125047.111; Tewhey R, 2011, NAT REV GENET, V12, P215, DOI 10.1038/nrg2950; Tong P, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-9-r91; Trapnell C, 2010, NAT BIOTECHNOL, V28, P511, DOI 10.1038/nbt.1621; Wang J, 2008, NATURE, V456, P60, DOI 10.1038/nature07484; Wang K, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkq603; Woolley AT, 2000, NAT BIOTECHNOL, V18, P760, DOI 10.1038/77760; Yang Mihi, 2012, Methods Mol Biol, V863, P67, DOI 10.1007/978-1-61779-612-8_5; Zhang GF, 2012, NATURE, V490, P49, DOI 10.1038/nature11413; Zook JM, 2014, NAT BIOTECHNOL, V32, P246, DOI 10.1038/nbt.2835	50	47	51	1	49	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156	1546-1696		NAT BIOTECHNOL	Nat. Biotechnol.	JUN	2015	33	6					617	+		10.1038/nbt.3200	http://dx.doi.org/10.1038/nbt.3200			10	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	CK2DE	26006006	Green Published			2022-12-27	WOS:000356019700021
J	Pepper, AR; Gala-Lopez, B; Pawlick, R; Merani, S; Kin, T; Shapiro, AMJ				Pepper, Andrew R.; Gala-Lopez, Boris; Pawlick, Rena; Merani, Shaheed; Kin, Tatsuya; Shapiro, A. M. James			A prevascularized subcutaneous device-less site for islet and cellular transplantation	NATURE BIOTECHNOLOGY			English	Article							PANCREATIC-ISLETS; TISSUE; IMPLANTS; NEOVASCULARIZATION; REVASCULARIZATION; REVERSAL; GROWTH; MICE	Transplantation of donor-derived islets into the liver is a successful cellular replacement therapy for individuals with diabetes. However, the hepatic vasculature is not an optimal transplant site for several reasons, including graft attrition and the inability to retrieve or image the islets. Here we describe islet transplantation into a prevascularized, subcutaneous site created by temporary placement of a medically approved vascular access catheter. In mice with streptozotocin (STZ)-induced diabetes, transplantation of similar to 500 syngeneic islets into the resulting 'device-less' space reversed diabetes in 91% of mice and maintained normoglycemia for >100 days. The approach was also effective in mice with pre-existing diabetes, in another mouse strain that mounts a more vigorous inflammatory response, and across an allogeneic barrier. These results demonstrate that transient priming of a subcutaneous site supports diabetes-reversing islet transplantation in mouse models without the need for a permanent cell-encapsulation device.	[Pepper, Andrew R.; Gala-Lopez, Boris; Pawlick, Rena; Merani, Shaheed; Kin, Tatsuya; Shapiro, A. M. James] Univ Alberta, Clin Islet Transplant Program, Alberta Diabet Inst, Edmonton, AB, Canada; [Kin, Tatsuya; Shapiro, A. M. James] Univ Alberta, Dept Surg, Edmonton, AB, Canada	University of Alberta; University of Alberta	Shapiro, AMJ (corresponding author), Univ Alberta, Clin Islet Transplant Program, Alberta Diabet Inst, Edmonton, AB, Canada.	amjs@islet.ca	Kin, Tatsuya/A-3776-2012; Merani, Shaheed/AFO-2184-2022	Kin, Tatsuya/0000-0002-5179-6067; Merani, Shaheed/0000-0002-3374-5303	Diabetes Research Institute Foundation of Canada; Collaborative Research & Innovation Opportunities (CRIO)-Alberta Innovates Healthcare Solutions; University Hospital Foundation/C.F; "Curly" and Gladys B. MacLachlan Fund; Canada Research Chair in Transplantation Surgery and Regenerative Medicine; Senior Clinical Scholarship from Alberta Innovates Healthcare Solutions; Alberta Innovates [201400106, 201400496, 201201154] Funding Source: researchfish	Diabetes Research Institute Foundation of Canada; Collaborative Research & Innovation Opportunities (CRIO)-Alberta Innovates Healthcare Solutions; University Hospital Foundation/C.F; "Curly" and Gladys B. MacLachlan Fund; Canada Research Chair in Transplantation Surgery and Regenerative Medicine; Senior Clinical Scholarship from Alberta Innovates Healthcare Solutions; Alberta Innovates	The authors thank H. Tanaka for Figure 1. We thank the Clinical Islet Laboratory and Alberta Health Services for providing human islet research preparations. This work was supported in part by the Diabetes Research Institute Foundation of Canada, Collaborative Research & Innovation Opportunities (CRIO)-Alberta Innovates Healthcare Solutions, and from University Hospital Foundation/C.F. "Curly" and Gladys B. MacLachlan Fund. All authors are members of the Alberta Diabetes Institute, and of the Canadian National Transplant Research Program. A.M.J.S. is supported through a Canada Research Chair in Transplantation Surgery and Regenerative Medicine, and through a Senior Clinical Scholarship from Alberta Innovates Healthcare Solutions.	Anderson JM, 2008, SEMIN IMMUNOL, V20, P86, DOI 10.1016/j.smim.2007.11.004; Anderson JM, 2001, ANNU REV MATER RES, V31, P81, DOI 10.1146/annurev.matsci.31.1.81; Brekken RA, 2000, CANCER RES, V60, P5117; Brissova M, 2008, DIABETES, V57, P2269, DOI 10.2337/db08-0814; Costa PZ, 2013, LIFE SCI, V92, P1037, DOI 10.1016/j.lfs.2013.04.001; Fujiwara Nagatoshi, 2005, Current Drug Targets - Inflammation and Allergy, V4, P281, DOI 10.2174/1568010054022024; Grainger DW, 2013, NAT BIOTECHNOL, V31, P507, DOI 10.1038/nbt.2600; Harlan DM, 2009, DIABETES, V58, P2175, DOI 10.2337/db09-0476; HELLERSTROM C, 1989, BAILLIERE CLIN GASTR, V3, P851, DOI 10.1016/0950-3528(89)90037-7; Kenneth Ward W, 2008, J Diabetes Sci Technol, V2, P768; Kin T, 2008, TRANSPL INT, V21, P1029, DOI 10.1111/j.1432-2277.2008.00719.x; Korsgren O, 2008, DIABETOLOGIA, V51, P227, DOI 10.1007/s00125-007-0868-9; Merani S, 2008, BRIT J SURG, V95, P1449, DOI 10.1002/bjs.6391; Nishimura R, 2011, TRANSPL P, V43, P3239, DOI 10.1016/j.transproceed.2011.09.095; Nyqvist D, 2005, DIABETES, V54, P2287, DOI 10.2337/diabetes.54.8.2287; Olsson R, 2011, DIABETES, V60, P2350, DOI 10.2337/db09-0490; Pepper AR, 2013, CLIN DEV IMMUNOL, DOI 10.1155/2013/352315; Pileggi A, 2001, CLIN CHIM ACTA, V310, P3, DOI 10.1016/S0009-8981(01)00503-4; Pileggi A, 2006, TRANSPLANTATION, V81, P1318, DOI 10.1097/01.tp.0000203858.41105.88; Plesner A, 2011, J TRANSPLANT, V2011, DOI 10.1155/2011/979527; Rajab A, 2010, CURR DIABETES REP, V10, P332, DOI 10.1007/s11892-010-0130-6; RICORDI C, 1989, DIABETES, V38, P140, DOI 10.2337/diab.38.1.S140; Ricordi C, 2004, NAT REV IMMUNOL, V4, P258, DOI 10.1038/nri1332; Ryan EA, 2005, DIABETES, V54, P2060, DOI 10.2337/diabetes.54.7.2060; Saito T, 2011, TRANSPLANTATION, V92, P1231, DOI 10.1097/TP.0b013e3182375835; Sakata N, 2014, DIABETES-METAB RES, V30, P1, DOI 10.1002/dmrr.2463; Shapiro A.M., 2014, TXB ORGAN TRANSPLANT, V1, P904; Shapiro A. M., 2007, ISLET TRANSPLANTATIO; Shapiro AMJ, 2000, NEW ENGL J MED, V343, P230, DOI 10.1056/NEJM200007273430401; Sharkawy AA, 1997, J BIOMED MATER RES, V37, P401; Sharkawy AA, 1998, J BIOMED MATER RES, V40, P586, DOI 10.1002/(SICI)1097-4636(19980615)40:4<586::AID-JBM10>3.3.CO;2-V; Sharkawy AA, 1998, J BIOMED MATER RES, V40, P598, DOI 10.1002/(SICI)1097-4636(19980615)40:4<598::AID-JBM11>3.3.CO;2-N; SIMEONOVIC CJ, 1986, AUST J EXP BIOL MED, V64, P37, DOI 10.1038/icb.1986.4; Tamarat R, 2004, AM J PATHOL, V164, P457, DOI 10.1016/S0002-9440(10)63136-7; van Amerongen Machteld J., 2002, Angiogenesis, V5, P173, DOI 10.1023/A:1023822504224; Veriter S, 2013, CURR DIABETES REP, V13, P745, DOI 10.1007/s11892-013-0412-x; Zhang HF, 2006, NAT BIOTECHNOL, V24, P848, DOI 10.1038/nbt1220; Zhang L, 2013, NAT BIOTECHNOL, V31, P553, DOI 10.1038/nbt.2580	38	204	210	12	80	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156	1546-1696		NAT BIOTECHNOL	Nat. Biotechnol.	MAY	2015	33	5					518	U233		10.1038/nbt.3211	http://dx.doi.org/10.1038/nbt.3211			8	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	CH8VP	25893782				2022-12-27	WOS:000354314500033
J	Doench, JG; Hartenian, E; Graham, DB; Tothova, Z; Hegde, M; Smith, I; Sullender, M; Ebert, BL; Xavier, RJ; Root, DE				Doench, John G.; Hartenian, Ella; Graham, Daniel B.; Tothova, Zuzana; Hegde, Mudra; Smith, Ian; Sullender, Meagan; Ebert, Benjamin L.; Xavier, Ramnik J.; Root, David E.			Rational design of highly active sgRNAs for CRISPR-Cas9-mediated gene inactivation	NATURE BIOTECHNOLOGY			English	Article							HUMAN-CELLS; CAS9; ENDONUCLEASE; SYSTEM; DNA; IDENTIFICATION; SPECIFICITY; NUCLEASES; IMMUNITY; CANCER	Components of the prokaryotic clustered, regularly interspaced, short palindromic repeats (CRISPR) loci have recently been repurposed for use in mammalian cells(1-6). The CRISPR-associated (Cas) 9 can be programmed with a single guide RNA (sgRNA) to generate site-specific DNA breaks, but there are few known rules governing on-target efficacy of this system(7,8). We created a pool of sgRNAs, tiling across all possible target sites of a panel of six endogenous mouse and three endogenous human genes and quantitatively assessed their ability to produce null alleles of their target gene by antibody staining and flow cytometry. We discovered sequence features that improved activity, including a further optimization of the protospacer-adjacent motif (PAM) of Streptococcus pyogenes Cas9. The results from 1,841 sgRNAs were used to construct a predictive model of sgRNA activity to improve sgRNA design for gene editing and genetic screens. We provide an online tool for the design of highly active sgRNAs for any gene of interest.	[Doench, John G.; Hartenian, Ella; Graham, Daniel B.; Tothova, Zuzana; Hegde, Mudra; Smith, Ian; Sullender, Meagan; Ebert, Benjamin L.; Xavier, Ramnik J.; Root, David E.] Broad Inst MIT & Harvard, Cambridge, MA 02142 USA; [Tothova, Zuzana; Ebert, Benjamin L.] Harvard Univ, Brigham & Womens Hosp, Sch Med, Dept Med,Div Hematol, Boston, MA 02115 USA; [Xavier, Ramnik J.] Massachusetts Gen Hosp, Gastrointestinal Unit, Boston, MA 02114 USA; [Xavier, Ramnik J.] Massachusetts Gen Hosp, Ctr Study Inflammatory Bowel Dis, Boston, MA 02114 USA; [Xavier, Ramnik J.] Harvard Univ, Sch Med, Boston, MA USA; [Xavier, Ramnik J.] Massachusetts Gen Hosp, Ctr Computat & Integrat Biol, Boston, MA 02114 USA	Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Harvard University; Brigham & Women's Hospital; Harvard Medical School; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; Harvard University; Massachusetts General Hospital	Doench, JG (corresponding author), Broad Inst MIT & Harvard, Cambridge, MA 02142 USA.	jdoench@broadinstitute.org; droot@broadinstitute.org	Doench, John G/HCI-9570-2022; Doench, John/ABE-6251-2020	Doench, John G/0000-0002-3707-9889; Doench, John/0000-0002-3707-9889; Hegde, Mudra/0000-0003-4530-4633; Sullender, Meagan/0000-0001-6666-8650	US National Institutes of Health [5T32CA009172-39]; NATIONAL CANCER INSTITUTE [T32CA009172] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U19AI109725] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK043351] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	E.H., D B G., Z T. and J.G.D. designed experiments; E.H., M.S., D.B.G. and Z.T. ran experiments; E.H. and J.G.D. analyzed experimental results; M.H. and J.G.D. analyzed sequencing data and developed analysis tools; I. S. developed the sgRNA scoring model; E.H., D.E.R. and J.G.D. wrote the manuscript with help from other authors; B.L.E., R.J.X. and D.E.R. supervised the research. J.G.D. is a Merkin Institute Fellow. Z.T. is supported by US National Institutes of Health 5T32CA009172-39.	Barrangou R, 2007, SCIENCE, V315, P1709, DOI 10.1126/science.1138140; Cheung HW, 2011, P NATL ACAD SCI USA, V108, P12372, DOI 10.1073/pnas.1109363108; Cho SW, 2014, GENOME RES, V24, P132, DOI 10.1101/gr.162339.113; Cong L, 2013, SCIENCE, V339, P819, DOI 10.1126/science.1231143; Fellmann C, 2011, MOL CELL, V41, P733, DOI 10.1016/j.molcel.2011.02.008; Fu YF, 2014, NAT BIOTECHNOL, V32, P279, DOI 10.1038/nbt.2808; Fu YF, 2013, NAT BIOTECHNOL, V31, P822, DOI 10.1038/nbt.2623; Gagnon JA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0098186; Garneau JE, 2010, NATURE, V468, P67, DOI 10.1038/nature09523; Hsu PD, 2013, NAT BIOTECHNOL, V31, P827, DOI 10.1038/nbt.2647; Jiang WY, 2013, NAT BIOTECHNOL, V31, P233, DOI 10.1038/nbt.2508; Jinek M, 2013, ELIFE, V2, DOI 10.7554/eLife.00471; Jinek M, 2012, SCIENCE, V337, P816, DOI 10.1126/science.1225829; Koike-Yusa H, 2014, NAT BIOTECHNOL, V32, P267, DOI 10.1038/nbt.2800; Kuscu C, 2014, NAT BIOTECHNOL, V32, P677, DOI 10.1038/nbt.2916; Luo B, 2008, P NATL ACAD SCI USA, V105, P20380, DOI 10.1073/pnas.0810485105; Mali P, 2013, SCIENCE, V339, P823, DOI 10.1126/science.1232033; Reynolds A, 2004, NAT BIOTECHNOL, V22, P326, DOI 10.1038/nbt936; Sapranauskas R, 2011, NUCLEIC ACIDS RES, V39, P9275, DOI 10.1093/nar/gkr606; Shalem O, 2014, SCIENCE, V343, P84, DOI 10.1126/science.1247005; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Wang T, 2014, SCIENCE, V343, P80, DOI 10.1126/science.1246981; Wu XB, 2014, NAT BIOTECHNOL, V32, P670, DOI 10.1038/nbt.2889; Yang H, 2013, CELL, V154, P1370, DOI 10.1016/j.cell.2013.08.022; Zhou YX, 2014, NATURE, V509, P487, DOI 10.1038/nature13166	25	1045	1169	14	316	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156	1546-1696		NAT BIOTECHNOL	Nat. Biotechnol.	DEC	2014	32	12					1262	U130		10.1038/nbt.3026	http://dx.doi.org/10.1038/nbt.3026			8	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	AW3AD	25184501	Green Accepted			2022-12-27	WOS:000346156800029
J	Wu, GA; Prochnik, S; Jenkins, J; Salse, J; Hellsten, U; Murat, F; Perrier, X; Ruiz, M; Scalabrin, S; Terol, J; Takita, MA; Labadie, K; Poulain, J; Couloux, A; Jabbari, K; Cattonaro, F; Del Fabbro, C; Pinosio, S; Zuccolo, A; Chapman, J; Grimwood, J; Tadeo, FR; Estornell, LH; Munoz-Sanz, JV; Ibanez, V; Herrero-Ortega, A; Aleza, P; Perez-Perez, J; Ramon, D; Brunel, D; Luro, F; Chen, CX; Farmerie, WG; Desany, B; Kodira, C; Mohiuddin, M; Harkins, T; Fredrikson, K; Burns, P; Lomsadze, A; Borodovsky, M; Reforgiato, G; Freitas-Astua, J; Quetier, F; Navarro, L; Roose, M; Wincker, P; Schmutz, J; Morgante, M; Machado, MA; Talon, M; Jaillon, O; Ollitrault, P; Gmitter, F; Rokhsar, D				Wu, G. Albert; Prochnik, Simon; Jenkins, Jerry; Salse, Jerome; Hellsten, Uffe; Murat, Florent; Perrier, Xavier; Ruiz, Manuel; Scalabrin, Simone; Terol, Javier; Takita, Marco Aurelio; Labadie, Karine; Poulain, Julie; Couloux, Arnaud; Jabbari, Kamel; Cattonaro, Federica; Del Fabbro, Cristian; Pinosio, Sara; Zuccolo, Andrea; Chapman, Jarrod; Grimwood, Jane; Tadeo, Francisco R.; Estornell, Leandro H.; Munoz-Sanz, Juan V.; Ibanez, Victoria; Herrero-Ortega, Amparo; Aleza, Pablo; Perez-Perez, Julian; Ramon, Daniel; Brunel, Dominique; Luro, Francois; Chen, Chunxian; Farmerie, William G.; Desany, Brian; Kodira, Chinnappa; Mohiuddin, Mohammed; Harkins, Tim; Fredrikson, Karin; Burns, Paul; Lomsadze, Alexandre; Borodovsky, Mark; Reforgiato, Giuseppe; Freitas-Astua, Juliana; Quetier, Francis; Navarro, Luis; Roose, Mikeal; Wincker, Patrick; Schmutz, Jeremy; Morgante, Michele; Machado, Marcos Antonio; Talon, Manuel; Jaillon, Olivier; Ollitrault, Patrick; Gmitter, Frederick; Rokhsar, Daniel			Sequencing of diverse mandarin, pummelo and orange genomes reveals complex history of admixture during citrus domestication	NATURE BIOTECHNOLOGY			English	Article							SINENSIS L. OSBECK; HORT. EX TAN.; MOLECULAR MARKERS; ORIGIN; CLEMENTINA; RUTACEAE; ORGANIZATION; EVOLUTION; SSRS; MAP	Cultivated citrus are selections from, or hybrids of, wild progenitor species whose identities and contributions to citrus domestication remain controversial. Here we sequence and compare citrus genomes-a high-quality reference haploid clementine genome and mandarin, pummelo, sweet-orange and sour-orange genomes- and show that cultivated types derive from two progenitor species. Although cultivated pummelos represent selections from one progenitor species, Citrus maxima, cultivated mandarins are introgressions of C. maxima into the ancestral mandarin species Citrus reticulata. The most widely cultivated citrus, sweet orange, is the offspring of previously admixed individuals, but sour orange is an F1 hybrid of pure C. maxima and C. reticulata parents, thus implying that wild mandarins were part of the early breeding germplasm. A Chinese wild 'mandarin' diverges substantially from C. reticulata, thus suggesting the possibility of other unrecognized wild citrus species. Understanding citrus phylogeny through genome analysis clarifies taxonomic relationships and facilitates sequence-directed genetic improvement.	[Wu, G. Albert; Prochnik, Simon; Hellsten, Uffe; Chapman, Jarrod; Rokhsar, Daniel] US DOE, Joint Genome Inst, Walnut Creek, CA 94598 USA; [Jenkins, Jerry; Grimwood, Jane; Schmutz, Jeremy] HudsonAlpha Biotechnol Inst, Huntsville, AL USA; [Salse, Jerome; Murat, Florent] UBA, INRA, UMR Genet Diversite Ecophysiol Cereales GDEC 1095, Clermont Ferrand, France; [Perrier, Xavier; Ruiz, Manuel; Ollitrault, Patrick] CIRAD, UMR AGAP, Montpellier, France; [Scalabrin, Simone; Cattonaro, Federica; Del Fabbro, Cristian; Pinosio, Sara; Zuccolo, Andrea; Morgante, Michele] Ist Genom Applicata, Udine, Italy; [Terol, Javier; Tadeo, Francisco R.; Estornell, Leandro H.; Munoz-Sanz, Juan V.; Ibanez, Victoria; Herrero-Ortega, Amparo; Talon, Manuel] IVIA, Ctr Genom, Valencia, Spain; [Takita, Marco Aurelio; Freitas-Astua, Juliana; Machado, Marcos Antonio] Inst Agron IAC, Ctr Citricultura Sylvio Moreira, Cordeiropolis, Brazil; [Labadie, Karine; Poulain, Julie; Couloux, Arnaud; Jabbari, Kamel; Brunel, Dominique; Quetier, Francis; Wincker, Patrick; Jaillon, Olivier] Genoscope, CEA, IG, Evry, France; [Zuccolo, Andrea] Scuola Super Sant Anna, Inst Life Sci, Pisa, Italy; [Aleza, Pablo; Navarro, Luis] Inst Valenciano Invest Agr, Ctr Protecc Vegetal & Biotecnol, E-46113 Moncada, Spain; [Perez-Perez, Julian; Ramon, Daniel] Lifesequencing, Valencia, Spain; [Perez-Perez, Julian] Secugen, Madrid, Spain; [Brunel, Dominique] INRA, US Etude Polymorphisme Genomes Vegetaux EPGV 1279, Evry, France; [Luro, Francois] INRA Genete & Ecophysiol Qualite Agrumes GEQA, San Giuliano, France; [Chen, Chunxian; Gmitter, Frederick] Univ Florida, CREC, IFAS, Lake Alfred, FL USA; [Farmerie, William G.] Univ Florida, Interdisciplinary Ctr Biotechnol Res, Gainesville, FL USA; [Desany, Brian; Kodira, Chinnappa; Mohiuddin, Mohammed; Harkins, Tim; Fredrikson, Karin] Roche, Life Sci 454, Branford, CT USA; [Burns, Paul; Lomsadze, Alexandre; Borodovsky, Mark] Georgia Inst Technol, Wallace H Coulter Dept Biomed Engn, Atlanta, GA 30332 USA; [Burns, Paul; Lomsadze, Alexandre; Borodovsky, Mark] Georgia Inst Technol, Sch Computat Sci & Engn, Atlanta, GA 30332 USA; [Borodovsky, Mark] Moscow Inst Phys & Technol, Dept Biol & Med Phys, Dolgoprudnyi, Russia; [Reforgiato, Giuseppe] Consiglio Ric & Sperimentaz Agr CRA ACM, Acireale, Italy; [Freitas-Astua, Juliana] Embrapa Cassava & Fruits, Cruz Das Almas, Brazil; [Quetier, Francis; Wincker, Patrick; Jaillon, Olivier] Univ Evry, Dept Biol, Evry, France; [Roose, Mikeal] Univ Calif Riverside, Dept Bot & Plant Sci, Riverside, CA 92521 USA; [Wincker, Patrick; Jaillon, Olivier] CNRS, Evry, France; [Morgante, Michele] Univ Udine, Dept Agr & Environm Sci, I-33100 Udine, Italy; [Rokhsar, Daniel] Univ Calif Berkeley, Div Genet Genom & Dev, Berkeley, CA 94720 USA	United States Department of Energy (DOE); Joint BioEnergy Institute - JBEI; Joint Genome Institute - JGI; HudsonAlpha Institute for Biotechnology; INRAE; CIRAD; Universite de Montpellier; Instituto Agronomico de Campinas (IAC); CEA; UDICE-French Research Universities; Universite Paris Saclay; Scuola Superiore Sant'Anna; Instituto Valenciano de Investigaciones Agrarias (IVIA); INRAE; INRAE; State University System of Florida; University of Florida; State University System of Florida; University of Florida; Roche Holding; University System of Georgia; Georgia Institute of Technology; University System of Georgia; Georgia Institute of Technology; Moscow Institute of Physics & Technology; Consiglio per la Ricerca in Agricoltura e L'analisi Dell'economia Agraria (CREA); Empresa Brasileira de Pesquisa Agropecuaria (EMBRAPA); UDICE-French Research Universities; Universite Paris Saclay; University of California System; University of California Riverside; Centre National de la Recherche Scientifique (CNRS); University of Udine; University of California System; University of California Berkeley	Rokhsar, D (corresponding author), US DOE, Joint Genome Inst, Walnut Creek, CA 94598 USA.	fgmitter@ufl.edu; dsrokhsar@gmail.com	Muñoz-Sanz, Juan Vicente/T-5951-2017; Terol, Javier/H-6401-2013; Schmutz, Jeremy/N-3173-2013; Aleza, Pablo/M-3710-2014; Tadeo, Francisco R/C-8977-2014; Labadie, Karine/AFL-7408-2022; Del Fabbro, Cristian/C-5523-2014; Navarro, Luis/D-1001-2012; Aleza, Pablo/ABF-4339-2020; Grimwood, Jane/ABD-5737-2021; Jenkins, Jerry/ABE-6479-2020; Labadie, Karine/AAG-7355-2022; Jaillon, Olivier/GRY-6287-2022; Zuccolo, Andrea/H-5636-2019; Wu, Guohong/W-3217-2019; Pinosio, Sara/AAX-7060-2020; MUÑOZ-SANZ, JUAN VICENTE/AAJ-7833-2020; Takita, Marco A/C-3430-2013; Talon, Manuel/C-8540-2014; Freitas-Astua, Juliana/C-5833-2013; Machado, Marcos Antonio/G-3582-2012; Quetier, Francis/J-7923-2017	Muñoz-Sanz, Juan Vicente/0000-0002-6752-7398; Terol, Javier/0000-0003-3345-0078; Schmutz, Jeremy/0000-0001-8062-9172; Aleza, Pablo/0000-0002-8936-1448; Tadeo, Francisco R/0000-0002-5839-4255; Labadie, Karine/0000-0001-7467-8509; Del Fabbro, Cristian/0000-0001-8189-6192; Navarro, Luis/0000-0001-5163-5960; Aleza, Pablo/0000-0003-3554-5337; Jenkins, Jerry/0000-0002-7943-3997; Labadie, Karine/0000-0001-7467-8509; Zuccolo, Andrea/0000-0001-7574-0714; Pinosio, Sara/0000-0002-1820-3637; MUÑOZ-SANZ, JUAN VICENTE/0000-0002-6752-7398; Takita, Marco A/0000-0003-3935-1361; Talon, Manuel/0000-0003-4291-9333; Freitas-Astua, Juliana/0000-0002-0506-6880; Couloux, Arnaud/0000-0003-2356-0062; Poulain, Julie/0000-0002-8744-3116; Perez-Perez, Julian/0000-0001-6091-0012; Jaillon, Olivier/0000-0002-7237-9596; MORGANTE, Michele/0000-0003-2591-2156; Fredrikson, Karin/0000-0001-7360-4276; Rokhsar, Daniel/0000-0002-8704-2224; Murat, Florent/0000-0003-2116-2511; Machado, Marcos Antonio/0000-0001-9780-3990; Quetier, Francis/0000-0003-4388-9287; Ollitrault, Patrick/0000-0002-9456-5517; PERRIER, Xavier/0000-0002-0092-003X; Ruiz, Manuel/0000-0001-8153-276X	National Science and Technology Institute of Genomics for Citrus Breeding, Brazil [FAPESP 08/57909-2, CNPq 573848/08-4]; Brazilian Agricultural Research Corporation (Embrapa); Embrapa-Monsanto Agreement; Agence Nationale de la Recherche (ANR) [CITRUSSEQ PCS-08-GENO]; program ANR Blanc-PAGE [ANR-2011-BSV6-00801]; US National Institutes of Health [HG00783]; Generalitat Valenciana, Spain [PrometeoII/2013/008]; Ministry of Economy and Innovation-Fondo Europeo de Desarrollo Regional (FEDER), Spain [AGL2011-26490]; Conselleria de Agricultura, Pesca, Alimentacion y Agua from the Generalitat Valenciana; Ministerio de Economia e Innovacion [PSE-060000-2009-8, IPT-010000-2010-43]; Citruseq-Citrusgenn consortium company (Anecoop S. Coop., Eurosemillas S.A.); Citruseq-Citrusgenn consortium company (Fundacion Ruralcaja Valencia); Citruseq-Citrusgenn consortium company (GCM Variedades Vegetales A.I.E.); Citruseq-Citrusgenn consortium company ( Investigacion Citricola Castellon S.A.); Citruseq-Citrusgenn consortium company (Source Citrus Genesis-Special New Fruit Licensing, Ltd.); Florida Citrus Production Research Advisory Council (FCPRAC); Florida Department of Agriculture and Consumer Services [013646]; Florida Department of Citrus (FDOC); Citrus Research and Development Foundation [71]; Ministero delle Politiche Agricole Alimentari e Forestali, Project Citrustart; Ministero dell'Istruzione, dell'Universita e della Ricerca (MIUR), Programma Operativo Nazionale 'Ricerca e Competitivita', Project IT-Citrus Genomics [PON_01623]; Office of Science of the US Department of Energy [DE-AC02-05CH11231]; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R01HG000783] Funding Source: NIH RePORTER	National Science and Technology Institute of Genomics for Citrus Breeding, Brazil; Brazilian Agricultural Research Corporation (Embrapa)(Empresa Brasileira de Pesquisa Agropecuaria (EMBRAPA)); Embrapa-Monsanto Agreement(Empresa Brasileira de Pesquisa Agropecuaria (EMBRAPA)); Agence Nationale de la Recherche (ANR)(French National Research Agency (ANR)); program ANR Blanc-PAGE(French National Research Agency (ANR)); US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Generalitat Valenciana, Spain(Center for Forestry Research & Experimentation (CIEF)); Ministry of Economy and Innovation-Fondo Europeo de Desarrollo Regional (FEDER), Spain; Conselleria de Agricultura, Pesca, Alimentacion y Agua from the Generalitat Valenciana; Ministerio de Economia e Innovacion(Spanish Government); Citruseq-Citrusgenn consortium company (Anecoop S. Coop., Eurosemillas S.A.); Citruseq-Citrusgenn consortium company (Fundacion Ruralcaja Valencia); Citruseq-Citrusgenn consortium company (GCM Variedades Vegetales A.I.E.); Citruseq-Citrusgenn consortium company ( Investigacion Citricola Castellon S.A.); Citruseq-Citrusgenn consortium company (Source Citrus Genesis-Special New Fruit Licensing, Ltd.); Florida Citrus Production Research Advisory Council (FCPRAC); Florida Department of Agriculture and Consumer Services; Florida Department of Citrus (FDOC); Citrus Research and Development Foundation; Ministero delle Politiche Agricole Alimentari e Forestali, Project Citrustart; Ministero dell'Istruzione, dell'Universita e della Ricerca (MIUR), Programma Operativo Nazionale 'Ricerca e Competitivita', Project IT-Citrus Genomics; Office of Science of the US Department of Energy(United States Department of Energy (DOE)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))	The authors acknowledge the following support: National Science and Technology Institute of Genomics for Citrus Breeding, Brazil, grants FAPESP 08/57909-2 and CNPq 573848/08-4, and Brazilian Agricultural Research Corporation (Embrapa) (M. A. T. and M. A. M.) and Embrapa-Monsanto Agreement (J.F.-A.); Agence Nationale de la Recherche (ANR) grant CITRUSSEQ PCS-08-GENO (O.J., X. P., M. Ruiz, P.O., F. L., D. B. and K.J.) and program ANR Blanc-PAGE, ref. ANR-2011-BSV6-00801 (J. Salse and F. M.); US National Institutes of Health grant HG00783 (M. B., P. B. and A. L.); Generalitat Valenciana, Spain grant PrometeoII/2013/008 and Ministry of Economy and Innovation-Fondo Europeo de Desarrollo Regional (FEDER), Spain, grant AGL2011-26490 (P. A. and L.N.); Conselleria de Agricultura, Pesca, Alimentacion y Agua from the Generalitat Valenciana (J. P.-P. and D. Ramon); Ministerio de Economia e Innovacion grants PSE-060000-2009-8 and IPT-010000-2010-43 and Citruseq-Citrusgenn consortium companies (Anecoop S. Coop., Eurosemillas S.A., Fundacion Ruralcaja Valencia, GCM Variedades Vegetales A.I.E., Investigacion Citricola Castellon S.A. and Source Citrus Genesis-Special New Fruit Licensing, Ltd.) (J. T., F. R. T., L. H. E., J.V.M.-S., V. I., A.H.-O. and M. T.); Florida Citrus Production Research Advisory Council (FCPRAC), Florida Department of Agriculture and Consumer Services grant no. 013646, Florida Department of Citrus (FDOC) and Citrus Research and Development Foundation grant no. 71, on behalf of the Florida citrus growers (F. G., C. C. and W. G. F.); Ministero delle Politiche Agricole Alimentari e Forestali, Project Citrustart and Ministero dell'Istruzione, dell'Universita e della Ricerca (MIUR), Programma Operativo Nazionale 'Ricerca e Competitivita' 2007-2013, Project IT-Citrus Genomics PON_01623 (M. Morgante, S. S., F. C., C. D. F., S. Pinozio and A.Z.). Pineapple Ridge sweet-orange sequencing was performed by 454 Life Sciences, a Roche company. The work conducted by the US Department of Energy Joint Genome Institute is supported by the Office of Science of the US Department of Energy under contract no. DE-AC02-05CH11231.	Aleza P, 2009, BMC PLANT BIOL, V9, DOI 10.1186/1471-2229-9-110; Barkley NA, 2006, THEOR APPL GENET, V112, P1519, DOI 10.1007/s00122-006-0255-9; Barrett H. C., 1976, Systematic Botany, V1, P105, DOI 10.2307/2418763; Bausher MG, 2006, BMC PLANT BIOL, V6, DOI 10.1186/1471-2229-6-21; Bove JM, 2006, J PLANT PATHOL, V88, P7; Bustamante CD, 2011, NATURE, V475, P163, DOI 10.1038/475163a; CAMERON JAMES W., 1961, HILGARDIA, V30, P359; Cornille A, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002703; Froelicher Y, 2011, TREE GENET GENOMES, V7, P49, DOI 10.1007/s11295-010-0314-x; Garcia-Lor A, 2013, ANN BOT-LONDON, V111, P1, DOI 10.1093/aob/mcs227; Germana MA, 2013, BMC PLANT BIOL, V13, DOI 10.1186/1471-2229-13-129; GMITTER FG, 1990, ECON BOT, V44, P267, DOI 10.1007/BF02860491; Gmitter FG, 2012, TREE GENET GENOMES, V8, P611, DOI 10.1007/s11295-012-0499-2; Gottwald TR, 2010, ANNU REV PHYTOPATHOL, V48, P119, DOI 10.1146/annurev-phyto-073009-114418; Huang XH, 2012, NATURE, V490, P497, DOI 10.1038/nature11532; Hufford MB, 2012, NAT GENET, V44, P808, DOI 10.1038/ng.2309; Johnson NA, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002410; LIU G, 1990, Acta Botanica Yunnanica, V12, P287; Moore GA, 2001, TRENDS GENET, V17, P536, DOI 10.1016/S0168-9525(01)02442-8; Morrell PL, 2012, NAT REV GENET, V13, P85, DOI 10.1038/nrg3097; Morton F, 1987, FRUITS WARM CLIMATES; Myles S, 2011, P NATL ACAD SCI USA, V108, P3530, DOI 10.1073/pnas.1009363108; Nicolosi E, 2000, THEOR APPL GENET, V100, P1155, DOI 10.1007/s001220051419; Novelli VM, 2006, GENET MOL BIOL, V29, P90, DOI 10.1590/S1415-47572006000100018; Ollitrault P, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-593; Pfeil BE, 2008, AM J BOT, V95, P1621, DOI 10.3732/ajb.0800214; Reuther W., 1967, CITRUS IND, VI; Salse J, 2012, CURR OPIN PLANT BIOL, V15, P122, DOI 10.1016/j.pbi.2012.01.001; SAMAAN LG, 1982, EUPHYTICA, V31, P167, DOI 10.1007/BF00028319; SCORA RW, 1975, B TORREY BOT CLUB, V102, P369, DOI 10.2307/2484763; Spiegel-Roy P, 1996, BIOL CITRUS; Swingle W T, 1967, CITRUS IND, P190; Talon Manuel, 2008, Int J Plant Genomics, V2008, P528361, DOI 10.1155/2008/528361; Tanaka T., 1977, STUD CITROG, V14, P1; Trabut JL, 1902, REV HORTICOLE, V10, P232; Tuskan GA, 2006, SCIENCE, V313, P1596, DOI 10.1126/science.1128691; Xu Q, 2013, NAT GENET, V45, P59, DOI 10.1038/ng.2472	37	397	414	13	226	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156	1546-1696		NAT BIOTECHNOL	Nat. Biotechnol.	JUL	2014	32	7					656	+		10.1038/nbt.2906	http://dx.doi.org/10.1038/nbt.2906			8	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	AK8VE	24908277	Green Accepted, Green Published, Green Submitted, hybrid			2022-12-27	WOS:000338705900031
J	Azvolinsky, A; Schmidt, C; Waltz, E; Webb, S				Azvolinsky, Anna; Schmidt, Charles; Waltz, Emily; Webb, Sarah			20 years of Nature Biotechnology biomedical research	NATURE BIOTECHNOLOGY			English	Article							PLURIPOTENT STEM-CELLS; IN-VIVO; QUANTUM DOTS; T-CELLS; CONJUGATION; EXPRESSION; EXOSOMES; DELIVERY; MOUSE; VITRO											Alvarez-Erviti L, 2011, NAT BIOTECHNOL, V29, P341, DOI 10.1038/nbt.1807; Baker M, 2006, NAT BIOTECHNOL, V24, P301, DOI 10.1038/nbt0306-301a; Baker M, 2011, NAT BIOTECHNOL, V29, P221, DOI 10.1038/nbt.1798; Choi HS, 2007, NAT BIOTECHNOL, V25, P1165, DOI 10.1038/nbt1340; Cibulskis K, 2013, NAT BIOTECHNOL, V31, P213, DOI 10.1038/nbt.2514; D'Amour KA, 2006, NAT BIOTECHNOL, V24, P1392, DOI 10.1038/nbt1259; Fabian MA, 2005, NAT BIOTECHNOL, V23, P329, DOI 10.1038/nbt1068; Im H, 2014, NAT BIOTECHNOL, V32, P490, DOI 10.1038/nbt.2886; Junutula JR, 2008, NAT BIOTECHNOL, V26, P925, DOI 10.1038/nbt.1480; Kim S, 2004, NAT BIOTECHNOL, V22, P93, DOI 10.1038/nbt920; Kloss CC, 2013, NAT BIOTECHNOL, V31, P71, DOI 10.1038/nbt.2459; Kroon E, 2008, NAT BIOTECHNOL, V26, P443, DOI 10.1038/nbt1393; Lee NS, 2002, NAT BIOTECHNOL, V20, P500, DOI 10.1038/nbt0502-500; Maher J, 2002, NAT BIOTECHNOL, V20, P70, DOI 10.1038/nbt0102-70; Nakagawa M, 2008, NAT BIOTECHNOL, V26, P101, DOI 10.1038/nbt1374; Perez EE, 2008, NAT BIOTECHNOL, V26, P808, DOI 10.1038/nbt1410; Reubinoff BE, 2000, NAT BIOTECHNOL, V18, P399, DOI 10.1038/74447; Rezania A, 2014, NAT BIOTECHNOL, V32, P1121, DOI 10.1038/nbt.3033; Shapiro AMJ, 2000, NEW ENGL J MED, V343, P230, DOI 10.1056/NEJM200007273430401; Shen BQ, 2012, NAT BIOTECHNOL, V30, P184, DOI 10.1038/nbt.2108; Shi LM, 2006, NAT BIOTECHNOL, V24, P1151, DOI 10.1038/nbt1239; Shlomi T, 2008, NAT BIOTECHNOL, V26, P1003, DOI 10.1038/nbt.1487; Shojaei F, 2007, NAT BIOTECHNOL, V25, P911, DOI 10.1038/nbt1323; Tebas P, 2014, NEW ENGL J MED, V370, P901, DOI 10.1056/NEJMoa1300662; Valadi H, 2007, NAT CELL BIOL, V9, P654, DOI 10.1038/ncb1596; Wang JB, 2015, NAT BIOTECHNOL, V33, P1256, DOI 10.1038/nbt.3408; Zhang L, 2013, NAT BIOTECHNOL, V31, P553, DOI 10.1038/nbt.2580; Zufferey R, 1997, NAT BIOTECHNOL, V15, P871, DOI 10.1038/nbt0997-871	28	5	5	0	21	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156	1546-1696		NAT BIOTECHNOL	Nat. Biotechnol.	MAR	2016	34	3					262	266		10.1038/nbt.3509	http://dx.doi.org/10.1038/nbt.3509			5	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	DG1CJ	26963547				2022-12-27	WOS:000371802600017
J	Pashuck, ET; Stevens, M				Pashuck, E. Thomas; Stevens, Molly			From clinical imaging to implantation of 3D printed tissues	NATURE BIOTECHNOLOGY			English	Article							VASCULAR NETWORKS; CELLS		[Stevens, Molly] Univ London Imperial Coll Sci Technol & Med, Dept Mat, London, England; Univ London Imperial Coll Sci Technol & Med, Dept Bioengn, London, England; Univ London Imperial Coll Sci Technol & Med, Inst Biomed Engn, London, England	Imperial College London; Imperial College London; Imperial College London	Stevens, M (corresponding author), Univ London Imperial Coll Sci Technol & Med, Dept Mat, London, England.	m.stevens@imperial.ac.uk	Pashuck, E./AAG-1741-2021; Pashuck, Eugene/ABC-2634-2021	Pashuck III, Eugene/0000-0003-2881-4965; Stevens, Molly/0000-0002-7335-266X				Discher DE, 2005, SCIENCE, V310, P1139, DOI 10.1126/science.1116995; Ford MC, 2006, P NATL ACAD SCI USA, V103, P2512, DOI 10.1073/pnas.0506020102; Hockaday LA, 2012, BIOFABRICATION, V4, DOI 10.1088/1758-5082/4/3/035005; Kang HW, 2016, NAT BIOTECHNOL, V34, P312, DOI 10.1038/nbt.3413; Kolesky DB, 2014, ADV MATER, V26, P3124, DOI 10.1002/adma.201305506; Ling Y, 2007, LAB CHIP, V7, P756, DOI 10.1039/b615486g; Miller JS, 2012, NAT MATER, V11, P768, DOI [10.1038/NMAT3357, 10.1038/nmat3357]; Uygun BE, 2010, NAT MED, V16, P814, DOI 10.1038/nm.2170; Visser J, 2013, BIOFABRICATION, V5, DOI 10.1088/1758-5082/5/3/035007	9	13	13	1	89	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156	1546-1696		NAT BIOTECHNOL	Nat. Biotechnol.	MAR	2016	34	3					295	296		10.1038/nbt.3503	http://dx.doi.org/10.1038/nbt.3503			2	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	DG1CJ	26963553				2022-12-27	WOS:000371802600023
J	Sun, SS; Shah, P; Eshghi, ST; Yang, WM; Trikannad, N; Yang, S; Chen, LJ; Aiyetan, P; Hoti, N; Zhang, Z; Chan, DW; Zhang, H				Sun, Shisheng; Shah, Punit; Eshghi, Shadi Toghi; Yang, Weiming; Trikannad, Namita; Yang, Shuang; Chen, Lijun; Aiyetan, Paul; Hoti, Naseruddin; Zhang, Zhen; Chan, Daniel W.; Zhang, Hui			Comprehensive analysis of protein glycosylation by solid-phase extraction of N-linked glycans and glycosite-containing peptides	NATURE BIOTECHNOLOGY			English	Article							HYDROPHILIC INTERACTION CHROMATOGRAPHY; MASS-SPECTROMETRY; GLYCOPEPTIDES; IDENTIFICATION; GLYCOPROTEINS; HETEROGENEITY; ENRICHMENT; DATABASE; SITES; TOOLS	Comprehensive characterization of protein glycosylation is critical for understanding the structure and function of glycoproteins. However, due to the complexity and heterogeneity of glycoprotein conformations, current glycoprotein analyses focus mainly on either the deglycosylated glycosylation site (glycosite)-containing peptides or the released glycans. Here, we describe a chemoenzymatic method called solid phase extraction of N-linked glycans and glycosite-containing peptides (NGAG) for the comprehensive characterization of glycoproteins that is able to determine glycan heterogeneity for individual glycosites in addition to providing information about the total N-linked glycan, glycosite-containing peptide and glycoprotein content of complex samples. The NGAG method can also be applied to quantitatively detect glycoprotein alterations in total and site-specific glycan occupancies.	[Sun, Shisheng; Shah, Punit; Eshghi, Shadi Toghi; Yang, Weiming; Trikannad, Namita; Yang, Shuang; Chen, Lijun; Aiyetan, Paul; Hoti, Naseruddin; Zhang, Zhen; Chan, Daniel W.; Zhang, Hui] Johns Hopkins Univ, Dept Pathol, Baltimore, MD USA	Johns Hopkins University	Zhang, H (corresponding author), Johns Hopkins Univ, Dept Pathol, Baltimore, MD USA.	hzhang32@jhmi.edu	Sun, Shisheng/P-5027-2019; Yang, Weiming/D-8480-2017	Yang, Weiming/0000-0002-5023-2155; Sun, Shisheng/0000-0002-7242-7164; Toghi Eshghi, Shadi/0000-0002-0254-7814	National Institutes of Health, National Cancer Institute, Clinical Proteomic Tumor Analysis Consortium [U24CA160036]; Early Detection Research Network (EDRN) [U01CA152813, U24CA115102]; National Institutes of Health, National Heart, Lung, and Blood Institute Programs of Excellence in Glycosciences (PEG) [P01HL107153]; Johns Hopkins Proteomics Center [N01-HV-00240];  [R01CA112314]; NATIONAL CANCER INSTITUTE [U24CA115102, R01CA112314, U01CA152813, U24CA160036] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL107153] Funding Source: NIH RePORTER	National Institutes of Health, National Cancer Institute, Clinical Proteomic Tumor Analysis Consortium; Early Detection Research Network (EDRN)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); National Institutes of Health, National Heart, Lung, and Blood Institute Programs of Excellence in Glycosciences (PEG); Johns Hopkins Proteomics Center; ; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by the National Institutes of Health, National Cancer Institute, Clinical Proteomic Tumor Analysis Consortium (U24CA160036), the Early Detection Research Network (EDRN, U01CA152813 and U24CA115102) and R01CA112314, and by the National Institutes of Health, National Heart, Lung, and Blood Institute Programs of Excellence in Glycosciences (PEG, P01HL107153) and the Johns Hopkins Proteomics Center (N01-HV-00240).	Bern M., 2012, CURRENT PROTOCOLS BI; Brancia FL, 2000, RAPID COMMUN MASS SP, V14, P2070, DOI 10.1002/1097-0231(20001115)14:21<2070::AID-RCM133>3.0.CO;2-G; Breidenbach MA, 2010, P NATL ACAD SCI USA, V107, P3988, DOI 10.1073/pnas.0911247107; Chen SM, 2007, NAT METHODS, V4, P437, DOI 10.1038/NMETH1035; Drake PM, 2010, CLIN CHEM, V56, P223, DOI 10.1373/clinchem.2009.136333; Eshghi ST, 2015, ANAL CHEM, V87, P5181, DOI 10.1021/acs.analchem.5b00024; Freeze H., 2009, ESSENTIALS GLYCOBIOL, P66; Jensen PH, 2012, NAT PROTOC, V7, P1299, DOI 10.1038/nprot.2012.063; Kaji H, 2003, NAT BIOTECHNOL, V21, P667, DOI 10.1038/nbt829; Kolarich D, 2012, NAT PROTOC, V7, P1285, DOI 10.1038/nprot.2012.062; Lattova E, 2006, ANAL CHEM, V78, P2977, DOI 10.1021/ac0519918; Liu T, 2001, ANAL CHEM, V73, P5875, DOI 10.1021/ac0106748; Moremen KW, 2012, NAT REV MOL CELL BIO, V13, P448, DOI 10.1038/nrm3383; Nilsson J, 2009, NAT METHODS, V6, P809, DOI [10.1038/NMETH.1392, 10.1038/nmeth.1392]; Nothaft H, 2010, NAT REV MICROBIOL, V8, P765, DOI 10.1038/nrmicro2383; Parker BL, 2013, J PROTEOME RES, V12, P5791, DOI 10.1021/pr400783j; PAXTON RJ, 1987, P NATL ACAD SCI USA, V84, P920, DOI 10.1073/pnas.84.4.920; Pompach P, 2012, J PROTEOME RES, V11, P1728, DOI 10.1021/pr201183w; Scott NE, 2011, MOL CELL PROTEOMICS, V10, DOI 10.1074/mcp.M000031-MCP201; Shah P, 2013, ANAL CHEM, V85, P3606, DOI 10.1021/ac3033867; Tian YA, 2007, NAT PROTOC, V2, P334, DOI 10.1038/nprot.2007.42; Vizcaino JA, 2013, NUCLEIC ACIDS RES, V41, pD1063, DOI 10.1093/nar/gks1262; Wada Y, 2004, ANAL CHEM, V76, P6560, DOI 10.1021/ac049062o; Wu SW, 2014, ANAL CHEM, V86, P5478, DOI 10.1021/ac500945m; Wu SW, 2013, J PROTEOMICS, V84, P1, DOI 10.1016/j.jprot.2013.03.026; Yang WM, 2014, ANAL CHEM, V86, P6959, DOI 10.1021/ac500876p; Yu L, 2009, CHEM-EUR J, V15, P12618, DOI 10.1002/chem.200902370; Zhang H, 2003, NAT BIOTECHNOL, V21, P660, DOI 10.1038/nbt827; Zhang W, 2011, ANAL CHEM, V83, P4975, DOI 10.1021/ac200753e; Zielinska DF, 2010, CELL, V141, P897, DOI 10.1016/j.cell.2010.04.012	30	157	162	14	272	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156	1546-1696		NAT BIOTECHNOL	Nat. Biotechnol.	JAN	2016	34	1					84	88		10.1038/nbt.3403	http://dx.doi.org/10.1038/nbt.3403			5	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	DB8HQ	26571101	Green Accepted			2022-12-27	WOS:000368758200031
J	Ramani, V; Qiu, RL; Shendure, J				Ramani, Vijay; Qiu, Ruolan; Shendure, Jay			High-throughput determination of RNA structure by proximity ligation	NATURE BIOTECHNOLOGY			English	Article							SECONDARY STRUCTURE; GENOME-WIDE; REVEALS; PRINCIPLES; MAP; VISUALIZATION; TRANSCRIPTOME; PREDICTION; RESOLUTION; SOFTWARE	We present an unbiased method to globally resolve RNA structures through pairwise contact measurements between interacting regions. RNA proximity ligation (RPL) uses proximity ligation of native RNA followed by deep sequencing to yield chimeric reads with ligation junctions in the vicinity of structurally proximate bases. We apply RPL in both baker's yeast (Saccharomyces cerevisiae) and human cells and generate contact probability maps for ribosomal and other abundant RNAs, including yeast snoRNAs, the RNA subunit of the signal recognition particle and the yeast U2 spliceosomal RNA homolog. RPL measurements correlate with established secondary structures for these RNA molecules, including stemloop structures and long-range pseudoknots. We anticipate that RPL will complement the current repertoire of computational and experimental approaches in enabling the high-throughput determination of secondary and tertiary RNA structures.	[Ramani, Vijay; Qiu, Ruolan; Shendure, Jay] Univ Washington, Dept Genome Sci, Seattle, WA 98195 USA	University of Washington; University of Washington Seattle	Shendure, J (corresponding author), Univ Washington, Dept Genome Sci, Seattle, WA 98195 USA.	shendure@uw.edu	Shendure, Jay/AAU-3684-2021		National Institutes of Health (NIH) [1DP1HG007811]; NIH National Human Genome Research Institute (NHGRI) [5T32HG000035]; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [T32HG000035, DP1HG007811] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH National Human Genome Research Institute (NHGRI)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))	We thank members of the Shendure laboratory (particularly D. Cusanovich, M. Kircher, A. McKenna and M. Snyder), D. Fowler, C. Trapnell and J. Underwood for helpful discussions and comments on the manuscript. We thank G. Kudla, A. Helwak and D. Tollervey for answering questions pertaining to the CLASH protocol. We would also like to acknowledge A. Dobin for making auxiliary scripts for processing STAR alignments publicly available. This work was funded by National Institutes of Health (NIH) Director's Pioneer Award (1DP1HG007811 to J.S.) and an NIH National Human Genome Research Institute (NHGRI) Genome Training Grant (5T32HG000035 to V.R.).	Anger AM, 2013, NATURE, V497, P80, DOI 10.1038/nature12104; Ben-Shem A, 2011, SCIENCE, V334, P1524, DOI 10.1126/science.1212642; Burge SW, 2013, NUCLEIC ACIDS RES, V41, pD226, DOI 10.1093/nar/gks1005; CAMERON V, 1977, BIOCHEMISTRY-US, V16, P5120, DOI 10.1021/bi00642a027; Cannone JJ, 2002, BMC BIOINFORMATICS, V3, DOI 10.1186/1471-2105-3-2; Cate JH, 1996, SCIENCE, V273, P1678, DOI 10.1126/science.273.5282.1678; Cordero P, 2012, BIOINFORMATICS, V28, P3006, DOI 10.1093/bioinformatics/bts554; Dekker J, 2002, SCIENCE, V295, P1306, DOI 10.1126/science.1067799; Ding YL, 2014, NATURE, V505, P696, DOI 10.1038/nature12756; Dobin A, 2013, BIOINFORMATICS, V29, P15, DOI 10.1093/bioinformatics/bts635; Engreitz JM, 2014, CELL, V159, P188, DOI 10.1016/j.cell.2014.08.018; Fredriksson S, 2002, NAT BIOTECHNOL, V20, P473, DOI 10.1038/nbt0502-473; Grosswendt S, 2014, MOL CELL, V54, P1042, DOI 10.1016/j.molcel.2014.03.049; Helwak A, 2013, CELL, V153, P654, DOI 10.1016/j.cell.2013.03.043; Kertesz M, 2010, NATURE, V467, P103, DOI 10.1038/nature09322; Kladwang W, 2011, NAT CHEM, V3, P954, DOI [10.1038/nchem.1176, 10.1038/NCHEM.1176]; Kudla G, 2011, P NATL ACAD SCI USA, V108, P10010, DOI 10.1073/pnas.1017386108; Latham MP, 2005, CHEMBIOCHEM, V6, P1492, DOI 10.1002/cbic.200500123; Lieberman-Aiden E, 2009, SCIENCE, V326, P289, DOI 10.1126/science.1181369; Lorenz R, 2011, ALGORITHM MOL BIOL, V6, DOI 10.1186/1748-7188-6-26; Lu XJ, 2003, NUCLEIC ACIDS RES, V31, P5108, DOI 10.1093/nar/gkg680; Lucks JB, 2011, P NATL ACAD SCI USA, V108, P11063, DOI 10.1073/pnas.1106501108; Mortimer SA, 2014, NAT REV GENET, V15, P469, DOI 10.1038/nrg3681; Nawrocki EP, 2013, BIOINFORMATICS, V29, P2933, DOI 10.1093/bioinformatics/btt509; Rao SSP, 2014, CELL, V159, P1665, DOI 10.1016/j.cell.2014.11.021; Reuter JS, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-129; Rouskin S, 2014, NATURE, V505, P701, DOI 10.1038/nature12894; Shendure J, 2012, NAT BIOTECHNOL, V30, P1084, DOI 10.1038/nbt.2421; Siegfried NA, 2014, NAT METHODS, V11, P959, DOI [10.1038/nmeth.3029, 10.1038/NMETH.3029]; Soderberg O, 2006, NAT METHODS, V3, P995, DOI 10.1038/nmeth947; Underwood JG, 2010, NAT METHODS, V7, P995, DOI 10.1038/NMETH.1529; Wan Y, 2014, NATURE, V505, P706, DOI 10.1038/nature12946; WANG YH, 1994, J MOL BIOL, V236, P64, DOI 10.1006/jmbi.1994.1118; Zuker M, 2003, NUCLEIC ACIDS RES, V31, P3406, DOI 10.1093/nar/gkg595	34	74	77	2	38	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156	1546-1696		NAT BIOTECHNOL	Nat. Biotechnol.	SEP	2015	33	9					980	U236		10.1038/nbt.3289	http://dx.doi.org/10.1038/nbt.3289			6	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	CR0EK	26237516	Green Accepted			2022-12-27	WOS:000360990900026
J	Snow, D; Cattapan, A; Baylis, F				Snow, Dave; Cattapan, Alana; Baylis, Francoise			Contesting estimates of cryopreserved embryos in the United States	NATURE BIOTECHNOLOGY			English	Letter									[Snow, Dave] Univ Guelph, Dept Polit Sci, Guelph, ON N1G 2W1, Canada; [Cattapan, Alana; Baylis, Francoise] Dalhousie Univ, Fac Med, Halifax, NS, Canada; [Baylis, Francoise] Dalhousie Univ, Fac Arts & Social Sci, Halifax, NS, Canada	University of Guelph; Dalhousie University; Dalhousie University	Snow, D (corresponding author), Univ Guelph, Dept Polit Sci, Guelph, ON N1G 2W1, Canada.	snow@uoguelph.ca	Baylis, Francoise/AAP-4565-2021; Cattapan, Alana/AAA-9207-2019	Baylis, Francoise/0000-0003-2961-5802				Beesley R, 2009, FERTIL STERIL, V91, P1717, DOI 10.1016/j.fertnstert.2008.02.003; Hoffman DI, 2003, FERTIL STERIL, V79, P1063, DOI 10.1016/S0015-0282(03)00172-9; Lomax GP, 2013, NAT BIOTECHNOL, V31, P288, DOI 10.1038/nbt.2541; Nachtigall RD, 2009, FERTIL STERIL, V92, P2094, DOI 10.1016/j.fertnstert.2009.06.027	4	10	10	0	1	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156	1546-1696		NAT BIOTECHNOL	Nat. Biotechnol.	SEP	2015	33	9					909	909		10.1038/nbt.3342	http://dx.doi.org/10.1038/nbt.3342			1	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	CR0EK	26348956	Bronze			2022-12-27	WOS:000360990900013
J	[Anonymous]				[Anonymous]			Revamp biotech rules, says White House	NATURE BIOTECHNOLOGY			English	News Item																		ANGRIST M, 2015, FUSION           080; HOLT N, 2015, NY TIMES; LORING J, 2015, BUZZFEED NEWS   0809; SABLE, 2015, FORBES	4	0	0	0	0	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156	1546-1696		NAT BIOTECHNOL	Nat. Biotechnol.	SEP	2015	33	9					894	894						1	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	VC0VG	26348945	Bronze			2022-12-27	WOS:000427612400001
J	Chambers, VS; Marsico, G; Boutell, JM; Di Antonio, M; Smith, GP; Balasubramanian, S				Chambers, Vicki S.; Marsico, Giovanni; Boutell, Jonathan M.; Di Antonio, Marco; Smith, Geoffrey P.; Balasubramanian, Shankar			High-throughput sequencing of DNA G-quadruplex structures in the human genome	NATURE BIOTECHNOLOGY			English	Article							C-KIT ONCOGENE; SMALL-MOLECULE; STABILITY; TRANSCRIPTION; CHEMISTRY; PROMOTER; CANCER; CELLS	G-quadruplexes (G4s) are nucleic acid secondary structures that form within guanine-rich DNA or RNA sequences. G4 formation can affect chromatin architecture and gene regulation and has been associated with genomic instability, genetic diseases and cancer progression(1-4). Here we present a high-resolution sequencing-based method to detect G4s in the human genome. We identified 716,310 distinct G4 structures, 451,646 of which were not predicted by computational methods(5-7). These included previously uncharacterized noncanonical long loop and bulged structures(8,9). We observed a high G4 density in functional regions, such as 5' untranslated regions and splicing sites, as well as in genes previously not predicted to contain these structures (such as BRCA2). G4 formation was significantly associated with oncogenes, tumor suppressors and somatic copy number alterations related to cancer development(10). The G4s identified in this study may therefore represent promising targets for cancer intervention.	[Chambers, Vicki S.; Di Antonio, Marco; Balasubramanian, Shankar] Univ Cambridge, Dept Chem, Cambridge CB2 1EW, England; [Marsico, Giovanni; Di Antonio, Marco; Balasubramanian, Shankar] Canc Res UK, Cambridge Res Inst, Li Ka Shing Ctr, Cambridge, England; [Boutell, Jonathan M.; Smith, Geoffrey P.] Illumina Cambridge Ltd, Saffron Walden, Essex, England; [Balasubramanian, Shankar] Univ Cambridge, Sch Clin Med, Cambridge, England	University of Cambridge; Cancer Research UK; CRUK Cambridge Institute; University of Cambridge; Illumina; University of Cambridge	Balasubramanian, S (corresponding author), Univ Cambridge, Dept Chem, Lensfield Rd, Cambridge CB2 1EW, England.	sb10031@cam.ac.uk	Balasubramanian, Shankar/C-1671-2009	Balasubramanian, Shankar/0000-0002-0281-5815; Di Antonio, Marco/0000-0002-7321-1867; Chambers, Vicki/0000-0003-3339-1813	Biotechnology and Biological Sciences Research Council (BBSRC); Illumina [BB/I015477/1]; Cancer Research UK; European Research Council; BBSRC; Biotechnology and Biological Sciences Research Council [1235154] Funding Source: researchfish; Cancer Research UK [11961, 12488, 18618] Funding Source: researchfish	Biotechnology and Biological Sciences Research Council (BBSRC)(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Illumina; Cancer Research UK(Cancer Research UK); European Research Council(European Research Council (ERC)European Commission); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Cancer Research UK(Cancer Research UK)	We thank C. Lowe and D. Tannahill for critical reading of the manuscript and D. Beraldi for technical support. We thank P. McCauley (Illumina) who prepared the custom sequencing buffers. We are grateful to the Biotechnology and Biological Sciences Research Council (BBSRC) and Illumina for the studentship supporting V.S.C. (BB/I015477/1). The S.B. research group is supported by program funding from Cancer Research UK and the European Research Council and project funding from BBSRC.	Bentley DR, 2008, NATURE, V456, P53, DOI 10.1038/nature07517; Biffi G, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0102711; Biffi G, 2013, NAT CHEM, V5, P182, DOI [10.1038/NCHEM.1548, 10.1038/nchem.1548]; Bochman ML, 2012, NAT REV GENET, V13, P770, DOI 10.1038/nrg3296; Bugaut A, 2008, BIOCHEMISTRY-US, V47, P689, DOI 10.1021/bi701873c; Cock PJA, 2010, NUCLEIC ACIDS RES, V38, P1767, DOI 10.1093/nar/gkp1137; Cruz JA, 2009, CELL, V136, P604, DOI 10.1016/j.cell.2009.02.003; Davis JT, 2004, ANGEW CHEM INT EDIT, V43, P668, DOI 10.1002/anie.200300589; De Cian A, 2007, J AM CHEM SOC, V129, P1856, DOI 10.1021/ja067352b; Eddy J, 2006, NUCLEIC ACIDS RES, V34, P3887, DOI 10.1093/nar/gkl529; Ewing B, 1998, GENOME RES, V8, P175, DOI 10.1101/gr.8.3.175; Fernando H, 2006, BIOCHEMISTRY-US, V45, P7854, DOI 10.1021/bi0601510; Guedin A, 2010, NUCLEIC ACIDS RES, V38, P7858, DOI 10.1093/nar/gkq639; Haeusler AR, 2014, NATURE, V507, P195, DOI 10.1038/nature13124; Henderson A, 2014, NUCLEIC ACIDS RES, V42, P860, DOI 10.1093/nar/gkt957; Hud NV, 1996, BIOCHEMISTRY-US, V35, P15383, DOI 10.1021/bi9620565; Huppert JL, 2005, NUCLEIC ACIDS RES, V33, P2908, DOI 10.1093/nar/gki609; Kikin O, 2006, NUCLEIC ACIDS RES, V34, pW676, DOI 10.1093/nar/gkl253; Maizels N, 2008, CURR BIOL, V18, pR613, DOI 10.1016/j.cub.2008.06.011; Marchand A, 2015, J AM CHEM SOC, V137, P750, DOI 10.1021/ja5099403; Mukundan VT, 2013, J AM CHEM SOC, V135, P5017, DOI 10.1021/ja310251r; Paeschke K, 2013, NATURE, V497, P458, DOI 10.1038/nature12149; Palumbo SL, 2009, J AM CHEM SOC, V131, P10878, DOI 10.1021/ja902281d; Rankin S, 2005, J AM CHEM SOC, V127, P10584, DOI 10.1021/ja050823u; Rodriguez R, 2014, NAT REV GENET, V15, P783, DOI 10.1038/nrg3796; Rodriguez R, 2012, NAT CHEM BIOL, V8, P301, DOI [10.1038/nchembio.780, 10.1038/NCHEMBIO.780]; Rodriguez R, 2008, J AM CHEM SOC, V130, P15758, DOI 10.1021/ja805615w; Siddiqui-Jain A, 2002, P NATL ACAD SCI USA, V99, P11593, DOI 10.1073/pnas.182256799; Weitzmann MN, 1996, J BIOL CHEM, V271, P20958, DOI 10.1074/jbc.271.34.20958; Wolfe AL, 2014, NATURE, V513, P65, DOI 10.1038/nature13485; Zack TI, 2013, NAT GENET, V45, P1134, DOI 10.1038/ng.2760	31	681	688	9	229	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156	1546-1696		NAT BIOTECHNOL	Nat. Biotechnol.	AUG	2015	33	8					877	+		10.1038/nbt.3295	http://dx.doi.org/10.1038/nbt.3295			7	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	CO6OB	26192317				2022-12-27	WOS:000359274900028
J	Scherf, N; Huisken, J				Scherf, Nico; Huisken, Jan			The smart and gentle microscope	NATURE BIOTECHNOLOGY			English	Editorial Material							LIGHT-SHEET MICROSCOPY; HIGH-SPEED; TOMOGRAPHY; RESOLUTION		[Scherf, Nico; Huisken, Jan] Max Planck Inst Mol Cell Biol & Genet, Dresden, Germany; [Scherf, Nico] Tech Univ Dresden, Fac Med Carl Gustav Carus, Inst Med Informat & Biometry, Dresden, Germany	Max Planck Society; Technische Universitat Dresden	Scherf, N (corresponding author), Max Planck Inst Mol Cell Biol & Genet, Dresden, Germany.		Huisken, Jan/B-2472-2009	Huisken, Jan/0000-0001-7250-3756; Scherf, Nico/0000-0003-4003-9121				Amat F, 2014, NAT METHODS, V11, P951, DOI [10.1038/NMETH.3036, 10.1038/nmeth.3036]; Bassi A, 2015, DEVELOPMENT, V142, P1016, DOI 10.1242/dev.116970; Bouchard MB, 2015, NAT PHOTONICS, V9, P113, DOI [10.1038/NPHOTON.2014.323, 10.1038/nphoton.2014.323]; Chaloner K, 1995, STAT SCI, V10, P273, DOI 10.1214/ss/1177009939; Cole R, 2014, CELL ADHES MIGR, V8, P452, DOI 10.4161/cam.28348; Conrad C, 2011, NAT METHODS, V8, P246, DOI [10.1038/nmeth.1558, 10.1038/NMETH.1558]; Fahrbach FO, 2013, OPT EXPRESS, V21, P21010, DOI 10.1364/OE.21.021010; Hawrylycz MJ, 2012, NATURE, V489, P391, DOI 10.1038/nature11405; Hooke R., 1665, MICROGRAPHIA; Huisken J, 2004, SCIENCE, V305, P1007, DOI 10.1126/science.1100035; Hyman AA, 2011, PHILOS T R SOC B, V366, P3635, DOI 10.1098/rstb.2011.0074; Ji N, 2008, NAT METHODS, V5, P197, DOI 10.1038/NMETH.1175; Kaufmann A, 2012, DEVELOPMENT, V139, P3242, DOI 10.1242/dev.082586; Keller PJ, 2013, SCIENCE, V340, P1184, DOI 10.1126/science.1234168; Megason SG, 2007, CELL, V130, P784, DOI 10.1016/j.cell.2007.08.031; Peng HC, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5342; Planchon TA, 2011, NAT METHODS, V8, P417, DOI [10.1038/NMETH.1586, 10.1038/nmeth.1586]; Schmid B, 2015, BIOINFORMATICS, V31, P3398, DOI 10.1093/bioinformatics/btv387; Schmid B, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3207; Seeger MW, 2010, IEEE SIGNAL PROC MAG, V27, P81, DOI 10.1109/MSP.2010.938082; Sharpe J, 2002, SCIENCE, V296, P541, DOI 10.1126/science.1068206; Stelzer EHK, 2014, CELL, V159, P1243, DOI 10.1016/j.cell.2014.11.032; Verveer PJ, 2007, NAT METHODS, V4, P311, DOI 10.1038/NMETH1017; Wang K, 2014, NAT METHODS, V11, P625, DOI [10.1038/NMETH.2925, 10.1038/nmeth.2925]; Zhang J, 2002, NAT REV MOL CELL BIO, V3, P906, DOI 10.1038/nrm976	25	53	53	1	18	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156	1546-1696		NAT BIOTECHNOL	Nat. Biotechnol.	AUG	2015	33	8					815	818		10.1038/nbt.3310	http://dx.doi.org/10.1038/nbt.3310			4	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	CO6OB	26252136				2022-12-27	WOS:000359274900015
J	Wittrup, A; Ai, A; Liu, X; Hamar, P; Trifonova, R; Charisse, K; Manoharan, M; Kirchhausen, T; Lieberman, J				Wittrup, Anders; Ai, Angela; Liu, Xing; Hamar, Peter; Trifonova, Radiana; Charisse, Klaus; Manoharan, Muthiah; Kirchhausen, Tomas; Lieberman, Judy			Visualizing lipid-formulated siRNA release from endosomes and target gene knockdown	NATURE BIOTECHNOLOGY			English	Article							INTRACELLULAR TRAFFICKING; RNAI THERAPEUTICS; DELIVERY; NANOPARTICLES; AUTOPHAGY; PROTEIN; CELLS; GLYCOSPHINGOLIPIDS; MATURATION; REPORTER	A central hurdle in developing small interfering RNAs (siRNAs) as therapeutics is the inefficiency of their delivery across the plasma and endosomal membranes to the cytosol, where they interact with the RNA interference machinery. With the aim of improving endosomal release, a poorly understood and inefficient process, we studied the uptake and cytosolic release of siRNAs, formulated in lipoplexes or lipid nanoparticles, by live-cell imaging and correlated it with knockdown of a target GFP reporter. siRNA release occurred invariably from maturing endosomes within similar to 5-15 min of endocytosis. Cytosolic galectins immediately recognized the damaged endosome and targeted it for autophagy. However, inhibiting autophagy did not enhance cytosolic siRNA release. Gene knockdown occurred within a few hours of release and required <2,000 copies of cytosolic siRNAs. The ability to detect cytosolic release of siRNAs and understand how it is regulated will facilitate the development of rational strategies for improving the cytosolic delivery of candidate drugs.	[Wittrup, Anders; Ai, Angela; Liu, Xing; Hamar, Peter; Trifonova, Radiana; Kirchhausen, Tomas; Lieberman, Judy] Harvard Univ, Sch Med, Boston Childrens Hosp, Program Cellular & Mol Med, Boston, MA 02163 USA; [Wittrup, Anders] Lund Univ, Dept Clin Sci, Sect Oncol & Pathol, Lund, Sweden; [Hamar, Peter] Semmelweis Univ, Inst Pathophysiol, H-1085 Budapest, Hungary; [Charisse, Klaus; Manoharan, Muthiah] Alnylam Pharmaceut, Cambridge, MA USA; [Kirchhausen, Tomas] Harvard Univ, Sch Med, Dept Cell Biol, Boston, MA USA; [Kirchhausen, Tomas; Lieberman, Judy] Harvard Univ, Sch Med, Dept Pediat, Boston, MA 02115 USA	Harvard University; Boston Children's Hospital; Program in Cellular & Molecular Medicine (PCMM); Harvard Medical School; Lund University; Semmelweis University; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School	Lieberman, J (corresponding author), Harvard Univ, Sch Med, Boston Childrens Hosp, Program Cellular & Mol Med, Boston, MA 02163 USA.	anders.wittrup@med.lu.se; judy.lieberman@childrens.harvard.edu	Lieberman, Judy/A-2717-2015; Hamar, Peter/A-8996-2010	Hamar, Peter/0000-0002-1095-3564; Wittrup, Anders/0000-0003-4918-0500	US National Institutes of Health (NIH) [AI090671, CA139444]; Swedish Research Council; NIH [GM075252]; New England Regional Center of Excellence in Biodefense and Emerging Infectious Disease [AI057159]; NATIONAL CANCER INSTITUTE [R01CA139444] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U54AI057159, R01AI090671] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM075252] Funding Source: NIH RePORTER	US National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Swedish Research Council(Swedish Research CouncilEuropean Commission); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); New England Regional Center of Excellence in Biodefense and Emerging Infectious Disease(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	The authors thank E. Marino for maintaining the Imaging Resource used in this study and K. Ketman and N. Barteneva for technical assistance. This work was supported by US National Institutes of Health (NIH) grants AI090671 and CA139444 (J.L.), the Swedish Research Council (A.W.), NIH grant GM075252 (T.K.) and New England Regional Center of Excellence in Biodefense and Emerging Infectious Disease, Core Imaging Facility grant AI057159 (T.K.).	Akinc A, 2010, MOL THER, V18, P1357, DOI 10.1038/mt.2010.85; Alabi CA, 2013, P NATL ACAD SCI USA, V110, P12881, DOI 10.1073/pnas.1306529110; Chen X, 2014, J BIOL CHEM, V289, P11162, DOI 10.1074/jbc.M113.531855; Choudhury A, 2002, J CLIN INVEST, V109, P1541, DOI 10.1172/JCI200215420; Coelho T, 2013, NEW ENGL J MED, V369, P819, DOI 10.1056/NEJMoa1208760; Elouahabi A, 2005, MOL THER, V11, P336, DOI 10.1016/j.ymthe.2004.12.006; FELGNER PL, 1987, P NATL ACAD SCI USA, V84, P7413, DOI 10.1073/pnas.84.21.7413; Gilleron J, 2013, NAT BIOTECHNOL, V31, P638, DOI 10.1038/nbt.2612; Huotari J, 2011, EMBO J, V30, P3481, DOI 10.1038/emboj.2011.286; Jayaraman M, 2012, ANGEW CHEM INT EDIT, V51, P8529, DOI 10.1002/anie.201203263; Kanasty R, 2013, NAT MATER, V12, P967, DOI [10.1038/NMAT3765, 10.1038/nmat3765]; Kimura S, 2007, AUTOPHAGY, V3, P452, DOI 10.4161/auto.4451; Li XQ, 1998, J BIOL CHEM, V273, P34970, DOI 10.1074/jbc.273.52.34970; Maier MA, 2013, MOL THER, V21, P1570, DOI 10.1038/mt.2013.124; McNamara JO, 2006, NAT BIOTECHNOL, V24, P1005, DOI 10.1038/nbt1223; MU FT, 1995, J BIOL CHEM, V270, P13503, DOI 10.1074/jbc.270.22.13503; Nechaev S, 2013, J CONTROL RELEASE, V170, P307, DOI 10.1016/j.jconrel.2013.06.007; Payne CK, 2007, TRAFFIC, V8, P389, DOI 10.1111/j.1600-0854.2007.00540.x; Paz I, 2010, CELL MICROBIOL, V12, P530, DOI 10.1111/j.1462-5822.2009.01415.x; Poteryaev D, 2010, CELL, V141, P497, DOI 10.1016/j.cell.2010.03.011; Rehman ZU, 2013, ACS NANO, V7, P3767, DOI 10.1021/nn3049494; Roberts R, 2013, AUTOPHAGY, V9, P667, DOI 10.4161/auto.23877; Sahay G, 2013, NAT BIOTECHNOL, V31, P653, DOI 10.1038/nbt.2614; Semple SC, 2010, NAT BIOTECHNOL, V28, P172, DOI 10.1038/nbt.1602; Sharma DK, 2003, J BIOL CHEM, V278, P7564, DOI 10.1074/jbc.M210457200; Stalder L, 2013, EMBO J, V32, P1115, DOI 10.1038/emboj.2013.52; Stewart SA, 2003, RNA, V9, P493, DOI 10.1261/rna.2192803; Thurston TLM, 2012, NATURE, V482, P414, DOI 10.1038/nature10744; Zimmermann TS, 2006, NATURE, V441, P111, DOI 10.1038/nature04688	29	311	319	11	215	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156	1546-1696		NAT BIOTECHNOL	Nat. Biotechnol.	AUG	2015	33	8					870	+		10.1038/nbt.3298	http://dx.doi.org/10.1038/nbt.3298			9	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	CO6OB	26192320	Green Accepted			2022-12-27	WOS:000359274900027
J	Dey, SS; Kester, L; Spanjaard, B; Bienko, M; van Oudenaarden, A				Dey, Siddharth S.; Kester, Lennart; Spanjaard, Bastiaan; Bienko, Magda; van Oudenaarden, Alexander			Integrated genome and transcriptome sequencing of the same cell	NATURE BIOTECHNOLOGY			English	Article							COPY NUMBER VARIATION; SINGLE-CELL; RNA-SEQ; GENE-EXPRESSION; CONSEQUENCES; NUCLEOTIDE; PHENOTYPES; WIDE	Single-cell genomics and single-cell transcriptomics have emerged as powerful tools to study the biology of single cells at a genome-wide scale. However, a major challenge is to sequence both genomic DNA and mRNA from the same cell, which would allow direct comparison of genomic variation and transcriptome heterogeneity. We describe a quasilinear amplification strategy to quantify genomic DNA and mRNA from the same cell without physically separating the nucleic acids before amplification. We show that the efficiency of our integrated approach is similar to existing methods for single-cell sequencing of either genomic DNA or mRNA. Further, we find that genes with high cell-to-cell variability in transcript numbers generally have lower genomic copy numbers, and vice versa, suggesting that copy number variations may drive variability in gene expression among individual cells. Applications of our integrated sequencing approach could range from gaining insights into cancer evolution and heterogeneity to understanding the transcriptional consequences of copy number variations in healthy and diseased tissues.	[Dey, Siddharth S.; Kester, Lennart; Spanjaard, Bastiaan; Bienko, Magda; van Oudenaarden, Alexander] KNAW Royal Netherlands Acad Arts & Sci, Hubrecht Inst, Utrecht, Netherlands; [Dey, Siddharth S.; Kester, Lennart; Spanjaard, Bastiaan; Bienko, Magda; van Oudenaarden, Alexander] Univ Med Ctr Utrecht, Canc Genom Netherlands, Utrecht, Netherlands	Royal Netherlands Academy of Arts & Sciences; Hubrecht Institute (KNAW); Utrecht University; Utrecht University Medical Center	van Oudenaarden, A (corresponding author), KNAW Royal Netherlands Acad Arts & Sci, Hubrecht Inst, Utrecht, Netherlands.	a.vanoudenaarden@hubrecht.eu	van Oudenaarden, Alexander/AAA-1705-2019; Bienko, Magda/AAM-8867-2020	Bienko, Magda/0000-0002-6499-9082; Spanjaard, Bastiaan/0000-0003-1309-8839; Dey, Siddharth S./0000-0002-1161-1654; Kester, Lennart/0000-0002-8259-9971	European Research Council Advanced grant (ERC-AdG) [294325-GeneNoiseControl]; Nederlandse Organisatie voor Wetenschappelijk Onderzoek (NWO) Vici award; Human Frontier Science Program	European Research Council Advanced grant (ERC-AdG)(European Research Council (ERC)); Nederlandse Organisatie voor Wetenschappelijk Onderzoek (NWO) Vici award; Human Frontier Science Program(Human Frontier Science Program)	We would like to thank C. Zong (Harvard University) for sharing details of MALBAC and D. Grun (Hubrecht Institute) for assistance in data analysis. We would also like to thank N. Crosetto (Hubrecht Institute) for assistance in preparing DNA FISH probes. This work was supported by the European Research Council Advanced grant (ERC-AdG 294325-GeneNoiseControl), the Nederlandse Organisatie voor Wetenschappelijk Onderzoek (NWO) Vici award and by the Human Frontier Science Program (to M.B.).	Baker SC, 2005, NAT METHODS, V2, P731, DOI 10.1038/nmeth1005-731; Bienko M, 2013, NAT METHODS, V10, P122, DOI [10.1038/nmeth.2306, 10.1038/NMETH.2306]; Conrad DF, 2010, NATURE, V464, P704, DOI 10.1038/nature08516; Deng QL, 2014, SCIENCE, V343, P193, DOI 10.1126/science.1245316; Evrony GD, 2012, CELL, V151, P483, DOI 10.1016/j.cell.2012.09.035; Falconer E, 2012, NAT METHODS, V9, P1107, DOI [10.1038/NMETH.2206, 10.1038/nmeth.2206]; Grun D, 2014, NAT METHODS, V11, P637, DOI [10.1038/NMETH.2930, 10.1038/nmeth.2930]; Hashimshony T, 2012, CELL REP, V2, P666, DOI 10.1016/j.celrep.2012.08.003; Hou Y, 2013, CELL, V155, P1492, DOI 10.1016/j.cell.2013.11.040; Islam S, 2014, NAT METHODS, V11, P163, DOI [10.1038/NMETH.2772, 10.1038/nmeth.2772]; Jaitin DA, 2014, SCIENCE, V343, P776, DOI 10.1126/science.1247651; Junker JP, 2014, CELL, V157, P8, DOI 10.1016/j.cell.2014.02.010; Keane TM, 2011, NATURE, V477, P289, DOI 10.1038/nature10413; McConnell MJ, 2013, SCIENCE, V342, P632, DOI 10.1126/science.1243472; Navin N, 2011, NATURE, V472, P90, DOI 10.1038/nature09807; Picelli S, 2013, NAT METHODS, V10, P1096, DOI [10.1038/nmeth.2639, 10.1038/NMETH.2639]; Raj A, 2008, CELL, V135, P216, DOI 10.1016/j.cell.2008.09.050; Shalek AK, 2013, NATURE, V498, P236, DOI 10.1038/nature12172; Shapiro E, 2013, NAT REV GENET, V14, P618, DOI 10.1038/nrg3542; Sheltzer JM, 2012, P NATL ACAD SCI USA, V109, P12644, DOI 10.1073/pnas.1209227109; Stranger BE, 2007, SCIENCE, V315, P848, DOI 10.1126/science.1136678; Tang FC, 2009, NAT METHODS, V6, P377, DOI [10.1038/NMETH.1315, 10.1038/nmeth.1315]; Venkatraman ES, 2007, BIOINFORMATICS, V23, P657, DOI 10.1093/bioinformatics/btl646; Wu AR, 2014, NAT METHODS, V11, P41, DOI 10.1038/nmeth.2694; Xue ZG, 2013, NATURE, V500, P593, DOI 10.1038/nature12364; Zhang CL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054236; Zong CH, 2012, SCIENCE, V338, P1622, DOI 10.1126/science.1229164	27	291	350	7	117	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156	1546-1696		NAT BIOTECHNOL	Nat. Biotechnol.	MAR	2015	33	3					285	+		10.1038/nbt.3129	http://dx.doi.org/10.1038/nbt.3129			7	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	CD0ME	25599178	Green Accepted			2022-12-27	WOS:000350766900025
J	Witty, AD; Mihic, A; Tam, RY; Fisher, SA; Mikryukov, A; Shoichet, MS; Li, RK; Kattman, SJ; Keller, G				Witty, Alec D.; Mihic, Anton; Tam, Roger Y.; Fisher, Stephanie A.; Mikryukov, Alexander; Shoichet, Molly S.; Li, Ren-Ke; Kattman, Steven J.; Keller, Gordon			Generation of the epicardial lineage from human pluripotent stem cells	NATURE BIOTECHNOLOGY			English	Article							TO-MESENCHYMAL TRANSITION; SMOOTH-MUSCLE-CELLS; RETINOIC ACID SYNTHESIS; WNT/BETA-CATENIN; MOUSE EMBRYOS; DIFFERENTIATION; HEART; SPECIFICATION; BMP; EXPRESSION	The epicardium supports cardiomyocyte proliferation early in development and provides fibroblasts and vascular smooth muscle cells to the developing heart. The epicardium has been shown to play an important role during tissue remodeling after cardiac injury, making access to this cell lineage necessary for the study of regenerative medicine. Here we describe the generation of epicardial lineage cells from human pluripotent stem cells by stage-specific activation of the BMP and WNT signaling pathways. These cells display morphological characteristics and express markers of the epicardial lineage, including the transcription factors WT1 and TBX18 and the retinoic acid-producing enzyme ALDH1A2. When induced to undergo epithelial-to-mesenchymal transition, the cells give rise to populations that display characteristics of the fibroblast and vascular smooth muscle lineages. These findings identify BMP and WNT as key regulators of the epicardial lineage in vitro and provide a model for investigating epicardial function in human development and disease.	[Witty, Alec D.; Mihic, Anton; Mikryukov, Alexander; Shoichet, Molly S.; Li, Ren-Ke; Kattman, Steven J.; Keller, Gordon] Univ Hlth Network, McEwen Ctr Regenerat Med, Toronto, ON, Canada; [Witty, Alec D.; Keller, Gordon] Univ Toronto, Dept Med Biophys, Toronto, ON, Canada; [Mihic, Anton; Li, Ren-Ke] Univ Toronto, Heart & Stroke Richard Lewar Ctr Excellence Cardi, Toronto, ON, Canada; [Mihic, Anton; Li, Ren-Ke] Toronto Gen Res Inst, Toronto, ON, Canada; [Mihic, Anton; Li, Ren-Ke] Univ Toronto, Dept Surg, Toronto, ON, Canada; [Tam, Roger Y.; Fisher, Stephanie A.; Shoichet, Molly S.] Donnelly Ctr Cellular & Biomol Res, Toronto, ON, Canada; [Tam, Roger Y.; Fisher, Stephanie A.; Shoichet, Molly S.] Univ Toronto, Dept Chem Engn & Appl Chem, Toronto, ON, Canada; [Tam, Roger Y.; Fisher, Stephanie A.; Shoichet, Molly S.] Univ Toronto, Inst Biomat & Biomed Engn, Toronto, ON, Canada; [Shoichet, Molly S.] Univ Toronto, Dept Chem, Toronto, ON M5S 1A1, Canada; [Keller, Gordon] Princess Margaret Canc Ctr, Toronto, ON, Canada	University of Toronto; University Toronto Affiliates; University Health Network Toronto; University of Toronto; University of Toronto; University of Toronto; University Toronto Affiliates; University Health Network Toronto; Toronto General Hospital; University of Toronto; University of Toronto; University of Toronto; University of Toronto; University of Toronto; University of Toronto; University Toronto Affiliates; University Health Network Toronto; Princess Margaret Cancer Centre	Keller, G (corresponding author), Univ Hlth Network, McEwen Ctr Regenerat Med, Toronto, ON, Canada.	gkeller@uhnresearch.ca		Mikryukov, Alexander/0000-0002-7632-9529; Keller, Gordon/0000-0001-9309-9297; Tam, Roger/0000-0002-8441-6681; Li, Ren-Ke/0000-0002-2584-060X	Canadian Institute of Health Research [MOP-84524, MOP-119507, MOP-106538, CPG-127793]; Natural Sciences and Engineering Research Council of Canada [CHRPJ 446379-13]; US National Institutes of Health [5U01 HL100405]; VistaGen Therapeutics, Inc.; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [U01HL100405] Funding Source: NIH RePORTER	Canadian Institute of Health Research(Canadian Institutes of Health Research (CIHR)); Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); VistaGen Therapeutics, Inc.; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	We thank T. Araki and B. Neel (Ontario Cancer Institute, Toronto) for providing the Sendai hiPSC line, O. El-Mounayri and M. Husain for their advice on epithelial-to-mesenchymal transition, Mark Gagliardi for his assistance in the culture of hESC-derived epicardial cells and the Sick Kids/UHN Flow Cytometry Facility for their assistance with cell sorting. We thank members of the Keller laboratory for their advice on the studies and comments on the manuscript. This work was supported by the Canadian Institute of Health Research (MOP-84524; MOP-119507; MOP-106538; CPG-127793), the Natural Sciences and Engineering Research Council of Canada (CHRPJ 446379-13) and the US National Institutes of Health (5U01 HL100405). This work was funded in part by VistaGen Therapeutics, Inc.	Acharya A, 2012, DEVELOPMENT, V139, P2139, DOI 10.1242/dev.079970; Austin AF, 2008, DEV DYNAM, V237, P366, DOI 10.1002/dvdy.21421; Bax NAM, 2011, BASIC RES CARDIOL, V106, P829, DOI 10.1007/s00395-011-0181-0; Bochmann L, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011429; Cai CL, 2008, NATURE, V454, P104, DOI 10.1038/nature06969; Casanova JC, 2013, GENESIS, V51, P32, DOI 10.1002/dvg.22353; Cheung C, 2012, NAT BIOTECHNOL, V30, P165, DOI 10.1038/nbt.2107; Christoffels V, 2011, NATURE, V474, P585, DOI 10.1038/474585a; Clarke RL, 2013, NAT CELL BIOL, V15, P502, DOI 10.1038/ncb2724; David R, 2008, NAT CELL BIOL, V10, P338, DOI 10.1038/ncb1696; de la Cuesta F, 2013, J PROTEOMICS, V82, P155, DOI 10.1016/j.jprot.2013.01.032; DERUITER MC, 1992, ANAT EMBRYOL, V185, P461; Dubois NC, 2011, NAT BIOTECHNOL, V29, P1011, DOI 10.1038/nbt.2005; El-Mounayri O, 2013, CARDIOVASC RES, V98, P125, DOI 10.1093/cvr/cvs357; Gaudesius G, 2003, CIRC RES, V93, P421, DOI 10.1161/01.RES.0000089258.40661.0C; Haenig B, 2004, DEV GENES EVOL, V214, P407, DOI 10.1007/s00427-004-0415-3; Huang GN, 2012, SCIENCE, V338, P1599, DOI 10.1126/science.1229765; JONASSON L, 1986, ARTERIOSCLEROSIS, V6, P131, DOI 10.1161/01.ATV.6.2.131; Kattman SJ, 2011, CELL STEM CELL, V8, P228, DOI 10.1016/j.stem.2010.12.008; Kennedy M, 2007, BLOOD, V109, P2679, DOI 10.1182/blood-2006-09-047704; Klaus A, 2007, P NATL ACAD SCI USA, V104, P18531, DOI 10.1073/pnas.0703113104; KOMIYAMA M, 1987, ANAT EMBRYOL, V176, P183, DOI 10.1007/BF00310051; Kruithof BPT, 2006, DEV BIOL, V295, P507, DOI 10.1016/j.ydbio.2006.03.033; Lepilina A, 2006, CELL, V127, P607, DOI 10.1016/j.cell.2006.08.052; Lian XJ, 2012, P NATL ACAD SCI USA, V109, pE1848, DOI 10.1073/pnas.1200250109; Lie-Venema H, 2007, THESCIENTIFICWORLDJO, V7, P1777, DOI 10.1100/tsw.2007.294; Limana F, 2011, PHARMACOL THERAPEUT, V129, P82, DOI 10.1016/j.pharmthera.2010.09.002; Liu JD, 2010, CIRC RES, V106, P1818, DOI 10.1161/CIRCRESAHA.110.217950; Ma Q, 2008, DEV BIOL, V323, P98, DOI 10.1016/j.ydbio.2008.08.013; MacNeill C, 2000, DEV BIOL, V217, P62, DOI 10.1006/dbio.1999.9539; Mahtab EAF, 2008, DEV DYNAM, V237, P847, DOI 10.1002/dvdy.21463; Mellgren AM, 2008, CIRC RES, V103, P1393, DOI 10.1161/CIRCRESAHA.108.176768; Moore AW, 1999, DEVELOPMENT, V126, P1845; Morabito CJ, 2001, DEV BIOL, V234, P204, DOI 10.1006/dbio.2001.0254; Moss JB, 1998, DEV BIOL, V199, P55, DOI 10.1006/dbio.1998.8911; Phillips MD, 2011, INT J CARDIOL, V150, P186, DOI 10.1016/j.ijcard.2010.04.007; Smart N, 2011, NATURE, V474, P640, DOI 10.1038/nature10188; Smith CL, 2011, CIRC RES, V108, pE15, DOI 10.1161/CIRCRESAHA.110.235531; Ueno S, 2007, P NATL ACAD SCI USA, V104, P9685, DOI 10.1073/pnas.0702859104; van Tuyn J, 2007, STEM CELLS, V25, P271, DOI 10.1634/stemcells.2006-0366; von Gise A, 2011, DEV BIOL, V356, P421, DOI 10.1016/j.ydbio.2011.05.668; Watt AJ, 2004, P NATL ACAD SCI USA, V101, P12573, DOI 10.1073/pnas.0400752101; Weeke-Klimp A, 2010, J MOL CELL CARDIOL, V49, P606, DOI 10.1016/j.yjmcc.2010.07.007; Winter EM, 2007, CIRCULATION, V116, P917, DOI 10.1161/CIRCULATIONAHA.106.668178; Winter EM, 2009, CIRC-HEART FAIL, V2, P643, DOI 10.1161/CIRCHEARTFAILURE.108.843722; Xavier-Neto J, 2000, DEV BIOL, V219, P129, DOI 10.1006/dbio.1999.9588; Yang L, 2008, NATURE, V453, P524, DOI 10.1038/nature06894; Yui PB, 2008, NAT CHEM BIOL, V4, P33, DOI 10.1038/nchembio.2007.54; Zhou B, 2008, NATURE, V454, P109, DOI 10.1038/nature07060	49	115	121	0	31	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156	1546-1696		NAT BIOTECHNOL	Nat. Biotechnol.	OCT	2014	32	10					1026	+		10.1038/nbt.3002	http://dx.doi.org/10.1038/nbt.3002			12	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	AR7MM	25240927	Green Accepted			2022-12-27	WOS:000343763800020
J	Nielsen, HB; Almeida, M; Juncker, AS; Rasmussen, S; Li, JH; Sunagawa, S; Plichta, DR; Gautier, L; Pedersen, AG; Le Chatelier, E; Pelletier, E; Bonde, I; Nielsen, T; Manichanh, C; Arumugam, M; Batto, JM; dos Santos, MBQ; Blom, N; Borruel, N; Burgdorf, KS; Boumezbeur, F; Casellas, F; Dore, J; Dworzynski, P; Guarner, F; Hansen, T; Hildebrand, F; Kaas, RS; Kennedy, S; Kristiansen, K; Kultima, JR; Leonard, P; Levenez, F; Lund, O; Moumen, B; Le Paslier, D; Pons, N; Pedersen, O; Prifti, E; Qin, JJ; Raes, J; Sorensen, S; Tap, J; Tims, S; Ussery, DW; Yamada, T; Renault, P; Sicheritz-Ponten, T; Bork, P; Wang, J; Brunak, S; Ehrlich, SD				Nielsen, H. Bjorn; Almeida, Mathieu; Juncker, Agnieszka Sierakowska; Rasmussen, Simon; Li, Junhua; Sunagawa, Shinichi; Plichta, Damian R.; Gautier, Laurent; Pedersen, Anders G.; Le Chatelier, Emmanuelle; Pelletier, Eric; Bonde, Ida; Nielsen, Trine; Manichanh, Chaysavanh; Arumugam, Manimozhiyan; Batto, Jean-Michel; dos Santos, Marcelo B. Quintanilha; Blom, Nikolaj; Borruel, Natalia; Burgdorf, Kristoffer S.; Boumezbeur, Fouad; Casellas, Francesc; Dore, Joel; Dworzynski, Piotr; Guarner, Francisco; Hansen, Torben; Hildebrand, Falk; Kaas, Rolf S.; Kennedy, Sean; Kristiansen, Karsten; Kultima, Jens Roat; Leonard, Pierre; Levenez, Florence; Lund, Ole; Moumen, Bouziane; Le Paslier, Denis; Pons, Nicolas; Pedersen, Oluf; Prifti, Edi; Qin, Junjie; Raes, Jeroen; Sorensen, Soren; Tap, Julien; Tims, Sebastian; Ussery, David W.; Yamada, Takuji; Renault, Pierre; Sicheritz-Ponten, Thomas; Bork, Peer; Wang, Jun; Brunak, Soren; Ehrlich, S. Dusko		MetaHIT Consortium	Identification and assembly of genomes and genetic elements in complex metagenomic samples without using reference genomes	NATURE BIOTECHNOLOGY			English	Article							MICROBIOTA; SEQUENCE; TREE; SETS; TOOL	Most current approaches for analyzing metagenomic data rely on comparisons to reference genomes, but the microbial diversity of many environments extends far beyond what is covered by reference databases. De novo segregation of complex metagenomic data into specific biological entities, such as particular bacterial strains or viruses, remains a largely unsolved problem. Here we present a method, based on binning co-abundant genes across a series of metagenomic samples, that enables comprehensive discovery of new microbial organisms, viruses and co-inherited genetic entities and aids assembly of microbial genomes without the need for reference sequences. We demonstrate the method on data from 396 human gut microbiome samples and identify 7,381 co-abundance gene groups (CAGs), including 741 metagenomic species (MGS). We use these to assemble 238 high-quality microbial genomes and identify affiliations between MGS and hundreds of viruses or genetic entities. Our method provides the means for comprehensive profiling of the diversity within complex metagenomic samples.	[Nielsen, H. Bjorn; Juncker, Agnieszka Sierakowska; Rasmussen, Simon; Plichta, Damian R.; Gautier, Laurent; Pedersen, Anders G.; Bonde, Ida; dos Santos, Marcelo B. Quintanilha; Dworzynski, Piotr; Lund, Ole; Ussery, David W.; Sicheritz-Ponten, Thomas; Brunak, Soren] Tech Univ Denmark, Ctr Biol Sequence Anal, Kongens Lyngby, Denmark; [Nielsen, H. Bjorn; Juncker, Agnieszka Sierakowska; Bonde, Ida; Blom, Nikolaj; Sicheritz-Ponten, Thomas; Brunak, Soren] Tech Univ Denmark, Novo Nordisk Fdn Ctr Biosustainabil, Kongens Lyngby, Denmark; [Almeida, Mathieu; Le Chatelier, Emmanuelle; Batto, Jean-Michel; Dore, Joel; Kennedy, Sean; Levenez, Florence; Moumen, Bouziane; Pons, Nicolas; Prifti, Edi; Renault, Pierre; Ehrlich, S. Dusko] INRA, UMR 14121 MICALIS, Jouy En Josas, France; [Almeida, Mathieu; Le Chatelier, Emmanuelle; Batto, Jean-Michel; Boumezbeur, Fouad; Dore, Joel; Kennedy, Sean; Leonard, Pierre; Levenez, Florence; Moumen, Bouziane; Pons, Nicolas; Prifti, Edi; Ehrlich, S. Dusko] INRA, US 1367 Metagenopolis, Jouy En Josas, France; [Almeida, Mathieu] Univ Maryland, Ctr Bioinformat & Computat Biol, Dept Comp Sci, College Pk, MD USA; [Li, Junhua; Qin, Junjie] BGI Hong Kong Res Inst, Hong Kong, Hong Kong, Peoples R China; [Li, Junhua; Arumugam, Manimozhiyan; Qin, Junjie; Wang, Jun] BGI Shenzhen, Shenzhen, Peoples R China; [Li, Junhua] S China Univ Technol, Sch Biosci & Biotechnol, Guangzhou, Guangdong, Peoples R China; [Sunagawa, Shinichi; Kultima, Jens Roat; Tap, Julien; Yamada, Takuji; Bork, Peer] European Mol Biol Lab, D-69012 Heidelberg, Germany; [Pelletier, Eric; Le Paslier, Denis] Inst Genom, Commissariat Energie Atom & Energies Alternat, Evry, France; [Pelletier, Eric; Le Paslier, Denis] Ctr Natl Rech Scientif, Evry, France; [Pelletier, Eric; Le Paslier, Denis] Univ Evry Val dEssonne, Evry, France; [Nielsen, Trine; Arumugam, Manimozhiyan; Burgdorf, Kristoffer S.; Hansen, Torben; Pedersen, Oluf; Wang, Jun] Univ Copenhagen, Novo Nordisk Fdn Ctr Basic Metabol Res, Copenhagen, Denmark; [Manichanh, Chaysavanh; Borruel, Natalia; Casellas, Francesc; Guarner, Francisco] Univ Hosp Vall dHebron, Digest Syst Res Unit, Ciberehd, Barcelona, Spain; [Hansen, Torben] Univ So Denmark, Fac Hlth Sci, Odense, Denmark; [Hildebrand, Falk] VIB, Dept Biol Struct, Brussels, Belgium; [Hildebrand, Falk; Raes, Jeroen] Vrije Univ Brussel, Dept Biosci Engn, Brussels, Belgium; [Kaas, Rolf S.] Tech Univ Denmark, Natl Food Inst, Div Epidemiol & Microbial Gen, Kongens Lyngby, Denmark; [Kristiansen, Karsten; Wang, Jun] Univ Copenhagen, Dept Biol, Copenhagen, Denmark; [Pedersen, Oluf] Hagedorn Res Inst, Gentofte, Denmark; [Pedersen, Oluf] Univ Copenhagen, Fac Hlth & Med Sci, Inst Biomed Sci, Copenhagen, Denmark; [Pedersen, Oluf] Aarhus Univ, Fac Hlth, Aarhus, Denmark; [Raes, Jeroen] Katholieke Univ Leuven, Rega Inst, Dept Microbiol & Immunol, Louvain, Belgium; [Raes, Jeroen] VIB, Ctr Biol Dis, Leuven, Belgium; [Sorensen, Soren] Univ Copenhagen, Dept Biol, Microbiol Sect, Copenhagen, Denmark; [Tims, Sebastian] Wageningen Univ, Microbiol Lab, NL-6700 AP Wageningen, Netherlands; [Yamada, Takuji] Tokyo Inst Technol, Dept Biol Informat, Yokohama, Kanagawa 227, Japan; [Bork, Peer] Max Delbruck Ctr Mol Med, Berlin, Germany; [Wang, Jun] King Abdulaziz Univ, Princess Al Jawhara Ctr Excellence Res Hereditary, Jeddah 21413, Saudi Arabia; [Ehrlich, S. Dusko] Kings Coll London, Guys Hosp, Ctr Host Microbiome Interact, Dent Inst Cent Off, London WC2R 2LS, England	Technical University of Denmark; Technical University of Denmark; INRAE; UDICE-French Research Universities; Universite Paris Saclay; INRAE; UDICE-French Research Universities; Universite Paris Saclay; University System of Maryland; University of Maryland College Park; Beijing Genomics Institute (BGI); Beijing Genomics Institute (BGI); South China University of Technology; European Molecular Biology Laboratory (EMBL); CEA; UDICE-French Research Universities; Universite Paris Saclay; UDICE-French Research Universities; Universite Paris Saclay; Novo Nordisk Foundation; University of Copenhagen; CIBER - Centro de Investigacion Biomedica en Red; CIBEREHD; Hospital Universitari Vall d'Hebron; University of Southern Denmark; Flanders Institute for Biotechnology (VIB); Vrije Universiteit Brussel; Technical University of Denmark; University of Copenhagen; Novo Nordisk; Hagedorn Research Institute; University of Copenhagen; Aarhus University; KU Leuven; Flanders Institute for Biotechnology (VIB); University of Copenhagen; Wageningen University & Research; Tokyo Institute of Technology; Helmholtz Association; Max Delbruck Center for Molecular Medicine; King Abdulaziz University; Guy's & St Thomas' NHS Foundation Trust; University of London; King's College London	Brunak, S (corresponding author), Tech Univ Denmark, Ctr Biol Sequence Anal, Kongens Lyngby, Denmark.	brunak@cbs.dtu.dk; dusko.ehrlich@jouy.inra.fr	Rasmussen, Simon/AAA-2308-2020; Lund, Ole/F-4437-2014; Dore, Joel/ABA-8921-2020; Bork, Peer/F-1813-2013; Sørensen, Søren J/J-5015-2014; Ehrlich, S./Y-2423-2019; Pedersen, Oluf/Z-1731-2019; GUEDON, Eric/N-8624-2019; Kristiansen, Karsten/J-5148-2014; Ussery, David/J-2026-2019; Knol, Jan/AAL-6487-2020; raes, jeroen/D-7835-2018; Tap, Julien/E-5760-2010; Prifti, Edi/F-3967-2019; LE CHATELIER, Emmanuelle/O-1243-2017; Sørensen, Søren Johannes/N-2120-2019; Guedon, Eric/S-5635-2016; van Hylckama Vlieg, Johan/F-7887-2014; Casellas, Francesc/AAT-1018-2021; Pedersen, Oluf/AAG-8015-2020; Li, Junhua/AAG-3919-2019; BLOTTIERE, Hervé M/C-6120-2011; Arumugam, Manimozhiyan/E-1211-2011; Knol, Jan/A-2178-2010; Rescigno, Maria/J-9704-2012; Borruel, Natalia/AFO-6891-2022; Veiga, Patrick/A-9862-2011; Nielsen, Henrik/B-8961-2019; Falony, Gwen/AAN-5011-2020; Rasmussen, Simon/G-6258-2016; Guarner, Francisco/ABF-1192-2020; Sunagawa, Shinichi/Q-5950-2019; Arumugam, Manimozhiyan/AAJ-2394-2020; Wang, Jun/C-8434-2016; Hildebrand, Falk/K-1914-2014; Brunak, Soren/O-6621-2016; Wang, Jun/B-9503-2016; Sicheritz-Ponten, Thomas/A-4325-2017	Rasmussen, Simon/0000-0001-6323-9041; Lund, Ole/0000-0003-1108-0491; Bork, Peer/0000-0002-2627-833X; Sørensen, Søren J/0000-0001-6227-9906; Ehrlich, S./0000-0002-7563-4046; Pedersen, Oluf/0000-0002-3321-3972; GUEDON, Eric/0000-0002-0901-4447; Kristiansen, Karsten/0000-0002-6024-0917; Ussery, David/0000-0003-3632-5512; Knol, Jan/0000-0002-2103-5961; raes, jeroen/0000-0002-1337-041X; Tap, Julien/0000-0001-8998-5413; Prifti, Edi/0000-0001-8861-1305; LE CHATELIER, Emmanuelle/0000-0002-2724-0536; Sørensen, Søren Johannes/0000-0001-6227-9906; Guedon, Eric/0000-0002-0901-4447; van Hylckama Vlieg, Johan/0000-0001-6656-8668; Casellas, Francesc/0000-0003-3196-039X; Li, Junhua/0000-0001-6784-1873; BLOTTIERE, Hervé M/0000-0002-8390-0607; Arumugam, Manimozhiyan/0000-0002-0886-9101; Knol, Jan/0000-0002-2103-5961; Rescigno, Maria/0000-0002-6464-509X; Borruel, Natalia/0000-0002-4449-2292; Veiga, Patrick/0000-0001-6318-8547; Nielsen, Henrik/0000-0003-2281-5713; Falony, Gwen/0000-0003-2450-0782; Rasmussen, Simon/0000-0001-6323-9041; Guarner, Francisco/0000-0002-4051-0836; Sunagawa, Shinichi/0000-0003-3065-0314; Arumugam, Manimozhiyan/0000-0002-0886-9101; Burgdorf, Kristoffer/0000-0001-5814-6844; Kleerebezem, Michiel/0000-0001-8552-2235; Wang, Jun/0000-0002-8540-8931; Derrien, Muriel/0000-0001-8841-9153; Varela Castro, Encarna/0000-0001-6334-9320; Chaysavanh, Manichanh/0000-0002-2287-4003; Pedersen, Anders Gorm/0000-0001-9650-8965; TORREJON, ANTONIO/0000-0002-3126-1532; Le Paslier, Denis/0000-0003-4335-9956; Delorme, Christine/0000-0002-5208-7238; Hildebrand, Falk/0000-0002-0078-8948; Kaas, Rolf Sommer/0000-0002-5050-8668; Brunak, Soren/0000-0003-0316-5866; Wang, Jun/0000-0002-2113-5874; Kennedy, Sean/0000-0002-3932-8922; Nielsen, Trine/0000-0002-2066-7895; Dworzynski, Piotr/0000-0002-6717-8052; Plichta, Damian/0000-0002-6555-2557; Pelletier, Eric/0000-0003-4228-1712; Sicheritz-Ponten, Thomas/0000-0001-6615-1141; Hansen, Torben/0000-0001-8748-3831; Blom, Nikolaj Sorgenfrei/0000-0001-7787-7853	European Community's Seventh Framework Programme [FP7-HEALTH-F4-2007-201052, FP7-HEALTH-2010-261376]; Novo Nordisk Foundation Center for Biosustainability; OpenGPU FUI collaborative research projects; DGCIS; Instituto de Salud Carlos III (Spain); Ministere de la Recherche et de l'Education Nationale (France);  [ANR-11-DPBS-0001]; Novo Nordisk Fonden [NNF10CC1016517] Funding Source: researchfish	European Community's Seventh Framework Programme(European Commission); Novo Nordisk Foundation Center for Biosustainability; OpenGPU FUI collaborative research projects; DGCIS; Instituto de Salud Carlos III (Spain)(Instituto de Salud Carlos III); Ministere de la Recherche et de l'Education Nationale (France); ; Novo Nordisk Fonden(Novo Nordisk Foundation)	The research leading to these results has received funding from the European Community's Seventh Framework Programme FP7-HEALTH-F4-2007-201052: Metagenomics of the Human Intestinal Tract (MetaHIT) and FP7-HEALTH-2010-261376: International Human Microbiome Standards, as well as the Novo Nordisk Foundation Center for Biosustainability. Work on the clustering concept has been supported by the OpenGPU FUI collaborative research projects, with funding from DGCIS. Researchers on the project were granted access to the HPC resources of CCRT under the allocation 2011-036707 made by GENCI (Grand Equipement National de Calcul Intensif). The company Alliance Services Plus (AS+) has provided help to scale up the process, especially, V. Arslan, D. Tello, V. Ducrot, T. Saidani and S. Monot. The authors affiliated with MGP are funded, in part, by the Metagenopolis ANR-11-DPBS-0001 grant. Ciberehd is funded by the Instituto de Salud Carlos III (Spain). M.A. was supported by a grant from the Ministere de la Recherche et de l'Education Nationale (France).	Albertsen M, 2013, NAT BIOTECHNOL, V31, P533, DOI 10.1038/nbt.2579; Bateman A, 2004, NUCLEIC ACIDS RES, V32, pD138, DOI [10.1093/nar/gkt1223, 10.1093/nar/gkr1065, 10.1093/nar/gkp985]; Bland C, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-209; Chain PSG, 2009, SCIENCE, V326, P236, DOI 10.1126/science.1180614; Chervaux C, 2011, J BACTERIOL, V193, P5560, DOI 10.1128/JB.05716-11; Ciccarelli FD, 2006, SCIENCE, V311, P1283, DOI 10.1126/science.1123061; Earl D, 2011, GENOME RES, V21, P2224, DOI 10.1101/gr.126599.111; Finn RD, 2011, NUCLEIC ACIDS RES, V39, pW29, DOI 10.1093/nar/gkr367; Fitzsimons MS, 2013, GENOME RES, V23, P878, DOI 10.1101/gr.142208.112; Fodor AA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041294; Gelman A., 1992, STAT SCI, V7, P457, DOI [10.1214/ss/1177011136, DOI 10.1214/SS/1177011136]; Gelman A, 2008, ANN APPL STAT, V2, P1360, DOI 10.1214/08-AOAS191; Iverson V, 2012, SCIENCE, V335, P587, DOI 10.1126/science.1212665; Karch H, 2012, EMBO MOL MED, V4, P841, DOI 10.1002/emmm.201201662; Kelley DR, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-11-r116; Kobayashi K, 2003, P NATL ACAD SCI USA, V100, P4678, DOI 10.1073/pnas.0730515100; Koren S, 2011, BIOINFORMATICS, V27, P2964, DOI 10.1093/bioinformatics/btr520; Kristensen DM, 2011, J BACTERIOL, V193, P1806, DOI 10.1128/JB.01311-10; Kruschke JK, 2010, WIRES COGN SCI, V1, P658, DOI 10.1002/wcs.72; Kultima JR, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047656; Le Chatelier E, 2013, NATURE, V500, P541, DOI 10.1038/nature12506; Leplae R, 2010, NUCLEIC ACIDS RES, V38, pD57, DOI 10.1093/nar/gkp938; Letunic I, 2011, NUCLEIC ACIDS RES, V39, pW475, DOI [10.1093/nar/gkr931, 10.1093/nar/gkr201]; Li H, 2009, BIOINFORMATICS, V25, P1094, DOI [10.1093/bioinformatics/btp100, 10.1093/bioinformatics/btp324]; Li RQ, 2010, GENOME RES, V20, P265, DOI 10.1101/gr.097261.109; Li RQ, 2009, BIOINFORMATICS, V25, P1966, DOI 10.1093/bioinformatics/btp336; Li WZ, 2006, BIOINFORMATICS, V22, P1658, DOI 10.1093/bioinformatics/btl158; Lukjancenko O, 2010, MICROB ECOL, V60, P708, DOI 10.1007/s00248-010-9717-3; Mavromatis K, 2007, NAT METHODS, V4, P495, DOI 10.1038/nmeth1043; Minot S, 2011, GENOME RES, V21, P1616, DOI 10.1101/gr.122705.111; Plummer M., 2003, JAGS PROGRAM ANAL BA, DOI DOI 10.1.1.13.3406; Pop M, 2009, BRIEF BIOINFORM, V10, P354, DOI 10.1093/bib/bbp026; Powell S, 2012, NUCLEIC ACIDS RES, V40, pD284, DOI 10.1093/nar/gkr1060; Qin JJ, 2012, NATURE, V490, P55, DOI 10.1038/nature11450; Qin JJ, 2010, NATURE, V464, P59, DOI 10.1038/nature08821; Raes J, 2008, NAT REV MICROBIOL, V6, P693, DOI 10.1038/nrmicro1935; Reyes A, 2010, NATURE, V466, P334, DOI 10.1038/nature09199; Roessner CA, 2006, J BACTERIOL, V188, P7331, DOI 10.1128/JB.00918-06; Salzberg SL, 2012, GENOME RES, V22, P557, DOI 10.1101/gr.131383.111; Stern A, 2012, GENOME RES, V22, P1985, DOI 10.1101/gr.138297.112; Teeling H, 2004, ENVIRON MICROBIOL, V6, P938, DOI 10.1111/j.1462-2920.2004.00624.x; Terns MP, 2011, CURR OPIN MICROBIOL, V14, P321, DOI 10.1016/j.mib.2011.03.005; Treangen Todd J, 2011, Curr Protoc Bioinformatics, VChapter 11, DOI 10.1002/0471250953.bi1108s33; Tringe SG, 2005, SCIENCE, V308, P554, DOI 10.1126/science.1107851; Wang Y, 2012, BIOINFORMATICS, V28, pI356, DOI 10.1093/bioinformatics/bts397; Wooley JC, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000667; Zankari E, 2012, J ANTIMICROB CHEMOTH, V67, P2640, DOI 10.1093/jac/dks261; Zerbino DR, 2008, GENOME RES, V18, P821, DOI 10.1101/gr.074492.107; Zhang Q, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-4-r40; Zhu Wenhan, 2010, Nucleic Acids Res, V38, pe132, DOI 10.1093/nar/gkq275	50	580	602	14	269	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1087-0156	1546-1696		NAT BIOTECHNOL	Nat. Biotechnol.	AUG	2014	32	8					822	828		10.1038/nbt.2939	http://dx.doi.org/10.1038/nbt.2939			7	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	AW7PF	24997787				2022-12-27	WOS:000346455900043
J	Speicher, MR; Pantel, K				Speicher, Michael R.; Pantel, Klaus			Tumor signatures in the blood	NATURE BIOTECHNOLOGY			English	Editorial Material							EVOLUTION; CELLS		[Speicher, Michael R.] Med Univ Graz, Inst Human Genet, Graz, Austria; [Pantel, Klaus] Univ Med Ctr Hamburg Eppendorf, Inst Tumor Biol, Hamburg, Germany	Medical University of Graz; University of Hamburg; University Medical Center Hamburg-Eppendorf	Speicher, MR (corresponding author), Med Univ Graz, Inst Human Genet, Graz, Austria.	michael.speicher@medunigraz.at; pantel@uke.de	Speicher, Michael R/B-5362-2013	Speicher, Michael R/0000-0003-0105-955X	Austrian Science Fund FWF [P 23284] Funding Source: Medline; Austrian Science Fund (FWF) [P 23284] Funding Source: researchfish	Austrian Science Fund FWF(Austrian Science Fund (FWF)); Austrian Science Fund (FWF)(Austrian Science Fund (FWF))		Bettegowda C, 2014, SCI TRANSL MED, V6, DOI 10.1126/scitranslmed.3007094; Gerlinger M, 2012, NEW ENGL J MED, V366, P883, DOI 10.1056/NEJMoa1113205; Heitzer E, 2013, CANCER RES, V73, P2965, DOI 10.1158/0008-5472.CAN-12-4140; Hou Y, 2012, CELL, V148, P873, DOI 10.1016/j.cell.2012.02.028; Im H, 2014, NAT BIOTECHNOL, V32, P490, DOI 10.1038/nbt.2886; Lawrence MS, 2014, NATURE, V505, P495, DOI 10.1038/nature12912; Lohr JG, 2014, NAT BIOTECHNOL, V32, P479, DOI 10.1038/nbt.2892; Pantel K, 2008, NAT REV CANCER, V8, P329, DOI 10.1038/nrc2375; Pantel K, 2013, CANCER RES, V73, P6384, DOI 10.1158/0008-5472.CAN-13-2030; Wan LL, 2013, NAT MED, V19, P1450, DOI 10.1038/nm.3391	10	76	80	0	27	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156	1546-1696		NAT BIOTECHNOL	Nat. Biotechnol.	MAY	2014	32	5					441	443		10.1038/nbt.2897	http://dx.doi.org/10.1038/nbt.2897			3	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	AH3PH	24811515				2022-12-27	WOS:000336036100016
J	Morizane, R; Lam, AQ; Freedman, BS; Kishi, S; Valerius, MT; Bonventre, JV				Morizane, Ryuji; Lam, Albert Q.; Freedman, Benjamin S.; Kishi, Seiji; Valerius, M. Todd; Bonventre, Joseph V.			Nephron organoids derived from human pluripotent stem cells model kidney development and injury	NATURE BIOTECHNOLOGY			English	Article							MOUSE KIDNEY; DIRECTED DIFFERENTIATION; METANEPHRIC MESENCHYME; INTERMEDIATE MESODERM; TUBULE FORMATION; IN-VIVO; PROGENITORS; EXPRESSION; FATE; MORPHOGENESIS	Kidney cells and tissues derived from human pluripotent stem cells (hPSCs) may enable organ regeneration, disease modeling and drug screening. We report an efficient, chemically defined protocol for differentiating hPSCs into multipotent nephron progenitor cells (NPCs) that can form nephron-like structures. By recapitulating metanephric kidney development in vitro, we generate SIX2(+)SALL1(+)WT1(+)PAX2(+) NPCs with 90% efficiency within 9 days of differentiation. The NPCs possess the developmental potential of their in vivo counterparts and form PAX8(+)LHX1(+) renal vesicles that self-organize into nephron structures. In both two-and three-dimensional culture, NPCs form kidney organoids containing epithelial nephron-like structures expressing markers of podocytes, proximal tubules, loops of Henle and distal tubules in an organized, continuous arrangement that resembles the nephron in vivo. We also show that this organoid culture system can be used to study mechanisms of human kidney development and toxicity.	[Morizane, Ryuji; Lam, Albert Q.; Freedman, Benjamin S.; Kishi, Seiji; Valerius, M. Todd; Bonventre, Joseph V.] Brigham & Womens Hosp, Dept Med, Div Renal, Boston, MA 02115 USA; [Morizane, Ryuji; Lam, Albert Q.; Freedman, Benjamin S.; Kishi, Seiji; Valerius, M. Todd; Bonventre, Joseph V.] Harvard Univ, Sch Med, Dept Med, Boston, MA USA; [Lam, Albert Q.; Valerius, M. Todd; Bonventre, Joseph V.] Harvard Stem Cell Inst, Cambridge, MA USA	Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School; Harvard University	Morizane, R (corresponding author), Brigham & Womens Hosp, Dept Med, Div Renal, 75 Francis St, Boston, MA 02115 USA.	morizanr@da2.so-net.ne.jp; jbonventre@partners.org	Valerius, M. Todd/AAK-3063-2020; Morizane, R/AAC-3215-2021; Wilson, Matthew H/K-3193-2013	Valerius, M. Todd/0000-0001-8143-9231; Morizane, R/0000-0002-0377-5667; 	US National Institutes of Health (NIH) [R37 DK039773, R01 DK072381]; Postdoctoral Fellowship for Research Abroad; American Heart Association [11FTF7320023]; Harvard Stem Cell Institute; NIH [DK102826]; National Kidney Foundation Young Investigator Grant; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK072381, K01DK102826, R37DK039773, F32DK092036] Funding Source: NIH RePORTER	US National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Postdoctoral Fellowship for Research Abroad; American Heart Association(American Heart Association); Harvard Stem Cell Institute; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Kidney Foundation Young Investigator Grant; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	The authors thank V. Bijol for providing electron microscopy images of normal human kidneys, L. Racusen (Johns Hopkins Hospital) for HKC-8, J. Barasch (Columbia University) for a mouse ureteric bud cell line, and A.P. McMahon (University of Southern California) for NIH3T3-Wnt4. This study was supported by US National Institutes of Health (NIH) grants R37 DK039773 and R01 DK072381 (J.V.B.); Grant-in-Aid for JSPS (Japan Society for the Promotion of Science); Postdoctoral Fellowship for Research Abroad (R.M.); American Heart Association grant 11FTF7320023 (A.Q.L.); Harvard Stem Cell Institute (A.Q.L., J.V.B. and M.T.V.); and NIH DK102826 and National Kidney Foundation Young Investigator Grant (B.S.F.).	Attia L, 2012, DEVELOPMENT, V139, P4143, DOI 10.1242/dev.085258; Barak H, 2012, DEV CELL, V22, P1191, DOI 10.1016/j.devcel.2012.04.018; Barasch J, 1996, AM J PHYSIOL-RENAL, V271, pF50, DOI 10.1152/ajprenal.1996.271.1.F50; Bock C, 2011, CELL, V144, P439, DOI 10.1016/j.cell.2010.12.032; Boyle S, 2008, DEV BIOL, V313, P234, DOI 10.1016/j.ydbio.2007.10.014; Carroll TJ, 2005, DEV CELL, V9, P283, DOI 10.1016/j.devcel.2005.05.016; Cheng HT, 2003, DEVELOPMENT, V130, P5031, DOI 10.1242/dev.00697; Cheng HT, 2007, DEVELOPMENT, V134, P801, DOI 10.1242/dev.02773; Coresh J, 2007, JAMA-J AM MED ASSOC, V298, P2038, DOI 10.1001/jama.298.17.2038; Deschamps J, 2005, DEVELOPMENT, V132, P2931, DOI 10.1242/dev.01897; Freedman BS, 2013, J AM SOC NEPHROL, V24, P1571, DOI 10.1681/ASN.2012111089; Georgas KM, 2011, DEV DYNAM, V240, P1600, DOI 10.1002/dvdy.22640; Georgas K, 2008, HISTOCHEM CELL BIOL, V130, P927, DOI 10.1007/s00418-008-0454-3; Georgas K, 2009, DEV BIOL, V332, P273, DOI 10.1016/j.ydbio.2009.05.578; Grote D, 2006, DEVELOPMENT, V133, P53, DOI 10.1242/dev.02184; HERZLINGER D, 1992, DEVELOPMENT, V114, P565; HINCHLIFFE SA, 1991, LAB INVEST, V64, P777; Humphreys BD, 2008, CELL STEM CELL, V2, P284, DOI 10.1016/j.stem.2008.01.014; Iimura T, 2006, NATURE, V442, P568, DOI 10.1038/nature04838; Imberti B, 2015, SCI REP-UK, V5, DOI 10.1038/srep08826; Kang M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094888; Kim D, 2005, J AM SOC NEPHROL, V16, P3527, DOI 10.1681/ASN.2005050544; Kispert A, 1998, DEVELOPMENT, V125, P4225; Kobayashi A, 2008, CELL STEM CELL, V3, P169, DOI 10.1016/j.stem.2008.05.020; Lam AQ, 2014, SEMIN NEPHROL, V34, P445, DOI 10.1016/j.semnephrol.2014.06.011; Lam AQ, 2014, J AM SOC NEPHROL, V25, P1211, DOI 10.1681/ASN.2013080831; Lancaster MA, 2013, NATURE, V501, P373, DOI 10.1038/nature12517; Lengerke C, 2008, CELL STEM CELL, V2, P72, DOI 10.1016/j.stem.2007.10.022; Liu PT, 1999, NAT GENET, V22, P361, DOI 10.1038/11932; Mae SI, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2378; Mahlapuu M, 2001, DEVELOPMENT, V128, P155; McCracken KW, 2014, NATURE, V516, P400, DOI 10.1038/nature13863; Morizane R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064843; Morizane R, 2009, BIOCHEM BIOPH RES CO, V390, P1334, DOI 10.1016/j.bbrc.2009.10.148; Nakai S, 2003, DEVELOPMENT, V130, P4751, DOI 10.1242/dev.00666; Narayanan K, 2013, KIDNEY INT, V83, P593, DOI 10.1038/ki.2012.442; Narlis M, 2007, J AM SOC NEPHROL, V18, P1121, DOI 10.1681/ASN.2006070739; NOUWEN EJ, 1993, KIDNEY INT, V44, P147, DOI 10.1038/ki.1993.225; Osafune K, 2008, NAT BIOTECHNOL, V26, P313, DOI 10.1038/nbt1383; Park JS, 2012, DEV CELL, V23, P637, DOI 10.1016/j.devcel.2012.07.008; Potter SS, 2007, GENESIS, V45, P432, DOI 10.1002/dvg.20309; Self M, 2006, EMBO J, V25, P5214, DOI 10.1038/sj.emboj.7601381; Taguchi A, 2015, KIDNEY INT, V87, P894, DOI 10.1038/ki.2014.358; Taguchi A, 2014, CELL STEM CELL, V14, P53, DOI 10.1016/j.stem.2013.11.010; Takasato M, 2014, NAT CELL BIOL, V16, P118, DOI 10.1038/ncb2894; Uchino S, 2005, JAMA-J AM MED ASSOC, V294, P813, DOI 10.1001/jama.294.7.813; Vaidya VS, 2010, NAT BIOTECHNOL, V28, P478, DOI 10.1038/nbt.1623; Vigneau C, 2007, J AM SOC NEPHROL, V18, P1709, DOI 10.1681/ASN.2006101078; Whiting PH, 1996, RENAL FAILURE, V18, P899, DOI 10.3109/08860229609047716; Xia Y, 2013, NAT CELL BIOL, V15, P1507, DOI 10.1038/ncb2872; Zimmerman LB, 1996, CELL, V86, P599, DOI 10.1016/S0092-8674(00)80133-6	51	473	481	16	129	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1087-0156	1546-1696		NAT BIOTECHNOL	Nat. Biotechnol.	NOV	2015	33	11					1193	U127		10.1038/nbt.3392	http://dx.doi.org/10.1038/nbt.3392			10	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	CW3TY	26458176	Green Submitted, Green Accepted			2022-12-27	WOS:000364916000027
J	Rotem, A; Ram, O; Shoresh, N; Sperling, RA; Goren, A; Weitz, DA; Bernstein, BE				Rotem, Assaf; Ram, Oren; Shoresh, Noam; Sperling, Ralph A.; Goren, Alon; Weitz, David A.; Bernstein, Bradley E.			Single-cell ChIP-seq reveals cell subpopulations defined by chromatin state	NATURE BIOTECHNOLOGY			English	Article							EMBRYONIC STEM-CELLS; RNA-SEQ; GENOME; PLURIPOTENT; EXPRESSION; HETEROGENEITY; DYNAMICS; CANCER; IMMUNOPRECIPITATION; DIFFERENTIATION	Chromatin profiling provides a versatile means to investigate functional genomic elements and their regulation. However, current methods yield ensemble profiles that are insensitive to cell-to-cell variation. Here we combine microfluidics, DNA barcoding and sequencing to collect chromatin data at single-cell resolution. We demonstrate the utility of the technology by assaying thousands of individual cells and using the data to deconvolute a mixture of ES cells, fibroblasts and hematopoietic progenitors into high-quality chromatin state maps for each cell type. The data from each single cell are sparse, comprising on the order of 1,000 unique reads. However, by assaying thousands of ES cells, we identify a spectrum of subpopulations defined by differences in chromatin signatures of pluripotency and differentiation priming. We corroborate these findings by comparison to orthogonal single-cell gene expression data. Our method for single-cell analysis reveals aspects of epigenetic heterogeneity not captured by transcriptional analysis alone.	[Rotem, Assaf; Sperling, Ralph A.; Weitz, David A.] Harvard Univ, Dept Phys, Cambridge, MA 02138 USA; [Rotem, Assaf; Sperling, Ralph A.; Weitz, David A.] Harvard Univ, Sch Engn & Appl Sci, Cambridge, MA 02138 USA; [Rotem, Assaf; Ram, Oren; Shoresh, Noam; Bernstein, Bradley E.] Broad Inst MIT & Harvard, Epigen Program, Cambridge, MA 02142 USA; [Ram, Oren; Bernstein, Bradley E.] Howard Hughes Med Inst, Chevy Chase, MD USA; [Ram, Oren; Bernstein, Bradley E.] Massachusetts Gen Hosp, Dept Pathol, Boston, MA 02114 USA; [Ram, Oren; Bernstein, Bradley E.] Harvard Univ, Sch Med, Boston, MA USA; [Goren, Alon] Broad Inst MIT & Harvard, Broad Technol Labs, Cambridge, MA USA	Harvard University; Harvard University; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Howard Hughes Medical Institute; Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute	Bernstein, BE (corresponding author), Broad Inst MIT & Harvard, Epigen Program, Cambridge, MA 02142 USA.	Weitz@seas.harvard.edu; Bernstein.Bradley@mgh.harvard.edu		Goren, Alon/0000-0001-5669-9357	Howard Hughes Medical Institute; National Human Genome Research Institute's Centers of Excellence in Genome Sciences [P50HG006193]; ENCODE Project [U54HG006991]; National Heart, Lung, and Blood Institute [U01HL100395]; National Science Foundation [DMR-1310266]; Harvard Materials Research Science and Engineering Center [DMR-1420570]; Defense Advanced Research Projects Agency [HR0011-11-C-0093]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [U01HL100395] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [U54HG006991, P50HG006193] Funding Source: NIH RePORTER; Division Of Materials Research [1310266] Funding Source: National Science Foundation	Howard Hughes Medical Institute(Howard Hughes Medical Institute); National Human Genome Research Institute's Centers of Excellence in Genome Sciences; ENCODE Project; National Heart, Lung, and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); National Science Foundation(National Science Foundation (NSF)); Harvard Materials Research Science and Engineering Center(National Science Foundation (NSF)); Defense Advanced Research Projects Agency(United States Department of DefenseDefense Advanced Research Projects Agency (DARPA)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); Division Of Materials Research(National Science Foundation (NSF)NSF - Directorate for Mathematical & Physical Sciences (MPS))	We thank A. Regev, N. Yosef, E. Shema, I. Tirosh, H. Zhang, S. Gillespie and J. Xing for their valuable comments and critiques of this work. We also thank G. Kelsey for sharing single-cell data for comparisons. This research was supported by funds from Howard Hughes Medical Institute, the National Human Genome Research Institute's Centers of Excellence in Genome Sciences (P50HG006193), ENCODE Project (U54HG006991), the National Heart, Lung, and Blood Institute (U01HL100395), the National Science Foundation (DMR-1310266), the Harvard Materials Research Science and Engineering Center (DMR-1420570) and the Defense Advanced Research Projects Agency (HR0011-11-C-0093).	Adli M, 2010, NAT METHODS, V7, P615, DOI [10.1038/NMETH.1478, 10.1038/nmeth.1478]; Alexandrov LB, 2013, NATURE, V500, P415, DOI 10.1038/nature12477; Azuara V, 2006, NAT CELL BIOL, V8, P532, DOI 10.1038/ncb1403; Baylin SB, 2011, NAT REV CANCER, V11, P726, DOI 10.1038/nrc3130; Ben-Porath I, 2008, NAT GENET, V40, P499, DOI 10.1038/ng.127; Bernstein BE, 2006, CELL, V125, P315, DOI 10.1016/j.cell.2006.02.041; Brown CR, 2013, PLOS BIOL, V11, DOI 10.1371/journal.pbio.1001621; Chambers I, 2007, NATURE, V450, P1230, DOI 10.1038/nature06403; Chen X, 2008, CELL, V133, P1106, DOI 10.1016/j.cell.2008.04.043; Cusanovich DA, 2015, SCIENCE, V348, P910, DOI 10.1126/science.aab1601; Dunham I, 2012, NATURE, V489, P57, DOI 10.1038/nature11247; Ernst J, 2011, NATURE, V473, P43, DOI 10.1038/nature09906; Farlik M, 2015, CELL REP, V10, P1386, DOI 10.1016/j.celrep.2015.02.001; Guo MT, 2012, LAB CHIP, V12, P2146, DOI 10.1039/c2lc21147e; Guttman M, 2010, NAT BIOTECHNOL, V28, P503, DOI 10.1038/nbt.1633; Hackett JA, 2014, CELL STEM CELL, V15, P416, DOI 10.1016/j.stem.2014.09.015; Hough SR, 2014, STEM CELL REP, V2, P881, DOI 10.1016/j.stemcr.2014.04.014; Kalisky T, 2011, NAT METHODS, V8, P311, DOI 10.1038/nmeth0411-311; Klein AM, 2015, CELL, V161, P1187, DOI 10.1016/j.cell.2015.04.044; Ku M, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000242; Kumar RM, 2014, NATURE, V516, P56, DOI 10.1038/nature13920; Langmead B, 2012, NAT METHODS, V9, P357, DOI [10.1038/NMETH.1923, 10.1038/nmeth.1923]; Lara-Astiaso D, 2014, SCIENCE, V345, P943, DOI 10.1126/science.1256271; Li ZY, 2012, CELL, V151, P1608, DOI 10.1016/j.cell.2012.11.018; Macosko EZ, 2015, CELL, V161, P1202, DOI 10.1016/j.cell.2015.05.002; Mazutis L, 2013, NAT PROTOC, V8, P870, DOI 10.1038/nprot.2013.046; Meshorer E, 2006, NAT REV MOL CELL BIO, V7, P540, DOI 10.1038/nrm1938; Munsky B, 2012, SCIENCE, V336, P183, DOI 10.1126/science.1216379; Murphy PJ, 2013, P NATL ACAD SCI USA, V110, P7772, DOI 10.1073/pnas.1218495110; Nagano T, 2013, NATURE, V502, P59, DOI 10.1038/nature12593; Nichols J, 2009, CELL STEM CELL, V4, P487, DOI 10.1016/j.stem.2009.05.015; O'Neill LP, 2006, NAT GENET, V38, P835, DOI 10.1038/ng1820; Patel AP, 2014, SCIENCE, V344, P1396, DOI 10.1126/science.1254257; Rotem A, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0116328; Sackmann EK, 2014, NATURE, V507, P181, DOI 10.1038/nature13118; Shalek AK, 2013, NATURE, V498, P236, DOI 10.1038/nature12172; Singer ZS, 2014, MOL CELL, V55, P319, DOI 10.1016/j.molcel.2014.06.029; Smallwood SA, 2014, NAT METHODS, V11, P817, DOI [10.1038/nmeth.3035, 10.1038/NMETH.3035]; Treutlein B, 2014, NATURE, V509, P371, DOI 10.1038/nature13173; Venables WN., 2002, MODERN APPL STAT S 4; Wang Y, 2014, NATURE, V512, P155, DOI 10.1038/nature13600; Wu AR, 2009, LAB CHIP, V9, P1365, DOI 10.1039/b819648f; Xu X, 2012, CELL, V148, P886, DOI 10.1016/j.cell.2012.02.025; Zhu J, 2013, CELL, V152, P642, DOI 10.1016/j.cell.2012.12.033	44	511	571	8	208	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1087-0156	1546-1696		NAT BIOTECHNOL	Nat. Biotechnol.	NOV	2015	33	11					1165	U91		10.1038/nbt.3383	http://dx.doi.org/10.1038/nbt.3383			11	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	CW3TY	26458175	Green Submitted, Green Accepted			2022-12-27	WOS:000364916000024
J	Clain, E; Trosman, JR; Douglas, MP; Weldon, CB; Phillips, KA				Clain, Elizabeth; Trosman, Julia R.; Douglas, Michael P.; Weldon, Christine B.; Phillips, Kathryn A.			Availability and payer coverage of BRCA1/2 tests and gene panels	NATURE BIOTECHNOLOGY			English	Letter							CANCER-RISK ASSESSMENT; POLICIES; BREAST		[Clain, Elizabeth] Albert Einstein Coll Med, Bronx, NY 10467 USA; [Trosman, Julia R.; Weldon, Christine B.] Ctr Business Models Healthcare, Chicago, IL USA; [Trosman, Julia R.; Douglas, Michael P.; Weldon, Christine B.; Phillips, Kathryn A.] Univ Calif San Francisco, Dept Clin Pharm, Ctr Translat & Policy Res Personalized Med TRANSP, San Francisco, CA 94143 USA; [Phillips, Kathryn A.] UCSF Philip R Lee Inst Hlth Policy, San Francisco, CA USA; [Phillips, Kathryn A.] UCSF Helen Diller Family Comprehens Canc Ctr, San Francisco, CA USA	Yeshiva University; Albert Einstein College of Medicine; University of California System; University of California San Francisco; University of California System; University of California San Francisco; UCSF Medical Center; UCSF Helen Diller Family Comprehensive Cancer Center	Clain, E (corresponding author), Albert Einstein Coll Med, Bronx, NY 10467 USA.	kathryn.phillips@ucsf.edu		Douglas, Michael/0000-0001-8517-6678; Weldon, Christine/0000-0003-3918-0048	NCI NIH HHS [5P30CA082013-15] Funding Source: Medline; NHGRI NIH HHS [R01HG007063, R01 HG007063] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R43CA082013] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R01HG007063] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NHGRI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))		Couch FJ, 2014, SCIENCE, V343, P1466, DOI 10.1126/science.1251827; Curnutte MA, 2014, NAT BIOTECHNOL, V32, P980, DOI 10.1038/nbt.3030; Daly M.B., 2015, NCCN CLIN PRACTICE G; Domchek SM, 2013, J CLIN ONCOL, V31, P1267, DOI 10.1200/JCO.2012.46.9403; Graf MD, 2013, PERS MED, V10, P235, DOI [10.2217/pme.13.9, 10.2217/PME.13.9]; Heger M., 2014, OFFICIAL DISCUSSES W; Hiraki S, 2014, J GENET COUNS, V23, P604, DOI 10.1007/s10897-014-9695-6; Kurian AW, 2015, CURR OPIN OBSTET GYN, V27, P23, DOI 10.1097/GCO.0000000000000141; Kurian AW, 2014, J CLIN ONCOL, V32, P2001, DOI 10.1200/JCO.2013.53.6607; Ratner M, 2013, NAT BIOTECHNOL, V31, P663, DOI 10.1038/nbt0813-663; Trosman JR, 2015, J NATL COMPR CANC NE, V13, P311, DOI 10.6004/jnccn.2015.0043; Trosman JR, 2011, J ONCOL PRACT, V7, p18S, DOI 10.1200/JOP.2011.000300; Turnbull C, 2008, ANNU REV GENOM HUM G, V9, P321, DOI 10.1146/annurev.genom.9.081307.164339; Wang G, 2011, GENET MED, V13, P1045, DOI 10.1097/GIM.0b013e31822a8113; Weldon CB, 2012, J ONCOL PRACT, V8, pE24, DOI 10.1200/JOP.2011.000448	15	19	19	0	3	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156	1546-1696		NAT BIOTECHNOL	Nat. Biotechnol.	SEP	2015	33	9					900	902		10.1038/nbt.3322	http://dx.doi.org/10.1038/nbt.3322			4	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	CR0EK	26348951	Green Accepted, Green Published			2022-12-27	WOS:000360990900009
J	Gunn, M; Lim, M; Cross, D; Goldman, M				Gunn, Magda; Lim, Mark; Cross, Didi; Goldman, Michel			Benchmarking the scientific output of the Innovative Medicines Initiative	NATURE BIOTECHNOLOGY			English	Letter									[Gunn, Magda] Innovat Med Initiat, Brussels, Belgium; [Lim, Mark] Ctr Milken Inst, Fastercures, Washington, DC USA; [Cross, Didi] Thomson Reuters, New York, NY USA; [Goldman, Michel] Univ Libre Bruxelles, Brussels, Belgium	Clarivate; Universite Libre de Bruxelles	Gunn, M (corresponding author), Innovat Med Initiat, Brussels, Belgium.	magda.gunn@imi.europa.eu	; Cross, Di/A-2326-2011	Lim, Mark D./0000-0003-3155-6522; Cross, Di/0000-0001-7002-281X				Goldman M, 2015, NAT REV DRUG DISCOV, V14, P1, DOI 10.1038/nrd4520; Lim MD, 2014, SCI TRANSL MED, V6, DOI 10.1126/scitranslmed.3009024; Printz C, 2013, CANCER-AM CANCER SOC, V119, P1925, DOI 10.1002/cncr.28172	3	10	10	0	17	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156	1546-1696		NAT BIOTECHNOL	Nat. Biotechnol.	AUG	2015	33	8					811	812		10.1038/nbt.3305	http://dx.doi.org/10.1038/nbt.3305			4	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	CO6OB	26252134				2022-12-27	WOS:000359274900012
J	Shi, JW; Wang, E; Milazzo, JP; Wang, ZH; Kinney, JB; Vakoc, CR				Shi, Junwei; Wang, Eric; Milazzo, Joseph P.; Wang, Zihua; Kinney, Justin B.; Vakoc, Christopher R.			Discovery of cancer drug targets by CRISPR-Cas9 screening of protein domains	NATURE BIOTECHNOLOGY			English	Article							MLL-REARRANGED LEUKEMIA; HUMAN-CELLS; INHIBITION; SYSTEM; GENE; CAS9	CRISPR-Cas9 genome editing technology holds great promise for discovering therapeutic targets in cancer and other diseases. Current screening strategies target CRISPR-Cas9-induced mutations to the 5' exons of candidate genes(1-5), but this approach often produces in-frame variants that retain functionality, which can obscure even strong genetic dependencies. Here we overcome this limitation by targeting CRISPR-Cas9 mutagenesis to exons encoding functional protein domains. This generates a higher proportion of null mutations and substantially increases the potency of negative selection. We also show that the magnitude of negative selection can be used to infer the functional importance of individual protein domains of interest. A screen of 192 chromatin regulatory domains in murine acute myeloid leukemia cells identifies six known drug targets and 19 additional dependencies. A broader application of this approach may allow comprehensive identification of protein domains that sustain cancer cells and are suitable for drug targeting.	[Shi, Junwei; Wang, Eric; Milazzo, Joseph P.; Wang, Zihua; Kinney, Justin B.; Vakoc, Christopher R.] Cold Spring Harbor Lab, Cold Spring Harbor, NY 11724 USA; [Shi, Junwei] SUNY Stony Brook, Mol & Cellular Biol Program, Stony Brook, NY 11794 USA	Cold Spring Harbor Laboratory; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook	Vakoc, CR (corresponding author), Cold Spring Harbor Lab, POB 100, Cold Spring Harbor, NY 11724 USA.	vakoc@cshl.edu	Wang, Zhiquan/HHS-6768-2022	Kinney, Justin/0000-0003-1897-3778; Wang, Eric/0000-0001-7865-6702	National Institutes of Health [NIH CA174793]; Burroughs-Wellcome Fund Career Award for Medical Scientists; Alex's Lemonade Stand Foundation 'A' Award; National Cancer Institute Cancer Center Support Grant Development Funds [CA45508]; Simons Center for Quantitative Biology at Cold Spring Harbor Laboratory; NATIONAL CANCER INSTITUTE [P30CA045508, R01CA174793] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Burroughs-Wellcome Fund Career Award for Medical Scientists(Burroughs Wellcome Fund); Alex's Lemonade Stand Foundation 'A' Award; National Cancer Institute Cancer Center Support Grant Development Funds; Simons Center for Quantitative Biology at Cold Spring Harbor Laboratory; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	Y. Jin for assistance with pooled sgRNA screen analysis. C.R.V. is supported by National Institutes of Health NIH CA174793, Burroughs-Wellcome Fund Career Award for Medical Scientists, Alex's Lemonade Stand Foundation 'A' Award and the National Cancer Institute Cancer Center Support Grant Development Funds CA45508. J.B.K. is supported by the Simons Center for Quantitative Biology at Cold Spring Harbor Laboratory.	Cong L, 2013, SCIENCE, V339, P819, DOI 10.1126/science.1231143; Daigle SR, 2011, CANCER CELL, V20, P53, DOI 10.1016/j.ccr.2011.06.009; Dawson MA, 2011, NATURE, V478, P529, DOI 10.1038/nature10509; Doench JG, 2014, NAT BIOTECHNOL, V32, P1262, DOI 10.1038/nbt.3026; Findlay GM, 2014, NATURE, V513, P120, DOI 10.1038/nature13695; Harris WJ, 2012, CANCER CELL, V21, P473, DOI 10.1016/j.ccr.2012.03.014; Hsu PD, 2014, CELL, V157, P1262, DOI 10.1016/j.cell.2014.05.010; Hsu PD, 2013, NAT BIOTECHNOL, V31, P827, DOI 10.1038/nbt.2647; Jinek M, 2012, SCIENCE, V337, P816, DOI 10.1126/science.1225829; Kim W, 2013, NAT CHEM BIOL, V9, P643, DOI [10.1038/NCHEMBIO.1331, 10.1038/nchembio.1331]; Koike-Yusa H, 2014, NAT BIOTECHNOL, V32, P267, DOI 10.1038/nbt.2800; Lehnertz B, 2014, GENE DEV, V28, P317, DOI 10.1101/gad.236794.113; Mali P, 2013, SCIENCE, V339, P823, DOI 10.1126/science.1232033; McJunkin K, 2011, P NATL ACAD SCI USA, V108, P7113, DOI 10.1073/pnas.1104097108; Mertz JA, 2011, P NATL ACAD SCI USA, V108, P16669, DOI 10.1073/pnas.1108190108; Morita S, 2000, GENE THER, V7, P1063, DOI 10.1038/sj.gt.3301206; Ran FA, 2013, NAT PROTOC, V8, P2281, DOI 10.1038/nprot.2013.143; Shalem O, 2014, SCIENCE, V343, P84, DOI 10.1126/science.1247005; Shi J, 2013, ONCOGENE, V32, P930, DOI 10.1038/onc.2012.110; Shi JW, 2014, MOL CELL, V54, P728, DOI 10.1016/j.molcel.2014.05.016; Shi J, 2013, GENE DEV, V27, P2648, DOI 10.1101/gad.232710.113; Wang E, 2013, P NATL ACAD SCI USA, V110, P3901, DOI 10.1073/pnas.1301045110; Wang T, 2014, SCIENCE, V343, P80, DOI 10.1126/science.1246981; Xu BW, 2015, BLOOD, V125, P346, DOI 10.1182/blood-2014-06-581082; Zhou YX, 2014, NATURE, V509, P487, DOI 10.1038/nature13166; Zuber J, 2011, NATURE, V478, P524, DOI 10.1038/nature10334; Zuber J, 2011, NAT BIOTECHNOL, V29, P79, DOI 10.1038/nbt.1720	27	432	449	6	210	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156	1546-1696		NAT BIOTECHNOL	Nat. Biotechnol.	JUN	2015	33	6					661	+		10.1038/nbt.3235	http://dx.doi.org/10.1038/nbt.3235			9	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	CK2DE	25961408	Green Accepted			2022-12-27	WOS:000356019700027
J	Jain, SH; Powers, BW; Hawkins, JB; Brownstein, JS				Jain, Sachin H.; Powers, Brian W.; Hawkins, Jared B.; Brownstein, John S.			The digital phenotype	NATURE BIOTECHNOLOGY			English	Article									[Jain, Sachin H.] Caremore Hlth Syst, Cerritos, CA 90703 USA; [Powers, Brian W.; Hawkins, Jared B.; Brownstein, John S.] Harvard Univ, Sch Med, Boston, MA USA; [Jain, Sachin H.] Boston Virginia Med Ctr, Boston, MA USA; [Jain, Sachin H.] Merck & Co Inc, Boston, MA USA; [Hawkins, Jared B.; Brownstein, John S.] Childrens Hosp Boston, Boston, MA USA	Harvard University; Harvard Medical School; Merck & Company; Harvard University; Boston Children's Hospital	Jain, SH (corresponding author), Caremore Hlth Syst, Cerritos, CA 90703 USA.	shjain@post.harvard.edu		Hawkins, Jared/0000-0002-6352-1618	NATIONAL HUMAN GENOME RESEARCH INSTITUTE [U54HG007963] Funding Source: NIH RePORTER	NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))		Brownstein JS, 2009, NEW ENGL J MED, V360, P2153, DOI 10.1056/NEJMp0904012; Dawkins R., 1982, pi; Gunn JF, 2013, J AFFECT DISORDERS, V148, P411, DOI 10.1016/j.jad.2012.11.004; Steins D, 2014, J NEUROENG REHABIL, V11, DOI 10.1186/1743-0003-11-36; Wicks P, 2011, NAT BIOTECHNOL, V29, P411, DOI 10.1038/nbt.1837	5	160	160	2	49	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1087-0156	1546-1696		NAT BIOTECHNOL	Nat. Biotechnol.	MAY	2015	33	5					462	463		10.1038/nbt.3223	http://dx.doi.org/10.1038/nbt.3223			2	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	CH8VP	25965751				2022-12-27	WOS:000354314500022
J	Obenaus, M; Leitao, C; Leisegang, M; Chen, XJ; Gavvovidis, I; van der Bruggen, P; Uckert, W; Schendel, DJ; Blankenstein, T				Obenaus, Matthias; Leitao, Catarina; Leisegang, Matthias; Chen, Xiaojing; Gavvovidis, Ioannis; van der Bruggen, Pierre; Uckert, Wolfgang; Schendel, Dolores J.; Blankenstein, Thomas			Identification of human T-cell receptors with optimal affinity to cancer antigens using antigen-negative humanized mice	NATURE BIOTECHNOLOGY			English	Article							ANTITUMOR-ACTIVITY; GENE-TRANSFER; TCR; LYMPHOCYTES; PEPTIDE; MHC; DIVERSE; EXPRESSION; EFFICIENT; RECOGNIZE	Identifying T-cell receptors (TCRs) that bind tumor-associated antigens (TAAs) with optimal affinity is a key bottleneck in the development of adoptive T-cell therapy of cancer(1). TAAs are unmutated self proteins, and T cells bearing high-affinity TCRs specific for such antigens are commonly deleted in the thymus(2). To identify optimal-affinity TCRs, we generated antigen-negative humanized mice with a diverse human TCR repertoire restricted to the human leukocyte antigen (HLA) A*02:01 (ref. 3). These mice were immunized with human TAAs, for which they are not tolerant, allowing induction of CD8(+) T cells with optimal-affinity TCRs. We isolate TCRs specific for the cancer/testis (CT) antigen MAGE-A1 (ref. 4) and show that two of them have an anti-tumor effect in vivo. By comparison, human-derived TCRs have lower affinity and do not mediate substantial therapeutic effects. We also identify optimal-affinity TCRs specific for the CT antigen NY-ESO. Our humanized mouse model provides a useful tool for the generation of optimal-affinity TCRs for T-cell therapy.	[Obenaus, Matthias; Leitao, Catarina; Leisegang, Matthias; Chen, Xiaojing; Gavvovidis, Ioannis; Uckert, Wolfgang; Blankenstein, Thomas] Max Delbruck Ctr Mol Med, Berlin, Germany; [van der Bruggen, Pierre] Ludwig Inst Canc Res, Brussels, Belgium; [van der Bruggen, Pierre] WELBIO, Brussels, Belgium; [van der Bruggen, Pierre] Catholic Univ Louvain, De Duve Inst, B-1200 Brussels, Belgium; [Uckert, Wolfgang] Humboldt Univ, Inst Biol, D-10099 Berlin, Germany; [Schendel, Dolores J.] Medigene AG, Planegg Martinsried, Germany; [Blankenstein, Thomas] Charite Campus Buch, Inst Immunol, Berlin, Germany	Helmholtz Association; Max Delbruck Center for Molecular Medicine; Ludwig Institute for Cancer Research; WELBIO; Universite Catholique Louvain; Humboldt University of Berlin; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin	Blankenstein, T (corresponding author), Max Delbruck Ctr Mol Med, Berlin, Germany.	tblanke@mdc-berlin.de	Leisegang, Matthias/S-5635-2017	Leisegang, Matthias/0000-0003-3692-7142; Gavvovidis, Ioannis/0000-0001-5644-9788; Leitao, Catarina/0000-0001-9884-2983	Deutsche Forschungsgemeinschaft (Sonderforschungsbereich) [TR36]; Berlin Institute of Health (BIH)	Deutsche Forschungsgemeinschaft (Sonderforschungsbereich)(German Research Foundation (DFG)); Berlin Institute of Health (BIH)	The authors thank G. Willimsky for discussion, S. Kupsch and S. Furl for technical assistance, and I. Hoeft for animal caretaking. C. Linnemann and T. Schumacher kindly provided the NY-ESO-1<INF>157</INF>/HLA-A2 multimer. This work was supported by the Deutsche Forschungsgemeinschaft (Sonderforschungsbereich TR36) and the Berlin Institute of Health (BIH).	Aleksic M, 2012, EUR J IMMUNOL, V42, P3174, DOI 10.1002/eji.201242606; Birnbaum ME, 2014, CELL, V157, P1073, DOI 10.1016/j.cell.2014.03.047; Bredenbeck A, 2008, GENE, V415, P68, DOI 10.1016/j.gene.2008.02.019; Chen JL, 2005, J EXP MED, V201, P1243, DOI 10.1084/jem.20042323; Chinnasamy N, 2011, J IMMUNOL, V186, P685, DOI 10.4049/jimmunol.1001775; Cohen CJ, 2007, CANCER RES, V67, P3898, DOI 10.1158/0008-5472.CAN-06-3986; Davis JL, 2010, CLIN CANCER RES, V16, P5852, DOI 10.1158/1078-0432.CCR-10-1280; de Castro E, 2006, NUCLEIC ACIDS RES, V34, pW362, DOI 10.1093/nar/gkl124; Engels B, 2003, HUM GENE THER, V14, P1155, DOI 10.1089/104303403322167993; Engels B, 2012, MOL THER, V20, P652, DOI 10.1038/mt.2011.286; Gotter J, 2004, J EXP MED, V199, P155, DOI 10.1084/jem.20031677; Heemskerk MHM, 2003, BLOOD, V102, P3530, DOI 10.1182/blood-2003-05-1524; HERIN M, 1987, INT J CANCER, V39, P390, DOI 10.1002/ijc.2910390320; Holler PD, 2003, NAT IMMUNOL, V4, P55, DOI 10.1038/ni863; Huang LQ, 1999, J IMMUNOL, V162, P6849; Huijbers IJ, 2012, J IMMUNOL, V188, P111, DOI 10.4049/jimmunol.1002612; Johnson LA, 2009, BLOOD, V114, P535, DOI 10.1182/blood-2009-03-211714; June CH, 2007, J CLIN INVEST, V117, P1466, DOI 10.1172/JCI32446; Kammertoens T, 2013, CANCER CELL, V23, P429, DOI 10.1016/j.ccr.2013.04.004; Kuball J, 2007, BLOOD, V109, P2331, DOI 10.1182/blood-2006-05-023069; Lee EC, 2014, NAT BIOTECHNOL, V32, P356, DOI 10.1038/nbt.2825; Leisegang M, 2008, J MOL MED, V86, P573, DOI 10.1007/s00109-008-0317-3; Li LP, 2010, NAT MED, V16, P1029, DOI 10.1038/nm.2197; Linette GP, 2013, BLOOD, V122, P863, DOI 10.1182/blood-2013-03-490565; Linnemann C, 2013, NAT MED, V19, P1534, DOI 10.1038/nm.3359; Morgan RA, 2013, J IMMUNOTHER, V36, P133, DOI 10.1097/CJI.0b013e3182829903; Morita S, 2000, GENE THER, V7, P1063, DOI 10.1038/sj.gt.3301206; Offringa R, 2009, CURR OPIN IMMUNOL, V21, P190, DOI 10.1016/j.coi.2009.02.006; Ottaviani S, 2005, CANCER IMMUNOL IMMUN, V54, P1214, DOI 10.1007/s00262-005-0705-2; Parkhurst MR, 2009, CLIN CANCER RES, V15, P169, DOI 10.1158/1078-0432.CCR-08-1638; Pascolo S, 2001, CANCER RES, V61, P4072; Pellat-Deceunynck C, 2000, EUR J IMMUNOL, V30, P803, DOI 10.1002/1521-4141(200003)30:3<803::AID-IMMU803>3.0.CO;2-P; Sadovnikova E, 1996, P NATL ACAD SCI USA, V93, P13114, DOI 10.1073/pnas.93.23.13114; Schmid DA, 2010, J IMMUNOL, V184, P4936, DOI 10.4049/jimmunol.1000173; Scott-Browne JP, 2009, NATURE, V458, P1043, DOI 10.1038/nature07812; Sommermeyer D, 2013, INT J CANCER, V132, P1360, DOI 10.1002/ijc.27792; Sommermeyer D, 2010, J IMMUNOL, V184, P6223, DOI 10.4049/jimmunol.0902055; Theobald M, 1997, J EXP MED, V185, P833, DOI 10.1084/jem.185.5.833; Toso JF, 1996, CANCER RES, V56, P16; Uckert W, 2000, HUM GENE THER, V11, P1005, DOI 10.1089/10430340050015310; VANDERBRUGGEN P, 1991, SCIENCE, V254, P1643, DOI 10.1126/science.1840703; Vierboom MPM, 1997, J EXP MED, V186, P695, DOI 10.1084/jem.186.5.695; Wang BM, 2009, SCIENCE, V326, P871, DOI 10.1126/science.1177627; Weynants P, 1999, AM J RESP CRIT CARE, V159, P55, DOI 10.1164/ajrccm.159.1.9805073; Wilde S, 2009, BLOOD, V114, P2131, DOI 10.1182/blood-2009-03-209387; Zarour H, 1996, J INVEST DERMATOL, V107, P63, DOI 10.1111/1523-1747.ep12298177	46	68	74	0	24	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156	1546-1696		NAT BIOTECHNOL	Nat. Biotechnol.	APR	2015	33	4					402	U116		10.1038/nbt.3147	http://dx.doi.org/10.1038/nbt.3147			8	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	CF2AE	25774714				2022-12-27	WOS:000352348500027
J	McCammon, MG; Pio, E; Barakat, S; Vyakarnam, S				McCammon, Margaret G.; Pio, Edwina; Barakat, Shima; Vyakarnam, Shailendra			Corporate venture capital and Cambridge	NATURE BIOTECHNOLOGY			English	Editorial Material									[McCammon, Margaret G.] Univ Cambridge, Judge Business Sch, Cambridge, England; [Pio, Edwina] Auckland Univ Technol, Sch Business & Law, Auckland, New Zealand; [Barakat, Shima] Univ Cambridge, Ctr Entrepreneurial Learning, Judge Business Sch, EnterpriseWISE & ETECH Projects, Cambridge, England; [Vyakarnam, Shailendra] Univ Cambridge, Ctr Entrepreneurial Learning, Judge Business Sch, Cambridge, England	University of Cambridge; Auckland University of Technology; University of Cambridge; University of Cambridge	McCammon, MG (corresponding author), Michigan Econ Dev Corp, Lansing, MI 48913 USA.	mccammonm@michigan.org; edwina.pio@aut.ac.nz; sb679@cam.ac.uk; sv246@cam.ac.uk						Horig H, 2005, NAT MED, V11, P705, DOI 10.1038/nm0705-705; Hudson J, 2013, DRUG DISCOV TODAY, V18, P610, DOI 10.1016/j.drudis.2013.01.012; Pammolli F, 2011, NAT REV DRUG DISCOV, V10, P428, DOI 10.1038/nrd3405	3	2	2	0	22	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156	1546-1696		NAT BIOTECHNOL	Nat. Biotechnol.	OCT	2014	32	10					975	978		10.1038/nbt.3029	http://dx.doi.org/10.1038/nbt.3029			4	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	AR7MM	25299912	Bronze			2022-12-27	WOS:000343763800009
J	Pollen, AA; Nowakowski, TJ; Shuga, J; Wang, XH; Leyrat, AA; Lui, JH; Li, NZ; Szpankowski, L; Fowler, B; Chen, PL; Ramalingam, N; Sun, G; Thu, M; Norris, M; Lebofsky, R; Toppani, D; Kemp, DW; Wong, M; Clerkson, B; Jones, BN; Wu, SQ; Knutsson, L; Alvarado, B; Wang, J; Weaver, LS; May, AP; Jones, RC; Unger, MA; Kriegstein, AR; West, JAA				Pollen, Alex A.; Nowakowski, Tomasz J.; Shuga, Joe; Wang, Xiaohui; Leyrat, Anne A.; Lui, Jan H.; Li, Nianzhen; Szpankowski, Lukasz; Fowler, Brian; Chen, Peilin; Ramalingam, Naveen; Sun, Gang; Thu, Myo; Norris, Michael; Lebofsky, Ronald; Toppani, Dominique; Kemp, Darnell W., II; Wong, Michael; Clerkson, Barry; Jones, Brittnee N.; Wu, Shiquan; Knutsson, Lawrence; Alvarado, Beatriz; Wang, Jing; Weaver, Lesley S.; May, Andrew P.; Jones, Robert C.; Unger, Marc A.; Kriegstein, Arnold R.; West, Jay A. A.			Low-coverage single-cell mRNA sequencing reveals cellular heterogeneity and activated signaling pathways in developing cerebral cortex	NATURE BIOTECHNOLOGY			English	Article							HEMATOPOIETIC STEM-CELLS; GENE-EXPRESSION; TRANSCRIPTIONAL LANDSCAPE; SEQ EXPERIMENTS; HUMAN BRAIN; MIGRATION; GENOME; EGR1	Large-scale surveys of single-cell gene expression have the potential to reveal rare cell populations and lineage relationships but require efficient methods for cell capture and mRNA sequencing(1-4). Although cellular barcoding strategies allow parallel sequencing of single cells at ultra-low depths(5), the limitations of shallow sequencing have not been investigated directly. By capturing 301 single cells from 11 populations using microfluidics and analyzing single-cell transcriptomes across downsampled sequencing depths, we demonstrate that shallow single-cell mRNA sequencing (similar to 50,000 reads per cell) is sufficient for unbiased cell-type classification and biomarker identification. In the developing cortex, we identify diverse cell types, including multiple progenitor and neuronal subtypes, and we identify EGR1 and FOS as previously unreported candidate targets of Notch signaling in human but not mouse radial glia. Our strategy establishes an efficient method for unbiased analysis and comparison of cell populations from heterogeneous tissue by microfluidic single-cell capture and low-coverage sequencing of many cells.	[Pollen, Alex A.; Nowakowski, Tomasz J.; Lui, Jan H.; Kriegstein, Arnold R.] Univ Calif San Francisco, Eli & Edythe Broad Ctr Regenerat Med & Stem Cell, San Francisco, CA 94143 USA; [Pollen, Alex A.; Nowakowski, Tomasz J.; Leyrat, Anne A.; Lui, Jan H.; Kriegstein, Arnold R.] Univ Calif San Francisco, Dept Neurol, San Francisco, CA 94143 USA; [Shuga, Joe; Wang, Xiaohui; Leyrat, Anne A.; Li, Nianzhen; Szpankowski, Lukasz; Fowler, Brian; Chen, Peilin; Ramalingam, Naveen; Sun, Gang; Thu, Myo; Norris, Michael; Lebofsky, Ronald; Toppani, Dominique; Kemp, Darnell W., II; Wong, Michael; Clerkson, Barry; Jones, Brittnee N.; Wu, Shiquan; Knutsson, Lawrence; Alvarado, Beatriz; Wang, Jing; Weaver, Lesley S.; May, Andrew P.; Jones, Robert C.; Unger, Marc A.; West, Jay A. A.] Fluidigm Corp, San Francisco, CA USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco	Pollen, AA (corresponding author), Univ Calif San Francisco, Eli & Edythe Broad Ctr Regenerat Med & Stem Cell, San Francisco, CA 94143 USA.	alex.pollen@gmail.com; kriegsteina@stemcell.ucsf.edu	Nowakowski, Tomasz/P-7731-2014	Nowakowski, Tomasz/0000-0003-2345-4964; Ramalingam, Naveen/0000-0003-2584-8094; Jones, Robert C/0000-0001-7235-9854	California Institute for Regenerative Medicine Tools and Technologies II [RT2-02052]; Damon Runyon Cancer Research Foundation postdoctoral fellowship [DRG-2166-13]; National Institute of Neurological Disorders and Stroke [R01NS075998, R01NS072630]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS075998, R01NS072630] Funding Source: NIH RePORTER	California Institute for Regenerative Medicine Tools and Technologies II; Damon Runyon Cancer Research Foundation postdoctoral fellowship; National Institute of Neurological Disorders and Stroke(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank M. Bershteyn (University of California, San Francisco (UCSF)), E. Di Lullo (UCSF), C. Gertz (UCSF), C. McLean (23andMe), F. Ng (Fluidigm Corporation), J. Liu (UCSF), C. Lowe (Stanford University), M. Oldham (UCSF), A. Diaz (UCSF) and H. Retallack (UCSF) for reading the manuscript and for useful suggestions, S. Wang and Y. Wang for technical assistance, K. Davies (University of Oxford) for providing the antibody to syncoilin, A. Simeone (Institute of Genetics and Biophysics, Adriano Buzzati-Traverso) for providing the Emx2 probe, S. Yao and S. Ku (Allen Institute for Brain Research) for assistance in the neural progenitor induction protocol, G. Wang (Stanford University) for providing human induced pluripotent stem cells (hiPSCs) and the staff at the San Francisco General Hospital for providing access to donated fetal tissue. L.S., N.L. and M.A.U. are partially supported by California Institute for Regenerative Medicine Tools and Technologies II grant RT2-02052 to M.A.U., and the generation and maintenance of the hiPSCs and neural progenitor cells was also supported by RT2-02052 to M.A.U. A.A.P. is supported by a Damon Runyon Cancer Research Foundation postdoctoral fellowship (DRG-2166-13). This research was also supported by National Institute of Neurological Disorders and Stroke awards R01NS075998 and R01NS072630 to A.R.K.	Bieche I, 2004, CLIN CANCER RES, V10, P6789, DOI 10.1158/1078-0432.CCR-04-0306; Bonnert TP, 2006, EUR J NEUROSCI, V24, P661, DOI 10.1111/j.1460-9568.2006.04912.x; Brennecke P, 2013, NAT METHODS, V10, P1093, DOI [10.1038/nmeth.2645, 10.1038/NMETH.2645]; Dalerba P, 2011, NAT BIOTECHNOL, V29, P1120, DOI 10.1038/nbt.2038; Deng QL, 2014, SCIENCE, V343, P193, DOI 10.1126/science.1245316; Faddah DA, 2013, CELL STEM CELL, V13, P23, DOI 10.1016/j.stem.2013.04.019; Fan JB, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030794; Fischer AJ, 2009, GLIA, V57, P1538, DOI 10.1002/glia.20868; Fujita PA, 2011, NUCLEIC ACIDS RES, V39, pD876, DOI 10.1093/nar/gkq963; Guo GJ, 2010, DEV CELL, V18, P675, DOI 10.1016/j.devcel.2010.02.012; Hansson ML, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046001; Housden BE, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003162; Islam S, 2014, NAT METHODS, V11, P163, DOI [10.1038/NMETH.2772, 10.1038/nmeth.2772]; Islam S, 2011, GENOME RES, V21, P1160, DOI 10.1101/gr.110882.110; Jaitin DA, 2014, SCIENCE, V343, P776, DOI 10.1126/science.1247651; Jiang LC, 2011, GENOME RES, V21, P1543, DOI 10.1101/gr.121095.111; Kawaguchi A, 2008, DEVELOPMENT, V135, P3113, DOI 10.1242/dev.022616; Kornack DR, 1998, P NATL ACAD SCI USA, V95, P1242, DOI 10.1073/pnas.95.3.1242; Kriegstein A, 2006, NAT REV NEUROSCI, V7, P883, DOI 10.1038/nrn2008; Krol AJ, 2011, DEVELOPMENT, V138, P2783, DOI 10.1242/dev.063834; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Miller JA, 2014, NATURE, V508, P199, DOI 10.1038/nature13185; Min IM, 2008, CELL STEM CELL, V2, P380, DOI 10.1016/j.stem.2008.01.015; Miyoshi G, 2012, NEURON, V74, P1045, DOI 10.1016/j.neuron.2012.04.025; Okada S, 1999, BLOOD, V93, P816, DOI 10.1182/blood.V93.3.816.403k21_816_825; Ramskold D, 2012, NAT BIOTECHNOL, V30, P777, DOI 10.1038/nbt.2282; Ross ME, 2001, ANNU REV NEUROSCI, V24, P1041, DOI 10.1146/annurev.neuro.24.1.1041; Shalek AK, 2014, NATURE, V510, P363, DOI 10.1038/nature13437; Shalek AK, 2013, NATURE, V498, P236, DOI 10.1038/nature12172; Shapiro E, 2013, NAT REV GENET, V14, P618, DOI 10.1038/nrg3542; Shimojo H, 2008, NEURON, V58, P52, DOI 10.1016/j.neuron.2008.02.014; Sims D, 2014, NAT REV GENET, V15, P121, DOI 10.1038/nrg3642; Suzuki R, 2006, BIOINFORMATICS, V22, P1540, DOI 10.1093/bioinformatics/btl117; Tarcic G, 2012, FASEB J, V26, P1582, DOI 10.1096/fj.11-194654; Trapnell C, 2009, BIOINFORMATICS, V25, P1105, DOI 10.1093/bioinformatics/btp120; Treutlein B, 2014, NATURE, V509, P371, DOI 10.1038/nature13173; Wallace VA, 1999, DEVELOPMENT, V126, P2901; Wu AR, 2014, NAT METHODS, V11, P41, DOI 10.1038/nmeth.2694	38	548	562	25	195	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156	1546-1696		NAT BIOTECHNOL	Nat. Biotechnol.	OCT	2014	32	10					1053	+		10.1038/nbt.2967	http://dx.doi.org/10.1038/nbt.2967			9	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	AR7MM	25086649	Green Accepted, Green Submitted			2022-12-27	WOS:000343763800023
J	Garber, K				Garber, Ken			Between disease and a dish	NATURE BIOTECHNOLOGY			English	News Item							ALZHEIMERS-DISEASE; NEURONS; CELLS											Chambers SM, 2012, NAT BIOTECHNOL, V30, P715, DOI 10.1038/nbt.2249; Cooper O, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003985; Donnelly CJ, 2013, NEURON, V80, P415, DOI 10.1016/j.neuron.2013.10.015; Duan LS, 2014, MOL NEURODEGENER, V9, DOI 10.1186/1750-1326-9-3; Griswold-Prenner I., 2013, ANN M SOC NEUR SAN D; Israel MA, 2012, NATURE, V482, P216, DOI 10.1038/nature10821; Kondo T, 2013, CELL STEM CELL, V12, P487, DOI 10.1016/j.stem.2013.01.009; Miller JD, 2013, CELL STEM CELL, V13, P691, DOI 10.1016/j.stem.2013.11.006; Qiang L, 2014, CELL, V157, P514, DOI 10.1016/j.cell.2014.03.002; Sanders LH, 2014, NEUROBIOL DIS, V62, P381, DOI 10.1016/j.nbd.2013.10.013; Sareen D, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3007529; Shi YC, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003771; Zhang YS, 2013, NEURON, V78, P785, DOI 10.1016/j.neuron.2013.05.029	13	4	5	0	3	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156	1546-1696		NAT BIOTECHNOL	Nat. Biotechnol.	AUG	2014	32	8					712	715		10.1038/nbt.2977	http://dx.doi.org/10.1038/nbt.2977			4	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	AW7PF	25093880				2022-12-27	WOS:000346455900006
J	Ghorbal, M; Gorman, M; Macpherson, CR; Martins, RM; Scherf, A; Lopez-Rubio, JJ				Ghorbal, Mehdi; Gorman, Molly; Macpherson, Cameron Ross; Martins, Rafael Miyazawa; Scherf, Artur; Lopez-Rubio, Jose-Juan			Genome editing in the human malaria parasite Plasmodium falciparum using the CRISPR-Cas9 system	NATURE BIOTECHNOLOGY			English	Article							GENE DELETION; ORC1; RNAS; DNA	Genome manipulation in the malaria parasite Plasmodium falciparum remains largely intractable and improved genomic tools are needed to further understand pathogenesis and drug resistance. We demonstrated the CRISPR-Cas9 system for use in P. falciparum by disrupting chromosomal loci and generating marker-free, single-nucleotide substitutions with high efficiency. Additionally, an artemisinin-resistant strain was generated by introducing a previously implicated polymorphism, thus illustrating the value of efficient genome editing in malaria research.	[Ghorbal, Mehdi; Gorman, Molly; Macpherson, Cameron Ross; Martins, Rafael Miyazawa; Scherf, Artur; Lopez-Rubio, Jose-Juan] Inst Pasteur, Biol Host Parasite Interact Unit, Paris, France; [Ghorbal, Mehdi; Gorman, Molly; Macpherson, Cameron Ross; Martins, Rafael Miyazawa; Scherf, Artur; Lopez-Rubio, Jose-Juan] Inst Pasteur, CNRS URA 2581, Paris, France	Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Centre National de la Recherche Scientifique (CNRS); Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris	Lopez-Rubio, JJ (corresponding author), Univ Montpellier I, CNRS 5290, IRD 224, Montpellier, France.	jose-juan.lopez-rubio@inserm.fr	; lopez-rubio, jose juan/A-4509-2014	MacPherson, Cameron/0000-0002-8945-9736; Scherf, Artur/0000-0003-2411-3328; miyazawa martins, rafael/0000-0001-7449-0696; lopez-rubio, jose juan/0000-0002-0555-1122; Ghorbal, Mehdi/0000-0002-8896-2786	Agence Nationale de la Recherche [ANR 11 JSV3 004 01]; ERC [250320]; French Parasitology consortium ParaFrap [ANR-11-LABX0024]; Institut National de la Sante et de la Recherche Medicale (INSERM)	Agence Nationale de la Recherche(French National Research Agency (ANR)); ERC(European Research Council (ERC)European Commission); French Parasitology consortium ParaFrap; Institut National de la Sante et de la Recherche Medicale (INSERM)(Institut National de la Sante et de la Recherche Medicale (Inserm))	We thank L. Mancio-Silva (Instituto de Medicina Molecular, Lisboa) and N. Siegel (Institute for Molecular Infection Biology, Wuerzburg) for critically reading the manuscript and PlasmoDB for the invaluable malaria-database support. F. Zhang laboratory (MIT, Boston) for deposition of pX330 in Addgene. A.B. Vaidya (Drexel University, Philadelphia) for pUF1 plasmid. D. Fidock laboratory (Columbia University, New York) for NF54<SUP>EGFP</SUP> strain. C. Buchrieser (Institut Pasteur, Paris) for lending Amaxa 4D electroporator (Lonza) and P. Escoll Guerrero (Institut Pasteur, Paris) for assistance. A. Nacer (Institut Pasteur, Paris) for help with immunofluorescence experiments. GenoScreen team, especially H. Blanquart and A. Gourbeyre, for sequencing. This work was supported by the Agence Nationale de la Recherche (ANR 11 JSV3 004 01 PlasmoPiggyBac), ERC Advanced Grant (PlasmoEscape 250320) and the French Parasitology consortium ParaFrap (ANR-11-LABX0024). Me.G. and Mo.G. were funded by ANR 11 JSV3 004 01 and J.-J.L.-R. by the Institut National de la Sante et de la Recherche Medicale (INSERM).	Ariey F, 2014, NATURE, V505, P50, DOI 10.1038/nature12876; Bawankar P, 2010, MOL BIOL REP, V37, P2125, DOI 10.1007/s11033-009-9682-4; Bhaya D, 2011, ANNU REV GENET, V45, P273, DOI 10.1146/annurev-genet-110410-132430; Collins CR, 2013, MOL MICROBIOL, V88, P687, DOI 10.1111/mmi.12206; Cong L, 2013, SCIENCE, V339, P819, DOI 10.1126/science.1231143; Crabb BS, 1997, CELL, V89, P287, DOI 10.1016/S0092-8674(00)80207-X; Deitsch KW, 2001, NUCLEIC ACIDS RES, V29, P850, DOI 10.1093/nar/29.3.850; Deshmukh AS, 2012, NUCLEIC ACIDS RES, V40, P5313, DOI 10.1093/nar/gks202; Duraisingh MT, 2002, INT J PARASITOL, V32, P81, DOI 10.1016/S0020-7519(01)00345-9; Ganesan SM, 2011, MOL BIOCHEM PARASIT, V177, P29, DOI 10.1016/j.molbiopara.2011.01.004; Gilbert LA, 2013, CELL, V154, P442, DOI 10.1016/j.cell.2013.06.044; Jinek M, 2012, SCIENCE, V337, P816, DOI 10.1126/science.1225829; Kirkman LA, 2014, NUCLEIC ACIDS RES, V42, P370, DOI 10.1093/nar/gkt881; Mali P, 2013, SCIENCE, V339, P823, DOI 10.1126/science.1232033; Mancio-Silva L, 2008, J CELL SCI, V121, P2046, DOI 10.1242/jcs.026427; Moon RW, 2013, P NATL ACAD SCI USA, V110, P531, DOI 10.1073/pnas.1216457110; Pfander C, 2011, NAT METHODS, V8, P1078, DOI [10.1038/NMETH.1742, 10.1038/nmeth.1742]; Ran FA, 2013, NAT PROTOC, V8, P2281, DOI 10.1038/nprot.2013.143; Salanti A, 2003, MOL MICROBIOL, V49, P179, DOI 10.1046/j.1365-2958.2003.03570.x; Straimer J, 2012, NAT METHODS, V9, P993, DOI [10.1038/NMETH.2143, 10.1038/nmeth.2143]; Witkowski B, 2013, LANCET INFECT DIS, V13, P1043, DOI 10.1016/S1473-3099(13)70252-4; WU YM, 1995, P NATL ACAD SCI USA, V92, P973, DOI 10.1073/pnas.92.4.973	22	394	418	1	139	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156	1546-1696		NAT BIOTECHNOL	Nat. Biotechnol.	AUG	2014	32	8					819	821		10.1038/nbt.2925	http://dx.doi.org/10.1038/nbt.2925			3	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	AW7PF	24880488				2022-12-27	WOS:000346455900042
J	Chan, AWK; Wong, AYT; Lee, HM				Chan, Albert Wai-Kit; Wong, Alice Yuen-Ting; Lee, Hon-Man			A patent perspective on US stem cell research	NATURE BIOTECHNOLOGY			English	Editorial Material									[Chan, Albert Wai-Kit; Lee, Hon-Man] Albert Wai Kit Chan PLLC, Whitestone, NY 11357 USA; [Wong, Alice Yuen-Ting] Albert Wai Kit Chan Intellectual Property Ltd, Hong Kong, Hong Kong, Peoples R China		Chan, AWK (corresponding author), Albert Wai Kit Chan PLLC, Whitestone, NY 11357 USA.	akitchan@aol.com; wonga@kitchanip.com; leehm@kitchanlaw.com						Armstrong L, 2012, STEM CELLS, V30, P2, DOI 10.1002/stem.1007; Bergman K, 2007, NAT BIOTECHNOL, V25, P419, DOI 10.1038/nbt0407-419; Burrone Esteban, 2006, PATENTS CORE BIOTECH; Hirshfeld A.H., 2012, 2012 INTERIM PROCEDU; Hirshfeld AH, 2014, 2014 PROCEDURE SUBJE; Offit K, 2013, J CLIN ONCOL, V31, P2743, DOI 10.1200/JCO.2013.49.7388; Rogers E.J., 2011, J PAT TRADEMARK OFF, V19, P93; Rosenfeld J, 2013, GENOME MED, V5, DOI 10.1186/gm431; Schwartz SD, 2012, LANCET, V379, P713, DOI 10.1016/S0140-6736(12)60028-2; Tachibana M, 2013, CELL, V153, P1228, DOI 10.1016/j.cell.2013.05.006; Wisconsin Alumni Research Foundation, 2001, [No title captured], Patent No. [US6200806, 6200806]; Zuhn D.L., 2014, USPTO HOLDS FORUM 1; Zuhn D.L., 2014, USPTO HOLDS FORUM 3	13	4	4	2	10	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156	1546-1696		NAT BIOTECHNOL	Nat. Biotechnol.	JUL	2014	32	7					633	638		10.1038/nbt.2945	http://dx.doi.org/10.1038/nbt.2945			6	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	AK8VE	25004228	Bronze			2022-12-27	WOS:000338705900025
J	Kuscu, C; Arslan, S; Singh, R; Thorpe, J; Adli, M				Kuscu, Cem; Arslan, Sevki; Singh, Ritambhara; Thorpe, Jeremy; Adli, Mazhar			Genome-wide analysis reveals characteristics of off-target sites bound by the Cas9 endonuclease	NATURE BIOTECHNOLOGY			English	Article							ONE-STEP GENERATION; HUMAN-CELLS; TRANSCRIPTION FACTORS; LIMITED NUMBERS; CRISPR; SPECIFICITY; SYSTEM; ALIGNMENT; NUCLEASES; SEQUENCES	RNA-guided genome editing with the CRISPR-Cas9 system has great potential for basic and clinical research, but the determinants of targeting specificity and the extent of off-target cleavage remain insufficiently understood. Using chromatin immunoprecipitation and high-throughput sequencing (ChIP-seq), we mapped genome-wide binding sites of catalytically inactive Cas9 (dCas9) in HEK293T cells, in combination with 12 different single guide RNAs (sgRNAs). The number of off-target sites bound by dCas9 varied from similar to 10 to > 1,000 depending on the sgRNA. Analysis of off-target binding sites showed the importance of the PAM-proximal region of the sgRNA guiding sequence and that dCas9 binding sites are enriched in open chromatin regions. When targeted with catalytically active Cas9, some off-target binding sites had indels above background levels in a region around the ChIP-seq peak, but generally at lower rates than the on-target sites. Our results elucidate major determinants of Cas9 targeting, and we show that ChIP-seq allows unbiased detection of Cas9 binding sites genome-wide.	[Kuscu, Cem; Arslan, Sevki; Singh, Ritambhara; Thorpe, Jeremy; Adli, Mazhar] Univ Virginia, Sch Med, Dept Biochem & Mol Genet, Charlottesville, VA 22908 USA; [Arslan, Sevki] Pamukkale Univ, Dept Biol, Denizli, Turkey; [Singh, Ritambhara] Univ Virginia, Dept Comp Sci, Charlottesville, VA 22903 USA	University of Virginia; Pamukkale University; University of Virginia	Adli, M (corresponding author), Univ Virginia, Sch Med, Dept Biochem & Mol Genet, Charlottesville, VA 22908 USA.	adli@virginia.edu		KUSCU, CEM/0000-0001-7154-6762	University of Virginia; American Cancer Society	University of Virginia; American Cancer Society(American Cancer Society)	The research was funded with a departmental startup fund from the University of Virginia and from an American Cancer Society institutional research grant. We would like to thank A. Quinlan, University of Virginia, for technical help with data analysis and D. Burke, University of Virginia, for his critical readings and comments.	Adli M, 2011, NAT PROTOC, V6, P1656, DOI 10.1038/nprot.2011.402; Adli M, 2010, NAT METHODS, V7, P615, DOI [10.1038/NMETH.1478, 10.1038/nmeth.1478]; Chen BH, 2013, CELL, V155, P1479, DOI 10.1016/j.cell.2013.12.001; Cho SW, 2014, GENOME RES, V24, P132, DOI 10.1101/gr.162339.113; Cong L, 2013, SCIENCE, V339, P819, DOI 10.1126/science.1231143; Crawford GE, 2006, GENOME RES, V16, P123, DOI 10.1101/gr.4074106; DiCarlo JE, 2013, NUCLEIC ACIDS RES, V41, P4336, DOI 10.1093/nar/gkt135; Dunham I, 2012, NATURE, V489, P57, DOI 10.1038/nature11247; Fu YF, 2013, NAT BIOTECHNOL, V31, P822, DOI 10.1038/nbt.2623; Fujita T, 2013, BIOCHEM BIOPH RES CO, V439, P132, DOI 10.1016/j.bbrc.2013.08.013; Heinz S, 2010, MOL CELL, V38, P576, DOI 10.1016/j.molcel.2010.05.004; Horvath P, 2010, SCIENCE, V327, P167, DOI 10.1126/science.1179555; Hsu PD, 2013, NAT BIOTECHNOL, V31, P827, DOI 10.1038/nbt.2647; Hwang WY, 2013, NAT BIOTECHNOL, V31, P227, DOI 10.1038/nbt.2501; Jiang WY, 2013, NAT BIOTECHNOL, V31, P233, DOI 10.1038/nbt.2508; Jinek M, 2013, ELIFE, V2, DOI 10.7554/eLife.00471; Jinek M, 2012, SCIENCE, V337, P816, DOI 10.1126/science.1225829; Koike-Yusa H, 2014, NAT BIOTECHNOL, V32, P267, DOI 10.1038/nbt.2800; Langmead B, 2012, NAT METHODS, V9, P357, DOI [10.1038/NMETH.1923, 10.1038/nmeth.1923]; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Mali P, 2013, NAT BIOTECHNOL, V31, P833, DOI 10.1038/nbt.2675; Mali P, 2013, SCIENCE, V339, P823, DOI 10.1126/science.1232033; Pattanayak V, 2013, NAT BIOTECHNOL, V31, P839, DOI 10.1038/nbt.2673; Perez-Pinera P, 2013, NAT METHODS, V10, P973, DOI [10.1038/NMETH.2600, 10.1038/nmeth.2600]; Poorey K, 2013, SCIENCE, V342, P369, DOI 10.1126/science.1242369; Prufer K, 2008, BIOINFORMATICS, V24, P1530, DOI 10.1093/bioinformatics/btn223; Qi LS, 2013, CELL, V152, P1173, DOI 10.1016/j.cell.2013.02.022; Quinlan AR, 2010, BIOINFORMATICS, V26, P841, DOI 10.1093/bioinformatics/btq033; Ran FA, 2013, CELL, V154, P1380, DOI 10.1016/j.cell.2013.08.021; Robinson JT, 2011, NAT BIOTECHNOL, V29, P24, DOI 10.1038/nbt.1754; Shalem O, 2014, SCIENCE, V343, P84, DOI 10.1126/science.1247005; Wang HY, 2013, CELL, V153, P910, DOI 10.1016/j.cell.2013.04.025; Wang T, 2014, SCIENCE, V343, P80, DOI 10.1126/science.1246981; Yang H, 2013, CELL, V154, P1370, DOI 10.1016/j.cell.2013.08.022; Zhang Y, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-9-r137	36	529	593	9	189	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156	1546-1696		NAT BIOTECHNOL	Nat. Biotechnol.	JUL	2014	32	7					677	+		10.1038/nbt.2916	http://dx.doi.org/10.1038/nbt.2916			9	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	AK8VE	24837660				2022-12-27	WOS:000338705900034
J	Yuan, Y; Van Allen, EM; Omberg, L; Wagle, N; Amin-Mansour, A; Sokolov, A; Byers, LA; Xu, YX; Hess, KR; Diao, LX; Han, L; Huang, XL; Lawrence, MS; Weinstein, JN; Stuart, JM; Mills, GB; Garraway, LA; Margolin, AA; Getz, G; Liang, H				Yuan, Yuan; Van Allen, Eliezer M.; Omberg, Larsson; Wagle, Nikhil; Amin-Mansour, Ali; Sokolov, Artem; Byers, Lauren A.; Xu, Yanxun; Hess, Kenneth R.; Diao, Lixia; Han, Leng; Huang, Xuelin; Lawrence, Michael S.; Weinstein, John N.; Stuart, Josh M.; Mills, Gordon B.; Garraway, Levi A.; Margolin, Adam A.; Getz, Gad; Liang, Han			Assessing the clinical utility of cancer genomic and proteomic data across tumor types	NATURE BIOTECHNOLOGY			English	Article							CELL LUNG-CANCER; SURVIVAL; EVEROLIMUS; BREAST; VALIDATION; RESISTANCE; SUPPRESSOR; EXPRESSION; BIOMARKERS; MUTATIONS	Molecular profiling of tumors promises to advance the clinical management of cancer, but the benefits of integrating molecular data with traditional clinical variables have not been systematically studied. Here we retrospectively predict patient survival using diverse molecular data (somatic copy-number alteration, DNA methylation and mRNA, microRNA and protein expression) from 953 samples of four cancer types from The Cancer Genome Atlas project. We find that incorporating molecular data with clinical variables yields statistically significantly improved predictions (FDR < 0.05) for three cancers but those quantitative gains were limited (2.2-23.9%). Additional analyses revealed little predictive power across tumor types except for one case. In clinically relevant genes, we identified 10,281 somatic alterations across 12 cancer types in 2,928 of 3,277 patients (89.4%), many of which would not be revealed in single-tumor analyses. Our study provides a starting point and resources, including an open-access model evaluation platform, for building reliable prognostic and therapeutic strategies that incorporate molecular data.	[Yuan, Yuan; Liang, Han] Baylor Coll Med, Grad Program Struct & Computat Biol & Mol Biophys, Houston, TX 77030 USA; [Yuan, Yuan; Diao, Lixia; Han, Leng; Weinstein, John N.; Liang, Han] Univ Texas MD Anderson Canc Ctr, Dept Bioinformat & Computat Biol, Houston, TX 77030 USA; [Van Allen, Eliezer M.; Wagle, Nikhil; Garraway, Levi A.] Dana Farber Canc Inst, Dept Med Oncol, Boston, MA 02115 USA; [Van Allen, Eliezer M.; Wagle, Nikhil; Amin-Mansour, Ali; Lawrence, Michael S.; Garraway, Levi A.; Getz, Gad] Broad Inst MIT & Harvard, Cambridge, MA USA; [Omberg, Larsson; Margolin, Adam A.] Sage Bionetworks, Seattle, WA USA; [Sokolov, Artem; Stuart, Josh M.] Univ Calif Santa Cruz, Dept Biomol Engn, Santa Cruz, CA 95064 USA; [Byers, Lauren A.] Univ Texas MD Anderson Canc Ctr, Dept Thorac Head & Neck Med Oncol, Houston, TX 77030 USA; [Xu, Yanxun] Univ Texas Austin, Div Stat & Sci Comp, Austin, TX 78712 USA; [Hess, Kenneth R.; Huang, Xuelin] Univ Texas MD Anderson Canc Ctr, Dept Biostat, Houston, TX 77030 USA; [Weinstein, John N.; Mills, Gordon B.] Univ Texas MD Anderson Canc Ctr, Dept Syst Biol, Houston, TX 77030 USA; [Garraway, Levi A.; Getz, Gad] Harvard Univ, Sch Med, Boston, MA USA; [Getz, Gad] Massachusetts Gen Hosp, Ctr Canc, Boston, MA 02114 USA; [Getz, Gad] Massachusetts Gen Hosp, Dept Pathol, Boston, MA 02114 USA	Baylor College of Medicine; University of Texas System; UTMD Anderson Cancer Center; Harvard University; Dana-Farber Cancer Institute; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; University of California System; University of California Santa Cruz; University of Texas System; UTMD Anderson Cancer Center; University of Texas System; University of Texas Austin; University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center; Harvard University; Harvard Medical School; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital	Liang, H (corresponding author), Baylor Coll Med, Grad Program Struct & Computat Biol & Mol Biophys, Houston, TX 77030 USA.	margolin@ohsu.edu; gadgetz@broadinstitute.org; hliang1@mdanderson.org	Hess, Kenneth/K-6546-2019; Han, Leng/HCH-3491-2022; Wagle, Nikhil/Q-7428-2019; Lawrence, Michael/AAC-8202-2020; Yuan, Yuan/H-4007-2013	Hess, Kenneth/0000-0003-1377-6070; Han, Leng/0000-0002-7380-2640; Yuan, Yuan/0000-0003-4706-7897; Stuart, Joshua/0000-0002-2171-565X; Omberg, Larsson/0000-0002-4719-9120; Weinstein, John/0000-0001-9401-6908	National Institutes of Health [CA143883, CA175486, CA016672]; UTMDACC - G.S. Hogan Gastrointestinal Research Fund; NCI-MDACC Uterine SPORE career development award; Lorraine Dell Program in Bioinformatics for Personalization of Cancer Medicine; Dana-Farber Leadership Council; Conquer Cancer Foundation; NATIONAL CANCER INSTITUTE [R01CA175486, P30CA016672, U24CA143883, P50CA100632, P50CA098258, T32CA009172] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); UTMDACC - G.S. Hogan Gastrointestinal Research Fund; NCI-MDACC Uterine SPORE career development award; Lorraine Dell Program in Bioinformatics for Personalization of Cancer Medicine; Dana-Farber Leadership Council; Conquer Cancer Foundation; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We gratefully acknowledge contributions from the TCGA Research Network and the TCGA Pan-Cancer Analysis Working Group (contributing consortium members are listed in the Supplementary Note). The TCGA Pan-Cancer Analysis Working Group is coordinated by J.M. Stuart, C. Sander and I. Shmulevich. This study was supported by the National Institutes of Health (CA143883 to G. B. M. and J.N.W., CA175486 to H. L., and CCSG grant CA016672); UTMDACC - G.S. Hogan Gastrointestinal Research Fund, NCI-MDACC Uterine SPORE career development award to H. L. and the Lorraine Dell Program in Bioinformatics for Personalization of Cancer Medicine to J.N.W.; Dana-Farber Leadership Council to E. M. V. A.; Conquer Cancer Foundation to E.M.V.A.	Antoon JW, 2012, SCI REP-UK, V2, DOI 10.1038/srep00539; Bell D, 2011, NATURE, V474, P609, DOI 10.1038/nature10166; Berchuck A, 2005, CLIN CANCER RES, V11, P3686, DOI 10.1158/1078-0432.CCR-04-2398; Bilal E, 2013, PLOS COMPUT BIOL, V9, DOI 10.1371/journal.pcbi.1003047; Brunet JP, 2004, P NATL ACAD SCI USA, V101, P4164, DOI 10.1073/pnas.0308531101; Chin L, 2008, NATURE, V455, P1061, DOI 10.1038/nature07385; Creighton CJ, 2013, NATURE, V499, P43, DOI 10.1038/nature12222; Douillard JY, 2006, LANCET ONCOL, V7, P719, DOI 10.1016/S1470-2045(06)70804-X; FALCONER JS, 1995, CANCER, V75, P2077, DOI 10.1002/1097-0142(19950415)75:8<2077::AID-CNCR2820750808>3.0.CO;2-9; Faragalla H, 2012, J MOL DIAGN, V14, P385, DOI 10.1016/j.jmoldx.2012.02.003; Garraway LA, 2013, J CLIN ONCOL, V31, P1806, DOI 10.1200/JCO.2012.46.8934; Getz G, 2013, NATURE, V497, P67, DOI 10.1038/nature12113; Hammerman PS, 2012, NATURE, V489, P519, DOI 10.1038/nature11404; Harrell FE, 1996, STAT MED, V15, P361, DOI 10.1002/(SICI)1097-0258(19960229)15:4<361::AID-SIM168>3.0.CO;2-4; Heng DYC, 2013, LANCET ONCOL, V14, P141, DOI 10.1016/S1470-2045(12)70559-4; Henry NL, 2006, ONCOLOGIST, V11, P541, DOI 10.1634/theoncologist.11-6-541; Holdhoff M, 2012, J NEURO-ONCOL, V110, P279, DOI 10.1007/s11060-012-0968-3; Ishwaran H, 2008, ANN APPL STAT, V2, P841, DOI 10.1214/08-AOAS169; Iyer G, 2012, SCIENCE, V338, P221, DOI 10.1126/science.1226344; Janne PA, 2013, LANCET ONCOL, V14, P38, DOI 10.1016/S1470-2045(12)70489-8; Johnson DR, 2012, J NEURO-ONCOL, V107, P359, DOI 10.1007/s11060-011-0749-4; Kallakury BVS, 2001, CLIN CANCER RES, V7, P3113; Khella HWZ, 2013, CARCINOGENESIS, V34, P2231, DOI 10.1093/carcin/bgt184; Kim KB, 2013, J CLIN ONCOL, V31, P482, DOI 10.1200/JCO.2012.43.5966; Krueger DA, 2010, NEW ENGL J MED, V363, P1801, DOI 10.1056/NEJMoa1001671; Liang SL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018409; Liu YC, 2012, BIOCHEM BIOPH RES CO, V417, P371, DOI 10.1016/j.bbrc.2011.11.119; MacConaill LE, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007887; Margolin AA, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3006112; McShane LM, 2012, J CLIN ONCOL, V30, P4223, DOI 10.1200/JCO.2012.42.6858; McShane LM, 2005, JNCI-J NATL CANCER I, V97, P1023, DOI 10.1093/jnci/dji193; Mermel CH, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-4-r41; Muzny DM, 2012, NATURE, V487, P330, DOI 10.1038/nature11252; Ni Y, 2013, GENE, V517, P197, DOI 10.1016/j.gene.2012.12.031; Noguchi S, 2011, CANCER LETT, V307, P211, DOI 10.1016/j.canlet.2011.04.005; Ohashi K, 2013, CLIN CANCER RES, V19, P2584, DOI 10.1158/1078-0432.CCR-12-3173; Sakurai T, 2012, BIOCHEM BIOPH RES CO, V422, P607, DOI 10.1016/j.bbrc.2012.05.035; Shi LM, 2010, NAT BIOTECHNOL, V28, P827, DOI 10.1038/nbt.1665; Shih KK, 2011, GYNECOL ONCOL, V121, P444, DOI 10.1016/j.ygyno.2011.01.025; Sturgeon CM, 2008, CLIN CHEM, V54, pE11, DOI 10.1373/clinchem.2008.105601; Tibshirani R, 1996, J ROY STAT SOC B MET, V58, P267, DOI 10.1111/j.2517-6161.1996.tb02080.x; Van Allen EM, 2014, NAT MED, V20, P682, DOI 10.1038/nm.3559; Van Allen EM, 2014, CANCER DISCOV, V4, P94, DOI 10.1158/2159-8290.CD-13-0617; Van Allen EM, 2013, J CLIN ONCOL, V31, P1825, DOI 10.1200/JCO.2013.48.7215; Wagle N, 2014, CANCER DISCOV, V4, P546, DOI 10.1158/2159-8290.CD-13-0353; Wagle N, 2014, CANCER DISCOV, V4, P61, DOI 10.1158/2159-8290.CD-13-0631; Wagle N, 2012, CANCER DISCOV, V2, P82, DOI 10.1158/2159-8290.CD-11-0184; Weigel MT, 2010, ENDOCR-RELAT CANCER, V17, pR245, DOI 10.1677/ERC-10-0136; Yuan Y, 2012, BIOINFORMATICS, V28, P1246, DOI 10.1093/bioinformatics/bts120; Zaman MS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031060	50	188	192	0	43	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156	1546-1696		NAT BIOTECHNOL	Nat. Biotechnol.	JUL	2014	32	7					644	+		10.1038/nbt.2940	http://dx.doi.org/10.1038/nbt.2940			11	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	AK8VE	24952901	Green Accepted, Bronze, Green Submitted			2022-12-27	WOS:000338705900029
